SAMPLE_ID	SAMPLE_NAME	PUBCHEM_SID	PRIMARY_MOA	ASSAY_NAME	LIBRARY	CAS	ALIAS	AC50	LOG_AC50	AUC	CURVE_CLASS2	DATA_POINTS	DRUG_NAME	EFFICACY	MAX_RESPONSE	P_HILL	R2	GENE_ID	GENE_SYMBOL	SMILES	SUPPLIER	SUPPLIER_ID	DATA0	DATA1	DATA2	DATA3	DATA4	DATA5	DATA6	DATA7	DATA8	DATA9	DATA10	DATA11	DATA12	DATA13	DATA14	CONC0	CONC1	CONC2	CONC3	CONC4	CONC5	CONC6	CONC7	CONC8	CONC9	CONC10	CONC11	CONC12	CONC13	CONC14
NCGC00370823-03	Pitolisant (hydrochloride)		Histamine H3 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	903576-44-3				-2.6457042602	4	4		0	0.54418243					ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1	MedChem Express	HY-12199B	1.16736739	-2.62112116	-3.20884699	0.54418243												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00016914-06	CEFOTETAN		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	6971256-7				-9.7041917203	4	4		0	-1.55480694					CO[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O	Microsource	01502424	-2.23186332	-2.07998647	-1.55003626	-1.55480694												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00017343-11	RETINOL		Retinol dehydrogenase 12 Substrate	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	68-26-8				-32.2051833351	4	4		0	-3.73153667			145226	RDH12	CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(\C)CCCC1(C)C	Microsource	01501203	-8.62778424	-6.73036273	-2.37490935	-3.73153667												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179658-04	Acenocoumarol	170465636	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	152-72-7				-37.1006394833	4	4		0	-5.77869914					[O-][N+](=O)c1ccc(cc1)C(CC(C)=O)C2=C(O)c3ccccc3OC2=O	Prestwick	Prestw-110	-9.53126398	-8.51441617	-2.61965192	-5.77869914												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00018125-05	Tripelennamine citrate	170465118	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	6138-56-3				-28.2696357764	4	5		0	-6.1695736					O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCN(Cc1ccccc1)c2ccccn2	Microsource	01500597	-7.7751399	-9.41935484	-2.75646114	-1.04119715	-6.1695736											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166236-02	Oteracil potassium		Orotate Phosphoribosyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2207-75-2		0.0127696788	-7.893820026	2.1527505274	4	5		9.8534000279	-3.3358741	0.1474249644	0.986538186		UMPS	OC1=NC(=NC(O)=N1)C([O-])=O	Bosche	O3085	-6.96116669	-5.6	-5.59671871	3.60137023	-3.3358741											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00015339-07	Dequalinium dichloride	225144172	Protein kinase C beta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	522-51-0				-20.9499416632	4	5		0	-7.65816258					CC1=CC(=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)N	Prestwick	Prestw-388	-5.77412244	-2.3827957	-3.45329452	1.25754981	-7.65816258											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00016760-08	Carbimazole	170465583		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	22232-54-8				-11.2132016683	4	5		0	-3.8470161					S=C1N(C=CN1C)C(=O)OCC	Microsource	01505323	-3.03544175	-5.16129032	-2.35071006	3.63742901	-3.8470161											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160620-02	L-Methionine	225144244	S-adenosylmethionine synthetase (MAT 1 and MAT 2) Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63-68-3				-23.1088279868	4	5		0	-4.07120118					CSCC[C@H](N)C(O)=O	SIGMA	64320	-6.10479905	-6.02150538	-3.74437682	-3.61939962	-4.07120118											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00263655-01	Huperzine A	170466837	Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	102518-79-6				-29.9075403784	4	5		0	-4.54647357				ACHE	CC2=C[C@H]\3CC=1NC(=O)C=CC=1[C@@](N)(C2)C/3=C\C	Enzo	C117	-8.91131084	-8.90322581	-3.8590456	-1.51897593	-4.54647357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095836-05	Guaiazulene	170465862	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	489-84-9				-20.1162024037	4	5		0	-4.46576694					CC(C)c1ccc(C)c2ccc(C)c2c1	Microsource	01502249	-6.0708835	-6.64946237	-3.16221223	1.91562246	-4.46576694											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188962-02	Pravastatin sodium	174007284	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	81131-70-6	Pravastatin	0.2818382931	-6.55	-20.4071708924	4	5		14.947939636	-6.96767251	0.2812638791	0.9486765562	3156	HMGCR	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12	Prestwick	Prestw-1319	-9.12328303	-4.84301075	-3.23277763	1.49193185	-6.96767251											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023373-03	Clobetasol propionate	170465385	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	25122-46-7	Clobetasol propionate	1.2589254118	-5.9	-13.3379362109	4	5		11.43623876	-3.38071111	0.036814308	0.9991761411		NR3C1	ClCC(=O)[C@@]4(OC(=O)CC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-781	-6.6135323	-5.94408602	-2.65061304	3.41206166	-3.38071111											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015748-17	Nifedipine	170465006	Voltage-gated L-type calcium channel alpha-1C subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	21829-25-4		14.1253754462	-4.85	-40.6810027458	4	5		-28.26765458	-28.13971215	0.1904470414	0.8887904096			CC=1NC(C)=C(C(C=1C(=O)OC)c2ccccc2[N+]([O-])=O)C(=O)OC	Specs	AN-153/I100964	-7.90232322	-5.69462366	-3.8237629	2.37537186	-28.13971215											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023509-13	Lovastatin	170464913	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	75330-75-5	; ; Lovastatin (Mevinolin); Monacolin K; Mevacor;LOVASTATIN; Mevinolin (lovastatin); 6-Methylcompactin; 6 Methylcompacti; Lovastatin;Lovastatin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin	7.9432823472	-5.1	-61.0025137383	-2.4	5		-48.60290096	-47.805228	0.0606967417	0.9682176719	3156	HMGCR	C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801953	-7.35119552	-6.24516129	1.31869101	-11.72360948	-47.805228											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164588-02	Malotilate	170465879	Liver Protein Metabolism	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	59937-28-9	 Kantec; Malotilate; Malotilato;Malotilate; 			-19.9555392121	4	5		0	-7.2097924				MMP1	CC(C)OC(=O)C(/C(=O)OC(C)C)=C1/SC=CS1	Sequoia	SRP01140m	-5.24843141	-6.95913978	-2.04198642	2.08690165	-7.2097924											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090903-11	Sulfasalazine	170464716	NFKB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	599-79-1	; Sulfasalazine; Azulfidine;Sulfasalazine; Sulfasalazina;Azulfidine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulphasalazine, N-; Sulfasalazine DR; Salazosulfapiridina; Salazopyrine			-23.3011423794	4	5		0	-6.33098686			4790	NFKB1	O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3	Microsource	01500552	-8.06342208	-5.52258065	-1.22166358	1.57306409	-6.33098686											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090820-03	4-Acetamidobenzoic acid	170466207	immune response Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	556-08-1				-12.6459250248	4	5		0	-4.38506031					O=C(C)Nc1ccc(cc1)C(=O)O	Specs	AE-562/J256200	-2.53518738	-2.51182796	-3.70027344	-0.46425674	-4.38506031											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016026-10	Terazosin hydrochloride	170465073	Alpha1-adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63074-08-8	; ; Terazosin hydrochloride;TERAZOSIN HYDROCHLORIDE; Hytrin; Terazosina;Terazosin hydrochloride			-13.929868076	4	5		0	-6.84212886			148	ADRA1A	Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1	Vitas	STK567029	-5.29082584	0.0516129	1.04525007	0.32903633	-6.84212886											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093351-06	Cefoxitin	170465105	Penicillin-binding protein 2B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	35607-66-0				-15.0785330619	4	5		0	-4.54647357			933948	penA	O=C(O)C=2N3C(=O)[C@](NC(=O)Cc1cccs1)(OC)[C@H]3SCC=2COC(N)=O	Microsource	01502031	-4.79905036	-2.90752688	-2.1919379	1.1223294	-4.54647357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182711-02	Picosulfate sodium	225144334		DPI_SARS-CoV-2_General	2019_NPC-4_Tox					-2.1290276088	4	5		0	-1.25543649					[O-][S](=O)(=O)OC1=CC=C(C=C1)C(C2=CC=C(O[S]([O-])(=O)=O)C=C2)C3=CC=CC=N3	APAC	877841	-0.43242327	-0.43010753	-1.23930493	1.1133147	-1.25543649											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00246113-02	NCGC00246113-02			DPI_SARS-CoV-2_General	2019_NPC-9_Tox			14.1253754462	-4.85	-7.1608845839	4	4		-10.951992952	-8.29332746	0.425912312	0.8699643335			C(CC1=CC=CC=C1)NCC2=CC=CC=C2	Specs	AN-465/J120002	-1.57706718	2.48149394	1.90347591	-8.29332746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163886-05	Fenchlorphos	170466415	Cholinesterases; ACHE & BCHE Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	299-84-3				-12.9707540763	4	5		0	-0.43012721					Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Cl	Microsource	01505668	-2.20517317	-5.3225253	-0.20552344	-6.71779141	-0.43012721											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016781-08	Ambroxol hydrochloride	225144182	surfactant homeostasis Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	23828-92-4				-35.907375216	4	5		0	-6.47936305					NC1=C(CNC2CCC(O)CC2)C=C(Br)C=C1Br	Prestwick	Prestw-366	-9.00920649	-6.00874936	-8.8460715	-5.68361087	-6.47936305											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166262-03	Ensulizole	170465490		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	27503-81-7		14.1253754462	-4.85	-38.4535226943	4	5		-15.6520507799	-16.97629725	0.1366774143	0.9245113949			O=S(=O)(O)c1cc2nc(nc2cc1)c3ccccc3	Vitas	STK034479	-7.08022797	-3.9329216	-7.44166131	-6.70026293	-16.97629725											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348371-01	Chloramphenicol palmitate		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	530-43-8				-28.1723756581	4	5		0	-4.27381715					CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	FLUKA	46109	-8.51819377	-4.45616744	-5.01819739	-3.65907099	-4.27381715											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159476-09	Tribromsalan	170465542		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	87-10-5		4.4668359215	-5.35	-128.9078912162	-2.1	5		-89.4185354547	-94.67374394	0.0061509149	0.9969108086			Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2	SIGMA	R416568	-8.67601929	-9.28546921	-5.54056947	-45.34180543	-94.67374394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093936-08	D-Glutamine	170465304	Protein-glutamine gamma-glutamyltransferase Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5959-95-5				-23.3099495136	4	5		0	-2.86446417			1503		O=C(N)CC[C@@H](N)C(=O)O	Microsource	01300018	-4.42349847	-6.18030537	-4.95825305	-7.41016652	-2.86446417											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016522-10	Bisacodyl	170464843		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	603-50-9		1	-6	-124.3222372933	-1.2	5		-67.6532890069	-64.24453189	0.0367759658	0.981092834			CC(=O)Oc1ccc(cc1)C(c2ccc(OC(C)=O)cc2)c3ccccn3	Labotest	LT00134695	-0.49539676	-4.97083548	-27.18903875	-75.69237511	-64.24453189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015854-10	Propantheline bromide	170464881	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50-34-0				-11.7627104314	4	5		0	-2.12318111					[Br-].CC(C)[N+](C)(CCOC(=O)C1c3ccccc3Oc2ccccc12)C(C)C	Microsource	01500511	-1.74923279	0.16726711	-7.06486834	-3.01928133	-2.12318111											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168085-05	Vorinostat (SAHA)	170465180	HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	149647-78-9	 ;MK-0683;SAHA; SAHA cpd; Vorinostat;Vorinostat; M344 compound;Zolinza	3.5481338923	-5.45	-169.2514745704	-2.1	5		-101.8477311549	-99.78036057	0.0002848123	0.9998575877	3065	HDAC1	O=C(Nc1ccccc1)CCCCCCC(=O)NO	Prestwick Chemical, Inc.	Prestw-1362	-11.42042964	-13.67730314	-26.22992935	-65.23663453	-99.78036057											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183881-09	Moxifloxacin hydrochloride		DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	186826-86-8				-22.8858916939	4	4		0	-8.1136433				TOP2B	COC1=C(N2C[C@@H]3CCCN[C@@H]3C2)C(=CC4=C1N(\C=C(\C(O)=O)C4=O)C5CC5)F	MedChem Express	HY-66011	-4.77199965	-4.44750312	-2.18475526	-8.1136433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274078-01	Fludrocortisone	170464959		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	127-31-1				-15.3403550711	4	4		0	-1.01965227					OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@]1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	F6127	-4.80661071	-2.72699901	-0.56936046	-1.01965227												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167510-02	Doripenem	170465085	Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	148016-81-3				-8.0011227861	4	4		0	-4.13961393				DPEP1	O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@@H](CNS(N)(=O)=O)NC1)[C@H](C)[C@@H]23)C(=O)O	Sequoia	148016-81-3	-0.51483949	-3.13131748	-2.00820938	-4.13961393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522012-01	CEFTOBIPROLE MEDOCARIL SODIUM			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	252188-71-9				-26.895859304	4	4		0	-1.21138176					C\C1=C(COC(=O)N2CC[C@H](C2)N3CC\C(=C/C4=C(/N5[C@H](SC4)[C@H](NC(=O)\C(N=O)=C/6NS/C(=N6)N)C5=O)C(O)=O)C3=O)\OC(=O)O1	CheMall	HE073132	-7.75720343	-5.95294421	-2.89093878	-1.21138176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507698-01	Talaporfin sodium			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	220201-34-3				-9.5235492869	4	4		0	-5.18541113					CCC1=C2[NH]C(=C1C)C=C3[NH]C(=CC4=NC(=C(CC(=O)N[C@@H](CC(O)=O)C(O)=O)C\5=NC(=C2)\C(=C5C(O)=O)C)[C@@H](CCC(O)=O)[C@@H]4C)C(=C3C=C)C	MedChem Express	HY-16477	-0.49753396	-2.71839649	-3.54415854	-5.18541113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346560-06	Telbivudine		DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	3424-98-4				-30.8822113196	4	4		0	-4.76709225				P	CC/1=C/N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	Enzo	AC3257	-8.38020247	-5.7808938	-2.68791102	-4.76709225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166299-03	BISMUTH SUBSALICYLATE	225144280		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	14882-18-9				-10.3670552409	4	4		0	-2.3181838					O[Bi]1OC(=O)C2=CC=CC=C2O1	Microsource	01505412	-3.53465432	-2.25386038	-0.6664607	-2.3181838												1.6E-9	8E-9	4E-8	2E-7											
NCGC00480770-01	MK-3102		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1226781-44-7				-16.9980693778	4	4		0	-6.90226154					C[S+]([O-])(=O)[N]1C=C2CN(CC2=N1)[C@H]3CO[C@@H]([C@@H](N)C3)C4=C(F)C=CC(=C4)F	Adooq	A13310	-3.33564074	-2.09901501	-2.65260184	-6.90226154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183846-01	Toborinone	144206841	Phosphodiesterase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	143343-83-3				-32.5347464325	4	4	toborinone;OPC 18790;6-(3-(3,4-DIMETHOXYBENZYLAMINO)-2-HYDROXYPROPOXY)-2(1H)-QUINOLINONE,DL-;torborinone;CIPLUS_208056;Toborinone;LS-141868;OPC-18790;TOBORINONE;2(1H)-Quinolinone, 6-(3-(((3,4-dimethoxyphenyl)methyl)amino)-2-hydroxypropoxy)-, (+-)-;6-(3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy)-2(1H)-quinolinone;toborinonum;taborinone;CIPLUS_197035;CIPLUS_698797;	0	-7.91319883					COc1ccc(cc1OC)CNCC(O)COc2ccc3NC(=O)C=Cc3c2	Pharmaron	PH-NIH-152870	-7.87834213	-5.29915265	-4.00317783	-7.91319883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371144-02	AWD 131-138			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	188116-07-6				-26.8184146134	4	4		0	-6.79768182					ClC1=CC=C(C=C1)N2CC(=N/C2=O)\N3CCOCC3	MedChem Express	HY-14953	-5.74110928	-6.58092821	-3.54415854	-6.79768182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163160-04	Talipexole	170466015	Dopamine D4 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	101626-70-4		1.4125375446	-5.85	1.0929166703	4	5		16.920205976	-3.28576018	0.1144077509	0.991878154			C=CCN1CCc2sc(N)nc2CC1	Tocris	2759	-4.38843849	-6.18350498	-4.20730942	11.40403252	-3.28576018											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179504-05	Etoposide	225144306	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	33419-42-0	Etoposide, (5S)-Isomer; ;Etoposide (VP-16); EI24 protein, human;Etoposide; Etoposide; Etoposide Phosphate; Etoposido; Lastet	14.1253754462	-4.85	-21.6108633922	4	5		-12.536172564	-13.21646551	0.1735805856	0.9010498511	7153	TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC	Prestwick	Prestw-396	-2.90800141	-5.46003915	-1.51965504	-2.08974418	-13.21646551											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182552-02	Atazanavir	170465290	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	198904-31-3	 ;ATAZANAVIR SULFATE; Atazanavir;Atazanavir sulfate; Reyataz			6.4329518417	4	5		0	2.22110045					CC(C)(C)[C@H](NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc2ccc(cc2)c3ccccn3	Sequoia	229975-97-7	3.50722594	-0.61707379	-1.74571943	-0.11482111	2.22110045											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022848-17	Hydrocortisone	170464635	immunosuppressant	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	50-23-7	 Hydrodexan; Proctosedyl ointment; Hydrocortisone Valerate; Hydrocortisone Buteprate; Acticort; Hydrocortisone Probutate; 11 Epicortiso;Calmurid-HC; ; Hidrocortisona; Reichstein's substance M; Hydrocortisone Caproate; Cortril; Hydrocortisone solution; Daktacort; Hydrocortisone Tebutate; 17-Hydroxycorticosterone; Hydrocortisone base; Hydrocortisone; Epicortisol; Kendall's compound F; Alphaderm; Hydrocortisone Base; Proctosedyl suppository; Canesten HC; oxycort A;Hydrocortisone; 11-Epicortisol; Cortifair			-14.1305646061	4	4		0	-3.92537718			5743	PTGS2	OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Prestwick Chemical, Inc.	Prestw-447	-3.74030252	-3.63159704	1.2775842	-3.92537718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163329-03	Clopidogrel bisulfate	170465231	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	135046-48-9	; Clopidogrel hydrochloride;Plavix; Isocover;CLOPIDOGREL SULFATE; Iscover; 4   Clopidogrel;Clopidogrel hydrogen sulfate			-0.0438414512	4	4		0	-2.90450809			64805	P2RY12	O=S(=O)(O)O.Clc1ccccc1[C@H](N2CCc3sccc3C2)C(=O)OC	Vitas	STK580572	0.9578295	-1.23345367	0.77727151	-2.90450809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522464-01	Lusutrombopag		Thrombopoietin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1110766-97-6		12.5892541179	-4.9	-83.4689501059	-3	4		-106.3765380758	-98.70358659	0.0485710997	0.9985421353			CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C2=CSC(=N2)NC(=O)C3=CC(=C(/C=C(C)/C(O)=O)C(=C3)Cl)Cl	MedChem Express	HY-19883	-2.77813895	-3.84648444	0.12507817	-98.70358659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095045-05	Sulfanitran	170466141	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	122-16-7		1	-6	-13.4349156668	4	5		17.088773512	-4.49726951	0.208860132	0.9722238347			O=S(=O)(Nc1ccc(cc1)[N+]([O-])=O)c2ccc(NC(C)=O)cc2	Microsource	01503339	-7.56080367	-10.90731126	-4.68455645	7.94102788	-4.49726951											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00386387-01	Buclizine HCl		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	129-74-8				-27.7536717761	4	4		0	-8.58846565					CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)C=C1	Selleck	S4140	-6.02638196	-4.89806496	-3.60793486	-8.58846565												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522025-01	Mepitiostane (Contains ~15% 3a,4a-Epithio isomer)		Estrogen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	21362-69-6				-25.1046127821	4	4		0	-10.44809829					COC1(CCCC1)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]5C[C@@H]6S[C@@H]6C[C@]5(C)[C@H]4CC[C@]23C	Toronto Research	M224920	-3.9743423	-6.14148186	-4.08290896	-10.44809829												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378682-03	Pasireotide (ditrifluoroacetate)		Somatostatin receptor 5 Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-17.3285502781	4	4		0	-2.53410426					NCCCC[C@@H]1NC(=O)[C@@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@H](CN4C(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC6=CC=C(OCC7=CC=CC=C7)C=C6)NC1=O)OC(=O)NCCN)C8=CC=CC=C8	MedChem Express	HY-79135	-5.50860313	-4.7833935	1.54560886	-2.53410426												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181009-02	Timepidium bromide	170465823	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	35035-05-3				-26.200873709	4	4		0	-7.0754717					[Br-].COC1C\C(C[N+](C)(C)C1)=C(/c2sccc2)c3cccs3	Bosche	T3573	-6.20284996	-2.12508639	-5.13253638	-7.0754717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538142-01	NCGC00538142-01		vasoconstriction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			7.0794578438	-5.15	-28.8597473987	4	4		-11.5947347401	-13.88394446	0.2020464526	0.9743114942			CCCCCCC(COC(=O)C1=CN=CC=C1)(COC(=O)C2=CN=CC=C2)COC(=O)C3=CN=CC=C3	Pharmaron	PH-NIH-2017-009-L1-20-0	-4.68522522	-2.97166551	-6.3539501	-13.88394446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261973-01	Butoctamide semisuccinate	170466034		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	32838-28-1	Butoctamide hydrogen succinate, monosodium salt;Butoctamide			-2.8382325718	4	4		0	-2.57927545					CC(CC(=O)NCC(CC)CCCC)OC(=O)CCC(=O)O	GVK	FFS-11-286-NCI-226	0.96649764	-1.69761045	-3.1358885	-2.57927545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181083-01	Piperilate hydrochloride	144206255		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	4544-15-4	PIPERILATE; Glymor; Pipetanato; 			-20.2174144177	4	4	Glymor;CIPLUS_163480;DPX-8;Benzilic acid, 2-piperidinoethyl ester, hydrochloride;2-(1-piperidino)ethyl benzilate;Pipethanate Hydrochloride;Benzilic acid, 2-piperidinoethyl ester;2-PIPERIDIN-1-YLETHYL HYDROXY(DIPHENYL)ACETATE;pipethanate;CIPLUS_163479;.ALPHA.-HYDROXY-.ALPHA.-PHENYL-, 2-(1-PIPERIDINYL)ETHYL ESTER;Pipethanatum;Pipethanate hydrochloride;pipethanate hydrochloride;LS-32519;LS-32518;Pipetanato;PIPETHANATE HYDROCHLORIDE;Piperilate;pipethanatum;N-piperidinoethyl benzilate;beta-Piperidylethyl benzilate;PIPETHANATE;PIPERILATE;piperilate;alpha-hydroxy-alpha-phenylbenzeneacetic acid, 2-(1-piperidinyl)ethyl ester;	0	-3.31104888					Cl.OC(c1ccccc1)(c2ccccc2)C(=O)OCCN3CCCCC3	NCI	NSC-30793	-4.97984657	-5.81485302	-1.37585991	-3.31104888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481544-01	Cetrorelix		Gonadotropin-releasing hormone receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-11.1354388293	4	4		0	1.5752937					CC(C)C[C@H](\N=C(/O)[C@@H](CCCNC(O)=N)\N=C(/O)[C@H](CC1=CC=C(O)C=C1)\N=C(/O)[C@H](CO)\N=C(/O)[C@@H](CC2=CN=CC=C2)\N=C(/O)[C@@H](CC3=CC=C(Cl)C=C3)\N=C(/O)[C@@H](CC4=CC5=CC=CC=C5C=C4)\N=C(\C)O)/C(O)=N/[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6\C(O)=N\[C@H](C)C(O)=N	APExBIO	B4975	-3.97935324	-3.30856945	-2.16129591	1.5752937												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181294-01	Thiamine disulfide	144206326	HIV Infection Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	67-16-3	thiaminedisulfide monoorotate; Thiamine Disulfide(TDS); Allynate F; Thiamine Phosphate; 			-14.7106836003	4	4	CIPLUS_3852341;thiaminedisulfide monoorotate;Thiamine Disulfide(TDS);Allynate F;CIPLUS_3887567;thiamine disulfide;Thiamine Disulfide Phosphate;Thiamine disulfide;THIAMINE DISULFIDE;thiooratin;N,N'-(dithiobis(2-(2-hydroxyethyl)-1-methylvinylene))bis(N-((4-amino-2-methyl-5-pyrimidinyl)-methyl)formamide);thiamine disulphide;Thiamine Phosphate;CIPLUS_789114;Thiamine Disulfide;CIPLUS_206877;CIPLUS_781198;	0	-3.14168743					Nc2nc(C)ncc2CN(C=O)C(C)=C(CCO)SSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N	ACC	thiamine disulfide	-4.26170203	-0.31098825	-1.80613306	-3.14168743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090905-12	Busulfan	170465232	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	55-98-1	Busulfan; 4   Busulfan; Busulfex;; ; Busulfan;BUSULFAN; Myleran; Busulfano			-20.2166093391	4	4		0	-3.52787063				H2AFX	O=S(C)(=O)OCCCCOS(C)(=O)=O	Microsource	01500152	-4.96251029	-5.35929173	-1.66175288	-3.52787063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181296-02	Seratrodast	170465940	Prostanoid TP Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	112665-43-7	 Bronica; (+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid;Seratrodast;AA 2414; 			-35.1776172815	4	4		0	-9.46956212			6915	TBXA2R	O=C2C(C)=C(C)C(=O)C(C)=C2C(CCCCCC(=O)O)c1ccccc1	Tocris	3025	-7.84400229	-5.58914997	-5.95547471	-9.46956212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178526-03	APRAMYCIN SULFATE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	65710-07-8				-19.6082395812	4	4		0	-5.28657885					CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]4O[C@H](CO)[C@@H](N)[C@H](O)[C@H]4O	Microsource	01505249	-4.55287422	-2.5138217	-3.252772	-5.28657885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091493-09	Anethole	170465678	TNF signaling pathway Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	104-46-1				-12.0828817459	4	5		0	-1.62452389			4313		COc1ccc(C=CC)cc1	Microsource	01503705	-3.89495946	-4.72806196	-1.042408	0.55573417	-1.62452389											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00389841-01	LINACLOTIDE (1 mg/ml)		Heat-stable enterotoxin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	851199-59-2				-9.066118202	4	4		0	-5.53577786					C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC4=CC=C(O)C=C4)C(O)=O)NC(=O)[C@H](CC5=CC=C(O)C=C5)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C)C(=O)N2	Microsource	01504425	0.84704637	-1.91776088	-5.47903673	-5.53577786												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00166055-04	SODIUM NITROPRUSSIDE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	13755-38-9				-25.9429425705	4	4		0	-8.87326451					[O]=[N][Fe--]([C]#[N])([C]#[N])([C]#[N])([C]#[N])[C]#[N]	Microsource	01300037	-4.78228261	-6.51347616	-3.64258489	-8.87326451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023673-10	Adenosine		Adenosine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	[58-61-7]				-5.2795034406	4	4		0	-0.79209683				ADORA1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Tocris	3624	-0.97057396	-2.08189357	-1.07848233	-0.79209683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253586-01	Isalon	170465491		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	5579-81-7		2.5118864315	-5.6	-14.0622249085	4	5		10.136096692	-8.719196	0.3091394494	0.9369512708			O=C(N)NC1N=C(O[Al](O)O)NC1=O	GVK	FFS-11-286-NCI-89	-4.72329926	-7.61341391	-6.00745175	2.91645616	-8.719196											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249928-01	Eicosapentaenoic acid ethyl ester	170466007		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	73310-10-8				-10.215072294	4	5		0	0.53232986					O=C(/C=C\C=C/C=C\C=C/C=C\CCCCCCCCC)OCC	GVK	FFS-11-286-NCI-230	-2.86394078	-5.06851647	-3.31979738	0.80374776	0.53232986											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016367-08	Succinylsulfathiazole	170465721		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	116-43-8		1.2589254118	-5.9	1.032865519	4	5		9.9828921639	-0.96370061	0.5680689891	0.7295088183			O=S(=O)(Nc1nccs1)c2ccc(NC(=O)CCC(=O)O)cc2	Vitas	STK079059	-0.28198802	-7.48574347	-2.76719555	6.03040463	-0.96370061											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160514-02	Idebenone	170465611	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	58186-27-9	 ;Idebenone;IDEBENONE; Idebenone	2.2387211386	-5.65	-13.3945915957	4	5		10.605455784	-3.34082878	0.2532297806	0.958758091			COC1=C(OC)C(=O)C(C)=C(CCCCCCCCCCO)C1=O	Vitas	STK801942	-5.06697215	-7.58787982	-5.99070624	3.79828228	-3.34082878											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166072-02	D-Galactitol	170465564	osmotic diuretic agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	608-66-2				-21.2132671179	4	4		0	-6.51477394				AVPR2	O[C@H]([C@@H](O)CO)[C@@H](O)[C@H](O)CO	SIGMA	D0256	-4.58816782	-3.80960608	-2.81098406	-6.51477394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094762-08	Piperazine			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	110-85-0				-24.8086453615	4	4		0	-4.66358135					C1CNCCN1	Microsource	01500490	-5.70873958	-4.56116102	-4.63877339	-4.66358135												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178145-03	Thonzylamine hydrochloride	170465519		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	63-56-9				-1.4285870316	4	4		0	-3.97828409					Cl.COc1ccc(cc1)CN(CCN(C)C)c2ncccn2	Microsource	01503135	1.47350774	-0.63061507	-2.54244629	-3.97828409												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253573-01	Tepoxalin	170466265	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	103475-41-8		12.5892541179	-4.9	-92.7045426558	-3	5		-86.0299053564	-85.6225047	0.0077310696	0.9961126962			CN(O)C(=O)CCc2cc(c1ccc(Cl)cc1)n(n2)c3ccc(OC)cc3	GVK	FFS-11-286-NCI-124	-7.07613676	-4.97489148	-10.81341315	-6.50806044	-85.6225047											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00483012-01	Phytic acid		lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	83-86-3				-24.1693520446	4	4		0	-6.48807405					O[P](O)(=O)OC1C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C1O[P](O)(O)=O	DC Chemicals	DCZ-023	-5.73520978	-4.57843815	-2.10932086	-6.48807405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178032-03	CITICOLINE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	987-78-0				-18.1642085888	4	4		0	-3.24848701					C[N+](C)(C)CCO[P]([O-])(=O)O[P](O)(=O)OC[C@H]1OC([C@H](O)[C@@H]1O)N2\C=C/C(=N\C2=O)N	Microsource	01505244	-6.16755636	-4.63890809	-3.69455994	-3.24848701												1.6E-9	8E-9	4E-8	2E-7											
NCGC00093985-11	Metolazone	170464665	Carbonic Anhydrase Type VII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	17560-51-9	; Metolazona; Microx;Metolazone; Metolazone; ; Diulo; Zaroxolyn;METOLAZONE; METOLAZONE	1	-6	-28.2015644996	4	5		10.200187252	-4.91028406	0.1389342033	0.9880791135	766	CA7	NS(=O)(=O)c1cc2C(=O)N(C(C)Nc2cc1Cl)c3ccccc3C	Microsource	02300325	-8.94430737	-10.16682271	-7.17963746	0.35364901	-4.91028406											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164569-02	Capecitabine	170464779	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	154361-50-9	Capecitabine;Capecitabine (Xeloda); Xeloda; Capecitabine; 	1.4125375446	-5.85	-4.115182853	4	5		11.0014469319	-3.69877472	0.217190606	0.9700700563		TYMS	O=C(OCCCCC)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Sequoia	SRP01237c	-3.60415932	-5.83453911	-3.38677942	6.23248978	-3.69877472											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016347-07	Benzthiazide	170465246	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	91-33-8				-28.8495869463	4	5		0	-5.48850443					NS(=O)(=O)c3cc1c(N=C(NS1(=O)=O)CSCc2ccccc2)cc3Cl	Microsource	01500141	-7.95734931	-7.78364116	-6.5767991	0.06889267	-5.48850443											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00345882-03	Silodosin		alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	160970-54-7				-19.9773548583	4	4		0	-6.24777501				ADRA1A	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC3=CC=CC=C3OCC(F)(F)F	Prestwick	Prestw-1749	-3.86464905	-3.87007602	-3.91112266	-6.24777501												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179239-05	Clocortolone pivalate			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	34097-16-0				-5.5435826155	4	4		0	-3.90708437					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	Prestwick	Prestw-1119	-0.89116337	-0.25915688	-0.23821899	-3.90708437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022653-09	Cefazolin	170465254	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	25953-19-9				-8.5988790998	4	5		0	-0.39465835					O=C(O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nnc(C)s2	Microsource	01500164	-1.82410998	-2.6002213	-5.17017625	0.73026225	-0.39465835											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090757-06	Melphalan	170464727	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	148-82-3	; Mustard, Phenylalanin; Melfalano;Melphalan; ; Sarcolisina; L-Phenylalanine mustard;MELPHALAN; Melphalan	14.1253754462	-4.85	-23.1289827022	4	5		-10.907817092	-12.57399844	0.1527551905	0.9146684396		H2AFX	O=C(O)[C@@H](N)Cc1ccc(cc1)N(CCCl)CCCl	Microsource	01500382	-4.43249912	-4.23440293	-2.24808473	-1.40081753	-12.57399844											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159497-02	Allylestrenol	144205271	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	432-60-0	Allylestrenol; Allyloestrenol; Turinal; Gestanon; Alilestrenol; Gestanin; Perselin; 	31.6227766017	-4.5	-40.9889071027	-3	4	Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-;Organon Brand of Allylestrenol;allylestrenolum;CIPLUS_153117;allylestrenol;Perselin;Allylestrenolum;Turinal;Gestanon;LS-64837;Alilestrenol;Gestanin;Allylestrenol Organon Bran;ALLYLESTRENOL;Allyloestrenol;Allylestrenol;ALLYL ESTRENOL;	-50.4512888252	-42.66419731	0.1459198543	0.9866433511			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC=C	SigmaAldrich	R187755	-5.70797035	-6.52827918	-1.55454302	-42.66419731												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00164543-02	Lomerizine dihydrochloride	170466010	Ca channel blocker - benzhydryl class	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	101477-54-7	 ; Terranas; Lomerizine HCl; LOMERIZINE DiHCl;Lomerizine; Lomerizine	12.5892541179	-4.9	-66.0965113272	-3	5		-86.400738832	-77.41728236	0.0077810652	0.9960874962			Cl.Cl.Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)Cc4ccc(OC)c(OC)c4OC	Sequoia	SRP01568l	0.31723652	-5.32385735	-3.84728095	-3.44922611	-77.41728236											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167546-03	S-(5 -Adenosyl)-L-methionine p-toluenesulfonate salt	225144292	S-adenosylmethionine synthase isoform type-2 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	17176-17-9		1.2589254118	-5.9	-11.7111307809	4	5		12.406767712	-2.93699234	0.1247475631	0.9903652465			C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=CN=C3N	SIGMA	A2408	-7.00563976	-5.57919823	-5.02783941	6.01203325	-2.93699234											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021226-04	Dexamethasone 21-phosphate disodium salt	225144188	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2392-39-4		0.5623413252	-6.25	-7.2774624143	4	5		12.6179302519	-2.93699234	0.1984050941	0.975191629			C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[P]([O-])([O-])=O	SIGMA	D1159	-5.85125132	-5.86858456	-7.59827521	4.14733845	-2.93699234											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00249905-01	Phthalofyne	170466477		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	131-67-9				-22.9764784555	4	5		0	-4.359598					O=C(O)c1ccccc1C(=O)OC(C)(C#C)CC	GVK	FFS-11-286-NCI-120	-6.21254847	-7.11975487	-6.10792481	1.5018601	-4.359598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166248-03	Green S			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	3087-16-9				-26.1194810222	4	4		0	-11.18890595					CN(C)C1=CC=C(C=C1)C(=C/2\C=C/C(/C=C2)=[N+](C)C)C3=C4C=CC(=CC4=CC(=C3O)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	199583	-5.05785984	-3.24479972	-3.68087197	-11.18890595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262958-01	Bravavir	170466041		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	77181-69-2	Bravavir;5-(2-Bromovinyl)uridine;2,4(1H,3h)-pyrimidinedione,			4.3107148254	4	4		0	0.39298943					Br\C=C/C1=CN(C(=O)NC1=O)[C@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	GVK	FFS-11-286-NCI-260	1.20053742	0.71772391	0.64325918	0.39298943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167521-02	Tenatoprazole	170465931	Potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	113712-98-4				-15.2946313806	4	5		0	-3.94658345				IDO1	Cc3c(OC)c(C)cnc3CS(=O)c1nc2nc(ccc2n1)OC	Sequoia	SRP011927t	-5.10222066	-5.29832326	-3.30305187	4.47802324	-3.94658345											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162150-04	Cilnidipine	170465867	Voltage-gated N-type calcium channel alpha-1B subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	132203-70-4		12.5892541179	-4.9	-46.4125055236	-3	5		-45.0342343222	-43.88967923	0.0342526018	0.9824336187			CC=1NC(C)=C(C(C=1C(=O)OCCOC)c2cccc(c2)[N+]([O-])=O)C(=O)OC/C=C/c3ccccc3	Prestwick	Prestw-1376	-4.83785689	-4.81317559	-2.83417759	1.0150186	-43.88967923											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181042-02	Menthyl salicylate	225144318		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	89-46-3				-19.9398314636	4	5		0	-4.31370749					CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2O	SIGMA	84320	-5.86887557	-6.37075496	-3.62958932	1.65801681	-4.31370749											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249907-01	Sulthiame	170465788	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	61-56-3		1.4125375446	-5.85	-17.5243489932	4	5		12.6695463439	-5.93823138	0.2995868015	0.9406951516			O=S2(=O)CCCCN2c1ccc(cc1)S(N)(=O)=O	GVK	FFS-11-286-NCI-132	-6.37997885	-10.14128862	-6.94520032	4.32186653	-5.93823138											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165976-02	Squalane	170465658		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	111-01-3				-22.1154143558	4	4		0	-3.19360376					CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C	SIGMA	234311	-6.15004551	-4.80058449	-0.95595461	-3.19360376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024846-08	Guanabenz	170465364	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	5051-62-7		14.1253754462	-4.85	-17.7393484824	4	5		-9.762654304	-9.80221192	0.4174702615	0.6937653632			Clc1cccc(Cl)c1/C=N/NC(=N)N	Enzo	AC153	-5.0493479	-1.08519874	-2.16435718	1.7498737	-9.80221192											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091320-05	Decanoic acid	225144209	Peroxisome proliferator-activated receptor gamma Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	334-48-5				-8.818352743	4	5		0	-0.93616631			5468	PPARG	CCCCCCCCCC(O)=O	SIGMA	D1653	-2.33521325	-5.41748234	-2.91790514	2.91645616	-0.93616631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164512-02	Guaiacol carbonate	170465684		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	553-17-3				-17.1024669058	4	5		0	-3.29493828					COc2ccccc2OC(=O)Oc1ccccc1OC	Labotest	LT02084807	-4.08882622	-3.62158482	-4.46686482	-2.00707298	-3.29493828											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185990-04	Ketorolac	170464659	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	74103-07-4	Ketorolac tromethamine;KETOROLAC TROMETHAMINE			-9.0968274198	4	4		0	-4.66618484				PTGS1	OCC(N)(CO)CO.O=C(O)[C@@H]1CCn2c(ccc12)C(=O)c3ccccc3	Vitas	STL018674	-1.85931608	-3.76052948	2.52836594	-4.66618484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263180-14	Trametinib		Mek 1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1204531-25-8		0.0707945784	-7.15	-105.8714930767	-1.4	4		-31.5349533241	-30.89258289	0.4223916963	0.8723501372		MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	ActiveBioChem	A-1258	-18.36345512	-25.95410005	-25.39086929	-30.89258289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181110-02	Cambendazole	124893647	glucose transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox			3.9810717055	-5.4	-64.0147755112	-2.2	4		-37.1720305719	-32.69943084	0.0128550933	0.9998982972			CC(C)OC(=O)NC1=CC2=C([NH]C(=N2)C3=CSC=N3)C=C1	SigmaAldrich	32593	-6.30607203	-11.54804882	-22.03162691	-32.69943084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095112-05	Avobenzone	170464749	UVA ray absorber	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	70356-09-1	; ; Avobenzona; AVOBENZONE;AVOBENZONE; Shade uvaguard; Photoplex;Avobenzone; 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione			-1.3536418865	4	5		0	-2.4066465				CAT	COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C	Microsource	01504190	-1.51930155	2.32928614	-0.77947101	3.11833326	-2.4066465											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159429-03	Coenzyme Q10	225144226	mitochondrial electron transport	DPI_SARS-CoV-2_General	2019_NPC-3_Tox					-4.860391571	4	5		0	1.83772068				NDUFV3	COC\1=C(/OC)C(=O)\C(=C(C)/C1=O)C\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CCC=C(C)C	Tocris	3003	-3.58212788	-5.24842849	-3.24049746	1.32086605	1.83772068											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00016421-07	Cyclizine hydrochloride	170465270	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	303-25-3		1	-6	-23.7692447925	4	5		11.716739864	-7.03029756	0.0631669317	0.9975593374			Cl.Cl.CN1CCN(CC1)C(c2ccccc2)c3ccccc3	Microsource	01500211	-8.86330566	-9.34728322	-5.6402172	2.17420907	-7.03029756											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090814-07	4-Chlorophenol	170465673	macrophage activation involved in immune response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	106-48-9		0.8912509381	-6.05	-6.6823849082	4	5		12.366387052	-3.4361313	0.1158898245	0.9917585398			Oc1ccc(Cl)cc1	Microsource	01500460	-5.72198921	-3.61233101	-0.28025924	4.59806636	-3.4361313											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181010-02	Mabuterol hydrochloride	170465921	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	54240-36-7				-20.2382847289	4	5		0	-2.84266691					Cl.Nc1c(cc(cc1Cl)C(O)CNC(C)(C)C)C(F)(F)F	Bosche	M5723	-5.91826352	-6.07311828	-3.25923966	-0.87893266	-2.84266691											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016611-10	Bufexamac	170465813	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2438-72-4	; ; 7   Bufexamac; Anderm; Droxarol; Bufexamaco;BUFEXAMAC; Bufexamac;Bufexamac	14.1253754462	-4.85	-26.0831829888	4	5		-19.2767504279	-19.14540645	0.0532539486	0.9723833408		PTGS1	ONC(=O)Cc1ccc(OCCCC)cc1	Microsource	01502003	-3.79854163	-2.94193548	-3.24159831	-0.58144776	-19.14540645											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167502-01	NCGC00167502-01	50112755		DPI_SARS-CoV-2_General	2019_NPC-5_Tox		CIPLUS_205233; Santeson; 	1.4125375446	-5.85	-12.0430112215	4	4	Santeson;CIPLUS_684703;Dexamethasone Metasulfobenzoate Sodium;Dexamethasone metasulfobenzoate sodium;CIPLUS_205233;DEXAMETHASONE METASULFOBENZOATE SODIUM;	10.432778576	-1.39579004	1	0.9995752275			CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)C5=CC=CC(=C5)S([O-])(=O)=O	Pharmeks	PHAR046594	-5.77731548	-5.01547189	4.29732869	-1.39579004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018249-05	Ethoxzolamide	170465083	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	452-35-7		0.8912509381	-6.05	-28.6857870076	4	5		10.9774458639	-0.98884725	0.2802801454	0.8223854264			NS(=O)(=O)c1nc2ccc(cc2s1)OCC	Labotest	LT00453128	-12.06453822	-7.03091363	-5.45629707	4.51636331	-0.98884725											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095122-05	Irbesartan	170464670		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	138402-11-6				-4.8444535112	4	5		0	2.16282115					CCCCC5=NC1(CCCC1)C(=O)N5Cc2ccc(cc2)c3ccccc3c4nnnn4	Microsource	01504259	-3.24830951	2.26900887	-1.92678227	-0.96681948	2.16282115											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183276-01	Hydrocortisone buteprate	144206491		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	72590-77-3				-21.8459029392	4	4	PANDEL;TS-408;HYDROCORTISONE PROBUTATE;Pandel;CIPLUS_189796;hydrocortisone 17-butyrate 21-propionate;LS-54998;Hydrocortisone Butyrate Propionate;Hydrocortisone butyrate propionate;HYDROCORTISONE BUTEPRATE;Hydrocortisone probutate;hydrocortisone buteprate;17-BUTYRYLOXY-21-PROPIONYLOXY-HYDROCORTISONE;Hydrocortisone buteprate;	0	-3.63414528					CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	ACC	HYDROCORTISONE PROBUTATE	-5.79302587	-6.52931309	-0.60466964	-3.63414528												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00178839-08	NAD+			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	53-84-9		14.1253754462	-4.85	-53.8827881314	-3	4		-32.7315229578	-34.18013857	0.1094797334	0.9925457147			NC(=O)C1=C[N+](=CC=C1)[C@@H]2O[C@H](CO[P]([O-])(=O)O[P](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)[N]4C=NC5=C(N)N=CN=C45)[C@@H](O)[C@H]2O	Adooq	A11679	-7.99082807	-6.15080218	-5.19486251	-34.18013857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00348378-01	FOSFOMYCIN		UDP-N-acetylglucosamine 1-carboxyvinyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	26016-99-9				-8.3028299301	4	5		0	-0.91516427					C[C@@H]1O[C@@H]1[P]([O-])([O-])=O	SIGMA	P5396	-3.1871986	0.39028993	-1.3273389	-2.48466258	-0.91516427											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00161602-06	Doxycycline	170465097	Matrix Metalloproteinase (MMP) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	10592-13-9	; ; Monodox;DOXYCYCLINE HYDROCHLORIDE; Doryx; 1   Doxycycline Mono; Doxycycline hydrochloride; Doxycycline SSa; Atridox;Doxycycline; Doxiciclina; Vibramycin; Vibra-Tabs;Doxycycline hydrochloride; 0   Doxycycline Hyclate; Periostat			-23.4498363657	4	5		0	-8.17717975			4312	MMP1	Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@H](C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick	Prestw-1399	-5.88461868	-7.09119091	-4.27395341	2.17420907	-8.17717975											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263575-01	Ezetimibe	170465013	NPC1L1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	163222-33-1		14.1253754462	-4.85	-20.7011153021	4	5		-13.8269743119	-13.18914526	0.3779281176	0.7339478732		NPC1L1	Fc1ccc(cc1)[C@@H](O)CC[C@H]3C(=O)N(c2ccc(F)cc2)[C@@H]3c4ccc(O)cc4	Sequoia	163222-33-1	-5.40528974	-1.76095755	-2.60991417	3.20003631	-13.18914526											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015043-10	GABA	225144171	GABA-A receptor; anion channel Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox					-31.6338397913	4	5		0	-7.54503996					NCCCC(O)=O	Vitas	STK301748	-9.86476076	-5.95453371	-5.22858644	-0.83064772	-7.54503996											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015080-08	Methylatropine nitrate	170465893	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	52-88-0				-11.4382594272	4	5		0	-3.41807017					C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3.[O-][N+]([O-])=O	Vitas	STK108600	-3.84747068	0.46930164	-0.83201962	-2.1378966	-3.41807017											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016599-04	Flucytosine	170465407	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	2022-85-7	 Flucytosine;Flucytosine;Flucytosine (Ancobon)			-34.8467693324	4	5		0	-4.26466551				TYMS	FC1=CNC(=O)N=C1N	Vitas	STK292386	-7.84305129	-6.6435066	-8.58060373	-9.25942156	-4.26466551											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090708-11	OXYQUINOLINE HEMISULFATE		Trichophyton interdigitale Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	134-31-6		11.220184543	-4.95	-62.1554140758	-3	4		-76.0711579161	-70.33252588	0.0593032213	0.9978249712			OC1=CC=CC2=CC=CN=C12	Microsource	01500456	-1.10656095	-4.91251682	-4.76086767	-70.33252588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319021-01	NCGC00319021-01	225144375	DNA synthesis involved in DNA replication Activator	DPI_SARS-CoV-2_General	2019_NPC-9_Tox					-2.8873459253	4	4		0	-0.75313808					COCC1=C(F)C(=C(COC(=O)C2C(\C=C\C)C2(C)C)C(=C1F)F)F	GVK	FFS-11-286-NCI-255	-0.48793239	1.12718708	-2.67009321	-0.75313808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249613-11	Carfilzomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	868540-17-4		0.1	-7	-377.3674125232	-1.3	4		-100.7100225809	-99.11913675	0.0591367883	0.9978395442		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	Selleck	S2853_CM1	-66.21068223	-94.86036339	-97.14696402	-99.11913675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181756-01	gamma-Oryzanol	144206489	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	11042-64-1	ORYZANOL; Hi-Z; 			2.3195956721	4	4	gamma-oryzanol;cycloartenol ferulic acid ester;ferulic acid cycloartenol ester;CIPLUS_3885867;LS-7631;triacontane 3-(4-hydroxy-3-methoxyphenyl)-2-propenate;ORYZANOL;R-ORIZANOL;oryzanol;CYCLOARTENOL FERULATE;Gamma Oryzanol;Hi-Z;CIPLUS_666235;GAMMA ORYZANOL;FRACYE;9,19-CYCLO-9.BETA.-LANOST-24-EN-3.BETA.-OL 4-HYDROXY-3-METHOXYCINAMATE;gamma Oryzanol;Gamma oryzanol;	0	1.43140277					Oc1ccc(cc1OC)/C=C/C(=O)O[C@H]4CC[C@]63C[C@@]56CC[C@]2(C)[C@H](CC[C@@]2(C)[C@@H]5CC[C@H]3C4(C)C)[C@H](C)CC\C=C(/C)C	ACC	GAMMA ORYZANOL	0.31367082	-1.27018843	1.91218747	1.43140277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015747-09	Nicardipine	170465173	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	55985-32-5	 ;Nicardipine hydrochloride; YC-93 hydrochloride; Dagan;Nicardipine?HCl;Nicardipine; Nicardipine; Cardene/SR; Nicardipino	14.1253754462	-4.85	-46.9069565087	-3	5		-30.9571045239	-32.19849189	0.0119347223	0.9939893001			CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC	Enzo	AC108	-6.05580758	-6.95341428	-4.9220529	-4.73423812	-32.19849189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016397-04	Benzydamine hydrochloride	170465576	prostaglandin production involved in inflammatory response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	132-69-4		1	-6	-4.0694622118	4	5		9.884784292	-5.37770353	0.1062735406	0.9930747309			Cl.CN(C)CCCOc3nn(Cc1ccccc1)c2ccccc23	Vitas	STK711092	-4.19840794	-4.90398691	-0.6831319	5.26984703	-5.37770353											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015513-11	Histamine dihydrochloride	170465001	Histamine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51-45-6	Histamine dihydrochloride;Histamine;HISTAMINE DIHYDROCHLORIDE;HISTAMINE; Histamine dihydrochloride	0.6309573445	-6.2	-23.5185466454	4	5		11.71116152	-5.47703978	0.016718162	0.9998301265	9704	HRH1	NCCc1cncn1	Vitas	STK346752	-9.3426346	-7.82312925	-2.96023822	0.93050701	-5.47703978											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013565-03	D-Leucine	170465492	Mammalian target of Rapamycin (mTORC1) Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	328-38-1				-18.5250570687	4	5		0	-3.94184314					CC(C)C[C@@H](N)C(=O)O	Bosche	L0932	-5.93597535	-5.58425902	-3.44193379	1.62952204	-3.94184314											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00164548-02	Danofloxacin	170466637	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	112398-08-0				-20.2524539513	4	5		0	-4.94188707					CN5C[C@@H]4C[C@H]5CN4c1cc2N(C=C(C(=O)O)C(=O)c2cc1F)C3CC3	Sequoia	SRP00900d	-5.03726436	-2.94647452	-2.61186042	-4.80718668	-4.94188707											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00091146-08	Phenothiazine	170466563	Trichostrongylus colubriformis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	92-84-2				-21.6301955231	4	5		0	-10.02104878					c1ccc2Sc3ccccc3Nc2c1	SIGMA	P14831	-2.5734327	-1.3081146	-4.34168272	-7.75197195	-10.02104878											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160423-02	Bamethan	225144236		DPI_SARS-CoV-2_General	2019_NPC-1_Tox					-17.8877400874	4	5		0	-3.84368994					CCCCNCC(O)C1=CC=C(O)C=C1	SIGMA	R416398	-3.09074967	-2.03722765	-4.72703918	-6.51621385	-3.84368994											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024427-05	Naltrexone hydrochloride	170465207	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	16590-41-3	;Naltrexone hydrochloride; ReVia;Naltrexone hydrochloride dihydrate; Naltrexona			-24.2473548514	4	5		0	-2.80040267			4988	OPRM1	O=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45	Prestwick	Prestw-116	-7.5624726	-3.64127638	-4.50438878	-3.48378615	-2.80040267											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00319022-01	Octotiamine	170465976		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	137-86-0				-34.696496091	4	5		0	-7.45858882					Nc1nc(C)ncc1CN(C=O)C(\C)=C(/CCO)SSCCC(CCCCC(=O)OC)SC(C)=O	GVK	FFS-11-286-NCI-250	-8.46558527	-5.15954709	-7.97259687	-6.06923751	-7.45858882											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016338-10	Dibucaine	170464829	Sodium channel protein type X alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	85-79-0				-11.2240712933	4	5		0	-4.26466551					CCN(CC)CCNC(=O)c1cc(OCCCC)nc2ccccc12	Microsource	01500236	0.00438404	-0.89638017	-5.06957825	-5.543383	-4.26466551											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017253-03	Ergobasine	124882896	Serotonin (5-HT) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	129-51-1				5.2328469244	4	4	ERGONOVINE MALEATE	0	-1.09808706					C[C@@H](CO)NC(=O)[C@H]\1CN(C)[C@@H]\2CC3=C[NH]C4=CC=CC(=C34)C2=C1	BIOMOL	AC824	2.98953015	-0.79143189	-1.46974445	-1.09808706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179767-02	NCGC00179767-02	363676967	lipid metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-32.0439676743	4	4		0	-8.76726655					CC(=O)OC(C)(C)\C=C\C(=O)[C@](C)(O)[C@H]1C(O)C[C@@]2(C)[C@@H]3C\C=C4/[C@@H](/C=C(/O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C	Analyticon	NP-005666	-5.3949987	-7.11428449	-7.32224037	-8.76726655												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00142611-02	D-HISTIDINE	26754413	Histidine decarboxylase Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_Tox		Histidine; L-Histidine hydrochloride; Cu-His; Zn(His)2; Histidine, L isome; DL-Histidine; L-Histidine-ul-13C,15N; Cu(His)2; poly(L-histidine); polyhistidine, (D)-isomer; Zn-His(2); L-Histidine-2,5-3H; D-His; Histidina; D-His-OH; L-isomer Histidin; L-Histidine-15N3; Fe(II)-histidinate; Levadial; L-Histidine-13C6,15N3; Poly-L-histidine; Pt(His)(adenine); PRu-Hi; Histidine, L-isomer; poly-(alpha-L-histidine); 			-27.9993798956	4	4	CIPLUS_688453;CIPLUS_670571;L-Histidine Monohydrochloride Monohydrate;L-Histidine monohydrochloride monohydrate;DL-Histidine monohydrochloride monohydrate;L-Histidine-15N3;Poly-L-histidine;L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE;CIPLUS_208166;polyhistidine;HISTIDINE, DL-;CIPLUS_163873;CIPLUS_213264;DL-Histidine;L-Histidine Monohydrochloride;poly-(alpha-L-histidine);CIPLUS_207332;(+/-)-2-Amino-3-(4-imidazolyl)propionic acid;S(+)-alpha-Amino-1H-imidazole-4-propanoic acid hydrochloride;HISTIDINE;L-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;NCGC00093950-01;Histidine, L isome;L-HISTIDINE;(R)-2-Amino-3-(4-imidazolyl)propionic acid;CIPLUS_3885719;NCGC00162189-01;L-Histidine hydrochloride;D-His;L-isomer Histidin;polyhistidine, (D)-isomer;D-HISTIDINE;L-Histidine;D-Histidine;D-alpha-Amino-beta-(4-imidazolyl)propionic acid;histidinum;CIPLUS_166016;CIPLUS_742841;Histidina;DL-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;D-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;L-Histidine dihydrochloride;(S)-2-Amino-3-(4-imidazolyl)propionic acid;L-Histidine Monohydrochloride Anhydride;L-Histidine-13C6,15N3;D-His-OH;CIPLUS_215801;CIPLUS_3886763;CIPLUS_149204;L-Histidine-2,5-3H;poly(L-histidine);L-Histidine hydrochloride solution;NCGC00015518-01;Histidinum;D-Histidine monohydrochloride monohydrate;Histidine, L-isomer;CIPLUS_214867;HISTIDINE, L-;L-HISTIDINE MONOHYDROCHLORIDE;L-Histidine monohydrochloride;CIPLUS_3887315;Histidine;CIPLUS_750166;histidine;L-Histidine-ul-13C,15N;NCGC00142611-02;Poly-L-histidine hydrochloride;CIPLUS_711628;	0	-7.65174953			3067	HDC	N[C@H](CC1=CNC=N1)C(O)=O	BIOMOL	BIOMOL_AC-1014	-5.83628969	-4.70557873	-5.84808227	-7.65174953												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344537-01	L-Glutathione oxidized disodium salt	225144384	Glutathione reductase Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	103239-24-3				-27.2655948268	4	4		0	-5.4207155					N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C([O-])=O)C(=O)NCC(O)=O)C(=O)NCC([O-])=O)C(O)=O	SIGMA	G4626	-6.72752444	-6.97664416	-3.52650395	-5.4207155												1.6E-8	8E-8	4E-7	0.000002											
NCGC00188399-06	Fingolimod hydrochloride		Sphingosine Kinase 1 (SphK1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox			12.5892541179	-4.9	-92.8738636389	-3	4		-106.0451427155	-99.6993333	0.0561780703	0.9980484485		SPHK1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1	Selleck	S5002	-6.01799775	-3.08830487	-1.18727104	-99.6993333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182073-03	Nedocromil	170464978	mast cell degranulation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	69049-73-6				-22.0181351628	4	4		0	-4.4097782					O=C(O)C2=CC(=O)c3cc1c(OC(=CC1=O)C(=O)O)c(CCC)c3N2CC	Kemprotec	69049-73-6	-6.26892792	-2.58935868	-1.29319857	-4.4097782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263897-02	PREDNISOLONE HEMISUCCINATE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	2920-86-7				-22.3144213058	4	4		0	-3.65157523					C[C@]12C[C@H](O)C3C(CCC/4=C/C(=O)/C=C\[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O	Microsource	01505450	-7.16881544	-3.45821326	1.62863574	-3.65157523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185748-01	Paramethasone acetate	144206683	Glucocorticoid receptor Interacts	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1597-82-6				-20.0599988272	4	4		0	-5.12440629					CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Kemprotec	1597-82-6	-4.94505494	-4.28405523	-0.86948846	-5.12440629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247988-03	Cochineal	170466801	Solute carrier organic anion transporter family member 1B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1343-78-8				-42.4970101319	4	4		0	-11.34689965					O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c4c(O)c3C(=O)c2c(C)c(C(=O)O)c(O)cc2C(=O)c3c(O)c4O	SIGMA	229253	-10.4482132	-6.28844251	-4.20620559	-11.34689965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483049-02	Gamithromycin			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	145435-72-9				-23.9264564776	4	4		0	-9.26402022					CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@H]1C	Ark Pharm	AK105038	-4.76334689	-2.12482257	-4.79763429	-9.26402022												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166257-03	NCGC00166257-03	50111747		DPI_SARS-CoV-2_General	2019_NPC-9_Tox					-10.7960167206	4	4	Mn3O4;Manganese(II,III) oxide;hausmannite;manganese oxide;manganous-manganic oxide;CIPLUS_158079;manganese oxide, hydrate;	0	-5.05175072					O=[Mn]O[Mn]O[Mn]=O	SigmaAldrich	377473	-1.78618106	-2.85161507	-0.66643436	-5.05175072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181170-02	Bendamustine	170465340	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	16506-27-7	Bendamustine HCL;Bendamustine;Inno-P08001; Bendamustine;SyB L-0501;SDX-105			-24.3750741251	4	4		0	-5.75644131			7515	XRCC1	ClCCN(CCCl)c1cc2nc(CCCC(=O)O)n(C)c2cc1	Sequoia	3543-75-7	-6.89204496	-1.55619112	-1.98187995	-5.75644131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253658-01	Dapoxetine	170466555	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	119356-77-3	Dapoxetine hydrochloride (Priligy);Dapoxetine	7.9432823472	-5.1	-13.528015411	4	4		-19.046685752	-16.70557146	0.0984983119	0.9939962461	6532	SLC6A4	CN(C)[C@@H](CCOc2cccc1ccccc12)c3ccccc3	GVK	FFS-12-73-NCI-1987	-0.05227847	1.38795424	-2.68751633	-16.70557146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013369-07	Pamoic acid disodium salt			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	[6640-22-8]				-22.5706954689	4	4		0	-7.23629157					OC(=O)C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C4C=CC=CC4=C1	Tocris	4298	-3.94702448	-6.67059219	-3.4628452	-7.23629157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346470-02	Zilpaterol·HCl		beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	119520-06-8				-9.258277946	4	4		0	0.99977978				ADRB1	CC(C)N[C@@H]1CCN2C(=O)NC3=CC=CC(=C23)[C@H]1O	Enzo	AR113	-2.79689814	-2.01884253	-2.07770712	0.99977978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183110-02	Imidafenacin		potassium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	170105-16-5				-7.8227597435	4	4		0	-7.16582251					CC1=NC=C[N]1CCC(C(N)=O)(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-B0662	-0.44436699	0.79912517	-2.70493945	-7.16582251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177979-05	Azelastine hydrochloride	170465172	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	79307-93-0	; Astelin; Azelastina;AZELASTINE HYDROCHLORIDE; Azelastine Hydrchloride	12.5892541179	-4.9	-70.7554788917	-3	5		-107.4863683534	-92.82069806	0.0000528575	0.999973574	9704	HRH1	Cl.Clc1ccc(cc1)CC3=NN(C(=O)c2ccccc23)C4CCCN(C)CC4	Microsource	01505340	-0.32953865	0.07319383	0.14012962	-1.31178794	-92.82069806											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094819-07	Hexetidine	170465729		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	141-94-6				-10.0714841619	4	5		0	-3.97796541					CCC(CCCC)CN1CC(C)(N)CN(CC(CCCC)CC)C1	Microsource	01500633	-3.642044	5.23120641	-2.01436329	-3.70841088	-3.97796541											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182989-01	Glyclopyramide	144206854		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	631-27-6	Glyclopyramide; Deamelin-S; Gliclopiramida; 			-19.662297873	4	5	glyclopyramidum;1-(p-chlorobenzenesulfonyl)-3-pyrrolidin-1- ylurea;Glyclopyramide;CIPLUS_214070;GLYCLOPYRAMIDE;Deamelin-S;glyclopyramide;Gliclopiramida;Glyclopyramidum;	0	-5.06163363					O=C(NS(=O)(=O)c1ccc(Cl)cc1)NN2CCCC2	Pharmaron	PH-NIH-169404	-6.47522041	-4.54232326	-3.22298126	2.22867777	-5.06163363											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183332-01	Dihydroergocriptine	144206629	D(1A) dopamine receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	25447-66-9				-32.1441532319	4	4	CIPLUS_752814;Vasobral;LS-174243;CIPLUS_746395;Dihydroergocryptine Mesylate;CIPLUS_691892;CIPLUS_737198;CIPLUS_3861508;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl;Dihydroergocryptine;DIHYDROERGOCRYPTINE MESYLATE;	0	-6.77204803			1812	DRD1	CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@H]56)C7=O)C(C)C	Chemical Block	A4425/0188924	-6.2393774	-8.5228714	-6.03698332	-6.77204803												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00246968-04	Olmesartan		Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	144689-24-7				-18.5526925541	4	4		0	-6.53018917				AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	Microsource	01505206	-4.0209321	-5.40289169	-1.13306744	-6.53018917												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179612-03	Neomycin sulfate	225144310	30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1405-10-3				-31.1018972278	4	4		0	-5.9687311					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O	Prestwick	Prestw-158	-8.67251096	-7.65198275	-2.86439449	-5.9687311												1.6E-8	8E-8	0.000002	0.000006											
NCGC00181091-01	Bunamidine hydrochloride	144206260		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1055-55-6	Bunamidine hydrochloride; Bunamidina; Scolaban; 	3.1622776602	-5.5	-72.7869967946	-3	4	bunamidinum;bunamidine monohydrochloride;N,N-DIBUTYL-4-(HEXYLOXY)-1-NAPHTHAMIDINE MONOHYDROCHLORIDE;bunamidine;LS-174664;Scolaban;CIPLUS_738221;CIPLUS_157296;Bunamidinum;N,N-dibutyl-4-(hexyloxy)-1-naphthamidine monohydrochloride;LS-95153;NSC-106571;1-Naphthamidine, N,N-dibutyl-4-hexyloxy-, monohydrochloride;CIPLUS_3885993;1-naphthalenecarboximidamide, n,n-dibutyl-4-(hexyloxy)-, hydrochloride;BUNAMIDINE HYDROCHLORIDE;Bunamidine hydrochloride;Bunamidina;BUNAMIDINE;Bunamidine;	-105.2825054425	-3.60196942	1	0.9999857324			Cl.CCCCN(CCCC)C(=N)c1ccc(OCCCCCC)c2ccccc12	NCI	NSC-106571	1.39100098	-6.47670584	-99.50145033	-3.60196942												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00531790-01	JTT-501		Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	170861-63-9				-10.5868451063	4	4		0	-2.58270709			5468	PPARG	CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C4=CC=CC=C4	Glixx	GLXC-08947	-0.73799088	-1.47120994	-6.97969543	-2.58270709												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522040-01	Carpipramine Dihydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	7075-03-8		4.4668359215	-5.35	-78.578147839	-3	4		-99.5762780168	-1.58072039	1	0.9999993129			NC(=O)C1(CCN(CCCN2C3=CC=CC=C3CCC4=C2C=CC=C4)CC1)N5CCCCC5	Toronto Research	C184320	-2.15135522	-3.26371861	-99.66461204	-1.58072039												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00248803-03	DL-Cysteine	170464842		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	3374-22-9				-16.1069537919	4	4		0	-2.67772307					O=C(O)C(N)CS	Bosche	C2088	-2.35709813	-5.26760802	-4.18781726	-2.67772307												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183877-01	Unoprostone isopropyl ester	144207178	Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	120373-24-2				-25.9450992354	4	4	Ciba Vision brand of isopropyl unoprostone;Unoprostone;isopropyl 20-ethyl-9alpha,11alpha-dihydroxy-15-keto-cis-delta-5-prostanoate;ISOPROPYL UNOPROSTONE;UNOPROSTONE ISOPROPYL;unoprostone isopropyl;UF-021;Isopropyl unoprostone;Unoprostone isopropyl;Novartis brand of isopropyl unoprostone;CIPLUS_3762607;Eescula;LS-176760;ISOPROPYL Z-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)HEPT-5-ENOATE, D-;isopropyl unoprostone;UF 021;Rescula;CIPLUS_729221;	0	-5.63185627					O[C@@H]1C[C@H](O)[C@H](C/C=C\CCCC(=O)OC(C)C)[C@H]1CCC(=O)CCCCCCC	Toronto Research	U800050	-6.08730656	-7.59279614	-1.1693256	-5.63185627												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181743-02	Lypressin	144206977	Vasopressin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	50-57-7				0.44448547	4	4	8-L-LYSINEVASOPRESSIN;CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1,6-DISULFIDE);Lypressin;Lyspressin;VASOPRESSIN, 8-LYSINE;Lysyl Vasopressin;Lipresina;Lypressinum;CIPLUS_148560;LYPRESSIN;LS-161412;Lysipressin;lypressine;Lypressine;Vasopressin, 8-Lysin;lypressinum;Lysine Vasopressin;[Lys8]-Vasopressin;VASOPRESSIN PIG;Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2, cyclic 1-6 disulfide;Lys Vasopressi;L-CYSTEINYL-L-TYROSYL-L-PHENYLALANYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LYSYLGLYCINAMIDE CYCLIC (1->6)-DISULFIDE;Lysine vasopressin;8 Lysine Vasopressi;8-Lysine Vasopressin;Lys-Vasopressin;8-l-lysine vasopressin;VASOPRESSIN, 8-L-LYSINE;Vasopressin, Lysy;Postacton;Diapid;Vasopressin, 8-L-lysine-;	0	-2.12490282					NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4	Sigma DiscoveryCPR	CPY6754	1.19420342	-1.74177729	-0.29006526	-2.12490282												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181136-01	Pyrrolnitrin	144206296	respiratory electron transport chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1018-71-9	Pyrrolnitrin; Pyrrolnitrin Microbial; Pirrolnitrina; 			-36.7269081957	4	4	3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole;Pirrolnitrina;pyrrolnitrine;LS-136879;Pyrrolnitrine;Pyrrolnitrinum;Pyrrolnitrin Microbial;PYRROLNITRIN;CIPLUS_157237;Pyrrolnitrin;pyrrolnitrinum;1H-Pyrrole, 3-chloro-4-(3-chloro-2-nitrophenyl)-;	0	-7.41988425					Clc2cncc2c1cccc(Cl)c1[N+]([O-])=O	NCI	NSC-107654	-5.44324179	-7.60125137	-13.95939086	-7.41988425												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00480787-02	Cangrelor (AR-C69931)			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	163706-36-3				16.0959481318	4	4		0	2.46177766					CSCCNC1=NC(=NC2=C1N=C[N]2[C@@H]3O[C@H](CO[P](O)(=O)O[P](O)(=O)C(Cl)(Cl)[P](O)(O)=O)[C@@H](O)[C@H]3O)SCCC(F)(F)F	DC Chemicals	DC7005	4.43241793	0.00845523	4.45975344	2.46177766												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00159498-03	Metipranolol	29215466	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox		Metipranolol; Disorat; 			-14.7254550027	4	4	Trimepranol;(+/-)-1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE HYDROCHLORIDE;LS-122351;Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, 1-acetate;CIPLUS_173566;TRIMEPRANOL;METIPRANOLOL HYDROCHLORIDE;1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE -DL;(+/-)-1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE;Disorat;Metipranololum;Methypranol;metipranololum;PHENOL, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-2,3,6-TRIMETHYL-, (+/-)-, 1-ACETATE;PHENOL, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-2,3,6-TRIMETHYL-, (+/-)-, 1-ACETATE, HYDROCHLORIDE;1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol;metipranolol;Metipranolol;METIPRANOLOL;Metipranolol (4-(2-Hydroxy-3-(isopropylamino)propoxy)-2,3,6-trimethylphenyl acetate);METHYPRANOL;	0	-2.78137687					CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C	SigmaAldrich	R736139	-0.40701315	-4.30371185	-8.94670051	-2.78137687												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00094594-13	Bacitracin			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1405-87-4				2.6150255534	4	4		0	-0.1036538					CCC(C)C(N)\C1=N\C(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC3=CN=C[NH]3)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC	Enzo	AC3027	1.84721353	-1.23446352	-0.21754895	-0.1036538												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00179312-03	Cyclopenthiazide	170466046	Solute carrier family 12 member 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	742-20-1				-26.8180532144	4	4		0	-8.9228643			6559	SLC12A3	NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)CC2CCCC2)cc3Cl	Prestwick Chemical, Inc.	Prestw-994	-5.46113248	-6.1215862	-4.61385062	-8.9228643												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00388420-02	Pentostatin	363680730	Adenosine Deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	53910-25-1				-18.4205094924	4	4		0	-5.10494947				ADA	OC[C@H]1O[C@H](C[C@@H]1O)[N]2C=NC3=C2N\C=N/C[C@H]3O	MedChem Express	HY-A0006	-3.98515073	-3.48355458	-3.59862219	-5.10494947												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183007-01	Risarestat	144206824	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	79714-31-1	CT-112; Risrestat; 			-2.1520917461	4	4	LS-151322;CT-112;Risarestat;risarestatum;5-(3-ethoxy-4-pentyloxyphenyl)-2,4-thiazolidinedione;RISARESTAT;5-(3-ETHOXY-4-PENTYLOXYPHENYL)-2,4-THIAZOLIDINEDIONE;Risrestat;CIPLUS_709552;2,4-Thiazolidinedione, 5-(3-ethoxy-4-(pentyloxy)phenyl)-;CT 112;	0	-4.02278391					CCCCCOc1ccc(cc1OCC)C2SC(=O)NC2=O	Pharmaron	PH-NIH-149775	1.41174394	-0.78610919	-3.1488219	-4.02278391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181308-01	Sorbitan monohexadecanoate	144206336		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	26266-57-9	Sorbitan monopalmitate; Span 40; Palmitato de sorbitano; 			-37.1087940747	4	4	sorbitan monopalmitate;SPAN-40;CIPLUS_158227;Palmitato de sorbitano;sorbitan monohexadecanoate;Span 40;SORBITAN PALMITATE;Palmitate de sorbitan;SORBITAN MONOPALMITATE;Sorbitani palmitas;sorbitan palmitate;CIPLUS_204868;palmitate de sorbitan;Sorbitan monopalmitate;sorbitani palmitas;	0	-6.7995728					O[C@H](COC(=O)CCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O	SigmaAldrich	388920	-8.74398906	-5.67553559	-8.19906445	-6.7995728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351603-13	Ceritinib		ALK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1032900-25-6		10	-5	-84.425673073	-3	4		-104.5950872213	-99.43040228	0.0467144635	0.998651652		ALK	CC(C)OC1=CC(=C(C)C=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)C4CCNCC4	MedChem Express	HY-15656	-3.23818767	1.14029026	-3.77252252	-99.43040228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160454-01	Felbinac ethyl	144205377		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	14062-23-8	ethyl 4-biphenyl acetate; BPAA-Et; 			-24.6143795687	4	4	BPAA-Et;Felbinac Ethyl;FELBINAC ETHYL;ethyl 4-biphenyl acetate;Felbinac ethyl;LS-44075;4-biphenylylacetic acid ethyl ester;CIPLUS_169170;LM-001;ethyl 4-biphenylacetate;felbinac ethyl ester;LM 001;	0	-6.68387326					O=C(OCC)Cc1ccc(cc1)c2ccccc2	Enamine	T5544767	-5.34698019	-2.91983414	-6.18936244	-6.68387326												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178483-14	Limonin			DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1180-71-8				-17.3948071351	4	5		0	-6.56234225					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	-4.34437786	-3.8769257	-0.06279566	-2.40205759	-6.56234225											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249886-01	Prednisolone tebutate	170465430		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	7681-14-3				-8.3092496112	4	5		0	-2.01918223					CC(C)(C)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-19	-3.94783222	-1.37458507	-1.12613555	3.24714095	-2.01918223											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167576-02	Aprindine hydrochloride	170465842	Calmodulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	33237-74-0				-13.6625006932	4	4		0	-9.33606266					Cl.CCN(CC)CCCN(c1ccccc1)C2Cc3ccccc3C2	Key Organics	KS-1222	-0.66175497	-1.87456807	-5.27113652	-9.33606266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263117-05	Panobinostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	404950-80-7		0.1122018454	-6.95	-387.5115206419	-1.3	4		-93.9402781268	-99.44820221	0.052492256	0.9982988324		HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	Selleck	S1030	-68.39017073	-98.79060124	-99.41528067	-99.44820221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179602-03	Testosterone propionate	170464835	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	57-85-2				-4.7680579243	4	5		0	-0.21109632				AR	CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801834	-2.62601339	-4.34505064	0.7074978	4.00955312	-0.21109632											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346501-07	Bleomycin sulfate		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	9041-93-4		3.1622776602	-5.5	-31.1790102223	4	4		-22.544569556	-21.90281239	0.030651599	0.9994221064			C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(=NC(=N1)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)N)C(O[C@H]2O[C@H](CO)[C@H](O)[C@@H](O)[C@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)C4=C[NH]C=N4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C	Selleck	S1214	-1.03233776	-3.70594333	-13.70841996	-21.90281239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-10	Maraviroc			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	[376348-65-1]				3.7808325895	4	4		0	-2.35849057					CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Tocris	3756	0.97939736	3.08396683	1.26905752	-2.35849057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094856-05	Adenine	170465950	Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	73-24-5				-15.3693735619	4	4		0	-4.10606197					Nc1ncnc2ncnc12	Microsource	01500807	-3.46292203	-2.2305312	-2.7159832	-4.10606197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379053-02	Desmopressin (Acetate)		Vasopressin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	62288-83-9				-19.0321943456	4	4		0	-6.46399855					NC(=N)NCCCC(NC(=O)C1CCCN1C(=O)C2CSSCCC(=O)NC(CC3=CC=C(O)C=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N2)C(=O)NCC(N)=O	MedChem Express	HY-17370	-2.88215663	-6.95805398	-1.28651836	-6.46399855												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00018269-05	Trimebutine maleate	170465734		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	34140-59-5		1	-6	-6.1974857536	4	5		13.00238318	-9.06796384	0.1284736793	0.989772582			COc1c(cc(cc1OC)C(=O)OCC(CC)(c2ccccc2)N(C)C)OC.O=C(O)/C=C\C(=O)O	Microsource	01505011	-5.21677829	-6.66865265	-2.29832126	6.73770266	-9.06796384											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023654-13	Captopril	170464644	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	62571-86-2				-9.8313120972	4	5		0	-0.95452251					OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)CS	Vitas	STK802012	-1.91223123	-2.13209635	-1.73734667	-4.10141	-0.95452251											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179384-10	Chlorcyclizine		Hepatitis C virus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	GRT00368		14.1253754462	-4.85	-24.0551013105	4	4		-11.4403036319	-13.3119523	0.2744781083	0.9511130273			CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3	SIGMA	SMl1473	-3.42824947	-5.12721334	-2.52836594	-13.3119523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166005-02	L-Cysteine methyl ester hydrochloride	225144264		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	18598-63-5				-1.4984358007	4	4		0	1.431927					COC(=O)[C@@H](N)CS	SIGMA	410209	-1.86798422	-1.13890321	4.28839453	1.431927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015889-11	Raloxifene hydrochloride	170465341	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	82640-04-8	 ; Keoxifene;Evista; Raloxifene Lilly Bran; Evista;RALOXIFENE HYDROCHLORIDE; Lilly Brand of Raloxifene; Raloxifene hydrochloride;Raloxifene hydrochloride	11.220184543	-4.95	-87.3597398733	-3	4		-104.0558036324	-94.58397326	0.0053789869	0.9999821548	2099	ESR1	Cl.Oc1ccc(cc1)c3sc2cc(O)ccc2c3C(=O)c5ccc(OCCN4CCCCC4)cc5	Microsource	01505622	-3.55827157	-3.82069795	-7.02224605	-94.58397326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091596-05	Octadecanoic acid	170465630		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	57-11-4				-9.0495876504	4	5		0	-3.71713093					O=C(O)CCCCCCCCCCCCCCCCC	Specs	AE-562/J263018	-0.84596405	-4.60039152	-3.73006238	1.60290268	-3.71713093											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159481-03	Sofalcone	170466017	Prostaglandin Synthesis and Regulation Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	64506-49-6		12.5892541179	-4.9	-25.1115445699	-3	5		-34.992955804	-32.07746317	0.0841299875	0.9551345001			C/C(C)=C\COc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)O)OC\C=C(/C)C	Bionet	KS-1141	0.78427917	-3.20452804	-3.91426299	3.41248335	-32.07746317											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00522453-01	MLN9708		Proteasome subunit beta type-5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1239908-20-3		0.316227766	-6.5	-273.5716413913	-1.1	4		-83.8831194879	-98.09829253	0.0204190801	0.9997427972	5693	PSMB5	CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(=CC=C1Cl)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2	MedChem Express	HY-10452	-27.35231656	-89.85301702	-96.71223086	-98.09829253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167498-02	Thiamphenicol glycinate			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	2393-92-2		1.1220184543	-5.95	-12.2972782971	4	4		12.118580164	-1.91977595	1	0.9991947811			C[S+]([O-])(=O)C1=CC=C(C=C1)[C@@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl	Enzo	DL143	-6.76548347	-4.67165205	5.69999107	-1.91977595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017326-05	(1S,9R)-beta-Hydrastine	170465706	GABA-A receptor; anion channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	29617-43-4				-18.6656053281	4	5		0	-3.57945941					CN2CCc1cc5OCOc5cc1[C@H]2[C@@H]4OC(=O)c3c(OC)c(ccc34)OC	Microsource	01500687	-5.4987663	-6.38777768	-4.19056391	2.29182933	-3.57945941											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016323-09	Sulfachloropyridazine	170466574	Salmonella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	80-32-0				-4.9436319715	4	5		0	-0.97287871					O=S(=O)(Nc1ccc(Cl)nn1)c2ccc(N)cc2	Microsource	01501142	0.14980613	-1.10222147	-2.3653033	-2.9623846	-0.97287871											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091112-09	Methylrosaniline chloride	170464787	TNFR1 (p55/CD120a) Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	548-62-9	; Triple Dye; Basic Violet 3; ; Methyl violet 2B; Hexamethyl-p-rosaniline chloride (Gentian violet); Crystal Violet;GENTIAN VIOLET; Genapax; Methyl Violet 10B; Gentian violet; Crystal violet solution;Gentian violet	1.1220184543	-5.95	-170.3088673538	-1.1	4		-95.4056837867	-99.82383232	0.0118428434	0.9999134863		TNFR1	[Cl-].C/[N+](C)=C1\C=C\C(C=C1)=C(/c2ccc(cc2)N(C)C)c3ccc(cc3)N(C)C	Microsource	01500315	-4.18237767	-22.47292419	-99.1601894	-99.82383232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182985-01	Trolnitrate	144206882	Soluble guanylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7077-34-1	TROLNITRATE PHOSPHATE; Trolnitrato; Angitrit; 			-16.8993311868	4	4	trolnitratum;Trolnitratum;Trolnitrate;TROLNITRATE PHOSPHATE;2,2',2''- nitrilotrisethanol, trinitrate (ester);Trolnitrate Phosphate;Trolnitrate phosphate;LS-66974;trolnitrate;Trolnitrato;Ethanol, 2,2',2''-nitrilotris-, trinitrate (ester), phosphate (1:2) (salt) (9CI);Angitrit;CIPLUS_154803;Ethanol, 2,2',2''-nitrilotri-, trinitrate (ester), phosphate (1:2);trolnitrate phosphate (1:2);CIPLUS_658463;triethanolamine trinitrate;TROLNITRATE;	0	-1.76619387					O=[N+]([O-])OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O	Pharmaron	PH-NIH-183589	-4.29506349	-5.90940347	-0.68792996	-1.76619387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249110-03	Sucralose	170466823		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	56038-13-2				-6.5848052837	4	4		0	-1.07055741					O[C@H]1[C@H](O[C@H](CO)[C@H](Cl)[C@@H]1O)O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O	Microsource	01505953	-1.82464352	-1.43115008	-0.17868311	-1.07055741												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015074-14	Acetazolamide	170464692	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	59-66-5				-20.6339483665	4	5		0	-5.47703978					O=S(N)(=O)c1nnc(NC(C)=O)s1	Specs	AN-153/I110543	-5.12282804	-1.91595626	-5.26361885	-2.89138033	-5.47703978											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262959-01	Difethialone	170465892		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	104653-34-1	2H-1-benzothiopyran-2-one,	8.9125093813	-5.05	-63.519365853	-2.2	5		-70.8966309789	-60.64478259	0.0002268593	0.9998865955			Brc1ccc(cc1)c2ccc(cc2)C4Cc3ccccc3C(C4)C5=C(O)c6ccccc6SC5=O	GVK	FFS-11-286-NCI-261	-2.49507832	-1.7954017	-2.87265721	-14.73832327	-60.64478259											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091345-04	Hexanedioic acid	170465352		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	124-04-9				-22.4642769866	4	5		0	-2.49695218					OC(=O)CCCCC(=O)O	Specs	AE-562/J262759	-7.14285714	-6.81563765	-4.18637239	0.48567927	-2.49695218											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015859-14	Procainamide	170464952	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51-06-9				-27.1879379597	4	5		0	-4.73653316					O=C(NCCN(CC)CC)c1ccc(N)cc1	Enzo	AC127	-9.05161346	-5.25703952	-5.32492556	0.7671009	-4.73653316											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013289-09	Pridinol	170465865	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	511-45-5				-22.0506279541	4	5		0	-6.28614985					OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3	Specs	AG-680/20240026	-7.51229439	-4.27526882	-2.27132398	1.65419634	-6.28614985											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	14.1253754462	-4.85	-41.2169041302	-3	5		-36.4499394683	-34.60521006	0.1922247544	0.8874869201	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-5.46888248	-7.01075269	-5.72020817	5.27810331	-34.60521006											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159380-05	Benzoyl peroxide	170464986		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	94-36-0				-23.4326532616	4	5		0	-7.81957584					O=C(OOC(=O)c1ccccc1)c2ccccc2	Labotest	LTBB002750	-6.49482788	-5.6344086	-2.20957925	-0.08563959	-7.81957584											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016066-14	Urapidil hydrochloride	170466013	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	64887-14-5		0.6309573445	-6.2	-12.7691169653	4	5		11.6838709719	-2.80679729	0.2800856286	0.9487868841	3350		Cl.COc3ccccc3N2CCN(CCCNC1=CC(=O)N(C)C(=O)N1C)CC2	Microsource	01503100	-6.22350348	-8.90322581	-0.30431331	3.60137023	-2.80679729											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164555-03	Entacapone	170464850	NCI-H1299 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	130929-57-6		1	-6	-13.290671943	4	5		11.8432253719	-8.91359907	0.0473987242	0.998631776			Oc1cc(\C=C(/C#N)C(=O)N(CC)CC)cc([N+]([O-])=O)c1O	Sequoia	SRP10885e	-6.95268781	-5.89247312	-2.03316574	3.55629676	-8.91359907											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023902-09	4-Androstene-3,17-dione	170465907	Cytochrome P450 19A1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63-05-8				-20.1060677487	4	5		0	-1.73070887					O=C2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801871	-6.46939122	-7.2172043	-3.34744641	0.8158298	-1.73070887											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159559-03	Eplerenone	170465283	Mineralocorticoid Receptor (MR) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	107724-20-9	;Eplerenone; ; 9   Eplerenone; Inspra; Eplerenone			-7.4458115532	4	4		0	-2.03722107			4306	NR3C2	O=C(OC)[C@@H]4CC1=CC(=O)CC[C@]1(C)[C@@]65O[C@@H]6C[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45	Tocris	2397	-1.85931608	-1.43115008	-0.25015635	-2.03722107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263480-01	Medroxyprogesterone acetate	170464622	Progesterone Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	71-58-9				-32.0022595467	4	4		0	-11.24311139				PGR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Vitas	STK801943	-6.30607203	-7.06979543	-3.65406951	-11.24311139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015997-10	Taurine	170465726	Antioxidant	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	107-35-7	L-Taurine;Taurine;l-Taurine; Taurine;TAURINE			-19.1073535837	4	5		0	-5.13387818				CAT	NCCS(=O)(=O)O	Microsource	01505463	-4.77189078	-3.08705761	-4.16885619	-1.9290999	-5.13387818											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165864-04	Pipamperone dihydrochloride	170465949	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2448-68-2		2.8183829313	-5.55	-26.6511888438	4	5		11.135581616	-6.14530185	0.4200834692	0.8740957047			Cl.Cl.Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(C(N)=O)N3CCCCC3	Microsource	01505690	-10.11298468	-5.77370189	-8.18006656	1.28455358	-6.14530185											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167506-04	Pimecrolimus		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	137071-32-0		14.1253754462	-4.85	-24.7142569922	4	4		-12.67577036	-12.90688047	0.4521701105	0.8494892529			CC[C@@H]1/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)/C(C)=C/[C@@H]4CC[C@H](Cl)[C@@H](C4)OC	Selleck	S5004	-5.43826252	-1.42801841	-0.26040517	-12.90688047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179456-04	Glycopyrrolate bromide	170465427		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	596-51-0				-16.8587751109	4	5		0	-2.48009518					[Br-].C[N+]3(C)CCC(OC(=O)C(O)(c1ccccc1)C2CCCC2)C3	Prestwick Chemical, Inc.	Prestw-746	-5.3441473	0.81917996	-2.07236138	-6.03418054	-2.48009518											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015251-13	Clotrimazole	170464807	Lanosterol 14alpha-demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	23593-75-1	 ; Bay b 5097; Clotrimazole;Clotrimazole; b 5097, F; Clotrimazol; Kanesten; Baycuten; Canesten; Canesten HC; FB b 5097; b 5097, Ba; Baycuten SD; Lotrimin; Mycelex; Klotrimazole;CLOTRIMAZOLE; 5097, Bay	12.5892541179	-4.9	-84.8693591211	-3	5		-89.940164964	-82.05362863	0.0131530002	0.9933592881	1595	CYP51A1	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4	Vitas	STK700023	-8.67601929	-0.85349116	-5.16377649	-4.64066608	-82.05362863											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188429-02	Acitazanolast	170466060	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	114607-46-4	Acitazanolast			-26.5389779761	4	5		0	-3.77962844					O=C(O)C(=O)Nc1cccc(c1)c2nnnn2	Life Chemicals	F2119-0003	-7.66768961	-4.15594442	-2.99721687	-6.42857143	-3.77962844											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016765-09	Diflunisal	170464956	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	22494-42-4				-28.1349597337	4	5		0	-5.07001007					OC(=O)c1cc(ccc1O)c2ccc(F)cc2F	Microsource	01500245	-5.27400263	-5.78572654	-6.05437808	-8.9964943	-5.07001007											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095109-08	Venlafaxine	170465123	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	93413-69-5	; ;D,L-Venlafaxine?HCl;VENLAFAXINE HYDROCHLORIDE; Effexor XR; VENLAFAXINE; Effexor;VENLAFAXINE; Venlafaxina;Venlafaxine hydrochloride; Venlafaxine	0.0501187234	-7.3	-29.4856727411	4	5		14.0889835879	-8.15911862	0.4704682733	0.8348529959	3350	HTR1A	OC1(CCCCC1)C(CN(C)C)c2ccc(OC)cc2	Microsource	01504171	-12.07309766	-3.35399983	-5.24610264	-0.74894467	-8.15911862											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164634-02	Balsalazide disodium	170465305	agents for IBS and constipation	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	80573-04-2	Balsalazide; Balsalazide; ;Balsalazide disodium; balsalzide Disodium; Colazide; Balsalazide sodium			-18.8978647295	4	5		0	0.41089087				ADORA1	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)C(=O)NCCC(=O)O	Sequoia	SRP00900b	-5.15706582	-8.03840524	-3.64337012	-2.11066225	0.41089087											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274084-01	DL-Isoleucine	170465505		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	443-79-8				-28.2179245578	4	5		0	-4.77265544					CC(CC)C(N)C(=O)O	SIGMA	I2752	-8.97457845	-7.99535004	-3.59957961	0.14071082	-4.77265544											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015227-08	Dexchlorpheniramine hydrochloride	170466889	Histamine H1 Receptor Antagonists; SNRI	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	5502-69-2	 ; Clorfenamina;Chlorpheniramine; Chlor-Trimeton; Mylaramine; Polaramine; Dexclorfeniramina; Chlortrimeton;Chlorpheniramine maleate; Ru-Tuss; Teldrin; Chlorpheniramine; Chlor-trimeton;Chlorpheniramine Maleate	1.2589254118	-5.9	-22.9142144357	4	5		11.05541204	-8.86350296	0.0621897726	0.9976350779		HRH1	Cl.Clc1ccc(cc1)[C@H](CCN(C)C)c2ccccn2	Vitas	STK736174	-8.19566892	-8.7961767	-7.19040112	2.39208388	-8.86350296											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263906-02	Rolitetracycline	170465919		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	751-97-3				-27.4103077687	4	5		0	-8.2223326					O=C(NCN1CCCC1)C4=C(O)[C@@H](N(C)C)[C@@H]5CC3C(C(=O)c2c(O)cccc2[C@@]3(C)O)=C(O)[C@]5(O)C4=O	Microsource	01505684	-7.95600445	-5.42926031	-5.14976353	1.26639735	-8.2223326											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253587-01	Sitaxentan	170465720	Endothelin ETA Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	184036-34-8	Sitaxentan			-11.304855194	4	5		0	-0.89854156				EDNRA	O=C(Cc1cc2OCOc2cc1C)c3sccc3S(=O)(=O)Nc4onc(C)c4Cl	GVK	FFS-11-286-NCI-102	-3.95874347	-2.38956342	-4.72937467	2.41024012	-0.89854156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095911-06	Quetiapine	170465146	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	111974-69-7				-14.8540908175	4	5		0	-3.49031472					OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23	Microsource	01505187	-3.23975006	-5.01593042	-3.5119986	-0.3948981	-3.49031472											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091861-07	Dacarbazine	170464655	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	4342-03-4	; ; Dacarbazino;Dacarbazine; Dacarbazine; DTIC-Dome; DACARBAZINE; Dacarbizine;DACARBAZINE; 6   Dacarbazine			-31.4683753875	4	5		0	-7.55407053				H2AFX	CN(C)/N=N/c1ncnc1C(N)=O	Microsource	01500218	-8.19566892	-8.27951434	-6.83131897	-0.08624211	-7.55407053											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274065-01	Desonide	174007408	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	638-94-8	Desonide			2.884485245	4	5		0	0.77788963				NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Selleck	S1701	2.09995616	2.50900669	-0.15414258	-4.63190184	0.77788963											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015659-14	Mexiletene hydrochloride	170464740		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5370-01-4				-32.439032728	4	5		0	-4.82291571					Cl.CC(N)COc1c(C)cccc1C	Microsource	01503929	-8.92152565	-3.958655	-6.45686149	-7.16476775	-4.82291571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025349-05	Apomorphine	170465297	D2-like dopamine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	58-00-4				-27.9664548048	4	5		0	-6.0400842					Oc3ccc2C[C@@H]1c4c(CCN1C)cccc4c2c3O	Specs	AE-562/J258166	-5.19508987	-4.60199005	-8.26375508	-6.90184049	-6.0400842											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00264003-02	(2R,3R)-2,3-Dimercaptosuccinic acid	170465255	Lead Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	27887-84-9				-21.257778304	4	5		0	-1.17141027					O=C(O)[C@@H](S)[C@H](S)C(O)=O	Microsource	01505007	-5.20385796	-5.07376909	-3.62235067	-6.65644172	-1.17141027											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090965-07	Propyl-4-hydroxybenzoate			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	94-13-3				-21.2320512723	4	5		0	-9.18824929					CCCOC(=O)C1=CC=C(O)C=C1	SigmaAldrich	P53357	-3.21350285	-3.8900326	-2.75743952	-5.3768624	-9.18824929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188690-02	Prasugrel	174006898	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	389574-19-0	Prasugrel(Effient);Prasugrel hydrochloride			-13.454849839	4	5		0	-2.36112382			64805	P2RY12	Cl.Fc1ccccc1C(N2CCc3sc(cc3C2)OC(C)=O)C(=O)C4CC4	Selleck	S1258	0.68829461	-2.92074112	-8.25519161	-7.37510955	-2.36112382											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015675-11	Milrinone	170465221	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	78415-72-2	 ; Milrinone Lact; Milrinone;Milrinone			-21.4784479794	4	5		0	-3.56914066			5139	PDE3A	N#CC1=CC(=C(C)NC1=O)c2ccncc2	Prestwick	Prestw-1065	-4.39719421	-4.98799108	-3.44251766	-6.81419807	-3.56914066											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164554-06	Mupirocin			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	12650-69-0				-22.193611348	4	4		0	-3.70386509					C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O	Prestwick	Prestw-1795	-6.54581639	-2.46892339	-1.40795339	-3.70386509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094207-05	Pentolinium bitartrate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	52-62-0				-21.7743833999	4	4		0	-0.84535274					C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	Prestwick	Prestw-188	-6.44198321	-4.7313863	-1.9817275	-0.84535274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181343-03	Ivabradine hydrochloride		HCN [I(f)] Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	148849-67-6				-27.4967152785	4	4		0	-7.03298619				HCN	COC1=C(OC)C=C2CC(=O)N(CCCN(C)C[C@H]3CC4=CC(=C(OC)C=C34)OC)CCC2=C1	MedChem Express	HY-B0162A	-6.05260881	-6.4088778	-3.29699431	-7.03298619												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186037-02	Ibandronate sodium hydrate	225144338	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	138926-19-9	Ibandronate sodium			-26.1708082887	4	4		0	-5.44686043				FDPS	CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	Prestwick	Prestw-1285	-8.23310548	-3.8969418	-0.42812376	-5.44686043												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00015453-08	Fexofenadine hydrochloride	170464669	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	153439-40-8				-3.8174675385	4	5		0	-0.28370092					Cl.O=C(O)C(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01504179	1.09162648	-2.17447247	-2.08092486	-3.79929886	-0.28370092											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016009-19	Tolazamide	170465136	ATP-sensitive inward rectifier potassium channel 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1156-19-0				-21.4104616596	4	5		0	-3.3448415					Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2	Enzo	KC135	-8.06342208	-5.00645161	-0.23374791	-0.41918327	-3.3448415											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094087-05	Mizoribine	170466027	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	50924-49-7	; ;Mizoribine (Bredinin);MIZORIBINE; Mizoribine;Mizoribine; Mizoribina	1	-6	-23.2639342799	4	5		10.484516124	-5.95435592	0.2182938018	0.9698113649	727833	IMPDH1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2O	Sequoia	50524-49-7	-7.95319654	-9.98709677	-5.0939402	1.40178491	-5.95435592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017048-03	Levopropoxyphene napsylate		Kappa Opioid Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	5714-90-9				-23.1328119818	4	4		0	-9.63876422					O[S+]([O-])(=O)C1=CC=C2C=CC=CC2=C1.CCC(=O)O[C@](CC3=CC=CC=C3)([C@@H](C)CN(C)C)C4=CC=CC=C4	Prestwick	Prestw-1054	-2.81647486	-6.60673577	-5.89221874	-9.63876422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379039-02	Tiotropium (Bromide)		Muscarinic M3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	136310-93-5				-34.3735307641	4	4		0	-5.97847401					C[N+]1(C)[C@H]2CC(C[C@@H]1[C@H]3O[C@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5	MedChem Express	HY-17360	-10.00692221	-4.8174115	-1.40795339	-5.97847401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263517-03	BORNEOL			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	507-70-0				-20.1747244282	4	4		0	-3.44241579					CC1(C)C2CCC1(C)C(O)C2	Microsource	01505747	-5.57670676	-4.30986279	-0.49874211	-3.44241579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167586-03	Piroctone Olamine	225144295		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	68890-66-4		3.9810717055	-5.4	-95.9483960673	-2.2	4		-60.6430652436	-64.90914637	0.0219378609	0.9997031383			CC(CC/1=C/C(=C\C(=O)N1O)C)CC(C)(C)C	Bosche	P6136	-6.63234403	-6.98524668	-36.64651101	-64.90914637												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183658-01	Quadrisol	144207184	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	71109-09-6				-15.0473740887	4	4	CIPLUS_214418;Vedaprofen;vedaprofen;VEDAPROFEN;vedaprofenum;2-(4-cyclohexyl-1-naphthalenyl)propanoic acid;	0	-6.9545514			791253	PTGS2	O=C(O)C(C)c2ccc(c1ccccc12)C3CCCCC3	Toronto Research		-2.35787834	-2.03879737	-3.43823101	-6.9545514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263521-01	Deflazacort	170466610	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	14484-47-0	Deflazacort;Deflazacort (Calcort)			-3.1183186568	4	4		0	-2.33561375				NR3C1	CC(=O)OCC(=O)[C@@]54N=C(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	14484-47-0	-0.03028468	-3.57004602	1.71690868	-2.33561375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018167-05	Cladribine		Adenosine Deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	4291-63-8		2.5118864315	-5.6	-62.7058114581	-1.4	4		-37.456294396	-39.13024533	0.1152592084	0.9917212731		ADA	NC1=NC(=NC2=C1N=C[N]2C3CC(O)C(CO)O3)Cl	APExBIO	A2187	-3.76827897	0.5849714	-34.68685175	-39.13024533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390569-01	Netupitant	363680908		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	290297-26-6		12.5892541179	-4.9	-98.6698941715	-3	4		-103.6685608097	-99.57732363	0.0226116707	0.999684527			CN1CCN(CC1)C2=CC(=C(C=N2)N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=C(C)C=CC=C4	MedChem Express	HY-16346	-6.65830233	-4.72278378	-5.63622721	-99.57732363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386242-02	Cilengitide		Integrin alpha-V/beta-5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	188968-51-6		0.2511886432	-6.6	-100.9414220524	-1.4	4		-30.6167096186	-39.91459323	0.2927182095	0.9432084827			CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O	MedChem Express	HY-16141	-8.83014623	-37.58441223	-31.88859955	-39.91459323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165979-06	CINNAMIC ACID			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	621-82-9				-31.77580824	4	4		0	-9.09491301					OC(=O)\C=C\C1=CC=CC=C1	Microsource	00270092	-7.35383811	-7.90713324	-1.71182159	-9.09491301												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00180997-01	Ethylphenylacetylurea	144206203		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	90-49-3	Pheneturide; Feneturida; Benuride; 			-12.4853977154	4	4	Ethylphenacemide;2-PHENYLBUTYRYLUREA;CIPLUS_778068;N-(AMINOCARBONYL)-2-PHENYLBUTANAMIDE;(2-phenylbutyryl)urea;2-Phenylbutyrylurea;PHENETURIDE;CIPLUS_778163;LS-7390;CIPLUS_778164;phenylethylacetylurea;ethylphenacemide, (+-)-isomer;BENZENEACETAMIDE, N-(AMINOCARBONYL)-.ALPHA.-ETHYL-;Benuride;ETHYLPHENACEMIDE;LS-28470;ethyl phenacemide;ethylphenacemide;pheneturide;Feneturida;CIPLUS_214323;ethylphenylacetylurea;Pheneturidum;Pheneturide;pheneturidum;	0	-4.29420832					CCC(C(=O)NC(N)=O)c1ccccc1	SigmaAldrich	MFCD00069050	-1.05428248	-5.20693136	-4.21203938	-4.29420832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344182-03	5-trans Prostaglandin F2?		Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	36150-01-3				-31.2314186499	4	4		0	-10.2840784					CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C\CCCC(O)=O	Cayman	16210	-6.26470332	-7.58748318	-3.21020995	-10.2840784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167426-03	Caramiphen edisylate	170465518		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	125-86-0				-27.9289263378	4	4		0	-4.99889892					O=S(=O)(O)CCS(=O)(=O)O.CCN(CC)CCOC(=O)C1(CCCC1)c2ccccc2.CCN(CCOC(=O)C1(CCCC1)c2ccccc2)CC	ASDI	100028134	-7.08373268	-8.5884926	-0.14374074	-4.99889892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181122-01	2-Dodecylisoquinolinium tosylate	144206285		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5412-37-3	CIPLUS_189611; 	2.8183829313	-5.55	-89.8386610914	-3	4	CIPLUS_160386;CIPLUS_150169;Lauryl isoquinolinium bromide;CIPLUS_164262;CIPLUS_189611;LAURYL ISOQUINOLINIUM BROMIDE;LAURYL ISOQUINOLINIUM SACCHARINATE;	-97.1490555227	-8.11090956	1	0.9999987752			[O-]S(=O)(=O)c1ccc(C)cc1.CCCCCCCCCCCC[n+]1cc2ccccc2cc1	NCI	NSC-4486	-3.98515073	-9.62205124	-99.53770848	-8.11090956												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00250399-08	Vemurafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1029872-54-5				-1.8446227105	4	4		0	-4.78535026				BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4	Bio Vision	2235	2.06190178	-2.40974042	-3.67113851	-4.78535026												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182064-02	Ceftezole sodium	144206691	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	41136-22-5	Ceftezole; Celoslin; Falomesin; 			0.2410898435	4	4	CEFTEZOLE SODIUM;LS-150087;LS-174169;Ceftezol;ceftezolum;Falomesin;Celoslin;ceftezol;Ceftezole sodium;Ceftezolum;Ceftezole;CIPLUS_748000;ceftezole;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, monosodium salt, (6R-trans)-;demethylcefazolin;Ceftezole Sodium;CIPLUS_207790;CEFTEZOLE;ceftezol, sodium salt;	0	-1.69301201					[Na+].[O-]C(=O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nncs2	Kemprotec	41136-22-5	1.48939977	-0.12682844	-3.22697607	-1.69301201												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181016-04	Bexarotene	170465308	Retinoid RXR Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	153559-49-0	 ; LG69 compound; Bexarotene;Bexarotene;Targretin; Elan brand of bexarotene; Bexarotene (Targretin); 3-methyl-TTNEB	3.9810717055	-5.4	-41.4104332188	-3	4		-55.6308635719	-1.90895742	1	0.9999931046	6256	RXRA	O=C(O)c1ccc(cc1)C(=C)c2cc3c(cc2C)C(C)(C)CCC3(C)C	CiVentiChem	CV-1209	-0.45173987	-5.80028748	-48.89412618	-1.90895742												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181325-03	Menaquinone		bone resorption Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	11032-49-8				-24.9931464228	4	4		0	-5.16541418					CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/1=C(C)/C(=O)C2=C(C=CC=C2)C1=O	Prestwick	Prestw-NAT-0236	-4.00304142	-4.9209436	-8.93763597	-5.16541418												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00091643-10	2-Mercaptobenzothiazole		Thyroid peroxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-41.6821997128	4	4		0	-5.00129567				Tpo	SC1=NC2=C(S1)C=CC=C2	Specs	AE-562/J262422	-9.5759907	-10.18009639	-5.71972444	-5.00129567												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181030-02	Uracil	170465915	Dihydropyrimidine dehydrogenase Substrate	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	66-22-8				-9.6692403465	4	4		0	-4.05977369					O=C1C=CNC(=O)N1	Specs	AC-907/30002021	-0.04025405	-2.49429272	-6.38143582	-4.05977369												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00015267-11	Citalopram hydrobromide		5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	[59729-32-7]				-29.5144055407	4	4		0	-6.16740088				HTR1A	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3	Tocris	1427	-5.33589767	-7.15312421	-7.37853517	-6.16740088												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378902-03	Toceranib		VEGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	[356068-94-5]		0.8912509381	-6.05	-77.9678371787	-2.4	4		-36.9563627365	-13.17266995	1	0.9998686649		FLT1	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NCCN4CCCC4	Tocris	3909	-4.62921549	-10.01944703	-40.79949239	-13.17266995												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00378574-01	Brexpiprazole		Dopamine D3 receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	913611-97-9		2.8183829313	-5.55	-10.7406265668	4	4		-21.3306744	0.97607325	1	0.9998719421			O=C\1NC2=C(\C=C1)C=CC(=C2)OCCCCN3CCN(CC3)C4=C5C=CSC5=CC=C4	MedChem Express	HY-15780	1.36416495	-1.7164116	-17.775562	0.97607325												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181039-02	Ethyl linoleate	170466006	regulation of prostaglandin secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	6114-21-2				-9.2092398083	4	4		0	-1.31294809					O=C(CCCCCCC/C=C\C/C=C\CCCCC)OCC	SIGMA	L6253	-3.5110475	-2.11380739	2.43836113	-1.31294809												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378920-01	Falecalcitriol			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	83805-11-2		3.1622776602	-5.5	8.3481549457	4	4		7.33930836	3.72289885	0.5548886389	0.747152191			C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32342	-0.20127024	-1.1160903	9.75344453	3.72289885												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166291-03	Lycopene		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-21.9872097162	4	4		0	-4.2757191					CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(C)\CCC=C(C)C	SigmaAldrich	75051	-4.6918329	-8.50596094	-0.07251632	-4.2757191												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00274056-01	Risedronate sodium	170464992	Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	115436-72-1		1	-6	-25.9454021582	4	5		9.814227576	-6.36685648	0.1676218527	0.9825504219		FDPS	[Na+].[Na+].[O-]P(=O)(O)C(O)(Cc1cccnc1)P([O-])(=O)O	Microsource	01505944	-9.42852298	-7.9655914	-5.5261533	0.6715947	-6.36685648											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016322-13	Dapsone	170464895	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	80-08-0				-29.5419863922	4	5		0	-6.48343272					Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2	Vitas	STK387118	-8.16516873	-8.62795699	-3.29452236	-1.74434328	-6.48343272											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164572-02	Rimonabant	170465599	Cannabinoid CB1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	168273-06-1	 ; Rimonabant;Rimonabant; Rimonabant Base; Rimonabant(Nlt); Rimonabant HCL	12.5892541179	-4.9	-71.5146193583	-3	5		-70.457468168	-65.5427521	0.0098589178	0.9950354715	56144	CNR1	O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(Cl)cc3)c4C	Sequoia	SRP01287r	-7.52925216	-5.19569892	-2.24486196	-4.80933922	-65.5427521											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091533-10	Ethinylestradiol	170464983	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	57-63-6	;ETHINYL ESTRADIOL; Minulet; Ovulen 50; Conova 30; Oviol; Ovoresta M; Ovostat; Serial C; Varnoline;Ethinyl Estradiol; ; Trikvilar; Desogen (contraceptive); Practil 21; Yermonil (CIBA); Ministat; Oraconal; Mircette; Modicon; Valdys;17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol; Cilest; Novacyclin 22;Ethinylestradiol; Ethinyl estradiol;Ethinyl estradiol; Ortho-Cept; Fisioquens; Femovan; Diane-35; Etinilestradiol; Ethynyl estradiol; Femodene; Gynatrol; Diane; Lestrin; Tri-Ervonum; Bisecurin II; Ovulen-50; Ovidol;17alpha-Ethynylestradiol; Estinyl; Oracon; Demulen; Triregol	10	-5	-48.8187599619	-3	5		-41.5305469691	-39.08891181	0.0113300133	0.9942924285	2099	ESR1	Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick	Prestw-1405	-4.64643039	-4.95483871	-2.13901385	-8.62255476	-39.08891181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015730-11	Neostigmine bromide	170465765	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	114-80-7				-1.0749715161	4	5		0	-1.91005694					[Br-].O=C(Oc1cccc(c1)[N+](C)(C)C)N(C)C	Enzo	AC743	0.16109886	-0.58494624	1.45982182	-0.79780041	-1.91005694											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159441-03	Deslanoside	170465236	Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	17598-65-1	Deslanoside; Cedilanid; Cedilanid-D; Cedilanid-d; C, Desacetyllanatosid; Lanatoside, Desacety; Deslanatoside C; C, Deslanatosid; C, Desacetyldigilanid; Desacetyl Lanatoside; Deslanosido; 	0.0630957344	-7.2	-291.0517054158	-1.1	5	Cedilanid-d;Cedilanid-D;C, Desacetyllanatosid;deslanoside;Cedilanid;LS-87553;C, Deslanatosid;Lanatoside, Desacety;CIPLUS_171064;Deslanatoside C;deslanosidum;Deslanosido;C, Desacetyldigilanid;CARD-20(22)-ENOLIDE, 3-((O-.BETA.-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-, (3B,5B,12B)-;Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-;DEACETYLANATOSIDE C;Desacetyl Lanatoside;deacetyllanatoside c;DESLANOSIDE;Deslanosidum;Deslanoside;	-89.181499952	-97.1797516	0.0027482283	0.9986232808			O=C1C=C(CO1)[C@H]2CC[C@@]9(O)[C@]2(C)[C@H](O)C[C@H]4[C@H]9CC[C@@H]3C[C@H](CC[C@@]34C)O[C@@H]8O[C@H](C)[C@@H](O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)C6)[C@@H](O)C7)[C@@H](O)C8	ChemDiv	N045-0007	-10.02204511	-96.18064516	-96.03510629	-93.67619219	-97.1797516											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094616-07	Chlorthalidone	170464745	renal sodium excretion Activator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	77-36-1		0.7943282347	-6.1	-13.9795313501	4	5		9.53935484	-5.94538851	0.3582517714	0.9126659697			NS(=O)(=O)c1cc(ccc1Cl)C3(O)NC(=O)c2ccccc23	Microsource	01500187	-5.36713583	-8.7827957	-2.05962777	2.4565041	-5.94538851											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164561-02	Zanamivir	170464662	Neuraminidase (Sialidase) Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	139110-80-8	 ; Zanamivir Anhydride;Zanamivir; Zanamivir; Relenza;Zanamivir (Relenza);Zanamavir			-10.1721059207	4	5		0	-2.23288347				NEU2	O[C@@H]([C@@H]1OC(=C[C@H](NC(=N)N)[C@H]1NC(C)=O)C(=O)O)[C@H](O)CO	Sequoia	SRP00400z	-2.61997626	-4.98924731	-1.68915939	1.46488777	-2.23288347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091125-07	Gallic acid	170465633	intrinsic apoptotic signaling pathway in response to oxidative stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	149-91-7				-27.0400383284	4	5		0	-9.09294714					Oc1cc(cc(O)c1O)C(=O)O	Vitas	STK298718	-7.06291335	-4.24946237	-6.35529682	0.38312449	-9.09294714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182990-01	Tandospirone	144206869	Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	87760-53-0	Tandospirone citrate; Sediel; 			-9.9686541393	4	5	LS-178008;TANDOSPIRONE;Sediel;CIPLUS_196843;CIPLUS_667992;TANDOSPIRONE CITRATE;tandospirone;Tandospirone;tandospironum;SM-3997;sm 3997;(3A-A,4B,7B,7A-A)-HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)-BUTYL)-4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE DIHYDROGEN CITRATE;SM 3997;Tandospirone citrate;LS-90979;4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione;	0	-2.41223154					O=C4N(CCCCN1CCN(CC1)c2ncccn2)C(=O)[C@@H]5[C@H]3CC[C@H](C3)[C@H]45	Pharmaron	PH-NIH-172250	-3.79854163	-2.14193548	0.11025845	0.42819796	-2.41223154											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263570-01	Sivelestat sodium hydrate	170465996	Neutrophil Elastase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	201677-61-4				-3.3919969724	4	5		0	-0.19728288				ELANE	O.O.O.O.[Na+].CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC([O-])=O	Bosche	S3046	-1.3651009	-0.61935484	-1.4686425	1.06824123	-0.19728288											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249918-01	Estriol tripropionate	170465876		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2236-31-9				-21.245779276	4	5		0	-5.25489844					CCC(=O)Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2C[C@@H](OC(=O)CC)[C@@H]1OC(=O)CC)c4cc3	GVK	FFS-11-286-NCI-183	-6.17263015	-6.49462366	-4.02663844	2.12296043	-5.25489844											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016345-08	4-Methylumbelliferone	170465819	MAO-A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	90-33-5	 Hymecromon; Cholestil; ; Mendiaxon; Himecromona; beta-Methylumbelliferone;4-Methylumbelliferone (4-MU); Cantabiline; 4-Methylumbelliferone;4-Methylumbelliferone;Hymecromone			-22.418518701	4	5		0	-4.83343048				MAOA	Oc1ccc2c(c1)OC(=O)C=C2C	Vitas	STK364326	-6.64744785	-7.32043011	-0.03087236	-1.91562246	-4.83343048											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159459-04	Mycophenolate mofetil	170464859	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	3.5481338923	-5.45	-39.1752561889	-2.2	5		-38.320719186	-36.2462449	0.007005184	0.9964817946	727833	IMPDH1	Oc3c1C(=O)OCc1c(C)c(OC)c3C\C=C(/C)CCC(=O)OCCN2CCOCC2	Sequoia	115007-34-6	0.14414109	2.57204301	1.44218047	-21.6848463	-36.2462449											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166312-02	Closantel	170466628		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	57808-65-8		7.9432823472	-5.1	-90.649689431	-2.1	5		-98.990509921	-89.57539344	0.001623911	0.9991871984			Clc3cc(NC(=O)c1cc(I)cc(I)c1O)c(C)cc3C(C#N)c2ccc(Cl)cc2	Vitas	STK378904	-2.51822961	-4.29247312	-2.1566552	-20.77436221	-89.57539344											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164557-11	Eprosartan mesylate		urate transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	144143-96-4				-18.8732737017	4	4		0	-4.47918961				AGTR1	CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O	SIGMA	E2535	-4.66149691	-6.0397039	0.85808868	-4.47918961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167477-01	Fidarestat	144206034	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	136087-85-9	SNK-860; Aldos; 			-59.5508061447	4	4	LS-145864;fidarestatum;fidarestat;Aldos;SNK-860;Fidarestat;FIDARESTAT;(2S,4S)-6-fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide;6-FLUORO-2',5'-DIOXOSPIRO(CHROMAN-4,4'-IMIDAZOLIDINE)-2-CARBOXAMIDE, 2S,4S, D-;CIPLUS_737489;Spiro(4H-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2',5'-dioxo-, (2S-cis)-;SNK 860;fedarestat;	0	-19.3481612					NC(=O)[C@@H]2C[C@]1(NC(=O)NC1=O)c3cc(F)ccc3O2	Chemical Block	A4376/0186841	-10.08103163	-15.46938089	-12.20925168	-19.3481612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381723-02	Taltirelin		Thyrotropin-Releasing Hormone (TRH) Analogs	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	103300-74-9				-25.4953944089	4	4		0	-5.33356573				TRHR	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=C[NH]C=N2)C(=O)N3CCC[C@H]3C(N)=O	MedChem Express	HY-B0596	-6.65830233	-2.75280657	-3.69422254	-5.33356573												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164533-02	Buformin	170465982	"AMP-activated protein kinase, AMPK Activator"	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	692-13-7				-7.5063929983	4	5		0	-2.38857875					NC(=N)NC(=N)NCCCC	Labotest	LT02684528	0.59184568	-1.07651398	-5.69471205	-2.98422436	-2.38857875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159414-01	p-Menthane-1,8-diol monohydrate	225144225		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	2451-01-6				-16.7671781703	4	5		0	-2.34282054					CC(C)(O)C1CCC(C)(O)CC1	SIGMA	M4031	-2.5208242	-4.39612283	-4.50438878	-5.89395267	-2.34282054											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095748-04	3-(Octadecyloxy)-1,2-propanediol	170465730		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	544-62-7				-21.0918443134	4	5		0	-6.4061499					OC(CO)COCCCCCCCCCCCCCCCCCC	Microsource	01503983	-3.72205173	-5.88866015	-3.67373153	-3.88694128	-6.4061499											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091470-05	Isoeugenol	170465654	Tyrosyl-DNA phosphodiesterase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	97-54-1				-33.9660076846	4	5		0	-4.08163265					Oc1ccc(cc1OC)C=CC	Bosche	I1325	-9.91231916	-4.42185624	-7.24470135	-6.26205083	-4.08163265											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025060-15	Methotrexate	170464688	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	59-05-2	 Methylaminopterin; Antifolan; Amethopterin (R,S); Mtx-1 protein, rat; Dl-Amethopterin; Methotrexate Hydrate;Abitrexate (Methotrexate); (+/-)Amethopterin; ; D-Methotrexate; (-)Amethopterin; Mexate; methotrexate; Methotrexate hydrate; Metotrexato; Slc19a1 protein, rat; L-Amethopterin hydrate; (+)-Amethopterin hydrate; Methotrexate; 8   D-(-)-Amethopterin;Methotrexate hydrate; DL-Amethopterin; MTXGlu3; Methotrexate Pres-Fre; (+)-Amethopterin;Methotrexate			-35.0137810345	4	5		0	-6.52512126			1719	DHFR	O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)nc(N)nc3N	Prestwick	Prestw-135	-6.79088119	-9.35409161	-8.30657247	-7.43645925	-6.52512126											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181788-01	Cefetamet pivoxil HCl	144206472		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	111696-23-2	Cefetamet pivoxil hydrochloride; Ro 15-8075; Ro-15-8075; Cefyl; 			-7.4118060117	4	4	cefetamet pivaloyloxymethyl ester;7-(2 (2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-desacetoxyceph-3-em-4-carboxylic acid pivaloyloxymethyl ester;Cefyl;CIPLUS_685427;CEFETAMET PIVOXIL HYDROCHLORIDE;cefetamet pivoxil;CIPLUS_691806;Cefetamet pivoxil hydrochloride;Cefetamet Pivoxil Hydrochloride;Ro 15-8075;Ro-15-8075;CIPLUS_741318;cefetamet pivoxyl;	0	-2.94566212					Cl.CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)C(=N\OC)\c1csc(N)n1)C=3C(=O)OCOC(=O)C(C)(C)C	ACC	CEFETAMET PIVOXIL HCl	-2.02042052	0.5849714	-0.6576334	-2.94566212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015408-05	RACEPHEDRINE HYDROCHLORIDE		Norepinephrine Transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	134-71-4, 90-81-3 [racephedrine]				-24.7868261151	4	4		0	-6.91097651					CNC(C)C(O)C1=CC=CC=C1	Microsource	01500525	-5.78437311	-6.54651813	-0.39281458	-6.91097651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263138-19	Regorafenib		VEGFR-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	835621-07-3		8.9125093813	-5.05	-96.9284142017	-2.1	4		-111.8569299745	-98.42694671	0.0127902476	0.9998990918		KDR	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C(=C2)F	MedChem Express	HY-13308	-3.09336333	-3.52703342	-18.5946948	-98.42694671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390584-01	Exatecan	384569198	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	169869-90-3		1	-6	-220.5050136989	-1.2	4		-80.0074063244	-97.26785481	0.0284177042	0.9995016335		TOP1	CC[C@@]1(O)C(=O)OC/C2=C1/C=C3\N(CC4=C5[C@@H](N)CCC6=C5C(=CC(=C6C)F)N=C34)C2=O	MedChem Express	HY-13631A	-18.36549277	-48.37197299	-95.99240853	-97.26785481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016373-08	Benzethonium chloride	170465473		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	121-54-0		1.2589254118	-5.9	-3.1450255582	4	5		12.0427695959	-5.86480657	0.2473061796	0.9606358781			[Cl-].CC(C)(C)CC(C)(C)c2ccc(OCCOCC[N+](C)(C)Cc1ccccc1)cc2	Microsource	01500138	-3.41029256	-6.28564133	-3.90589023	7.12350158	-5.86480657											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015686-11	Gallopamil hydrochloride	170465991	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	16662-46-7				-6.8504344669	4	5		0	-6.16768391					Cl.COc1c(cc(cc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C)OC	Enzo	AC103	-0.18505464	2.75342582	-2.34018504	-3.127727	-6.16768391											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015060-18	Azathioprine	170464989	Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	446-86-6	 Azathiopurine;Azathioprine; Imurel; Imuran; ; Azatioprina; Immuran; Azathioprine Sulfate; Azathioprine Sodium Salt; Azathioprine;AZATHIOPRINE; Azothioprine	11.220184543	-4.95	-25.8109330888	4	4		-19.493622572	-17.53997651	0.2711726527	0.952050572		HPRT1	O=[N+]([O-])c3ncn(C)c3Sc2ncnc1ncnc12	Specs	AG-670/36150031	-1.7119577	-5.59137012	-6.32538194	-17.53997651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262537-04	Thiethylperazine dimalate 		Dopamine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	52239-63-1		11.220184543	-4.95	-97.0791754239	-3	4		-105.6492434774	-99.49270203	0.0025336123	0.9999960409			CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN4CCN(C)CC4)C=C1	Prestwick	Prestw-1068	-5.32050999	-5.3731859	-7.68797644	-99.49270203												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485958-01	Eluxadoline	363681443		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	864821-90-9				-21.6047804283	4	4		0	-2.35849057					COC1=CC=C(CN([C@@H](C)C2=NC=C([NH]2)C3=CC=CC=C3)C(=O)[C@@H](N)CC4=C(C)C=C(C=C4C)C(N)=O)C=C1C(O)=O	MedChem Express	HY-12247	-6.89107513	-2.3064962	-0.90523216	-2.35849057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166144-03	2,3-Dihydroxypropyl octanoate	170465212		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	502-54-5				-21.5796650991	4	4		0	-3.91598434					OCC(O)COC(=O)CCCCCCC	SIGMA	M2265	-5.67344598	-1.92639945	-4.03239778	-3.91598434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274273-01	NCGC00274273-01	225144371	Mu opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-6.2035792575	4	4		0	-4.01388394					C[C@@]12CCCCC[C@@H](CC3=C1C=C(O)C=C3)[C@@H]2N	GVK	FFS-11-286-NCI-03	0.1147042	-3.25673808	-1.7454955	-4.01388394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179274-03	Tribenoside	170465999		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	10310-32-4		14.1253754462	-4.85	-42.6022895913	4	4		-27.7741511079	-27.94588822	0.2108401344	0.9716022705			O[C@@H]2[C@@H](OCc1ccccc1)[C@H](O[C@H]2OCC)C(COCc3ccccc3)OCc4ccccc4	Prestwick	Prestw-1019	-6.59990294	-5.07083621	-1.88409563	-27.94588822												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263540-04	Asenapine		Dopamine D1/D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	65576-45-6				-20.130111249	4	4		0	-6.92474478				HTR2A	CN1C[C@@H]2[C@@H](C1)C3=C(OC4=C2C=CC=C4)C=CC(=C3)Cl	MedChem Express	HY-10121	-2.96883804	-8.79749012	-1.75109443	-6.92474478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346435-13	MK-4827			DPI_SARS-CoV-2_General	2019_NPC-5_Tox			12.5892541179	-4.9	-22.0073257095	4	4		-16.3936926641	-17.39542867	0.081683614	0.9958860376			NC(=O)C1=CC=CC2=CN(N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	Bio Vision	9462-5	-2.06735145	-3.12446278	-2.20673635	-17.39542867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095156-06	Carbadox	170466261		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	6804-07-5				-14.3600151079	4	4		0	-4.44936309					O=C(OC)N\N=C\c2c[n+]([O-])c1ccccc1[n+]2[O-]	Microsource	01505294	-3.07285572	-3.64019254	-0.92021799	-4.44936309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167509-02	Pipethanate ethylbromide	170465967	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	23182-46-9				-33.8708971197	4	4		0	-9.4250623					[Br-].CC[N+]3(CCOC(=O)C(O)(c1ccccc1)c2ccccc2)CCCCC3	Sequoia	23182-46-9	-7.12048352	-6.15065653	-6.21534997	-9.4250623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095029-08	NCGC00095029-08		Staphylococcus aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			2.5118864315	-5.6	-154.1099226497	-2.1	4		-97.6566740509	-99.57280171	0.0218171321	0.999706322			CC[C@H]([C@H]1O[C@@](CC)(C[C@@H]1C)[C@H]2CC[C@](O)(CC)[C@H](C)O2)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC3=C(C([O-])=O)C(=C(C)C=C3)O	Analyticon	NP-009923	-5.99991177	-19.05666897	-73.02927928	-99.57280171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346688-03	Alectinib (CH5424802)		ALK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1256580-46-7				-27.1057347222	4	4		0	-8.48166607				ALK	CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C)(C)C5=C(C2=O)C6=CC=C(C=C6[NH]5)C#N	Axon Medchem	1884	-6.38814135	-3.28265377	-2.18728344	-8.48166607												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00274270-01	NCGC00274270-01			DPI_SARS-CoV-2_General	2019_NPC-5_Tox					6.7807597078	4	4		0	0.52850303					COC1[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/C(O)[C@H](C)C[C@H](CC=O)C1OC2OCC(OC3CC(C)(O)C(O)C(C)O3)C(C2O)N(C)C	GVK	FFS-11-286-NCI-160	3.21154596	-0.86384734	-1.73322612	0.52850303												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015830-08	Phenelzine	170465229	MAO Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	156-51-4	 ;PHENELZINE SULFATE;Phenelzine sulfate; Phenelzine sulfate; 2-Phenelzine; Nardil;Phenylethylhydrazine sulfate; Phenylethylhydrazine sulfate; Fenelzina; Felazine			-17.329567729	4	4		0	-7.38549101			4128	MAOA	O=S(=O)(O)O.NNCCc1ccccc1	Microsource	01500476	-2.69145755	-7.70586213	0.64325918	-7.38549101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167492-03	Lercanidipine hydrochloride	170465587	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	132866-11-6		11.220184543	-4.95	-63.5880469923	-3	4		-58.638208264	-57.0487718	0.0286329658	0.9994941865			Cl.CC=3NC(C)=C(C(C=3C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c2ccccc2)c4cccc(c4)[N+]([O-])=O)C(=O)OC	Sequoia	132866-11-6	-5.42639079	-4.01693158	-6.12872488	-57.0487718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018239-11	ISOETHARINE MESYLATE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	7279-75-6		14.1253754462	-4.85	-29.1466760267	4	4		-12.3134652559	-12.84264863	0.5752351899	0.7205156955			CCC(NC(C)C)C(O)C1=CC=C(O)C(=C1)O	Microsource	01505977	-6.22049676	-4.74257084	-0.49809425	-12.84264863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188437-01	Sultamicillin tosylate	144206543	Staphylococcus Aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	83105-70-8				-26.499977664	4	4	Sultamicillin tosilate	0	-7.91206835					O=S(=O)(O)c1ccc(C)cc1.O=C1C[C@@H]5N1[C@@H](C(=O)OCOC(=O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@H](N)c2ccccc2)[C@H]4SC3(C)C)C(C)(C)S5(=O)=O	APAC	812244	-5.92932457	-3.73185902	-4.05838531	-7.91206835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167505-03	Eptifibatide		Integrin alpha-IIb/beta-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	188627-80-7				-22.6772770408	4	4		0	-7.34247063					NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=C[NH]C4=CC=CC=C34)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O	MedChem Express	HY-B0686	-4.48228703	-2.95438839	-5.26247401	-7.34247063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181337-03	2,4-Dichlorobenzyl alcohol	170465574		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1777-82-8				-2.0763056053	4	5		0	-2.09260704					OCc1ccc(Cl)cc1Cl	Bosche	D0540	-0.33486077	-0.32768746	-1.47779127	1.96114454	-2.09260704											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179265-03	Netilmicin sulfate	170465142	Lysosomal phospholipase A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56391-57-2				-2.7590848701	4	5		0	0.42097557					O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.NC3CC=C(CN)OC3O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H]2O.NC3CC=C(CN)OC3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](NCC)C[C@@H]2N	Bosche	N2413	0.72336694	-0.54469034	-1.19032327	-4.22874671	0.42097557											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00179408-03	Iodixanol	170464924		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	92339-11-2				-7.9568746484	4	5		0	-1.03413563					OCC(O)CNC(=O)c1c(I)c(c(I)c(C(=O)NCC(O)CO)c1I)N(CC(O)CN(C(C)=O)c2c(I)c(c(I)c(c2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C(C)=O	SIGMA	D1556	-1.07409031	-0.82775776	-2.77456647	-3.82559159	-1.03413563											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179625-03	Thioproperazine dimethanesulfonate	170465871	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	2347-80-0		10	-5	-21.4313606312	4	4		-18.7486164999	-17.29051375	0.2004652523	0.9744959802			CS(=O)(=O)O.CS(=O)(=O)O.CN(C)S(=O)(=O)c2cc3N(CCCN1CCN(C)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-149	-2.73859998	0.3354983	-2.50253785	-17.29051375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345812-02	Ingenol mebutate		PKC Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	75567-37-2				-31.114759139	4	4		0	-2.98052203				PRKCA	C\C=C(C)/C(=O)O[C@H]1C(=C/C23[C@H](C)C[C@@H]4[C@H](C(\C=C(CO)/[C@@H](O)[C@]12O)C3=O)C4(C)C)\C	MedChem Express	HY-B0719	-7.85238384	-10.65852295	-1.9817275	-2.98052203												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166124-03	Benzyl cinnamate	170465584		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	103-41-3				-7.0895673842	4	4		0	-1.43797115					O=C(OCc1ccccc1)C=Cc2ccccc2	SIGMA	234214	-1.30224107	-2.23665534	-1.61098115	-1.43797115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182544-01	Triamcinolone hexacetonide	144206532		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	5611-51-8	Triamcinolone hexacetonide; Aristospan; 			-29.0058922535	4	4	hexacetonide de triamcinolone;CL-34433;TATBA;Hexacetonide de triamcinolone;9-fluoro-11 beta,16 alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-(3,3-dimethylbutyrate);triamcinolone hexacetonide;Tiamcinoloni hexacetonidum;Aristospan;Hexacetonido de triancinolona;CIPLUS_164534;triamcinoloni hexacetonidum;TRIAMCINOLONE ACETONIDE 21-T-BUTYLACETATE;Triamcinolone hexacetonide;LS-1379;SQ-21360;Triamcinoloni hexacetonidum;TRIAMCINOLONE HEXACETONIDE;(11 beta, 16 alpha)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy)) pregna-1,4-diene-3,20-dione;Triamcinolone Hexacetonide;	0	-7.8870539					CC(C)(C)CC(=O)OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	APAC	555785	-5.41230423	-8.38745753	-4.90356181	-7.8870539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532496-01	P-T-BUTYL-M-CRESOL			DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-23.5950273496	4	4		0	-3.95659942					CC1=CC(=CC=C1C(C)(C)C)O	SIGMA	A000011660	-6.18240028	-3.84532668	-3.09396654	-3.95659942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346555-05	Apixaban		Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	503612-47-3				-0.7861031477	4	4		0	-2.60577803				F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	APExBIO	A4341	1.90793459	-3.41520065	-1.89345456	-2.60577803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166226-02	4-Propylbenzoic acid	225144274		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	2438-05-3				-8.121113592	4	4		0	-2.0567345					CCCC1=CC=C(C=C1)C(O)=O	SIGMA	332976	-1.72622653	-0.2924857	-2.82032043	-2.0567345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095123-10	Candesartan cilexetil (Atacand)			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	145040-37-5		12.5892541179	-4.9	-82.6821955699	-3	4		-80.0764591633	-77.52843261	0.0675120839	0.9971786012			CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5)C(=O)OC(C)OC(=O)OC6CCCCC6	Adooq	A10176	-7.64471749	-3.87113424	-3.58829501	-77.52843261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024379-29	EMETINE DIHYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	316-42-7, 483-18-1 [emetine]		0.1122018454	-6.95	-359.6429441162	-1.1	4		-100.5171165914	-99.51631879	0.0294614949	0.9994647293			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	Microsource	01500272	-59.9852903	-91.28994795	-97.67842168	-99.51631879												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179245-04	Alcuronium chloride			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	15180-03-7				-4.7199454504	4	4		0	-4.14446157					OC\C=C1/C[N@@+]2(CC[C@@]34[C@@H]2C[C@@H]1\C5=C\N6C7\C(=C/N(C35)C8=C4C=CC=C8)[C@H]\9C[C@H]%10[C@@]7(CC[N@@+]%10(CC=C)CC9=C\CO)C%11=C6C=CC=C%11)CC=C	Prestwick	Prestw-1036	-1.17626557	2.84320323	-0.86680024	-4.14446157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248146-03	4-Methylbenzenesulfonic acid			DPI_SARS-CoV-2_General	2019_NPC-9_Tox					-0.9905100346	4	4		0	-5.14864567					CC1=CC=C(C=C1)[S+](O)([O-])=O	Specs	AE-562/J260927	2.24797421	-2.70861373	-1.41562854	-5.14864567												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091400-02	Allylthiourea	170465680		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	109-57-9				-20.5548960166	4	5		0	-3.56255926					NC(=S)NCC=C	Labotest	LT00025093	-6.61217153	-5.70481357	-0.94587493	-1.40256911	-3.56255926											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160540-03	Ethiazide	170465925		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1824-58-4				-12.0820561366	4	5		0	2.98460288					NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)CC)cc2Cl	Menai	H2748	-3.49653342	-2.34650822	-3.5557891	-5.29708139	2.98460288											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263872-02	SPIRAMYCIN		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	8025-81-8				-13.4491845545	4	4		0	-0.5269068					CO[C@H]1[C@H](O)CC(=O)O[C@@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C	Microsource	01503423	-3.96726004	-2.48583749	-0.62545323	-0.5269068												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522029-01	Zuclopenthixol Decanoate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	64053-00-5				-23.1497067042	4	4		0	-4.85445279					CCCCCCCCCC(=O)OCCN1CCN(CC\C=C/2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1	Toronto Research	Z701490	-4.2445657	-5.55508582	-5.68346628	-4.85445279												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00025325-03	Vapiprost hydrochloride	174006925	Prostanoid TP Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	87248-13-3	GR 32191 hydrochloride; Vapiprost hydrochloride;GR-32191B; 			-24.5952550816	4	4		0	-4.23253002			6915	TBXA2R	O[C@H]1C[C@H](OCC2=CC=C(C=C2)C3=CC=CC=C3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4	SIGMA	G5044	-4.02987745	-7.13621375	-6.20014503	-4.23253002												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00249930-01	Tolycaine	170465945		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	3686-58-6				-9.2989625225	4	4		0	-5.11358729					O=C(Nc1c(C)cccc1C(=O)OC)CN(CC)CC	GVK	FFS-11-286-NCI-233	-2.32131675	-0.61723176	-1.6044235	-5.11358729												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00249416-01	Oberadilol	144206753	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	114856-44-9				-16.5927889668	4	4		0	-4.1202384					Clc3cc(OCC(O)CNC(C)(C)CNc1ccc(cc1)C2=NNC(=O)CC2C)c(C#N)cc3	NCGCChem	DJM10-028	-3.01905358	-3.45818889	-4.55946338	-4.1202384												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00162383-04	Vancomycin hydrochloride		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1404-93-9				-22.5669297715	4	4		0	-2.22855662					CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=CC4=CC(=C3O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@H]6C[C@](C)(N)[C@H](O)[C@H](C)O6)OC7=C(Cl)C=C(C=C7)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C9=CC=C(O)C(=C9)C%10=C(C=C(O)C=C%10O)[C@H](NC8=O)C(O)=O)C(=C2)Cl	Selleck	S2575	-5.25538957	-7.9817367	-1.4231327	-2.22855662												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00183831-01	Aceglatone	144206883		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	642-83-1				-10.8207744089	4	4	Aceglatone;aceglatone monosodium salt;CIPLUS_211093;2,5-di-o-acetyl-d-glucaro-1,4:6,3-dilactone;aceglatonum;Aceglatona;ACEGLATONE;LS-71328;glucaron;aceglatone;2,5-di-O-acetyl glucaro-(1,4)-(6-3)-dilactone;Glucaron;Aceglatonum;Glucaric acid, 1,4:6,3-dilactone, diacetate, D-;diacetyl glucaro-(1,4)-(6-3)-dilactone;	0	-1.01062451					O=C1O[C@H]2[C@@H](OC(C)=O)C(=O)O[C@H]2[C@@H]1OC(C)=O	Pharmaron	PH-NIH-183676	-2.4733876	-3.07770356	-1.10587382	-1.01062451												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522023-01	Paliperidone Palmitate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	199739-10-1				-21.8838239453	4	4		0	-4.42256198					CCCCCCCCCCCCCCCC(=O)OC1CCCN\2C(=O)/C(=C(C)\N=C12)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Toronto Research	P141020	-4.90652116	-5.6058172	-2.58339376	-4.42256198												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00253572-01	Embutramide	170465662		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	15687-14-6				-19.5123371288	4	4		0	-3.67107195					COc1cc(ccc1)C(CC)(CC)CNC(=O)CCCO	GVK	FFS-11-286-NCI-121	-5.25538957	-4.66728672	-0.3444525	-3.67107195												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167536-03	Tosufloxacin toluenesulfonic acid	170466053	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	115964-29-9				-28.1339702989	4	4		0	-3.79200138					O=S(=O)(O)c1ccc(C)cc1.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3CCC(N)C3)c4ccc(F)cc4F	Sequoia	SRP02535t	-8.27891582	-4.98013021	-0.92458303	-3.79200138												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00185000-22	Afatinib (BIBW2992)			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	439081-18-2		1.4125375446	-5.85	-153.8366009077	-2.4	4		-66.8953660401	-56.2840114	0.4928177758	0.8120266638			CN(C)C\C=C\C(=O)NC1=CC2=C(NC3=CC(Cl)=C(F)C=C3)N=CN=C2C=C1O[C@H]4CCOC4	APExBIO	A8247	-11.00724573	-18.14492263	-99.49238579	-56.2840114												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00188443-01	Dapiprazole hydrochloride	144206586	Adrenergic Receptor Alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	72822-13-0				-28.1206251495	4	4	DAPIPRAZOLE HYDROCHLORIDE	0	-5.71823443					Cl.Cc4ccccc4N3CCN(CCc1nnc2CCCCn12)CC3	APAC	878039	-5.53269523	-7.44060201	-5.14865845	-5.71823443												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181097-01	Dimefline hydrochloride	144206266		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	2740-04-7	Dimefline hydrochloride; Dimeflina; Remeflin; Reanimil; 			-34.0163829541	4	4	Flavone, 8-(dimethylaminomethyl)-7-methoxy-3-methyl-;4H-1-BENZOPYRAN-4-ONE, 8-((DIMETHYLAMINO)METHYL)-7-METHOXY-3-METHYL-2-PHENYL-;dimeflinum;LS-68986;Dimeflina;Dimefline hydrochloride;dimefline;4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl-, hydrochloride;3-methyl-7-methoxy-8-dimethylamino-methylflavone;Flavone, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-, hydrochloride;Reanimil;dimefline hydrochloride;CIPLUS_157700;Remeflin;8-((DIMETHYLAMINO)METHYL)-7-METHOXY-3-METHYLFLAVONE;LS-68987;DIMEFLINE HYDROCHLORIDE;DIMEFLINE;CIPLUS_160797;Dimeflinum;	0	-3.29100803					Cl.CN(C)Cc3c(ccc1c3OC(=C(C)C1=O)c2ccccc2)OC	NCI	NSC-114650	-6.60613651	-8.68352076	-7.74111675	-3.29100803												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00242511-03	Seocalcitol		Vitamin D Analog	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	134404-52-7				10.8798286627	4	4		0	1.82257925				VDR	CCC(O)(CC)/C=C/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCCC12C)=C\C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32341	1.38205564	0.93853048	6.32704859	1.82257925												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00164100-01	Trisiloxane, octamethyl-	26757517		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	107-51-7	Octamethyltrisiloxane; Poly(dimethylsiloxane); Trisiloxane, octamethyl-; 			-17.9370998491	4	4	Trisiloxane, octamethyl-;Octamethyltrisiloxane;NCGC00164100-01;Poly(dimethylsiloxane);CIPLUS_208116;	0	-0.82923037					C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	SigmaAldrich	MFCD00008264	-4.55765274	-5.18305572	0.75235678	-0.82923037												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00345881-04	Conivaptan hydrochloride		Vasopressin (AVP) V1a/V2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	168626-94-6				-8.5375633328	4	4		0	1.20929429				AVPR1A	CC1=NC2=C([NH]1)C3=CC=CC=C3N(CC2)C(=O)C4=CC=C(NC(=O)C5=CC=CC=C5C6=CC=CC=C6)C=C4	APExBIO	A8402	0.65748278	-4.33753276	-6.3542422	1.20929429												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00510907-01	Etafedrine hydrochloride		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5591-29-7				-28.8693972995	4	4		0	-4.72488555			154	ADRB2	CCN(C)C(C)C(O)C1=CC=CC=C1	SantaCruz Bio	sc-497331	-6.58824582	-8.77652828	-1.83103698	-4.72488555												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00015467-20	Glybenclamide	170464964	Sulfonylurea receptor 2 Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	10238-21-8		0.7079457844	-6.15	-15.8716624161	4	5		9.6586399839	0.83396852	0.1015249841	0.9455972265			O=C(NC1CCCCC1)NS(=O)(=O)c3ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc3	Enzo	KC120	-7.21553332	-6.82150538	-1.51274588	3.88082575	0.83396852											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015234-19	Carbamazepine	170464712	Sodium channel protein type 5 subunit alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	298-46-4				-16.3375588903	4	5		0	-2.93234094			6331	SCN5A	NC(=O)N2c3ccccc3C=Cc1ccccc12	Vitas	STK177357	-4.95167034	-4.0688172	-1.97142101	-1.05922654	-2.93234094											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166088-02	Decitabine	170465126	DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2353-33-5	 ;5-Aza-2 -deoxycytidine; Dacogen; 5-Aza-2??-deoxycytidine;Decitabine; Decitabine	0.4466835922	-6.35	-8.5459619935	4	5		10.926064104	3.54212438	0.032345751	0.9835778867	1786	DNMT1	NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	Tocris	2624	-6.60505342	-4.84301075	1.26576696	5.08879474	3.54212438											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249924-01	Ibuprofen piconol	170465895		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	64622-45-3				0.4197387786	4	5		0	1.47962158					CC(C)Cc1ccc(cc1)C(C)C(=O)OCc2ccccn2	GVK	FFS-11-286-NCI-203	-2.72172291	3.09677419	0.1278998	3.01541513	1.47962158											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094881-07	Glafenine hydrochloride	170465943		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	65513-72-6				-39.9822948675	4	5		0	-13.6214859					Cl.OCC(O)COC(=O)c3ccccc3Nc1ccnc2cc(Cl)ccc12	Microsource	01500996	-8.63150755	-6.44301075	-6.84925465	-6.44099883	-13.6214859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090974-06	Diethyl phthalate	225144200	Androgen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	84-66-2				-15.7198448899	4	5		0	-2.07147021			367	AR	CCOC(=O)C1=CC=CC=C1C(=O)OCC	SIGMA	524972	-5.47736137	-7.01075269	-1.15109817	2.42044533	-2.07147021											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00273481-01	Metixene hydrochloride	170465287	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1553-34-0		12.5892541179	-4.9	-91.0427200732	-3	5		-90.8418233118	-88.22131552	0.0133320167	0.9932678179			Cl.CN1CCCC(C1)CC2c4ccccc4Sc3ccccc23	Prestwick Chemical, Inc.	Prestw-491	-7.85144989	-9.07526882	-4.34418276	-1.66321103	-88.22131552											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161643-05	Fluorescein sodium	170464991		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	518-47-8				-14.4526882682	4	5		0	-6.33098686					[Na+].[Na+].[O-]c4cc5Oc1cc([O-])ccc1C3(OC(=O)c2ccccc23)c5cc4	Microsource	01505396	-4.30727489	-1.28172043	-2.56240628	1.36572613	-6.33098686											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018213-06	Cyclopentolate hydrochloride	170464720	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	5870-29-1		1	-6	-5.6473283397	4	5		11.295234868	-3.80217908	0.2441608038	0.9617435512			Cl.OC1(CCCC1)C(C(=O)OCCN(C)C)c2ccccc2	Microsource	01500212	-6.07936239	-3.44946237	-2.20075858	6.62129271	-3.80217908											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023193-06	Triamcinolone acetonide	170464660	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	76-25-5	; ; Cinonide; Kenalog; Pevisone; Kenacort A; Acetonide, Triamcinolon; A, Kenacor; Azmacort; Tricort 4;Triamcinolone acetonide; Kenalog 40; 40, Kenalo; Tricort4;TRIAMCINOLONE ACETONIDE; Triamcinolone acetonide; Monacort; Tricort-40			-5.9387656854	4	5		0	-0.21521768				NRC31	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	76-25-5	-2.92521621	-0.34408602	-0.4895475	0.32903633	-0.21521768											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179492-03	Flunisolide	170465331	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	3385-03-3		0.8912509381	-6.05	-9.4635609122	4	5		7.950967744	-4.1160382	0.564915327	0.7355261367		NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-643	-2.81499067	-8.29247312	-2.56240628	2.312269	-4.1160382											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate			-10.059351694	4	5		0	-2.52880778			7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	-5.13820587	-0.69677419	1.15991885	1.48291715	-2.52880778											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015819-15	Propafenone hydrochloride	170464755	Potassium Channel Subfamily K Member 3 (TASK-1; KCNK3) Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	54063-53-5	Propafenona; ;Propafenone; Propafenone Hcl; Propafenone;Propafenone hydrochloride; Rythmol;Propafenone?HCl; Propafenone, (S)-Isomer; Rhythmol; Propafenone, (R)-Isomer			-19.2934494262	4	5		0	-8.69838138				KCNK3	CCCNCC(O)COc2ccccc2C(=O)CCc1ccccc1	SigmaAldrich	P-4670	-4.73121926	-1.68602151	-0.59539561	-3.46614982	-8.69838138											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015385-18	Dipyridamole	170464694	Phosphodiesterase PDE3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	58-32-2	; ; Prandiol; Dipyridamole;DIPYRIDAMOLE; Asasantin; Dipiridamol;Dipyridamole; Persantine			-13.4200488636	4	5		0	0.08967403			8654	PDE5A	OCCN(CCO)c2nc1c(nc(nc1c(n2)N3CCCCC3)N(CCO)CCO)N4CCCCC4	Enzo	EI127	-4.27335934	-3.84516129	-2.82702655	-1.28459389	0.08967403											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159477-05	Phenylacetic acid	170465102		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	103-82-2				-16.4842606093	4	5		0	-1.91902435					OC(=O)Cc1ccccc1	Vitas	STK297835	-4.92623368	-5.41935484	-0.26903061	-2.77201839	-1.91902435											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016530-07	Sulfameter	170465428	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	651-06-9	; Sulfametoxidine; Sulfamethoxydine; 5-Methoxysulfadiazine; ;Sulfameter; Sulfameter;SULFAMETER; Sulfametoxidiazina; Sulla; Sulfamethoxydiazine; Sulphamethoxydiazine			-22.7888113113	4	5		0	-2.00869838					O=S(=O)(Nc1ncc(cn1)OC)c2ccc(N)cc2	Microsource	01501155	-8.65694421	-5.5655914	-2.88877128	0.9690796	-2.00869838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159325-05	Desloratadine	170464781	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	100643-71-8		14.1253754462	-4.85	-28.8946878182	4	5		-15.996780444	-16.07855445	0.423395092	0.684922623			Clc2cc3CCc4cccnc4\C(=C1\CCNCC1)c3cc2	Vitas	STK586537	-5.80803799	-8.10322581	-0.38369939	-0.24790408	-16.07855445											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015691-06	Cysteamine hydrochloride	170466795	Protein-glutamine gamma-glutamyltransferase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	156-57-0				1.701907315	4	5		0	-0.15244586			7052	TGM2	Cl.NCCS	Microsource	01504226	0.72070544	-0.26666667	0.5601129	0.39213919	-0.15244586											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182987-01	Esonarimod	144206833	cytokine production involved in inflammatory response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	101973-77-7	Esonarimod; 			-4.8908765026	4	5	LS-171798;Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-;esonarimod;ESONARIMOD;CIPLUS_704625;KE-298;2-acetylthiomethyl-3-(4-methylbenzoyl)propionic acid;(?)-3-MERCAPTO-2-(P-METHYLPHENACYL)PROPIONIC ACID ACETATE;esonarimodum;KE 298;Esonarimod;	0	-3.32690669					Cc1ccc(cc1)C(=O)CC(CSC(C)=O)C(=O)O	Pharmaron	PH-NIH-151652	-0.55112769	-2.12473118	-1.37161507	1.51897593	-3.32690669											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016344-07	5-Aminosalicylic acid	170464840	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	89-57-6				-18.2964634063	4	5		0	-3.31793929			16534		OC(=O)c1cc(N)ccc1O	Vitas	STK301678	-5.74868577	-5.07526882	-4.46767222	2.1680339	-3.31793929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183137-01	Sulfadiazine silver	144207020		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	22199-08-2				-25.2554780841	4	4	Silver Sulfadiazine;Silver(I) sulfadiazine;Sulfadiazine silver;	0	0.89407619					[Ag+].O=S(=O)([N-]c1ncccn1)c2ccc(N)cc2	SigmaAldrich	481181	-7.6413697	-7.50336474	-1.66826379	0.89407619												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016600-08	Clofazimine	387065713	DNA Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2030-63-9		12.5892541179	-4.9	-69.9519224406	-3	5		-71.5856316796	-68.49616814	0.0671540238	0.9646414818			CC(C)\N=C\1/C=C\2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)\N=C2\C=C1NC5=CC=C(Cl)C=C5	SIGMA	C8895	-7.23475502	-5.68133458	-7.57315695	5.61704864	-68.49616814											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160615-03	Sucrose octaacetate	170465525		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	126-14-7				-27.5764656008	4	5		0	-3.75384333					CC(=O)O[C@H]1[C@H](O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)O[C@]2(COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]2OC(C)=O	SIGMA	252603	-7.52555516	-6.3622436	-7.60664797	-1.5018601	-3.75384333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024822-03	EVANS BLUE		Serum albumin Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	314-13-6		14.1253754462	-4.85	-28.3167823217	4	5		-25.157702716	-23.88141893	0.1583348644	0.9102155688	6339		CC1=C(C=CC(=C1)C2=CC=C(\N=N\C3=C(O)C4=C(C=C3)C(=CC(=C4N)[S]([O-])(=O)=O)[S]([O-])(=O)=O)C(=C2)C)/N=N/C5=C(O)C6=C(N)C(=CC(=C6C=C5)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	206334	-2.83750441	-4.34505064	-5.42973165	2.32857208	-23.88141893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016023-18	Theobromine	170465487	Phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	83-67-0	; ;Theobromine; Limptar; Theobromine;THEOBROMINE; 3,7-Dimethylxanthine			-9.9670414698	4	4		0	-1.77522811			5141	PDE4A	Cn1cnc2c1C(=O)NC(=O)N2C	Microsource	01500649	-1.48658605	-4.03558535	-2.89466631	-1.77522811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344378-02	Norgestrel		Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	6533-00-2				-16.328739834	4	4		0	-5.67817729				CYP19A1	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CCC34)[C@@H]1CC[C@@]2(O)C#C	Cayman	10006319	-4.39405303	0.63925363	-1.87543313	-5.67817729												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386699-01	Fluphenazine decanoate dihydrochloride			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	2376-65-0				-13.1754414271	4	4		0	-5.11747953					CCCCCCCCCC(=O)OCCN1CCN(CCCN2C3=C(SC4=CC=C(C=C24)C(F)(F)F)C=CC=C3)CC1	Axon Medchem	2127	-3.83817885	0.2073255	0.43745669	-5.11747953												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253588-01	Gimatecan	170465615		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	292618-32-7		1.1220184543	-5.95	-190.4503317884	-1.1	4		-83.0550098888	-97.17680007	0.0344762784	0.9992662135			CC(C)(C)O\N=C\c1c3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccccc12	GVK	FFS-11-286-NCI-141	-12.55580115	-28.79920921	-93.88903779	-97.17680007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023016-07	Cefmetazole sodium	170465052	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	56796-39-5				-17.1103700372	4	4		0	-1.99204987					[Na+].N#CCSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C([O-])=O	Prestwick	Prestw-700	-5.75131106	-4.71462953	3.37711069	-1.99204987												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178756-05	LEUCOVORIN CALCIUM	225144299	Antineoplastic Enhancing Agents	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1492-18-8				-8.6091196701	4	4		0	-0.08582528				TYMS	N\C1=N\C(=O)\C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)N2C=O)/N1	Microsource	01500364	-5.78598362	-6.93226749	-0.46457607	-0.08582528												1.6E-9	8E-9	4E-8	2E-7											
NCGC00509863-01	Naloxegol (oxalate)		Mu-type opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1354744-91-4				2.3222696403	4	4		0	-1.06799573			4988	OPRM1	COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC=C	MedChem Express	HY-A0118A	0.91763356	0.414651	0.69733195	-1.06799573												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167433-05	Rocuronium bromide		Steroid non-depolarizing neuromuscular Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	119302-91-9				-15.0474333276	4	4		0	-4.79708081					CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CCCC6)CC=C	MedChem Express	HY-17440	-3.17642388	-3.48997927	-1.30370755	-4.79708081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160471-02	Crocin?		Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	42553-65-1				-7.7287304678	4	4		0	-1.31719473					CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)\C=C\C=C(/C)C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O	DC Chemicals	DCZ-122	-2.6734901	-0.552868	0.67134442	-1.31719473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182076-03	Polythiazide	170465068	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	346-18-9				-16.2245814991	4	4		0	-5.5425061					NS(=O)(=O)c2cc1c(NC(CSCC(F)(F)F)N(C)S1(=O)=O)cc2Cl	Kemprotec	346-18-9	-2.58743986	-5.62575211	-2.20673635	-5.5425061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160444-02	Clofenamide	170466058	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	671-95-4				-16.9578023104	4	4		0	-3.70855543					O=S(N)(=O)c1cc(ccc1Cl)S(N)(=O)=O	Enamine	Z401602360	-4.49443072	-3.10727179	-0.76833735	-3.70855543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00273482-01	Nafcillin sodium monohydrate	170465253		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7177-50-6				-9.8992621106	4	4		0	-1.4770982					[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c1c2ccccc2ccc1OCC)[C@H]4SC3(C)C	Prestwick Chemical, Inc.	Prestw-843	-2.61344429	-1.53429603	-1.50093809	-1.4770982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185767-01	Spiramycin II	144207139	Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	24916-51-6				-20.6197411542	4	4		0	-7.57521005					CN(C)[C@H]1CC[C@H](O[C@@H]1C)O[C@H]4C=CC=CC[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@H](OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]3O)N(C)C)[C@@H](CC=O)C[C@H]4C	Toronto Research	A187800	-3.81831578	-6.26181881	-1.18824265	-7.57521005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021394-04	Anisotropine methylbromide	144207024	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	80-50-2	Anisotropine methylbromide; Valpin; Lytispasm; Valpin 50; 			9.088845514	4	4	LS-157873;Octatropini methylbromidum;ANISOTROPINE;(3-ENDO)-8,8-DIMETHYL-3-((2-PROPYLPENTANOYL)OXY)-8-AZONIABICYCLO(3.2.1)OCTANE BROMIDE;METHYLOCTATROPINE BROMIDE;OCTATROPINE METHYLBROMIDE;8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide;ANISOTROPINE METHYLBROMIDE;methylbromure d'octatropine;8-AZONIABICYCLO(3.2.1)OCTANE, 8,8-DIMETHYL-3-((1-OXO-2-PROPYLPENTYL)OXY)-, BROMIDE, (3-ENDO);3.ALPHA.-HYDROXY-8-METHYL-1.ALPHA.H,5.ALPHA.H-TROPANIUM BROMIDE 2-PROPYLVALERATE;Octatropine methylbromide;Valpin;CIPLUS_750008;Lytispasm;octatropine;Anisotropine methyl bromide;Metilbromuro de octatropina;CIPLUS_149624;anisotropine methylbromide;anisotropine methylbromide, (endo)-isomer;Methyloctatropine bromide;8-Azoniabicyclo(3.2.1)octane, 8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-, bromide, endo-, mixt. with 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;octotropine methylbromide;Valpin 50;valpinax;Methylbromure d'octatropine;CIPLUS_709435;octatropini methylbromidum;Methyloctatropine Bromide;Anisotropine methylbromide;	0	6.80847277					[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC	SigmaAldrich	A5181	1.90585433	-1.07982032	-0.16025641	6.80847277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166015-02	C.I. Basic Violet 14	124893209		DPI_SARS-CoV-2_General	2019_NPC-5_Tox			12.5892541179	-4.9	-77.5941323027	-3	4		-79.7043615977	-77.66284217	0.0648740131	0.9973955423			CC1=CC(=CC=C1N)C(C2=CC=C(N)C=C2)=C/3\C=C/C(=N)/C=C3	SigmaAldrich	B0904	-4.5551077	-7.71445762	-3.60939873	-77.66284217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168747-01	Methoxyflurane	144206179	synaptic transmission Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	76-38-0				-7.386848338	4	4	Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy-;CIPLUS_149389;METHOXYFLURANE;Penthrane;Pentrane;methoxyflurane;Methoxyflurane;methoxyfluranum;LS-1693;Methoxyfluranum;Anecotan;Metoxiflurano;	0	-2.16269135					ClC(Cl)C(F)(F)OC	Alfa Aesar	L17285	-2.04702872	0.61333794	-1.39033264	-2.16269135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390805-02	Icatibant		Bradykinin B2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	130308-48-4				-8.6712393398	4	4		0	-2.82128871					N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CC=CS3)C(=O)N[C@@H](CO)C(=O)N4CC5=C(C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C5	MedChem Express	HY-17446	-2.28526051	-0.31098825	-0.49809425	-2.82128871												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00017256-17	Galanthamine		Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	357-70-0				-23.6734550157	4	4		0	-5.01957992				ACHE	COC1=CC=C2CN(C)CC[C@@]34\C=C/[C@H](O)C[C@@H]3OC1=C24	MedChem Express	HY-76299	-6.74107734	-0.97615757	-2.89760915	-5.01957992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178241-04	Dichloro(ethylenediamine)platinum(II)	170466890	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	14096-51-6				-3.5676893157	4	5		0	2.06507274					[Cl-][Pt]1([Cl-])NCCN1	Microsource	01502107	-1.70074022	-2.38743723	-2.28157575	1.86928765	2.06507274											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262603-04	Idelalisib		PI3Kdelta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	870281-82-6		6.3095734448	-5.2	-24.6017314153	4	4		-14.2078152081	-14.63154147	0.2569158058	0.9573290734		PIK3CD	CC[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=N/C4=C(C(=CC=C4)F)C(=O)N3C5=CC=CC=C5	Axon Medchem	2170	-3.45877267	-0.70836213	-6.20668746	-14.63154147												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091399-01	Benzothiazole	17389158		DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-19.2673414697	4	4	CIPLUS_150270;Benzothiazole;benzothiazole;AB07993090-01;	0	-5.500178					S1C=NC2=CC=CC=C12	NIEHS	AB07993090	-3.83817885	-3.29129233	-4.37023562	-5.500178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167491-04	Lenalidomide	170465201	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	191732-72-6	; IMiD3 cpd; Lenalidomide;Lenalidomide;ENMD-0997; Revimid;CC-5013; Lenalidomide(Revlimid);Revlimid; Revlimid			-18.5431269063	4	5		0	-3.14808866			7124	TNF	O=C1NC(=O)CCC1N3Cc2c(cccc2N)C3=O	Selleck	S1029	-4.32675361	-6.88994808	0.16326872	-4.95567905	-3.14808866											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00522037-01	Oxitropium Bromide		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	30286-75-0				-30.0737416581	4	4		0	-3.82698469					CC[N@@+]1(C)C2C[C@@H](CC1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4	Toronto Research	O847165	-8.28517228	-3.93054596	-4.73406098	-3.82698469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159366-02	m-Cresol	29215286		DPI_SARS-CoV-2_General	2019_NPC-7_Tox		3-Methylphenol-d8; m-Cresol-d8; 			-17.6913923929	4	4	3-Methylphenol-d8;3-cresol, sodium salt;CIPLUS_723418;CIPLUS_151039;CIPLUS_3741557;3-cresol;NCGC00159366-04;NCGC00159366-05;CIPLUS_3755532;m-Cresol;NCGC00159366-03;meta-cresol;Methylphenol tricresol;CRESOL, M-;CIPLUS_719811;3-Methylphenol;NCGC_FLUKA_61020;Cresol mixture of isomers;CIPLUS_161251;LS-460;Metacresol;3-cresol, calcium salt(1:2);m-Cresol-d8;m-Cresylic acid;CIPLUS_746155;3-methylphenol;	0	-7.54716981					CC1=CC(O)=CC=C1	Labotest	LTBB001401	-3.17642388	-2.89391845	-2.74168399	-7.54716981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344578-01	Flavin adenine dinucleotide disodium salt hydrate	225144395	oxidative phosphorylation Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	84366-81-4		3.9810717055	-5.4	-45.9484804872	4	4		-18.520583572	-22.33891064	0.2553565655	0.9576763103			O.[Na+].[Na+].CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO[P]([O-])(=O)O[P]([O-])(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)[N]4C=NC5=C4N=CN=C5N)C\6=N\C(=O)NC(=O)C6=N/C2=C1	SIGMA	F8384	-7.08518992	-2.73842433	-6.65713791	-22.33891064												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179246-05	VIOMYCIN SULFATE		70s Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	37883-00-4				-25.1932744219	4	4		0	-6.20327519					NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)[C@H]2C[C@H](O)N=C(N)N2	Microsource	01503848	-6.59990294	-2.75570145	-2.54244629	-6.20327519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408835-01	Frovatriptan succinate		Serotonin 1d (5-HT1d) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	158930-09-7				-31.3824958772	4	4		0	-6.06977572					CN[C@@H]1CCC2=C(C1)C3=C([NH]2)C=CC(=C3)C(N)=O	Glixx	GLXC-06564	-8.62928486	-3.4122322	-3.46933472	-6.06977572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024246-15	Daunorubicin	170465048	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	20830-81-3	 WP900 hydrochloride; Cerubidine;Daunorubicin hydrochloride; ;; Daunoblastine;DAUNORUBICIN; Daunorubicin; Daunomycin HCL; Dauno-Rubidomycine; Daunomycin, hydrochloride; Daunomycin hydrochloride; Daunoblastin; Dauno Rubidomycin;Daunomycin hydrochloride; (-)-Daunorubicin	10	-5	-125.6521610588	-2.1	5		-111.6956448229	-95.47060713	0.0149722252	0.9924301927		TOP2A	CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c(O)c5C4	Microsource	01500223	-6.57384561	-12.13294748	-17.15158873	-30.95117806	-95.47060713											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164612-02	Propyphenazone	170465821	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	479-92-5				-18.8774354304	4	5		0	-8.01248222					CC(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Specs	AE-562/J258456	-3.1811773	-4.5833688	-2.0303931	-3.38492628	-8.01248222											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183009-01	Pranazepide	144206813	Cholecystokinin A receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	150408-73-4	Panazepide; 			-4.7542391483	4	5	PANAZEPIDE;PRANAZEPIDE;FK480;FR120480;CIPLUS_709224;1H-Indole-2-carboxamide, N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-, (S)-;Panazepide;LS-173385;FR 120480;FK 480;Pranazepide;N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxo-pyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-1H-indole-2-carboxamide;FR-120480;pranazepide;pranazepidum;	0	-5.28658621					Fc6ccccc6C3=N[C@H](NC(=O)c1cc2ccccc2n1)C(=O)N5CCc4cccc3c45	Pharmaron	PH-NIH-126867	0.62566091	-3.74074389	-3.63796207	4.56988013	-5.28658621											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM			-23.249292271	4	5		0	-10.31618558			217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-4.74092351	-4.84722104	-4.91899359	0.11482111	-10.31618558											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166122-01	Perflexane	144205881		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	355-42-0	Perflexane; Imavist; Imagent; 			-8.5137924584	4	4	perflexane;perfluorohexane;NCGC_FLUKA_77273;perflexanum;PERFLEXANE;PERFLUOROHEXANE;Perflexane;NCGC00166122-01;Tetradecafluorohexane;AF0150;AFO 150;CIPLUS_152856;Imavist;TETRADECAFLUOROHEXANE;Perfluorohexane;Imagent;perfluoro-n-hexane;	0	4.0761837					FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F	FLUKA	FLUKA-77273	-4.01464684	-1.16620594	-0.70599446	4.0761837												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167552-01	Piperocaine hydrochloride	144206100	Nicotinic acetylcholine receptor  Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	533-28-8	piperocaine; Piperocainio; Neothesin; 			-5.2925807508	4	4	Piperocaine;2-methylpiperidinepropanol benzoate;piperocaine hydrochloride;Neothesin;Piperocainio;CIPLUS_667885;piperocaine;Piperocainum;LS-172947;Methycaine hydrochoride;LS-116051;piperocaine, (+-)-isomer;(+/-)-2-methyl-1-piperidinepropanol benzoate (ester);PIPEROCAINE;piperocainum;CIPLUS_699088;piperocaine monohydrochloride, (+-)-isomer;CIPLUS_154086;CIPLUS_660991;PIPEROCAINE HYDROCHLORIDE;1-Piperidinepropanol, 2-methyl-, benzoate (ester), hydrochloride;METHYCAINE HYDROCHORIDE;metycaine hydrochloride;	0	-3.37308651					Cl.CC2CCCCN2CCCOC(=O)c1ccccc1	SigmaAldrich	S403253	-1.35880355	0.4837595	0.51541927	-3.37308651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167421-02	Sevoflurane	225144283	GABA-B receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-20.8145935865	4	4		0	-6.75309423			2890		FCOC(C(F)(F)F)C(F)(F)F	Alfa Aesar	L16891	-4.11303255	-5.78906653	-1.74216028	-6.75309423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182994-01	Anacolin	144206808		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	21216-78-4	Diphenylpiperidinomethyldioxolan iodide; Gastrophyllin-A; 			-8.7132348461	4	5	Gastrophyllin-A;N-(2,2-diphenyl-1,3-dioxolan-4-ylmethyl)-N-methylpiperidinium;anacoline;Diphenylpiperidinomethyldioxolan Iodide;Diphenylpiperidinomethyldioxolan iodide;anacoline iodide;DIPHENYLPIPERIDINOMETHYLDIOXOLAN IODIDE;CIPLUS_770363;CIPLUS_784768;	0	-4.07507687					[I-].C[N+]1(CCCCC1)CC2COC(O2)(c3ccccc3)c4ccccc4	Pharmaron	PH-NIH-117094	-0.96052168	0.99157375	-1.68711014	-3.52271162	-4.07507687											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00183858-01	Blonanserin	144206818	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	132810-10-7				-18.7543443271	4	5	AD-5423;BLONANSERIN;blonanserin;AD 5423;2-(4-ETHYLPIPERAZIN-1-YL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[B]PYRIDINE;blonanserinum;Blonanserin;blonanserine;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;CIPLUS_702318;	0	-4.30452939					CCN1CCN(CC1)c3cc(c2ccc(F)cc2)c4CCCCCCc4n3	Pharmaron	PH-NIH-148160	-4.71448713	-6.88994808	-2.81743208	-0.18830662	-4.30452939											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016382-07	Oxethazaine	170465643		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	126-27-2		15.8489319246	-4.8	-5.8669444276	4	4		-11.479221252	-8.31601771	0.414696072	0.8781367535			CC(C)(Cc1ccccc1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2	Microsource	01503279	-0.13435617	-1.42255458	2.41222192	-8.31601771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015146-17	Brompheniramine (maleate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	980-71-2				-25.8609998968	4	4		0	-6.96088174					CN(C)CCC(C1=CC=C(Br)C=C1)C2=CC=CC=N2	MedChem Express	HY-B0480	-5.9766827	-3.9410349	-3.77914768	-6.96088174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263874-02	BLEOMYCIN (bleomycin B2 shown)			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	9041-93-4, 11056-06-7 [bleomycin]		3.9810717055	-5.4	-49.5032126573	4	4		-15.157303584	-21.09043274	0.2870282955	0.9458915827			CC[C@@H]1OC(OC(C(NC(=O)C2=NC(=NC(=C2C)N)C(CC(N)=O)NCC(N)C(N)=O)C(=O)NC(C)C(O)C(C)C(=O)NC(C(C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCCCNC(N)=N)C5=C[NH]C=N5)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]6O)[C@@H](C)[C@@H]1C	Microsource	01503692	-5.95934642	-9.72580368	-10.25641026	-21.09043274												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016265-08	Folic acid	170464833	folic acid-containing compound metabolic process Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	59-30-3		1	-6	-15.2978592495	4	5		11.1305643	-5.82809417	0.5743887326	0.7207058807			O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2cnc3NC(N)=NC(=O)c3n2	Microsource	01502020	-3.98308072	-11.77547025	-5.46322267	2.86134203	-5.82809417											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183853-01	Mosapramine	144206880	Dopamine D4 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	89419-40-9		12.5892541179	-4.9	-95.8174587616	-3	5	MOSAPRAMINE HYDROCHLORIDE;LS-178090;Cremin;3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine;Spiro(imidazo(1,2-a)pyridine-3(2H),4'-piperidin)-2-one, 1'-(3-(3-chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)hexahydro-, dihydrochloride;CIPLUS_3853867;mosapraminum;CIPLUS_703731;Mosapramine hydrochloride;Y 516;(+/-)-1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F]AZEPIN-5-YL)PROPYL)HEXAHYDROSPIRO(IMIDAZO(1,2-A)PYRIDINE-3(2H),4'-PIPERIDIN)-2-ONE;Mosapramine Hydrochloride;Mosapramine;mosapramine;Y-516;MOSAPRAMINE;	-104.0842757014	-99.5732183	0.0079124155	0.9960207187			Clc5ccc6CCc1ccccc1N(CCCN2CCC4(CC2)C(=O)NC3CCCCN34)c6c5	Pharmaron	PH-NIH-183543	-5.26083891	-7.48574347	-7.70712103	-1.45593166	-99.5732183											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159393-03	N-Acetyl-L-tyrosine	170465742		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	537-55-3				-2.2294191445	4	5		0	-1.99164793					Oc1ccc(C[C@H](NC(C)=O)C(=O)O)cc1	Labotest	LT03380081	-0.30842439	-0.73623287	-2.54113116	3.03587011	-1.99164793											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161344-07	Eicosapentaenoic Acid		lipoprotein oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	10417-94-4				-24.6163702635	4	4		0	-5.09982835					CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/CCCC(O)=O	MedChem Express	HY-B0660	-4.92783773	-7.94653602	-3.8148843	-5.09982835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263960-01	OXANTEL PAMOATE		antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-20.8165107029	4	4		0	-4.98238323					CN1CCC/N=C1/C=C/C2=CC=CC(=C2)O.OC(=O)C3=CC4=CC=CC=C4C(=C3O)CC5=C(O)C(=CC6=CC=CC=C56)C(O)=O	Microsource	MS-01505982	-5.42192173	-3.5198556	-1.12570356	-4.98238323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-02	Camostat	170465784	Serine Protease Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	59721-29-8	 ; Camostat mesylate;Camostat mesylate; Camostat Mesylate; Foipan; Foy-305;Camostat			-14.2156721045	4	4		0	-3.85310326				PRSS1	O=C(Oc1ccc(cc1)CC(=O)OCC(=O)N(C)C)c2ccc(NC(=N)N)cc2.CS(=O)(=O)O	Sequoia	SRP01202c	-2.67412127	-3.57142857	-2.876798	-3.85310326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094652-06	DIGITOXIN			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	71-63-6		0.0028183829	-8.5499999999	-450.5501364429	5	4		22.019986564	-96.98708104	1	0.9998729521			C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C	Sequoia	71-63-6	-96.88813765	-95.33694344	-94.37148218	-96.98708104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016407-08	Sulfamethizole	170465369	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	144-82-1	; Sulfapral; ;Sulfamethizole; Sulfamethizole; Rufol; Sulfametizol; FNA, Sulfamethizo; Sulphamethizole; Thiosulfil; Sulfamethizol FNA;SULFAMETHIZOLE			-5.1161551609	4	5		0	-1.56027718					Cc2nnc(NS(=O)(=O)c1ccc(N)cc1)s2	Labotest	LT00772293	-1.17201269	-1.54481232	-2.79231381	1.79580214	-1.56027718											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164595-02	Voglibose	170465993		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	83480-29-9				-10.7119030769	4	5		0	-3.19397917					O[C@H]1[C@@H](NC(CO)CO)C[C@](O)(CO)[C@@H](O)[C@@H]1O	Sequoia	SRP01065v	-2.03560099	-2.75342582	-4.55896513	0.80374776	-3.19397917											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015501-09	Apresoline	170464806	Smooth Muscle Relaxant	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	304-20-1	 Hydrochloride, Hydralazin; ; Apressoline; Rolazine;Hydralazine?HCl; Apressin; Hydrazinophthalazine; Hipoftalin;HYDRALAZINE HYDROCHLORIDE; Hidralazina; Hydralazine hydrochloride;Hydralazine hydrochloride; Nepresol; Apresoline			-16.9094618471	4	5		0	-6.02083429				SMO	Cl.NNc2nncc1ccccc12	Microsource	01500334	-3.6305957	-4.24291429	1.23498137	-4.08303863	-6.02083429											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00182054-03	Aranidipine	170465977	Voltage-gated calcium channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	86780-90-7		14.1253754462	-4.85	-35.5208181422	4	4		-29.77646932	-28.58885175	0.1173986576	0.9914188214			CC=1NC(C)=C(C(C=1C(=O)OCC(C)=O)c2ccccc2[N+]([O-])=O)C(=O)OC	APAC	826079	-3.62761669	-4.88653945	-2.10846065	-28.58885175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167479-01	Bicisate dihydrochloride	144206036		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	14344-58-2	Technetium tc 99m bicisate; 99mTc-ECD; Tc-ethyl cysteinate dimer; Tc-99m-L,L-ECD; Tc-99m ECD; Tc-99m-ECD; Tc-99m-bicisate; 			-22.1821883421	4	4	BICISATE DIHYDROCHLORIDE;N,N'-1,2-ETHYLENEDIYLBIS-CYSTEINE, DIETHYL ESTER DIHYDROCHLORIDE;	0	-3.22974072					Cl.Cl.O=C(OCC)C(CS)NCCNC(CS)C(=O)OCC	Epsilon	INVP_51441657	-5.8900013	-4.41378718	-2.34968284	-3.22974072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183363-01	Sincalide	144207030	Cholecystokinin A receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	25126-32-3				-20.3119466992	4	4	Sincalide;ASP-TYR(SO3-H)-MET-GLY-TRP-MET-ASP-PHE-NH2;Sincalida;(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide;sincalidum;SINCALIDE;Pancreozymin C-terminal octapeptide;NTOC00000205-01;CCK Octapeptide, sulfated;sincalide;Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-;Cholecystokinin octapeptide;SQ-19844;Sincalidum;CCK-8;CIPLUS_174725;	0	-7.14156654					NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc2ccc(OS(=O)(=O)O)cc2)NC(=O)[C@@H](N)CC(=O)O)Cc4cnc3ccccc34	SigmaAldrich	C2175	-4.47709444	-7.3448513	2.2782096	-7.14156654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094719-08	Methenamine	170465468		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	100-97-0				-8.1940697434	4	4		0	-0.35685247					C1N3CN2CN(CN1C2)C3	Microsource	01500394	-2.76947081	-0.12463469	-1.0989011	-0.35685247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023217-08	Meclofenamate sodium	170464886	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	6385-02-0		1	-6	-26.77432207	4	5		9.899340928	-8.19524089	0.2104055028	0.972115591			[Na+].O.Clc2ccc(C)c(Cl)c2Nc1ccccc1C([O-])=O	Microsource	01500377	-9.91611744	-7.82312925	-5.17603783	0.48567927	-8.19524089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183012-01	Penflutizide	144206843	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1766-91-2	Penflutizide; Penflutizida; 	0.4466835922	-6.35	-25.7057393872	4	5	LS-40450;Penflutizida;Penflutizidum;FT-124;Penflutizide;PENFLUTIZIDE;2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE, 3,4-DIHYDRO-3-PENTYL-6-(TRIFLUOROMETHYL)-, 1,1-DIOXIDE;3-n-pentyl-6-trifluoromethyl-7-sulfamyl-3,4- dihydro-1,2,4-benzothiadiazine-1,1-dioxide;penflutizidum;penfluzide;3-PENTYL-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE;penflutizide;CIPLUS_214081;	18.91581786	-4.4114327	0.3308611355	0.926381807			FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)CCCCC	Pharmaron	PH-NIH-153110	-12.01318155	-6.37647464	-4.67682606	2.97308338	-4.4114327											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164576-04	Lopinavir	170464773	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	192725-17-0	;ABT-738; Lopinavir/Ritonavir;Lopinavir;LOPINAVIR; Lopinavir	14.1253754462	-4.85	-61.0468345748	-3	5		-48.1485528554	-45.74434461	0.1315118662	0.9270055093			CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)N4CCCNC4=O	Bosche	L2844	-11.46537704	-5.6445363	-4.9570853	2.60088058	-45.74434461											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025125-18	Colchicine	170465011	Tubulin polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	64-86-8	; ; Colchicine;COLCHICINE; Colchicine derivatives; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer;Colchicine	3.5481338923	-5.45	-82.7766574711	-2.2	5		-63.8532531625	-65.28649478	0.0054870423	0.9972459688	203068	TUBB	CC(=O)N[C@H]2CCc3cc(OC)c(OC)c(OC)c3C1=CC=C(OC)C(=O)C=C12	Prestwick Chemical, Inc.	Prestw-363	-3.58212788	-0.546801	-1.64652303	-36.91616359	-65.28649478											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091505-07	Nitrofurantoin	170464739	Probable pyruvate-flavodoxin oxidoreductase Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	67-20-9				-18.3806784988	4	5		0	-4.25054925			946587	ydbK	O=[N+]([O-])c2ccc(/C=N/N1CC(=O)NC1=O)o2	Labotest	LT00134625	-5.27386807	-5.91827957	-2.83584723	0.99612368	-4.25054925											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016934-06	Nizatidine	170464780	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	76963-41-2				-20.2446310863	4	5		0	-2.52880778					CN(C)Cc1nc(CSCCNC(=C[N+]([O-])=O)NC)cs1	Microsource	01505985	-6.89333559	-5.59139785	-0.5248302	-1.85251961	-2.52880778											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024715-05	L-Arginine	170465748		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	74-79-3		0.05704006	-7.243820026	-19.6386622339	4	5		7.283870968	-3.71250504	0.3723808472	0.7408617119			N[C@@H](CCCNC(=N)N)C(=O)O	Tocris	0663	-6.67288452	-10.23655914	-2.2272206	1.80744614	-3.71250504											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00015149-16	Bumetanide	170464735	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	28395-03-1	; ;BUMETANIDE;bumetanide; Bumex; Bumethanide; Bumetanida;Bumetanide; Bumetanide			-18.8802003991	4	5		0	-2.43016635				SLC12A2	O=S(N)(=O)c2cc(cc(NCCCC)c2Oc1ccccc1)C(=O)O	Microsource	01502004	-4.81600814	-5.24731183	-3.48857722	-2.89822411	-2.43016635											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164624-02	Adefovir dipivoxil	170464742	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	142340-99-6	 ;Hepsera;Adefovir Dipivoxil (Preveon, Hepsera);Adefovir dipivoxil; Preveon; Adefovir dipivoxil; Adefovir pivoxil; Adefovir Pivoxil			-22.2532168195	4	4		0	-8.90324329					CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)COCCn2cnc1c(N)ncnc12	Sequoia	SRP02645a	-5.79465176	-3.21041774	2.06378987	-8.90324329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016697-04	Trimetazidine dihydrochloride	170465797	"Trifunctional enzyme subunit beta, mitochondrial Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	13171-25-0				-10.1953791243	4	5		0	-1.58486477			3032	HADHB	Cl.Cl.COc2ccc(CN1CCNCC1)c(OC)c2OC	Vitas	STK315643	-4.53222631	2.17428744	-3.87983885	0.83972584	-1.58486477											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00390779-02	Brivaracetam		Synaptic vesicle glycoprotein 2A Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	357336-20-0				-8.7826868967	4	4		0	-0.07843479					CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1	MedChem Express	HY-14449	-3.1971965	-0.26667814	-0.53405129	-0.07843479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181762-01	Nequinate	144206498	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	13997-19-8	Nequinate; Nequinato; Statyl; 			-23.4736845827	4	4	nequinatum;Nequinato;CIPLUS_169121;LS-173071;methyl 7-(benzyloxy)-6-butyl-1,4-dihydro-4-oxo-3-quinolinecarboxylate;benzoquate;methylbenzoquate;Statyl;Nequinatum;nequinate;NEQUINATE;Nequinate;	0	-6.96326637					O=C(OC)C3=CNc2cc(OCc1ccccc1)c(CCCC)cc2C3=O	ACC	NEQUINATE	-4.49511119	-5.04967956	-4.66522488	-6.96326637												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378736-01	Cinepazide Maleate		Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	26328-04-1				-32.7146447788	4	4		0	-6.41422284					COC1=C(OC)C(=CC(=C1)\C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3)OC	MedChem Express	HY-66010	-7.99948083	-4.75719386	-5.96283709	-6.41422284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017043-03	Denatonium benzoate		Taste receptor type 2 member 8 Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	3734-33-6				-10.5670880313	4	4		0	-4.88910192			50836	TAS2R8	CC[N+](CC)(CC(=O)NC1=C(C)C=CC=C1C)CC2=CC=CC=C2	Prestwick	Prestw-961	-2.90300251	0.81723945	-0.10151388	-4.88910192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016383-05	Trimethadione	225144178	Voltage-gated T-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	127-48-0				-26.2858417313	4	5		0	-2.94682896					CN1C(=O)OC(C)(C)C1=O	Prestwick	Prestw-515	-7.6150811	-3.68416538	-4.10190537	-6.4636284	-2.94682896											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023722-08	Floxuridine	170465247	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50-91-9	; ; Floxiridina; 5-Fluorodeoxyuridine; Floxuridine; 5-Fluro-2??-Deoxyuridine; 5-FUdR;Floxuridine; 5 Fluorodeoxyuridin	11.220184543	-4.95	-110.0572641643	-2.4	5		-57.2381606936	-55.58707788	0.1688710147	0.9031865225		TYMS	FC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Vitas	STK801909	-10.11398509	-19.44158518	-25.87026333	-25.86765995	-55.58707788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159447-07	8-Quinolinol Salicylic acid (1:1)	170465482	Trichophyton Interdigitale Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	2439-07-8				-33.1312517566	4	5		0	-5.89365791					O=C(O)c1ccccc1O.Oc1cccc2cccnc12	Specs	AE-562/J262360	-8.53572994	-4.54194545	-5.85741811	-8.04995618	-5.89365791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263585-01	Zaltoprofen	170465838	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	74711-43-6				-4.3352819193	4	5		0	1.22632012				PTGS2	O=C(O)C(C)c1cc2CC(=O)c3ccccc3Sc2cc1	Sequoia	74711-43-6	-1.8018413	-2.25167267	1.26739456	-1.74846626	1.22632012											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182704-02	Luliconazole	144206804	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	187164-19-8	Luliconazole; Lulicon; 			-21.2790534659	4	5	Lulicon;Luliconazole;LULICONAZOLE;CIPLUS_787907;	0	-4.44755497			3641571	ERG11	N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3	Pharmaron	PH-NIH-102266	-5.40528974	-4.68871093	-4.78192328	-1.8746312	-4.44755497											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018295-05	Isoxsuprine hydrochloride	170465968		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	579-56-6				-23.8939794316	4	5		0	-7.29218404					Cl.Oc1ccc(cc1)C(O)C(C)NC(C)COc2ccccc2	Prestwick Chemical, Inc.	Prestw-68	-7.09150047	-2.92344786	-3.87983885	-0.7671009	-7.29218404											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167489-03	Sarpogrelate hydrochloride	174006666	5HT(2A) and 5HT(2B) inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	135159-51-2	 ; Sarpogrelate;Sarpogrelate; Anplag; Sarpogrelate HCl	3.1622776602	-5.5	-12.759387468	4	5		-15.777328752	-11.89777396	0.2049921393	0.8792420294			Cl.O=C(O)CCC(=O)OC(COc2ccccc2CCc1cccc(OC)c1)CN(C)C	Tocris	3739	-0.57776256	4.63704469	-2.28586442	-6.35014298	-11.89777396											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015519-11	Dopamine hydrochloride	170464942	Neurotransmitter	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51-61-6	 ; Tensophoril; Actopamin; Dopamine hydrobromide;DOPAMINE HYDROCHLORIDE; 8   Dopamine; Hydrochloride, Dopamin; Dopamina; Dopamine hydrochloride;Dopamine hydrochloride; Intropin;Dopamine;3-HYDROXYTYRAMINE			-25.8314712415	4	5		0	-5.242245				DRD2	Oc1ccc(CCN)cc1O	Vitas	STK301601	-6.6635282	-4.36149143	-5.00087581	-4.30756661	-5.242245											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091149-21	VALPROATE SODIUM			DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1069-66-5, 99-66-1 [valproic acid]				-30.314736043	4	5		0	-5.7569874					CCCC(CCC)C(O)=O	Microsource	01500606	-9.7962852	-4.66287781	-5.48257138	-1.07575689	-5.7569874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095161-05	Rebamipide	170465891	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	90098-04-7	 ; Rebamipida;REBAMIPIDE; REBAMIPIDE; Rebamipide; Mucosta			-24.9017900189	4	5		0	-5.30545898				CAT	Clc1ccc(cc1)C(=O)NC(CC3=CC(=O)Nc2ccccc23)C(=O)O	Microsource	01505310	-7.15141659	-6.67786102	-4.18637239	-0.11347646	-5.30545898											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253611-01	Isoaminile	170465846		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	77-51-0				-0.6926696537	4	5		0	-2.90332776					CC(C)C(C#N)(CC(C)N(C)C)c1ccccc1	GVK	FFS-11-286-NCI-202	0.2268253	-3.04400241	-0.33280785	4.88856611	-2.90332776											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015110-09	Aminoglutethimide	170465259	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	125-84-8	 (S)-(-)-Aminoglutethimide; (+-)-p-Aminoglutethimide;(?)-p-Aminoglutethimide; Glutethimide, para-amino; (?)-p-Aminoglutethimide;AMINOGLUTETHIMIDE; (R)-(+)-Aminoglutethimide;Glutethimide, para-amino;p-Aminoglutethimide; Orimeten; p-Aminoglutethimide; ;Aminoglutethimide (Cytadren); Cytadren;Aminoglutethimide; Aminoglutetimida			-17.7192176742	4	5		0	-4.78168601			1588	CYP19A1	CCC1(CCC(=O)NC1=O)c2ccc(N)cc2	Vitas	STK802074	-5.02867414	-0.62430035	-3.93238746	-2.33761518	-4.78168601											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183016-01	Cefteram	144206853		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	82547-58-8	Cefteram; Ro 19-5247; Cefteram Pivoxil; Ro-19-5247; 			-11.8841154407	4	5	7-(2-(2-amino-4-thiazoyl)-2-(methoxyimino)acetamido)-3-((5-methyl-2H-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene carboxylic acid;ceftetrame;CIPLUS_213480;cefteram;Ro 19-5247;CEFTERAM;Cefteram Pivoxil;Ro-19-5247;cefteramum;Cefteram;LS-177691;	0	-2.28021854					Nc1scc(n1)/C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(Cn2nc(C)nn2)CS[C@@H]34)C(=O)O	Pharmaron	PH-NIH-169126	-4.10425404	1.69206923	-4.32650201	-1.03944442	-2.28021854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167440-02	Bosentan	170465245	"Endothelin receptor, ET-A/ET-B Antagonist"	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	147536-97-8		7.0794578438	-5.15	-37.2790498876	4	5		-17.59286464	-20.42646655	0.022788793	0.9884717374			CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc3nc(nc(OCCO)c3Oc2ccccc2OC)c4ncccn4	Prestwick	Prestw-1244	-4.09907935	-6.09452736	-5.11239563	-9.40841367	-20.42646655											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016643-09	Trioxsalen	170465339	phototherapy treatment of skin disorders	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3902-71-4	 ; Trisoralen; ICN Brand of Trioxsalen; Trioxisalenum; Trioxisaleno; 4,5',8-Trimethylpsoralen;Trioxsalen; Trioxsalen;TRIOXSALEN			-3.4519451328	4	5		0	-2.38857875					Cc1oc2c(C)c3OC(=O)C=C(C)c3cc2c1	Microsource	01500596	-1.67908812	3.66700978	0.60800685	-2.20420684	-2.38857875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016438-04	Procarbazine hydrochloride	170465402	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	366-70-1	; ; PROCARBAZINE HCl; Procarbazine Hcl; Procarbazina; Procarbazine HCl;Procarbazine hydrochloride (Matulane); Matulane;Procarbazine hydrochloride; Procarbazine hydrochloride			-5.76832313	4	5		0	1.43680791				H2AFX	Cl.CC(C)NC(=O)c1ccc(CNNC)cc1	Prestwick	Prestw-1112	0.66199036	-3.46114256	-3.3911368	-4.69325153	1.43680791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167557-01	DL-Methionine methylsulfonium chloride	144206105	ERK1 and ERK2 cascade Activator	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	3493-12-7	Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-; Vitamin U; S-Methylmethionine; Vitamin U Chloride; S Methylmethionin; 			-17.9142978762	4	4	Methylsulfonium Chloride, Methionin;Vitamin U Chloride;CIPLUS_203938;LS-148013;Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-;Vitamin U;S Methylmethionin;S-Methylmethionine;CIPLUS_723454;methionylmethylsulfonium chloride;Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, L-;DL-Met-S-methylsulfonium chloride;CIPLUS_3886671;Methylmethionine sulfonium chloride;CIPLUS_8144825;DL-methionine-S-methylsulfonium chloride;CIPLUS_742496;Methylmethionine Sulfonium Chloride;Chloride, Methionine Methylsulfoniu;DL-Methionine Methylsulfonium Chloride;(3-Amino-3-carboxypropyl)dimethyl sulfonium chloride;CIPLUS_157505;CIPLUS_777498;Methyl-methionine sulphonium chloride;MMSC;Chloride, Methylmethioninesulfoniu;DL-Methionine methylsulfonium chloride;CIPLUS_775683;METHYLMETHIONINE SULFONIUM CHLORIDE;	0	-3.73926448					[Cl-].C[S+](C)CCC(N)C(=O)O	SigmaAldrich	64382	-4.40881764	-4.98822342	-0.53576095	-3.73926448												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180461-02	Hydroquinidine HCl		Sodium channel alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1476-98-8				-34.7372402927	4	4		0	-8.76018498					CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	Prestwick	Prestw-NAT-0284	-9.03546223	-7.6295424	0.30926039	-8.76018498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025018-10	Yohimbine	170465467	alpha2-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	146-48-5	; ; Yohimbine HCL; YOHIMBINE;Yohimbine hydrochloride;YOHIMBINE HYDROCHLORIDE; Yohimbine hydrochloride	0.1412537545	-6.85	-29.0672960188	4	5		17.926089188	-9.26084797	0.4527756368	0.8494249757	150	ADRA2A	O=C(OC)[C@H]2[C@@H](O)CC[C@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23	Microsource	01500663	-12.02174099	-4.87815379	-5.43878087	0.30411693	-9.26084797											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015500-19	Haloperidol	170464841	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	52-86-8	; ;Haloperidol; Haloperidol hydrochloride; Haloperidol Lact;Haloperidol..HCl; Vesadol;HALOPERIDOL;Haloperidol?HCl;Haloperidol hydrochloride; Haloperidol metabolite II; Haloperidol Dec; Haldol	2.8183829313	-5.55	-19.9111110186	4	5		10.9482396239	-6.7593805	0.2797491051	0.9491510205	1813	DRD2	Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3	Enzo	AC250	-7.46811607	-5.44648239	-7.87353302	2.24683401	-6.7593805											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090691-03	2',3'-Dideoxyinosine	174006954	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	69655-05-6	 Videx; Didanosina;Didanosine; ; didanosine (ddI);2',3'-Dideoxyinosine; didanosine??(ddI); 0   Didanosine; ddIno; 2',3' Dideoxyinosin; NunclonD multidishes; 2',3'-Dideoxyinosine (ddI); Inosine, 2',3'-dideoxy-	0.7079457844	-6.15	-27.5646106026	4	5		14.631901056	-6.47943288	0.3035759807	0.9392836587	7015	TERT	O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1	Prestwick	Prestw-153	-10.94325088	-7.00508051	-5.39499037	0.96681948	-6.47943288											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015806-06	Pirfenidone	170465606		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	53179-13-8				1.954111392	4	5		0	0.82364784					CC2=CN(c1ccccc1)C(=O)C=C2	Sequoia	53179-13-8	1.50372644	0.80202436	-2.32926568	-0.54776512	0.82364784											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00390666-01	Opicapone		Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	923287-50-7				-29.8145259	4	4		0	-12.27068718					CC1=C(Cl)C(=[N+]([O-])C(=C1C2=NOC(=N2)C3=CC(=C(O)C(=C3)O)[N+]([O-])=O)Cl)C	MedChem Express	HY-14896	-5.87955352	-5.12710224	-2.92624796	-12.27068718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378911-02	(S)-Tedizolid		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1431699-67-0				-28.5219787512	4	4		0	-4.41849318					C[N]1N=NC(=N1)C2=CC=C(C=N2)C3=CC=C(C=C3F)N4C[C@@H](CO)OC4=O	MedChem Express	HY-14855A	-8.62247988	-3.94855693	-0.63115152	-4.41849318												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016374-05	Carbarsone	170466507		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	121-59-5				-27.1475751068	4	5		0	-4.92358378					O=C(N)Nc1ccc(cc1)[As](O)(O)=O	Prestwick Chemical, Inc.	Prestw-413	-8.64094695	-3.67558758	-7.51016913	0.53900088	-4.92358378											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090762-11	Rifabutin		Cytochrome P450 3a4 Substrate	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	72559-06-9				-17.1536285723	4	4		0	-5.47456507				PRKDC	[H][C@]1(C)\C=C\C=C(C)\C(=O)NC2=C3NC4(CCN(CC(C)C)CC4)N=C3C5=C(C2=O)C(O)=C(C)C6=C5C(=O)[C@](C)(O6)O\C=C\[C@]([H])(OC)[C@@]([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@]([H])(C)[C@@]1([H])O	MedChem Express	HY-17025	-3.54622288	-4.29845222	-1.43305166	-5.47456507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021268-04	Hydroxyprogesterone caproate	170465210		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	630-56-8		11.220184543	-4.95	-66.1115906774	-3	5		-95.1434062432	-88.58790153	0.0044514784	0.9977671586			CC(=O)[C@@]3(OC(=O)CCCCC)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Bosche	H1727	0.5830776	-2.88642992	2.30357525	-0.81945662	-88.58790153											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015429-14	Felbamate	170465178	GABA(A) Receptor Modulators	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	25451-15-4	 Taloxa;; Felbamyl; ; Essex brand of felbamate;FELBAMATE; Felbatol;Felbamate; Felbamate			-6.6808918621	4	5		0	-1.35444312			2554	GABRA1	NC(=O)OCC(COC(N)=O)c1ccccc1	SIGMA	F0778	0.38141166	-2.75776291	-2.74887604	-3.61524978	-1.35444312											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016667-04	Benoxinate hydrochloride	170464771	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5987-82-6				-33.5450277465	4	5		0	-6.95524847					Cl.CCN(CC)CCOC(=O)c1cc(OCCCC)c(N)cc1	Vitas	STK520615	-8.52696186	-5.48550352	-6.22564761	-6.21822962	-6.95524847											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015191-13	Chlormezanone	170465161	GABA Modulators	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	80-77-3	 ; Beserol;CHLORMEZANONE; Chlormezanone; Trancopal; Lobak; Clormetazon; Clormezanona;Chlormezanone			-27.1365757172	4	5		0	-8.85879015			2554	GABRA1	O=C1CCS(=O)(=O)C(N1C)c2ccc(Cl)cc2	Microsource	02300062	-6.25602806	-1.61691542	-5.26653821	-5.86765995	-8.85879015											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021925-03	Prednisolone acetate	170464632	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	52-21-1	; Pred forte;PREDNISOLONE ACETATE;Prednisolone acetate (Omnipred); Supercortyl;Prednisolone acetate			-18.6942691373	4	5		0	-1.09819713				NRC31	CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Bosche	P0845	-6.47523016	-0.63904615	-3.04003425	-4.71078002	-1.09819713											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023648-04	Desoximetasone	170464795	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	382-67-2				-27.1683995458	4	5		0	-1.18971355					OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	SIGMA	D6038	-8.43051293	-3.10087494	-7.41597088	-4.71078002	-1.18971355											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167527-03	Grepafloxacin hydrochloride	170466148	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	161967-81-3				-3.1920345992	4	4		0	-2.61449301					Cl.CC1CN(CCN1)c4cc2c(C(=O)C(=CN2C3CC3)C(=O)O)c(C)c4F	Sequoia	SRP02578g	0.12546509	-0.31829326	-1.91110915	-2.61449301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389762-01	D-(+)-MALTOSE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	69-79-4				-18.5601394864	4	4		0	-6.16148852					OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O	Microsource	01301024	-3.48273773	-3.44100822	-3.80015006	-6.16148852												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094048-01	Iofetamine hydrochloride	144204790		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	82691-32-5	Iofetamine hydrochloride; Iofetamine; Spectamine; iofetaminum (123I); 			-35.2746092712	4	4	(123I)(+/-)-N-ISOPROPYL-P-IODOAMPHETAMINE;Spectamine;NCGC00162226-01;BENZENEETHANAMINE, 4-(IODO-(SUP 123) I)-.ALPHA.-METHYL-N-(1-METHYLETHYL)-, HYDROCHLORIDE;IOFETAMINE HYDROCHLORIDE I-123;IOFETAMINE (123 I);CIPLUS_733786;NCGC00015533-01;N-Isopropyl-p-Iodoamphetamine(123I) Hydrochloride;Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-;CIPLUS_192774;Iofetamine hydrochloride;M123 I-123;(+/-)-2-(N-Isopropyl)amino-4'-iodophenylpropane;NCGC_SIGMA_I120;N-ISOPROPYL-1-(4-IODOPHENYL)-2-PROPYLAMINE HYDROCHLORIDE, I-123, DL-;N-Isopropyl-p-iodoamphetamine(123I) hydrochloride;IOFETAMINE HYDROCHLORIDE I 123;IPRIOFENAMINE HYDROCHLORIDE, I-123;iofetaminum (123I);WHO NO. 5526;Iofetamine hydrochloride I 123;CIPLUS_210740;(+/-)-P-IODO-123I-N-ISOPROPYL-.ALPHA.-METHYLPHENETHYLAMINE;Iofetamine;iofetamine (123 I);N-Isopropyl-p-iodoamphetamine hydrochloride;RO-22-6303/001, I-123;NCGC00094048-01;IOFETAMINE I-123;BENZENEETHANAMINE, 4-(IODO-123I)-.ALPHA.-METHYL-N-(1-METHYLETHYL)-, (+/-)-;	0	-8.88927622					Cl.Ic1ccc(CC(C)NC(C)C)cc1	SigmaAldrich	Lopac-I-120	-8.71766029	-3.45821326	-5.6538818	-8.88927622												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246969-06	Latanoprost		Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	130209-82-4				-22.5223479189	4	4		0	-5.69959475					CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2	SIGMA	L1167	-5.63727611	-4.67116865	-0.79887011	-5.69959475												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00179636-04	Clindamycin hydrochloride		Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	21462-39-5				0.9331401006	4	4		0	0.54904353					CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	Prestwick	Prestw-137	0.89556113	-0.53335627	-1.9905548	0.54904353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386382-03	Lurasidone (Hydrochloride)			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	367514-88-3				-23.9486072225	4	4		0	-10.43182709					O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)C6=NSC7=C6C=CC=C7	MedChem Express	HY-B0032	-3.02414121	-5.18731988	-6.87204837	-10.43182709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015919-14	Sotalol		beta-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	959-24-0				-26.3274502174	4	4		0	-2.40131295				ADRB1	CC(C)NCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0437	-5.21960819	-8.26075928	-4.01559101	-2.40131295												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179514-05	Ceforanide		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	60925-61-3				-35.0265125206	4	4		0	-6.25377904					NCC1=C(CC(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4CC(O)=O)C=CC=C1	Prestwick	Prestw-470	-7.18758386	-9.2669316	-5.82849891	-6.25377904												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160603-02	4-Styrylpyridine	144205483		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	103-31-1	4-styrylpyridine; 4-stilbazole, (E)-isomer; 4-stilbazole, (Z)-isomer; 			-30.9424752705	4	4	CIPLUS_714835;4-stilbazole, (E)-isomer;STYRYLPYRIDINIUM CHLORIDE;CIPLUS_679001;4-STYRYLPYRIDINIUM CHLORIDE;4-stilbazole;4-styrylpyridine;4-stilbazole, (Z)-isomer;4-stilbazole monohydrochloride, (E)-isomer;4-stilbazole monohydrochloride;	0	-5.21724108					C(=Cc1ccncc1)c2ccccc2	Maybridge	JFD 00085	-5.55953126	-6.67963135	-7.27882524	-5.21724108												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00178860-06	Ethopropazine hydrochloride	170465065	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1094-08-2				13.1976261142	4	4		0	-1.67573637					Cl.CCN(CC)C(C)CN1c3ccccc3Sc2ccccc12	Microsource	01500293	3.56471956	2.13071785	2.41116751	-1.67573637												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00016912-06	Terconazole			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	67915-31-5		4.4668359215	-5.35	-81.1787260646	-3	4		-99.1545846821	-4.41392416	1	0.999986975			CC(C)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2	Prestwick	Prestw-495	-2.76858395	-4.42208506	-99.39267585	-4.41392416												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378845-01	Trelagliptin succinate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1029877-94-8				-24.7331193879	4	4		0	-4.05113587					CN1C(=O)\C=C(\N2CCC[C@@H](N)C2)N(CC3=C(C=CC(=C3)F)C#N)C1=O	MedChem Express	HY-15408A	-5.45218714	-5.55508582	-4.28752719	-4.05113587												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00347131-03	D(-)-Tartaric acid			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	526-83-0				-28.607429045	4	4		0	-4.26708128					OC(C(O)C(O)=O)C(O)=O	DC Chemicals	DCJ-065	-5.9531264	-6.59507906	-5.83756345	-4.26708128												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167472-03	Amlexanox	170465365	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	68302-57-8	 3   Amlexanox; ; Solfa;Amlexanox; Aphthasol; Amlenanox	0.3981071706	-6.4	-29.0073095959	4	5		12.4899847239	-12.42882123	0.0334109477	0.9993200386		IL3	CC(C)c1cc2C(=O)c3cc(c(N)nc3Oc2cc1)C(=O)O	Bosche	A2169	-11.08190605	-8.50752688	-3.05636412	-0.25691878	-12.42882123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249931-01	Docarpamine	170465850	Dopamine D1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	74639-40-0				-28.0951341243	4	5		0	-7.38017307					CC(=O)N[C@@H](CCSC)C(=O)NCCc1cc(OC(=O)OCC)c(cc1)OC(=O)OCC	GVK	FFS-11-286-NCI-235	-7.85992878	-8.25806452	-2.93287466	-0.25691878	-7.38017307											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015156-15	Baclofen	170465099	GABA-B receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1134-47-0				-8.695366921	4	5		0	-0.68152267					Clc1ccc(cc1)C(CN)CC(=O)O	Vitas	STK535284	-2.99304731	-7.02795699	-1.1422775	-0.09465429	-0.68152267											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00249916-01	Dimorpholamine	170465773	skeletal muscle contraction Activator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	119-48-2				-30.5110711518	4	5		0	-7.74783661					O=C(N(CCCC)CCN(CCCC)C(=O)N1CCOCC1)N2CCOCC2	GVK	FFS-11-286-NCI-176	-8.52128201	-8.93763441	-3.85022493	0.03155143	-7.74783661											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015692-08	Methoxamine hydrochloride	225144174		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	61-16-5				-22.2391820404	4	5		0	-4.3760929					COC1=CC(=C(OC)C=C1)C(O)C(C)N	Prestwick	Prestw-535	-7.58012549	-3.65591398	-2.99461939	-0.3741098	-4.3760929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015801-12	Pentoxifylline	170465384	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	6493-05-6				-33.5462236053	4	5		0	-7.02147693					CC(=O)CCCCN2C(=O)c1n(C)cnc1N(C)C2=O	Vitas	STK177321	-8.87739529	-9.98709677	-6.05539384	-0.88794735	-7.02147693											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016872-12	Ticlopidine hydrochloride	170464698	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	55142-85-3	 Ticlid; Ticlopidina;Ticlopidine; ;; Ticlodone; Ticlopidine Hcl;TICLOPIDINE HYDROCHLORIDE; Ticlopidine hydrochloride; Hydrochloride, Ticlopidin;Ticlopidine hydrochloride	0.7079457844	-6.15	-22.7225223488	4	5		14.506104796	-6.98560732	0.1865974284	0.9781601654	64805	P2RY12	Clc3ccccc3CN1CCc2sccc2C1	Vitas	STK589340	-10.00508733	-6.73548387	-3.65617006	2.14098981	-6.98560732											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00174046-02	Imidocarb dipropionate	170466330	Adenosine deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	55750-06-6				23.4354598473	4	4		0	8.48711738					CCC(=O)O.CCC(=O)O.O=C(Nc1cc(ccc1)C2=NCCN2)Nc3cccc(c3)C4=NCCN4	Vitas	STK379516	3.00601202	3.70121131	7.40918198	8.48711738												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346667-02	Lornoxicam		non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	70374-39-9				-6.3009446972	4	4		0	-1.40311125				PTGS1	CN1\C(=C(O)/C2=C(C=C(Cl)S2)[S+]1([O-])=O)C(=O)NC3=NC=CC=C3	Selleck	S2047	-1.91658735	-1.84954192	1.33733504	-1.40311125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249936-01	Iocarmic acid	170465965		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	10397-75-8				-7.4226366546	4	5		0	3.41356273					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)O)C(=O)NC)CCCCC(=O)Nc2c(I)c(C(=O)NC)c(I)c(C(=O)O)c2I	GVK	FFS-11-286-NCI-245	-2.74879439	-2.47469549	-1.83258403	-2.66871166	3.41356273											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274268-01	NCGC00274268-01	225144369		DPI_SARS-CoV-2_General	2019_NPC-1_Tox					-17.1093412721	4	5		0	-2.41603368					CCCCCCCC\C=C\CCCCCCCC(=O)NCCOC(=O)CC(C([O-])=O)[S]([O-])(=O)=O	GVK	FFS-11-286-NCI-103	-5.01972819	-1.95144965	-3.63947763	-2.98422436	-2.41603368											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016570-06	Mephentermine hemisulfate	170465271		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1212-72-2				-24.4173362442	4	5		0	-5.11576828					O=S(=O)(O)O.CC(C)(NC)Cc1ccccc1.CC(C)(NC)Cc1ccccc1	Microsource	01503250	-7.41341517	0.19300051	-6.42260758	-3.56266433	-5.11576828											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179582-03	Bacampicillin hydrochloride	170465170		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	37661-08-8				-8.8073816046	4	5		0	-2.77294774					Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]3C(=O)N2[C@@H](C(=O)OC(C)OC(=O)OCC)C(C)(C)S[C@@H]23	Prestwick Chemical, Inc.	Prestw-416	0.19728189	-1.94287185	-1.89252837	-6.32340053	-2.77294774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094689-06	Guaifenesin	170464855		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	93-14-1				-40.2800873392	4	5		0	-8.46526952					OCC(O)COc1ccccc1OC	Vitas	STK365152	-9.92985533	-5.14239149	-8.23806465	-8.84750219	-8.46526952											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179541-03	Carteolol hydrochloride	170465122	Adrenergic receptor beta Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	51781-21-6				-23.9348855361	4	5		0	-2.70888624					Cl.CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12	Prestwick Chemical, Inc.	Prestw-446	-4.22183253	-5.69994853	-8.37508028	-6.06923751	-2.70888624											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00389554-01	DORAMECTIN		chloride transmembrane transport Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	117704-25-3		4.4668359215	-5.35	-109.3191979033	-2.1	4		-85.1075142469	-86.53100353	0.031232212	0.9993979417			CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]2[C@H](C)O[C@@H](C[C@@H]2OC)O[C@H]\3[C@@H](C)\C=C\C=C\4CO[C@@H]5C(O)\C(=C/[C@@H](C(=O)O[C@H]6C[C@@H](C/C=C3C)O[C@@]\7(C6)O[C@@H]([C@@H](C)\C=C7)C8CCCCC8)[C@]45O)C	Microsource	01505902	-4.81526348	-4.32706783	-41.9517147	-86.53100353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159461-07	Amprenavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	161814-49-9				-25.1480712857	4	4		0	-5.97847401					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	SIGMA	SML0685	-6.29488622	-2.41730827	-4.17089641	-5.97847401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389663-01	Empagliflozin (BI 10773)		Sodium/glucose cotransporter 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	864070-44-0				-10.7615410498	4	4		0	-4.30519848					OCC1OC(C(O)C(O)C1O)C2=CC(=C(Cl)C=C2)CC3=CC=C(OC4CCOC4)C=C3	APExBIO	A4601	-3.74232067	1.78932427	1.09017081	-4.30519848												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178852-05	Tobramycin	225144300	30S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	32986-56-4	 Nebcin; Tobrex; Obracin;TOBRAMYCIN; Tobramycin Sulphate;; Sulfate, Tobramyci; Brulamycin;Tobramycin; Tobramycin Base; Tobramicina; Tobracin; Nebicin			-16.7626096814	4	4		0	-3.37269598					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	Microsource	01500579	-4.39127801	-3.14852252	-2.20240985	-3.37269598												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00178554-03	AZLOCILLIN SODIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	37091-66-0				-12.1696813805	4	4		0	-5.11569132					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)C4=CC=CC=C4)C(=O)N2C1C([O-])=O	Microsource	01503101	-2.36653111	-1.10112263	-2.19358256	-5.11569132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167542-01	Tiamulin	144206092	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	55297-95-5	Tiamulin; Tiamulina; 			2.1423948984	4	4	TIAMULIN FUMARATE;THIAMUTILIN FUMARATE;tiamulin hydrochloride;(3AS,4R,5S,6S,8R,9S,9AR,10R)-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-6-VINYLDECAHYDRO-3A,9-PROPANOCYCLOPENTA(8)ANNULEN-8-YL ((2-(DIETHYLAMINO)ETHYL)THIO)ACETATE (2E)-BUT-2-ENEDIOATE (SALT);Tiamulina;sandoz 81723hfu;Tiamuline;Tiamulinum;ACETIC ACID, ((2-(DIETHYLAMINO)ETHYL)THIO)-, (3AS,4R,5S,6S,8R,9S,9AR,10R)-6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER, (2E)-2-BUTENEDIOATE (1:1) (SALT);tiamulinum;Tiamulin Hydrogen Fumarate;tiamuline;(1S,2R,3S,4S,6R,7S,14R)-6-[(2-Diethylaminoethylthio)acetoxy]-3-hydroxy-2,4,7,14-tetramethyl-4-vinyltricyclo[5,4,3,01.8]tetradecan-9-one;LS-174933;Thiamutilin fumarate;2-(diethylaminoethyl)thioacetoxymutilin;14-DEOXY-14-((2-DIETHYLAMINOETHYL)THIOACETOXY)MUTILIN HYDROGEN FUMARATE;CIPLUS_182128;Tiamulin;TIAMULIN HYDROGEN FUMARATE;Tiamulin Fumarate;TIAMULIN;LS-11694;LS-11693;(3AS,4R,5S,6S,8R,9S,9AR,10R)-6-ETHENYL-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXODECAHYDRO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL((2-(DIETHYL-AMINO)ETHYL)SULPHANYL)ACETATE HYDROGEN (E)-BUT-2-ENEDIOATE;CIPLUS_207320;Tiamulin fumarate;	0	1.93472482					CCN(CC)CCSCC(=O)O[C@@H]3C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]21CCC(=O)[C@H]1[C@@]3(C)C(C)CC2	SigmaAldrich	34044	0.91286666	-0.86025205	-1.47857174	1.93472482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181774-02	Chrysarobin	170465659		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	491-59-8		0.316227766	-6.5	-14.4039294749	4	5		8.742745868	-0.60956337	0.3695296092	0.7444881301			Oc2c3c(cc1cccc(O)c12)cc(C)cc3O	Sequoia	491-59-8	-6.86895489	-3.54344269	-2.31213873	4.12600427	-0.60956337											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016523-05	Iodipamide	170464888	Complement factor B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	606-17-7				-15.6451219182	4	5		0	1.42231453					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Prestwick Chemical, Inc.	Prestw-939	-4.91740135	-6.86730388	-2.25959012	-1.72938133	1.42231453											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00387997-02	Valganciclovir·HCl		Viral Dna Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	175865-59-5				-33.9273947572	4	4		0	-8.62782692					CC(C)[C@H](N)C(=O)OCC(CO)OC[N]1C=NC2=C1N\C(=N/C2=O)N	Enzo	AC3286	-8.03409189	-6.08198202	-3.87959571	-8.62782692												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166125-02	Meglumine	170465359	amino sugar	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	6284-40-8	 hypaque(M)90; Isopaque coronar; N-Methyl-D-glucamine; Isteropac; Banamine; Urovist; Isopaque cerebral;Meglumine; Renovue-65; ; Uropolinum Polfa; Vascoray; Uropolin; Renovist II; Conraxin-H; Hypaque 76; Telebrix 350; Salicylate Meglumine; Uromiron; Meglumine iotalamate; Meglumine; Fortombrine; Sch 14714 meglumine; N-Methyl-D-Glucamine; Vasurix; Visotrast; Meglumina			-4.2617321095	4	4		0	-2.96309207				GLUT1	O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO	Prestwick	Prestw-884	-1.12053301	1.18714783	-0.02206823	-2.96309207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016508-04	Methazolamide		Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	554-57-4				-19.5546944223	4	4		0	-5.05468648					CN/1\N=C(/SC1=N\C(C)=O)[S+](N)([O-])=O	Selleck	S4039	-4.20091719	-3.767904	-3.4558856	-5.05468648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181124-02	Sparteine	170465740	sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	90-39-1				-28.8887094906	4	5		0	-7.77889631					C3CCCN4C[C@@H]2C[C@@H](CN1CCCC[C@H]12)[C@@H]34	Vitas	STK801664	-5.88776852	-4.79927946	-6.32840933	-6.26205083	-7.77889631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018241-07	Betamipron	170466040	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3440-28-6				-30.0940478872	4	5		0	-5.38116592			9376	SLC22A8	O=C(NCCC(=O)O)c1ccccc1	Vitas	STK288042	-7.77290662	-5.15096929	-5.41211732	-6.11305872	-5.38116592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091517-06	L-Ascorbic acid	170464728		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	50-81-7				-19.1620594634	4	5		0	-4.12245451					OC=1C(=O)O[C@H]([C@@H](O)CO)C=1O	Microsource	01502230	-7.18565437	-2.30345303	-3.5295148	1.89278744	-4.12245451											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018204-13	Vinpocetine	170465859	Na channel blocker, also PDE1, IKK inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	42971-09-5	;Vinpocetine; Cavinton			-20.1427768734	4	5		0	-1.17848919					O=C(OCC)C1=C[C@@]5(CCCN4CCc3c(n1c2ccccc23)[C@@H]45)CC	Prestwick Chemical, Inc.	Prestw-268	-7.11717881	-6.73813829	-2.57488177	0.64000726	-1.17848919											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090808-04	Amphotericin B		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1397-89-3	 Amphotericin B trihydrate; L-AmB; Amphotericinum B; PAME amphotericin B ester; Abelcet; ; liposomal amphotericin B; Ambisome; amphotericinum B; Amphocil; D-AmB cpd; AmBisome;Amphotericin B;Amphotericin B (Abelcet); Amphotericin B solution; amphotericin??B; HAmB-DOC; Amphozone; Amfotericina B; Fungizone; Amphotericin B; Amphotericine B			-15.8284742398	4	5		0	-4.49270782					C[C@H]1O[C@@H](O[C@@H]\2C[C@@H]3O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C[C@H](O)[C@H]3C(O)=O)[C@@H](O)[C@@H](N)[C@@H]1O	SIGMA	A9528	-4.3610374	-3.4573323	-4.39656682	1.58413145	-4.49270782											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016509-06	Trimethobenzamide hydrochloride	170465132	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	554-92-7				-31.328426386	4	5		0	-11.73522373					Cl.COc1c(cc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2)OC	Microsource	01500594	-9.53950184	-2.91483682	-3.45069189	-0.59461668	-11.73522373											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166413-02	Argatroban	170464871	Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	74863-84-6	; 2   Argatroban; Argatroban Anhydride; Argipidine monohydrate; Acova; Novastan;Argatroban			-21.2670990695	4	5		0	-2.37955479				F2	C[C@H]1C[C@H](C(=O)O)N(CC1)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c3cccc2C[C@@H](C)CNc23	Sequoia	SRP07170a	-7.05726269	-4.23232584	-4.00245227	-0.9214289	-2.37955479											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016012-12	Triflupromazine hydrochloride	170465325	Muscarinic acetylcholine receptor M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1098-60-8		14.1253754462	-4.85	-27.1066161346	4	5		-26.7488373159	-22.70736443	0.1292037336	0.9285685353	1129	CHRM2	Cl.FC(F)(F)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Microsource	01503118	-4.29256184	2.26039783	-3.72219303	-1.64767827	-22.70736443											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00186464-03	Aliskiren hemifumarate	170465199	Renin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	173399-03-6	ALISKIREN HEMIFUMARATE;Aliskiren hydrochloride	1.77827941	-5.75	-20.9781078808	4	5		9.0776341719	-3.02072515	0.5032016988	0.8045445165		REN	Cl.NC(=O)C(C)(C)CNC(=O)[C@@H](C[C@H](O)[C@@H](N)C[C@H](Cc1cc(OCCCOC)c(cc1)OC)C(C)C)C(C)C	Microsource	01505710	-9.23136181	-3.93093946	-6.21825188	2.23775589	-3.02072515											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018172-09	Indapamide	170465366	Carbonic Anhydrase Type VII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	26807-65-8	; Veroxil;Indapamide; Indapamida; Lozol;INDAPAMIDE; Natrix; Indapamide Anhydride	1	-6	-18.9085399446	4	5		12.560772064	-4.04117939	0.0423190091	0.9989058035	766	CA7	NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C	Microsource	01500349	-8.38397672	-8.15895979	-3.4944824	3.30897372	-4.04117939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182995-01	Etomidoline	144206828		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	21590-92-1	Etomidoline; Smedolin; Etomidolina; 	0.0446683592	-7.35	-25.1711227391	4	5	Etomidolina;2-ethyl-3-(p-(beta-piperidinoethoxy)phenylamino)-isoindoline-1-one;Etomidolinum;K-2680;2-ETHYL-3-(.BETA.-PIPERIDINO-P-PHENETIDINO)PHTHALIMIDINE;K 2680;Phthalimidine, 2-ethyl-3-(beta-piperidino-p-phenetidino)-;etomidolinum;Etomidoline;LS-109527;CIPLUS_213965;Smedolin;ETOMIDOLINE;amidoline;1h-isoindol-1-one, 2-ethyl-2,3-dihydro-3-((4-(2-(1-piperidinyl)ethoxy)phenyl)amino)- (9ci);etomidoline;	9.204185564	-8.29457714	0.6296560388	0.6375216831			O=C4c1ccccc1C(Nc3ccc(OCCN2CCCCC2)cc3)N4CC	Pharmaron	PH-NIH-150630	-9.75348797	0.81374322	-5.78910492	-2.49194317	-8.29457714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015893-06	Ropinirole	170465139	Dopamine D3 receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	91374-21-9				-23.7400788082	4	5		0	-5.25127557					CCCN(CCC)CCc1cccc2NC(=O)Cc12	Microsource	01505178	-7.59650775	0.03013864	-3.90611315	-4.31664473	-5.25127557											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183020-01	Minopafant	144206826	Platelet activating factor receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	128420-61-1	Menopafant; Minopafant; 	12.5892541179	-4.9	-84.7199387046	-3	5	E-5880;E 5880;1-ethyl-2-(N-(2-methoxy)benzoyl-N-(2-methoxy-3-(4-octadecylcarbamoyloxy)piperidinocarbonyloxypropyloxy)carbonyl)aminomethylpyridinium chloride;MENOPAFANT;CIPLUS_707454;Minopafant;Menopafant;minopafantum;	-86.7375999994	-83.21217321	0.0043931614	0.9977966034			[Cl-].COc1ccccc1C(=O)N(Cc2cccc[n+]2CC)C(=O)OC[C@@H](COC(=O)N3CCC(CC3)OC(=O)NCCCCCCCCCCCCCCCCCC)OC	Pharmaron	PH-NIH-150353	-7.63930497	-4.09454921	-3.85356455	-4.00798874	-83.21217321											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249915-01	Bupranolol	170465802	Beta-3 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	14556-46-8				-8.2285437086	4	5		0	-3.41807017					Clc1ccc(C)cc1OCC(O)CNC(C)(C)C	GVK	FFS-11-286-NCI-172	-3.41093897	-3.13872384	0.7356805	3.33620807	-3.41807017											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016960-07	Glimepiride	170464966	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	93479-97-1	 Glimepride; Glimepiride; Amaryl;Glimepiride; 			-23.8664283208	4	5		0	-1.81965955				KCNJ8	CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC	Sequoia	SRP01525g	-7.11717881	-7.47007664	-7.37432125	1.52966275	-1.81965955											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183836-01	Emiglitate	144206827	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	80879-63-6		0.1412537545	-6.85	-21.3130316892	4	5	N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin;Emiglitate;BAY-o-1248;EMIGLITATE;BAY-o 1248;BAY o 1248;LS-177593;N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin;CIPLUS_214267;emiglitate;emiglitatum;	15.170076184	-8.57452477	0.3365085636	0.9243905291			O=C(OCC)c2ccc(OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)cc2	Pharmaron	PH-NIH-150421	-9.30839682	-4.06010505	-3.30180417	0.75802279	-8.57452477											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160624-04	Ethopabate	170466827	folic acid biosynthetic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	59-06-3				-14.1688522523	4	5		0	-0.48313541					CCOc1cc(ccc1C(=O)OC)NC(C)=O	SIGMA	00275	-6.07292647	-5.09342978	-1.3750219	2.82783351	-0.48313541											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00386237-08	Brintellix		5-HT1D Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	508233-74-7		12.5892541179	-4.9	-97.5879071794	-3	4		-103.8073460612	-99.55956838	0.0595914897	0.9978033896		HTR1D	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C	MedChem Express	HY-15414	-5.88132787	-8.32772544	-3.34088335	-99.55956838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485994-01	Bivalirudin (Trifluoroacetate)			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	128270-60-0				-6.979788722	4	4		0	-1.2199956					CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CCCN3C(=O)[C@@H](N[2H])CC4=CC=CC=C4)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(O)=O	MedChem Express	HY-15664	-1.62063257	-1.86742934	-1.2936667	-1.2199956												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00179306-04	Zuclopenthixol (-)-10-Camphorsulfonic Acid Salt		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	53772-83-1		12.5892541179	-4.9	-91.5196828447	-3	4		-105.2324728195	-99.38339573	0.035917628	0.9992034877			OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1	Toronto Research	Z701495	-4.7050623	-5.06393001	-2.40874641	-99.38339573												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183031-08	D-Pantothenic acid			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	79-83-4				-12.5636831841	4	4		0	-2.1977538					[H][C@](O)(C(=O)NCCC(O)=O)C(C)(C)CO	Selleck	S2498	-3.58978827	-2.54878869	0.03920202	-2.1977538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166323-02	Trifluridine	170464911	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	70-00-8	 ; Viroptic; Trifluridina; Trifluridine;Trifluridine;Trifluridine (Viroptic)	7.0794578438	-5.15	-39.9305784837	4	5		-25.0656748401	-26.37377523	0.0212411491	0.9892360628	7298	TYMS	FC(F)(F)C1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1056	-3.40237953	-5.68759149	-3.5207567	-10.689483	-26.37377523											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183024-01	Proglumetacin	144206876	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	57132-53-3	Proglumetacin; Miridacin; Proglumetacina; 			-19.8211371479	4	5	LS-82118;proglumetacine;Proglumetacinum;proxil;Proglumetacina;Proglumetacin Maleate;Proglumetacin;Proglumetacine;CIPLUS_182770;proglumetacin;Proglumetacin maleate;METACINE-P;LS-175816;Miridacin;PROGLUMETACIN MALEATE;PROTACINE;3'-(4-(2-(1-p-chlorobenzoyl-5-methoxy-2-methylindol-3-ylacetoxy)ethyl)piperazin-1-yl)propyl-4-benzamido-N,N-dipropylglutaramate (+-) dimaleate;PROGLUMETACIN;proglumetacinum;CIPLUS_685564;3-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)PROPYL DL-4-BENZAMIDO-N,N-DIPROPYLGLUTARAMATE 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETATE;	0	-2.69562469					CCCN(CCC)C(=O)C(NC(=O)c1ccccc1)CCC(=O)OCCCN5CCN(CCOC(=O)Cc4c2cc(OC)ccc2n(C(=O)c3ccc(Cl)cc3)c4C)CC5	Pharmaron	PH-NIH-183347	-4.54078576	-4.14621545	-5.51760378	-3.76287958	-2.69562469											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159365-04	m-Cresyl acetate	170466849		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	122-46-3				-20.1490414028	4	5		0	-2.33366889					O=C(C)Oc1cc(C)ccc1	Labotest	LTBB001299	-4.86190267	-4.33607823	-4.03339756	-5.06134969	-2.33366889											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021141-05	Phenyltoloxamine citrate	170465477	Histamine H1 receptor Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1176-08-5				-34.9915730086	4	5		0	-8.95030658					O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc2ccccc2Cc1ccccc1	SIGMA	P8404	-7.14160456	-6.00017156	-6.07150503	-9.46976337	-8.95030658											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00386317-11	Ribociclib (LEE011)		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-22.7283307293	4	4		0	-7.76504423				CDK4	CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5	Bio Vision	9481-5	-3.60387644	-4.40449052	-4.85059805	-7.76504423												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00532509-01	ISAVUCONAZONIUM SULFATE		Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-20.8626691115	4	4		0	-3.25940128					CNCC(=O)OCC1=C(N=CC=C1)N(C)C(=O)OC(C)[N+]2=C[N](C[C@@](O)([C@@H](C)C3=NC(=CS3)C4=CC=C(C=C4)C#N)C5=CC(=CC=C5F)F)N=C2	Astatech	40206	-4.75469412	-3.33777797	-5.6538818	-3.25940128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024501-04	D-Glutamic acid	225144193	Metabotropic glutamate receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	6893-26-1				-20.096946346	4	5		0	-2.15063604					N[C@H](CCC(O)=O)C(O)=O	SIGMA	49460	-5.23893029	-4.73065706	-3.502462	-5.6485539	-2.15063604											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00183046-03	Mequitazine	170465794	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	29216-28-2		11.220184543	-4.95	-100.4261983745	-3	5		-101.9062509029	-99.48750801	0.0017860474	0.9991059092			c3ccc4Sc5ccccc5N(CC2CN1CCC2CC1)c4c3	Vitas	STK324459	-5.19508987	-6.66066221	-8.65767502	-8.19018405	-99.48750801											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025341-06	Isradipine	170465070	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	75695-93-1	;Isradipine; Isradipine; DynaCirc; Lomir; Isradipine, (S)-Isomer; Dynacirc; Isaradipine; Isradipine, (R)-Isomer; Isradipine, (+-)-Isomer			-27.1858156021	4	5		0	-8.06259724					O=C(OC)C3=C(C)NC(C)=C(C(=O)OC(C)C)C3c1cccc2nonc12	Tocris	2004	-6.1245068	-2.89500772	-3.70798544	-7.41893076	-8.06259724											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164344-04	Symclosene	170465634		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	87-90-1				-29.3699221186	4	5		0	-6.70815411					ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O	SIGMA	176125	-7.38711092	-2.6719849	-7.82701777	-4.74583699	-6.70815411											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015862-07	Pyridostigmine bromide	170464878	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	101-26-8				-24.0314762702	4	5		0	-3.1481651					[Br-].O=C(Oc1ccc[n+](C)c1)N(C)C	Specs	AQ-776/42801589	-5.51950899	-3.88145479	-5.46349818	-7.02453988	-3.1481651											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095150-08	Telmisartan	170464873	Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	144701-48-4	; Telmisartan and diuretics;Telmisartan; Telmisartan; Micardis; Telmisartan Sodium;TELMISARTAN			-6.440035678	4	5		0	3.39864592			189	AGT	O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(C)c4nc3CCC)c6nc5ccccc5n6C	Microsource	01505261	-3.3406817	-3.9483871	-0.8511952	0.8158298	3.39864592											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00507799-01	Flumethasone acetate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	2823-42-9				-28.1588088902	4	4		0	-6.77153689					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	Carbosynth	FF23330	-7.77450896	-6.29704503	1.65511762	-6.77153689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164789-04	Fulvestrant	170464917	Estrogen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	129453-61-8	; Faslodex;Fulvestrant;Fulvestrant (Faslodex)			-8.9033495689	4	4		0	-4.92396183			2099	ESR1	FC(F)(F)C(F)(F)CCCS(=O)CCCCCCCCC[C@@H]2Cc1cc(O)ccc1[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@H]23	Prestwick	Prestw-1424	-0.82633902	-2.35709063	-2.09648232	-4.92396183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178638-02	Valaciclovir	170465373	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	124832-27-5	Valaciclovir HCl; Valaciclovir Hcl;;Valacyclovir hydrochloride; valacyclovir, (DL)-isomer; valacyclovir, (D)-isomer; Valtrex;VALACYCLOVIR HYDROCHLORIDE			-15.3038415762	4	4		0	-3.32040612					Cl.CC(C)[C@H](N)C(=O)OCCOCn2cnc1c2N=C(N)NC1=O	Vitas	STK802272	-3.43947391	-4.68837369	-1.09017081	-3.32040612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249414-01	Fonazine	144206752	Serotonin (5-HT) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	7456-24-8		22.3872113857	-4.65	-25.1419945081	4	4		-13.9963493721	-17.25565384	0.1627250031	0.9834396272	3269		CN(C)S(=O)(=O)c1cc2N(CC(C)N(C)C)c3ccccc3Sc2cc1	NCGCChem	DJM10-019	-3.50869603	-5.20452493	-5.41554486	-17.25565384												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00161327-01	Calcitriol	26754891	Vitamin D Analog	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	32222-06-3	; ;Calcitriol (Rocaltrol); Receptors, Calcitriol; 1(alpha),25-DIHYDROXYVITAMIN D3;Calcitriol; Calcitriol			4.413739762	4	4	Receptors, Calcitriol;Calcitriolum;9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-;1alpha,25-Dihydroxyvitamin D3;RO-21-5535;CIPLUS_177636;Calcitriol;1,25-dihydroxyvitamin D3 monoglucuronide;1(alpha),25-DIHYDROXYVITAMIN D3;calcitriol glycoside;1,25-DIHYDROXY VITAMIN D3;CIPLUS_701127;1,25-DVDMG;calcitriolum;NCGC00161327-02;NCGC00161327-03;1 alpha,25-dihydroxy-previtamin D(3);1,25-dihydroxycholecalciferol glycoside;beta-D-Glucopyranosiduronic acid, (1alpha,3beta,5Z,7E)-dihydroxy-9,10-secocholesta-5,7,10(19)-trienyl;1,25-DIHYDROXYCHOLECALCIFEROL;HS_1248;LS-53093;CIPLUS_710322;1,25-dihydroxy-previtamin D(3);1,25-dihydroxytachysterol;1alpha,25-Dihydroxycholecalciferol;HS_234;9,10-secocholesta-5(10),6,8-triene-1,3,25-triol, (1 alpha,3 beta,6Z)-;Rocaltrol;CALCITRIOL;rocaltrol;1,25-dihydroxy-previtamin D(3), (1alpha,3alpha,6Z)-isomer;CIPLUS_682461;calcitriol;	0	5.90875419			7421	VDR	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC\C2=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	BIOMOL	BIOMOL_DM200	-0.20333997	-1.09252011	1.8316635	5.90875419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167584-01	Nicametate citrate	144206129	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1641-74-3	Buffer solution from sodium citrate; Citric acid ammonium salt; Advil PM; Citric acid disodium salt; Euclidan; Alka-Seltzer; Sodium citrate buffer; Ammonium citrate dibasic; Sodium citrate monobasic; Citrate, Calciu; Tectlol; Pectamol; Citric acid-2,2,4,4-d4; Tc-99m-citrate; Citrate standard for IC; Bryrel; Astomatop; Pax??ladine; Caffeine, citrated; Antepar; Etoheptazina; Bismuth(III) citrate; Citric acid-13C6; DACH-Pt(II)citrate; Isoaminilo; Chemosol; Peracon; Aciletten; Tussimol; (239)Pu citrate; Tripelenamina; Anhydrous Citric Acid; Alverine citrate salt; Tritec; Tripelennamine Maleate; Toness; Citrato de galio (67 Ga); Cafcit; Oseltamivir citrate; Ferriseltz; Ammonium bismuth citrate; Citric acid solution; Ga-67 citrate; Sodium dihydrogencitrate; Pentoxyverine citrate; Tricalcium dicitrate; Silver citrate hydrate; Uralyt U; Zinc citrate dihydrate; Ascarex Syrup; Sinutab; Sodium dihydrogen citrate; DN 1417, (S)-isomer; Pyribenzamine; Tipepidina; AD 1308, citrate; Naldecon; U, Uraly; Oxeladin citrate salt; Citrate, Potassiu; 0.5 citrate CPD; Ammonium hydrogencitrate; Raniberl; technetium Tc 99m citrate; Citric acid lead salt; Citric acid calcium salt; Azanplus; Pentoxyverine Citrate; Citracal; Citric acid-2,4-13C2; Neoscan; Azaron; Citrates, Calciu; copper(II) citrate; Toclase; Citra ph; Citrate Solution; Banminth D; Oxeladina; Anhydrous citric acid; ethoheptazine HCl; Citric acid-1,5-14C; Clinitest; Oxeladin Tannate; Lithium citrate hydrate; Citric acid-1,5-13C2; Pylorid; Asverin; Tripotassium citrate; Alka Seltzer; DN 1417 citrate (1:1); Hetrazan; Butethamate citrate salt; DADP-PrD; ACD-A solution; Tri-lithium citrate; Gallii (67 Ga) citras; Citric acid zinc salt; Citric acid barium salt; Carricide citrate; gallii (67Ga) citras; Potassium hydroxycitrate; 67Ga-labeled; Negram-Citrat; Provasan; Banmint D; ACD solution; Iron(III) citrate; Mictral; Platinex; Acid, Citri; Trisodium citrate hydrate; Perogan; Norgesic forte; Orfenadrina; Citric Acid (Renacidin); Ammonium citrate tribasic; Magurlit; Sinecod; Cerebyx; Tetrodotoxin citrate; Dietilcarbamazina; 			-26.9355570956	4	4	Nicametate Citrate;2-(diethylamino)ethyl nicotinate;nicametatum;NICAMETATE CITRATE;Nicametate citrate;Nicotinic acid, 2-(diethylamino)ethyl ester;3-(diethylaminoethoxycarbonyl)pyridine citrate;LS-96550;Nicametate;Provasan;Euclidan;NICAMETATE;nicametate;Nicametatum;2-(diethylaminoethyl)nicotinate citrate;LS-96549;CIPLUS_213922;CIPLUS_669827;	0	-7.24214563					O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CC)CCOC(=O)c1cccnc1	SigmaAldrich	R288020	-7.60145366	-2.46032087	-0.56053317	-7.24214563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183879-01	Bisbentiamine	144206468		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	2667-89-2				-14.2817189869	4	4	BISBENTIAMINE;Bisbentiamina;Beston;CIPLUS_213921;bisbentiaminum;Bisbentiamine;bisbentiamine;Bisbentiaminum;	0	-6.22329883					Nc4nc(C)ncc4CN(C=O)C(/C)=C(/CCOC(=O)c1ccccc1)SSC(/CCOC(=O)c2ccccc2)=C(/C)N(C=O)Cc3cnc(C)nc3N	ACC	Bisbentiamine	-2.25668729	-0.81594886	-4.71730987	-6.22329883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021123-03	Diatrizoic acid dihydrate	170464638		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	50978-11-5				-2.5770225313	4	5		0	0.50119655					O.O.O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C(=O)O	Bosche	D0803	-0.71471369	-2.46706277	-1.48887721	1.62952204	0.50119655											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015237-07	Carbachol	170464972	Acetylcholinesterase Substrate	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51-83-2				-18.5477647049	4	5		0	-3.78832347					[Cl-].C[N+](C)(C)CCOC(=O)N	Enzo	AC911	-5.31969528	-5.56703694	-3.66964442	0.86696019	-3.78832347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167444-04	Cefpiramide (sodium)		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	74849-93-7				-32.9867407351	4	4		0	-5.45046212					C[N]1N=NN=C1SCC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@H](NC(=O)C4=C(O)C=C(C)N=C4)C5=CC=C(O)C=C5)C3=O)C(O)=O	MedChem Express	HY-B0798	-8.11789963	-7.49978862	-3.29949239	-5.45046212												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00165957-07	Amlodipine	225144262		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	88150-42-9				-16.1503182171	4	4		0	-2.87639285					CCOC(=O)C/1=C(COCCN)/N\C(=C(C1C2=C(Cl)C=CC=C2)\C(=O)OC)C	Prestwick	Prestw-1219	-2.28553538	-2.33364336	-7.6595359	-2.87639285												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378937-01	Setiptiline		serotonin receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	57262-94-9				-32.3874684882	4	4		0	-4.62986957					CN1CC\C2=C(/C1)C3=C(CC4=CC=CC=C24)C=CC=C3	MedChem Express	HY-32329	-6.29304947	-6.68808658	-8.74728064	-4.62986957												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166141-06	Carbinoxamine maleate	170465237	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	3505-38-2				-28.7177128216	4	4		0	-2.13354064					O=C(O)/C=C\C(=O)O.Clc1ccc(cc1)C(OCCN(C)C)c2ccccn2	Specs	AN-153/I210051	-6.42722963	-7.26304219	-4.45975344	-2.13354064												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182974-01	Improsulfan tosylate	144206762		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	32784-82-0	NSC-140117; Improsulfano; 			-18.8937357896	4	4	Improsulfano;improsan hydrochloride;LS-1222;NSC-102627;3,3'-IMINO BIS(DIMETHANESULFONATE)1-PROPANOL HYDROCHLORIDE;IMPROSULFAN TOSILATE;improsan tosylate;Improsulfan;iminodipropyl dimethanesulfonate 4-toluenesulphonate;alkylating agent 864;yoshi 864;dimesyloxydipropylamine tosylate;improsulfan;CIPLUS_161918;Improsulfanum;bis(3-mesyloxypropyl)amine;3,3'-iminobis-1-propanol dimethanesulfonate;864 T;improsan;LS-122362;LS-122363;CIPLUS_168735;improsulfanum;IMPROSULFAN;3,3'-iminodi-1- propanol dimethanesulfonate;NSC-140117;Improsulfan Tosilate;Improsulfan tosilate;CIPLUS_731133;	0	-3.42057528					Cc1ccc(cc1)S(O)(=O)=O.CS(=O)(=O)OCCCNCCCOS(C)(=O)=O	NCI	NSC_140117	-3.40370337	-5.96939207	-3.33575054	-3.42057528												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178027-08	VALSARTAN		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	137862-53-4				5.6523317464	4	4		0	3.61924505					CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=N[NH]N=N3)[C@@H](C(C)C)C(O)=O	Microsource	01505209	2.17819125	-1.17527691	0.48948513	3.61924505												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00483033-01	Tildipirosin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	328898-40-4				-0.6002407614	4	4		0	-0.69102531					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](OC2OC(C)C(O)C(C2O)N(C)C)[C@@H](CCN3CCCCC3)C[C@@H](C)C(=O)\C=C\C(=C\[C@@H]1CN4CCCCC4)C	DC Chemicals	DC8853	1.22998479	-1.14145599	-2.53807107	-0.69102531												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00345789-05	Venetoclax (ABT-199)		Bcl-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	8444499-71-4		3.9810717055	-5.4	7.5718027756	4	4		10.033736368	6.82387492	0.3355370586	0.9241014305		BCL2	CC1(C)CCC(=C(\C1)C2=CC=C(Cl)C=C2)/CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S+]([O-])(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7	ChemieTek	CT-A769	-0.42490384	-2.52811364	10.32451051	6.82387492												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00164076-03	SODIUM GLUCONATE			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	527-07-1				-21.3056244276	4	4		0	-4.26708128					OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O	Microsource	01300035	-3.5915556	-5.10695865	-6.1457578	-4.26708128												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00180998-01	Amylmetacresol	144206204		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1300-94-3	Amylmetacresol; 			-23.6538881174	4	4	amylmetacresolum;amylmetacresol;AMYLMETACRESOL;CIPLUS_158004;6-N-AMYL-M-CRESOL;Amylmetacresol;	0	-5.2777058					Oc1cc(C)ccc1CCCCC	SigmaAldrich	MFCD00127710	-5.57742195	-8.09165469	0.35351704	-5.2777058												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181341-02	Emedastine difumarate	170465197	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	87233-62-3				-5.5237307532	4	4		0	-0.39733955			3269	HRH1	CN1CCCN(CC1)c3nc2ccccc2n3CCOCC.O=C(O)\C=C\C(=O)O.O=C(O)\C=C\C(=O)O	Prestwick	Prestw-1274	0.69326416	-2.96778558	-4.36004351	-0.39733955												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00510144-01	Gestonorone			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	2137-18-0				-20.2293215273	4	4		0	-0.33687484					CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC\C4=C\C(=O)CC[C@@H]4[C@H]3CC[C@]12C	Glixx	GLXC-08149	-3.94936935	-4.35444322	-5.86475707	-0.33687484												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00249911-01	Normethadone	170465674	Mu-type opioid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	467-85-6				-8.1590696374	4	4		0	-5.81325041			25601	Oprm1	CCC(=O)C(CCN(C)C)(c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-156	-2.17819125	-4.58273442	3.83430022	-5.81325041												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00390545-01	Valrubicin		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	56124-62-0		3.9810717055	-5.4	-51.0354341002	-2.4	4		-48.2157898541	-18.13941436	1	0.9999638049		TOP2A	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(=C4C(=O)C5=C(C(=O)C4=C3O)C(=CC=C5)OC)O	MedChem Express	HY-13772	-4.62921549	-11.50756743	-38.84155185	-18.13941436												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00163742-05	d-LIMONENE		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	138-86-7				-18.3775811913	4	4		0	-2.97140883					CC(=C)C1CC\C(=C/C1)C	Microsource	00307080	-2.19608194	-7.13621375	-4.17875272	-2.97140883												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00015033-03	p-Aminoclonidine hydrochloride	90341674	Alpha-2A adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-26.0678667082	4	4		0	-1.58935821			150	ADRA2A	NC1=CC(=C(N=C2NCCN2)C(=C1)Cl)Cl	SigmaAldrich	Lopac-A-0779	-6.00679846	-6.83182548	-3.39920232	-1.58935821												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00021305-19	Sirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	(53123-88-9)				-133.8647139444	4	4		0	-23.50349832				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	SynKinase	SYN-1185	-27.74398426	-25.77999493	-32.40572879	-23.50349832												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00094932-04	NCGC00094932-04			DPI_SARS-CoV-2_General	2019_NPC-6_Tox			89.1250938134	-4.05	-460.0236785298	5	4		19.404139716	-94.3508681	0.4539393371	0.8748007748			CC1O[C@@H](CC(O)[C@H]1O[C@H]2CC(O)[C@@H](O[C@H]3CC(OC(C)=O)[C@H](O[C@H]4OC(CO)C(O)C(O)C4O)[C@@H](C)O3)C(C)O2)OC5CC[C@]6(C)C(CCC7C6CC(O)[C@@]8(C)C(CC[C@@]78O)\C9=C\C(=O)OC9)C5	SIGMA	L2261	-95.95223186	-96.93075167	-96.91805656	-94.3508681												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00095055-13	SALINOMYCIN, SODIUM			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	55721-31-8; 53003-10-4 (acid)		0.3548133892	-6.45	-183.6368088626	-1.4	4		-63.3358470289	-51.44683424	0.4884480637	0.8162033883			[H]C1(CC[C@@](O)(CC)C(C)O1)[C@@]2(C)CC[C@@]3(O2)OC4(OC(C(CC)C(=O)C(C)C(O)C(C)C5OC(CCC5C)C(CC)C([O-])=O)C(C)CC4C)\C=C/C3O	Microsource	01503602	-7.03551302	-68.08996364	-87.47280638	-51.44683424												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00185003-01	NCGC00185003-01	124896579		DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-26.0056551743	4	4	PPIX;NCGC00094273-03;3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid;protoporphyrin IX;NCGC00094273-02;NCGC00094273-01;CIPLUS_213719;Ooporphyrin disodium salt;Cobalt Protoporphyrin;Protoporphyrin disodium;CIPLUS_732479;Ooporphyrin;Prolmon;Protoporphyrin IX disodium salt;PROTOPORPHYRIN IX;Protoporphyrin;Protoporphyrin IX;NCGC00015844-01;NCGC00162303-01;Zinc ionophore II;3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid disodium salt;PROTOPORPHYRIN DISODIUM;NCGC00166283-01;Kammerer's porphyrin;NCGC_FLUKA_30157;MgProto;CIPLUS_154404;CIPLUS_744647;Mg protoporphyrin;Protoporphyrin IX disodium;divinyl-Mg-protoporphyrin;protoporphyrin IX, disodium salt;protoporphyrin IX dihydride;magnesium protoporphyrin;CIPLUS_736051;Depocolin-S;Protoporphyrin Disodium;	0	-6.51291354					CC1=C2[NH]C(=C1C=C)C=C\3N=C(C=C\4N=C(C=C5[NH]C(=C2)C(=C5C)C=C)\C(=C4CCC([O-])=O)C)\C(=C3C)CCC([O-])=O	FLUKA	30157	-4.42347258	-8.64124461	-4.36910805	-6.51291354												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181092-01	Ipodate sodium	144206261		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1221-56-3	IPODATE SODIUM; Ipodate; Biloptin; Oragrafin sodium; SoluBilopti; Calcium Ipodate; Calcium Iopodate; Iodopato sodico; Bilimin; Sodium, Ipodat; Solu Bilopti; Iopodate, Sodiu; Ipodate, Sodiu; Ipodate, Calciu; Solu-Biloptin; Iopodate, Calciu; 			-8.349672703	4	4	CIPLUS_157668;Ipodate sodium;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, SODIUM SALT;Benzenepropanoic acid, 3-(((dimethylamino)methylene)amino)-2,4,6-triiodo-;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, CALCIUM SALT;natrii iopodas;SODIUM 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOHYDROCINNAMATE;Ipodate Sodium;NSC-106962;CIPLUS_157904;Natrii iopodas;IPODATE CALCIUM;Ipodate;Iopodate, Sodiu;Bilimin;iopodate de sodium;SoluBilopti;Sodium, Ipodat;Ipodate, Sodiu;Sodium iopodate;Ipodate, Calciu;Calcium Ipodate;Iopodate de sodium;Biloptin;Ipodate Calcium;Oragrafin sodium;Solu-Biloptin;CALCIUM 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOHYDROCINNAMATE;Ipodic acid;CIPLUS_164488;Iodopato sodico;Sodium Iopodate;Solu Bilopti;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-;SODIUM IOPODATE;Iopodate, Calciu;IPODATE SODIUM;IPODIC ACID;3-(3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOPHENYL)PROPANOIC ACID;Calcium Iopodate;	0	-4.44847543					[Na+].[O-]C(=O)CCc1c(I)c(/N=C/N(C)C)c(I)cc1I	NCI	NSC-106962	0.69326416	-4.49818213	-4.6319797	-4.44847543												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346712-07	Verteporfin			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	129497-78-5				-23.9032526241	4	4		0	-1.87440615					COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(C=C)=C(N4)C=C5N=C(C=C1N2)\C(CCC(O)=O)=C5\C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Prestwick	Prestw-1105	-6.89238751	-6.67117612	1.2146483	-1.87440615												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167500-02	Etretinate	170465372	Retinoic acid receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	54350-48-0				-10.6410149812	4	5		0	-3.01304757					Cc1c(C)c(/C=CC(\C)=C\C=C\C(\C)=C\C(=O)OCC)c(C)cc1OC	LKT Lab	E7668	-2.82346956	-0.20645161	2.21839993	-6.52213107	-3.01304757											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253581-01	Indomethacin farnesil	170466014		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	85801-02-1				-20.5230803628	4	5		0	-3.26413487					Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C)c3C)OC	GVK	FFS-11-286-NCI-252	-7.13922333	-6.25376344	-1.70680074	1.03218246	-3.26413487											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016306-08	D-Cycloserine	170465249	NMDA Glycine-Site Receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	68-41-7	D-cycloserine;CYCLOSERINE; Cycloserine;CYCLOSERINE (D);D-Cycloserine;(S)-(-)-Cycloserine; (S)-(-)-Cycloserine	0.7943282347	-6.1	-18.3406865226	4	5		12.593267764	-2.88750392	0.0389926503	0.9990738776	2903	GRIN2A	N[C@@H]1CONC1=O	Microsource	01500215	-8.41105647	-6.76129032	-2.26250331	2.4655188	-2.88750392											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016878-04	Piretanide	170465869	Cystic fibrosis transmembrane conductance regulator Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	55837-27-9				-21.2679039614	4	5		0	-4.02636417					O=C(O)c2cc(c(Oc1ccccc1)c(c2)N3CCCC3)S(N)(=O)=O	Prestwick Chemical, Inc.	Prestw-1047	-6.80854672	-5.29892473	-1.68915939	-1.06824123	-4.02636417											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164568-04	Montelukast sodium	170465230	Cysteinyl leukotriene receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	151767-02-1		12.5892541179	-4.9	-44.0326979527	-3	5		-46.119100508	-44.2092992	0.0049787993	0.9975030559			[Na+].CC(C)(O)c5ccccc5CC[C@@H](SCC1(CC([O-])=O)CC1)c2cccc(c2)/C=C/c3ccc4ccc(Cl)cc4n3	Sequoia	SRP06641m	-3.46786502	-3.24301075	-1.7950075	-1.48291715	-44.2092992											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164620-02	Nadifloxacin	170465882	DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	124858-35-1		1	-6	-21.7285053543	4	5		11.599354836	-8.33071784	0.3190680446	0.9321408587			O=C(O)C3=CN2C(C)CCc1c(c(F)cc(c12)C3=O)N4CCC(O)CC4	Sequoia	SRP00810n	-7.33423775	-10.91612903	-5.58789803	2.35734247	-8.33071784											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018121-07	Proxyphylline	170465953	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	603-00-9				-18.9590476873	4	5		0	-0.84293593					CC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Microsource	01505915	-7.40206885	-5.16989247	-0.94822263	-0.46425674	-0.84293593											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179392-03	Beclomethasone	170464981		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	4419-39-0				-9.9114218204	4	5		0	-6.76142223					OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(Cl)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-855	-3.4085128	-1.38494624	2.4830202	0.99612368	-6.76142223											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164140-07	Dioctyl sulfosuccinate sodium salt	225144252		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	577-11-7				4.533023837	4	5		0	2.11630722					CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	SIGMA	323586	-0.87332542	1.5311828	1.81264885	3.19570901	2.11630722											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160611-03	1-Ethyl-2-pyrrolidinone	170465488		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2687-91-4		0.7943282347	-6.1	-25.8331689379	4	5		10.701290328	-5.18315922	0.1389660241	0.988051933			O=C1CCCN1CC	SIGMA	146358	-9.17415635	-10.16774194	-3.89432831	0.69863878	-5.18315922											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095838-04	Sumatriptan	170465377	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	103628-46-2	; ;SUMATRIPTAN; Sumatriptan; Imigran;Sumatriptan succinate;SUMATRIPTAN SUCCINATE; Succinate, Sumatripta; Imitrex	0.7943282347	-6.1	-22.990165124	4	5		11.494838704	-5.99022553	0.1502469689	0.9859729294	3351	HTR1B	CNS(=O)(=O)Cc1cc2c(cc1)ncc2CCN(C)C	Microsource	01505372	-8.6654231	-9.99569892	-3.71791479	1.84350491	-5.99022553											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249885-01	Estradiol acetate	170465258		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	4245-41-4				-23.8098282354	4	5		0	-7.07528135					CC(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	GVK	FFS-11-286-NCI-18	-6.38460234	-8.66236559	-1.51274588	0.61750654	-7.07528135											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015162-10	Buspirone	170464909	Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	36505-84-7				-34.3740452829	4	5		0	-7.2097924					O=C4CC1(CCCC1)CC(=O)N4CCCCN2CCN(CC2)c3ncccn3	Enzo	AC526	-10.20858063	-5.70322581	-5.87898033	-2.79906247	-7.2097924											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018193-11	Fluvoxamine	170464809	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	54739-18-3	;FLUVOXAMINE MALEATE;Fluvoxamine; Fluvoxamina;Fluvoxamine maleate; Fluvoxamine, (Z)-Isomer			-36.8036244893	4	5		0	-14.32991077			3350	HTR1A	FC(F)(F)c1ccc(cc1)C(\CCCCOC)=N\OCCN	Tocris	1033	-9.0045786	-8.11182796	-4.15894858	-1.16740287	-14.32991077											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015580-13	Ketotifen	170465378	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	34580-13-7	Ketotifen; Zaditor;Ketotifen fumarate; Ketotifen fumarate;; ; Fumarate, Ketotife; Ketotiphen;KETOTIFEN FUMARATE; Zaditen; Ketotifen fumarate salt; Ketotifen Maleate; Ketotiphene; Ketotifeno	0.7079457844	-6.15	-18.9691402014	4	5		12.6121756879	-9.14675156	0.0418463383	0.9989292135	9704	HRH1	CN1CC/C(CC1)=C3\c4ccccc4CC(=O)c2sccc23	Vitas	STK048448	-8.84347974	-8.28387097	-2.07726912	3.23176778	-9.14675156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016834-07	Fenbufen	170465799	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	36330-85-5				-5.7198205392	4	5		0	-2.16114424			5743	PTGS2	O=C(CCC(=O)O)c1ccc(cc1)c2ccccc2	Microsource	01501008	-1.76360861	-0.30967742	-0.42780277	-0.45524204	-2.16114424											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163470-27	FK-506		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	109581-93-3				-10.6230563726	4	4		0	-4.12684431				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Microsource	01503968	-1.76004182	-1.11877524	-3.23634463	-4.12684431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014648-04	Spiclomazine hydrochloride		Adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox			12.5892541179	-4.9	-49.3708427703	-3	4		-34.6579725991	-36.30477868	0.1149680362	0.9917679022			ClC1=CC2=C(SC3=C(C=CC=C3)N2CCCN4CCC5(CC4)NC(=O)CS5)C=C1	NCI	NSC-290956	-6.68293108	-3.52456258	-3.87228853	-36.30477868												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166301-04	SODIUM TETRADECYL SULFATE		Vitamin K-dependent protein S Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	139-88-8				-15.1000400429	4	4		0	-1.04382295			5627	PROS1	CCCCC(CC)CCC(CC(C)C)O[S]([O-])(=O)=O	Microsource	01300042	-3.88603294	-4.02927322	-2.26064988	-1.04382295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179351-03	Quinethazone	170465167	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	73-49-4				-12.7962863749	4	4		0	-4.03503421					NS(=O)(=O)c1cc2C(=O)NC(Nc2cc1Cl)CC	Prestwick	Prestw-1050	-2.23673964	-3.74209643	-2.07882774	-4.03503421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183040-01	NCGC00183040-01	124894246		DPI_SARS-CoV-2_General	2019_NPC-8_Tox		Betamethasone benzoate; Uticort; 			-25.2891350918	4	4	LS-118426;betamethasone 17-benzoate;9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-BENZOATE;BETAMETHASONE 17-BENZOATE;BETAMETHASONE BENZOATE;W 5975;Betamethasone benzoate;CIPLUS_173148;PREGNA-1,4-DIENE-3,20-DIONE, 17-(BENZOYLOXY)-9-FLUORO-11,21-DIHYDROXY-16-METHYL-, (11.BETA.,16.BETA.)-;Betamethasone Benzoate;Uticort;Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-,(11-beta,16-beta)-;	0	-9.70848403					C[C@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CC=C5)C(=O)CO	USP	1067307	-5.20463788	-5.37657534	-1.40795339	-9.70848403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263572-01	Deferasirox	170464723	Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	201530-41-8		7.9432823472	-5.1	-98.197154819	-2.2	5		-79.9671615915	-77.08428663	0.0056961831	0.9971404572		CAT	O=C(O)c1ccc(cc1)n3nc(nc3c2ccccc2O)c4ccccc4O	Sequoia	201530-41-8	-9.42130644	-5.2367473	-6.59387711	-21.23137599	-77.08428663											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178404-03	Triamcinolone	170465188		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	124-94-7				-28.4443153005	4	5		0	-2.98343553					OCC(=O)[C@@]3(O)[C@H](O)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C	Microsource	01500586	-6.57167909	-8.61640075	-5.96874331	-5.4820333	-2.98343553											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167471-02	Anethole trithione	170465669		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	532-11-6				-17.4306555693	4	5		0	0.74128306					COc1ccc(cc1)C2=CC(=S)SS2	Prestwick	Prestw-1223	-8.00964489	-2.96363013	-3.27124813	1.7572305	0.74128306											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159361-06	Menthyl Anthranilate			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	134-09-8				-21.4864476311	4	5		0	-4.67648943					CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2N	SigmaAldrich	437387	-4.83559842	-1.80562704	-5.09526868	-6.00788782	-4.67648943											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025262-02	Cisapride	170465200		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	81098-60-4				-32.5056813016	4	5		0	-8.79472865					Clc1cc(c(OC)cc1N)C(=O)NC3CCN(CCCOc2ccc(F)cc2)CC3OC	Tocris	1695	-6.42262166	-2.56047349	-7.81845429	-9.68010517	-8.79472865											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182057-03	Detomidine hydrochloride	170465639	Alpha-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	90038-01-0				-27.8559804729	4	5		0	-6.96440011					Cl.Cc2cccc(Cc1cncn1)c2C	Selleck	S1579	-4.59009206	-6.90941843	-7.86127168	-5.45574058	-6.96440011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016394-10	2-Hydroxy-4-methoxybenzophenone	170465010		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	131-57-7				-9.4033071672	4	5		0	0.11897136					O=C(c1ccc(cc1O)OC)c2ccccc2	Vitas	STK057962	-2.26654976	-3.40967576	-2.32926568	-1.82734443	0.11897136											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015061-13	Aciclovir	170464640	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	59277-89-3	; ; Acyclovir Sod; Zovirax; Acycloguanosine;ACYCLOVIR; ACVbetaglc; Acyclovir;Acyclovir; Acyclovir-side chain-2-3H; Zovirax sodium			6.759000897	4	5		0	1.9492999					NC2=Nc1c(ncn1COCCO)C(=O)N2	Microsource	01503603	3.69574748	-0.76771316	-2.50909869	1.05609115	1.9492999											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178500-07	Streptozotocin	170464827	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	18883-66-4				0.3194617208	4	5		0	-1.83948019				H2AFX	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O	Microsource	01500543	-0.17974573	2.25167267	2.3977735	-1.74846626	-1.83948019											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015323-11	Decamethonium bromide	170465349	Muscle-type nicotinic acetylcholine receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	541-22-0				-25.8994004164	4	5		0	-2.28791068					[Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	Enzo	AC737	-5.71240684	-4.32750043	-7.86127168	-7.26117441	-2.28791068											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159351-05	Cholesterol	225144221	Transient receptor potential cation channel subfamily V member 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57-88-5				-15.838527166	4	5		0	-3.18477167			7442	TRPV1	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	SIGMA	362794	-4.77422183	-0.91353577	-4.53007921	-1.82734443	-3.18477167											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015007-14	R-(+)-Atenolol	170464744	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56715-13-0				-28.6085139269	4	5		0	-7.67822824					CC(C)NC[C@@H](O)COc1ccc(cc1)CC(N)=O	Vitas	STK528649	-7.2292854	-3.22954195	-5.01819739	-5.28921998	-7.67822824											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00188442-01	Estradiol enanthate	144206583		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	4956-37-0				-32.7882184523	4	4	ESTRADIOL ENANTHATE	0	-10.27495751					CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C	APAC	877917	-7.4457039	-5.96154673	-2.75852937	-10.27495751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185751-06	Cefuroxime Axetil			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	64544-07-6				-9.9631392973	4	4		0	-3.68643514					[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N\OC)\C3=CC=CO3)C(=O)OC(C)OC(C)=O	Enzo	AC3055	-1.92524011	-1.04950751	-2.22889173	-3.68643514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183655-01	Tazanolast	144206520	histamine secretion by mast cell Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	82989-25-1				-22.8904714402	4	4	CIPLUS_710388;tazanolast;tazanolastum;butyl 3'-(1h-tetrazol-5-yl)oxanilate;Tazanolastum;TAZANOLAST;LS-12662;butyl-3'-(1H-tetrazol-5-yl)oxanilate;Acetic acid, oxo((3-(1H-tetrazol-5-yl)phenyl)amino)-, butyl ester;Tazanolast;Tazanol;	0	-6.70181707					O=C(OCCCC)C(=O)Nc1cccc(c1)c2nnnn2	ACC		-4.92774942	-5.6948686	-1.88462727	-6.70181707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182998-01	Bisoxatin acetate	144206872		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	14008-48-1	Bisoxatin acetate; 	7.0794578438	-5.15	-68.3791206582	-2.4	4	LS-41817;2H-1,4-Benzoxazin-3-(4H)-one, 2,2-bis(p-hydroxyphenyl)-, diacetate;BISOXATIN ACETATE;bisoxatin diacetate;Bisoxatin Acetate;bisoxatin acetate;CIPLUS_169129;laxonalin;Bisoxatin acetate;	-46.7429690096	-47.29617848	0.0747428675	0.9965410542			CC(=O)Oc1ccc(cc1)C2(Oc3ccccc3NC2=O)c4ccc(OC(C)=O)cc4	Pharmaron	PH-NIH-183223	-6.86596868	-4.73998882	-17.42949199	-47.29617848												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185772-01	Vindesine sulfate salt	124896659	Tubulin polymerization inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	59917-39-4	Vindesine sulfate salt			-25.2974150163	4	4		0	0.6710532			203068	TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@H]4C[C@@](O)(CC)C[N@@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](O)[C@]6(O)C(N)=O)[C@H]78	Toronto Research	V414550	-7.50627325	-6.01316186	-3.47354019	0.6710532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160621-05	DEXTROSE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	50-99-7				-30.0881458	4	4		0	-4.73223234					[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Microsource	01300015	-8.06870295	-6.30564755	-2.20240985	-4.73223234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178214-04	BENZALKONIUM CHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	8001-54-5		8.9125093813	-5.05	-64.5657810926	-3	4		-79.43823984	-77.85088675	0.0333713003	0.9993125806			CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1	Microsource	01503610	-0.40235355	-2.8044217	-4.85059805	-77.85088675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167984-01	Tiquizium bromide	144206157		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	71731-58-3	Tiquizium bromide; Bromuro de tiquizio; 			-21.730090456	4	4	CIPLUS_214419;tiquizium bromide;thiaton;Bromuro de tiquizio;Tiquizium Bromide;bromide (cis)-isomer;Tiquizii bromidum;LS-176911;tiquizii bromidum;TIQUIZIUM BROMIDE;bromure de tiquizium;Tiquizium bromide;3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide;3-(Di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide;LS-142883;Thiaton;Bromure de tiquizium;HSR 902;HSR-902;	0	-5.62987494					[Br-].C[N@@+]14CCCC[C@@H]4CC\C(C1)=C(/c2sccc2)c3cccs3	Bosche	T6489	-5.26520723	-1.60006882	-4.23268747	-5.62987494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386206-03	Azilsartan (TAK-536)		Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	147403-03-0				-13.9559989886	4	4		0	-2.07416445					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)ON5)C(O)=O	Adooq	A11775	-1.82140694	-5.29915265	-5.79511851	-2.07416445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164598-03	CEFPODOXIME PROXETIL			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	87239-81-4				-27.430631495	4	4		0	-4.47078304					COCC/1=C(/N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)/C3=CSC(=N3)N)C2=O)C(=O)OC(C)OC(=O)OC(C)C	Microsource	01505637	-6.91788526	-7.23471977	-1.95524562	-4.47078304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091110-01	Glutaraldehyde	144204634		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	111-30-8	Glutaraldehyde (Glutaric dialdehyde)			-4.4050676679	4	4	glutaral;polyglutaraldehyde;glutaralum;poly(glutaraldehyde);CIPLUS_151232;Glutaral;Sterihyde L;Glutaraldehyde (Glutaric dialdehyde);GLUTARALDEHYDE;pentanedial, homopolymer;Sonacide;Glutaraldehyde solution;CIPLUS_690280;Glutaralum;Glutaric dialdehyde solution;Pentanedial;AB07944785-01;Pentane-1,5-dial;Glutaraldehyde;CIPLUS_765795;GLUTARAL;	0	2.06544947					O=CCCCC=O	NIEHS	AB07944785	-1.15514407	-1.49683857	-2.79383855	2.06544947												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017360-04	Aconitine			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	302-27-2				-8.9250483887	4	4		0	-2.86722733					CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34C5C[C@]6(O)[C@@H](OC)[C@H](O)[C@](OC(C)=O)(C([C@H](OC)C23)[C@@H]14)C5[C@H]6OC(=O)C7=CC=CC=C7	Prestwick	Prestw-NAT-0127	-1.25897724	-4.51632328	-0.58701505	-2.86722733												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174736-02	Uridine triacetate	174006168	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	4105-38-8	Uridine triacetate			-40.7307434799	4	4		0	-5.71702471				TYMS	CC(=O)OC[C@@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2\C=C/C(=O)NC2=O	SIGMA	T6001	-11.39136454	-6.15940471	-4.38275147	-5.71702471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263565-01	Gestodene	170466131	Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	60282-87-3	Gestodene	1	-6	-16.7390066619	4	5		16.93108918	-4.3320637	0.0108095503	0.9999282951	5241	PGR	O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2C=C[C@@]1(O)C#C)=C4	Bosche	G2883	-9.52590765	-9.40080007	-4.52547411	7.37151518	-4.3320637											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094437-05	d-Tryptophan	170465485	Tryptophan metabolism Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	153-94-6				-21.1776330493	4	5		0	-5.80973797					O=C(O)[C@H](N)Cc2cnc1ccccc12	SIGMA	93660	-4.24744448	-5.61324368	-8.41043245	1.20791806	-5.80973797											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016507-05	Thonzonium bromide	170465335	osteoclast development Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	553-08-2		12.5892541179	-4.9	-82.1898514056	-3	4		-107.9280151789	-99.66121601	0.0536543565	0.9982202484			[Br-].COc1ccc(cc1)CN(CC[N+](C)(C)CCCCCCCCCCCCCCCC)c2ncccn2	Prestwick Chemical, Inc.	Prestw-925	-2.41407706	-3.2963727	1.0989011	-99.66121601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015810-12	Papaverine hydrochloride	170465687	Phosphodiesterase X (PDE10) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	61-25-6	; ;Papaverine?HCl;PAPAVERINE HYDROCHLORIDE; Pavatym; Cerespan;Papaverine hydrochloride; Albatran; Omnopon-Scopolamine; Hydrochloride, Papaverin; Cepaverin; Papaverine hydrochloride; Papaverine Hcl; Pavabid			-30.6996596645	4	4		0	-11.91164514			10846	PDE10A	Cl.COc1ccc(cc1OC)Cc3nccc2cc(OC)c(cc23)OC	Vitas	STK039035	-5.95934642	-6.80333505	-2.60877334	-11.91164514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018210-05	Oxyphencyclimine hydrochloride	170465276	Muscarinic acetylcholine receptor M4 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	125-52-0				-25.53338962	4	5		0	-7.92987931					Cl.CN3CCCN=C3COC(=O)C(O)(c1ccccc1)C2CCCCC2	Microsource	01503932	-6.26542122	-8.10707294	-3.09373299	-0.22504937	-7.92987931											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346457-02	Copanlisib		PI3K alpha/delta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1032568-63-0		0.1412537545	-6.85	-154.0663151512	-1.4	4		-45.2670572896	-49.83980064	0.1284492918	0.9896953313		PIK3CA	COC1=C(OCCCN2CCOCC2)C=CC\3=C1/N=C(/NC(=O)C4=CN=C(N)N=C4)N5CC/N=C35	Selleck	S2802	-15.4585962	-28.93054596	-47.33627859	-49.83980064												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00016242-05	Metyrapone	170465268	Cytochrome P450 11B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	54-36-4				-24.7261610503	4	4		0	-4.6571506					CC(C)(c1cccnc1)C(=O)c2cccnc2	Prestwick Chemical, Inc.	Prestw-904	-5.82065618	-5.11861784	-4.01143572	-4.6571506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160504-01	Testosterone 17-phenylpropionate	144206667		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1255-49-8	testosterone 17-phenylpropionate; Retandrol; Mixogen; 			-17.3907141039	4	4	TESTOSTERONE PHENYL PROPIONATE;CIPLUS_3882657;testosterone phenylpropionate;Retandrol;Testosterone Phenylpropionate;CIPLUS_157987;Testosterone 17-phenylpropionate;testosterone 17-phenylpropionate;estandron prolongatum;4-Androsten-17beta-ol-3-one 17-phenylpropionate;Testosterone phenylpropionate;Mixogen;Testosterone hydrocinnamate;	0	-3.56400759					O=C5CC[C@@]4(C)C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	InterBioScreen	STOCK1N-42343	-4.06102371	-5.6343476	-0.5985884	-3.56400759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094851-05	Iodamide	170465213		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	440-58-4				-20.4894328148	4	4		0	-3.70855543					O=C(C)Nc1c(I)c(c(I)c(CNC(C)=O)c1I)C(=O)O	Microsource	01500772	-4.91050145	-3.92384391	-3.48432056	-3.70855543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510509-02	Vesnarinone		p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	81840-15-5				-16.0925564555	4	4		0	-4.87397236				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	-4.60711654	-1.77496992	0.79513982	-4.87397236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160481-02	Tioxidazole	124892286	microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox			2.5118864315	-5.6	-64.2453957774	-2.2	4		-41.773236216	-39.0956726	0.0167473587	0.9998271692			CCCOC1=CC=C2N=C(NC(=O)OC)SC2=C1	Chembridge	5175278	-3.19420968	-10.89479113	-27.54400071	-39.0956726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166322-02	PROTIRELIN		Thyrotropin-releasing hormone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	24305-27-9		10	-5	-67.2353239491	-3	4		-98.6374866455	-94.00142399	0.0240596113	0.9996428107			NC(=O)C1CCCN1C(=O)C(CC2=CN=C[NH]2)NC(=O)C3CCC(=O)N3	Microsource	01506101	1.62350554	-0.552868	-1.0524948	-94.00142399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386194-01	Clindamycin palmitate HCl		Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	25507-04-4				-25.1845977401	4	4		0	-3.62228551					CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C2CC(CCC)CN2C)C(C)Cl	Selleck	S2596	-6.79401773	-1.80545957	-5.53101178	-3.62228551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178714-04	Topiramate	170464746	Na channel blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	97240-79-4	 Ortho brand of topiramate; ; Topamax;Topiramate; Topiramate; Epitomax; McN 4853; Cilag brand of topiramate; Topiramato			-23.9354913932	4	4		0	-4.85938056					NS(=O)(=O)OC[C@]23OC[C@H]1OC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2	Microsource	01505801	-6.85578153	-1.98686938	-2.01403326	-4.85938056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188865-03	Pazopanib	170465625	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	444731-52-6	Pazopanib; Pazopanib;GSK-786034/Votrient/Armala	14.1253754462	-4.85	-48.3728952958	-3	4		-32.36568418	-32.94766821	0.0963963531	0.9942339731	10715	FLT1	NS(=O)(=O)c1cc(ccc1C)Nc2nccc(n2)N(C)c3ccc4c(C)n(C)nc4c3	Sequoia	SRP010772p	-6.70578374	-5.1658604	-4.30959806	-32.94766821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015713-13	Nitrendipine	170465897	Intermediate conductance calcium-activated potassium channel protein 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	39562-70-4				-27.1044089608	4	5		0	-11.60111973					CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(c2)[N+]([O-])=O)C(=O)OC	SigmaAldrich	N144	-4.47655975	-8.02195932	-5.42973165	-1.04257567	-11.60111973											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181297-01	Mebrofenin	144206328		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	78266-06-5	Mebrofenin; Mebrofenino; 			-28.6912102439	4	4	Technetium (99mTc) mebrofenin;TECHNETIUM TC-99M MEBROFENIN KIT;mebrofeninum;Mebrofenin;Mebrofenine;CIPLUS_191790;technetium Tc 99m mebrofenin;MEBROFENIN;Technetium Tc 99m Mebrofenin;2,2'-((2-((3-BROMO-2,4,6-TRIMETHYLPHENYL)-AMINO)-2-OXOETHYL)IMINO)DIACETIC ACID;Mebrofenin ((3-Bromo-2,4,6-trimethylphenylcarbamoyl) methyliminodiacetic acid);Mebrofeninum;mebrofenine;Mebrofenino;SQ-26962;	0	-5.96297615					Cc1cc(C)c(Br)c(C)c1NC(=O)CN(CC(=O)O)CC(=O)O	ACC	mebrofenin	-7.90576609	-3.91326883	-1.87543313	-5.96297615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093347-05	Mestranol	170465357	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	72-33-3	; Sequens;Mestranol; Infecundin; Aconcen;Ethynylestradiol 3-methyl ether; Norinyl 1-50; Angravid; Estirona; Orthonovin; Bisecurin I; Ovosiston; Ovaras; Ortho Novum; Sequence-Ovosiston; Bisecurin; Sesquelan; ; Ovulen; Ortho-Novum; Norinyl; Femigen; C-quens; Gestranol; Mestranol; Enovid-E			-23.8956280595	4	5		0	-1.33082465			2099	ESR1	COc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick Chemical, Inc.	Prestw-846	-8.53894959	-8.72840242	-2.54950391	1.17117531	-1.33082465											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183029-02	Troxipide	170465889	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	30751-05-4				-11.141104821	4	5		0	-2.85438943					O=C(NC1CCCNC1)c2cc(OC)c(OC)c(OC)c2	Sequoia	30751-05-4	-4.34437786	-3.05983488	0.74936158	0.95071878	-2.85438943											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00379076-01	Maxacalcitol-D6		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-3.3486368409	4	4		0	-1.59309363					C[C@H](OCCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-15329	0.22940839	-4.22425708	0.29885655	-1.59309363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022019-03	Clobetasone butyrate	170465575	corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	25122-57-0				-27.1912050248	4	5		0	-10.34371988					ClCC(=O)[C@@]3(OC(=O)CCC)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)C(=O)C[C@@]23C	SIGMA	C5548	-5.8776877	-4.86424377	-5.81487839	-1.56615992	-10.34371988											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018277-06	Mebeverine hydrochloride	170466168		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2753-45-9				-27.3332890053	4	5		0	-12.31701161					Cl.COc1cc(ccc1OC)C(=O)OCCCCN(CC)C(C)Cc2ccc(OC)cc2	Microsource	01501117	-6.47691223	-5.17065282	-4.11520911	0.53736279	-12.31701161											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178255-02	QUININE ETHYL CARBONATE		Ferriprotoporphyrin IX Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	83-75-0		15.8489319246	-4.8	-28.7599836408	4	4		-11.4801499399	-13.34104664	0.2814584647	0.948524927			CCOC(=O)O[C@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)C3=C4C=C(OC)C=CC4=NC=C3	Microsource	00310050	-5.1528654	-5.11402903	-2.94092169	-13.34104664												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015159-13	Betaxolol HCl		Beta1-adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	63659-19-8				-12.2922260399	4	4		0	-4.84158063				ADRB1	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1	Selleck	S1827	-0.90881016	-7.17000691	-1.91874567	-4.84158063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142615-08	Epinephrine	170464973	alpha/beta-adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	51-43-4	 TEC solution;;(-)-Epinephrine bitartrate; L-Epinephrine; DL-Adrenaline; 4-(1-Hydroxy-2-; ; (+/-)-Adrenalin; TAC combination; L-(-)-EPINEPHRINE; Epinephrin; Asmatane mist; (+/-)-Epinephrine; Epinephrine; Epinefrina; (-)-Epinephrine bitartrate; dl-Adrenaline; (-)-Adrenalin; Adrenaline-L Bitartrate; Adrenalin chloride; Piladren; Sphygmogenin; Racepinephrine Hcl;Epinephrine; Levorenone; Racepinefrina; (-)-Epinephrine			-20.965211627	4	5		0	-7.10385021			148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CNC	Labotest	LT03210011	-4.12407473	-4.44718699	-2.24808473	-3.47678317	-7.10385021											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00090955-06	Dicyclohexylamine	170466864	spermidine biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	101-83-7				-25.5277303415	4	5		0	-7.76467349					C1CCCCC1NC2CCCCC2	Vitas	STK379549	-7.12019739	-6.24308452	-3.72168962	0.63840536	-7.76467349											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094956-04	Cephaloridine	124891818	Solute carrier family 22 member 7 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-27.5653642329	4	4		0	-4.85938056			939990		[O-]C(=O)C/1=C(CSC2C(NC(=O)CC3=CC=CS3)C(=O)N12)\C[N+]4=CC=CC=C4	Waterstone	40972	-8.06458729	-2.95438839	-1.82345807	-4.85938056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179419-05	Guanadrel sulfate		Norepinephrine transporter Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	22195-34-2				-22.9274625017	4	4		0	-4.77928088					NC(=N)NCC1COC2(CCCCC2)O1	Prestwick	Prestw-767	-4.81757621	-5.07947478	-5.01126126	-4.77928088												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241103-06	Masitinib		FGFR 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1048007-93-7		12.5892541179	-4.9	-89.6357738714	-3	4		-101.5816660729	-95.24741901	0.1068482558	0.9928920022		FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	Axon Medchem	1419	-6.67049014	-4.22425708	2.20460845	-95.24741901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159384-04	6-Chlorothymol	170465546	Estrogen receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	89-68-9				-21.4455597007	4	5		0	-6.04836859					Oc1cc(C)c(Cl)cc1C(C)C	Labotest	LTBB003695	-5.33133592	-5.74091412	-4.15707288	-0.16993524	-6.04836859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167453-02	Clinofibrate	174007296	treatment of lipoprotein diseases	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	30299-08-2	 ; Lipoclin;Clinofibrate; Clinofibrate; Clinofibrato			-29.9909787976	4	5		0	-2.83603322				HMGCR	O=C(O)C(C)(CC)Oc1ccc(cc1)C2(CCCCC2)c3ccc(OC(C)(CC)C(=O)O)cc3	Selleck	S2664	-7.91328869	-9.1199251	-8.10901327	-1.64883112	-2.83603322											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179521-03	Cefixime		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	125110-14-7				-30.1844292982	4	5		0	-5.86480657					NC1=NC(=CS1)\C(=N\OCC(O)=O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	FLUKA	18588	-8.1952767	-7.2729594	-7.71549378	-0.17912093	-5.86480657											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249906-01	Nicoboxil	170465989	positive regulation of vasodilation Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	13912-80-6				-27.1204802973	4	5		0	-5.67206645					O=C(OCCOCCCC)c1cccnc1	GVK	FFS-11-286-NCI-130	-6.83820938	-6.7026981	-7.21312848	-0.67514812	-5.67206645											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018185-23	Tranilast		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	53902-12-8				-30.4607467726	4	4		0	-4.9750801				TNF	COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC	Enzo	CT110	-9.14986544	-2.33241189	-2.49913375	-4.9750801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253670-01	Meropenem	170466350	Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	96036-03-2				5.4374152234	4	5		0	3.14808866					O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@H](NC1)C(=O)N(C)C)[C@H](C)[C@@H]23)C(=O)O	GVK	FFS-12-73-NCI-194	1.53330983	-0.89794876	-0.8749529	2.11730124	3.14808866											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185741-02	Nepafenac	170465203	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	78281-72-8	Nepafenac			-6.0753540268	4	4		0	-5.77739633			5743	PTGS2	Nc1c(cccc1CC(N)=O)C(=O)c2ccccc2	Selleck	S1255	0.57643133	-1.90390236	-2.7159832	-5.77739633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167447-02	Prosultiamine	170465884	Apoptosis Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	59-58-5				-7.1656503478	4	4		0	-4.02475382					Nc1nc(C)ncc1CN(C=O)C(C)=C(CCO)SSCCC	Bosche	P5775	0.27304642	-5.46243768	-1.48306978	-4.02475382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183013-01	Doranidazole	144206845	Apoptosis Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	149838-23-3	DORANIDAZOLE; 			11.4826606119	4	4	Doranidazole;RP 343;1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole;doranidazolum;(2RS,3SR)-3-((2-NITROIMIDAZOL-1-YL)METHOXY)BUTANE-1,2,4-TRIOL;RP-343;1,2,4-Butanetriol, 3-((2-nitro-1H-imidazol-1-yl)methoxy)-, (R*,S*)-;CIPLUS_741927;DORANIDAZOLE;	0	6.26524528			81656		OC[C@@H](O)[C@H](CO)OCn1ccnc1[N+]([O-])=O	Pharmaron	PH-NIH-153447	1.82464352	0.16761217	2.89466631	6.26524528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094754-05	Phenacemide	170465322	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	63-98-9				-31.328803899	4	5		0	-6.15850581					O=C(Cc1ccccc1)NC(N)=O	Microsource	01500472	-7.57842792	-8.4815729	-8.41043245	-1.23547513	-6.15850581											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182033-01	Felypressin	144206485	Vasopressin V1a receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	56-59-7	Felypressin; Octopressin; Felipresina; 			-27.8326165052	4	4	LS-175689;Felypressine;Felypressin;Felypressinum;felypressine;H-CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2  (1-6);PLV-2;Phenylalanyl-Lysyl Vasopressi;Vasopressin, 2-L-phenylalanine-8-L-lysine-;Lysine Vasopressin, Phenylalanin;Vasopressin, Phenylalanine Lysin;Vasopressin, Phenylalanyl Lysy;felypressinum;FELYPRESSIN;CIPLUS_148784;Octopressin;Felipresina;	0	-3.65434999					NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4	ACC	FELYPRESSIN	-7.99635938	-6.52827918	-0.16974895	-3.65434999												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095304-05	Furazolidone	170464641	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	67-45-8				-33.7512908685	4	5		0	-3.4785003					[O-][N+](=O)c2oc(/C=N/N1CCOC1=O)cc2	Vitas	STK388219	-10.01938668	-9.35824325	-6.92008205	-1.70394525	-3.4785003											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159352-14	ETIDRONATE DISODIUM			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7414-83-7				-4.9030982935	4	4		0	-2.04625531					CC(O)(P(O)(O)=O)P(O)(O)=O	Microsource	01505537	-0.48974992	-1.70620595	-1.33118914	-2.04625531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161621-03	Cepharanthine	170465994		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	481-49-2				-28.1681673714	4	4		0	-6.52723823					COc8ccc1cc8Oc7ccc(C[C@H]4c5c(Oc3cc2c(CCN(C)[C@@H]2C1)cc3OC)c6OCOc6cc5CCN4C)cc7	Vitas	STK801907	-3.98301045	-8.78889462	-9.97945144	-6.52723823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016686-13	Pimaricin		Anti-fungal	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7681-93-8				-28.4212024589	4	4		0	-8.38829163					C[C@@H]1O[C@@H](O[C@H]2C[C@@H]3O[C@@](O)(C[C@@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]4O[C@@H]4C=CC(=O)O[C@@H](C)CC=CC=CC=CC=C2)[C@H](O)[C@H](N)[C@@H]1O	Enzo	NP232	-5.60395267	-8.95220904	0.51818101	-8.38829163												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00073457-04	Metomidate hydrochloride	170466159	Cytochrome P450 2A5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	35944-74-2				-9.9514954185	4	5		0	-4.91946216					Cl.CC(c1ccccc1)n2cncc2C(=O)OC	Vitas	STK331722	-1.87698273	-5.30683462	-2.33181228	3.64212557	-4.91946216											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090766-07	Prednisone	170464847	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	53-03-2	 Prednisona; ; Dehydrocortisone; Prednisone;Prednisone;; Deltasone;Prednisone (Adasone); 1-Cortisone; Meticorten; Kortancyl; Deltamid			-13.5036794153	4	5		0	-3.95576155				NRC31	OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Prestwick Chemical, Inc.	Prestw-77	-4.33556574	-2.25976679	-4.13195462	2.8062279	-3.95576155											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00509861-02	Auristatin PE		microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	149606-27-9		0.0354813389	-7.4499999999	-300.4635036322	5	4		-81.8783669108	-78.86439606	0.2247269316	0.9676065737			CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCC2=CC=CC=C2)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	MedChem Express	HY-14672	-55.70580332	-69.66219701	-72.35772358	-78.86439606												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090764-04	2-Ethylhexyl 4-(dimethylamino)benzoate	170465499		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	21245-02-3				-35.3068669477	4	5		0	-8.14097563					CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC	Bosche	E2279	-10.19562919	-8.05600477	-4.42500105	-2.27345795	-8.14097563											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096122-05	Thioinosine	170465903	Serine/threonine-protein kinase N1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	574-25-4		14.1253754462	-4.85	-47.2696934034	4	5		-15.1172100479	-21.01785141	0.1149950852	0.9374473288	29355	Pkn1	Sc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	SIGMA	852686	-7.97497356	-7.92833433	-10.14359275	-5.92017637	-21.01785141											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160628-03	Rutin trihydrate	170465691	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	153-18-4		2.8183829313	-5.55	-19.2144517855	4	5		13.539331016	-6.51645175	0.2648453973	0.9545053437			Oc1ccc(cc1O)C=4Oc5cc(O)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O	Enzo	NP266	-6.56503349	-7.80066389	-9.61610918	3.55026868	-6.51645175											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024357-07	Scopolamine hydrobromide	170464830	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	114-49-8		2.8183829313	-5.55	-25.8634326235	4	5		10.78046636	-6.24110871	0.2903567049	0.9449539765		CHRM1	Br.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34	Prestwick Chemical, Inc.	Prestw-877	-7.20831865	-8.84756149	-9.8170553	0.38120608	-6.24110871											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016288-06	Bemegride		GABA-A receptor; anion channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	64-65-3				-21.0019182395	4	4		0	-5.46119794					CCC1(C)CC(=O)NC(=O)C1	APExBIO	B1672	-4.95384215	-4.3708097	-1.95658001	-5.46119794												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00016244-15	Isoniazid	170466877	Cytochrome P450 CYP1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	54-85-3	 Isoniazid; Phthivazide;ISONIAZID; ;; Fintosid; Thiazina; Tubazide; Ftivazide; Pasiniazida;Isoniazid; Isoniazida; Isonex; Isonicotinic hydrazide			10.7223517441	4	4		0	2.62444665				CYP1A2	O=C(NN)c1ccncc1	Vitas	STK086288	3.32423179	-0.01289324	0.40203699	2.62444665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095082-06	Iopanoic acid	170465056		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	96-83-3				-12.8109187426	4	5		0	-1.54874249					Ic1cc(I)c(N)c(I)c1CC(CC)C(=O)O	Microsource	01503923	-4.44663186	2.00206665	-5.24610264	-1.62952204	-1.54874249											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015216-17	Chlorpropamide	170464898	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	94-20-2				-24.5057005349	4	5		0	-3.42710074					O=S(=O)(NC(=O)NCCC)c1ccc(Cl)cc1	Microsource	01500185	-8.44389284	-3.90510635	-2.07566999	-3.00939585	-3.42710074											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022003-06	Diflorasone diacetate	170465294		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	33564-31-7		1.2589254118	-5.9	-16.4366740097	4	5		12.3109646519	-3.16521425	0.0726179761	0.9967747464			CC(=O)OCC(=O)[C@@]4(OC(C)=O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-619	-7.75913721	-6.78119349	-3.27552987	3.44514548	-3.16521425											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167468-02	Benorylate	170466237	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	5003-48-5				-29.3223601628	4	5		0	-6.29882151					O=C(C)Oc2ccccc2C(=O)Oc1ccc(NC(C)=O)cc1	Bosche	B1551	-9.35119404	-3.71566348	-6.17446138	-0.51291362	-6.29882151											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015656-12	Mianserin	170465596	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	24219-97-4	; ; Org GB 94;Mianserin; Mianserin Hcl;Mianserin hydrochloride; Mianserin hydrochloride; Mianserina;MIANSERIN HYDROCHLORIDE; Mianserine hydrochloride; Mianserine Hcl;Mianserin..HCl;Mianserine hydrochloride; Lerivon; Bolvidon; Tetramide; Hydrochloride, Mianseri; Tolvon	0.7943282347	-6.1	-10.5304458179	4	5		10.368767764	4.11342394	0.0250328526	0.9873765913	3356	HTR2A	CN1CC2N(CC1)c4ccccc4Cc3ccccc23	Enzo	AC554	-5.5679192	-6.55730647	-1.27868278	3.14556761	4.11342394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159460-04	Indinavir sulfate	170465228	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	157810-81-6	 ;Indinavir sulfate salt hydrate; Crixivan; Indivanir Sulfate; Indinavir, Sulfate (1:1);Indinavir;Indinavir Sulfate; Indinavir sulfate; Sulfate, Indinavi			-22.9307773518	4	5		0	-4.47473434					O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc2cccnc2)C[C@@H](Cc3ccccc3)C(=O)N[C@H]4c5ccccc5C[C@H]4O.O=S(=O)(O)O	Bosche	I2146	-7.19857555	-2.81290323	-4.27361736	-1.83449022	-4.47473434											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015767-10	Oxybutynin chloride		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1508-65-2	 Oxibutinina; ;; Oxytrol; Tropax;Oxybutynin Chloride; Esoxybutynin Chloride; Ditropan; Oxybutinin;OXYBUTYNIN CHLORIDE; Oxybutynin Hcl; Oxybutynin Chloride;Oxybutynin chloride			-25.5575792684	4	5		0	-8.58180514				CHRM1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2	SIGMA	O2881	-6.83398338	-5.44516129	-3.44447385	-0.3650951	-8.58180514											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00485883-01	Forodesine (hydrochloride)	363681392	Purine nucleoside phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	284490-13-7				-35.1521700232	4	4		0	-11.09856356					OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C2=C[NH]C3=C2\N=C/NC3=O	MedChem Express	HY-16209	-6.05469596	-11.94344164	-4.35986777	-11.09856356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185766-04	Esmolol hydrochloride	170465277	sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	81161-17-3				-14.1422214803	4	4		0	-4.36209726					Cl.CC(C)NCC(O)COc1ccc(cc1)CCC(=O)OC	Prestwick	Prestw-1137	-1.40889167	-4.96321975	-4.586657	-4.36209726												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00168786-02	Deserpidine	144206653	Synaptic vesicular amine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	131-01-1	Deserpidine			-45.6476304011	4	4	deserpidinum;CIPLUS_151707;LS-178544;CIPLUS_743119;deserpidine;reserpidine;ORETICYL FORTE;Deserpidine;METHYCLOTHIAZIDE;LS-7299;3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester);Deserpidina;Deserpidinum;LS-178610;DESERPIDINE;	0	-9.59661398					COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccccc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	GVK	GVK-NIH-19	-8.51149477	-10.07863363	-11.79296592	-9.59661398												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	923604-59-5		7.9432823472	-5.1	-78.3528915888	-3	4		-115.3388692899	-14.43379114	1	0.9999966262			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-1.94561231	-3.56810687	-99.63741842	-14.43379114												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167503-02	Aclarubicin	174007366	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	57576-44-0	; Aclacin;Aclarubicin; Aclaplastin; Aclacinon; Aclarubicino;Aclacinomycin A	2.5118864315	-5.6	-43.7675563193	4	4		-25.072493392	-8.40459532	1	0.999903279	7153	TOP2A	CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C5=C(O)C6=C(C=C5[C@H]1C(=O)OC)C(=O)C7=CC=CC(=C7C6=O)O	Carbosynth	OA08264	-5.62214867	-8.42986387	-29.43255983	-8.40459532												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178510-09	Roxithromycin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	80214-83-1				-28.7133937597	4	4		0	-0.18139414					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	Prestwick	Prestw-854	-7.15180249	-7.1784899	-3.0728789	-0.18139414												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00390740-04	Avibactam sodium			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1192491-61-4				-23.8075007849	4	4		0	-2.14217846					NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S]([O-])(=O)=O	Glixx	GLXC-04187	-5.17488147	-4.57427919	-5.63814358	-2.14217846												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179357-05	PREDNICARBATE		Glucocorticoid Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	73771-04-7				-29.0251479187	4	4		0	-3.29100803					CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC	Microsource	01503876	-5.59531264	-7.00093008	-7.05221175	-3.29100803												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00476141-01	11?-Prostaglandin E1		Prostanoid EP1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	24570-01-2				-16.4503761081	4	4		0	-4.56940485				PTGER2	CCCCCC(O)\C=C\[C@H]1[C@@H](O)CC(=O)C1CCCCCCC(O)=O	Cayman	13450	-2.1871366	-8.86953581	-0.50761421	-4.56940485												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167534-02	Pazufloxacin	170465985	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	127045-41-4				-21.4598595013	4	4		0	-4.91491751					NC1(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)[C@@H](C)COc34	Sequoia	SRP010775p	-6.37355756	-2.56193456	-1.41406817	-4.91491751												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160513-01	Testosterone decanoate	144205416	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5721-91-5	TESTOSTERONE UNDECANOATE; 			-10.8113889777	4	4	CIPLUS_669074;Testosterone decanoate;ORG-538;testosterone decanoate;CIPLUS_732550;TESTOSTERONE UNDECANOATE;	0	-2.54815583					CCCCCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	InterBioScreen	STOCK1N-56645	-0.89900707	-3.4328232	-4.59572154	-2.54815583												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00164507-02	Nifuroxime	124893124		DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-27.3583692475	4	4		0	-4.28435691					[O-][N+](=O)C1=CC=C(CN=O)O1	Enamine	T1302-8796 	-4.26245639	-7.88027395	-7.66860044	-4.28435691												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00024494-02	D-Alanine	170465038	Alanine aminotransferase 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	338-69-2				-16.5748614723	4	5		0	-2.34049231					C[C@@H](N)C(=O)O	Tocris	0205	-5.44344582	-5.45376344	-1.36279439	0.04958082	-2.34049231											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274075-01	1-Octacosanol		PI3K-Akt signaling pathway Activator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	557-61-9				-19.7530445597	4	5		0	-2.69022105					CCCCCCCCCCCCCCCCCCCCCCCCCCCCO	SIGMA	O3379	-8.81804307	-9.18709677	-3.00344006	-1.08627062	-2.69022105											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00015718-12	Naftopidil	170466026	alpha1-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	57149-07-2	;Naftopidil;Naftopidil dihydrochloride; Flivas; KT-611 dihydrochloride; Naftopidil			-32.5716175511	4	5		0	-13.22692015			148	ADRA1A	OC(CN1CCN(CC1)c2ccccc2OC)COc4cccc3ccccc34	Tocris	0597	-7.18161777	-7.12258065	-5.18214695	-1.09528531	-13.22692015											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167523-03	Ormetoprim	170465718	Folate biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	6981-18-6		1.2589254118	-5.9	-17.9504823351	4	5		9.775483872	-3.00408017	0.1938676109	0.9764077079			Nc2nc(N)ncc2Cc1cc(OC)c(OC)cc1C	Sequoia	SRP01245o	-6.33372901	-8.14623656	-6.22298668	2.65482737	-3.00408017											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015004-13	Amoxapine	170465376	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	14028-44-5	 Amoxapina; ; Asendin; Amoxapine; 2   Amoxapine;Amoxapine;AMOXAPINE;	7.9432823472	-5.1	-4.8177365221	4	5		-14.546428728	-9.62202394	0.0084074685	0.9958152667	3356	HTR2A	Clc1ccc2Oc4ccccc4N=C(c2c1)N3CCNCC3	Enzo	AC814	1.40749534	1.94408602	0.48072682	-2.7630037	-9.62202394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183829-01	Minodronic acid	144206806	Geranylgeranyl pyrophosphate synthetase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	180064-38-4				-24.0711840424	4	5	Minodronic Acid;MINODRONIC ACID;acidum minodronicum;CIPLUS_707422;acide minodronique;YM 529;Minodronic Acid Hydrate;	0	-5.52392055					O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O	Pharmaron	PH-NIH-115451	-7.03747668	-6.49462366	-5.39384317	2.68187145	-5.52392055											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00021569-09	Enalapril maleate	170464969	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	75847-73-3	 Enalaprila;;Enalapril; 7   Enalapril; Enalapril; ; Vasotec; Maleate, Enalapri; Renitec; 8   Enalapril maleate;Enalapril maleate; Enalapril maleate salt; Renitek;ENALAPRIL MALEATE; Renivace			-12.9985215033	4	5		0	-6.91386809			1636	ACE	OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	Microsource	01501214	-2.94217399	-6.3827957	0.31313399	2.67285676	-6.91386809											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090887-04	Phenyl salicylate	170465501	Estrogen receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	118-55-8				-26.3694630688	4	5		0	-5.56875757					Oc2ccccc2C(=O)Oc1ccccc1	Specs	AT-084/J165064	-7.0968289	-8.36129032	-4.91752668	0.33805102	-5.56875757											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159450-04	Parethoxycaine	170465538		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	94-23-5				-20.9460474924	4	5		0	-1.82038291					CCOc1ccc(cc1)C(=O)OCCN(CC)CC	Specs	AO-365/40892107	-6.08784128	-6.95913978	-2.28014466	-2.62778329	-1.82038291											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263584-01	Tirofiban hydrochloride monohydrate	170465092	Integrin alpha-IIb/beta-3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	150915-40-5		1	-6	-19.486159695	4	5		13.205189076	-8.66251177	0.0170560863	0.9998227906			Cl.O.O=C(O)[C@@H](NS(=O)(=O)CCCC)Cc1ccc(cc1)OCCCCC2CCNCC2	Sequoia	142373-60-2	-8.50432423	-7.60430108	-3.10928817	2.6097539	-8.66251177											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090970-03	Maleic acid	170465983	"NADP-dependent malic enzyme, mitochondrial Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	110-16-7				-24.2518857685	4	5		0	-4.85136529					O=C(O)/C=C\C(=O)O	SIGMA	M0375	-7.38511107	-5.39354839	-5.57907736	1.05922654	-4.85136529											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160397-04	Irsogladine maleate	170465947	M1 Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	84504-69-8	; ;Irsogladine maleate; Irsogladine maleate;irsogladine; Gaslon N			-23.385964918	4	5		0	-4.22364704			1128	CHRM1	Nc1nc(nc(N)n1)c2cc(Cl)ccc2Cl.O=C(O)/C=C\C(=O)O	Enzo	PD141	-6.65592674	-3.56989247	-3.95607304	-3.75462003	-4.22364704											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166020-03	Ethyl 3-aminobenzoate methanesulfonic acid salt	170465717	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	886-86-2		0.7079457844	-6.15	-32.4232024047	4	5		8.610967736	-4.66304981	0.3100143209	0.798243192			Nc1cc(ccc1)C(=O)OCC.CS(=O)(=O)O	Vitas	STK344228	-9.37764965	-11.75913978	-5.76431155	1.00513838	-4.66304981											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178802-06	Deferoxamine mesylate	170464752	Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	138-14-7		12.5892541179	-4.9	-27.5664924279	4	4		-18.83857046	-19.53897773	0.0564696983	0.998037974		APP	ON(CCCCCNC(=O)CCC(=O)N(O)CCCCCN)C(=O)CCC(=O)NCCCCCN(O)C(C)=O.CS(=O)(=O)O	Microsource	01500224	-3.00683568	-3.73349391	-3.82663195	-19.53897773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015966-10	Levosulpiride	170465834	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	23672-07-3	(?)-Sulpiride;SULPIRIDE; Sulpirida; Dogmatyl; Levosulpirida; Sulpiride (+/-)-; (?)-Sulpiride; (-)-Sulpiride;Sulpiride; (RS)-(+/-)-Sulpiride;(RS)-(+/-)-Sulpiride;(RS)-SULPIRIDE; ; (S)-(-)-Sulpiride			-12.1876535093	4	5		0	-0.97007413			1813	DRD2	CCN2CCC[C@H]2CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	Prestwick	Prestw-56	-2.41560719	-3.15234174	-2.74887604	-4.08851884	-0.97007413											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016408-09	Sulfapyridine	170464707	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	144-83-2	; ; Sulphapyridine; Sulfapiridina;Sulfapyridine; Sulfapyridine;SULFAPYRIDINE; Sulphapyridin			-25.2232860959	4	5		0	-6.36954333					O=S(=O)(Nc1ccccn1)c2ccc(N)cc2	Vitas	STK292439	-6.93117054	-1.38531481	-5.11239563	-4.38650307	-6.36954333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263909-02	Tadalafil	170464819	Phosphodiesterase V (PDE5) inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	171596-29-5				-40.1622777858	4	5		0	-9.96613892				PDE5A	O=C6N(C)CC(=O)N4[C@@H]6Cc1c5ccccc5nc1[C@H]4c2ccc3OCOc3c2	Microsource	01505639	-10.31565103	-3.81283239	-6.91072575	-8.70727432	-9.96613892											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018153-10	Dienestrol	170465362	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	84-17-3	 (E,E)-Dienestrol; Ortho Dienestrol; Dienestrol, (Z,E)-Isomer; Dienoestrol; Ortho Brand of Dienestrol; Dienestrol, (E,E)-Isomer; Dienestrol, (Z,Z)-Isomer; Oestrasid;DIENESTROL; Synestrol;Dienestrol;	11.220184543	-4.95	-47.6667866174	-2.2	5		-36.9104032881	-31.40843781	0.000788941	0.9996060548	2099	ESR1	Oc1ccc(cc1)C(=C\C)/C(=C/C)c2ccc(O)cc2	Microsource	01500241	-4.99342394	-4.81643507	-5.54056947	-11.0035057	-31.40843781											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091454-07	Phenol	170465486		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	108-95-2				-27.6372941658	4	5		0	-5.34455935					Oc1ccccc1	Specs	AE-562/J262148	-6.49276633	-3.69274318	-7.14193963	-5.76248904	-5.34455935											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00538320-01	NCGC00538320-01		Prostamide/prostaglandin F synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-18.928924545	4	4		0	-4.50564295			127281	FAM213B	OC(=O)C1CCC2=C1C=C(Cl)C(=C2)C3CCCCC3	Pharmaron	PH-NIH-2017-009-L1-7-0	-4.57298607	-2.38289819	-3.17341219	-4.50564295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229704-01	Raltitrexed	124939249	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	112887-68-0	Raltitrexed	0.7079457844	-6.15	-86.2057690595	4	4	Raltitrexed	-30.4112934281	-28.30624428	0.2879435941	0.9456025287	7298	TYMS	O=C(N[C@@H](CCC(=O)O)C(=O)O)c1ccc(s1)N(C)Cc2ccc3N=C(C)NC(=O)c3c2	Waterstone	WS10046	-13.79683309	-20.56862661	-22.09030322	-28.30624428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178734-06	Sitagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	654671-77-9				-37.1473977386	4	4		0	-8.13107325				DPP4	N[C@@H](CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F	Adooq	A10848	-9.85117245	-6.75297862	-1.70808139	-8.13107325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095899-09	Rizatriptan Benzoate		5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	145202-66-0				-22.6082412352	4	4		0	-4.57536276				HTR1B	CN(C)CCC1=C[NH]C2=CC=C(C[N]3C=NC=N3)C=C12	APExBIO	A8516	-5.14406853	-5.24753753	-3.41174913	-4.57536276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014617-01	Benzylhydrochlorothiazide	144203604		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1824-50-6	Benzylhydrochlorothiazide; Behyd; BHCTh; 			-27.3247936566	4	4	6-Chloro-3,4-dihydro-3-(phenylmethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;Behyd;Benzylhydrochlorothiazide;LS-40438;BENZYLHYDROCHLOROTHIAZIDE;BHCTh;CIPLUS_208144;benzylhydrochlorothiazide;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(phenylmethyl)-, 1,1-dioxide;	0	-7.73018432					NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)Cc2ccccc2)cc3Cl	NCI		-5.61131782	-5.62604843	-4.70053405	-7.73018432												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016003-10	Trihexyphenidyl hydrochloride	170464756	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	52-49-3				-19.9025269479	4	5		0	-5.73631316					Cl.OC(CCN1CCCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500592	-5.17271766	-4.57485743	-6.1665341	2.12648693	-5.73631316											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167538-02	Clorprenaline hydrochloride	170466032	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	6933-90-0		1.77827941	-5.75	-10.5364607906	4	5		12.4220784719	-5.69042265	0.2544487923	0.9581888725			Cl.OC(CNC(C)C)c1ccccc1Cl	Sequoia	SRP036805c	-4.82023264	-7.85173206	-5.999079	5.58949157	-5.69042265											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015344-16	NCGC00015344-16			DPI_SARS-CoV-2_General	2019_NPC-2_Tox			1.77827941	-5.75	-9.8566663792	4	5		13.430912932	-9.14138865	0.0838699605	0.9956704427			CN(C)CC\C=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2	Microsource	01500264	-6.60909411	-5.66431186	-5.33763135	6.97653057	-9.14138865											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024667-14	Methyldopa	170464643	DOPA decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	41372-08-1	; L-alpha-Methyl DOPA;METHYLDOPA; L-alpha-Methyl-DOPA;Methyldopa; ; DL-alpha-Methyl-DOPA; Methoplain; Metildopa;L-alpha-Methyl DOPA; alpha-Methyl-L-DOPA; L(-)-alpha-Methyldopa;Methyldopa sesquihydrate; Methyldopa (L,-);Methyldopa (L,-); L-Methyldopa; Methyldopa sesquihydrate; Aldomet; L-Alphamethyl Dopa	2.8183829313	-5.55	-10.9364453265	4	5		9.4702150119	-4.55233812	0.5950129312	0.6930641896	1644	DDC	O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1	Microsource	01500403	-7.05851251	-0.62558516	-4.2659187	3.85339641	-4.55233812											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00390559-05	Azilsartan Medoxomil		Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	863031-21-4				-23.2843101792	4	4		0	-2.88358847			185	AGTR1	CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)O[N-]5)C(=O)OC\C6=C(/C)OC(=O)O6	APExBIO	B2218	-6.15873296	-7.21319972	-0.51541927	-2.88358847												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379014-01	Cariprazine		Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	839712-12-8				-11.4419771743	4	4		0	-2.40299039					CN(C)C(=O)N[C@H]1CC[C@@H](CC1)CCN2CCN(CC2)C3=CC=CC(=C3Cl)Cl	MedChem Express	HY-14763	-3.28230467	0.03455425	-2.22193347	-2.40299039												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167435-07	Nilvadipine		Voltage-gated L-type calcium channel alpha-1C subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	75530-68-6				-24.0209187666	4	4		0	-12.08329569					COC(=O)C\1=C(\N\C(=C(/C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C)C#N	MedChem Express	HY-14284	-3.12486456	-4.98108991	-5.04779773	-12.08329569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181026-02	Robenidine	170465629	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	25875-51-8		12.5892541179	-4.9	-93.4254370198	-3	4		-104.6753347409	-98.98364803	0.0484485903	0.9985495031			Clc2ccc(/C=N/NC(=N)N\N=C/c1ccc(Cl)cc1)cc2	SIGMA	33979	-5.53460755	-5.50541516	-2.09059233	-98.98364803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017366-08	Pergolide methanesulfonate	170465250	Dopamine D3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	66104-23-2				-18.3844514243	4	4		0	-8.71352426					CS(=O)(=O)O.CSC[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CCC)c34	Enzo	AC755	-3.49759459	-0.82946536	-3.37711069	-8.71352426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016572-12	Sulfamonomethoxine	170465768		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1220-83-3				-2.332488151	4	4		0	0.08582528					O=S(=O)(Nc1cc(OC)ncn1)c2ccc(N)cc2	Microsource	01501147	-1.24387813	-1.21626268	2.33181453	0.08582528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178768-03	POLYMYXIN B SULFATE		Peptide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1405-20-5, 1404-26-8 [polymyxin B]				-17.483388319	4	4		0	-2.07335803					CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCN)NC1=O)C(C)O	Microsource	01500492	-4.37307676	-7.5597387	-0.25015635	-2.07335803												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00091865-02	Benzyl alcohol	124891475		DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-17.9367296617	4	4		0	-4.77038092					OCC1=CC=CC=C1	SigmaAldrich	108006	-3.89994265	-2.41879751	-3.89379764	-4.77038092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167969-02	Rubitecan	124893436		DPI_SARS-CoV-2_General	2019_NPC-5_Tox			2.5118864315	-5.6	-151.9409793064	-1.1	4		-90.6854402541	-96.78832776	0.0260009831	0.9995828219			CC[C@@]1(O)C(=O)OC/C2=C1/C=C/3N(CC4=CC5=C(C=CC=C5[N+]([O-])=O)N=C34)C2=O	SIGMA	R3655	-7.81432844	-35.2114492	-88.43920307	-96.78832776												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00181300-01	Riboflavin tetrabutyrate	144206329	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	752-56-7	CIPLUS_668986; Hibon; vitamin B2 tetrabutyrate; 			3.4224521933	4	4	Hibon;Riboflavin butyrate;Riboflavin Butyrate;riboflavin tetrabutyrate, riboflavin-2-14C-labeled;vitamin B2 tetrabutyrate;RIBOFLAVIN BUTYRATE;riboflavin tetrabutyrate;CIPLUS_668986;	0	3.41042551					CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12	ACC	riboflavin butyrate	0.48974992	-0.02148874	-0.51818101	3.41042551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379082-01	Anidulafungin			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	166663-25-8		7.0794578438	-5.15	-4.8376072158	4	4		-10.85043816	-7.7920318	0.560705227	0.7392124002			CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(NC(=O)C(NC(=O)C6CC(O)CN6C(=O)C(NC4=O)C(C)O)C(O)C(O)C7=CC=C(O)C=C7)C(C)O	MedChem Express	HY-13553	-0.03033849	-0.68334193	5.54811043	-7.7920318												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181109-03	Decoquinate	170466244	Antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	18507-89-6				-25.021837203	4	4		0	-5.78497686					O=C(OCC)c1cnc2cc(OCC)c(cc2c1O)OCCCCCCCCCC	Microsource	01505356	-6.87342833	-3.60228058	-2.45582121	-5.78497686												1.6E-8	8E-8	4E-7	0.000002											
NCGC00160431-02	2-[(4-Chloro-3-methylphenyl)amino]benzoic acid			DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-34.0797690596	4	4		0	-13.18084728					CC1=CC(=CC=C1Cl)NC2=CC=CC=C2C(O)=O	Scientific Exchange	F-137102	-5.91167777	-7.14409122	-5.92082467	-13.18084728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095187-08	RAMELTEON			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	196597-26-9				-23.6507874887	4	4		0	-3.25738697					CCC(=O)NCC[C@@H]1CCC2=C1C3=C(OCC3)C=C2	Microsource	01505817	-5.43521419	-5.57187284	-4.92463617	-3.25738697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167973-02	Eperisone hydrochloride	170465796	skeletal muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	56839-43-1				-8.1873584367	4	4		0	-5.30437878					Cl.CC(CN1CCCCC1)C(=O)c2ccc(CC)cc2	Bosche	E3497	-0.92645696	0.57878369	-3.23544699	-5.30437878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390238-01	Isepamicin		30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	58152-03-7				-23.6495582508	4	4		0	-6.05197579					CN[C@@H]1[C@@H](O)[C@H](OC[C@]1(C)O)O[C@@H]2[C@@H](O)[C@H](OC3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN	Adooq	A11662	-5.50580139	-2.75570145	-4.25762301	-6.05197579												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00018117-17	Theophyllamine	170466874	Adenosine Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	58-55-9	; Theocolin; 1,3-Dimethylxanthine; Choledyl-SA; Quadrinal; Theophylline solution; Novurite; Mercurofilina; Guaithylline; Choledyl; oxtripylline-SA;Theophylline; Guaifilina; Mercumatilina sodica; Aminofilina; Elixophyllin;Aminophylline ethylenediamine;THEOPHYLLINE; Teofilinato de colina; Mercumatiline sodique;Aminophylline; Brondecon; Theobret; Aminophylline, dihydrate; Brondaxin; Butaphyllamine; Tedral; Theodur G; Theophylline-[8-3H]; Mercumatilinum natricum; Euspirax; Novurit; Somophyllin;Theophylline monohydrate			0.3619085409	4	5		0	-2.00082603			134	ADORA1	O=C2c1ncnc1N(C)C(=O)N2C	Labotest	LT00000171	0.64328516	1.54481232	0.5400427	-1.13443255	-2.00082603											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024309-17	(+)-Diltiazem	170464699	Ca2+ channel blocker, similar pharmacology to verapamil	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	42399-41-7				-24.9309684384	4	5		0	-11.28906429					CN(C)CCN1c3ccccc3S[C@H]([C@@H](OC(C)=O)C1=O)c2ccc(OC)cc2	Enzo	CA205	-4.27388086	-7.51978892	-4.57571064	-0.16074955	-11.28906429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00250382-07	Sonidegib		Smo Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1218778-77-8				4.0816289129	4	4		0	4.36988252				SMO	C[C@H]1CN(C[C@@H](C)O1)C2=NC=C(NC(=O)C3=C(C)C(=CC=C3)C4=CC=C(OC(F)(F)F)C=C4)C=C2	Aobious	AOB87343	0.53822738	-0.57878369	-0.22089397	4.36988252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371104-01	Cevimeline hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	[107220-28-0]				-33.3283088843	4	4		0	-3.01708793					C[C@H]1O[C@]2(CS1)CN3CCC2CC3	Tocris	3689	-9.19398244	-6.41845197	-4.4481982	-3.01708793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181140-02	Carboquone	124893654	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			1.1220184543	-5.95	-31.9201782778	4	4		-15.5650002761	-15.66393734	0.027795558	0.9995274303			CO[C@@H](COC(N)=O)\C1=C(/N2CC2)C(=O)\C(=C(\N3CC3)C1=O)C	NCI	NSC-134679	-2.27643711	-7.27366966	-13.32726958	-15.66393734												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181775-02	Toluidine blue	170466390		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	92-31-9		8.9125093813	-5.05	-51.8329891989	4	4		-29.553175048	-33.89106444	0.068453076	0.9971035019			[Cl-].CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1	Labotest	LT00451843	-6.86460493	-5.0967519	-7.73995149	-33.89106444												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018102-12	Flunarizine	170466037	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	52468-60-7	Sibelium; ; Flu Narizine;Flunarizine dihydrochloride; Hydrochloride, Flunarizin;Flunarizine; Flunarizin; Flunarizina; Flunarizine	12.5892541179	-4.9	-42.9861720268	-3	5		-34.307263724	-35.8404846	0.0091021881	0.9954233396			Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)C/C=C/c4ccccc4	Enzo	CA225	-3.53366232	-5.03447102	-5.38786788	-3.3757406	-35.8404846											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253579-01	Bolandiol dipropionate	170465909	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1986-53-4				2.3495425353	4	5		0	-4.43302281					CCC(=O)O[C@H]2CCC3C4CCC1(C)C(CC[C@@H]1OC(=O)CC)C4CCC3=C2	GVK	FFS-11-286-NCI-219	0.65209729	1.57885778	0.8749529	3.91769623	-4.43302281											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164583-02	Amdinocillin	170465354		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	32887-01-7		1.1220184543	-5.95	-22.662604751	4	5		14.445314492	-4.13932357	0.0969331879	0.994200468			OC(=O)[C@@H]2N3C(=O)[C@@H](/N=C/N1CCCCCC1)[C@H]3SC2(C)C	Sequoia	SRP01690m	-9.15579838	-10.37109541	-7.06241889	4.49639462	-4.13932357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185757-01	Diethylmethyl(2-3-methyl-2-phenylvaleryloxy)-ethyl)ammonium bromide	144207102	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	90-22-2				-25.2491145711	4	4		0	-6.64827341					[Br-].CC[N+](C)(CC)CCOC(=O)C(C(C)CC)c1ccccc1	SigmaAldrich	S422649	-6.13226276	-4.2674499	-2.34320859	-6.64827341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093350-05	Amikacin	174006656	30S ribosomal protein S12 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	37517-28-5				-28.4483921585	4	4		0	-7.46707013					NCC[C@H](O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O	Vitas	STK039706	-4.99404421	-2.7902557	-4.60412335	-7.46707013												1.6E-9	8E-9	4E-8	2E-7											
NCGC00390702-02	Efinaconazole		Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	164650-44-6				-33.8978614462	4	4		0	-8.33926664					C[C@@H](N1CCC(=C)CC1)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-15660	-8.73516566	-4.58707671	-3.07952183	-8.33926664												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183859-01	Prifinium bromide	144206846	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	4630-95-9				-30.9382452677	4	4	Pyrrolidinium, 1,1-diethyl-3-diphenylmethylene-2-methyl-, bromide;Prifinium Bromide;PRIFINIUM BROMIDE;Prifinium bromide;CIPLUS_213773;Bromuro de prifinio;Prifinii bromidum;pyrodifenium bromide;CIPLUS_163551;Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, bromide;3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidinium bromide;prifinii bromidum;prifinium;Bromure de prifinium;prifinium bromide;bromure de prifinium;Padrin;LS-138326;	0	-9.36276255					[Br-].CC[N+]3(CC)CC/C(=C(\c1ccccc1)c2ccccc2)C3C	Pharmaron	PH-NIH-153498	-6.97048573	-4.2674499	-4.51749827	-9.36276255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090705-15	2',3'-Dideoxycytidine	170465128	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	7481-89-2	; ; 2',3' Dideoxycytidin; Cytidine, 2',3'-dideoxy-; 2',3'-dideoxycytidine;2',3'-Dideoxycytidine; 2',3'-Dideoxycytidine; Hivid; 2';Zalcitabine;2',3'-dideoxycytidine; Dideoxycytidine-3H; HIVID Roche; Zalcitibine			-31.462500697	4	5		0	-6.18604011			7015	TERT	NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1037	-8.93549524	-7.37509575	-7.0791644	-0.23423506	-6.18604011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178815-03	Tolmetin sodium dihydrate	170465216	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	64490-92-2		1.77827941	-5.75	-14.5999721825	4	5		11.21342968	-4.48809141	0.1607224528	0.9838915607			[Na+].O.O.O=C([O-])Cc2ccc(C(=O)c1ccc(C)cc1)n2C	Microsource	01500582	-7.2611914	-5.5621755	-5.99070624	4.79952234	-4.48809141											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164057-03	2-Bromo-2-nitro-1,3-propanediol	225144251	reactive oxygen species biosynthetic process Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	52-51-7				5.1687485667	4	5		0	1.50520857					OCC(Br)(CO)[N+]([O-])=O	SIGMA	134708	1.94747973	-1.75759639	-0.90844392	3.28388371	1.50520857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164600-10	ARTESUNATE		Antimalarial Agents	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	182824-33-5		5.0118723363	-5.3	-26.4955047406	4	4		-18.9196390361	-20.13171947	0.1363239289	0.988405948		PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Microsource	01504829	-2.10879252	-0.19868694	-8.47626473	-20.13171947												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182079-09	TRANDOLAPRIL			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	87679-37-6				-33.5767994727	4	4		0	-7.52046992					[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O	Microsource	01505264	-8.09988088	-4.65618521	-5.7475745	-7.52046992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091695-03	Triethylenetetramine	170465257	Copper Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	112-24-3				-20.4348213519	4	5		0	-3.20315727					NCCNCCNCCN	Labotest	LTBB000434	-6.26542122	-5.59622095	-5.41298614	1.82335921	-3.20315727											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095048-06	Pipobroman	170465158	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	54-91-1				-23.5528353924	4	5		0	-4.59822863					O=C(CCBr)N1CCN(CC1)C(=O)CCBr	Microsource	01503393	-5.26083891	-7.67299345	-8.12575878	0.97827585	-4.59822863											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183845-01	Pibutidine	144206830	Histamine H2 receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	103922-33-4				-15.142146588	4	4	LS-55930;Pibutidine hydrochloride;IT-066;pibutidine hydrochloride;pibutidinum;PIBUTIDINE;PIBUTIDINE HYDROCHLORIDE;3-amino-4-(4-(4-(1-piperidinomethyl)-2-pyridyloxy)-2-butenylamino)-3-cyclobutene-1,2-dione;3-Cyclobutene-1,2-dione, 3-amino-4-((4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)amino)-, monohydrochloride, (Z)-;IT 066;Pibutidine Hydrochloride;CIPLUS_3889336;pibutidine;CIPLUS_696295;	0	-5.85617658					NC=3C(=O)C(=O)C=3NC\C=C/COc2cc(CN1CCCCC1)ccn2	Pharmaron	PH-NIH-151621	-2.20584991	-4.25017277	-1.52027027	-5.85617658												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167456-02	Bisibutiamine	170466019		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3286-46-2				-20.0459075532	4	5		0	-4.00165206					Nc2nc(C)ncc2CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SSC(/CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N	Bosche	B6282	-6.38879098	-1.55332369	-3.71331687	-2.18160107	-4.00165206											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025179-12	Mifepristone	170465151	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	84371-65-3	RU-486; ;VX-410;RU-38486;VGX-410C;VGX-410;Mifepristone (Mifeprex); Corlux; Mifepristone;C-1073;CI-1073;Mifepristone; Mifeprex	12.5892541179	-4.9	-82.7793892637	-3	5		-75.0847368126	-72.44275159	0.0667276445	0.9648775024	5241	PGR	CN(C)c1ccc(cc1)[C@H]5C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC)[C@@H]4CCC3=CC(=O)CCC3=C45	Prestwick	Prestw-299	-10.20444131	-10.37109541	-5.95721522	2.43880035	-72.44275159											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160450-03	4-Acetylaminophenylacetic acid	170465954		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	18699-02-0				-8.9125251096	4	5		0	-1.43178376					O=C(C)Nc1ccc(cc1)CC(=O)O	Specs	AE-562/J260765	-2.00916461	-4.10673249	-3.97287227	2.19078675	-1.43178376											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167445-02	Eprazinone dihydrochloride	170465851	Neurokinin 1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	10402-53-6				-21.1821899085	4	4		0	-2.84798861					Cl.Cl.O=C(c1ccccc1)C(C)CN3CCN(CC(OCC)c2ccccc2)CC3	Bosche	E5680	-6.30873075	-4.05148583	-1.6502079	-2.84798861												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00092386-13	Sertraline hydrochloride	170465121	Selective Seratonin Reuptake Inhibitor (SSRI)	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	79559-97-0		12.5892541179	-4.9	-105.3076527936	-3	5		-101.1650404589	-99.63746501	0.007789045	0.9960831532		SLC6A4	Cl.Clc1ccc(cc1Cl)[C@@H]3CC[C@H](NC)c2ccccc23	Microsource	01505262	-8.39795559	-8.60073198	-9.78356428	-3.44922611	-99.63746501											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015826-13	Perphenazine	170464834	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	58-39-9		14.1253754462	-4.85	-34.7258308828	4	5		-23.4367944001	-23.68867881	0.0896617163	0.9520568077	1128	CHRM1	OCCN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Microsource	01503934	-5.11984491	-6.5665163	-2.54113116	-1.65801681	-23.68867881											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179676-03	Lynestrenol	170465984		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	52-76-6				-16.3415464635	4	4		0	-4.44032885					C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@]2(O)C#C	Prestwick Chemical, Inc.	Prestw-95	-3.64495298	-4.67165205	-0.64325918	-4.44032885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095143-07	Rosuvastatin calcium (Crestor)			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	147098-20-2				-24.5964146871	4	4		0	-5.47926642					CC(C)C1=C(\C=C\C(O)CC(O)CC(O)=O)C(=NC(=N1)N(C)[S+](C)([O-])=O)C2=CC=C(F)C=C2	Adooq	A10810	-6.21072249	-4.53412412	-2.42115608	-5.47926642												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167423-01	Bevonium metilsulfate	144205980	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	5205-82-3	BEVONIUM METILSULFATE; Acabel; Metilsulfato de bevonio; 			-23.0573875449	4	4	Bevonii metilsulfas;Bevonium Methylsulfate;bevonii metilsulfas;bevonium;CIPLUS_213756;metilsulfate de bevonium;Metilsulfate de bevonium;LS-116671;Bevonium methylsulfate;Benzilsaeure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat (German);piribenzil methyl sulfate;bevonium methyl sulfate;BEVONIUM METHYLSULFATE;2-(HYDROXYMETHYL)-1,1-DIMETHYLPIPERIDINIUM METHYLSULFATE, BENZILATE;BEVONIUM METILSULFATE;CG 201;2-(hydroxymethyl)-N,N-dimethylpiperidinium benzilate;Bevonium metilsulfate;Metilsulfato de bevonio;CIPLUS_3883657;CIPLUS_173844;Acabel;bevonium methylsulfate;bevonium sulfate (1:1);Piperidinium, 2-hydroxymethyl-1,1-dimethyl-, methanesulfonate, benzilate;	0	-3.62724727					[O-]S(=O)(=O)OC.OC(C(=O)OCC1CCCC[N+]1(C)C)(c2ccccc2)c3ccccc3	Apollo	OR3501T	-7.33758072	-3.36513667	1.06316448	-3.62724727												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015099-11	Alprenolol	170465812	Beta-adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	13655-52-2				-25.6961668109	4	5		0	-10.00413015					CC(C)NCC(O)COc1ccccc1CC=C	Enzo	AC812	-6.52097286	-7.14528896	-1.03403525	-0.58329123	-10.00413015											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017112-10	Ciclopirox	170464708	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	41621-49-2	; Dafnegin-CSC;Ciclopirox ethanolamine; Ciclopirox ethanolamine; Penlac;Ciclopirox; Batrafen; Loprox;ciclopirox; ciclopirox	5.0118723363	-5.3	-122.0615595552	-2.1	5		-93.5037211665	-86.95332936	0.0142106945	0.9928195282		CAT	CC=2C=C(C1CCCCC1)N(O)C(=O)C=2.NCCO	Microsource	01500189	-5.4987663	-5.10256192	-18.74241219	-43.21407248	-86.95332936											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263467-03	2-Pyrrolidone-5-carboxylic acid	225144361		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	149-87-1				-17.2237655003	4	4		0	-2.71478905					OC(=O)C1CCC(=O)N1	SIGMA	292915	-4.86716075	-4.89513495	0.9380863	-2.71478905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164524-02	D-Glucuronolactone	50111689		DPI_SARS-CoV-2_General	2019_NPC-5_Tox		Glucuronolactone; D-Glucurone; D-Glucurono-6,3-lactone; 			-15.3558623069	4	4	NCGC00164524-01;mannurono-gamma-lactone;D-(+)-Glucurono-6,3-lactone;GLUCUROLACTONE;GLUCURONOLACTONE, D-;CIPLUS_672794;D-Glucurone;D-Glucurono-6,3-lactone;Glucurolactone;CIPLUS_149024;mannuronolactone;D-(+)-Glucuronic acid gamma-lactone;Glucuronolactone;D(+)-Glucuronic acid gamma-lactone;	0	-4.18737013					[H][C@]1(O)C(O)O[C@]2([H])[C@]([H])(O)C(=O)O[C@]12[H]	Labotest	LT03210628	-3.72296624	-4.00979887	-0.0804074	-4.18737013												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00263824-02	GENTAMICIN SULFATE	225144365	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1405-41-0, 1403-66-3 [gentamicin]				-21.3388533776	4	4		0	-5.98518385					CN[C@H](C)[C@@H]1CC[C@@H](N)[C@H](O1)O[C@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O	Microsource	01500314	-4.85849261	-3.31356369	-1.93871169	-5.98518385												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00018268-08	Itraconazole			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	84625-61-6		4.4668359215	-5.35	-100.250729863	-2.1	4		-81.9298599347	-82.35161261	0.0085996935	0.9999543892			CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(CN6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Selleck	S2476	-3.34156807	-4.49974214	-38.65808988	-82.35161261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00348372-01	LINDANE		GABA-A receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	58-89-9				3.1060875247	4	5		0	3.56255926					[Cl][C@H]1[C@H]([Cl])[C@H]([Cl])[C@@H]([Cl])[C@H]([Cl])[C@@H]1[Cl]	SigmaAldrich	233390	-2.28965163	5.26565056	1.10352076	0.34042939	3.56255926											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022819-04	Ipratropium bromide		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	66985-17-9	; Berodual; Atrovent; Bronchodual;Ipratropium bromide; fenoterol-ipratropium IK6; Duovent; Bromuro de ipratropio; Ipratroprium bromide; Iprafen			-5.1688584027	4	5		0	-1.58486477					CC(C)[N+]1(C)[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	SIGMA	I1637	-1.81888214	0.64152243	-2.37344544	0.85788208	-1.58486477											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016634-04	Acetopromazine maleate	170465731		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	3598-37-6				-19.3613570381	4	5		0	-7.02126699					O=C(O)/C=C\C(=O)O.CC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Prestwick Chemical, Inc.	Prestw-576	-5.833262	-0.91707569	-3.29304607	-0.5038355	-7.02126699											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093560-05	Finasteride	170464818	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	98319-26-7	; ; Propecia; Proscar; Finasterida;Finasteride; Finasteride			-20.8645577723	4	5		0	-1.11527521			374	AR	CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C	Prestwick Chemical, Inc.	Prestw-717	-7.34828383	-5.74786877	-2.89017341	-0.52199174	-1.11527521											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167958-05	Imipenem	170464934	Penicillin-binding protein 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	64221-86-9				-19.5915989416	4	5		0	-4.99841965			945240	mrdA	O[C@H](C)[C@H]2C(=O)N1C(=C(C[C@@H]12)SCCNC=N)C(=O)O	Prestwick Chemical, Inc.	Prestw-519	-6.59505264	-1.40790493	-2.8376248	-0.93958513	-4.99841965											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015643-11	Metoclopramide	170464848	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	364-62-5				-27.6315435118	4	5		0	-5.47703978					Nc1cc(OC)c(cc1Cl)C(=O)NCCN(CC)CC	Enzo	AC840	-8.61508174	-8.71867734	-1.85671746	-0.24057011	-5.47703978											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253590-01	Variotin	170465957		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	19504-77-9				-8.1874534363	4	5		0	-2.78593037					O=C1CCCN1C(=O)/C=C/C=CC(\C)=C\C(O)CCCC	GVK	FFS-11-286-NCI-227	-2.46939998	2.23456471	-2.72376949	-1.69306886	-2.78593037											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094817-05	Flopropione	170465817	Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2295-58-1				-22.3854613122	4	5		0	-4.39337156			1312	COMT	O=C(CC)c1c(O)cc(O)cc1O	Microsource	01500629	-7.50235385	-2.18289848	-3.08285164	-2.15605283	-4.39337156											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015774-06	Oxatomide	170466059	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	60607-34-3		14.1253754462	-4.85	-61.6415090675	-3	5		-37.8598695585	-38.96336816	0.101367246	0.9451713111	3269	HRH1	O=C5Nc1ccccc1N5CCCN2CCN(CC2)C(c3ccccc3)c4ccccc4	Enzo	EI114	-10.1661862	-10.01290323	-7.40495722	-2.13197512	-38.96336816											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091886-04	Denatonium benzoate	170464678	Glycolysis / Gluconeogenesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	3734-33-6				-10.3687702651	4	5		0	-3.0847868					O=C(Nc1c(C)cccc1C)C[N+](Cc2ccccc2)(CC)CC.[O-]C(=O)c1ccccc1	Vitas	STK301730	-4.298796	-3.10537634	0.35723736	2.61876859	-3.0847868											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163736-04	Imidacloprid	170465741		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	138261-41-3				-18.9282674619	4	5		0	-2.71712326					[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1	Vitas	STK786692	-5.98609462	-3.49247312	-2.72999912	-2.06887226	-2.71712326											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015964-17	Spiperone	170465856	Dopamine D4 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	749-02-0		3.1622776602	-5.5	-49.9506851954	4	5		-14.788690528	-21.19894185	0.0361558068	0.9815060486			Fc1ccc(cc1)C(=O)CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3	Enzo	AC807	-6.1387146	-8.36989247	-5.95836641	-18.17813035	-21.19894185											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015766-13	Oxymetazoline hydrochloride	170464916	alpha2A(2D)-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1491-59-4	; ; Oximetazolina;Oxymetazoline;OXYMETAZOLINE HYDROCHLORIDE; Afrazine; 3-[(4,5-Dihydro-; Afrin;OXYMETAZOLINE;Oxymetazoline..HCl;Oxymetazoline hydrochloride; Oxymetazoline hydrochloride			-2.2572331813	4	5		0	-2.13424203			148	ADRA1A	CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2O	Enzo	AC138	-2.44191962	-1.45376344	3.70909412	3.27684125	-2.13424203											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00510940-01	Kebuzone		Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	853-34-9				-24.5923426461	4	4		0	-4.20543861					CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	SantaCruz Bio	sc-488996	-5.95934642	-8.08406395	-0.83087644	-4.20543861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164560-05	ABACAVIR SULFATE			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	188062-50-2				-13.3728205896	4	4		0	-3.17553528					NC1=NC2=C(N=C[N]2[C@@H]\3C[C@H](CO)\C=C3)C(=N1)NC4CC4	SIGMA	SML0089	-3.55827157	-2.98693485	0.25015635	-3.17553528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159392-05	1,1,1-Trichloro-2-methyl-2-propanol	170465458		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	57-15-8				-12.2843165345	4	5		0	-2.47889105					ClC(Cl)(Cl)C(C)(C)O	Labotest	LT03378907	-3.76187623	-3.88788427	-3.80977404	2.75520857	-2.47889105											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159451-06	Tinoridine	170465864	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	24237-54-5				-34.0511957901	4	5		0	-7.78886531					O=C(OCC)c1c2CCN(Cc2sc1N)Cc3ccccc3	Vitas	STK036143	-9.47958572	-7.78868509	-6.28831669	-1.15745994	-7.78886531											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166308-02	Difloxacin hydrochloride	170465623	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	91296-86-5				-34.3187055591	4	4		0	-11.57348904					Cl.CN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4	Vitas	STK618168	-7.48031496	-5.47980558	-3.91490489	-11.57348904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091390-04	4-Methoxyphenol	170464687	Tyrosinase Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	150-76-5				-20.9725755891	4	5		0	-1.79372197					Oc1ccc(OC)cc1	Bosche	M0306	-4.52871548	-4.19025562	-4.84692785	-7.03330412	-1.79372197											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016557-06	Ethaverine hydrochloride	170466346	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	985-13-7				-25.4007320867	4	5		0	-3.79793173					Cl.CCOc1ccc(cc1OCC)Cc3nccc2cc(OCC)c(cc23)OCC	Microsource	01501000	-4.87943884	-3.44398696	-8.477842	-7.41016652	-3.79793173											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263839-02	Pentisomicin	170465779	Staphylococcus aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	55870-64-9				-33.7825118038	4	5		0	-4.04502608					N[C@@H]3CC=C(CN)O[C@@H]3O[C@H]2[C@@H](O)[C@@H](O[C@H]1OC[C@@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N	Microsource	01500536	-8.88645331	-6.6091954	-7.42453436	-6.39351446	-4.04502608											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025297-04	Gabexate mesilate	170465830	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56974-61-9	; ;Gabexate mesylate; Gabexate mesylate;Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester;Gabexate mesilate; Gabexate Methanesulfonate; Arodate; Gabexato			-24.0495360855	4	5		0	-7.89786767			4790	NFKB1	O=C(Oc1ccc(cc1)C(=O)OCC)CCCCCNC(=N)N.CS(=O)(=O)O	Prestwick	Prestw-1008	-4.0727751	-3.9414994	-6.73945622	-4.47414549	-7.89786767											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160482-02	Sulfalene	170465930	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	152-47-6				-25.891729639	4	5		0	-4.93273543					COc2nccnc2NS(=O)(=O)c1ccc(N)cc1	Vitas	STK386859	-5.81762385	-5.2367473	-3.57953329	-7.51533742	-4.93273543											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021202-03	Famotidine	170464877	Histamine H2 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	76824-35-6				-20.2959469502	4	5		0	-5.71183456				HRH2	N/C(N)=N/c1nc(CSCCC(\N)=N/S(N)(=O)=O)cs1	Enzo	AC925	-5.33681417	-2.50150693	-6.49851112	0.23149199	-5.71183456											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094736-05	Nitromide	170466818	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	121-81-3				-11.6583219159	4	5		0	-3.21939766					O=[N+]([O-])c1cc(cc(c1)[N+]([O-])=O)C(N)=O	Microsource	01500435	-3.95874347	-5.11065186	0.38535645	1.99264672	-3.21939766											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015817-14	Promethazine	170465107		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	60-87-7				-9.5557840279	4	5		0	-7.13866438					CN(C)C(C)CN1c3ccccc3Sc2ccccc12	Enzo	AC765	-0.62055979	0.67596659	-1.07724645	-3.98983251	-7.13866438											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015340-14	Desipramine hydrochloride	170465424	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	58-28-6				-22.5885762479	4	5		0	-10.2542105					Cl.CNCCCN2c3ccccc3CCc1ccccc12	Microsource	01500227	-6.62073098	-2.53595109	-0.7356805	-0.51291362	-10.2542105											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095933-04	Phenyl 4-aminosalicylate	170465273		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	133-11-9		1.1220184543	-5.95	-27.3980174911	4	5		11.361550976	-9.50467332	0.21320702	0.9712982494			Oc2cc(N)ccc2C(=O)Oc1ccccc1	Microsource	00305025	-10.30129248	-7.92646172	-5.28113505	0.64908538	-9.50467332											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164589-02	Phenprobamate	170465902		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	673-31-4				-19.4450136955	4	5		0	-3.62577324					NC(=O)OCCCc1ccccc1	Sequoia	SRP014251p	-5.38817085	-2.99233617	-5.86792783	-0.78525714	-3.62577324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164155-02	Benzylparaben	170465711	Estrogen receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	94-18-8				-11.7222036883	4	5		0	-1.66559897					Oc1ccc(cc1)C(=O)OCc2ccccc2	SIGMA	380709	-5.33537922	0.73340196	-1.04474417	-0.52147239	-1.66559897											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093889-12	Physostigmine	170465757		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57-47-6				-27.7819289892	4	5		0	-3.73387023					CNC(=O)Oc1cc2c(cc1)N(C)[C@H]3N(C)CC[C@@]23C	Enzo	AC241	-6.83472161	-5.45977011	-6.77371013	-5.38562664	-3.73387023											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024452-04	Miglustat	170464950	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	72599-27-0				5.5548470202	4	5		0	0.51249199					OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCC	Tocris	3117	1.94213064	4.74781266	0.35966602	-2.86152498	0.51249199											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167533-02	Vardenafil	170465607	Phosphodiesterase V (PDE5) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1193386-64-9	 ;Levitra;Vardenafil citrate; Vardenafil citrate; Vardenafil Hcl; Vardenafil HCLTrihydrate;Vardenafil Hydrochloride Trihydrate (Vivanza			-17.1006873509	4	5		0	-5.67401849			8654	PDE5A	O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN1CCN(CC1)S(=O)(=O)c4cc(C2=NC(=O)c3c(C)nc(CCC)n3N2)c(OCC)cc4	Sequoia	SRP01005v	-3.75712407	-1.11082518	-4.66709484	-2.65118317	-5.67401849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016666-06	Hydrocotarnine hydrobromide	170465806	Cytochrome P450 3A4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5985-00-2				-15.7345292448	4	5		0	-3.37695616					Br.CN1Cc2c(OC)c3OCOc3cc2CC1	Vitas	STK802005	-3.43270495	-1.64264882	-0.63369728	-7.51533742	-3.37695616											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164492-02	Sulfisomidine	170465986		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	515-64-0				-18.8777479735	4	5		0	-2.56245996					Cc2cc(NS(=O)(=O)c1ccc(N)cc1)nc(C)n2	Labotest	LT00452030	-3.62560281	-2.86927432	-5.8231642	-5.95530237	-2.56245996											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159479-05	Methyl nicotinate	170465506		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	93-60-7				-30.8057663797	4	5		0	-5.00594857					COC(=O)c1cccnc1	Vitas	STK803258	-7.6150811	-7.61279808	-3.97345322	-6.92813322	-5.00594857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178499-08	Cefdinir		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	91832-40-5				-7.7512406453	4	4		0	-4.03875798					NC1=NC(=CS1)\C(=N\O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	Adooq	A10187	-1.94301647	-1.00942127	1.3372245	-4.03875798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164253-04	LITHIUM CITRATE			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	6080-58-6, 919-16-4 [anhydrous]				-21.669165608	4	4		0	-2.77912354					OC(CC([O-])=O)(CC([O-])=O)C([O-])=O	Microsource	01504269	-6.52609567	-4.35733513	0.16987542	-2.77912354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167430-04	Tioconazole	170465343	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	65899-73-2	 ; Vagistat-1;Tioconazole; Tioconazol;TIOCONAZOLE; Tioconazole	12.5892541179	-4.9	-93.5201588761	-3	4		-91.4751183	-89.50891874	0.0757589416	0.9964435247			Clc3sccc3COC(Cn1ccnc1)c2ccc(Cl)cc2Cl	Microsource	01505581	-7.18828962	-8.68102288	-3.14051747	-89.50891874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346829-03	Fotemustine		DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	92118-27-9				-27.1615734418	4	4		0	-5.12221978				H2AFX	CCO[P](=O)(OCC)C(C)NC(=O)N(CCCl)N=O	SIGMA	F7307	-6.3518341	-7.17530283	-3.0011325	-5.12221978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167543-05	CEFTIOFUR HYDROCHLORIDE		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	80370-57-6				-25.1299933606	4	4		0	-3.99471482					CO\N=C(\C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)CSC(=O)C3=CC=CO3)C4=CSC(=N4)N	Microsource	01504832	-6.5958003	-6.82200538	-0.76226152	-3.99471482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022858-08	Sodium cromoglycate	170464887	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	15826-37-6	;CROMOLYN SODIUM; Nasalcrom; Cromolyn sodium salt; Cromoglycate; Cromoglycic Acid; Cromolyn disodium salt; Cromoglycate, Disodiu; Aarane; Intal;Cromolyn disodium salt; Cromoglycate, Sodiu; Sodium Cromoglicate; Opticrom; Gastrocrom; Cromoglycic acid; Sodium cromoglicate; 6   Cromolyn Sodium; Acido cromoglicico; Lomudal; Vicrom; Disodium chromoglycate; Nalcrom; Bicromat Spray			-28.7596118621	4	5		0	-5.74795683				KCNMA1	[Na+].[Na+].[O-]C(=O)C=4Oc3cccc(OCC(O)COc1cccc2OC(=CC(=O)c12)C([O-])=O)c3C(=O)C=4	Microsource	01500210	-9.31695626	-3.89649531	-4.86074619	-1.52058463	-5.74795683											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165966-06	Vinorelbine tartrate 			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	125317-39-7		3.5481338923	-5.45	-140.567622538	-2.2	5		-100.6172931208	-78.07266404	0.0486925632	0.9747347087			[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@@]7([H])CN(CC(CC)=C7)CC8=C6NC9=C8C=CC=C9)C(=O)OC	Bosche	V5183	-6.61551951	-14.40641619	-37.55940912	-48.10254163	-78.07266404											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016255-10	SULFINPYRAZONE	170464677	Canalicular Multispecific Organic Anion Transporter 1 Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57-96-5				-26.5367389647	4	5		0	-5.34455935					O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1	Microsource	01500554	-7.36080666	-4.18167782	-4.61571398	-3.92199825	-5.34455935											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166115-02	Dibutyltin dilaurate	170466843		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	77-58-7				-18.8687661095	4	4		0	-5.9436141					O=C(O[Sn](CCCC)(OC(=O)CCCCCCCCCCC)CCCC)CCCCCCCCCCC	SIGMA	291234	-4.1749589	-2.11622005	-3.27051242	-5.9436141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161605-02	L-Ascorbyl 6-palmitate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	137-66-6				-16.630618935	4	4		0	-2.73650268					CCCCCCCCCCCCCCCC(=O)OCC(O)C\1OC(=O)\C(=C1O)O	APExBIO	B2105	-2.72994722	-2.85603682	-8.03725118	-2.73650268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183837-01	Monatepil	124894552	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	103377-41-9	Monatepil; Monatepil	12.5892541179	-4.9	-59.3339764884	-3	4	CIPLUS_696267;AJ 2615;MONATEPIL;monatepil, (S)-isomer;monatepil, (+-) monatepil;LS-172819;LS-172817;Monatepil Maleate;monatepil maleate;LS-173001;maleate;LS-171860;11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleate;1-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl)-, (Z)-2-butenedioate (1:1);CIPLUS_3853864;MONATEPIL MALEATE;monatepil;Monatepil maleate;CIPLUS_197056;monatepil x maleate;monatepil, (R)-isomer;monatepilum;LS-173055;AJ-2615;N-(6,11-DIHYDRODIBENZO(B.E)THIEPIN-11-YL)-4-(4-FLUOROPHENYL)-1-PIPERAZINEBUTYRAMIDE MALEATE, DL-;LS-173056;	-47.5201863613	-47.95851671	0.0256194057	0.9995952119			Fc1ccc(cc1)N2CCN(CC2)CCCC(=O)NC3c5ccccc5SCc4ccccc34	Pharmaron	PH-NIH-152406	-6.16509475	-5.12710224	-5.9540098	-47.95851671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319018-01	Exametazime	170465570		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	105613-48-7				1.4491911788	4	5		0	5.00594857					C/C(=N\O)[C@@H](C)NCC(C)(C)CN[C@H](C)C(\C)=N\O	GVK	FFS-11-286-NCI-100	-0.10083297	-3.00651913	0.05138086	-0.05696757	5.00594857											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016384-15	Sulfisoxazole	170464636	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	127-69-5	; ;SULFISOXAZOLE; Sulfisoxazole; Sulfafurazole(SIZ);Sulfisoxazole			5.1188186996	4	5		0	0.35691407					Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C	Microsource	01500555	1.65278387	3.77852119	-0.76214943	-0.4601227	0.35691407											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00390678-03	Sevelamer Hydrochloride (Technical Grade)			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	152751-57-0				-14.8495349457	4	4		0	-2.49248333					CCC(CN)CC(C)CNCC(O)CNCC(CC)CC(CC)CN	Toronto Research	S256000	-3.71636238	-1.62587638	-3.37643995	-2.49248333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262575-02	Cyproterone acetate	170465682	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	427-51-0				-23.634027169	4	4		0	-8.31408776				AR	CC(=O)[C@@]4(OC(C)=O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C	Prestwick	Prestw-1074	-3.54330709	-7.32074498	-4.65639758	-8.31408776												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181134-04	Haloprogin			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	777-11-7		12.5892541179	-4.9	-63.2124032635	-3	4		-44.0368960724	-46.40725086	0.1135833579	0.9919631476			[Cl]C1=CC(=C([O][CH2][C]#[C][I])C=C1[Cl])[Cl]	Prestwick	Prestw-1269	-8.09466124	-7.18310465	-4.05614159	-46.40725086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178319-06	Thiamphenicol	170465845	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	15318-45-3	;THIAMPHENICOL; Thiomycetin; Thiamcol;Thiamphenicol (Thiophenicol);Thiamphenicol; Vicemycetin; Tiamfenicol; Raceophenidol; Urfamycin; Armai; Thiocymetin			-29.7874967126	4	4		0	-5.90875419					O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl	Microsource	01503136	-7.80912001	-6.58092821	-1.18727104	-5.90875419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510003-01	Vaborbactam			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1360457-46-0				-7.5923647828	4	4		0	-1.8301451					OB1O[C@@H](CC[C@@H]1NC(=O)CC2=CC=CS2)CC(O)=O	MedChem Express	HY-19930	-2.47901705	-0.90326466	1.05486163	-1.8301451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344326-02	9(E),12(E)-Octadecadienoic acid		Streptococcus mutans Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	n/a				-10.1136628591	4	4		0	0.99977978					CCCCC/C=C/C/C=C/CCCCCCCC(O)=O	Enzo	BL118	-4.46109611	0.80753701	-0.04791358	0.99977978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164544-02	Lanoconazole	170465886	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	101530-10-3		1.2589254118	-5.9	-21.6883793488	4	5		9.8722074799	-3.67995665	0.3309247281	0.9267362353	3641571	ERG11	N#C\C(=C1/SCC(S1)c2ccccc2Cl)n3ccnc3	Sequoia	SRP01160l	-9.0601729	-5.80814604	-5.99929935	2.32853706	-3.67995665											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183004-01	Alilusem potassium	144206835	renal sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	114417-20-8	M-17055; Alilusem Potassium; 			-20.6614981515	4	5	Alilusem Potassium;M-17055;7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid;LS-77484;M17055;CIPLUS_774461;M 17055;	0	-5.05260306					[K+].Cc1ccccc1C(=O)N3CC/C(=N\OS([O-])(=O)=O)c2ccc(Cl)cc23	Pharmaron	PH-NIH-151932	-6.69776598	0.76207698	-6.75249606	-0.3948981	-5.05260306											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249899-01	Cinoxate	170465555		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	104-28-9				-31.8402832479	4	5		0	-5.34158125					COc1ccc(C=CC(=O)OCCOCC)cc1	GVK	FFS-11-286-NCI-86	-9.97603355	-5.30009472	-5.07969872	-2.99123962	-5.34158125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346502-04	Dienogest		Synthetic progesterone	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	65928-58-7				-9.0518795687	4	4		0	0.74285221				PGR	C[C@]12CCC\3=C\4CCC(=O)\C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	MedChem Express	HY-B0084	-2.11557384	-4.56582396	1.02429297	0.74285221												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00248275-02	S-Hydroprene	225144342		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	65733-18-8				8.5183835685	4	4		0	-2.35812387					CCOC(=O)\C=C(C)\C=C\C[C@@H](C)CCCC(C)C	SIGMA	46426	2.58073173	0.99771709	1.54097172	-2.35812387												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386347-01	Ospemifene		Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	128607-22-7		1	-6	-28.2133725609	4	4		-13.1053856881	-5.13086292	1	0.9993888669	2100	ESR2	OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3	Selleck	S4285	-3.48421147	-7.15312421	-16.90536621	-5.13086292												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00274062-01	Zosuquidar trihydrochloride	174006281	P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	167465-36-3	LY335979	7.9432823472	-5.1	-97.4044366534	-3	4		-101.0481930009	-6.72022113	1	0.9999931176		ABCBA	Cl.Cl.Cl.FC3(F)[C@@H]2c7ccccc7[C@H](c1ccccc1[C@@H]23)N4CCN(CC4)C[C@@H](O)COc6cccc5ncccc56	Selleck	S1481	-8.1715717	-9.38530481	-95.42240754	-6.72022113												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179623-04	Lisinopril dihydrate	170464907	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	83915-83-7				1.3073633718	4	4		0	-3.1700786					O.O.OC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)N[C@@H](CCc1ccccc1)C(=O)O	Microsource	01501217	1.32838358	-2.61266593	1.50471356	-3.1700786												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00164632-02	Tibolone	170465874	Steryl-sulfatase  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	5630-53-5				-27.8921634308	4	5		0	-10.48289468				AR	O=C1CC=2C[C@@H](C)[C@H]3[C@@H]4CC[C@@](O)(C#C)[C@@]4(C)CC[C@@H]3C=2CC1	Sequoia	SRP02352t	-7.27488554	-7.32903226	-2.11255182	0.04958082	-10.48289468											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015821-10	Piracetam	170465901	"Glutamate receptor ionotropic, AMPA 3 Positive Allosteric Modulator"	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	7491-74-9				-19.1311061333	4	5		0	-3.30897189					O=C1CCCN1CC(=O)N	Specs	AE-641/30117005	-5.731728	-4.84301075	-3.5326806	-0.24790408	-3.30897189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091616-03	2-Ethoxybenzamide	170465775		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	938-73-8				-22.17692659	4	5		0	-5.28180065					CCOc1ccccc1C(N)=O	Specs	AN-153/I166787	-7.92775988	-4.00860215	-2.07726912	1.04119715	-5.28180065											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164529-04	1-Stearoyl-rac-glycerol	170465522	Phospholipase A2 group IIA Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	123-94-4				-23.3313216033	4	5		0	-6.18750841					OCC(O)COC(=O)CCCCCCCCCCCCCCCCC	SIGMA	M2015	-5.68933356	-6.26236559	-3.4621152	-1.94266655	-6.18750841											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015155-11	Bepridil	170465240	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	64706-54-3	 ; Bepridil, (-)-Isomer; Bepridil;Bepridil; Vascor;Bepridil hydrochloride; Bepridil, (+)-Isomer			-32.4368213786	4	5		0	-12.42882123				KCNT1	CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3	BIOMOL	AC104	-7.28336442	-6.26236559	-4.8734233	-2.65482737	-12.42882123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249927-01	Simetride	170466023		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	154-82-5		0.5011872336	-6.3	-21.5689519243	4	5		11.54968628	-6.31305206	0.034258454	0.9992847929			O=C(COc1ccc(CCC)cc1OC)N2CCN(CC2)C(=O)COc3ccc(CCC)cc3OC	GVK	FFS-11-286-NCI-224	-9.2080719	-7.72473118	-1.75090412	1.47390246	-6.31305206											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016740-18	Prazosin	170465415	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	19216-56-9	Prazosin hydrochloride;PRAZOSIN HYDROCHLORIDE;PRAZOSIN; Polypress;; ; Pratsiol;Terazosin hydrochloride; Prazosina; Justac; Minipress;Prazosin; Prazosin hydrochloride; Furazosin hydrochloride			-18.5216892463	4	5		0	-5.86468188			148	ADRA1A	O=C(N1CCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3)c4ccco4	Vitas	STK301545	-5.99457351	-5.37634409	-0.74534709	1.74434328	-5.86468188											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00159346-04	Terbinafine	170465174	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	91161-71-6	 ;Terbinafine; terbinafine, (Z)-isomer; Lamasil;TERBINAFINE HYDROCHLORIDE; Terbinafine; TERBINAFINE HCl;Terbinafine?HCl; Terbinafine HCl	0.8912509381	-6.05	-23.4325455788	4	5		10.01096774	-7.55055374	0.3073782715	0.9376863501			CC(C)(C)C#C\C=C\CN(C)Cc2cccc1ccccc12	Vitas	STK802069	-7.54620994	-10.42580645	-4.67054776	0.77075633	-7.55055374											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164594-02	Loteprednol etabonate	170465195	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	82034-46-6	Loteprednol etabonate; Lotemax; Loteprednol etabonate; Alrex; 			-15.6510608227	4	5		0	-6.64484598				NR3C1	O=C(OCCl)[C@@]4(OC(=O)OCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	SRP01583l	-3.77310497	-4.42150538	1.08053277	-1.93365185	-6.64484598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164071-03	Isopropyl tetradecanoic acid	170465683		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	110-27-0				-14.4895425641	4	5		0	-3.63179841					CC(C)OC(=O)CCCCCCCCCCCCC	SIGMA	172472	-5.5960658	-4.02580645	-0.80709182	2.83512125	-3.63179841											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167437-02	Ramosetron hydrochloride	170465928	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	132907-72-3				-22.1169129277	4	4		0	-7.26829056					Cl.O=C(c2cn(C)c1ccccc12)[C@H]3Cc4ncnc4CC3	Bosche	R2999	-5.81898417	-1.5914663	-1.01955246	-7.26829056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344541-01	Adrenochrome semicarbazone	225144387		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	69-81-8				7.6590571969	4	4		0	0.72334307					CN1CC(O)C\2=C\C(=N/NC(N)=O)C(=O)\C=C12	SIGMA	A5877	1.03400536	5.31635769	1.09017081	0.72334307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178692-04	N-METHYL (-)EPHEDRINE [1R,2S]		Beta-1 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	552-79-4				-1.4436275073	4	4		0	-3.51213561					C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C	Microsource	02300220	1.15514407	-1.31618564	-1.21375292	-3.51213561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091635-09	Fenthion	170466807	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	55-38-9				-33.1751338138	4	5		0	-5.11576828					Cc1cc(ccc1SC)OP(=S)(OC)OC	Bosche	F1401	-9.75449364	-4.43043404	-8.16955684	-3.51007888	-5.11576828											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253601-01	Calcium undecylenate	170465553		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1322-14-1				-9.0531577398	4	5		0	-0.79619292					[Ca+2].[O-]C(=O)\C=C\CCCCCCCC.[O-]C(=O)\C=C\CCCCCCCC	GVK	FFS-11-286-NCI-082	-2.75756247	3.52976497	-5.57482338	-2.73882559	-0.79619292											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263529-01	Lacidipine	170465580	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	103890-78-4		8.9125093813	-5.05	-4.28427739	4	5		-17.9471034999	-11.62258625	0.0129586855	0.9935062622			CC=1NC(C)=C(C(C=1C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C)C(=O)OCC	Sequoia	SRP00900l	2.38053485	1.11940299	1.20745022	-2.34443471	-11.62258625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164619-02	Anastrozole	170464923	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	120511-73-1	Anastrozole; Anastrozole; ; Arimidex; Zeneca ZD 1033; 4   Anastrazole			-17.1684802279	4	5		0	-3.69726366			1588	CYP19A1	N#CC(C)(C)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2	Sequoia	SRP05647a	-4.20429636	-3.10087494	-2.12374224	-4.22874671	-3.69726366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166397-04	Lofepramine hydrochloride	170465926	norepinephrine uptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	26786-32-3				-13.5355857643	4	5		0	-2.15063604					Cl.Clc1ccc(cc1)C(=O)CN(C)CCCN3c4ccccc4CCc2ccccc23	Sequoia	23047-25-8	-2.37176677	-1.04220278	-5.35217298	-4.37773883	-2.15063604											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164602-03	RACTOPAMINE HYDROCHLORIDE		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	90274-24-1				-28.4690332864	4	5		0	-4.88697721					CC(CCC1=CC=C(O)C=C1)NCC(O)C2=CC=C(O)C=C2	FLUKA	34198	-6.65935993	-6.00874936	-4.93256262	-6.89307625	-4.88697721											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016065-11	Tropicamide	170464754	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1508-75-4				-18.5624285669	4	5		0	-2.05911961					OCC(c1ccccc1)C(=O)N(CC)Cc2ccncc2	Enzo	AC222	-3.16966243	-3.70989878	-6.17426675	-6.06047327	-2.05911961											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015260-22	CEFACLOR			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	70356-03-5, 53994-73-3 [anhydrous]				-9.3299176064	4	5		0	-1.52832433					N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3	Microsource	01500771	-1.70539237	-1.78847144	-1.54142582	-4.03593339	-1.52832433											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00164431-01	Terpineol	144205671	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	8000-41-7	(S)-p-Menth-1-en-8-ol; (-)-alpha-Terpineol; D-alpha-terpineol; (R)-p-Menth-1-en-8-ol; Terpineol mixed isomers; DL-alpha-terpineol; (+)-alpha-Terpineol; 			-23.3010223443	4	4	ALPHA-TERPINEOL;CIPLUS_658650;alpha,alpha,4-trimethyl-3-cyclohexene-1-methanol;alpha-terpineol, sodium salt;DL-alpha-terpineol;CIPLUS_160295;CIPLUS_168066;NCGC00164431-01;1-alpha-terpineol;3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-;(+)-alpha-Terpineol;CIPLUS_167185;CIPLUS_197210;(S)-2-(4-Methyl-3-cyclohexenyl)-2-propanol;TERPINEOL;alpha-terpineol;D-alpha-terpineol;(R)-2-(4-Methyl-3-cyclohexenyl)isopropanol;Terpineol mixed isomers;Terpineol;(R)-p-Menth-1-en-8-ol;CIPLUS_167234;CIPLUS_687752;CIPLUS_688650;alpha-Terpineol;(-)-alpha-Terpineol;(S)-p-Menth-1-en-8-ol;CIPLUS_167096;	0	-4.25290862					CC1=CCC(CC1)C(O)(C)C	SigmaAldrich	MFCD00166983	-5.9574284	-4.72278378	-1.56684468	-4.25290862												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00159521-09	Zoledronic acid monohydrate		Farnesyl Pyrophosphate Synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	118072-93-8				-13.9271908571	4	4		0	-3.95659942				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	APExBIO	A1352	-3.6125292	-0.23226805	-2.26420091	-3.95659942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166037-04	beta-Glycerol phosphate disodium salt pentahydrate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	13408-09-8				-29.278282283	4	4		0	-5.86517931					OCC(CO)OP([O-])([O-])=O	SIGMA	50020	-7.22073202	-5.81530388	-3.42057642	-5.86517931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167561-03	D-alpha-Tocopherol succinate	225144294		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	4345-03-3		2.8183829313	-5.55	-11.2707960075	4	4		17.6473133199	6.79768182	0.2933975189	0.9434693015			CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)OC(=O)CCC(O)=O	SIGMA	T3126	-6.3727611	-0.9634823	0.85183387	6.79768182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165846-04	Nefazodone hydrochloride	170465078	Serotonin transporter Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	82752-99-6				-32.8879334088	4	4		0	-10.45797202					Cl.Clc1cccc(c1)N4CCN(CCCN3N=C(CC)N(CCOc2ccccc2)C3=O)CC4	Prestwick	Prestw-1152	-6.71021891	-6.16800723	-5.18603522	-10.45797202												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096056-02	Ethacridine lactate hydrate	170465798		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	6402-23-9				-21.8802726572	4	5		0	-2.96452664					O.O=C(O)C(C)O.CCOc1ccc2nc3cc(N)ccc3c(N)c2c1	Labotest	LT00244813	-6.21254847	-7.94535705	-3.47887973	-0.22504937	-2.96452664											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00521080-01	Digitoxin 3'''-Acetate		Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1111-39-3		31.6227766017	-4.5	-450.6186867275	5	4		30.495484832	-97.34845063	1	0.9862336577			CC1OC(CC(OC(C)=O)C1O)OC2C(O)CC(OC2C)OC3C(O)CC(OC3C)OC4CCC5(C)C(CCC6C5CCC7(C)C(CCC67O)\C8=C\C(=O)OC8)C4	Toronto Research	D445385	-96.68010228	-96.58329036	-94.18386492	-97.34845063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095105-05	Acetrizoic acid	170465154	Solute carrier organic anion transporter family member 1B1 Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	85-36-9				-17.9514114829	4	4		0	-3.70855543					O=C(C)Nc1c(I)c(c(I)cc1I)C(=O)O	Microsource	01504142	-4.72847051	-3.46828262	-0.97382293	-3.70855543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167574-03	Xaliproden hydrochloride	170465603	Serotonin 1a (5-HT1a) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	90494-79-4				-19.7815623248	4	4		0	-3.30201464					Cl.FC(F)(F)c1cccc(c1)C4=CCN(CCc2cc3ccccc3cc2)CC4	Tocris	2491	-5.11853682	-4.55131511	-1.5188064	-3.30201464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253591-01	Nepaprazole	170465906		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	156601-79-5				-5.933671525	4	4		0	-2.47086458					COc4ccnc1c4CCCCC1S(=O)c2nc3ccccc3n2	GVK	FFS-11-286-NCI-253	-1.25254627	-2.54856455	1.2775842	-2.47086458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263955-02	TYLOSIN TARTRATE			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	74610-55-2				-22.1589661467	4	4		0	-4.28674677					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	FLUKA	33847	-4.75447493	-7.3362558	-2.41222192	-4.28674677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168778-06	Solifenacin (hydrochloride)		Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	180468-39-7				-18.5623388338	4	4		0	-8.69526522					O=C(O[C@H]1CN2CCC1CC2)N3CCC4=C(C=CC=C4)[C@@H]3C5=CC=CC=C5	MedChem Express	HY-I0230	-2.39996471	-4.18106427	-4.30959806	-8.69526522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379087-02	Tipranavir			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	174484-41-4				-6.0856847798	4	4		0	2.27839089					CCC[C@@]1(CCC2=CC=CC=C2)CC(=C([C@H](CC)C3=CC=CC(=C3)N[S+]([O-])(=O)C4=CC=C(C=N4)C(F)(F)F)/C(=O)O1)\O	MedChem Express	HY-15148	-2.6293731	-0.25915688	-1.27772003	2.27839089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181782-03	Sertindole	170465613	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	106516-24-9		12.5892541179	-4.9	-100.4246984265	-3	4		-102.7085011874	-99.54610182	0.047085351	0.9986301336			Fc1ccc(cc1)n5cc(C3CCN(CCN2CCNC2=O)CC3)c4cc(Cl)ccc45	Prestwick	Prestw-1341	-7.36753871	-6.56530753	-3.746535	-99.54610182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532514-01	FLUPENTIXOL DECANOATE		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-24.1610700746	4	4		0	-6.78177287					CCCCCCCCCC(=O)OCCN1CCN(CC\C=C2/C3=CC=CC=C3SC4=CC=C(C=C24)C(F)(F)F)CC1	SynInnova	SL-1062	-4.78228261	-3.73185902	-6.11139986	-6.78177287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164551-05	Biapenem			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	120410-24-4				-7.5611482861	4	4		0	-1.02538621					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(\N2C1=O)C([O-])=O)/SC3C[N]4C=NC=[N+]4C3	MedChem Express	HY-13573	-2.66545313	-3.81210246	2.18886804	-1.02538621												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00181750-01	Cefozopran hydrochloride	144206474	Bacterial penicillin-binding protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	113981-44-5	Cefozopran; Firstcin; 			-13.5251690078	4	4	Cefozopran Hydrochloride;CEFOZOPRAN;LS-172220;Cefozopran;CEFOZOPRAN HYDROCHLORIDE;CIPLUS_766339;SCE-2787;CZOP;Firstcin;cefozopranum;SCE 2787;cefozopran;CIPLUS_214061;Cefozopran hydrochloride;	0	-4.64811636					Cl.CO\N=C(/c1nc(N)sn1)C(=O)N[C@@H]5C(=O)N4C(C([O-])=O)=C(C[n+]3ccn2ncccc23)CS[C@@H]45	ACC	CEFOZOPRAN HYDROCHLORIDE	-1.52992675	-6.02974042	-2.76065398	-4.64811636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538147-01	NCGC00538147-01			DPI_SARS-CoV-2_General	2019_NPC-7_Tox			14.1253754462	-4.85	-24.9864830822	4	4		-18.6090891439	-18.24492702	0.1968073865	0.9754423563			CCCCCCCCNC(=N)NC(=N)NCC1=CC(=C(Cl)C=C1)Cl	Pharmaron	PH-NIH-2017-009-L1-5-0	-3.71465126	-2.01278507	-0.6540194	-18.24492702												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188430-01	Moperone	144207164	Serotonin 2a (5-HT2a) receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1050-79-9				-30.3660001336	4	4	Moperone	0	-8.23246707					O=S(=O)(O)O.Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(C)cc3	Toronto Research	M610500	-6.67049014	-5.71008984	-4.56081081	-8.23246707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167480-02	N-Hydroxymethylsuccinimide	225144289		DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-26.340359399	4	4		0	-6.28331376					OCN1C(=O)CCC1=O	Innovapharm	BBS-00004790	-6.88683743	-3.10727179	-2.69811489	-6.28331376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015619-13	Loratadine	170464867	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	79794-75-5	 Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;	11.220184543	-4.95	-54.8757408752	-3	4		-66.7372183121	-62.5395248	0.0084764076	0.9999556931	9704	HRH1	Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3	Vitas	STK574925	-1.97200191	-1.50850954	-2.92146878	-62.5395248												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091021-01	Trichloroacetic acid	17388684		DPI_SARS-CoV-2_General	2019_NPC-7_Tox		Trichloroacetic acid			-27.8713247182	4	4	TCA sodium salt;Rubidium Trichloroacetate;CIPLUS_695902;Sodium trichloroacetate;Trichloroacetic acid-1-13C;Acid, Trichloroaceti;Acetic acid, trichloro-;TRICHLOROACETIC ACID;AB07944365-01;CIPLUS_665666;TRICHLOROACETIC-ACID;Sodium Trichloroacetate;CIPLUS_3745296;CIPLUS_166806;Trichloroacetic acid;Trichloroacetate, Rubidiu;CIPLUS_155922;CIPLUS_664828;CIPLUS_149367;Trichloroacetic acid solution;Trichloroacetic Acid;Trichloroacetate, Sodiu;AB07944376-01;CIPLUS_3859089;	0	-8.54396582					OC(=O)C(Cl)(Cl)Cl	NIEHS	AB07944365	-5.86756077	-2.06461645	-7.23752599	-8.54396582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165972-02	1-Phenyl-1-propanol		Glycolysis / Gluconeogenesis Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	93-54-9				-24.7410968756	4	4		0	-3.30201464					CCC(O)C1=CC=CC=C1	SIGMA	111309	-6.73947904	-6.51108819	-0.73260073	-3.30201464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522306-02	Valbenazine			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1025504-45-3				-29.9756457604	4	4		0	-5.02755443					COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1	MedChem Express	HY-16771	-7.49360725	-8.02389548	-2.10846065	-5.02755443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159462-04	Ritonavir	170464891	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	155213-67-5				-16.1707720487	4	4		0	-6.53627247					CC(C)c4nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)C(C)C)cs4	Bosche	R1692	-1.99800633	-4.61148358	-4.2347896	-6.53627247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248225-03	9(Z)-Hexadecenoic acid		Gap junction Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	373-49-9				-25.0064743241	4	4		0	-4.37708917					CCCCCC\C=C/CCCCCCCC(O)=O	Enzo	BL103	-5.75131106	-7.43940175	-2.64450996	-4.37708917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182851-02	Meprednisone	170465165	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1247-42-3	 ;Betapar;Meprednisone; Meprednisone; Meprednisona; Meprendisone; Betapar; Bitanisone			-20.0146982179	4	4		0	-0.79049598				NRC31	OCC(=O)[C@@]3(O)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Bosche	B1751	-6.09803667	-6.50249269	0.99169124	-0.79049598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179506-05	Kanamycin (sulfate)		30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	25389-94-0				-29.1839418745	4	4		0	-6.62157351					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	MedChem Express	HY-16566A	-7.5704769	-3.2740152	-5.09788635	-6.62157351												1.6E-8	8E-8	4E-7	0.000002											
NCGC00167470-05	Mezlocillin Sodium		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	42057-22-7				-12.5267188181	4	4		0	-3.50658597					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(C3=O)[S+](C)([O-])=O)C4=CC=CC=C4)C(=O)N2[C@H]1C(O)=O	APExBIO	B4959	-2.02055852	-2.02142364	-4.76871102	-3.50658597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181031-03	Hydroxycitronellal	225144317	Transient receptor potential cation channel subfamily M member 8 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	107-75-5		2.8183829313	-5.55	-14.2409411789	4	5		11.5854966439	-5.74549126	0.3700391864	0.9059173288			CC(CCCC(C)(C)O)CC=O	SIGMA	82934	-4.37081424	-7.98791387	-7.28011052	3.13691269	-5.74549126											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182048-01	Pipothiazine palmitate	144206970	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	37517-26-3	Pipotiazine palmitate; Pipotiazin Retard; Piportil depot; 			-0.8181894896	4	4	Hexadecanoic acid, 2-(1-(3-(2-((dimethylamino)sulfonyl)-10H-phenothiazin-10-yl)propyl)-4-piperidinyl)ethyl ester;Pipotiazine palmitate;pipotiazine palmitate;pipothiazin palmitate;Pipotiazin Retard;LS-74847;CIPLUS_179082;Piportil depot;pipothiazine palmitate;PIPOTIAZINE PALMITATE;19552 RP;	0	-0.23139907					CN(C)S(=O)(=O)c2cc3N(CCCN1CCC(CCOC(=O)CCCCCCCCCCCCCCC)CC1)c4ccccc4Sc3cc2	Sigma - DiscoveryCPR	CSZ6713	0.42352318	-0.98479613	-1.48562024	-0.23139907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378598-01	PSI-7976		RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1190308-01-0				-27.2309821209	4	4		0	-7.5738697					CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005A	-6.36167115	-3.29993089	-4.31826057	-7.5738697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261968-01	Bufetolol	170465825	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	53684-49-4	1-Tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol;B	2.8183829313	-5.55	-9.2144718313	4	5		14.9802193679	-4.57069432	0.1047429714	0.9932281261			CC(C)(C)NCC(O)COc2ccccc2OCC1CCCO1	GVK	FFS-11-286-NCI-171	-5.9481847	-5.12809601	-6.23351614	6.74688835	-4.57069432											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166409-02	Sodium 2,3-dimercaptopropanesulfonate monohydrate	225144282	reactive oxygen species metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	207233-91-8				3.8200174869	4	4		0	1.41509434					O.[Na+].[O-][S](=O)(=O)CC(S)CS	SIGMA	38530	0.69704857	0.80338632	0.60204435	1.41509434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378640-03	Alvimopan		mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1383577-62-5				-35.644851962	4	4		0	-7.88536846				OPRM1	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(O)=O	MedChem Express	HY-76657	-8.55869767	-4.63890809	-6.65713791	-7.88536846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167454-02	Pilsicainide	170465988	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	88069-67-4				-5.309549414	4	4		0	-3.03488786					Cc3cccc(C)c3NC(=O)CC12CCCN2CCC1	SIGMA	P0026	-0.90881016	-1.59813407	0.56739432	-3.03488786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023643-15	Estrone	170465020	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	53-16-7				-21.7545490763	4	5		0	-4.94699647				ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)c4cc3	Vitas	STK801833	-5.64857244	-5.50259597	-5.13668523	-0.206678	-4.94699647											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181912-01	Iomazenil	144206800	GABAergic synapse Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	127985-21-1		1.1220184543	-5.95	-9.3281725967	4	5	IOMAZENIL (123I);iomazenilum (123I);iomazenil (123 I);Ro 16-0154;Iomazenil(123I);Ro-16-0154;IOMAZENIL (123 I);CIPLUS_208012;Iomazenil (123I);Benzodine;ethyl 7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate;iomazenil;Iomazenil ((sup 123)I);(123I)iomazenil;	12.3501148999	-2.73507411	0.1987079165	0.9750661624			O=C(OCC)c3ncn2c3CN(C)C(=O)c1c(I)cccc12	Pharmaron	PH-NIH-10	-5.11984491	-7.37509575	-4.40825554	5.8099481	-2.73507411											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021274-04	ESTRADIOL BENZOATE			DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50-50-0		2.8183829313	-5.55	-23.9846791699	4	5		11.3313359199	-6.47973934	0.1851188939	0.9785436004			C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)C5=CC=CC=C5)[C@@H]1CC[C@@H]2O	SIGMA	E8515	-8.6094466	-6.94101626	-8.22623184	1.78661645	-6.47973934											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015116-13	Aniracetam	170465854	AMPA receptor modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	72432-10-1	; ; Aniracetamun; Aniracetam;Aniracetam; Ro 13-5057; 3   Aniracetam	1.1220184543	-5.95	-18.9018779066	4	5		11.33433204	-5.63535405	0.0838557284	0.9956916817		GRIA1	O=C2CCCN2C(=O)c1ccc(OC)cc1	Enzo	AC439	-8.1952767	-7.37509575	-4.29940972	3.08179856	-5.63535405											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015693-09	Mitoxantrone	170465183	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	70476-82-3	 ;Mitoxantrone; Mitoxantrone Hcl; Mitoxantrone; Mitozantrone;MITOXANTRONE HYDROCHLORIDE; Mitoxantrone dihydrochloride;Mitoxantrone dihydrochloride; Mitoxantrona;Mitoxantrone di?HCl;MITOXANTHRONE HYDROCHLORIDE	8.9125093813	-5.05	-163.7942591977	-2.2	5		-101.4834855044	-92.34087467	0.0498473182	0.9741109204	7153	TOP2A	Cl.Cl.OCCNCCNc3ccc(NCCNCCO)c2C(=O)c1c(O)ccc(O)c1C(=O)c23	Microsource	01503278	-13.16531547	-25.64048004	-29.87817641	-45.1430671	-92.34087467											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183030-02	Terodiline hydrochloride		HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	7082-21-5				-28.8024115454	4	4		0	-11.10715557					CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C	SIGMA	T4577	-4.56169762	-7.96475466	-4.69941095	-11.10715557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263961-02	Ceftriaxone disodium trihydrate	170465387	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	104376-79-6		2.8183829313	-5.55	-18.0480514031	4	5		9.5747896399	-6.53480795	0.4629042174	0.8419108237	9376	SLC22A8	[Na+].[Na+].O.O.O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSC2=NC(=O)C([O-])=NN2C)CS[C@@H]34)C([O-])=O	Microsource	01503111	-5.66619669	-4.87275513	-8.8123247	1.40081753	-6.53480795											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013683-06	Chlorprothixene	170465069	Serotonin (5-HT) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	113-59-7		12.5892541179	-4.9	-63.277993635	-3	5		-63.3848377778	-61.74108577	0.0549788861	0.9713330453	3269		CN(C)CC\C=C1/c3ccccc3Sc2ccc(Cl)cc12	Microsource	01503203	-4.47655975	-6.22606179	-9.05513459	2.65007119	-61.74108577											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015226-12	Mitotane	170464927	Antineoplastic Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	53-19-0	 ; ortho,para DD;Mitotane; Lysodren; Chlodithane; Mitotano; 2,4'-DDD solution; Khloditan;MITOTANE;1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; Mytotan;o,p'-DDD; Chloditan	14.1253754462	-4.85	-19.3109696256	4	5		-14.383924184	-14.14345372	0.1416969396	0.9212725012		CYP11B1	Clc2ccccc2C(C(Cl)Cl)c1ccc(Cl)cc1	Microsource	00330082	-1.59499471	-1.3235169	-5.06970319	-1.87847334	-14.14345372											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015970-11	Sulindac	170464648	ABCC1 Expression Enhancer	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	38194-50-2	 ; Sulindac;Sulindac; Sulindaco; Clinoril; Sulindac sulfide; Sulindac sulfone;SULINDAC; Suldinac			-26.2353394105	4	5		0	-5.87398467				ABCC1	CS(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C	Microsource	01500556	-6.44166373	-6.31968678	-7.4140746	-0.42713452	-5.87398467											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183876-03	Tenofovir disoproxil fumarate	170465338	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	202138-50-9	Tenfovir disoproxil fumarate;TENOFOVIR DISOPROXIL FUMARATE			-14.7302454191	4	4		0	-0.73869705			7015	TERT	O=C(O)C=CC(=O)O.CC(C)OC(=O)OCOP(=O)(OCOC(=O)OC(C)C)CO[C@H](C)Cn2cnc1c(N)ncnc12	Sequoia	202138-50-9	-4.79110601	-1.59813407	-1.18243243	-0.73869705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389304-01	Clindamycin Phosphate		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	24729-96-2				-35.6176969397	4	4		0	-9.40726237					CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O[P](O)(O)=O)C(O)C2O	APExBIO	B1708	-7.90576609	-6.60850035	-4.76004851	-9.40726237												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179596-03	Butoconazole nitrate	170464901	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	64872-77-1	 Butoconazol;;Butoconazole nitrate; Femstat	12.5892541179	-4.9	-76.0827021399	-3	5		-100.0559587029	-92.64375201	0.0016524344	0.9991728827			[O-][N+](=O)O.Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3	Prestwick Chemical, Inc.	Prestw-408	-1.47162496	-3.47689165	-1.84619249	-0.55573417	-92.64375201											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091285-03	Tricaprylin	170465841		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	538-23-8				-14.5357431447	4	4		0	-4.521637					O=C(CCCCCCC)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC	SIGMA	91039	-3.41958133	-3.25339522	-0.21441973	-4.521637												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166222-04	N,N'-Dibenzylethane-1,2-diamine dihydrochloride	170465030	F-box only protein 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	3412-76-8				-11.3751179141	4	4		0	-3.27491192			26273	FBXO3	Cl.Cl.C(NCc1ccccc1)CNCc2ccccc2	SIGMA	D35201	-3.10752828	-3.32215919	1.90297507	-3.27491192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164584-03	Cetraxate hydrochloride	170465783	Prostaglandin Synthesis and Regulation Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	27724-96-5				-30.0119820858	4	5		0	-5.2223395					Cl.NC[C@H]1CC[C@@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2	Sequoia	SRP02040c	-8.53013747	-6.46437995	-7.88294888	-0.37202039	-5.2223395											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016853-06	Nabumetone	170464970	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	42924-53-8				-26.9376434625	4	5		0	-1.42260566					CC(=O)CCc1ccc2cc(ccc2c1)OC	Microsource	01503650	-6.52978498	-10.12426589	-8.46066898	-1.10687549	-1.42260566											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163150-07	Clenbuterol	170465955	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	37148-27-9				-10.3549548941	4	5		0	-3.00123904					Clc1cc(cc(Cl)c1N)C(O)CNC(C)(C)C	Enzo	AC174	-3.20761368	-2.14911907	-0.10465944	-0.84049052	-3.00123904											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183864-01	Adesulfone sodium	144206768	Dihydropteroate synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	144-75-2				-11.1689056588	4	4	DIASONE;Aldesulfone sodique;aldesulfone sodique;aldesulfonum natricum;SULFOXONE SODIUM;Adesulfone Sodium;METHANESULFINIC ACID, (SULFONYLBIS(4,1-PHENYLENEIMINO))BIS-;SULFOXONE;(SULFONYLBIS(4,1-PHENYLENEIMINO))DIMETHANESULFINIC ACID;Methanesulfinic acid, (sulfonylbis(p-phenyleneimino))di-, disodium salt;DISODIUM (SULFONYLBIS(P-PHENYLENEIMINO))DIMETHANESULFINATE;(sulfonylbis(p-phenyleneimino))dimethanesulfinic acid disodium salt;ALDESULFONE SODIUM;aldesulfon sodium;sulfoxone, disodium salt;CIPLUS_152107;Aldesulfonum natricum;CIPLUS_152108;LS-90060;Sulfoxone;METHANESULFINIC ACID, (SULFONYLBIS(1,4-PHENYLENEIMINO))BIS-, DISODIUM SALT;Sulfoxone sodium;sulfoxone;sulfoxone sodium;Diasone;Aldesulfona sodica;	0	-1.63068028					[Na+].[Na+].O=S(=O)(c1ccc(NCS([O-])=O)cc1)c2ccc(NCS([O-])=O)cc2	NCI	NSC_27222	-3.12486456	-2.03283479	-0.78620566	-1.63068028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015955-16	Salbutamol sulfate	170465034	beta2-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	18559-94-9	 Ventolin;Albuterol; Albuterol (Salbutamol); ;Salbutamol hemisulphate; Proventil; Albuterol hemisulfate;Albuterol hemisulfate; Sultanol; R-albuterol hydrochloride; Xopenex; Salbutamol hemisulfate;ALBUTEROL (+/-);Salbutamol; Salbutamol; Salbutamol hemisulphate;Salbutamol sulfate; Asmaven sulfate; Levalbuterol	2.8183829313	-5.55	-10.6260911763	4	5		11.286955248	-4.51562572	0.1310242222	0.9894117547	154	ADRB2	OCc1cc(ccc1O)C(O)CNC(C)(C)C	Enzo	AC176	-5.31371167	-4.52378926	-5.65579604	4.38616635	-4.51562572											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183014-01	Sulfamethomidine	144206847	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3772-76-7	Sulfametomidine; Sulfametomidina; Sulfametomidine Anhydride; 	1	-6	-24.6407152381	4	5	LS-147802;sulfamethomidine;Sulfametomidina;sulfamidine;Sulfanilamide, N(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)-;Sulfametomidine Anhydride;SULFAMETOMIDINE;CIPLUS_162501;Sulfamethomidine;Sulfametomidine;Sulfametomidinum;sulfametomidine;4-sulfanilamido-2-methyl-6-methoxypyrimidine;sulfametomidinum;	12.200187252	-6.70919187	0.1297466677	0.9895834254			Cc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Pharmaron	PH-NIH-154290	-8.89143461	-10.16682271	-5.93209696	2.14485831	-6.70919187											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00378665-02	Ixabepilone		Microtubule-Stabilizing Agents	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	219989-84-1		0.5623413252	-6.25	-124.6158974826	-1.4	4		-45.8840719604	-44.39877134	0.0751983686	0.9965042937		TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Adooq	A11449	-17.54864994	-29.28915248	-37.40730814	-44.39877134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181149-01	3-Anilinopropan-1-ol	144206306		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	31121-11-6	PHENYLPROPANOLAMINE MALEATE; 			-22.0030079717	4	4	PHENYLPROPANOLAMINE MALEATE;	0	-1.88363899					OCCCNc1ccccc1	NCI	NSC-29092	-6.39275343	-4.22468626	-1.88510676	-1.88363899												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015443-17	Flecainide acetate	170464874	Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	54143-55-4	Tambocor; Flecainide, (R)-Isomer; Flecainide acetate salt; ; Flecainide, (S)-Isomer;Flecainide; Flecainide; Flecainida;Flecainide acetate			-10.3269849897	4	5		0	-5.79138176			6331	SCN5A	FC(F)(F)COc2cc(C(=O)NCC1CCCCN1)c(OCC(F)(F)F)cc2	Enzo	AC130	-2.48501939	-3.98757341	-2.52438565	4.52395168	-5.79138176											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016951-05	Clebopride maleate	170465853	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	84370-95-6				-5.6184019965	4	5		0	-6.65412326					O=C(O)/C=C\C(=O)O.Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3	Prestwick	Prestw-380	0.51110328	-2.75342582	-0.06279566	0.53736279	-6.65412326											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091469-04	Saquinavir	225144210	protease inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	149845-06-7	Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ; Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ;saquinavir			-24.3789378771	4	5		0	-7.63618007					CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4	Prestwick	Prestw-1114	-4.85548114	-6.35373223	-8.43555072	0.95990447	-7.63618007											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016529-07	Pramoxine hydrochloride	170465004	Sodium channel alpha subunit Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	637-58-1				-3.3293697982	4	4		0	-0.33878399					Cl.CCCCOc1ccc(cc1)OCCCN2CCOCC2	Microsource	01501139	-0.4204048	-3.81210246	0.94702046	-0.33878399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238451-11	Olaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	763113-22-0				-27.4490316967	4	4		0	-11.83937122				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	Adooq	A10111	-4.78047935	-6.53687468	-2.60877334	-11.83937122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347676-02	Schisandrol B		MAPK signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	58546-54-6				-26.7404284457	4	4		0	-7.0421899					COC1=CC2=C(C(=C1OC)OC)C3=C(OC)C4=C(OCO4)C=C3C[C@H](C)[C@@](C)(O)C2	MedChem Express	HY-N0692	-5.16187752	-8.4106928	-3.45751809	-7.0421899												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016055-16	Trimethoprim	170464633	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	738-70-5				-14.9444156431	4	5		0	0.0367124					Nc2nc(N)ncc2Cc1cc(OC)c(OC)c(OC)c1	Vitas	STK177322	-5.85125132	-4.71103924	-2.66672249	1.48348872	0.0367124											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183011-01	Itasetron	144206831	Serotonin 3 (5-HT3) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	123258-84-4	Itasetron; DAU 6215 hydrochloride; 	2.8183829313	-5.55	-10.805010445	4	5	itasetronum;itasetron;DAU 6215 hydrochloride;ITASETRON HYDROCHLORIDE HYDRATE;(endo-N-8-methyl-8-azabicyclo(3.2.1.)-oct-3-yl)-2,3-dihydro-2-oxo-1H-benzimidazol-1-carboxamide;Itasetron Hydrochloride Hydrate;U-98079A;CIPLUS_197009;Itasetron;DAU 6215;CIPLUS_3881158;LS-32715;N-(8-methyl-8-azabicyclo (3.2.1.)oct-3-yl)2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxamide;ENDO-2,3-DIHYDRO-N-((8-METHYL)-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO-1H-BENZIDAZOLE-1-CARBOXAMIDE HYDROCHLORIDE HYDRATE;2-OXO-N-1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-YL-1-BENZIMIDAZOLINE-1-CARBOXAMIDE;ITASETRON;LS-172560;1H-BENZIMIDAZOLE-1-CARBOXAMIDE, 2,3-DIHYDRO-N-(8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO, ENDO-;	10.6634361759	-7.93905741	0.3799048894	0.9004096366			CN4[C@@H]1CC[C@H]4C[C@H](C1)NC(=O)N2c3ccccc3NC2=O	Pharmaron	PH-NIH-151623	-3.47197744	-6.2005277	-6.80286348	3.26551233	-7.93905741											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181023-03	NOLATREXED HCL			DPI_SARS-CoV-2_General	2019_NPC-2_Tox	152946-68-4				-7.7741256078	4	5		0	-7.72796108					CC1=C(SC2=CC=NC=C2)C3=C(C=C1)N=C(N)N=C3O	Sequoia	152946-68-4	1.02220656	-1.92782364	-1.92992004	-1.71313094	-7.72796108											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016710-05	Clemastine fumarate	170465318	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	14976-57-9	 ;CLEMASTINE FUMARATE; Clemastine fumarate salt; Meclastine;Clemastine fumarate; Corto-Tavegil; Clemastine fumarate; Tavist; Tavegyl;CLEMASTINE; Clemastina	14.1253754462	-4.85	-19.1071559601	4	4		-15.38799666	-14.29668443	0.2611862953	0.9557776329	9704	HRH1	CN3CCC[C@@H]3CCO[C@](C)(c1ccccc1)c2ccc(Cl)cc2.O=C(O)/C=C/C(=O)O	Microsource	01500191	-2.32739566	-3.32215919	-0.22335388	-14.29668443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159469-04	Methoxyphenamine	170465530	Adrenergic receptor beta Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	93-30-1		0.6309573445	-6.2	-24.2812230768	4	5		13.676666952	-5.0977559	0.1294892834	0.9896481268			COc1ccccc1CC(C)NC	ASDI	500012445	-10.14722246	-7.33230001	-3.59082151	1.5024284	-5.0977559											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015316-05	Eflornithine Hydrochloride	170465007	Ornithine Decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	96020-91-6	 ; 1   Eflornithine; DFMO hydrochloride; Ornidyl; DL-alpha-Difluoromethylornithine hydrochloride;DFMO;Eflornithine Hydrochloride;DL-alpha-Difluoromethylornithine hydrochloride	14.1253754462	-4.85	-44.4548588955	4	5		-16.206466924	-20.7387005	0.1416067438	0.9211120205	89874	ODC1	Cl.FC(F)C(N)(CCCN)C(=O)O	Bosche	E2777	-9.3426346	-5.66175837	-6.65615695	-4.31664473	-20.7387005											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166104-04	alpha-Lipoic acid amide	170465868	apoptotic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	940-69-2				-22.2340804315	4	5		0	-3.36388676					NC(=O)CCCCC1CCSS1	Microsource	01505740	-5.86749979	-6.80702661	-6.84007707	1.00313195	-3.36388676											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016542-06	Levonordefrin	170464794	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	829-74-3				-11.7648293345	4	5		0	-3.55352869					Oc1ccc(cc1O)[C@@H](O)[C@H](C)N	Enzo	AC1038	-4.08713515	1.71790235	-0.83201962	-3.07294267	-3.55352869											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183108-01	Propamidine	144206602		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	104-32-5	Propamidine; DAPP-Br; Propamidina; 			-15.6565956929	4	5	Propamidine;Propamidinum;propamidinum;Propamidina;LS-171900;1,3-di-(p-amidinophenoxymethyl)-propane;propamidine;4,4'-(trimethylenedioxy)dibenzamidine dihydrochloride;CIPLUS_209523;DAPP-H;4,4'-(TRIMETHYLEDEDIOXY)DIBENZAMIDINE;CIPLUS_657475;CIPLUS_206886;propamidine diisethionate;1,3-bis(p-amidinophenoxy)propane;1,3-di-(4-amidinophenoxy)propane;PROPAMIDINE;propamidine isethionate;LS-27580;propamidine dihydrochloride;DAPP-Br;4,4'-(trimethylenedioxy)dibenzamidine;	0	-1.66613988					N=C(N)c1ccc(cc1)OCCCOc2ccc(cc2)C(=N)N	Beta Pharma	86-41342	-4.17272961	-2.44122966	-2.45226835	-4.65253506	-1.66613988											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091835-10	Chlormethine	170465017	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	55-86-7	 Nitrogen mustard HCl;Nitrogen mustard HCl;Nitrogen mustard hydrochloride; Nitrogen mustard hydrochloride;MECHLORETHAMINE			-34.0315886171	4	5		0	-15.71089091				H2AFX	Cl.ClCCN(C)CCCl	Microsource	01500375	-6.24046125	-9.27311828	-4.97045074	-1.08627062	-15.71089091											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016936-04	Aztreonam	170465110	beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	78110-38-0	; ;Aztreonam; Aztreonam; Aztreonam lysinate;AZTREONAM; Azactam			-21.801052941	4	5		0	-6.56413935					Nc1nc(cs1)/C(=N\OC(C)(C)C(=O)O)C(=O)N[C@@H]2C(=O)N([C@H]2C)S(=O)(=O)O	Microsource	01505122	-6.84246227	-2.4516129	-1.5039252	-2.05985757	-6.56413935											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181100-01	Ormeloxifene	144206269	Estrogen receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	31477-60-8	Levormeloxifene; Compound 672; Compound 67-20; Compound 67 2; Centchroman; 	12.5892541179	-4.9	-73.7519942844	-3	4	ORMELOXIFENE;levormeloxifenum;Centchroman;(-)-3,4-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane;CIPLUS_3865012;LEVORMELOXIFENE;LEVORMELOXIFENE FUMARATE;CIPLUS_676257;CIPLUS_709447;1-(2-(p-(trans-7-methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine;CIPLUS_3853907;ormeloxifenum;Compound 67-20;CIPLUS_3847290;Compound 672;NNC-46-0020 FUMARATE;CIPLUS_177424;CIPLUS_731807;Compound 67 2;Ormeloxifene;LS-137582;Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-;ormeloxifene;levormeloxifene;trans-2,2-Dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman;LS-137965;Levormeloxifene Fumarate;7-METHOXY-2,2-DIMETHYL-3-PHENYL-4-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)CHROMANE FUMARATE, TRANS-3R,4R, L-;Levormeloxifene;	-111.0758514798	-99.70638721	0.0743412737	0.9965757771			COc1ccc2c(c1)OC(C)(C)[C@H]([C@@H]2c4ccc(OCCN3CCCC3)cc4)c5ccccc5	NCI	NSC-147956	-0.64577645	-1.37098161	4.833378	-99.70638721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390804-01	Goserelin (acetate)		LNCaP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	145781-92-6				-19.3414378357	4	4		0	-6.64468335					CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@H](CC4=CN=C[NH]4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6C(=O)NNC(N)=O	MedChem Express	HY-13673A	-2.34473194	-7.62850266	-2.51943179	-6.64468335												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00164637-02	Nifekalant	170465960	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	130636-43-0	NIFEKALANT HCl; ; Nifekalant;Nifekalant; Shinbit			-7.4778233504	4	4		0	-1.41385852				KCNH2	Cl.CN1C(=CC(=O)N(C)C1=O)NCCN(CCCc2ccc(cc2)[N+]([O-])=O)CCO	Sequoia	SRP034084n	-1.0878516	-3.42530514	-1.78683106	-1.41385852												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091238-03	2,2'-Dithiobisbenzothiazole	170465723		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	120-78-5		0.7079457844	-6.15	-12.8164215456	4	5		9.646623296	-5.43188694	0.3548178065	0.9145761347			c1cccc2sc(nc12)SSc3nc4ccccc4s3	Bosche	D1170	-7.62218608	-4.25815896	-5.27237695	3.25450502	-5.43188694											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00095978-06	Lufenuron	170465736		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	103055-07-8		1	-6	-19.6351889967	4	5		10.355345372	2.03639319	0.0370252403	0.9811755752			Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F	Microsource	01505355	-8.21278781	-6.21286489	-3.98493607	1.72030321	2.03639319											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016682-06	ESTROPIPATE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	7280-37-7				-21.713364627	4	4		0	-6.65824219					C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O[S+](O)([O-])=O)=C4)[C@H]1CCC2=O	Microsource	01505116	-4.01920914	-8.55950794	-0.70176987	-6.65824219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249913-01	Isoniazid pyruvate	170465758	Isocitrate lyase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1081-50-1				-9.2208002108	4	5		0	-1.51917269					O=C(N\N=C(\C)C(=O)O)c1ccncc1	GVK	FFS-11-286-NCI-164	-1.34590092	1.50540401	-4.99250696	-4.50920245	-1.51917269											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159324-04	2-Ethylhexyl salicylate	170465498		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	118-60-5				-32.9071103437	4	5		0	-4.20060401					Oc1ccccc1C(=O)OCC(CC)CCCC	Bosche	E1869	-8.29899167	-5.77714874	-7.45878827	-7.33128834	-4.20060401											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091011-08	Chloramphenicol	225144201	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56-75-7	 Cloramfenicol;; Chlornitromycin;Chloramphenicol (Chloromycetin); Ophthochlor; ; Detreomycin; Corti-fluoral; Syntomycin;Chloramphenicol; Cloromisan; Chloramphenicol; Pantofenicol; Chloromycetin; Chlorocid			-16.4306312179	4	5		0	-1.91269333					OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Prestwick	Prestw-31	-2.77509864	-4.13021101	-4.91543567	-5.05258545	-1.91269333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015095-15	Amitriptyline hydrochloride	170464758	Sodium-dependent serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	549-18-8				-18.9476209	4	5		0	-7.67146792			6532	SLC6A4	Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12	Microsource	01500117	-6.3040315	-2.68233876	0.47293747	0.03177341	-7.67146792											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015834-19	Primidone	170464846	Anticonvulsant agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	125-33-7	; ;Primaclone; Primidona;Primidone; Primidone; 2-Desoxyphenobarbital; Primaclone; Mysoline;Primidone (primaclone); Primidone (primaclone);PRIMIDONE	0.8912509381	-6.05	-24.937537094	4	5		11.2247282319	-6.89483903	0.1426685373	0.9874168889		GABRA1	CCC1(C(=O)NCNC1=O)c2ccccc2	Specs	AN-153/I262077	-9.77060686	-7.73701886	-4.2038886	1.05760065	-6.89483903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166218-02	4,4'-Dinitrodiphenylurea	170465744		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	587-90-6		0.316227766	-6.5	-18.1893657925	4	5		15.187323456	-5.5854066	0.4793048149	0.827455321			O=C(Nc1ccc(cc1)[N+]([O-])=O)Nc2ccc(cc2)[N+]([O-])=O	Specs	AN-153/I108774	-8.90610288	-3.00094721	-3.73970923	2.10158413	-5.5854066											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024504-09	Kainic acid	170465818	Glutamate receptor ionotropic kainate 5 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	487-79-6				-21.5509546121	4	5		0	-1.64807875					CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O	Enzo	EA123	-8.45245228	-1.97623353	-4.34401822	-0.32227316	-1.64807875											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178318-04	Sodium 2-mercaptoethanesulfonate	170464862	Antineoplastic Enhancing Agents	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	19767-45-4				-25.3744738917	4	5		0	-4.91714453				CAT	[Na+].[O-]S(=O)(=O)CCS	Microsource	01502014	-7.63074553	-8.95117541	-1.52390962	-0.32227316	-4.91714453											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262929-01	BIBR-1048	170466107	Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	211915-06-9	Bibr 1048;BIBR-1048 (Dabigatran);3-((2-((4-Amino((e)-hexyloxycarbonylimino)methyl)-phenylamino)methyl-1-1h-benzoimidazole-5-carbonyl)pyridin-2-yl-amino)propionic acid ethyl ester;Dabigatranum etexilatum;Dabigatran etexilate; Dabigatran etexilate	0.5623413252	-6.25	-2.4082539355	4	5		12.691774368	-1.37716169	0.013624411	0.9998867149		F2	O=C(OCCCCCC)\N=C(\N)c1ccc(cc1)NCc3nc2cc(ccc2n3C)C(=O)N(CCC(=O)OCC)c4ccccn4	GVK	FFS-12-73-NCI-1548	-5.57647864	-3.9826057	2.26834822	6.31383051	-1.37716169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091396-05	Benzoin	170465507		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	119-53-9				-21.7038518419	4	5		0	-2.15978768					OC(C(=O)c1ccccc1)c2ccccc2	Vitas	STK358785	-4.80929417	-3.19523074	-5.85741811	-6.92813322	-2.15978768											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00483924-02	Brigatinib	384569265	IGF-1R Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1197953-54-0		12.5892541179	-4.9	-82.3392386649	-3	4		-66.135092676	-68.0863246	0.029332132	0.9994690971		IGFR1	COC1=C(NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[P](C)(C)=O)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-12857	-8.09444977	-8.35296097	-7.06943114	-68.0863246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182551-01	Cythioate	144206631	Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	115-93-5	Cythioate; Cyflee; 			-2.1250182589	4	4	Cyflee;CIPLUS_151430;CYTHIOATE;Cythioate;cythioate;O,O-dimethyl-O-(p-sulfamoylphenyl)-phosphorothioate;	0	-1.94230346					O=S(N)(=O)c1ccc(OP(=S)(OC)OC)cc1	Chemos	10702	0.29624466	0.07570659	-2.12126492	-1.94230346												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509984-01	Omapatrilat		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	167305-00-2				-4.8597675899	4	4		0	-2.36511782			1636		OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)CC3=CC=CC=C3)C(=O)N12	MedChem Express	HY-18208	-1.38537945	0.56359354	0.07404826	-2.36511782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167979-01	Methenolone enanthate	144206153		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	303-42-4	Methenolone enanthate; Metenolone enanthate; Metenolone Enanthate; Primobolan Depot; Primobolan depot; 			-5.0829388488	4	4	Primobolan Depot;LS-174294;Primobolan depot;Methenolone Enanthate;CIPLUS_152547;methenolone oenanthate;Schering brand of methenolone enanthate;Metenolone Enanthate;Methenolone enanthate;methenolone enanthate, (17beta)-isomer;methenolone enanthate, (17alpha)-isomer;methenolone enanthate;methenolone heptanoate;METHENOLONE ENANTHATE;Metenolone enanthate;	0	-3.29002422					CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]1CC(=O)C=C(C)[C@]1(C)[C@H]4CC[C@]23C	Bosche	M5729	-1.13270018	2.29643338	-1.91218747	-3.29002422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179370-05	Methotrimeprazine maleat salt		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	7104-38-3		14.1253754462	-4.85	-18.137099958	4	4		-11.5015037839	-12.14269985	0.3971935861	0.8893863116			COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1	Prestwick	Prestw-797	-2.15213035	-4.62651413	-0.47478003	-12.14269985												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168777-04	Etonogestrel		contraceptive	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	54048-10-1				-23.7484521413	4	4		0	-7.57982823					CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0652	-5.23656008	-3.86944818	-2.8704591	-7.57982823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356592-02	Ergotamine tartrate			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	379-79-3				-10.9964882773	4	4		0	-1.30808192					CN1C[C@@H](\C=C2/[C@H]1CC3=C[NH]C4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O	Prestwick	Prestw-NAT-0314	-2.97987279	-1.42160161	-2.02543776	-1.30808192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182979-02	Perlapine		Histamine H1 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	[1977-11-3]				-7.8326006351	4	4		0	-2.8495926					CN1CCN(CC1)C/2=N/C3=C(CC4=C2C=CC=C4)C=CC=C3	Tocris	5549	-1.1675525	-3.07873486	-0.81453088	-2.8495926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181165-01	Sodium decanehydroxamate	144206782		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	35440-53-0	n-decanohydroxamic acid; 			-30.5565027819	4	4	n-decanohydroxamic acid;Decanohydroxamic acid;CIPLUS_720094;DECANOHYDROXAMIC ACID;	0	-9.73794318					[Na+].[O-]NC(=O)CCCCCCCCC	NCI	NSC-111679	-5.86390172	-8.25201884	-3.62836484	-9.73794318												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166294-03	Sparfloxacin	170465370	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	110871-86-8	; Esparfloxacino;Sparfloxacin; Zagam			-12.9020975481	4	4		0	-3.78330764			7155	TOP2B	C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK802067	-3.52879672	-0.84959623	-0.56189564	-3.78330764												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00142624-05	Lactulose	170464861	Synthetic sugar	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	4618-18-2	; Cephulac; Lactulosa; Chronulac; Duphalac;LACTULOSE; Amivalex; Normase;Lactulose	1	-6	-18.4106440741	4	5		9.908421596	-4.20372962	0.0806553895	0.9960258656			O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@]2(O)CO	Microsource	01500363	-7.14285714	-7.84035133	-4.57172885	2.42839635	-4.20372962											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165740-05	Benazepril	170465003	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	86541-74-4	; Briem; Benazepril Free base; BENAZEPRIL HCl; Lotensin HCT 20/12.5mg;Benzapril; Labopal; Benazepril Hcl; Cibacen; Lotensin; Benzapril;Benazepril hydrochloride; Cibac???ne			-32.4457850802	4	5		0	-4.77265544			1636	ACE	Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@H]3CCc2ccccc2N(CC(=O)O)C3=O	Microsource	01505200	-9.13720791	-7.84035133	-5.87668593	-3.3543643	-4.77265544											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015836-12	Pirenzepine	170465793	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	28797-61-7		0.05704006	-7.243820026	-8.0929556105	4	5		9.4227589759	-0.23931006	0.1871741025	0.8918232673	1128	CHRM1	O=C(CN1CCN(C)CC1)N4c2ccccc2C(=O)Nc3cccnc34	Enzo	AC220	-7.07438158	-7.43563248	0.52548607	4.57991013	-0.23931006											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00262549-02	Ajmaline		Voltage-gated potassium channel subunit Kv4.3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	12/7/4360				-18.2564651513	4	4		0	-2.51862826					CC[C@@H]1[C@@H](O)N2[C@H]3CC1C4[C@@H](O)[C@]5(C[C@@H]24)[C@H]3N(C)C6=CC=CC=C56	Prestwick	Prestw-NAT-0151	-5.18733235	-3.24315024	-1.23140751	-2.51862826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163699-07	Fumagillin		Methionine Aminopeptidase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	23110-15-8				-38.9728650394	4	4		0	-8.44481241					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	MedChem Express	HY-B0751	-8.40616077	-8.47348273	-7.54292272	-8.44481241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179359-04	Penbutolol sulfate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	38363-32-5		10	-5	-78.0943219212	-3	4		-105.199660112	-99.437884	0.0269620892	0.9995513727			CC(C)(C)NCC(O)COC1=C(C=CC=C1)C2CCCC2	Prestwick	Prestw-1043	0.25525655	-2.20224526	-4.12675994	-99.437884												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021301-06	Fluocinolone acetonide	170464630	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	67-73-2	; ; Fluocet; Synalar-C; Acetonida de fluocinolona; Sinalar; Synandone; Fluocinolone acetonide;Fluocinolone acetonide			-20.2523516401	4	5		0	0.95177084				NRC31	OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-1419	-6.60675142	-5.02230228	-4.7184757	-2.72129711	0.95177084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093366-05	(4-Aminophenyl)arsonic acid	170465635	Apoptosis Activator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	98-50-0				-18.9793697473	4	5		0	-2.21469754					O=[As](O)(O)c1ccc(N)cc1	Labotest	LTBB003365	-2.28408593	-4.94510208	-6.08006851	-7.6993865	-2.21469754											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091519-09	p-Cresol	170465495		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	106-44-5				-32.9091344009	4	5		0	-7.32131418					Cc1ccc(O)cc1	Microsource	01500209	-8.00087681	-5.51123692	-7.02205095	-5.49079755	-7.32131418											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159372-04	Butanedioic acid	170465738		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	110-15-6				-15.1547519321	4	5		0	-4.21890729					O=C(O)CCC(=O)O	Labotest	LTBB001662	-3.29241561	-1.02504718	-1.54142582	-5.86765995	-4.21890729											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00027930-07	Moclobemide	170465663	Monoamine oxidase A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	71320-77-9				-17.7634682495	4	5		0	-4.06332937					Clc1ccc(cc1)C(=O)NCCN2CCOCC2	Vitas	STK222240	-3.5203858	-4.42185624	-3.32262899	-3.98334794	-4.06332937											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018200-12	Phenolphthalein	170465559	store-operated calcium entry Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	77-09-8		12.5892541179	-4.9	-19.6106990911	4	5		-17.219964976	-16.87665336	0.0446011427	0.9770492946			Oc1ccc(cc1)C3(OC(=O)c2ccccc23)c4ccc(O)cc4	Vitas	STK029876	-1.52619976	-3.51827957	-0.86001588	-1.58207879	-16.87665336											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183867-06	ALOIN			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	5133-19-7				-12.5159673202	4	4		0	-1.08065711					[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@]2([H])C3=C(C(O)=CC=C3)C(=O)C4=C2C=C(CO)C=C4O	Microsource	01503427	-4.95370771	-0.03441008	1.38147151	-1.08065711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189076-01	Dibromopropamidine dihydrochloride	144207153		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	50357-61-4		14.1253754462	-4.85	-25.9551380313	4	4	Dibromopropamidine dihydrochloride	-15.536331784	-16.43644603	0.2053062115	0.9732638065			Cl.Cl.Brc2cc(ccc2OCCCOc1ccc(cc1Br)C(=N)N)C(=N)N	Toronto Research	D425800	-3.65579303	-4.37868295	-1.82283621	-16.43644603												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025167-02	Formoterol hemifumarate		Voltage-Gated K(V) 7 (KCNQ) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1448				-10.3076002786	4	4		0	-2.64063794					COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC(=C(O)C=C2)NC=O)C=C1	Tocris	1448	-3.01548845	1.07531507	-1.9817275	-2.64063794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247029-04	2-Deoxyglucose		sugar	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	154-17-6				-28.9664894138	4	4		0	-7.97621669					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	Cayman	14325	-7.45839505	-3.49932705	-2.16482272	-7.97621669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166280-02	Bismuth(III) gallate basic hydrate	225144278		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	99-26-3				-14.6601834914	4	4		0	-1.88945166					O[Bi]1OC2=CC(=CC(=C2O1)O)C(O)=O	SIGMA	15102	-6.61322645	-5.05551817	-3.25376775	-1.88945166												1.6E-9	8E-9	4E-8	2E-7											
NCGC00095121-16	NATEGLINIDE			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	105816-04-4				-18.1568368266	4	4		0	-3.08742568					CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(O)=O	Microsource	01504258	-4.89675002	-2.48990579	-2.29549612	-3.08742568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095125-05	Losartan	170465135	Angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	114798-26-4		0.8912509381	-6.05	-21.40387553	4	5		9.677731856	-1.80159841	0.3137083895	0.7946190573			OCc4c(Cl)nc(CCCC)n4Cc1ccc(cc1)c2ccccc2c3nnnn3	Microsource	01504268	-6.71488488	-10.14810988	-4.98335961	4.25309791	-1.80159841											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253606-01	Mexazolam	170465840		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	31868-18-5				-17.2199079743	4	5		0	-1.69323159					Clc1ccccc1C34OCC(C)N4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-217	-6.90319267	-5.21398433	-1.78665265	2.49194317	-1.69323159											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167499-02	Roxatidine acetate hydrochloride	170465941		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	93793-83-0		1.1220184543	-5.95	-24.5713001226	4	5		14.9675597	-4.11342394	0.1563070117	0.9847594073			Cl.CC(=O)OCC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Prestwick Chemical, Inc.	Prestw-428	-10.80629975	-8.25368122	-4.51042214	3.0366302	-4.11342394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00510142-01	Methylprednisolone aceponate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	86401-95-8				-22.1739059224	4	4		0	-1.85713052					CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Glixx	GLXC-08106	-5.61320333	-3.99932358	-3.4173314	-1.85713052												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181785-03	Aprepitant			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	170729-80-3				-21.6797940869	4	4		0	-8.47369785					C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	Prestwick	Prestw-1600	-4.07460417	-7.02629576	-2.01232777	-8.47369785												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179585-04	Rescinnamin	363676949	Serotonergic synapse Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-2.5286827974	4	4		0	-4.24980565					CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)\C=C\C6=CC(=C(OC)C(=C6)OC)OC	Analyticon	NP-011016	2.1871366	-2.02925509	-2.35678028	-4.24980565												5.2799999999E-8	2.64E-7	0.0000065999999999	0.0000198											
NCGC00507775-01	Midecamycin Acetate		Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	55881-07-7				-17.5201060701	4	4		0	-3.56741816					CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@](C)(OC(C)=O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC	AvaChem	2845	-3.43948475	-5.67345903	-2.06671501	-3.56741816												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182977-01	Trimethoquinol	144206771	Beta-3 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	18559-59-6	Tretoquinol; Tetroquinol; Trimetoquinol; Inolin; Tretoquinol-(S) HCl; Tretoquinol-(R); 			-23.7454218718	4	4	CIPLUS_207808;AQ11;1,2,3,4-TETRAHYDRO-1-(3,4,5-TRIMETHOXYBENZYL)-6,7-ISOQUINOLINEDIOL MONOHYDRATE HYDROCHLORIDE;TRETOQUINOL;Tretoquinol Hydrochloride, (S)-Isomer;CIPLUS_169251;Inolin;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, (S)-;TETRAHYDROISOQUINOLINE;tretoquinol;Trimetoquinol hydrochloride;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, hydrochloride, (S)-;AQ-110;Tetroquinol;Trimetoquinol Hydrochloride Anhydride;Tretoquinolum;AQL 20;Tretoquinol;Tretoquinol-(S) HCl;LS-173897;AQ 11;Trimetoquinol;LS-85640;CV 70;Tretoquinol-(R);CIPLUS_171514;CIPLUS_171515;Trimetoquinol Hydrochloride;tretoquinolum;AQL-208;CV-705;CIPLUS_171513;TRIMETOQUINOL HYDROCHLORIDE;l-trimetoquinol;AQL20;CV70;	0	-4.33618381					Cl.COc1cc(cc(OC)c1OC)C[C@@H]2NCCc3cc(O)c(O)cc23	NCI	NSC_288748	-4.62027015	-6.29069079	-4.60478608	-4.33618381												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00387409-02	Ertapenem		Peptidoglycan synthase FtsI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	153832-46-3				-20.492885432	4	4		0	-4.6989721			944799	ftsI	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)\C(=C(/N2C1=O)C(O)=O)S[C@@H]3CN[C@@H](C3)C(=O)NC4=CC=CC(=C4)C(O)=O	Glixx	GLXC-05077	-3.57366491	-6.01166822	-4.20594634	-4.6989721												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00013037-01	Thanite	144203555		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	115-31-1	isobornyl thiocyanoacetate; 			-29.006121509	4	4	CIPLUS_151404;isobornyl thiocyanoacetate;CIPLUS_745354;ISOBORNYL THIOCYANOACETATE;thanite;isobornyl thiocyanoacetate, (exo)-isomer;	0	-5.44182431					N#CSCC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C	NCI		-6.30199481	-9.35993912	-1.92168238	-5.44182431												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179297-04	Azapropazone		interleukin-1 alpha production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	13539-59-8				-14.0876738659	4	4		0	-7.50626242					CCCC1C(=O)N2N(C1=O)\C(=N/C3=C2C=C(C)C=C3)N(C)C	Prestwick	Prestw-1003	-1.04213257	-2.73103915	-6.88905004	-7.50626242												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00093644-07	Amsacrine	404904675	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	54301-15-4		3.9810717055	-5.4	-114.3280853773	-2.3	4		-101.5328828796	-25.56793643	1	0.9999759701		TOP2A	COC1=C(NC2=C3C=CC=CC3=NC4=C2C=CC=C4)C=CC(=C1)N[S+](C)([O-])=O	Glixx	GLXC-03289	-9.75489758	-20.0811702	-97.80638144	-25.56793643												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00188863-02	Dronedarone hydrochloride	170465064	alpha,beta-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	141626-36-0	Dronedarone; Dronedarone	3.5481338923	-5.45	-89.8280110269	-3	4		-98.8732641362	-9.08698281	1	0.9999911093	148	ADRA1A	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c3cc(ccc3oc2CCCC)NS(C)(=O)=O	SIGMA	D9696	-4.11933089	-9.22465545	-99.62835388	-9.08698281												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166147-02	Dihydrotachysterol	144205894	Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	67-96-9	Dihydrotachysterol; Dihydrotachysterin; Dihidrotaquisterol; Calcamine; Tachysterol, dihydro-; Tachystin; Hytakerol; 			-29.9551184142	4	4	parterol;LS-148512;Tachystin;CIPLUS_149136;Dihydrotachysterin;AT 10;Calcamine;dihydrotachysterol;dihydrotachysterolum;Hytakerol;NCGC00166147-01;Tachysterol, dihydro-;DIHYDROTACHYSTEROL;Dihydrotachysterol;AT-10;Dihydrotachysterolum;Dihidrotaquisterol;9,10-Secoergosta-5,7,22-trien-3-ol, (3beta,5E,7E,10alpha,22E)-;VITAMIN D1;9,10-Secoergosta-5,7,22-trien-3beta-ol;NCGC_SIGMA_D9257;	0	-3.42921309					C[C@H]3CC[C@H](O)C/C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C	SIGMA	D9257	-6.77609804	-9.10628224	-2.43836113	-3.42921309												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378907-01	Edoxaban tosylate monohydrate		Coagulation Factor X Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1229194-11-9				-3.9680179722	4	4		0	-0.59600933					CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C	MedChem Express	HY-10264B	0.46068521	-3.0607931	-1.91261784	-0.59600933												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346529-03	Safinamide		Sodium channel inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	133865-89-1				-6.9314749654	4	4		0	-2.4790533					C[C@H](NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O	MedChem Express	HY-70057	1.00635119	-4.39671937	-4.586657	-2.4790533												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00482546-01	Ganirelix			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	123246-29-7		0.7079457844	-6.15	-97.744915641	-2.4	4		-49.504374019	-35.67418157	0.4873347022	0.8172964769			CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CO)NC(=O)[C@H](CC2=CN=CC=C2)NC(=O)[C@H](CC3=CC=C(Cl)C=C3)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N6CCCC6C(=O)N[C@H](C)C(N)=O	DC Chemicals	DC8877	-1.03318723	-27.20892872	-61.93799855	-35.67418157												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00510944-01	Cyclopentamine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	538-02-3				-32.8091476033	4	4		0	-7.70493219					CNC(C)CC1CCCC1	SantaCruz Bio	sc-500096	-7.46488953	-7.70271413	-4.08810732	-7.70493219												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00389219-01	Oxeladin Citrate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	52432-72-1				-23.1215451542	4	4		0	-6.1242118					CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1	APExBIO	A8493	-3.66311835	-7.27149742	-4.99456128	-6.1242118												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386381-04	Besifloxacin Hydrochloride		Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	405165-61-9				-30.9957260554	4	4		0	-4.2238922					N[C@@H]1CCCCN(C1)C2=C(Cl)C3=C(C=C2F)C(=O)\C(=C/N3C4CC4)C(O)=O	Glixx	GLXC-06708	-7.71535916	-5.95248161	-4.31472081	-4.2238922												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00253604-01	Rescimetol	170465875	smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	73573-42-9				-38.6894461227	4	4		0	-6.29696813					Oc1ccc(cc1OC)/C=C/C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	GVK	FFS-11-286-NCI-194	-5.39851507	-9.14855838	-14.72987672	-6.29696813												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166300-02	Pyridoxal phosphate hydrate	170466028	P2X purinoceptor 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	41468-25-1				-21.7683755294	4	4		0	-4.12887622					O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O	SIGMA	P3657	-4.11038554	-5.19151095	-5.16678753	-4.12887622												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00037856-01	Medronic acid	144204525		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1984-15-2				-23.6629514888	4	4	Medronate disodium;Acido medronico;Acide medronique;PHOSPHONIC ACID, METHYLENEBIS-;Methylene Diphosphonic Acid;CIPLUS_159401;acidum medronicum;METHYLENE DIPHOSPHONIC ACID;METHYLENEDIPHOSPHONIC ACID;Methylenediphosphonic acid trisodium salt tetrahydrate;CIPLUS_738322;MEDRONIC ACID;Medronic acid;MEDRONATE DISODIUM;Acidum medronicum;MEDRONATE SODIUM;Methylenediphosphonic acid;methylene diphosphonate;METHYLENE DIPHOSPHONIC ACID, SODIUM SALT;acide medronique;CIPLUS_175020;	0	-5.45909994					O=P(O)(O)CP(=O)(O)O	DPISMR	3714055	-4.772341	-6.50207153	-3.58049311	-5.45909994												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346433-07	Peramivir		Influenza Infection Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	330600-85-6				-26.9322382323	4	4		0	-5.16541418				NEU1	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	Adooq	A11124	-7.91215672	-6.89946732	-4.44162437	-5.16541418												1.6E-9	8E-9	2E-7	6E-7											
NCGC00167490-03	Lumefantrine	170465388	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	82186-77-4	;benflumetol, (+-)-isomer;Lumefantrine; Lumefantrine			-11.2614213531	4	4		0	-5.88235294					CCCCN(CCCC)CC(O)c4cc(Cl)cc3c4c1ccc(Cl)cc1\C3=C\c2ccc(Cl)cc2	SIGMA	L5420	-0.82744432	-3.60192779	-4.23313996	-5.88235294												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00389431-01	RIBOFLAVIN 5-PHOSPHATE SODIUM		NADH oxidation Oxidative Enzyme	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	130-40-5				-18.0184076853	4	4		0	-4.84581498					CC1=C(C)C=C2N(C[C@@H](O)[C@@H](O)[C@@H](O)CO[P](O)([O-])=O)C\3=N\C(=O)NC(=O)C3=N/C2=C1	Microsource	01505763	0.41595849	-7.36450495	-7.36947063	-4.84581498												3.2E-8	1.6E-7	0.000004	0.000012											
NCGC00016371-08	Diclofenamide		Carbonic Anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	120-97-8				-33.8334304604	4	4		0	-5.57139155				CA1	N[S+]([O-])(=O)C1=CC(=C(Cl)C(=C1)[S+](N)([O-])=O)Cl	APExBIO	A8408	-6.9102782	-10.26464869	-4.36910805	-5.57139155												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178711-03	Gemifloxacin mesylate	170465333	Topoisomerase IV subunit A  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	204519-65-3				-32.6994618141	4	4		0	-1.71028764					CS(=O)(=O)O.CO\N=C1/CN(CC1CN)c2nc3c(cc2F)C(=O)C(=CN3C4CC4)C(=O)O	Microsource	01505802	-7.85848466	-9.48676757	-2.42929659	-1.71028764												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00091056-05	Styrene	225144204		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	100-42-5				-34.4695240886	4	4		0	-6.38334629					C=CC1=CC=CC=C1	SIGMA	S4972	-7.45594418	-7.93100533	-5.96446701	-6.38334629												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386241-01	Avanafil		Phosphodiesterase 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	330784-47-9				-5.3938012622	4	4		0	0.18139414					COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N3CCC[C@H]3CO)C(=O)NCC4=NC=CC=N4)C=C1	Selleck	S4019	1.23893014	-2.75640484	-6.09137056	0.18139414												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00263129-08	Palbociclib		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	571189-11-2		5.0118723363	-5.3	-86.2389182419	-3	4		-97.2291388441	-12.99127581	1	0.9999993714		CDK4	CC(=O)C\1=C(/C)C2=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N=C2N(C5CCCC5)C1=O	Axon Medchem	1505	-4.60237946	-6.8064598	-96.35605511	-12.99127581												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00345885-04	Etravirine		P-glycoprotein 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	269055-15-4				-31.9401806137	4	4		0	-5.08767384					CC1=C(OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C(=CC(=C1)C#N)C	MedChem Express	HY-90005	-4.19089364	-8.68352076	-11.64793328	-5.08767384												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00016797-11	Amoxicillin sodium		beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	26787-78-0				-34.3310283512	4	4		0	-3.58469379					CC1(C)S[C@H]2[C@H](NC(=O)[C@@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O	Selleck	S3015	-7.61696037	-8.69197599	-5.23930384	-3.58469379												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167469-02	NCGC00167469-02			DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-10.9373080962	4	4		0	-4.37073508					[H][C@@]2(CC1=CC(OC)=C(OC)C(OC)=C1)C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]4(C)CCC5=CC(OC)=C(OC)C=C5[C@@]4([H])CC6=CC(OC)=C(OC)C(OC)=C6	ACC	API-03789	-1.19420342	-2.44356134	-4.56852792	-4.37073508												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00165791-04	Epinastine hydrochloride	170465284	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	108929-04-0				-24.7717115266	4	4		0	-3.39466183					Cl.NC2=NCC3c4ccccc4Cc1ccccc1N23	SIGMA	E5156	-4.56659809	-6.94174347	-5.35714286	-3.39466183												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182070-03	Ioxilan	170465160		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	107793-72-6				-27.6468165172	4	4		0	-6.1760387					OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCCO	Kemprotec	107793-72-6	-6.35566688	-5.893295	-4.01559101	-6.1760387												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179264-03	Tiletamine Hydrochloride		Glutamate [NMDA] receptor subunit epsilon 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	14176-50-2				-18.5354849438	4	4		0	-3.84382828					CCNC1(CCCCC1=O)C2=CC=CS2	USP	1667359	-3.42159406	-4.3206223	-4.64104423	-3.84382828												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00085849-02	MEBHYDROLIN		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	524-81-2				-21.3349960719	4	4		0	-5.88235294					CN1CCC2=C(C1)C3=CC=CC=C3[N]2CC4=CC=CC=C4	Microsource	01501116	-3.01010824	-7.22922127	-4.9764322	-5.88235294												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00015708-15	Maprotiline hydrochloride	170464778	Noradrenaline Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	10262-69-8	 ; Ciba 34276 Ba;MAPROTILINE HYDROCHLORIDE; Maprotilene Hydrochloride; Maprotiline hydrochloride;Maprotiline hydrochloride; Maprotilline HCl; Ludiomil; Maprotilina;Maprotiline			-29.2366123076	4	5		0	-11.60382011				SLC6A2	CNCCCC24CCC(c1ccccc12)c3ccccc34	Vitas	STK711156	-7.4359844	-5.5827957	-2.23604128	-1.87054899	-11.60382011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159418-05	Tegafur	170465809	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	37076-68-9	; S-1 compound; S-1 (combination); ; Tegafur (Ftorafur); UFT protocol; Tegafur; 1-UFT protocol; Franroze; Tegafur-Uracil; TS-1 cpd; S 1 (combination);Tegafur; S-1 cpd; Atillon	1	-6	-9.9978823803	4	5		9.86645752	-2.85163431	0.1302371833	0.9895352726		TYMS	FC1=CN(C(=O)NC1=O)C2CCCO2	Labotest	LT00138127	-6.1387146	-5.03225806	-2.72999912	4.71017759	-2.85163431											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025176-02	Etomidate	170465117	GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	33125-97-2	 Etomidato; ; Radenarkon; Ethomidate;ETOMIDATE; Etomidate;Etomidate; Amidate			-18.0837647431	4	5		0	-2.55570999			2554	GABRA1	CC(c1ccccc1)n2cncc2C(=O)OCC	Microsource	01505599	-7.74122435	-3.67311828	-0.89529858	1.96971063	-2.55570999											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344532-01	Mucic acid	170464883		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	526-99-8				-20.6559535681	4	5		0	-4.51957136					O[C@@H]([C@H](O)[C@H](O)[C@@H](O)C(=O)O)C(=O)O	SIGMA	M89617	-5.70629133	-3.41505376	-3.8237629	-2.33931308	-4.51957136											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091585-05	Octocrylene	170464719	photosensitizer	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	6197-30-4	2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; ; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; "2-Ethylhexyl-2-cyano-3; Octocrileno;OCTOCRYLENE			-20.0619903059	4	5		0	-6.04402995				CAT	CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2	Labotest	LT00159303	-5.35017806	-3.49247312	-1.30987034	-3.24078248	-6.04402995											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015455-10	Felodipine	170464849	Voltage-gated calcium channel alpha2/delta subunit 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	72509-76-3		14.1253754462	-4.85	-53.5278908738	-3	5		-32.1614611921	-32.1212393	0.2170030904	0.8701098933			CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(Cl)c2Cl)C(=O)OC	Specs	AE-641/11429675	-10.31880617	-9.32473118	-5.20860898	-0.32002164	-32.1212393											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262941-01	Ipenoxazone hydrochloride	170465754	Glutamate [NMDA] receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	118635-68-0	2-Oxazolidinone,			-6.5644467258	4	4		0	-2.59734393					Cl.CC(C)C[C@H]3N(CCCN1CCCCCC1)C(=O)O[C@H]3c2ccccc2	GVK	FFS-11-286-NCI-165	-0.3337234	-4.68024755	-0.71473242	-2.59734393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159486-06	Hippuric acid	170464791	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	495-69-2				-30.6718912656	4	5		0	-3.17424482					O=C(NCC(=O)O)c1ccccc1	Vitas	STK011394	-9.55662073	-8.43451305	-5.95550885	-0.73986655	-3.17424482											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163128-08	Pioglitazone hydrochloride	170465116	PPARgamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	112529-15-4	Pioglitazona; Pioglitazone HCl;AA-10090;Pioglitazone HCl;PIOGLITAZONE HYDROCHLORIDE; ;Zactos;Actos;U-72107A;Glustin			-14.933213302	4	5		0	0.10385154			5468	PPARG	Cl.CCc1ccc(nc1)CCOc3ccc(CC2SC(=O)NC2=O)cc3	Microsource	01504401	-6.2098776	-3.85344011	-3.81853214	2.67350551	0.10385154											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183856-01	Phenyl 11-iodo-10-undecynoate	144206805		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2020-25-9		14.1253754462	-4.85	-42.7895446483	4	5	Phenyliodoundecynoate;PHENYLIODOUNDECYNOATE;CIPLUS_3885239;CIPLUS_3845000;10-UNDECYNOIC ACID, 11-IODO-, PHENYL ESTER;11-IODOUNDECYNOIC ACID PHENYL ESTER;002020259;	-24.0152165079	-24.17934709	0.3141054102	0.7931132266			O=C(Oc1ccccc1)CCCCCCCCC#CI	Pharmaron	PH-NIH-102558	-9.18856458	-7.78868509	-4.9132948	1.72030321	-24.17934709											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183001-01	Tolvaptan	124894207	Vasopressin (AVP) V2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	150683-30-0	 ; Tolvaptan;Tolvaptan			-34.080787452	4	4	OPC 41061;OPC-41061;7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine;tolvaptan;TOLVAPTAN;Tolvaptan;7-CHLORO-5-HYDROXY-1-(2-METHYL-4-(2-METHYLBENZOYLAMINO)BENZOYL)-2,3,4,5-TETRAHYDRO-1H-BENZAPINE, DL-;CIPLUS_789421;tolvaptanum;	0	-5.57758508			554	AVPR2	Cc1ccccc1C(=O)Nc2ccc(c(C)c2)C(=O)N4CCCC(O)c3cc(Cl)ccc34	Pharmaron	PH-NIH-116369	-8.56191053	-6.7873887	-4.72701593	-5.57758508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249900-01	Glyceryl 1-(2-aminobenzoate)	170465551		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	71574-35-1				-32.3568376038	4	5		0	-5.70147341					Nc1ccccc1C(=O)OCC(O)CO	GVK	FFS-11-286-NCI-90	-6.73827269	-6.80648482	-7.41597088	-8.09377739	-5.70147341											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181356-02	Oxapium iodide	170465824		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	6577-41-9				-30.5668964024	4	5		0	-6.25972362					[I-].C[N+]1(CCCCC1)CC2COC(O2)(C3CCCCC3)c4ccccc4	APAC	877482	-8.79000438	-3.36678676	-2.92870906	-7.41893076	-6.25972362											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015520-11	Hydroxyurea	170465025	Ribonucleoside-Diphosphate Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	127-07-1	 Hydroxyurea;HYDROXYUREA;Hydroxyurea	0.7943282347	-6.1	-22.6956295098	4	5		15.69720962	-4.46561611	0.0499215702	0.9984757054	6240	RRM1	NC(=O)NO	Microsource	01500344	-10.16434135	-7.75424094	-2.97775442	2.52825564	-4.46561611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179295-03	Meptazinol hydrochloride	170466363	Mu opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	59263-76-2				-26.0562513156	4	5		0	-5.97372105					Cl.CN1CCCCC(CC)(C1)c2cccc(O)c2	Prestwick Chemical, Inc.	Prestw-1004	-7.91320722	-5.40342719	-5.93799264	1.44795969	-5.97372105											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160421-03	Tetrabenazine	170464675	Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	58-46-8	 ; Nitoman;Tetrabenazine; Tetrabenazine; Tetrabenazina; Xenazine			-27.0175803368	4	5		0	-7.5631011			6571	SLC18A2	CC(C)CC2CN3CCc1cc(OC)c(OC)cc1C3CC2=O	Chemical Block	A2708/0115225	-7.75057776	-3.1301128	-6.37589771	-0.49475739	-7.5631011											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263574-01	Diflucortolone valerate	170465700	Annexin A1 Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	59198-70-8				-8.2336637998	4	5		0	-3.58965097			301	ANXA1	CCCCC(=O)OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Sequoia	59198-70-8	-2.8117778	2.42400758	-4.36153442	1.45703781	-3.58965097											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164552-06	Bromfenac Na			DPI_SARS-CoV-2_General	2019_NPC-3_Tox					-15.6688587589	4	5		0	-5.69377342					NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	Sequoia	SRP034005b	-2.95728837	-7.18591234	-1.92678227	0.63092915	-5.69377342											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015897-08	Ranolazine	170465435	Sodium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	95635-55-5	 ;RANOLAZINE;Ranolazine dihydrochloride; Ranolazine dihydrochloride; Ranexa;Ranolazine			-28.5442662438	4	5		0	-2.84914435			6335	SCN9A	OC(CN1CCN(CC1)CC(=O)Nc2c(C)cccc2C)COc3ccccc3OC	Microsource	01505366	-10.27561414	-4.2237148	-5.28989315	-1.01221007	-2.84914435											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017354-07	Spectinomycin dihydrochloride	170465149	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	21736-83-4	; Trobicin sulfate; Spectinomycin Sulfate; Espectinomicina;SPECTINOMYCIN HYDROCHLORIDE; Spectam; Stanilo;Spectinomycin dihydrochloride; Spectinomycin Sulphate			-20.7059770647	4	5		0	-5.04357249					Cl.Cl.C[C@H]1O[C@H]2O[C@@H]3[C@@H](O)[C@H](NC)[C@H](O)[C@H](NC)[C@H]3O[C@@]2(O)C(=O)C1	Microsource	01500538	-5.73054866	-4.91259795	-4.09879138	-0.01361718	-5.04357249											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249919-01	Nandrolone furylpropionate	170465918		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	7642-64-0				-8.832079968	4	5		0	-1.63904818					O=C4C=C5CC[C@@H]2[C@H](CC[C@]3(C)[C@@H](OC(=O)CCc1ccco1)CC[C@@H]23)[C@H]5CC4	GVK	FFS-11-286-NCI-187	-3.83891124	1.15818479	-1.52390962	-0.33135128	-1.63904818											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016069-13	Brimonidine	170464941	Alpha-2C adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	59803-98-4				-5.4316977834	4	5		0	-1.16945862			152	ADRA2C	Brc2c3nccnc3ccc2NC1=NCCN1	Enzo	AC155	-2.66626723	-1.21846207	-0.43790506	2.21052154	-1.16945862											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183010-01	Pelubiprofen	144206823	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	69956-77-0	PELUBIPROFEN; 			-4.5480273811	4	5	2-OCMPP;BENZENEACETIC ACID, .ALPHA.-METHYL-4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)-;2-(4-((2-oxocyclohexylidene)methyl)phenyl)propionic acid;PELUBIPROFEN;CIPLUS_706216;Pelubiprofen;pelubiprofene;LS-176792;2-(4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)PHENYL)PROPANOIC ACID;(+/-)-P-(((E)-2-OXOCYCLOHEXYLIDENE)METHYL)HYDRATROPIC ACID;CS-670;pelubiprofenum;CS 670;	0	-1.51262022			5743	PTGS2	O=C(O)C(C)c1ccc(cc1)\C=C2/CCCCC2=O	Pharmaron	PH-NIH-149772	-1.00573483	1.16679583	-4.80819758	1.42072534	-1.51262022											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018284-06	MEPIVACAINE HYDROCHLORIDE		Sodium channel protein type X alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1722-62-9				-19.8756393101	4	5		0	-7.50891769					CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C	SIGMA	M3189	-4.31824018	-1.60595884	-5.39499037	-1.94725614	-7.50891769											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159424-04	Tetramethylthiuram monosulfide	170465567		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	97-74-5				-20.3270614139	4	5		0	-3.69726366					CN(C)C(=S)SC(=S)N(C)C	Labotest	LT02090816	-2.33669443	-5.34825871	-7.13337615	-6.44609991	-3.69726366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015882-15	Riluzole	170464928	Glutamate Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1744-22-5	 ; Rilutek;PK-26124/RP-54274/Rilute;Riluzol; Prestwick-03A08;Riluzole; Riluzole; Riluzole hydrochloride			0.9635580679	4	5		0	-5.12491992			2911	GRM1	FC(F)(F)Oc1ccc2nc(N)sc2c1	Vitas	STK503686	2.74879439	-1.90856064	0.50524513	0.96844873	-5.12491992											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025357-04	Nicorandil	170465582	K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	65141-46-0	;Nicorandil; Nicorandil; ; Sigmart			3.9567983028	4	5		0	0.13727464				KCNJ8	O=C(NCCO[N+]([O-])=O)c1cccnc1	Prestwick	Prestw-106	2.81017098	1.20518099	-0.13701563	-3.01051709	0.13727464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094571-08	Crotamiton	170464851	antipruritic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	483-63-6	; Eurax;CROTAMITON;Crotamiton; ; CROTAMITON; 7   Crotamiton; Veteusan			-35.3095740569	4	5		0	-6.61663769					CCN(C(=O)C=CC)c1ccccc1C	Microsource	01505271	-7.87812363	-6.70355121	-7.41597088	-8.41805434	-6.61663769											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253595-01	Clocapramine	170465785	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	47739-98-0		12.5892541179	-4.9	-102.1814657833	-3	5		-109.6181585281	-99.71629908	0.0125465921	0.9936679354			Clc4ccc5CCc1ccccc1N(CCCN2CCC(CC2)(C(N)=O)N3CCCCC3)c5c4	GVK	FFS-11-286-NCI-179	-10.5523893	-1.46251501	-5.36929994	-4.7283085	-99.71629908											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015471-08	Ganciclovir	170464961	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	82410-32-0	 ; Gancyclovir; UL97 protein, HCMV; Biolf 62;Ganciclovir; Cytovene; Vitrasert; Ganciclovir			-4.828427701	4	5		0	-1.23547177				UL54	OCC(CO)OCn2cnc1c2N=C(N)NC1=O	Prestwick	Prestw-839	1.354669	-0.09006691	-6.05437808	-3.03680982	-1.23547177											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178851-03	Moxalactam disodium	170465353	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	64953-12-4				-9.64273491	4	5		0	-0.96092249					[Na+].[Na+].O=C3N1C(=C(CO[C@@H]1[C@]3(OC)NC(=O)C(c2ccc(O)cc2)C([O-])=O)CSc4nnnn4C)C([O-])=O	Microsource	01500418	-3.5203858	-0.11580031	-1.74694926	-1.56441718	-0.96092249											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00319175-03	Rilpivirine			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	500287-72-9		8.9125093813	-5.05	-80.5237291261	-2.1	4		-111.5831050471	-97.51596565	0.0287278286	0.9994906504			CC1=C(NC2=CC=NC(=N2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C	APExBIO	A3765	-0.25267927	1.92631225	-11.93048175	-97.51596565												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522019-01	Polaprezinc			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	107667-60-7				-23.2276373412	4	4		0	-6.29376789					O=C1CCN[Zn++]2[O-]C(=O)[C@H](CC3=CN=C[NH]3)[N-]12	Toronto Research	P688000	-4.97516773	-6.17429341	-1.01489677	-6.29376789												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00188864-02	Iloperidone	170465198	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	133454-47-4	Iloperidone			-28.4145149844	4	4		0	-12.38053292			1813	DRD2	CC(=O)c4ccc(OCCCN1CCC(CC1)c3noc2cc(F)ccc23)c(OC)c4	Bosche	I2337	-4.13871221	-5.23216689	-7.06071957	-12.38053292												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090991-02	N,N-Dimethylbenzylamine	144207006		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	103-83-3				-1.1176265112	4	4	Zephiran chloride;CIPLUS_150764;Drapolene;Cloruro de benzalconio;N,N-Dimethylbenzylamine;N-benzyl-N,N-dimethylamine hydrochloride;CIPLUS_167204;N-benzyl-N,N-dimethylamine nitrate;Benzalkonium chloride;Compounds, Benzalkoniu;CIPLUS_776792;Germex;Osvan;ALKYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE;N,N-dimethylbenzylamine;NCGC00095057-01;Alkyl* dimethyl benzyl ammonium chloride *(50%C12, 30%C14, 17%C16, 3%C18);chlorure de benzalkonium;BENZALKONIUM CHLORIDE;Alkyldimethylbenzylammonium Chloride;AB07944111-01;ALKYLBENZYL TRIMETHYL AMMONIUM CHLORIDE;N-Benzyldimethylamine;Chloride, Alkyldimethylbenzylammoniu;BTC212;Zephiran;NCGC00095057-02;N-benzyl-N,N-dimethylamine;DMBA;BTC-2125;NCGC00164245-01;benzalkonii chloridum;Chloride, Benzalkoniu;Asepsol;CIPLUS_718497;CIPLUS_159160;benzyldimethylamine;N-benzyl-N,N-dimethylamine hydrobromide;Benzalkonium Chloride;Benzalkonii chloridum;Chlorure de benzalkonium;BTC 212;ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE;BDMA;Benzalkonium Compounds;ALKYL ETHYLBENZYL DIMETHYL AMMONIUM CHLORIDE;	0	-2.4972473					CN(C)Cc1ccccc1	SigmaAldrich	136921	0.63605472	2.01884253	-3.27119087	-2.4972473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390811-01	Oxytocin		Oxytocin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	50-56-6				-7.7092137293	4	4		0	-0.65624312					CC[C@H](C)C1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	MedChem Express	HY-17571	-2.97115971	0.97577389	-0.44864535	-0.65624312												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017400-10	Dihydroergotamine	174006617	serontonin, dopamine, epinephrine receptor agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	511-12-6	 Dihydroergotamine; ;Dihydroergotamine;DIHYDROERGOTAMINE MESYLATE; Dihydergot plus; Migranal; Dihidroergotamina; Venelbin; Silentan	0.0446683592	-7.35	-15.33566284	4	5		8.26658392	-4.89005283	0.6478154351	0.6047035735			CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O	Microsource	01500248	-7.3054866	2.77706019	-3.91487126	-0.68539785	-4.89005283											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249912-01	Floctafenine	170465681	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	23779-99-9				-22.4725130928	4	5		0	-5.7569874			5743	PTGS2	OCC(O)COC(=O)c3ccccc3Nc1ccnc2c(cccc12)C(F)(F)F	GVK	FFS-11-286-NCI-159	-7.44243773	-6.66063894	-0.50796987	0.9214289	-5.7569874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181354-02	Tocoretinate	225144326	Retinoic acid receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	40516-48-1				-15.2763692099	4	4		0	-4.22676369			1282		CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(=C(C)C(=C2C)OC(=O)\C=C(C)\C=C\C=C(C)\C=C\C3=C(/C)CCCC3(C)C)C	Bosche	T3082	-2.17617029	-3.25175276	-3.19989407	-4.22676369												1.6E-8	8E-8	4E-7	0.000002											
NCGC00183097-01	Beraprost sodium	144206467	Thyroid hormone receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	88475-69-8	Beraprost sodium; Procylin; 			-25.3301217533	4	4	TRK-100;1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-, monosodium salt;beraprost;4-(1,2,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyloct-6-yne-1-enyl)-5-cyclopenta(b)benzofuranyl)butyrate;BERAPROST;CIPLUS_685106;beraprost sodium;Procylin;Beraprost sodium;TRK 100;Beraprost Sodium;CIPLUS_193198;Beraprostum;1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-;Beraprost;trk-100;BERAPROST SODIUM;ML-1129;2,3,3A,8B-TETRAHYDRO-2-HYDROXY-1((E)-(3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-1H-CYCLOPENTA(B)BENZOFURAN-5-BUTYRIC ACID SODIUM SALT;LS-57735;beraprostum;LS-57736;	0	-9.31631008			19222		[Na+].CC(CC#CC)[C@H](O)/C=C/[C@H]2[C@H](O)C[C@@H]3Oc1c(cccc1CCCC([O-])=O)[C@H]23	ACC	BERAPROST SODIUM	-4.11438955	-4.91203923	-6.33358344	-9.31631008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185769-02	Stiripentol		"Gaba Synthesis, Release, Reuptake And Degradation Modulator"	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-30.5566636465	4	4		0	-4.20061876					CC(C)(C)C(O)C=CC1=CC=C2OCOC2=C1	APExBIO	A8704	-8.97724323	-2.82162674	-3.6059496	-4.20061876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160570-01	Butonate	144205461		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	126-22-7	Butonate; Butonato; Pedix PE 50; 			-35.1606204773	4	4	Pedix PE 50;Tribufon;butonatum;0,0,dimethyl-2,2,2-trichloro-1-n-butyryloxyethyl phosphonate;CIPLUS_173408;LS-47987;Butonate;BUTONATE;butonate;tribuphon;tribufon;Butonatum;Butonato;	0	-11.86979825					O=P(OC)(OC)C(OC(=O)CCC)C(Cl)(Cl)Cl	SigmaAldrich	S360910	-7.34187073	-9.27351714	-3.46471289	-11.86979825												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00094572-12	Amitraz	170465703		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	33089-61-1				-13.0022266076	4	5		0	-1.03413563					Cc2ccc(/N=C/N(C)/C=N/c1ccc(C)cc1C)c(C)c2	Microsource	01505299	-2.59973696	-2.45753989	-3.6137872	-4.52673094	-1.03413563											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00273564-01	Bropirimine	170465913	Toll-like receptor 7 Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56741-95-8				-37.9568242515	4	5		0	-9.01436808					BrC1=C(NC(N)=NC1=O)c2ccccc2	Tocris	4316	-9.21087242	-7.26110825	-4.99250696	-7.971078	-9.01436808											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022735-06	Methylprednisolone	170465051	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	83-43-2	; Medrone; Metipred;Methylprednisolone, 6-alpha; 6alpha-Methylprednisolone; Urbason;6alpha-Methylprednisolone; 6 Methylprednisolon; Medrol Veriderm; Medrol; Metilprednisolona;Methylprednisolone; 6-Methylprednisolone; Methylprednisolone Base; 6-alfa-Methylprednisolone			-4.2259360948	4	5		0	1.01583234				NRC31	OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-279	-0.67075844	-1.63407102	0.65938771	-4.37773883	1.01583234											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091268-12	Oxytetracycline	225144208	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	79-57-2	; ; Oxytetracycline hydrochloride; Terramycin hydrochloride; Oxitetraciclina;Oxytetracycline hydrochloride;OXYTETRACYCLINE; Oxytetracycline Base;Oxytetracycline; Riomitsin;Oxytetracycline dihydrate; Oxytetracycline HCl; Oxytetracycline base; Oxytetracycline dihydrate; oxycort A; Terramycin			-36.8302783274	4	5		0	-7.46774046					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@H]3\C(=C(O)/[C@]2(O)C(=O)\C(=C1O)C(N)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Prestwick	Prestw-307	-9.48268303	-6.5663064	-7.31320916	-5.66608238	-7.46774046											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094810-04	Warfarin sodium	170464790	Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2610-86-8	 ; Coumafene;WARFARIN; (S)-(-)-Warfarin;Warfarin; Warfarin; WARFARIN;Potassium warfarin; (R)-(+)-Warfarin; Warfarina; Warfarin Sodium Clathrate; actosin P; Coumadin; Athrombin-K;(?)-Warfarin			-13.6190325965	4	5		0	-0.86087073			79001	VKORC1	[K+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3	Labotest	LT00771738	-4.34966932	-3.78494624	-1.98906236	-1.24853511	-0.86087073											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015257-14	Clofibrate	170465329	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	637-07-0	 ; Aluminium clofibrate; Miscleron; Athromidin; Atromid-S; Atromid S; Miskleron; Clofibrate;Clofibrate; Clofibrato; Atromid;CLOFIBRATE			-14.018310373	4	5		0	-0.85190333			5465	PPARA	Clc1ccc(OC(C)(C)C(=O)OCC)cc1	Microsource	01503429	-3.67135832	-5.90107527	-2.66825439	-0.83385919	-0.85190333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00065934-05	Oxcarbazepine	170464811	Sodium channel inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	28721-07-5	; Oxcarbazepina; Oxcarbazepine;Oxcarbazepine;OXCARBAZEPINE; Timox; Trileptal; Oxacarbazepine			-36.3106087487	4	5		0	-9.66686096					NC(=O)N3c1ccccc1C(=O)Cc2ccccc23	Vitas	STK594696	-9.97965067	-9.34193548	-4.8028579	-0.98710899	-9.66686096											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344529-02	Cefamandole (nafate)		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	42540-40-9				-13.1033065092	4	4		0	-6.3183581					C[N]1N=NN=C1SCC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@H](OC=O)C4=CC=CC=C4)C3=O)C([O-])=O	MedChem Express	HY-B1166	-1.63104612	-4.80880898	-1.22258022	-6.3183581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016446-17	Metronidazole		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	443-48-1				-23.5856095684	4	4		0	-3.363981					CC1=NC=C([N]1CCO)[N+]([O-])=O	Enzo	DL447	-6.23431686	-2.90765194	-4.46219711	-3.363981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274275-01	Tripamide	170466047	Solute carrier family 12 member 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	73803-48-2				-8.0623684832	4	4		0	0.24401935					NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN3C[C@@H]4C2CC[C@@H](C2)[C@@H]4C3	GVK	FFS-11-286-NCI-189	-2.25404517	-3.75930148	0.19861411	0.24401935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166309-02	Altrenogest	170465646		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	850-52-2				6.7739793277	4	4		0	3.02409691					O=C3C=C4CC[C@@H]2C(C=C[C@@]1(C)[C@H]2CC[C@@]1(O)CC=C)=C4CC3	SIGMA	33994	0.54079778	1.27317304	3.20872137	3.02409691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263579-01	rac Nebivolol hydrochloride	170465208	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	169293-50-9		12.5892541179	-4.9	-105.7068601227	-3	4		-102.4039331284	-99.5511787	0.0752258567	0.9964934944		ADRB1	Cl.Fc1cc2CC[C@@H](Oc2cc1)[C@@H](O)CNC[C@H](O)[C@@H]3CCc4cc(F)ccc4O3	Sequoia	99200-09-6	-9.83386692	-5.26474257	-3.58829501	-99.5511787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090851-10	5-Azacitidine	170465076	DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	320-67-2	 ;AZACITIDINE; Azacytidine, 5-; Ladakamycin;Azacitidina; Azacytidine-5; 5-Azacitidine;5-Azacitidine; 5 Azacytidin; Azacytidine; Vidaza; ara-5-aza-Cyd;5-azacytidine;5-Azacytidine	12.5892541179	-4.9	-63.3371074122	-3	5		-50.3231818253	-50.96401318	0.0256665494	0.9869219961	1786	DNMT1	NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01502111	-9.19712403	-4.5078791	-3.64337012	-3.563161	-50.96401318											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185763-03	6?-Methylprednisolone 21-hemisuccinate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	2921-57-5				-19.0686264605	4	4		0	-4.14615185					C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]\4(C)/C=C\C(=O)\C=C14	Cayman	11800	-4.65605153	-3.01006172	-3.23604061	-4.14615185												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167429-04	Temozolomide	170464968	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	85622-93-1	Temozolomide; ; Temodar;; Temozolomide			-28.4317749044	4	4		0	-5.57139155			7153	TOP2A	NC(=O)c1ncn2C(=O)N(C)N=Nc12	Prestwick	Prestw-1183	-4.45925396	-10.04481272	-5.52936911	-5.57139155												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00510931-01	Mavacoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	170569-88-7				-17.6893811673	4	4		0	-4.70760992					N[S+]([O-])(=O)C1=CC=C(C=C1)[N]2N=C(C=C2C3=CC=C(F)C=C3)C(F)(F)F	SantaCruz Bio	sc-488033	-3.20690581	-3.08615879	-5.48404641	-4.70760992												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00261970-01	BEMOTRIZINOL	225144355		DPI_SARS-CoV-2_General	2019_NPC-6_Tox		Tinosorb s;Bemotrizinol;Bis-ethylhexyloxyphenol methoxyphenyl			-21.83208507	4	4		0	-2.21128099					CCCCC(CC)COC1=CC(=C(C=C1)C2=NC(=NC(=N2)C3=C(O)C=C(OCC(CC)CCCC)C=C3)C4=CC=C(OC)C=C4)O	GVK	FFS-11-286-NCI-081	-3.76151713	-6.2061385	-7.37853517	-2.21128099												1.6E-8	8E-8	0.000002	0.000006											
NCGC00386281-05	Fidaxomicin			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	873857-62-6				-24.0408697304	4	4		0	-6.59065388					CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)C3=C(CC)C(=C(O)C(=C3O)Cl)Cl)[C@H](O)[C@@H]2OC)\C(=O)O[C@@H](C\C=C(C)\C=C(C)\[C@@H]1O[C@@H]4OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]4O)[C@@H](C)O	Glixx	GLXC-90140	-5.33589767	-7.16157944	-1.4231327	-6.59065388												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00249891-01	Bromodiphenhydramine	170465292	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	118-23-0				-15.4250350418	4	4		0	-2.71227434					Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2	GVK	FFS-11-286-NCI-046	-1.85615887	-3.95704743	-6.28172589	-2.71227434												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00095158-08	Secnidazole		antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	3366-95-8				-3.7175866371	4	4		0	0.4750799					CC(O)C[N]1C(=NC=C1[N+]([O-])=O)C	Prestwick	Prestw-1340	-1.22103945	-0.515769	0.20848441	0.4750799												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00166290-03	Polyoxyethylene (9) lauryl ether	170466791		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	3055-99-0				-26.3805913864	4	4		0	-6.68566986					CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	SIGMA	P9641	-4.11933089	-4.06696542	-10.66896302	-6.68566986												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00263173-09	Rucaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	283173-50-2				-32.9253939499	4	4		0	-4.88036624				PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	APExBIO	A8893	-4.70077824	-9.37684958	-10.58738216	-4.88036624												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00016886-04	Ioxaglic Acid		Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	59017-64-0				-16.9475827453	4	4		0	0.36278829					CNC(=O)C1=C(I)C(=C(I)C(=C1I)C(=O)NCC(=O)NC2=C(I)C(=C(I)C(=C2I)C(O)=O)C(=O)NCCO)N(C)C(C)=O	USP	1345159	-4.0209321	-3.95704743	-2.79187817	0.36278829												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00263445-02	Brucine-N-oxide		Vascular endothelial growth factor receptor 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	357-57-3				-16.2236735399	4	4		0	-4.63850739					COC1=CC2=C(C=C1OC)[C@@]34CCN5CC/6=C/CO[C@H]7CC(=O)N2[C@H]3[C@H]7[C@H]6C[C@@H]45	Enzo	NP038	-2.13346453	-5.8341084	-3.78897752	-4.63850739												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178501-04	CEFTIBUTEN		Peptidoglycan synthase FtsI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	97519-39-6				-0.6881070381	4	4		0	-2.57406928			944799	ftsI	NC1=NC(=CS1)\C(=C\CC(O)=O)C(=O)N[C@H]2[C@H]3SC\C=C(/N3C2=O)C(O)=O	Microsource	01505207	0.56802934	0.11837321	-1.75852067	-2.57406928												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160391-09	Auranofin		Thioredoxin Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox			2.2387211386	-5.65	-130.1731732998	-1.1	4		-95.3948198396	-97.28772566	0.0235780071	0.9996569608		TXNRD1	CC[P](CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	SIGMA	A6733	-3.1442884	-5.24224233	-99.66461204	-97.28772566												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183366-07	NORETHINDRONE ACETATE		Progesterone Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	51-98-9				-1.4619758616	4	4		0	4.04249806					CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C	Microsource	01500438	-0.45173987	-2.50274795	1.44126178	4.04249806												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182975-01	Amoebicon	144206766		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	116-49-4	Glycobiarsol; Glicobiarsol; 			-18.5998899803	4	4	GLYCOBIARSOL;LS-172304;Glicobiarsol;Glycobiarsol;glycobiarsolum;Glycobiarsolum;CIPLUS_151450;glycobiarsol;	0	-1.99533558					O=C(Nc1ccc(cc1)[As](O)(=O)O[Bi]=O)CO	NCI	NSC_221709	-6.3198855	-4.04159973	2.40210297	-1.99533558												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00018250-06	Sulconazole nitrate	170465344	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	61318-91-0		11.220184543	-4.95	-68.4529213646	-3	5		-110.4924270246	-95.04550957	0.0034098154	0.9982909549			[O-][N+](=O)O.Clc3ccc(C(SCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501148	1.88231304	2.68387097	-1.93613831	-2.04182818	-95.04550957											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095303-04	Cloxyquin	170465523	Mycobacterium tuberculosis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	130-16-5				-23.0111943017	4	5		0	-11.8369726					Oc1ccc(Cl)c2cccnc12	Vitas	STK015543	-5.02798033	-6.40860215	-3.25923966	2.74497431	-11.8369726											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016902-04	Etifenin	170466635		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63245-28-3		0.8912509381	-6.05	-10.9769153643	4	5		9.743225812	-5.73913823	0.2285948007	0.9667969857			O=C(Nc1c(cccc1CC)CC)CN(CC(=O)O)CC(=O)O	Prestwick Chemical, Inc.	Prestw-504	-5.22299474	-7.28602151	-2.23604128	3.70954656	-5.73913823											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094857-05	9-Aminoacridine, monohydrochloride, monohydrate	170465046		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	52417-22-8		7.0794578438	-5.15	-106.4265916543	-2.1	5		-103.9703480299	-98.60556876	0.0032187662	0.9983869612			Cl.O.Nc1c3ccccc3nc2ccccc12	Vitas	STK387428	-5.36713583	-4.7827957	-1.83911088	-25.95781123	-98.60556876											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015831-06	Pheniramine maleate	170464902	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	132-20-7				-26.7263248325	4	5		0	-4.64511501					[O-]C(=O)/C=C\C([O-])=O.C[NH+](C)CCC(c1ccccc1)c2[nH+]cccc2	Microsource	01500478	-7.61404104	-7.83655914	-5.66728411	0.43721266	-4.64511501											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164283-07	Hexadecyltrimethylammonium bromide	170465714	Cell membrane Interacts	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	57-09-0		12.5892541179	-4.9	-96.616205105	-3	5		-112.053765785	-99.37676546	0.0012760426	0.9993614575			[Br-].C[N+](C)(C)CCCCCCCCCCCCCCCC	Microsource	01503200	-6.49482788	-4.42150538	-3.59442533	-6.71143965	-99.37676546											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160654-06	Ethylparaben	170465715		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	120-47-8				-31.8483034956	4	5		0	-8.70734879					Oc1ccc(cc1)C(=O)OCC	Vitas	STK070911	-7.64795659	-10.3827957	-3.7884802	-1.78941675	-8.70734879											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179663-03	(-)-(5S,8R)-Lisuride	170465966	Dopamine D5 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	159701-44-7				-12.260581725	4	5		0	-1.92799175					CCN(CC)C(=O)N[C@@H]2C=C1c3cccc4ncc(C[C@@H]1N(C)C2)c34	Tocris	4052	-3.17958284	-4.37849462	-2.65061304	-0.01352204	-1.92799175											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181028-02	D-Pantethine	225144316	HMG-CoA reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	16816-67-4				-10.7855663737	4	5		0	-1.91005694					CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO	SIGMA	P2125	-3.41699169	-4.34408602	0.20728588	-0.18480123	-1.91005694											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159368-05	1-Hexadecanol	170465348	Fatty aldehyde dehydrogenase Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	36653-82-4				-18.4238855135	4	5		0	-2.89647133			224	ALDH3A2	CCCCCCCCCCCCCCCCO	Labotest	LTBB001504	-5.56215025	-4.97204301	-3.00344006	-0.5273596	-2.89647133											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013687-03	Pyrophosphoric acid			DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2466-09-3				-29.1310747019	4	5		0	-7.95408689					O[P](O)(=O)O[P](O)(O)=O	SIGMA	433314	-7.94471765	-6.60645161	-4.74111317	-0.74371225	-7.95408689											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159478-04	Benzoxiquine	170465534		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	86-75-9				-10.7122080744	4	5		0	-1.09402323					O=C(Oc1cccc2cccnc12)c3ccccc3	Specs	AE-848/01460057	-4.12073936	-3.71612903	-1.56566993	2.05985757	-1.09402323											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095606-02	(2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone	170465578	TNF-alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	14073-97-3				-13.0498919103	4	5		0	-2.42119894					CC(C)[C@@H]1CC[C@@H](C)CC1=O	SIGMA	63680	-5.49431915	-1.48817204	-0.98350534	0.9690796	-2.42119894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165862-02	Pamidronic acid	170464689	Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	40391-99-9				-1.5246158129	4	5		0	2.08043761					OC(CCN)(P(O)(=O)O)P(=O)(O)O	Selleck	S1311	-3.69679498	0.7827957	2.65061304	1.96971063	2.08043761											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164581-02	Estramustine	170466403	Estrogen receptor beta Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2998-57-4				-25.0163824787	4	5		0	-2.03560059			4130		ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	Sequoia	SRP01725e	-7.81753434	-8.65376344	-4.1854106	-0.03155143	-2.03560059											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016272-05	Guanethidine sulfate	170464954		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	60-02-6				-8.2854123586	4	5		0	-1.99973098					O=S(=O)(O)O.O=S(=O)(O)O.N=C(N)NCCN1CCCCCCC1	Vitas	STK895063	-3.9596405	-3.07096774	-0.11907912	1.17641756	-1.99973098											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00091595-07	Sodium 2-phenylphenate tetrahydrate	170465724		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	6152-33-6				-14.6817325789	4	5		0	-2.85163431					[Na+].O.O.O.O.[O-]c2ccccc2c1ccccc1	Vitas	STK177354	-3.84093607	-3.42365591	-3.90314898	-0.43721266	-2.85163431											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249904-01	Butamisole	170466389	Nicotinic acetylcholine receptor alpha subunit Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	54400-59-8				-16.8610144472	4	5		0	-3.87391831					CC(C)C(=O)Nc1cccc(c1)C2N=C3SCCN3C2	GVK	FFS-11-286-NCI-117	-5.25691029	-3.53548387	0.36605804	-2.86216533	-3.87391831											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015399-16	Etodolac	170464915	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	41340-25-4	; ; Etodolac;Etodolac; Etodolaco; 6-OH etodolac glucuronide;ETODOLAC; Etodolac, (+-)-Isomer; Lodine; Etodolac, Monosodium Salt			-26.8147706082	4	5		0	-3.50625476			5743	PTGS2	O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC	Microsource	01501005	-9.19959301	-5.80645161	-4.17658993	-0.22086	-3.50625476											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017291-17	Riboflavin			DPI_SARS-CoV-2_General	2019_NPC-4_Tox	 83-88-5				-27.2485485128	4	5		0	-6.56413935					CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2	Selleck	S2540 	-7.08835001	-8.92903226	-3.27688101	-1.17641756	-6.56413935											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00018107-05	2-Thiosalicylic acid	170465571	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	147-93-3				-16.2322592332	4	5		0	-0.95951217					OC(=O)c1ccccc1S	SIGMA	T33200	-6.59657453	-5.47096774	-0.90411926	1.68124042	-0.95951217											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00248247-02	Dimethyl maleate	170466784	NFkappaB-inducing kinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	624-48-6				-24.9633789602	4	4		0	-4.64655362				NFE2L2	COC(=O)/C=C\C(=O)OC	GVK	FFS-12-73-NCI-3423	-7.04016729	-6.26682369	1.24139733	-4.64655362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167532-02	Balofloxacin	170465911	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	127294-70-6	 ;Balofloxacin; Balofloxacin; Balofloxacin Hydrate			-10.2564353378	4	4		0	-3.21955516					CNC1CCCN(C1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Sequoia	SRP00850b	-1.7687549	-3.44044415	-1.32851294	-3.21955516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389470-01	Dirithromycin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	62013-04-1				-19.5096705711	4	4		0	-5.49218234					CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C4NC(COCCOC)OC(C4C)C1(C)O	APExBIO	B1731	-5.38468241	-5.08916555	2.72236258	-5.49218234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181096-01	Chlophedianol	144206265		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	791-35-5	CHLOPHEDIANOL HYDROCHLORIDE; Coldrin; Baltix; 			-27.315842645	4	4	sl 501;BENZENEMETHANOL, 2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)- .ALPHA.-PHENYL;CHLOPHEDIANOL;Clofedanol hydrochloride;2-chloro-alpha-(2-dimethylaminoethyl)benzhydrol;clofedanol;Clofedanolum;clofedanol hydrochloride;Baltix;1-(2-CHLOROPHENYL)-3-(DIMETHYLAMINO)-1-PHENYLPROPAN-1-OL;2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)BENZHYDROL HYDROCHLORIDE;CIPLUS_660723;chlophedianol;CLOFEDANOL;CHLOPHEDIANOL HYDROCHLORIDE;BENZENEMETHANOL, 2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)-.ALPHA.-PHENYL-, HYDROCHLORIDE;Coldrin;1-Phenyl-1-(o-chlorophenyl)-3-dimethylaminopropanol;Benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)-, hydrochloride;Chlophedianol;Clofedanol Hydrochloride;chlophendianol hydrochloride;clofedanolum;Clofedanol;Benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)-;CIPLUS_156451;Chlophedianol hydrochloride;1-(2-CHLOROPHENYL)-3-(DIMETHYLAMINO)-1-PHENYLPROPAN-1-OL HYDROCHLORIDE;LS-32307;LS-32306;	0	-4.2325479					OC(CCN(C)C)(c1ccccc1Cl)c2ccccc2	NCI	NSC-113595	-7.58037815	-4.89569314	-1.96445683	-4.2325479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177995-02	Sarafloxacin hydrochloride	170466185	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	91296-87-6	;Sarafloxacin hydrochloride;SARAFLOXACIN HYDROCHLORIDE;Sarafloxacin HCl; Sarafloxacin Hcl; Sarafloxacin HCl; Sarafloxacino			-14.0297848143	4	4		0	-2.5236732					Cl.Fc1ccc(cc1)N2C=C(C(=O)O)C(=O)c3cc(F)c(cc23)N4CCNCC4	Vitas	STK713346	-3.4590921	-5.7705249	0.63158812	-2.5236732												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00379079-03	Cefoselis (sulfate)		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	122841-12-7				-15.3062138859	4	4		0	-3.25478969					CO\N=C(/C(=O)N[C@H]1[C@H]2SC/C(=C(N2C1=O)/C(O)=O)CN3\C=C/C(=N)N3CCO)C4=CSC(=N4)N	MedChem Express	HY-B0186B	-3.44166594	-3.58344549	-2.26064988	-3.25478969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016927-11	Enoxacin	170465263	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	74011-58-8	; ; Enoxiacin Gluconate;Enoxacin; Penetrex; Enoxacin;ENOXACIN; 2   Enoxacin			-32.1501218091	4	5		0	-5.07916171					O=C(O)C2=CN(CC)c1nc(c(F)cc1C2=O)N3CCNCC3	Microsource	01503215	-7.63261727	-5.93154915	-9.56540355	-4.81595092	-5.07916171											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159515-03	Eszopiclone	170465445	GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	138729-47-2	Eszopiclone; ; Estorra; Eszopiclone; Zopiclona;Zopiclone; Amoban			-3.6814742204	4	5		0	-0.60400842			2554	GABRA1	CN1CCN(CC1)C(=O)O[C@H]4c2nccnc2C(=O)N4c3ccc(Cl)cn3	Bionet	KS-1055	0.00438404	-0.15011151	-0.38535645	-4.09728308	-0.60400842											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183830-01	Lemildipine	144206840	Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	94739-29-4		11.220184543	-4.95	-70.8484453625	-3	5	CIPLUS_208006;NPK 1886;isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;lemildipine;Lemidipine;Lemildipine;LS-131203;LEMILDIPINE;NB-818;NPK-1886;CIPLUS_701996;NB 818;lemildipinum;	-61.5802021517	-58.85421433	0.0114088844	0.9942488795			O=C(OC)C1=C(C)NC(COC(N)=O)=C(C1c2cccc(Cl)c2Cl)C(=O)OC(C)C	Pharmaron	PH-NIH-152804	-7.52740026	-7.02950763	-2.98008992	-8.44434706	-58.85421433											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167434-02	Pemirolast potassium	170465431		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	100299-08-9				-11.1558938903	4	5		0	-2.58076325					[K+].CC3=CC=CN1C3=NC=C(C1=O)c2[n-]nnn2	Bosche	P2486	0.15344147	-3.58980957	-5.15521302	-3.68536372	-2.58076325											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016737-04	Epirizole	170465827		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	18694-40-1				-15.5946285957	4	5		0	-3.26713645					Cc1cc(nc(n1)n2nc(C)cc2OC)OC	Prestwick	Prestw-32	-4.31828146	-1.01646938	-2.16655962	-4.17616126	-3.26713645											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016511-08	Chlorotrianisene	170465394	Estrogen receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	569-57-3				-11.4366709801	4	5		0	-7.27555596					COc1ccc(cc1)C(\Cl)=C(/c2ccc(OC)cc2)c3ccc(OC)cc3	Prestwick	Prestw-757	0.49539676	-2.70629611	-3.3911368	-3.79929886	-7.27555596											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178874-03	DL-Carnitine HCl		Mitochondrial carnitine/acylcarnitine carrier protein Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	461-05-2				-16.7090813872	4	4		0	-6.75410693			788	SLC25A20	C[N+](C)(C)CC(O)CC(O)=O	Selleck	S2293	-2.02907329	-4.17222246	-5.09776228	-6.75410693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179493-03	Solanine alpha		Cholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	20562-02-1				-34.0532222141	4	4		0	-8.61039697					C[C@H]1CC[C@@H]2[C@@H](C)[C@H]3[C@H](C[C@H]4[C@@H]5C\C=C6\C[C@H](CC[C@]6(C)[C@H]5CC[C@]34C)O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O)N2C1	Prestwick	Prestw-NAT-0174	-9.1070347	-3.90554432	-2.33481926	-8.61039697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181745-03	Bimatoprost		prostaglandin	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	155206-00-1				-13.7819236762	4	4		0	-3.03281189				PTGER1	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC2=CC=CC=C2	Enzo	RA121	-3.67309855	-0.80863693	-2.24654632	-3.03281189												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242596-02	Pralatrexate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	146464-95-1		1.5848931925	-5.8	-394.0556396239	5	4		1.2907556601	-83.11473267	0.409879355	0.9130943508			NC1=NC(N)=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1	Selleck	S1497	-84.3514753	-84.27889372	-82.44251225	-83.11473267												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532505-01	N,N-DIMETHYLGLYCINE HYDROCHLORIDE		Glutamate [NMDA] receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-28.469290585	4	4		0	-5.95232908					CN(C)CC(O)=O	SIGMA	MFCD00012610	-6.90057974	-6.21101983	-2.94390255	-5.95232908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181783-03	Iguratimod		NF-kappaB (NFKB) Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	123663-49-0				-18.0379145722	4	4		0	-2.82365245			24835	NFKB1	C[S+]([O-])(=O)NC1=CC2=C(C=C1OC3=CC=CC=C3)C(=O)\C(=C/O2)NC=O	MedChem Express	HY-17009	-5.55940123	-0.66239408	-1.81400892	-2.82365245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164520-02	L-Threonine	170465476		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	72-19-5				-21.4132591941	4	5		0	-7.24152173					O=C(O)[C@@H](N)[C@@H](C)O	Labotest	LTBB004859	-5.03172365	-5.01744829	-3.04349646	-0.5281771	-7.24152173											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016032-11	alpha-Lipoic acid	170465713		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1077-28-7				-30.7890541392	4	5		0	-5.2315176					O=C(O)CCCCC1CCSS1	Vitas	STK801969	-8.56538597	-7.75810707	-8.92954327	0.95990447	-5.2315176											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00487176-01	EAA-090			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	144912-63-0				-16.3745191166	4	4		0	-4.48550005					O[P](O)(=O)CCN1CCCN/C2=C1/C(=O)C2=O	SIGMA	SML0206	-3.02084688	-7.00962696	-1.21504512	-4.48550005												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00181120-02	Acetophenazine Maleate		Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	5714-00-1				-28.1959868679	4	4		0	-6.14780016					[CH3][C](=[O])C1=CC=C2[S]C3=C(C=CC=C3)[N]([CH2][CH2][CH2][N]4[CH2][CH2][N]([CH2][CH2][OH])[CH2][CH2]4)C2=C1	USP	1007000	-6.86083301	-8.54822073	-0.15188064	-6.14780016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160529-06	Tizanidine hydrochloride	170465419	alpha2-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	51322-75-9	;Tizanidine hydrochloride; Tizanadine; ; Tizanidina; TIZANIDINE; Tizanidine;Tizanidine; Tizanidine Hcl; Zanaflex			-13.1277978467	4	4		0	-3.01291896			150	ADRA2A	Clc2ccc3nsnc3c2NC1=NCCN1	Vitas	STK711168	-3.66228926	-2.37665463	0.19655142	-3.01291896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00074022-02	Pyricarbate	144204540	Bradykinin B2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1882-26-4	Angioxine; Anginin; Movecil; Lisator; Sospitan; Duaxol; Prodectin; Pyricarbato; Duvaline; Gasparol; Parmidine; Colesterinex; 			-15.1542438236	4	4	CIPLUS_159179;Pyricarbate;Parmidine;Pyricarbato;Duaxol;2,6-Pyridinedimethanol, bis(methylcarbamate) (ester);Angioxine;Colesterinex;Gasparol;Movecil;Pyridinolcarbamate;Prodectin;LS-50369;Pyridinol carbamate;ravenil;Pyricarbatum;Duvaline;2,6-Pyridinedimethanol-bis-(N-methylcarbamate);Pyridinol Carbamate;PYRIDINOL CARBAMATE;pyricarbatum;Anginin;Sospitan;PYRICARBATE;Lisator;P-23;pyricarbate;PYRIDINOLCARBAMATE;	0	-0.73629054					CNC(=O)OCc1cccc(COC(=O)NC)n1	InterBioScreen	STOCK4S-68399	-3.8443202	-5.65153859	-1.19717681	-0.73629054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386200-02	Vildagliptin		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	274901-16-5				-13.1450768208	4	4		0	-2.2721113					OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N	Axon Medchem	1631	-4.19104581	-2.10159876	1.03636201	-2.2721113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015150-04	Betaine	174007375	Nitric Oxide (NO) Donors	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	590-46-5	Betaine-trimethyl-d9  hydrochloride; ;Betaine hydrochloride; Betaine hydrochloride;Betaine			-15.9202035214	4	4		0	-5.22630771					[Cl-].C[N+](C)(C)CC(=O)O	Selleck	S2580	-3.28955923	-6.08131339	0.91128384	-5.22630771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522534-01	Quinagolide (hydrochloride)			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	94424-50-7				-14.9302296764	4	4		0	-6.40075888					CCCN1C[C@H](C[C@@H]2CC3=C(O)C=CC=C3C[C@@H]12)N[S+]([O-])(=O)N(CC)CC	MedChem Express	HY-13736A	-2.54409916	-3.19322675	-2.02805325	-6.40075888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015219-07	Choline Chloride			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	67-48-1				6.2048469218	4	4		0	-0.49839801					C[N+](C)(C)CCO	Selleck	S4171	2.35584771	-1.01071182	0.58471933	-0.49839801												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00090548-04	Deferiprone		Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	30652-11-0		35.4813389234	-4.45	-32.6064655016	4	4		-12.8659050961	-13.37664649	0.5038478986	0.8044417395			CN/1\C=C/C(=O)/C(=C1C)O	Selleck	S4067	-7.09401332	-6.47892191	-2.65505891	-13.37664649												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00018248-26	MELOXICAM SODIUM			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	71125-38-7				-24.3616494208	4	4		0	-6.05745776					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	01504150	-5.52593941	-8.17001891	-0.01786831	-6.05745776												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165825-02	Milnacipran hydrochloride	225144261	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	101152-94-7				-5.4298670997	4	4		0	-2.19829121					CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	SIGMA	M1318	-0.97939736	-0.43192813	-1.40765766	-2.19829121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183277-01	Micronomicin sulfate	144206497		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	66803-19-8				-31.955146713	4	4	D-Streptamine, O-2-amino-6-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-;micronomicine;Santemycin;micronomicin;XK-62-2;KW-1062;Micronomicin Sulfate;gentamicin C2b;D-Streptamine, O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-D-erythro-hexopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy;LS-146966;CIPLUS_684924;Micronomicine;MICRONOMICIN;Micronomicina;MICRONOMICIN SULFATE;Micronomicin sulfate;6'-N-methylgentamicin C;Micronomicin;DE 020;Micronomicinum;sagamicin;DE-020;micronomicinum;KW 1062;CIPLUS_749329;Sagamicin;	0	-10.01245995					O=S(=O)(O)O.N[C@@H]3CC[C@@H](CNC)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N	ACC	Micronomycin sulfate	-6.85578153	-3.87871458	-6.08541234	-10.01245995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181012-01	Cefuzonam hydrochloride	144206215	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	NOCAS_46800	Cefuzonam; Cefozopran; 			-12.9246411714	4	4	LS-177675;Cefuzonam Sodium;Cefuzonam sodium;5-((7-((2-amino-4-(thiazoyl)-2-(methoxy-imino))acetyl)amino-4-carboxyceph-3-em-3-yl)methyl)-1,2,3-thiadiazole;CIPLUS_772243;CEFUZONAM;CIPLUS_735294;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-5-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(1,2,3-thiadiazol-5-ylmethyl)-, (6R-(6alpha,7beta(Z)))-;Cefozopran;CEFUZONAM SODIUM;cefuzonamum;CL-118523;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-((1,2,3-thiadiazol-5-ylthio)methyl)-, (6R-(6alpha,7beta(Z)))-;CL 118523;cefuzonam;Cefuzonam;CIPLUS_213477;cefuzoname;	0	-2.47086458					Cl.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(CS[C@@H]23)CSc4cnns4)C(=O)O	Bosche	C3450	-3.08152386	-6.94945848	2.35861699	-2.47086458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093358-08	Cefotaxime sodium salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	64485-93-4				-15.2235366743	4	4		0	-3.48269943					CO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)COC(C)=O)C3=CSC(=N3)N	SIGMA	C7039	-3.31556365	-4.83496648	-1.10783525	-3.48269943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165912-03	Tofisopam			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	22345-47-7				-18.4565485204	4	4		0	-11.68565326					CCC1\C(=N/N=C(C2=CC(=C(OC)C=C2)OC)\C3=C1C=C(OC)C(=C3)OC)C	SIGMA	T8200	-2.37349451	-2.46199032	-2.77633403	-11.68565326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390187-02	Delafloxacin (meglumine)		Staphylococcus Aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	352458-37-8				-18.7662123323	4	4		0	-7.36027056					NC1=C(F)C=C(F)C(=N1)N2\C=C(C(O)=O)/C(=O)C3=CC(=C(N4CC(O)C4)C(=C23)Cl)F	MedChem Express	HY-14814A	-3.37936207	-2.90255701	-3.72920998	-7.36027056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183015-01	Temoporfin	144206848	cell proliferation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	122341-38-2	Temoporfin; 	12.5892541179	-4.9	-92.6409086536	-3	5	M-THPC;CIPLUS_197002;5,10,15,20-TETRA(3-HYDROXYPHENYL)-CHLORIN;TEMOPORFIN;Temoporfin;LS-172529;temoporfinum;	-105.7910834781	-99.5365059	0.0399473368	0.9794100198			Oc1cccc(c1)c9c2CCc(n2)c(c3cccc(O)c3)c4ccc(n4)c(c5cccc(O)c5)c6C=Cc(n6)c(c7cccc(O)c7)c8ccc9n8	Pharmaron	PH-NIH-154455	-6.60909411	-7.67299345	-7.54803868	6.65503146	-99.5365059											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344521-01	1-(cis-3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride	225144377		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	51229-78-8				-22.2298359966	4	4		0	-6.35457458					Cl\C=C/C[N]12CN3CN(CN(C3)C1)C2	SIGMA	C3892	-5.41756739	-4.20697996	-1.00918226	-6.35457458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159411-02	Triethanolamine	144206717		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	102-71-6	trolamine salicylate; Tris(2-hydroxyethyl)amine; Solupront; Thiofaco T-35; Myoflex; texapon TH; 			-9.4936942416	4	4	CIPLUS_734310;CIPLUS_3747852;CIPLUS_740704;CIPLUS_752482;CIPLUS_750425;CIPLUS_737530;CIPLUS_737531;Triethanolamine aluminate barium salt;CIPLUS_749510;CIPLUS_686266;triethanolamine salicylate;TRIETHANOL AMMONIUM CHLORIDE;CIPLUS_740747;CIPLUS_3755473;CIPLUS_732537;CIPLUS_739845;CIPLUS_749773;CIPLUS_749544;CIPLUS_749685;CIPLUS_740695;CIPLUS_3889761;CIPLUS_745468;CIPLUS_691861;CIPLUS_753415;CIPLUS_740654;CIPLUS_3730238;CIPLUS_175532;CIPLUS_3749955;NCGC_FLUKA_90290;CIPLUS_739743;LS-173901;2,2',2''-Nitrilotriethanol hydrochloride;CIPLUS_749503;CIPLUS_738415;trolamine salicylate;CIPLUS_752427;CIPLUS_752428;CIPLUS_3756040;NCGC00159411-04;CIPLUS_666794;CIPLUS_3885762;Tris(2-hydroxyethyl)amine hydrochloride;CIPLUS_193084;CIPLUS_748749;CIPLUS_3755605;CIPLUS_3733577;CIPLUS_740728;Myoflex;CIPLUS_739153;CIPLUS_3745711;CIPLUS_3755043;Trolamine (Triethanolamine hydrochloride);CIPLUS_736952;CIPLUS_687637;Triethanolamine;CIPLUS_732449;CIPLUS_3749677;CIPLUS_746627;CIPLUS_3753376;CIPLUS_668732;CIPLUS_193079;CIPLUS_667351;Triethanolamine Hydrochloride;CIPLUS_193078;Tris(2-hydroxyethyl)amine;CIPLUS_3887736;CIPLUS_749757;CIPLUS_737348;CIPLUS_738912;CIPLUS_767549;Trolamine salicylate;2,2',2''-Nitrilotriethanol;CIPLUS_753583;Triethanolamine hydrochloride;CIPLUS_750558;CIPLUS_3752239;CIPLUS_3745729;	0	-4.15628337					OCCN(CCO)CCO	Labotest	LT03329084	-0.63528478	-1.6845197	-5.13253638	-4.15628337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095166-04	Clopidol	170465668		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2971-90-6		1.4125375446	-5.85	-5.6159743149	4	5		12.1049876599	-2.45055298	0.4190884614	0.8744709098			Oc1c(Cl)c(C)nc(C)c1Cl	Vitas	STK802181	-2.78463165	-7.17082305	-6.71913593	4.81789372	-2.45055298											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00024499-06	D-Aspartic acid	225144192	Isoaspartyl peptidase/L-asparaginase Interacts	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	56-84-8				-23.4682572948	4	5		0	-5.2406957			80150	ASRGL1	N[C@@H](CC(O)=O)C(O)=O	Enzo	AC367	-6.52978498	-4.83019831	-5.02783941	-2.63169981	-5.2406957											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00187912-17	Ibrutinib (PCI-32765)		BTK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	936563-96-1		10	-5	-110.106437882	-2.1	4		-97.2564291762	-86.99715201	0.0264994477	0.99956669	695	BTK	NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H]5CCCN(C5)C(=O)C=C	APExBIO	A3001	-8.52340407	-10.92778162	-22.43156618	-86.99715201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166213-02	2-Octyl-1-dodecanol	170465533		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	5333-42-6				-32.299651622	4	4		0	-7.41367035					CCCCCCCCC(CCCCCCCCCC)CO	SIGMA	464481	-8.37340627	-4.98445059	-2.70703396	-7.41367035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179526-05	Demecarium bromide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	56-94-0				-32.4867103461	4	4		0	-10.44855821					CN(CCCCCCCCCCN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C)C(=O)OC2=CC(=CC=C2)[N+](C)(C)C	Prestwick	Prestw-616	-6.37931795	-7.29958535	-4.69941095	-10.44855821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181323-02	Squalene	225144321	Steroid biosynthesis Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	111-02-4				-22.0901999905	4	4		0	-6.36347455					CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C	SIGMA	85634	-4.99404421	-2.77297858	-3.78118503	-6.36347455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181088-01	Melitracen hydrochloride	144206258		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	10563-70-9	Melitracen hydrochloride; Melitraceno; Trausabun; Deanxit; Metrisil; 			1.2198322177	4	4	Melitracen Hydrochloride;LS-20367;n,n,10,10-tetramethyl-delta(sup 9(10h)),gamma-anthracenepropylamine hydrochloride;melitracenum;Melitracene;Melitracen hydrochloride;Metrisil;Trausabun;9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene (Italian);melitracene hydrochloride;N,N-dimethyl-3-(9,10-dihydro-10,10-dimethylanthracen-9-yliden)propylamine;CIPLUS_670601;melitracene;CIPLUS_168125;Melitracen;LS-20365;Melitracenum;MELITRACEN;MELITRACEN HYDROCHLORIDE;Melitraceno;	0	2.38519046					Cl.CN(C)CC\C=C2/c1ccccc1C(C)(C)c3ccccc23	NCI	NSC-78229	-0.59116778	3.58500346	-2.23059598	2.38519046												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015256-12	Chloroquine	170464753	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50-63-5	 ;Chloroquine (CQ); Chloroquine (CQ); Aralen hydrochloride;Chloroquine Diphosphate; Aralen; Chloroquine Sulphate; Cloquiante; Contramibial;Arequin; Cloroquina; Khingamin; Chlorochin; Arechine; Aralen phosphate; Cloquinato; Chingamin;Chloroquine diphosphate; ChloroquineSulphate; Sulfate, Chloroquin; Sulphate, Chloroquin	0.5623413252	-6.25	-7.7766249312	4	5		11.3598604079	-5.49768253	0.1136887943	0.9920326859			O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Specs	AN-153/J116554	-5.81600282	-6.96655034	-3.62121656	4.95567905	-5.49768253											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00091544-18	Estradiol		Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50-28-2		1	-6	-13.624333933	4	5		9.7164013999	0.80767289	0.2039825882	0.8802677729	2099	ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-441	-5.89531195	-6.4303345	-4.15707288	5.87424792	0.80767289											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263559-01	Carbocysteine	170465800	regulation of mucus secretion Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2387-59-9		0.316227766	-6.5	-6.3753492587	4	5		5.571069884	-2.16603185	0.6740063111	0.5500656985			OC(=O)C(N)CSCC(O)=O	Bosche	S0868	-2.93443779	-4.22589157	5.78976012	-1.40081753	-2.16603185											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00390241-07	LX1606 (Hippurate)		5-HT Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1137608-69-5				-10.7492333391	4	4		0	-0.16909932				TPH1	CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(Cl)C=C3)[N]4C=CC(=N4)C)C(F)(F)F	MedChem Express	HY-13055	-3.26465787	-2.86800276	-0.40280665	-0.16909932												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094908-06	Mephenesin	170466586	Glutamate NMDA receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	59-47-2				-21.271429279	4	5		0	-4.20357028					OCC(O)COc1ccccc1C	Microsource	01501140	-3.92139584	-6.08136863	-7.10428266	-2.34694346	-4.20357028											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00351599-02	Abemaciclib		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1231930-82-7		11.220184543	-4.95	-96.5722185721	-2.4	4		-72.194847848	-62.8248487	0.0748846097	0.9965267971		CDK4	CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2	Selleck	S7158	-9.36162703	-13.73531444	-23.0466043	-62.8248487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182046-04	Efonidipine hydrochloride monoethanolate			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	[111011-76-8]				-12.0546096349	4	4		0	-10.56425774					CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P3(=O)OCC(C)(C)CO3)C(=O)OCCN(Cc4ccccc4)c5ccccc5	Tocris	3733	-1.12057176	-0.84657913	-1.00918226	-10.56425774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095255-08	dl-alpha-Tocopheryl acetate	170465444		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	52225-20-4				-0.7806405797	4	5		0	1.49603047					CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	Microsource	00310040	0.40535777	-3.40880075	-1.44430025	1.06094704	1.49603047											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022408-04	Flumethasone pivalate			DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2002-29-1				-22.1284212704	4	5		0	-1.61534578					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	SIGMA	F0891	-5.47232993	-8.17516384	-5.89023318	-1.34570339	-1.61534578											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00538143-01	NCGC00538143-01		surfactant homeostasis Activator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			14.1253754462	-4.85	-45.6811996315	4	4		-28.309436776	-28.75578498	0.2245622784	0.9676161599			O[C@H]1CC[C@@H](CC1)NCC2=CC(=CC(=C2O)Br)Br	Pharmaron	PH-NIH-2017-009-L1-3-0	-7.53518331	-4.82895646	-2.247921	-28.75578498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091687-01	Benzene sulfonic acid	17389167		DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-13.7220743494	4	4	CIPLUS_668287;CIPLUS_746452;CIPLUS_158198;Benzene sulfonic acid;Sodium benzenesulfonate;SODIUM BENZENESULFONATE;CIPLUS_188702;AB08082695-01;CIPLUS_750422;Benzenesulfonic acid monohydrate;CIPLUS_3730420;Benzenesulfonic Acid Sodium Salt;CIPLUS_750425;CIPLUS_740728;CIPLUS_153872;CIPLUS_213852;4-Formyl-1-methylpyridinium benzenesulfonate;CIPLUS_213853;CIPLUS_750569;Benzenesulfonic acid;Benzene Sulfonic Acid;p-Toluenesulfonic acid, polymer-bound;benzenesulfonic acid;CIPLUS_664858;ALUMINUM PHENOLSULFONATE;SODIUM DECYLBENZENESULFONATE;CIPLUS_198271;CIPLUS_3741824;CIPLUS_753058;CIPLUS_203733;CIPLUS_752981;CIPLUS_198836;CIPLUS_763507;CIPLUS_210324;CIPLUS_750514;CIPLUS_750536;CIPLUS_198267;CIPLUS_198368;Benzenesulfonic acid sodium salt;CIPLUS_3729342;CIPLUS_198511;CIPLUS_150435;CIPLUS_204905;CIPLUS_198364;CIPLUS_670392;CIPLUS_3825062;CIPLUS_3745729;	0	-6.22997508					O[S+]([O-])(=O)C1=CC=CC=C1	NIEHS	AB08082695	-1.49115454	-3.54181064	-3.98042273	-6.22997508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181132-01	Halofuginone hydrochloride	144206292		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1217623-74-9	halofuginone; Halofuginona; Stenorol; 	10	-5	-44.996082456	4	4	halofunginone;LS-176413;Halofuginone hydrobromide;halofuginone;LS-140372;HALOFUGINONE;RU-19110;Halofuginonum;4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans-;7-bromo-6-chlorofebrifugine;Halofuginone Hydrobromide;HALOFUGINONE HYDROBROMIDE;CIPLUS_205078;7-bromo-6-chloro- 3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)- quinazolinone;CIPLUS_205079;Halofuginona;halofuginone lactate;LS-173665;Stenorol;halofuginonum;7-bromo-6-chloro-3,3-(3-hydroxy-2-piperidyl)acetonyl-4(3H)-quinazolinone-hydrolactate;Halofuginone;CIPLUS_205081;CIPLUS_205080;	-26.591087532	-29.5745817	0.0408940408	0.9989694215			Cl.O[C@@H]3CCCN[C@H]3CC(=O)CN2C=Nc1cc(Br)c(Cl)cc1C2=O	Toronto Research	H102500	-5.83226717	-4.91534209	-6.52720028	-29.5745817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017013-05	Thiamine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	67-03-8				-25.3763468666	4	4		0	-7.83196867					CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N	Prestwick	Prestw-631	-6.52049235	-3.76641327	-0.34216909	-7.83196867												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167356-07	Raltegravir			DPI_SARS-CoV-2_General	2019_NPC-2_Tox	871038-72-1				-27.1648806618	4	5		0	-5.28658621					CN1C(=O)C([O-])=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3	Selleck	S2005	-7.53436729	-6.59205039	-7.89969439	1.27221788	-5.28658621											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090782-06	Nelfinavir mesylate	170465351	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	159989-65-8	 Mesylate, Nelfinavi;; ; Viracept; Nelfinavir mesylate;Nelfinavir mesylate;Nelfinavir; Viracept 250mg; Nelfinavir mesilate; Nelfinavir Mesilate	12.5892541179	-4.9	-95.520572479	-3	5		-104.2323281812	-99.39883438	0.0025132368	0.9987411848			CS(=O)(=O)O.Oc1cccc(c1C)C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C	Tocris	3766	-5.93056045	-4.54081198	-6.8363545	-3.25632664	-99.39883438											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262957-01	Tobicillin	170466044		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	151287-22-8	Tobicillinum;Tobicilline;Tobicillin			0.888633353	4	4		0	1.18369527					CC(C)C(=O)OCc4cc(OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SC2(C)C)ccc4	GVK	FFS-11-286-NCI-195	-0.30881899	1.90912232	-0.77529453	1.18369527												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182708-01	Pipecuronium bromide	144206565	Muscle-type nicotinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	52212-02-9	Pipecuronium bromide; Arduan; Pipecuronium; Bromuro de pipecuronio; 			-15.1570215806	4	4	CIPLUS_188694;Arduan;LS-113699;Bromuro de pipecuronio;pipecuronii bromidum;4,4'-(3A,17B-DIHYDROXY-5A-ANDROSTAN-2B,16B-YLENE)BIS-(1,1-DIMETHYLPIPERAZINIUM)DIBROMIDE,DIACETATE;bromure de pipecuronium;Pipecuronium Dibromide, (3 beta)-Isomer;pipecuronio bromuro (spanish);CIPLUS_207311;4,4'-(3.ALPHA.,17.BETA.-DIHYDROXY-5.ALPHA.-ANDROSTAN-2.BETA.,16.BETA.-YLENE)BIS(1,1-DIMETHYLPIPERAZINIUM)DIBROMIDE, DIACETATE (ESTER);Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl);LS-177113;Pipecuronium;PIPECURONIUM BROMIDE;LS-172842;Pipecuronium Dibromide, (16 alpha)-Isomer;Bromure de pipecuronium;Pipecuronium Dibromide, (17 alpha)-Isomer;Pipecuronii bromidum;Pipecuronium bromide;LS-176664;LS-172841;CIPLUS_188695;PIPERAZINIUM, 4,4'-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)ANDROSTANE-2,16-DIYL)BIS(1,1-DIMETHYL-, DIBROMIDE;	0	-2.78568886					[Br-].[Br-].C[N+]1(C)CCN(CC1)[C@H]6C[C@@]5(C)[C@@H](CC[C@@H]3[C@@H]5CC[C@]2(C)[C@@H](OC(C)=O)[C@H](C[C@H]23)N4CC[N+](C)(C)CC4)C[C@@H]6OC(C)=O	APAC	872548	-4.49993382	0.276434	-2.54244629	-2.78568886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016418-15	Methoxsalen	170465041	Cytochrome P450 CYP1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	298-81-7	 ;METHOXSALEN; Methoxsalen, 8-;Methoxy-8-psoralen; Ammoidin;Methoxsalen;8-Methoxypsoralen; Methoxy-8-psoralen			-5.8260838511	4	5		0	-2.01918223			1544	CYP1A2	COc1c3occc3cc2C=CC(=O)Oc12	Microsource	01500400	-2.83750441	-1.45118733	-3.33654289	6.14063289	-2.01918223											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021152-06	Hydroxyzine	170464958	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	68-88-2				-19.101006467	4	4		0	-6.56337519					Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCCO	Microsource	01500345	-3.1335327	-3.33075468	-5.53024212	-6.56337519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164549-02	Dofetilide	170465418	K(V)11.1 (erg1) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	115256-11-6	; 2   Dofetilide; Tikosyn; Dofetilide;Dofetilide; Dofetilida			-5.9701484249	4	4		0	-1.93784443				KCNH2	CS(=O)(=O)Nc1ccc(cc1)CCN(C)CCOc2ccc(cc2)NS(C)(=O)=O	Sequoia	SRP045723d	-1.0878516	-2.32508166	-0.16974895	-1.93784443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091010-03	Domiphen bromide	170465494	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	538-71-6		12.5892541179	-4.9	-86.8266342671	-3	4		-106.4148739164	-99.63411329	0.0280710633	0.9995136854			[Br-].CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1	Labotest	LT00847867	-3.40224505	-3.59721506	-1.65281873	-99.63411329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345792-04	AN-2728		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	906673-24-3		14.1253754462	-4.85	-39.7495836774	4	4		-11.393634108	-16.98888789	0.5345119776	0.7707307103		PDE4A	OB1OCC2=CC(=CC=C12)OC3=CC=C(C=C3)C#N	MedChem Express	HY-10978	-6.20205435	-11.04951006	-4.9941928	-16.98888789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179652-04	Nalbuphine hydrochloride		Kappa opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	23277-43-2				-23.5266946802	4	4		0	-4.81073268					O[C@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC6CCC6	Axon Medchem	1577	-4.25172279	-9.85473612	-3.12695435	-4.81073268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178830-05	Isosorbide dinitrate	170464980		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	87-33-2				-25.4844731882	4	4		0	-3.97054838					[O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+]([O-])=O)CO[C@H]12	Microsource	01500358	-6.27139947	-8.45367028	-0.84874475	-3.97054838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095054-05	Resorcinol monoacetate	170465513		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	102-29-4				-4.9953831089	4	4		0	-0.03161984					O=C(C)Oc1cccc(O)c1	Microsource	01503500	-0.68911715	-5.24755028	0.65219334	-0.03161984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164128-02	Hexadecanoic acid, 1-methylethyl ester	170465544	N-acylsphingosine-amidohydrolase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	142-91-6				-13.387978283	4	4		0	-3.22070648					CC(C)OC(=O)CCCCCCCCCCCCCCC	SIGMA	291781	-3.39357691	-6.30479629	2.99294202	-3.22070648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091195-08	Hexachlorophene	170464690	Glucose-6-phosphate dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	70-30-4		4.4668359215	-5.35	-108.9239278673	-2.2	5		-75.4776145103	-76.70139048	0.0004732674	0.9997633456			Clc2c(Cc1c(O)c(Cl)cc(Cl)c1Cl)c(O)c(Cl)cc2Cl	Vitas	STK377478	-6.13323934	-7.08570942	-10.50362122	-39.95315299	-76.70139048											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016229-14	Propylthiouracil	170464965	Antithyroid Drugs	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	51-52-5	; ; 6 Propyl 2 Thiouraci;Propylthiouracil;6-Propyl-2-thiouracil; Propiltiouracilo;PROPYLTHIOURACIL; Propylthiouracil			-14.5349322199	4	5		0	-1.41342756			7173	TPO	S=C1NC(CCC)=CC(=O)N1	Microsource	01500515	-3.53366232	-4.43867563	-6.68564491	1.21710375	-1.41342756											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016692-05	Bromperidol	170465873	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	10457-90-6				-20.5722078295	4	5		0	-7.10385021					Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Br)cc3	Microsource	01505972	-3.48078957	-7.69852753	-6.66052665	1.75905939	-7.10385021											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183103-01	Tocophersolan	144206517		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	9002-96-4	TOCOFERSOLAN; Tocofersolano; vitamin E-TPGS; 			-28.732347914	4	4	Tocofersolanum;tocofersolanum;dl-a-Tocopherol Polyethylene Glycol  Succinate;Tocophersolan;tocofersolan;tocopheryl poly(ethylene glycol) 1000 succinate;Tocofersolano;VITAMIN E POLYETHYLENE GLYCOL 1000 SUCCINATE;VITAMIN E POLYETHYLENE GLYCOL SUCCINATE;TOCOFERSOLAN;vitamine E PEG-1000-succinate;CIPLUS_698430;TPGS;CIPLUS_213643;ALPHA-TOCOPHERYL PEG-20 SUCCINATE, D-;A-TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE;VITAMIN E TPGS;vitamin E-TPGS;.ALPHA.-(4-(((2R)-3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-YL)OXY)-1,4-DIOXOBUTYL)-.OMEGA.-HYDROXY-POLY(OXY-1,2-ETHANEDIYL);alpha-tocopheryl polyethylene glycol succinate;TOCOPHERSOLAN;tocophersolan, (2R-(2R*(4R*,8R*)))-isomer;tocophersolan;	0	-6.03035505					O=C(OCCO)CCC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	ACC	V-00037	-7.10354094	-5.66872959	-3.03761279	-6.03035505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182047-03	Fludarabine phosphate	170464764	Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	21679-14-1	 ; Fludarabine phosphate; F-ara-AMP;Fludarabine phosphate; Fludara;FLUDARABINE PHOSPHATE			-8.6275144063	4	5		0	-6.20439631				HPRT1	Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	Microsource	01505705	-0.4494184	-1.74057367	0.2051325	-2.98075598	-6.20439631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159406-12	Noradrenaline bitartrate monohydrate	170465227	alpha/beta-adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	69815-49-2	; Norepinephrine bitartrate; Noreinefrina; L-(-)-NOREPINEPHRINE; L-Arterenol; NET protein, human; SLC6A2 protein, human; ;Norepinephrine bitartrate;L(-)-Norepinephrine bitartrate; Arterenol hydrochloride; Slc6a2 protein, mouse; (-)-Norepinephrine; Receptors, Adrenergic; (-)Arterenol; (-)-Arterenol bitartrate; Receptor, Adrenergi; Arterenol; Epinephrine Receptors; L(-)-Norepinephrine bitartrate; Norepinephrine Receptors;NOREPINEPHRINE; Noradrenaline bitartrate; Slc6a2 protein, rat; D-Norepinephrine Tartrate;(+/-)-NOREPINEPHRINE; Net protein, rat; Adrenergic Receptor; Norepinephrine; L-Arterenol hydrochloride; Noradrenaline Bitartrate			-22.1903793877	4	4		0	-3.63628151			148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CN.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O	Microsource	01500436	-5.7166385	-4.51693313	-2.4568927	-3.63628151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00070736-03	Imiquimod	170464691	TLR 7 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	99011-02-6	; ; 3M Brand of Imiquimod; Aldara; Imiquimod;Imiquimod			-20.0248778755	4	5		0	-6.30785208			51284	TLR7	CC(C)Cn3cnc2c(N)nc1ccccc1c23	Vitas	STK583860	-4.52366687	-2.8890037	-4.9045367	-1.33902229	-6.30785208											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00182546-02	Gefarnate	170465908	positive regulation of mucus secretion Interacts	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	51-77-4				-29.8011422694	4	4		0	-6.3375192					C\C(C)=C\CCC(\C)=C\COC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C	Sequoia	51-77-4	-7.46760283	-8.27316486	-0.30376128	-6.3375192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015755-10	Nimustine	170466029	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	42471-28-3				-21.0415265416	4	5		0	-3.21939766					Nc1nc(C)ncc1CNC(=O)N(CCCl)N=O	Microsource	01504151	-7.33972439	-5.11065186	-1.96181468	-0.11347646	-3.21939766											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159331-07	CHOLECALCIFEROL		Vitamin D receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	67-97-0		0.3548133892	-6.45	-12.2813689093	4	5		9.201660532	1.25073373	0.0669221912	0.9652065431			CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	C9756	-6.83471711	-5.00731938	0.76195481	3.47237983	1.25073373											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178069-05	Cloperastine hydrochloride	170465832		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	14984-68-0				-12.9244812102	4	5		0	-3.82011389					Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-793	-4.5701204	-1.87526882	-2.11255182	1.7082845	-3.82011389											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164582-02	Feprazone	170465969		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	30748-29-9		1.1220184543	-5.95	-10.3294193342	4	5		17.603442432	-2.49293817	0.0490146705	0.9985221264			C/C(C)=C\CC2C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Sequoia	SRP00472f	-8.41953536	-7.9311828	-4.15894858	9.49698008	-2.49293817											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094721-07	Methimazole	170464856	Thyroid peroxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	60-56-0				-11.7453425256	4	5		0	-3.5959288					S=C1NC=CN1C	Vitas	STK802184	-2.08580634	-3.62150538	-1.30104966	-2.50157757	-3.5959288											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00264001-02	CALCIUM GLUCEPTATE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	299-28-5				-24.7072732022	4	4		0	-7.64303455					OC[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C(O)C([O-])=O	Microsource	01300012	-4.7373886	-6.63254334	-3.23520325	-7.64303455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182065-02	Dimemorfan phosphate	144206689		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	36304-84-4	dimemorfan; Astomin; Dimemorfano; Dimemorfane; Dastosin; 			-17.385689202	4	4	LS-174594;Dimemorfano;DIMEMORFAN;CIPLUS_789081;Dimemorfane;3,17-dimethylmorphinan;Astomin;CIPLUS_775315;Dastosin;LS-174593;dimemorfanum;CIPLUS_739426;CIPLUS_207834;dimemorfan, (9alpha,13alpha,14alpha)-isomer;Yamanouchi brand of dimemorfan phosphate;Dimemorfan Phosphate;at-17;dinemorphan;Dimemorfan;(+)-3,17-DIMETHYLMORPHINAN;dimemorfan phosphate;dimemorfan phosphate (1:1) salt;dimemorfan;d-3-methyl-N-methylmorphinan;LS-174853;DIMEMORFAN PHOSPHATE;Dimemorfan phosphate;AT 17;LS-91711;Dimemorfanum;	0	-1.48154604					O=P(O)(O)O.Cc3ccc4C[C@@H]1N(C)CC[C@]2(CCCC[C@H]12)c4c3	Kemprotec	36304-84-4	-5.19598512	-4.28405523	-0.02206823	-1.48154604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522039-01	Pyrethrin 1		Trypanosoma brucei rhodesiense Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	121-21-1				-34.1659493737	4	4		0	-5.2725609					CC(C)=C[C@H]1[C@H](C(=O)O[C@H]\2CC(=O)\C(=C2C)C\C=C/C=C)C1(C)C	Toronto Research	P991245	-8.89071558	-6.89922147	-3.86194112	-5.2725609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178896-05	Mepenzolate bromide	170465214	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	76-90-4				1.9414990282	4	4		0	2.34750055					[Br-].O=C(OC1CCC[N+](C)(C)C1)C(O)(c2ccccc2)c3ccccc3	Microsource	01500383	-0.17426157	0.17664872	0.72741528	2.34750055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016961-06	Atovaquone	170464681	Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	95233-18-4	 ; Atovaquone;Atovaquone; Mepron	2.8183829313	-5.55	-103.9553086326	-2.2	5		-87.4641260716	-72.32130763	0.0156580472	0.9920798756		PFF0160c	Clc1ccc(cc1)[C@H]2CC[C@@H](CC2)C=4C(=O)c3ccccc3C(=O)C=4O	Bosche	A2953	-1.18548318	0.09902695	-21.8514626	-46.49357723	-72.32130763											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182082-03	Tesaglitazar	170466025		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	251565-85-2		0.0891250938	-7.05	-4.2033654497	4	5		11.845844384	0.97078611	0.3347482404	0.7768076169			O=S(C)(=O)Oc1ccc(cc1)CCOc2ccc(C[C@@H](OCC)C(=O)O)cc2	Tocris	3965	-5.70487032	-0.29708086	1.76913645	6.61340838	0.97078611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262543-01	Midecamycin		Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	35457-80-8				-14.3853867705	4	4		0	-2.92821975					CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](OC2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC	Prestwick Chemical, Inc.	Prestw-153	-2.16924591	-7.19540036	-0.64358231	-2.92821975												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183868-02	Fentiazac	170466003		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	18046-21-4				-1.325108183	4	4		0	-1.23520774					O=C(O)Cc1sc(nc1c2ccc(Cl)cc2)c3ccccc3	Prestwick	Prestw-1254	-1.16736739	-2.24909106	4.59572154	-1.23520774												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00185743-02	Cloflucarban	170465550		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	369-77-7		1.5848931925	-5.8	-107.6453904623	-1.3	4		-89.9789702693	-76.53105295	0.2217600995	0.9683859247			FC(F)(F)c1cc(ccc1Cl)NC(=O)Nc2ccc(Cl)cc2	Enamine	Z124030490	1.73092405	-0.87934387	-99.07541697	-76.53105295												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181085-01	Miripirium chloride	144206257		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	2748-88-1	CIPLUS_160809; Cloruro de miripirio; 	2.8183829313	-5.55	-87.4644595414	-3	4	Miripirii chloridum;Miripirium chloride;1-TETRADECYL-4-PICOLINIUM CHLORIDE;MIRIPIRIUM CHLORIDE;Cloruro de miripirio;Chlorure de miripirium;CIPLUS_160809;MYRISTYL-GAMMA-PICOLINIUM CHLORIDE;miripirii chloridum;chlorure de miripirium;myristyl-gamma-picolinium chloride;1-myristylpicolinium;	-87.3912290028	-4.87172843	1	0.9999947087			[Cl-].Cc1cc[n+](CCCCCCCCCCCCCC)cc1	NCI	NSC-36338	-5.74738349	-7.35604972	-93.10188542	-4.87172843												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181104-04	Dithiazanine chloride	124893646		DPI_SARS-CoV-2_General	2019_NPC-6_Tox			3.5481338923	-5.45	-67.0755935965	-3	4		-69.6553951559	-4.5953183	1	0.9999912013			CCN1C(/SC2=C1C=CC=C2)=C/C=C/C=C/C3=[N+](CC)C4=C(S3)C=CC=C4	NCI	NSC-221154	-4.25351105	-4.58273442	-73.54967368	-4.5953183												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179305-04	Lymecycline			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	992-21-2				-18.6739493292	4	4		0	-4.76807463					CN(C)[C@H]\1[C@@H]2C[C@H]3\C(=C(\O)[C@]2(O)C(=O)\C(=C1O)C(=O)NCNC(CCCCN)C(O)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Prestwick	Prestw-1000	-3.60944628	-3.5173755	-4.94017404	-4.76807463												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00022678-23	Rifampicin			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	[13292-46-1]				-32.6680589884	4	4		0	-3.47240218					CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(\C=N\N5CCN(C)CC5)=C(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C	Tocris	4121	-6.77609804	-6.36678786	-8.38469906	-3.47240218												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160478-02	Menadione sodium bisulfite	225144239	NQO1 protein Substrate	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	130-37-0				-18.7025252555	4	4		0	-3.68834759					CC1(CC(=O)C2=CC=CC=C2C1=O)[S]([O-])(=O)=O	SIGMA	M5750	-2.68807586	-4.4051746	-6.76214648	-3.68834759												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00022787-04	Oxacillin sodium		beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1173-88-2				-26.4483919248	4	4		0	-6.30560594					CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C(=NO1)C4=CC=CC=C4	Prestwick	Prestw-1475	-6.7671527	-5.8341084	-1.64974619	-6.30560594												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522030-01	Budralazine		adrenergic receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	36798-79-5				-20.0159466899	4	4		0	-5.32953269					CC(C)=C\C(C)=N/NC1=NN=CC2=C1C=CC=C2	Toronto Research	B689515	-2.70596654	-2.85786759	-9.4271211	-5.32953269												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179276-04	Etilefrine hydrochloride	225144301		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	534-87-2				-22.9759969501	4	4		0	-4.6989721					CCNCC(O)C1=CC(=CC=C1)O	Prestwick	Prestw-1017	-4.84390375	-6.50207153	-2.84626541	-4.6989721												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00344520-01	L-Valine	225144376	tryptophan transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	72-18-4				-15.206116875	4	4		0	-6.51291354					CC(C)[C@H](N)C(O)=O	SIGMA	94620	-1.79354146	-4.61655534	-4.51414068	-6.51291354												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182965-05	Biperiden	170465324	Anticholinergic	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1235-82-1	 ; Biperideno;BIPERIDEN;Biperiden hydrochloride; Akineton lactate; Akineton hydrochloride; Hydrochloride, Biperide;Biperiden; Biperidine; Biperiden hydrochloride; Tasmolin; 2   Biperiden Hcl; Beperiden; Akineton			-17.9889536815	4	4		0	-1.13155394				CHRNA2	Cl.OC(CCN1CCCCC1)(c2ccccc2)C4CC3C=CC4C3	Microsource	01505514	-3.64522766	-6.01166822	-2.2480058	-1.13155394												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182026-02	Tiludronate disodium salt hydrate	225144329	Osteoclasts Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	89987-06-4				-14.9706432684	4	4		0	-1.64982292					O[P]([O-])(=O)C(SC1=CC=C(Cl)C=C1)[P](O)([O-])=O	SIGMA	T4580	-4.51292602	-6.15540712	-2.61965192	-1.64982292												1.6E-9	8E-9	2E-7	6E-7											
NCGC00159502-03	N-Cyclohexyl-2-benzothiazolesulfenamide	29215472	Aryl hydrocarbon receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox		N-cyclohexyl-2-benzothiazylsulfenamide; 			1.9596391304	4	4	N-Cyclohexyl-2-benzothiazolesulfenamide;N-CYCLOHEXYLBENZOTHIAZYLSULFENAMIDE;N-cyclohexyl-2-benzothiazylsulfenamide;CIPLUS_150281;N-cyclohexyl-2-benzothiazyl sulfenamide;N-cyclohexyl-2-benzothiazolesulfenamide;thiohexam;	0	-3.81791483					C1CCC(CC1)NSC2=NC3=CC=CC=C3S2	SigmaAldrich	S365971	2.78647464	-2.98469603	-2.08484409	-3.81791483												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00532503-01	BUNITROLOL		Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-31.4302962827	4	4		0	-2.91094411			154	ADRB2	CC(C)(C)NCC(O)COC1=CC=CC=C1C#N	UkrOrg	BBV-45651151	-7.43805349	-7.77881119	-3.82523568	-2.91094411												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00261967-01	Prednisolone farnesylate	170466045	Glucocorticoid and meneralocorticoid receptor agonists/antagonists Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	118244-44-3	No2-cbl;Nitritocobalamin;Nitrocobalamin			-33.1175578757	4	4		0	-2.22855662					C/C(C)=C\CCC(\C)=C\CCC(/C)=C/C(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-185	-8.10895429	-7.40678109	-4.38723713	-2.22855662												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181008-02	Olsalazine sodium	225144315	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	6054-98-4				-28.1606447567	4	4		0	-4.66442083					OC1=CC=C(C=C1C([O-])=O)/N=N/C2=CC=C(O)C(=C2)C([O-])=O	Bosche	O2307	-7.31281868	-6.34142217	-1.84010152	-4.66442083												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00379065-05	Riociguat		Soluble Guanylate Cyclase (sGC) Activator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	625115-55-1				-28.2545297604	4	4		0	-4.18070312				GUCY1A2	COC(=O)N(C)C1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24	MedChem Express	HY-14779	-7.66168709	-7.08548237	-0.28100073	-4.18070312												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00159339-10	Streptomycin sulfate		30s Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	3810-74-0				-32.587018331	4	4		0	-5.40727304					CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)C=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	Prestwick	Prestw-321	-8.02844619	-9.07246132	-3.77991298	-5.40727304												3.2E-8	1.6E-7	0.000004	0.000012											
NCGC00262578-03	Flucloxacillin sodium		Penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1847-24-1				-8.8936901639	4	4		0	-4.43119979					CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@H](N3C2=O)C([O-])=O)C(=NO1)C4=C(Cl)C=CC=C4F	Prestwick	Prestw-1011	0.51435728	-4.44745075	-4.78607687	-4.43119979												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179566-03	Ritodrine hydrochloride	225144308	beta2-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	23239-51-2				-21.7141946662	4	4		0	-4.60294516				ADRB2	C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2	Prestwick	Prestw-349	-4.13903697	-7.65428915	-3.36817654	-4.60294516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015678-10	Moxisylyte hydrochloride	170465759	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	964-52-3				-20.9094691482	4	4		0	-5.15403379					Cl.CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C	Prestwick Chemical, Inc.	Prestw-42	-4.76314307	-4.71462953	-2.28714375	-5.15403379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016957-05	Aceclofenac	170465979	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	89796-99-6				-0.3988068843	4	4		0	3.1122956					Clc2cccc(Cl)c2Nc1ccccc1CC(=O)OCC(=O)O	Vitas	STK594349	-1.26988255	0.13323019	0.60752256	3.1122956												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181167-01	Isoniazid sodium methanesulfonate	144206321		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	3804-89-5	Methaniazide; Neoiscotin; Metaniazida; 			-7.9611014284	4	4	CIPLUS_739573;Isoniazid Sodium Methanesulfonate Anhydride;Methaniazide;CIPLUS_207620;Isoniazid sodium methanesulfonate;Neoiscotin;Methaniazidum;LS-172896;METHANIAZIDE;methaniazide, sodium salt;isoniazid methanesulfonate;Isoniazid Sodium Methanesulfonate;Metaniazida;ISONICOTINIC ACID 2-(SULFOMETHYL)HYDRAZINE;CIPLUS_162545;methaniazidum;isoetam;methaniazide;ISONIAZID SODIUM METHANESULFONATE;	0	-6.28331376					[Na+].O=C(NNCS([O-])(=O)=O)c1ccncc1	NCI	NSC-81103	-0.88848438	-2.49699158	1.07209863	-6.28331376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179499-05	Dipivefrin hydrochloride		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	64019-93-8				-19.4754203626	4	4		0	-5.30437878					CNCC(O)C1=CC(=C(OC(=O)C(C)(C)C)C=C1)OC(=O)C(C)(C)C	Prestwick	Prestw-632	-4.12052764	-1.86592951	-5.27113652	-5.30437878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159390-14	PERMETHRIN		Voltage-sensitive sodium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	52341-33-0, 52645-53-1				-5.5503911386	4	4		0	-7.21787113					CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC2=CC=CC(=C2)OC3=CC=CC=C3	Microsource	01504932	0.97939736	0.78610919	-4.58679834	-7.21787113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024196-05	Megestrol acetate	170465406	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	595-33-5	; Novacyclin 22; Serial C; Megeron; Megace;Megestrol acetate; Megestrol 17-acetate;Megestrol Acetate; Oraconal; Me-quingestanol			-10.9162357541	4	4		0	-6.18393712			5241	PGR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick Chemical, Inc.	Prestw-956	-1.40857279	-2.17036273	-1.68855535	-6.18393712												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159354-06	BORNYL ACETATE			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	76-49-3				-20.8387520965	4	4		0	-4.75652724					CC(=O)OC1CC2CCC1(C)C2(C)C	Microsource	01502510	-5.32657218	-5.4280557	0.16081479	-4.75652724												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184999-01	Sultopride hydrochloride	144207174	Dopamine D3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	23694-17-9				-12.8765881878	4	4	Sanofi Synthelabo brand of sultopride hydrochloride;CIPLUS_3883483;DAN 2163;N-(ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide;Sultopride;Sultopride Hydrochloride;sultopridum;SULTOPRIDE;sultopride;LIN 1418;CIPLUS_181627;sultopride hydrochloride;SULTOPRIDE HYDROCHLORIDE;Sultopride hydrochloride;Barnetil;Sultroprida;LS-20057;amisulpride;CIPLUS_182211;Solian;Sultopridum;	0	-7.7251691					Cl.CCN2CCCC2CNC(=O)c1cc(ccc1OC)S(=O)(=O)CC	Toronto Research	S790510	-1.59703534	0.00863856	-4.33558559	-7.7251691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274079-01	Sodium urate	170465686		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1198-77-2				-25.9553230866	4	4		0	-7.52936988					[Na+].O=C1NC(=O)NC=2[N-]C(=O)NC1=2	SIGMA	U0881	-5.89403097	-5.64098134	-0.27286902	-7.52936988												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00482976-01	Vorapaxar Sulfate		Proteinase-activated receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	705260-08-8				-24.6692985935	4	4		0	-9.10466358			2149	F2R	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3C([C@@H](C)OC3=O)[C@H]2\C=C\C4=NC=C(C=C4)C5=CC(=CC=C5)F	DC Chemicals	DC8229	-5.1087484	-5.26952315	-1.62422037	-9.10466358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181118-01	Sulfabromomethazine	144206282		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	116-45-0	CIPLUS_654340; 			-12.1709145615	4	4	CIPLUS_654340;CIPLUS_151449;SULFABROMOMETHAZINE;SULFABROMOMETHAZINE SODIUM;	0	-3.32008312					O=S(=O)(Nc1nc(C)c(Br)c(C)n1)c2ccc(N)cc2	NCI	NSC-5874	-2.5094266	-3.18463125	-1.50987224	-3.32008312												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022398-05	Fluocinonide	170464717	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	356-12-7	;Fluocinonide; Lidex; Fluocinonido;Fluocinonide (Vanos)			-17.9106362784	4	4		0	-3.37428855				NRC31	CC(=O)OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-774	-4.09569627	-5.90940347	-1.14357188	-3.37428855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018166-02	Estradiol valerate			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	979-32-8				-34.0004726661	4	4		0	-9.55856177					CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C=CC(=C4)O)[C@H]3CC[C@]12C	APExBIO	B1506	-7.34989191	-5.62370422	-5.9468122	-9.55856177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160408-06	Benziodarone			DPI_SARS-CoV-2_General	2019_NPC-5_Tox			14.1253754462	-4.85	-47.2582932195	-3	4		-35.8873152594	-35.64459301	0.1906294259	0.9769230984			CCC1=C(C(=O)C2=CC(=C(O)C(=C2)I)I)C3=CC=CC=C3O1	Bionet	KS-1133_CM2	-5.8033199	-6.83771704	-1.45626731	-35.64459301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160355-01	NCGC00160355-01	29216036		DPI_SARS-CoV-2_General	2019_NPC-5_Tox		Xylose; Xylan; D-Lyxopyranose; D-Arabinose-1-13C; D-Xylose-1-13C; L-(+)-Arabinose; DL-Xylose; D-(+)-Xylose; D-(-)-Arabinose; D-(-)-Lyxose; D Xylos; DL-Arabinose; 	3.5481338923	-5.45	-21.0910829511	4	4	NCGC_FLUKA_95740;CIPLUS_718758;Xylose;NCGC00165998-01;D Xylos;D-Arabinose-1-13C;CIPLUS_756836;L-(+)-Arabinose;CIPLUS_148884;D-Xylose-1-13C;D-(-)-Arabinose;DL-Xylose;CIPLUS_694406;XYLOSE, D-;CIPLUS_3887049;XYLOSE;CIPLUS_149908;D-Lyxopyranose;D-(-)-Lyxose;L-(-)-Xylose, mixture of anomers;DL-Arabinose;D-(+)-Xylose;ARABINOSE, L-;Xylan;D-Xylose;D-XYLOSE;CIPLUS_711441;	10.1192952759	-3.16650104	1	0.9987527726			[H][C@]1(O)CO[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Alfa Aesar	A11921	-6.34941273	-4.55991061	3.83275261	-3.16650104												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00167487-15	BICALUTAMIDE		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	90357-06-5				-16.5987562602	4	4		0	-8.20576718				AR	C[C@](O)(C[S+]([O-])(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	Microsource	01504827	-3.69700446	-0.73427782	-0.73198198	-8.20576718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164553-02	Clofarabine	170465145	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	123318-82-1	 Clofarabine; ; Clolar;Clofarabine	12.5892541179	-4.9	-31.1485119051	-3	5		-34.444518384	-32.45376532	0.0514704871	0.9732594305		POLA1	Nc3nc(Cl)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	Sequoia	SRP03671c	-3.73634121	-2.06400545	-0.33909658	2.45717173	-32.45376532											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178854-03	Minocycline hydrochloride	170465049	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	13614-98-7				-17.4303866173	4	4		0	-10.5998576				PARP1	Cl.CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O	Microsource	01500414	-2.28526051	-3.18762958	-2.06600832	-10.5998576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182063-03	Cadralazine	170466021		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	64241-34-5				-25.1347326793	4	4		0	-6.14097544					O=C(OCC)NNc1ccc(nn1)N(CC(C)O)CC	Kemprotec	64241-34-5	-7.11166012	-5.28680028	1.87543313	-6.14097544												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159369-04	1-Octadecanol	170465526		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	112-92-5				-18.3405979088	4	5		0	-5.03877748					CCCCCCCCCCCCCCCCCCO	Labotest	LTBB001505	-5.12865703	-5.51961869	-4.86038431	3.13691269	-5.03877748											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	12.5892541179	-4.9	-56.0958195732	-3	5		-53.1496771659	-52.4161351	0.0304009899	0.9844520927			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-4.80260839	-7.4772321	-3.89751748	-0.08726404	-52.4161351											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016590-06	Azaperone	170465697		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1649-18-9				-18.9372288425	4	5		0	-3.57028131					Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3	Vitas	STK802185	-4.44131124	-4.86424377	-3.74680789	-2.87971341	-3.57028131											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249920-01	Nandrolone cyclohexylpropionate	170465905	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	912-57-2				-18.0730905523	4	4		0	-6.53257387					O=C5CC[C@H]4C(CC[C@@H]3[C@@H]4CC[C@@]2(C)[C@H]3CC[C@@H]2OC(=O)CCC1CCCCC1)=C5	GVK	FFS-11-286-NCI-188	-2.6029029	-5.50276434	-3.85914761	-6.53257387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182980-01	Fominoben hydrochloride	144206774		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	24600-36-0	Fominoben; Noleptan; 			-27.4564193198	4	4	Fominoben;fominoben;Noleptan;VNC-3;LS-173706;fominobene;CIPLUS_3734982;fominobenum;Fominobenum;3'-CHLORO-1-(METHYL((MORPHOLINOCARBONYL)METHYL)-AMINO)-O-BENZOTOLUIDIDE;Fominobene;FOMINOBEN;CIPLUS_171289;PB-89;	0	-5.58917764					Cl.O=C(CN(C)Cc2c(NC(=O)c1ccccc1)cccc2Cl)N3CCOCC3	NCI	NSC_293901	-6.92636873	-3.08396683	-4.91597367	-5.58917764												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166113-04	Diphenylcyclopropenone	170465593	immune system process Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	886-38-4				-8.2576732506	4	5		0	-0.76178239					O=C2C(=C2c1ccccc1)c3ccccc3	Vitas	STK289679	-1.58618259	-4.14077794	-1.84619249	-0.80374776	-0.76178239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00063561-03	4,5-Diphenylimidazole	170465946		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	668-94-0				-22.9771785825	4	5		0	-3.63452802					c1ccc(cc1)c2ncnc2c3ccccc3	Labotest	LT03333454	-6.91751851	-5.81751638	-6.14141583	1.32733202	-3.63452802											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178877-03	Methicillin sodium hydrate	170465152	peptidoglycan biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	7246-14-2				-14.5485907277	4	4		0	-1.26379494					[Na+].O.O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)c1c(OC)cccc1OC)[C@H]3SC2(C)C	Microsource	01500395	-3.57347686	-2.50518314	-3.90246015	-1.26379494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185778-04	Nitisinone		4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	104206-65-7				-18.5979925708	4	4		0	-2.6254895				HPD	[O-][N+](=O)C1=CC(=CC=C1C(=O)C2C(=O)CCCC2=O)C(F)(F)F	MedChem Express	HY-B0607	-4.92345701	-4.5438839	-1.26905752	-2.6254895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160673-01	Propicillin	144205529		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	551-27-9	Propicillin; Levopropylcillin; Propicilina; 			-31.600234495	4	4	Propicillinum;CIPLUS_782900;Propicillin;levopropicillinum;levopropicilline;LS-175596;CIPLUS_750386;Propicilina;CIPLUS_206990;PROPICILLIN POTASSIUM;Propicillin potassium;LS-175076;CIPLUS_669806;Levopropylcillin Potassium;propicilline;Propicilline;brocillin;propicillin;propicillinum;Propicillin Potassium;alpha-phenoxy propylpenicillin;LS-174659;Levopropylcillin potassium;Levopropylcillin;PROPICILLIN;	0	-8.50836597					OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)C(CC)Oc1ccccc1)[C@H]3SC2(C)C	Vitas	STK177353	-7.08518992	-6.82446441	-4.01507277	-8.50836597												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00092310-06	Amisulpride	170466480	Dopamine D2/D3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	71675-85-9	; Amisulprida;Amisulpride; Deniban			-1.4447910975	4	5		0	1.28493415			1813	DRD2	CCN2CCCC2CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC	Tocris	2132	-0.78427917	-0.99157375	-2.44903085	2.08055849	1.28493415											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167562-01	Buquinolate	144206110		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	5486-03-3	Buquinolate; Buquinolato; Bonaid; 			-14.885847935	4	4	buquinolatum;BUQUINOLATE;Buquinolatum;CIPLUS_164381;buquinolate;Buquinolato;ethyl 4-hydroxy-6,7-diisobutoxy-3-quinolinecarboxylate;Buquinolate;Bonaid;	0	-2.750089					CC(C)COc1cc2ncc(c(O)c2cc1OCC(C)C)C(=O)OCC	SigmaAldrich	R239542	-4.13817444	-2.28921907	-0.9485447	-2.750089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016348-15	Ethoxyquin		Heat shock protein HSP 90-beta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	91-53-2				-9.8539774138	4	4		0	-5.24207903			3326	HSP90AB1	CCOC1=CC\2=C(NC(C)(C)\C=C2C)C=C1	Prestwick	Prestw-765	-2.82348789	0.967519	-0.18624394	-5.24207903												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00262526-04	CINCHONIDINE		Alkaloid; P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	485-71-2				-5.240056067	4	4		0	-3.00818797				ABCB1	O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)C3=CC=NC4=C3C=CC=C4	Microsource	01500839	-1.04116116	-1.59813407	1.12179487	-3.00818797												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408838-01	Piroheptine Hydrochloride		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	16378-22-6				-35.1507939107	4	4		0	-5.81167675					CCN1CCC(C1C)=C2C3=CC=CC=C3CCC4=CC=CC=C24	Glixx	GLXC-06115	-9.68809282	-4.43158258	-4.2489605	-5.81167675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178826-03	Glucosamine hydrochloride	170466505	Solute carrier organic anion transporter family member 1B3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	66-84-2				-19.5716899415	4	4		0	-5.89177643					Cl.O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1N	Microsource	01500316	-5.82344377	-1.26986869	0.84459459	-5.89177643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015876-11	Ranitidine	170465134	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	66357-35-5		2.8183829313	-5.55	-11.8896726751	4	5		11.107882952	-6.00247809	0.3409832313	0.921734619	3274	HRH2	[O-][N+](=O)\C=C(/NC)NCCSCc1ccc(CN(C)C)o1	Microsource	01501151	-4.50299612	-5.00893693	-7.58990246	3.64212557	-6.00247809											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164556-02	Fudosteine	170465764	Mucin-5AC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	13189-98-5				-23.078184275	4	5		0	-3.98329586			4586	MUC5AC	OCCCSC[C@H](N)C(=O)O	Sequoia	SRP02575f	-5.29608742	-7.09422078	-7.93318541	-0.24342075	-3.98329586											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00263198-04	Lenvatinib		VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	417716-92-8				-28.6091558236	4	4		0	-7.60946956				FLT1	COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O	APExBIO	A2174	-5.36462699	-4.17242571	-9.02200277	-7.60946956												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507798-01	Drostanolone propionate		Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	521-12-0				-33.4801870464	4	4		0	-5.99857601					CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C	Carbosynth	FD22623	-8.66457846	-5.43365584	-4.39622315	-5.99857601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166266-03	1,3-Bis(4-carboxyphenoxy)propane	170466646		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	3753-81-9				-31.0762788277	4	4		0	-6.87957358					O=C(O)c1ccc(cc1)OCCCOc2ccc(cc2)C(=O)O	SIGMA	655538	-7.48493911	-8.22159189	-1.53667471	-6.87957358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162385-04	Olprinone	170465898	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	119615-63-3	;Olprinone; Olprinone;Loprinone; Coretec;Olprinone hydrochloride			-7.4409419105	4	5		0	-2.25781286			5139	PDE3A	Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O	SIGMA	O7389	-3.19880155	-1.94484637	-2.04713861	4.24838102	-2.25781286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00092361-06	Prostaglandin E2	174006772	prostaglandin	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	363-24-6	; alpha, Prostaglandin E; 15-ketoprostaglandin E; E2alpha, Prostaglandi; Prostenon; E2, Prostaglandi; ; PROSTAGLANDIN E2; Prostaglandin,PGE2; 8-iso-PGE2; Dinoprostone Betadex; Prepidil; alpha, PGE; 15-ketoprostaglandin E1; Dinoprostone; Dinoprostona;Prostaglandin E2; Gel, Prepidi; 8-isoprostaglandin E2; 8,12-epi-PGE2; 8,12-epi-prostaglandin E2; 15-keto-PGE;Dinoprostone; E2 alpha, Prostaglandi; 15-keto PGE1; Prepidil Gel; PGE2 alpha; Prostaglandin E2 alpha			-24.3915196368	4	5		0	-2.86356753				PTGER2	O[C@@H]1CC(=O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC	Tocris	2296	-5.04053578	-9.01778875	-8.05040399	-1.39163184	-2.86356753											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160445-02	Bromisovalum	170465828		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	496-67-3		2.8183829313	-5.55	-11.233601669	4	5		13.2615439359	-1.68877059	0.1347114958	0.9887491911			CC(C)C(Br)C(=O)NC(N)=O	Labotest	LT00134620	-6.07155446	-5.06000511	-6.46795328	5.58949157	-1.68877059											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183839-01	Rapacuronium bromide	144206855	Muscarinic acetylcholine receptor M5 Negative Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	156137-99-4				-16.6136093904	4	4	rapacuronium bromide;rapacuronium;RAPACURONIUM BROMIDE;Rapacuronium Bromide;RAPACURONIUM;Org-9487;rapacuronii bromidum;ORG-9487;Raplon;LS-173498;bromure de rapacuronium;CIPLUS_755198;Org 9487;1-(3A-(ACETYLOXY)-17B-(1-OXYPROPOXY)-2B-(1-PIPERIDINYL)-5A-ANDROSTAN-16B-YL)-1-(2-PROPENYL)PIPERIDINIUM BROMIDE;1-ALLYL-1-(3.ALPHA.,17.BETA.-DIHYDROXY-2.BETA.-PIPERIDINO-5.ALPHA.-ANDROSTAN-16.BETA.-YL)PIPERIDINIUM BROMIDE, 3-ACETATE 17-PROPIONATE;Organon brand of rapacuronium bromide;	0	-4.98238323					[Br-].C=CC[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(=O)CC	Pharmaron	PH-NIH-169871	-4.16504139	-3.0814853	-0.14294648	-4.98238323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182849-01	Epristeride	144206545	3-oxo-5-alpha-steroid 4-dehydrogenase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	119169-78-7	Epristeride; 			-13.8341193479	4	4	SK&F 105657;EPRISTERIDE;CIPLUS_210870;17-N-t-butylcarboxamide androst-3,5-diene-3-carboxylic acid;SKF 105657;LS-19325;ONO 9302;Epristeride;ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID, 17-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)-, (17B)-;epristeride;ONO-9302;epristeridum;17B-(TERT-BUTYLCARBAMOYL)ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID;SK&F-105657;	0	-2.23597434			6716	SRD5A2	CC(C)(C)NC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C1C=C(CC[C@]1(C)[C@H]4CC[C@]23C)C(=O)O	APAC	816099	-3.99167859	-3.87227093	1.05423032	-2.23597434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015754-16	Nilutamide	170465021	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	63612-50-0	 ;Nilutamide; Nilutamide;NILUTAMIDE; Nilandron			-32.5446399332	4	5		0	-4.73590014			374	AR	FC(F)(F)c1cc(ccc1[N+]([O-])=O)N2C(=O)C(C)(C)NC2=O	Microsource	01504152	-8.38033134	-8.73691378	-9.02164357	-1.5018601	-4.73590014											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023339-16	Pilocarpine	170464845	Muscarinic acetylcholine receptor M3 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	92-13-7		2.8183829313	-5.55	-0.8636673257	4	5		12.5200017	-2.49644349	0.1049047521	0.9932258425	1131	CHRM3	Cn2cncc2C[C@H]1COC(=O)[C@H]1CC	Enzo	AC214	-3.13711667	-4.18333475	-3.62121656	7.19698709	-2.49644349											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262945-01	Rivaroxaban	170466121	Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	366789-02-8	Bay 59-7939;Rivaroxaban (Xarelto);5-Chloro-n-(((5s)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;Rivaroxaban;Rivaroxabanum; Rivaroxaban			-25.6301246864	4	4		0	-7.45776493			83541	F10	O=C(NCC3CN(c1ccc(cc1)N2CCOCC2=O)C(=O)O3)c4ccc(Cl)s4	GVK	FFS-12-73-NCI-1931	-4.16504139	-8.6169847	-4.86018047	-7.45776493												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013226-32	NCGC00013226-32			DPI_SARS-CoV-2_General	2019_NPC-5_Tox			12.5892541179	-4.9	-90.8290241299	-3	4		-106.4892561314	-99.65218177	0.0583867461	0.9978915368			CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	Labotest	LT00452002	-5.36124474	-3.44249613	-0.35736621	-99.65218177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025195-06	Ozagrel hydrochloride	170466054	Thromboxane Synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	78712-43-3	; ; Ozagrel hydrochloride;Ozagrel hydrochloride; Ozagrel HCL; OZAGREL HCl; Ozapen;Ozagrel			-26.5770784098	4	4		0	-3.9073087			6915	TBXA2R	Cl.O=C(O)/C=C/c2ccc(Cn1ccnc1)cc2	Prestwick	Prestw-979	-6.45343042	-6.39075125	-3.87742339	-3.9073087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167547-02	Agaric acid	170465652		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	666-99-9				-18.1478801675	4	4		0	1.33255037					O=C(O)C(CCCCCCCCCCCCCCCC)C(O)(CC(=O)O)C(=O)O	SIGMA	A7384	-6.31474017	-3.65738353	-0.66112749	1.33255037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182036-01	Peplomycin sulfate	144206501		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	70384-29-1	Peplomycin sulfate; Peplomycin Sulfate (1:1); Peplomycina; Sulfate, Peplomyci; Pepleo; 	6.3095734448	-5.2	-41.4672357717	4	4	nk 631;Peplomycin;Sulfate, Peplomyci;Pepleo;Peplomycine;bleomycin pep;Peplomycina;NK63;Peplomycin Sulfate;CIPLUS_188638;LS-177021;PEPLOMYCIN SULFATE;Peplomycinum;LS-44906;Bleomycinamide, N1-(3-((1-phenylethyl)amino)propyl)-, (S)-;NK-631;peplomycinum;LS-102345;CIPLUS_699356;Peplomycin Sulfate (1:1);Peplomycin sulfate;NK 63;PEPLOMYCIN;peplomycine;	-31.694938592	-26.90848315	0.2858410032	0.9461166476			O=C(N)C(N)CNC(CC(=O)N)c1nc(N)c(C)c(n1)C(=O)NC(C(O[C@@H]3O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]2O)c4cncn4)C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCN[C@@H](C)c7ccccc7)C(C)O.O=S(=O)(O)O	ACC	PEPLOMYCIN SULFATE	-2.16270099	-9.78597215	-12.8651836	-26.90848315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021146-09	Ketanserin	170466645	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	74050-98-9	Ketanserin tartrate;Ketanserin;KETANSERIN TARTRATE			-28.5035565909	4	5		0	-7.57193337			3356	HTR2A	Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=O)CC4	Enzo	NS515	-6.62671836	-6.48991404	-8.01691297	-0.59247692	-7.57193337											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181911-01	Bucolome	144206890	Cytochrome P450 2C9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	841-73-6	Bucolome; Bucolom; Paramidine; Paramidin; Bucolomo; 	1.1220184543	-5.95	-27.5531027311	4	5	Paramidine;2,4,6(1H,3H,5H)-Pyrimidnetrione, 5-butyl-1-cyclohexyl-;Barbituric acid, 5-butyl-1-cyclohexyl-;bucolome;CIPLUS_156649;LS-23912;Bucolomo;Paramidin;Bucolomum;Bucolome;bucolomum;1-cyclohexyl-5-butylbarbituric acid;Bucolom;BUCOLOME;CIPLUS_165895;	7.812069116	-2.6432931	0.1959062475	0.8863832796			O=C2C(CCCC)C(=O)NC(=O)N2C1CCCCC1	Pharmaron	PH-NIH-95	-7.39337328	-9.84339093	-7.71549378	0.58329123	-2.6432931											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253600-01	Iothalamate sodium	170465058		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1225-20-3				2.7423676214	4	5		0	0.94534441					[Na+].O=C(C)Nc1c(I)c(c(I)c(c1I)C([O-])=O)C(=O)NC	GVK	FFS-11-286-NCI-047	0.15861826	-0.71069878	1.07589902	2.12648693	0.94534441											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016533-24	NCGC00016533-24			DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-21.100055406	4	4		0	-6.40979312					CC1=CC(N[S+]([O-])(=O)C2=CC=C(N)C=C2)=NO1	Labotest	LT00452029	-3.65362112	-8.35911982	-1.62601626	-6.40979312												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163355-05	Indigo	170465746		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	482-89-3				-15.4538838753	4	4		0	-1.78426235					O=C3c4ccccc4N/C3=C2/Nc1ccccc1C2=O	Enzo	AC1057	-3.40224505	-5.35069624	-2.42115608	-1.78426235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164631-05	Sunitinib malate	170465289	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	341031-54-7	 Sunitinib malate;Sunitinib malate; Sunitinib base; ;Sutent	7.9432823472	-5.1	-122.2025823995	-2.1	5		-106.606648821	-99.58459385	0.0074167026	0.9962714758	2321	FLT1	O=C(O)C(O)CC(=O)O.CCN(CC)CCNC(=O)C1C(C)=C(N=C1C)/C=C2/c3cc(F)ccc3NC2=O	Sequoia	SRP01785s	-11.02028589	-4.51649014	-6.85759327	-27.72910898	-99.58459385											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095129-06	Valdecoxib	170465163	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	181695-72-7				-23.4527803662	4	5		0	-6.32591322				COX2	NS(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2	SIGMA	PZ0179	-8.06727724	-0.48652372	-4.99211771	0.09532023	-6.32591322											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016973-06	Letrozole	225144183	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	112809-51-5	 Letrozole; F??mara;Letrozole; ;Femara; Femara;CGS-20267;FEM-345?	0.7943282347	-6.1	-19.7542331651	4	5		13.15650946	-6.00984332	0.2228411881	0.9685526942	1588	CYP19A1	N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N	Prestwick	Prestw-1025	-8.88042455	-5.65314733	-3.31932037	2.06527166	-6.00984332											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159522-05	Cephalexin	170464982	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	15686-71-2				-10.9453267656	4	5		0	-2.64144128					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C=3C(=O)O	SIGMA	33989	-4.60926132	-1.0720744	-1.98808898	2.4556307	-2.64144128											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015841-11	Pargyline hydrochloride	170465066	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	306-07-0				-14.682317693	4	5		0	-3.14715311					Cl.CN(Cc1ccccc1)CC#C	Microsource	01500462	-4.24976462	-0.91707569	-1.61149063	-3.83550452	-3.14715311											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095124-08	Rosiglitazone	170465417	PPARgamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	122320-73-4	; ;Rosiglitazone;ROSIGLITAZONE MALEATE; Avandia; ROSIGLTAZONE HCl; Rosiglitazone; rosiglitazone (Avandia); ROSIGLITAZONE;ROSIGLITAZONE			-2.825867775	4	5		0	-3.21939766			5468	PPARG	CN(CCOc2ccc(CC1SC(=O)NC1=O)cc2)c3ccccn3	Microsource	01504263	-2.41804331	2.31206407	0.88456823	2.61903681	-3.21939766											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162149-07	Demeclocycline hydrochloride	170465205	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	64-73-3				-5.6010938595	4	5		0	-2.20797399					Cl.NC(=O)C=2C(=O)[C@@]3(O)C(O)=C4C(=O)c1c(c(Cl)ccc1O)[C@@H](O)[C@H]4C[C@H]3[C@@H](C=2O)N(C)C	Microsource	01500226	-3.04288282	3.85344011	-2.18076721	0.74894467	-2.20797399											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346442-02	Phenprocoumon		Cytochrome P450 3A4 Substrate	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	435-97-2				-19.4629158969	4	4		0	-3.75372662					CCC(C1=CC=CC=C1)C/2=C(\O)C3=CC=CC=C3OC2=O	Adooq	A10656	-5.08386426	-5.89221248	0.63432502	-3.75372662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178810-03	Novobiocin sodium	170465360	Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1476-53-5				-15.4725170958	4	4		0	-1.6126118				HSP90AB1	[Na+].C/C(C)=C\Cc1cc(ccc1O)C(=O)NC3=C([O-])c4ccc(O[C@@H]2OC(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@H]2O)c(C)c4OC3=O	Microsource	01500444	-4.03501929	-5.40226921	-0.26802466	-1.6126118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016352-07	Benzocaine	170465463	Sodium channel protein type 10 subunit alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	94-09-7		14.1253754462	-4.85	-48.0958305503	-3	5		-37.5963335888	-36.48801192	0.1433387766	0.91966033	6336	SCN10A	Nc1ccc(cc1)C(=O)OCC	Vitas	STK043620	-8.46101173	-5.34314992	-5.05342442	3.05478644	-36.48801192											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022248-04	Hydrocortisone 21-hemisuccinate sodium salt	170465053		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	125-04-2				-6.7006471815	4	5		0	0.40353316					[Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Sequoia	125-04-2	-2.12820078	-1.87526882	-2.5183029	0.02253673	0.40353316											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016362-05	Benzonatate	170465391	Slowly adapting pulmonary stretch receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	104-31-4				-10.8786282337	4	5		0	-3.30897189					O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)c1ccc(NCCCC)cc1	Prestwick	Prestw-12	-3.17110395	0.62795699	0.51600953	-4.75525106	-3.30897189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159373-04	Thymol	170465504	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	89-83-8		0.3981071706	-6.4	-26.4579236534	4	5		8.29387824	-2.91440613	0.2360965339	0.8577705184	231	AKR1B1	CC(C)c1ccc(C)cc1O	Labotest	LTBB001943	-9.4115652	-7.83655914	-3.36508777	1.43784369	-2.91440613											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015883-11	Risperidone	170464925	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	106266-06-2	 ; Risperdal;Risperidone; Risperidone; Risperidal; Risperdal Consta; Consta, Risperda			-32.4430125101	4	4		0	-10.50230373			1813	DRD2	CC=5N=C1CCCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34	Tocris	2865	-6.28006761	-6.41653773	-5.82506924	-10.50230373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164615-02	Prulifloxacin	170465849	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	123447-62-1	 ;Prulifloxacin; Prulifloxacin; Sword			-24.7175891191	4	5		0	-7.23800063					CC=5OC(=O)OC=5CN1CCN(CC1)c2cc3c(cc2F)C(=O)C(=C4SC(C)N34)C(=O)O	Bosche	P2859	-6.57793375	-0.96013089	-6.97144859	-2.23775589	-7.23800063											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167507-04	Lapatinib	170465125	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	231277-92-2	;Lapatinib; Lapatinib;GW-572016F?; Lapatinib base;LAPATINIB DITOSYLATE; Tykerb;Tykerb	12.5892541179	-4.9	-111.986683055	-3	5		-100.3552358778	-99.25949339	0.0148585383	0.9924880383	1956	EGFR	Fc1cccc(c1)COc2ccc(cc2Cl)Nc3ncnc4ccc(cc34)c5ccc(CNCCS(C)(=O)=O)o5	Sequoia	231277-92-2	-11.66224429	-8.38284681	-11.38553162	-3.36344242	-99.25949339											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346570-04	Tebipenem pivoxil		Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	161715-24-8				-17.3686339561	4	4		0	-3.69515012					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)\C(=C(/N2C1=O)C(=O)OCOC(=O)C(C)(C)C)SC3CN(C3)/C4=N/CCS4	MedChem Express	HY-B0396	-3.98459808	-3.45821326	-2.88211149	-3.69515012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016855-10	Fenbendazole	170465647	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	43210-67-9	; ; Phenbendasol; Fenbendazole; Panacur;FENBENDAZOLE; Fenbendazol;Fenbendazole	0.1995262315	-6.7	-98.3047739425	-1.4	5		-31.583218504	-31.63722888	0.0827756804	0.9558993819		CYP3A4	O=C(OC)Nc1nc2cc(ccc2n1)Sc3ccccc3	Vitas	STK378581	-5.28277071	-14.84388403	-39.7430957	-38.20771253	-31.63722888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016850-15	Bezafibrate	170465743	Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	41859-67-0				-2.3975776209	4	5		0	1.72966047					O=C(NCCc1ccc(OC(C)(C)C(=O)O)cc1)c2ccc(Cl)cc2	Microsource	01502046	-0.47786059	2.20020587	-3.63091415	-2.58106924	1.72966047											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253867-02	Prucalopride	170466188	5-HT4 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	179474-81-8	Resolor;R093877;R 093877;Prucalopride; Prucalopride;Prucalopridum	1.2589254118	-5.9	-12.1981787117	4	5		9.12709894	-6.01887389	0.2160654065	0.9705435803	3360	HTR4	COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23	GVK	FFS-12-73-NCI-2606	-4.95163913	-6.77258245	-4.38780872	3.30897372	-6.01887389											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167962-06	Quinapril hydrochloride	170465312	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	82586-55-8				-28.7698984943	4	5		0	-5.26030614					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O	Microsource	01503076	-8.53804673	-5.71342461	-5.71028201	-1.45703781	-5.26030614											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090797-12	Digoxin		Steroid	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	20830-75-5	; ; 12beta-Hydroxydigitoxin; Card-Cosaldon; Lanoxin;Digoxin; Digoxin	0.0630957344	-7.2	-292.7959135449	-1.1	5		-88.2816113999	-96.73996478	0.0050573328	0.9974621385		RORC	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C/8=C/C(=O)OC8)C4	Prestwick	Prestw-437	-10.77206197	-97.17988461	-96.75950254	-92.9281467	-96.73996478											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015273-19	Chlorpromazine	170465371	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	50-53-3		12.5892541179	-4.9	-39.0656475986	-3	5		-44.3658960568	-41.98762812	0.0215452811	0.9890584043			CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12	Vitas	STK182870	-2.73474279	-4.00843882	-0.38535645	0.6581635	-41.98762812											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018194-08	Bendroflumethiazide	170465156	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	73-48-3				-22.1351060507	4	5		0	-4.79071658					FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)Cc3ccccc3	Microsource	01503104	-6.05580758	-5.44648239	-4.56297075	-0.46752304	-4.79071658											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016798-11	(S)-Timolol	170465062	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	26839-75-8				-0.3461495173	4	5		0	-1.09721407					O[C@H](COc1nsnc1N2CCOCC2)CNC(C)(C)C	Enzo	AC172	-1.93015493	-0.8309653	-0.96339114	7.59384504	-1.09721407											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018171-06	Clidinium bromide	170464768		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	3485-62-9		1.2589254118	-5.9	-8.2498295877	4	5		10.318325772	-3.95087371	0.2880860614	0.9457659149			[Br-].OC(c1ccccc1)(c2ccccc2)C(=O)OC4C[N+]3(C)CCC4CC3	Microsource	01500192	-6.09860481	-3.25927839	-3.39814328	5.33339385	-3.95087371											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094574-15	Fipronil	170465992		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	120068-37-3				-21.4838543081	4	5		0	-4.75885421					FC(F)(F)S(=O)c1c(N)n(nc1C#N)c2c(Cl)cc(cc2Cl)C(F)(F)F	Microsource	01505354	-4.54625164	-2.6033625	-6.55105973	-4.43032428	-4.75885421											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024674-14	NCGC00024674-14			DPI_SARS-CoV-2_General	2019_NPC-1_Tox					-14.5054844482	4	5		0	-3.25798481					OC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC=C	Microsource	01500422	-2.38053485	-4.61056785	-2.95439949	-3.38737949	-3.25798481											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167744-02	Methylperone	170466288		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3575-80-2				-20.7522585939	4	5		0	-4.48430493					Fc1ccc(cc1)C(=O)CCCN2CCC(C)CC2	Tocris	2495	-4.33581762	-2.6977183	-6.91928923	-3.77300613	-4.48430493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179435-06	Ifomide	170464854	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3778-73-2	 Isofamide (Ifosfamide?);Ifosfamide; Asta Z 4942; Ifosfamida;; Holoxan; Iso Endoxa;IFOSFAMIDE; Iphosphamide; Iso-Endoxan; Ifosfamide Sterile			-9.0435214054	4	5		0	-0.95177084				H2AFX	O=P1(NCCCl)OCCCN1CCCl	Microsource	01505480	-1.25822008	-1.11082518	-1.50717191	-5.96406661	-0.95177084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181130-02	Eletriptan	170465317	5-hydroxytryptamine receptor 1F Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	143322-58-1				-31.2876760034	4	4		0	-7.00726712			3355	HTR1F	CN4CCC[C@@H]4Cc2cnc3ccc(CCS(=O)(=O)c1ccccc1)cc23	Sequoia	143322-58-1	-6.97917574	-7.87348587	-3.89842321	-7.00726712												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181320-01	Mersalyl acid	144206341		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	486-67-9	2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid; Salyrganic acid; Mersalyl acid; 			-18.2164418397	4	4	Mersalyl acid;2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid;2-[N-(3-Hydroxymercuri-2-methoxypropyl)carbamoyl]phenoxyacetic acid;Salyrganic acid;	0	-3.94186303					O[Hg]CC(OC)CNC(=O)c1ccccc1OCC(=O)O	SIGMA	M9784	-5.68964015	-5.86305518	3.29732555	-3.94186303												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00095118-17	Rofecoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	162011-90-7				-11.2907211305	4	4		0	-4.57608456				PTGS2	C[S+]([O-])(=O)C1=CC=C(C=C1)C/2=C(/C(=O)OC2)C3=CC=CC=C3	SIGMA	SML0613	-1.21983097	-3.30585464	-3.49769144	-4.57608456												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015036-11	Amantadine hydrochloride	170464860	Dopamine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	768-94-5	 Adamantamine fumarate;Adamantamine fumarate;AMANTADINE HYDROCHLORIDE; 1-Adamantylamine;AMANTIDINE; ; Symmetrel; Ambroxol Hydrochloride;Amantadine hydrochloride; Amantadine hydrochloride; 1-Aminoadamantane; Midantan; Amantadina;Amantadine; Adamantine hydrochloride			-26.5416902335	4	5		0	-2.55113559			1812	DRD1	NC13CC2CC(CC(C1)C2)C3	Vitas	STK298781	-9.63365574	-4.37010247	-5.53511999	0.22241387	-2.55113559											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095264-04	Chloroxine	170465084	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	773-76-2	; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine	6.3095734448	-5.2	-72.3980256069	-2.1	5		-93.6242793028	-80.39718129	0.002983125	0.9985053838			Oc1c(Cl)cc(Cl)c2cccnc12	Vitas	STK075368	1.84568172	1.13655859	2.61186042	-26.25328659	-80.39718129											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091106-05	Methyl salicylate	225144206		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	90045-28-6				-21.8034324825	4	5		0	-3.85284159					COC(=O)C1=C(O)C=CC=C1	SIGMA	84330	-4.91451118	-2.71487391	-6.73945622	-4.57931639	-3.85284159											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163338-03	D-Phenylalanine			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	673-06-3				-14.5971462117	4	4		0	-3.27683123					N[C@H](CC1=CC=CC=C1)C(O)=O	Selleck	S4153	-4.11438955	-1.89255452	-0.81652469	-3.27683123												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182074-03	Nicomolol	170465790	Cholesterol biosynthesis Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	27959-26-8				-8.7268468033	4	4		0	-6.39679289			311849		O=C(OCC4(COC(=O)c1cccnc1)CCCC(COC(=O)c2cccnc2)(COC(=O)c3cccnc3)C4O)c5cccnc5	Kemprotec	27959-26-8	-1.45799083	-1.83233687	1.51388092	-6.39679289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165993-02	Picolinic acid	170466822		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	98-98-6				-28.4897073411	4	5		0	-2.8278576					O=C(O)c1ccccn1	Bosche	P0843	-5.60718983	-9.51706982	-6.48255192	-6.85801928	-2.8278576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159326-03	Lincomycin hydrochloride	170465252	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	859-18-7	 ; Lincocin; Lincomycin HCL; Lincomycin hydrochloride; Lincomicina;Lincomycin hydrochloride; Lincolcina	3.1622776602	-5.5	-14.4954348473	4	5		-10.070990356	-1.72050883	0.7396081317	0.3668607094			Cl.O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@@H]1SC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@@H](C)O	Prestwick	Prestw-302	-3.30118369	-3.64127638	7.30464569	-7.55915863	-1.72050883											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016309-06	Sulfathiazole	170465454	Escherichia coli Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	72-14-0				-16.3860551172	4	5		0	-1.2629267					O=S(=O)(Nc1nccs1)c2ccc(N)cc2	Labotest	LT00114899	-3.59929855	-2.23451707	-2.75743952	-7.55039439	-1.2629267											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015605-09	Lamotrigine	170465024	Sodium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	84057-84-1	; Labileno; Lamiktal; Faes Brand of Lamotrigine; Lamictal; Lamotrigine;Lamotrigine; Crisomet			-37.5436848523	4	5		0	-6.93694518					Clc1cccc(c1Cl)c2nnc(N)nc2N	Prestwick Chemical, Inc.	Prestw-1492	-9.07935116	-6.84937382	-8.04966817	-7.30499562	-6.93694518											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016991-05	Proparacaine	170465400	Sodium Channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5875-06-9	; ;PROPARACAINE HYDROCHLORIDE; Alcaine; Proximetacaina; Proparacaine hydrochloride;Proparacaine hydrochloride			-8.1437720673	4	5		0	-1.78457033				SCN10A	Cl.CCN(CC)CCOC(=O)c1ccc(OCCC)c(N)c1	Vitas	STK520616	-1.61771153	-0.85349116	1.49860843	-6.09553024	-1.78457033											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015594-09	LOXOPROFEN SODIUM			DPI_SARS-CoV-2_General	2019_NPC-4_Tox	80382-23-6				-5.5038517284	4	5		0	-0.97744698					CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1	Sequoia	80382-23-6	-2.87434289	-3.66451613	2.87112993	1.59109348	-0.97744698											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183281-03	Valeric acid			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	109-52-4				-14.8652263838	4	4		0	-3.20462987					CCCCC(O)=O	SIGMA	110140	-2.73280258	-5.69882472	-1.22371284	-3.20462987												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00344533-01	Nalpha-Acetyl-L-glutamine	170465810		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	2490-97-3				-23.5383199469	4	4		0	-7.01390688					O=C(C)NC(CCC(N)=O)C(=O)O	SIGMA	A9125	-4.48608999	-7.42369155	-2.80094271	-7.01390688												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166079-02	C.I. Solvent Red 24	170465710		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	85-83-6				-27.4482868504	4	4		0	-6.79796148					Cc4ccccc4/N=N/c3ccc(/N=N/c1c2ccccc2ccc1O)c(C)c3	SIGMA	198102	-5.48796851	-7.05166145	-4.71356055	-6.79796148												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00017258-08	Methergine	170465383	Serotonin 2b (5-HT2b) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	113-42-8				-15.6944147328	4	5		0	-4.21467964					CC[C@@H](CO)NC(=O)[C@@H]2C=C1c3cccc4ncc(C[C@H]1N(C)C2)c34	Enzo	AC576	-4.42597931	-4.70537634	-1.1775602	-0.32002164	-4.21467964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160424-02	Clobenzorex hydrochloride	170465619		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	5843-53-8				-15.1600506122	4	5		0	-3.18342824					Cl.Clc2ccccc2CNC(C)Cc1ccccc1	Specs	AN-153/I197377	-4.24792267	-6.11612903	1.45982182	-2.35734247	-3.18342824											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249903-01	Dexamethasone isonicotinate	170466851		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2265-64-7				-24.3390202852	4	5		0	-1.06712102					O=C1C=C2CC[C@@H]5[C@@](F)([C@@]2(C)C=C1)[C@@H](O)C[C@@]4(C)[C@H]5C[C@@H](C)[C@]4(O)C(=O)COC(=O)c3ccncc3	GVK	FFS-11-286-NCI-109	-8.61454977	-7.44086021	-3.63852871	0.25691878	-1.06712102											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094818-09	Hexestrol	170466031	17-betahydroxysteroid dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	84-16-2	; ; Hexoestrolum; Hexestrol, (R*,S*)-Isomer;Hexestrol; Dihydrodiethylstilbestrol;meso-Hexestrol;HEXESTROL; HEXESTROL	14.1253754462	-4.85	-36.6247576213	4	5		-24.4260189199	-24.9383491	0.3399378815	0.7696450455	1645	AKR1C1	Oc1ccc(cc1)[C@@H](CC)[C@@H](CC)c2ccc(O)cc2	Microsource	01500632	-6.10479905	-9.6688172	-4.14130722	4.27747228	-24.9383491											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090726-12	Ribavirin	170464657	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	36791-04-5	; ;Ribavirin; Levovirin; Ribavirin; Virazole;RIBAVIRIN; Ribavirina; Drug:  Ribavirin			-21.1642120874	4	5		0	-3.82908129			727833	IMPDH1	NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503938	-5.44344582	-6.23655914	-4.25597601	-1.24853511	-3.82908129											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095042-09	ThioTEPA	225144216	Cytochrome P450 Oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	52-24-4	;Thiotepa; THIOTEPA;Tris(aziridinyl)phosphine sulfide;Thio-TEPA; Thiofozil; Thio-Tep; ; Tiotepa; Tiofosyl; Tris(aziridinyl)phosphine sulfide; Tiofosfamid; Thio Tep; Tespamin; Thiopeta; Tespa; Girostan; Tiofozil;THIOTEPA; Thiotef; Thio-TEPA; Tio-tef			-2.9720817667	4	5		0	-1.38994754				CYP2B6	S=[P](N1CC1)(N2CC2)N3CC3	Microsource	01503324	-2.5945396	-0.21505376	1.58331128	1.14035878	-1.38994754											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00160662-02	Ambrisentan	170465143	Endothelin ETA Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	177036-94-1				-20.441781102	4	5		0	-5.23696364				EDNRA	O=C(O)[C@@H](Oc1nc(C)cc(C)n1)C(OC)(c2ccccc2)c3ccccc3	Prestwick	Prestw-1497	-5.14668475	-7.99139785	-0.96586399	-1.03218246	-5.23696364											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181776-02	Dicyclopentamethylenethiuram disulfide	170465709		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	94-37-1		0.6309573445	-6.2	-9.2239502561	4	5		12.4885535	-5.1383222	0.0271598543	0.9995519893			S=C(SSC(=S)N1CCCCC1)N2CCCCC2	Labotest	LT00159442	-6.24046125	-4.47311828	-0.08379642	3.82673758	-5.1383222											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017325-06	Kojic acid	170466814	Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	501-30-4				-20.2802384794	4	5		0	-4.01739676					O=C1C=C(CO)OC=C1O	Labotest	LT00068503	-5.82499576	-7.38064516	-3.37390844	1.49193185	-4.01739676											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179308-04	Fluticasone propionate	170464975	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	80474-14-2	 Flovent;;Fluticasone propionate (Flonase, Veramyst); Cutivate;Fluticasone propionate	0.5011872336	-6.3	-17.064144607	4	5		7.955146684	-1.63206743	0.2667728123	0.8343088492		NR3C1	O=C(SCF)[C@@]4(OC(=O)CC)[C@H](C)C[C@H]3C2C[C@H](F)C1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Prestwick Chemical, Inc.	Prestw-997	-7.04595557	-6.69247312	-0.71006439	3.43009105	-1.63206743											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159336-03	Sulbactam	170465248	beta-Lactamase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	68373-14-8	; Sultamicillin (base); B??tamaze; Sodium Sulbactam; Penicillanic Acid Sulfone; Sodium, Sulbacta; Combactam; Sulfone, Penicillanic Aci;Sulbactam sodium;Sulbactam			-30.416848078	4	5		0	-6.64484598				bla	O=S2(=O)C(C)(C)[C@@H](N1C(=O)C[C@H]12)C(=O)O	Vitas	STK801889	-8.32626759	-7.00215054	-5.08511952	-2.23113675	-6.64484598											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016602-04	Benperidol	170466409	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2062-84-2				-23.76424068	4	5		0	-6.24131283					Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)N3c4ccccc4NC3=O	Prestwick Chemical, Inc.	Prestw-484	-8.1821265	-5.52258065	-1.1422775	1.05021185	-6.24131283											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164385-05	Clomifene citrate	170464951	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	911-45-5	; Zuclomifeno; Clomifeno; Clomiphene citrate (Z,E);CLOMIPHENE CITRATE; Clomifene Citrate; ; Clomiphene Hydrochloride; Clomid; Clomiphene citrate salt; (E)-isomer, HCl; Clomifen; cis-Clomiphene citrate; Clomifene citrate; Enclomifeno; (Z)-isomer, citrate; Clomiphene citrate	12.5892541179	-4.9	-85.0548021386	-3	5		-107.8323050663	-99.57404833	0.0366389801	0.9811636214	2099	ESR1	CCN(CCOc1ccc(cc1)C(c2ccccc2)=C(Cl)c3ccccc3)CC	Microsource	01500196	-5.91826352	-7.56989247	0.58657493	7.47768863	-99.57404833											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167737-02	Lazabemide hydrochloride	170466038	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	103878-83-7				-31.4368093134	4	5		0	-5.44321392					Cl.Clc1cnc(cc1)C(=O)NCCN	Tocris	2460	-8.22452094	-9.29032258	-8.14589398	0.10366898	-5.44321392											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161599-09	Troglitazone	170465091	CCL2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	97322-87-7	; Rezulin;GR-92132X;Troglitazone; Troglitazone; Prelay;CS-045;CI-991	14.1253754462	-4.85	-46.5680424919	-3	5		-33.282226604	-32.31852217	0.2639363006	0.8346282947	6347	CCL2	Cc1c(O)c(C)c(C)c2OC(C)(CCc12)COc4ccc(CC3SC(=O)NC3=O)cc4	Prestwick Chemical, Inc.	Prestw-1467	-10.80210276	-6.22795699	-1.80382817	4.62904534	-32.31852217											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274080-01	Estriol	170465807	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	50-27-1		0.6309573445	-6.2	-31.6576701576	4	4		-18.4161146559	-16.22990531	0.1483417782	0.9862935204		ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]12)c4cc3	SIGMA	E3625	-1.71647643	-8.91655451	-12.74936841	-16.22990531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167537-02	Donepezil hydrochloride	170464858	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	120011-70-3				-0.7433345907	4	4		0	-4.96366439					Cl.COc1cc2C(=O)C(Cc2cc1OC)CC4CCN(Cc3ccccc3)CC4	Sequoia	SRP04573d	2.17826958	-1.02624495	-2.68751633	-4.96366439												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346701-07	Laquinimod		Immunomodulators	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	248281-84-7				-11.3554479891	4	4		0	-3.18968147				BDNF	CCN(C(=O)C/1=C(O)/C2=C(C=CC=C2Cl)N(C)C1=O)C3=CC=CC=C3	MedChem Express	HY-13010	-2.22808687	-2.57215364	-2.12296421	-3.18968147												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178086-03	Aminolevulinic acid hydrochloride	170464700	DNA Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5451-09-2				-32.0517185383	4	5		0	-8.41035966					Cl.NCC(=O)CCC(=O)O	Microsource	01504184	-7.7816747	-4.41327844	-6.72232927	-5.07887818	-8.41035966											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015358-18	Disopyramide	174006632	Na channel blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3737-09-5	 Rythmodan P; ;Disopyramide; Searle 703; Disopyramide, (S)-Isomer; Norpace; Disopyramide; Disopyramide, (R)-Isomer; Disopiramida			-11.4017415233	4	5		0	-3.0841036					CC(C)N(CCC(c1ccccn1)(c2ccccc2)C(N)=O)C(C)C	Microsource	01500261	-3.39763262	-1.01646938	-1.19032327	-1.79228747	-3.0841036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159388-05	Pentaerythritol tetranitrate	225144224	Soluble guanylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox					-32.0718986202	4	5		0	-7.87041274					[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O	Labotest	LTBB004589	-7.79044279	-4.20741122	-6.34553629	-6.24452235	-7.87041274											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262939-01	Cycotiamine	170465848		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	6092-18-8	Cycotiamine;Cicotiamina;Cycotiaminum;Cycothiamine			-9.3025000182	4	5		0	-0.10066807					O=C1OCC\C(S1)=C(/C)N(C=O)Cc2cnc(C)nc2N	GVK	FFS-11-286-NCI-198	-2.44191144	-3.19523074	-0.78783986	-2.73882559	-0.10066807											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016569-09	TRANEXAMIC ACID	225144181	Tissue-type Plasminogen Activator Inhibitor (tpa) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1197-18-8	; ;TRANEXAMIC ACID; cis-AMCHA; Cyklokapron; Tranexamic acid; Acido tranexamico; Transamin; Rikavarin;Tranexamic acid			-26.6263117471	4	5		0	-6.18651048			5054	SERPINE1	NC[C@H]1CC[C@@H](CC1)C(O)=O	Microsource	01502026	-5.88776852	-3.9929662	-5.24941126	-6.31463628	-6.18651048											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00016087-11	Vigabatrin	225144175	Gamma-amino-N-butyrate transaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	[60643-86-9]				-16.4405883994	4	5		0	-2.26045575					NC(CCC(O)=O)C=C	Tocris	0808	-3.48531346	-3.35820896	-2.8773282	-6.14811569	-2.26045575											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00182053-03	Acrivastine		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	87848-99-5				-32.0431464006	4	4		0	-9.81306375					CC1=CC=C(C=C1)\C(=C/CN2CCCC2)C3=CC=CC(=N3)\C=C\C(O)=O	Enzo	AC3005	-6.77944103	-3.27756033	-7.30458578	-9.81306375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025323-08	Ubenimex		Leukotriene A4 Hydrolase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	[58970-76-6]				-2.5514391137	4	4		0	-5.1592662				LTA4H	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	Tocris	1956	0.18603444	-0.32689578	1.51388092	-5.1592662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386509-01	Fluticasone furoate	384569143	Glucocorticoid Receptor (GR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	397864-44-7				-13.3840849018	4	4		0	-1.18523683				NRC31	C[C@@H]1CC2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)SCF	Axon Medchem	1172	-5.30847106	0.03441008	1.47857174	-1.18523683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167427-02	Epoprostenol sodium	124893308	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	61849-14-7				-34.0995365369	4	4	PROSTAGLANDIN I2 Na	0	-5.0111116			64805		CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC([O-])=O	BIOMOL	PG011	-9.21086787	-5.41098542	-4.36509688	-5.0111116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387800-02	AHU-377			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	149709-62-6				-27.4673176339	4	4		0	-4.35748834					CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(O)=O	Aobious	AOB2046	-7.2986069	-5.84971397	-2.12296421	-4.35748834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166142-04	Diperodon hydrochloride	170465536	sodium ion transmembrane transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	537-12-2				-35.4643691959	4	4		0	-10.64970151					Cl.O=C(Nc1ccccc1)OCC(OC(=O)Nc2ccccc2)CN3CCCCC3	Prestwick	Prestw-300	-8.73496582	-3.68187879	-3.75601359	-10.64970151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319020-01	NCGC00319020-01	225144374	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-19.4457170266	4	4		0	-6.63209726					CCCCC[C@@H](O)CC[C@@H]1[C@@H](O)C[C@H]2CC3=C(C[C@@H]12)C=CC=C3OCC(O)=O	GVK	FFS-11-286-NCI-96	-2.70398892	-4.85182158	-5.99814627	-6.63209726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181306-04	Docetaxel	170464919	Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	114977-28-5	 Docetaxolum; Docetaxel Hydrate; ; AE-docetaxel;DOCETAXEL; 5   Docetaxel; Docetaxel hydrate; Docetaxel Anhydrous; Docetaxel Trihydrate; Docetaxel;Docetaxel; Taxoltere metro	0.2511886432	-6.6	-136.1253204894	4	4		-19.2041334761	-39.55727918	0.2596539889	0.9561925524	203068	TUBB	CC(C)(C)OC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]5C[C@@]6(O)[C@@H](OC(=O)c2ccccc2)[C@H]4[C@@](C)([C@@H](O)C[C@H]3OC[C@]34OC(C)=O)C(=O)[C@H](O)C(=C5C)C6(C)C	Alfa Aesar	J60174	-21.88716795	-36.99944084	-35.4901355	-39.55727918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188943-03	Orotic acid	170465761	metabolite	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	65-86-1	Orotic acid;Orotic acid (6-Carboxyuracil)	0.0794328235	-7.1	-17.3816226001	4	5		10.636411704	-3.03795145	0.5359071831	0.5379747301		DHODH	OC(=O)c1cc(O)nc(O)n1	Vitas	STK301771	-7.61367642	-3.18750532	-2.90953238	4.68010839	-3.03795145											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181795-02	Lumiracoxib	170465597	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	220991-20-8				-6.964206176	4	5		0	4.21274838					Clc2cccc(F)c2Nc1ccc(C)cc1CC(=O)O	Sequoia	220991-20-8	-4.31794149	-1.14477828	-3.01000544	1.14361824	4.21274838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016035-13	Trazodone hydrochloride	170465234	alpha2-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	25332-39-2	; ;Trazodone hydrochloride; Desyrel; Trazodone hydrochloride;TRAZODONE HYDROCHLORIDE; Trazodona;Trazodone?HCl			-20.2444348539	4	5		0	-4.13932357			150	ADRA2A	Cl.Clc1cccc(c1)N2CCN(CC2)CCCN3N=C4C=CC=CN4C3=O	Microsource	01503121	-5.33133592	-5.80049366	-2.39042157	-2.19997244	-4.13932357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344542-01	Transfluthrin	225144388	Cytochrome P450 3A2 Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	118712-89-3		1.2589254118	-5.9	-17.6823454392	4	5		11.2085283879	2.79014272	0.0416245633	0.9786765179			CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=C(F)C(=CC(=C2F)F)F	SIGMA	46114	-6.4328516	-8.50710699	-6.38422573	3.67886832	2.79014272											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274074-01	2-(Dodecyloxy)ethanol	170466587		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	4536-30-5				-25.76054681	4	4		0	-6.22007408					OCCOCCCCCCCCCCCC	SIGMA	03819	-5.11853682	-7.45659275	-4.04717234	-6.22007408												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262588-02	Merbromin	225144359		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	129-16-8				-6.0196447444	4	4		0	-7.64506942					O.O.O.[Na+].[Na+].O[Hg]C1=C([O-])C(=CC2=C1OC3=CC(=C(Br)C=C3C24OC(=O)C5=CC=CC=C45)[O-])Br	Prestwick	Prestw-787	0.63528478	-0.3455425	-2.41250866	-7.64506942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178357-03	BUCLADESINE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	362-74-3				-25.0644087229	4	4		0	-9.96796013					CCCC(=O)NC1=C2N=C[N](C3O[C@@H]4CO[P](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1	Microsource	01503043	-5.1793356	-2.40152039	-3.87647263	-9.96796013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183005-01	Zanapezil fumerate	144206802	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	263248-42-6	CIPLUS_775863; Zanapezil Fumarate; 			-21.5283698811	4	4	CIPLUS_775863;ZANAPEZIL;Zanapezil Fumarate;CIPLUS_3882440;CIPLUS_3882439;zanapezilum;	0	-3.66338423					O=C(O)/C=C/C(=O)O.O=C(CCC2CCN(Cc1ccccc1)CC2)c3ccc4CCCCNc4c3	Pharmaron	PH-NIH-100582	-5.04052356	-5.59996562	-2.86786384	-3.66338423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185750-01	Astromicin	144206938	Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	55779-06-1				-16.7214828597	4	4		0	-5.08175987					NCC(=O)N(C)[C@H]2[C@@H](O)[C@H](O[C@H]1O[C@@H](CC[C@H]1N)[C@H](C)N)[C@@H](N)[C@H](O)[C@@H]2OC	Sequoia	ASTROMICIN SULPHATE	-3.61028041	-5.52260615	0.22335388	-5.08175987												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183003-01	Depolipon	144206803		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	16488-48-5	p-Butylaminobenzoyldiethylaminoethyl hydrochloride; Calvital liquid; T cain; 			-3.99952555	4	4	P-BUTYLAMINOBENZOYLDIETHYLAMINOETHYL HYDROCHLORIDE;Calvital liquid;T cain;CIPLUS_170427;p-Butylaminobenzoyldiethylaminoethyl Hydrochloride;p-Butylaminobenzoyldiethylaminoethyl hydrochloride;CIPLUS_162500;	0	-1.06152317					[Cl-].CC[NH+](CC)CCOC(=O)c1ccc(NCCCC)cc1	Pharmaron	PH-NIH-101688	-1.47791791	0.58019598	0.23228804	-1.06152317												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532506-01	SODIUM LAURYL SULFOACETATE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-32.1835571895	4	4		0	-5.71377714					CCCCCCCCCCCCOC(=O)C[S]([O-])(=O)=O	SIGMA	MFCD00214054	-7.7734151	-5.89149965	-5.64362439	-5.71377714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167563-01	Mofezolac	144206111	Cyclooxygenase-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	78967-07-4	Mofezolac; Mofezolaco; 			-13.1671431047	4	4	mofezolac;n-22;(3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid;mofezolacum;(3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid;Mofezolac;CIPLUS_213447;Mofezolaco;LS-86501;N-22;3,4-BIS(P-METHOXYPHENYL)-5-ISOXAZOLEACETIC ACID;3,4-DMPIAA;N 22;MOFEZOLAC;Mofezolacum;	0	-3.1505874					O=C(O)Cc2onc(c1ccc(OC)cc1)c2c3ccc(OC)cc3	SigmaAldrich	R678899	-2.94701549	-2.06461645	-2.63773389	-3.1505874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390090-01	Alclometasone dipropionate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	66734-13-2		1.1220184543	-5.95	-3.6467672136	4	4		10.20608504	-2.47086458	1	0.9989395499			CCC(=O)OCC(=O)[C@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3[C@H](Cl)CC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	Prestwick	Prestw-771	-4.3384042	-2.05002579	6.12883052	-2.47086458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390646-02	Isavuconazole			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	241479-67-4				-25.568671014	4	4		0	-5.35777857					C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](O)(C[N]3C=NC=N3)C4=CC(=CC=C4F)F	MedChem Express	HY-14273	-6.88225173	-1.84865238	-3.85914761	-5.35777857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386235-04	Cobicistat		Cytochrome P450 3A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1004316-88-4				-28.6995825426	4	4		0	-3.55998576					CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	Glixx	GLXC-90002	-8.12635108	-3.96510021	-3.59927235	-3.55998576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024995-43	Paclitaxel		Tubulin Depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	33069-62-4		5.6234132519	-5.25	-101.0725799166	-2.4	4		-66.4853706815	-57.47131629	0.3098878357	0.9357002712		TUBB	CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)C4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7	Aobious	AOB5558	-8.27373987	-23.85679904	-29.06280711	-57.47131629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387301-01	Timiperone		serotonin receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-10.5737742499	4	4		0	0.97118078					FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)N3C(=S)NC4=C3C=CC=C4	Toronto Research	T443110	-3.2202141	-1.55148702	-2.84999553	0.97118078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249917-01	Cloxazolam	170465787	GABA-A receptor; benzodiazepine site Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	24166-13-0				-18.1236806695	4	4		0	-4.25060981					Clc1ccccc1C34OCCN4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-177	-4.80648377	-4.64586557	0.82194229	-4.25060981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015242-13	Chlorothiazide	170465303	Hypertension treatment	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	58-94-6	; ; Clorotiazida;CHLOROTHIAZIDE; Chlorothiazide;Chlorothiazide; Fluitoran; SK-Chlorothiazide	3.5481338923	-5.45	17.3534965544	4	4		-16.214382508	-2.67865209	0.7446752838	0.3454485581		SLC12A3	NS(=O)(=O)c2cc1c(N=CNS1(=O)=O)cc2Cl	Microsource	01500180	-0.3337234	26.87381812	2.0369874	-2.67865209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159492-03	Perazine	29215457	Cytochrome P450 1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox		Perazine; Perazine Maleate (1:1); Perazine Maleate (1:2); Maleate, Perazin; Taxilan; Dihydrochloride, Perazin; Perazine Dihydrochloride; Perazine Fendizoate; 	31.6227766017	-4.5	-77.0177190899	-3	4	CIPLUS_744600;Perazine Fendizoate;LS-172810;CIPLUS_776815;PERAZINE DIMALONATE;Maleate, Perazin;10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-;Perazine Dihydrochloride;Dihydrochloride, Perazin;CIPLUS_666528;10-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine dihydrochloride;Perazine Dimalonate;CIPLUS_660985;Perazine Maleate (1:1);Perazine Maleate;10h-phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-, (z)-2-butenedioate;CIPLUS_777988;PERAZINE MALEATE;LS-105591;LS-105593;pernazine;LS-173237;Perazine maleate;Pernazine;Perazine Maleate (1:2);Perazine;LS-105589;Perazine dimalonate;CIPLUS_149789;Cinchonan-9-ol, 6'-methoxy-, (9S)-, sulfate (2:1) (salt), mixt. with 5,5-diphenyl-2,4-imidazolidinedione and 10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazine (Z)-2-butenedioate (1:2);Taxilan;CIPLUS_769544;phenrytmat;	-121.6910892677	-99.36810253	0.0483165485	0.9985574223			CN1CCN(CCCN2C3=CC=CC=C3SC4=CC=CC=C24)CC1	AKos	AKJ-93711	-8.75281246	-6.40117484	-4.57813583	-99.36810253												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00167550-08	Narasin		Nf-kappa B Signaling Pathway Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	55134-13-9		1.995262315	-5.7	-248.9552008672	-2.3	4		-122.9498936875	-99.41260235	0.5627247386	0.733809435			CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C)C(O)=O	Enzo	NP198	-32.74363612	-71.89011748	-58.3549896	-99.41260235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522027-01	Predocol			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	630-67-1				-14.0197225476	4	4		0	-3.08828765					C[C@]12C[C@H](O)[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C5=CC(=CC=C5)[S]([O-])(=O)=O	Toronto Research	P703795	-4.84404641	-0.70836213	1.6502079	-3.08828765												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183833-01	Bimosiamose	144206811	Selectin E Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	187269-40-5				-1.4074172261	4	4		0	-0.94339623					O=C(O)Cc1cccc(c1)c3cc(ccc3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)CCCCCCc5ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(c5)c6cccc(CC(=O)O)c6	Pharmaron	PH-NIH-124707	0.49411038	0.15549413	1.1477824	-0.94339623												1.6E-9	8E-9	4E-8	2E-7											
NCGC00179250-03	Halofantrine	170465140	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	36167-63-2	; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine	12.5892541179	-4.9	-37.6224241204	4	4		-16.591937804	-17.65752937	0.318087356	0.9324393973			Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F	Prestwick Chemical, Inc.	Prestw-1031	-7.01460273	-2.9975812	-6.31930007	-17.65752937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181044-04	Selenomethionine		dietary supplement	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	3211-76-5				-13.7041274649	4	4		0	-4.521637				CAT	C[Se]CC[C@H](N)C(O)=O	Enzo	RD122	-1.23520999	-7.86917655	-0.97382293	-4.521637												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00184994-02	Cidofovir	225144336	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	113852-37-2	Cidofovir;CIDOFOVIR;Cidofovir (Vistide)			0.1508150544	4	4		0	0.96214654					NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	Sequoia	113852-37-2	-0.09968361	-3.44249613	-0.04467078	0.96214654												1.6E-9	8E-9	4E-8	2E-7											
NCGC00017244-16	ENOXOLONE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	471-53-4				-14.6965618408	4	4		0	1.79779281					[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]3(C)C2=CC(=O)[C@]4([H])[C@@]5(C)CC[C@H](O)C(C)(C)[C@]5([H])CC[C@@]34C)C(O)=O	Microsource	01500990	-5.0293378	-1.36489288	-3.20945946	1.79779281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241107-02	Bosutinib	170466788	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	918639-10-8	 Bosutinib;Bosutinib;PF-5208763/SKI-606	5.6234132519	-5.25	-121.7040970746	-2.3	4		-105.096493894	-99.73300107	0.08237454	0.9957915223	25	ABL1	CO.COc4cc(Nc3c(C#N)cnc2cc(OCCCN1CCN(C)CC1)c(OC)cc23)c(Cl)cc4Cl	Sequoia	380843-75-4	-7.17342392	-2.67795439	-38.58714484	-99.73300107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183866-01	Oxypertine hydrochloride	144206763	Adenylate cyclase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	17506-66-0				-47.9778694925	4	4	OXYPERTINE;LS-82918;oxypertine;CIPLUS_152240;Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-;Oxipertina;Equipertine;Forit;CIPLUS_179718;Oxypertinum;Oxypertin;oxypertinum;1H-Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-;Oxypertine;	0	-12.86044856					Cl.COc3cc4nc(C)c(CCN1CCN(CC1)c2ccccc2)c4cc3OC	NCI	NSC_169107	-10.94983897	-6.84174153	-8.04313929	-12.86044856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016981-05	Troleandomycin		70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	311074				-24.1658708295	4	4		0	-6.75507298					CO[C@@H]1C[C@@H](O[C@H](C)[C@H]1OC(C)=O)O[C@H]2[C@H](C)[C@H](O[C@@H]3O[C@@H](C)C[C@H]([C@H]3OC(C)=O)N(C)C)[C@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@H](C)[C@H](C)OC(=O)[C@@H]2C	Enzo	EI249	-4.91463361	-6.01243953	-3.38270963	-6.75507298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178575-05	Morantel tartrate	170465696	Neuronal acetylcholine receptor; alpha3/beta2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	26155-31-7				-22.8561307881	4	4		0	-1.78889284					Cc2ccsc2\C=C\C1=NCCCN1C.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503931	-6.28226055	-6.21976503	-1.61555787	-1.78889284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159319-04	Zonisamide	174006630	Na channel blocker, T-type Ca channel blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	68291-97-4	 ; Zonisamide sodium salt; Elan brand of zonisamide; Excegran; Zonegran; Zonisamide;Zonisamide; Zonisamide sodium			-21.6878811584	4	5		0	-5.41507962					NS(=O)(=O)Cc2noc1ccccc12	Vitas	STK711131	-5.65738456	-5.17065282	-3.83890819	-1.21710375	-5.41507962											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00480885-01	INT-747 (Obeticholic acid)		Bile acid receptor FXR Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	459789-99-2				-34.2077035887	4	4		0	-12.38875044					CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14	Glixx	GLXC-05527	-6.56460934	-5.46821009	-6.24133749	-12.38875044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181160-01	Ecabet	144206316	Urease subunit alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	33159-27-2	Ecabet; 			-29.1160948795	4	4	LS-174407;CIPLUS_207819;ECABET;ecabet sodium;TA-2711;ecabetum;12-sulfodehydroabietic acid;Ecabet Sodium;Ecabetum;Ecabet;TA 2711;CIPLUS_3872531;ecabet;1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt;	0	-6.44357423				ureC	CC(C)c2cc3CC[C@@H]1[C@](C)(CCC[C@@]1(C)C(=O)O)c3cc2S(=O)(=O)O	NCI	NSC-659804	-7.35871531	-5.27816171	-2.60308385	-6.44357423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014711-14	Oxaprozin	170464987	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	21256-18-8		1.77827941	-5.75	-18.3036718132	4	5		11.1469862479	-7.98494791	0.0937625254	0.9946016057			OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3	Microsource	01505267	-7.62248854	-6.66865265	-6.67727216	3.56864006	-7.98494791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015014-11	Acetohexamide	170465411	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	968-81-0				-10.1938334943	4	5		0	0.39465835					O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O	Microsource	01505425	-5.64857244	-5.23874372	1.29359066	3.92688192	0.39465835											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183000-01	Lanperisone hydrochloride	144206892	Sodium channel alpha subunit Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	116287-13-9	Lanperisone; 			-7.4797440845	4	5	Lanperisone hydrochloride;lanperisone;LANPERISONE HYDROCHLORIDE;Lanperisone Hydrochloride;CIPLUS_775823;CIPLUS_3846316;LANPERISONE;Lanperisone;lanperisonum;	0	-3.08384195					C[C@H](CN1CCCC1)C(=O)c2ccc(cc2)C(F)(F)F	Pharmaron	PH-NIH-98442	-3.03137117	-2.69384628	-1.98015657	5.31392091	-3.08384195											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00389453-01	Chlortetracycline HCl		translation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	64-72-2 				-28.4728038222	4	4		0	-10.12815949					CN(C)C1C2CC3\C(=C(O)/C4=C(O)C=CC(=C4C3(C)O)Cl)C(=O)C2(O)\C(=C(C(N)=O)/C1=O)O	APExBIO	B1699	-7.06754312	-3.02349689	-1.06115731	-10.12815949												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186054-01	Tannic acid	124896727	Beta-secretase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			7.0794578438	-5.15	-101.0098201153	-2.1	4		-81.3351615928	-81.51477394	0.0210107994	0.9997276627			OC1=CC(=CC(=C1O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@H]3O[C@@H](OC(=O)C4=CC(=C(O)C(=C4)OC(=O)C5=CC(=C(O)C(=C5)O)O)O)[C@H](OC(=O)C6=CC(=C(O)C(=C6)OC(=O)C7=CC(=C(O)C(=C7)O)O)O)[C@@H](OC(=O)C8=CC(=C(O)C(=C8)OC(=O)C9=CC(=C(O)C(=C9)O)O)O)[C@@H]3OC(=O)C%10=CC(=C(O)C(=C%10)OC(=O)C%11=CC(=C(O)C(=C%11)O)O)O	SIGMA	16201	-7.38518551	-6.47028334	-23.89553015	-81.51477394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182027-01	Amogastrin	144206458	Cholecystokinin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	16870-37-4	Amogastrin; Amogastrina; 			-16.4816500842	4	4	AMOGASTRIN;amogastrin;CIPLUS_214157;Amogastrina;tert-amyloxycarbonyltetragastrin;Amogastrinum;Amogastrin;Amogastrine;amogastrine;amogastrinum;	0	-4.14738341					NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)OC(C)(C)CC)Cc3cnc2ccccc23	ACC	AMOGASTRIN	-5.0469846	0.16413269	-0.87058212	-4.14738341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344524-01	Benzylhexadecyldimethylammonium chloride	170465465		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	122-18-9		12.5892541179	-4.9	-92.1661148635	-3	4		-104.8716747711	-99.25240299	0.0222144876	0.9996955158			[Cl-].C[N+](C)(Cc1ccccc1)CCCCCCCCCCCCCCCC	SIGMA	13400	-5.0205144	-3.00621976	-4.37889813	-99.25240299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016640-06	Todralazine hydrochloride	170465782	histone acetylation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3778-76-5				-27.0441868964	4	5		0	-5.15809279					Cl.O=C(OCC)NNc2nncc1ccccc12	Microsource	01501174	-7.44624603	-6.52395949	-6.09955206	-0.79456207	-5.15809279											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095152-09	Alfuzosin hydrochloride	170465022	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	81403-68-1	; Uroxatral ER; ; ALFLUZOCIN;ALFUZOSIN HYDROCHLORIDE; Uroxatral; Alfuzosin Hcl (Uroxatral);Alfuzosin hydrochloride; Afluzosin;ALFLUZOSIN			-10.1653531401	4	5		0	-0.8902758			148	ADRA1A	Cl.O=C(NCCCN(C)c2nc1cc(OC)c(OC)cc1c(N)n2)C3CCCO3	Microsource	01505263	-2.6965104	-4.16631203	-2.54113116	0.27097782	-0.8902758											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164563-04	Entecavir (monohydrate)		DNA Polymerase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	209216-23-9				-21.6978644669	4	4		0	-6.49697401				SLC22A3	NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	MedChem Express	HY-13623A	-4.30581903	-5.96060815	-2.40384615	-6.49697401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386298-01	Rifapentine		DNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	61379-65-5				-6.4862034993	4	4		0	-1.3260947				PRKDC	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(CC5)C6CCCC6	Selleck	S1760	-1.02351436	-1.92639945	-2.19594595	-1.3260947												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182705-02	Azatadine	170464865	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	3964-81-6				-16.4656689343	4	4		0	-8.499466					CN1CC\C(CC1)=C2\c4ncccc4CCc3ccccc23	APAC	555789	-2.4881987	-2.06461645	-3.31340956	-8.499466												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261972-01	NCGC00261972-01	225144356		DPI_SARS-CoV-2_General	2019_NPC-7_Tox		Cymelarsan;Rm-110;Melarsominum;Merial brand of melarsomine			-29.4604363405	4	4		0	-6.99537202					NCCS[As](SCCN)C1=CC=C(NC2=NC(=NC(=N2)N)N)C=C1	GVK	FFS-11-286-NCI-125	-7.7028279	-6.44436766	-0.08229383	-6.99537202												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241108-04	Axitinib	170466656	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	319460-85-0	AG-013736;Inlyta;Axitinib; Axitinib;AG-13736			-28.2370603103	4	4		0	-7.78746885			2321	FLT1	CNC(=O)c4ccccc4Sc1ccc3c(c1)nnc3/C=C/c2ccccn2	Sequoia	319460-85-0	-6.91754533	-5.31271596	-1.48562024	-7.78746885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090868-06	HALOTHANE		GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	151-67-7				-22.0070764511	4	4		0	-7.17337131					FC(F)(F)C(Cl)Br	Microsource	01505434	-5.69109278	-1.77954388	-1.24306999	-7.17337131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160596-03	Aluminum monostearate	225144243		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	7047-84-9		0.1276967882	-6.893820026	-9.3552966774	4	5		11.704441308	-5.48850443	0.0476584372	0.9986111197			CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O	SIGMA	06270	-8.50370109	-8.38794791	-6.12467032	3.2930694	-5.48850443											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00181129-14	Dasatinib		Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	302962-49-8		1.2589254118	-5.9	-187.9913752487	-2.4	4		-83.3009111768	-65.41473834	0.5219980578	0.7824676113		ABL1	CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Adooq	A10290	-29.20545286	-48.81651693	-43.49012474	-65.41473834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249932-01	Emorfazone	170465843		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	38957-41-4				-7.1226674915	4	5		0	-3.65288422					CCOC1=C(C=NN(C)C1=O)N2CCOCC2	GVK	FFS-11-286-NCI-236	-0.47585478	-5.36641416	-2.03876586	2.38368622	-3.65288422											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018271-07	Homochlorcyclizine	170465786		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	848-53-3		14.1253754462	-4.85	-30.2003339901	4	5		-17.144096184	-16.78674682	0.4953734886	0.5944163749			Clc1ccc(cc1)C(c2ccccc2)N3CCCN(C)CC3	Enzo	AC927	-5.48114205	-7.57936846	-5.66416879	2.53065724	-16.78674682											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167493-04	Manidipine	174006297	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	89226-75-5	; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride	14.1253754462	-4.85	-25.5561515498	4	5		-21.899775136	-19.91647928	0.421674075	0.6858468277			Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5	Selleck	S2481	-5.20796616	-4.24291429	-5.05295768	7.84917099	-19.91647928											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183854-01	Oxendolone	144206842		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	33765-68-3				-9.9634349972	4	4	16 ethyl-17-hydroxy-4-estren-3-one;oxendolone;16-beta-Ethyl-19-nortestosterone;NE-19595;Oxendolonum;oxendolonum;(16 beta,17 beta)-16-ethyl-17-hydroxyestr-4-en-3-one;16 beta-ethyl-19-nortestosterone;CIPLUS_178076;Oxendolona;16 beta-ethyl-17 beta-hydroxyestr-4-en-3-one;TSAA291;LS-64849;Oxendolone;OXENDOLONE;EHOO;Prostetin;TSAA-291;TSAA 291;PROSTETIN;16B-ETHYL-17B-HYDROXYESTR-4-EN-3-ONE;	0	0.08582528					CC[C@H]2C[C@H]3[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@]3(C)[C@H]2O	Pharmaron	PH-NIH-152939	-3.47159017	-0.98418429	-0.6789958	0.08582528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025000-14	Ketoconazole		Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	13463-41-7	; ; Ketoconazol; Nizoral;Ketoconazole; Ketoconazole; Ketocanazole			-10.9603666015	4	4		0	-4.64811636			1588	CYP19A1	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@@](C[N]4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	SIGMA	K1003	-2.30139124	-0.17620767	-2.12632896	-4.64811636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091151-04	Phenoxyacetic acid	170465537	cell proliferation Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	122-59-8				-6.047539419	4	4		0	-3.45559671					O=C(O)COc1ccccc1	Vitas	STK300005	-1.57326746	2.94395737	-2.15313142	-3.45559671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159455-09	Gefitinib	170464828	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	184475-35-2	;Iressa/ZD-1839;Gefitinib; Iressa; Gefitinib	11.220184543	-4.95	-120.9162432044	-3	5		-109.5299493353	-97.43472076	0.0020487661	0.9989742189	1956	EGFR	Fc1ccc(cc1Cl)Nc2ncnc3cc(OC)c(cc23)OCCCN4CCOCC4	Tocris	3000	-9.49947127	-10.27747042	-13.02382049	-20.29577918	-97.43472076											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00379009-01	Octreotide acetate		Growth Hormone Release Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	79517-01-4				-16.7903464554	4	4		0	-3.63628151				SSTR1	CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=C[NH]C5=C4C=CC=C5)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1	MedChem Express	HY-17365	-3.74897066	-6.4853017	0	-3.63628151												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181137-01	Sulfathiourea	144206297		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	515-49-1	Sulfatolamide; Marbadal; Sulfatolamida; Sulfanilthiocarbamide; Sulfatiourea; 			-22.2075042081	4	4	LS-160708;Sulfatolamida;Sulfanilthiocarbamide;Sulfatolamidum;CIPLUS_210321;sulfathiouree;Urea, 1-sulfanilyl-2-thio-;sulfatolamidum;sulfathiourea;LS-172308;Sulfatolamide;SULFATHIOUREA;sulphatolamide;SULFATOLAMIDE;CIPLUS_213879;Sulfathiouree;Marbadal;1-sulfanilyl-2-thiourea compound with alpha-amino-p-toluenesulfonamide (1:1) marbalettes;sulfatolamide;1-sulfanilyl-2-thiourea;Sulfatiourea;Sulfathiourea;	0	-6.49110127					Nc1ccc(cc1)S(=O)(=O)NC(N)=S	NCI	NSC-108228	-4.3384042	-7.31906481	-1.66175288	-6.49110127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164462-01	Pyriproxyfen	26757881	juvenile hormone metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	95737-68-1				-13.7369440475	4	4	pyriproxyfen;pyriproxyfen, (S)-isomer;2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine;CIPLUS_668570;Pyriproxifen;pyriproxyfen, (R)-isomer;NCGC00164462-01;S 31183;juvinal;2-[1-Methyl-2-(4-phenoxyphenoxy)ethoxy]pyridine;NCGC00163945-01;CIPLUS_760107;Pyriproxyfen;S-31183;	0	0.36588671					CC(COC1=CC=C(OC2=CC=CC=C2)C=C1)OC3=NC=CC=C3	EPA	EPA-CAS-95737-68-1	-4.4684263	-4.12154031	0.40203699	0.36588671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178060-03	Tolperisone hydrochloride	170465769	Voltage-gated calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3644-61-9				-9.0717491906	4	5		0	-0.0183562					Cl.CC(CN1CCCCC1)C(=O)c2ccc(C)cc2	Microsource	01501194	-1.9034191	-6.26861861	-3.92263574	2.28264364	-0.0183562											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015368-11	Dicyclomine	170464896	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	77-19-0				-17.8229769216	4	4		0	-5.93097841					CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2	Microsource	01500240	-4.19971395	-2.8665979	-0.94702046	-5.93097841												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016498-08	Dyclonine hydrochloride	170464776	Sodium channel protein type II alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	536-43-6				8.3383816294	4	5		0	2.36149366					Cl.CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2	Microsource	01500268	2.60635111	0.98596401	-0.75319671	2.25591212	2.36149366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015277-17	Cinoxacin	170465414	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	28657-80-9		1.1220184543	-5.95	-24.3351958208	4	5		9.5262774959	-4.03214882	0.2620916124	0.9558043826			O=C(O)C2=NN(CC)c1cc3OCOc3cc1C2=O	Microsource	01500190	-9.18856458	-6.86730388	-6.11315467	1.23008488	-4.03214882											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164534-02	4-Phenolsulfonic acid	170465916		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	98-67-9		0.8912509381	-6.05	-17.0379124183	4	5		16.70089018	-4.21276019	0.1181650326	0.9913682303			Oc1ccc(cc1)S(O)(=O)=O	Labotest	LT03353562	-9.33407515	-6.41952984	-2.21579961	4.36203531	-4.21276019											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025158-02	(S)-(+)-Dimethindene maleate	170465880	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1217457-81-2				-25.43924957	4	5		0	-7.91529327					C[C@@H](C=1c2ccccc2CC=1CCN(C)C)c3ccccn3.O=C(O)/C=C\C(=O)O	Tocris	1425	-5.58503809	-3.37983295	-3.09160974	-6.64064273	-7.91529327											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017358-15	Rotenone	170466816	NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	83-79-4	;ROTENONE;Rotenone	1.1220184543	-5.95	-103.7524384244	-2.4	5		-63.0807085835	-47.67688626	0.2833048658	0.8189468015	51103	NDUFAF1	C=C(C)[C@@H]2Oc3ccc1C(=O)[C@H]4c5cc(OC)c(OC)cc5OC[C@H]4Oc1c3C2	Microsource	00200013	-8.74347342	-11.89615087	-35.13750219	-27.22073442	-47.67688626											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015680-18	Melatonin	170465589	NOS2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	73-31-4	; ;Melatonin;MELATONIN; Melatonin			-23.9992140322	4	5		0	-6.28076037				MTNR1B	CC(=O)NCCc2cnc1ccc(cc12)OC	Specs	AN-153/I149495	-8.31550116	-1.18401791	-3.24049746	-1.13022559	-6.28076037											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178317-03	Foscarnet trisodium	170465060	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63585-09-1				-5.4998046654	4	5		0	-1.19266466					[Na+].[Na+].[Na+].[O-]C(=O)P([O-])([O-])=O	Microsource	01502019	-0.46633882	-4.0516129	-0.95704331	-0.34706572	-1.19266466											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015096-17	Amiodarone hydrochloride	170464920	Muscarinic M3 Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1951-25-3	; Ancaron; Kordaron; Amiodarone;Amiodarone; Amiodarona;Amiodarone hydrochloride;Amiodarone?HCl	12.5892541179	-4.9	-70.5205319447	-3	5		-73.7288481411	-70.37618258	0.0361363002	0.9814320709		CHRM3	CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC	Microsource	02300165	-6.41851789	-8.77419355	-1.07171209	1.23952042	-70.37618258											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164499-03	DL-alpha Tocopheryl nicotinate	170465780	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	43119-47-7				-18.5649145881	4	5		0	-4.55544097					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc3c(O1)c(C)c(C)c(OC(=O)c2cccnc2)c3C	Labotest	LT00772349	-6.25741903	-5.20430108	-1.69798007	1.81646083	-4.55544097											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183871-04	N-Acetyl sulfamethoxazole	170466005		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	21312-10-7				-23.1557282865	4	5		0	-5.46114872					Cc2cc(NS(=O)(=O)c1ccc(NC(C)=O)cc1)no2	Specs	AA-504/07985056	-6.78311006	-7.58709677	-2.88877128	1.18543225	-5.46114872											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016551-04	Meprylcaine hydrochloride	170466009	"Sodium channel alpha subunits; brain (Types I, II, III) Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	956-03-6		1	-6	-23.5828817861	4	5		11.34619298	-8.02582612	0.0519120803	0.9983537233			Cl.CC(C)(COC(=O)c1ccccc1)NCCC	Prestwick Chemical, Inc.	Prestw-1064	-9.03849415	-8.56774194	-6.01129046	2.33029839	-8.02582612											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015959-09	Sanguinarine	170466353	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2447-54-3		6.3095734448	-5.2	-118.8628614879	-3	5		-105.9012285356	-99.63682016	0.0255104564	0.9869971579	100009298	PPP1CA	C[n+]2cc1c6OCOc6ccc1c3ccc4cc5OCOc5cc4c23	Tocris	2302	-5.42648804	-10.10752688	-1.29222898	2.86216533	-99.63682016											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00160387-04	Clothiapine	170465938	GABA-A receptor; benzodiazepine site Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2058-52-8				-33.3354891298	4	5		0	-9.90001345					CN1CCN(CC1)C3=Nc4ccccc4Sc2ccc(Cl)cc23	Enzo	D108	-7.66491436	-7.99139785	-5.08511952	-3.69151717	-9.90001345											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00522017-01	rac Alminoprofen		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	39718-89-3				-28.6443508821	4	4		0	-4.72039028					CC(C(O)=O)C1=CC=C(NCC(C)=C)C=C1	Toronto Research	A575150	-7.24223118	-8.3935018	-1.08103279	-4.72039028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346456-05	Macitentan		Endothelin ETA/ETB Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	441798-33-0				-6.1090884289	4	4		0	-2.69672057				EDNRA	CCCN[S+]([O-])(=O)NC1=NC=NC(=C1C2=CC=C(Br)C=C2)OCCOC3=NC=C(Br)C=N3	Glixx	GLXC-90056	-2.53543102	0.50283651	2.90360046	-2.69672057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015288-09	Cyclothiazide	170465274	renal sodium ion absorption Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	2259-96-3				-20.5926380574	4	4		0	-4.28674677					NS(=O)(=O)c4cc1c(NC(NS1(=O)=O)C3CC2C=CC3C2)cc4Cl	Microsource	01503263	-3.8876609	-7.64569366	-3.02867864	-4.28674677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015646-05	Fomepizole	170465026	Alcohol Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	56010-88-9	FOMEPIZOLE HYDROCHLORIDE;4-Methylpyrazole hydrochloride; 4-Methylpyrazole hydrochloride			-17.4199568686	4	5		0	-4.67331919			124	ADH1	Cl.Cc1cnnc1	Microsource	01505432	-5.08859026	-4.97287523	-1.92678227	0.47660115	-4.67331919											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090987-05	1-Naphthaleneacetic acid	170466030	Fusarium oxysporum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	86-87-3				-34.443795225	4	5		0	-6.71422766					O=C(O)Cc2cccc1ccccc12	Specs	AE-562/J257199	-10.69502696	-7.42702144	-5.03590822	-1.25731923	-6.71422766											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159383-04	Propyl benzoate	170465563		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2315-68-6				-17.2124302586	4	5		0	-5.00745022					O=C(OCCC)c1ccccc1	Labotest	LTBB003527	-4.26688351	-6.72091621	-4.27395341	3.04570832	-5.00745022											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179584-05	Ceftazidime		Penicillin-binding protein 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	72558-82-8				-29.9493513128	4	4		0	-5.5340102					CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)C[N+]3=CC=CC=C3)C4=CSC(=N4)N)C(O)=O	Enzo	DL348	-8.74361859	-6.42608284	0.05737741	-5.5340102												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016267-06	Isocarboxazid		Monoamine oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	59-63-2				-30.7922025706	4	4		0	-4.07860909					CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Prestwick	Prestw-795	-8.88206282	-1.13553271	-4.038487	-4.07860909												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00093976-08	Idarubicin hydrochloride	170464627	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57852-57-0	 ; Idarubicina; Idamycin; Idarubicin hydrochloride;Idarubicin HCl; Idarubicin Hcl; 4 Desmethoxydaunorubici; IDARUBICIN HCl; 4 Demethoxydaunorubici; 4-Desmethoxydaunorubicin;Idarubicin; Idarubicin; Hydrochloride, Idarubici;Idarubicin?HCl	5.6234132519	-5.25	-50.9469062423	-2.4	5		-37.36095222	-31.24370825	0.1060717135	0.9424359932	7153	TOP2A	Cl.CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2ccccc2C(=O)c3c(O)c5C4	Sequoia	57852-57-0	-3.71328365	-1.3595814	-12.44273175	-15.82383874	-31.24370825											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016098-11	Xylazine	170466147	Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	7361-61-7				-36.2548618493	4	5		0	-8.19987188					Cc2cccc(C)c2NC1=NCCCS1	Enzo	AC809	-7.8956598	-5.76857094	-7.97259687	-8.4092901	-8.19987188											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348375-01	TILMICOSIN		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	108050-54-0				-36.8244967461	4	5		0	-7.30301089					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN3C[C@H](C)C[C@H](C)C3)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	FLUKA	33864	-9.0004384	-6.81506262	-6.27702847	-7.90096407	-7.30301089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015673-13	Minoxidil	170464704	K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	38304-91-5	Minoxidil; Loniten; Minoxidil; ;MINOXIDIL; Minoxidil Pfizer Bran; Riup; Pfizer Brand of Minoxidil; Regaine			-28.8373462696	4	5		0	-8.19524089					Nc1cc(nc(N)[n+]1[O-])N2CCCCC2	Microsource	01500415	-7.85329111	-6.0836993	-4.15133999	-1.42072534	-8.19524089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159417-05	Triclosan	170464936	Bacterial enoyl-[acyl-carrier-protein] reductase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	3380-34-5				-14.5990466652	4	5		0	-5.34158125					Clc2cc(Cl)ccc2Oc1ccc(Cl)cc1O	Labotest	LT02056532	-4.01865959	-4.48204598	-2.7938343	2.76428669	-5.34158125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166105-04	BENZYL NICOTINATE	225144269		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	94-44-0				-23.5888783113	4	5		0	-6.97611415					O=C(OCC1=CC=CC=C1)C2=CN=CC=C2	SIGMA	72351	-7.31404605	-1.84706794	-3.71343493	-1.32086605	-6.97611415											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162116-04	Cephapirin sodium	170465306	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	24356-60-3		0.1122018454	-6.95	-22.0531627974	4	5		15.060386888	-4.8990834	0.4921543072	0.8159448732			[Na+].[O-]C(=O)C=2N3C(=O)[C@@H](NC(=O)CSc1ccncc1)[C@H]3SCC=2COC(C)=O	Microsource	01500167	-9.63365574	-3.35399983	-4.33526012	0.82156961	-4.8990834											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018243-09	Sulfamethazine	170464893	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	57-68-1		1.1220184543	-5.95	-12.4177857644	4	5		10.0340237919	-2.25312683	0.0531258428	0.9982810971			O=S(=O)(Nc1nc(C)cc(C)n1)c2ccc(N)cc2	Vitas	STK097514	-6.27835316	-5.79092396	-3.32807847	3.87181699	-2.25312683											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179578-03	Mometasone furoate	170464666	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	83919-23-7	; 2-Furoate;Mometasone furoate; Nasonex; Mometasone Fuorate; Elocon; Sch 32088	1	-6	-30.6437934249	4	5		10.072557268	-5.96469048	0.1514569192	0.9858165534		CYP3A4	ClCC(=O)[C@@]5(OC(=O)c1ccco1)[C@H](C)C[C@@H]3[C@]5(C)C[C@H](O)[C@]2(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]23	Prestwick Chemical, Inc.	Prestw-572	-10.45536249	-9.02006372	-6.26204239	-0.3948981	-5.96469048											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159474-03	Fluprednisolone	170465086	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	53-34-9		1.1220184543	-5.95	-10.6547238223	4	5		13.0505007239	-4.56495236	0.3290849234	0.927185712			OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	SIGMA	34206	-8.37541727	-4.06010505	-3.41565948	6.98561118	-4.56495236											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016893-04	Clorsulon	170466229	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	60200-06-8				-11.9855001302	4	5		0	1.12430578					Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl	Prestwick Chemical, Inc.	Prestw-540	-3.02576393	-5.8856454	-3.70467683	-0.73078843	1.12430578											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015479-19	Genistein	170466848	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	446-72-0	; ; Genistein;GENISTEIN;Genistein (4',5,7-Trihydroxyisoflavone); Genestein;Genistein	14.1253754462	-4.85	-46.847079662	4	5		-18.201301416	-22.0842552	0.1956423815	0.8855156087	7153	TOP2A	Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O	Vitas	STK801619	-10.7207053	-5.360372	-5.18479594	-4.41650402	-22.0842552											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016526-07	Berberine	170465752	Protein Tyrosine Phosphatase (PTP) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	633-65-8	 ; Natural Yellow- 18; Berberine bisulfate; Berberine chloride form; Erben; Umbellatine; Berberine sulphate;Berberine chloride; Berberine chloride; 0   Berberin Sulfate;BERBERINE CHLORIDE; Kyoberin; Natural Yellow 18; Berberine Tannate	1.1220184543	-5.95	-15.6283648374	4	5		13.6634854039	-5.93759877	0.2033823671	0.9738956677	7803	PTP4A1	[Cl-].COc2ccc1cc3c4cc5OCOc5cc4CC[n+]3cc1c2OC	Labotest	LT00440956	-8.46957117	-5.48092655	-2.41723594	3.87181699	-5.93759877											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00247665-04	Anagrelide hydrochloride	170465269	Phosphodiesterase III (PDE3) inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	58579-51-4				-6.2379923232	4	5		0	0.53994692					Cl.Oc1cn2Cc3c(Nc2n1)ccc(Cl)c3Cl	Microsource	01505590	1.60894345	-3.29816435	-4.51295226	-5.49956179	0.53994692											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015279-08	Meclofenoxate hydrochloride	170465815		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3685-84-5				-14.5473616455	4	5		0	0.34776242					Cl.Clc1ccc(OCC(=O)OCCN(C)C)cc1	Microsource	01503226	-3.02937308	-3.69274318	-4.42731749	-5.02629273	0.34776242											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179542-03	Brinzolamide	170464926	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	138890-62-7				-33.4281053061	4	5		0	-6.62578933					NS(=O)(=O)c1cc2[C@H](CN(CCCOC)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-365	-7.9482683	-5.67421513	-5.9344894	-8.04119194	-6.62578933											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179401-03	Ethotoin	225144304	Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	86-35-1				-1.3860040556	4	4		0	-2.67341995					CCN1C(=O)NC(C1=O)C2=CC=CC=C2	Prestwick	Prestw-696	0.89744707	-1.87584118	-0.52704939	-2.67341995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182042-04	Propylhexedrine (hydrochloride)		Trace amine-associated receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1007-33-6				-33.2087991464	4	4		0	-7.99383396					CNC(C)CC1CCCCC1	Cayman	12058	-7.57166507	-7.83983849	-3.56738392	-7.99383396												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00167420-01	Perflenapent	144205977		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	678-26-2	QW-7437; 2H,3H-perfluoropentane; 			-28.1570084523	4	4	CIPLUS_156010;QW7437;perfluoropentane;DODECAFLUOROPENTANE;dodecafluoropentane;QW-7437;2H,3H-perfluoropentane;perflenapentum;QW 7437;PERFLUOROPENTANE;PERFLENAPENT;Perflenapent;	0	-8.06430302					FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F	Alfa Aesar	L16969	-6.74392263	-5.24057873	-1.78151407	-8.06430302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091219-08	DEET	170466080		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	134-62-3				-14.3009937473	4	5		0	-0.34767689					Cc1cccc(c1)C(=O)N(CC)CC	Microsource	01601020	-4.29256184	-5.89425644	-2.88141531	0.077164	-0.34767689											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091325-09	Dichlorophen	170465475	"Indoleamine 2,3-dioxygenase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	97-23-4		12.5892541179	-4.9	-82.1946327671	-3	5		-77.2111835796	-75.21108954	0.0196753644	0.9900172888			Oc2ccc(Cl)cc2Cc1cc(Cl)ccc1O	Microsource	01500626	-8.58084396	-6.24730905	-7.29549834	-0.85788208	-75.21108954											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160546-02	Haloxon	170466328	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	321-55-1				-33.1261447266	4	5		0	-9.71904457					O=P(OCCCl)(OCCCl)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	SIGMA	290963	-6.93117054	-5.34825871	-6.5253693	-6.73531989	-9.71904457											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274276-01	NCGC00274276-01	225144372	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					4.398220675	4	4		0	0.27887925					CC(CC1=CC2=C(OCO2)C=C1)NCC(O)C3=CC(=C(O)C=C3)O	GVK	FFS-11-286-NCI-024	2.47901705	-2.8904469	-0.17213223	0.27887925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182055-03	Bazedoxifene	170466793	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	198481-33-3	TSE-424/WAY-140424;Bazedoxifene; Bazedoxifene	12.5892541179	-4.9	-92.0861131889	-3	5		-104.7189612842	-99.57902443	0.0002184941	0.9998907501	2099	ESR1	CC(=O)O.Oc1ccc(cc1)c5c(C)c2cc(O)ccc2n5Cc3ccc(cc3)OCCN4CCCCCC4	APAC	872287	-4.26567295	-4.99656888	-4.67565832	-4.27256792	-99.57902443											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016239-04	Methantheline bromide	170465350	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	53-46-3				-2.5356274065	4	5		0	0.83279949			3274	HRH2	[Br-].CC[N+](C)(CC)CCOC(=O)C1c3ccccc3Oc2ccccc12	Prestwick	Prestw-1066	0.44278825	-0.71624635	-2.48340826	-2.49342682	0.83279949											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179367-03	Iopromide	170465023		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	73334-07-3				-1.0512656235	4	5		0	1.58323419					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)N(C)CC(O)CO)C(=O)NCC(O)CO)COC	Prestwick Chemical, Inc.	Prestw-872	1.91582639	-3.74420998	-1.46435453	-3.07186678	1.58323419											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016013-06	Trimipramine maleate	170465260	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	521-78-8				-24.7433155357	4	5		0	-8.60254416					O=C(O)/C=C\C(=O)O.CN(C)CC(C)CN2c3ccccc3CCc1ccccc12	Microsource	01503117	-3.7921964	-3.84714359	-4.1275958	-8.16389132	-8.60254416											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167525-02	Tazarotene	170464671	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	118292-40-3	 ; Tazarotene;Tazarotene; Zorac; Tazorac;Tazarotene (Avage)	1	-6	-3.1970996717	4	5		12.685806456	3.40761333	0.2705173234	0.8300084105	5915	RARB	O=C(OCC)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2	Sequoia	SRP01178t	-4.06138715	-6.82150538	-1.85675223	11.23681601	3.40761333											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182978-01	Tiaramide hydrochloride	144206772		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	35941-71-0				-25.8811823081	4	4		0	-8.70626171					Cl.OCCN1CCN(CC1)C(=O)CN2c3cc(Cl)ccc3SC2=O	NCI	NSC_289337	-6.39006663	-1.74631167	-2.62611996	-8.70626171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183844-01	Sitafloxacin hydrate	124894559	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	127254-12-0	Sitafloxacin			-34.8056579762	4	4	DU-6859A;Sitafloxacin Hydrate;sitafloxacin;sitafloxacinum;SITAFLOXACIN;CIPLUS_215256;Sitafloxacin;3-Quinolinecarboxylic acid, 7-(7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, (1R-(1alpha(S*),2alpha))-;SITAFLOXACIN SESQUIHYDRATE;sitafloxacine;CIPLUS_3818295;	0	-7.26829056			7155	TOP2B	N[C@H]2CN(CC12CC1)c3c(F)cc4c(c3Cl)[N@@](C=C(C4=O)C(=O)O)C5C[C@H]5F	Pharmaron	PH-NIH-183573	-9.47045081	-4.87762915	-2.54667432	-7.26829056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386213-04	Rupatadine (Fumarate)		Platelet activating factor receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	182349-12-8		11.220184543	-4.95	-51.9858946521	-3	4		-66.44688222	-59.12240185	0.1158161101	0.9916368132			CC1=CN=CC(=C1)CN2CCC(CC2)=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C35	MedChem Express	HY-13511A	-3.4913905	3.07109983	-1.46974445	-59.12240185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181111-02	Tamibarotene	170465883	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	94497-51-5	 ; Am80; Am 80;AM 80; Tamibarotene;tamibarotene; Amnoid			17.6853880324	4	4		0	10.74556626			5915	RARB	O=C(O)c1ccc(cc1)C(=O)Nc2ccc3c(c2)C(C)(C)CCC3(C)C	Tocris	3507	1.88197629	1.94416964	4.99183475	10.74556626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482904-01	Capromorelin		Ghrelin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	193273-66-4				-20.5042733786	4	4		0	-6.78896684					CN1\N=C2\CCN(C[C@]2(CC3=CC=CC=C3)C1=O)C(=O)[C@H](COCC4=CC=CC=C4)NC(=O)C(C)(C)N	DC Chemicals	DC7615	-3.87211214	-3.80231408	-4.12675994	-6.78896684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389572-01	FIROCOXIB		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	189954-96-9				-28.0858436839	4	4		0	-10.78042616					CC\1(C)OC(=O)\C(=C1C2=CC=C(C=C2)[S+](C)([O-])=O)OCC3CC3	Microsource	01504526	-4.89313836	-8.30143232	-2.47605597	-10.78042616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00385183-01	NCGC00385183-01		Potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-38.2442518936	4	4		0	-15.1030546					OC[C@H]1O[C@@H](OC2=CC=CC3=C2C(=O)C4=C(C=C(C=C4O)C(O)=O)[C@@H]3[C@@H]5C6=C(C(=O)C7=C5C=C(C=C7O)C(O)=O)C(=CC=C6)O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-010759	-6.2256641	-6.21962235	-5.77746392	-15.1030546												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00178520-03	Bromhexine hydrochloride	170465803	Mucolytic Agent	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	611-75-6	; Amiorel;abiadin;Bromhexine hydrochloride;Bromhexine HCl;BROMHEXINE HYDROCHLORIDE; Amyorel			-28.5532783946	4	4		0	-8.73240664					Cl.CN(Cc1cc(Br)cc(Br)c1N)C2CCCCC2	Vitas	STK177356	-6.16509475	-6.46909544	-2.52019243	-8.73240664												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168251-01	Ethylmorphine	144206163	Opioid receptors; mu/kappa/delta Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	76-58-4	Ethylmorphine hydrochloride; Veralgin; Dionin; Morphine 3-ethyl ether; 			-18.0944530897	4	4	Dionin;LS-91899;CIPLUS_781610;Veralgin;Morphine 3-ethyl ether;Ethylmorphine;LS-91901;LS-91902;LS-91903;CIPLUS_173377;CIPLUS_165781;O-Ethylmorphine hydrochloride;CIPLUS_730767;CIPLUS_149399;ETHYLMORPHINE HYDROCHLORIDE;Ethylmorphine hydrochloride;Morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-ethoxy-17-methyl-, hydrochloride,dihydrate;ethyl-alpha-isomorphine;CIPLUS_3884309;Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, (5alpha,6alpha)-;Ethylmorphine Hydrochloride;ETHYLMORPHINE;	0	0.71790355					CCOc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45	SigmaAldrich	E8512	-4.65278383	-5.13963661	-4.51694398	0.71790355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine	0.1432781529	-6.843820026	-4.4032712057	4	5		9.1811178639	-2.59628844	0.2554031874	0.9581681636	84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	-6.81759822	-4.55954534	-4.9220529	3.29081748	-2.59628844											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00183025-01	Biliscopin	144206809		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51022-74-3	Iotroxic acid; Acido iotroxico; 			8.1780744025	4	5	Acido iotroxico;3,3'-(oxybis(2,1-ethanediyloxy(1-oxo-2,1-ethanediyl)imino)bis(2,4,6-tri iodobenzoic acid));iotroxic acid, calcium salt;iotroxic acid;BENZOIC ACID, 3,3'-(OXYBIS(2,1-ETHANEDIYLOXY(1-OXO-2,1-ETHANEDIYL)IMINO))BIS(2,4,6, TRIIODO-;SH 213 AB;acidum iotroxicum;3,3'-(3,6,9-TRIOXAUNDECANEDIOYLDIAMINO)BIS(2,4,6-TRIIODOBENZOIC ACID);IOTROXIC ACID;Iotroxic acid;3,3'-(OXYBIS(ETHYLENEOXYMETHYLENECARBONYLIMINO))BIS(2,4,6-TRIIODOBENZOIC ACID);Iotroxic Acid;iotroxinate;iotroxic acid, magnesium salt;CIPLUS_180821;Acide iotroxique;Acidum iotroxicum;acide iotroxique;	0	-0.07675983					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)COCCOCCOCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Pharmaron	PH-NIH-120888-3	0.57776256	6.18703177	1.49763531	2.56456811	-0.07675983											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024994-06	Selegiline hydrochloride	170464993	MAO-B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	14611-52-0	; ; (R)-(-)-Deprenyl hydrochloride; Selegiline, (R,S)-Isomer;Selegiline hydrochloride; Selegiline, (S)-Isomer;Selegiline; Selegilina; Selegiline Hcl; Deprenyl; Jumex			-22.532720564	4	5		0	-4.25791304			4129	MAOB	Cl.C#CCN(C)[C@H](C)Cc1ccccc1	Prestwick Chemical, Inc.	Prestw-552	-7.98168279	-1.13235167	-5.12348923	-0.24964822	-4.25791304											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164528-04	GLYCERYL LAURATE	225144258	Toxic shock syndrome toxin-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	142-18-7		0.2818382931	-6.55	-34.7956160423	4	5		9.1671858599	-4.24888247	0.2243610425	0.8667945389	3552	tst	CCCCCCCCCCCC(=O)OCC(O)CO	SIGMA	M1765	-11.25139091	-8.19340394	-6.07812226	-1.11206936	-4.24888247											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167459-02	Doxapram hydrochloride	170465313	Potassium channel subfamily K member 9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	113-07-5				-19.2710375623	4	4		0	-3.99067116					Cl.O=C4N(CC)CC(CCN1CCOCC1)C4(c2ccccc2)c3ccccc3	Sequoia	113-07-5	-2.6970212	-5.91866069	-5.57469181	-3.99067116												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181107-01	Arotinolol hydrochloride	144206274	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	68377-91-3	5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide; Almarl; 			-19.5035852553	4	4	arotinolol, (+-)-isomer;LS-175382;AROTINOLOL HYDROCHLORIDE;CIPLUS_732431;CIPLUS_211026;arotinololum;s 596;Arotinolol Hydrochloride;S 596;5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide;2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole hydrochloride;S-596;arotinolol;LS-176661;LS-152938;AROTINOLOL;Arotinolol hydrochloride;Almarl;arotinolol hydrochloride;Arotinolol;CIPLUS_695770;	0	-0.88105727					Cl.OC(CSc1nc(cs1)c2ccc(s2)C(N)=O)CNC(C)(C)C	NCI	NSC-317940	-4.60237946	-4.96321975	-2.49274837	-0.88105727												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00263918-08	Epirubicin hydrochloride		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	56390-09-1		2.2387211386	-5.65	-64.1947277188	-2.4	4		-30.8219719908	-21.80184849	1	0.9999193219		TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	MedChem Express	HY-13624A	-9.09294212	-14.61909191	-36.69325598	-21.80184849												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00017063-07	Amodiaquin dihydrochloride dihydrate		Antimalarial; Histamine N-methyl Transferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	6398-98-7		3.9810717055	-5.4	-25.4787486915	4	4		-17.8934518761	-5.38135959	1	0.9997747988			CCN(CC)CC1=C(O)C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl	Prestwick	Prestw-309	-3.01905358	-4.43899552	-18.76359681	-5.38135959												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00015954-04	Sobuzoxane	90341303	DNA topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-20.2774816452	4	4		0	-1.43387752					CC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O	SigmaAldrich	Lopac-S-4692	-1.7398694	-6.27378033	-9.50870196	-1.43387752												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00015009-23	4-Aminopyridine		Voltage-gated potassium channel subunit Kv1.3 Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	504-24-5				-22.440539206	4	4		0	-3.77472575					NC1=CC=NC=C1	MedChem Express	HY-B0604	-4.2445657	-3.69493532	-5.91914431	-3.77472575												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00250406-02	Tipifarnib		Farnesyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	192185-72-1		4.4668359215	-5.35	-93.7989586072	-2.3	4		-91.8186282658	-12.2484236	1	0.9999950053		COX10	C[N]1C=NC=C1[C@@](N)(C2=CC=C(Cl)C=C2)C3=CC=C4N(C)C(=O)\C=C(\C5=CC=CC(=C5)Cl)C4=C3	Selleck	S1453	-6.93711423	-10.64513402	-92.88433648	-12.2484236												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00262598-02	Atracurium besylate	225144360		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	64228-81-5	Atracurium besylate			-30.6889200928	4	4		0	-4.1202384					COC1=CC2=C(C=C1OC)C(CC3=CC(OC)=C(OC)C=C3)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=C(C=C(OC)C(OC)=C5)C4CC6=CC(OC)=C(OC)C=C6)CC2	Prestwick	Prestw-5	-6.01574381	-9.38530481	-4.80420595	-4.1202384												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00091099-01	Dibromomannitol	17389938	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC-6_Tox		Mitobronitol; Dibromomannitol; 			-7.1594413173	4	4	NSC 9410;MITOBRONITOL;mitobronitol;CIPLUS_725146;R 54;mitobronitolum;Mitolactolum;Mitolactol;elobromol;NCGC00091099-02;Mitobronitolum;Mitobronitol (1,6-Dibromo-1,6-dideoxy-D-mannitol);Galactitol, 1,6-dibromo-1,6-dideoxy-;CIPLUS_167927;NSC-94,100;Dibromodulcitol;NSC-94100;DIBROMODULCITOL;NSC9410;CIPLUS_153526;NCGC_SIGMA_D4393;1,6-Dibromo-1,6-dideoxy-D-mannitol;NSC94,10;NSC-104800;D-Mannitol, 1,6-dibromo-1,6-dideoxy-;AB07944772-01;mitolactol;NSC 10480;LS-369;Myelobromol;NSC10480;LS-1295;Dibromomannitol;MITOLACTOL;mitolactolum;Mitobronitol;NSC 94,10;MYELOBROMOL;1,6-DIBROMO-1,6-DIDEOXY-D-GALACTITOL;	0	-1.89168178					O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr	NIEHS	AB07944772	-0.66642812	-1.78405344	-3.34481508	-1.89168178												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00091351-01	m-Dinitrobenzene	17388932		DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-1.0917023332	4	4	NCGC00091351-02;1,3-Dinitrobenzene-15N2;1,3-Dinitrobenzene-d4;3-dinitrobenzene;m-dinitrobenzene;1,3-dinitrobenzene;m-Dinitrobenzene;1,3-Dinitrobenzene;CIPLUS_150522;meta-dinitrobenzene;1,3-Dinitrobenzene-13C6;AB07990178-01;CIPLUS_763212;	0	-1.01062451					[O-][N+](=O)C1=CC=CC(=C1)[N+]([O-])=O	NIEHS	AB07990178	2.22291797	-2.16453877	-4.5413343	-1.01062451												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00094852-04	L-Thyroxine		synthetic hormone	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	51-48-9				-33.3773526874	4	4		0	-7.91223979				THRA	NC(CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C(O)=O	APExBIO	B2107	-6.2393774	-8.4383191	-7.28788978	-7.91223979												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00167512-04	Everolimus		mTOR inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	159351-69-6				-113.5232633244	4	4		0	-25.70614149				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C\C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Adooq	A10374	-21.08864836	-26.82844339	-27.79187817	-25.70614149												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00160511-01	Desoxycorticosterone Pivalate	29216193		DPI_SARS-CoV-2_General	2019_NPC-6_Tox		DESOXYCORTICOSTERONE PIVALATE; Percorten; 			-28.4520693279	4	4	CIPLUS_156479;percoten pivalate;DESOXYCORTICOSTERONE PIVALATE;Percorten;Pregn-4-ene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-;dtma;11-DEOXYCORTICOSTERONE PIVALATE;LS-118664;deoxycortone pivalate;desoxycoticosterone trimethylacetate;desoxycorticosterone pivalate;Desoxycorticosterone pivalate;PREGN-4-ENE-3,20-DIONE, 21-(2,2-DIMETHYL-1-OXOPROPOXY)-;	0	-2.55679364					[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)COC(=O)C(C)(C)C	InterBioScreen	STOCK1N-55228	-6.35566688	-5.76646656	-5.93727339	-2.55679364												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183271-01	Bucillamine	144206469		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	65002-17-7				-25.4189179234	4	4	Bucilant;CIPLUS_186785;BUCILLAMINE;CIPLUS_3866301;bucillamine disulfide;Bucillamine;SA981 cpd;bucillaminum;2-mercapto-2-methylpropanoyl-L-cysteine;SA-96;N-(2-mercapto-2-methylpropionyl)-L-cysteine;L-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-;LS-59032;bucillamine;N-(2-MERCAPTO-2-METHYLPROPIONYL)-CYSTEINE;SA 96;tiobutarit;SA-981;SA 981;	0	-4.09432495					O=C(N[C@@H](CS)C(=O)O)C(C)(C)S	ACC	Bucillamine	-4.79917703	-5.30142893	-7.07034083	-4.09432495												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386239-01	Mirabegron		Beta-3 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	223673-61-8				-7.7956136895	4	4		0	-0.9501598					NC1=NC(=CS1)CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2	Selleck	S4009	-1.81143215	-3.59347256	0.87926033	-0.9501598												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378990-02	Ledipasvir (GS 5885)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1256388-51-8				-37.5372574383	4	4		0	-5.11358729					COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	Adooq	A13155	-6.61508185	-6.97556439	-13.83248731	-5.11358729												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00159409-08	myo-Inositol			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	87-89-8				-19.1904154472	4	4		0	-0.85514382					O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O	SIGMA	57569	-4.65605153	-4.71801809	-2.2933285	-0.85514382												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00095056-04	Retinyl palmitate	225144218		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	79-81-2				-16.6358131437	4	5		0	-3.36277631					CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)\CCCC1(C)C	SIGMA	R1512	-4.68882483	-3.53548387	-2.87112993	-1.35671144	-3.36277631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015925-12	Sulfaphenazole	170465185	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	526-08-9	; ; Sulphaphenazole; Sulfaphenazole;Sulfaphenazole; Sulfafenazol; Sulfabid;SULFAPHENAZOLE	0.1995262315	-6.7	-25.989668404	4	5		7.607096776	-4.44783213	0.2720015535	0.8300692045			Nc1ccc(cc1)S(=O)(=O)Nc3ccnn3c2ccccc2	Specs	AN-153/I226112	-9.22502968	-9.25591398	-1.53038723	0.77977103	-4.44783213											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00167564-03	8-Bromotheophylline	170465479		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	10381-75-6				-20.3379031215	4	5		0	-3.53315697					O=C2c1nc(Br)nc1N(C)C(=O)N2C	Vitas	STK803299	-5.731728	-4.79139785	-2.85348858	-2.4655188	-3.53315697											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018251-05	Methyl delta-aminolevulinate hydrochloride	225144187	Porphyrin and chlorophyll metabolism Modulator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	79416-27-6				-20.3728904329	4	5		0	-5.63152939					COC(=O)CCC(=O)CN	SIGMA	A5575	-7.05443446	-3.79354839	-3.25923966	2.64581267	-5.63152939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160508-03	Isosorbide	170465187		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	652-67-5				-18.0289684466	4	5		0	-6.25028023					O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	Vitas	STK801813	-5.46040359	-4.99784946	-2.76528182	3.14162084	-6.25028023											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274057-01	Phenylpropanolamine hydrochloride	170465627	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	154-41-6				-19.0505788437	4	4		0	-4.39110328					Cl.O[C@H]([C@@H](C)N)c1ccccc1	Microsource	02300253	-4.81833232	-4.53398385	-0.42251067	-4.39110328												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-12	Ruxolitinib		Jak1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	941678-49-5		14.1253754462	-4.85	-16.906427577	4	4		-15.973904428	-13.72825369	0.4180546458	0.8746262317		JAK1	N#CC[C@H](C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	MedChem Express	HY-50856	-3.52879672	2.69179004	0.69256904	-13.72825369												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379061-01	Umeclidinium bromide		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	869113-09-7				-19.8275251032	4	4		0	-6.98084122			1131	CHRM3	OC(C1=CC=CC=C1)(C2=CC=CC=C2)C34CC[N+](CCOCC5=CC=CC=C5)(CC3)CC4	MedChem Express	HY-12100	-3.91217217	-1.42160161	-5.18773412	-6.98084122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014810-01	Pirbuterol hydrochloride	144203612	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	38029-10-6	Pirbuterol hydrochloride; Maxair; 			-24.2170788195	4	4	6-(2-(tert-butylamino)-1-hydroxyethyl)-3-hydroxy-2-pyridinemethanol dihydrochloride;CIPLUS_3865153;CIPLUS_749202;pirbuterol sulfate;PIRBUTEROL HYDROCHLORIDE;Maxair;CIPLUS_210786;CP-24315-1;LS-176467;Pirbuterolum;pirbuterol acetate;Pirbuterol Hydrochloride;LS-66540;PIRBUTEROL;cp-24,314-14;CP 24315-1;pirbuterol acetate salt;LS-176523;CP-24,314-1;Pirbuterol Acetate;2-HYDROXYMETHYL-3-HYDROXY-6-(1-HYDROXY-2-TERT-BUTYLAMINOETHYL)-PYRIDINE, ACETATE;pirbuterolum;pyrbuterol;pirbuterol;PIRBUTEROL ACETATE;CIPLUS_179342;Pirbuterol acetate;LS-131417;Pirbuterol hydrochloride;pirbuterol dihydrochloride;Pirbuterol;2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride;	0	0.78837261					Cl.Oc1ccc(nc1CO)C(O)CNC(C)(C)C	NCI		-7.77206587	-6.60329744	-0.49220315	0.78837261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091058-11	Linolenic acid	225144205	Fatty acid desaturase 2 Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	463-40-1				10.694880817	4	5		0	1.43680791			9415	FADS2	CC\C=C/C/C=C\C\C=C/CCCCCCCC(O)=O	SIGMA	62160	3.66944323	1.62549322	0.13701563	2.26555653	1.43680791											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015971-05	Succinylcholine chloride	170464625	Muscle-type nicotinic acetylcholine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	71-27-2				-26.7095730668	4	5		0	-4.79546079					[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Vitas	STK177290	-5.51950899	-6.96088523	-6.27702847	-5.20157756	-4.79546079											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160515-02	Acarbose	170464784	alpha-Glucosidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56180-94-0	; Lasa Brand of Acarbose; Glucobay; Glumida; Bayer Brand of Acarbose; Precose;ACARBOSE; Prandase;Acarbose; Glucor; Acarbosa			-4.4911425628	4	5		0	-3.58744395			2548	GAA	OCC4=C[C@H](N[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]1C)O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](O)[C@@H]4O	Vitas	STK801930	1.34590092	0.0300223	-2.68036823	-3.51007888	-3.58744395											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159437-03	Clobutinol hydrochloride	170466051	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1215-83-4				-12.7142591436	4	5		0	-3.15731674					Cl.Clc1ccc(CC(C)(O)C(C)CN(C)C)cc1	Prestwick	Prestw-1380	-1.8018413	-3.915766	-2.07236138	-4.04469763	-3.15731674											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167514-02	Ethylestrenol	170465211	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	965-90-2		14.1253754462	-4.85	-51.7931493964	-3	4		-31.3115293321	-32.524293	0.1730334541	0.9810985254			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC	Sequoia	965-90-2	-8.29367483	-3.93135189	-5.08893499	-32.524293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167544-02	2,2'-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]	225144291		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	103597-45-1				-16.5929350897	4	4		0	-3.11996165					CC(C)(C)CC(C)(C)C1=CC(=C(O)C(=C1)[N]2N=C3C=CC=CC3=N2)CC4=CC(=CC(=C4O)[N]5N=C6C=CC=CC6=N5)C(C)(C)CC(C)(C)C	SIGMA	407941	-3.82019555	-5.99595682	-1.45208986	-3.11996165												1.6E-8	8E-8	4E-7	0.000002											
NCGC00420892-01	NKH477		Adenylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox			7.0794578438	-5.15	-54.4082684535	-2.2	4		-57.2638977504	-45.78848752	0.0182534092	0.9997945841			CN(C)CCC(=O)OC1C(OC(C)=O)C2(C)OC(C)(CC(=O)C2(O)C3(C)C(O)CCC(C)(C)C13)C=C	Bio Vision	9427-5	-1.39742148	-4.53352832	-19.23908726	-45.78848752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164034-05	Triclocarban	170465481		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	101-20-2		3.5481338923	-5.45	-124.0949349921	-2.1	5		-90.0647121711	-92.23991556	0.0021738152	0.9989114814			Clc2ccc(NC(=O)Nc1ccc(Cl)cc1)cc2Cl	Specs	AN-153/I101902	-4.23863236	-4.18333475	-4.80177502	-58.67358655	-92.23991556											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167798-05	Oxaliplatin		DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	61825-94-3				-14.2570467241	4	4		0	-9.92411239				H2AFX	O=C1O[Pt]2(NC3CCCCC3N2)OC1=O	Cayman	13106	-1.39990465	-3.10727179	-1.56347717	-9.92411239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166307-05	ERGOCALCIFEROL		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	50-14-6				-13.3777216005	4	4		0	-2.79609721					CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	E5750	-2.73479825	-6.17586385	0.01786831	-2.79609721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389552-01	CEFONICID SODIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	71420-79-6				-15.902198862	4	4		0	-5.93627625					O[C@@H](C(=O)N[C@@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)CSC3=NN=N[N]3C[S]([O-])(=O)=O)C4=CC=CC=C4	Microsource	01505474	-3.12348348	-3.88735314	-1.10446985	-5.93627625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161345-07	DOCONEXENT		Voltage-gated L-type calcium channel Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	6217-54-5				-8.4033989712	4	4		0	-5.69597722					CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/C\C=C/CCC(O)=O	Microsource	01503885	-1.09410156	-3.68002764	1.7454955	-5.69597722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183873-03	Granisetron·HCl			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	107007-99-8				-16.4672055534	4	4		0	-6.24777501					CN1N=C(C(=O)NC2C[C@H]3CCC[C@H](C2)N3C)C4=C1C=CC=C4	Enzo	DL166	-2.94701549	-2.98894264	-3.12283437	-6.24777501												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248905-02	(1S,2R,5S)-(+)-Menthol	225144344	Transient receptor potential cation channel subfamily A member 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	15356-60-2				-29.4036197115	4	4		0	-8.0989676			8989	TRPA1	CC(C)[C@H]1CC[C@H](C)C[C@@H]1O	SIGMA	224464	-6.24696696	-5.22633034	-5.35776161	-8.0989676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018158-09	Doxazosin mesylate	170465395	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	77883-43-3	; Doxazosin Mesilate; Doxazosin mesylate salt;Doxazosin mesylate; Doxazosin mesilate; Doxazosin hydrochloride;DOXAZOSIN MESYLATE			-3.0493306198	4	4		0	-5.96711537			148	ADRA1A	CS(=O)(=O)O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4	Microsource	01505976	0.36839596	-0.62317346	1.29545251	-5.96711537												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182066-02	Fluprednidene acetate	144206681		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1255-35-2	fluprednidene acetate; Decoderm; 			-16.9020728701	4	4	LS-172629;SQ-20918;9A-FLUORO-16-METHYLENEPREGNA-1,4-DIENE-11B,17A,21 TRIOL-3,20-DIONE,21 ACETATE;Decoderm;Fluprednidene acetate;fluprednylidene acetate;CIPLUS_157986;fluprednidene acetate;FLUPREDNIDENE ACETATE;Hermal brand of fluprednidene acetate;Boots brand of fluprednidene acetate;	0	-6.22007408					CC(=O)OCC(=O)[C@@]4(O)C(=C)CC3C2CCC1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Kemprotec	1255-35-2	-3.37624063	-5.43665119	0.24122219	-6.22007408												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	915087-33-1				1.5903691369	4	4		0	-1.10669437				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	0.48108178	-1.11311673	2.81425891	-1.10669437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181334-04	DIBUNATE SODIUM	225144323		DPI_SARS-CoV-2_General	2019_NPC-5_Tox			2.8183829313	-5.55	-19.0810793734	4	4		13.391954616	-4.7926642	1	0.9849036478			CC(C)(C)C1=CC=C2C(=C1)C=CC(=C2[S]([O-])(=O)=O)C(C)(C)C	Bosche	D6477	-7.06020023	-8.65996218	3.45751809	-4.7926642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015787-09	PINACIDIL		"Sulfonylurea receptor 2, Kir6.2 Opener"	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	85371-64-8, 60560-33-0 [anhydrous]				-32.0524902089	4	4		0	-3.18618726					CC(N\C(NC1=CC=NC=C1)=N\C#N)C(C)(C)C	Microsource	02300270	-9.67926942	-0.95888044	-6.12872488	-3.18618726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253613-01	Anileridine	170465266		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	144-14-9				-22.4331656569	4	4		0	-5.3488786					O=C(OCC)C2(CCN(CCc1ccc(N)cc1)CC2)c3ccccc3	GVK	FFS-11-286-NCI-043	-5.43521419	-3.31720802	-3.20079695	-5.3488786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015383-07	NCGC00015383-07			DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-21.0146694544	4	4		0	-4.44936309					OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O	BIOMOL	S-110	-4.25172279	-6.68299811	-3.09121773	-4.44936309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091034-10	Captan	225144202		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	133-06-2				-23.0732603152	4	4		0	-4.86493812					ClC(Cl)(Cl)SN1C(=O)C2C\C=C/CC2C1=O	SIGMA	32054	-4.90183331	-8.93501805	-0.96488877	-4.86493812												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378936-02	Letermovir		Tripartite terminase subunit UL28 homolog Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	917389-32-3				-21.2637462516	4	4		0	-3.75578498			3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-5.26756959	-2.62612301	-4.53482328	-3.75578498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386236-02	TAK 438		Potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	881681-01-2				-17.3451452412	4	4		0	-9.21146315					CNCC1=C[N](C(=C1)C2=CC=CC=C2F)[S+]([O-])(=O)C3=CC=CN=C3	Axon Medchem	1971	-1.78232673	-5.00172771	-3.4520097	-9.21146315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182039-02	Cilazapril	225144330	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-24.9780000131	4	4		0	-4.22748309					CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(O)=O	APAC	500074	-6.11461596	-2.7211472	-6.1547124	-4.22748309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015469-09	Guanfacine hydrochloride	170465381	Alpha-2a adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	29520-14-7				-4.1252266904	4	4		0	-2.55217273					Cl.Clc1cccc(Cl)c1CC(=O)NC(=N)N	Enzo	AR102	0.63710831	-4.49974214	-1.00062539	-2.55217273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091612-09	Triacetin	170465543		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	102-76-1		1.995262315	-5.7	-28.4527573024	4	5		12.2507873	-7.80138589	0.0247011647	0.9996271741			O=C(C)OC(COC(C)=O)COC(=O)C	Microsource	01500585	-9.58759253	-9.79232275	-9.45702683	1.92440178	-7.80138589											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016794-13	Gemfibrozil	170464998	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	25812-30-0	 Gemfibrozilo; ;; Lopid;GEMFIBROZIL; Gemfibrozil;Gemfibrozil			-27.7777377789	4	5		0	-5.89234087			5465	PPARA	O=C(O)C(C)(C)CCCOc1cc(C)ccc1C	Vitas	STK618740	-6.55622136	-8.73691378	-6.5767991	-0.73026225	-5.89234087											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183104-02	Nizofenone	170466022		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	54533-86-7				-14.2759421443	4	4		0	-9.40726237					Clc1ccccc1C(=O)c2cc(ccc2n3ccnc3CN(CC)CC)[N+]([O-])=O	APAC	556416	-1.57056514	-1.13165169	-3.49532225	-9.40726237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522015-01	Pirlimycin Hydrochloride		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	78822-40-9				-20.8793276456	4	4		0	-5.92737629					CC[C@@H]1CCN[C@@H](C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	Toronto Research	P509300	-4.12935104	-4.24153421	-4.20564796	-5.92737629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014602-05	L-Penicillamine		Copper Chelator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1113-41-3				-26.6617260026	4	4		0	-7.68066928				CAT	CC(C)(S)[C@H](N)C(O)=O	Enzo	NP226	-5.96461817	-3.80960608	-1.87543313	-7.68066928												1.6E-8	8E-8	4E-7	0.000002											
NCGC00181094-01	Sodium tyropanoate	144206263		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	7246-21-1	TYROPANOATE SODIUM; Bilopaque; Tyropanoate; Tyropanoic acid; Sodium, Tyropanoat; Tiropanoato sodico; Tyropanoate, Sodiu; 			-33.6077158497	4	4	Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-;Bilopaque;BENZENEPROPANOIC ACID, .ALPHA.-ETHYL-2,4,6-TRIIODO-3-((1-OXOBUTYL)AMINO)-;natrii tyropanoas;Tyropanoate de sodium;Sodium, Tyropanoat;Sodium tyropanoate;Natrii tyropanoas;WIN 8851;BENZENEPROPANOIC ACID, .ALPHA.-ETHYL-2,4,6-TRIIODO-3-((1-OXOBUTYL)AMINO)-, MONOSODIUM SALT;Tyropanoate sodium;TYROPANOATE SODIUM;Tyropanoic acid;WIN8851;Tyropanoate;WIN-88512;Tiropanoato sodico;CIPLUS_166239;SODIUM TYROPANOATE;2-(3-(BUTYRYLAMINO)-2,4,6-TRIIODOBENZYL)BUTANOIC ACID;Tyropanoate Sodium;CIPLUS_175604;Tyropanoate, Sodiu;TYROPANIC ACID;Sodium Tyropanoate;tyropanoate de sodium;	0	-4.68138127					[Na+].O=C(Nc1c(I)c(CC(CC)C([O-])=O)c(I)cc1I)CCC	NCI	NSC-107434	-8.77045926	-5.41637871	-5.61763687	-4.68138127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159513-03	Cefprozil	225144231	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	92665-29-7	 ;Cefprozil hydrate; Cefprozilo; Cefprozil monohydrate;CEFPROZIL; cis-Cefprozil			-10.4030820271	4	5		0	-2.12931944					C/C=C/C1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O	Selleck	S2544 	-2.40571026	-5.68133458	-3.78867166	3.127727	-2.12931944											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00168785-03	Diclazuril		antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	101831-37-2	 ; Diclazuril;Diclazuril;DICLAZURIL	12.5892541179	-4.9	-34.2389630657	-3	5		-34.715478868	-33.09623239	0.0918222064	0.9507227155			ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O	FLUKA	34057	-4.60874163	-4.75359605	1.81270147	1.57534561	-33.09623239											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166140-02	Pyrithioxin dihydrochloride	170465839	acetylcholine biosynthetic process Activator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	10049-83-9				-25.5253769649	4	4		0	-8.09006764					Cl.Cl.Oc1c(CO)c(cnc1C)CSSCc2cnc(C)c(O)c2CO	Vitas	STK801801	-7.46459611	-1.95231513	1.35568261	-8.09006764												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164564-06	Emtricitabine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	143491-57-0				-28.9868051616	4	4		0	-9.15806337				TERT	NC\1=N\C(=O)N(\C=C1F)[C@@H]2CS[C@H](CO)O2	Adooq	A10349	-6.52931575	-4.15514858	-3.66857242	-9.15806337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167466-02	Lomustine	170464967	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	13010-47-4	 ;Lomustine (CeeNU); CeeBU; CeeNU; Lomustina; Lomustine;Lomustine	2.8183829313	-5.55	-4.260228367	4	5		11.960710844	-2.56069019	0.0868139997	0.9953788312		H2AFX	O=C(NC1CCCCC1)N(CCCl)N=O	Bosche	L0449	-3.93020797	-4.0131075	-4.55059237	6.23248978	-2.56069019											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016801-05	Levobunolol hydrochloride	170464743	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	27912-14-7				-22.9770809022	4	5		0	-7.92070121					Cl.CC(C)(C)NC[C@H](O)COc2cccc1c2CCCC1=O	Prestwick Chemical, Inc.	Prestw-847	-5.93937258	-6.81334582	-4.80177502	2.97157029	-7.92070121											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095089-10	Fluconazole	170464782	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	86386-73-4	; ;Hexaflumuron; Hexaflumuron; Diflucan; Sonet; Fluconazole;FLUCONAZOLE;Fluconazole; FLUCONAZOLE	1.1220184543	-5.95	-13.5157726482	4	5		12.4807895679	-2.94617044	0.0372832289	0.9991499793			OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F	Vitas	STK619301	-7.06732464	-7.0005958	-4.33290074	5.19450696	-2.94617044											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015786-16	Pindolol	170464892	Serotonin 1a (5-HT1a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	13523-86-9				-3.2424470421	4	5		0	-2.11096324					CC(C)NCC(O)COc2cccc1nccc12	Enzo	AC181	1.87698273	-2.6683122	-2.273203	-2.42042897	-2.11096324											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162143-03	Clodronate	225144247	ADP/ATP translocase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	22560-50-5		0.285877499	-6.543820026	-0.03264401	4	5		16.28578306	-5.19480519	0.2735058034	0.951125179	293	SLC25A6	O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O	Prestwick	Prestw-1381	-5.27846317	-8.09005022	-8.98815255	6.71014559	-5.19480519											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00483038-01	TAK-599			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	400827-46-5				-8.9079959096	4	4		0	-4.0494838					CCO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)SC3=NC(=CS3)C4=CC=[N+](C)C=C4)C5=NSC(=N5)N[P](O)(O)=O	DC Chemicals	DC7923	-0.97057396	-1.5463027	-3.32207207	-4.0494838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263444-01	Metocurine iodide	170465111		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	7601-55-0		1.2589254118	-5.9	-12.7913385688	4	5		14.157460204	-5.47932633	0.1540802101	0.9851724716			[I-].[I-].COc7ccc1cc7Oc6cc5c(CC[N+](C)(C)[C@H]5Cc4ccc(Oc3c2c(CC[N+](C)(C)[C@@H]2C1)cc(OC)c3OC)cc4)cc6OC	Specs	AE-562/J259582	-6.48572436	-8.46455017	-5.78976012	6.36108942	-5.47932633											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094614-06	4-Chloro-3,5-dimethylphenol	170465503		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	88-04-0		1.1220184543	-5.95	-15.3428413927	4	5		13.0056600599	-4.30452939	0.244510977	0.9615175141			Oc1cc(C)c(Cl)c(C)c1	Microsource	01500182	-6.50334861	-9.58805005	-5.72277808	5.13020714	-4.30452939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091023-06	Cetylpyridinium bromide	170465500		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	140-72-7		8.9125093813	-5.05	-87.1058943422	-2.1	4		-119.963366156	-99.55280513	0.0093050192	0.9999465951			[Br-].CCCCCCCCCCCCCCCC[n+]1ccccc1	Vitas	STK177346	0.39440038	-0.42547705	-19.18163138	-99.55280513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390564-03	GS-7340			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	379270-37-8				-26.2208853439	4	4		0	-6.292348					CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3	MedChem Express	HY-15232	-6.11537295	-8.26456937	-0.17868311	-6.292348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025355-12	Paroxetine	170465075	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	61869-08-7	;Paroxetine;Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetina; ; Paroxetine Base;PAROXETINE HYDROCHLORIDE; Paxil; Paroxetine maleate;Paroxetine?HCl;Paroxetine Hydrochloride			1.9826457148	4	4		0	3.04002168			3350	HTR1A	Fc1ccc(cc1)[C@@H]4CCNC[C@H]4COc2ccc3OCOc3c2	Microsource	01504085	0.03900663	-1.62884648	1.07209863	3.04002168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016285-05	Sulfanilamide	170464653	Carbonic Anhydrase Type I/II/IX Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	63-74-1	 ; p-Aminobenzenesulfonamide; Sulfonamide CS61; Trikolpon; Sulfanilamida;SULFANILAMIDE; Sulfanilamide;Sulfanilamide			-7.1932174833	4	4		0	-3.25684344			759	CA1	Nc1ccc(cc1)S(=O)(N)=O	Labotest	LT00847607	-0.88848438	-3.11586729	-0.44670776	-3.25684344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018143-05	Enrofloxacin	170465572	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	93106-60-6				-13.9594244901	4	4		0	-4.81073268					CCN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4	Vitas	STK711109	-2.71746197	-2.52277806	-2.3764853	-4.81073268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018130-09	Phenazopyridine hydrochloride	170465267		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	136-40-3		14.1253754462	-4.85	-15.5287595719	4	5		-13.9588821039	-13.29906842	0.3760911297	0.7356687879			Cl.Nc2nc(N)ccc2/N=N/c1ccccc1	Microsource	01500473	-1.74480085	-4.31100519	-3.1104785	4.05548156	-13.29906842											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015202-08	Ciprofibrate	170466356	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	52214-84-3				-14.7253142453	4	5		0	0.15602772				PPARA	ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1	Vitas	STK624758	-5.79837857	-3.08536897	-5.88186043	3.11854131	0.15602772											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159508-04	Rose Bengal disodium	225144230	Free Radical Stimulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	632-69-9	; Bengal Rose B sodium salt; Rose Bengal Sodium I 125; ; Rose Bengal sodium salt; Rose bengal sodium;Rose bengal; Rose bengal;Rose Bengal; Bengal, Ros;Rose Bengal disodium; Acid Red- 94	8.9125093813	-5.05	-25.0102750104	4	5		-24.035312212	-24.14758386	0.0078798158	0.9960466505			[O-]C(=O)C1=C(C(=C(Cl)C(=C1Cl)Cl)Cl)C/2=C/3\C=C(I)/C(=O)/C(=C3OC4=C2C=C(I)C(=C4I)[O-])I	SIGMA	R3877	-1.23369757	-2.65128947	-1.20149035	-2.83378496	-24.14758386											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091888-09	3,3,5-Trimethylcyclohexyl salicylate	170465478		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	118-56-9		1.5848931925	-5.8	-20.1976162423	4	5		12.28903772	1.26657795	0.1838126034	0.8936458295			O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O	Microsource	01505020	-8.5741981	-7.02612988	-7.89132164	7.41744362	1.26657795											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159377-04	4-tert-Butylphenol	170465689	UDP-glucuronosyltransferase 1-6 Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	98-54-4		1.995262315	-5.7	6.6953006291	4	5		15.836156264	-0.99123491	0.0716486251	0.9968376143			CC(C)(C)c1ccc(O)cc1	Labotest	LTBB002519	-3.04018329	-4.03013022	-3.17746054	12.01028797	-0.99123491											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016393-07	2,2'-Dihydroxy-4-methoxybenzophenone	170465540		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	131-53-3		1.1220184543	-5.95	-21.3543692154	4	5		11.884500812	-5.60781974	0.316823129	0.9331404801			O=C(c1ccc(cc1O)OC)c2ccccc2O	Microsource	01500255	-7.07613676	-10.73708401	-6.76937246	2.76948514	-5.60781974											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016049-07	Tetracaine hydrochloride	170465190	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	136-47-0				-21.8689866511	4	5		0	-5.29576431					Cl.CN(C)CCOC(=O)c1ccc(NCCCC)cc1	Microsource	01500564	-6.42403948	-4.37909609	-5.0864487	0.88641896	-5.29576431											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024595-08	Carbetapentane	170465562	Sigma-1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	77-23-6				-10.2533464614	4	4		0	-1.66681724					CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2	Enzo	NO103	-1.90265678	-3.88086643	-2.05485571	-1.66681724												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510316-02	Ombitasvir			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1258226-87-7				-14.1648088074	4	4		0	-1.54033788					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)C=C5	MedChem Express	HY-13997	-3.53226715	-7.48237923	1.76896274	-1.54033788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016613-10	Antazoline hydrochloride	170464765	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2508-72-7		1.995262315	-5.7	-7.0678605484	4	5		14.3997786999	-1.22986554	0.0466328649	0.9986655472			Cl.C(c1ccccc1)N(CC2=NCCN2)c3ccccc3	Microsource	01500126	-5.56045118	-6.16648225	-5.6809143	7.96858494	-1.22986554											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159491-04	Rimantadine	170465164	M2 Channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1501-84-4	; Flumadine; Riamantadine;Rimantadine hydrochloride; Rimantadina; ; Hydrochloride, Rimantadin; Flumadine Oral; Roflual;RIMANTADINE HYDROCHLORIDE; Rimantadine hydrochloride; Rimantadine Hcl			-18.8323340548	4	4		0	-3.7266239					Cl.CC(N)C12CC3CC(C1)CC(C2)C3	Vitas	STK177253	-5.14454124	-3.97541688	-0.18761726	-3.7266239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015482-07	Gallamine triethiodide	170465398	Muscarinic M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	65-29-2	 Triethiodide, Gallamin; ;Gallamine triethiodide; Gallamine triethiodide; Gallamine Triethyl Iodide; Triethyl Iodide, Gallamin;GALLAMINE TRIETHIODIDE; Triethioduro de galamina; Iodide, Gallamoniu; Triethochloride, Gallamin; Iodide, Gallamine Triethy; Gallamine Triethochloride; Flaxedil			-9.9303858482	4	5		0	-3.45419244				ACHE	[I-].[I-].[I-].CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	Enzo	C112	-2.79465891	-0.81374322	1.27868278	-3.563161	-3.45419244											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	657-27-2				-27.5712239371	4	5		0	-7.17478665					NCCCC[C@H](N)C(O)=O	Bosche	L1919	-6.56081486	-5.41203823	-4.09003328	1.53874087	-7.17478665											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00016308-06	Isopropamide	170465291	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	7492-32-2				-11.8908782251	4	5		0	-2.62338014					CC(C)[N+](C)(CCC(c1ccccc1)(C(N)=O)c2ccccc2)C(C)C	Microsource	01500356	-4.38671574	-3.63816413	-0.36784025	1.43888158	-2.62338014											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022662-05	Dexamethasone acetate	170466872	Mineralocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1177-87-3				-8.5117709016	4	5		0	-2.78593037					CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-130	-4.11281349	0.81374322	-0.17516202	1.07575689	-2.78593037											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015428-15	(+/-) -Fluoxetine	170465374	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	54910-89-3				-14.5574191423	4	5		0	-10.20905766					FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2	Vitas	STK734483	-2.40092442	-0.79652114	-1.07724645	-1.66583451	-10.20905766											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018257-08	Methocarbamol	170464808	Muscle relaxant	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	532-03-6	 Metocarbamol;;METHOCARBAMOL; Robaxin;Methocarbamol			-23.4911936501	4	5		0	-5.16096988					NC(=O)OCC(O)COc1ccccc1OC	Microsource	01500397	-7.35684328	-7.52174287	-3.5119986	2.46470882	-5.16096988											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168774-02	Rasagiline mesylate	170465410	MAO-B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	161735-79-1	 ; Azilect; N-2-propynyl-1-indanamine;Rasagiline mesylate; Rasagiline mesylate			-16.4296679783	4	5		0	-1.90093466			4129	MAOB	CS(=O)(=O)O.C#CCN[C@@H]2CCc1ccccc12	Tocris	4308	-6.08148592	-5.49814863	-0.57803468	0.73986655	-1.90093466											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249883-01	Hydrocortamate	170465314	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	76-47-1				-8.0313706961	4	5		0	-0.54634939					CCN(CC)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-02	-4.26688351	-1.76956859	-0.79698721	2.9821615	-0.54634939											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091641-12	MERCAPTOPURINE			DPI_SARS-CoV-2_General	2019_NPC-3_Tox	6112-76-1, 50-44-2 [anhydrous]		14.1253754462	-4.85	-39.4206428134	4	5		-16.261567708	-18.91452567	0.2163763481	0.8711751339			S=C1NC=NC2=C1NC=N2	Microsource	01500387	-7.88752889	-5.799535	-6.99772289	-2.44655258	-18.91452567											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024868-09	Bisoprolol fumarate	170464815	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	104344-23-2	;Bisoprolol fumarate; Zebeta; ; Bisoprolol hemifumarate; Bisoprolol Hydrochloride; Bisoprolol fumarate; Bisoprolol hemifumarate salt; Bisoprolol, (+-)-Isomer; Bisoprolol, (-)-Isomer;Bisoprolol hemifumarate salt; 3   Bisoprolol Fumarate; Prestwick-05A11;BISOPROLOL FUMARATE	0.1584893192	-6.8	-20.0974413061	4	5		9.745656076	-2.2621574	0.3216006559	0.7890064679	153	ADRB1	O=C(O)/C=C/C(=O)O.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C	Microsource	01505704	-8.53804673	-4.48204598	-1.97057278	2.7733648	-2.2621574											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181349-02	Ranelic acid distrontium salt	225144325	Calcium-Sensing Receptor (CaSR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	135459-87-9	Strontium Ranelate;3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; Strontium ranelate heptahydrate; 	0.0090402403	-8.043820026	-4.8894540856	4	5		11.164516132	-6.9497377	0.2575125736	0.9572661309	846	CASR	O.O.O.O.O.O.O.[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(=C(S1)C([O-])=O)CC([O-])=O	APAC	825889	-7.25792776	-9.72043011	-4.29125871	2.1590192	-6.9497377											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00249893-01	Lodoxamide	170465346	type I hypersensitivity Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	53882-12-5		1.2589254118	-5.9	-14.4528449843	4	5		14.64991868	-2.90332776	0.1252652719	0.9902981161			Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O	GVK	FFS-11-286-NCI-60	-8.0415989	-6.09231034	-2.8376248	4.63437883	-2.90332776											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160484-02	Etafenone	170466000	vascular smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	90-54-0				-3.7303731103	4	5		0	-3.923782					CCN(CCOc2ccccc2C(=O)CCc1ccccc1)CC	Vitas	STK321191	-0.8687837	2.33789718	-1.04221405	-0.1316327	-3.923782											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018238-09	Oxibendazole	170465661	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	20559-55-1	OXIBENDAZOLE;Oxibendazole; Loditac; Oxibendazolo;	0.316227766	-6.5	-104.2509885803	4	5		-25.4991286231	-35.32306859	0.1482604014	0.9165592919		POLB	O=C(OC)Nc1nc2cc(ccc2n1)OCCC	Microsource	01503373	-12.10733544	-8.64978903	-40.56752496	-30.03495075	-35.32306859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160617-03	Thiamine pyrophosphate			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	154-87-0				-8.0193175774	4	5		0	-1.57408255					CC1=NC=C(C[N+]2=CSC(=C2C)CCO[P](O)(=O)O[P](O)(O)=O)C(=N1)N	SIGMA	C8754	-0.79351162	-3.46114256	0.90772854	-2.33567046	-1.57408255											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00021147-11	Doxylamine succinate	170465171	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	562-10-7				-32.3634405155	4	5		0	-6.41530155					O=C(O)CCC(=O)O.CN(C)CCOC(C)(c1ccccn1)c2ccccc2	Vitas	STL018676	-8.02718106	-5.68279293	-5.18090345	-7.27870289	-6.41530155											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253598-01	Sulfacytine	170465286	Dihydropteroate synthetase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	17784-12-2				-22.2584323609	4	5		0	-4.0682711					O=C1N=C(C=CN1CC)NS(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-041	-7.81905333	-5.42926031	-3.05657733	1.73845944	-4.0682711											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249052-02	Calcium levulinate	170465651		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	5743-49-7				-9.7409770827	4	5		0	-2.49695218					[Ca+2].O.O.O=C([O-])CCC(C)=O.CC(=O)CCC([O-])=O	SIGMA	L2009	-2.89737225	-2.04512185	-4.62427746	3.09109891	-2.49695218											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181000-02	Suplatast tosylate	170465881	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	94055-76-2	 ;IPD-1151T; Tosilato de suplatast; Suplatast;Suplatast tosylate; Suplatast tosylate			-26.1018292092	4	5		0	-6.67810539					Cc1ccc(cc1)S(=O)([O-])=O.C[S+](C)CCC(=O)Nc1ccc(OCC(O)COCC)cc1	Tocris	3543	-7.44243773	-7.45285456	-2.94272202	-0.05900776	-6.67810539											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095133-06	Famciclovir	170464774	antiviral	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	104227-87-4	; ; Famciclovir; FAMCICLOVIR;FAMCICLOVIR;Famciclovir			-23.1321371053	4	5		0	-6.44331061					CC(=O)OCC(COC(C)=O)CCn2cnc1cnc(N)nc12	Microsource	01505201	-5.95309424	-2.98372514	-6.3583815	-1.06667877	-6.44331061											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091208-09	4-Hexylresorcinol	170465471	Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	136-77-6		14.1253754462	-4.85	-36.1336530867	4	5		-15.301012068	-17.31611505	0.2381850248	0.855375699			Oc1cc(O)ccc1CCCCCC	Microsource	01500330	-7.33972439	-4.92120899	-6.71746365	-2.06527166	-17.31611505											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159518-05	Rabeprazole	170464736	H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	117976-90-6	; ; Pariet;RABEPRAZOLE SODIUM;Rabeprazole sodium; Rabeprazole sodium; Sodium rabeprazole; Aciphex; Sodium Rabeprazole			-19.1168937805	4	5		0	-7.60825394				ATP4A	[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1	Microsource	01505943	-5.14850638	-1.54568156	-2.24207392	-1.7656938	-7.60825394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016743-08	Piromidic acid	170466042		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	19562-30-2				-9.9612704178	4	5		0	-4.39337156					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCCC3	Microsource	01502045	-0.62055979	-1.60595884	-2.98651252	0.45844492	-4.39337156											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00178480-03	(+)-Tubocurarine chloride hydrochloride	170464882	Small conductance calcium-activated potassium channel protein 2 Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	57-94-3				1.5376250074	4	5		0	-1.16945862			1135		[Cl-].Cl.Oc7ccc1cc7Oc5cc6[C@H](Cc4ccc(Oc2c3[C@@H](C1)[N+](C)(C)CCc3cc(OC)c2O)cc4)N(C)CCc6cc5OC	Microsource	01500602	1.72472824	-1.89873418	-0.40287266	1.17561618	-1.16945862											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015252-12	Cyproheptadine hydrochloride	170465127	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	129-03-3	; ; Cyproheptadine hydrochloride;Cyproheptadine hydrochloride; Dihexazin; 1   Cyprohetadine;Cyproheptadine;CYPROHEPTADINE HYDROCHLORIDE; Viternum; 9   Cyproheptadine; Ciproheptadina; Periactin; Peritol; Antergan			-31.3488576229	4	5		0	-8.34876055			9704	HRH1	CN1CC\C(CC1)=C2\c4ccccc4C=Cc3ccccc23	Vitas	STK802098	-8.1357528	-8.77034358	-4.84322999	-0.72171032	-8.34876055											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015771-13	Orphenadrine dihydrogen citrate	170464910	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	4682-36-4	; ; Mebedrol; Norgesic forte; Orphenadrine citrate salt; Orfenadrina; Orphenadrine Hcl;ORPHENADRINE CITRATE;Orphenadrine dihydrogen citrate; Orphenadrine hydrochloride;Orphenadrine hydrochloride	1.77827941	-5.75	-13.4731650155	4	5		12.9342206599	-8.10493521	0.2281545112	0.9667311059		CHRM1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C	Microsource	01500447	-7.86185055	-5.05037458	-5.88544404	6.05056511	-8.10493521											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274059-01	Nelarabine	170464759	Antimetabolite	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	121032-29-9		1.2589254118	-5.9	-24.4765680657	4	5		11.9165882	-5.30545898	0.105222591	0.9931953139		HPRT1	Nc3nc2c(ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O)c(OC)n3	Selleck	S1213	-9.5138235	-8.2709033	-5.30740935	1.83831873	-5.30545898											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015199-20	Chlorambucil	170464770	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	305-03-3	; ;CHLORAMBUCIL; Chlorambucil;Chlorambucil; Leukeran; Clorambucilo			-33.0798215894	4	5		0	-10.78978677				H2AFX	O=C(O)CCCc1ccc(cc1)N(CCCl)CCCl	Microsource	01500171	-7.77290662	-4.49047864	-4.7184757	-5.95530237	-10.78978677											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249923-01	Cholesolvin	170466018	Triglyceride Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	14929-11-4				-29.7636297381	4	5		0	-3.98096458					Clc2ccc(OC(C)(C)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1)cc2	GVK	FFS-11-286-NCI-201	-8.21131083	-6.22319437	-4.72703918	-5.58720421	-3.98096458											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00532508-01	DROMETRIZOLE TRISILOXANE			DPI_SARS-CoV-2_General	2019_NPC-9_Tox					-13.7770446295	4	4		0	-3.2019379					CC(CC1=CC(=CC(=C1O)[N]2N=C3C=CC=CC3=N2)C)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C	SIGMA	68790	-4.42624379	-2.23755047	1.06716613	-3.2019379												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00167981-03	Isosorbide mononitrate			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	16051-77-7				-21.112229568	4	4		0	-4.11803567					O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O	Prestwick	Prestw-1294	-5.24527315	-5.92193809	-0.23085635	-4.11803567												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00370833-02	NS-304		platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	475086-01-2				-18.4144873157	4	4		0	-0.56815679					CC(C)N(CCCCOCC(=O)N[S+](C)([O-])=O)C1=NC(=C(N=C1)C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-14870	-5.68964015	-5.9051144	0.95391585	-0.56815679												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167457-02	Gestrinone	170466364	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	16320-04-0		15.8489319246	-4.8	-9.2999032088	4	4		-7.0874256719	-5.90618806	0.7231816254	0.4242947854	5241	PGR	O=C3C=C4CC[C@@H]2C(C=C[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4CC3	Bosche	G6427	-2.2915396	-2.97779273	4.3601359	-5.90618806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013364-03	Vitamin B6			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	8059-24-3				-12.7521493889	4	4		0	-1.29927329					CC1=C(O)C(=C(CO[P](O)(O)=O)C=N1)C	DC Chemicals	DCZ-121	-3.39810055	-3.12920592	-1.31108982	-1.29927329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379044-01	Paricalcitol-D6 (ABT-358)		Vitamin D Receptor (VDR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox			3.1622776602	-5.5	5.7345135613	4	4		12.415265308	10.14314028	0.0370156753	0.9991616866		VDR	C[C@H](\C=C\[C@H](C)C(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/[CH]=[C]3C[C@@H](O)[CH2][C@H](O)C3	MedChem Express	HY-76585	-2.01272109	-1.53936743	6.25054447	10.14314028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016251-13	Probenecid	170464839	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	57-66-9				-35.3521837213	4	5		0	-4.79974714					O=S(=O)(N(CCC)CCC)c1ccc(cc1)C(=O)O	Microsource	01500502	-9.82196354	-11.50865409	-5.47381328	-2.401162	-4.79974714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015769-32	Ouabain octahydrate			DPI_SARS-CoV-2_General	2019_NPC-3_Tox	11018-89-6		0.0316227766	-7.4999999999	-398.6328491966	5	5		-58.1052510521	-96.53226171	0.0311289988	0.9840874841			C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O	Enzo	CM109	-67.90635967	-97.55877034	-96.05885444	-93.29127139	-96.53226171											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016490-12	Flufenamic acid	170465857	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	530-78-9				-9.4302677604	4	5		0	-4.0682711					FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)O	Vitas	STK985630	-3.37670119	-2.99233617	2.70625328	0.10439835	-4.0682711											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016786-15	Mycophenolic acid	170465182	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	24280-93-1	; ; Acido micofenolico; Acid, Mycophenoli; Mycophenolic acid;Mycophenolic acid;MYCOPHENOLIC ACID	3.1622776602	-5.5	-68.12608559	4	5		-26.7428992521	-33.11057931	0.0670064738	0.9647639504	727833	IMPDH1	O=C(O)CCC(\C)=C\Cc1c(O)c2C(=O)OCc2c(C)c1OC	Microsource	01500674	-10.30129248	-3.7414966	-5.03590822	-25.94979801	-33.11057931											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162218-05	Molindone hydrochloride	170465047	Serotonin 7 (5-HT7) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	15622-65-8				-35.3665299491	4	5		0	-3.75217352					Cl.O=C1C(CCc2nc(C)c(CC)c12)CN3CCOCC3	Prestwick	Prestw-1035	-10.48224463	-4.29318923	-7.2618283	-7.2173532	-3.75217352											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181040-02	dl-Coniine	170465693	Nicotinic acetylcholine receptor alpha1/beta1/gamma/delta Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3238-60-6				-5.0670972491	4	5		0	-3.56914066					CCCC1CCCCN1	Specs	AE-562/J259451	-0.4690925	0.85349116	-0.91629201	-2.12532866	-3.56914066											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274064-01	Betamethasone valerate	174007479	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	33755-46-3	Betamethasone valerate			-15.1665467047	4	5		0	-2.70888624				NRC31	OCC(=O)[C@@]4(OC(=O)CCCC)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Selleck	S1690	-3.45900921	-4.73065706	-1.19888675	-3.69412796	-2.70888624											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253577-01	Lenampicillin hydrochloride	170465777		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	80734-02-7				-33.3443218992	4	5		0	-4.61242793					Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]4C(=O)N3[C@@H](C(=O)OCC=2OC(=O)OC=2C)C(C)(C)S[C@@H]34	GVK	FFS-11-286-NCI-173	-7.99210872	-6.6349288	-7.39884393	-7.53286591	-4.61242793											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095165-07	Carmofur	170465833	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	61422-45-5	 Mifurol;CARMOFUR; CARMOFUR; Carmofur; 	8.9125093813	-5.05	-49.4961600688	-2.2	5		-32.920593904	-30.68545804	0.0264343649	0.9865418123		TYMS	O=C1NC(=O)C(F)=CN1C(=O)NCCCCCC	Microsource	01505317	-6.29986848	-2.83496312	-6.14001285	-12.30937774	-30.68545804											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018187-09	Cinnarizine	170465920	Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	298-57-7				-38.4102055727	4	5		0	-6.74476068					c1ccccc1C(c2ccccc2)N3CCN(CC3)C/C=C/c4ccccc4	Prestwick	Prestw-278	-11.28014029	-5.99159376	-7.86983515	-3.94829097	-6.74476068											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015572-06	MIBG			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	103346-16-3				-32.3725767186	4	4		0	-8.5232472					NC(=N)NCC1=CC=CC(=C1)I	Axon Medchem	1750	-7.81777278	-4.66256613	-3.97669594	-8.5232472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015948-10	Spironolactone			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	52-01-7				5.4447690788	4	5		0	-3.27628809					[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]4([H])[C@@]2([H])[C@@]([H])(CC5=CC(=O)CC[C@]45C)SC(C)=O	Prestwick	Prestw-128	3.24857519	2.26025047	0.88203811	-0.46888694	-3.27628809											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015209-11	Cyclophosphamide	170464624	Bcl-2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	6055-19-2	Cytophosphane;Endoxan;Neosar; Neosar; ; Sendoxan;Clafen;Revimmune; Cyclophosphane; Ciclophosphamide; Endoxon; Ciclofosfamida; (+-)-Cyclophosphamide; Cyclophosphamide; Cytoxan; Cytophosphan; Procytox;Cyclophosphamide;Cyclophosphamide monohydrate; Endoxan; (-)-Cyclophosphamide; Cytoxan Tablet; Cytoxan Injection;Procytox;Cytoxan			-14.4306306136	4	5		0	-1.61068912			596	BCL2	O.O=P1(NCCCO1)N(CCCl)CCCl	Vitas	STK177249	-3.41516879	-2.6977183	-2.2864483	-4.87730061	-1.61068912											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178831-03	Acriflavine hydrochloride	170465670	Hypoxia-inducible factor 1 alpha Interacts	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	69235-50-3		14.1253754462	-4.85	-46.8856593896	-3	5		-33.44287764	-31.6190647	0.1399105064	0.9218521571			[Cl-].C[n+]1c3cc(N)ccc3cc2ccc(N)cc12.Nc1cc2nc3cc(N)ccc3cc2cc1	Microsource	01500618	-9.01305749	-5.75483871	-4.07956249	0.48228613	-31.6190647											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178529-06	Levofloxacin		DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	100986-85-4				-28.4019473796	4	4		0	-6.36193298				TOP2B	C[C@H]1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0330	-6.84001038	-6.0303669	-2.81149314	-6.36193298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378691-02	Asunaprevir (BMS-650032)		Solute carrier organic anion transporter family member 2B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	630420-16-5				-32.5499191338	4	4		0	-6.54494749					COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)N[S+]([O-])(=O)C4CC4)C5=CC(=CC=C15)Cl	Adooq	A11295	-8.38885524	-6.34005764	-2.58198349	-6.54494749												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485328-01	(6R)-5,6,7,8-Tetrahydrobiopterin dihydrochloride	363681287	Phenylalanine-4-hydroxylase Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	69056-38-8				-8.4810225682	4	4		0	-4.86295699					C[C@H](O)[C@H](O)[C@H]1CNC\2=C(N1)\C(=O)N\C(=N2)N	SIGMA	T4425	-1.40607424	-1.3419932	-0.45460564	-4.86295699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168746-02	Methyldigoxin	99455400		DPI_SARS-CoV-2_General	2019_NPC-8_Tox			100	-4	-452.5017335913	5	4		33.8924260079	-97.37243453	1	0.9879167036			CO[C@H]1[C@@H](O)CC(O[C@@H]1C)OC2[C@@H](O)CC(O[C@@H]2C)OC3[C@@H](O)C[C@@H](O[C@@H]3C)OC4CC[C@@]5(C)C(CCC6C5CC(O)[C@]7(C)[C@@H](CCC67O)C/8=C/C(=O)OC8)C4	Chemdiv	N001-0009	-96.73358138	-96.68372833	-94.97726972	-97.37243453												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00142483-09	CYTIDINE		Dna Polymerase Inhibitors; Nucleoside	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	65-46-3				-12.9388351852	4	4		0	-2.85851235				POLB	NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503431	-3.32698797	-3.2689578	-0.03089553	-2.85851235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181135-02	Pentamycin	144206785		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	6834-98-6	Pentamycin; 			-34.2453409739	4	4	lagosin;NSC-277813;CIPLUS_3864474;PENTAMYCIN;fungichromin;pentamycin;LS-69889;Pentamycin;cogomycin;CIPLUS_215789;	0	-6.18763345					CCCCC[C@@H](O)C1C(=O)OC(C)[C@H](O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O	NCI	NSC-276732	-8.48403565	-6.7873887	-4.59460652	-6.18763345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181786-02	Naratriptan hydrochloride	170465423	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	143388-64-1	Naratriptan hydrochloride; Naratriptan hydrochloride; Amerge; 			-14.8959719611	4	4		0	-5.51860824			3351	HTR1B	Cl.CN1CCC(CC1)c2cnc3ccc(CCS(=O)(=O)NC)cc23	SIGMA	N1415	-3.34582208	-1.15242261	-2.03414932	-5.51860824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182997-01	Melinamide	144206837	Acyl coenzyme A:cholesterol acyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	14417-88-0	Melinamide; Artes; Melinamida; 			-11.297553181	4	5	MELINAMIDE;LS-173854;N-(2-methylbenzyl)linoleamide;(z,z)-n-(1-phenylethyl)-9,12-octadecadienamide;melinamide;melinamidum;CIPLUS_214142;Artes;Melinamidum;LS-88004;Melinamida;N-(2-methylbenzyl)linoleamide, (S-(Z,Z))-isomer;Melinamide;	0	-2.0634849					CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC(C)c1ccccc1	Pharmaron	PH-NIH-152054	-3.00008559	1.9245673	-5.71028201	-2.21052154	-2.0634849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018302-07	Trichlormethiazide	170464812	Diuretic	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	133-67-5	;Trichlormethiazide; Esmalorid; Naqua; Triclormetiazida; Esmaloride; Triazide;TRICHLORMETHIAZIDE			-13.373958834	4	5		0	-2.87623606				SLC12A3	NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)C(Cl)Cl)cc2Cl	Prestwick Chemical, Inc.	Prestw-825	-4.96019858	-0.89985361	-2.36468734	0.36766375	-2.87623606											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00378796-01	Tacalcitol		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	57333-96-7				21.3158077535	4	4		0	1.50298005					CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32337	6.58824582	-3.25526338	8.04931109	1.50298005												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00163732-03	Moxidectin			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	113507-06-5		3.5481338923	-5.45	-57.3931720273	-3	4		-105.7074691785	-4.45711324	1	0.999992488			CO\N=C/1C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C\4CO[C@@H]5[C@H](O)\C(=C/[C@@H](C(=O)O3)[C@]45O)C)O2)O[C@@H]([C@H]1C)\C(C)=C\C(C)C	MedChem Express	HY-B0777	4.48608999	-0.2874778	-98.06925308	-4.45711324												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00483046-01	SCE 2174			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	95789-30-3				4.3248633817	4	4		0	0.5787337					CC(OC(=O)OC1CCCCC1)OC(=O)\C2=C(CS[C@@H]3[C@H](NC(=O)CC4=CSC(=N4)N)C(=O)N23)/CSC5=NN=N[N]5CCN(C)C	DC Chemicals	DC9200	1.87404956	-0.48194808	-0.09970993	0.5787337												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00344535-01	5alpha-Cholestan-3beta-ol	225144382	Sterol regulatory element-binding protein cleavage-activating protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	80-97-7				-21.7500596331	4	4		0	-3.65379632			22937	SCAP	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	SIGMA	D6128	-3.57366491	-4.92939883	-7.30601885	-3.65379632												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00159435-03	Amiloxate	29215377		DPI_SARS-CoV-2_General	2019_NPC-6_Tox		Amiloxate; Neo Heliopan; 			-26.6655499594	4	4	3-MPMBEPA;3-(4-methoxyphenyl)-2-propenoic acid 3-methylbutyl ester;CIPLUS_669269;3-(4-Methoxy-phenyl)-acrylic acid pentyl ester;3-(4-methoxyphenyl)-3-methylbutylester, propenoic acid;AMILOXATE;ISOAMY 4-METHOXYCINNAMATE;Amiloxate;Neo Heliopan;amiloxatum;	0	-1.76211454					COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1	Chembridge	CB_5258581	-5.3627337	-6.64581043	-4.23313996	-1.76211454												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00167515-03	Enocitabine		cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	55726-47-1 				-18.779855093	4	4		0	-2.4272264					CCCCCCCCCCCCCCCCCCCCCC(=O)NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	Glixx	GLXC-05978	-2.7775293	-7.86336349	-3.3720087	-2.4272264												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00166059-02	Aluminum acetate, basic			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	142-03-0				-10.3110764467	4	4		0	-3.42057528					CC(=O)O[Al](O)OC(C)=O	SIGMA	289825	-1.08685929	-2.67185254	-2.7284264	-3.42057528												3.2E-8	1.6E-7	0.000004	0.000012											
NCGC00161827-01	NCGC00161827-01	26755462	Xanthine dehydrogenase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-14.5738077045	4	4		0	-0.28504794			6821		[O-][Mo]([O-])(=O)=O	SigmaAldrich	MFCD00049622	-2.23186332	-4.5489135	-3.58955765	-0.28504794												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00179291-04	Fursultiamine Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	2105-43-3				-18.7595366399	4	4		0	-3.17871642					CC1=NC(=C(CN(C=O)C(/C)=C(\CCO)SSCC2CCCO2)C=N1)N	Prestwick	Prestw-1007	-2.16924591	-6.54434768	-5.97353154	-3.17871642												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386215-04	ALOGLIPTIN BENZOATE			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	850649-62-6				-35.2072627482	4	4		0	-2.79001468					CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC3=CC=CC=C3C#N)C1=O	Microsource	01506318	-8.13579032	-9.96871565	-3.53517041	-2.79001468												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183598-02	Ximelagatran		Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	192939-46-1				-10.5334015527	4	4		0	-1.9521465					CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)\C(N)=N\O	DC Chemicals	DC7647	-1.57885321	-2.40128519	-3.75271936	-1.9521465												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00496851-01	NCGC00496851-01			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	207300-70-7				5.2966987538	4	4		0	0.38006392					OC1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O	SIGMA	G8645	2.51811432	-2.25754629	1.00616389	0.38006392												1.92E-7	9.6E-7	0.000024	0.000072											
NCGC00373041-03	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	259793-96-9				-13.5419496402	4	4		0	-4.99265786					NC(=O)C1=NC(=CN=C1O)F	Bio Vision	2778	-2.11557384	-4.6334658	-2.22987672	-4.99265786												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179342-03	Oxprenolol hydrochloride	170464995	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	6452-73-9				-27.2156508591	4	4		0	-6.25377904					Cl.CC(C)NCC(O)COc1ccccc1OCC=C	Tocris	3288	-6.26621344	-6.8656464	-2.69216824	-6.25377904												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00532495-01	Sizofilan			DPI_SARS-CoV-2_General	2019_NPC-6_Tox			0.2511886432	-6.6	-123.3458851449	-1.4	4		-67.3716073408	-94.09173361	0.7478630964	0.3331272584			OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H]3[C@@H](O)[C@H](O)O[C@H](CO)[C@H]3O)[C@H](O)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	Kemprotec	TC838	0.01341802	-96.01758688	-0.28100073	-94.09173361												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00263538-01	Trovafloxacin mesylate	170465074	Streptococcus pneumoniae Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	147059-75-4				-26.7997804085	4	4		0	-3.53286689					CS(=O)(=O)O.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3C[C@H]4[C@H](N)[C@H]4C3)c5ccc(F)cc5F	Tocris	3863	-4.59343412	-5.70727995	-8.79260334	-3.53286689												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181794-01	Dimethyl(2-phenoxyethyl)-2-thenylammonium iodide	144207154	acetylcholine metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	109732-56-1	Thenium closylate; Thenatol; Closilato de tenio; Canopar; 			-34.9561471484	4	4	Closilato de tenio;thenium closylate;thenii closilas;Closilate de thenium;THENIUM CLOSYLATE;CIPLUS_163117;closilate de thenium;Thenii closilas;Canopar;CIPLUS_3795079;Thenatol;THENIUM CLOSILATE;CIPLUS_3750771;Thenium closylate;Thenium closilate;	0	-3.2219055					[I-].C[N+](C)(Cc1cccs1)CCOc2ccccc2	Toronto Research	D476690	-8.02844619	-7.33913926	-6.39050036	-3.2219055												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00162222-04	Cibenzoline succinate		Voltage-sensitive sodium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	100678-32-8				-28.8626785321	4	4		0	-4.1720653					C1C/N=C(N1)/C2CC2(C3=CC=CC=C3)C4=CC=CC=C4	SIGMA	C1618	-6.7671527	-4.06696542	-6.7440174	-4.1720653												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346655-02	Linagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	668270-12-0				-32.0083666909	4	4		0	-5.55411592				DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	Selleck	S3031	-7.20547455	-8.50596094	-3.58955765	-5.55411592												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00249921-01	Omoconazole	170465847		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	74512-12-2		12.5892541179	-4.9	-20.7171971275	4	5		-20.273505804	-16.89458817	0.0506014842	0.9738334301			C\C(=C(\OCCOc1ccc(Cl)cc1)c2ccc(Cl)cc2Cl)n3ccnc3	GVK	FFS-11-286-NCI-199	-2.96761065	-1.30752688	0.14554115	-2.53763635	-16.89458817											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023234-05	Flurandrenolide	170465298		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1524-88-5				-20.9982350113	4	5		0	-3.56005918					OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-645	-7.63099881	-5.31612903	-1.88321425	1.21247634	-3.56005918											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094874-05	Esculin hydrate	225144214	tumor necrosis factor production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	66778-17-4				-21.8328308766	4	5		0	-3.8649509					OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)\C=C/C3=C2)[C@H](O)[C@@H](O)[C@@H]1O	SIGMA	E8250	-6.38460234	-6.89892473	-0.41898209	-2.84413594	-3.8649509											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162068-06	Opipramol dihydrochloride	170465942	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	909-39-7				-12.7777933094	4	5		0	-5.26386585					Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Prestwick Chemical, Inc.	Prestw-1456	-1.91622859	-1.78064516	-3.70909412	-2.07788696	-5.26386585											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179248-03	Articaine hydrochloride	170464825	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	23964-57-0				-9.223751381	4	5		0	-3.53315697					Cl.O=C(Nc1c(scc1C)C(=O)OC)C(C)NCCC	Prestwick Chemical, Inc.	Prestw-1032	-2.75563846	-3.42365591	0.35723736	0.96006491	-3.53315697											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182983-01	Fezatione	144206829		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	15387-18-5	Fezatione; 	14.1253754462	-4.85	-36.3804733455	4	5	Fezatione;FEZATIONE;fezationum;fezatione;3-((P-METHYLBENZYLIDENE)AMINO)-4-PHENYL-4-THIAZOLINE-2-THIONE;CIPLUS_789398;	-19.9152744959	-19.10056943	0.3859012386	0.7251384585			S=C2SC=C(N2/N=C/c1ccc(C)cc1)c3ccccc3	Pharmaron	PH-NIH-150803	-9.19959301	-4.22365591	-2.98579871	-0.00450735	-19.10056943											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015704-09	Methapyrilene hydrochloride	170465531		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	135-23-9				-22.9241640619	4	5		0	-4.01739676					Cl.CN(C)CCN(Cc1cccs1)c2ccccn2	Microsource	01503229	-7.90232322	-6.78709677	-0.09261709	-0.65356531	-4.01739676											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017134-08	Meclocycline sulfosalicylate			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	73816-42-9		14.1253754462	-4.85	-23.517807272	4	4		-14.45800122	-15.30851929	0.1461393142	0.9867049612			CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@@H]\3C(=C)C4=C(Cl)C=CC(=C4C(=O)C3=C(\O)[C@@]2(O)C(=O)\C(=C1O)C(N)=O)O.OC(=O)C5=C(O)C=CC(=C5)[S+](O)([O-])=O	SIGMA	M1388	-3.16820526	-3.69176551	-2.01018494	-15.30851929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263156-14	Nintedanib		VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	928326-83-4		5.0118723363	-5.3	-46.9473232426	4	4		-23.2123809561	-26.29049484	0.0764089407	0.9963933267	2324	FLT1	COC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)C5=CC=CC=C5	APExBIO	A8252	-5.55874178	-4.86351071	-13.88167013	-26.29049484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420878-02	Dalbavancin			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	171500-79-1				-12.4470563271	4	4		0	-2.37148794					CN[C@H]1C(=O)N[C@@H]2CC3=CC=C(OC4=CC5=CC(=C4O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6NC(=O)CCCCCCCCC(C)C)C(O)=O)OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)C9=C(Cl)C(=CC(=C9)OC%10=C(O)C=CC1=C%10)O)C%11=CC=C(O)C(=C%11)C%12=C(O[C@H]%13O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%13O)C=C(O)C=C%12[C@H](NC8=O)C(=O)NCCCN(C)C)C=C3	MedChem Express	HY-17586	-2.19737355	-5.68592058	-1.48306978	-2.37148794												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00509862-02	Fluralaner			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	864731-61-3		10	-5	-102.0058199813	-2.1	4		-100.573501274	-99.28800285	0.0187371428	0.9997834079			CC1=C(C=CC(=C1)\C2=N\OC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F	MedChem Express	HY-16973	-5.96461817	-7.59329648	-10.38201663	-99.28800285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013556-15	Liothyronine Sodium		Thyroid hormone receptor beta-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1955-6-1				-61.0951147454	4	4		0	-21.03951584					N[C@@H](CC1=CC(=C(OC2=CC(=C(O)C=C2)I)C(=C1)I)I)C(O)=O	APExBIO	B1779	-11.29395156	-11.10919143	-12.53898129	-21.03951584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249894-01	Fosphenytoin	170465016	Sodium channel protein type VIII alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	93390-81-9		2.2387211386	-5.65	-27.6812833463	4	5		9.45223828	-4.76343445	0.2815553498	0.9484997768			OP(=O)(O)OCN1C(=O)C(NC1=O)(c2ccccc2)c3ccccc3	GVK	FFS-11-286-NCI-63	-9.5435319	-7.01761852	-8.39368694	0.54654848	-4.76343445											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160580-02	2-Hydroxy-N-(4-hydroxyphenyl)-benzamide		Ribonucleoside-diphosphate reductase M2 chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	526-18-1				-31.6613020339	4	4		0	-4.46778213					OC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1	DC Chemicals	DC8981	-9.43221423	-2.88527989	-3.17480942	-4.46778213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182981-01	Proxazole citrate	144206776		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	132-35-4	Proxazole; Proxazol; 			-27.9818977872	4	4	CIPLUS_151746;proxazole, (+)-isomer;Proxazole;LS-99108;PROXAZOLE;pirecin;Proxazole citrate;LS-175790;3 alpha-phenylpropyl-5 beta- diethylaminoethyl-1,2,4-oxadiazole;proxazole, (+-)-isomer;3-(alpha-ethylbenzyl)-5-(2-diethylaminoethyl)- 1,2,4-oxadiazole;toness;CIPLUS_210763;Proxazol;Proxazole Citrate;N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate;Proxazolum;CIPLUS_177396;CIPLUS_177395;CIPLUS_177394;proxazolum;propazoline;proxazole, (-)-isomer;Toness;PROXAZOLE CITRATE;1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate;proxazole;	0	-6.04307583					CCC(c1nc(CCN(CC)CC)on1)c2ccccc2.O=C(O)C(O)(CC(=O)O)CC(=O)O	NCI	NSC_303872	-7.20871752	-4.09467865	-3.14015939	-6.04307583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018291-03	Procaterol	170465820	beta2-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	72332-33-3				-2.5571281075	4	5		0	0.33041164				ADRB2	CC(C)N[C@@H](CC)[C@H](O)c2ccc(O)c1NC(=O)C=Cc12	Bosche	P2505	-2.10609799	-1.14477828	-0.21350525	2.93482754	0.33041164											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167531-02	Rivastigmine tartrate	170464721	Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	129101-54-8	Rivastigmine tartrate;Rivastigmine tartrate (Exelon); Rivastigmine tartrate; ;RIVASTIGMINE			-2.6732462362	4	5		0	1.46849617			43	ACHE	O=C(Oc1cc(ccc1)[C@H](C)N(C)C)N(C)CC.O=C(O)[C@@H](O)[C@H](O)C(=O)O	Sequoia	SRP01333r	-1.33063095	-3.36624394	-1.18474484	2.68681394	1.46849617											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00387269-01	Rifaximin		Pregnane X Receptor (PXR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	[80621-81-4]				-26.5721559501	4	4		0	-9.30936276				rpoB	CO[C@H]1\C=C/O[C@@]2(C)OC3=C(C)C(=C4C(=C(NC(=O)\C(=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C5=C(N=C6C=C(C)C=C[N]56)C4=C3C2=O)O)O	Tocris	5359	-6.15873296	-1.59813407	-3.96309771	-9.30936276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094476-03	Terguride	144204835	Serotonin 1a (5-HT1a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	37686-84-3	R(+)-Terguride; S(+)-Terguride; Teluron; 			-21.6478804183	4	4	Teluron;R(+)-TERGURIDE;transdihydrolisuride;CIPLUS_3867987;S(+)-N,N-Diethyl-N'([8alpha]-6-methylergolin-8-yl)urea;TERGURIDE;NCGC00016838-01;NCGC00015990-01;Terguride;N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea;NCGC00016838-02;CIPLUS_739798;S(+)-Terguride;S(-)-terguride hydrogen maleate;terguride;VUFB 6638;dironyl maleate (1:1);NCGC00094476-01;trans-9,10-dihydrolisuride hydrogen maleate;LS-159804;NCGC00094476-03;LS-159803;NCGC00094476-02;R(+)-Terguride;R(+)-N,N-Diethyl-N'[(8alpha)-6-methylergolin-8-yl]urea;S(+)-Terguride (5R, 8S, 10R);CIPLUS_179126;1,1-DIETHYL-3-(6-METHYL-ERGOLIN-8A-YL)UREA;terguridum;dironyl;urea, N,N-diethyl-N'-((8 alpha)-6-methylergolin-8-yl)-, (Z)-2-butenedioate (1:1);	0	0.67639729					CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C)C1)c34	BIOMOL	AC-839	-7.06754312	-4.4056669	-1.46829522	0.67639729												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159506-06	Cyclandelate		Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	456-59-7				-26.1022736292	4	4		0	-4.67248131					CC1CC(CC(C)(C)C1)OC(=O)C(O)C2=CC=CC=C2	APExBIO	B1718	-6.89107513	-4.96717346	-2.20460845	-4.67248131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183273-04	Chloroprocaine HCl		"Sodium Channel Alpha Subunits; Brain (types I, Ii, Iii) Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	3858-89-7				-25.5479227493	4	4		0	-5.70487718					CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1	APExBIO	B4870	-6.49402215	-3.53317208	-3.19213444	-5.70487718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166153-02	Climbazole	170465557		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	38083-17-9				-20.0022590968	4	5		0	-7.67289248					CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2ccnc2	Bosche	C1228	-5.5340148	-1.34053962	-5.89860594	1.51104579	-7.67289248											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013095-10	Geraniol	170465692	Trichomonas vaginalis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	106-24-1		2.8183829313	-5.55	-15.2511606709	4	5		12.250319176	-4.3412418	0.4503470867	0.8510912028			C\C(C)=C\CCC(\C)=C\CO	Microsource	01501132	-4.26506873	-9.37526598	-7.44756562	3.05424149	-4.3412418											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00532512-01	HYDROCORTISONE ACEPONATE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-15.1040113706	4	4		0	-6.55927376					CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CC\C4=C\C(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	BOC Sciences	74050-20-7	-3.14113028	-1.30442294	-1.81479556	-6.55927376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181093-01	Metrizoate sodium	144206262		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	7225-61-8	Isopaque; Metrizoate; Isopaque cerebral; Isopaque coronar; Metrizoato sodico; Sodium, Metrizoat; 			-17.4533093775	4	4	Isopaque;natrii metrizoas;BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, MAGNESIUM SALT (2:1);CIPLUS_166229;MEGLUMINE METRIZOATE;Natrii metrizoas;Sodium, Metrizoat;methylglucamine metrizoate calcium;Isopaque cerebral;Sodium Metrizoate;Metrizoate Sodium;Metrizoate sodium;Triosil;CIPLUS_159326;METRIZOATE MEGLUMINE;SODIUM 3-ACETAMIDO-2,4,6-TRIIODO-5-(N-METHYLACETAMIDO)BENZOATE;methylglucamine metrizoate;CIPLUS_166216;Benzoic acid, 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodo-;METRIZOIC ACID;TRIOSIL;METRIZOATE MAGNESIUM;Isopaque coronar;CIPLUS_172535;Metrizoato sodico;metrizoate de sodium;METRIZOATE SODIUM;Metrizoate de sodium;Metrizoic acid;1-deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-5-(acetyl methylamino)-2,4,6-triiodobenzoate(salt) mixt. with 3-(acetylamino)-5-(acetylmethylamino)-2,4,6,- triiodobenzoic acid calcium salt (2:1);BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, MONOSODIUM SALT;Metrizoate;SODIUM METRIZOATE;BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, COMPD. WITH D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)- (1:1);sodium meglumine calcium metrizoate;meglumine metrizoate;meglumine calcium metrizoate;Sodium metrizoate;	0	-2.42079032					[Na+].Ic1c(NC(C)=O)c(I)c(c(I)c1N(C)C(C)=O)C([O-])=O	NCI	NSC-107431	-5.011691	-1.40808569	-2.66372141	-2.42079032												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160530-13	Toremifene citrate		Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	89778-27-8		12.5892541179	-4.9	-82.5155092224	-3	4		-106.8004727623	-99.54610182	0.0179966589	0.9998001896		ESR1	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-B0005	-1.66762253	-3.17035245	-2.34320859	-99.54610182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485891-01	Norgestimate metabolite Norelgestromin	363681397	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	53016-31-2				-15.3432459466	4	4		0	-5.19757921					CC[C@]12CC[C@H]3[C@@H](CC\C4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-G0018	-5.82344377	2.90255701	1.97938323	-5.19757921												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159425-09	ZINC UNDECYLENATE		Fatty Acid Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	557-08-4				-27.6940970651	4	5		0	-3.14808866					OC(=O)CCCCCCCCC=C	Microsource	01505467	-8.60063447	-8.99225466	-6.60191736	-0.18830662	-3.14808866											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00263855-02	CEFAMANDOLE SODIUM			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	34444-01-4				-5.270199696	4	4		0	-2.52758989					C[N]1N=NN=C1SCC/2=C(/N3C(SC2)[C@@H](NC(=O)C(O)C4=CC=CC=C4)C3=O)C([O-])=O	Microsource	01502038	-1.37645035	-1.91776088	2.10932086	-2.52758989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181355-02	Carpronium chloride	225144327	Muscarinic acetylcholine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-27.2549640179	4	4		0	-10.8490566					COC(=O)CCC[N+](C)(C)C	APAC	877481	-5.0646314	-4.28472702	-4.60412335	-10.8490566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159370-04	Docosanol	124892111	Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	661-19-8	; ; Tadenan;DOCOSANOL; Docosanol (Abreva); Abreva; Doconsanol; 1-Docosanol			-17.5723561629	4	5		0	-3.78137763					CCCCCCCCCCCCCCCCCCCCCCO	Labotest	LTBB001507	-6.15086359	-5.57919823	-3.25281534	1.63045974	-3.78137763											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00178213-05	Nafronyl oxalate	170465616	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3200-06-4				-25.7564166956	4	5		0	-9.00371713					O=C(O)C(=O)O.CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC3CCCO3	Microsource	01503419	-5.74550582	-5.07702783	-4.53384686	-2.36531484	-9.00371713											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015163-09	Benserazide	170465804	DOPA decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	14919-77-8	; ; Benserazida; Benserazide Hcl; Ro 8-0576-12; Ro 8-0576-7;Benserazide hydrochloride; Benserazide hydrochloride; Ro 8-0576;BENSERAZIDE HYDROCHLORIDE; Benseraszide; Ro 4460; Ro 4 460			-25.2401219116	4	4		0	-6.40979312			1644	DDC	Cl.Oc1ccc(CNNC(=O)C(N)CO)c(O)c1O	Microsource	01500137	-6.02869154	-5.69451607	-1.53667471	-6.40979312												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522503-01	Velpatasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1377049-84-7				-19.8479174749	4	4		0	-3.45559671					COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=CC7=C(C=CC8=C7[NH]C(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56	MedChem Express	HY-12530	-5.11853682	-6.53687468	0.53604932	-3.45559671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178782-04	Dicloxacillin sodium salt monohydrate	170465296	peptidoglycan biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	13412-64-1				-14.8667505713	4	4		0	-5.84063601					[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1c(Cl)cccc1Cl)[C@H]4SC3(C)C	Microsource	01500238	-1.01850648	-8.47086127	-2.83212722	-5.84063601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093588-04	cAMP	170466839	cAMP-dependent protein kinase type II-alpha regulatory subunit Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	60-92-4		0.2547885892	-6.593820026	-9.8466450118	4	5		10.5097751919	-7.8289202	0.1761305941	0.9806411968	5576	PRKAR2A	Nc4ncnc3c4ncn3[C@@H]2O[C@@H]1COP(=O)(O)O[C@H]1[C@H]2O	SIGMA	A9501	-6.91751851	-6.33670951	-7.92481266	2.46635742	-7.8289202											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00016636-05	Flavoxate hydrochloride	170466285	Muscarinic acetylcholine receptors; M1 & M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3717-88-2				-16.705357513	4	5		0	-2.49644349					Cl.O=C(OCCN1CCCCC1)c4cccc2c4OC(=C(C)C2=O)c3ccccc3	Prestwick	Prestw-242	-3.05780754	-5.27278917	-7.57315695	-0.27097782	-2.49644349											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00043225-04	Disodium 2-hydroxybutanedioate	170465632		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	676-46-0				-27.9929682207	4	5		0	-6.1309715					[Na+].[Na+].[O-]C(=O)C(O)CC([O-])=O	Specs	AE-562/J255939	-6.38879098	-6.34522087	-5.39624063	-4.79952234	-6.1309715											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163127-04	Acitretin	225144249	retinoid	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	55079-83-9	Acitretin; ; Acitretin; ACITRETIN; Soriatane	6.3095734448	-5.2	-6.0560626811	4	4		15.195683272	8.85807209	0.0857440467	0.9954802882		RXRA	COC1=C(C)C(=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(=C1)C)C	Prestwick	Prestw-1165	-4.32973606	-2.95255286	0.63432502	8.85807209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159397-03	Iodoantipyrine	170465556		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	129-81-7				-24.5259937549	4	4		0	-6.2471768					O=C2C(I)=C(C)N(C)N2c1ccccc1	Labotest	LT00454726	-5.31790404	-6.20165034	-2.77852229	-6.2471768												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021148-08	Metoprolol tartrate	170464652		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	56392-17-7				-21.7108081104	4	5		0	-4.3687761					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC	Microsource	01500411	-4.83785689	-6.90697081	-6.95357307	0.30772057	-4.3687761											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016892-04	Iopamidol	170464646		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	60166-93-0		1.4125375446	-5.85	-15.7940570013	4	5		13.6575608039	-1.59698958	0.0172592609	0.9998175946			O=C(Nc1c(I)c(c(I)c(c1I)C(=O)NC(CO)CO)C(=O)NC(CO)CO)[C@H](C)O	Prestwick	Prestw-871	-7.63130067	-7.52830028	-6.93682756	5.85587654	-1.59698958											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093802-06	Dehydroepiandrosterone	170465614	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	53-43-0	 DHEA phosphatide; ; Prasterona; DHEA sulfotransferase; Androstenolone; Dehydroepiandrosterone;Dehydroepiandrosterone; DHEA receptor;Dehydroepiandrosterone (DHEA); 5a-Androstanedione; Prasterone, 3 alpha Isome; trans-Dehydroandrosterone;trans-Dehydroandrosterone; DHEA sulphotransferase; 5-Androsten-3-ol-17-one;; 7   Androstanedione;DHEA; 5 Androsten 3 ol 17 on			-21.3743427604	4	5		0	-5.82809417				HSD11B1	O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Labotest	LT03329654	-6.60028199	-3.74925526	-2.28157575	-0.80374776	-5.82809417											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00184998-02	Dopexamine	170466408	D(2) dopamine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	86197-47-9				-4.9506704964	4	4		0	0.24844159			1813	DRD2	Oc2ccc(CCNCCCCCCNCCc1ccccc1)cc2O	APAC	877916	-2.40540892	1.44834107	-0.00893416	0.24844159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015838-06	Propionylpromazine hydrochloride	170466841	Trypanothione reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	7681-67-6				-16.7665840396	4	5		0	-7.0212473					Cl.CCC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	SIGMA	P7780	-3.18998943	-2.65128947	-2.84255034	-2.52147155	-7.0212473											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021761-05	Flumethasone	170465750	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	2135-17-3				-3.3638133061	4	4		0	-0.8627699					OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-734	-0.2037013	-1.90390236	-1.24184758	-0.8627699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016018-11	Tetrahydrozoline HCl		Adrenergic receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	522-48-5				-25.8769179461	4	4		0	-5.85870449					C1CC(\C2=N\CCN2)C3=C(C1)C=CC=C3	Selleck	S4043	-6.35808087	-7.00103146	-0.52711516	-5.85870449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090686-11	Nitrofurazone	170464946	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	59-87-0	; ;Nitrofurazone; Furacilin; Nitrofurazone solution; Furacillin;NITROFURAZONE; Nitrofurazone;Nitrofural; Furacin			-15.926812843	4	4		0	-3.34718583					O=[N+]([O-])c1ccc(/C=N/NC(N)=O)o1	Microsource	01500434	-3.8876609	-4.40519168	-0.5985884	-3.34718583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183106-01	NCGC00183106-01	124894306	Aeromonas salmonicida Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox		Nifurpirinol; Furanace; 	2.8183829313	-5.55	-18.3594759914	4	4	P 7138;LS-131753;nifurpirinol;Nifurpirinolum;NIFURPIRINOL;Furanace;nifurpirinolum;6-(2-(5-nitro-2-furanyl)ethenyl)-2-pyridinemethanol;CIPLUS_208451;Nifurpirinol;6-hydroxymethyl-2-(2-(5-nitro-2-furyl)vinyl)pyridine;	9.8457968	-4.21447285	1	0.8676042798			OCC1=CC=CC(\C=C\C2=CC=C(O2)[N+]([O-])=O)=N1	APAC	877864	-5.31790404	-9.038164	1.06316448	-4.21447285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015760-12	Octopamine	170465959	Dopamine transporter Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	104-14-3		0.0562341325	-7.25	-27.5885682069	4	5		12.5669776559	-3.39097846	0.3593198281	0.7542624479			OC(CN)c1ccc(O)cc1	Vitas	STK801377	-10.47248138	-4.43037975	-4.72937467	1.10299124	-3.39097846											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178024-05	Metaraminol bitartrate	170465256	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	33402-03-8				-16.011564514	4	5		0	-2.38858536					O[C@H](c1cc(O)ccc1)[C@H](C)N.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503251	-5.84182145	-4.43037975	-2.23331582	1.81108438	-2.38858536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181011-02	Gimeracil	170466048	Dihydropyrimidine Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	103766-25-2	Gimeracil			-4.5250746758	4	5		0	-0.9166027			1806	DPYD	ClC1=CNC(=O)C=C1O	Bosche	G3084	-4.07857571	1.28735038	0.34156595	3.69933276	-0.9166027											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182034-01	Teprenone	144206513	Heat shock 70 kDa protein 1 Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	6809-52-5	Teprenone; Selbex; Teprenona; 			-28.6014162429	4	4	CIPLUS_165824;tetraprenylacetone;geranyl-geranyl-acetone;Teprenone;teprenonum;Selbex;LS-174701;teprenon;TEPRENONE;LS-174702;Teprenona;geranylgeranylacetone, (Z,E,E)-isomer;6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one;CIPLUS_3885398;LS-96803;tetraprenyl acetone;geranylgeranylacetone;Teprenonum;geranylgeranylacetone, (E,E,E)-isomer;teprenone;	0	-8.23470955					C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CCC(C)=CCCC(C)=O	ACC	TEPRENONE	-6.0200234	-6.28760529	-3.83275261	-8.23470955												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016385-08	Sulfabenzamide	170465133		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	127-71-9				-17.3918287752	4	5		0	-6.21754639					Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2	Vitas	STK985629	-4.90884191	1.15818479	-4.01996847	-2.3466933	-6.21754639											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181915-01	Mepranoprofen arbamel	144206887		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	118635-52-2	Y-23023; 			-18.9592072484	4	5	N,N-DCDBPA;CIPLUS_747910;N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-1-benzopyrano(2,3-b)pyridine-7-acetate;LS-172989;Tilnoprofen Arbamel;TILMICOSIN PHOSPHATE;Mepranoprofen Arbamel;Mepranoprofen arbamel;CIPLUS_741518;TILNOPROFEN ARBAMEL;Y-23023;CIPLUS_3889595;Tilnoprofen arbamel;Tilmicosin Phosphate;Tilmicosin phosphate;tilnoprofenum arbamelum;THYMOSTIMULIN TILNOPROFEN ARBAMEL;Y 23023;MEPRANOPROFEN ARBAMEL;	0	-8.86350296					CN(C)C(=O)COC(=O)C(C)c1cc2Cc3ccc(C)nc3Oc2cc1	Pharmaron	PH-NIH-7	-4.34391851	-3.30233359	-2.75004379	-0.06808588	-8.86350296											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093926-05	Doxifluridine	170465861	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	3094-09-5	 ;5'dFUrd; Ro 21-9738; Furtulon; 5'dFUrd;Doxifluridine; Doxifluridine; Doxifluridina; 5-Fluro-5??-Deoxyuridine;5-fluoro-5'-deoxyuridine; 5-fluoro-5'-deoxyuridine	0.6309573445	-6.2	-21.1443419896	4	5		8.603870972	-5.47908353	0.3831286009	0.8983668082	7298	TYMS	FC1=CN(C(=O)NC1=O)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Bosche	D1649	-6.79158894	-10.50322581	-2.33306871	0.29297755	-5.47908353											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016246-09	Chlorhexidine	170464748	N-Acetyltransferase Eis (Mycobacterium tuberculosis) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	55-56-1	 Corsodyl ICI; Chlorhexidine base; Anticataracticum; Arlacide H; Lisium; 8   Chlorhexidine Base; Hibiclens; Tubilicid blue label; Hexidine; Curasept ADS 220; Clorhexidina;Chlorhexidine; Eludril; Instillagel; Hibisol; Trisdine; A, Sebidi; Sebidin A; Chlorhexidine; Gibitan; Hibident; Progaron; ; Anticataracticum tablet; Perio Chip; Chlorhexamed; Tubilicid red label;CHLORHEXIDINE; Tubilicid; Acetate, Chlorhexidin;Chlorhexidine diacetate; Novalsan; Hibiscrub; Dyna-Hex; Peridex; Dantroche hibitane			-16.76319137	4	5		0	0.95951217			4312	MMP1	Clc2ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)cc2	Vitas	STK089248	-6.2065457	-1.18709677	1.1069948	-8.46029027	0.95951217											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274269-01	NCGC00274269-01	225144370		DPI_SARS-CoV-2_General	2019_NPC-4_Tox					-20.9231988692	4	5		0	-6.71658521					CCCCCCCCCCCCNCCNCCNCC(O)=O	GVK	FFS-11-286-NCI-158	-3.66287943	-5.82365591	-3.33862574	-2.55566574	-6.71658521											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00015822-15	Pyrilamine	170464656	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	91-84-9				-26.3745210142	4	5		0	-5.18315922					COc1ccc(cc1)CN(CCN(C)C)c2ccccn2	Enzo	AC277	-8.83500085	-6.3827957	-1.88321425	-0.48228613	-5.18315922											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095116-05	Metaxalone	170465241		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1665-48-1				-7.5915956443	4	5		0	-2.95027575					Cc1cc(cc(C)c1)OCC2CNC(=O)O2	Microsource	01504229	-3.94268272	0.35268817	1.4333598	0.9690796	-2.95027575											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015823-17	Piroxicam	170464817	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	36322-90-4	; ;Piroxicam; Piroxicam cyclodextrin;PIROXICAM; Piroxicam;piroxicam; Feldene			-30.34460309	4	5		0	-4.84239788			5742	PTGS1	OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Vitas	STK177288	-8.81804307	-10.20215054	-3.60324601	-1.03218246	-4.84239788											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183283-01	Iomeprol	144207160		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	78649-41-9				-22.988410263	4	4	Iomeprol;Iomeron 300;IOMEPROL;iomeprol 350;Iomeprolum;iomeprol 400;iomeprol;iomeprolum;Altana Pharma brand of iomeprol;Rovi brand of iomeprol;Imeron;CIPLUS_191882;Iomeron;N,N'-BIS(2,3-DIHYDROXYPROPYL)-5-((HYDROXYACETYL)METHYLAMINO)-2,4,6-TRIIODO-1,3-BENZENEDICARBOXAMIDE;	0	-4.62101364					Ic1c(c(I)c(c(I)c1N(C)C(=O)CO)C(=O)NCC(O)CO)C(=O)NCC(O)CO	Toronto Research	I730500	-4.76314307	-7.95513151	-2.59090503	-4.62101364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160485-01	Diamthazole	144205400		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	95-27-2	Diamthazole; Asterol; 			-22.2478399113	4	4	DIAMTHAZOLE HYDROCHLORIDE;diamthazole dihydrochloride;CIPLUS_151863;Benzothiazole, 6-(2-diethylaminoethoxy)-2-dimethylamino-, dihydrochloride;amikazol;DIMAZOLE DIHYDROCHLORIDE;DIAMTHAZOLE;Dimazole Dihydrochloride;diamthazole;dimazole;dimazol;Dimazole dihydrochloride;Dimazol;6-(2-diethylaminoethylaminoethoxy)-2- dimethylaminobenzothiazole;Dimazole;Asterol;Diamthazole;CIPLUS_207319;LS-40729;dimazolum;DIMAZOLE-DIHYDROCHLORIDE;CIPLUS_166123;dimazole hydrochloride;Dimazolum;DIMAZOLE;	0	-12.24591201					CCN(CC)CCOc1ccc2nc(sc2c1)N(C)C	InterBioScreen	STOCK1S-45555	-3.78364322	-5.40226921	-3.15375681	-12.24591201												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00024714-11	Triprolidine	170464931	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	486-12-4				-16.4006739378	4	5		0	-5.28739784					Cc1ccc(cc1)C(=C\CN2CCCC2)/c3ccccn3	SigmaAldrich	T6764	-5.59359753	0.5898562	-2.1282186	-1.42980346	-5.28739784											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016329-07	Phenindione	170465130	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	83-12-5				-29.0891959714	4	5		0	-5.77504854					O=C2c1ccccc1C(=O)C2c3ccccc3	Specs	AN-153/I102301	-9.49670461	-6.41952984	-3.547031	-0.27688257	-5.77504854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015389-14	Propofol	170464994	TRPV1 (Vanilloid VR1 Receptor) Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2078-54-8	 ; Dipravan; Propofol;Propofol; propofol HP-beta-CD; 2,6-Bis(Isopropyl)-phenol;2,6-Diisopropylphenol;PROPOFOL			-0.925051937	4	5		0	1.53068136			7442	TRPV1	CC(C)c1cccc(C(C)C)c1O	SigmaAldrich	Lopac-D126608	-0.91158093	-0.93429777	-0.93711683	1.32994417	1.53068136											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167473-02	Capreomycin IB	174006669		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	33490-33-4				-22.6400845316	4	5		0	-6.36203549					NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)C(\NC1=O)=C\NC(N)=O)[C@@H]2CCNC(N)=N2	Bosche	C2304	-6.46666096	-2.07095496	-2.1019443	0.02269529	-6.36203549											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00167452-03	Pirenoxine Sodium	225144286	maintenance of lens transparency Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	51410-30-1				-0.3672038194	4	4		0	-1.28981655					OC1=C2C(=NC(=C1)C([O-])=O)C(=O)/C=C\3OC4=CC=CC=C4\N=C23	Bosche	P6175	0.41100632	-0.0430126	-0.60466964	-1.28981655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015649-08	Moxonidine hydrochloride hydrate	170466534	Imidazoline I1 Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	75438-57-2	 Zint; ; Moxon; MOXONIDINE HCl; Cynt;Moxonidine; Moxonidine; Lilly brand of moxonidine; Physiotens; Normatens;Moxonidine hydrochloride; Moxonidine hydrochloride			-28.3434179402	4	5		0	-2.46179189			11188	NISCH	COc2nc(C)nc(Cl)c2NC1=NCCN1	Prestwick	Prestw-1016	-6.66812801	-6.5577286	-6.76514665	-6.90184049	-2.46179189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015716-09	Nylidrin	170465637	Glutamate NMDA receptor; Grin1/Grin2c Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	447-41-6				-13.8729816479	4	5		0	-0.86025442					OC(c1ccc(O)cc1)C(C)NC(C)CCc2ccccc2	Specs	AO-080/40212238	-4.13415169	-3.43540916	-3.15135945	-1.37160386	-0.86025442											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167442-03	Tamsulosin hydrochloride	170464826	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	106463-17-6				-26.820017878	4	5		0	-5.49098563				ADRA1A	Cl.O=S(N)(=O)c1cc(ccc1OC)C[C@@H](C)NCCOc2ccccc2OCC	Sequoia	106463-17-6	-5.70363875	-6.73786241	-7.07343181	-3.55390009	-5.49098563											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091563-12	Thiram	170465664		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	137-26-8				-41.9667980556	4	5		0	-8.66660566					CN(C)C(=S)SSC(=S)N(C)C	Microsource	01503322	-10.13152126	-5.88008235	-9.15435667	-8.85626643	-8.66660566											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163468-05	Mitomycin C	170464814	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	50-07-7	; ; Ametycine; Mitomycin-C;Mitomycin C;Mitomycin; Mutamycin; MITOMYCIN C; Mitocin;MITOMYCIN C; Mitocin-C; Muamycin			-20.9378229195	4	5		0	-4.45658554				H2AFX	NC(=O)OC[C@@H]3C=1C(=O)C(N)=C(C)C(=O)C=1N2C[C@@H]4N[C@@H]4[C@@]23OC	Sequoia	50-07-7	-5.19986305	-6.81563765	-5.79786302	1.22100676	-4.45658554											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024584-17	BROMOCRIPTINE			DPI_SARS-CoV-2_General	2019_NPC-3_Tox	22260-51-1		12.5892541179	-4.9	-54.7606447878	-3	5		-38.6135209413	-39.92865851	0.0555894697	0.9710188753			[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N3C(=O)[C@](NC(=O)[C@H]4CN(C)[C@]5([H])CC6=C(Br)NC7=CC=CC(=C67)C5=C4)(O[C@@]23O)C(C)C	SIGMA	B2134	-9.44534794	-4.76621028	-2.8376248	-2.9821615	-39.92865851											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159510-05	Aripiprazole	170465392	5-HT1A/2A Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	129722-12-9	 Abilify;;Aripiprazole; ;ARIPIPRAZOLE; Aripiprazole			-24.6512132895	4	5		0	-4.71847203			3356	HTR2A	Clc4cccc(N3CCN(CCCCOc1ccc2CCC(=O)Nc2c1)CC3)c4Cl	Microsource	01505851	-7.62218608	-7.16007922	-2.96023822	0.12255458	-4.71847203											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016612-05	Sulfadoxine	170464751	Dihydropteroate Synthase (DHPS) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2447-57-6	; Sulfadoxine Roche Bran; Ro 4439; Ro 4 439; Sulphorthodimethoxine; Ro 4-4393; Sulphormetoxin; Sulformetoxine; Suldox; Ro 6-2153; Borgal; Sulfadoxin;SULFADOXINE; Fanasil; Fansimef; Sulfadoxina; Sulfadoxine;Sulfadoxine			-24.5644913146	4	5		0	-4.69138032					O=S(=O)(Nc1ncnc(OC)c1OC)c2ccc(N)cc2	Microsource	01506086	-7.82761277	-6.66063894	-3.58206341	0.88511643	-4.69138032											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094748-07	Oxyphenbutazone	170465310		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	129-20-4		12.5892541179	-4.9	-31.3423748821	-3	5		-44.1377613272	-39.59452748	0.0223528148	0.9886414953			Oc1ccc(cc1)N3C(=O)C(CCCC)C(=O)N3c2ccccc2	Microsource	01500455	-2.21261662	0.59846723	-0.18392013	2.95492715	-39.59452748											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015452-20	Flutamide	170464921	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	13311-84-7	Flutamide; ; Eulexin; 2-Methyl-N-(4-nitro-3-;FLUTAMIDE; Flutamide; Flutamida	1	-6	-8.9919437228	4	5		21.6388769999	-6.43428004	0.1655364816	0.9827612175	374	AR	O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C	Microsource	01500995	-10.5323975	-7.27202273	-3.61709581	12.55049703	-6.43428004											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091250-12	Reserpine	170465405	Alkaloid anitpsychotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50-55-5				-38.2854860428	4	5		0	-12.82145145				SLC18A2	COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	Vitas	STK801975	-6.3963174	-6.583462	-7.76707343	-9.74145486	-12.82145145											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016715-04	Trapidil	170465770	C-C motif chemokine 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	15421-84-8				7.4103821207	4	5		0	0.36606571			100009130	CCL2	CCN(CC)c1cc(C)nc2ncnn12	Prestwick Chemical, Inc.	Prestw-1012	2.53836037	1.99433865	2.81738386	-1.33654689	0.36606571											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164597-02	Ropivacaine hydrochloride	170465120	Voltage-gated potassium channel subunit Kv1.5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	98717-15-8				-41.3139171015	4	5		0	-7.94362588					Cl.CCCN2CCCC[C@H]2C(=O)Nc1c(C)cccc1C	Sequoia	SRP01307r	-8.57957036	-9.62000343	-8.49496896	-9.73269062	-7.94362588											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015054-12	Tacrine hydrochloride	170465420	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	321-64-2	 THA hydrochloride hydrate; THA hydrochloride; 9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;Tacrine hydrochloride hydrate; ;TACRINE HYDROCHLORIDE;Tetrahydroaminoacridine Monohydrate;Tacrine hydrochloride;Tacrine (hydrochloride);Tacrine; Tetrahydroaminacrin;1,2,3,4-Tetrahydro-9-acridinamine hydrochloride; Tacrina; Cognex;Tacrin?HCl			-14.4048980971	4	5		0	-3.0841036			43	ACHE	Nc1c3ccccc3nc2CCCCc12	Vitas	STK101308	-2.45944761	-3.15234174	-5.46349818	-2.16914987	-3.0841036											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178054-06	Clarithromycin		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	81103-11-9	;CLARITHROMYCIN;Clarithromycin (Biaxin, Klacid); 6-O-Methylerythromycin; 14-OH-clarithromycin; Claritromicina;Clarithromycin; Erythromycin, 6-O-methyl-; Biaxin			-24.6665167808	4	5		0	-4.55751807					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC	SIGMA	C9742	-6.78211311	-1.80562704	-3.85356455	-6.76161262	-4.55751807											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160682-02	Isocaine	170466550		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	94-14-4		5.0118723363	-5.3	-16.9219515207	4	5		-18.13640524	-15.5303377	0.0112296174	0.9943683538			Nc1ccc(cc1)C(=O)OCC(C)C	Vitas	STK267625	0.32880316	0.43317893	-1.88396489	-7.02453988	-15.5303377											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021191-09	Cortisone acetate	170464685	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50-04-4	Cortisone acetate; ;; Cortisone 21-acetate;Cortisone 21-acetate; 6   Cortisone Acetate; Cortone acetate	0.3981071706	-6.4	-9.7849201465	4	5		-5.2992935119	-1.87608676	0.5678029138	0.4864273931		NRC31	CC(=O)OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4C(=O)C[C@@]23C	Selleck	S2559	-2.46821569	4.91079087	-5.24941126	-5.1051709	-1.87608676											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165774-05	Cloprostenol (sodium salt)			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	55028-72-3				-22.9271857868	4	4		0	-3.97709756					O[C@@H](COC1=CC(=CC=C1)Cl)\C=C\[C@H]2[C@H](O)C[C@H](O)[C@@H]2C\C=C/CCCC([O-])=O	Cayman	16764	-4.81833232	-6.13223419	-4.81313703	-3.97709756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378669-02	Boldenone Undecylenate			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	13103-34-9				-17.2366344256	4	4		0	-4.5848932					C[C@]12CC[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C	MedChem Express	HY-17434	-3.19769975	-4.05450875	-4.02038505	-4.5848932												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274077-01	Hydrocortisone 17-butyrate	170465456		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	13609-67-1				-10.2997382908	4	4		0	-5.75644131					OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	H5270	-1.28953559	-3.0282638	-0.84066556	-5.75644131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263825-02	HETACILLIN POTASSIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	5321-32-4, 3511-16-8 [hetacillin]				-14.1313942947	4	4		0	-6.12640388					CC1(C)N[C@@H](C(=O)N1[C@@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C4=CC=CC=C4	Microsource	01500327	-3.11056896	-1.76648721	-0.53576095	-6.12640388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094854-07	Allantoin	170465460	Allantoinase Substrate	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	97-59-6				-10.8973352785	4	5		0	-0.67277735			854845	DAL1	O=C1NC(=O)NC1NC(=O)N	Specs	AE-562/J258555	-4.42095352	-0.17652631	-2.97775442	0.01361718	-0.67277735											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160623-04	Octinoxate	170464894		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	5466-77-3				-16.6694252314	4	5		0	-6.47936305					COc1ccc(C=CC(=O)OCC(CC)CCCC)cc1	SIGMA	437174	-1.72292854	-2.54331789	-4.76129308	-5.04382121	-6.47936305											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344561-01	Norgestimate	170464733	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	35189-28-7		14.1253754462	-4.85	-24.247721732	4	4		-14.521613148	-13.35134429	0.6321172762	0.6293224652			CC(=O)O[C@@]3(C#C)CC[C@H]2[C@@H]4CCC1=CC(\CC[C@@H]1[C@H]4CC[C@@]23CC)=N\O	Prestwick	Prestw-1452	-6.27758069	-2.38289819	4.90356181	-13.35134429												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018242-07	Sulfacetamide	170464944	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	144-80-9				-15.7579973095	4	5		0	-2.44348861					Nc1ccc(cc1)S(=O)(=O)NC(C)=O	Labotest	LT00053160	-1.45111793	-3.40967576	-7.72425605	-4.94741455	-2.44348861											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024016-03	Hydrocortisone valerate	170464775		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57524-89-7				-7.3493871106	4	5		0	0.18303285					OCC(=O)[C@@]4(OC(=O)CCCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	H5395	-3.31871986	-0.51895694	0.96767288	-2.35319895	0.18303285											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164622-02	Voriconazole	170464890	Lanosterol 14alpha-demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	137234-62-9	 ; Vfend; Voriconazole;Voriconazole			-26.8563880291	4	5		0	-8.12665874			1595	CYP51A1	O[C@](Cn1cncn1)([C@@H](C)c2ncncc2F)c3ccc(F)cc3F	Sequoia	SRP01070v	-6.41385357	-1.41104821	-6.27702847	-5.02629273	-8.12665874											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016268-08	Niacin	170465044	Nicotinic acid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	59-67-6	NIACIN;Niacin; ; Niacin; Niacin-d4 (ring-d4);Nicotinic acid			-22.3813127642	4	5		0	-3.34950124				HCAR3	O=C(O)c1cccnc1	Vitas	STK301803	-4.43226655	-5.11665809	-6.85078142	-4.71078002	-3.34950124											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182060-03	l-Oxyfedrine hydrochloride	170465929	Adrenergic receptor beta Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	16777-42-7				-12.6170597894	4	5		0	-3.41356273					Cl.COc1cc(ccc1)C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2	APAC	555781	-1.8544498	-4.24172242	0.07707129	-5.31551271	-3.41356273											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179580-04	Biotin	170464763		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	58-85-5				-4.913895453	4	5		0	-0.47527238					O=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1	Vitas	STK801941	-1.57707309	-4.17204301	-0.62185763	2.4565041	-0.47527238											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015856-10	Prochlorperazine dimaleate	170464761	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	84-02-6	; ;Prochloperazine dimaleate; Proclorperazina; Prochlorperazine dimaleate; Compazine syrup;Prochlorperazine; Compro; Compazine;Prochlorperazine dimaleate; Maleate, Prochlorperazin			-21.5404842549	4	5		0	-6.81522665			1813	DRD2	O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Prestwick Chemical, Inc.	Prestw-399	-5.5282347	-3.83655914	-3.93843168	-1.08627062	-6.81522665											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346550-02	Lumacaftor		CFTR Channel Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	936727-05-8				-16.932457302	4	4		0	1.1590919				CFTR	CC1=C(N=C(NC(=O)C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)C=C1)C5=CC=CC(=C5)C(O)=O	Selleck	S1565	-5.29981829	-3.79371156	-2.30833738	1.1590919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182029-01	Fosfluconazole	144206487	Cytochrome P450 51 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	194798-83-9	Fosfluconazole; Prodif; 			-19.6577210423	4	4	Fosfluconazole;fosfluconazole;fosfluconazolum;CIPLUS_787926;FOSFLUCONAZOLE;Prodif;	0	-6.45779773					Fc1ccc(c(F)c1)C(OP(=O)(O)O)(Cn2cncn2)Cn3cncn3	ACC	Fosfluconazole	-3.62983473	-4.07759474	-3.87959571	-6.45779773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344544-01	Cabergoline	170464667	Serotonin 2b (5-HT2b) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	81409-90-7				-33.7543076211	4	4		0	-8.21822302					CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CC=C)c34	SIGMA	C0246	-7.18612097	-7.59602564	-5.6538818	-8.21822302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179673-03	Idoxuridine	170465014	Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	54-42-2	Idoxuridine			-3.408087758	4	4		0	-4.60150769					IC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick	Prestw-18	0.23795103	-1.37640329	0.55170587	-4.60150769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510028-01	Amezinium methylsulfate		Amine oxidase [flavin-containing] B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	30578-37-1				-27.123552668	4	4		0	-6.02204889			403451	MAOB	COC1=CC(=CN=[N+]1C2=CC=CC=C2)N	Ark Pharm	AK396807	-6.77944103	-7.02825928	-0.56936046	-6.02204889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168290-05	Avermectin B1a			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	65195-55-3		11.220184543	-4.95	-72.7978089166	-3	4		-97.0774932118	-85.45034642	0.0253620617	0.9996030871			CC[C@H](C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C/C=C(C)/[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C/6CO[C@@H]7[C@H](O)\C(=C/[C@@H](C(=O)O3)[C@]67O)C)O2)\C=C/[C@@H]1C	MedChem Express	HY-15308	-2.23673964	-0.30108822	-4.30330582	-85.45034642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482960-01	Xanthophyll			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	127-40-2				-22.5191338032	4	4		0	-1.6819905					CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(\C)CC(O)CC1(C)C)\C=C\C=C(C)\C=C\C2\C(=C/C(O)CC2(C)C)C	DC Chemicals	DCY-149	-6.1045254	-5.7378812	-2.37895573	-1.6819905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017337-17	(E)-Capsaicin		Nf-kappab Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	[404-86-4]				-19.0324966936	4	4		0	-4.07860909				NFKB1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1	Tocris	0462	-4.91044389	-5.13570476	0.20744141	-4.07860909												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178220-05	Dipyrone	170465672	Prostaglandin G/H synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	68-89-3				-28.5444156016	4	4		0	-5.35124422			5742	PTGS1	[Na+].[O-]S(=O)(=O)CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Vitas	STK177347	-7.37126427	-5.59387618	-2.59168917	-5.35124422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181917-01	Carbenicillin indanyl	144206652	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	35531-88-5	Carbenicillin indanyl			-9.3253460795	4	4	Geocillin;Carbenicillin Indanyl Sodium;carindacillinum;Carindacillin;CARINDACILLIN;LS-149775;CARINDACILLIN SODIUM;CIPLUS_670161;Malonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenyl-, 1-(5-indanyl) ester, monosodium salt;CARBENICILLIN INDANYL SODIUM;CIPLUS_175403;carbenicillin indanyl;4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((3-((2,3-DIHYDRO-1H-INDEN-5-YL)OXY)-1,3-DIOXO-2-PHENYLPROPYL)AMINO)-3,3-DIMETHYL-7-OXO-, MONOSODIUM SALT, (2S,5R,6R)-;LS-88733;Carindacilline;1-(5-INDANYL)(2S,5R,6R)-N-(2-CARBOXY-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPT-6-YL)-2-PHENYLMALONAMATE MONOSODIUM SALT;Carindacilina;CIPLUS_197131;SODIUM (2S,5R,6R)-6-((3-(2,3-DIHYDRO-1H-INDEN-5-YLOXY)-3-OXO-2-PHENYLPROPANOYL)AMINO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE;Carindacillin sodium;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1H-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2-alpha,5-alpha,6-beta))-;4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((3-((2,3-DIHYDRO-1H-INDEN-5-YL)OXY)-1,3-DIOXO-2-PHENYLPROPYL)AMINO)-3,3-DIMETHYL-7-OXO-, MONOSODIUM SALT, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.))-.;carindacilline;Carbenicillin indanyl sodium;Carindacillinum;Carindacillin Sodium;	0	-2.16251927					OC(=O)[C@@H]4N5C(=O)[C@@H](NC(=O)C(c1ccccc1)C(=O)Oc2cc3CCCc3cc2)[C@H]5SC4(C)C	GVK	GVK-NIH-11	-1.22854404	-4.32368775	-2.21709208	-2.16251927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186632-01	Strychnine	124897819	Glycine receptor subunit alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1421-86-9				-16.0223053397	4	4	STRYCHNINE HCl	0	-7.65029729					O=C1C[C@@H]2OC\C=C/3C[N@]4CC[C@@]56[C@@H]4C[C@@H]3[C@@H]2[C@@H]5N1C7=C6C=CC=C7	BIOMOL	AC745	-2.68362813	-3.34791386	-1.58985974	-7.65029729												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014993-12	Nonanedioic acid	170465358	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	123-99-9				-15.4285769512	4	5		0	-4.35724929			7299		O=C(O)CCCCCCCC(=O)O	Microsource	01500648	-3.59068732	-1.29596142	-5.09721492	-1.49335028	-4.35724929											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183861-01	(2R)-2-Propyloctanoic acid	144206875	S100 beta biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	185517-21-9		1	-6	-30.0175146806	4	5	Arundic Acid;Acido ar?ndico;(R)-2-Propyloctanoic acid;acidum arundicum;arundic acid;(R)-(-)-2-propyloctanoic acid;CIPLUS_783758;Acide arundique;ONO-2506;Arundic acid;ONO2506;Acidum arundicum;	11.443721648	-10.52512756	0.0272667555	0.9995476298			O=C(O)[C@@H](CCCCCC)CCC	Pharmaron	PH-NIH-183336	-10.36976804	-9.82089038	-5.67524961	0.03177341	-10.52512756											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017324-07	Simvastatin	170464984	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	79902-63-9	; Zocor;Simvastatin;SIMVASTATIN	3.5481338923	-5.45	-118.3191069494	-2.1	5		-93.4332940382	-93.83212173	0.0017226031	0.9991377099	3156	HMGCR	CC(C)(CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801938	-3.49653342	-2.26039783	-3.09160974	-54.30983614	-93.83212173											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263152-12	Ponatinib		FGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1114544-31-8		1.995262315	-5.7	-124.5013983766	-1.3	4		-100.8464829558	-95.1973741	0.055243609	0.9981129412		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Glixx	GLXC-01988	1.60568924	-11.62594064	-99.94561276	-95.1973741												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00531794-01	Cimicoxib			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	265114-23-6				16.7958211624	4	4		0	2.66044744					COC1=CC=C(C=C1F)C2=C(Cl)N=C[N]2C3=CC=C(C=C3)[S+](N)([O-])=O	Toronto Research	C441690	6.84766079	-1.9447028	0.76142132	2.66044744												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00388518-02	Ticarcillin sodium			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	74682-62-5				-29.3138304679	4	4		0	-5.70959661					CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)C3=CSC=C3)C(=O)N2[C@H]1C([O-])=O	Prestwick	Prestw-1067	-4.53976205	-9.40221527	-6.93437273	-5.70959661												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178697-04	Irinotecan	170464824	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	100286-90-6	;Irinotecan hydrochloride trihydrate;Irinotecan; Campto;Irinotecan hydrochloride			-17.9638835701	4	4		0	-1.89168178			7150	TOP1	Cl.CC[C@]3(O)C=4C=C5c6nc7ccc(OC(=O)N1CCC(CC1)N2CCCCC2)cc7c(CC)c6CN5C(=O)C=4COC3=O	Prestwick	Prestw-1494	-3.45737544	-3.10306925	-5.79224075	-1.89168178												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178579-04	Levobupivacaine hydrochloride	170465452	Sodium channel protein type IV alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	27262-48-2				-33.8086574699	4	4		0	-5.60594282					Cl.Cc2cccc(C)c2NC(=O)[C@@H]1CCCCN1CCCC	Specs	AN-153/I154112	-6.52562841	-8.04937854	-7.85895577	-5.60594282												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346580-04	Vinflunine (Tartrate)			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1201898-17-0		1.995262315	-5.7	-72.443359669	-2.3	4		-88.1154822312	-35.65690593	1	0.9999926481			[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)\C=C/C3)C(=O)OC)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=C8C=CC=C9)C(C)(F)F)C(=O)OC	MedChem Express	HY-B0628A	0.4785759	-16.49615287	-80.64720812	-35.65690593												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00389390-01	Abiraterone acetate		Cytochrome P450 17A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	154229-18-2		4.4668359215	-5.35	-55.9537311603	-3	4		-102.4015228471	-6.86706401	1	0.9999891688			CC(=O)OC1CCC\2(C)C3CCC\4(C)C(C\C=C4C5=CN=CC=C5)C3C\C=C2C1	APExBIO	A8202	3.57366491	-1.66568022	-90.60913706	-6.86706401												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179310-03	Cefalonium	170466431	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5575-21-3				-21.0057823384	4	4		0	-3.24781895					NC(=O)c4cc[n+](CC=2CS[C@@H]3[C@H](NC(=O)Cc1cccs1)C(=O)N3C=2C([O-])=O)cc4	SIGMA	32904	-5.91734502	-3.23835292	-1.84010152	-3.24781895												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181041-01	5-Chloro-2-methyl-3(2H)-isothiazolone	144206242	aerobic respiration Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	26172-55-4				-27.4757654212	4	4	MBC-215;5-chloro-N-methylisothiazolone;5-Chloro-2-methyl-4-isothiazolin-3-one solution;5-chloro-2-methyl-4-isothiazolin-3-one hydrochloride;5-Chloro-2-methyl-3(2H)-isothiazolone;5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE;5243-K-Cg;CIPLUS_182875;Kathon 886 biocide;MBC 215;5-Chloro-2-methyl-isothiazol-3-one;Kathon CG;5-chloro-2-methylisothiazolin-3-one;CIPLUS_182376;CIPLUS_180763;methylchloro-isothiazolinone;CIPLUS_175198;METHYLCHLOROISOTHIAZOLINONE;LS-86318;LS-174152;CIPLUS_694515;5-chloro-2-methyl-4-isothiazolin-3-one;Kathon 886;Kathon WT;Kathon biocide;kathon cg 5243;	0	-3.30828367					ClC1=CC(=O)N(C)S1	SigmaAldrich	344	-5.77421952	-6.89101209	-5.03081943	-3.30828367												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179247-04	Nomegestrol acetate		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	58652-20-3				-20.1577178259	4	4		0	-0.92424635					CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O	SIGMA	SML0133	-2.88487342	-6.69654181	-5.91914431	-0.92424635												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522018-01	Echothiophate Iodide		Cholinesterases; ACHE & BCHE Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	513-10-0				-36.7824606557	4	4		0	-4.92355533					CCO[P](=O)(OCC)SCC[N+](C)(C)C	Toronto Research	E325800	-7.67063244	-10.60285787	-5.2302393	-4.92355533												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182081-04	Zotepine	170465934	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	26615-21-4				-13.3399857914	4	4		0	-4.72488555			3269	HRH1	CN(C)CCOC1=Cc3ccccc3Sc2ccc(Cl)cc12	Prestwick	Prestw-1368	-1.20314876	-4.42208506	-4.80420595	-4.72488555												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181159-03	Trabectedin	384568393	DNA-Damaging Drug	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	114899-77-3		31.6227766017	-4.5	-453.15270715	5	4		-17.135428896	-96.59670035	0.7896179593	0.8774625016		H2AFX	COC1=CC2=C(CCN[C@]23CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=C6C(=C(OC)C(=C7)C)O)[C@H](O)N5[C@@H](COC3=O)C8=C4C(=C(C)C9=C8OCO9)OC(C)=O)C=C1O	MedChem Express	HY-50936	-96.37266303	-96.67709478	-96.1475707	-96.59670035												3.2E-8	1.6E-7	0.000004	0.000012											
NCGC00250402-09	Dapagliflozin		SGLT-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	461432-26-8				16.5695011552	4	4		0	-1.73620109				SCL5A2	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C1	DC Chemicals	DC6904	7.48278021	-0.58341084	-1.61348803	-1.73620109												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00248587-03	METHYLPHENIDATE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	298-59-9, 113-45-1(base)				-30.9716185785	4	4		0	-5.97736892					COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Microsource	01505907	-7.1339118	-8.04092331	-3.09100798	-5.97736892												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00373220-03	CEFMENOXIME HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	75738-58-8				-27.8313333728	4	4		0	-2.98004664					CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4	Microsource	01502422	-6.23043206	-7.66889321	-3.38107324	-2.98004664												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00042523-03	N-Oxydiethylenebenzothiazole-2-sulfenamide	170465568		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	102-77-2				-27.4435989782	4	5		0	-2.87853652					c1cccc2sc(nc12)SN3CCOCC3	Labotest	LT00078541	-8.46192979	-8.48172043	-3.51503925	-1.73532859	-2.87853652											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016819-05	Gliquidone	170465581	Cytochrome P450 3A4 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	33342-05-1		0.5011872336	-6.3	-19.4932737357	4	5		9.726451612	-2.12527463	0.2700388721	0.8309726822			O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3cc(ccc3C(C)(C)C4=O)OC	Prestwick Chemical, Inc.	Prestw-991	-7.35119552	-9.77204301	-0.07497574	3.73659064	-2.12527463											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095049-04	Exalamide	170465990		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	53370-90-4		1	-6	-14.1793743176	4	5		15.9900796959	-6.03506255	0.1045014539	0.9932588246			NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	-8.74173308	-6.62365591	-1.87439358	5.51248535	-6.03506255											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00189077-01	Methsuximide	144207162	Voltage-gated T-type calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	77-41-8				-10.3720555307	4	5	Methsuximide	0	-0.83396852					CC1(CC(=O)N(C)C1=O)c2ccccc2	Toronto Research	M271900	-3.68831609	-1.71182796	-3.41801182	0.9690796	-0.83396852											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015705-07	Memantine hydrochloride	170464999	NMDA Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	19982-08-2	 Namenda; ;Memantine;MEMANTINE HYDROCHLORIDE; Axura;Memantine hydrochloride; Ebixa; Memantine hydrochloride; Memantine HCL; Memantina;Memantine Hydrochloride; Memantin			-27.1429556858	4	5		0	-5.94538851			2903	GRIN2A	CC13CC2(C)CC(N)(C1)CC(C2)C3	Vitas	STK520682	-7.35119552	-7.50967742	-3.40919114	-2.05084287	-5.94538851											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249901-01	Thiocyanoacetic acid sodium salt	170465517		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63906-52-5				-4.5767944535	4	5		0	-1.76657849					[Na+].[O-]C(=O)CSC#N	GVK	FFS-11-286-NCI-92	-2.43344073	-2.91612903	-0.38369939	5.09780943	-1.76657849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016258-06	Menadione	170464997	CDC25 Phosphatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	58-27-5	 ; Menadione (K3);Menadione / vitamin K3;MENADIONE; Kappaxin; Kipca, oil soluble;Menadione; Menadione; Vitamin- K3			-28.9523260387	4	5		0	-5.10245258			5923	CDC25	O=C2C=C(C)C(=O)c1ccccc12	Specs	AE-562/J257372	-7.9108021	-7.63010753	-5.42912587	-1.91562246	-5.10245258											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249892-01	Lexiscan	170465244	Adenosine A2a receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	313348-27-5		1	-6	-24.1610292394	4	5		13.4741935439	-7.1918576	0.0341358358	0.9992867672			CNC(=O)c1cn(nc1)c2nc(N)c3ncn(c3n2)[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O	GVK	FFS-11-286-NCI-48	-9.88638291	-9.97849462	-4.8381406	3.13260615	-7.1918576											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015400-05	Enoximone	170466419	Phosphodiesterase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	77671-31-9		0.316227766	-6.5	-22.9132267514	4	5		13.3651009039	-7.00354212	0.5250411637	0.7830039795			O=C(C=1NC(=O)NC=1C)c2ccc(SC)cc2	Tocris	1693	-9.47091742	-3.84516129	-5.10276087	0.62652123	-7.00354212											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00271789-02	Actinomycin D	170464668	DNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	50-76-0		10	-5	-112.4733416293	-2.1	5		-120.7159720988	-95.86154329	0.0302402884	0.984530693		PRKDC	CC(C)[C@H]6NC(=O)[C@@H](NC(=O)c1ccc(C)c2OC3=C(C)C(=O)C(N)=C(C3=Nc12)C(=O)N[C@@H]5C(=O)N[C@@H](C(=O)N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C6=O	SIGMA	A1410	-1.51772087	-6.74408602	-17.1606245	-30.4741729	-95.86154329											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016528-05	Proguanil hydrochloride	170464800	DHFR inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	637-32-1	Proguanil hydrochloride; Chlorguanide; ; Proguanil hydrochloride;Proguanil hydrochloride; Chlorguanide; ;Proguanil hydrochloride;CHLOROGUANIDE HYDROCHLORIDE			-26.2415951307	4	5		0	-7.31740125					Cl.Clc1ccc(NC(=N)NC(=N)NC(C)C)cc1	Prestwick Chemical, Inc.	Prestw-999	-6.99508225	-3.31182796	-3.94725236	-3.89885513	-7.31740125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016395-06	Diphenylpyraline hydrochloride	170464816	Histamine H1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	132-18-3				-24.5555316476	4	5		0	-5.87364928					Cl.CN3CCC(OC(c1ccccc1)c2ccccc2)CC3	Microsource	01500258	-5.9352213	-8.8688172	-3.86786628	-0.3650951	-5.87364928											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015989-17	Thalidomide	170465323	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	50-35-1	(?)-Thalidomide; ; (+)-Thalidomide; Sedoval; Thalidomide;Thalidomide; Thalomid;thalidomide;THALIDOMIDE; Talidomida; (-)-Thalidomide; (+/-)-Thalidomide; (R)-(+)-Thalidomide; (S)-(-)-Thalidomide; (?)-Thalidomide			1.8768934947	4	5		0	-2.90543873			7124	TNF	O=C1NC(=O)CCC1N3C(=O)c2ccccc2C3=O	Microsource	01503607	0.85636764	-0.93763441	-1.00996736	5.46741188	-2.90543873											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095099-05	Sildenafil citrate	170465285	Phosphodiesterase V (PDE5) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	171599-83-0	 ; Sildenafil(Viagra); SILDENAFIL;SILDENAFIL; Caverta; Viagra;SILDENAFIL CITRATE			-28.7087153852	4	5		0	-9.64892615			8654	PDE5A	CN1CCN(CC1)S(=O)(=O)c4cc(C3=Nc2c(CCC)nn(C)c2C(=O)N3)c(OCC)cc4.O=C(O)C(O)(CC(=O)O)CC(=O)O	Microsource	01504099	-7.56316771	-4.12903226	-5.1292229	-1.42882899	-9.64892615											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181020-01	Zeaxanthin	144206223	osteoclast development Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	144-68-3	Lutein; alpha-Carotene-3,3'-diol; gamma Lutein; Lutein, gamm; Lutein G; Lutein F; 			-2.799846603	4	4	XANTHOPHYLL;zeaxanthin;beta, epsilon-carotene;ZEAXANTHIN;(3R,3'R)-beta,beta- carotene-3,3'-diol;Lutein G;beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-;meso-zeaxanthin;Lutein F;CIPLUS_173450;LUTEIN A;alpha-Carotene-3,3'-diol;LUTEIN;beta,epsilon-Carotene-3,3'-diol, (3R,3'R,6'R)-;CIPLUS_758859;CIPLUS_668195;beta,beta-Carotene-3,3'-diol;Xanthophyll;gamma Lutein;Lutein;Lutein, gamm;B,B-CAROTENE-3,3'-DIOL, (3R,3'R), TRANS;Zeaxanthin;B,E-CAROTENE-3,3'-DIOL, (3R,3'R,6'R), TRANS;beta, epsilon-carotene-3,3'-diol;CIPLUS_759357;beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-;beta-carotene-3,3'-diol;	0	3.77449901					CC2(C)C[C@H](O)CC(C)=C2/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C	Sequoia	SRP00500Z	-1.84717261	-0.49629879	-0.79710776	3.77449901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163953-03	Allethrin	144214035	Testis-specific androgen-binding protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	584-79-2				-14.8266658284	4	4	Allethrin	0	-10.09909712					O=C2CC(OC(=O)C1C(/C=C(\C)C)C1(C)C)C(C)=C2CC=C	LightBiologicals	MOP-20453	-2.52679272	-1.10195155	-3.34088335	-10.09909712												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00188433-02	Hygromycin B		Ribosome-associated ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	31282-04-9				-23.0009515524	4	4		0	-5.47456507			947998	rbbA	CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]3OC4(O[C@H]([C@@H](N)CO)[C@H](O)[C@H](O)[C@H]4O)O[C@H]23)[C@@H]1O	MedChem Express	HY-B0490	-5.81162325	-4.72745626	-1.09330081	-5.47456507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187598-03	Amaranth			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	915-67-3		14.1253754462	-4.85	-46.3441805677	4	4		-14.3963694479	-19.05747633	0.3735198179	0.9034819573			OC1=C(N=NC2=CC=C(C3=CC=CC=C23)[S]([O-])(=O)=O)C4=CC=C(C=C4C=C1[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	06409	-9.27071534	-7.49495289	-4.56050179	-19.05747633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015466-11	Gabapentin	170464715	Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	60142-96-3	 Go 3450;; Gabapentin hydrochloride;Gabapentin hydrochloride; ; Neurontin;Gabapentin; Gabapentino; Gabapentin; gabapentin ISTD			-31.1304172329	4	5		0	-4.841219				CACNA2D1	NCC1(CC(=O)O)CCCCC1	Vitas	STK598009	-7.76413854	-5.48550352	-7.82701777	-5.44697634	-4.841219											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166006-02	L-Cystine	170465457	Cystine/glutamate transporter Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56-89-3				-7.9176333729	4	5		0	-0.34776242					N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O	Bosche	C0896	2.95046032	-2.6119403	-4.74416613	-4.0797546	-0.34776242											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00181770-02	Garenoxacin mesylate hydrate	170465937	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	223652-90-2				-18.7598381235	4	5		0	-3.7704768					O.CS(=O)(=O)O.C[C@H]1NCc2cc(ccc12)c3ccc4c(c3OC(F)F)N(C=C(C4=O)C(=O)O)C5CC5	APAC	816272	-5.15124945	-1.83136044	-4.79554699	-3.10692375	-3.7704768											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00023037-08	Pancuronium bromide	225144191	Steroid non-depolarizing Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	15500-66-0	; ;Pancuronium bromide; Pancuronium bromide; Bromide, Pancuroniu; Pancuronium Organon; Pancuronium dibromide; Pancuronium Curamed; Bromuro de pancuronio; Pavulon			-27.5865112699	4	5		0	-2.92852567					CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6	Prestwick	Prestw-1034	-6.18588338	-8.72791216	-6.06294155	-5.13146363	-2.92852567											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023064-05	Medroxyprogesterone	170466063		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	520-85-4				-29.7351877994	4	5		0	-6.57087947					CC(=O)[C@@]3(O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	SIGMA	M6013	-7.05392372	-3.9672328	-5.41211732	-7.41893076	-6.57087947											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016010-09	Terbutaline hemisulfate	170464990	cAMP biosynthetic process Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	23031-32-5				-13.5808708106	4	5		0	-1.99505811					Oc1cc(cc(O)c1)C(O)CNC(C)(C)C.O=S(=O)(O)O.CC(C)(C)NCC(O)c1cc(O)cc(O)c1	Microsource	01500558	-1.38097326	-3.8986104	-2.57760651	-7.15600351	-1.99505811											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185753-04	Etoposide  Phosphate			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	117091-64-2		14.1253754462	-4.85	-91.3473662136	-2.4	4		-66.65943662	-66.17281799	0.3069418617	0.9369992115			COC1=C(O[P](O)(O)=O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26)OC	Glixx	GLXC-06447	-7.28995414	-22.84829455	-10.44710244	-66.17281799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185745-01	Cefroxadine	144206693		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	51762-05-1				-39.0556877578	4	4		0	-7.87833893					N[C@H](C1=CCC=CC1)C(=O)N[C@@H]3C(=O)N2C(=C(OC)CS[C@@H]23)C(=O)O	Kemprotec	51762-05-1	-10.30111621	-6.18521227	-3.63243148	-7.87833893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262569-03	Thiostrepton		Toll-like receptor 9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1393-48-2		12.5892541179	-4.9	-43.7013319881	4	4		-29.8210523999	-31.12989673	0.1515079658	0.9855935752	2305		CCC(C)[C@@H]1N[C@@H]2\C=C/C3=C(N=C(C=C3[C@H](C)O)C(=O)O[C@H](C)[C@@H]4NC(=O)C5=CSC(=N5)[C@@H](NC(=O)[C@H]\6CSC(=N6)\C(NC(=O)[C@@H](NC(=O)C7=CSC(=N7)[C@]8(CCC(=N/[C@H]8C9=CSC4=N9)\C%10=NC(=CS%10)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C/C)[C@@](C)(O)[C@@H](C)O)[C@H]2O	Prestwick	Prestw-522	-6.32084451	-3.61305863	-2.52901973	-31.12989673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164248-05	Sucrose		Starch and sucrose metabolism Substrate	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	57-50-1				-18.4360559544	4	4		0	-6.28349819					OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCZ-038	-3.66444579	-3.8109166	-2.45840138	-6.28349819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346704-03	Cabazitaxel		Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	183133-96-2		1.995262315	-5.7	-163.7158502785	5	4		3.8724434161	-34.10170378	0.7080453521	0.4766164458		TUBB	CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)/C(=C(/[C@@H](OC)C(=O)[C@]13C)C5(C)C)C	APExBIO	B2157	-34.38175997	-39.56299196	-32.58595578	-34.10170378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538148-01	NCGC00538148-01			DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-16.683946375	4	4		0	-4.27033858					OCCN(CCO)CCOC(=O)C1=CC=CC=C1O	Pharmaron	PH-NIH-2017-009-L1-9-0	-4.92774942	-0.07742268	-1.22258022	-4.27033858												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183050-01	Bethanidine sulfate (2:1)	144206760	adrenergic receptor signaling pathway involved in heart process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	114-85-2	Betanidine sulfate; Betanidin; Batel; Sulfate, Bethanidin; Benzaidin; Tenathan; Betanidina; 			-32.2037698358	4	4	BETHANIDINE SULFATE;LS-73259;Bethanidine;Bethanidine, Sulfate (2:1);BETHANIDINE;Tenathan;Betanidine Sulfate;Betanidine sulfate;BETANIDINE SULFATE;Betanidinum;Batel;GUANIDINE, N,N'-DIMETHYL-N''-(PHENYLMETHYL)-, SULFATE (2:1);betanidine;Betanidina;CIPLUS_151384;Wellcome Brand of Betanidine Sulfate;1-BENZYL-2,3-DIMETHYLGUANIDINE SULFATE (2:1);Bethanidine sulfate;Betanidine;GUANIDINE, N,N'-DIMETHYL-N''-(PHENYLMETHYL)-;betanidinum;Betanidin;Sulfate, Bethanidin;Bethanidine Sulfate;Benzaidin;BETANIDINE;1-BENZYL-2,3-DIMETHYLGUANIDINE;CIPLUS_3728831;Guanidine, N,N'-dimethyl-N''-(phenylmethyl)-;CIPLUS_148752;LS-73261;	0	-7.89576888					O=S(=O)(O)O.C\N=C(/NC)NCc1ccccc1.C\N=C(\NCc1ccccc1)NC	NCI	NSC_106563	-8.40616077	-4.95505183	-1.96407291	-7.89576888												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371080-02	Dexmedetomidine		Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	113775-47-6				-18.7874190829	4	4		0	-3.53828054					C[C@H](C1=CN=C[NH]1)C2=C(C)C(=CC=C2)C	Selleck	S3075	-5.8103314	-1.99578476	0.12799576	-3.53828054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092321-03	Tetrabenazine Mesylate		Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	804-53-5				-33.457822324	4	4		0	-7.56459976				SLC18A2	COC1=C(OC)C=C2[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CCC2=C1	Glixx	GLXC-06104	-8.17253613	-5.27334509	-4.64757029	-7.56459976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018181-12	Nalidixic acid	170465215	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	389-08-2	; Negram-Citrat;NALIDIXIC ACID; Sodium, Nalidixat; Nevigramon; Acid, Nalidixi; Acido nalidixico; Nalidixic acid sodium; Mictral;Nalidixic acid; NegGram; Prestwick-03C08			-32.7754889764	4	5		0	-9.07714194					O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O	Vitas	STK735579	-8.09834332	-6.39628905	-8.18436807	-1.11606118	-9.07714194											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091575-03	2-Ethyl-1,3-hexanediol	170465521		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	94-96-2		2.8183829313	-5.55	-16.4677755069	4	5		10.167673848	-3.42343169	0.4342018306	0.8642639839			CCCC(O)C(CC)CO	SIGMA	E29125	-4.42368699	-8.47306154	-6.97031858	1.7498737	-3.42343169											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181029-01	1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine	144206232	Apolipoprotein A-I Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	18656-38-7	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; 			-21.3622104996	4	4	L-beta,gamma-Dimyristoyl-alpha-lecithin;L-LECITHIN, BETA,GAMMA-DIMYRISTOYL;DL-beta,gamma-Dimyristoyl-alpha-lecithin;9   Dimyristoyl-L-3-Lecithin;3-sn-Phosphatidylcholine, 1,2-dimyristoyl;1,2-Dimyristoyl-sn-glycero-3-phosphocholine;1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine;Dimyristoylphosphatidylcholine;1,2-Dimyristoyl-rac-glycero-3-phosphocholine;DMPC;CIPLUS_670039;DL-alpha-Dimyristoyl-phosphatidylcholine;CIPLUS_168945;rac-Phosphatidylcholine, 1,2-dimyristoyl;1,2-Ditetradecanoyl-sn-glycero-3-phosphocholine;DIMYRISTOYL LECITHIN;DIMYRISTOYL PHOSPHATIDYLCHOLINE;1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE;CIPLUS_664335;3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxotetradecyl)oxy)-, inner salt, 4-oxide;	0	-7.12349806					C[N+](C)(C)CCOP([O-])(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC	SigmaAldrich	P7930	-3.68829368	-8.27316486	-1.19717681	-7.12349806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388506-02	Pinaverium bromide			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	53251-94-8				-20.6120342337	4	4		0	-5.83160177					COC1=C(OC)C=C(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)C(=C1)Br	Prestwick	Prestw-1601	-3.48025831	-6.33058277	-4.20798713	-5.83160177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484907-01	(-)-Scopolamine N-oxide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	6106-81-6				-28.5781526561	4	4		0	-6.20327519					C[N+]1([O-])[C@H]2C[C@@H](C[C@H]1[C@H]3O[C@@H]23)OC(=O)C(CO)C4=CC=CC=C4	Enzo	NP278	-6.67049014	-5.04492053	-4.83801109	-6.20327519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017246-10	PICROTIN			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	21416-53-5				-23.8567660013	4	4		0	-6.58144367					[H][C@@]12OC(=O)[C@@]([H])([C@]1([H])C(C)(C)O)[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@@]2([H])[C@]35C	Microsource	00100346	-4.48576258	-8.44507478	-2.26034128	-6.58144367												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016497-09	Ethionamide	170465169	Cell Wall Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	536-33-4	 ; Ethionamide; Trecator S; Trecator;Ethionamide; Etionamida;ETHIONAMIDE; 9   Ethionamide; Trecator-SC			-16.9777904255	4	4		0	-2.94967928					CCc1cc(ccn1)C(N)=S	Microsource	01500292	-3.8443202	-6.53687468	-0.55391763	-2.94967928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346566-09	Roflumilast		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	162401-32-3				-11.4645195468	4	4		0	-6.68387326				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	SIGMA	SML1099	-1.16468875	-4.15514858	-0.84459459	-6.68387326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263532-01	Olopatadine hydrochloride	170465181	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	140462-76-6	Olopatadine HCl;Olopatadine hydrochloride (Opatanol)			-18.2545438876	4	4		0	-6.70792303				HRH1	Cl.O=C(O)Cc1ccc2OCc3ccccc3C(=C\CCN(C)C)\c2c1	Sequoia	SRP01210o	-3.12486456	-6.34777377	-1.1793085	-6.70792303												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167449-02	Desogestrel	225144285	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	54024-22-5		10	-5	-36.5396766892	4	4		-20.526543552	-22.50800997	0.1512264026	0.9856802464			CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/CCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	SIGMA	32809	-5.51462478	-2.90255701	-5.15852391	-22.50800997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346716-02	Dabrafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1195765-45-7		3.1622776602	-5.5	-63.6707682667	4	4		-30.499324716	-6.18547526	1	0.9986470617		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	Selleck	S2807	-6.87342833	-6.04699378	-28.96309771	-6.18547526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522551-01	Monepantel			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	887148-69-8		14.1253754462	-4.85	-20.850889674	4	4		-13.8320986519	-13.61008221	0.5858367177	0.7043100332			C[C@](COC1=CC(=CC=C1C(F)(F)F)C#N)(NC(=O)C2=CC=C(SC(F)(F)F)C=C2)C#N	MedChem Express	HY-14774	-2.87348849	-6.7001891	1.92084338	-13.61008221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167446-02	Methyclothiazide	170465243	Sodium-(potassium)-chloride cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	135-07-9		3.1622776602	-5.5	0.0923176043	4	5		14.84777428	-1.99164793	0.2674099467	0.9535569808			NS(=O)(=O)c2cc1c(NC(CCl)N(C)S1(=O)=O)cc2Cl	Bosche	M5731	-2.25590412	-5.2898119	-4.41662829	7.64708584	-1.99164793											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015207-12	Cilostazol	170465347	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	73963-72-1	Cilostazol;CILOSTAZOL;; ; Pletal; Pletaal; Cilostazole; Cilostazol			-2.531840139	4	4		0	-4.68425332			5139	PDE3A	O=C1CCc2cc(ccc2N1)OCCCCc4nnnn4C3CCCCC3	Microsource	01505230	0.56776319	1.00997078	-1.6974895	-4.68425332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162106-17	Cefsulodin Sodium Salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	52152-93-9				-18.8376496165	4	4		0	-3.63628151					NC(=O)C1=CC=[N+](CC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@@H](C4=CC=CC=C4)[S]([O-])(=O)=O)C3=O)C([O-])=O)C=C1	Glixx	GLXC-08405	-4.87582889	-5.89221248	0.64325918	-3.63628151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253567-01	Talbutal	170465408	GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	115-44-6				-23.7342392002	4	4		0	-6.91571054					O=C1NC(=O)NC(=O)C1(CC=C)C(C)CC	GVK	FFS-11-286-NCI-35	-4.3817449	-9.37338834	-1.1793085	-6.91571054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014483-16	Pamelor		Norepinephrine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	894-71-3				-2.9943808581	4	5		0	-4.24028269					CNCCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	N7261	2.247092	-1.46821006	-1.79595596	-2.44798604	-4.24028269											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094779-05	Salicyl alcohol	170465547		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	90-01-7				-21.9895000439	4	5		0	-4.14850168					OCc1ccccc1O	Microsource	01500531	-5.81600282	-7.26444804	-6.14141583	1.81417352	-4.14850168											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015444-07	Fenoldopam	170465321	Dopamine D1 Receptor (DRD1) Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	67227-56-9	 ;FENOLDOPAM MESYLATE;Fenoldopam; Fenoldopam bromide;Fenoldopam bromide; Fenoldopam mesilate; Hydrobromide, Fenoldopa; Fenoldopam Hydrobromide; Fenoldopam hydrochloride;Fenoldopam hydrochloride	1	-6	-22.813187895	4	5		11.8645416599	-5.50686063	0.2786043502	0.9493398477	1812	DRD1	Oc1ccc(cc1)C3CNCCc2c3cc(O)c(O)c2Cl	Sequoia	67227-57-0	-8.00140994	-11.13711805	-5.27902206	2.42042897	-5.50686063											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160622-04	D-delta-Tocopherol	144206758		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	119-13-1				-5.6727999738	4	5		0	-0.41301455					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1	NCGCChem	XJB03-045	-1.92104336	-3.0087667	-1.41918198	1.85091627	-0.41301455											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015092-10	Aminocaproic acid	170465057	PAI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	60-32-2	 6-Aminohexanoic acid;6-Aminohexanoic acid;AMINOCAPROIC ACID;6-AMINOCAPROIC ACID;Aminocaproic acid; 6-Aminocaproic acid			-7.8550750537	4	5		0	-0.77096049			5054	SERPINE1	NCCCCCC(=O)O	Microsource	01500114	-1.69192809	-3.04281215	-4.47523758	1.59371699	-0.77096049											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018261-06	Perhexiline	170466435	mitochondrial carnitine palmitoyltransferase-1 inhbitior	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	6724-53-4	Perhexiline;rac Perhexiline Maleate; Perhexiline			5.7504997114	4	4		0	6.61758063				CPT1A	O=C(O)\C=C/C(=O)O.C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3	Microsource	01503227	-0.11701989	1.55148702	0.02680247	6.61758063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179431-03	Carbenoxolone sodium	170465951	gap junction assembly Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7421-40-1				7.7959440948	4	4		0	-0.24844159					[Na+].[Na+].[O-]C(=O)CCC(=O)O[C@H]4CC[C@]3(C)[C@H]5C(=O)C=C1[C@@](C)(CC[C@@]2(C)CC[C@@](C)(C[C@@H]12)C([O-])=O)[C@]5(C)CC[C@H]3C4(C)C	Prestwick Chemical, Inc.	Prestw-837	3.03818316	0.16761217	0.15188064	-0.24844159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162179-08	cis-Flupentixol	170465964		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	53772-82-0		12.5892541179	-4.9	-82.6291138511	-3	5		-107.9208735201	-99.545684	0.0014340278	0.9992823074			FC(F)(F)c2cc3C(=C\CCN1CCN(CCO)CC1)/c4ccccc4Sc3cc2	Tocris	4057	-3.23405005	-1.48523279	-1.38569096	-0.31690626	-99.545684											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164559-03	Duloxetine hydrochloride	170465319	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	136434-34-9	 ; Duloxetine hydrochloride;Duloxetine hydrochloride; Cymbalta;DULOXETINE HYDROCHLORIDE;Duloxetine HCl; DULOXETINE HCl; 0   Duloxetine Hcl	14.1253754462	-4.85	-38.3968802228	4	4		-22.283226312	-24.02656066	0.2307634339	0.9657654545	6532	SLC6A4	Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3	Sequoia	SRP05005d	-5.20521822	-7.26749183	-2.9572054	-24.02656066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016759-04	Naproxen sodium	170465301	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	26159-34-2	NAPROXEN(+); ; Naprosin; Synflex; Anaprox; 2   Dl-Naproxen;(S)-Naproxen; (S)-Naproxen; Proxen; Naproxeno; (R) -Naproxen sodium salt; (-)-Naproxen sodium; DL-Naproxen;Naproxen; Naprosyn; Aleve; Naproxen			-31.7805089828	4	5		0	-6.7322888			5743	PTGS2	[Na+].[O-]C(=O)[C@@H](C)c1ccc2cc(ccc2c1)OC	Microsource	01500425	-8.38397672	-9.64005855	-6.314591	-0.06808588	-6.7322888											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024683-23	Parthenolide			DPI_SARS-CoV-2_General	2019_NPC-3_Tox	20554-84-1				2.8026253354	4	5		0	-2.95751118					C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	SIGMA	P0667	0.49216811	1.08929648	5.28989315	-0.51291362	-2.95751118											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167488-08	Sorafenib	170465175	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	475207-59-1	;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar	11.220184543	-4.95	-81.7222050611	-3	5		-110.8048403852	-99.64780783	0.0011336481	0.9994327671	2321	FLT1	O=C(NC)c3cc(Oc2ccc(NC(=O)Nc1cc(c(Cl)cc1)C(F)(F)F)cc2)ccn3.O=S(=O)(O)c1ccc(C)cc1	Sequoia	284461-73-0	-2.40948387	-0.99457505	0.53424418	-3.5086923	-99.64780783											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015360-08	Pentetic acid	170465150	Radioactive metals Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	67-43-6				-39.817636676	4	5		0	-9.45048991					O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	Vitas	STK373226	-11.47393649	-8.66701111	-5.20231214	-3.41791113	-9.45048991											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00253576-01	Amelometasone	170465753		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	123013-22-9				-24.2002730808	4	5		0	-4.7545943					COCC(=O)[C@]3(OC(=O)CC)[C@@]4(C)C[C@H](O)C2(F)[C@@H](CCC1=CC(=O)C=C[C@@]12C)[C@@H]4C[C@@H]3C	GVK	FFS-11-286-NCI-162	-7.43387828	-5.71342461	-3.68716062	-0.41305433	-4.7545943											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024027-09	Methysergide	170464684	Serotonin 7 (5-HT7) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	361-37-5				-7.6174240811	4	5		0	-3.63480381					CC[C@@H](CO)NC(=O)[C@@H]3C=C2c4cccc1c4c(cn1C)C[C@H]2N(C)C3	Enzo	AC577	-2.17837884	1.77817963	0	-3.00939585	-3.63480381											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015608-11	Loperamide hydrochloride	170464852	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	53179-11-6	 ;LOPERAMIDE; Hydrochloride, Loperamid;Loperamide; Loperamide Hcl;Loperamide hydrochloride; Loperamide hydrochloride; Loperamida	14.1253754462	-4.85	-19.5077603206	4	5		-14.7530519201	-14.30300856	0.0157981256	0.9920711684	4988	OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4	Enzo	ALX-550-253	-2.77259624	-2.03870968	-1.59213196	-1.62715226	-14.30300856											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016241-10	Furosemide	170464879	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	54-31-9	 ; Diumide-K; Frusemid;FUROSEMIDE; Errolon; Lasix; Furosemide;Furosemide; Furosemide and potassium; Furosemida; Furantral; Furosemide solution; Fusid; Diumide-K continus; Furanthril			-31.2370486938	4	5		0	-2.39429673					NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O	Vitas	STK177334	-10.32728506	-10.05591398	-3.59442533	-1.07725593	-2.39429673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094981-07	Benzyl benzoate	170465382		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	120-51-4		0.7079457844	-6.15	-19.0008043029	4	5		12.507741936	-4.79756087	0.371710984	0.9045349232			O=C(OCc1ccccc1)c2ccccc2	Microsource	01503002	-7.28336442	-11.67311828	-1.8655729	2.74497431	-4.79756087											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181914-01	Alloclamide	144206889		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	5486-77-1	Alloclamide; Aloclamida; Hexacol; 	0.0707945784	-7.15	-29.8461993872	4	5	ALLOCLAMIDE HYDROCHLORIDE;Hexacol;Alloclamide;Alloclamidum;alloclamidum;alloclamide hydrochloride;alloclamide;ALLOCLAMIDE;2-allyloxy-4-chloro-N-(2-diethylaminoethyl)benzamide;264 CE;Aloclamida;LS-25294;CIPLUS_774246;CIPLUS_214111;Alloclamide hydrochloride;Benzamide, 2-(allyloxy)-4-chloro-N-(2-(diethylamino)ethyl)-;	11.823761024	-3.91475143	0.4039221166	0.7096093598			O=C(NCCN(CC)CC)c1ccc(Cl)cc1OCC=C	Pharmaron	PH-NIH-93	-10.68646752	-4.5078791	-5.71904011	0.06808588	-3.91475143											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015436-11	Fluphenazine hydrochloride	170465375	Nicotinic alpha7 Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	69-23-8	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S	12.5892541179	-4.9	-99.6790265328	-3	5		-104.2723821116	-99.69296067	0.0079117819	0.9960210347	1813	DRD2	FC(F)(F)c2cc3N(CCCN1CCN(CCO)CC1)c4ccccc4Sc3cc2	Vitas	STK050763	-9.14576735	-5.86842332	-2.24207392	-3.62670782	-99.69296067											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253608-01	Chlorexolone	170466039		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2127-01-7				-8.3150305848	4	5		0	-4.00505712					NS(=O)(=O)c1cc2C(=O)N(Cc2cc1Cl)C3CCCCC3	GVK	FFS-11-286-NCI-259	-3.49653342	-1.09790752	-0.43790506	3.20003631	-4.00505712											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025345-02	Atomoxetine hydrochloride	170465067	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	82248-59-7				-30.650684857	4	5		0	-11.84222568			24409		Cl.Cc2ccccc2O[C@H](CCNC)c1ccccc1	Tocris	2011	-6.55414292	-5.50265912	-2.26932134	-6.0254163	-11.84222568											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015208-19	Caffeine	170464929	Chitinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	69-22-7	; Annaca; Sig 8304;Caffeine; Vincents Powder; Spalt-tablette; Norgesic forte; Impletol; ; Fioricet; Syndol; Bex Powder; Dolomo; Caffeine solution; Sedalgin; Caffeine, Anhydrous; Synalgos; Caffeine-13C3 solution; Caffeine-sodium benzoate; Cerebyx; Midol; Theobromine, 1-methyl-; Caffeine benzoate sodium; Amidochin; impletol depot Bayer; Triaminicin; Caffeine, citrated; Caffeine-trimethyl-13C3; Sig-8304; Fiorinal; Elsinore pill; Doleron; Caffeine; 3   Caffeine; Migraine-Kranit;Caffeine, citrated;CAFFEINE; Rectoval; Propain; Cafcit			-22.4663082149	4	5		0	-1.25377505				ADORA2B	O=C(O)C(O)(CC(=O)O)CC(=O)O.O=C2c1n(C)cnc1N(C)C(=O)N2C	Enzo	AC1295	-6.14204296	-5.2967919	-3.71654892	-5.49079755	-1.25377505											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164601-02	Liranaftate	170466057	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	88678-31-3	 ;LIRANAFTATE; Liranaftate;Liranaftate; Zefnart; Liranaftato	11.220184543	-4.95	-24.5142381646	4	5		-15.534153592	-13.63164311	0.0686489438	0.9642086192			COc1cccc(n1)N(C)C(=S)Oc2cc3CCCCc3cc2	Sequoia	SRP01523l	-3.56500899	-1.51984845	-4.03748467	-5.47864373	-13.63164311											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179680-05	Clonidine	170464900	alpha1-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	4205-90-7				-23.2881165465	4	5		0	-3.97796541				ADRA1A	Clc2cccc(Cl)c2\N=C1/NCCN1	Enzo	AC152	-6.40674484	-7.6595195	-2.30338063	-2.10158413	-3.97796541											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094937-04	Carprofen	170464799	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	53716-49-7		0.7943282347	-6.1	-17.3793685757	4	5		14.5262774959	-5.79310968	0.1174422408	0.9914796241			O=C(O)C(C)c1ccc2c3cc(Cl)ccc3nc2c1	Microsource	01502006	-9.18856458	-6.6089727	-2.0931862	3.97167627	-5.79310968											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015523-13	Hydroquinone	170464661		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	123-31-9				-21.0067873427	4	5		0	-6.57876913					Oc1ccc(O)cc1	Vitas	STK397446	-6.38106651	-4.59398949	-2.72376949	1.23008488	-6.57876913											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274070-01	Perindopril	170464836	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	82834-16-0				-36.6194937807	4	5		0	-6.39699826				ACE	O=C(OCC)[C@H](CCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C(=O)O	Selleck	S1506	-10.14905743	-4.38754503	-7.65574823	-6.57756354	-6.39699826											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091501-06	Resorcinol	170465462	leukotriene B4 biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	108-46-3				-24.4310513056	4	5		0	-5.07001007					Oc1cccc(O)c1	Specs	AE-562/J255633	-5.72117492	-4.40470063	-3.97345322	-5.97283085	-5.07001007											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164591-04	Artemether	225144260	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	71963-77-4	duplicate RN; ; Artemetero; Arthemeter; Artemether;artemether;Artemether			-4.3425633474	4	5		0	-3.50507916				PfATP6	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	SIGMA	A9361	1.56510302	1.88282724	-3.96488975	-4.53549518	-3.50507916											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164127-07	4-(1,1,3,3-Tetramethylbutyl)phenol	170465157		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	140-66-9				-12.8191814497	4	5		0	1.40020134					Oc1ccc(cc1)C(C)(C)CC(C)(C)C	SIGMA	290823	-2.37176677	-4.57625665	-2.71462214	-6.25328659	1.40020134											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168784-03	Gemcitabine	170465129	Ribonucleotide reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	122111-03-9	 Gemcitabine; ; Gemcitabina;Gemzar;Gemcitabine;Inno-D07001	0.1258925412	-6.9	-97.3802853236	4	5		-25.4113332878	-27.45492816	0.1198367557	0.93423012	6241	RRM2	Cl.NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	Prestwick	Prestw-1266	-7.44848751	-22.06639218	-34.65639049	-33.47502191	-27.45492816											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021145-11	Loxapine succinate	170465094	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	27833-64-3				-36.6595789612	4	5		0	-7.89786767			1128	CHRM1	O=C(O)CCC(=O)O.CN1CCN(CC1)C3=Nc4ccccc4Oc2ccc(Cl)cc23	Microsource	02300242	-7.6150811	-6.83221822	-7.03917791	-9.92550394	-7.89786767											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00229511-10	Tofacitinib		Jak1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	477600-75-2				1.5264780081	4	4		0	-0.09249064				JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N	XcessBio	M60033-2s	0.08713078	0.24394347	1.72053315	-0.09249064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263884-02	Zolmitriptan	170464875	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	139264-17-8	ZOLMITRIPTAN;Zolmitriptan (Zomig)			-1.1874411404	4	4		0	-1.59876679			3351	HTR1B	CN(C)CCc2cnc1ccc(cc12)C[C@@H]3NC(=O)OC3	Microsource	01505281	0.01742616	1.36271871	-1.41562854	-1.59876679												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018139-07	Ipriflavone	170466811	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	35212-22-7	; (Ipriflavone); Osten; Osteoquine; Quinogin;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;IPRIFLAVONE; Ipriflavona;Ipriflavone	0.0707945784	-7.15	-12.5417268701	4	5		10.892750148	2.32537138	0.376055259	0.7361836225			CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3	SIGMA	381551	-9.07729179	1.24429519	-2.76755999	5.17906586	2.32537138											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274067-01	Eltrombopag olamine	174006931	Thrombopoietin Receptor (TpoR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	496775-61-2	Eltrombopag	8.9125093813	-5.05	-91.8509920424	-2.1	5		-83.4957010515	-85.28415851	0.0007227514	0.9996385021	4352	MPL	O=C(O)c1cccc(c1)c4cccc(N\N=C2\C(=O)N(N=C2C)c3ccc(C)c(C)c3)c4O	Selleck	S2229	-6.79964928	-6.38617259	-5.04388782	-10.74057844	-85.28415851											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00242597-01	Saxagliptin	124950715	DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	361442-04-8	Saxagliptin			5.6618919015	4	5		0	-0.08236478			1803	DPP4	O=C([C@@H](N)C13CC2CC(C1)CC(O)(C2)C3)N5[C@H](C#N)C[C@@H]4C[C@@H]45	ACC	API0007051	1.03024989	2.20020587	3.04859773	0.20595968	-0.08236478											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159320-04	Triamcinolone diacetate	170464837		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	67-78-7				-28.5855804037	4	5		0	-4.41109179					CC(=O)OCC(=O)[C@@]3(O)[C@@H](C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C)OC(C)=O	Sequoia	67-78-7	-5.53704516	-7.42408646	-7.40740741	-6.65644172	-4.41109179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015851-10	Protriptyline hydrochloride	170465077	Norepinephrine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1225-55-4		5.6234132519	-5.25	-16.1925707513	4	5		-13.512995332	-11.67749611	0.0885177122	0.9530731262			Cl.CNCCCC2c3ccccc3C=Cc1ccccc12	Microsource	01505984	-1.02148181	0.71624635	-3.18561336	-5.49956179	-11.67749611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160584-01	Chlorphenesin	144207103		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	104-29-0	1,2-Propanediol, 3-(4-chlorophenoxy)-; Mycil; Clorfenesina; Chlorphenesin carbamate; 			-38.1096537038	4	4	CIPLUS_150785;CHLORPHENESIN;Clorfenesina;1,2-Propanediol, 3-(4-chlorophenoxy)-;chlorphenesinum;Chlorphenesin carbamate;4-CHLOROPHENYL GLYCERYL ETHER;Mycil;Chlorphenesinum;1,2-PROPANEDIOL, 3-(4-CHLOROPHENOXY);LS-120277;3-(P-CHLOROPHENOXY)PROPANE-1,2-DIOL;Chlorphenesine;chlorphenesine;3-(4-CHLOROPHENOXY)PROPANE-1,2-DIOL;Chlorphenesin;	0	-7.17242581					Clc1ccc(OCC(O)CO)cc1	SigmaAldrich	S427640	-9.9117418	-5.01526947	-2.94390255	-7.17242581												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00532504-01	CARNIDAZOLE		Trichomonas Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-30.658016494	4	4		0	-5.0459715					COC(=S)NCC[N]1C(=NC=C1[N+]([O-])=O)C	SIGMA	32671	-9.5223674	-4.03458213	0.35750541	-5.0459715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167558-02	Fleroxacin	170466056	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	79660-72-3	 Ro 23-6240; ; Ro 23624; Quinodis; Megalocin; Fleroxacin;Fleroxacin; fleroxacin N-oxide; Megalone; Ro 23 624			-16.3863516634	4	5		0	-1.72050883					CN1CCN(CC1)c2c(F)c3c(cc2F)C(=O)C(=CN3CCF)C(=O)O	Prestwick	Prestw-1414	-2.23147742	-5.17670269	-4.39306358	-6.11305872	-1.72050883											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160456-03	2-Iodohippuric acid	170465302	renal filtration Interacts	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	147-58-0				-28.0042898164	4	5		0	-3.02919374					O=C(NCC(=O)O)c1ccccc1I	SIGMA	106577	-8.35160018	-6.13741637	-3.88781845	-4.64066608	-3.02919374											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017245-10	Ellagic acid	170466649	Aldose Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	476-66-4	; Elagostasine; Acid, Ellagi; Acido elagico;ELLAGIC ACID; Acid, Benzoari;Ellagic Acid; EADME cpd;Ellagic acid; Ellagic acid hydrate	3.1622776602	-5.5	-59.2766797686	-2.2	5		-30.696891244	-33.67804521	0.0074475391	0.9962613393	231	AKR1B1	Oc1c4OC(=O)c2cc(O)c(O)c3OC(=O)c(cc1O)c4c23	Vitas	STK801964	-5.58088558	-5.45119231	-3.93063584	-12.50219106	-33.67804521											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00181131-04	Epothilone B		Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	152044-54-7		1	-6	-200.4365814619	4	4		15.6339709919	-35.29565558	0.3282308549	0.9273985504		TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Adooq	A10360	-47.99255862	-43.71800938	-29.96424946	-35.29565558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378916-02	MK-5172			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1350514-68-9		14.1253754462	-4.85	-37.1093707233	4	4		-20.0629132679	-20.04444638	0.4146502147	0.8768346917			COC1=CC2=C(C=C1)N=C3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)N[S+]([O-])(=O)C7CC7)OC3=N2)C(C)(C)C	MedChem Express	HY-15298	-7.07363503	-4.98946191	-0.82535199	-20.04444638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182058-01	Doxercalciferol			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	54573-75-0				-14.7928928365	4	4		0	0.42703386					[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3/CC(=C)[C@@H](O)C[C@@H]3O)[C@H](C)\C=C\C(C)C(C)C	Axon Medchem	1746	-4.88448559	-4.31846531	0.54287858	0.42703386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166289-02	Hydroxystilbamidine bis(methanesulfonate)	124893257		DPI_SARS-CoV-2_General	2019_NPC-8_Tox			3.5481338923	-5.45	-31.2235139846	4	4		-9.235694112	-12.85459061	0.3087102754	0.9372378811			NC(=N)C1=CC=C(C=C1)/C=C/C2=CC=C(C=C2O)C(N)=N	FLUKA	39286	-5.27386	-2.65817885	-8.99942623	-12.85459061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388369-01	Prednisolone Phosphate (sodium salt)		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	125-02-0				-13.907939818	4	4		0	-2.64063794					C[C@]12C[C@H](O)[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO[P]([O-])([O-])=O	Cayman	15933	-3.28372415	-3.87113424	-1.84931809	-2.64063794												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00386518-01	Cannabidiol	377020361	Cannabinoid Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	13956-29-1		12.5892541179	-4.9	-79.5746535266	-3	4		-67.3747925636	-67.98553314	0.0307095714	0.999418018		CNR1	CCCCCC1=CC(=C([C@@H]2\C=C(C)/CC[C@H]2C(C)=C)C(=C1)O)O	Axon Medchem	1234	-7.77450896	-6.35726268	-6.3865472	-67.98553314												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167520-06	Cilomilast		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	153259-65-5				-12.6099341472	4	4		0	-6.69015635				PDE4A	COC1=CC=C(C=C1OC2CCCC2)C3(CCC(CC3)C(O)=O)C#N	APExBIO	A4329	-2.52679272	-1.33748318	-0.31797195	-6.69015635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167832-06	Carvedilol tartrate	170465440	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	NOCAS_45916	; carvedilol, 14C-labeled; 8   Carvedilol;Carvedilol; Coreg; carvedilol, (S)-isomer; Carvedilol; carvedilol, (R)-isomer			-22.7146562858	4	5		0	-6.44331061			153	ADRB1	O=C(O)C(O)C(O)C(=O)O.COc4ccccc4OCCNCC(O)COc2cccc3nc1ccccc1c23	Microsource	01504257	-5.97021313	-2.57900629	-5.6664915	-1.52058463	-6.44331061											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167436-02	Azelnidipine	174006618	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	123524-52-7	 ; Calblock;Azelnidipine; Azelnidipine	12.5892541179	-4.9	-86.6954409781	-3	5		-107.2447284106	-99.49428817	0.0067332111	0.9966167429			[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC(C)C)=C(C)NC(N)=C2C(=O)OC3CN(C3)C(c4ccccc4)c5ccccc5	Bosche	A2998	-5.2854575	-3.92232842	0.7181643	-0.41305433	-99.49428817											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179259-06	Meropenem			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	96036-03-2				-19.3011758381	4	4		0	-6.45244882					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C([N@@]2C1=O)C(O)=O	Prestwick	Prestw-1106	-3.10850702	-4.50663736	-5.43872371	-6.45244882												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00532510-01	PREDNISOLONE VALERATE ACETATE			DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-19.5711513841	4	4		0	-0.64783623					CCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Biosynth	Q-101384	-3.82413454	-3.85558468	-5.98259608	-0.64783623												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182543-02	Xipamide	170466623	renal sodium excretion Activator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	14293-44-8				-13.7653048064	4	4		0	-3.93020644					O=S(N)(=O)c1cc(c(O)cc1Cl)C(=O)Nc2c(C)cccc2C	APAC	555772	-2.1066285	-3.22144246	-4.34191443	-3.93020644												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00094558-09	CACODYLIC ACID			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	75-60-5				-26.2280211286	4	4		0	-7.20393884					C[As](C)(O)=O	Microsource	01503947	-5.9531264	-4.37980891	-3.1182016	-7.20393884												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00386364-01	Lomitapide		Microsomal triglyceride transfer protein large subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	182431-12-5		2.5118864315	-5.6	-83.5690462979	-3	4		-96.4974928039	-3.53286689	1	0.9999856693	4547	MTTP	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C3=C(C=CC=C3)C4=CC=C(C=C4)C(F)(F)F)C5=C(C=CC=C5)C6=C1C=CC=C6	Selleck	S7635	-3.10850702	-5.78337702	-99.52864394	-3.53286689												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00016361-20	Acetaminophen		Cyclooxygenase-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	103-90-2				-9.3181645914	4	4		0	-3.6451585				PTGS1	CC(=O)NC1=CC=C(O)C=C1	Adooq	A10030	-1.33732892	-2.21527014	-2.89158811	-3.6451585												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00165924-04	(S)-Mephenytoin	170465368	Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	70989-04-7				-24.8478605481	4	4		0	-3.43785091					CC[C@]1(NC(=O)N(C)C1=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-1108	-5.04964666	-6.07931005	-5.07614213	-3.43785091												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179009-06	Phenethicillin potassium salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	132-93-4				-1.2392956645	4	4		0	0.69966313					CC(OC1=CC=CC=C1)C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O	Prestwick	Prestw-723	1.49834511	-2.09689693	-3.23604061	0.69966313												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167301-02	Triptorelin		Gonadotropin-releasing hormone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	57773-63-4				-17.1645246676	4	4		0	-4.77671245					CC(C)C[C@H](NC(=O)[C@@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=C[NH]C5=C4C=CC=C5)NC(=O)[C@H](CC6=CN=C[NH]6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N8CCC[C@H]8C(=O)NCC(N)=O	Enzo	DL310	-0.54119331	-7.55052	-6.21827411	-4.77671245												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00165719-15	ALENDRONATE SODIUM			DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-1.6549006421	4	4		0	-2.2199188					NCCCC(O)(P(O)(O)=O)P(O)([O-])=O	Microsource	01505166	0.57697468	-0.93853048	-1.72226251	-2.2199188												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378604-01	ABT-333			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1132935-63-7		3.9810717055	-5.4	-41.5973030617	-3	4		-50.3800995152	-2.34084823	1	0.9999992668			COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C	MedChem Express	HY-13998	25.0245997	-1.69104591	-50.79767948	-2.34084823												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160567-01	Acetomenaphthone	144205458		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	573-20-6	Acetomenaphtone; Acetomenaphthone; Menadiol diacetate; Vitamin K4; 			-30.9383662061	4	4	Menadiol diacetate;ACETOMENAPHTONE;Acetomenaphtone;Vitamin K4;Acetomenaphthone (2-Methyl-1,4-naphthalenediol diacetate);Acetomenaphthone;CIPLUS_154611;	0	-6.21058996					CC(=O)Oc1cc(C)c(OC(C)=O)c2ccccc12	SigmaAldrich	S353078	-5.55058592	-8.17620698	-5.37527194	-6.21058996												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00164626-02	Tiagabine hydrochloride	170465153	GAT-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	145821-59-6				-33.5257999395	4	4		0	-3.38602401				SLC6A1	Cl.Cc3ccsc3C(=C\CCN1CCC[C@H](C1)C(=O)O)\c2sccc2C	Sequoia	SRP023505t	-6.13203328	-8.10856515	-9.1279913	-3.38602401												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183599-01	NCGC00183599-01	124894454		DPI_SARS-CoV-2_General	2019_NPC-6_Tox					2.8465716559	4	4	CIPLUS_736638;Uvinul-T-150;Uvinul T150;octyl triazone;CIPLUS_741452;Uvinul T 150;	0	-0.03455127					CCCCC(CC)COC(=O)C1=CC=C(NC2=NC(=NC(=N2)NC3=CC=C(C=C3)C(=O)OCC(CC)CCCC)NC4=CC=C(C=C4)C(=O)OCC(CC)CCCC)C=C1	USP	1265537	2.07084712	-0.4565824	-2.08484409	-0.03455127												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00090714-01	Sodium xylenesulfonate	144204551		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1300-72-7	PENTOSAN POLYSULFATE SODIUM; Sodium xylenesulfonate; 			6.2149489372	4	4	XYLANPOLYSULFATE SODIUM;ELMIRON;Sodium xylenesulfonate;AB02509377-01;PENTOSAN POLYSULFATE SODIUM;CIPLUS_158001;	0	0.48371772					[Na+].Cc1ccc(cc1C)S(=O)([O-])=O	NIEHS	AB02509377	2.60756776	1.41202334	-2.17548949	0.48371772												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160575-01	Uracil mustard	144205464	DNA Interacts	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	66-75-1	Uracil Mustard; Uramustina; Uracil Mustard Capsules; Mustard, Uraci; 			-6.3131008422	4	4	5-(Bis(2-chloroethyl)amino)-2,4-(1H,3H)pyrimidinedione;URACIL MUSTARD;LS-285;Uramustina;Mustard, Uraci;uramustinum;uramustine;URAMUSTINE;Uramustine;Uracil Mustard;CIPLUS_149101;2,4(1H,3H)-PYRIMIDINEDIONE, 5-(BIS(2-CHLOROETHYL)AMINO)-;2,4(1H,3H)-Pyrimidinedione, 5-(bis(2-chloroethyl)amino)-;Uracil Mustard Capsules;5-(BIS(2-CHLOROETHYL)AMINO)URACIL;Uracil mustard;Uramustinum;	0	-0.31096139					O=C1NC(=O)NC=C1N(CCCl)CCCl	SigmaAldrich	S375063	0.53224796	-4.10078634	-3.68926759	-0.31096139												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00386547-01	Difluprednate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	23674-86-4				-0.7656042166	4	4		0	-0.27641012					CCCC(=O)O[C@@]1(CC[C@H]2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Axon Medchem	1428	0.46963056	0.30438826	-2.36584481	-0.27641012												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00344555-01	Proscillaridin	170465956	Steroid	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	466-06-8		100	-4	-460.2278788689	5	4		33.2885189121	-93.62529153	0.3406109271	0.9303500393		ATP1A1	O=C1C=CC(=CO1)[C@H]6CC[C@@]5(O)[C@]6(C)CC[C@H]3[C@H]5CCC2=C[C@H](CC[C@@]23C)O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O	Prestwick	Prestw-986	-96.16692012	-96.51644542	-97.19905729	-93.62529153												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00389655-01	Angiotensin II			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	68521-88-0				-16.8856038475	4	4		0	0.91560853					CCC(C)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(O)=O)C(C)C)C(=O)NC(CC2=CN=C[NH]2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(O)=O	APExBIO	A1042	-4.08354951	-6.78109411	0.46229152	0.91560853												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00408859-01	Cetilistat		Pancreatic lipase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	282526-98-1				-20.5101970805	4	4		0	-3.75745012					CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1	Glixx	GLXC-06700	-4.1819483	-7.3222288	-1.34155185	-3.75745012												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00531792-01	PYRETHRIN II		Plasmodium falciparum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	121-29-9				-26.0449775634	4	4		0	-2.7468256					COC(=O)C(/C)=C/[C@H]1[C@H](C(=O)O[C@@H]2CC(=O)/C(=C2/C)C\C=C\C=C)C1(C)C	Toronto Research	P991240	-5.2822256	-7.52515431	-4.27846265	-2.7468256												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181340-02	Azosemide	170465933		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	27589-33-9				-9.1066522607	4	4		0	0.06046471					NS(=O)(=O)c2cc(c(NCc1cccs1)cc2Cl)c3nnnn3	APAC	814905	-1.50729046	-2.81559144	-2.47461929	0.06046471												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00159443-05	BETAMETHASONE 17,21-DIPROPIONATE		Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5593-20-4				-6.5016433121	4	4		0	-1.89168178				NR3C1	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	Microsource	01503210	1.16736739	-2.49429272	-6.84372734	-1.89168178												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00506889-01	Sugammadex			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	343306-71-8				0.9558065847	4	4		0	0.06046471					O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]4O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]5O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]6O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]7O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]8O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]9O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]1O[C@@H]2CSCCC([O-])=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O	Proactive Molecular	P283-1548	1.963503	-2.98469603	-1.00616389	0.06046471												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00249908-01	Mefenorex	170465601		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	17243-57-1				-18.9464863972	4	4		0	-2.91094411					CC(NCCCCl)Cc1ccccc1	GVK	FFS-11-286-NCI-140	-4.33401914	-4.59118965	-2.52900653	-2.91094411												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00080392-05	Phosmet	170466810	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	732-11-6				-25.3239467628	4	5		0	-6.05299735					COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O	Vitas	STK097158	-7.04595557	-5.90107527	-4.70583047	-0.45524204	-6.05299735											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167522-02	Hexoprenaline sulfate	170465755	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	32266-10-7				-17.0256871964	4	5		0	-2.03560059					Oc1ccc(cc1O)C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2.O=S(=O)(O)O	Sequoia	SRP01560h	-5.7995591	-7.59569892	-0.83355385	1.63616695	-2.03560059											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015714-16	Nimodipine	170466561	Voltage-gated L-type calcium channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	66085-59-4				-24.5282961825	4	5		0	-12.6081693					CC=1NC(C)=C(C(C=1C(=O)OC(C)C)c2cccc(c2)[N+]([O-])=O)C(=O)OCCOC	SigmaAldrich	N149	-3.99355605	-4.38709677	-3.66499074	-2.96132696	-12.6081693											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00068236-07	Gatifloxacin	170465592	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	112811-59-3	; Tequin;GATIFLOXACIN;Gatifloxacin; Gatifloxacin Anhydride; Gatifloxacin hydrate; Gatifloxacin Hydrate; Gatiflo; Zymar			-25.6348988203	4	5		0	-4.65408241			7155	TOP2B	CC1CN(CCN1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK801620	-7.69882991	-7.07096774	-3.74437682	-0.45524204	-4.65408241											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00261971-01	Mazaticol	170466055		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	42024-98-6	Mazaticol;Mazaticolum;Pentona;Mazaticol			-19.7436170694	4	5		0	-3.3448415					OC(C(=O)OC1CC2CCC(C)(C)C(C1)N2C)(c3cccs3)c4cccs4	GVK	FFS-11-286-NCI-243	-6.57113787	-4.21505376	-1.67151804	-1.34769675	-3.3448415											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095239-05	1,3,5-Trimethoxybenzene	170465963		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	621-23-8				-15.3397054753	4	5		0	-3.03994978					COc1cc(cc(OC)c1)OC	Microsource	00231043	-5.54519247	-5.24731183	-0.5601129	1.82547553	-3.03994978											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015529-15	Ibuprofen lysine	170464979	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	15687-27-1	; Ibuprofen, Aluminum Salt; Ibuprofen, (R)-Isomer;Ibuprofen Lysine (NeoProfen); Doctrin; Dexibuprofeno; (S)-(+)-Ibuprofen; Ibuprofen, Calcium Salt; Ibuprofen, (+-)-Isomer; Naproxen;IBUPROFEN; S-(+)-Ibuprofen; ; (?)-Ibuprofen; S(+)-Ibuprofen; Ibuprofen, Potassium Salt; ibuprofen-Lys; S-(+)-ibuprofen;(?)-Ibuprofen; Saren; Advil; Ibuprofen sodium salt; Ibuprofene; Arflamin;Ibuprofen; Ibufen; Ibuprofen, Magnesium Salt; Ibuprofeno			-0.5682783585	4	5		0	1.44375196			5742	PTGS1	CC(C(=O)O)c1ccc(CC(C)C)cc1	Vitas	STK177358	0.55960658	-3.92258065	-1.62741466	1.7082845	1.44375196											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015870-27	Quercetin	170466817	Flavone	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	6151-25-3	 Quercetine; quercetin-ATS; quercetin 3-O-glucuronide; quercetin RGRGal; ;quercetin 3-3AcAra-Gal;Quercetin dihydrate;Quercetine; quercetin HMGGlc; QME-Ara-Glc; amurenoside B; amurenoside A; Q-RR cpd; quercetin 3-O-fGalp; Q3MG cpd; Q-3-AP cpd; Q-tC-L-A-D-G;Sophoretin; Quercetin hydrate; Q-M-beta-D-G; flavonol 3-OMT; quercetin digal-Gal; quercetin 3-XR; Quercetine dihydrate;Meletin;Quercetin (Sophoretin); quercetin 3-RhaGlcGal	15.8489319246	-4.8	-18.6663045559	4	5		-9.265883516	-8.55490293	0.5578402923	0.5025874167		CYP75A12	O.O.Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O	Vitas	STK365650	-6.67288452	-0.80860215	-0.87765723	1.83449022	-8.55490293											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016610-07	Tolnaftate	170465508	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2398-96-1	; ; Separin;TOLNAFTATE; Tolnafrate;Tolnaftate; Tolnaftate; Tolnaftato; Tinactin			-2.6116126658	4	5		0	-2.33152491					Cc1cc(ccc1)N(C)C(=S)Oc2ccc3ccccc3c2	Prestwick Chemical, Inc.	Prestw-70	-0.75462099	1.17849462	-0.60421628	0.18480123	-2.33152491											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164547-06	Zafirlukast	174007053	Leukotriene CysLT1 (LTD4) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	107753-78-6	 ; Zafirlukast;Zafirlukast	0.5623413252	-6.25	-23.9896472104	4	5		9.823870968	-1.65000224	0.1772502795	0.8984198189	10800	CYSLTR1	Cc1ccccc1S(=O)(=O)NC(=O)c5ccc(Cc3cn(C)c2ccc(cc23)NC(=O)OC4CCCC4)c(OC)c5	Sequoia	SRP00200z	-9.08088859	-9.43655914	-2.09491047	3.06950329	-1.65000224											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016401-09	Hydroflumethiazide	170465082	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	135-09-1				-31.904702837	4	5		0	-6.80625925					FC(F)(F)c1cc2NCNS(=O)(=O)c2cc1S(N)(=O)=O	Microsource	01500341	-8.75021197	-10.08172043	-4.02663844	-1.04119715	-6.80625925											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016089-06	Nonivamide	170466476	Vanilloid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2444-46-4				-11.5155343568	4	5		0	0.61875084					Oc1ccc(cc1OC)CNC(=O)CCCCCCCC	Specs	AN-153/I105041	-4.60403595	-6.16774194	-2.20075858	3.44812044	0.61875084											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015735-11	Niclosamide	170465184	STAT-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	50-65-7	 Yomesan;Niclosamide; Niclosamida;NICOLSAMIDE; ; Bayluscide;NICLOSAMIDE; Niclocide; Phenasal; Fenasal; Niclosamid; Radewerm; Bayer 73; Bayer 2353; Niclosamide; Clonitralide; Niclosamidel; Devermine; Niclosamide-olamine; Tr??d??mine	0.6309573445	-6.2	-193.4602597508	-2.1	5		-99.2799789435	-91.81724432	0.041232386	0.9787272967	6774	STAT3	Clc2cc(ccc2NC(=O)c1cc(Cl)ccc1O)[N+]([O-])=O	Vitas	STK396676	-7.16466	-7.02795699	-46.71870865	-69.38159199	-91.81724432											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00091070-02	Diisopropylamine	170466002	Pyruvate dehydrogenase kinase isoform 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	108-18-9				-26.5193399386	4	5		0	-5.06658297					CC(C)NC(C)C	Labotest	LTBB000412	-8.30083093	-8.84301075	-2.65061304	0.99612368	-5.06658297											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185770-01	Sucrose octasulfate, sodium salt	144207173		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	74135-10-7				-22.9692775551	4	5		0	-3.14755862					[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)O[C@H]1[C@H](O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]1OS([O-])=O)O[C@]2(COS([O-])=O)O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]2OS([O-])=O	Toronto Research	S699020	-7.842971	-7.00215054	-1.75090412	0.0676102	-3.14755862											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00379007-02	Retapamulin		70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	224452-66-8				-24.3536189726	4	4		0	-3.16353654					C[C@@H]1CCC23CCC(=O)[C@H]2C1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC4C[C@@H]5CC[C@H](C4)N5C	MedChem Express	HY-17010	-6.02665051	-4.69697621	-4.74467052	-3.16353654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181161-03	Ethyl salicylate	170466844		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	118-61-6				-29.8075900252	4	5		0	-4.38363686					Oc1ccccc1C(=O)OCC	Labotest	LT02097419	-8.38667251	-3.13518614	-5.73752944	-6.83172656	-4.38363686											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016101-10	Xylometazoline hydrochloride	170465470	alpha2A/B/C-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1218-35-5	; Otrivine-Antistin; ;XYLOMETAZOLINE HYDROCHLORIDE;Xylometazoline hydrochloride; Xylometazoline hydrochloride; Neo-Synephrine II; Xilometazolina; Otrivin hydrochloride			-32.3866406417	4	5		0	-5.71062506			150	ADRA2A	Cl.CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2	Microsource	01500614	-8.93029373	-4.01869961	-7.71569257	-4.79842244	-5.71062506											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159448-05	4-Methoxycinnamic acid	225144227		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	943-89-5				-33.3179869878	4	5		0	-7.27555596					COC1=CC=C(\C=C\C(O)=O)C=C1	SIGMA	M13807	-7.29066199	-4.94510208	-7.79276386	-7.80455741	-7.27555596											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179366-03	Florfenicol	170465648		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	73231-34-2				-3.1592952286	4	5		0	-0.23794271					O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl	Prestwick Chemical, Inc.	Prestw-955	0.46032442	-0.0128667	-4.45300792	-1.02103418	-0.23794271											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090827-07	Guaiacol	225144199	intestine smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	90-05-1				-13.1565146497	4	5		0	-3.09325524					COC1=C(O)C=CC=C1	Prestwick	Prestw-1268	-1.70539237	1.42820381	-8.4435881	-3.9745837	-3.09325524											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016391-13	Clioquinol	170465019		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	130-26-7		10	-5	-84.3812366607	-2.1	5		-107.2684176766	-86.72096641	0.0040146888	0.9979869626			Oc1c(I)cc(Cl)c2cccnc12	Microsource	01505114	-2.38930294	0.80202436	-4.39306358	-18.05872042	-86.72096641											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274069-01	Nandrolone phenpropionate	170465193	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	62-90-8				-18.6998117995	4	5		0	-1.83032854				AR	O=C5CC[C@H]4C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	Selleck	S1310	-4.1253836	-3.9929662	-2.1751231	-7.68185802	-1.83032854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274271-01	Dimethisteron	170465914		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	79-64-1		14.1253754462	-4.85	-9.7269116424	4	4		-16.086343636	-13.82195303	0.213448977	0.9710085917			C[C@H]3C[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#CC)[C@@]4(C)CCC(=O)C=C34	GVK	FFS-11-286-NCI-184	0.83499178	-1.96137468	-0.225096	-13.82195303												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532517-01	OZENOXACIN		Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-23.0658585467	4	4		0	-8.02649353					CNC1=C(C)C=C(C=N1)C2=CC=C3C(=O)\C(=C/N(C4CC4)C3=C2C)C(O)=O	NanjingKaimubo Pharm	KB-80783	-5.10080471	-3.38079057	0.11916847	-8.02649353												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00356590-01	Arsenic trioxide 			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1327-53-3				-21.4008350441	4	4		0	-2.65806789					[O]1[As]2[O][As]1[O]2	Enzo	AC2011	-4.46915289	-5.28194761	-6.16586485	-2.65806789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179665-04	Danazol	170464884	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	17230-88-5				-13.8056435284	4	4		0	-4.38363327					C#C[C@]3(O)CC[C@H]2[C@@H]4CCC1=Cc5oncc5C[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-105	-4.57298607	0.46453611	1.17844375	-4.38363327												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344565-01	Mizolastine	170465604	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	108612-45-9				-24.6497872934	4	4		0	-7.91319883				HRH1	O=C1C=CN=C(N1)N(C)C2CCN(CC2)c4nc5ccccc5n4Cc3ccc(F)cc3	Prestwick	Prestw-1506	-6.52851086	0.00860252	-2.96155713	-7.91319883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386257-02	Aclidinium (Bromide)		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	320345-99-1				-21.6728047155	4	4		0	-6.94583642					OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C4=CC=CS4)C5=CC=CS5	MedChem Express	HY-14144	-5.19598512	-2.96786959	-1.62863574	-6.94583642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090730-03	D-Camphor	170465497		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	464-49-3		2.8183829313	-5.55	-11.5231088064	4	5		13.76840582	-2.89110183	0.1957271685	0.9758222558			CC2(C)[C@H]1CC(=O)[C@]2(C)CC1	Vitas	STK803534	-5.14628128	-7.30700485	-6.78611797	5.44252055	-2.89110183											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160606-01	Sulbentine	144205485		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	350-12-9	Dibenzthion; Sulbentina; Afungin; 			-17.3568552681	4	4	Sulbentinum;Sulbentine;D 47;Afungin;Sulbentina;dibenzthione;DIBENZTHION;CIPLUS_209804;carbothialdine;2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dibenzyl-;SULBENTINE;sulbentinum;CIPLUS_3866698;LS-150185;sulbentine;Dibenzthion;3,5-dibenzylperhydro-1,3,5-thiadiazine-2-thione;	0	-5.81353329					S=C3SCN(Cc1ccccc1)CN3Cc2ccccc2	SigmaAldrich	S545791	-4.41641746	-3.96682139	0.88448137	-5.81353329												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00389499-01	TELITHROMYCIN		Ketolide antibiotic	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	191114-48-4				-21.9016846023	4	4		0	-10.52865789					CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]3N(CCCC[N]4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC	Microsource	01505265	-3.37936207	-3.74049758	-3.98908524	-10.52865789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538146-01	NCGC00538146-01		Adrenergic receptor beta Blocker	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-24.8294290722	4	4		0	-6.10537558					CN1\C=C(\OCC(O)CNC(C)(C)C)C2=C(C=CC=C2)C1=O	Pharmaron	PH-NIH-2017-009-L1-4-0	-6.44990515	-1.9609537	-3.46933472	-6.10537558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015623-10	Proglumide	170465774	Cholecystokinin B receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	6620-60-6				-12.4487075557	4	4		0	-4.31384949				CCKBR	O=C(NC(CCC(=O)O)C(=O)N(CCC)CCC)c1ccccc1	Microsource	01501119	-2.48342218	-2.91817088	-1.20611096	-4.31384949												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094772-04	PYRVINIUM PAMOATE		Cryptosporidium parvum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			12.5892541179	-4.9	-83.0098187092	-3	4		-106.8917778415	-98.80740477	0.0375134813	0.9991310476			CN(C)C1=CC=C2C(=C1)C=CC(=[N+]2C)/C=C/C3=C(C)[N](C(=C3)C)C4=CC=CC=C4.OC(=O)C5=CC6=CC=CC=C6C(=C5O)CC7=C(O)C(=CC8=CC=CC=C78)C([O-])=O	Microsource	MS-01500521	-2.84995809	-2.60884589	-0.08229383	-98.80740477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346551-03	Pomalidomide		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	19171-19-8				-24.2419466462	4	4		0	-4.35208259				TNF	NC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1	APExBIO	A4212	-6.97930913	-1.55494126	-2.97557173	-4.35208259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390625-02	Maropitant		Substance-P receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	147116-67-4		14.1253754462	-4.85	-29.9414910173	4	4		-27.1005915639	-26.02312765	0.2030591244	0.9737370559	403815	TACR1	COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)(C)C	MedChem Express	HY-10053	-1.77263468	-5.97816744	-2.55516841	-26.02312765												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532494-01	PHENINDAMINE		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-28.9959483213	4	4		0	-4.28088288					CN1CC\C2=C(/C1)C(C3=CC=CC=C3)C4=CC=CC=C24	SIGMA	A001025678	-7.5881237	-4.11195577	-5.07189882	-4.28088288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159519-14	Tolterodine Tartrate 			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	124937-52-6		4.4668359215	-5.35	-6.7409355685	4	4		-17.243147032	-11.03595586	0.2405011851	0.9629299859			[H][C@@](CCN(C(C)C)C(C)C)(C1=CC=CC=C1)C2=CC(C)=CC=C2O	Bosche	T0008	2.24996691	-1.80545957	-4.25762301	-11.03595586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163469-03	Monensin sodium salt			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	22373-78-0		1.1220184543	-5.95	-130.018415124	-1.2	4		-69.5045223552	-72.05257928	0.0105471094	0.9999313907			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	SIGMA	M5273	-3.02951502	-4.07856283	-64.09362995	-72.05257928												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167529-02	Itopride hydrochloride	170465974	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	122892-31-3				-18.0228001643	4	4		0	-8.26806693			43	ACHE	Cl.COc1cc(ccc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2	Sequoia	SRP02400i	-2.36467111	-5.71008984	-2.59442134	-8.26806693												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167455-02	Zofenopril	170465605		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	81872-10-8				-17.4783886144	4	4		0	-5.3488786					O=C([C@@H](C)CSC(=O)c1ccccc1)N3C[C@@H](Sc2ccccc2)C[C@H]3C(=O)O	Bosche	Z6238	-3.46759606	-3.36040083	-2.4471587	-5.3488786												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016806-13	Mebendazole	170464914	Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	31431-39-7	; ; Vermox;Mebendazole; Mebendazol; Mebendazole;MEBENDAZOLE	0.6309573445	-6.2	-102.4539624937	-1.2	5		-43.757953804	-48.30434583	0.0136347632	0.993116728	203068	TUBB	O=C(OC)Nc1nc2cc(ccc2n1)C(=O)c3ccccc3	Microsource	01501110	-5.17271766	-8.90714103	-30.53962406	-41.75354797	-48.30434583											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016305-11	Silver sulfadiazine		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	68-35-9	; Diazin; Silver Sulphadiazine; Ditrim; Sulphadiazine; Sulfadiazine sodium salt; Perfringens Supplement I;Sulfadiazine; ;SULFADIAZINE; Tibirox; Diaziprim Forte; Silver(I) sulfadiazine; SPS Agar Supplement; Tribrissen; Zinc Sulfadiazine; Sulfadiazina sodica; Sulfazine; Triglobe; Silvadene; Sterinor; Sulfadiazine; Sulfadiazina; Sulfazin; Sulfadiazine, Zin	2.8183829313	-5.55	-10.3004004081	4	5		13.1835307879	-6.1217934	0.1851696723	0.9784649279			NC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NC=CC=N2	SIGMA	S8626	-5.27846317	-4.98340284	-6.81960899	5.35066367	-6.1217934											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025346-08	Mirtazapine		5-HT2A/3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	85650-52-8 				-10.4939613265	4	4		0	-4.61018156				HTR2A	CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3	APExBIO	B2113	-2.6117263	0.23324119	-0.77529453	-4.61018156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016281-11	Phenacetin	170465554	Prostaglandin G/H synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	62-44-2		1.1220184543	-5.95	-14.7540126211	4	5		9.5543876119	0.64246707	0.193062198	0.8878413617	403544	PTGS1	CCOc1ccc(cc1)NC(C)=O	Vitas	STK011463	-5.36658442	-7.54532301	-5.00272115	4.99242181	0.64246707											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015264-13	Clomipramine hydrochloride	170464702	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	303-49-1	 7   Clomipramine; ; Chlomipramine;; Hydiphen;CLOMIPRAMINE HYDROCHLORIDE; Anafranil;Clomipramine; Anafranil hydrochloride; Chloripramine;Clomipramine?HCl; Clomipramina; 8   Clomipramine Hcl;Clomipramine hydrochloride; Clomipramine hydrochloride	15.8489319246	-4.8	-21.1407093022	4	5		-18.214561056	-16.42880088	0.3687388542	0.7425772613	6532	SLC6A4	CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12	Microsource	02300061	-2.07966161	-5.34939144	-5.47996818	3.66968263	-16.42880088											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164566-09	Pitavastatin Calcium			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	147526-32-7		3.1622776602	-5.5	-142.2295964101	-2.1	4		-91.6296919363	-96.79601282	0.0203074051	0.9997455753			O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	APExBIO	A8504	-6.33520095	-12.04215619	-64.79123354	-96.79601282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249888-01	Vitamin B12	170464872		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	68-19-9				-20.578163662	4	4		0	-6.84407262					NC(=O)CC[C@@H]8C=2N=C(C(C)=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@](C)(N1[Co+]C#N)[C@@H]7N=C(C(C)=C3N=C(C=2)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@H](n5cnc4cc(C)c(C)cc45)[C@@H]6O)[C@H]7CC(N)=O)[C@@]8(C)CC(N)=O	GVK	FFS-11-286-NCI-25	-5.055808	0.04319281	-3.69455994	-6.84407262												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182059-03	Febuxostat	170465220	Xanthine Oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	144060-53-7	 ; Febuxostat;Febuxostat	2.8183829313	-5.55	-15.9376574987	4	5		11.257724064	4.71754394	0.0047034468	0.9976583108	7498	XDH	CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O	Tocris	4427	-6.49453648	-6.88143672	-6.30887093	2.57658568	4.71754394											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178417-03	Ribostamycin sulfate	170465814	Protein disulfide-isomerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	53797-35-6				-13.0762756948	4	4		0	-4.81488074			5034	P4HB	O=S(=O)(O)O.N[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@@H]2[C@@H](N)C[C@@H](N)C(O)[C@H]2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Microsource	01503939	-1.38527375	-1.14892882	-3.91978517	-4.81488074												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00016059-13	Thioridazine	170465080	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50-52-2		12.5892541179	-4.9	-97.1488567779	-3	5		-103.2459349436	-99.02253224	0.0015754534	0.9992114543			CN4CCCCC4CCN1c3ccccc3Sc2ccc(SC)cc12	Enzo	NS835	-6.28304547	-7.1367776	-4.56733788	-4.72603683	-99.02253224											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00386356-02	Bepotastine (Beslilate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	190786-44-8				-20.7622642336	4	4		0	-6.68387326					OC(=O)CCCN1CCC(CC1)O[C@@H](C2=CC=C(Cl)C=C2)C3=NC=CC=C3	MedChem Express	HY-A0015	-4.91463361	-0.829302	-3.77252252	-6.68387326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181909-01	Sulcaine	144206885		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	41653-21-8	Ethyl piperidinoacetylaminobenzoate; Sulcain; Nichicaine; 	1.4125375446	-5.85	-16.9866803109	4	5	Ethyl Piperidinoacetylaminobenzoate;CIPLUS_3838938;P-(PIPERIDINOACETAMIDE)BENZOIC ACID ETHYL ESTER;Nichicaine;ETHYL PIPERIDINOACETYLAMINOBENZOATE;CIPLUS_196504;CIPLUS_180054;Sulcain;Ethyl piperidinoacetylaminobenzoate;	13.320410252	-6.54398605	0.0539243915	0.998216708			O=C(CN1CCCCC1)Nc2ccc(cc2)C(=O)OCC	Pharmaron	PH-NIH-22	-7.57842792	-8.18367521	-6.70239042	5.16694989	-6.54398605											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091439-07	Cimetidine	170464651	Multidrug and toxin extrusion protein 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	51481-61-9		3.1622776602	-5.5	-3.7499971157	4	5		13.995583368	-0.92698821	0.2413953714	0.9626403997			N#C\N=C(/NC)NCCSCc1ncnc1C	Microsource	01500684	-4.21219598	-2.81300536	-5.41298614	6.7836311	-0.92698821											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181082-01	Benzactyzine methobromide	144206254	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	3166-62-9	Methylbenactyzium bromide; 			-5.3801106953	4	4	diethyllachesine;diethyllachesine bromide;Methylbenactyzium Bromide;Methylbenactyzium bromide;CIPLUS_777361;diethyllachesine iodide;Ethanaminium, N,N-diethyl-2-((hydroxydiphenylacetyl)oxy)-N-methyl-;methylbenactyzium bromide;METHYLBENACTYZIUM BROMIDE;BENACTYZINE METHOBROMIDE;CIPLUS_161517;Bromure de methylbenactyzium;filcilin;methylbenactyzii bromidum;CIPLUS_3883265;bromure de methylbenactyzium;Methylbenactyzii bromidum;CIPLUS_157705;2-diethylaminoethyldiphenylglycolate methylbromide;Bromuro de metilbenacticio;(2-benziloyloxyethyl)diethylmethylammonium iodide;	0	1.56639373					OC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2.BrC	NCI	NSC-11525	-2.4617285	0.6219765	-1.00051975	1.56639373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263218-07	Teriflunomide		DHODH Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	108605-62-5				-31.1173980781	4	4		0	-11.50510435				DHODH	C\C(O)=C(C#N)\C(=O)NC1=CC=C(C=C1)C(F)(F)F	Bio Vision	1973	-6.80882417	-4.26766374	-3.07334941	-11.50510435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388389-01	N-acetyl-D-Glucosamine			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7512-17-6				-17.8606427234	4	4		0	-4.94624627					CC(=O)NC(C=O)C(O)C(O)[C@H](O)CO	Cayman	13136	-4.07835999	-4.33642771	-1.02742786	-4.94624627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183285-15	Nilotinib		Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	641571-10-0				12.12405688	4	4		0	7.68956924				ABL1	CC1=C[N](C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC(=C(C)C=C3)NC4=NC(=CC=N4)C5=CC=CN=C5)C(F)(F)F	Glixx	GLXC-90226	1.26174615	4.63026952	-0.11694387	7.68956924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167476-02	Calcium hopantenate	50112729		DPI_SARS-CoV-2_General	2019_NPC-5_Tox		Calcium hopantenate; Hopate; Acido hopantenico; 			-21.0419863376	4	4	Calcium hopantenate;Hopate;acide hopantenique;CIPLUS_171572;CIPLUS_170762;Acide hopantenique;Acidum hopantenicum;Calcium Hopantenate;Hopantenic acid;CALCIUM HOPANTENATE;HOPANTENIC ACID;Calcium Hopantenate Anhydride;pantogab;CIPLUS_159419;Acido hopantenico;CIPLUS_685059;acidum hopantenicum;	0	-4.8378354					CC(C)(CO)C(O)C(=O)NCCCC([O-])=O	InterBioScreen	STOCK1N-30476	-5.3092359	-7.49097473	1.95658001	-4.8378354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371122-04	Betrixaban		Coagulation factor X Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	330942-05-7				-4.2937976977	4	4		0	-4.29868281					COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=NC=C(Cl)C=C3	MedChem Express	HY-10268	-1.17351215	3.39495508	-0.6540194	-4.29868281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510497-02	Eribulin mesylate		Tubulin Polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	441045-17-6		0.3981071706	-6.4	-107.5766484962	-1.2	4		-49.11044806	-44.6511214	0.0492131137	0.9985051646		TUBB	CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C	MedChem Express	HY-13442A	-10.09396921	-29.31928127	-39.96448371	-44.6511214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166241-02	2,6-DIIODO-4-NITROPHENOL	225144276		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	305-85-1		12.5892541179	-4.9	-70.4417486603	-3	4		-55.7463646706	-56.72837309	0.0859613973	0.9954163564			OC1=C(I)C=C(C=C1I)[N+]([O-])=O	SIGMA	145416	-8.25870208	-4.10331721	-5.84286209	-56.72837309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164571-14	Dutasteride			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	164656-23-9				-15.9798443991	4	4		0	-5.70487718					[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)C3CC[C@]12C)C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	APExBIO	A1659	-2.6734901	-3.35176227	-3.64258489	-5.70487718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161326-08	Calcifediol (monohydrate)			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	63283-36-3		3.5481338923	-5.45	13.364055639	4	4		14.3927282119	13.61911645	0.0980577832	0.9940599941			C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)CCC3=C	MedChem Express	HY-32351A	-0.42907294	-1.57727351	7.70124185	13.61911645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263155-09	Belinostat	404904701	HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	414864-00-9		1.1220184543	-5.95	-204.9043786288	-1.3	4		-77.6342375721	-99.70630117	0.1219707838	0.9907112752		HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	MedChem Express	HY-10225	-17.48797812	-32.98203179	-89.66129591	-99.70630117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181168-01	Trifluomeprazine 2-butenedioate	144206322		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	71609-19-3	Trifluomeprazine; Trifluomeprazina; 	10	-5	-22.1054783109	4	4	Trifluomeprazinum;Trifluomeprazine;CIPLUS_214394;trifluomeprazine;TRIFLUOMEPRAZINE;trifluomeprazinum;Trifluomeprazina;TRIFLUOMEPRAZINE MALEATE;	-23.145425416	-19.70452118	0.34265036	0.9201403272			O=C(O)C=CC(=O)O.FC(F)(F)c1cc2N(CC(C)CN(C)C)c3ccccc3Sc2cc1	NCI	NSC-170991	0.18529139	-5.7878369	-5.44438669	-19.70452118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014482-03	Methdilazine hydrochloride	124878446	ion channel	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			11.220184543	-4.95	-42.0450172856	-3	4	Methdilazine hydrochloride	-37.8847452226	-34.77216091	0.0384699844	0.9990873258			CN1CC[C@@H](C1)CN2C3=C(SC4=C2C=CC=C4)C=CC=C3	NCGC	NSC-169091	-3.27348127	-4.39702833	-6.61382536	-34.77216091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506872-01	Acotiamide hydrochlorid		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	773092-05-0				-13.9410530695	4	4		0	-5.52687789					COC1=C(OC)C=C(C(=O)NC2=NC(=CS2)C(=O)NCCN(C(C)C)C(C)C)C(=C1)O	TargetMol	T2319	-2.96466228	-1.94367657	-1.26039501	-5.52687789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016353-08	Butyl 4-aminobenzoate	170465735		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	94-25-7		8.9125093813	-5.05	-63.0561527533	-2.2	5		-80.4565875872	-65.11862696	0.0027455076	0.9986248639			Nc1ccc(cc1)C(=O)OCCCC	Specs	AE-562/J257667	0.66972154	-1.57885778	-3.40352493	-17.37473017	-65.11862696											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015418-09	Ethosuximide	170464802	T-Type Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	77-67-8	 Etosuximida; ; Suxilep;ETHOSUXIMIDE;Ethosuximide; Ethosuximide; Zarontin			-15.7863486031	4	5		0	-3.94658345				CACNA1G	CC1(CC)CC(=O)NC1=O	Microsource	01502196	-3.84208671	-4.6514597	-3.0183782	-0.50062003	-3.94658345											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178433-02	HYDROXYAMPHETAMINE HYDROBROMIDE		Adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	306-21-8, 1518-86-1 [hydroxyamphetamine]				-30.7890465307	4	4		0	-5.75827697					CC(N)CC1=CC=C(O)C=C1	Microsource	00211425	-8.54987427	-3.62819627	-3.02754678	-5.75827697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344330-02	Elaidic Acid		SiHa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	112-79-8				-13.5513777193	4	4		0	-6.18547526					CCCCCCCC/C=C/CCCCCCCC(O)=O	Cayman	90250	-1.79997353	-3.36040083	-2.83697159	-6.18547526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166134-02	Estradiol cypionate	170464789	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	313-06-4				-30.2782986895	4	4		0	-9.3004628					Oc4cc5CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CCC3CCCC3)c5cc4	SIGMA	E8004	-6.55578594	-5.53731859	-3.88513514	-9.3004628												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181006-02	1-(4-Hydroxyphenyl)-2-methyl-2-methylaminoethanol hydrochloride	225144314		DPI_SARS-CoV-2_General	2019_NPC-7_Tox					9.2348864695	4	4		0	-2.93698825					CNC(C)[C@@H](O)C1=CC=C(O)C=C1	SIGMA	CDS014222	4.75581241	-1.59813407	0.57605683	-2.93698825												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016624-05	Diphenidol	170465280	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	972-02-1				-27.8364308463	4	5		0	-3.89151485					OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3	Prestwick	Prestw-252	-7.58724004	-6.10690272	-7.56478419	-1.86010196	-3.89151485											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018163-10	Bithionol	170465515	Adenylate cyclase type 10 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	97-18-7		8.9125093813	-5.05	-70.9716117121	-3	5		-70.4433824773	-68.34014042	0.0062319234	0.9968703541			Oc2c(Sc1cc(Cl)cc(Cl)c1O)cc(Cl)cc2Cl	Specs	AN-153/J117612	-5.86006345	-2.19167589	-1.80432871	-8.91471088	-68.34014042											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183597-01	Betamethasone butyrate propionate	144206581		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	5534-02-1				-9.8213086994	4	4	Betamethasone butyrate propionate;BETAMETHASONE BUTYRATE PROPIONATE;Antebate;Betamethasone Butyrate Propionate;CIPLUS_213705;	0	-4.28088288					CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	APAC	877861	-3.05289628	-1.34761576	3.02754678	-4.28088288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181765-03	Pranlukast hydrate	384568399	Leukotriene CysLT1/2 (LTD4) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	103177-37-3				-25.5295764308	4	4		0	-7.81416874				CYSLTR1	O=C(NC1=CC=C2C(=O)\C=C(/OC2=C1)C3=NN=N[NH]3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4	Selleck	S1829	-5.35580359	-1.55494126	-7.0469508	-7.81416874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181048-02	Dolasetron mesylate hydrate	225144319	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	115956-13-3				-20.6054960282	4	4		0	-2.98148807					O=C1CN2[C@H]3CC(C[C@@H]2CC1C3)OC(=O)C4=C[NH]C5=CC=CC=C45	SIGMA	D9571	-5.82344377	-1.28714582	-3.72920998	-2.98148807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344534-01	Indigo carmine	225144381		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	860-22-0		1	-6	1.3333404721	4	4		10.523470244	-6.11427554	1	0.9989736588			[O-][S](=O)(=O)C1=CC2=C(NC(\C2=O)=C/3NC4=CC=C(C=C4C3=O)[S]([O-])(=O)=O)C=C1	SIGMA	131164	-3.35289187	-0.60469938	7.13357588	-6.11427554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016764-04	Benfotiamine	170465987		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	22457-89-2		0.285877499	-6.543820026	-0.7313325933	4	5		13.388614732	-6.46138314	0.1032278157	0.9934352996			Nc2nc(C)ncc2CN(C=O)C(C)=C(CCOP(=O)(O)O)SC(=O)c1ccccc1	SIGMA	B9636	-6.57384561	-5.5621755	-6.14141583	5.34147798	-6.46138314											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	57-41-0				-22.0290217547	4	5		0	-3.32247258					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	-5.9481847	-7.50276619	-1.10939004	-3.56864006	-3.32247258											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016260-13	Ethacrynic acid	170465426	Sodium/potassium-transporting ATPase subunit alpha-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	58-54-8		1	-6	-16.1324694449	4	5		13.45506	1.7621954	0.2039622004	0.8797692563	476	ATP1A1	Clc1c(ccc(OCC(=O)O)c1Cl)C(=O)C(=C)CC	Specs	AN-153/J108037	-6.51216073	-9.96255	-5.57206849	7.84917099	1.7621954											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178395-04	Piperidolate hydrochloride	170465927		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	129-77-1				-27.9706154172	4	5		0	-9.53604699					Cl.CCN3CCCC(OC(=O)C(c1ccccc1)c2ccccc2)C3	Prestwick Chemical, Inc.	Prestw-1055	-7.23475502	-3.40880075	-2.80068657	-4.41372342	-9.53604699											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00180889-03	Flunixin meglumine	170466598	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	42461-84-7		2.8183829313	-5.55	-18.2773790877	4	5		11.4642227719	-5.08466798	0.2887907228	0.9454720588	791253	PTGS2	CNC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.FC(F)(F)c2cccc(Nc1ncccc1C(=O)O)c2C	Microsource	01505113	-7.88685231	-5.04298238	-6.72750869	3.16446976	-5.08466798											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274274-01	Benzquinamide	170465138	Dopamine D2 receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	63-12-7		1.5848931925	-5.8	-14.3004415392	4	5		10.0655374919	-4.24946079	0.3484628679	0.9177674464			CCN(CC)C(=O)C2CN3CCc1cc(OC)c(OC)cc1C3CC2OC(C)=O	GVK	FFS-11-286-NCI-037	-4.78498414	-8.38794791	-6.20839787	3.30225509	-4.24946079											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016913-14	Astemizole	170465888	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	68844-77-9		12.5892541179	-4.9	-102.9049950978	-3	5		-102.2702670249	-99.68335551	0.0051024625	0.997439332			Fc1ccc(cc1)Cn4c5ccccc5nc4NC3CCN(CCc2ccc(OC)cc2)CC3	Enzo	NH101	-8.72400423	-7.44318665	-6.63540838	-3.40329766	-99.68335551											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183026-01	Dicethiamine hydrochloride	144206821		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	616-96-6	Cetotiamine; Cetotiamine Hydrochloride; O,S-dicarbethoxythiamine; Cetotiamina; 	2.8183829313	-5.55	-13.0558729675	4	5	Cetotiamine Hydrochloride;Cetotiamine;O,S-dicarbethoxythiamine;CETOTIAMINE;CIPLUS_210876;Cetotiaminum;Cetotiamina;CIPLUS_697013;O,S-bis(ethoxycarbonyl)thiamine;cetotiamine;cetotiaminum;	18.280960084	-6.29617732	0.1818694432	0.9791337858			Cl.Nc1nc(C)ncc1CN(C=O)C(/C)=C(/CCOC(=O)OCC)SC(=O)OCC	Pharmaron	PH-NIH-149305	-6.61790624	-9.40080007	-7.94155817	7.8399853	-6.29617732											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182973-01	Chromonar hydrochloride	144206761	Platelet Aggregation (Plug Formation) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	655-35-6	Carbocromene; Intercordin; Carbocromeno; Cardiocap; Carbocromen Hydrochloride; Carbochromene; Carbocromen hydrochloride; Intensain; Hydrochloride, Chromona; 			-24.6345525534	4	4	Carbocromenum;Carbocromen hydrochloride;NSC-110430;Chromonar;Intensain;Carbocromen;Carbocromen Hydrochloride;carbocromene;Intercordin;((3-(2-(DIETHYLAMINO)ETHYL)-4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-YL)-OXY)ACETIC ACID ETHYL ESTER HYROCHLORIDE;Chromonar Hydrochloride;Hydrochloride, Chromona;chromonar;Carbocromeno;Carbochromene;carbocromenum;Acetic acid, ((3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)-, ethyl ester;Cardiocap;Chromonar hydrochloride;Carbocromene;CHROMONAR HYDROCHLORIDE;CIPLUS_155933;LS-11691;LS-11690;CIPLUS_156471;CARBOCROMEN;	0	-3.18618726					Cl.O=C(OCC)COc1ccc2c(c1)OC(=O)C(CCN(CC)CC)=C2C	NCI	NSC_110430	-6.71460714	-3.42950933	-3.87647263	-3.18618726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095787-05	(-)-Inosine			DPI_SARS-CoV-2_General	2019_NPC-2_Tox	58-63-9				-23.2747150863	4	5		0	-4.65329723					OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CNC3=O	Bosche	I0819	-6.26542122	-3.46838029	-8.14250429	-0.08726404	-4.65329723											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164526-02	Camylofin	170465936	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	54-30-8				-25.5031088504	4	5		0	-7.81056399					CC(C)CCOC(=O)C(NCCN(CC)CC)c1ccccc1	Labotest	LT03328450	-5.12865703	-5.94518682	-3.67145309	-4.90975061	-7.81056399											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013841-09	Cyclobenzaprine hydrochloride	170464953	5-HT2A Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	6202-23-9	 Lisseril; ; Flexeril; Ciclobenzaprina;CYCLOBENZAPRINE HYDROCHLORIDE; Cyclobenzaprine hydrochloride;Cyclobenzaprine hydrochloride	2.8183829313	-5.55	-17.6251988029	4	5		10.602566252	-14.34537194	0.3820959165	0.8990412022	3356	HTR2A	Cl.CN(C)CC\C=C2/c3ccccc3C=Cc1ccccc12	Microsource	01503207	-4.93479027	-7.64745936	-8.41880521	1.9060304	-14.34537194											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182993-01	Betiatide	144206816		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	103725-47-9	Betiatide; 			-20.4113560471	4	5	CIPLUS_762860;MP-600;BETIATIDE;THIOBENZOIC ACID, S-ESTER WITH N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE;Betiatide;betiatidum;N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE BENZOATE (ESTER);GLYCINE, N-(N-(N-((BENZOYLTHIO)ACETYL)GLYCYL)GLYCYL)-;betiatide;BENZOYLMERCAPTOACETYLGLYCYLGLYCYLGLYCINE;	0	-4.27699509					O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1	Pharmaron	PH-NIH-137963	-4.73211139	-6.54098221	-3.95612676	-1.57534561	-4.27699509											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00507976-02	Derquantel			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	187865-22-1				-36.3951158168	4	4		0	-9.39836241					CN1C(=O)[C@]23C[C@H]4C(C)(C)[C@]5(CNC6=C7O\C=C/C(C)(C)OC7=CC=C56)C[C@]14CN2CC[C@@]3(C)O	SantaCruz Bio	sc-391516	-8.06458729	-6.09882516	-6.45790021	-9.39836241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179240-04	Levocabastine hydrochloride	170465061	Neurotensin receptor type 2 Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	79547-78-7				2.2391372012	4	4		0	-2.08259167			23620	NTSR2	Cl.Fc1ccc(cc1)[C@@]2(CC[C@H](CC2)N3CC[C@@]([C@H](C)C3)(c4ccccc4)C(=O)O)C#N	Prestwick Chemical, Inc.	Prestw-1039	0.95292716	1.57221838	0.37681913	-2.08259167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015243-10	Clemizole hydrochloride	170465924	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1163-36-6		1.2589254118	-5.9	-25.5219119288	4	5		8.944846368	-7.38837135	0.2959963281	0.9427117165		HRH1	Cl.Clc1ccc(cc1)Cn3c4ccccc4nc3CN2CCCC2	Microsource	01505990	-7.40218541	-9.95403864	-7.42244736	0.24342075	-7.38837135											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182992-01	Fasoracetam	144206891	GABA-B receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	110958-19-5	FASORACETAM; Fasoracetam Anhydride; Fasoracetam Hydrate; 			-6.5602896914	4	5	FASORACETAM;Fasoracetam Anhydride;CIPLUS_775811;CIPLUS_3849428;Fasoracetam;fasoracetam;(+)-1-(((R)-5-OXO-2-PYRROLIDINYL)CARBONYL)PIPERIDINE;Fasoracetam Hydrate;	0	-0.46808315					O=C([C@H]1CCC(=O)N1)N2CCCCC2	Pharmaron	PH-NIH-97984	-2.96087416	-2.2342327	-1.25172688	2.45717173	-0.46808315											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263893-02	Lactitol	170465917	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	585-86-4		2.8183829313	-5.55	-14.5961739207	4	5		12.0901536399	-5.16727089	0.2746542846	0.9509219826			OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	Microsource	01505436	-5.17271766	-7.19635714	-7.9917947	3.88095347	-5.16727089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182037-01	Alacepril	124893756	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	74258-86-9	Alacepril; ; Alacepril			-18.1909564005	4	4	N-(1-(3-(acetylthio)-2-methyl-1-oxopropyl)-L-prolyl)-L-phenylalanine;CIPLUS_214255;aracepril;alacepril;ALACEPRIL;DU-1219;Alacepril;DU 1219;cetapril;alaceprilum;LS-105750;Cetapril;	0	-5.29547882			1636	ACE	O=C(N[C@@H](Cc1ccccc1)C(=O)O)[C@@H]2CCCN2C(=O)[C@H](C)CSC(C)=O	ACC	ALACEPRIL	-3.49406626	-4.46613683	-3.13149688	-5.29547882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015833-15	Pyrazinamide	170464703	Fatty Acid Synthase (FAS) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	98-96-4	Pyrazinecarboxamide;PYRAZINAMIDE; Pyrazinamide;Pyrazinamide; Pyrazinecarboxamide			-10.1921034934	4	5		0	-4.57069432			2194	FAS	NC(=O)c1cnccn1	Vitas	STK801661	-0.50229115	-4.08970976	-3.40352493	-0.86804758	-4.57069432											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164604-10	Fluvastatin Na			DPI_SARS-CoV-2_General	2019_NPC-2_Tox			12.5892541179	-4.9	-71.4929503833	-3	5		-80.1757835854	-76.03138911	0.0364291105	0.9812765175			CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C3=CC=C(F)C=C3	Sequoia	SRP01980f	-4.96122665	-5.5621755	-6.5767991	4.32186653	-76.03138911											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249937-01	Amidoflumet	170465981		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	84466-05-7				-4.0790380857	4	4		0	-0.54657151					Clc1cc(c(NS(=O)(=O)C(F)(F)F)cc1)C(=O)OC	GVK	FFS-11-286-NCI-248	-1.07918346	-1.13890321	-0.16974895	-0.54657151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163169-05	Pizotifen	170466311	Antimigraine drugs	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	15574-96-6	 Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran			-31.8045816638	4	5		0	-9.25152586				CHRM1	CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23	BIOMOL	NS740	-8.53894959	-7.63043663	-5.45484992	0.13319249	-9.25152586											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018254-08	Bifonazole	170465826	Cytochrome P450 51 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	60628-96-8		12.5892541179	-4.9	-76.8113118398	-3	4		-72.0362401463	-71.98030536	0.0857086973	0.9954424796			c1cc(ccc1c2ccccc2)C(c3ccccc3)n4ccnc4	Microsource	01505309	-5.1792138	-9.39917483	-4.60108997	-71.98030536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159379-04	BETA-HYDROXYETHYL SALICYLATE	225144223		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	87-28-5				-16.9757100383	4	4		0	-7.0873611					OCCOC(=O)C1=CC=CC=C1O	SIGMA	172049	-3.32423179	-4.01839436	-0.54498347	-7.0873611												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167419-03	ENZACAMENE			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	36861-47-9				-12.5514823385	4	4		0	-1.19703677					CC1=CC=C(C=C1)\C=C/2C3CCC(C)(C2=O)C3(C)C	SIGMA	78551	-3.61894855	-1.29362214	-2.16206558	-1.19703677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090997-11	Dichlorvos	170466226	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	62-73-7				-12.5414724713	4	5		0	-3.68041852					COP(=O)(OC)O\C=C(\Cl)Cl	Microsource	00330018	0.29961227	-6.14094817	-4.2659187	-4.39535204	-3.68041852											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167539-03	Indole	170465733	Tryptophan synthase beta chain Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	120-72-9				-35.7653634338	4	5		0	-9.21481345			945768	trpB	c1cccc2nccc12	Specs	AE-562/J262413	-6.99682763	-11.06051579	-9.03001633	-2.65925688	-9.21481345											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165767-04	Cyclofenil	170465970	Estrogen receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	2624-43-3				-20.6265005124	4	4		0	-4.49453428			2100	ESR2	CC(=O)Oc1ccc(cc1)C(/c2ccc(OC(C)=O)cc2)=C3/CCCCC3	Tocris	3999	-5.0491917	-5.24755028	-1.00955955	-4.49453428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015542-07	Ibudilast	170466049	Phosphodiesterase 4A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50847-11-5				-22.815002719	4	5		0	-5.05713368					CC(C)C(=O)c1c2ccccn2nc1C(C)C	Prestwick	Prestw-1286	-6.26542122	-6.19201634	-1.72060116	-2.69599963	-5.05713368											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344528-01	TRYPAN BLUE	225144379		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	72-57-1				-8.0598129069	4	5		0	-2.6524712					CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(O)C4=C(C=C(C=C4N)[S]([O-])(=O)=O)C=C3[S]([O-])(=O)=O)C)N=NC5=C(O)C6=C(C=C(C=C6N)[S]([O-])(=O)=O)C=C5[S]([O-])(=O)=O	SIGMA	302643	-1.53330983	-1.93633501	-3.98961778	1.29977495	-2.6524712											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182710-02	Flurbiprofen axetil	144206486		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	91503-79-6				-18.5919802362	4	4	Flurbiprofen Axetil;CIPLUS_701423;Flurbiprofen axetil;FLURBIPROFEN AXETIL;Ropion;FP83;FP 83;FP-83;1-acetoxyethyl-2-(2-fluoro-4-biphenyl)propionate;	0	-5.57864306					Fc2cc(ccc2c1ccccc1)C(C)C(=O)OC(C)OC(C)=O	ACC	Flurbiprofen Axetil	-3.90499718	-5.62575211	-0.74153489	-5.57864306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015701-06	Metyrosine	170465112	Tyrosine 3-hydroxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	672-87-7				-15.4725266843	4	5		0	-3.21036709					Oc1ccc(C[C@](C)(N)C(=O)O)cc1	Vitas	STK272180	-4.11281349	-4.3098252	-3.69591872	-1.07575689	-3.21036709											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00160518-03	Orbifloxacin	170465644	DNA gyrase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	113617-63-3				-29.0649557769	4	5		0	-4.28500474					C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(F)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	SIGMA	34041	-10.66078918	-7.71118574	-2.89017341	-0.85788208	-4.28500474											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00024596-08	Carbidopa	225144194	decarboxylase inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	28860-95-9				-28.0924643713	4	5		0	-6.38009663				DDC	C[C@@](CC1=CC(=C(O)C=C1)O)(NN)C(O)=O	Prestwick	Prestw-1177	-8.69211675	-6.75536037	-3.59082151	0.04085153	-6.38009663											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091071-08	p,p'-DDT	170465529		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	50-29-3		14.1253754462	-4.85	-14.3936408321	4	5		-13.27102994	-10.64252495	0.0910763173	0.9517590614			Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl	Specs	AE-562/J256064	-2.35812719	0.08180487	-1.72534594	-1.31178794	-10.64252495											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021125-03	Diclofenac sodium	170464642	Cyclooxygenase-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	15307-79-6		0.1584893192	-6.8	-34.1070560346	4	5		14.3607806239	-2.35246309	0.2390949194	0.8550085366		PTGS1	[Na+].Clc2cccc(Cl)c2Nc1ccccc1CC([O-])=O	Vitas	STK984493	-12.80065052	-6.74674933	-6.22700998	0.6581635	-2.35246309											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181154-03	Nitarsone	170465716		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	98-72-6				-22.7421147765	4	5		0	-2.03639319					O=[N+]([O-])c1ccc(cc1)[As](O)(O)=O	Vitas	STK368450	-6.20131815	-6.43675192	-4.9395691	-2.52825564	-2.03639319											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015204-09	Carmustine	170464880	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	154-93-8	 Bicnu; Gliadel; ; Carmustina; Carmustine;Carmustine; 6   Carmustine; Nitrumon;CARMUSTINE; BiCNU			-5.472838092	4	5		0	-0.7711967				H2AFX	O=C(NCCCl)N(CCCl)N=O	Microsource	01503110	-1.76360861	-3.22580645	-1.16873953	2.06887226	-0.7711967											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015430-06	Fenoterol hydrobromide	170465657		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1944-12-3				-19.6278434381	4	5		0	-2.25978568					Br.Oc1cc(cc(O)c1)C(O)CNC(C)Cc2ccc(O)cc2	Microsource	01501007	-5.8673902	-6.00430108	-4.13248655	0.04056612	-2.25978568											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344584-01	Verapamil	170464904	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	52-53-9				-27.2591454194	4	5		0	-8.734251				DRD2	COc1cc(ccc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C	SIGMA	V106	-8.03798542	-7.01075269	-1.4333598	0.11268367	-8.734251											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015508-16	Hydrochlorothiazide	170465005	Hypertension treatment	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	58-93-5	; Moduretic; Dyazide;HYDROCHLOROTHIAZIDE; ; Tenesor; Capozide; Slimin; Hydrochlorothiazide; Esidrix; HydroDIURIL; Tolerzide; Oretic; Sectrazide; Triampur compositum; Spiridazide; Esidrex; Triampur (combination); Hypothiazide; Dihydrochlorothiazide; Hydrochlorothiazid;Hydrochlorothiazide; Dichlothiazide; Maxzide; Triampur; Hidroclorotiazida; Moducren	0.5623413252	-6.25	-25.7917264438	4	5		7.2619354879	-3.68560283	0.286344492	0.8191288615		SLC12A3	NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl	Specs	AN-153/I107325	-7.82601323	-9.38494624	-3.47975655	0.6715947	-3.68560283											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00510317-02	Elbasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1370468-36-2				-20.5540841663	4	4		0	-2.57024121					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C4C(=C3)O[C@H]([N]5C6=C(C=C(C=C6)C7=CN=C([NH]7)[C@@H]8CCCN8C(=O)[C@@H](NC(=O)OC)C(C)C)C=C45)C9=CC=CC=C9	MedChem Express	HY-15789	-5.933342	-6.11569538	1.13463772	-2.57024121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024622-05	Dantrolene sodium	170464793	Ryanodine receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	14663-23-1				-24.0720687378	4	5		0	-2.35246309			6261	RYR1	[Na+].[O-][N+](=O)c1ccc(cc1)c3ccc(/C=N/N2CC(=O)[N-]C2=O)o3	Enzo	AC100	-8.09295558	-6.29897529	-0.30653354	-3.84458263	-2.35246309											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166146-02	Quinestrol	170465054	Estrogen receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	152-43-2		12.5892541179	-4.9	-80.9453205039	-3	4		-104.8838860094	-95.97803826	0.1206299674	0.9909163403			C#C[C@]5(O)CC[C@@H]2[C@]5(C)CC[C@@H]3c4ccc(OC1CCCC1)cc4CC[C@@H]23	SIGMA	E7887	-4.24418102	-3.21734268	5.54795427	-95.97803826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373228-02	Fluorometholone Acetate	363678077		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	3801-06-7				-3.8975874661	4	4		0	-2.26589394					C[C@H]\1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)\C=C/C(=O)/C=C14	Selleck	S4228	0.14277062	-2.77001161	-0.90479763	-2.26589394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159340-05	Tazobactam sodium	170465148	Bacterial beta-lactamase TEM Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	89785-84-2				-3.2412491767	4	5		0	1.86693511					[Na+].O=S3(=O)[C@@](C)(Cn1ccnn1)[C@@H](N2C(=O)C[C@H]23)C([O-])=O	Prestwick	Prestw-1349	-0.39017975	-1.73700463	-2.21794048	-1.64329535	1.86693511											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253593-01	Bitolterol	170465239	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	30392-40-6		1.1220184543	-5.95	-15.2257484574	4	5		11.036934012	-4.49270782	0.2260090176	0.9674636493			O=C(Oc2cc(ccc2OC(=O)c1ccc(C)cc1)C(O)CNC(C)(C)C)c3ccc(C)cc3	GVK	FFS-11-286-NCI-028	-7.94744501	-5.54981486	-4.64179366	4.58898824	-4.49270782											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094812-05	Acetarsol	170466503		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	97-44-9				-33.9099751273	4	5		0	-4.63719691					Oc1ccc(cc1NC(C)=O)[As](O)(O)=O	Microsource	01500616	-9.63365574	-5.40342719	-7.35680504	-5.23353456	-4.63719691											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253592-01	Menadiol	170465455	regulation of blood coagulation Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	481-85-6				-6.1313187289	4	5		0	-1.80159841					Oc1cc(C)c(O)c2ccccc12	GVK	FFS-11-286-NCI-27	-0.25250364	-4.5509343	-0.38535645	-1.239163	-1.80159841											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263544-01	Dexrazoxane hydrochloride	170464709	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	24584-09-6	Dexrazoxane hydrochloride;Dexrazoxane Hydrochloride			-24.9811417356	4	5		0	-6.77744164			7153	TOP2A	O=C2CN(C[C@H](C)N1CC(=O)NC(=O)C1)CC(=O)N2	Tocris	3857	-7.42531884	-4.08593817	-6.27955859	1.57505333	-6.77744164											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016278-10	Mefenamic acid	170464813	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	61-68-7				-26.470969717	4	5		0	-2.29827968					O=C(O)c2ccccc2Nc1cccc(C)c1C	Vitas	STK666691	-8.6065223	-7.60785327	-5.23734454	0.26780446	-2.29827968											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015321-11	Dobutamine	170465050	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	34368-04-2	 ; Dobutamine, (-)-Isomer;Dobutamine hydrochloride; Dobutamine hydrochloride;Dobutamine; Dobutamina; Dobutaminum; Dobutamine HCl; Dobutamine (+)-Isomer			-24.3689548768	4	5		0	-1.54662762			153	ADRB1	Oc2ccc(CCNC(C)CCc1ccc(O)cc1)cc2O	Tocris	0515	-5.21262604	-7.32973066	-5.48062513	-6.5687993	-1.54662762											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249898-01	Sodium 3, 4-dimethylphenyl-glyoxylate	170465549		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	81632-85-1				-35.7153871735	4	5		0	-6.21396541					[Na+].Cc1ccc(cc1C)C(=O)C([O-])=O	GVK	FFS-11-286-NCI-75	-8.43928102	-5.67421513	-7.44166131	-8.94390885	-6.21396541											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162445-05	Misoprostol	225144248	Prostanoid EP3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	59122-46-2				2.1960331513	4	5		0	-0.13727464					CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	Prestwick	Prestw-1443	1.89829022	-0.69909075	-0.66795119	-0.38124452	-0.13727464											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018258-10	Econazole nitrate	170465422	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	24169-02-6	; Pevisone; Spectazole;Econazole nitrate;ECONAZOLE NITRATE; Econazole nitrate salt	12.5892541179	-4.9	-99.8589351702	-3	5		-100.5953595972	-92.12043562	0.0001355785	0.9999322158			[O-][N+](=O)O.Clc3ccc(C(OCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501185	-7.28189391	-7.50128667	-8.0753586	-9.46099912	-92.12043562											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166217-02	1-Bromoheptadecafluorooctane	170465144		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	423-55-2				-5.5888672286	4	5		0	0.22879107					FC(F)(C(F)(F)C(Br)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	SIGMA	343862	-0.77597545	1.40247041	-3.42539071	-4.15863278	0.22879107											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015437-17	Fenofibrate	170464718	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	49562-28-9	; Fenofibrato; Tricor; ;FENOFIBRATE; Fenofibrate;Fenofibrate; Lipofene; Lipantil; Procetofen; Fenofibrate micronised			-7.8601930201	4	5		0	-6.25057198			5465	PPARA	O=C(c1ccc(Cl)cc1)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2	Microsource	01501010	1.03024989	-1.45393721	-1.87540141	-3.96581946	-6.25057198											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016549-05	Dosulepin hydrochloride		Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	897-15-4		11.220184543	-4.95	-14.1777519005	4	4		-20.292997136	-16.49416428	0.1050842344	0.9931636846			CN(C)CC\C=C1/C2=C(CSC3=C1C=CC=C3)C=CC=C2	Prestwick	Prestw-488	0.27010543	-1.33748318	-2.29549612	-16.49416428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346540-03	FESOTERODINE FUMARATE		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	286930-03-8				-22.6600245676	4	4		0	-4.90200396				CHRM1	CC(C)N(CC[C@H](C1=CC=CC=C1)C2=C(OC(=O)C(C)C)C=CC(=C2)CO)C(C)C	Microsource	01504374	-5.68964015	-4.61810229	-1.77280251	-4.90200396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249611-04	Ixazomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1072833-77-2		0.316227766	-6.5	-266.9967897368	-1.1	4		-89.8066007743	-98.56419291	0.0277424767	0.9995250742		PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Selleck	S2180	-25.30277947	-87.55888291	-96.58942417	-98.56419291												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018113-07	Sodium 4-phenylbutyrate	170465108	Glutamine Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	1716-12-7				-4.8456454408	4	5		0	-4.66428862					[Na+].[O-]C(=O)CCCc1ccccc1	Microsource	00306001	-0.68903535	1.10651856	-0.43790506	-0.78525714	-4.66428862											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182988-01	Acreozast	144206850		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	123548-56-1	Acreozast; Acreozst; Adeozast; 			-24.1557359619	4	5	LS-172573;Acetamide, N,N'-(2-chloro-5-cyano-1,3-phenylene)bis(2-(acetyloxy))-;Acreozst;CIPLUS_706509;TYB-2285;TYB 2285;Acreozast;acreozast;Adeozast;ACREOZAST;acreozastum;3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile;	0	-4.45658554					Clc1c(cc(cc1NC(=O)COC(C)=O)C#N)NC(=O)COC(C)=O	Pharmaron	PH-NIH-154940	-7.16853548	-6.50564023	-5.33368366	1.06667877	-4.45658554											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	56776-01-3				-31.8669274142	4	5		0	-4.70944146					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-10.21569802	-3.36261087	-7.0590296	-3.02755209	-4.70944146											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094985-05	Zoalene	170465727		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	148-01-6				-22.2647745915	4	5		0	-3.50507916					Cc1c(cc(cc1[N+](=O)[O-])[N+]([O-])=O)C(N)=O	Vitas	STK395739	-6.00175362	-1.87424944	-2.81738386	-7.4890447	-3.50507916											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016896-06	Amrinone	170465367	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	60719-84-8				-9.2820088353	4	5		0	0.70467649					NC1=CC(=CNC1=O)c2ccncc2	Microsource	01503084	-1.84568172	-2.70629611	-3.69942197	-2.73006135	0.70467649											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016876-12	Albendazole	170464897	Tubulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	54965-21-8		0.6309573445	-6.2	-69.6367043955	-1.2	5		-30.061997152	-32.18632745	0.0013265216	0.9993368874			O=C(OC)Nc1nc2cc(ccc2n1)SCCC	Vitas	STK387550	-2.96799649	-4.23314462	-21.1603511	-31.94127958	-32.18632745											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346565-04	Elvitegravir		HIV Integrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	697761-98-1		10	-5	-80.6007475643	-3	4		-55.9466257159	-60.20305896	0.0944462806	0.9944596533			COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	MedChem Express	HY-14740	-9.98961668	-5.24753753	-9.19362669	-60.20305896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384190-03	(S)-Crizotinib		HGFR (MET; c-Met) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1374356-45-2		12.5892541179	-4.9	-101.1633446885	-3	4		-103.9430471782	-99.86491786	0.0405799757	0.9989829866		MET	C[C@H](OC1=CC(=CN=C1N)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C=CC(=C4Cl)F	Axon Medchem	2296	-7.76585619	-4.75719386	-4.81528887	-99.86491786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094916-06	Suprofen	170465412	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	40828-46-4				-1.3510637158	4	5		0	3.99926787			5743	PTGS2	O=C(c1ccc(cc1)C(C)C(=O)O)c2cccs2	SIGMA	s9894	0.18851381	-2.98936353	-0.75358596	-2.96669588	3.99926787											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262960-01	Resocortol butyrate	170466824	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	76738-96-0	Resocortol			-24.869972379	4	5		0	-7.09252311					CCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-149	-4.83559842	-5.81145994	-3.79362021	-5.56091148	-7.09252311											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249922-01	Estriol benzoate diacetate	170465998		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	2508-47-6				-21.2148691084	4	5		0	-3.85284159					CC(=O)O[C@@H]4C5(C)CCC2C(CCc3cc(OC(=O)c1ccccc1)ccc23)C5C[C@H]4OC(C)=O	GVK	FFS-11-286-NCI-200	-3.64313897	-5.47692572	-3.49389852	-7.5942156	-3.85284159											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018099-09	Dyphylline	170465316	Xanthine Derivative	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	479-18-5	; Major Brand of Dyphylline;Diprophylline; Lufyllin; Dilin; Hauck Brand of Dyphylline; Dilor Brand of Dyphylline;Dyphylline; Dylix;DYPHYLLINE; Diprofilina; Diphylline			-21.5645447479	4	5		0	-1.99505811				XDH	OCC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Vitas	STK796769	-4.23060061	-5.88866015	-4.27317491	-7.33128834	-1.99505811											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159404-04	Sulisobenzone	170465489		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	4065-45-6				-3.1694784451	4	5		0	0.128123					OS(=O)(=O)c1cc(c(O)cc1OC)C(=O)c2ccccc2	Labotest	LT03210147	0.10960105	-1.16229199	-1.46435453	-2.33567046	0.128123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022043-06	Deoxycorticosterone acetate	170465334	Mineralocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	56-47-3				-22.7796084618	4	5		0	-6.41169349					CC(=O)OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	SIGMA	D7000	-7.17313888	-3.65591398	-2.54476493	-0.50031551	-6.41169349											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179344-04	Pivmecillinam			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	32886-97-8				-25.6214381368	4	4		0	-6.51008759					CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N3CCCCCC3)C2=O	SIGMA	SML0817	-5.55074846	-7.04546432	-2.37012844	-6.51008759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178778-07	DIETHYLCARBAMAZINE CITRATE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1642-54-2				-26.7095770024	4	4		0	-6.24863828					CCN(CC)C(=O)N1CCN(C)CC1	Microsource	01500242	-6.19105304	-3.32057293	-5.59209074	-6.24863828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167528-02	Alosetron hydrochloride	170465416	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	122852-69-1				-36.270752545	4	4		0	-9.3075951					Cl.Cc4ncnc4CN1CCc3c(C1=O)c2ccccc2n3C	Sequoia	SRP04894a	-8.97724323	-5.03247451	-4.10910535	-9.3075951												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532501-01	ARIPIPRAZOLE LAUROXIL		Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-12.763926639	4	4		0	-2.06544947					CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C4=C(Cl)C(=CC=C4)Cl)C=C12	Astatech	42552	-2.22808687	-5.16151232	-2.89093878	-2.06544947												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00179364-03	Ioversol	170464725		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	87771-40-2		2.5118864315	-5.6	-12.8972538387	4	4		10.479698056	-5.6821648	1	0.9833952864			OCC(O)CNC(=O)c1c(I)c(N(CCO)C(=O)CO)c(I)c(c1I)C(=O)NCC(O)CO	Prestwick	Prestw-878	-5.2479017	-6.64974838	3.56181313	-5.6821648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182548-02	Flutropium bromide	170465904	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	63516-07-4				-16.9176384206	4	4		0	-3.94788444					[Br-].[Br-].C[N+]2(CCF)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(O)(c3ccccc3)c4ccccc4	APAC	871826	-4.30475037	-5.55722827	1.30202586	-3.94788444												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167462-03	Acamprosate Calcium	225144287		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	77337-73-6				-9.2667459136	4	4		0	-1.67327552					CC(=O)NCCC[S]([O-])(=O)=O	Bosche	A0044	-2.15021199	-2.09901501	-1.51388092	-1.67327552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174007-04	Pyrantel tartrate	170465676	Antiparasitic Agent	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	33401-94-4				-17.9843067405	4	4		0	-5.15055122					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2CCCN=C2/C=C/c1cccs1	Vitas	STK676402	-4.33070866	-2.36569315	-2.03469127	-5.15055122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095086-04	PERICIAZINE		Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	2622-26-6		15.8489319246	-4.8	-37.2078510743	4	4		-11.124020112	-14.205412	0.439552757	0.8601871645			OC1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(C=C24)C#N)CC1	Microsource	MS-01503936	-7.85238384	-5.66906103	-3.68539524	-14.205412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179669-04	Norethindrone	170464683		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	68-22-4				-10.351058476	4	5		0	-2.21700456					O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4	Prestwick Chemical, Inc.	Prestw-253	-4.17272961	1.65762508	-1.58521633	-1.43888158	-2.21700456											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181771-02	Ibutilide fumarate		K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	[122647-32-9]				-31.9721746334	4	4		0	-3.89565518					CCCCCCCN(CC)CCCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	Tocris	3908	-6.80293407	-7.57588569	-6.10949964	-3.89565518												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167448-02	Trepibutone	170465772	Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	41826-92-0				-15.2855963192	4	4		0	-4.83717716					CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(=O)O	Bosche	T5812	-1.92772162	-3.84712945	-5.52030457	-4.83717716												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00164613-08	Epalrestat		Aldose Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	82159-09-9				2.2358415465	4	4		0	0.51826898				AKR1B1	CC(=C/C1=CC=CC=C1)\C=C2/SC(=S)N(CC(O)=O)C2=O	MedChem Express	HY-66009	1.40889167	-2.70567346	1.44126178	0.51826898												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00387803-01	Atosiban		Oxytocin receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	90779-69-4				6.2693690377	4	4		0	2.93685756					CCOC1=CC=C(CC2NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(NC2=O)C(C)CC)C(C)O)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)C=C1	ChemieTek	CT-ATOS	1.78459612	0.20292551	0.85206671	2.93685756												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00274083-01	Loxiglumide	170465971	Cholecystokinin A receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	107097-80-3				-25.4452422936	4	4		0	-4.37937289					Clc1ccc(cc1Cl)C(=O)NC(CCC(=O)O)C(=O)N(CCCCC)CCCOC	SIGMA	SML0130	-5.55953126	-7.18694513	-2.84626541	-4.37937289												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00532500-01	GABAPENTIN ENACARBIL			DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-15.1389387668	4	4		0	-2.40995076					CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(O)=O	AdvChemBlocks	G-5813	-3.61839163	-3.03542741	-2.28426396	-2.40995076												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346691-02	Canagliflozin		SGLT-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	842133-18-0				-5.5667176629	4	4		0	-1.48570441				SCL5A2	CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O	Selleck	S2760	0.85428035	-1.37820242	-6.34517766	-1.48570441												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167781-12	CETIRIZINE HYDROCHLORIDE		Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	83881-52-1				-12.0182008392	4	4		0	-3.84382828				HRH1	OC(=O)COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3	Microsource	01505371	-1.54307183	-5.21687664	-1.80384336	-3.84382828												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00142423-06	Phlorizin		SGLT-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	60-81-1				-26.4803336828	4	4		0	-5.86507731				SCL5A2	OC[C@H]1O[C@@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(=CC(=C2)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Prestwick	Prestw-NAT-0295	-4.74550496	-4.97167498	-8.26686004	-5.86507731												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183365-02	ORNITHINE HYDROCHLORIDE		G-protein coupled receptor family C group 6 member A Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	70-26-8				-16.8928718957	4	4		0	-6.08102272			222545	GPRC6A	NCCCC(N)C(O)=O	Microsource	01504524	-3.08167099	-4.60810011	-2.47461929	-6.08102272												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00166414-11	Pemetrexed Disodium heptahydrate		Thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	150399-23-8				-34.5957459489	4	4		0	-9.04379373					NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Aobious	AOB2160	-4.96019322	-6.38369832	-13.95032632	-9.04379373												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00186014-02	Paliperidone	170464996	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	144598-75-4				-23.981538479	4	4		0	-5.5454781					CC=5N=C1[C@H](O)CCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34	Tocris	4493	-4.27140174	-7.70271413	-3.97933285	-5.5454781												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00181916-01	Sulfaethoxypyridazine	144206640		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	963-14-4	CIPLUS_157090; 			-33.9196497215	4	4	SULFAETHOXYPYRIDAZINE;sulfaethoxypyridazine;CIPLUS_157090;N-1-(6-ethoxy-3-pyridazinyl)sulfanilamide;	0	-4.03386024					O=S(=O)(Nc1ccc(OCC)nn1)c2ccc(N)cc2	FLUKA	02743	-7.93004741	-8.86953581	-3.63488035	-4.03386024												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00532499-01	ROMIFIDINE		Alpha-2B adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-7.4687073534	4	4		0	-3.34283493				ADRA2B	FC1=CC=CC(=C1N\C2=N\CCN2)Br	Enamine	EN300-177066	-0.559084	-2.94241989	-2.30239304	-3.34283493												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00185775-01	Salidroside	144207114	beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	10338-51-9				-16.7678667784	4	4		0	-4.05113587				APP	Oc2ccc(CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)cc2	Sinova	SL-02667	-2.07979247	-6.94174347	-3.42639594	-4.05113587												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00017074-02	Hydergine	144206902	Adrenergic receptor alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	8067-24-1				-24.178938099	4	4		0	-2.54815583					CS(=O)(=O)O.CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@H](C(=O)N5CCC[C@H]56)C(C)C)C7=O)C(C)C	Prestwick Chemical, Inc.	CAS-8067-24-1	-4.26245639	-7.80417688	-4.80420595	-2.54815583												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166000-04	Iohexol	170464962		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	66108-95-0				-18.4987166592	4	4		0	-5.73551006					OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCC(O)CO	Prestwick	Prestw-512	-3.26057787	-5.48744398	-3.25416969	-5.73551006												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00521082-01	Mebezonium Iodide			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	7681-78-9				-13.7805298654	4	4		0	-5.63185627					C[N+](C)(C)C1CCC(CC1)CC2CCC(CC2)[N+](C)(C)C	Toronto Research	M202535	-2.52705967	-3.35672614	-2.62871646	-5.63185627												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167460-03	Ceftizoxim·Na		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	68401-82-1				-25.7907101852	4	4		0	-8.75010797					[H][C@@]2(NC(=O)C(=N\OC)\C1=CSC(N)=N1)C(=O)N3C(=CCS[C@]23[H])C([O-])=O	Enzo	AC3053	-4.68288756	-6.47670584	-5.28462654	-8.75010797												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00389765-01	DIBEKACIN			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	34493-98-6				-25.0005416174	4	4		0	-4.97538222					NC[C@@H]1CC[C@@H](N)[C@H](O1)O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O	Microsource	01503114	-6.25726809	-6.02012345	-2.45649021	-4.97538222												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00179501-03	Aurantiamarin (Methyl Hesperidin)	225144305	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	11013-97-1	; Aurantiamarin; Hesperitin-7-rutinoside;Vitamin P; Hesperetin-7-Rutinoside;Methyl-Hesperidin;Hesperidin; Hesperetin 7 Rutinosid			-6.2779431349	4	4		0	-2.21128099					COC1=C(O)C=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-400	0.26388765	-2.34209859	-4.23313996	-2.21128099												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00159403-03	Nandrolone decanoate	26754490		DPI_SARS-CoV-2_General	2019_NPC-6_Tox		Nandrolone decanoate; Deca-durabolin; Retabolyl; Decadurobolin; Decadurabolin; Retabolil; Deca-Durabol; 			-29.8743358886	4	4	CIPLUS_152890;Decadurabolin;Nandrolone Decanoate;Decadurobolin;Retabolil;Retabolyl;17 beta-hydroxyestr-4-en-3-one 17-decanoate;Deca-durabolin;LS-64854;NCGC00159403-03;Nandrolone decanoate;NANDROLONE DECANOATE;nandrolone decanoate;19-nor-4-androstene-17 beta-ol-3-one 17-decanoate;19-nortestosterone decanoate;Deca-Durabol;	0	-4.87172843					[H]C1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCC	Labotest	LT01138619	-6.49879238	-5.25069756	-7.05221175	-4.87172843												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00094646-04	Dibenzothiophene	170465511	Cytochrome P450 2C9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	132-65-0				-23.5390834353	4	5		0	-3.44348294					c1cccc2sc3ccccc3c12	Vitas	STK367232	-7.5038155	-5.79784946	-3.90314898	-0.38312449	-3.44348294											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179382-03	Hexylcaine hydrochloride	170465088	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	532-76-3				-22.9869137583	4	5		0	-6.89593328					Cl.CC(CNC1CCCCC1)OC(=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-788	-7.0289978	-5.98709677	-3.65617006	2.78103308	-6.89593328											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159412-04	Tromethamine	170464686	calcium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	77-86-1				-24.6932644198	4	5		0	-4.8962023					OCC(N)(CO)CO	Labotest	LT03329109	-6.95268781	-9.10967742	-2.80056452	0.26593347	-4.8962023											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016959-06	Ciprofloxacin	170464757	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	93107-08-5	 ;CIPROFLOXACIN; Bay0986; Ciprofloxacin hydrochloride; Bay 0986; Cipro IV;Ciprofloxacin; Ciprobay; Cipro; Ciprofloxacino; Ciprofloxacin Lactate; Ciprofloxacin Hcl; Ciprinol; Ciloxan;Ciprofloxacin hydrochloride; Bay-09867; Ciprofloxacin Base			-32.2092628806	4	5		0	-4.21467964			7155	TOP2B	Cl.O=C(O)C2=CN(c1cc(c(F)cc1C2=O)N3CCNCC3)C4CC4	Vitas	STK021082	-9.29286078	-10.06451613	-4.8734233	-1.97872532	-4.21467964											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00142384-03	Cholic Acid		Bile acid receptor FXR Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	81-25-4				-31.3340358899	4	5		0	-7.42501009					C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	C1129	-8.90283195	-8.44731183	-4.26479668	-0.55440368	-7.42501009											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091051-04	4-Aminobenzoic acid	170466660	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	150-13-0				-19.9906294873	4	5		0	-6.70761781					OC(=O)c1ccc(N)cc1	Specs	AE-562/J257681	-5.36713583	-5.26451613	-2.37717209	0.45524204	-6.70761781											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179460-03	Medrysone	170465194	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2668-66-8				-10.2844598083	4	5		0	-0.40353316					CC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3[C@@H](C)C[C@H]12	Prestwick Chemical, Inc.	Prestw-743	-4.6379515	-5.16989247	-0.53365088	3.72757595	-0.40353316											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183049-01	Zelandopam	144206852		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	139233-53-7	ZELANDOPAM; 	0.7943282347	-6.1	-17.3753875277	4	5	ZELANDOPAM;CIPLUS_3879393;zelandopamum;	10.8301678799	-13.76496435	0.036269094	0.9991996365			Cl.Oc1ccc(cc1O)[C@H]3CNCc2c3ccc(O)c2O	Pharmaron	PH-NIH-155132	-7.7751399	-6.97634409	-2.29778601	2.43847471	-13.76496435											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094516-08	Coumaphos	170466302		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	56-72-4				-7.1530438694	4	5		0	1.21059947					CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	Microsource	00330012	-3.31524504	-3.69892473	-2.17429655	3.14162084	1.21059947											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016868-12	Acemetacin	170466043	Cyclooxygenase-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	53164-05-9	; ; Acemetacina; Rantudil;ACEMETACIN; Acemetacin;Acemetacin			-13.9733808496	4	5		0	-0.42146796			5742	PTGS1	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OCC(=O)O)c3C)OC	Microsource	01500666	-5.34169917	-4.39569892	-1.32751169	0.35608041	-0.42146796											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016257-10	4-Dimethylaminoantipyrine	170465863		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	58-15-1				-16.6035471376	4	5		0	-4.6361476					CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Microsource	01500621	-4.52772596	-4.12903226	-3.52385993	0.86991797	-4.6361476											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249926-01	Pirmenol	170466004		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	68252-19-7				-29.9546791441	4	5		0	-7.42501009					C[C@H]3CCC[C@@H](C)N3CCCC(O)(c1ccccc1)c2ccccn2	GVK	FFS-11-286-NCI-216	-8.28387316	-6.00430108	-5.79077357	-1.14035878	-7.42501009											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015860-06	Prilocaine hydrochloride	170464697	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1786-81-8				-18.4528269636	4	5		0	-5.34457248					Cl.O=C(Nc1ccccc1C)C(C)NCCC	Microsource	01503270	-3.84093607	-5.40215054	-2.13901385	-2.95231227	-5.34457248											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253737-01	Istradefylline	174007485	Adenosine A2A Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	155270-99-8	Istradefylline	0.4466835922	-6.35	-18.9725120736	4	5		9.9361290279	-2.044568	0.2742788807	0.8273661938	135	ADORA2A	COc1ccc(cc1OC)/C=C/c3nc2c(C(=O)N(CC)C(=O)N2CC)n3C	GVK	FFS-12-73-NCI-1738	-8.38561981	-8.69677419	1.04525007	4.94455963	-2.044568											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	51773-92-3		12.5892541179	-4.9	-100.9468930098	-3	5		-103.8836606957	-99.68165718	0.0071991934	0.9963813599		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-9.275903	-5.80645161	-4.85578195	-2.55566574	-99.68165718											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018218-10	Edaravone	170465935	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	89-25-8	;MCI-186; Developer Z; N-demethylantipyrine; Radicut;1-Phenyl-3-methyl-5-pyrazolone			-24.6529668649	4	5		0	-2.48397077				NT5E	O=C2CC(C)=NN2c1ccccc1	Vitas	STK201315	-8.41953536	-6.90752688	-4.32654141	0.96006491	-2.48397077											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163700-12	Vincristine sulfate	404904683		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	[2068-78-2]		6.3095734448	-5.2	-132.5764449078	-2.4	5		-85.0214014184	-71.00390082	0.1444424135	0.9189134888			CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]67[C@H]89)C(=O)OC)C1	Tocris	1257	-8.91978972	-20.59354839	-33.54061921	-35.94609213	-71.00390082											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094619-06	Chloramphenicol sodium succinate	170465429	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	982-57-0				-17.1157653769	4	5		0	-1.76657849					[Na+].O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](COC(=O)CCC([O-])=O)NC(=O)C(Cl)Cl	SIGMA	C3787	-5.89282686	-4.33548387	0.15436182	-2.78103308	-1.76657849											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021575-05	Fluorometholone	170464629	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	426-13-1				-17.9404779803	4	5		0	-3.93669013					CC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-718	-5.5960658	-2.74408602	-2.57122696	-1.29360858	-3.93669013											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181784-01	Iloprost	144207135	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	78919-13-8	Iloprost; 			-19.5611376155	4	4	LS-101845;ZK 3637;i1oprost;iloprostum;ZK 36 374;ZK-36374;ZK-00036374;Ventavis;ZK3637;CIPLUS_190653;Iloprost;(5E)-5-((3AS,4R,5R,6AS)-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYLOCT-1-EN-6-YN-1-YL)HEXAHYDROPENTALEN-2(1H)-YLIDENE)PENTANOIC ACID;CIPLUS_191919;Pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-;ILOPROST;VENTAVIS;5-((E)-(1S,5S,6R 7R)-7-HYDROXY-6((E)-(3S,4RS)-3-HYDROXY-4-METHYL-1-OCTEN-6-INYL)-BICYLO (3,3,0)-OCTAN-3-YLIDENE)-PENTANOIC ACID;CoTherix Brand of Iloprost;PENTANOIC ACID, 5-((3AS,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-2(1H)-PENTALENYLIDENE)-, (5E)-;	0	-5.42171328					O[C@@H]2C[C@@H]1C/C(C[C@@H]1C2/C=C/[C@@H](O)C(C)CC#CC)=C\CCCC(=O)O	Tocris	Tocris-2038	-3.81632831	-4.88728129	-3.35830647	-5.42171328												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532507-01	INOSITOL NIACINATE			DPI_SARS-CoV-2_General	2019_NPC-9_Tox					-10.7553015704	4	4		0	-3.96828892					O=C(O[C@@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C3=CC=CN=C3)[C@@H](OC(=O)C4=CN=CC=C4)[C@H](OC(=O)C5=CC=CN=C5)[C@H]1OC(=O)C6=CC=CN=C6)C7=CC=CN=C7	SIGMA	MFCD00006387	-3.06700357	-0.88324361	1.72053315	-3.96828892												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00179611-05	DIHYDROSTREPTOMYCIN [5mM]		Large-conductance mechanosensitive channel Modulator	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	128-46-1				-34.8296147462	4	4		0	-4.44395508			947787	mscL	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	Microsource	01500249	-9.15744533	-6.9397712	-4.68246363	-4.44395508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015999-19	Tolbutamide	170465238	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	64-77-7				-14.9858232923	4	5		0	-4.67648943					Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC	Enzo	AC117	-2.72249014	-0.20157832	-3.37400985	-5.63978966	-4.67648943											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00378622-03	Osimertinib mesylate		EGFR (Thr790Met Mutant) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1421373-65-0		11.220184543	-4.95	-94.4121836244	-2.1	4		-117.9402988745	-99.50760382	0.0420664838	0.9989070073		EGFR	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C	Axon Medchem	2342	-2.46171152	-6.33145512	-13.34245487	-99.50760382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263546-01	Moexipril hydrochloride	170465131	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	82586-52-5				-10.4042115737	4	4		0	-5.22027104					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O	Tocris	2691	-0.98208878	-1.04090499	-4.67405217	-5.22027104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185754-01	Terlipressin	144206925	Vasopressin V1a Receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	14636-12-5		0.3548133892	-6.45	-35.0930459074	4	4		11.050426548	-2.99795198	0.2394683775	0.9634542348		AVPR1A	NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N3	Sequoia	TERLIPRESSIN	-11.46058666	-4.12920986	-1.00189787	-2.99795198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509864-02	ORNIPRESSIN			DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-24.8620074937	4	4		0	-9.42960478					NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O	MedChem Express	HY-P0083_cm1	-4.35666695	-5.20452493	-4.36509688	-9.42960478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271513-02	Lofexidine	170466275	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	31036-80-3				-36.0949244368	4	4		0	-6.26606824					Clc2cccc(Cl)c2OC(C)C1=NCCN1	Prestwick	Prestw-1430	-10.13671368	-3.65607123	-4.25034206	-6.26606824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159322-14	ANCITABINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	10212-25-6		2.5118864315	-5.6	-65.5513158956	4	4		-22.716838504	-30.13638939	0.0587662953	0.9978684592			[H][C@]1(CO)O[C@@]2([H])N3C=CC(=N)N=C3O[C@@]2([H])[C@]1([H])O	Microsource	01504137	-7.03902397	-8.53370037	-27.30723397	-30.13638939												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183654-01	Etidocaine	144206521	Sodium channel protein type II alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	36637-18-0				-0.198835874	4	4	LS-45490;etidocaine;2',6'-Butyroxylidide, 2-(N-ethylpropylamino)-, hydrochloride, (+-)-;W-19053;etidocainum;DURANEST;CIPLUS_178862;CIPLUS_178863;BUTANAMIDE, N-(2,6-DIMETHYLPHENYL)-2-(ETHYLPROPYLAMINO)-, (+/-)-, MONOHYDROCHLORIDE;CIPLUS_183648;ETIDOCAINE HYDROCHLORIDE;Etidocaina;Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+-)-;Etidocaine;LS-178540;w-19053;2-(Ethylpropylamino)-2',6'-butyroxylidide;LS-48494;W1905;Duranest;W 1905;ETIDOCAINE;BUTANAMIDE, N-(2,6-DIMETHYLPHENYL)-2-(ETHYLPROPYLAMINO)-, (+/-);(+-)-n-(2,6-dimethylphenyl)-2-(ethylpropylamino)butanamide;Etidocainum;	0	-2.27460892					O=C(Nc1c(C)cccc1C)C(CC)N(CC)CCC	ACC		0.61867267	-0.25807562	0.14565035	-2.27460892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262907-01	Bilastine	170466329		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	202189-78-4	Bilastine;Bilastinum			-19.2654578467	4	4		0	-5.98718898					O=C(O)C(C)(C)c4ccc(CCN1CCC(CC1)c3nc2ccccc2n3CCOCC)cc4	GVK	FFS-12-73-NCI-1870	-3.33564074	-4.68837369	-4.28565123	-5.98718898												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015595-14	Labetalol HCl		Adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	32780-64-6				-23.8546761457	4	4		0	-8.64525687					CC(CCC1=CC=CC=C1)NCC(O)C2=CC(=C(O)C=C2)C(N)=O	APExBIO	B4795	-5.86224799	-2.28827046	-1.17844375	-8.64525687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179332-03	Naftifine hydrochloride	170464903	Squalene monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	65473-14-5		7.9432823472	-5.1	-19.24808624	4	4		-9.660638812	-9.71719901	0.5107847906	0.7976999887	3646509		Cl.CN(C\C=C\c1ccccc1)Cc3cccc2ccccc23	Prestwick	Prestw-1063	-3.88941767	0.76562433	-3.70304983	-9.71719901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181037-03	Isoflurane		Glycine receptor Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	26675-46-7				-16.374279476	4	4		0	-1.45540111					FC(F)OC(Cl)C(F)(F)F	SigmaAldrich	CPX6609	-5.23059618	-1.60867134	-1.15196187	-1.45540111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263531-05	Linezolid		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	165800-03-3				-21.7598724746	4	4		0	-3.05895682				MAOA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Selleck	S1408	-6.16509475	-3.01088219	-2.32599197	-3.05895682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389662-01	Luteinizing hormone releasing hormone human acetate salt (LHRH)		Putative gonadotropin-releasing hormone II receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	71447-49-9				-25.5110706537	4	4		0	-2.82365245				GNRHR2	CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC2=C[NH]C3=CC=CC=C23)NC(=O)C(CC4=CN=C[NH]4)NC(=O)C5CCC(=O)N5)C(=O)NC(CCCN=C(N)N)C(=O)N6CCCC6C(=O)NCC(N)=O	APExBIO	A1147	-6.63234403	-6.35726268	-2.89093878	-2.82365245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179341-04	Ondansetron	170464701	5-HT3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	99614-02-5	; ; Ondansetron, (R)-Isomer; Zofran;Ondansetron hydrochloride; Methoxamine HCl;Ondansetron Hydrochloride; Zofran ODT; Ondansetron, (S)-Isomer; Ondansetron; Ondansetron, (+,-)-Isomer			-19.8664900262	4	4		0	-3.27683123			3359	HTR3A	O=C1C(CCc3c1c2ccccc2n3C)Cn4ccnc4C	Prestwick	Prestw-1058	-5.72380376	-3.8969418	-0.11034117	-3.27683123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181080-01	Phenacaine hydrochloride	144206789	"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	620-99-5	phenacaine hydrochloride; Fenacaina; 			-6.4716095087	4	4	Phenacainum;phenacaine hydrochloride;Phenacaine (N,N'-bis-(4-ethoxy-phenyl)-acetamidine);phenacainum;CIPLUS_150668;PHENACAINE;Phenacaine hydrochloride;Acetamidine, N,N'-bis(p-ethoxyphenyl)-, hydrochloride;phenacaine;LS-10332;CIPLUS_155428;PHENACAINE HYDROCHLORIDE;Phenacaine;LS-176183;Phenacaine Hydrochloride;CIPLUS_743918;Fenacaina;	0	-2.03930454			5136	PDE1A	Cl.CCOc1ccc(cc1)NC(\C)=N\c2ccc(OCC)cc2	NCI	NSC-9293	-0.71385308	-0.03441008	-4.43571523	-2.03930454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242497-12	Vismodegib		Hedgehog Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	879085-55-9				-4.3692279262	4	4		0	-1.21138176				SHH	C[S+]([O-])(=O)C1=CC=C(C(=C1)Cl)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC=CC=C3	ActiveBioChem	A-1113	-0.28986761	-1.37640329	-2.52019243	-1.21138176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378631-01	Boceprevir		"Hepatitis C virus serine protease, NS3/NS4A Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	394730-60-0				-23.4193026428	4	4		0	-5.0459715					CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C	MedChem Express	HY-10237	-4.91909665	-4.72278378	-5.41554486	-5.0459715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389454-01	IMEXON		Ribonucleoside-Diphosphate Reductase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	59643-91-3				-19.1659117721	4	4		0	0.44446381				RRM1	N=C1NC(=O)N2CC12	Microsource	01506181	-5.6632344	-3.44961074	-1.12547998	0.44446381												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00090957-05	Octanoic acid		Solute carrier family 22 member 8 Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	124-07-2		1	-6	-16.4100162104	4	5		9.5854966439	-4.58905053	0.1874209342	0.978024501			CCCCCCCC(O)=O	SIGMA	C2875	-6.3271061	-7.98791387	-4.09009084	2.60414275	-4.58905053											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016064-12	Terfenadine	170465598		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50679-08-8		12.5892541179	-4.9	-98.3826359103	-3	5		-104.5908135627	-99.64664311	0.009722683	0.9951036058			CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01503708	-7.6401128	-7.01761852	-6.22514338	-0.68433381	-99.64664311											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182996-01	Pamicogrel	144206832	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	101001-34-7	KBT-3022; 	12.5892541179	-4.9	-35.2509004359	-3	4	KB-3022;KB 3022;pamicogrel;1H-Pyrrole-1-acetic acid, 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-, ethyl ester;LS-136537;CIPLUS_207912;PAMICOGREL;Pamicogrel;ETHYL 2-(4,5-BIS(P-METHOXYPHENYL)-2-THIAZOLYL)PYRROLE-1-ACETATE;pamicogrelum;ethyl 2-(4,5-bis(4-methoxyphenyl)thiazol-2-yl)pyrrol-1-ylacetate;KBT-3022;	-72.537582432	-62.3136688	0.0389243099	0.9990645316			O=C(OCC)Cn1cccc1c2nc(c(s2)c3ccc(OC)cc3)c4ccc(OC)cc4	Pharmaron	PH-NIH-151650	2.2927231	3.33075468	4.4938801	-62.3136688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182986-01	Acetylpheneturide	144206817		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	13402-08-9	ACETYLPHENETURIDE; Crampol; 			-14.2614043078	4	4	CIPLUS_669097;ACETYLPHENETURIDE;Crampol;Urea, 1-acetyl-3-(2-phenylbutyryl)-;Acetylpheneturide;LS-158754;acetylpheneturide;	0	-2.33535098					CCC(C(=O)NC(=O)NC(C)=O)c1ccccc1	Pharmaron	PH-NIH-148128	-3.89632904	-2.39384562	-1.2775842	-2.33535098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263831-02	NYSTATIN		Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	114-90-9				-26.4232010426	4	4		0	-8.69526522					C[C@@H]1OC(=O)CC(O)CC(O)CC(O)CCC(O)C(O)C[C@]2(O)CC(O)C(C(CC(OC3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H]1C)O2)C(O)=O	Microsource	01500446	-5.2146292	-6.66897028	-2.78499653	-8.69526522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389455-01	Penicillin G Sodium		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	69-57-8				-1.9395002033	4	4		0	-4.81488074					CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C([O-])=O	APExBIO	B1678	1.09410156	-3.45542502	1.83212058	-4.81488074												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508820-02	Dalfopristin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	112362-50-2				-25.0622710141	4	4		0	-2.92257657					CCN(CC)CC[S+]([O-])(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(=C\[C@@H](O)CC(=O)CC3=NC(=CO3)C2=O)C	MedChem Express	HY-A0241_cm1	-6.95618255	-5.32490975	-1.99231663	-2.92257657												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160383-02	Lenperone Hydrochloride		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	24677-86-9				-20.9855442597	4	4		0	-6.23887504					FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)C(=O)C3=CC=C(F)C=C3	Glixx	GLXC-06484	-3.99700004	-4.52660677	-4.22297297	-6.23887504												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388284-07	Darunavir (Ethanolate)		Hiv Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	635728-49-3				-27.8503315195	4	4		0	-6.31897472					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)[S+]([O-])(=O)C4=CC=C(N)C=C4	MedChem Express	HY-17041	-5.76167998	-8.79405667	-3.24410949	-6.31897472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188440-01	Zinc dibutyldithiocarbamate	144206589		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	136-23-2		12.5892541179	-4.9	-79.1418248895	-3	4	ZINC DIBUTYLDITHIOCARBAMATE	-108.5608807111	-99.64400142	0.0195739058	0.999763619			[Zn+2].[S-]C(=S)N(CCCC)CCCC.CCCCN(CCCC)C([S-])=S	APAC	878050	-1.64115234	-0.38873531	-0.29019404	-99.64400142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379052-01	Ticagrelor		Purinergic receptor P2Y12 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	274693-27-5		8.9125093813	-5.05	-97.2187637165	-3	4		-91.4647959729	-93.41402634	0.0413468548	0.9989441577			CCCSC1=NC(=C2N=N[N]([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)C2=N1)N[C@@H]4C[C@H]4C5=CC=C(F)C(=C5)F	MedChem Express	HY-10064	-7.19107072	-3.74913614	-9.17792793	-93.41402634												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024928-23	Tamoxifen	170465425	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	54965-24-1	Soltamox; "Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife	11.220184543	-4.95	-95.511514972	-3	4		-102.7731628878	-99.56183937	0.0100677449	0.9999374806	2099	ESR1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc1ccc(cc1)/C(c2ccccc2)=C(/CC)c3ccccc3	Microsource	01500557	-4.87582889	-5.67732508	-6.6916823	-99.56183937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183848-01	Troxacitabine	124894563	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	145918-75-8	Troxacitabine			-16.1020937329	4	4	2R(-)-cis-HMD-cytosine;Troxacitabine;LS-173247;LS-173246;LS-173400;TROXACITABINE;BCH-4556;BCH 4556, trans-(+-)-isomer;LS-173262;2'-DEOXY-3'-OXACYTIDINE,1'S,4'S,L-;BCH 4556, cis-(+-)-isomer;BCH 4556, (2S-trans)-isomer;BCH 4556, 2R(-)-cis-isomer;LS-173106;troxacitabine;CIPLUS_728716;troxacitabinum;CIPLUS_703293;	0	-4.62101364				POLB	OC[C@H]1OCC(O1)[N@@]2C=CC(N)=NC2=O	Pharmaron	PH-NIH-148677	-3.46292203	-5.92659446	0.48244438	-4.62101364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091066-01	3-Methylbutyl nitrite	144204625	vasodilation Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	110-46-3	Isoamyl nitrite	3.1622776602	-5.5	-15.9787100332	4	4	Vaporole;CIPLUS_151172;Isopentyl nitrite-15N;Amyl nitrite;Nitrite, Amy;Amyl Nitrite;Amyl nitrite II;AMYL NITRITE;Isoamyl nitrite;LS-505;Isoamyl nitrite-15N;Isopentyl alcohol, nitrite;Amyl nitrite I;CIPLUS_167285;Isopentyl nitrite;isoamyl nitrite;Aspiral;isopentyl nitrite;AB07944735-01;	9.634605468	-4.20543861	1	0.7529822645			CC(C)CCON=O	NIEHS	AB07944735	-4.20838209	-9.27883789	0.86661306	-4.20543861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271596-03	Exemestane	170464628	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	107868-30-4	Exemestane	0.2238721139	-6.65	-6.2309843735	4	4		9.3128556919	0.48059808	0.508012176	0.8004302006	1588	CYP19A1	O=C3C=C4C(=C)C[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)[C@@]4(C)C=C3	Tocris	3759	-4.84404641	2.9975812	5.27113652	0.48059808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091297-05	Anilinium nitrate	170465650		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	542-15-4				-18.3753458745	4	5		0	-0.22124893					O[N+]([O-])=O.[NH3+]c1ccccc1	Vitas	STK301792	-6.06436703	-6.35925256	-2.40847784	-1.19377241	-0.22124893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094906-06	Nefopam hydrochloride	170465579	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	23327-57-3		1.2589254118	-5.9	-22.1393226311	4	5		9.4305401	-5.78407911	0.3042056591	0.9391547394			Cl.CN1Cc3ccccc3C(OCC1)c2ccccc2	Microsource	01501137	-8.69211675	-5.92870059	-6.41093011	1.80200626	-5.78407911											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164603-04	Ebastine	170465995	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	90729-43-4		12.5892541179	-4.9	-96.1232472377	-3	5		-105.4430396839	-99.67489953	0.0194401515	0.9901372008	3269	HRH1	CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4	Sequoia	SRP00750e	-9.23136181	-1.65762508	-6.3233491	1.53874087	-99.67489953											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183017-01	Ethyl 4-nitrophenyl ethylphosphonate	144206877		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	546-71-4	Ethyl-p-Nitrophenyl Ethylphosphonate; Armin; Armine; 			-31.6450722948	4	5	ETHYL 4-NITROPHENYL-ETHYL PHOSPHONATE;Armine;p-Nitrophenyl-O-ethyl ethylphosphonate;ETHYL 4-NITROPHENYL ETHYLPHOSPHONATE;Ethyl 4-nitrophenyl ethylphosphonate;LS-106606;CIPLUS_208139;Ethyl-p-Nitrophenyl Ethylphosphonate;Ethyl 4-Nitrophenyl Ethylphosphonate;Armin;	0	-7.418612					[O-][N+](=O)c1ccc(OP(=O)(OCC)CC)cc1	Pharmaron	PH-NIH-183377	-8.72635453	-7.72840782	-4.2476791	-2.21052154	-7.418612											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178065-03	TENIPOSIDE		DNA Topoisomerase II Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	29767-20-2		12.5892541179	-4.9	-93.9655814058	-2.4	4		-58.4649268519	-62.76538079	0.1788537125	0.9797446754		TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@H](OC5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7)OC	Microsource	01504094	-9.46127508	-18.03764827	-14.71455374	-62.76538079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263905-04	TOLTRAZURIL			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	69004-03-1		2.8183829313	-5.55	-14.4771565556	4	4		10.8550799359	-8.4515313	1	0.9606400617			CN1C(=O)NC(=O)N(C1=O)C2=CC=C(OC3=CC=C(SC(F)(F)F)C=C3)C(=C2)C	Microsource	01505681	-5.24855892	-7.37923328	2.82319307	-8.4515313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015462-14	Glipizide	170465089	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	29094-61-9	; ; Glucotrol;Glipizide; Glipizide; Glypidizine; Glipizida; Samarium(III) ionophore I;GLIPIZIDE			-16.1140697047	4	4		0	-2.39859066				KCNJ8	Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3	Enzo	AC120	-4.13036883	-3.88946192	-1.50987224	-2.39859066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015898-15	Rolipram	170465962	Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	61413-54-5	; ;Rolipram; Rolipram; (R)-(+)-Rolipram; (S)-(-)-Rolipram			-20.8318473961	4	5		0	-1.09721407			5141	PDE4A	COc2ccc(cc2OC1CCCC1)C3CC(=O)NC3	Prestwick Chemical, Inc.	Prestw-924	-7.88752889	-1.95901145	-3.70467683	-2.03803731	-1.09721407											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253575-01	Arimoclomol	170465602	Heat shock 70 kDa protein 1 Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	289893-25-0				-11.1936806381	4	5		0	-2.00930149					O[C@H](CN1CCCCC1)CO\N=C(/Cl)c2ccc[n+]([O-])c2	GVK	FFS-11-286-NCI-145	-4.44663186	-0.56402308	-0.47293747	-1.0303663	-2.00930149											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091038-04	Sodium deoxycholate monohydrate	225144203		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	145224-92-6				-41.3413970118	4	5		0	-8.36658745					C[C@H](CCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	D5670	-11.48041377	-10.27096774	-6.09067655	-3.37600288	-8.36658745											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164593-02	Enalapril acid	170464938		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	76420-72-9		1.1220184543	-5.95	-14.4717677549	4	5		12.872307952	-3.68560283	0.028120182	0.9995172168			OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@H](CCc1ccccc1)C(=O)O	Sequoia	76420-72-9	-7.39358996	-7.22580645	-2.8799506	4.35860453	-3.68560283											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016311-19	Phentolamine mesilate	170464866	alpha-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	50-60-2	 Regitine;Phentolamine mesylate;Phentolamine;PHENTOLAMINE; ; Regitin;Phentolamine hydrochloride; Regitin mesylate; Vasomax;PHENTOLAMINE HYDROCHLORIDE; Phentolamine hydrochloride; Fentolamina;			-23.2953806747	4	5		0	-4.86033269			148	ADRA1A	Cc1ccc(cc1)N(CC2=NCCN2)c3cc(O)ccc3	Vitas	STK802099	-5.60454468	-8.99784946	-4.1854106	-0.0766249	-4.86033269											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091326-06	Acetanilide	170465493		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	103-84-4				-16.9072059294	4	5		0	-4.27745146					O=C(C)Nc1ccccc1	Vitas	STK046402	-4.92623368	-4.42150538	-3.52385993	1.40178491	-4.27745146											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166245-04	Proflavin hemisulfate	170466523	RNA Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1811-28-5		12.5892541179	-4.9	-91.2549375609	-3	5		-101.7459483647	-96.71344662	0.0028116619	0.9985914037			O=S(=O)(O)O.Nc1cc2nc3cc(N)ccc3cc2cc1.Nc1cc2nc3cc(N)ccc3cc2cc1	Vitas	STK380650	-5.84195354	-5.78924731	-2.97697804	-2.87118002	-96.71344662											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164590-02	Drospirenone	170464870	Synthetic progesterone	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	67392-87-4	 ; Drospirenone and estrogen;Drospirenone; Drospirenone; Yasmin; Drospirenona;DROSPIRENONE			-12.7574377081	4	4		0	-7.10542958			5241	PGR	O=C1CC[C@]6(O1)[C@H]2C[C@H]2[C@H]5[C@@H]7[C@H]3C[C@H]3C4=CC(=O)CC[C@]4(C)[C@H]7CC[C@@]56C	Sequoia	SRP04800d	-2.38807264	-1.71480144	-0.21441973	-7.10542958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178127-02	Ramipril	170464731	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	87333-19-5	;RAMIPRIL;Ramipril (Altace);Ramipril; Tritace; Altace; Ramipril and diuretics			-26.1245057167	4	4		0	-8.01788779			1636	ACE	O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@@H]3CCC[C@H]23)C(=O)O	Vitas	STK801937	-5.19655008	-5.82344851	-3.99356741	-8.01788779												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016403-06	Mafenide hydrochloride	170465055	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	138-37-4				-21.3249405931	4	5		0	-2.56919673					Cl.O=S(N)(=O)c1ccc(CN)cc1	Vitas	STK083032	-8.52092784	-5.06759666	-1.27868278	1.19377241	-2.56919673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249925-01	Tilmacoxib	170466033	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	180200-68-4		1.4125375446	-5.85	-19.9789217873	4	5		8.478601392	-7.69855962	0.4101669825	0.8813758193			Cc2nc(C1CCCCC1)c(o2)c3ccc(c(F)c3)S(N)(=O)=O	GVK	FFS-11-286-NCI-214	-8.31550116	-4.56815638	-5.99929935	1.95633426	-7.69855962											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179360-05	Tridihexethyl chloride		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	4310-35-4				-12.0011834431	4	4		0	-2.55348817					CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C2=CC=CC=C2	Prestwick	Prestw-1042	-3.29237691	-3.16572756	0.75473364	-2.55348817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344134-02	Limaprost			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	74397-12-9				-14.1575151725	4	4		0	-1.08065711					CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O	MedChem Express	HY-B0683	-4.00190361	-2.74420405	-1.73456327	-1.08065711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167432-05	Fosinopril·Na		Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	98048-97-6				-7.0162386795	4	4		0	-1.15037692					CCC(=O)O[C@@H](O[P](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C([O-])=O)C3CCCCC3)C(C)C	Enzo	DL155	-3.51734879	3.27756033	-1.60215386	-1.15037692												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00390656-02	Pimavanserin			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	706779-91-1		12.5892541179	-4.9	-109.4435071983	-3	4		-101.3464412529	-99.76033814	0.0517361438	0.9983455375			CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C3CCN(C)CC3)C=C1	MedChem Express	HY-14557	-10.08479709	-7.14869457	-5.90987333	-99.76033814												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183870-01	Ethoheptazine hydrochloride	144206778	Opioid receptors; mu/kappa/delta Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	5982-61-6				-26.8258155445	4	4	Equagesic;Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester;Ethoheptazinum;heptacyclazin;Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester, citrate;MEPROBAMATE;ERBULOZOLE ETHOHEPTAZINE;CIPLUS_213306;4-carbethoxy-1-methyl-4-phenylazacycloheptane;ethoheptazine citrate (1:1);ethylheptazine;CIPLUS_149424;LS-22816;ETHOHEPTAZINE CITRATE;ASPIRIN;ethoheptazine;LS-178547;LS-22817;1-methyl-1-carbethoxy-4-phenyl hexamethylenimine citrate;ethoheptazine HCl;ETHOHEPTAZINE;CIPLUS_165746;Etoheptazina;CIPLUS_675824;Ethoheptazine;ethoheptazinum;Ethoheptazine citrate;Ethoheptazine Citrate;	0	-7.31186544					Cl.CN1CCCC(CC1)(C(=O)OCC)c2ccccc2	NCI	NSC_400484	-6.19970581	-4.51632328	-3.39409454	-7.31186544												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165810-02	Indoramin hydrochloride	170466233	Alpha-1d adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	38821-52-2				-44.1836008032	4	5		0	-10.41456942					Cl.O=C(NC3CCN(CCc1cnc2ccccc12)CC3)c4ccccc4	SigmaAldrich	I2909	-12.46383165	-3.9243438	-6.6709484	-8.4092901	-10.41456942											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090793-05	NAPHTHALENE, ZONE REFINED	225144198	Metabolism of xenobiotics by cytochrome P450 Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	91-20-3				-22.9019257522	4	5		0	-4.09993594					C1=CC=C2C=CC=CC2=C1	SIGMA	147141	-4.99342394	-3.29816435	-5.72040248	-6.11305872	-4.09993594											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00165856-03	Orlistat	170464663	Fatty acid synthase inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	96829-58-2		12.5892541179	-4.9	-75.7497460298	-3	5		-73.1505395804	-70.30749086	0.029523391	0.9849074695		FASN	O=C(O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC)C(CC(C)C)NC=O	Sequoia	96829-58-2	-9.41966961	-5.3173168	-3.27552987	0.3948981	-70.30749086											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016637-10	Diloxanide furoate	170466783		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	3736-81-0		0.0446683592	-7.35	-33.359347642	4	5		12.270208788	-5.40479523	0.5526529564	0.5130308598			ClC(Cl)C(=O)N(C)c1ccc(cc1)OC(=O)c2ccco2	Microsource	01505532	-11.18291535	-3.77594076	-7.54072517	-0.95774136	-5.40479523											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094561-06	Phenothrin	170465585		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	26002-80-2				-31.9380914411	4	5		0	-11.03986996					C/C(C)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C	Microsource	01504098	-6.24411538	-7.03091363	-6.48975302	-3.79919205	-11.03986996											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159387-03	Laureth 10s	170465561		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	13081-34-0		0.0794328235	-7.1	-30.4368466953	4	5		11.477805728	-4.25791304	0.41619398	0.696678589			OCCOCCSCCCCCCCCCCCC	Labotest	LT00000347	-10.57519473	-4.86093171	-5.89420214	-0.17702329	-4.25791304											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018237-09	Trichlorfon	170465707	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	52-68-6				-25.0409515764	4	5		0	-4.67648943					OC(C(Cl)(Cl)Cl)P(=O)(OC)OC	Prestwick	Prestw-51	-6.63305568	-3.78709899	-4.35880968	-5.07887818	-4.67648943											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00093362-05	Betahistine mesylate	170465694	Histamine H3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	54856-23-4				-8.982262457	4	5		0	-3.86199323					CS(=O)(=O)O.CNCCc1ccccn1	Prestwick Chemical, Inc.	Prestw-543	-1.84568172	3.22954195	-1.01905374	-6.03418054	-3.86199323											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024257-08	Phenylephrine hydrochloride	170465356	alpha1-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	61-76-7	; Naldecon; Neosynephrine; Metaoxedrin;Phenylephrine hydrochloride; Glauko-Biciron; ; Neo Synephrin; Neooxedrine chloride;PHENYLEPHRINE HYDROCHLORIDE; Neo-synephrine; dimotapp L.A.; Metasympatol; Fenilefrina; (-)-m-Oxedrine; Tannate, Phenylephrin; Neo-Synephrine; Phenylephrine Hcl; Mezaton; Dimetapp; Ru-Tuss; Phenylephrine hydrochloride			-13.8061534128	4	5		0	-1.50086941			148	ADRA1A	Cl.O[C@@H](CNC)c1cc(O)ccc1	Microsource	01500483	-2.93292416	-2.02864985	-4.23035753	-4.10604733	-1.50086941											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090753-06	Azithromycin		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	83905-01-5	; Azithromycin hydrate; ADES azithromycin; N-desmethylazithromycin; Zitromax; Zithromax  (azithromycin); NDES azithromycin;Azithromycin (AZ);Azithromycin; Azithromycin (AZ); Azithromycin Hydrate			-27.8609957467	4	5		0	-6.99185504					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	FLUKA	57947	-6.80841736	-4.70492366	-1.72982231	-7.88343558	-6.99185504											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016747-07	Dilazep	170465831	Equilibrative nucleoside transporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	35898-87-4		10	-5	-44.7196155417	4	5		-23.9274131481	-23.74851286	0.0035947693	0.9982054162			COc1cc(cc(OC)c1OC)C(=O)OCCCN3CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC3	Enzo	AC640	-5.47566857	-6.11168296	-6.77371013	-11.17002629	-23.74851286											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094887-05	Fenoprofen calcium salt dihydrate	170465299	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	71720-56-4				-13.0326223435	4	5		0	-0.55825021					[Ca+2].O.O.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2	Microsource	01501011	-4.77422183	-0.25304512	-2.40633697	-2.72129711	-0.55825021											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021277-04	Hydrocortisone acetate	170466796		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50-03-3				-24.8109581917	4	5		0	-4.41109179					CC(=O)OCC(=O)[C@@]4(O)CCC3C2CCC1=CC(=O)CC[C@]1(C)C2[C@@H](O)C[C@@]34C	Prestwick	Prestw-1486	-8.21131083	-3.47829816	-3.14279598	-2.37072743	-4.41109179											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159458-05	Atorvastatin calcium	170465113	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	134523-03-8		12.5892541179	-4.9	-24.4990616641	4	5		-20.179652468	-17.56200238	0.0295568112	0.9849699658			[Ca+2].O[C@H](CCn1c(c(c(c1C(C)C)C(=O)Nc2ccccc2)c3ccccc3)c4ccc(F)cc4)C[C@@H](O)CC([O-])=O.[O-]C(=O)C[C@H](O)C[C@H](O)CCn4c(c1ccc(F)cc1)c(c2ccccc2)c(C(=O)Nc3ccccc3)c4C(C)C	Prestwick	Prestw-1232	-3.10828584	-1.16229199	-3.23699422	-3.62401402	-17.56200238											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167524-02	Amorolfine hydrochloride	170466078	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	78613-35-1	 ;Amorolfine Hydrochloride;Amorolfine; Amorolfine; Amorolfine [USAN:BAN:INN];Amorolfine hcL; Loceryl; Pekiron			-15.7232228235	4	4		0	-2.67341995					C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H](C)O2	Sequoia	SRP0563571a	-5.14071622	-0.08411844	-0.77097308	-2.67341995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386216-07	Indacaterol (maleate)			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	753498-25-8				-26.5055845042	4	4		0	-6.1880643					CCC1=CC2=C(CC(C2)NC[C@H](O)C3=CC=C(O)C4=C3\C=C/C(=O)N4)C=C1CC	MedChem Express	HY-14299A	-6.30826871	-5.53499327	-2.72236258	-6.1880643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186637-01	Chromomycin A<SUB>3</SUB> from Streptomyces griseus	124897824		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	7059-24-7				-24.2964494525	4	4	CHROMOMYCIN A3	0	-3.26359833					CO[C@H]1[C@@H](O)CC(O[C@H]1C)O[C@H]2CC(O[C@@H](C)[C@H]2OC(C)=O)OC3=CC4=CC5=C(C(=C4C(=C3C)O)O)C(=O)[C@@H](OC6C[C@@H](OC7C[C@H](OC8C[C@](C)(O)[C@@H](OC(C)=O)[C@H](C)O8)[C@@H](O)[C@H](C)O7)[C@H](O)[C@@H](C)O6)[C@@H](C5)[C@@H](OC)C(=O)[C@@H](O)[C@H](C)O	BIOMOL	GR302	-6.68293108	-6.99024226	0.13502918	-3.26359833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253646-01	Agomelatine	174006904	5-HT2C Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	138112-76-2	Agomelatine			-6.4906984188	4	5		0	-0.27543234			3358	HTR2C	CC(=O)NCCc1cccc2ccc(OC)cc12	GVK	FFS-12-73-NCI-2563	-2.58067277	-0.80513218	-2.48730075	1.14838183	-0.27543234											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016270-09	Levodopa	225144176	Dopamine Precursors	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	59-92-7	 beta Hydroxytyrosin; Dopaflex; 3-Hydroxy-DL-tyrosine; 3,4 Dihydroxyphenylalanin; DL-Tyrosine, 3-hydroxy-; Dihydroxyphenylalanine; DL-3-Hydroxytyrosine; ;L-3,4-Dihydroxyphenyl-alanine; Levopa; Sinemet CR4;LEVODOPA; L-3-Hydroxytyrosine; 3 Hydroxy DL tyrosin; Sinemet CR; Roberts Brand of Levodopa; 3 Hydroxy L tyrosin; Levodopa;L-3,4-Dihydroxyphenylalanine; beta-Hydroxytyrosine; Ro 8-0576-12;Levodopa; 3-Hydroxy-L-tyrosine;L-Dopa; Nakom; Larodopa; L-DOPA-ring-d3; Dopar; Maipedopa; Roche Brand of Levodopa; Ro 8-0576-7; L Dop; Ro 8-0576; D-3-Hydroxytyrosine			4.7015678541	4	5		0	3.03878629				DRD1	N[C@@H](CC1=CC(=C(O)C=C1)O)C(O)=O	Enzo	AC1036	-3.52221176	-1.70068027	-1.99684708	0.24057011	3.03878629											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00179619-06	Erythromycin propionate	170465433	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	134-36-1				-13.049308334	4	4		0	-3.80844481					CCC(=O)O[C@@H]3[C@H](C[C@@H](C)O[C@H]3O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C	Microsource	01500280	-2.15021199	-4.32706783	-2.41426491	-3.80844481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181101-01	Isothipendyl hydrochloride	144206270	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1225-60-1	Isothipendyl hydrochloride; Andantol; Isotipendilo; Adanton hydrochloride; 			-32.9583502792	4	4	ISOTHIPENDYL HYDROCHLORIDE;isothipendylum;isothipendyl;Isotipendilo;LS-133223;N,N,alpha-trimethyl-10H-pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine;LS-133221;Isothipendyl;CIPLUS_157919;CIPLUS_213648;Andantol;10H-Pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine, N,N,alpha-trimethyl-;Isothipendylum;Isothipendyl hydrochloride;Adanton hydrochloride;ISOTHIPENDYL;CIPLUS_694884;10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-dimethylamino-2-methylethyl)-, hydrochloride;10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-(dimethylamino)propyl)-;Isothipendyl Hydrochloride;	0	-7.38158525					Cl.CN(C)C(C)CN1c3ccccc3Sc2cccnc12	NCI	NSC-169186	-7.93025872	-5.4453955	-4.84177076	-7.38158525												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016360-06	Monobenzone	170464724	topical medical depigmentation treatment	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	103-16-2	; ; 4-(Benzyloxy)phenol;4-(Benzyloxyl)phenol; 4-(Benzyloxyl)phenol; Benoquin;MONOBENZONE;Monobenzone; Monobenzona; Novo-depigman; ICN brand of monobenzone			-23.3440878776	4	5		0	-3.68811202				TYR	Oc2ccc(OCc1ccccc1)cc2	Microsource	01503031	-5.75624726	-4.80785727	-2.64611432	-6.72655565	-3.68811202											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015073-05	Amifostine	170465179	Alkaline phosphatase placental-like Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	20537-88-6				-33.7724150497	4	5		0	-6.90949025					OP(=O)(O)SCCNCCCN	Prestwick	Prestw-1489	-8.8338448	-7.07239664	-7.23613787	-5.1051709	-6.90949025											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00013109-03	Phenol red	170465805	amyloid fibril formation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	143-74-8				-26.7699590576	4	5		0	-6.68069919					Oc1ccc(cc1)C3(OS(=O)(=O)c2ccccc23)c4ccc(O)cc4	Labotest	LT00455865	-4.47610697	-5.98301595	-5.7889103	-7.50657318	-6.68069919											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014925-06	Topotecan hydrochloride	170465137	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	119413-54-6	; Hycamtamine; Topotecane; Nogitecan hydrochloride;Nogitecan hydrochloride/NSC-609699;Topotecan hydrochloride; Topotecan hydrochloride;TOPOTECAN HYDROCHLORIDE; Nogitecan Hydrochloride; Hycamtin	6.3095734448	-5.2	-59.6822215509	4	5		-24.39084576	-29.51404777	0.0036589543	0.9981707683	7150	TOP1	Cl.CN(C)Cc1c2cc3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccc1O	Prestwick	Prestw-1196	-8.42174485	-8.03311031	-7.93834297	-15.50832603	-29.51404777											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262928-01	Clevidipine	170466066	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	167221-71-8	Butyroxymethyl methyl 4-(2 ,3 -dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;Clevidipinum;Clevidipine			-17.4534557937	4	5		0	-5.0334035					CC=1NC(C)=C(C(C=1C(=O)OCOC(=O)CCC)c2cccc(Cl)c2Cl)C(=O)OC	GVK	FFS-12-73-NCI-1401	-1.40727751	-4.96225768	-5.14664954	-5.74496056	-5.0334035											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022882-03	Diazoxide	170465328	"Sulfonylurea receptor 1, Kir6.2 Opener"	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	364-98-7				-8.9587615393	4	5		0	-2.59906653					Clc1ccc2N=C(C)NS(=O)(=O)c2c1	Enzo	KC115	-1.62647961	-0.61331275	1.65275102	-6.76161262	-2.59906653											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179273-03	Rimexolone	170464695	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	49697-38-3				-21.9209479422	4	4		0	-2.38790361					O=C(OC)[C@@]4(C)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-1020	-7.87834213	-1.5484537	1.52270821	-2.38790361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023282-21	AMPICILLIN SODIUM			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	69-52-3, 69-53-4 [ampicillin]				-26.1668152422	4	4		0	-4.67994248					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O	Microsource	01500123	-6.90057974	-6.89922147	-0.32219623	-4.67994248												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168748-02	Rotigotine	170465204	Dopamine D4 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	99755-59-6				-23.6800517554	4	4		0	-4.99368164					Oc2cccc1C[C@H](CCc12)N(CCC)CCc3cccs3	Tocris	3896	-5.6891927	-4.76579638	-2.98803902	-4.99368164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164005-06	PENICILLIN V POTASSIUM			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	132-98-9, 87-08-1 [penicillin, V]				-14.4048712015	4	4		0	-5.54272517					CC1(C)S[C@@H]2[C@H](NC(=O)COC3=CC=CC=C3)C(=O)N2[C@H]1C([O-])=O	Microsource	01500467	-2.34057281	-4.72278378	-1.40795339	-5.54272517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179626-05	NCGC00179626-05		Mineralocorticoid Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-0.2820918366	4	4		0	-2.34432873					C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC([O-])=O	Prestwick	CAS-102731	0.05624297	0.17205041	1.72573598	-2.34432873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263164-17	Cabozantinib		VEGFR-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	849217-68-1		7.9432823472	-5.1	-20.9678482326	-3	4		-42.008780344	-30.42398362	0.0631810569	0.9975331195		KDR	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3	MedChem Express	HY-13016	3.02414121	-0.01720504	-8.49627047	-30.42398362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165722-03	Plerixafor hydrochloride		Chemokine CXCR4 (SDF-1 Receptor) Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	155148-31-5				-19.1434638855	4	4		0	-3.93045449				CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	Selleck	S3013	-3.85480661	-4.26685019	-4.72701593	-3.93045449												1.6E-8	8E-8	4E-7	0.000002											
NCGC00183872-01	Brotizolam	144207150		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	57801-81-7		8.9125093813	-5.05	-62.3719789493	-2.4	4	We 941;CIPLUS_183076;2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;brotizolamum;Lendormin;Europharma brand of brotizolam;Sintonal;Boehringer Ingelheim brand of brotizolam;Lindormin;Brotizolam;brotizolam;LS-152570;Lendorm;WE-941;2-BROMO-4-(2-CHLOROPHENYL)-9-METHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;Brotizolamum;BROTIZOLAM;Promeco brand of brotizolam;WHO NO. 4549;WE 941;	-33.5093053549	-38.51148198	0.0816189992	0.995874106			Clc4ccccc4C2=NCc1nnc(C)n1c3sc(Br)cc23	Toronto Research	B689280	-8.57921606	-6.26263495	-10.44710244	-38.51148198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166138-04	Ethynodiol diacetate	170464933	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	297-76-7				-16.229426683	4	4		0	-2.82365245			5241	PGR	CC(=O)O[C@@]4(C#C)CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=C[C@H](CC[C@@H]12)OC(C)=O	Prestwick Chemical, Inc.	Prestw-908	-3.40486285	-3.50122586	-4.25916935	-2.82365245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178783-03	HYOSCYAMINE		M1 Muscarinic acetylcholine receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	101-31-5				-9.7443285173	4	4		0	-3.33406739				CHRM1	CN1C2CC[C@@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3	Microsource	01500346	-3.82504139	-0.87483176	4.47338618	-3.33406739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-07	Ammonium Glycyrrhizinate			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1407-03-0				-29.7909919995	4	4		0	-5.27196653					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	Selleck	S2376	-8.14672824	-6.02288022	-1.19783953	-5.27196653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159507-02	Alclofenac	144205279	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	22131-79-9	Alclofenac; Mervan; Prinalgin; Alclofenaco; 			-7.7057786855	4	4	NCGC_ALDRICH_L129054;mervan ethanolamine salt;NCGC00159507-03;Acetic acid, 4-allyloxy-3-chlorophenyl-, compd. with 2-aminoethanol;CIPLUS_758519;Alclofenaco;Benzeneacetic acid, 3-chloro-4-(2-propenyloxy)-;Alclofenacum;Prinalgin;alclofenacum;CIPLUS_173003;epinal;Mervan;CIPLUS_785326;Acetic acid, 4-allyloxy-3-chlorophenyl-;alclofenac;LS-10937;LS-10936;4-allyloxy-3-chlorophenylacetic acid;Alclofenac;ALCLOFENAC;CIPLUS_174183;	0	-3.38691918					Clc1cc(ccc1OCC=C)CC(=O)O	SigmaAldrich	T100277	-1.80360721	1.74966353	-3.24505619	-3.38691918												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00024778-02	Bifemelane	170465900	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	90293-01-9				-27.7693988794	4	5		0	-11.67200975					CNCCCCOc2ccccc2Cc1ccccc1	Tocris	0767	-5.70487032	-2.33789718	-6.45472062	-3.31805184	-11.67200975											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015620-17	NCGC00015620-17			DPI_SARS-CoV-2_General	2019_NPC-3_Tox					-21.3422965622	4	5		0	-3.71607893					C1CN2CC(N=C2S1)C3=CC=CC=C3	Vitas	STL019093	-7.33116494	-5.30870576	-2.8113505	1.01221007	-3.71607893											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181103-02	Propiverine hydrochloride	170466036	Muscarinic acetylcholine receptor Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	54556-98-8				-2.6716667888	4	5		0	-3.58965097					Cl.CN3CCC(OC(=O)C(OCCC)(c1ccccc1)c2ccccc2)CC3	Sequoia	54556-98-8	-2.10134383	0.56402308	0.41163076	4.6162226	-3.58965097											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179594-03	Cefotiam hydrochloride	170465103	Escherichia coli Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	66309-69-1				-21.8228292418	4	4		0	-5.07903602					Cl.Nc1scc(n1)CC(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2CCN(C)C)CS[C@@H]34)C(=O)O	Prestwick	Prestw-482	-5.90839968	-5.67345903	0.45322698	-5.07903602												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181290-01	Furazabol	144206325		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1239-29-8	Furazabol; Miotolan; 			-20.7717037056	4	4	androfurazanol;Miotolan;CIPLUS_157956;17 alpha-methyl-5 alpha-androstano(2,3-c)furazan-17 beta-ol;furazabol;FURAZABOL;LS-19413;Furazabol;17-METHYL-5.ALPHA.-ANDROSTANO(2,3-C)FURAZAN-17.BETA.-OL;Furazabolum;furazabolum;17-methyl-5 alpha-androstano(2,3-c)(1,2,5)oxadiazol-17 beta-ol;5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl-;	0	-5.7527857					C[C@]5(O)CC[C@@H]4[C@]5(C)CC[C@H]1[C@H]4CC[C@H]2Cc3nonc3C[C@]12C	ACC	furazabol	-2.07979247	-4.26989093	-10.2519942	-5.7527857												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178840-05	Cloxacillin sodium	170465404	beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	642-78-4	; Viccillin S (combination);CLOXACILLIN SODIUM; Tegopen; Dicloxacillin Sodium; Sodium syntarpen; Cloxacilina; Sodium, Cloxacilli; Syntarpen;Cloxacillin sodium salt; Orbenin D.C.; 4   Cloxacillin Sodium;Cloxacillin sodium; Sodium cloxacillin; Cloxapen; Cloxacillin, Sodiu; Oxacillin; Ampiclox; Cloxacillin sodium salt			-19.7811456482	4	4		0	-4.18070312					[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1ccccc1Cl)[C@H]4SC3(C)C	Microsource	01500201	-4.34296449	-5.35216031	-2.22081218	-4.18070312												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00182044-02	Toltrazuril (sulfone)			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	69004-04-2				-34.2908842358	4	4		0	-2.53951801					CN1C(=O)NC(=O)N(C1=O)C2=CC=C(OC3=CC=C(C=C3)[S+]([O-])(=O)C(F)(F)F)C(=C2)C	MedChem Express	HY-17008	-7.68852312	-6.9501987	-7.21537346	-2.53951801												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00344562-01	Celiprolol hydrochloride	170465958	Beta-2 adrenergic receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	57470-78-7				-31.0457997868	4	4		0	-3.86110391					Cl.CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O	Prestwick	Prestw-1132	-7.38438143	-6.84028071	-4.36910805	-3.86110391												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00159505-03	Octadecanoic acid, monoester with 1,2-propanediol	29215477		DPI_SARS-CoV-2_General	2019_NPC-6_Tox		PROPYLENE GLYCOL MONOSTEARATE; 			-12.8864180047	4	4	CERASYNT PA;CIPLUS_158145;PROPYLENE GLYCOL STEARATE SE;PROPYLENE GLYCOL MONOSTEARATE;CIPLUS_679055;PROPYLENE GLYCOL STEARATE;	0	-1.13155394					CCCCCCCCCCCCCCCCCC(=O)OCC(C)O	SigmaAldrich	S591173	-0.18337955	-5.68191426	-6.54459753	-1.13155394												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00095191-12	Oseltamivir Phosphate		Neuraminidase (sialidase) Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	204255-11-8				-22.9085938653	4	4		0	-5.7527857				NEU1	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	Enzo	DL194	-3.30530459	-6.85719117	-6.29985497	-5.7527857												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00390707-01	Oclacitinib		Tyrosine-protein kinase JAK3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1208319-26-9				-27.7850025982	4	4		0	-5.18268982					CN[S+]([O-])(=O)C[C@H]1CC[C@@H](CC1)N(C)C2=C3C=C[NH]C3=NC=N2	MedChem Express	HY-13577	-5.90839968	-7.56743046	-3.7617839	-5.18268982												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386267-03	(R)-Lansoprazole		H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	138530-94-6				-8.8576456916	4	4		0	-3.10961389				ATP4A	CC1=C(C[S@@+]([O-])C2=NC3=C([NH]2)C=CC=C3)N=CC=C1OCC(F)(F)F	MedChem Express	HY-13662B	-0.76482691	-4.34598799	-1.71319797	-3.10961389												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00183838-01	Perisoxal citrate	144206844		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	14838-45-0				-12.6731466696	4	4	Perisoxal Citrate;perisoxal, (S)-isomer;1-Piperidineethanol, alpha-(5-phenyl-3-isoxazolyl)-, citrate (2:1);LS-115490;perisoxal citrate (2:1);Perisoxalum;CIPLUS_213305;CIPLUS_744614;LS-115487;perisoxal citrate;3-(1-hydroxy-2-piperidinoaethyl)-5-phenyl-isoxazol (german);Isoxal;CIPLUS_791151;1-Piperidineethanol, alpha-(5-phenyl-3-isoxazolyl)-;3-(1-hydroxy-2-piperidinoethyl)-5-phenylisoxazole;PERISOXAL;perisoxal citrate (1:1);perisoxal;perisoxalum;31252-S;isoxal;alpha-(5-phenyl-3-isoxazolyl)-1-piperidineethanol;Perisoxal citrate;perisoxal, (R)-isomer;PERISOXAL CITRATE;CIPLUS_742412;perisoxal, (+-)-isomer;Perisoxal;	0	-6.03783364					OC(CN1CCCCC1)c2cc(on2)c3ccccc3.O=C(O)C(O)(CC(=O)O)CC(=O)O	Pharmaron	PH-NIH-153178-6	-0.15654352	-4.65037626	-6.3542422	-6.03783364												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00094358-05	Isotretinoin	26753641	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	4759-48-2	; Panretin; Retinoic acid, all-trans-; RETINOIC ACID, 9-cis-; Retinoic acid, trans; Roaccutane; "RETINOIC ACID, 13-cis-"; 9-cis-Tretinoin;13-cis-retinoic acid; Retinoic acid, 13-cis-; Tretinoin Potassium Salt; Retin A; 13 cis Retinoic Aci; ISOTRETINON; 9,13-di-cis-RA; Tretinoin Zinc Salt; Velac; 13-cis-retinoic acid; 13-cis-Retinoic acid; RETINOIC ACID, 13-cis-; Ro 4 378; ; Ro 4378; Ro 4-3780; Tretinoine;ISOTRETINON; Tretinoina;13-cis Retinoic acid; Isotretinoino; Tretinoino; Retinoic acid; Vesanoid; Tretinoin Tocoferil; Isotretinoin Anisatil; 9cRA compound;Isotretinoin			-5.3641195639	4	4	TRETINOIN;Tretinoinum;RETINOIC ACID, 9-cis-;9,13-di-cis-RA;Retinoic acid, trans;13-CIS-RETINOIC ACID;Tretinoina;ISOTRETINOIN;NCGC00161590-04;Panretin;9-cis-retinoic acid;ALL-TRANS-RETINOIC ACID;LG-100057;Isotrex;Tretinoin Tocoferil;CIPLUS_152537;9-cis-Retinoic acid;9-cis,13-cis-retinoic acid;9,13-di-cis-retinoic acid;Accutane;isotretinoine;Vitamin A acid;NCGC00161590-03;9-CIS-RETINOIC ACID;Velac;Retinoic acid, all-trans-;Tretinoin;SOLAGE;Tretinoin (Retinoic acid, all trans);NCGC00015890-01;RO-4-3780;CIPLUS_163676;NCGC00015890-02;TRETINOIN ZINC;NCGC00015890-03;NCGC00015890-04;Tretinoin Potassium Salt;LS-173936;Isotretinoin;Ro 4-3780;CIPLUS_711531;NCGC_Prestw-256;NCGC00021808-06;13 cis Retinoic Aci;NCGC00021808-05;NCGC_Prestw-257;Isotretinoinum;Isotretinoine;Isotretinoin Zinc Salt, 13-cis-Isomer;Isotretinoino;tretinoine retinoic acid;Tretinoine;Tretinoino;NCGC00021808-02;NCGC00021808-04;RETINOIC ACID, 13-cis-;Isotretinoin Anisatil;CIPLUS_660447;9cRA compound;CIPLUS_725243;13-cis-Retinoic acid;Vesanoid;alitretinoinum;tretinoin;CIPLUS_164122;alitretinoin;Isotretinoin (13-cis-retinoic acid);VITAMIN A ACID;CIPLUS_710508;9-cis-Tretinoin;CIPLUS_710507;ALITRETINOIN;LS-1328;LS-178647;NCGC00021808-14;9,13-retinoic acid;Retinoic acid, 13-cis-;Retin A;all-trans-Retinoic acid;ACCUTANE;ISOTREX;NSC-122758;Tretinoin,all-trans-retinoie acid;clindamycin phosphate - tretinoin formulation;Alitretinoin;isotretinoinum;13-cis-retinoic acid;Isotretinoin Zinc Salt, 13 cis Isome;VITAMIN A ACID, 13-CIS-;CIPLUS_3881593;Ro 4378;RETINOIC ACID, ALL-TRANS;NCGC00094358-02;NCGC00094358-01;NCGC00094358-04;Isotretinoin,13-cis-retinoic acid;NCGC00094358-03;NCGC00094358-06;NCGC00094358-08;NCGC00094358-07;Roaccutane;NCGC00094358-09;ISOTRETINON;Ro 4 378;Retinoic acid;CIPLUS_711632;LGD-1057;ATRA;LS-143465;LS-1154;tretinoinum;Ligand brand of alitretinoin;TRETINON;	0	3.65379632			5915	RARB	CC/1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1	BIOMOL	GR102	-0.69326416	-2.8325019	-1.59535896	3.65379632												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00532515-01	ROBENACOXIB		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					7.2726931706	4	4		0	2.57406928					CCC1=CC=C(NC2=C(F)C(=CC(=C2F)F)F)C(=C1)CC(O)=O	J&W Pharm	99R0028	-0.09392611	-0.24520166	7.63234228	2.57406928												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00263951-01	CEPHRADINE		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-15.1045852757	4	4		0	-0.0518269					CC/1=C(/N2[C@@H](SC1)[C@H](NC(=O)[C@H](N)/C3=C/C/C=C\C3)C2=O)C(O)=O	Microsource	MS-01500168	-3.97620539	-4.53200304	-0.19941987	-0.0518269												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00262943-01	Tocanfil	170466061		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5634-42-4	Tocamphylum;Tocanfil;Tocamphyl			1.5407998647	4	4		0	-4.79398808					CC1(CCC(C(=O)O)C1(C)C)C(=O)OC(C)c2ccc(C)cc2.OCCNCCO	GVK	FFS-11-286-NCI-206	3.03694427	-3.85558468	-1.09680928	-4.79398808												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00270540-02	Miglitol	170465326	alpha-Glucosidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	72432-03-2	Miglitol;Miglitol (Glyset)			-12.7515130801	4	4		0	-3.82655265			2548	GAA	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	Prestwick	Prestw-1169	-1.34627426	-4.21915955	-4.2422045	-3.82655265												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166415-03	Palonosetron hydrochloride	170465300	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	135729-62-3		3.1622776602	-5.5	-30.350976022	4	4		-14.3836085919	-6.43517319	1	0.9999743853			Cl.O=C1N(C[C@H]3CCCc2cccc1c23)[C@@H]5CN4CCC5CC4	Bosche	P5846	-4.55765274	-5.70727995	-18.2106599	-6.43517319												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00264046-02	Glutathione	170465600	"Glutathione reductase, mitochondrial Substrate"	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	70-18-8				-13.3862569059	4	4		0	-5.90826639			2936	GSR	O=C(NCC(=O)O)[C@@H](NC(=O)CC[C@H](N)C(=O)O)CS	Microsource	01502248	-2.67913051	-4.69265241	0.30819434	-5.90826639												8E-8	4E-7	0.0000099999999999	0.000029999999999											
NCGC00024567-03	Ambenonium chloride	170465386	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	115-79-7				-7.4886032783	4	5		0	-0.41250056					[Cl-].[Cl-].Clc2ccccc2C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](Cc1ccccc1Cl)(CC)CC	Tocris	0388	-1.45836866	-4.16344086	0.18082385	-2.42044533	-0.41250056											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015238-13	Chlorzoxazone	170464957	Intermediate conductance calcium-activated potassium channel protein 4 Activator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	95-25-0				-8.4901946385	4	5		0	-2.02663319					Clc1cc2NC(=O)Oc2cc1	Vitas	STK071582	-2.63693403	-0.53333333	-0.5248302	-1.92463716	-2.02663319											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179475-03	Halcinonide	170465389		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	3093-35-4				2.7458332527	4	5		0	0.64565305					ClCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-655	-1.66186196	0.28387097	4.15894858	3.2047237	0.64565305											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182982-01	Dalcotidine	144206834	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	120958-90-9	Dalcotidine; 			-12.0379469072	4	5	dalcotidine;KU-1257;CIPLUS_705874;DALCOTIDINE;dalcotidinum;N-ethyl-N'-(3-(3-(piperidinomethyl)phenoxy)propyl)urea;Dalcotidine;KU 1257;	0	-4.14294041			3274	HRH2	CCNC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Pharmaron	PH-NIH-151679	-3.48482279	-3.31182796	-1.66269736	1.42882899	-4.14294041											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015603-08	Lomefloxacin hydrochloride	170465262	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	98079-52-8	 ; Maxaquin;LOMEFLOXACIN HYDROCHLORIDE; Lomefloxacin hydrochloride;Lomefloxacin hydrochloride; Lemofloxacin			-6.4051108603	4	5		0	-2.78886248					Cl.O=C(O)C2=CN(CC)c1c(F)c(c(F)cc1C2=O)N3CC(C)NCC3	Microsource	01502037	-1.34814312	-2.31397849	0.90411926	-1.19444695	-2.78886248											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013895-08	Benzbromarone	170465792	Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	3562-84-3		14.1253754462	-4.85	-49.0293491777	-3	5		-36.0633098678	-35.14325427	0.1440713948	0.9192101925			Brc1cc(cc(Br)c1O)C(=O)c2c3ccccc3oc2CC	Labotest	LT00134669	-8.67390198	-6.85591398	-4.5470583	1.85251961	-35.14325427											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016564-06	Metformin	170464804	AMPK Activator	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			-24.9668393834	4	5		0	-3.66766803			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	-7.7751399	-8.8688172	-2.88877128	0.59046245	-3.66766803											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016324-09	Sulfamethoxypyridazine	170466374		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	80-35-3		0.8912509381	-6.05	-13.0823007352	4	5		11.5677419399	-4.99484374	0.0514818951	0.9983801251			O=S(=O)(Nc1ccc(OC)nn1)c2ccc(N)cc2	Microsource	01501156	-6.99508225	-7.13978495	-1.8302902	4.25944289	-4.99484374											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091367-05	Danthron	170465532	DNA topoisomerase II alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	117-10-2		1	-6	-12.161952287	4	5		12.6789893199	-8.06169574	0.0506500215	0.9984292348			Oc3cccc2C(=O)c1cccc(O)c1C(=O)c23	Labotest	LT00455159	-7.2324911	-6.77849462	-2.80056452	5.49445596	-8.06169574											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091330-07	Anthralin	170466655		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1143-38-0		0.8912509381	-6.05	-20.884048055	4	5		9.850322584	-0.23315249	0.1779051312	0.897992374			Oc2cccc1Cc3cccc(O)c3C(=O)c12	Microsource	01500127	-6.86789893	-9.87526882	-5.00573344	3.47516452	-0.23315249											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181002-04	Cinacalcet hydrochloride	170465336	Calcium-Sensing Receptor (CaSR) Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	364782-34-3	 Cinacalcet;Cinacalcet;Cinacalcet hydrochloride; Sensipar; 	12.5892541179	-4.9	-95.0729658089	-3	5		-110.3765949792	-99.61888535	0.0024607758	0.9987675078	846	CASR	Cl.FC(F)(F)c3cccc(CCCN[C@H](C)c2cccc1ccccc12)c3	Selleck	S1260	-6.1387146	-5.68602151	-2.40363412	-5.11583882	-99.61888535											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263910-02	Aminopentamide sulfate	170466283	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	20701-77-3		0.316227766	-6.5	-25.5314432411	4	5		8.34619298	-4.08016859	0.3065844329	0.8015857629			O=S(=O)(O)O.NC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2	Microsource	01505650	-9.03849415	-8.26666667	-1.40689777	1.49193185	-4.08016859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016271-05	Tolazoline hydrochloride	170465219	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	59-97-2				-23.5834320315	4	5		0	-5.3983769					Cl.c2cc(CC1=NCCN1)ccc2	Specs	AT-139/J221336	-7.29184331	-7.77634409	-3.05636412	2.21310736	-5.3983769											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016016-18	Triamterene	170464706	Heart phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	396-01-0		12.5892541179	-4.9	-73.1793397015	-3	5		-56.9620931633	-58.62888401	0.0062374918	0.996868057			Nc2nc(N)nc1nc(N)c(nc12)c3ccccc3	Vitas	STK300348	-8.27539427	-8.35268817	-5.72902884	-5.96322005	-58.62888401											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179358-04	Methacycline hydrochloride	170465224	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	3963-95-9				-10.9923240089	4	4		0	-8.61924686					Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1C(=C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick Chemical, Inc.	Prestw-964	-0.30495774	-3.21332436	-2.18224584	-8.61924686												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378606-02	Ipragliflozin		Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	761423-87-4				-3.4064435523	4	4		0	1.96872935					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=CC=C(F)C(=C2)CC3=CC4=C(S3)C=CC=C4	MedChem Express	HY-14894	-1.79489414	0.2102961	-0.63158812	1.96872935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00065890-14	Nevirapine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	129618-40-2				-6.4032003076	4	4		0	-0.8976426				TERT	CC1=CC=NC2=C1NC(=O)C3=CC=CN=C3N2C4CC4	MedChem Express	HY-10570	-2.75590551	2.01298981	-0.14565035	-0.8976426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166139-03	3-Hydroxy-4-butyrophenetidide	170465885		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1083-57-4				-25.4895270337	4	4		0	-4.15704388					CCOc1ccc(cc1)NC(=O)CC(C)O	SIGMA	B4027	-6.6150385	-5.97014925	-1.88462727	-4.15704388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016741-09	Tinidazole	170465196		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	19387-91-8				-1.2118335978	4	5		0	-1.44595955					O=S(=O)(CCn1c(cnc1C)[N+]([O-])=O)CC	Vitas	STK801761	1.77553705	0.63904615	0.88203811	-6.41980719	-1.44595955											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159422-04	Tiopronin	170465217	Copper Chelator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1953-02-2	 Dextiopronin; Meprin (detoxicant); ; Tiopronino;Tiopronin; Tiopronin; Thiopronine			-14.0926240501	4	5		0	-0.60400842				MPO	OC(=O)CNC(=O)C(C)S	Labotest	LT00451995	-1.64401578	-4.30176703	-5.33504603	-5.51709027	-0.60400842											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013058-02	Malachite green oxalate	170465712		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	2437-29-8		0.5011872336	-6.3	-217.1733370066	-1.1	5		-94.3789323774	-99.79866386	0.0044514115	0.9977671158			C/[N+](C)=C1\C=C/C(C=C1)=C(/c2ccccc2)c3ccc(cc3)N(C)C.[O-]C(=O)C(=O)O.[O-]C(=O)C(=O)O.O=C(O)C(=O)O.CN(C)c1ccc(cc1)C(\c2ccccc2)=C3/C=C/C(C=C3)=[N+](/C)C	SIGMA	38800	-8.68478737	-12.27054383	-71.73624492	-96.93689746	-99.79866386											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00238452-03	Enzastaurin	170465609	PKCa, PKCb, PKCg inhbitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	170364-57-5	 Enzastaurin;LY-317615;Enzastaurin			-39.6598033343	4	5		0	-10.01189714			5578	PRKCA	Cn2cc(c1ccccc12)C=3C(=O)NC(=O)C=3c7cn(C5CCN(Cc4ncccc4)CC5)c6ccccc67	Selleck	S1055	-6.78211311	-7.02950763	-7.2275744	-13.78177038	-10.01189714											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015610-17	Leflunomide	170464823	DHODH Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	75706-12-6	; Arava;Leflunomide; Leflunomida; Leflunomide;HWA-486/RS-34821			-33.0541762322	4	5		0	-12.0618651			3716	DHODH	Cc2oncc2C(=O)Nc1ccc(cc1)C(F)(F)F	Selleck	S1247	-3.80973257	-7.81866529	-6.31984586	-10.14460999	-12.0618651											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016375-09	Sulfadimethoxine	170465690	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	122-11-2	; ; Sulfadimetoxina; Sulfadimethoxine Sodium; Rofenaid; Sulfadimethoxine;Sulfadimethoxine;SULFADIMETHOXINE; Deposul; Abcid; Agribon; Sulphadimethoxine; Sulfadimethoxine Base			-27.8119520821	4	5		0	-4.87782557					COc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Vitas	STK018258	-5.93160894	-6.16314977	-5.09526868	-7.57668712	-4.87782557											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249935-01	Phenylacetylglycine dimethylamide	170465887		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3738-06-5				-2.7932581594	4	5		0	0.128123					CN(C)C(=O)CN(C(C)=O)c1ccccc1	GVK	FFS-11-286-NCI-239	0.14467339	-2.79207411	0.49668165	-2.22173532	0.128123											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179607-03	Chlorphensin carbamate	225144309		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	886-74-8				-21.0177451863	4	4		0	-4.80195215					NC(=O)OCC(O)COC1=CC=C(Cl)C=C1	Prestwick	Prestw-234	-6.19105304	-2.39150071	0.075032	-4.80195215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168248-02	Benzoylecgonine	144206406		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	519-09-5				-25.3110494934	4	4		0	-8.00906358					CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)O	RTI	9180-001	-4.93640218	-6.82179879	-4.52398817	-8.00906358												3.96E-7	0.00000198	0.00000991	0.0000496											
NCGC00166270-02	1,3,5-Trihydroxybenzene dihydrate	225144277	Voltage-gated calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	6099-90-7				7.3520900634	4	4		0	-0.07843479					OC1=CC(=CC(=C1)O)O	SIGMA	P38005	2.20212858	-1.07531507	3.63243148	-0.07843479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379027-01	(24S)-24,25-Dihydroxyvitamin D3		Vitamin D3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	55700-58-8				-33.3875092769	4	4		0	-2.0915944			7421	VDR	C[C@H](CC[C@H](O)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	MedChem Express	HY-15439	-9.99826945	-7.64764076	-1.35498963	-2.0915944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183121-01	Zinc pyrithione	144206950		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	13463-41-7		1.995262315	-5.7	-158.5266744162	-1.1	4	pyrithionum zincicum;LS-784;Pyrithione zincique;PYRITHIONE ZINC;pyrithione zinc;Zinc Pyrithione;Zinc pyrithione;NCGC00094659-02;ZINC OMADINE;NCGC00094659-01;CIPLUS_168786;ZINC DI(2-PYRIDINETHIOL-1-OXIDE);Piritionato cincico;zinc pyrithione;ZINC PYRION;AB07944716-01;Finecide ZPT;Pyrithione zinc;VANCIDE ZP;Pyrithionum zincicum;Sebulon shampoo;2-Mercaptopyridine N-oxide zinc salt Pyrithione zinc;(T-4)-bis(1-hydroxy-2(1H)- pyridinethionato-O,S)zinc;2-Mercaptopyridine N-oxide zinc salt;	-98.1079323931	-99.68190335	0.035468092	0.9992232933			[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]	SIGMA	H6377	-4.30475037	-4.84321906	-99.63808095	-99.68190335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510033-02	Distigmine Bromide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	15876-67-2				-4.0315876246	4	4		0	-1.62970064					CN(CCCCCCN(C)C(=O)OC1=C[N+](=CC=C1)C)C(=O)OC2=C[N+](=CC=C2)C	SantaCruz Bio	sc-482341	-0.35043696	-1.19575035	-1.5491901	-1.62970064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160614-01	Glucuronamide	144205490		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	61914-43-0	Glucuronamide; D-Glucuronic acid amide; Guronamin; 			-22.7885737791	4	4	Glucuronamide;CIPLUS_791650;GLUCURONAMIDE;glucuronamide;D-Glucuronic acid amide;glucuronamidum;Guronamin;	0	-4.71480239					O[C@H]1[C@H](O)[C@H](O[C@@H](O)[C@@H]1O)C(N)=O	SigmaAldrich	MFCD00006619	-6.00934499	-3.69048131	-0.49874211	-4.71480239												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00181760-01	Lobenzarit sodium	144206494	response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	64808-48-6	lobenzarit; Carfenil; CCA lobenzarit; 			-32.0302558033	4	4	U-69951F;2-((2-carboxyphenyl)amino)-4-chlorobenzoic acid;LOBENZARIT;CIPLUS_685410;Benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt;LS-36386;LOBENZARIT SODIUM;lobenzarit, disodium salt;Carfenil;4-chloro-2,2'-iminodibenzoic acid;CCA lobenzarit;CIPLUS_186740;lobenzarit disodium;lobenzarit;Lobenzarit Disodium;DISODIUM 4-CHLORO-2,2'-IMINODIBENZOATE;disodium 4-chloro-2,2'-iminodibenzoate;Lobenzaritum;N-(2-carboxyphenyl)-4-chloroanthranilic acid;Lobenzarit sodium;Lobenzarit;Lobenzarit disodium;lobenzaritum;lobenzart;LS-176311;	0	-7.32929539			2936		[Na+].[Na+].O=C([O-])c2ccc(Cl)cc2Nc1ccccc1C([O-])=O	ACC	LOBENZARIT DISODIUM	-7.78316172	-6.14219966	-3.6059496	-7.32929539												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00253603-01	Mibolerone	170466095	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	3704-09-4				-21.7897536204	4	4		0	-0.67976818					C[C@@H]3CC1=CC(=O)CC[C@@H]1[C@H]4CC[C@@]2(C)[C@@H](CC[C@]2(C)O)[C@H]34	GVK	FFS-11-286-NCI-098	-6.96980185	-3.34638049	-1.63746304	-0.67976818												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179520-04	Metrizamide			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	31112-62-6				-29.4595305185	4	4		0	-5.0459715					CN(C(C)=O)C1=C(I)C(=C(I)C(=C1I)NC(C)=O)C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-463	-7.80912001	-5.4453955	-2.77618396	-5.0459715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389632-02	Tipiracil		Thymidine Phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	183204-72-0				-27.2989986686	4	4		0	-6.51880256				TYMP	ClC\1=C(/CN2CCCC2=N)NC(=O)NC1=O	Adooq	A13098	-6.32084451	-4.98085939	-4.01200512	-6.51880256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015818-14	Praziquantel	170464906	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	55268-74-1	; ; Praziquantel, (R)-Isomer; Praziquantel, (+-)-Isomer;PRAZIQUANTEL;Praziquantel; Praziquantel, (S)-Isomer; Biltricide; Praziquantel			-23.0639268947	4	5		0	-4.02918636					O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4	Vitas	STK030186	-6.65315474	-5.14511873	-5.65579604	-0.23423506	-4.02918636											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016925-11	Omeprazole	170465443	ABCC3 Expression Enhancer	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	73590-58-6	 ; Omeprazole ER; Zegerid; Prilosec;AGI-010/DM-3458;Omepral; ESOMEPRAZOLE Mg; Losec sodium; Esomeprazole;Omeprazole; Omeprazole; Omeprazol; Nexium; Losec			-15.9636592092	4	5		0	-2.10178514			8714	ABCC3	Cc3c(OC)c(C)cnc3CS(=O)c1nc2cc(ccc2n1)OC	Microsource	01505693	-4.52062037	-6.08987999	-5.40461339	2.89808478	-2.10178514											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015563-13	Imipramine	170464777	Serum paraoxonase/arylesterase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50-49-7		1.4125375446	-5.85	-10.757392599	4	5		13.7028551239	-5.50686063	0.1720198761	0.9814878492	5444	PON1	CN(C)CCCN2c3ccccc3CCc1ccccc12	Enzo	AC813	-7.25237927	-5.09405056	-2.52438565	5.54356313	-5.50686063											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090874-06	Piperonyl butoxide	170464741		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	51-03-6				-26.7351511229	4	5		0	-8.48974347					CCCc1cc2OCOc2cc1COCCOCCOCCCC	SIGMA	45626	-4.17694748	-8.23474338	-5.99070624	-3.8625821	-8.48974347											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167439-03	Trenbolone (acetate)		Progesterone receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	10161-34-9				-19.7298148615	4	4		0	-4.68425332					CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CCC4=C3/C=C\[C@]12C	MedChem Express	HY-12360	-4.82382005	-3.69176551	-1.90297507	-4.68425332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509859-03	ABT-450			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1221573-85-8				-23.8845318218	4	4		0	-4.91010931					CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCCC=C[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S+]([O-])(=O)C8CC8	Glixx	GLXC-90367	-4.60711654	-8.70293966	-3.38604485	-4.91010931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241101-09	Neratinib		EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	698387-09-6		1.1220184543	-5.95	-167.822444836	-2.3	4		-82.0641591058	-90.77073692	0.0563420992	0.9980371495		EGFR	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(=C(C=N2)C#N)NC3=CC=C(OCC4=CC=CC=N4)C(=C3)Cl	Glixx	GLXC-90246	-6.57343274	-10.75501037	-24.06878032	-90.77073692												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00390266-01	Nalfurafine hydrochloride		Kappa opioid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	152658-17-8				-24.1653088268	4	4		0	-6.78019695					CN([C@@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC6CC6)C(=O)\C=C\C7=COC=C7	Adooq	A12579	-5.51727127	-5.53979715	-1.62601626	-6.78019695												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095107-09	Gliclazide	170465698	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	21187-98-4	; ; Gliclazida;Gliclazide; GLICLAZIDE; Glimicron;GLICLAZIDE			18.0200807556	4	4		0	5.35278706				KCNJ8	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	Vitas	STK803142	3.81831578	2.24772219	3.85955508	5.35278706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185747-02	Niceritrol	170465789	Hydroxycarboxylic acid receptor 2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	5868-05-3		14.1253754462	-4.85	-19.982778477	4	4		-10.236700772	-10.89981028	0.5962705129	0.6914546534			O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c2cccnc2)COC(=O)c3cccnc3)c4cccnc4	Kemprotec	5868-05-3	-2.84748407	-6.24462782	-0.28589297	-10.89981028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390365-01	Delamanid			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	681492-22-8				-24.12342751	4	4		0	-5.3488786					CC1(COC2=CC=C(C=C2)N3CCC(CC3)OC4=CC=C(OC(F)(F)F)C=C4)C[N]5C=C(N=C5O1)[N+]([O-])=O	Bio Vision	2280	-5.88520757	-2.14236351	-5.1498614	-5.3488786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167565-06	Carbazochrome sodium sulfonate		Hemostatics	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	51460-26-5				-1.6090638376	4	4		0	-0.63189747					CN1C(CC\2=C\C(=N\NC(N)=O)C(=O)\C=C12)[S]([O-])(=O)=O	MedChem Express	HY-B0491A	-0.18529139	0.31098825	-1.26039501	-0.63189747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016505-06	PROPOXYCAINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	550-83-4				-21.7639074572	4	4		0	-3.79138483					CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC	Microsource	01505572	-6.20284996	-3.37767795	-1.04383229	-3.79138483												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181342-02	Imidapril hydrochloride	170466024		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	89396-94-1				-21.8557177199	4	4		0	-5.06407974					Cl.OC(=O)[C@@H]2CN(C)C(=O)N2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	SIGMA	SML0148	-5.71756298	-4.23289565	-0.73198198	-5.06407974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532516-01	IOBITRIDOL			DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-31.8617284791	4	4		0	-6.60377358					CN(CC(O)CO)C(=O)C1=C(I)C(=C(I)C(=C1I)NC(=O)C(CO)CO)C(=O)N(C)CC(O)CO	Carbosynth	FI24594	-7.19989412	-6.31478922	-5.90349965	-6.60377358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018186-07	Procyclidine hydrochloride	170464805	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1508-76-5				-10.5476159063	4	4		0	-3.1574668					Cl.OC(CCN1CCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500507	-1.29588697	-4.82637098	-2.15313142	-3.1574668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1446502-11-9		14.1253754462	-4.85	-24.4630294943	4	4		-11.707245464	-11.83937122	0.6141861102	0.6620885634		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	-5.12720496	-4.93811243	1.33118914	-11.83937122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165883-04	Rufinamide	170465202	Sodium channel protein type IX alpha subunit Modulator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	106308-44-5				-14.4647141879	4	4		0	-3.83503478					NC(=O)c2cn(Cc1c(F)cccc1F)nn2	Tocris	3828	-2.31872752	-5.75468455	-2.36755115	-3.83503478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188435-01	2-Hydroxyethyl octadecanoate	144206587		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	111-60-4				-19.1134644629	4	4	Polyoxyl 40 Stearate	0	-3.83588466					O=C(CCCCCCCCCCCCCCCCC)OCCO	APAC	878043	-4.05876384	-3.29129233	-5.12387387	-3.83588466												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522020-01	Butropium Bromide		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	29025-14-7				-24.9624385917	4	4		0	-8.20576718					CCCCOC1=CC=C(C[N+]2(C)C3CCC2CC(C3)OC(=O)[C@H](CO)C4=CC=CC=C4)C=C1	Toronto Research	B690080	-6.02638196	-4.12059433	-0.80128205	-8.20576718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242506-06	Bortezomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	179324-69-7		35.4813389234	-4.45	-458.5369506546	5	4		-9.5804730721	-98.58490566	0.7375643164	0.5788278967		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	Axon Medchem	1810_cm1	-97.29562801	-98.28956462	-96.8511781	-98.58490566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378841-01	Levomefolate calcium			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	151533-22-1				-25.019442986	4	4		0	-7.70736917					CN\1[C@@H](CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC\3=C1C(=O)NC(=N3)\N	MedChem Express	HY-17383	-3.76759165	-4.45749827	-3.69455994	-7.70736917												1.6E-8	8E-8	4E-7	0.000002											
NCGC00390657-02	Lesinurad (sodium)		Solute carrier family 22 member 12 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1151516-14-1				-14.0876407544	4	4		0	-5.98077608					[Na]OC(=O)CSC1=NN=C(Br)[N]1C2=C3C=CC=CC3=C(C=C2)C4CC4	MedChem Express	HY-15258A	-3.15877708	-0.967519	-1.2517325	-5.98077608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507845-01	Netarsudil	384569326	ROCK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1253952-02-1		5.0118723363	-5.3	-113.5070736767	-3	4		-101.0822591725	-99.2257031	0.0071455326	0.9999685076		ROCK1	CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C	Selleck	S8226	-2.09114572	-2.71250864	-4.10169785	-99.2257031												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510884-01	Tylvalosin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	63409-12-1				-3.1726416462	4	4		0	-0.39159843					CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	SantaCruz Bio	sc-473950	-1.05880796	-1.26123013	1.00918226	-0.39159843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496843-01	Ripasudil		ROCK1/ROCK2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	887375-67-9		15.8489319246	-4.8	-37.0777689824	4	4		-13.19799314	-13.80384478	0.4992335374	0.8088290275		ROCK1	C[C@H]1CNCCCN1[S+]([O-])(=O)C2=CC=CC3=CN=CC(=C23)F	Selleck	S7995	-8.06458729	-3.22218383	-5.60031185	-13.80384478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168771-03	Fosamprenavir (Calcium Salt)			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	226700-81-8				-28.8722848549	4	4		0	-3.61338555					CC(C)CN(C[C@@H](OP([O-])([O-])=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	MedChem Express	HY-17431	-7.25283452	-6.04699378	-4.89864865	-3.61338555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015094-22	Allopurinol			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	315-30-0				-10.1520361139	4	4		0	-1.07055741					OC1=C2C=NNC2=NC=N1	APExBIO	A8360	-1.94599749	-4.28485474	-1.60814795	-1.07055741												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00166238-02	Benznidazole	170466539	Pyruvate:ferredoxin oxidoreductase Substrate	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	22994-85-0				-13.4476632294	4	4		0	-6.06087576					O=C(Cn1ccnc1[N+]([O-])=O)NCc2ccccc2	SIGMA	419656	-2.41761151	-4.09467865	0.16891892	-6.06087576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253602-01	Thenyldiamine	170465520		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	91-79-2				-16.5898679741	4	4		0	-7.36027056					CN(C)CCN(Cc1ccsc1)c2ccccn2	GVK	FFS-11-286-NCI-087	-3.07936648	-2.64340014	-1.97072072	-7.36027056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179642-03	Isoconazole nitrate	170466012	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	27523-40-6	;Isoconazole; Isoconazol; Travocort; Adestan-G;Isoconazole nitrate (Travogen)	12.5892541179	-4.9	-94.0677523662	-3	4		-87.7357008892	-86.38305447	0.0367157845	0.9991677075			Clc3ccc(C(OCc1c(Cl)cccc1Cl)Cn2ccnc2)c(Cl)c3	Prestwick Chemical, Inc.	Prestw-127	-8.25870208	-6.12474084	-5.91216216	-86.38305447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015122-11	Bupropion hydrochloride	170464747	Dopamine Transporter (DAT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	31677-93-7	; ;Bupropion hydrochloride; 3   Bupropion Hcl; Bupropion hydrochloride; Bupropine HCl; Amfebutamonum;BUPROPION; Amfebutamona; Bupropion hydrocloride;Bupropion?HCl; Wellbutrin	1.1220184543	-5.95	-11.1674330132	4	5		15.085964768	-6.24110871	0.1081549043	0.9927611132	6531	SLC6A3	Cl.O=C(c1cc(Cl)ccc1)C(C)NC(C)(C)C	Microsource	01504174	-6.92633063	-8.40497064	-4.46686482	7.38070087	-6.24110871											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095795-06	5,7-Dichloro-8-hydroxy-2-methylquinoline	170465701	Botulinum neurotoxin type A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	72-80-0		1.1220184543	-5.95	-11.5280118845	4	5		11.595242152	-4.56151622	0.2003066473	0.9746790812			Oc1c(Cl)cc(Cl)c2ccc(C)nc12	Microsource	00212151	-5.4282693	-7.57936846	-4.65106543	4.90056492	-4.56151622											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00184708-02	NCGC00184708-02	124896555	smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	26538-44-3		7.9432823472	-5.1	-5.0512256856	4	4	Zearalanol`	-12.6557493719	-10.54645781	0.2176391943	0.9698808369			CC1CCCC(O)CCCCCC2=CC(=CC(=C2C(=O)O1)O)O	SIGMA	NTP_SID_1403	0.47646358	2.62612301	-5.06323631	-10.54645781												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00178376-05	Sulfaquinoxaline	170465653		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	59-40-5				9.0907312925	4	5		0	-1.32164655					Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2	Microsource	01501145	4.1505111	0.71069878	-3.63796207	6.33353236	-1.32164655											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015725-15	Nimesulide	170465612	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	51803-78-2	; ;NIMESULIDE; Nimesulide;Nimesulide; Nimesulida			-18.0077784312	4	5		0	-2.08342894			5743	PTGS2	[O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(C)(=O)=O	Vitas	STL018679	-3.85089884	-6.26010724	-4.70130196	-2.35612915	-2.08342894											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015100-15	Altretamine	170464714	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	645-05-6	; ; Altretamine; Hexamethylmelamine;ALTRETAMINE; Melamine, hexamethyl-; Hexalen; Altretamina;Altretamine	1.1220184543	-5.95	-13.0599368259	4	5		14.3719465479	-6.44302694	0.1229656074	0.9906217673		H2AFX	CN(C)c1nc(nc(n1)N(C)C)N(C)C	Microsource	01503065	-7.03207614	-8.64328879	-4.86875706	6.51724613	-6.44302694											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164375-03	1-Phenoxy-2-propanol	170465645		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	770-35-4		2.8183829313	-5.55	-11.2084184288	4	5		13.6318293999	-2.75343032	0.2003869083	0.974622271			CC(O)COc1ccccc1	SIGMA	484423	-6.7765245	-4.49825517	-5.94046971	5.98447619	-2.75343032											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185774-02	Erdosteine	170465586	Mucolytic Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	84611-23-4	Erdosteine	2.8183829313	-5.55	-13.9084932255	4	5		15.45271938	-4.94699647	0.115117848	0.9918001058		CAT	O=C1SCCC1NC(=O)CSCC(=O)O	Bosche	E2165	-6.52097286	-7.87726615	-6.8363545	5.85587654	-4.94699647											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262940-01	Iodoxamic Acid	170465432		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	31127-82-9	Acide iodoxamique;Iodoxamate meglumine;Iodoxamic acid			-6.4627328768	4	5		0	-0.64246707					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCOCCOCCOCCOCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	GVK	FFS-11-286-NCI-61	-1.54212196	-1.34053962	-3.08536024	-0.0413356	-0.64246707											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182040-01	Bevantolol hydrochloride	144206530	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	42864-78-8	Bevantolol hydrochloride; Calvan; Vantol; 			-31.0212283248	4	4	bevantolol;1-((3,4-DIMETHOXYPHENETHYL)AMINO)-3-M-TOLYLOXY-2-PROPANOL HYDROCHLORIDE;1-((2-(3,4-dimethoxyphenyl)ethyl)amino)- 3-(3-methylphenoxy)-2-propanol;Bevantolol;CI 775;bevantololum;Bevantololum;Calvan;CIPLUS_180342;Bevantolol Hydrochloride;2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-, hcl (10ci);Bevantolol hydrochloride;bevantolol hydrochloride;CI-775;LS-122160;BEVANTOLOL;BEVANTOLOL HYDROCHLORIDE;Vantol;LS-122167;CIPLUS_668470;	0	-10.5998576					Cl.COc1cc(ccc1OC)CCNCC(O)COc2cc(C)ccc2	APAC	555783	-6.97930913	-3.4122322	-4.13634789	-10.5998576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016279-05	Aminohippuric acid	170465155		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	61-78-9				-4.3998490928	4	5		0	-0.27534303					O=C(NCC(=O)O)c1ccc(N)cc1	Vitas	STK801822	0.22030314	-3.74074389	-2.96814167	0.1240068	-0.27534303											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263949-02	Piperacillin sodium salt	170465380	Penicillin-binding protein 2B Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	59703-84-3		0.7943282347	-6.1	-20.7992028826	4	5		12.0260873239	-6.51645175	0.1154940584	0.9917639643	933948	penA	[Na+].O=C([O-])[C@H]3N4C(=O)[C@@H](NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)c2ccccc2)[C@H]4SC3(C)C	Microsource	01500489	-8.65350723	-9.60507277	-2.95976891	2.78785652	-6.51645175											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024025-05	Dehydrocholic acid	170465502	bile acid secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	81-23-2		2.8183829313	-5.55	4.4734406824	4	5		11.184824244	-3.4601441	0.5808885743	0.7120783617	1045		O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)C(=O)C[C@H]2[C@H]3C(=O)C[C@@H]1CC(=O)CC[C@@]12C	Prestwick	Prestw-123	1.24250969	-5.57068687	-4.79340227	6.50806044	-3.4601441											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166298-02	Melengestrol acetate	170465702		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2919-66-6				-13.2692146744	4	5		0	-3.00123904					CC(=O)[C@@]3(OC(C)=O)C(=C)C[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1435	-2.75819528	-6.23457316	-3.42027044	1.19873237	-3.00123904											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164493-02	Dipyrithione	170465699		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3696-28-4		7.0794578438	-5.15	-33.7639704066	4	5		-18.137579732	-18.44798311	0.4942024281	0.595193673			[O-][n+]2ccccc2SSc1cccc[n+]1[O-]	Labotest	LT00452770	-6.76771237	-5.43450506	-6.81123624	6.65503146	-18.44798311											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00022185-14	Progesterone		Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	[57-83-0]		14.1253754462	-4.85	-11.469287454	4	4		-11.8703832121	-11.27625489	0.2701251138	0.9526798361		PGR	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C	Tocris	2835	-0.42352318	-2.66931583	-0.13426888	-11.27625489												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016527-06	Clopamine			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	636-54-4				-5.0019425385	4	4		0	-4.70808117					C[C@H]1CCC[C@@H](C)N1NC(=O)C2=CC(=C(Cl)C=C2)[S+](N)([O-])=O	Enzo	CM112	-0.0264702	0.829302	-2.8542966	-4.70808117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532497-01	CEFPODOXIME			DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-0.672299385	4	4		0	-3.04378782					COC\C1=C(\N2[C@H](SC1)[C@H](NC(=O)\C(=N/OC)C3=CSC(=N3)N)C2=O)C(O)=O	Alfa Aesar	J66225	0.29117219	1.88320663	-0.6540194	-3.04378782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183095-01	Tigecycline	124894296	glycylcycline antibiotics	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	220620-09-7	Tigecycline; ; Tigecycline; Tygacil			-14.2324839017	4	4	Tigecycline;tigecycline;TIGECYCLINE;TetX protein, Bacillus fragilis;tigecycline 11a-hydroxylase, Bacillus fragilis;GAR-936;CL-346635;4,6-BIS(DIMETHYLAMINO)-9-((((DIMETHYLETHYL)AMINO)ACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-2-NAPHTHACENECARBOXAMIDE;2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-((((1,1-DIMETHYLETHYL)AMINO)ACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-;TBG-MINO;CIPLUS_736709;GAR 936;WAY-156936;9-(tert-butylglycylamido)minocycline;Tygacil;	0	-8.51726593					CC(C)(C)NCC(=O)Nc1cc(N(C)C)c2C[C@H]3C[C@H]4[C@@H](C(O)=C(C(=O)[C@@]4(O)C(O)=C3C(=O)c2c1O)C(N)=O)N(C)C	ACC	API-03922	-3.20289408	-0.32826538	0.77529453	-8.51726593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371130-03	Vilazodone Hydrochloride		Sodium-dependent serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	163521-08-2		14.1253754462	-4.85	-29.8514523797	4	4		-25.897664108	-24.46600214	0.1386588814	0.9879822409	6532	SLC6A4	NC(=O)C1=CC2=CC(=CC=C2O1)N3CCN(CCCCC4=C[NH]C5=C4C=C(C=C5)C#N)CC3	APExBIO	A3919	-3.43230247	-3.2049067	-0.80128205	-24.46600214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017147-02	CEFEPIME HYDROCHLORIDE		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	123171-59-5				-6.0903444717	4	4		0	-2.3495906					CO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)C[N+]3(C)CCCC3)C4=CSC(=N4)N	Microsource	01502420	-0.49411038	-3.32584658	-1.06981982	-2.3495906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022579-05	Carbenicillin disodium	170465106	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	4800-94-6				-23.4960747654	4	5		0	-4.84603735					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)C(c1ccccc1)C([O-])=O)[C@H]3SC2(C)C	Microsource	01500160	-7.79873105	-5.51110733	-4.0984636	1.86928765	-4.84603735											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015703-06	Mecamylamine	170465225	Neuronal acetylcholine receptor; alpha4/beta2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	60-40-2				-13.7629794421	4	5		0	-2.86356753					CNC2(C)C1CCC(C1)C2(C)C	Enzo	AC741	-4.17694748	-4.64294834	-1.58663708	0.68433381	-2.86356753											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00319019-01	Nemorubicin	170465590	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	108852-90-0		11.220184543	-4.95	-458.1781689782	5	5		92.7814035241	-98.45348997	0.323264047	0.961052305		TOP2A	COC1CN(CCO1)C6CC(OC5C[C@@](O)(Cc4c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c4O)C(=O)CO)OC(C)C6O	GVK	FFS-11-286-NCI-135	-97.76172013	-97.91897183	-98.11613011	-96.68396638	-98.45348997											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00389674-01	Apremilast (CC-10004)		Phosphodiesterase 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	608141-41-9				4.6493644326	4	4		0	-0.07679104					CCOC1=C(OC)C=CC(=C1)C(C[S+](C)([O-])=O)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(C)=O	APExBIO	A4317	1.03584276	0.08165721	2.86786384	-0.07679104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162247-06	Levallorphan	170465778	Mu-type opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	152-02-3				4.9470963929	4	4		0	1.04345469			4988	OPRM1	Oc3ccc4C[C@H]1N(CC[C@@]2(CCCC[C@@H]12)c4c3)CC=C	SIGMA	L121	0.67178087	0.20199416	3.30563745	1.04345469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018296-07	Meclizine hydrochloride	170464899	Constitutive Androstane Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1104-22-9	; Meclozine dihydrochloride;Meclozine dihydrochloride; Meclizine Hcl;Meclizine dihydrochloride;MECLIZINE HYDROCHLORIDE;Meclizine hydrochloride; Meclozina			-10.750003373	4	5		0	-2.01000413			9970	NR1I3	Cl.Cl.Cc1cccc(c1)CN2CCN(CC2)C(c3ccc(Cl)cc3)c4ccccc4	Microsource	01500376	-2.63482552	-5.90263001	-3.34491564	3.00831305	-2.01000413											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091414-07	Salicylamide	170465496		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	65-45-2				-6.474674424	4	5		0	0.97287871					O=C(N)c1ccccc1O	Vitas	STK301812	-1.37469158	-4.18333475	-1.40243647	-1.07013273	0.97287871											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021122-08	Alverine citrate	170466248		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	5560-59-8				-30.6035829287	4	5		0	-3.58863751					O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCCc1ccccc1)CCCc2ccccc2	Microsource	01500109	-8.81212548	-8.30283428	-7.2466195	-1.0150186	-3.58863751											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016504-09	Droperidol	170464722	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	548-73-2				-1.2773677595	4	5		0	-3.72630903					Fc1ccc(cc1)C(=O)CCCN2CC=C(CC2)N3c4ccccc4NC3=O	Microsource	01501002	0.4494184	-1.79164184	-3.41189768	6.16818996	-3.72630903											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00522533-01	Olodaterol		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	868049-49-4				-24.6332848403	4	4		0	-8.41539434			154	ADRB2	COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(=C2)O)C=C1	MedChem Express	HY-14301	-4.85849261	-7.89496304	-0.5985884	-8.41539434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091019-23	Dexamethasone		Antiinflammatory agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	50-02-2				-4.9855221855	4	4		0	0.40202367				NR3C1	C[C@@H]1C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	Microsource	01500230	-2.38807264	1.23345367	-0.07147324	0.40202367												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167553-02	Norphenylephrine hydrochloride	225144293	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	4779-94-6				-11.2776554185	4	4		0	-2.57024121					NCC(O)C1=CC=CC(=C1)O	SIGMA	113727	-1.94599749	-3.61440605	-2.66237827	-2.57024121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181307-01	Febantel	144206335		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	58306-30-2	Febantel; Bayer brand of febantel; Rintal; Armadose; 	11.220184543	-4.95	-43.3489304183	-3	4	N-{2-[2,3-Bis-(methoxycarbonyl)-guanido]-5-(phenylthio)-phenyl}-2-methoxyacetamide;Bayer brand of febantel;febantel;DIMETHYL ((2-(2-METHOXYACETAMIDO)-4-(PHENYLTHIO)PHENYL)IMIDOCARBONYL)DICARBAMATE;BAY H 5757;FEBANTEL / PRAZIQUANTEL / PYRANTEL AS PYRANTEL EMBONATE;FEBANTEL / IMIDACLOPRID / IVERMECTIN / PRAZIQUANTEL / PYRANTEL AS PYRANTEL EMBONATE;FEBANTEL / PYRANTEL EMBONATE;CARBAMIC ACID, ((2-((METHOXYACETYL)AMINO)-4-(PHENYLTHIO)PHENYL)CARBONIMIDOYL)BIS-, DIMETHYL ESTER;Febantel;febantelum;Bay Vh 5757;LS-50021;((2-((methoxyacetyl)amino)-4-(phenylthio)phenyl)carbonimidoyl)bis(carbamic acid), dimethyl ester;Febantelum;2'-(2,3-bis(methoxycarbonyl)guanidino)-5'-phenylthio-2-methoxyacetanilide;Rintal;BAY VH 5757;dimethyl 2-(methoxyacetyl)amino-4-(phenylthio)phenyl(carbonimidoyl)bis(carbamate);CIPLUS_183199;FEBANTEL;Armadose;	-39.4834169881	-37.44240672	0.0363039185	0.9991871153			O=C(OC)N/C(NC(=O)OC)=N\c2ccc(Sc1ccccc1)cc2NC(=O)COC	FLUKA	33981	-3.28955923	-4.40519168	-5.55704458	-37.44240672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168776-03	Delavirdine	170464664	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	136817-59-9				-24.0826932065	4	4		0	-5.37988978					O=C(c1cc2cc(NS(C)(=O)=O)ccc2n1)N3CCN(CC3)c4ncccc4NC(C)C	Sequoia	147221-93-0	-5.42192173	-8.17861441	-0.71473242	-5.37988978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-11	Imatinib	170465393	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	220127-57-1	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	14.1253754462	-4.85	-29.2417657534	4	5		-15.9105594	-15.7587995	0.4633432019	0.6371213464	25	ABL1	CS(=O)(=O)O.Cc3ccc(cc3Nc1nc(ccn1)c2cccnc2)NC(=O)c4ccc(cc4)CN5CCN(C)CC5	Prestwick	Prestw-1290	-6.24779697	-6.14094817	-4.57571064	2.31020071	-15.7587995											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181335-02	Fosfestrol tetrasodium	225144324	estrogen-related receptor gamma Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	4719-75-9				-4.3986247259	4	4		0	0.09485952			2104	ESRRG	CC\C(=C(\CC)C1=CC=C(O[P](O)(O)=O)C=C1)C2=CC=C(O[P](O)(O)=O)C=C2	Bosche	F12397	-2.53543102	-6.15867286	1.50093809	0.09485952												1.6E-9	8E-9	4E-8	2E-7											
NCGC00167518-09	Temsirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	162635-04-3				-118.3851681828	4	4		0	-26.19477821				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(C)(CO)CO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Adooq	A10906	-25.28929918	-27.00275056	-21.57598499	-26.19477821												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00159511-04	Butenafine	170465093	Trichophyton mentagrophytes Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	101828-21-1				-13.9443112164	4	4		0	-6.10262896					CN(Cc1ccc(cc1)C(C)(C)C)Cc3cccc2ccccc23	Bionet	KS-1035	-1.8419798	-3.66597903	-3.02867864	-6.10262896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167496-03	Methylene blue	170465461	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	61-73-4	; Ehrlich's reagent III; Urolene Blue; Yamamoto Methylene Blue B; Methylene Blue Hydrate; Azure II eosinate; Blue, Swis; Taylor's Blue; Cloruro de metiltioninio; Blue, Methylen; ; Methylene blue trihydrate; N, Methylene Blu; Methylene blue; Methylene blue hydrate; Methylene Blue hydrate; Basic Blue 9; Chromosmon;Methylene blue; Methylene Blue solution; Blue N, Methylen; Azure II; Methylene Blue N;Methylene Blue	10	-5	-65.8233159146	-2.2	4		-46.6714318457	-41.87546298	0.0426147306	0.9988795419		MAOA	[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	Labotest	LT00032971	-6.75348274	-8.80037851	-15.92002472	-41.87546298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485920-01	Tofogliflozin (hydrate)	363681416	Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1201913-82-7				-25.8740230269	4	4		0	-7.13756591					CCC1=CC=C(CC2=CC3=C(CO[C@]34O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=C2)C=C1	MedChem Express	HY-13413	-5.23924894	-7.09707944	-3.14693031	-7.13756591												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247716-01	(+)-Pentazocine succinate	144206429		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	124819-26-7				-9.3786284022	4	4		0	0.16558456					O=C(O)CCC(=O)O.C/C(C)=C\CN2CC[C@]1(C)c3cc(O)ccc3C[C@H]2[C@H]1C	RTI	9709-002	-2.28000346	-2.48612844	-1.72573598	0.16558456												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346438-03	Retaspimycin (Hydrochloride)		Heat shock protein HSP90 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	857402-63-2		8.9125093813	-5.05	-64.8647372541	-2.4	4		-42.1783924775	-42.36350168	0.1924870629	0.9764498566		HSP90AB1	CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=CC(=C2O)NC(=O)C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C\[C@H](C)[C@H]1O)/C)/C)O	MedChem Express	HY-10210	-9.20221511	-2.70119145	-11.17976784	-42.36350168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00348365-01	INDOCYANINE GREEN			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3599-32-4				-27.7138929684	4	5		0	-1.93099661					CC1(C)C(=C\C=C\C=C\C=C\C2=[N+](/CCCC[S]([O-])(=O)=O)C3=CC=C4C=CC=CC4=C3C2(C)C)/N(CCCC[S]([O-])(=O)=O)C5=CC=C6C=CC=CC6=C15	SIGMA	I2633	-8.1148619	-5.77714874	-4.87261828	-5.40315513	-1.93099661											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091231-04	Quinidine hydrochloride monohydrate	170465031	Antimalarial Agents; Cytochrome P450 Cyp2d6 Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	6151-40-2				-27.6718041678	4	5		0	-6.13160062				CYP2D6	[H][C@@]1(CC2CCN1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12	Prestwick	Prestw-280	-7.27312582	-2.76634071	-5.62620424	-5.34180543	-6.13160062											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091120-13	Griseofulvin	170465739	Tubulin beta chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	126-07-8				-31.1374132892	4	5		0	-12.65672188				TUB2	O=C2c3c(O[C@]12C(=CC(=O)C[C@H]1C)OC)c(Cl)c(OC)cc3OC	Prestwick	Prestw-226	-5.06356861	-4.90221307	-4.56433312	-8.11130587	-12.65672188											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023212-14	Stavudine	170464820	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3056-17-5	 2',3'-didehydro-3'-deoxythymidine; ; Zerit; Dideoxydidehydrothymidine;; Stavudine;Stavudine; 2',3'-Anhydrothymidine; stavudine (d4T);2',3'-didehydro-3'-deoxythymidine; D4T (2',3'-Didehydro-3'-deoxythymidine); Sanilvudine; Estavudina; 2',3'-Didehydro-3'-deoxythymidine; Estavudina (INN-Spanish);2',3'-Didehydro-3'-deoxythymidine			-13.8264633301	4	5		0	0			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@@H](CO)O2	Prestwick	Prestw-1279	-3.26611135	-4.19025562	-3.51102548	-3.41367222	0											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274060-01	Posaconazole	170464963	Lanosterol 14alpha-demethylase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	171228-49-2		1.1220184543	-5.95	-54.8929055187	4	5		-23.85767286	-0.74128306	0.1011505493	0.9936513638		CYP51A1	C[C@H](O)[C@H](CC)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OCC6C[C@@](Cn5cncn5)(OC6)c7ccc(F)cc7F	Selleck	S1257	-4.59886015	-2.40607308	-7.45878827	-27.28746713	-0.74128306											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018097-06	Paroxypropione	170465896	Succinate semialdehyde dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	70-70-2				-17.9415138812	4	5		0	-4.08633223					O=C(CC)c1ccc(O)cc1	Labotest	LT00855519	-5.73910811	-3.19900112	-2.52233316	-0.34950751	-4.08633223											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091050-09	Phenylmercuric acetate	170465524		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	62-38-4		12.5892541179	-4.9	-72.215705001	-3	5		-112.4214521118	-99.56653271	0.0127931836	0.993542146			CC(=O)O[Hg]c1ccccc1	Microsource	01500644	-3.50509287	3.64677517	2.62743037	6.17765875	-99.56653271											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015442-15	Fluorouracil	170464762	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51-21-8	 5-Fluorouracil;FLUOROURACIL;5-Fluorouracil	12.5892541179	-4.9	-45.635253687	4	5		-19.2195769559	-23.52011559	0.1494918813	0.915991844		TYMS	FC1=CNC(=O)NC1=O	Vitas	STK297802	-9.3426346	-7.4614656	-4.13382379	-3.75380146	-23.52011559											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015996-10	Tiapride hydrochloride	170465877	Dopamine D3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51012-33-0				-22.4588231642	4	5		0	-4.57398293					Cl.O=S(C)(=O)c1cc(c(OC)cc1)C(=O)NCCN(CC)CC	Microsource	01503086	-6.55225541	-1.82984586	-4.10754948	-3.91720757	-4.57398293											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094960-06	Anthraquinone	170466833	Beta amyloid A4 protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	84-65-1		0.4466835922	-6.35	-20.253621608	4	5		11.006070784	-7.53600939	0.1356504329	0.9886246756			O=C2c1ccccc1C(=O)c3ccccc23	Vitas	STK398385	-8.49524951	-9.58839232	-4.238921	1.49335028	-7.53600939											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00017323-08	Tetracycline hydrochloride	170464838	30S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	64-75-5	 Achromycin;; Tetraciclina; Tetracycline Hcl; Bristacycline; Tetrabid; Hostacyclin; Contramibial; Sustamycin;Tetracycline hydrochloride; Tetracycline hydrate; Ulcrux powder;Tetracycline;TETRACYCLINE HYDROCHLORIDE; Achromycin V; 4 Epitetracyclin; 4-Epitetracycline; Topicycline	1	-6	-11.4522720135	4	5		10.5853804679	-2.5782273	0.0503287558	0.9984577349		PADI1	Cl.NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O	Microsource	01500566	-6.32115039	-5.70481357	-1.90050797	3.86273887	-2.5782273											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263922-02	Darifenacin hydrobromide	170465079	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	133099-07-7		1	-6	-31.7435872756	4	5		9.306930744	-9.37824536	0.1781392419	0.9802226641	1131	CHRM3	Br.NC(=O)C(c1ccccc1)(c2ccccc2)[C@@H]3CCN(C3)CCc4cc5CCOc5cc4	Microsource	01505714	-10.67790807	-9.12339619	-7.08530391	-0.42213245	-9.37824536											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00168759-05	PTC-124	170466862	CFTR-G542X nonsense allele Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	775304-57-9	Ataluren;PTC124	12.5892541179	-4.9	-33.8003996353	4	5		-16.179240872	-15.63642931	0.1406845251	0.9220583506	1080	CFTR	O=C(O)c1cccc(c1)c2nc(on2)c3ccccc3F	Selleck	S6003	-6.14996148	-2.57039525	-5.76283062	-6.98561118	-15.63642931											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159376-04	Methylparaben	170465480	canonical glycolysis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	99-76-3				-10.164339401	4	5		0	-3.66189552					Oc1ccc(cc1)C(=O)OC	Labotest	LTBB002210	-3.28254729	-0.68457763	-2.68873708	1.45703781	-3.66189552											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015798-11	Dexpropranolol	170464682	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	5051-22-9				-25.5464207494	4	5		0	-10.66961665					CC(C)NC[C@@H](O)COc2cccc1ccccc12	Specs	AN-153/I110481	-7.45099718	-2.81150435	-2.92520582	0.36766375	-10.66961665											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091737-05	Sorbic acid			DPI_SARS-CoV-2_General	2019_NPC-3_Tox	110-44-1				-29.2994142984	4	5		0	-5.15193931					C/C=C/C=C/C(O)=O	SIGMA	S1626	-8.37541727	-8.26229226	-5.96426695	0.04085153	-5.15193931											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183008-01	Israpafant	144206851	Interleukin-5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	117279-73-9	ISRAPAFANT; 	12.5892541179	-4.9	-99.2251920534	-3	5	6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 4-(2-chlorophenyl)-6,9-dimethyl-2-(2-(4-(2-methylpropyl)phenyl)ethyl)-;4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;Y 24180;CIPLUS_695838;(+/-)-4-(O-CHLOROPHENYL)-2-(P-ISOBUTYLPHENETHYL)-6,9-DIMETHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;israpafant;ISRAPAFANT;Israpafant;Y-24180;israpafantum;	-103.743502955	-99.40398248	0.0095202825	0.995206278			CC(C)Cc1ccc(cc1)CCc2cc5c(s2)n3c(C)nnc3C(C)N=C5c4ccccc4Cl	Pharmaron	PH-NIH-155125	-7.74201832	-8.95978645	-4.16009809	-2.00172484	-99.40398248											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00186658-01	Dexpanthenol	170464647		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	81-13-0				-16.6359361696	4	5		0	-2.19894342					CC(C)(CO)[C@@H](O)C(=O)NCCCO	Labotest	LT00244791	-6.55225541	-1.69206923	-1.80416886	-0.56738232	-2.19894342											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163778-09	Imazalil sulfate	170466809	O75469|||Q9UJ26 REC20 - 20% relative effective concentration; the concentration of the test compound showing 20% of the agonistic activity of 1 _ 10_5 M rifampicin via hPXR	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	58594-72-2				-32.588715741	4	5		0	-10.35354676					O=S(=O)(O)O.Clc2ccc(C(OCC=C)Cn1ccnc1)c(Cl)c2	Prestwick Chemical, Inc.	Prestw-963	-9.29983737	-7.1342461	-1.80416886	-1.93817802	-10.35354676											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015254-20	Clozapine	170464853	Dopamine D4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	5786-21-0	;Clozapine; ; clozapine N-glucuronide;CLOZAPINE; Leponex; Clozaril; Clozapine; Clozapina; Clo-Glu			-31.71233193	4	5		0	-8.47518851			1815	DRD4	CN1CCN(CC1)C2=Nc4cc(Cl)ccc4Nc3ccccc23	Enzo	D107	-8.68355731	-6.44536296	-4.00245227	-2.81875539	-8.47518851											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00162129-06	Tocainide hydrochloride	170465114	Sodium channel alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	35891-93-1				-9.4152562324	4	5		0	-4.05417772					Cl.O=C(Nc1c(C)cccc1C)C(C)N	Prestwick	Prestw-1027	-1.01271372	0.94784697	-3.9820167	-3.41367222	-4.05417772											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167513-04	Vandetanib	170465617	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	443913-73-3	 ;AZD-6474;Caprelsa;ZD-6474;Zactima;Vandetanib; Vandetanib;CH-331			-19.7514034429	4	5		0	-3.72471859			1956	EGFR	CN4CCC(COc2cc3ncnc(Nc1ccc(Br)cc1F)c3cc2OC)CC4	Sequoia	443913-73-3	-3.0732135	-4.04443301	-8.82894455	-3.24715162	-3.72471859											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016809-07	Moricizine hydrochloride	174006664	class 1c antiarrhythmic, Na(v)1.5 channel blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	29560-58-5	 Moracizina;Moricizine hydrochloride; Ethmozine; Moracizine;Moracizine; ; Ethmozin; Hydrochloride, Moricizin; Etmozin			-31.2210126391	4	5		0	-7.01015832					Cl.O=C(OCC)Nc1cc2N(c3ccccc3Sc2cc1)C(=O)CCN4CCOCC4	Prestwick	Prestw-1051	-8.03594915	-3.76994339	-6.85078142	-5.22787029	-7.01015832											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022680-05	Chlormadinone acetate	170465776	Androgen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	302-22-7		10	-5	-66.9587315943	-3	5		-54.2922514973	-54.03129862	0.0125644359	0.9936613765	367	AR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1374	-8.15870232	-3.57265397	-4.55576964	-8.2427695	-54.03129862											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091532-06	Clorophene	170465725		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	120-32-1				-17.1669680499	4	5		0	-5.30795278					Oc2ccc(Cl)cc2Cc1ccccc1	Bosche	B0598	-4.03770276	-1.43678161	-1.17319632	-5.56091148	-5.30795278											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015121-17	Phenoxybenzamine hydrochloride	170465147	Adrenergenic Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	59-96-1	; ;Phenoxybenzamine; Fenoxibenzamina;PHENOXYBENZAMINE; Phenoxybenzamine HCl;Phenoxybenzamine HCl;Phenoxybenzamine hydrochloride;PHENOXYBENZAMINE HYDROCHLORIDE; Phenoxybenzamine hydrochloride			-26.4722807878	4	5		0	-5.13407157				ADORA1	CC(COc1ccccc1)N(Cc2ccccc2)CCCl	Microsource	02300176	-6.55414292	-5.33110311	-5.65189467	-4.00964067	-5.13407157											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164607-01	Bentiromide sodium	144205782		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	41748-47-4	Bentiromide; N-benzoyl-L-tyrosyl-PABA; Bentiromido; benzoyl-tyrosyl-PABA; PABA-peptide; 			-19.1336348724	4	4	N-Benzoyl-L-tyrosyl-4-aminobenzoic acid sodium salt;benzoyl-tyrosyl-PABA;bentiromidum;bentiromide;CIPLUS_3741566;NCGC00164607-02;N-BENZOYL-L-TYROSYL-P-AMINOBENZOIC ACID;N-Benzoyl-L-tyrosine p-amidobenzoic acid sodium salt;Bentiromidum;BENTIROMIDE;PABA-peptide;NCGC00164607-01;N-benzoyl-L-tyrosyl-PABA;4-((2-(BENZOYLAMINO)-3-(4-HYDROXYPHENYL)-1-OXOPROPYL)AMINO)BENZOIC ACID;Bentiromide (N-Benzoyl-L-tyrosyl-p-aminobenzoic acid (bentiromide);Bentiromide;CIPLUS_178986;Bentiromido;NCGC_FLUKA_13135;N-benzoyl-L-tyrosyl-p-aminobenzoic acid;	0	-2.69984585					[Na+].Oc3ccc(C[C@H](NC(=O)c1ccccc1)C(=O)Nc2ccc(cc2)C([O-])=O)cc3	Labotest	LT00645584	-5.08843775	-4.29845222	-1.5985713	-2.69984585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090693-11	D-Nicotine	170464932	Neuronal acetylcholine receptor; alpha4/beta2 Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	25162-00-9				-32.4384773813	4	5		0	-6.4162189					CN2CCC[C@@H]2c1cnccc1	Microsource	02300259	-9.93323633	-6.75536037	-5.10597302	-1.32994417	-6.4162189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023699-09	Cephalothin	170465101	Solute carrier family 22 member 7 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	153-61-7				-29.4586723912	4	5		0	-5.60995699			10864	SLC22A7	O=C(O)C=2N3C(=O)[C@@H](NC(=O)Cc1cccs1)[C@H]3SCC=2COC(C)=O	Microsource	01500166	-8.91275756	-4.99656888	-6.19995718	-1.30148992	-5.60995699											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094363-07	D-SERINE		Serine palmitoyltransferase 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	312-84-5				-31.9391955971	4	5		0	-6.26887526					N[C@H](CO)C(O)=O	SIGMA	S4250	-7.90442788	-6.75501801	-6.14001285	-5.12269939	-6.26887526											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159504-04	Thymol iodide	170465466		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	552-22-7				-8.0105323276	4	5		0	-1.2629267					IOc1cc(C)c(cc1C(C)C)c2cc(C(C)C)c(OI)cc2C	SIGMA	T2763	0.2498904	-2.32887288	-4.11903233	-4.32515337	-1.2629267											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094918-07	Saccharin	170465766	Taste receptor type 1 member 3 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	81-07-2				-20.1894481349	4	5		0	-2.67227967			83756	TAS1R3	O=C2NS(=O)(=O)c1ccccc12	Vitas	STK803263	-6.1245068	-1.71984903	-7.57011347	-0.48641543	-2.67227967											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179685-03	Isoflupredone acetate	170465628		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	338-98-7				-29.6901680099	4	4		0	-7.28572051					CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-6	-7.85238384	-3.02808723	-2.97038443	-7.28572051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015741-13	4,4 -(2,3-Dimethyltetramethylene)dipyrocatechol		5-Lipoxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	500-38-9				-21.3256586519	4	4		0	-8.6714018				ALOX5	CC(CC1=CC(=C(O)C=C1)O)C(C)CC2=CC(=C(O)C=C2)O	Prestwick	Prestw-NAT-0055	-4.33936143	-4.57654093	-0.8076974	-8.6714018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181755-01	Delapril hydrochloride	144206480		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	83435-67-0	Delapril hydrochloride; Adecut; 			-23.0214187272	4	4	Delapril Hydrochloride;Delapril hydrochloride;RHC-6000-A;RO-16-3037;N-(2,3-DIHYDRO-1H-INDEN-2-YL)-N-(N-((1S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)-L-ALANYL)GLYCINE HYDROCHLORIDE;CIPLUS_192483;derapril;USV 6000-A(SS);delapril;N-(2,3-dihydro-1H-inden-2-yl)-N-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)alanyl)glycine;CV 3317;N-(1-(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-(S)-ALANYL-N-(2-INDANYL)GLYCINE HYDROCHLORIDE;N-(N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl)-N-(indan-2-yl)glycine hydrochloride;DELAPRIL;LS-72517;DELAPRIL HYDROCHLORIDE;delaprilum;CV-3317;CIPLUS_667977;Delapril;LS-177754;Adecut;	0	-7.35544032					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C2Cc3ccccc3C2	ACC	DELAPRIL HYDROCHLORIDE	-5.70649823	-3.07970235	-1.14313457	-7.35544032												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016889-06	Tenoxicam	170465677	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	59804-37-4	 Tilcotil; Tenoxicam; ;TENOXICAM;Tenoxicam; Mobiflex			-22.8731669154	4	5		0	-4.43854672				PTGS2	OC=2c1sccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Microsource	01503142	-3.60806664	-5.3053697	-7.81845429	-5.28045574	-4.43854672											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018234-07	Sulfaguanidine	170465708		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57-67-0				-13.2351493195	4	5		0	-1.51002105					Nc1ccc(cc1)S(=O)(=O)NC(=N)N	Specs	AT-084/J157969	-4.66900482	-1.71127123	-0.38535645	-2.83523225	-1.51002105											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095164-04	Protionamide	170465795	tuberculosis treatment	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	14222-60-7	; ; Trevintix; Peteha; PROTHIONAMIDE; Prothionamide; Protionamida;PROTHIONAMIDE;PROTIONAMIDE;Prothionamide			-35.8868845172	4	5		0	-8.77642537					CCCc1cc(ccn1)C(N)=S	Vitas	STK366469	-8.7812363	-3.49545377	-8.03254121	-7.12971078	-8.77642537											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016506-07	Naphazoline hydrochloride	170464797	Alpha-1b adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	550-99-2				-1.0142730751	4	5		0	0.53994692					Cl.c2cc(CC1=NCCN1)cc3ccccc23	Vitas	STK300042	1.41604559	-2.10585006	-1.35302933	-2.32690622	0.53994692											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179599-03	Cefoperazone sodium	170465235	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	62893-20-3				-28.3557640631	4	5		0	-6.28717855					[Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]5C(=O)N4C(=C(CSc3nnnn3C)CS[C@@H]45)C([O-])=O	Prestwick Chemical, Inc.	Prestw-327	-7.83428321	-2.08011666	-7.46735174	-3.51007888	-6.28717855											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016411-10	Butacaine	170465459		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	149-16-6				-21.3252280212	4	5		0	-2.37942711					Nc1ccc(cc1)C(=O)OCCCN(CCCC)CCCC	Microsource	01503914	-5.77378343	-2.21736147	-5.12095911	-5.30674847	-2.37942711											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015861-09	Propentofylline	170465624	Adenosine receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	55242-55-2				-14.1305312432	4	5		0	-2.05911961					CC(=O)CCCCN2C(=O)c1n(cnc1N(C)C2=O)CCC	SIGMA	P9689	-2.94169224	-2.92074112	-3.70798544	-3.58019281	-2.05911961											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167540-03	3-Methylindole	170465747	Aryl hydrocarbon receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	83-34-1				-37.3436098667	4	4		0	-5.71702471					Cc2cnc1ccccc12	Vitas	STK033388	-9.15029852	-8.0003441	-5.88339145	-5.71702471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091512-04	(2E)-3-Phenylprop-2-enal	144204695	Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	14371-10-9	CINNAMALDEHYDE; trans-3-Phenyl-2-propenal; 			2.6475298472	4	4	CIPLUS_757838;CINNAMALDEHYDE;cinnamaldehyde;trans-3-Phenyl-2-propenal;2-propenal, 3-phenyl- (9ci);trans-cinnamaldehyde;CIPLUS_150798;Cinnamic aldehyde;LS-378;cinnamic aldehyde, (E)-isomer;AB08006278-01;cinnamic aldehyde;trans-Cinnamaldehyde;Cinnamaldehyde (trans), neat;CIPLUS_169354;beta-phenylacrolein;AB08007164-01;Cinnamaldehyde;LS-850;	0	-3.4772757			5468	PPARG	O=C\C=C\c1ccccc1	Labotest	LT00939010	2.89434974	-2.00438729	-1.06368893	-3.4772757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484900-01	Estramustine Phosphate·Na		Dna Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	52205-73-9		14.1253754462	-4.85	-17.816050201	4	4		-22.948755932	-19.95729661	0.2359391401	0.9641327618		H2AFX	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)N(CCCl)CCCl)[C@@H]1CC[C@@H]2O[P](O)(O)=O	Enzo	AC1524	-0.73981137	-2.95926707	1.51388092	-19.95729661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167559-01	Androstenone	144206107		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	18339-16-7	5A-ANDROSTA-16-ENE-3-ONE; Androstenone; 			-20.616235481	4	4	3-Keto-5alpha,16-androstene;5 alpha-androst-16-en-3-one;CIPLUS_663558;androsta-5,16-dien-3 beta-ol;5,16-androstadien-3 beta-ol;ANDROSTAENEONE;andien-beta;androstadienol;CIPLUS_728432;5A-ANDROSTA-16-ENE-3-ONE;androst-16-en-3-one;androst-16-en-3-one, (5beta)-isomer;16-(5alpha)Androsten-3-one;Androstenone;5alpha-Androst-16-en-3-one;	0	-2.6929278					O=C2C[C@@H]3CC[C@H]1[C@@H]4CC=C[C@@]4(C)CC[C@@H]1[C@@]3(C)CC2	SigmaAldrich	A8008	-5.10080471	-4.54213084	-3.43823101	-2.6929278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179430-04	Iocetamic acid			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	16034-77-8				-19.8226337362	4	4		0	-2.83236742					CC(CN(C(C)=O)C1=C(I)C(=C(I)C=C1I)N)C(O)=O	Prestwick	Prestw-838	-5.25655447	-4.53352832	-1.59332657	-2.83236742												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182972-01	Hexocyclium	144206775	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	115-63-9	4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium; Metilsulfato de hexociclo; 			-24.5054337781	4	4	HEXOCYCLIUM METHYLSULFATE;Hexocyclium Methylsulfate;Metilsulfato de hexociclo;4-(.BETA.-CYCLOHEXYL-.BETA.-HYDROXYPHENETHYL)-1,1-DIMETHYLPIPERAZINUM METHYLSULFATE;LS-113656;LS-113657;4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium;Hexocyclium metilsulfate;hexocyclii metilsulfas;Hexocyclii metilsulfas;Tral;hexocyclium;metilsulfate d'hexocyclium;Metilsulfate d'hexocyclium;hexociclium;CIPLUS_679015;CIPLUS_669959;CIPLUS_3863310;hexocyclium methylsulfate;CIPLUS_166714;TRAL;Hexocyclium;HEXOCYCLIUM METILSULFATE;	0	-3.07638677					OC(CN1CC[N+](C)(C)CC1)(c2ccccc2)C3CCCCC3.[O-]S(=O)(=O)OC	NCI	NSC_30256	-7.27264861	-4.19803002	-1.00189787	-3.07638677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522021-01	Dexamethasone 21-Palmitate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	14899-36-6				-17.0813568438	4	4		0	-1.17652185					CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	Toronto Research	D298830	-5.99203946	-0.85164953	-0.43695105	-1.17652185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378896-03	Teneligliptin		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	760937-92-6				-17.7225050113	4	4		0	-3.15482156					CC1=N[N](C2=CC=CC=C2)C(=C1)N3CCN(CC3)[C@@H]4CN[C@@H](C4)C(=O)N5CCSC5	MedChem Express	HY-14806	-3.68175132	-4.42169556	-4.10910535	-3.15482156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162137-02	Dehydroepiandrosterone Sulfate (sodium salt)		Estrogen receptor alpha Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	1099-87-2				-14.4166127642	4	4		0	-4.14446157					C[C@]12CC[C@H]3[C@@H](C\C=C4\C[C@H](CC[C@]34C)O[S]([O-])(=O)=O)[C@@H]1CCC2=O	Cayman	15873	-2.31767884	-3.32267833	-4.4036937	-4.14446157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095312-04	Deracoxib	170465679	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	169590-41-4				-35.3558754578	4	5		0	-9.0802366			791253	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(OC)c(F)c2)C(F)F	Microsource	01505222	-9.44534794	-4.68871093	-8.03117884	-3.09109891	-9.0802366											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094969-05	Anisindione	170465379	Vitamin K-dependent gamma-carboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	117-37-3				-23.3454144259	4	5		0	-2.94848061					COc1ccc(cc1)C3C(=O)c2ccccc2C3=O	Microsource	01502198	-7.34828383	-7.30646689	-4.79068138	1.3481004	-2.94848061											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166022-02	D-(-)-Mandelic acid	170465573		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	611-71-2				-11.7256123262	4	4		0	-2.19400536					O[C@@H](C(=O)O)c1ccccc1	SIGMA	154210	-0.46068521	-4.2614357	-5.92820885	-2.19400536												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346629-02	Dolutegravir (GSK1349572)		HIV Integrase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1051375-16-6		1	-6	-14.7958135566	4	4		-16.742567076	-3.67107195	1	0.9992559919			C[C@@H]1CCO[C@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	Selleck	S2667	0.28177833	-3.83021899	-16.45213923	-3.67107195												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00186629-04	ATP (disodium salt)			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	987-65-5				-27.3088533165	4	4		0	-5.03584694					NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO[P](O)(=O)O[P]([O-])(=O)O[P](O)([O-])=O)[C@@H](O)[C@H]3O	MedChem Express	HY-B0345A	-8.10895429	-6.19768327	-5.81036983	-5.03584694												1.6E-9	8E-9	2E-7	6E-7											
NCGC00344531-01	Droxidopa	170465890	Adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	23651-95-8		0.4466835922	-6.35	6.7183428694	4	4		-13.071065984	-4.33618381	0.196450147	0.9756212888			Oc1ccc(cc1O)[C@H](O)[C@H](N)C(=O)O	SIGMA	D2384	7.17863852	-4.07542065	-6.72588832	-4.33618381												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00378832-01	Eldecalcitol			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	104121-92-8				-15.1584244467	4	4		0	-1.65846074					C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)[C@@H](OCCCO)[C@H](O)C3=C	MedChem Express	HY-A0020	-4.41452724	-4.43899552	1.24184191	-1.65846074												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00164633-02	Nisoldipine	170465320	Ca2+ channel blocker (dihydropyridine)	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	63675-72-9	Nisoldipine;Nisoldipine; Sular; Bay K 5552; Nisoldipino; ; Nisoldipine;NISOLDIPINE	3.5481338923	-5.45	-56.2404825658	-3	4		-86.8781725907	-4.83717716	1	0.9999932174			CC=1NC(C)=C(C(C=1C(=O)OCC(C)C)c2ccccc2[N+]([O-])=O)C(=O)OC	Sequoia	SRP03410n	1.56096252	-3.12843494	-81.47208122	-4.83717716												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00386545-01	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	126544-47-6		11.220184543	-4.95	-33.0664453803	4	4		-23.007936324	-10.59860067	1	0.9996857515		NR3C1	CC(C)C(=O)OCC(=O)[C@@]12OC(O[C@@H]1C[C@H]3[C@@H]4CCC\5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	Axon Medchem	1426	-4.26245639	-4.02468927	-25.69796954	-10.59860067												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00161419-07	Trimetrexate	404904680	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	[82952-64-5]		4.4668359215	-5.35	-56.5897493529	-3	4		-63.5236851919	-8.83648614	1	0.9999737181	1719	DHFR	COC1=C(OC)C(=CC(=C1)NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)OC	NCGCChem	NCGC00161419-05pur	-3.04588961	-9.51213325	-55.56562727	-8.83648614												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00166271-02	Pregnenolone acetate			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1778-02-5				-14.8949381543	4	4		0	-2.48769111					CC(=O)O[C@H]1CC[C@]\2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4C(C)=O)[C@@H]3C\C=C2C1	SIGMA	P49902	-2.70596654	-4.85330177	-2.45649021	-2.48769111												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179290-03	Pivampicillin	170466065		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	33817-20-8				-10.7764715621	4	4		0	-4.10296277					CC(C)(C)C(=O)OCOC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C	Prestwick	Prestw-1009	-2.49127829	-3.19607677	-0.0906454	-4.10296277												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00264110-02	AN-2690			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	174671-46-6				-34.5311801317	4	4		0	-4.25844347					OB1OCC2=CC(=CC=C12)F	MedChem Express	HY-10980	-5.11226407	-7.56743046	-13.36113125	-4.25844347												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00484056-01	Testosterone (undecanoate)			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5949-44-0				-32.9459788061	4	4		0	-5.51092684					CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0626	-7.12496645	-8.64969984	-4.65917331	-5.51092684												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00253596-01	Ethchlorvynol	170464750	GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	113-18-8				-23.2291690676	4	4		0	-4.49166451					C#CC(O)(/C=C\Cl)CC	GVK	FFS-11-286-NCI-036	-2.80436533	-9.14010315	-5.77411168	-4.49166451												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00015998-06	THIOTHIXENE		dopamine secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	5591-45-7, 3313-26-6 [//Z//]				-30.9443795611	4	4		0	-4.70760992					CN(C)[S+]([O-])(=O)C1=CC2=C(SC3=C(C=CC=C3)\C2=C/CCN4CCN(C)CC4)C=C1	Microsource	01500576	-6.50773772	-6.19768327	-7.15192168	-4.70760992												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00090731-08	2-Phenoxyethanol	170465671	Vanilloid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	122-99-6				-22.1883795749	4	4		0	-2.24583225					OCCOc1ccccc1	Bosche	P2904	-4.1014402	-6.50207153	-3.33575054	-2.24583225												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00508704-02	HALOPERIDOL DECANOATE		Dopamine D4 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox					-7.9198048522	4	4		0	-0.50963117					CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Key Organics	KS-1419	0.02236336	-3.39900228	-4.57759246	-0.50963117												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00344522-01	Gluconolactone	170465327	Calcium Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	90-80-2				-29.1798005932	4	4		0	-7.46307333					O[C@H]1[C@H](O)[C@@H](O)C(=O)O[C@@H]1CO	SIGMA	G2164	-5.97101709	-6.64581043	-5.52936911	-7.46307333												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00186028-02	Levetiracetam	170464988	N-Type Calcium Channel (Ca(v) 2.2) Blocker	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	33996-58-6	Levetiracetam			-30.6514978378	4	4		0	-3.42057528				CACNA1B	O=C1CCCN1C(CC)C(N)=O	Prestwick	Prestw-1427	-7.52750693	-7.81263211	-2.58339376	-3.42057528												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181153-01	Treosulfan	144206310	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	299-75-2	treosulfan; Dimesyl-meso-erythritol; Treosulfano; L-dihydroxybusulfan; 			-16.0426374834	4	4	treosulfan, (R*,R*)-isomer;Treosulfano;LS-173863;CIPLUS_677281;treosulfan, ((R*,R*)-(+-))-isomer;CIPLUS_152492;(S-(R*,R*))- 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate;LS-1145;(2R,3R)-4,5-Bis(mesyloxy)butane-2,3-diol;L-threitol-1,4-bismethanesulfonate;TREOSULFAN;CIPLUS_673029;Dimesyl-meso-erythritol;L-dihydroxybusulfan;treosulfan;Treosulfanum;LS-64629;NSC 39069;CIPLUS_168615;LS-174277;LS-173777;treosulfan, (R*,S*)-isomer;treosulfanum;treosulfan, (R-(R*,R*))-isomer;Treosulfan;	0	-4.90627969					CS(=O)(=O)OCC(O)C(O)COS(C)(=O)=O	NCI	NSC-39068	0.56802934	-7.38987063	-9.14612038	-4.90627969												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00178754-06	Primaquine diphosphate	174006623	antimalarial	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	63-45-6		0.7079457844	-6.15	-22.0954859233	4	5		12.9477419399	-10.91333005	0.0678165992	0.9971794096			O=P(O)(O)O.O=P(O)(O)O.CC(CCCN)Nc1cc(cc2cccnc12)OC	Microsource	01500500	-9.4115652	-9.53978495	-2.5183029	2.61876859	-10.91333005											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159391-03	Sulfobromophthalein	170465816	Solute carrier organic anion transporter family member 1B1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	71-67-0				-22.224602594	4	5		0	-2.93234094					[Na+].[Na+].[O-]S(=O)(=O)c1cc(ccc1O)C3(OC(=O)c2c(Br)c(Br)c(Br)c(Br)c23)c4ccc(O)c(c4)S([O-])(=O)=O	Labotest	LT03378988	-5.89282686	-7.54408602	-3.29452236	-2.18606328	-2.93234094											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016296-07	Dicumarol	170465275	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	66-76-2		14.1253754462	-4.85	-34.2130543821	4	5		-25.8238775321	-24.88454468	0.0577561827	0.9698846038			OC=3c4ccccc4OC(=O)C=3CC1=C(O)c2ccccc2OC1=O	Vitas	STK801287	-5.98609462	-2.78709677	-1.69798007	-1.96971063	-24.88454468											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096081-04	beta-Carotene	225144219	Vitamin/Supplement	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	7235-40-7	; ;BETA-CAROTENE; Solatene; Provitamin A; beta,beta-Carotene; Ro 8-8427; Ro-8-8427;beta-CAROTENE; Betacaroteno; beta-Carotene			-14.7048286761	4	5		0	-2.23288347				CAT	CC\1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)/CCCC2(C)C)C(C)(C)CCC1	Microsource	01500143	-5.47736137	-6.31397849	-5.77313222	2.56468043	-2.23288347											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00249896-01	Cinnamedrine	170465535		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	90-86-8				-23.2460154316	4	5		0	-6.37582388					OC(C(C)N(C)C/C=C/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-72	-6.73223673	-5.04086022	-2.78292317	-0.75272694	-6.37582388											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179244-03	Dorzolamide hydrochloride	170465119	Carbonic Anhydrase Type II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	130693-82-2	; Trusopt; 1   Dorzolamide;Dorzolamide HCL;Dorzolamide hydrochloride			9.9844664941	4	5		0	0			760	CA2	Cl.NS(=O)(=O)c1cc2[C@H](C[C@H](C)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-1116	1.89927082	2.64946237	3.83258358	2.7630037	0											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249910-01	Ibafloxacine	170466478	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	91618-36-9				-26.5012938941	4	5		0	-9.12881675					O=C(O)C3=CN1c2c(cc(F)c(C)c2CCC1C)C3=O	GVK	FFS-11-286-NCI-148	-6.81702561	-5.79784946	-3.1357502	-1.13134409	-9.12881675											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249933-01	Nitrogen mustard N-oxide	170465894		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	126-85-2		0.7943282347	-6.1	-26.929015714	4	5		10.690967736	-5.29973546	0.0900565041	0.9950268741			[O-][N+](C)(CCCl)CCCl	GVK	FFS-11-286-NCI-237	-9.64897405	-10.15913978	-4.22951398	0.70765348	-5.29973546											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090787-08	Benzophenone	170465649		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	119-61-9		0.8912509381	-6.05	-18.0127747453	4	5		9.6677419359	-4.1250056	0.215851193	0.9705904506			O=C(c1ccccc1)c2ccccc2	Specs	AE-562/J256170	-6.6135323	-8.47311828	-3.63852871	1.87956369	-4.1250056											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249887-01	Indecainide	170465192	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	74517-78-5				-15.1499778297	4	5		0	-4.25951666					NC(=O)C3(CCCNC(C)C)c1ccccc1c2ccccc23	GVK	FFS-11-286-NCI-023	-3.90876717	-6.58924731	-2.59768898	2.43847471	-4.25951666											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00096014-03	Salsalate	170465545	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	552-94-3				-23.7966006295	4	5		0	-4.56440838					O=C(Oc1ccccc1C(=O)O)c2ccccc2O	Specs	AN-153/I262078	-5.41800916	-8.30967742	-4.22951398	-2.24916614	-4.56440838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00184993-03	Amfenac Sodium	225144335	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox			0.3548133892	-6.45	-12.4564996304	4	5		13.256062404	-2.77989508	0.0240080754	0.9996464861			NC1=C(C=CC=C1CC([O-])=O)C(=O)C2=CC=CC=C2	APAC	872965	-8.54671867	-8.32688172	4.07074182	4.403678	-2.77989508											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015562-25	Indomethacin	170464705	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	53-86-1	 Indocin;; Cu salt; Indocid; Al salt; Indocin I.V.; ; Li salt; Cu(2+) salt; Metindol; Mg salt; Indomethacin; Ca salt; Osmosin; Cu-IMCC; Zn salt; Combiflex;Indomethacin; Indomet 140; Amuno; NH4 salt;INDOMETHACIN; Indometacina			-21.8515441104	4	5		0	-0.95054477				PTGS2	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC	Microsource	01500350	-8.42801424	-7.07956989	-1.57449061	0.77075633	-0.95054477											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016410-13	Thiabendazole	170464939	Methionine Aminopeptidase-1 (MetAP1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	148-79-8	;THIABENDAZOLE; ; Omnizole;Thiabendazole; Thibendole; Mintezol; Tiabendazole;Tiabendazole; Mintesol			-29.2687457142	4	5		0	-6.65381339				METAP1	n1c3ccccc3nc1c2cscn2	Labotest	LT00134862	-8.42801424	-9.04946237	-3.1710329	-0.17578653	-6.65381339											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013082-04	trans-Aconitic acid	170466847	Cytoplasmic aconitate hydratase Substrate	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	4023-65-8				-29.1165770678	4	5		0	-7.64022777			48	ACO1	OC(=O)C(\CC(=O)O)=C\C(=O)O	Specs	AE-562/J255898	-8.10581652	-7.70752688	-2.95051601	-1.32065266	-7.64022777											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00022304-21	ACETYLCYSTEINE			DPI_SARS-CoV-2_General	2019_NPC-4_Tox	616-91-1				-20.8750313082	4	5		0	-7.12908577					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-4.35814821	-5.16989247	-4.07956249	-1.42882899	-7.12908577											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179034-07	Pentamidine isethionate	170464786	PRL Phosphatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	140-64-7	 cis-Pt(II) pentamidine; Pentamidin; Pt-pentamidine complex; platinum(II) pentamidine;4,4 -(Pentane-1,5-diylbis(oxy))dibenzimidamide; Pentam 300; Pt-pent; cis-Pt pentamidine iodide;Pentamidine isethionate;	0.7079457844	-6.15	-16.1657506581	4	5		12.164516132	-6.56413935	0.271015949	0.9522457807		PTP4A1	OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N	Prestwick Chemical, Inc.	Prestw-553	-6.96964558	-9.72043011	-1.58331128	3.22275309	-6.56413935											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00506887-01	Sodium aurothiomalate(I)		Prostaglandin E synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	12244-57-4				-14.7287370537	4	4		0	-4.18850473					OC(=O)CC(S[Au])C([O-])=O	Alfa Aesar	39740	-3.12799512	-3.60026918	-0.04791358	-4.18850473												1.6E-8	8E-8	4E-7	0.000002											
NCGC00509905-01	Eliglustat (Tartrate)		Ceramide glucosyltransferase Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	491833-29-5				-50.788907767	4	4		0	-14.64987581			7357	UGCG	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C2=CC=C3OCCOC3=C2	Selleck	S7852	-10.06749156	-9.8842961	-10.33234762	-14.64987581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263571-01	Bendazac sodium	170465952	Xanthine dehydrogenase/oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	23255-99-4				-25.2955048876	4	5		0	-5.36286263					[Na+].[O-]C(=O)COc3nn(Cc1ccccc1)c2ccccc23	Sequoia	20187-55-7	-4.55501973	-5.63132613	-6.03725112	-6.70026293	-5.36286263											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166206-04	1,2-Benzenedicarboxaldehyde	170466016		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	643-79-8				-26.160731441	4	5		0	-4.21890729					O=Cc1ccccc1C=O	Vitas	STK802214	-6.86979395	-4.37896723	-7.19332049	-3.11568799	-4.21890729											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00092377-04	Apafant	170466052	Platelet activating factor receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	105219-56-5				-34.2725502722	4	5		0	-7.22064611					Clc1ccccc1C4=NCc2nnc(C)n2c3sc(cc34)CCC(=O)N5CCOCC5	Tocris	2339	-8.25515125	-6.540573	-9.85656176	-3.01051709	-7.22064611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274063-01	Pimobendan	174007050	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	77469-98-8	Pimobendan(Vetmedin)	6.3095734448	-5.2	-58.5797196256	-2.4	5		-34.4652103526	-34.70302919	0.081988743	0.9563632252	5139	PDE3A	Cl.COc1ccc(cc1)c2nc3ccc(cc3n2)C4=NNC(=O)CC4C	Selleck	S1550	-8.33406401	-0.91353577	-7.2618283	-16.41104294	-34.70302919											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090680-06	Carbaryl	170465695	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	63-25-2				-18.925710127	4	5		0	-2.91022238					CNC(=O)Oc2cccc1ccccc12	Bosche	C1592	-4.6251644	-3.51260937	-3.06572468	-5.11393514	-2.91022238											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00180892-03	CLAVULANATE LITHIUM	225144312	Beta-lactamase TEM Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox					5.3617429716	4	5		0	1.96760318					[Li].OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O	Microsource	01505124	3.30995178	0.35597873	-1.472918	-1.52059597	1.96760318											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00016256-17	Pyrimethamine	170464930	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	58-14-0	Pirimetamina; ; Daraprim; Tindurine; Fansimef; Chloridin;Pyrimethamine; Suldox; Maloprim; Pyrimethamine; A.E.S. mixture; Folaprim; Malocide	6.3095734448	-5.2	-86.5763133545	-2.1	5		-98.1637686452	-83.07861261	0.0004512227	0.9997743559	1719	DHFR	CCc1nc(N)nc(N)c1c2ccc(Cl)cc2	Microsource	01500520	0.4690925	0.82775776	-4.37593663	-32.72129711	-83.07861261											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016372-07	4-Hydroxy-3-nitrophenylarsonic acid	170465666		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	121-19-7				-26.1482228742	4	5		0	-5.5916537					O=[N+]([O-])c1cc(ccc1O)[As](O)(O)=O	Microsource	01500530	-6.79088119	-3.8900326	-3.39970028	-6.12182296	-5.5916537											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164617-04	Adapalene	170464674	topical retinoid	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	106685-40-9	 ; Differin; Alcon brand of adapalene; Differine; Adapalene;Adapalene; Adapalene (Differin); Adaferin; Adapaleno			-23.6571567576	4	5		0	-2.61736982				RARB	O=C(O)c1ccc2cc(ccc2c1)c3cc(c(OC)cc3)C46CC5CC(CC(C4)C5)C6	Tocris	2852	-8.79000438	-1.11082518	-5.22372083	-1.38913234	-2.61736982											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179333-03	Phensuximide	170465315		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	86-34-0				6.374448416	4	5		0	3.12071017					O=C1C(CC(=O)N1C)c2ccccc2	Specs	AE-562/J258174	0.18851381	2.21736147	1.78120317	1.28396144	3.12071017											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016386-06	Sulfamerazine	170464738	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	127-79-7				-30.3419866468	4	5		0	-5.09746499					O=S(=O)(Nc1nc(C)ccn1)c2ccc(N)cc2	Vitas	STK520614	-6.87856203	-5.41688111	-5.96874331	-8.32164768	-5.09746499											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181034-03	Liarozole	170465610	Cytochrome P450 CYP17A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	145858-50-0				15.5088557721	4	5		0	1.72050883				CYP17A1	Cl.Clc1cc(ccc1)C(c2ccc3ncnc3c2)n4ccnc4	Tocris	2705	6.09820254	3.36678676	0.05138086	0.74934268	1.72050883											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00025212-08	Cantharidin	170465704	PP-1 Inhibitors;PP-2A Inhibitors	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56-25-7				-32.8669269088	4	5		0	-11.1192459				PPP1CA	O=C2OC(=O)[C@]3(C)C1CCC(O1)[C@]23C	Enzo	PR105	-7.84305129	-2.34602848	-6.02868765	-5.94653812	-11.1192459											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181045-01	Pyridoxamine phosphate	144206246		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	529-96-4	Pyridoxamine phosphate; pyridoxamine-P; Pyridoxamine-5'-phosphate; 			-24.7538555641	4	4	4-Aminomethyl-5-hydroxy-6-methyl-3-pyridylmethyl phosphate;CIPLUS_3727741;Pyridoxamine Phosphate;CIPLUS_154034;pyridoxamine phosphate hydrochloride;PYRIDOXAMINE PHOSPHATE;pyridoxamine phosphate;Pyridoxamine Phosphate Anhydride;Pyridoxamine-5'-phosphate;Pyridoxamine phosphate;CIPLUS_3861203;pyridoxamine-P;	0	-6.78896684					Oc1c(CN)c(cnc1C)COP(=O)(O)O	SigmaAldrich	82890	-6.60638574	-1.40221085	-2.61729267	-6.78896684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167422-01	Enflurane	144205979	Glycine receptor Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	13838-16-9	Enflurane; Ethrane; Enflurano; Pisa Brand of Enflurane; Enlirane; Zeneca Brand of Enflurane; Etran; Abbott Brand of Enflurane; Alyrane; Enfran; 			-10.6412030422	4	4	enfluranum;LS-7376;Enfran;ENFLURANE;Alyrane;Etran;Zeneca Brand of Enflurane;Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-;Enflurano;Baxter Anaesthesia Brand of Enflurane;CIPLUS_169039;HS_566;Pisa Brand of Enflurane;Enlirane;Enflurane;Ethrane;AstraZeneca Brand of Enflurane;nsc-115944;Enfluranum;Abbott Brand of Enflurane;enflurane;	0	-3.89559458					FC(Cl)C(F)(F)OC(F)F	Alfa Aesar	L16725	-1.27628277	-4.37868295	-2.01703668	-3.89559458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345883-07	DESVENLAFAXINE SUCCINATE		Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	93413-62-8				-10.22980438	4	4		0	-2.96309207					CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2	Microsource	01504280	-2.33192005	-1.883952	-1.06368893	-2.96309207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185765-02	Encainide hydrochloride		Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	66794-74-9				-12.8544942012	4	4		0	-7.2160007					COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C	SIGMA	E9156	-1.62239335	-4.97225687	0.225096	-7.2160007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166061-02	L-Cysteine ethyl ester hydrochloride	225144266		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	868-59-7				-19.4227302816	4	4		0	-1.46411608					CCOC(=O)[C@@H](N)CS	SIGMA	C121908	-6.51985809	-2.47752592	0.075032	-1.46411608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182049-02	Nitroscanate	225144331	ATP biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox			14.1253754462	-4.85	-8.6148494755	4	4		-12.429307068	-10.35775589	0.4027664287	0.8855787378			[O-][N+](=O)C1=CC=C(OC2=CC=C(C=C2)N=C=S)C=C1	Oakwood	8991	-0.54175877	-1.86092488	2.59090503	-10.35775589												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346587-16	Bergenin monohydrate			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	477-90-7				-28.4978172652	4	4		0	-7.22287469					[H][C@]12OC(=O)C3=C(C(O)=C(OC)C(O)=C3)[C@]1([H])O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-NAT-0201	-5.12720496	-9.77737665	-4.53855088	-7.22287469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181099-01	Siccanin	144206268		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	22733-60-4	Siccanin; Ladar; Sicanina; Piadar; 	12.5892541179	-4.9	-39.9627702542	-3	4	Siccaninum;LS-173961;siccanine;Siccanine;Siccanin;Ladar;SICCANIN;CIPLUS_214175;Sicanina;Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester, mixt. with (4aS-(4aalpha,6aalpha,11balpha,13aR*,13balpha))-1,2,3,4,4a,5,6,6a,11b,13b-decahydro-4,4,6a,9-tetramethyl-13H-benzo(a)furo(2,3,4-mn)xanthen-11-ol;CIPLUS_769555;siccaninum;Piadar;siccanin;	-48.066763031	-45.67259915	0.1706631102	0.9816045559			Cc1cc2O[C@@]4(C)CC[C@H]5C(C)(C)CCCC53CO[C@@H](c2c(O)c1)[C@H]34	NCI	NSC-135048	-0.85381181	-6.0555269	0.8398106	-45.67259915												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389309-01	Lubiprostone		ClC-2 Channel Activators	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	136790-76-6				-41.3469907089	4	4		0	-7.24457102				CLCN2	CCCCC(F)(F)C1(O)CCC2C(CC(=O)C2CCCCCCC(O)=O)O1	APExBIO	B2108	-9.82044382	-8.65583967	-6.87370062	-7.24457102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521078-02	Cephaloglycin		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	3577-01-3				-26.4811674556	4	4		0	-3.29298683					CC(=O)OCC/1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O	Toronto Research	C258000	-6.92636873	-5.0276434	-4.03239778	-3.29298683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538144-01	NCGC00538144-01		Taenia pisiformis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox			11.220184543	-4.95	-75.2493257357	-3	4		-80.56544947	-77.8746885	0.0134410054	0.9998885705			CC1CCCC(C)N1C(=S)NC2=CC(=CC=C2)C(F)(F)F	Pharmaron	PH-NIH-2017-009-L1-6-0	-3.92641285	-4.80304077	-5.23648649	-77.8746885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346455-05	Cobimetinib		Mek Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1453848-26-4				-36.0153359017	4	4		0	-13.57244571				MAP2K1	OC1(CN(C1)C(=O)C2=C(NC3=C(F)C=C(I)C=C3)C(=C(F)C=C2)F)[C@@H]4CCCCN4	ActiveBioChem	A-1318	-5.77050337	-7.5414651	-8.38963964	-13.57244571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093704-12	Cyclosporine A	170466812	immunosuppressant	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	59865-13-3	 Antibiotic S 7481F1; ; 11-me-Leu-CsA;Cyclosporin A; cyclosporin A synthetase;; Cyclophilins; F-7-62 cyclosporin; CYCLOSPORIN A;CYCLOSPORINE; Cyclosporine; cyclosporin O; CYCLOSPORINE; Cyclosporin A; cyclosporin metabolite M1; H-7-94 cyclosporin; cyclosporin A-SPTP; 3-MeAla-7-Phe-8-Ser-CsA; Cs29 (cyclosporin); M1 cyclosporin metabolite; Cyclosporin SG	12.5892541179	-4.9	-63.5363175665	-3	4		-87.7423700064	-71.77251784	0.0548427221	0.9981406178		PPP3CC	C[C@H](C\C=C\C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C)C(C)C	Microsource	01502202	-0.99250206	-4.61148358	-5.91441079	-71.77251784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094740-05	NORETHYNODREL		Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	68-23-5				6.3801427328	4	4		0	0.47169811					C[C@]12CCC\3C(CCC\4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C	Microsource	01500439	1.19115895	1.14892882	3.12283437	0.47169811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379045-01	Alfacalcidol-D6		Increase blood calcium level via a variety of mechanisms	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-12.3921706569	4	4		0	1.34389462					C(C(C([2H])([2H])[2H])CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C)([2H])([2H])[2H]	MedChem Express	HY-15332	-3.89111925	-3.17035245	-1.78014553	1.34389462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249929-01	Neticonazole	170466035	ergosterol biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	130726-68-0		10	-5	-21.964863401	4	4		-22.2949448159	-19.82912068	0.1373529779	0.988225161			CS\C=C(/c1ccccc1OCCCCC)n2ccnc2	GVK	FFS-11-286-NCI-232	-1.98526492	0.37145819	-3.33939709	-19.82912068												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261969-01	Alatrofloxacin mesylate	170465095		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	146961-77-5	Alatrofloxacin mesylate;Cp-116,517;Cp 116517;Cp			-16.9313322382	4	4		0	-2.01915259					CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@]2(C)[C@@H]1CN(C[C@@H]12)c3nc4c(cc3F)C(=O)C(=CN4c5ccc(F)cc5F)C(=O)O	GVK	FFS-11-286-NCI-04	-4.39041304	-5.48822417	-0.53604932	-2.01915259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181156-01	Oxabolone cipioncate	144206313	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1254-35-9	Oxabolone cipionate; Cipionato de oxabolona; 			-24.7319156565	4	4	LS-172626;oxaboloni cipionas;OXABOLONE CIPIONATE;cipionate d'oxabolone;Oxabolone cipionate;4,17beta-dihydroxy-estr-4-en-3-one 17-cyclopentylpropionate;CIPLUS_211114;Cipionato de oxabolona;Oxabolone Cipionate;oxabolone cypionate;Oxaboloni cipionas;Cipionate d'oxabolone;	0	-7.36742253					OC=5C(=O)CC[C@H]4C=5CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCC1CCCC1)CC[C@@H]23	NCI	NSC-522767	-4.83248819	-9.28743338	-0.56285178	-7.36742253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181773-05	Parecoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	198470-84-7				-16.2839081514	4	4		0	-5.67801969					CCC(=O)N[S+]([O-])(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3	MedChem Express	HY-17474	-3.22888224	-4.72322503	-0.70579827	-5.67801969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166215-05	2-Phenylethanol	170466787		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	60-12-8				-25.6842426049	4	4		0	-9.06906372					OCCc1ccccc1	Microsource	01505398	-5.80579697	-2.01278507	-3.82449757	-9.06906372												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378610-02	Topiroxostat		Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-21.8164934093	4	4		0	-6.12973168					[N]#[C]C1=NC=CC(=C1)C2=N[NH]C(=N2)C3=CC=NC=C3	APExBIO	B1192	-4.15637325	-5.48822417	-3.98463325	-6.12973168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163125-06	Pregnenolone	170465558	Steroid	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	145-13-1	; ; 5-Pregnen-3beta-ol-20-one; Allopregnandione; Allopregnane-3,20-dione; Pregnenolona; Pregnenolone acetate; PREGNENOLONE; 5 Pregnen 3 beta ol 20 on;Pregnenolone; Pregnenolone			-0.5846134956	4	4		0	0.38395519					CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-546	-1.52992675	-0.12463469	4.46707764	0.38395519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015938-05	Salmeterol xinafoate	170465397	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	94749-08-3				-24.585350323	4	4		0	-8.50573674					OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2.O=C(O)c2ccc1ccccc1c2O	Prestwick Chemical, Inc.	Prestw-945	-2.94283362	-8.8318721	-6.49513089	-8.50573674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167451-04	Halobetasol Propionate			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	66852-54-8				-17.9571392231	4	4		0	-4.87397236					CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	APExBIO	B1767	-2.82147965	-8.4020973	-1.76896274	-4.87397236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091015-01	Phenolphthalin	17389504		DPI_SARS-CoV-2_General	2019_NPC-7_Tox		Phenolphthalin; 			-17.2332286363	4	4	PHENOLATHALAIN, YELLOW;2-(Bis[4-hydroxyphenyl]methyl)benzoic acid;PHENOLPHTHALEIN;Phenolphthalin;NCGC00091015-02;CIPLUS_208575;AB07944344-01;phenolphthalin;	0	-9.18476326					OC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C3=C(C=CC=C3)C(O)=O	NIEHS	AB07944344	-1.68526933	-5.79647547	-2.88028413	-9.18476326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091534-02	o-Cresol	26753043		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	95-48-7	2-Methylphenol-d8; o-Cresol-d8; 			-4.2098182204	4	4	2-methylphenol;CIPLUS_732542;CIPLUS_723417;methylphenol, polymer with formaldehyde;phenoaldehyde resinifying agent;CIPLUS_3741557;CIPLUS_3751665;CIPLUS_3881950;2-cresol, sodium salt;2-METHYLPHENOL;CIPLUS_749387;2-cresol, potassium salt;phenoaldehyde;CRESOL;CIPLUS_150287;CIPLUS_749458;O-CRESOL;ortho-cresol;Methylphenol tricresol;o-Cresol-d8;CIPLUS_3882512;o-cresol;NCGC00091534-02;Cresol mixture of isomers;CIPLUS_743211;CIPLUS_749586;AB08007336-01;2-cresol;CIPLUS_3752378;CIPLUS_671502;2-cresol, ammonium salt;CIPLUS_745732;tricresolformalin;2-Methylphenol-d8;CIPLUS_653786;CIPLUS_163487;2-Methylphenol;CIPLUS_3750176;CIPLUS_714209;CIPLUS_682977;o-Cresol;	0	-4.37878248					CC1=C(O)C=CC=C1	SigmaAldrich	MFCD00002226	-0.50293378	-0.50103663	-0.67134442	-4.37878248												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00091338-06	4-Chloro-3-methylphenol	170466134		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	59-50-7		2.8183829313	-5.55	-2.5716002346	4	5		11.9406162319	-2.68918361	0.1587074494	0.984343782			Oc1ccc(Cl)c(C)c1	Microsource	01500178	-3.1811773	-3.46838029	-4.53384686	6.16818996	-2.68918361											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00185755-03	Cefatrizine			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	51627-14-6				-20.1469394875	4	4		0	-6.50587398					[H][C@](N)(C(=O)N[C@]1([H])C(=O)N2\C(C(O)=O)=C(CSC3=CNN=N3)/CS[C@]12[H])C4=CC=C(O)C=C4	DC Chemicals	DC9221	-4.01464684	-4.22425708	-2.97557173	-6.50587398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021382-07	ERYTHROMYCIN ETHYLSUCCINATE		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1264-62-6, 114-07-8 [erythromycin]				-5.0750281268	4	4		0	-4.21858313					CCOC(=O)CCC(=O)O[C@@H]1[C@H](C[C@@H](C)O[C@H]1O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C	Microsource	01500279	-0.16764459	0.691085	-2.82830908	-4.21858313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507682-01	Emodepside		synaptic transmission Modulator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	155030-63-0				-22.8512120101	4	4		0	-11.95265219			174419		CC(C)C[C@@H]1N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC2=CC=C(C=C2)N3CCOCC3)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC4=CC=C(C=C4)N5CCOCC5)OC1=O	AdvChemBlocks	M15352	-3.10583668	-2.49654457	-6.06808732	-11.95265219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090698-06	1,3-Diphenylguanidine	170465656		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	102-06-7				-28.1530455184	4	5		0	-7.38837135					N=C(Nc1ccccc1)Nc2ccccc2	Vitas	STK802182	-7.19950652	-7.78364116	-5.89023318	0.39957746	-7.38837135											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178864-03	Ethambutol dihydrochloride	174006619		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	1070-11-7				-16.782274285	4	4		0	-6.09647561					Cl.Cl.CC[C@@H](CO)NCCN[C@H](CO)CC	Microsource	01500288	-4.04111704	-2.11644782	-0.61070686	-6.09647561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263560-01	6-Aminopenicillanic acid	225144362		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	551-16-6		0.285877499	-6.543820026	-6.0037174655	4	5		13.280023836	-3.57945941	0.3161372687	0.9334288824			CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O	Bosche	A0928	-5.14628128	-8.56668653	-8.11738603	4.11059569	-3.57945941											3.2E-9	1.6E-8	8E-8	4E-7	0.000002										
NCGC00274280-01	Pixantronemaleate	225144373	DNA Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox			7.0794578438	-5.15	-36.0595047004	4	5		-19.5544918641	-21.76127759	0.1172710036	0.9359322741			NCCNC1=C2C(=O)C3=C(C=NC=C3)C(=O)C2=C(NCCN)C=C1	GVK	FFS-12-73-NCI-2833	-2.13253437	-5.66431186	-7.43919287	-9.55770909	-21.76127759											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013495-15	Benztropine mesylate		Dopamine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	132-17-2				-19.389203101	4	4		0	-8.36596654					CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4	APExBIO	B1554	-2.97348568	-3.14443677	-4.78603604	-8.36596654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015848-09	Tranylcypromine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-2_Tox			2.8183829313	-5.55	-10.7060610885	4	5		11.4299828319	-6.02083429	0.2087288932	0.9724956825			N[C@@H]1C[C@H]1C2=CC=CC=C2	Tocris	3852	-4.43249912	-6.09839135	-6.19165236	4.22082396	-6.02083429											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179556-03	Cefadroxil	170464658	Solute carrier family 15 member 2 Substrate	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	50370-12-2				-1.8733109999	4	4		0	-3.41758633					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccc(O)cc1)C=3C(=O)O	Vitas	STK801939	0.0617638	0.19868694	0.5500693	-3.41758633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181152-02	Nedaplatin			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	95734-82-0				-33.9490338419	4	4		0	-6.72837309					O=C1C[O-][Pt++][O-]1	MedChem Express	HY-13700	-7.7204747	-5.9260539	-7.67065142	-6.72837309												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00166310-02	Marbofloxacin	170465732	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	115550-35-1	 ;Marbofloxacin; Marbofloxacin; Zeniquin;MARBOFLOXACIN; Marbofloxacino; Marbocyl; Marbocyl FD; Dexamethasone			-7.7165202432	4	5		0	-1.66123629					CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)N(C)COc34	Sequoia	115550-35-1	-2.03560099	-3.05132352	-3.04349646	2.0713728	-1.66123629											1.6E-8	8E-8	4E-7	0.000002	0.0000099999999999										
NCGC00253585-01	Cyclomethycaine	170465528		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	139-62-8		1.5848931925	-5.8	-17.9759601328	4	5		13.37663024	-15.23564774	0.064192423	0.9974702423			CC3CCCCN3CCCOC(=O)c2ccc(OC1CCCCC1)cc2	GVK	FFS-11-286-NCI-76	-8.2305252	-7.45169802	-7.06241889	5.13939283	-15.23564774											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017331-08	(-)-Epicatechin	170465932	superoxide anion generation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	490-46-0		1.1220184543	-5.95	-13.1828057788	4	5		10.0441739679	-2.38630627	0.2182682336	0.9698253338			Oc1ccc(cc1O)[C@H]2Oc3cc(O)cc(O)c3C[C@H]2O	Microsource	00210205	-5.4635178	-7.53681164	-4.45849207	3.68805401	-2.38630627											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00484844-01	Cilastatin		Renal dipeptidase  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	81129-83-1				-16.5751174606	4	4		0	-5.84967025					CC1(C)C[C@H]1C(=O)N\C(=C/CCCCSC[C@@H](N)C(O)=O)C(O)=O	Enzo	PI153	-3.47159017	-5.2131683	0.43777361	-5.84967025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015409-11	Edrophonium chloride	170464801	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	116-38-1				-6.5558432478	4	4		0	-2.95871352					[Cl-].C[N+](C)(CC)c1cccc(O)c1	Microsource	02300219	-2.54409916	1.32800413	1.75109443	-2.95871352												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095135-05	Almotriptan	170465288	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	154323-57-6	; ; ALMOTRIPTAN; Almogran; Almotriptan;ALMOTRIPTAN; Axert			-16.2869568451	4	4		0	-1.72102268			3351	HTR1B	O=S(=O)(Cc1ccc2ncc(CCN(C)C)c2c1)N3CCCC3	Microsource	01505204	-4.49443072	-3.68317002	-1.3579916	-1.72102268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090770-09	5-Bromo-2'-deoxyuridine	170465870	base conversion or substitution editing Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	59-14-3		12.5892541179	-4.9	-38.5092175014	4	5		-17.11249688	-18.51222982	0.0463578349	0.9761755564			BrC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Bosche	B0691	-6.01868171	-4.66848242	-7.09590991	-7.56441464	-18.51222982											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160631-02	Famphur	170466840	Trichostrongylus axei Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	52-85-7		2.8183829313	-5.55	-15.4303862019	4	5		11.80409846	-5.98412189	0.1029142592	0.9934923124			O=S(=O)(N(C)C)c1ccc(OP(=S)(OC)OC)cc1	SIGMA	34341	-6.38879098	-5.98774364	-6.92008205	3.76153952	-5.98412189											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091449-10	Eugenol	170465464	reactive oxygen species biosynthetic process Modulator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	97-53-0		2.8183829313	-5.55	-15.39638851	4	5		14.029869804	-3.79055573	0.1995582969	0.9748327031			Oc1ccc(cc1OC)CC=C	Microsource	01500296	-7.06732464	-5.66431186	-7.94155817	4.99242181	-3.79055573											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021666-04	Nalmefene	170465281	Kappa opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	55096-26-9				-3.6617299863	4	4		0	-1.69391996					C=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45	Prestwick Chemical, Inc.	Prestw-1490	-1.31322325	1.3881726	-0.01786831	-1.69391996												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014017-03	L-Proline	225144170		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	147-85-3				-20.5142131397	4	5		0	-4.63494103					OC(=O)[C@@H]1CCCN1	SIGMA	81710	-4.80260839	-7.35807303	-5.65579604	1.36407477	-4.63494103											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163157-05	Mesoridazine	170465272	D(2) dopamine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	5588-33-0				-32.2219706021	4	5		0	-13.18893121			1813	DRD2	CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2	Prestwick Chemical, Inc.	Prestw-529	-5.17271766	-4.42165291	-8.54439653	-5.30473522	-13.18893121											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00186628-02	Butylscopolamine bromide	170465685	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	149-64-4	Butylscopolammonium Br			-30.0807438017	4	4		0	-7.85527148			1128	CHRM1	[Br-].OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)CCCC	Enzo	NP527	-6.18471807	-9.24445591	-2.7963906	-7.85527148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160621-08	Dextrose			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	50-99-7				-26.3487222849	4	4		0	-6.292348					[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O	MedChem Express	HY-B0389	-5.66462965	-7.40501977	-2.86786384	-6.292348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165736-04	Acadesine	170465608	AMPK Activator	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	2627-69-2	AICAR/AR-100/SCH-900395; AICA ribonucleoside; Acadesine (AICAR); Acadesine;Acadesine; Acadesina; AICA riboside; Z-riboside; 			-22.8105881801	4	4		0	-6.28331376			5562	PRKAA1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2N	Tocris	2840	-5.39591731	-6.18445934	-0.01786831	-6.28331376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182709-03	Landiolol hydrochloride	170465910	Beta-1 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	144481-98-1				-24.2807603796	4	4		0	-5.75932785					Cl.CC3(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N1CCOCC1)cc2)O3	APAC	877817	-5.51727127	-7.65428915	-0.76833735	-5.75932785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379034-03	Caspofungin Acetate			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	179463-17-3				2.1122558364	4	4		0	4.55777396					CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)C4=CC=C(O)C=C4)[C@H](O)CCN	Selleck	S3073	-1.39990465	-2.83221592	3.52899133	4.55777396												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00096077-06	Olanzapine	170465009	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	132539-06-1	; ;OLANZAPINE; Zyprexa; OLANZAPINE;Olanzapine; Olanzapine; Lilly brand of olanzapine			-10.1120271798	4	5		0	-4.07507687			1813	DRD2	CN1CCN(CC1)C2=Nc4ccccc4Nc3sc(C)cc23	SIGMA	O1141	-2.7670074	-3.82585752	-3.5207435	4.57906582	-4.07507687											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017020-06	NCGC00017020-06			DPI_SARS-CoV-2_General	2019_NPC-2_Tox			1.2589254118	-5.9	-15.5193625662	4	5		7.953187504	-1.16561883	0.3627302529	0.7498444114			CCCC1=NC=C(C[N+]2=C(C)C=CC=C2)C(N)=N1	Vitas	STL018669	-4.25625661	-8.29432292	-5.95721522	4.5882515	-1.16561883											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179546-05	Bambuterol hydrochloride	170466370	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	81732-46-9				-13.2290229801	4	5		0	-5.28658621					Cl.O=C(Oc1cc(cc(c1)OC(=O)N(C)C)C(O)CNC(C)(C)C)N(C)C	Microsource	01505173	-2.43214663	-3.39177802	-4.99434839	1.56615992	-5.28658621											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091455-09	Celecoxib	170464693	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	169590-42-5	; 5   Celecoxib (Celebrex);Celecoxib; Celecoxib; Celebrex;CELECOXIB			-30.2785102068	4	5		0	-9.54982616			5743	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(C)cc2)C(F)(F)F	Microsource	01503678	-8.18710948	-2.99233617	-5.26361885	-3.12741137	-9.54982616											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167438-02	Trospium chloride	174006890	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	10405-02-4	Trospium chloride; Cloruro de trospio; Trospium chloride; Spasmoplex; 			-9.8984503787	4	5		0	-1.747415					[Cl-].OC(c1ccccc1)(c2ccccc2)C(=O)O[C@@H]3C[C@@H]5CC[C@H](C3)[N+]45CCCC4	Selleck	S2549	-3.37670119	0.89985361	-4.27395341	0.04085153	-1.747415											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178737-05	Trimeprazine tartrate	170465278	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	4330-99-8				-0.317149713	4	5		0	-4.7275026					O=C(O)[C@H](O)[C@H](O)C(=O)O.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12	Microsource	01500593	0.75751091	4.01704986	0.13137152	-1.5568971	-4.7275026											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263530-01	Lafutidine	170465978	Histamine H2 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	118288-08-7		0.5011872336	-6.3	-22.7762645457	4	5		13.70089018	-6.06402673	0.0897994248	0.995076642		HRH2	O=S(CC(=O)NC/C=C\COc2cc(CN1CCCCC1)ccn2)Cc3ccco3	Sequoia	SRP01115l	-9.33407515	-6.55730647	-3.07409354	0.87603831	-6.06402673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159453-05	Zileuton	170465222	5-Lipoxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	111406-87-2	;Zileuton; Zileuton; Zyflo;A-64077/ABT-077	1	-6	-26.2442801661	4	5		10.616584708	-8.78805542	0.3319846879	0.9261755703	240	ALOX5	NC(=O)N(O)C(C)c1cc2ccccc2s1	Prestwick Chemical, Inc.	Prestw-1365	-10.51382059	-7.09677419	-5.32327776	1.33868205	-8.78805542											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095169-05	Miltefosine	170465622		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	58066-85-6		7.9432823472	-5.1	-73.1044149846	-2.2	5		-79.70806618	-73.2636865	0.006812481	0.9965771516			C[N+](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCC	Microsource	01505329	-2.78955401	-4.08602151	0.47190615	-15.23032543	-73.2636865											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249909-01	Fenbutrazate	170465618	Monoamine transporters; Norepinephrine & dopamine Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	4378-36-3				-24.6071441516	4	5		0	-3.57799399					CCC(c1ccccc1)C(=O)OCCN2CCOC(C2C)c3ccccc3	GVK	FFS-11-286-NCI-142	-7.03747668	-5.67741935	-3.83258358	-3.19570901	-3.57799399											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179590-04	Syrosingopine			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	84-36-6		12.5892541179	-4.9	-51.5292303268	-3	4		-43.971883109	-45.10344205	0.0403374432	0.9989957977			CCOC(=O)OC1=C(OC)C=C(C=C1OC)C(=O)O[C@@H]2C[C@@H]3CN4CCC5=C([NH]C6=C5C=CC(=C6)OC)[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC	Glixx	GLXC-06136	-4.12170069	-5.59996562	-4.833378	-45.10344205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095227-06	Alizarin	170465641	Calcium Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	72-48-0		12.5892541179	-4.9	-17.3077038889	4	4		-19.901797812	-19.08483151	0.1652653356	0.98283349			O=C3c1ccccc1C(=O)c2c3ccc(O)c2O	Vitas	STK801841	-0.4637455	-2.67749699	0.01786831	-19.08483151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161336-01	Potassium ricinoleate	26754911	Prostanoid EP3 receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox		Ricinoleic acid; 12-Hydroxyoleic acid; 			-28.9901082225	4	4	ricinelaidic acid;ricinoleic acid, (R-(E))-isomer;LS-195;12-oxooctadecanoic acid;Ricinoleic acid;RICINOLEIC ACID, SODIUM SALT;CIPLUS_658255;CIPLUS_680366;12-hydroxy-9-octadecenic acid;CIPLUS_750550;RICINOLEIC ACID;CIPLUS_671898;CIPLUS_166631;12-hydroxy-9-octadecenoic acid;CIPLUS_151987;CIPLUS_663822;CIPLUS_3886623;Ricinelaidic acid sodium salt;(R)-12-Hydroxy-9(E)-octadecenoic acid;kyselina 12-hydroxy-9-oktadecenova (czech);12-Hydroxyoleic acid;CIPLUS_661801;CIPLUS_164143;12-ketostearate;CIPLUS_689393;(R)-12-Hydroxy-cis-9-octadecenoic acid;Potassium ricinoleate;CIPLUS_686506;ricinoleic acid;CIPLUS_689370;CIPLUS_664600;LS-143811;HSDB 4280;CIPLUS_684810;POTASSIUM RICINOLEATE;CIPLUS_666567;12-HYDROXY-9-OCTADECENOIC ACID;	0	-5.48830066					CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O	BIOMOL	BIOMOL_AL-112	-7.64963377	-6.83771704	-0.82194229	-5.48830066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183860-01	Mefruside	144206878	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	7195-27-9				-23.7953062075	4	4	LS-30042;Mefrusida;Mefrusidum;1,3-Benzenedisulfonamide, 4-chloro-N1-methyl-N1-((tetrahydro-2-methyl-2-furanyl)methyl)-;CIPLUS_166167;fda 1902;Mefruside;MEFRUSIDE;mefruside;Baycaron;mefrusidum;	0	-4.19640437					CC2(CN(C)S(=O)(=O)c1ccc(Cl)c(c1)S(N)(=O)=O)CCCO2	Pharmaron	PH-NIH-183408	-5.39591731	-6.30479629	-3.53792549	-4.19640437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167464-02	Hydrocortisone Sodium Phosphate	225144288		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	6000-74-4				-0.4892151001	4	4		0	0.83566718					C[C@]\12CCC(=O)\C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO[P]([O-])([O-])=O)[C@@]4(C)C[C@H](O)[C@H]23	Bosche	H6475	0.00433407	-2.33367715	0.36630037	0.83566718												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016916-11	Norfloxacin	170464769	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	70458-96-7	; ; Norfloxacin-d5;NORFLOXACIN; Norfloxacino; Noroxin; Norfloxacin;Norfloxacin; Norfloxacin Glutamate			-16.732468721	4	5		0	-2.31634081			7155	TOP2B	O=C(O)C2=CN(CC)c1cc(c(F)cc1C2=O)N3CCNCC3	Vitas	STK177250	-5.68775143	-5.00731938	-4.81695568	3.45422359	-2.31634081											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015089-17	Amiloride hydrochloride	170465124	Epithelial Sodium Channels (ENaC) Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2609-46-3	 Amilorida; uranidil-A;Amiloride HCl;Amiloride hydrochloride; Amiloride hydrochloride; ;;AMILORIDE; Moduretic;AMILORIDE HYDROCHLORIDE; Esmaloride; Esmalorid;Amiloride; uranidil A;Amiloride..HCl; Midamor; Moducren	1.1220184543	-5.95	-24.4828844579	4	5		8.8614053239	-4.34821872	0.2287319026	0.9668467454	6339	SCNN1D	Clc1nc(C(=O)NC(=N)N)c(N)nc1N	Enzo	CA200	-7.51947274	-9.46783777	-6.74373796	0.54922609	-4.34821872											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164625-04	Cerivastatin sodium	170465109	HMG-CoA reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	143201-11-0		0.6309573445	-6.2	-205.1431208662	-1.1	5		-94.5938522814	-99.13306543	0.000735716	0.9996319863			[Na+].CC(C)c1nc(c(/C=C/[C@@H](O)C[C@@H](O)CC([O-])=O)c(c1COC)c2ccc(F)cc2)C(C)C	Sequoia	143201-11-0	-5.27689806	-15.3836218	-61.53441934	-96.5684717	-99.13306543											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00183852-01	Diponium bromide	144206825	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	2001-81-2				-29.1175522132	4	4	Diponium Bromide;diponium iodide;SA-267;triethyl(2-hydroxyethyl)ammonium bromide dicyclopentyl acetate;Diponii bromidum;diponium bromide;DIPONIUM BROMIDE;Dipenine bromide;TRIETHYL(2-HYDROXYETHYL)AMMONIUM BROMIDE DICYCLOPENTYLACETATE;CIPLUS_771421;Ammonium, (2-hydroxyethyl)triethyl-, bromide, dicyclopentylacetate;Unospaston;DIPENINE BROMIDE;Bromuro de diponio;LS-18253;HL 267;2-((dicyclopentylacetyl)oxy)-N,N,N-triethylethanaminium;diponii bromidum;diponium;Dipenine Bromide;Bromure de diponium;Diponium bromide;bromure de diponium;CIPLUS_769588;spaslar;Ethanaminium, 2-((dicyclopentylacetyl)oxy)-N,N,N-triethyl-, bromide, mixt. with (T-4)-bis(((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonato)magnesium;CIPLUS_214084;	0	-8.47967232					[Br-].CC[N+](CC)(CC)CCOC(=O)C(C1CCCC1)C2CCCC2	Pharmaron	PH-NIH-150206	-6.81405209	-6.30564755	-1.3902988	-8.47967232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263875-02	SELAMECTIN			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	165108-07-6		12.5892541179	-4.9	-98.6990703432	-3	4		-105.1866539114	-99.53374875	0.0750481269	0.9965101001			CO[C@H]1C[C@H](O[C@@H](C)[C@H]1O)O[C@H]\2[C@@H](C)\C=C\C=C\3CO[C@@H]4C(=N/O)\C(=C/[C@@H](C(=O)O[C@H]5C[C@@H](C/C=C2C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)C	Microsource	01503720	-8.19849442	-2.16783518	-2.65260184	-99.53374875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182606-01	Physalien	144206657		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	144-67-2	Helenien; Palmitato de xantofila; 			-27.9045390034	4	4	xanthophyll dipalmitate;Xantofyl palmitate;Helenien;Palmitate de xantofyle;heleniene;CIPLUS_214390;palmitate de xantofyle;xantofyle palmitate;Xantofyli palmitas;helenien;Palmitato de xantofila;xantofyli palmitas;XANTOFYL PALMITATE;HELENIEN;	0	-4.4097782					O=C(O[C@@H]2CC(C)=C(/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C)C(C)(C)C2)CCCCCCCCCCCCCCC	INDOFINE	020309S	-8.83014623	-3.26035528	0.31336894	-4.4097782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160543-01	Pregnandiol	144205439	G-protein coupled bile acid receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	80-92-2	Pregnandiol; Diol; Pregnantriol; 	31.6227766017	-4.5	-24.7408095275	4	4	ALLOPREGNANDIOL;CIPLUS_3727430;CIPLUS_149642;CIPLUS_679210;5BETA-PREGNANE-3ALPHA,20ALPHA-DIOL;CIPLUS_742702;CIPLUS_678965;allopregnane-3,20-diol;PREGNANDIOL;CIPLUS_696772;(3 alpha,5 alpha,20S)-pregnane-3,20-diol;Pregnantriol;Diol;Pregnanediol;Pregnandiol;PREGNANEDIOL;CIPLUS_742124;	-10.664785032	-10.14595942	0.6492381049	0.6006138799			CC(O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@@H]2C[C@@H](O)CC[C@]12C	SigmaAldrich	R195952	-6.82048793	-0.00863856	-1.0524948	-10.14595942												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00378877-01	Methylnaltrexone Bromide			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	73232-52-7				-22.6876074816	4	4		0	-4.70808117			4988	OPRM1	[H][C@]12OC3=C4C(C[C@@H]5[C@](O)(CCC1=O)[C@]24CC[N+]5(C)CC6CC6)=CC=C3O	MedChem Express	HY-75766	-5.1616888	-4.93261921	-3.63392238	-4.70808117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344556-01	Epitiostanol	225144391		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	2363-58-8				-23.5310881213	4	4		0	-9.47846209					C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-1006	-5.1087484	-2.53973739	-2.32588358	-9.47846209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165752-04	Eslicarbazepine (acetate)		Sodium channel alpha subunit Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	236395-14-5				-24.0992145928	4	4		0	-4.83268067					CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C3=C1C=CC=C3	MedChem Express	HY-B0703	-6.22932016	-3.4122322	-3.14015939	-4.83268067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179363-03	Ursodiol	225144303	Steroid	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	128-13-2	; Urosiol; Ursodexycholic Acid; Antigall; Chenique Acid; Acido chenodeoxicholico;Urosiol; Sodium chenodeoxycholate; Litursol; Acido ursodeoxicolico; Urso;Ursodiol (Actigal Urso); UDCA-menthol; Ursodeoxy cholic acid; Chenodesoxycholic acid;URSODIOL; Ursometh; Acide chenodeoxycholique			-27.1099034272	4	4		0	-7.15557138				NR14H	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Prestwick	Prestw-958	-7.09401332	-3.99965446	-1.21708247	-7.15557138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018123-07	Acetylcholine chloride	170464783	Acetylcholinesterase Substrate	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	60-31-1		1.5848931925	-5.8	-18.3121008171	4	5		8.1499823799	-0.77096049	0.311761397	0.7966140124			[Cl-].C[N+](C)(C)CCOC(=O)C	Microsource	01500104	-7.20831865	-4.62592561	-6.56842634	4.94649336	-0.77096049											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016866-11	Pipemidic acid	170465767		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	51940-44-4		1	-6	-19.4176067056	4	5		7.030666192	-1.7346611	0.3469905154	0.765990886			O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCNCC3	Microsource	01502024	-7.52555516	-5.04298238	-4.20730942	3.2930694	-1.7346611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024842-05	Clomethiazole	170466516		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	533-45-9				-28.5698972238	4	5		0	-5.16727089					ClCCc1scnc1C	Tocris	0881	-7.90447656	-7.2048685	-7.60664797	0.43632021	-5.16727089											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249884-01	Sulfisoxazole acetal	170465159	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	80-74-0				-3.8118030552	4	5		0	-2.26699096					Cc1c(onc1C)N(C(C)=O)S(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-17	-2.15015862	-0.71069878	2.20622096	1.180361	-2.26699096											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016605-08	Nifenazone	170466050		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	2139-47-1				-19.0153710629	4	5		0	-0.60575467					O=C3C(NC(=O)c1cccnc1)=C(C)N(C)N3c2ccccc2	Microsource	01503230	-4.83785689	-6.57502766	-5.11993972	-2.02544436	-0.60575467											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015606-06	LOBELINE HYDROCHLORIDE		Synaptic vesicular amine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	90-69-7				-17.3724342368	4	4		0	-3.34638661					CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(O)C3=CC=CC=C3	Microsource	01500758	-3.65288746	-3.10988252	-4.82068607	-3.34638661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179630-03	Homatropine hydrobromide	170465642	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	51-56-9				-14.1343461137	4	4		0	-4.34318263					Br.CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(O)c2ccccc2	Labotest	LT00112435	-3.58230026	-0.2073255	-2.28257103	-4.34318263												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274272-01	Iobenzamic acid	170465948		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	3115-05-7				-13.2430148228	4	5		0	-0.28452113					Ic1cc(I)c(N)c(I)c1C(=O)N(CCC(=O)O)c2ccccc2	GVK	FFS-11-286-NCI-258	-5.02291153	-2.71938037	-4.49198309	1.89684472	-0.28452113											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160527-03	Mosapride citrate	170466008	5-HT4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	112885-42-4	; Gasmotin; ;Mosapride citrate; Mosapride citrate;AS-4370	2.8183829313	-5.55	-11.6459757115	4	5		11.5033194279	-3.77219953	0.3650144097	0.9087205443	3360	HTR4	O=C(O)C(O)(CC(=O)O)CC(=O)O.Clc1cc(c(OCC)cc1N)C(=O)NCC3CN(Cc2ccc(F)cc2)CCO3	Vitas	STK711184	-3.87733521	-7.50276619	-6.84472726	3.85339641	-3.77219953											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249890-01	Mebutamate	170465233		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	64-55-1				-32.973664327	4	4		0	-10.42185831					O=C(N)OCC(C)(COC(=O)N)C(C)CC	GVK	FFS-11-286-NCI-34	-7.53518331	-6.55666897	-1.94473319	-10.42185831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344523-01	L-(-)-Sorbose	170465548		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	87-79-6				-32.23472924	4	4		0	-7.29797081					O[C@H](C(=O)CO)[C@H](O)[C@@H](O)CO	SIGMA	140929	-7.84400229	-5.50276434	-4.1536729	-7.29797081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016283-04	Diphemanil methylsulfate	170464876	antimitotic	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	62-97-5	 Vagophemanil; ; Diphemanil; Prantal;Diphemanil methylsulfate; Diphemanil methylsulfate			1.3830814915	4	5		0	-1.7346611					[O-]S(=O)(=O)OC.C[N+]1(C)CC\C(CC1)=C(\c2ccccc2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-79	1.61261896	-1.18733509	-1.20986311	1.95195885	-1.7346611											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090964-04	Tetraethylenepentamine	170464940	Oxidative Stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	112-57-2				-24.2833319958	4	5		0	-5.77302556					NCCNCCNCCNCCN	Prestwick	Prestw-1387	-4.60874163	-7.32402758	-6.17490685	-1.67638819	-5.77302556											6.4E-9	3.2E-8	1.6E-7	8E-7	0.000004										
NCGC00182030-01	Sulbenicillin disodium	144206509		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	28002-18-8	Sulbenicillin; Lilacillin; I.M., Kedacilli; Sulbenicilina; Kedacillin I.M.; 			-36.091725242	4	4	Hormona Brand of Sulbenicillin Sodium Salt;Disodium alpha-Sulfobenzylpenicillin;CIPLUS_711187;Sulbenicillin;alpha-Sulfobenzylpenicillin, Disodiu;Sulbenicillin sodium;Sulbenicillinum;SULBENICILLIN SODIUM;Sulbenicilina;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylsulfoacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-;sulbenicillinum;I.M., Kedacilli;CIPLUS_180114;Disodium alpha Sulfobenzylpenicilli;SULBENICILLIN;Sulbenicilline;LS-174908;Sulbenicillin Sodium;Kedacillin I.M.;Lilacillin;sulbenicilline;	0	-7.33357067					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)[C@@H](c1ccccc1)S([O-])(=O)=O)[C@H]3SC2(C)C	ACC	SULBENICILLIN DISODIUM	-8.65575506	-4.6821009	-7.48873874	-7.33357067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182031-05	Etizolam		GABA-A receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	40054-69-1		7.9432823472	-5.1	-40.2768561922	4	4		-10.8763881681	-16.28693485	0.2528908848	0.9589186433			CCC1=CC\2=C(S1)[N]3C(=NN=C3C\N=C2C4=CC=CC=C4Cl)C	MedChem Express	HY-B0677	-7.54400671	-5.13994471	-7.50606376	-16.28693485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159503-02	Methylprednisolone acetate	144205275		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	53-36-1	Methylprednisolone acetate; Depo-Medrol; Depo-medrol; Depo-Medrone; 			-6.2666676507	4	4	methylprednisolone acetate, (11beta,16alpha)-isomer;6alpha-METHYLPREDNISOLONE ACETATE;methylprednisolone acetate;NCGC00095841-01;Methylprednisolone Acetate;Methylprednisolone acetate;methylprednisolone acetate, (11beta,16beta)-isomer;6-Methyl Prednisolone Acetate;LS-118505;METHYLPREDNISOLONE ACETATE;11.BETA.,17,21-TRIHYDROXY-6.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE;PREGNA-1,4-DIENE-3,20-DIONE, 21-(ACETYLOXY)-11,17-DIHYDROXY-6-METHYL-,   (6.ALPHA.,11.BETA.)-;Depo-medrol;acetyl-methylprednisolone;(6.ALPHA.,11.BETA.)-11,17-DIHYDROXY-6-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-21-YL ACETATE;Depo-Medrone;methylprednisolone-21-acetate;Depo-Medrol;CIPLUS_148680;	0	-0.93449626					CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	SigmaAldrich	R201170	-1.10292496	-3.2049067	-0.73198198	-0.93449626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183832-01	Ro 22-9194	144206801	Thromboxane A2 receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	106134-33-2				-16.9880571454	4	4	(-)-(R)-2-AMINO-N-(3-(3-PYRIDYL)PROPYL)-2',6'-PROPIONOXYLIDIDE;Milacainide Tartrate;CIPLUS_3853846;milacainide;MILACAINIDE TARTRATE;CIPLUS_705772;Ro 22-9194;MILACAINIDE;Ro-22-9194;Milacainide tartrate;Milacainide;milacainidum;2-amino-N-(2,6-dimethylphenyl)-N-(3-(3-pyridyl)propyl)propionamide;	0	-3.45318619					Cl.Cl.CC(N)C(=O)N(CCCc1cccnc1)c2c(C)cccc2C	Pharmaron	PH-NIH-100499-100	-3.44112587	-4.22425708	-3.81583507	-3.45318619												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179445-03	Dydrogesterone	170465104	signaling/transport	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	152-62-5		1.4125375446	-5.85	-6.7526081532	4	5		18.391437564	-5.88316277	0.0588678819	0.9978652612			CC(=O)[C@H]2CC[C@H]3[C@@H]4C=CC1=CC(=O)CC[C@@]1(C)[C@@H]4CC[C@]23C	Prestwick Chemical, Inc.	Prestw-671	-6.82939725	-7.82619797	-6.05768828	10.79777706	-5.88316277											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091666-04	1,8-Cineol	170465483	tumor necrosis factor production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	470-82-6		2.8183829313	-5.55	-12.8265664349	4	5		16.417342268	-5.69042265	0.0240813088	0.9996445648			CC2(C)OC1(C)CCC2CC1	Labotest	LT00440774	-7.01445189	-6.99208443	-7.01218236	6.89385937	-5.69042265											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344538-01	1,3-Propanedisulfonic acid disodium salt	225144385		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	36589-58-9				0.9097703426	4	4		0	0.02669989					[O-][S](=O)(=O)CCC[S]([O-])(=O)=O	SIGMA	P8579	0.51175718	-1.9609537	1.36434511	0.02669989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181749-01	Cefminox sodium	144206473	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	75498-96-3	Cefminox; Tencef; Meicelin; Alteporina; 			-17.395172394	4	4	cefminox Sodium;Alter brand of cefminox sodium;Tedec Meiji brand of cefminox sodium;CEFMINOX;Cefminox sodium;Alteporina;Cefminox Sodium;cefminox;MT 141;CEFMINOX SODIUM;Cefminox;CIPLUS_685509;cefminox sodium;Tencef;CIPLUS_733759;cefminoxum;LS-177815;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha,7(S*)))-;CIPLUS_213346;Meicelin;MT-141;	0	-7.76966892					[Na+].[O-]C(=O)[C@H](N)CSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C(=O)O	ACC	CEFMINOX SODIUM	-2.90289849	-2.98894264	-2.98423423	-7.76966892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344546-01	Fenipentol	225144389		DPI_SARS-CoV-2_General	2019_NPC-7_Tox	583-03-9				-25.596119452	4	4		0	-4.89498042					CCCCC(O)C1=CC=CC=C1	Prestwick	Prestw-1501	-6.27343716	-3.63683483	-4.82934858	-4.89498042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247735-02	Varenicline tartrate	174007164	Nicotinic alpha3beta4 Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	230615-23-3	Varenicline dihydrochloride;Varenicline tartrate	1	-6	-12.7846448531	4	5		10.2828692319	-3.96493965	0.0741967964	0.9966357113	1136	CHRNA3	Cl.c1c4c(cc2nccnc12)C3CC4CNC3	Selleck	S1440	-6.48572436	-5.85156184	-3.75518064	4.11978138	-3.96493965											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263541-01	Reboxetine mesylate	170465620		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	98769-84-7		15.8489319246	-4.8	-7.505459095	4	5		-11.1656647239	-8.47138727	0.5088001549	0.5775752576			CS(=O)(=O)O.CCOc3ccccc3O[C@H](c1ccccc1)[C@H]2CNCCO2	Prestwick Chemical, Inc.	Prestw-1328	-0.62566091	-2.31083496	-2.88441412	5.17613558	-8.47138727											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160451-02	Ibufenac	170465922		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1553-60-2				-23.207839854	4	5		0	-5.75466936					CC(C)Cc1ccc(cc1)CC(=O)O	Enamine	Z104507406	-6.61790624	-5.16214146	-4.91062084	0.58329123	-5.75466936											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00386567-02	FLIBANSERIN		Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	167933-07-5				-22.7963297039	4	4		0	-7.01317195					FC(F)(F)C1=CC(=CC=C1)N2CCN(CC2)CCN3C(=O)NC4=CC=CC=C34	SIGMA	SML0797	-4.47346363	-2.85072564	-5.92082467	-7.01317195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261966-01	NCGC00261966-01			DPI_SARS-CoV-2_General	2019_NPC-5_Tox		Selamectin	12.5892541179	-4.9	-89.3422190589	-3	4		-113.8052218179	-99.48956545	0.0122121874	0.9999080067			CO[C@H]1C[C@H](O[C@@H](C)[C@H]1O)O[C@H]\2[C@@H](C)\C=C\C=C\3CO[C@@H]4C\C(=C/[C@@H](C(=O)O[C@H]5C[C@@H](C/C=C2C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)C	GVK	FFS-11-286-NCI-104	-3.15953712	-4.19030428	-5.69999107	-99.48956545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015245-10	Bethanechol chloride	170464912	Muscarinic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	590-63-6	; ;Carbamyl-b-Methylcholine Cl; Urecholine; Bethanechol chloride;BETHANECHOL CHLORIDE;Bethanechol chloride			-21.8227632387	4	5		0	-4.13932357				CHRM2	[Cl-].C[N+](C)(C)CC(C)OC(=O)N	Enzo	AC912	-6.42403948	-6.05583454	-3.1104785	-0.58329123	-4.13932357											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00510749-15	Loracarbef		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	121961-22-6				-24.8392270341	4	4		0	-5.84063601					N[C@@H](C(=O)N[C@H]1[C@H]2CCC(=C(N2C1=O)/C(O)=O)/Cl)C3=CC=CC=C3	USP	1370203	-5.66462965	-7.32766031	-1.26865005	-5.84063601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532513-01	ADRENOCHROME MONOAMINOGUANIDINE MESILATE ANHYDROUS			DPI_SARS-CoV-2_General	2019_NPC-5_Tox					-24.2699710961	4	4		0	-6.79826543					CN1CC(O)C/2=C/C(=N/NC(N)=N)C(=O)/C=C12	Carbosynth	FA17227	-5.12720496	-5.96957194	-2.75171982	-6.79826543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016777-08	Probucol	170464772	Serine Protease Hepsin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	23288-49-5	 Bisbid; Aventis Brand of Probucol; Panavir; Lorelco; Biphenabid;PROBUCOL; Probucol; Superlipid;Probucol; Lurselle; Hoechst Brand of Probucol; 			-18.4488184775	4	5		0	-3.78137763				ABCA1	CC(C)(C)c2cc(SC(C)(C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)cc(c2O)C(C)(C)C	Microsource	01501109	-2.45858301	-6.91548217	-2.34855779	-6.56317457	-3.78137763											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016879-06	Torsemide	170465279	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	56211-40-6	 ;Torsemide (Demadex); Torasemida;TORSEMIDE; Luprac; Demadex;Torsemide; Torsemide			-14.5844685933	4	5		0	-3.90987105					O=S(=O)(NC(=O)NC(C)C)c2cnccc2Nc1cc(C)ccc1	Prestwick	Prestw-1030	-3.81565033	-4.8557324	-1.83781973	0.13319249	-3.90987105											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023945-12	3'-Azido-3'-deoxythymidine	170464737	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	30516-87-1	3'-Azido-3'-deoxythymidine; ; 3'-Azido-3'-deoxythymidine (AZT); Zidovudine, AZT;; 3'-Azido-3'-deoxythymidine; Antiviral AZ; AZT Antiviral; Retrovir; AZTMP-MAN-SA conjugate; 3' Azido 3' deoxythymidin; bis(t-butyl-SATE)-AZTMP; zidovudine (ZDV or AZT);Zidovudine; AZT, Antiviral;Zidovudine, AZT;ZIDOVUDINE [AZT]			0.9000663449	4	5		0	2.52397779			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2	Vitas	STK801891	-0.04406063	-1.26393736	-0.91681668	0.88641896	2.52397779											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00346517-07	Daptomycin		Lipopeptide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	103060-53-3				-18.1400956187	4	4		0	-2.85933689					CCCCCCCCCC(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)C4=CC=CC=C4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@@H](C)CC(O)=O	Enzo	A201	-4.45109002	-5.50541516	-1.81363352	-2.85933689												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00018256-06	Oxyphenonium bromide	170465282	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	50-10-2				-7.7444550098	4	5		0	-3.18480106					[Br-].OC(C(=O)OCC[N+](C)(CC)CC)(c1ccccc1)C2CCCCC2	SIGMA	O5501	-2.19421925	-2.71086901	-0.99217147	1.85091627	-3.18480106											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182991-01	Glybuzole	144206873	insulin secretion Activator	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	1492-02-0	Glybuzole; Gludiase; Glibuzol; 			-3.9649983584	4	5	CIPLUS_216125;Glibuzol;desaglybuzole;LS-31372;glybuzole;Gludiase;N-(5-tert-butyl-1,3,4- thiadiazol-2-yl)benzenesulfonamide;GLYBUZOLE;Benzenesulfonamide, N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-;TH-1395;glybuzolum;Glybuzolum;Glybuzole;	0	-1.32164655					O=S(=O)(Nc1nnc(s1)C(C)(C)C)c2ccccc2	Pharmaron	PH-NIH-183235	-1.36587945	-2.50659631	1.44430025	0.42713452	-1.32164655											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018157-13	Flurbiprofen		non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	5104-49-4	 R-(-)-Flurbiprofen;;FLURBIPROFEN;(?)-Flurbiprofen;Flurbiprofen; Anside; Flurbiprofeno; (R)-2-Flurbiprofen; Ansaid; (S)-(+)-Flurbiprofen; S-(+)-Flurbiprofen; Ocufen			-5.9521599507	4	5		0	-0.81685099				PTGS2	CC(C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2	SIGMA	F8514	-2.8022559	-4.87275513	2.273203	2.39287191	-0.81685099											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015661-12	Molsidomine	170465872		DPI_SARS-CoV-2_General	2019_NPC-2_Tox	25717-80-0				-23.6475963346	4	5		0	-5.19480519					O=C(OCC)[N-]c1c[n+](no1)N2CCOCC2	Microsource	01500673	-5.74550582	-5.94518682	-8.27646837	1.18954669	-5.19480519											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00023230-10	Noscapine	170465539	Tubulin polymerization inhibitors	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	128-62-1		14.1253754462	-4.85	-13.9544445509	4	5		-14.1901702479	-13.49180854	0.4497847676	0.653887024		TUBB	COc3c5OCOc5cc4CCN(C)[C@@H]([C@H]2OC(=O)c1c(OC)c(ccc12)OC)c34	Vitas	STK054401	0.67853366	-6.25159588	-4.42500105	3.33899784	-13.49180854											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00378997-07	Micafunginsodium			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	208538-73-2				-18.7612616428	4	4		0	-3.31104888					CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)C5[C@@H](O)[C@@H](C)CN5C(=O)C(NC(=O)C(NC(=O)C6C[C@@H](O)CN6C(=O)C(NC4=O)[C@@H](C)O)[C@H](O)[C@@H](O)C7=CC=C(O)C(=C7)O[S+](O)([O-])=O)[C@H](O)CC(N)=O	Bio Vision	2585	-4.34707234	-5.47103318	-2.39435361	-3.31104888												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00164574-06	Erlotinib	170465434	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	183321-74-6	 ;CP-358774; Erlotinib hydrochlorid;Erlotinib hydrochlorid;OSI-774; erlotinib HCl; Erlotinib HCL;RG-1415;Tarceva;Ro-50-8231;NSC-718781	8.9125093813	-5.05	-90.656772753	-2.2	4		-74.976493996	-64.7890505	0.0222827358	0.9996937405	1956	EGFR	C#Cc1cc(ccc1)Nc3ncnc2cc(OCCOC)c(cc23)OCCOC	Sequoia	SRP01330e	-7.12087722	-9.88052261	-24.52425623	-64.7890505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159341-18	Lamivudine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	134678-17-4				-9.6334062848	4	4		0	-5.39795826				TERT	NC\1=N\C(=O)N(\C=C1)[C@@H]2CS[C@H](CO)O2	SIGMA	L1295	-1.68595328	-4.62867457	1.1793085	-5.39795826												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00016618-04	Dimethisoquin hydrochloride	170465516	Neuronal acetylcholine receptor; alpha4/beta4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	2773-92-4				-17.185611048	4	4		0	-6.22910832					Cl.CN(C)CCOc2nc(cc1ccccc12)CCCC	Prestwick Chemical, Inc.	Prestw-630	-3.19420968	-2.31648616	-3.93996248	-6.22910832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016799-08	Suxibuzone	170465972	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	27470-51-5				2.2130317254	4	5		0	-0.48313541			791253	PTGS2	O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Prestwick Chemical, Inc.	Prestw-658	-0.20114697	0.71902179	-0.43790506	3.93536381	-0.48313541											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253607-01	Watanidipine	170465844	calcium ion transmembrane transport Blocker	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	116308-55-5				-21.9971453476	4	5		0	-3.82444575					[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCc3ccc(cc3)N4CCN(CC4)C(c5ccccc5)c6ccccc6	GVK	FFS-11-286-NCI-247	-6.48377985	-3.68121932	-5.44753897	-1.04852254	-3.82444575											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016642-04	Piperacetazine	170465363		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	3819-00-9				-33.5622209414	4	5		0	-9.01702262					CC(=O)c2cc3N(CCCN1CCC(CCO)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-1048	-10.08730634	-7.12563506	-4.37905062	-0.10439835	-9.01702262											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00090749-12	Diethylstilbestrol	170464803	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	6898-97-1	; ;DIETHYLSTILBESTROL;Diethylstilbestrol; Diethylstilbesterol; pseudo-DES; (Z,E)-Diethylstilbestrol; 5   Diethylstilbestrol; Dietilestilbestrol; (E)-Diethylstilbestrol; Stilbestrol; Diethylstilbestrol [DES]	11.220184543	-4.95	-75.6340505639	-3	5		-58.632953248	-59.75978688	0.01739596	0.9911907656	2099	ESR1	Oc1ccc(cc1)C(CC)=C(CC)c2ccc(O)cc2	Microsource	01500244	-10.21569802	-4.23232584	-5.50008758	-7.4667514	-59.75978688											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015802-18	Pimozide	170464864	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2062-78-4		12.5892541179	-4.9	-97.8616580225	-3	5		-105.4430396839	-99.67489953	0.0170084378	0.9913869269			Fc1ccc(cc1)C(CCCN2CCC(CC2)N3c4ccccc4NC3=O)c5ccc(F)cc5	NCGCChem	NCGC00015802-17pur	-8.37541727	-7.28924481	-5.13224733	1.22100676	-99.67489953											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00179573-03	Tiaprofenic acid	170465577	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	33005-95-7		4.4668359215	-5.35	-10.3531906009	4	5		-6.7334853519	-6.02790446	0.5652014928	0.4920999722			O=C(c1ccc(s1)C(C)C(=O)O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-496	-3.17983395	4.34426935	-1.4363286	-2.83691162	-6.02790446											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021193-03	AMCINONIDE			DPI_SARS-CoV-2_General	2019_NPC-4_Tox	51022-69-6				-21.8071791338	4	5		0	0.11657625					CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]4[C@@H]5CCC/6=C/C(=O)/C=C\[C@]6(C)[C@@]5(F)[C@@H](O)C[C@]24C	FLUKA	A2428	-8.42801424	-7.76774194	-2.72117844	1.52799062	0.11657625											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00344583-01	Vinblastine sulfate	170464976	Tubulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	18556-44-0		1.4125375446	-5.85	-173.3686034926	-2.3	5		-97.9263077301	-80.33000045	0.0848417529	0.9546891203		TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@@H]4C[C@@](O)(CC)C[N@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]6(O)C(=O)OC)[C@H]78	SIGMA	V1377	-9.67441072	-35.40645161	-38.7271765	-62.33210133	-80.33000045											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015611-18	Lidocaine	170464729	Sodium channel protein type IX alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	137-58-6		1	-6	-19.3583570618	4	5		11.051127692	-6.14267139	0.1996803532	0.974863228			O=C(Nc1c(C)cccc1C)CN(CC)CC	Vitas	STK552033	-8.79260641	-6.76129032	-4.60880303	3.38501758	-6.14267139											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00161414-03	Tropisetron	170466432	5-HT3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	89565-68-4	 ;Tropisetron hydrochloride; Tropisetron hydrochloride;Navoban			-17.2669041948	4	4		0	-6.74405999			3359	HTR3A	CN4[C@H]1CC[C@@H]4CC(C1)OC(=O)c3cnc2ccccc23	Bosche	T0234	-4.10436441	-3.63159704	1.13463772	-6.74405999												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181019-01	Testosterone isocaproate	144206222		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	15262-86-9	Testosterone isocaproate; Ambosex; Mixogen; 			-21.6620597752	4	4	Testosterone 4-methylvalerate;TESTOSTERONE ISOCAPROATE;estrandron;Testosterone Isocaproate;Androst-4-en-3-one, 17-((4-methyl-1-oxopentyl)oxy)-, (17beta)-;4-Androsten-17beta-ol-3-one 17-(4-methylpentanoate);Ambosex;testosterone isocaproate;CIPLUS_662693;Testosterone isocaproate;CIPLUS_750718;	0	-7.20480622					CC(C)CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	InterBioScreen	BB_NC-1398	-4.11303255	-5.6429431	-2.6177075	-7.20480622												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274082-01	Sodium dodecyl sulfate	170465474		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	151-21-3				-19.761016	4	4		0	-7.34935405					[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCC	SIGMA	61749	-2.97750618	-6.86350352	-2.67131243	-7.34935405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015578-12	Ketoprofen	170465449	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	22071-15-4	 Alrheumat; Orudis; Alrheumum; ; Ketoprofen;Ketoprofen; Ketoprofeno; (S)-(+)-Ketoprofen; (S)-Ketoprofen; Profenid;KETOPROFEN			-19.9021886539	4	5		0	-4.61913577				PTGS1	CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2	Microsource	01501215	-7.12573825	-3.84482907	-3.56454721	2.78244292	-4.61913577											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015496-08	N,N,N,N',N',N'-Hexamethylhexane-1,6-diaminium	170465837		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	60-26-4				2.8300522254	4	5		0	-2.56919673					C[N+](C)(C)CCCCCC[N+](C)(C)C	Enzo	AC740	1.41658821	4.93843107	0.47293747	-2.37392765	-2.56919673											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160395-04	Dibenzepin hydrochloride	170466001	Monoamine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	315-80-0				-22.6713825888	4	5		0	-5.07916171					Cl.CN(C)CCN3c1ccccc1N(C)c2ccccc2C3=O	Enzo	NS107	-6.22095572	-5.55412592	-3.15992293	-1.78352323	-5.07916171											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015439-11	Flumazenil	170464960	GABA(A) BZ Site Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	78755-81-4	 Lanexat; Anexate; Romazicon; ; Ro- 15-1788; Flumazenil;Flumazenil; Roche Brand of Flumazenil;FUMAZENIL; Ro 15178;FlUMAZENIL; Ro 15-1788; Ro 15 178			-9.7603848422	4	5		0	0.63665508			2554	GABRA1	O=C(OCC)c3ncn2c3CN(C)C(=O)c1cc(F)ccc12	Microsource	01505701	-4.84892579	-5.46370447	-0.10509721	3.79011393	0.63665508											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178286-05	Pralidoxime chloride	170465059	Butyrylcholinesterase Activator	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51-15-0				-9.0049630962	4	5		0	-4.16760735					[Cl-].O\N=C\c1cccc[n+]1C	Prestwick Chemical, Inc.	Prestw-943	-3.72763845	4.38732455	-3.35435278	0.43121057	-4.16760735											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021318-08	Budesonide		Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	51333-22-3				-15.3576724149	4	5		0	-4.01408769				NR3C1	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	SIGMA	B7777	-5.39673029	-4.4648239	-0.05254861	1.15745994	-4.01408769											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00024643-10	Ifenprodil	170465791	Kir3.1/Kir3.4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	23210-56-2				0.8813698602	4	5		0	1.42231453					OC(C(C)N1CCC(CC1)Cc2ccccc2)c3ccc(O)cc3	SigmaAldrich	I-2892	0.52640589	-1.09790752	-1.72534594	1.16653806	1.42231453											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00021623-05	Nadolol	170464945	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	42200-33-9				-7.7837100127	4	5		0	-2.78593037					CC(C)(C)NCC(O)COc2cccc1C[C@@H](O)[C@@H](O)Cc12	Microsource	01503260	-1.57921767	-2.65650564	-1.28744088	-0.02269529	-2.78593037											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249938-01	Glymidine sodium	170465939		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	3459-20-9				-6.3523893333	4	5		0	-2.21700456					[Na+].O=S(=O)([N-]c1ncccn1)c2cc(OCCOC)ccc2	GVK	FFS-11-286-NCI-256	-2.28109219	2.57039525	-0.52548607	-2.70981798	-2.21700456											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249914-01	Bencyclane	170465760		DPI_SARS-CoV-2_General	2019_NPC-3_Tox	2179-37-5				-28.6735154304	4	5		0	-5.99178218					CN(C)CCCOC1(CCCCCC1)Cc2ccccc2	GVK	FFS-11-286-NCI-166	-8.4182145	-4.37010247	-5.79786302	-2.11066225	-5.99178218											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015829-12	Promazine hydrochloride	170464766	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	53-60-1				-40.2849580823	4	5		0	-11.29312712					Cl.CN(C)CCCN1c3ccccc3Sc2ccccc12	Microsource	01500509	-9.18456817	-7.99022131	-5.44637123	-7.75197195	-11.29312712											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015067-14	Aspirin	170465039	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50-78-2	 Komineks mixture; Alka Seltzer; Ascriptin; Micristin; 2-Acetoxybenzoic acid; Veganine; Vincents Powder; Solupsan; Istopirin; Norgesic forte; Alka-Seltzer; Carbasalato calcico; Aloxiprimum;Aspirin; Endosprin; Bayer Aspirin; Bayer EC Aspirin; Lysine acetylsalicylate; Equagesic; Dolomo; Kominek's mixture; Solprin; Sedalgin; Colfarit; DP-neuralgen; Bex Powder; Cu-aspirinate; Aspirin DL-lysine; Cogla; Magnyl; Aspisol; Apyron; Midol; Easprin; ; Acetard; Synalgos; Ecotrin; Triaminicin; Zorprin;Acetylsalicylic acid; 2-(Acetyloxy)benzoic Acid; Oxycodone w/Aspirin; Acylpyrin; Dispril;ASPIRIN; Acid, Acetylsalicyli; Polopiryna; Aspirin DL-Lysine; Fiorinal; Doleron; Astra 2167; Carisoprodol/Aspirin; Acetylsalicylic acid; Aspirin Tri-Buffered; O-Acetylsalicylic acid; Acetysal; Magnecyl; Polopirin			-23.5537582547	4	5		0	-3.12986181				HMGCR	O=C(C)Oc1ccccc1C(=O)O	Microsource	01500130	-5.22139413	-4.05301081	-6.61100407	-5.83260298	-3.12986181											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091398-01	Nitrobenzene	17389793	Glutathione reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-9_Tox		Nitrobenzene; Nitrobenzene-d5; Pentadeuteronitrobenzene; 			-19.8517460491	4	4	Nitrobenzene;CIPLUS_150482;NCGC00091398-02;CIPLUS_699787;Nitrobenzene-13C6;1,2-dinitrobenzene;ortho-dinitrobenzene;AB07993089-01;o-dinitrobenzene;nitrobenzene;Nitrobenzene-d5;CIPLUS_763567;Pentadeuteronitrobenzene;CIPLUS_174736;Nitrobenzene-15N;	0	-5.5626514					[O-][N+](=O)C1=CC=CC=C1	NIEHS	AB07993089	-3.97316372	-4.72745626	-3.21020995	-5.5626514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249902-01	Epsiprantel	170465737	calcium ion homeostasis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	98123-83-2				-4.0658809933	4	5		0	-3.30067278					O=C2CN(CC1c3ccccc3CCCN12)C(=O)C4CCCCC4	GVK	FFS-11-286-NCI-105	-1.17692374	-0.32291398	-1.01593974	2.17420907	-3.30067278											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016978-04	Repaglinide	225144184	Insulin Secretagogues	DPI_SARS-CoV-2_General	2019_NPC-3_Tox	135062-02-1	; ; Prandin; Repaglinide;Repaglinide; Repaglinida; Novonorm	14.1253754462	-4.85	-43.6038109188	4	5		-29.80816446	-29.38095453	0.0337472189	0.9827232335		INS	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)C(O)=O	Prestwick	Prestw-1046	-6.18419926	-6.78119349	-4.48414784	-3.29081748	-29.38095453											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167982-04	Pirarubicin			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	72496-41-4		5.6234132519	-5.25	-35.2764957763	4	5		-25.0723095319	-23.10789787	0.0340045924	0.9826101994			[H][C@]1(N)C[C@]([H])(O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O[C@@]6([H])CCCCO6	SIGMA	P8624	-1.38097326	-4.02727741	-6.33697281	-11.73093777	-23.10789787											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00166210-02	PAROMOMYCIN SULFATE		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	1263-89-4				-0.0800414712	4	5		0	1.51002105					NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)[C@H](N)[C@@H](O)[C@@H]1O	SIGMA	P9297	-1.8018413	-1.17944759	-2.45771783	-1.51183173	1.51002105											3.2E-10	1.6E-9	8E-9	4E-8	2E-7										
NCGC00348363-01	ARABITOL(D)		sugar alcohol	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	488-82-4				-3.3262590307	4	5		0	1.14395534					OC[C@@H](O)C(O)[C@H](O)CO	SIGMA	A3381	-0.36387549	-1.3166924	-2.37208307	-1.32778265	1.14395534											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00178238-05	Midodrine hydrochloride	170464672	Alpha-1b adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3092-17-9				0.705703927	4	5		0	-2.35197218					Cl.COc1ccc(cc1C(O)CNC(=O)CN)OC	Microsource	01503257	1.77553705	0.0214445	1.61849711	-2.82646801	-2.35197218											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00017041-05	Dobesilate Calcium			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	20123-80-2 (anhydrous)				-24.2077306518	4	4		0	-6.35321801					OC1=CC(=C(O)C=C1)[S+](O)([O-])=O	SIGMA	SML0488	-6.30353898	-2.54634608	-2.26420091	-6.35321801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167441-02	Pramipexole hydrochloride	170465264	Dopamine D3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	104632-26-0	 ; PRAMIPEXOLE HCl; pramipexol, (R)-isomer;Pramipexole; Pramipexole; Pramipexole Hcl; Mirapex;Pramipexole (Mirapex)			-20.4907942084	4	5		0	-1.5649309			1814	DRD3	CCCN[C@@H]1Cc2sc(N)nc2CC1	Prestwick Chemical, Inc.	Prestw-1316	-4.9583516	-5.82861554	-5.49775209	-3.1595092	-1.5649309											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00094557-06	2-Chloro-4-nitrobenzamide	170466191		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	3011-89-0				-25.2942731568	4	5		0	-5.39031756					O=C(N)c1ccc(cc1Cl)[N+]([O-])=O	Vitas	STK061509	-7.81674704	-3.35820896	-5.91736245	-0.40753725	-5.39031756											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00348215-03	Bedaquiline (TMC-207)		ATP synthase subunit c Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	843663-66-1				-39.3970062173	4	4		0	-11.58220402			886937	atpE	COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C3=CC=CC=C3)[C@@](O)(CCN(C)C)C4=CC=CC5=C4C=CC=C5	Adooq	A12327	-8.47538288	-6.43468536	-6.58074767	-11.58220402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168783-01	Diisopropyl fluorophosphate	144206196	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	55-91-4	Isoflurophate; Floropryl; Fluorostigmine; Dyflos; 			-17.9537218282	4	4	Diisopropylphosphofluoridate;DIFP;PHOSPHOROFLUORIDIC ACID, BIS(1-METHYLETHYL) ESTER;Bis(1-methylethyl) Phosphorofluoridate;Isoflurophate;CIPLUS_148756;DIISOPROPYLFLUOROPHOSPHATE;Phosphorofluoridic acid, bis(1-methylethyl) ester;Dyflos;Di isopropylphosphorofluoridat;diisopropyl phosphofluoridate;Fluorostigmine;Phosphoric acid diisopropyl ester fluoride;LS-108313;Floropryl;Di-isopropylphosphorofluoridate;6   Diisopropyl Fluorophosphate;ISOFLUROPHATE;Diisopropylfluorophosphate;Merck Brand of Isoflurophate;Diisopropyl phosphorofluoridate;	0	-5.03725653					FP(=O)(OC(C)C)OC(C)C	Toronto Research	D455300	-4.09708402	-2.21084778	-3.12044843	-5.03725653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166097-02	Cinnamyl alcohol	225144268	prostaglandin secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	104-54-1				-7.8704983642	4	4		0	-0.77563293					OC\C=C\C1=CC=CC=C1	SIGMA	108197	-2.67803063	-1.76351671	1.11665269	-0.77563293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177980-03	Oxiconazole nitrate	170465226	Steroid biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	64211-46-7		12.5892541179	-4.9	-97.9143653647	-3	4		-103.7393993103	-99.50760382	0.0469393584	0.9986386293			[O-][N+](=O)O.Clc3ccc(C(=N\OCc1ccc(Cl)cc1Cl)\Cn2ccnc2)c(Cl)c3	Microsource	01505330	-6.42467768	-6.85620887	-3.34995807	-99.50760382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390731-01	Tafamidis		Transthyretin Modulator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	594839-88-0				-40.1472959188	4	4		0	-12.95045536					OC(=O)C1=CC=C2N=C(OC2=C1)C3=CC(=CC(=C3)Cl)Cl	MedChem Express	HY-14852	-8.22445271	-7.20891221	-6.33358344	-12.95045536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181148-01	Metharbital	144206305	GABA-A receptor; anion channel Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	50-11-3	Metharbital; Metarbital; 			-26.2131415366	4	4	metharbitone;Metharbital;metharbital;endiemal;metharbitalum;CIPLUS_148525;Metarbital;2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-1-methyl-;LS-24178;Metharbitalum;METHARBITAL;Barbituric acid, 5,5-diethyl-1-methyl-;methobarbitone;5,5-DIETHYL-1-METHYLBARBITURIC ACID;2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5,5-DIETHYL-1-METHYL-;CIPLUS_178471;	0	-5.57758508					O=C1NC(=O)N(C)C(=O)C1(CC)CC	NCI	NSC-27156	-6.64964956	-6.01316186	-1.23140751	-5.57758508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179867-02	NCGC00179867-02			DPI_SARS-CoV-2_General	2019_NPC-8_Tox			14.1253754462	-4.85	-23.9958890652	4	4		-11.572205388	-13.3077694	0.1719039468	0.9815519591			O[C@@H]1[C@@H](COC(=O)C2=CC(=C(O)C(=C2)O)O)O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](O)[C@H]1OC(=O)C4=CC(=C(O)C(=C4)O)O	Analyticon	NP-005114	-3.99325084	-3.09690739	-2.41426491	-13.3077694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242480-03	Ivacaftor		CFTR Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	873054-44-5		12.5892541179	-4.9	-92.5273119165	-3	4		-106.8837465639	-99.62089851	0.0830754705	0.9957190786		CFTR	CC(C)(C)C1=CC(=C(NC(=O)C/2=C/NC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C	APExBIO	A5047	-6.69291339	-2.07320745	0.67528799	-99.62089851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168463-06	Bretylium tosylate		norepinephrine secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	61-75-6				-17.9552930626	4	4		0	-4.65379755					CC[N+](C)(C)CC1=C(Br)C=CC=C1	Prestwick	Prestw-942	-4.10573678	-0.81723945	-4.89473452	-4.65379755												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378889-01	PF-04971729		Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	1210344-57-2				-27.6130116891	4	4		0	-5.23770099					CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)C=C1	MedChem Express	HY-15461	-6.96980185	-5.4884081	-2.95272984	-5.23770099												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522014-01	Zolazepam Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-8_Tox	33754-49-3				-25.4888003283	4	4		0	-7.48616497					C[N]1N=C(C)C2=C1N(C)C(=O)C\N=C2\C3=CC=CC=C3F	Toronto Research	Z613500	-4.69412477	-7.11428449	-4.19737829	-7.48616497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017030-10	Fusidic Acid (sodium salt)			DPI_SARS-CoV-2_General	2019_NPC-9_Tox	751-94-0				-23.2120275762	4	4		0	-7.69434045					C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]3(C)[C@H]2[C@H](O)C[C@H]4\C([C@H](CC34C)OC(C)=O)=C(CCC=C(C)C)/C([O-])=O	Cayman	14825	-4.88803694	-4.84522207	-2.278073	-7.69434045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183600-04	PARAMETHADIONE		Voltage-gated T-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC-9_Tox	115-67-3				-15.5057976108	4	4		0	-1.38735961					CCC1(C)OC(=O)N(C)C1=O	Microsource	01505456	-5.5502309	-3.89468371	3.47155676	-1.38735961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181352-01	Aspoxicillin	144206363		DPI_SARS-CoV-2_General	2019_NPC-9_Tox	63358-49-6	Aspoxicillin; Aspoxicillin Anhydride; Doyle; 			-19.3038774421	4	4	TA 058;TA-058;Doyle;Glycinamide, N-methyl-D-asparaginyl-N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-D-2-(4-hydroxyphenyl)-, (2S-(2-alpha,5-alpha,6-beta))-;LS-72203;n(sup 4)-methyl-d-asparagininylamoxicillin;N(4)-methyl-D-asparaginylamoxicillin;CIPLUS_214228;aspoxicillinum;ASPOXICILLIN;Aspoxicillin;aspoxicilline;aspoxicillin;Aspoxicillin Anhydride;	0	-4.72583131					OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)NC)c1ccc(O)cc1)[C@H]3SC2(C)C	APAC	550484	-4.01672911	-3.63391655	-4.25559718	-4.72583131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167980-02	Pranoprofen	170465811	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	52549-17-4				-21.5194011326	4	4		0	-2.67772307					O=C(O)C(C)c1cc2Cc3cccnc3Oc2cc1	Prestwick	Prestw-1318	-3.60050094	-6.29914602	-5.42059463	-2.67772307												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522560-01	Tasimelteon		Melatonin receptor type 1B Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	609799-22-6				-8.4821507355	4	4		0	-0.11229161			4544	MTNR1B	CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2	MedChem Express	HY-14803	-2.00822972	-1.47120994	-1.9035533	-0.11229161												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00159467-03	(-)-Cocaine hydrochloride	144206436	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	53-21-4				-30.0353552306	4	4		0	-6.33151939					Cl.CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)OC	RTI	9041-001	-6.21254137	-9.25002114	-1.18745468	-6.33151939												3.18E-7	0.00000159	0.0000397	0.00011899999999											
NCGC00346741-02	Travoprost		Prostanoid TP Agonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	157283-68-6				-0.5604602403	4	4		0	-3.23054332				TBXA2R	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC2=CC(=CC=C2)C(F)(F)F	MedChem Express	HY-B0584	1.34627426	-2.90014374	-0.19941987	-3.23054332												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167519-02	Ramatroban	170465980	prostaglandin D2 CRTH2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	116649-85-5	BAY u-3405; ; Ramatroban;Ramatroban; Baynas; BAY u3405;BAY-u3405; BAY u 3405; BAY u 3406			14.8286982486	4	4		0	-0.06046471			11251	PTGDR2	Fc1ccc(cc1)S(=O)(=O)N[C@H]3Cc4c2ccccc2n(CCC(=O)O)c4CC3	Sequoia	SRP0101165r	5.71160211	-0.12682844	0.41696882	-0.06046471												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00095136-09	Olmesartan medoxomil			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	144689-63-4				-24.1218716549	4	4		0	-5.26043016					CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(=O)OCC/5=C(C)/OC(=O)O5)C(C)(C)O	APExBIO	A4082	-5.12120941	-6.25686987	-3.44452502	-5.26043016												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00179313-05	Imidazolidinyl urea		T-lymphocyte activation antigen CD86 Activator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	39236-46-9				-31.6182697635	4	4		0	-7.09164723					OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O	MedChem Express	HY-B1158	-6.23043206	-8.2945802	-5.67440174	-7.09164723												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00346533-09	Daclatasvir dihydrochloride		HCV NS5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	1009119-65-6		3.5481338923	-5.45	-76.8589651317	-3	4		-99.0511336466	-4.04249806	1	0.9999928973			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	Glixx	GLXC-90137	-1.41783702	-4.32907753	-98.28680203	-4.04249806												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00522022-01	Befunolol		Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	39552-01-7				-31.582340014	4	4		0	-5.08767384					CC(C)NCC(O)COC1=C2OC(=CC2=CC=C1)C(C)=O	Toronto Research	B131100	-5.08542803	-9.48676757	-7.93147208	-5.08767384												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181021-02	Bufogenin	124893634	Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-6_Tox			3.9810717055	-5.4	-97.5008035298	-2.3	4	CIPLUS_153297;resibufogenin;Bufogeninum;Bufogenine;Bufogenina;BUFOGENIN;14,15 beta-epoxy-3 beta-hydroxy-5 beta-bufa-20,22-dienolide;Bufogenin;bufogenine;bufogeninum;RESIBUFOGENIN;bufogenin;Resibufogenin;LS-45295;	-93.8748649631	-36.86620022	1	0.9999919554			C[C@]12CC[C@H](O)C[C@H]1CCC3C2CC[C@]4(C)[C@H](C[C@H]5O[C@@]345)C/6=C/OC(=O)/C=C6	Sequoia	RESIBUFOGENIN	-7.09813042	-10.90724613	-97.19905729	-36.86620022												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00167465-02	Calcipotriene	170464710	Vitamin D receptor Activator	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	112965-21-6				1.6866564191	4	4		0	3.58469379					C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@@H](O)C4CC4	Prestwick Chemical, Inc.	Prestw-1257	-0.74693622	-1.70795637	4.83139956	3.58469379												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00484057-01	Methenolone (acetate)	363681150		DPI_SARS-CoV-2_General	2019_NPC-6_Tox	434-05-9				-20.9133416228	4	4		0	-4.83717716					CC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C=C(C)/[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-A0094B	-3.18901512	-7.02629576	-4.53226976	-4.83717716												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00160502-01	NCGC00160502-01	29216184		DPI_SARS-CoV-2_General	2019_NPC-6_Tox		Kliostom; 			-36.1595010765	4	4	CIPLUS_3884272;Kliostom;	0	-6.14148743					CC1=NC=C(N1CCOC(=O)C2=CC=CC=C2)[N+]([O-])=O	InterBioScreen	STOCK1S-09026	-6.71348063	-8.31149066	-7.2697607	-6.14148743												3.2E-7	0.0000016	0.000039999999999	0.00011999999999											
NCGC00263539-01	Ziprasidone	170465342	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	146939-27-7	Ziprasidone hydrochloride;Ziprasidone  Hydrochloride			-10.8010845311	4	4		0	-2.48769111			3356	HTR2A	O=C4Cc5cc(CCN1CCN(CC1)c3nsc2ccccc23)c(Cl)cc5N4	Prestwick Chemical, Inc.	Prestw-1188	-3.99409607	-1.75868775	1.95794054	-2.48769111												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00094792-18	Tioguanine		Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	154-42-7		3.5481338923	-5.45	-48.5472747179	-3	4		-56.2995086193	-2.11626501	1	0.9999936366		HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	Cayman	15774	-1.71303337	-5.08159297	-55.57469181	-2.11626501												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00521081-01	Cycrimine Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC-6_Tox	126-02-3				-23.1401495415	4	4		0	-5.77869914					OC(CCN1CCCCC1)(C2CCCC2)C3=CC=CC=C3	Toronto Research	C991450	-4.48608999	-4.25298047	-6.23640319	-5.77869914												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00181319-01	Plicamycin	144206340	DNA Antagonist	DPI_SARS-CoV-2_General	2019_NPC-6_Tox	18378-89-7	Plicamycin; Mithracin; Mithramycine; Mitramycin; Plicamicina; Mithramycinum; Mitramicina; Acid, Aureoli; 	3.9810717055	-5.4	-24.6556768188	4	4	Mithramycine;Plicamycinum;CIPLUS_741126;plicamycinum;Mithramycinum;Acid, Aureoli;Mithracin;mithramycin A;PA-144;Mithramycin A;NCGC00162423-01;NSC-24559;Mithramycin A Streptomyces plicatus;MITHRAMYCIN A;mithramycin;Plicamycin;MITHRAMYCIN;WHO NO. 2029;Mitramycin;Plicamicina;CIPLUS_171437;Aureolic acid;Plicamycine;PLICAMYCIN;Mitramicina;Mithramycin;plicamycin;AUREOLIC ACID;plicamycine;A-2371;LS-91528;	-30.1157282321	-5.01857131	1	0.999948953			C[C@@H](O)[C@H](O)C(=O)[C@@H](OC)C6Cc7cc8cc(O[C@H]2C[C@@H](O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1)[C@@H](O)[C@@H](C)O2)c(C)c(O)c8c(O)c7C(=O)[C@H]6O[C@H]5C[C@@H](O[C@H]4C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O5	SIGMA	M6891	-0.68431881	-3.55119641	-27.44742567	-5.01857131												1.6E-7	8E-7	0.000019999999999	0.000059999999999											
NCGC00018098-07	Iodoquinol	170465640		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	83-73-8		3.5481338923	-5.45	-135.1779205104	-2.1	5		-84.5321566528	-91.57512442	0.0081164252	0.995917596			Oc1c(I)cc(I)c2cccnc12	Vitas	STK070581	-9.72528404	-8.49032258	-3.93843168	-57.23879924	-91.57512442											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00262942-01	Etifelmine hydrochloride	170465899		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	1146-95-8	Etifelmine;Etifelmine			-16.3618136759	4	5		0	-8.18723938					Cl.CCC(\CN)=C(/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-209	-4.37510599	-3.59569892	-0.4542648	1.00513838	-8.18723938											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249897-01	Nitromersol	170465514		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	133-58-4		12.5892541179	-4.9	-72.3834878415	-3	5		-111.667349686	-99.78926602	0.0094142417	0.9952599557			Cc1ccc(c2[Hg]Oc12)[N+]([O-])=O	GVK	FFS-11-286-NCI-74	-1.68729863	-0.8	6.24062803	2.18606328	-99.78926602											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015558-14	Isoprenaline hydrochloride	170464679	beta-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	7683-59-2	Isoproterenol;Isoproterenol HCl; Isoprenalina; Isopropyl noradrenaline; Isuprel;(-)-Isoproterenol hydrochloride; ;Isoproterenol hydrochloride; Isoproterenol HCl; Isopreterenol sulfate; Isoproterenol ALSO 123; Levisoprenalina; Isoproterenol hydrochloride;(?)-Isoproterenol hydrochloride;ISOPROTERENOL HYDROCHLORIDE; Luf-Iso; Proternol-L; Isoprenaline Hcl; (-)-Isoproterenol hydrochloride; Proternol-S	1	-6	-16.5236279125	4	5		11.9832258039	-3.04891719	0.193903162	0.976299866	153	ADRB1	Oc1ccc(cc1O)C(O)CNC(C)C	Microsource	01500357	-6.97812447	-9.15268817	-4.45003087	4.0971784	-3.04891719											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00015045-09	Methacholine chloride	170464971	Muscarinic acetylcholine receptor M2 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	62-51-1				-1.8729283822	4	5		0	-0.03586961					[Cl-].C[N+](C)(C)CC(C)OC(=O)C	Microsource	01500391	-3.06087841	-0.0172043	0.87765723	4.62003065	-0.03586961											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00182999-01	Flomoxef	144206879	Streptococcus pneumoniae Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	99665-00-6	FLOMOXEF; 			2.4498681001	4	5	CIPLUS_207906;LS-178431;FLOMOXEF;Flomoxef;flomoxefum;flomoxef;'(-)-(6R,7R)-7-(2-((DIFLUOROMETHYL)THIO)ACETAMIDO)-3-(((1-(2-HYDROXYETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-7-METHOXY-8-OXO-5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID;flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];Flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];S 6315;	0	-3.12962382					O=C2N1C(=C(CO[C@H]1[C@@]2(OC)NC(=O)CSC(F)F)CSc3nnnn3CCO)C(=O)O	Pharmaron	PH-NIH-183450	1.98405969	-3.68172043	2.67707506	2.59172451	-3.12962382											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263447-01	alpha-Santonin	170465728		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	481-06-1				-20.32301116	4	5		0	-4.59131059					O=C1C=C[C@]2(C)CC[C@H]3[C@H](C)C(=O)O[C@@H]3C2=C1C	Specs	AE-562/J257885	-7.3681533	-1.50537634	-0.8159125	-2.29423961	-4.59131059											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164605-02	Ampiroxicam	170466020	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	99464-64-9		1	-6	-25.5698580746	4	5		14.8825806439	-5.06658297	0.0517153469	0.9983591852			O=C(OCC)OC(C)OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Sequoia	SRP05637a	-10.4375106	-10.73548387	-5.13804357	3.37600288	-5.06658297											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249895-01	Bornelone	170465560		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	2226-11-1		0.0501187234	-7.3	-10.6120727026	4	5		13.181956928	7.48778191	0.5102040932	0.5734139052			CC2(C)C(=C\C=C\C(C)=O)/C1CCC2C1	GVK	FFS-11-286-NCI-70	-9.31829744	4.92903226	-4.33536209	0.94203552	7.48778191											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00018100-08	Fasudil hydrochloride	170466011	ROCK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	105628-07-7	;HA-1077; Fasudil; Fasudil (HA 1077); HA 1077 hydrochloride; Eril-S;Fasudil; HA-1077 dihydrochloride	1	-6	-19.9047480574	4	5		12.93741936	-9.12881675	0.1148314408	0.9918519541	6093	ROCK1	Cl.O=S(=O)(c2cccc1cnccc12)N3CCCNCC3	Enzo	EI233	-8.22452094	-9.5311828	-5.02337479	3.81772289	-9.12881675											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016261-08	Pyridoxine	170464634	Oxidative Stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	65-23-6				-25.5689135524	4	5		0	-7.22772721					Oc1c(CO)c(cnc1C)CO	Vitas	STK177324	-6.29981346	-7.71612903	-4.78521655	0.3650951	-7.22772721											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263583-01	Temocapril hydrochloride	170465944	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	110221-44-8				-25.0906072612	4	5		0	-3.36277631				ACE	Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3	Sequoia	110221-44-8	-7.48685772	-7.63870968	-3.25041898	-1.54602001	-3.36277631											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00164578-02	Etoricoxib	170465621	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	202409-33-4				-20.2474009203	4	5		0	-3.28206968			5743	PTGS2	CS(=O)(=O)c1ccc(cc1)c3cc(Cl)cnc3c2cnc(C)cc2	Sequoia	SRP02700e	-5.77412244	-8.46451613	-3.06518479	1.39277022	-3.28206968											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181913-02	Difeterol	144206884	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	14587-50-9	Difeterol; Difeterol Phosphate; Difeterol Hydrochloride; 			3.3592688718	4	5	CIPLUS_783660;DIFETEROL;Difeterol;difeterolum;difeterol;Difeterol Phosphate;Difeterol Hydrochloride;	0	-0.30489172					OC(C(C)N(C)CCOC(c1ccccc1)c2ccccc2)c3ccccc3	Pharmaron	PH-NIH-2	1.95862303	0.51612903	2.23604128	-2.81709186	-0.30489172											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00253597-01	Isosulfan blue	170464639		DPI_SARS-CoV-2_General	2019_NPC-4_Tox	68238-36-8				-36.4253430624	4	5		0	-13.83670358					[Na+].CC/[N+](CC)=C1\C=C/C(C=C1)=C(/c2ccc(cc2)N(CC)CC)c3cc(ccc3S([O-])(=O)=O)S([O-])(=O)=O	GVK	FFS-11-286-NCI-038	-8.23299983	-6.37419355	-5.25271236	-3.84476697	-13.83670358											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00263533-01	Penciclovir	170464955	Human herpesvirus 1 DNA polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	39809-25-1				-6.4385061495	4	5		0	-2.00869838			1487316		OCC(CO)CCn2cnc1c2NC(N)=NC1=O	Sequoia	SRP01095p	-2.27234187	-0.30107527	0.1278998	-0.86090327	-2.00869838											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00095188-05	Pantoprazole	170466337	H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-4_Tox	102625-70-7	; ; Protonix; PANTOPRAZOLE;Pantoprazole; Pantoprazol; Pantoprazole;PANTOPRAZOLE	0.8912509381	-6.05	-22.910226218	4	5		10.333135488	-0.07173923	0.1948859112	0.8864100615		ATP4A	COc3c(OC)ccnc3CS(=O)c1nc2cc(ccc2n1)OC(F)F	Microsource	01505818	-9.86094624	-7.00215054	-4.00017641	4.46678085	-0.07173923											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00181116-02	Carbomycin A	124893648	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-8_Tox					-16.6835171365	4	4		0	-7.27700553					CO[C@H]1[C@@H](CC(=O)O[C@H](C)C[C@@H]2OC2\C=C/C(=O)[C@H](C)C[C@H](CC=O)[C@@H]1OC3OC(C)C(OC4CC(C)(O)C(OC(=O)CC(C)C)C(C)O4)C(C3O)N(C)C)OC(C)=O	NCI	NSC-51001	-2.76455828	-1.09252011	-4.89473452	-7.27700553												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183865-01	Flugestone	144206781		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	337-03-1				-13.2770280346	4	4	CIPLUS_160491;Flugestonum;CIPLUS_679087;FLUROGESTONE ACETATE;Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11beta)-;Fluorogestone acetate;Flurogestone acetate;FLUGESTONE;Flugestona;flugestonum;flugestone;Flugestone;Flurogestone Acetate;Flugestone acetate;LS-118677;	0	-3.25940128					CC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)C1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12	NCI	NSC_79327	-2.37518387	-5.57443331	-1.25788939	-3.25940128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018215-06	Acebutolol hydrochloride	170465309	Beta-1 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	34381-68-5				-31.2147008768	4	5		0	-5.16152649					Cl.CC(C)NCC(O)COc1ccc(cc1C(C)=O)NC(=O)CCC	Microsource	01500665	-9.10565541	-5.05661348	-3.91350888	-6.00788782	-5.16152649											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00167467-03	Vecuronium bromide	170465295	Steroid non-depolarizing neuromuscular Blocker	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50700-72-6	 ; Vecuronium bromide;Vecuronium bromide;Vecuronium Bromide; Bromuro de vecuronio; Norcuron			-22.0308731307	4	5		0	-4.48430493					[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(C)=O	Prestwick	Prestw-1359	-4.53748356	-7.80150969	-2.31213873	-4.57055215	-4.48430493											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091902-11	Malathion	170465311	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	121-75-5				-15.4786631472	4	5		0	-2.06827125					CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	Microsource	00330021	-1.83691363	-5.64848173	-4.38450011	-5.02629273	-2.06827125											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00016354-11	Butylparaben	170465688		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	94-26-8				-28.0626006513	4	5		0	-12.11677496					Oc1ccc(cc1)C(=O)OCCCC	Microsource	01505995	-6.74704077	-4.19883342	-2.12374224	-2.96669588	-12.11677496											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00013724-07	(-)-Scopolamine methyl bromide			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	155-41-9				-32.5971239783	4	5		0	-4.0267228					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@@H](C[C@@]2([H])[N+]3(C)C)OC(=O)[C@H](CO)C4=CC=CC=C4	SIGMA	S8502	-9.04427882	-5.81145994	-6.68807536	-5.83260298	-4.0267228											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00274061-01	Trilostane	174007161	Estrogen Receptor (ER) beta Modulators	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	13647-35-3	Trilostane			-31.3433801854	4	5		0	-1.41850462			2099	ESR1	N#CC=2C[C@]4(C)[C@H]5CC[C@]1(C)[C@@H](O)CC[C@H]1[C@@H]5CC[C@@]34O[C@@H]3C=2O	Selleck	S1404	-9.35992986	-5.18528049	-6.8935988	-6.41104294	-1.41850462											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00159430-04	Hexobarbital	170465860	GABA-A receptor; benzodiazepine site Activator	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	56-29-1				-23.5873461236	4	5		0	-3.79793173					CC1(C(=O)N=C(O)N(C)C1=O)C2=CCCCC2	Labotest	LT00244803	-2.88031565	-5.36541431	-9.23142796	-7.44522349	-3.79793173											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249934-01	Tolciclate	170465866		DPI_SARS-CoV-2_General	2019_NPC-1_Tox	50838-36-3		7.0794578438	-5.15	-36.4574225612	4	5		-19.4977076399	-17.19593667	0.2705687274	0.8303330835			Cc1cc(ccc1)N(C)C(=S)Oc2ccc4c(c2)C3CCC4C3	GVK	FFS-11-286-NCI-238	-5.624726	-0.94784697	-8.70905588	-9.18930762	-17.19593667											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00014670-17	Domperidone	170465594	Dopamine Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	57808-66-9	 ; Motilium; 5   Domperidone; Prestwick-06G02;Domperidone; Domperidona; Domperidone; TFMP domperidone;DOMPERIDONE; Domperidone Maleate (1:1)			-32.7725869667	4	5		0	-9.60922486			1812	DRD1	Clc4cc5NC(=O)N(C3CCN(CCCN1c2ccccc2NC1=O)CC3)c5cc4	Microsource	02300212	-8.79000438	-6.24892777	-4.59858703	-2.44084137	-9.60922486											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00163798-06	Triethylene glycol			DPI_SARS-CoV-2_General	2019_NPC-1_Tox	112-27-6				-0.1517735092	4	5		0	1.16225863					OCCOCCOCCO	SIGMA	T59455	2.05611574	-1.10224738	-2.68893171	-3.12445223	1.16225863											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00091502-11	Coumarin	170465665	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-1_Tox	91-64-5				-24.5827343398	4	5		0	-5.07001007					O=C1C=Cc2ccccc2O1	Vitas	STK066167	-6.28233231	-4.68776806	-4.88118176	-3.51007888	-5.07001007											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00249415-01	Fabesetron	144206751	5-hydroxytryptamine receptor 4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	129300-27-2				-24.2220964927	4	4		0	-3.68643514			3360	HTR4	Cc4ncnc4C[C@H]3CCc2c(C)c1ccccc1n2C3=O	NCGCChem	DJM10-012	-6.80539932	-4.00877457	-1.8404908	-3.68643514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183869-01	Gusperimus trihydrochloride	144206777	Heat shock protein HSP90 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	85468-01-5				3.926438689	4	4	CIPLUS_667980;15-DEOXYSPERGUALIN TRIHYDROCHLORIDE;LS-171915;Gusperimus;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)-;gusperimus trihydrochloride;gusperimus;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-;Gusperimus Hydrochloride;deoxyspergualin;LS-74249;CIPLUS_667979;LS-74248;NKT-01;CIPLUS_756341;NSC-356894;1-amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione;(-)-15-Deoxyspergualin;BMY-42215-1;gusperimusum;Gusperimus trihydrochloride;Gusperimus hydrochloride;GUSPERIMUS TRIHYDROCHLORIDE;15-deoxyspergualin;3HCl of gusperimus;GUSPERIMUS;gusperimus, (+-)-isomer;Spanidin;DEOXYSPERGUALIN;CIPLUS_192812;	0	0.23530437			3303		Cl.Cl.Cl.O=C(NCCCCNCCCN)C(O)NC(=O)CCCCCCNC(=N)N	NCI	NSC_356894	-0.09085403	2.37429567	3.32347619	0.23530437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506875-01	Vilanterol (GW642444; GW 642444X)		"adrenoceptor beta 2, surface Agonist"	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	503068-34-6				-22.6633561819	4	4		0	-9.54289947			154	ADRB2	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl	TargetMol	T2645	-4.39127801	-6.01316186	-0.16330494	-9.54289947												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095175-08	Cefditoren (Pivoxil)		Cephalosporin Antibiotic	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	117467-28-4				-30.7913162094	4	4		0	-3.96531439					[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C4=CSC(N)=N4)C(=O)OCOC(=O)C(C)(C)C	MedChem Express	HY-17452A	-8.73496582	-5.92713665	-1.97290021	-3.96531439												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179649-06	Prednisolone	170464732	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	50-24-8	; Prednisolona; Predonine; Delta-cortef;Prednisolone; Prednisolone Pivalate; P21EC cpd; 1-Dehydrohydrocortisone; 1-Dehydrocortisol;Benzo(a)pyrene; Di-Adreson-F;Prednisolone (Hydroretrocortine); Di Adreson; Socketol; Vasocidin; 21-NO-prednisolone; Predate; Prednisolone hexanoate; DiAdreson; Pal-PLS			-21.8615174278	4	4		0	-4.82809708				NRC31	OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-274	-5.65458164	-6.23682739	0.78121552	-4.82809708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025155-07	Omacetaxine mepesuccinate		Alkaloid	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	26833-87-4		0.7943282347	-6.1	-222.1382081634	-1.1	4		-91.6532800463	-99.33330428	0.0261268736	0.9995787973		RPL3	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]\1[C@H]2C3=CC4=C(OCO4)C=C3CCN5CCC[C@]25\C=C1OC	MedChem Express	HY-14944	-18.72890889	-53.74854832	-89.4160745	-99.33330428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183107-01	NCGC00183107-01	124894307		DPI_SARS-CoV-2_General	2019_NPC-8_Tox		Carbetocin; Depotocin; Carbetocino; 			-20.3528601744	4	4	carbetocin;1-BUTYRIC ACID-2-(3-(4-METHOXYPHENYL)-ALANINE)OXYTOCIN;oxytocin, 1-desamino-1-monocarba-(Tyr(OMe))(2)-;1-Carbaoxytocin, 1-butanoic acid-2-(O-methyl-L-tyrosine)-;Carbetocino;Depotocin;dcomot;oxytocin, 1-desamino-1-monocarba-(tyrosine(O-methyl))(2)-;LS-174644;carbetocinum;Carbetocinum;1-deamino-1-monocarba-2-(Tyr(OMe))-oxytocin;CIPLUS_213985;carbetocine;Carbetocin;CARBETOCIN;	0	-6.71924703					CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)N(C)C(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	APAC	877872	-5.11811024	-2.03879737	-1.19609834	-6.71924703												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166076-07	Arbutin	170465722	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	497-76-7	Arbutin;ARBUTIN; 0   Arbutin; p-Arbutin;			-21.841203745	4	4		0	-6.29221317					Oc1ccc(cc1)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O	SIGMA	A4256	-5.33442935	-3.92274937	-1.1078254	-6.29221317												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166249-03	Erythrosin B	170465719		DPI_SARS-CoV-2_General	2019_NPC-8_Tox	15905-32-5		14.1253754462	-4.85	-26.8544716429	4	4		-21.676152448	-21.07281363	0.2620905216	0.9552468635			Ic4c5Oc1c(I)c(O)c(I)cc1C3(OC(=O)c2ccccc23)c5cc(I)c4O	SIGMA	200964	-2.98087739	-4.90343671	-0.09268659	-21.07281363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521952-01	ROMURTIDE		TNF-alpha Activator	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	78113-36-7				6.7010235808	4	4		0	4.25290862			3557		CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(O)=O	Carbosynth	FA110464	-0.21199273	1.65168394	4.16206912	4.25290862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181767-03	Tolcapone	170465081	catechol-O-methyltransferase (COMT)	DPI_SARS-CoV-2_General	2019_NPC-8_Tox	134308-13-7	 ; Roche brand of tolcapone; Tasmar;TOLCAPONE; Tolcapone;Tolcapone	11.220184543	-4.95	-75.1849731283	-3	4		-63.220348812	-64.23809316	0.0085939574	0.9999544577	1312	COMT	Oc1cc(cc([N+]([O-])=O)c1O)C(=O)c2ccc(C)cc2	Sequoia	134308-13-7	-6.55446915	-6.88201643	-8.04607847	-64.23809316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160594-03	IPROHEPTINE		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	13946-02-6				-20.0475739797	4	4		0	-5.01852019					CC(C)CCCC(C)NC(C)C	Microsource	01506195	-5.25722706	-5.35929173	1.25078174	-5.01852019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016561-05	Meticrane	170465801	Translocator protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	1084-65-7				-8.764091597	4	4		0	-2.56120697					NS(=O)(=O)c2cc1c(CCCS1(=O)=O)cc2C	Microsource	01506077	-2.18870541	-2.63451951	0.83087644	-2.56120697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262961-01	Cromoglicate lisetil	170465975	mast cell activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-2_Tox	110816-79-0	O	1	-6	-14.9913056909	4	5		12.4989425479	-3.44178789	0.0308757152	0.999417361			O=C(OCC)C=4Oc3cccc(OCC(OC(=O)[C@@H](N)CCCCN)COc1cccc2OC(=CC(=O)c12)C(=O)OCC)c3C(=O)C=4	GVK	FFS-11-286-NCI-234	-7.49911879	-7.40062984	-3.94775401	4.73522252	-3.44178789											3.2E-8	1.6E-7	8E-7	0.000004	0.000019999999999										
NCGC00160469-01	Gamolenic acid	144205388	prostanoid metabolic process Interacts	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	506-26-3	Gamolenic acid; 			-9.7620113365	4	4	CIS,CIS,CIS-6,9,12-OCTADECATRIENOIC ACID;GAMMA-LINOLENIC ACID (18:3 N-6);CIPLUS_710725;gamma-Linolenic Acid;cis,cis,cis-6,9,12-Octadecatrienoic acid;GAMMA-LINOLENIC ACID;GAMMA-LINOLENIC ACID (18:3 n-6);CIS-LINOLEIC ACID/GAMMA-LINOLENIC ACID;GAMOLENIC ACID;NCGC00160469-03;EVENING PRIMROSE OIL;6,9,12-Octadecatrienoic acid, (Z,Z,Z)-;acide gamolenique;Gamolenic acid;acidum gamolenicum;CIPLUS_153754;gamma-Linolenic acid;	0	1.77522811					O=C(O)CCCC\C=C/C/C=C\C/C=C\CCCCC	FLUKA	FLUKA_62172	-2.92549733	-4.00979887	0.85767891	1.77522811												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00182622-03	EFLOXATE			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	119-41-5				-29.2893887184	4	4		0	-5.6328485					CCOC(=O)COC1=CC=C2C(=O)\C=C(/OC2=C1)C3=CC=CC=C3	Microsource	01504518	-7.25956746	-5.90080798	-3.45751809	-5.6328485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094047-10	Ivermectin		Glutamate-gated Chloride Channel Activator	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	70288-86-7		7.9432823472	-5.1	-71.1021065603	-2.1	4		-112.7230509095	-99.65290139	0.0332872248	0.9993159735			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	APExBIO	A2813	2.69996029	5.6496199	-10.67654193	-99.65290139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167443-02	Afloqualone			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	56287-74-2				-10.391834491	4	4		0	-5.68707725					CC1=CC=CC=C1N2C(=O)C3=C(C=CC(N)=C3)N=C2CF	DC Chemicals	DC9026	-1.78232673	0.21596406	-2.49047124	-5.68707725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182971-01	Hexafluorenium dibromide	144206765	Cholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox	317-52-2	HEXAFLUORENIUM BROMIDE; Bromuro de hexafluronio; Bromure d'hexafluronium; Mylaxen; 			-13.7860806846	4	4	Bromuro de hexafluronio;Hexafluorenium bromide;hexafluronium bromide;hexafluorenium dibromide salt;N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYLHEXANE-1,6-DIAMINIUM DIBROMIDE;hexafluorenium bromide;HEXAMETHYLENEBIS(FLUOREN-9-YLDIMETHYLAMMONIUM) DIBROMIDE;CIPLUS_163766;IN-117;Mylaxen;Bromure d'hexafluronium;Hexafluronium bromide;Hexafluronii bromidum;hexafluorenium;Mallinckrodt Brand of Hexafluronium Bromide;1,6-HEXANEDIAMINIUM, N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYL-, DIBROMIDE;CIPLUS_152643;hexamethylenebis(fluoren-9-yldimethylammonium) dibromide;HEXAFLUORENIUM BROMIDE;hexafluronii bromidum;HEXAFLURONIUM BROMIDE;LS-18141;bromure d'hexauronium;	0	-5.64257743			590	BCHE	[Br-].[Br-].C[N+](C)(CCCCCC[N+](C)(C)C3c1ccccc1c2ccccc23)C6c4ccccc4c5ccccc56	NCI	NSC_19477	-2.41761151	-2.4447132	-2.41250866	-5.64257743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344540-01	17-BETA-ESTRADIOL 3,17-DIPROPIONATE	225144386		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	113-38-2				-25.2200010918	4	4		0	-6.87053934					CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C=CC(=C4)OC(=O)CC)[C@H]3CC[C@]12C	SIGMA	E9125	-5.73397478	-6.79473956	-0.99169124	-6.87053934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159423-03	Phytonadione	170464798	Vitamin K epoxide reductase complex subunit 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	84-80-0				-4.7105205674	4	4		0	2.70575481			79001	VKORC1	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(\C)=C\CC2=C(C)C(=O)c1ccccc1C2=O	Labotest	LT00452032	-2.21470983	-2.48839608	0.94702046	2.70575481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507774-01	Cefbuperazone 		Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	76610-84-9				-24.8005621218	4	4		0	-3.42849399					CCN1CCN(C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@]2(OC)[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4C)C(=O)C1=O	AvaChem	2487A	-6.38408529	-8.6169847	0.12507817	-3.42849399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538141-01	NCGC00538141-01		Microsomal triglyceride transfer protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-7_Tox					-24.5280489722	4	4		0	-7.80526878					CN(CC1=CC=CC=C1)C(=O)[C@H](NC(=O)C2=CC3=C(C=CC(=C3)NC(=O)C4=CC=CC=C4C5=CC=C(C=C5)C(F)(F)F)[N]2C)C6=CC=CC=C6	Pharmaron	PH-NIH-2017-009-L1-1-0	-4.42052323	-4.24153421	-6.3539501	-7.80526878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510891-01	Cefacetrile			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	10206-21-0				-13.769756261	4	4		0	-5.89177643					CC(=O)OC\C1=C(\N2[C@H](SC1)[C@H](NC(=O)CC#N)C2=O)C(O)=O	SantaCruz Bio	sc-396239	-2.14408612	-2.75570145	-2.81098406	-5.89177643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183096-01	Cefcapene pivoxil hydrochloride	144206464	Penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	147816-23-7	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(6alpha,7beta(Z)))-; Flomox; 			-23.2875934843	4	4	Cefcapene pivoxil hydrochloride;S-1108;CIPLUS_3875022;CEFCAPENE PIVOXIL HYDROCHLORIDE;LS-171990;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(6alpha,7beta(Z)))-;Flomox;Cefcapene Pivoxil Hydrochloride;S 1108;CIPLUS_695832;	0	-5.27147891					Cl.Nc1scc(n1)\C(=C\CC)C(=O)N[C@@H]3C(=O)N2C(=C(COC(N)=O)CS[C@@H]23)C(=O)OCOC(=O)C(C)(C)C	ACC	API-04911	-4.58111212	-7.84339006	-3.10015188	-5.27147891												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510315-02	Finafloxacin			DPI_SARS-CoV-2_General	2019_NPC-5_Tox	209342-40-5				-19.2502604035	4	4		0	-5.24437619					OC(=O)\C1=C\N(C2CC2)C3=C(C#N)C(=C(F)C=C3C1=O)N4C[C@@H]5NCCO[C@H]5C4	MedChem Express	HY-13451	-4.29506349	-6.09850438	-0.14294648	-5.24437619												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346545-03	Telaprevir (VX-950)		HCV NS3 NS4A Protease Inhibitor	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	402957-28-2				-13.5162660225	4	4		0	-5.14499955					CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	Selleck	S1538	-1.77263468	-6.74316658	-0.61645671	-5.14499955												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178803-03	HOMATROPINE METHYLBROMIDE			DPI_SARS-CoV-2_General	2019_NPC-7_Tox	80-49-9, 87-00-3 [homatropine]				-12.6051200224	4	4		0	-7.10217159					C[N+]1(C)C2CC[C@H]1CC(C2)OC(=O)C(O)C3=CC=CC=C3	Microsource	01500333	-1.43821414	-2.95438839	-2.23059598	-7.10217159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182984-01	Tolindate	144206849		DPI_SARS-CoV-2_General	2019_NPC-5_Tox	27877-51-6	Tolindate; 			-34.3332420469	4	4	tolindate;LS-174201;Tolindate;tolindatum;CIPLUS_175837;TOLINDATE;	0	-14.08889692					Cc1cc(ccc1)N(C)C(=S)Oc2ccc3CCCc3c2	Pharmaron	PH-NIH-154731	-5.90733758	-6.22743682	-6.24497454	-14.08889692												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095157-05	Oxfendazole	170466223	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC-5_Tox	53716-50-0	; OXFENDAZOLE;OXFENDAZOLE;Oxfendazole; ; Synanthic; Oxfendazol	0.2238721139	-6.65	-104.8130521758	4	4		-26.8532826953	-33.09693739	0.2360148618	0.9640719162		TUBB	O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3	Vitas	STK378905	-11.87101807	-37.84167096	-33.35120164	-33.09693739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384596-01	NCGC00384596-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-16.8431998383	4	4		0	-4.58954237					OC(=O)[C@@H](CC1=CC(O)=C(O)C=C1)OC(=O)\C=C\C2=C3[C@@H]([C@H](OC3=C(O)C=C2)C4=CC(O)=C(O)C=C4)C(O)=O	Analyticon	NP-017967	-2.90223813	-5.63135483	-2.95512426	-4.58954237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159461-08	Amprenavir		HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	161814-49-9				-19.6274135557	4	4		0	-2.01481351					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	MedChem Express	HY-17430	-4.03208418	-7.24776223	-3.94748397	-2.01481351												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	126544-47-6		10	-5	-40.6354298594	-3	4		-48.5288325001	-47.1607442	0.0580979418	0.9979134736			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625	-0.47005045	-2.96341357	-3.02537982	-47.1607442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00487399-01	TAK-779			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	229005-80-5				-25.4504903996	4	4		0	-5.25085971					CC1=CC=C(C=C1)C2=CC\3=C(CCC\C(=C3)C(=O)NC4=CC=C(C[N+](C)(C)C5CCOCC5)C=C4)C=C2	SIGMA	SML0911	-4.04933374	-9.38559138	-6.61719505	-5.25085971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510002-01	GLPG0187	384569406	Integrin Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	298708-81-3		11.220184543	-4.95	-38.7405609882	4	4		-11.6068695361	-15.86720748	0.2618494797	0.9557750554			COC(=O)\C1=C(C)\N=C(N[C@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029	-7.43887188	-4.9448162	-6.33617283	-15.86720748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522288-01	PERETINOIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-18.0900208118	4	4		0	-2.94065779					CC(C)=CCC/C(C)=C/CC/C(C)=C/C=C/C(C)=C/C(O)=O	Ark Pharm	AK162192	-3.07473371	-5.51838012	-5.98489506	-2.94065779												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346463-01	Nesbuvir	174007343	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	691852-58-1	Nesbuvir			-34.2440612617	4	4		0	-6.70575787					CNC(=O)C1=C(OC2=CC(=C(C=C12)C3CC3)N(CCO)[S+](C)([O-])=O)C4=CC=C(F)C=C4	Chemscene	CS-0689	-9.03445599	-1.42521943	-7.39000615	-6.70575787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601813-01	Bictegravir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1611493-60-7		10	-5	-43.0868477384	4	4		-21.920215372	-25.71642712	0.0156301107	0.9998498009			OC1=C2N(CC3OC4CCC(C4)N3C2=O)C=C(C(=O)NCC5=C(F)C=C(F)C=C5F)C1=O	Selleck	S5911	-5.78291431	-6.04849222	-6.96847282	-25.71642712												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159447-01	Sodium Salicylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	54-21-7				-13.5623771766	4	4		0	-4.31767338					OC(=O)C1=CC=CC=C1O	MedChem Express	HY-B0167A_cm1	-2.92540224	-1.84915675	-2.24961479	-4.31767338												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134138-01	NCGC00134138-01	24409521		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-38.0327425649	4	4		0	-8.77404922					CC1=CC=C(C=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)NC5=CC(=CC=C5C)Cl)\N=C3S2	Sytravon	G768-1156	-6.88282139	-9.92209571	-9.96257979	-8.77404922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163489-05	Shikonin		Drugs Acting on Chemokine Receptors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	517-89-5		12.5892541179	-4.9	-69.3706846573	-3	4		-75.0748219982	-71.80583723	0.0130940593	0.9998942539		CCR5	CC(C)=CC[C@@H](O)C/1=C/C(=O)C2=C(O)C=CC(=C2C1=O)O	Cayman	14751	-4.10108241	-3.91066307	-3.56986037	-71.80583723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274067-03	NCGC00274067-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			5.6234132519	-5.25	-134.2275802416	-2.3	4		-88.5657209091	-96.64876957	0.0742656793	0.9965829352		MPL	CC1=CC=C(C=C1C)N2/N=C(C)\C(=N/NC3=CC=CC(=C3O)C4=CC=CC(=C4)C(O)=O)C2=O	Toronto Research	E508000	-12.2298066	-10.2302885	-70.13427251	-96.64876957												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00109256-01	NCGC00109256-01	24383835		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-42.4675829217	4	4		-12.808264784	-18.30425056	0.053464568	0.9982516129			CCN1\C=C(C(=O)NC(C)C2=CC=CC=C2)/C(=O)C3=CC(=CC=C13)[S+]([O-])(=O)N4CCC5=CC=CC=C5C4	Sytravon	C519-2054	-7.32163172	-6.79736324	-7.63812459	-18.30425056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017375-03	Berbamine dihydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6078-17-7		14.1253754462	-4.85	-48.997590704	-3	4		-33.20307988	-32.70701333	0.03274333	0.9993393147			COC1=CC2=C3C=C1OC4=C(OC)C(=CC5=C4[C@@H](CC6=CC=C(O)C(=C6)OC7=CC=C(C[C@@H]3N(C)CC2)C=C7)N(C)CC5)OC	Prestwick	Prestw-NAT-0350	-6.3948606	-5.89134126	-5.87111343	-32.70701333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134170-01	NCGC00134170-01	24409553		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.307790225	4	4		0	-11.3064877					COC1=CC=C(C=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)NC5=CC(=CC=C5C)C)\N=C3S2	Sytravon	G768-1619	-4.29871607	-11.65139971	-9.63680387	-11.3064877												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132097-01	NCGC00132097-01	24407480		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-14.743665166	4	4		0	0.50559284					CC1=C(Cl)C=C(C=C1)[S+]([O-])(=O)\C2=C\N=C(/NC2=O)SCC(=O)NC3=CC=C4OCCOC4=C3	Sytravon	G605-0145	-4.42060783	0.10273093	-5.58661677	0.50559284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015471-09	Ganciclovir	384567853	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	82410-32-0				-36.5464819448	4	4		0	-7.61073826					N\C1=N\C2=C(N=C[N]2COC(CO)CO)C(=O)N1	Selleck	S1878	-8.06923452	-6.98570328	-7.68214836	-7.61073826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00113556-01	NCGC00113556-01	24388135		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-17.7213122481	4	4		0	-3.68232662					CCC1=CC=C(CNC(=O)C2=CC=C(CSC3=NC4=CC=NC=C4[N]3CC5=CC=C(OC)C=C5)C=C2)C=C1	Sytravon	C797-0831	-4.34747278	-3.74111805	-1.79176755	-3.68232662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388311-01	Z-VAD(OH)-FMK			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	161401-82-7				-30.1996684303	4	4		0	-5.82477605					CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)CF	Cayman	14467	-5.65586161	-8.10696095	-8.20739969	-5.82477605												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163654-01	HARRINGTONINE	26757033		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			1.4125375446	-5.85	-212.5236467157	-2.1	4	Harringtonine;harringtonine hydrochloride;CIPLUS_701701;HARRINGTONINE;LS-52750;NCGC00163654-01;LS-177419;LS-176258;harringtonine, (S)-isomer;harringtonin;CIPLUS_214594;harringtonine;harringtonine, (R)-isomer;LS-176636;	-100.3167782576	-99.22219795	0.0157910455	0.9998461931			[H][C@]12[C@H](OC(=O)[C@](O)(CCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]13CCCN3CCC4=CC5=C(OCO5)C=C24	BIOMOL	BIOMOL_NP-435	-19.94877393	-44.83870968	-80.23276012	-99.22219795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346716-03	Dabrafenib		Raf kinase B Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1195765-45-7		6.3095734448	-5.2	-91.6665387264	-2.4	4		-62.5910844887	-53.46296701	0.5134684627	0.7914369293		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	ChemieTek	CT-DABRF	-7.31021162	-26.48556876	-20.78339413	-53.46296701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017351-07	Psoralen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	66-97-7				-12.8677501417	4	4		0	3.89337994					O=C\1OC2=CC3=C(C=CO3)C=C2\C=C1	MedChem Express	HY-N0053	-5.30315754	0.475382	-3.67378843	3.89337994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116054-01	NCGC00116054-01	24390633		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.0330187519	4	4		0	-7.45861298					CC1=C2C(=O)/C=C(\C=C(OC(=O)C3=CC=C(C)C=C3)/C2=C(C)O1)C4=CC5=C(OCO5)C=C4	Sytravon	D132-0066	-8.27238745	-3.34731615	-7.14505833	-7.45861298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00098694-01	NCGC00098694-01	24272392		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.491501292	4	4		0	-3.70917226					COC1=CC=C(C=C1)C2=NC3=CC(=N[N]3C(=C2)C(F)(F)F)C(=O)NC4=C(C(=O)OC(C)C)C5=C(CC(C)CC5)S4	Sytravon	3209-0156	-8.58930603	-5.07662015	-3.20052829	-3.70917226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390751-02	SPK-601			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1096687-52-3				-27.2269560166	4	4		0	-0.14419926					[K]SC(=S)O[C@H]1C[C@H]2C[C@@H]1[C@@H]3CCC[C@H]23	MedChem Express	HY-70083	-7.79727914	-5.12733447	-5.18499218	-0.14419926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160146-02	Cephalotaxlen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	24316-19-6				-7.222658831	4	4		0	-1.92702644					COC/1=C/[C@]23CCCN2CCC4=C(C=C5OCOC5=C4)[C@@H]3[C@@H]1O	MedChem Express	HY-N0838	-1.25545852	-2.47877759	-1.20722599	-1.92702644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388362-02	Glycitin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	40246-10-4				-26.3268305128	4	4		0	-4.06816692					COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C3O\C=C(/C(=O)C3=C1)C4=CC=C(O)C=C4	Prestwick	Prestw-NAT-0037	-6.61320121	-3.74363328	-5.41080424	-4.06816692												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398026-01	NCGC00398026-01	375798682		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.6949180541	4	4		0	-4.76510067					COC1=CC=C(NC(=O)N2C[C@@H]3C[C@H](C2)\C4=C\C=C(\N[S+]([O-])(=O)C5=CC=C(NC(C)=O)C=C5)C(=O)N4C3)C=C1	Analyticon	NAT11-292327	-5.70453437	-8.38113175	-8.16640986	-4.76510067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344804-01	NCGC00344804-01	170466906		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-21.5333365026	4	4		0	-2.49217002					CC1=C(N=C(NC(=O)CC2=CC3=C(C=CC=C3)C=C2)S1)C4=CC5=C(C=C4)N(CC5)C(=O)C6=C(C)C=CC=C6	NCGCChem	JMR03-026-A6	-5.29822851	-4.83691465	-3.94893242	-2.49217002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025029-03	U-0126	26752096	Mek 1/2 inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	218601-62-8	U0126;U0126-EtOH;U-0126	7.9432823472	-5.1	-63.0472242654	4	4	1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene;UO126;CIPLUS_753356;U0126 ethanolate;U 0126;UO-126;1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene;U0126;U126 cpd;1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene ethanolate;NCGC00094462-02;NCGC00094462-01;NCGC00016074-01;UO 126;U-0126;NCGC00025029-03;NCGC00025029-02;NCGC00025029-01;U0126 cpd;	-21.0662784719	-26.81669216	0.0945908874	0.9944681192	5604	MAP2K1	NC(/SC1=CC=CC=C1N)=C(C#N)\C(C#N)=C(N)\SC2=CC=CC=C2N	BIOMOL	EI282	-10.15703729	-9.2614601	-15.15546291	-26.81669216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093674-07	CYCLOSERINE (L)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	339-72-0		31.6227766017	-4.5	-23.1478495394	4	4		-23.160954988	-20.76032336	0.136340976	0.9884056043			[H][C@]1(N)CONC1=O	Microsource	01506178	-3.18693315	-4.55008489	-2.29286087	-20.76032336												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00686697-01	4E2RCat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	432499-63-3				-21.9448376762	4	4		0	-3.70111427					OC(=O)C1=CC(=CC=C1Cl)C2=CC=C(O2)\C=C3/SC(=S)N(CC4=CC=CC=C4)C3=O	MedChem Express	HY-100733	-3.63201209	-8.10696095	-6.06218517	-3.70111427												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00070736-17	Imiquimod	384568073	TLR 7 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	99011-02-6				-26.8574639853	4	4		0	-1.71728206				TLR7	CC(C)C[N]1C=NC2=C(N)N=C3C=CC=CC3=C12	MedChem Express	HY-B0180	-8.24235808	-2.5721562	-6.71356609	-1.71728206												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00095987-05	NCGC00095987-05			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			0.1995262315	-6.7	-302.3067046829	-1.3	4		-44.4945821885	-77.33012891	0.3260259776	0.9281676878			CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C	Analyticon	NP-007859	-46.99781659	-89.43972835	-86.68577384	-77.33012891												1.44E-7	7.2E-7	0.0000036	0.000018											
NCGC00159341-20	LAMIVUDINE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	134678-17-4				-37.5225378992	4	4		0	-6.98710946					[H][C@@]1(CO)O[C@@]([H])(CS1)N2C=CC(N)=NC2=O	Microsource	01503839	-8.62025529	-6.52801358	-8.19002953	-6.98710946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402337-02	BGP-15	384569215	Insulin Sensitizers	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	66611-37-8				-40.3772935076	4	4		0	-7.93095914				PARP1	N\C(=N/OCC(O)CN1CCCCC1)C2=CN=CC=C2	Glixx	GLXC-05825	-8.56147128	-8.11544992	-9.89230502	-7.93095914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163638-01	TUBERCIDIN	26757019		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			0.4466835922	-6.35	-216.7805204349	-1.1	4	NCGC00163638-01;CIPLUS_740558;7-DEAZAADENOSINE;Sparsomycin A;CIPLUS_158314;CIPLUS_149167;7 Deazaadenosin;xylotubercidin hydrochloride;7-Deazaadenosine;LS-139541;Tubercidin;4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine;Deazaadenosine;7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-beta-D-ribofuranosyl-;ara-tubercidin;TUBERCIDIN;CIPLUS_701898;xylotubercidin;	-98.5239406414	-99.23967664	0.0129800344	0.9998960759			NC1=C2C=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1	BIOMOL	BIOMOL_NP-327	-6.93231441	-80.3820034	-98.31509467	-99.23967664												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016786-25	Mycophenolic acid		Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	24280-93-1		3.5481338923	-5.45	-55.5228498898	-2.4	4		-33.1147129694	-35.83017371	0.1072758416	0.9928425761		IMPDH1	COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2	MedChem Express	HY-B0421	-4.45469835	-1.85973755	-22.98673926	-35.83017371												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356072-01	N/A	363677795	Lysine-specific histone demethylase 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-29.7201346794	4	4		0	-7.87849396					N[C@H]1C[C@H]1C2=CC=C(C=C2)C3=CC=CC(=C3)O	Selleck	S7237	-5.57591962	-6.43086817	-7.29340476	-7.87849396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261043-01	Desipramine hydrochloride	312344483	Serotonin transporter Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-45.5612223305	4	4		0	-10.55276382					Cl.CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	D 3900	-10.165435	-7.95415959	-8.80667014	-10.55276382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482591-01	Atractylon			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6989-21-5				-26.6903505831	4	4		0	-1.55123443					CC1=COC2=C1C[C@H]3C(=C)CCC[C@]3(C)C2	DC Chemicals	DCZ-188	-5.9161908	-5.74702886	-6.01007469	-1.55123443												4.8E-7	0.0000024	0.000012	0.000059999999999											
NCGC00241099-04	Saracatinib	384568470	cSRC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	379231-04-6		2.2387211386	-5.65	-152.5714819751	-2.1	4		-99.613632054	-99.30959144	0.0223757728	0.9996910849		SRC	CN1CCN(CCOC2=CC3=NC=NC(=C3C(=C2)OC4CCOCC4)NC5=C6OCOC6=CC=C5Cl)CC1	Selleck	S1006	-5.31155526	-20.93378608	-71.7474379	-99.30959144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510523-01	Pimodivir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1629869-44-8				-12.281771004	4	4		0	-7.08491315					OC(=O)[C@H]1C2CCC(CC2)[C@@H]1NC3=NC(=NC=C3F)C4=C[NH]C5=NC=C(F)C=C45	MedChem Express	HY-12353A	-0.63392126	-3.38924133	-4.2899798	-7.08491315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263570-02	Sivelestat sodium salt			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	150374-95-1				-19.0318452154	4	4		0	-3.67251565					CC(C)(C)C(=O)OC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC=C2C(=O)NCC(O)=O	Tocris	3535	-2.60899564	-6.29182237	-7.47782559	-3.67251565												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00651745-01	ABBV-744			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2138861-99-9		4.4668359215	-5.35	-233.5851283569	-2.2	4		-73.9065726997	-98.81144855	0.0047514849	0.9999860785			CCNC(=O)C1=CC2=C(N1)C(=O)N(C)C=C2C3=C(OC4=C(C)C=C(F)C=C4C)C=CC(=C3)C(C)(C)O	Selleck	S8723	-33.63705072	-38.82003396	-66.81431301	-98.81144855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164561-11	Zanamivir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	139110-80-8				-13.1403931421	4	4		0	-5.21558945					[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(NC(N)=N)[C@@]1([H])NC(C)=O)C(O)=O	Enzo	AC3291	-1.35840269	-4.1366125	-4.12312286	-5.21558945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024379-17	Emetine dihydrochloride hydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	7083-71-8		0.2818382931	-6.55	-332.0033492841	-1.3	4		-61.5431283035	-99.19319284	0.1533584377	0.9852170783			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	SIGMA	E2375	-52.08072793	-86.45172504	-92.19724247	-99.19319284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00087387-05	Droxinostat	384568077	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	99873-43-5		12.5892541179	-4.9	-58.0887916277	-3	4		-39.75363434	-39.5159157	0.017594751	0.9998092354		HDAC6	CC1=CC(=CC=C1OCCCC(=O)NO)Cl	Selleck	S1422	-7.06800638	-6.80455375	-8.22429086	-39.5159157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386310-01	Selinexor		Exportin-1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1393477-72-9		8.9125093813	-5.05	-145.8369897524	-2.4	4		-65.2579425336	-64.60563688	0.2078403924	0.9723939581		XPO1	FC(F)(F)C1=CC(=CC(=C1)C2=N[N](\C=C/C(=O)NNC3=CN=CC=N3)C=N2)C(F)(F)F	Selleck	S7252	-19.18458179	-30.79796265	-38.67465694	-64.60563688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486904-01	MRT-68601 hydrochloride	377020217	IKK-epsilon Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			8.9125093813	-5.05	-78.6832473268	-2.4	4		-60.2108580875	-61.97509286	0.0664494818	0.9972675903		IKBKE	O=C(NCCCNC1=C(C=NC(=N1)NC2=CC=C(C=C2)N3CCOCC3)C4CC4)C5CCC5	Tocris	5067	-8.30114209	-4.89813243	-11.07347577	-61.97509286												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388284-12	Darunavir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	635728-49-3				-24.1448469301	4	4		0	-5.71819064					[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(CC(C)C)[S+]([O-])(=O)C4=CC=C(N)C=C4	APExBIO	A8206	-4.05795851	-7.88215869	-5.72143673	-5.71819064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015412-21	Ebselen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	60940-34-3				-26.9936547612	4	4		0	-7.13781853					[O]=[C]1[N]([Se]C2=C1C=CC=C2)C3=CC=CC=C3	Bio Vision	2169	-4.85143818	-6.92621882	-6.33617283	-7.13781853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386335-01	SC75741	363680219	Nuclear factor NF-kappa-B complex Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	913822-46-5		5.6234132519	-5.25	-35.7953991146	4	4		-15.2317019879	-16.44308499	0.5483393798	0.7535590136			O=C(NC1=NC2=CC=C(C=C2[NH]1)C(=O)C3=CC=CC=C3)C4=CSC(=N4)C5CCN(CC5)C6=C7SC=CC7=NC=N6	Selleck	S7273	-7.37739335	0.26315789	-6.93937815	-16.44308499												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346556-07	Semagacestat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	425386-60-3				-28.6864702222	4	4		0	-7.6933251					CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=C(CCN(C)C1=O)C=CC=C2	DC Chemicals	DC7496	-5.31717625	-6.60467541	-6.78405199	-7.6933251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601824-01	UPGL00004			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1890169-95-5		0.6309573445	-6.2	-44.6158208832	4	4		-22.0738187558	-18.68882815	0.1703900144	0.9818305818			O=C(CC1=CC=CC=C1)NC2=NN=C(NC3CCN(CC3)C4=NN=C(NC(=O)CC5=CC=CC=C5)S4)S2	Selleck	S8778	-4.87731252	-11.4365169	-14.59120049	-18.68882815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178027-11	Valsartan		Neprilysin Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	137862-53-4				-28.3288546146	4	4		0	-6.64403492					CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=N[NH]N=N3)[C@@H](C(C)C)C(O)=O	MedChem Express	HY-18204	-5.83466299	-8.91631181	-3.19223676	-6.64403492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018130-08	PHENAZOPYRIDINE HYDROCHLORIDE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	136-40-3, 94-78-0 [phenazopyridine]		10	-5	-20.9663205049	4	4		-12.440906248	-13.16021515	0.0812961857	0.9959542899			NC1=CC=C(\N=N\C2=CC=CC=C2)C(=N1)N	Microsource	MS-01500473	-2.37612661	-3.15460155	-4.08799508	-13.16021515												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	192725-17-0		14.1253754462	-4.85	-41.7824889691	-3	4		-32.7267461041	-31.95926285	0.1576422571	0.9843795205			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204	-3.43697443	-7.47371165	-5.57214367	-31.95926285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398354-01	NCGC00398354-01	375798676		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-39.3311116292	4	4		0	-7.6196868					[O-][S+](=O)(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC5=C(OCO5)C=C4)C6=CC7=CC=CC=C7C=C6	Analyticon	NAT6-319064	-9.02811637	-8.37257084	-6.76645388	-7.6196868												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166368-01	NCGC00166368-01	29218127		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-9.3011449304	4	4		0	0.89038031					COC1=CC=C(C=C1COC2=CC=C(NC(C)=O)C=C2)C3NC4=C(C=CC=C4)C(=O)N3CC5=CC(=CC=C5)C6=CC=CC=C6	NCGCChem	WH-A-014-0001-B5	-4.02242808	-1.56664669	2.00308166	0.89038031												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024936-06	N-Desmethylclozapine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	6104-71-8		14.1253754462	-4.85	-48.2132773589	4	4		-22.784708948	-26.75689974	0.2385731387	0.9632870051			ClC1=CC2=C(NC3=C(C=CC=C3)C(=N2)N4CCNCC4)C=C1	Adooq	A13762	-6.74026478	-10.05474928	-5.68630895	-26.75689974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137854-02	NCGC00137854-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-31.7629752032	4	4		0	-3.33333333					CCOC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C(OC)C=C4)SC5=C1CCC(C)C5	Chemdiv	K061-0670	-7.86608159	-5.28208201	-7.85824345	-3.33333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00140567-02	NCGC00140567-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-36.7787809036	4	4		0	-6.7606264					COC1=CC(=CC=C1)N[S+]([O-])(=O)C2=CC=C3N\C=C(C(=O)NCCC4=CC=C(C)C=C4)/C(=O)C3=C2	Chemdiv	K788-1747	-9.42629612	-8.25271809	-2.69865727	-6.7606264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183680-01	NCGC00183680-01	87544174		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.7437900301	4	4		0	-5.37360179					CC(C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C#N	NCGCChem	mbb07-52	-6.73655128	-7.19972605	-4.99669822	-5.37360179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094792-17	Tioguanine		Purine Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	154-42-7		11.220184543	-4.95	-65.0407390175	-3	4		-84.1094499004	-70.76957494	0.0487229523	0.9985332219		HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	MedChem Express	HY-13765	-1.30017877	-4.46023457	-8.16640986	-70.76957494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016382-09	Oxethazaine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	126-27-2				-21.1423611297	4	4		0	-9.59791905					CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC2=CC=CC=C2	APExBIO	A8494	-3.09198327	-4.29303902	-4.39536313	-9.59791905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485944-01	TAPI-1	363681435	ADAM17 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	163847-77-6				-35.8385060156	4	4		0	-11.34379684					CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)NCCN	MedChem Express	HY-16657	-4.62719393	-11.86234466	-10.37586722	-11.34379684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095196-07	TILORONE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	27591-69-1, 27591-97-5 [tilorone]				-15.6558382814	4	4		0	-4.67771801					CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009	-1.53089827	-7.03050317	-4.77298674	-4.67771801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163510-01	Aloe-emodin	26756894	Caspase 3 Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	481-72-1	ALOE-EMODINE;Aloe-emodin			-9.664805083	4	4	ALOE-EMODINE;Aloe Emodin;aloe-emodin;ALOE-EMODIN;LS-2202;aloe-emodin 1-O-glucopyranoside;Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,;Aloe-emodin;ALOE EMODIN;Anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-;NCGC00163510-02;NCGC00163510-01;aloe-emodin 1-O-Glc;1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone;CIPLUS_153452;	0	-4.36241611			836	CASP3	OCC1=CC(O)=C2C(=O)C3=C(C=CC=C3O)C(=O)C2=C1	BIOMOL	BIOMOL_NP-005	-3.06354624	-0.63350741	2.66343826	-4.36241611												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246971-04	Polydatin	363677157	V/ICAM1 Expression Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	65914-17-2				-16.5187187482	4	4		0	-2.72903624				ICAM1	OC[C@H]1O[C@@H](OC2=CC(=CC(=C2)/C=C/C3=CC=C(O)C=C3)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2390	-2.27262926	-5.12731381	-7.28462282	-2.72903624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388216-01	Corilagin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	23094-69-1		12.5892541179	-4.9	-35.3737753722	4	4		-14.793624036	-15.55859272	0.4704460461	0.8351283467			OC1C2COC(=O)C3=CC(=C(O)C(=C3C4=C(O)C(=C(O)C=C4C(=O)OC1C(O)C(O2)OC(=O)C5=CC(=C(O)C(=C5)O)O)O)O)O	Cayman	11832	-4.48057269	-9.29868776	-8.30332836	-15.55859272												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00392372-01	NCGC00392372-01	375809155		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-10.0239448971	4	4		0	-1.30201342					C[C@@H]1[C@H](CC[C@]2(C)CCC([C@H](O)[C@@H]12)[C@H](C)C(=O)N3CCC4=C(C3)C=CC=C4)NC(=O)C5=CN=CC=N5	Analyticon	NAT5-397554	-3.09605071	-2.93639243	1.2987013	-1.30201342												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016246-21	Chlorhexidine HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	3697-42-5		11.220184543	-4.95	-72.4964346851	-3	4		-123.8260402684	-97.48098434	0.0481996661	0.9985643941			ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	APExBIO	B1695	2.80351048	-1.62657307	-8.09597182	-97.48098434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023945-24	Zidovudine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	30516-87-1				-36.4591943081	4	4		0	-8.92778415					C\C1=C\N([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O	MedChem Express	HY-17413	-7.71486481	-8.69905275	-5.73021867	-8.92778415												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00599627-01	Adaptavir   D-Ala1-peptide T-NH2   DAPTA   RAP-101  			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-37.416614993	4	4		0	-8.69852747					C[C@@H](O)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O	MedChem Express	HY-P1034	-7.9649834	-5.50099939	-9.62940195	-8.69852747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347064-06	KUC107871N		p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1346527-98-7		1.995262315	-5.7	-156.7328126055	-1.1	4		-98.5687128695	-99.42320297	0.0451168179	0.9987424145		VCP	COC1=C2N=C(N=C(NCC3=CC=CC=C3)C2=CC=C1)[N]4C(=NC5=C4C=CC=C5)N	SIGMA	SML1071	-4.5389654	-1.9524618	-99.38335939	-99.42320297												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249694-01	NCGC00249694-01	144116880		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-32.0178846391	4	4		0	-5.42729306					[O-][S+](=O)(NC1=NC(=NC2=CC=CC=C12)C3=C(C=CC=C3)C(F)(F)F)C4=CC=C(C=C4)C5=CN=CC=C5	NCGCChem	ASR12-076	-9.80009751	-3.8524099	-0.34778781	-5.42729306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399493-01	NCGC00399493-01	375804029		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-47.7295268312	4	4		0	-4.4966443					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC=C(C=C4)C5=CC=CC=C5)C6=CC=C7OCOC7=C6	Analyticon	NAT6-321062	-12.06728425	-11.18911052	-8.20162888	-4.4966443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386356-05	Bepotastine (Beslilate)		Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	190786-44-8				-18.3928960879	4	4		0	-2.53878086					OC(=O)CCCN1CCC(CC1)O[C@@H](C2=CC=C(Cl)C=C2)C3=NC=CC=C3	MedChem Express	HY-A0015	-3.22052402	-5.81494058	-6.01875977	-2.53878086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095003-07	Tioxolone	384568140	Carbonic Anhydrase Type I Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	4991-65-5				-25.1261320241	4	4		0	-5.8684728				CA1	OC1=CC2=C(SC(=O)O2)C=C1	Selleck	S2603	-5.04282835	-7.4533107	-3.79537954	-5.8684728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398345-01	NCGC00398345-01	375798575		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-37.7790565004	4	4		0	-6.95749441					O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)O[C@@H]3CO[C@@H]4[C@H](CO[C@H]34)[N]5N=NN=C5C6=CC=C(C=C6)C7=CC=CC=C7	Analyticon	NAT6-296405	-8.35364863	-8.96327369	-7.12744882	-6.95749441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00125549-01	NCGC00125549-01	24400932		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-55.5162530508	4	4		0	-12.55928412					CC1=C(Cl)C=CC=C1NC(=O)CN2C(=O)N(CC3=NC(=NO3)C4=CC=CC=C4)C(=O)C5=CC6=C(OCO6)C=C25	Sytravon	E843-0235	-12.96928328	-10.01626573	-8.59784284	-12.55928412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378947-03	AMD-070 (hydrochloride)		Human immunodeficiency virus 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	880549-30-4				-37.3310914153	4	4		0	-5.8335154					NCCCCN(CC1=NC2=CC=CC=C2[NH]1)[C@H]3CCCC4=CC=CN=C34	MedChem Express	HY-50101A	-8.48589184	-6.14601019	-10.02258121	-5.8335154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025146-05	NU-1025			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	90417-38-2				-25.1581472626	4	4		0	-2.83591872					CC/1=N/C2=C(C=CC=C2O)C(=O)N1	SIGMA	N7287	-5.79022506	-5.10186757	-6.70488101	-2.83591872												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346683-02	YM-201636	384568907	PIKfyve Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	371942-69-7		3.1622776602	-5.5	-125.2508122772	-2.1	4		-89.8704527255	-92.3803132	0.0189634581	0.9997781462		PIKFYVE	NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6	Selleck	S1219	-3.95741915	-5.29064292	-60.66035659	-92.3803132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388372-01	Angelicin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	523-50-2				-32.1435326431	4	4		0	-5.85973345					O=C\1OC2=C(\C=C1)C=CC3=C2C=CO3	Cayman	11683	-7.68810883	-4.34634975	-6.82647212	-5.85973345												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00346477-02	Emricasan	384568791	Caspase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	254750-02-2				-35.2553852632	4	4		0	-6.58509941				CASP3	C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F	MedChem Express	HY-10396	-6.98270071	-8.29371817	-9.93573042	-6.58509941												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00115987-01	NCGC00115987-01	24390566		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-18.8527592048	4	4		0	-5.81208054					CC1=CC2=C(OC(=C/C2=O)\C(=O)NC3=C(OC4=C3C=CC=C4)C(=O)NC5=CC=CC=C5)C=C1	Sytravon	D103-1101	-3.25044694	-3.31307251	-5.56900726	-5.81208054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398412-01	NCGC00398412-01	375799462		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-52.1651556836	4	4		0	-17.00671141					FC(F)(F)C1=CC=CC(=C1)NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC6=C(OCO6)C=C5	Analyticon	NAT6-318363	-10.30391679	-9.30571013	-9.4959278	-17.00671141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00401264-01	NCGC00401264-01	375801833		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.4377815401	4	4		0	-2.41163311					C[N]1C=CC=C1C(=O)N[C@H]2C[C@H](N(C2)C(=O)CSCC(=O)N3C[C@H](C[C@H]3C(O)=O)NC(=O)C4=CC=C[N]4C)C(O)=O	Analyticon	NAT3-206800	-5.41199415	-7.1569215	-8.31609069	-2.41163311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126023-01	NCGC00126023-01	24401406		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-54.2888208827	4	4		-24.7327619601	-28.20134228	0.2095062487	0.9719907523			COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCC5=CC=CC(=C5)F	Sytravon	E859-1200	-9.67007964	-6.67751049	-5.50737398	-28.20134228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015508-23	Hydrochlorothiazide	384567858	Hypertension treatment	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	58-93-5				-39.6643921852	4	4		0	-4.50513437					N[S+]([O-])(=O)C1=C(Cl)C=C2NCN[S+]([O-])(=O)C2=C1	Enzo	AC3145	-8.93097078	-9.26994907	-10.03126628	-4.50513437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016343-13	Gramine	376241757		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	87-52-5				-43.0639547488	4	4		0	-10.06336028					CN(C)CC1=C[NH]C2=C1C=CC=C2	CANVASS	578ff292f1709662a82ed8de	-8.58666443	-9.08319185	-10.3960396	-10.06336028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00099045-01	NCGC00099045-01	24272743		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-43.3359366603	4	4		0	-7.92393736					CC1=CC2=C(C=C1C)N=C(O2)C3=CC(=CC=C3)NC(=O)C4=C5C=CC=CC5=CC=C4	Sytravon	3729-3012	-8.74370226	-10.90660046	-10.67576491	-7.92393736												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00105403-01	NCGC00105403-01	24268748		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.7144307917	4	4		0	-1.52572707					CC1=CC=C(C=C1)C2=NC(=NO2)/C3=C/C4=CC=CC(=C4OC3=O)OCC5=CC=C(F)C=C5	Sytravon	C200-5363	-9.22314318	-9.14305282	-6.62557781	-1.52572707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408830-04	BRD73954			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1440209-96-0				-3.0354536004	4	4		0	-5.33537251					ONC(=O)C1=CC(=CC=C1)C(=O)NCCC2=CC=CC=C2	Tocris	6284	1.35623111	-0.51782683	-3.07451798	-5.33537251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00135612-01	NCGC00135612-01	24410995		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-22.1377686221	4	4		0	-5.06935123					CC(=O)N1CCCC2=C1C=CC(=C2)[S+]([O-])(=O)N3CCCC(C3)C(=O)N4CCN(CC4)C5=CC=CC=C5F	Sytravon	G855-6099	-5.68015602	-4.29757726	-1.201849	-5.06935123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090691-14	Didanosine		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	69655-05-6				-29.9358475767	4	4		0	-7.92258178					OC[C@@H]1CC[C@@H](O1)[N]2C=NC3=C2\N=C/NC3=O	MedChem Express	HY-B0249	-5.23955324	-8.34274789	-6.87187143	-7.92258178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093846-07	3-Deazaadenosine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6736-58-9				-31.3386331304	4	4		0	-6.2792222					NC1=NC=CC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Bio Vision	2771	-7.18424589	-5.56876061	-6.30536738	-6.2792222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178317-04	Foscarnet Sodium		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	63585-09-1				-26.1168065782	4	4		0	-1.20166048					[O-][C](=[O])[P]([O-])([O-])=[O]	Selleck	S3076	-6.96590527	-4.50764007	-6.12298072	-1.20166048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090791-01	2'	17389408		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-35.7277451132	4	4	NCGC00090791-02;Kolibri-D 002;NCGC00090791-03;2',3'-Dideoxyadenosine;2',3'-Dideoxyadenosine (ddA);2',3' Dideoxyadenosin;2',3'-DIDEOXYADENOSINE;Adenosine, 2',3'-dideoxy-;Dideoxyadenosine;CIPLUS_162883;LS-112;NunclonD multidishes;AB02911402-01;	0	-7.42407691					NC1=NC=NC2=C1N=C[N]2[C@H]3CC[C@@H](CO)O3	NIEHS	AB02911402	-7.79727914	-8.13242784	-6.55723467	-7.42407691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480772-03	Oroxylin A	376241613		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	480-11-5				-21.4612102771	4	4		0	-4.58954237					COC1=C(O)C=C2O\C(=C/C(=O)C2=C1O)C3=CC=CC=C3	CANVASS	57a2faeef1704b5b7a46901d	-4.17870542	-6.21360911	-4.31632563	-4.58954237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091231-18	NCGC00091231-18			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-22.921350702	4	4		0	-10.46204038					[H][C@@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	BIOMOL	AC-129	-2.3416275	-8.6642913	-4.38658119	-10.46204038												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024196-12	Megestrol acetate	384568021	Progesterone Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	595-33-5				-21.347291823	4	4		0	-8.06366282				PGR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	MedChem Express	HY-13676	-3.06610893	-5.98765969	-4.72907702	-8.06366282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00599701-01	BDD   BFD   DDB   alpha-DDB   Bifendate Biphenyldimethyldicarboxylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					0.2286577883	4	4		0	-1.00079358					COC(=O)C1=C(C2=C(OCO2)C(OC)=C1)C3=C(C=C(OC)C4=C3OCO4)C(=O)OC	BLD Pharma	BD40653	-0.37517789	-1.40783871	4.17581453	-1.00079358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165961-04	FTI-277 hydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-44.3672983337	4	4		0	-6.53266332					COC(=O)[C@H](CCSC)NC(=O)C1=CC=C(NC[C@@H](N)CS)C=C1C2=CC=CC=C2	Bio Vision	2874-5	-10.14024185	-10.62818336	-8.81535522	-6.53266332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378593-08	Alvelestat (AZD9668£©			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	848141-11-7				-13.2269915356	4	4		0	-3.7606913					CN1N=CC=C1C2=C(C)N(C(=O)C(=C2)C(=O)NCC3=NC=C(C=C3)[S+](C)([O-])=O)C4=CC=CC(=C4)C(F)(F)F	Selleck	S7218	-4.32532666	-1.90318936	2.55993677	-3.7606913												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346708-03	Aloperine		Mediator Release Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	56293-29-9				-34.0684590976	4	4		0	-6.30544024					C1CCN2C[C@H]3C[C@H](\C=C/4CCCN[C@@H]34)[C@H]2C1	APExBIO	B1654	-8.15838092	-6.81663837	-5.37606392	-6.30544024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345885-02	Etravirine (TMC125)		P-glycoprotein 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	269055-15-4		3.9810717055	-5.4	-38.742654269	4	4		-12.6763389879	-17.62289709	0.1571582678	0.9845870599			CC1=C(OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C(=CC(=C1)C#N)C	Selleck	S3080	-5.81541821	-4.1426146	-11.19506688	-17.62289709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390568-02	Bevirimat		Gag-Pol polyprotein Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	174022-42-5		10	-5	-76.7242429495	-3	4		-78.2691383761	-77.82827179	0.0106075751	0.9999306025			CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	MedChem Express	HY-N0842	-4.46338596	-3.85398981	-6.38353309	-77.82827179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263102-06	Degrasyn	384568591	Jak2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	856243-80-6		2.2387211386	-5.65	-158.3274209344	-1.1	4		-93.1464389929	-99.66052376	0.0103727617	0.999933633		JAK2	CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-13264	-5.92953556	-7.49978274	-90.78334943	-99.66052376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178086-06	AMINOLEVULINIC ACID HYDROCHLORIDE		DNA Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	5451-09-2				-30.6373295	4	4		0	-8.13196417					NCC(=O)CCC(O)=O	Microsource	01504184	-5.89939536	-5.25466893	-8.32899079	-8.13196417												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017325-10	KOJIC ACID		Tyrosinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	501-30-4				-14.6727906872	4	4		0	-3.10683854					OC\C1=C\C(=O)\C(=C/O1)O	Microsource	01504324	-3.52284179	-1.88455008	-2.7357999	-3.10683854												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00015673-19	Minoxidil		K(ATP) Channel Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	38304-91-5				0.7023129846	4	4		0	-1.17714487					NC1=[N+]([O-])C(=NC(=C1)N2CCCCC2)N	MedChem Express	HY-B0112	0.99616197	-0.69522899	-0.68060068	-1.17714487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250404-15	ABT-888			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	912445-05-7				-34.6175338238	4	4		0	-8.59271669					C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(N)=O	ChemieTek	CT-A888	-6.96450903	-7.9256105	-6.96847282	-8.59271669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389721-01	Q-VD-OPh hydrate	363680840	Irreversible pan-Caspase inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1135695-98-5				-19.6731557179	4	4		0	0.3482938				CASP3	CC(C)C(NC(=O)C1=NC2=CC=CC=C2C=C1)C(=O)NC(CC(O)=O)C(=O)COC3=C(F)C=CC=C3F	APExBIO	A1901	-3.71296736	-6.45693925	-8.49653113	0.3482938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015142-02	Benzamide	124879383		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-24.2483432026	4	4	Benzamide-15N;Benzamide-13C1 (carbonyl-13C);NCGC00015142-01;Benzoylamide;AB07990186-01;Benzamide;benzamide;NCGC00091355-03;CIPLUS_148736;Benzoic acid amide;Benzamide-alpha-13C;NCGC00091355-02;	0	-8.18710872					NC(=O)C1=CC=CC=C1	NIEHS	AB07990186	-4.1442063	-6.75241158	-4.04408536	-8.18710872												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159462-20	Ritonavir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	155213-67-5				-26.5030847017	4	4		0	-9.93298651					[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1	-2.81599034	-8.17763101	-8.83024502	-9.93298651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015097-03	4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride	90340895		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-4.1630836891	4	4		0	-2.28815801					NCCC1=CC=C(C=C1)[S+]([O-])(F)=O	SigmaAldrich	Lopac-A-8456	-0.53042391	-1.30355436	-0.2678493	-2.28815801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095125-15	Losartan potassium		Angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	124750-99-8				-38.8283354191	4	4		0	-4.97751521					CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[NH]4)Cl	Glixx	GLXC-05212	-8.4134719	-10.08951073	-9.4010714	-4.97751521												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00457027-01	NCGC00457027-01	375831663		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.6370157754	4	4		0	-7.21700224					CC1=C(C)C=C(C=C1)C2=N[N]3\C=C/N(CCNC(=O)C4=NC5=C(C=CC=C5)C=C4)C(=O)C3=C2	Chemdiv	S539-0652	-6.01332683	-6.16385583	-7.98151002	-7.21700224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398199-01	NCGC00398199-01	375801055		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-31.6317383119	4	4		0	-8.98881432					COC1=CC=C(NC(=O)N[C@H]2C[C@H](N(C2)C(=O)C3CC3)C(=O)N[C@H](CC4=C[NH]C5=C4C=CC=C5)C(N)=O)C=C1	Analyticon	NAT3-155438	-5.34698521	-8.03869532	-8.06955756	-8.98881432												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263556-10	P 22077			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1247819-59-5				-16.5574579368	4	4		0	-2.89656997					CC(=O)C1=CC(=C(S1)SC2=CC=C(F)C=C2F)[N+]([O-])=O	MedChem Express	HY-13865	-4.10970719	-4.57113062	-1.00553262	-2.89656997												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165856-15	Orlistat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	96829-58-2		12.5892541179	-4.9	-72.6429123679	-3	4		-64.6526686102	-64.43435323	0.0186363197	0.9997857825			[H]C(=O)N[C@@H](CC(C)C)C(=O)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC	APExBIO	A8492	-6.4470223	-5.80516208	-5.66874506	-64.43435323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	12.5892541179	-4.9	-55.9688116542	-3	4		-60.47362698	-58.9145578	0.1171573995	0.9914402089			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	-1.82414076	-7.56930564	-2.84095899	-58.9145578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686694-01	Remdesivir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1809249-37-3				2.4875590409	4	4		0	5.43602857					CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077	-0.01293717	-1.85104719	-0.35566875	5.43602857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182390-05	NCGC00182390-05			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			12.5892541179	-4.9	-33.9710187049	-3	4		-54.3213120493	-48.52746671	0.0410147305	0.9989614577			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029	0.21130709	0.64308682	1.87494511	-48.52746671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00651732-01	ROC-325			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1859141-26-6				-32.7816075232	4	4		0	-5.89454193					CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527	-7.71486481	-8.29060572	-4.9047159	-5.89454193												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182416-01	NCGC00182416-01	87225661		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-34.9385976864	4	4		-13.262619312	-15.78970917	0.3918805567	0.8929970152			[O-][S+](=O)(N1CCN(CC1)[S+]([O-])(=O)C2=CC3=C(CCN(C3)C(=O)C(F)(F)F)C=C2)C4=CC=C5OCCOC5=C4	NCGCChem	mbb01-82	-4.73752641	-8.5780327	-7.21549637	-15.78970917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00135267-01	NCGC00135267-01	24410650		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.4942826761	4	4		0	-6.34004474					COC1=C(NC(=O)C2CCN(CC2)[S+]([O-])(=O)C3=CC4=C(C=C3)N(CCC4)C(C)=O)C=C(C)C=C1	Sytravon	G855-0577	-6.91532586	-4.91396285	-6.66960158	-6.34004474												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178714-18	Topiramate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	97240-79-4				-29.3847883653	4	4		0	-8.24883167					CC1(C)O[C@@H]2CO[C@@]3(CO[S+](N)([O-])=O)OC(C)(C)O[C@H]3[C@@H]2O1	DC Chemicals	DC9074	-5.20505412	-9.29868776	-4.9047159	-8.24883167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378746-04	NBD 556		Envelope glycoprotein gp160 Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[333353-44-9]				-32.2722702578	4	4		0	-13.38947183					CC1(C)CC(CC(C)(C)N1)NC(=O)C(=O)NC2=CC=C(Cl)C=C2	Tocris	5811	-4.351201	-6.23968019	-9.71722139	-13.38947183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168725-01	NCGC00168725-01	85736143		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.4541920188	4	4		0	-4.21923937					FC(F)(F)C1=CC(=C(Cl)C=C1)NC(=O)C(CC2=CC=CC=C2)OC(=O)CNC(=O)C3=CC=CC=C3	NCGCChem	BTM01-083	-7.02096538	-7.62777159	-5.78032137	-4.21923937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016622-11	Hycanthone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	3105-97-3		10	-5	-60.8566367207	-3	4		-82.2254434088	-71.44071588	0.008272188	0.999957799			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355	-0.6582155	-0.75336016	-7.51485802	-71.44071588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238681-01	NCGC00238681-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-24.7862062291	4	4		0	-2.66219239					OC(=O)C1=CC(=CC=C1Br)[S+]([O-])(=O)N2CCN(CC2)[S+]([O-])(=O)C3=CC=C4C=CC=CC4=C3	NCGCChem	MLS002156571-02pur	-5.9970746	-3.6212653	-7.08342505	-2.66219239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine			3.2754331001	4	4		0	2.16107383			84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	0.94262961	-1.59232942	-1.21945851	2.16107383												1.6E-8	8E-8	4E-7	0.000002											
NCGC00120966-01	NCGC00120966-01	24395545		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-32.5601723663	4	4		0	-5.68680089					CCOC1=C2OC(=O)C(=C/C2=CC=C1)\C3=N\C4=C(C(=O)N3)C(=C(S4)C(=O)NC5=CC=C(C)C=C5)C	Sytravon	E210-0056	-6.09458801	-9.37419741	-8.86198547	-5.68680089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00100060-01	NCGC00100060-01	24273758		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			10	-5	-54.2013515833	-3	4		-30.105245832	-34.39373602	0.074490629	0.9965675342			CC1=C(NC2=C3C=CC=CC3=C(N=N2)C4=CC(=C(C)C=C4)[S+]([O-])(=O)NCC5CCCO5)C=CC=C1	Sytravon	4903-2163	-7.50853242	-5.55603116	-7.77900066	-34.39373602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249613-08	Carfilzomib		Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	868540-17-4		0.1122018454	-6.95	-383.1486824128	-1.1	4		-90.6326055551	-99.21082797	0.028294639	0.9995065434		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	Aobious	AOB87759	-67.67432835	-96.54123577	-98.29191183	-99.21082797												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481568-01	AZD3839			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-34.747518671	4	4		0	-7.49052112					FC(F)C1=NC=CC(=C1)[C@@]2(NC(=N)C3=C2C=CC=C3F)C4=CC=CC(=C4)C5=CN=CN=C5	APExBIO	B5951	-6.65401699	-8.29929608	-9.09370335	-7.49052112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178864-04	Ethambutol HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1070-11-7				-8.6680543722	4	4		0	-1.05145414					CC[C@@H](CO)NCCN[C@@H](CC)CO	Selleck	S4004	-2.2509345	-0.22258368	-2.83072859	-1.05145414												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263173-05	Rucaparib	384568643	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	459868-92-9		12.5892541179	-4.9	-12.292816415	4	4		-14.837227544	-12.09395973	0.1775802749	0.9802535243		PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	Selleck	S1098	-0.14627011	-2.02037497	-2.09993396	-12.09395973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016564-06	Metformin	170464804	AMPK Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			-5.7313190528	4	4		0	-3.08173882			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	-0.65979559	0.39106631	-2.88486871	-3.08173882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241102-05	Midostaurin		PKC/flt3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	120685-11-2		1.1220184543	-5.95	-175.2925886009	-1.3	4		-77.3502180451	-91.68944538	0.0754059261	0.9964767783		PRKCA	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N3C4=CC=CC=C4C5=C6CNC(=O)C6=C7C8=CC=CC=C8N2C7=C35)N(C)C(=O)C9=CC=CC=C9	MedChem Express	HY-10230	-11.01815516	-27.09654993	-85.39123562	-91.68944538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00650297-01	Biphenyl-4-sulfonyl chloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1623-93-4				-42.2177680997	4	4		0	-10.27687153					[O-][S+](Cl)(=O)C1=CC=C(C=C1)C2=CC=CC=C2	Selleck	S5438	-7.93048428	-9.39428174	-11.04329499	-10.27687153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095192-08	Tegaserod maleate		5-HT4 Partial Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	189188-57-6		11.220184543	-4.95	-99.8811999833	-3	4		-98.9011659215	-97.08105746	0.0128342498	0.9998983965		HTR4	CCCCCNC(=N)N/N=C/C1=C[NH]C2=C1C=C(OC)C=C2	Cayman	14692	-6.91551898	-5.8573854	-7.96421747	-97.08105746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-15	NCGC00263152-15	384568626		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	943319-70-8		0.8912509381	-6.05	-213.7219701583	-1.1	4		-88.9805306931	-99.66442953	0.0090198305	0.9999498204		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Selleck	S1490	-11.98602308	-93.59643866	-99.56856703	-99.66442953												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00141392-03	NCGC00141392-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-78.9816829204	-3	4		-78.4694766606	-75.85234899	0.0816416588	0.9958668805			COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCC5=CC=C(C)C=C5	Chemdiv	E859-1146	-6.75280351	-5.54747025	-1.66850099	-75.85234899												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250410-11	GSK-650394	384568558	SGK1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	890842-28-1				-25.9968210395	4	4		0	-7.33668342				SGK1	OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5	MedChem Express	HY-15192	-5.04282835	-6.07809847	-4.8462741	-7.33668342												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346506-05	LY-2886721	384568809	beta-Secretase 1/2 (BACE1/2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1262036-50-9				-43.1827189671	4	4		0	-10.35175879				BACE1	NC/1=N/[C@]2(COC[C@H]2CS1)C3=CC(=CC=C3F)NC(=O)C4=NC=C(F)C=C4	MedChem Express	HY-13240	-9.16610682	-7.46179966	-9.76202883	-10.35175879												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379087-02	Tipranavir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	174484-41-4		10	-5	-16.5528806922	4	4		-24.1532663359	-22.21105528	0.0396191977	0.9990331782			CCC[C@@]1(CCC2=CC=CC=C2)CC(=C([C@H](CC)C3=CC=CC(=C3)N[S+]([O-])(=O)C4=CC=C(C=N4)C(F)(F)F)/C(=O)O1)\O	MedChem Express	HY-15148	0.41568693	-0.40747029	-1.04220948	-22.21105528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093560-19	Finasteride		Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[98319-26-7]				-16.7659058669	4	4		0	0.08302381				AR	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)\C=C/[C@]4(C)[C@H]3CC[C@]12C	Tocris	3293	-4.66493114	-1.60441426	-5.4281744	0.08302381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015256-29	Chloroquine		antimalarial agents	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	50-63-5				-31.3344293581	4	4		0	-4.30872483					CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1	-8.54867544	-6.32651314	-8.72991415	-4.30872483												1.6E-8	8E-8	4E-7	0.000002											
NCGC00390606-01	TNKS-656	363680925	Tachykinin NK2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1419949-20-4		0.3981071706	-6.4	-64.017455225	4	4		-23.1287356919	-24.27293065	0.0412823349	0.9989521245		TACR2	COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)C\C4=N\C5=C(\COCC5)C(=O)N4	MedChem Express	HY-13990	-6.24898424	-18.60285934	-24.19986793	-24.27293065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420587-01	NCGC00420587-01	375889531		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-33.4302386256	4	4		0	-8.35346756					OC(=O)COC1=CC=C(C=C1)C2=NC=CC3=C2C(=O)N(CC(CNC(=O)CC4=CC=CC=C4)O3)CC5=C[NH]C6=CC=CC=C56	Charles River	1444_8467_2002	-5.90768731	-7.49935793	-9.81289897	-8.35346756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346833-03	PD-151746			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	179461-52-0				-35.6083878709	4	4		0	-7.0657636					OC(=O)/C(S)=C/C1=C[NH]C2=C1C=C(F)C=C2	Glixx	GLXC-06766	-6.68878065	-10.48387097	-8.46795206	-7.0657636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123293-01	NCGC00123293-01	24397872		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-16.545987226	4	4		0	-6.86800895					CCOC(=O)C1=CC=CC=C1NC(=O)CSC2=C[N](CC(=O)N3CCOCC3)C4=C2C=CC=C4	Sytravon	E587-0338	-1.02389078	-6.15529492	-6.43187321	-6.86800895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370784-05	Resiquimod	363677855	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	144875-48-9				-19.1594877366	4	4		0	-3.57002403				TLR7	CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2[N]1CC(C)(C)O	MedChem Express	HY-13740	-4.24504535	-3.4295416	-4.65520236	-3.57002403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482848-01	Orientin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	28608-75-5				-3.9123412182	4	4		0	-2.83221477					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC(=C(O)C=C4)O	DC Chemicals	DCH-044	-1.0320169	-2.77373513	3.97534669	-2.83221477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384200-03	HPOB		Histone deacetylase 6 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1429651-50-2		3.9810717055	-5.4	-30.6145356574	4	4		-21.812802492	-16.75770155	0.2713128573	0.9521007882			OCCN(C(=O)CC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Adooq	A14197	-2.33036614	-7.68251273	-9.68386312	-16.75770155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164977-01	NCGC00164977-01	29216731		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-22.0393299669	4	4		0	-3.70917226					FC(F)(F)C1=CC=C(Cl)C(NC(=O)C2=NN3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C5OCOC5=C4)=C1	Sytravon	A0001411	-4.32309443	-5.13654653	-6.63438257	-3.70917226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399481-01	NCGC00399481-01	375799752		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.7892234718	4	4		0	-3.10961969					FC(F)(F)C1=CC=CC(=C1)NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC=C(C=C5)C6=CC=CC=C6	Analyticon	NAT6-318788	-6.67154234	-5.70156665	-4.92626018	-3.10961969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371106-01	(±)-PPCC oxalate	363678033	Sigma-1 receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[932736-91-9]				-25.3125966757	4	4		0	-6.66375355					COC(=O)[C@]1(C[C@H]1CN2CCC(O)(CC2)C3=CC=CC=C3)C4=CC=C(C)C=C4	Tocris	3870	-5.79862277	-4.11714771	-3.78669446	-6.66375355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398391-01	NCGC00398391-01	375801564		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-41.7112969351	4	4		0	-9.06935123					O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)O[C@@H]3CO[C@@H]4[C@H](CO[C@H]34)NC5=NC(=CC=N5)C6=CC=CC(=C6)C#N	Analyticon	NAT6-322408	-8.93872908	-9.05744371	-8.26326216	-9.06935123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241103-01	NCGC00241103-01	124950162		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	790299-79-5	 Masitinib;Masitinib;AB-1010?	12.5892541179	-4.9	-103.1910286204	-3	4		-104.9719354399	-99.66442953	0.1077849624	0.9927655638	3815	FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	Toronto Research	M197500	-9.87323257	-4.60577005	-0.38300682	-99.66442953												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095049-04	Exalamide	170465990		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	53370-90-4				-4.7138159134	4	4		0	4.13870246					NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	-1.05639525	-5.64164027	-1.66850099	4.13870246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015693-13	Mitoxantrone		DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	70476-82-3		11.220184543	-4.95	-161.5176991295	-2.4	4		-54.9733135232	-61.10115796	0.1568005591	0.9845422501		TOP2A	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	Selleck	S1889	-25.56684582	-32.74193548	-39.59527532	-61.10115796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161662-08	Calpain Inhibitor I, ALLN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	110044-82-1				-17.4252005943	4	4		0	-2.32903649					CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C=O	APExBIO	A2602	-3.59842123	-4.51612903	-4.77679347	-2.32903649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182549-04	Vicriviroc (SCH-417690)	384568410	Chemokine CCR5 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	541503-81-5				-21.7417565241	4	4		0	-8.37227758				CCR5	COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F	Adooq	A10971	-2.94536203	-6.05718258	-5.33503118	-8.37227758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-05	Ponatinib		FGFR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	943319-70-8		1.1220184543	-5.95	-159.5842966319	-1.1	4		-99.4836648465	-99.93386827	0.0157058989	0.9998478261		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Axon Medchem	1857	-0.1250593	-21.49995655	-99.4950382	-99.93386827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024683-20	NCGC00024683-20			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			11.220184543	-4.95	-11.5514600523	4	4		-35.883001968	-26.15250164	0.08220721	0.995815449			C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	BIOMOL	T-113	3.22052402	0.98471986	-1.31144693	-26.15250164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163431-06	CA-074 Me	384568238	Cathepsin B Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	147859-80-1				-5.8011515916	4	4		0	3.8496832				CTSB	CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N2CCC[C@H]2C(=O)OC	APExBIO	A8239	-2.35555929	-3.86247878	0.05211047	3.8496832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263180-08	Trametinib	384568648	Mek 1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	871700-17-3		0.2818382931	-6.55	-117.4774416847	4	4		-24.258178164	-37.04699762	0.335729863	0.9237053811		MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	APExBIO	A3018	-18.08184915	-31.12018771	-31.2768947	-37.04699762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015385-22	Dipyridamole	384567839	Phosphodiesterase PDE3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	58-32-2				-21.3520601947	4	4		0	0.46755517				PDE5A	OCCN(CCO)C1=NC(=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO)N4CCCCC4	Prestwick	Prestw-142	-5.21078267	-5.28862479	-6.72225117	0.46755517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379250-01	ME 0328		Poly [ADP-ribose] polymerase 3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[1445251-22-8]				-31.0067236754	4	4		0	-9.8359933					C[C@H](NC(=O)CCC/1=N/C2=CC=CC=C2C(=O)N1)C3=CC=CC=C3	Tocris	5054	-5.09293199	-7.95168159	-7.28462282	-9.8359933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161826-02	Phenylmercuric borate	124892360	platelet aggregation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			4.4668359215	-5.35	-109.9234940087	-2.1	4		-102.5081198606	-99.66934133	0.0140392158	0.999878418			[Hg+]C1=CC=CC=C1	SigmaAldrich	S366137	-1.12553366	-1.74676284	-44.82743479	-99.66934133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482789-01	8-O-Acetylharpagide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6926-14-3				-25.4683996579	4	4		0	-7.00458816					CC(=O)O[C@@]1(C)C[C@@H](O)[C@]2(O)\C=C/O[C@@H](OC3OC(CO)C(O)C(O)C3O)[C@H]12	DC Chemicals	DCY-112	-3.84195499	-6.8336163	-8.0771235	-7.00458816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017363-18	Cycloheximide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	66-81-9		0.8912509381	-6.05	-196.5521377697	-1.4	4		-67.7128862053	-75.53856238	0.0779558429	0.9962353831			[H][C@]1(C[C@@H](C)C[C@H](C)C1=O)[C@H](O)CC2CC(=O)NC(=O)C2	SIGMA	1810_cm3	-27.83422909	-52.52122241	-66.76220254	-75.53856238												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00024379-25	Emetine		antiprotozoal agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	316-42-7		0.2818382931	-6.55	-325.4656861417	-1.3	4		-66.2229423475	-99.27255092	0.1468845333	0.98645997			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	USP	1235004_cm1	-49.72616327	-85.78256713	-92.03038553	-99.27255092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017352-31	Resveratrol		Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-9.8092185735	4	4		0	-7.18190636				PTGS2	OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O	Analyticon	NP-012969	-0.18543275	-2.58972799	-3.08685343	-7.18190636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351072-01	ML414			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			10	-5	-57.7592354555	-3	4		-54.348498988	-54.33824178	0.050475876	0.9984259043			CN(C)[S+]([O-])(=O)C1=CC(=C(C=C1)N2CCCC2)C(=O)NC3=NC=C(C)S3	NCGCChem	YSM004-073	-4.78243995	-2.38115929	-4.67638535	-54.33824178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180626-04	Cephaeline			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	483-17-0		0.4466835922	-6.35	-381.1047301343	5	4		-38.4729282252	-99.13146989	0.0316744066	0.9993817064			CC[C@H]1CN2CCC3=C(C=C(OC)C(=C3)OC)[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(=C5)O	Carbosynth	FC19891	-69.39065936	-87.65099505	-98.07236322	-99.13146989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016032-14	THIOCTIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1077-24-7				-17.5318228318	4	4		0	-5.7270082					OC(=O)CCCCC1CCSS1	Microsource	01503941	-1.26353012	-8.62952985	-5.71265478	-5.7270082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247556-02	Fangchinoline			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	436-77-1		12.5892541179	-4.9	-87.7369003917	-3	4		-107.022644473	-99.75751697	0.0471383017	0.9986270309			COC1=C2OC3=CC=C(C[C@@H]4N(C)CCC5=CC(=C(OC6=C(O)C(=CC7=C6[C@H](CC(=C2)C=C1)N(C)CC7)OC)C=C45)OC)C=C3	DC Chemicals	DCF-007	-4.03208418	-3.69340401	-0.4259243	-99.75751697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015829-14	PROMAZINE HYDROCHLORIDE		Serotonin 2a (5-HT2a) receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	53-60-1, 58-40-2 [promazine]		12.5892541179	-4.9	-97.9747252836	-3	4		-100.7565386891	-97.96755136	0.0097638918	0.9999411981			CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2	Microsource	01500509	-6.36077451	-6.15277657	-6.02002283	-97.96755136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344588-04	I-BET151		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			0.5011872336	-6.3	-208.8952081263	-1.3	4		-93.2974203087	-94.14072833	0.0631628758	0.9975315682		BRD4	COC1=CC2=C(C=C1C3=C(C)ON=C3C)N=CC4=C2N([C@H](C)C5=CC=CC=N5)C(=O)N4	Tocris	4650	-13.61421364	-62.28382724	-86.17282866	-94.14072833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016251-17	Probenecid		Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	57-66-9				-22.8649322991	4	4		0	-4.13102901					CCCN(CCC)[S+]([O-])(=O)C1=CC=C(C=C1)C(O)=O	APExBIO	B2014	-4.54957092	-6.85669592	-4.81689646	-4.13102901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378998-01	HIV-1 integrase inhibitor 2	363678307	Human immunodeficiency virus type 1 integrase Negative Allosteric Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	957890-42-5				-18.493639552	4	4		0	-2.85248214					CCCC(C(O)=O)C1=C(C2=CC=CC=C2)C3=CC(=CC=C3N=C1C)Cl	MedChem Express	HY-10522	-3.02298504	-7.16954897	-5.19452007	-2.85248214												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137795-01	NCGC00137795-01	24413178		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.700082353	4	4		0	-6.22371365					CC1=CC=C(C=C1)C(=O)N2CCC3=CC(=CC=C23)CNC(=O)C4=CC=C(Br)C=C4	Sytravon	G883-0331	-7.70355924	-8.32976629	-7.946291	-6.22371365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482529-01	Epigoitrin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1072-93-1				-30.4154594867	4	4		0	-6.62639821					C=C[C@@H]1CNC(=S)O1	DC Chemicals	DCB-014	-5.98894848	-7.13979967	-7.40920097	-6.62639821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137882-01	NCGC00137882-01	24413265		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-14.7020856691	4	4		0	-4.81879195					COC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C(Br)C=C4)SC5=C1CCCC5	Sytravon	K061-0796	-3.15293353	-2.18303227	-2.17917676	-4.81879195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346883-02	6-Bromoindirubin-3'-acetoxime	384568960	GSK-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[667463-85-6]		3.1622776602	-5.5	-137.7970739272	-2.1	4		-100.5859686977	-96.18640332	0.0093036383	0.999946613		GSK3B	CC(=O)O\N=C1\C(NC2=CC=CC=C12)=C3/C(=O)NC4=C3C=CC(=C4)Br	Tocris	3874	-4.76519039	-16.01633788	-60.86326513	-96.18640332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015898-28	Rolipram	384567905	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	61413-54-5				-3.5067395433	4	4		0	-2.4645093				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3	MedChem Express	HY-16900	-0.7374186	-1.72938212	2.04180205	-2.4645093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386232-01	Cathepsin Inhibitor 1	363680160		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	225120-65-0				-38.5763671576	4	4		0	-3.81359668					C[N]1N=C(C=C1C(=O)N[C@@H](CC2=CC=CC(=C2)Cl)C(=O)NCC#N)C(C)(C)C	Selleck	S2847	-9.68131442	-10.72390719	-5.01888118	-3.81359668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126021-02	NCGC00126021-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-110.6071349715	-3	4		-98.995435183	-98.70693512	0.0298776975	0.9994490382			COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCC5=CC=CC=C5C	Chemdiv	E859-1199	-9.96261986	-8.55234997	-7.74378164	-98.70693512												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398410-01	NCGC00398410-01	375800513		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			15.8489319246	-4.8	-58.6371396061	4	4		-11.972926852	-19.44071588	0.441184838	0.8586491705			COC1=CC=C(C=C1)C2=CC=NC(=N2)N[C@H]3CO[C@@H]4[C@@H](CO[C@H]34)OC(=O)NC5=CC(=CC=C5)C(F)(F)F	Analyticon	NAT6-318838	-12.05915813	-11.2490369	-7.79661017	-19.44071588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00131816-01	NCGC00131816-01	24407199		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-53.4385047815	4	4		-24.015275212	-28.05816555	0.2242120707	0.967749031			CC1=C(NC(=O)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CC5=CC=CC=C5)C(=O)N24)C=C(Cl)C=C1	Sytravon	G567-0208	-8.78433285	-9.22866193	-5.12876954	-28.05816555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386200-01	Vildagliptin (LAF-237)	363680148	Dipeptidyl peptidase IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	274901-16-5				-30.8900830618	4	4		0	-5.95626488					OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N	Selleck	S3033	-6.7747639	-8.99452507	-4.07921314	-5.95626488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379189-01	P005091			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[882257-11-6]				-9.2778229325	4	4		0	-4.46609646					CC(=O)C1=CC(=C(S1)SC2=CC=CC(=C2Cl)Cl)[N+]([O-])=O	Tocris	4733	-2.55724697	-2.2421135	3.08685343	-4.46609646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106481-02	NCGC00106481-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-37.7038866607	4	4		0	-8.18344519					CC1=CC=CC(=C1)NC(=O)CN2C(=O)N(CC3=CC=C(C=C3)C(=O)NCC4=CC=C5OCOC5=C4)C(=O)C6=CC=CC=C26	Chemdiv	C260-1157	-7.80919876	-9.02320007	-7.63812459	-8.18344519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00124334-01	NCGC00124334-01	24399717		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-82.4431146057	-3	4		-73.939908504	-71.57494407	0.0460590221	0.9986895411			CC1=C(C=CC=C1)C(=O)NC2=CC=C3N=C(NC4=CC(=CC=C4)C(F)(F)F)C=C(C)C3=C2	Sytravon	E683-0130	-6.20835365	-8.99751734	-9.73365617	-71.57494407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344901-01	NCGC00344901-01	161004131		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-44.7035944494	4	4		0	-10.94854586					[O-][S+](=O)(NC1=NC(=CS1)C2=CC=CC=C2)C3=CC=C(NC(=O)C4=CC=C5C=CC=CC5=C4)C=C3	NCGCChem	RAP12-043	-8.98748578	-10.05907029	-9.35505173	-10.94854586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137432-01	NCGC00137432-01	24412815		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.3536436132	4	4		0	-5.70469799					CC1=CC=C(C=C1)C2=N[N]3C(=O)N(CC(=O)N4CCN(CC4)C5=CC=C(F)C=C5)C6=CC=CC=C6C3=N2	Sytravon	G860-0093	-8.1992524	-7.22540878	-5.86836892	-5.70469799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378713-01	Nirogacestat	363678166	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1290543-63-3		3.9810717055	-5.4	-37.4250881877	4	4		-17.9899855119	-15.30288334	0.3209750177	0.9317689866		NOTCH1	CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C	MedChem Express	HY-15185	-4.89456208	-9.22047449	-10.07728111	-15.30288334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015202-21	NCGC00015202-21			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-33.4752142382	4	4		0	-8.50775617					CC(C)(OC1=CC=C(C=C1)C2CC2(Cl)Cl)C(O)=O	SigmaAldrich	C0330	-5.28636211	-10.11035654	-9.37120028	-8.50775617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483135-03	CPI-0610	384569263	Bromodomain-containing protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1380087-89-7		0.316227766	-6.5	-274.0796767818	-1.2	4		-64.6044101651	-86.86475858	0.0209339576	0.9997297398			CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(N)=O)C4=CC=C(Cl)C=C4	ChemieTek	CT-C0610_cm2	-37.0213302	-77.20713073	-86.77262463	-86.86475858												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090851-14	5-Azacitidine		DNA Methyltransferase (DNMT) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	320-67-2		10	-5	-53.1247168131	-3	4		-41.4857491572	-41.69106402	0.0865437395	0.9953558634		DNMT1	NC/1=N/C(=O)N(/C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	XcessBio	M60131-5s	-5.98337252	-2.95415959	-6.60934514	-41.69106402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344933-01	NCGC00344933-01	161004144		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.3390134289	4	4		0	-12.28187919					[O-][S+](=O)(NC1=CN=CC=C1C(=O)NC2=NC(=CS2)C3=CC=CC=C3)C4=CC(=C(F)C=C4)F	NCGCChem	RAP12-060	-7.55728913	-7.3195788	-2.49614792	-12.28187919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115610-01	NCGC00115610-01	24390189		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-46.0900599333	4	4		-23.80892846	-24.39821029	0.3035860665	0.9386803599			CC1=CC2=C(C=C1Cl)C(=C(O2)C(=O)N(CC3=C(F)C=CC=C3)C4CC[S+]([O-])(=O)C4)C	Sytravon	D076-0328	-8.20737851	-2.47410324	-7.39159146	-24.39821029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091914-04	Cichoric Acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-16.7222420723	4	4		0	-3.950783					OC(=O)[C@H](OC(=O)\C=C\C1=CC(=C(O)C=C1)O)[C@@H](OC(=O)\C=C\C2=CC=C(O)C(=C2)O)C(O)=O	Analyticon	NP-015790	-3.42922152	-2.48266416	-4.68853181	-3.950783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091469-15	Saquinavir Mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	149845-06-7		14.1253754462	-4.85	-62.8137219859	-3	4		-32.8688086517	-36.82324667	0.0226289331	0.9996845375			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4)[C@@H](C2)C(=O)NC(C)(C)C	Enzo	AC3247	-8.93936849	-8.98981324	-8.84141046	-36.82324667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015415-05	N-Ethylmaleimide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	128-53-0				-24.3358063858	4	4		0	-9.76622242					CCN1C(=O)\C=C/C1=O	Enzo	PI149	-3.11975143	-8.03904924	-7.79920097	-9.76622242												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00164951-01	NCGC00164951-01	29216705		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.2471921053	4	4		0	-8.81879195					COC1=C(OC)C=C(C=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)F)C(=O)NC4=CC(=CC=C4Cl)C(F)(F)F	Sytravon	A0001277	-4.43686007	-10.25597124	-5.94761171	-8.81879195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00119897-01	NCGC00119897-01	24394476		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.2958841268	4	4		0	-4.50559284					CC(N1C(=O)\C(=N/C2=C1C=CC=C2)C3=CC=CC=C3NC(C)=O)C(=O)NC4=CC(=CC=C4C)Cl	Sytravon	D384-0046	-5.94019178	-3.92089718	-7.18027735	-4.50559284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094916-09	.		Prostaglandin G/H synthase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	GRT01099				-11.2332065887	4	4		0	-1.7959362			5743	PTGS2	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2	SIGMA	SML1495	-1.86849177	-3.86247878	-3.43060622	-1.7959362												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346654-11	INK-128	384568885	mTORC1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	?1224844-38-5		12.5892541179	-4.9	-277.8639764028	-2.2	4		-66.7849637068	-87.87852305	0.0345446032	0.9992640306		MTOR	CC(C)[N]1N=C(C2=CC3=C(OC(=N3)N)C=C2)C4=C(N)N=CN=C14	ActiveBioChem	A-1023	-49.70188109	-55.22071307	-66.76220254	-87.87852305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00112114-02	NCGC00112114-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-23.233775809	4	4		0	-6.00894855					[O-][S+](=O)(N1CCCCCC1)C2=CC=C3OCC(=O)N(CC(=O)N4CCN(CC4)C5=CC(=CC=C5)C(F)(F)F)C3=C2	Chemdiv	C700-0994	-5.91581342	-1.45535485	-3.74642307	-6.00894855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00130409-01	NCGC00130409-01	24405792		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-38.7572623942	4	4		-17.382036528	-18.67114094	0.5009713214	0.8052981108			CC1=CC=C(C=C1C)C/2=N/C3=C(C=CC=C3)N(CC(=O)NC4=CC=CC=C4F)C(=O)C2	Sytravon	G353-0232	-7.10222656	-7.85035528	-1.6861105	-18.67114094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091641-16	6-Mercaptopurine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	50-44-2		5.6234132519	-5.25	-40.8344235285	4	4		-12.83873528	-17.18592965	0.1322573125	0.989183488			S=C1NC=NC2=C1NC=N2	MedChem Express	HY-13677	-6.56281491	-5.65365025	-10.41340976	-17.18592965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095703-06	NOBILETIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	478-01-3				-8.3872558092	4	4		0	-3.63993882					COC1=C(OC)C=C(C=C1)C/2=C/C(=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC	Microsource	01505268	-0.80198186	-2.21561969	-2.96161195	-3.63993882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510185-01	CCT365623			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	N/A				-25.3052647231	4	4		0	-2.03189862					C[S+]([O-])(=O)C1=CC(=CC(=C1)C2=CC=CC=C2)[S+]([O-])(=O)C3=CC=C(CN)S3	Glixx	GLXC-10154	-5.60547531	-4.37181664	-9.18012854	-2.03189862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492296-03	eFT508		MNK1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1849590-01-7		6.3095734448	-5.2	-37.0547729131	4	4		-10.388349808	-14.40681669	0.3355274612	0.9247242628		MKNK1	CC/1=C2/N(C(=O)C(=C1)/NC3=CC(=NC=N3)N)C4(CCCCC4)NC2=O	MedChem Express	HY-100022	-6.78955324	-4.08319185	-8.71981935	-14.40681669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345839-16	Baricitinib		Jak2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1187594-09-7				-3.0532560972	4	4		0	0.25781079				JAK2	CC[S+]([O-])(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	MedChem Express	HY-15315	-0.80198186	-2.87775891	1.16380059	0.25781079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346877-07	Batimastat	384568955	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	130370-60-4				-56.3078485075	4	4		0	-12.91238803				MMP1	CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)[C@H](CSC2=CC=CS2)C(=O)NO	MedChem Express	HY-13564	-10.87924085	-11.15449915	-15.85026924	-12.91238803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408859-01	Cetilistat		Pancreatic lipase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	282526-98-1				-11.1189559006	4	4		0	-2.19686801					CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1	Glixx	GLXC-06700	-1.94214204	-1.68649944	-4.77657935	-2.19686801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164571-04	Dutasteride	384568256	Steroid 5alpha-Reductase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-10.2619410757	4	4		0	-1.38255034					C[C@]12CCC3[C@@H](CC[C@H]4NC(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	Selleck	S1202	-1.46270112	-3.98082356	-3.87849439	-1.38255034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483024-01	BMS-791325 hydrochloride	377020421		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	958002-36-3		12.5892541179	-4.9	-63.7966240769	-3	4		-94.5314572831	-83.8147258	0.1191203542	0.9911452436			COC1=CC2=C(C=C1)C3=C(C4CCCCC4)C5=C(C=C(C=C5)C(=O)N[S+]([O-])(=O)N(C)C)[N]3C[C@]6(C[C@@H]26)C(=O)N7[C@H]8CC[C@@H]7CN(C)C8	DC Chemicals	DC9232	-2.9433994	2.4533107	6.65277054	-83.8147258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179673-05	Idoxuridine		Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	54-42-2				-43.5300492293	4	4		0	-12.88616998					OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(\I)C(=O)NC2=O	Selleck	S1883	-7.48656365	-10.96774194	-10.17891263	-12.88616998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378668-01	PD 144418 oxalate	363678143	Sigma opioid receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[154130-99-1]				-9.209111516	4	4		0	-4.6362246					CCCN1CC\C=C(/C1)C2=CC(=NO2)C3=CC=C(C)C=C3	Tocris	2606	-0.75999328	-0.56876061	-4.87232934	-4.6362246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482625-01	Dendrobine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2115-91-5				-17.7248171627	4	4		0	-6.36661569					CC(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@@H]3CC[C@@H]4CN(C)[C@H]2[C@]34C	DC Chemicals	DCS-082	-2.45633188	-4.6434635	-4.93312489	-6.36661569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346534-07	MC-1568		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	852475-26-4		7.9432823472	-5.1	-20.5463209037	4	4		-13.2860455241	-12.83396526	0.2830540481	0.9476567786		HDAC2	C[N]1C=C(/C=C/C(=O)C2=CC=CC(=C2)F)C=C1\C=C\C(=O)NO	Adooq	A10560	-2.92811247	-0.09559399	-4.87837007	-12.83396526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016028-08	Tyrphostin AG 555	90341437		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			8.9125093813	-5.05	-59.9190065925	-3	4		-56.9439795874	-55.62158619	0.0571882108	0.997978185			OC1=C(O)C=C(C=C1)\C=C(/C#N)C(=O)NCCCC2=CC=CC=C2	SigmaAldrich	Lopac-T-4818	-4.54736312	-1.78268251	-7.85131145	-55.62158619												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386253-01	Valganciclovir HCl	363680169	Human herpesvirus 5 DNA polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	175865-59-5				10.9245959033	4	4		0	0.10050251					CC(C)[C@H](N)C(=O)OCC(CO)OCN1\C=N/C2C1\N=C(N)/NC2=O	Selleck	S4050	5.16879409	-1.11205433	-2.24943547	0.10050251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015735-22	Niclosamide		STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	50-65-7		0.316227766	-6.5	-196.1314332466	-1.3	4		-92.7053549873	-84.18569791	0.1377663701	0.988108536		STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	MedChem Express	HY-B0497	-1.05653543	-90.67524116	-96.04373408	-84.18569791												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346542-10	Hesperadin		Aurora Kinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	422513-13-1		3.9810717055	-5.4	-154.2655577207	-2.2	4		-67.8778580886	-82.72198219	0.0355466312	0.9992200224		AURKA	CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1	Glixx	GLXC-03283	-17.02100134	-17.82393326	-52.2393958	-82.72198219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164560-17	Abacavir hemisulfate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[188062-50-2]				-15.2906124932	4	4		0	-3.21171073					NC1=NC2=C(N=C[N]2[C@@H]\3C[C@H](CO)\C=C3)C(=N1)NC4CC4	Tocris	4148	-2.71666107	-4.28692699	-4.22963349	-3.21171073												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016016-28	Triamterene		Heart phosphodiesterase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	396-01-0		8.9125093813	-5.05	-65.0601844609	-2.2	4		-56.6010431516	-54.07472143	0.0341998914	0.9992782435			NC1=NC(=C2N=C(C3=CC=CC=C3)C(=NC2=N1)N)N	MedChem Express	HY-B0575	-5.24437353	-3.98132428	-12.11568525	-54.07472143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346565-08	Elvitegravir		HIV Integrase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	697761-98-1		10	-5	-58.5934697957	-3	4		-66.2624780714	-62.35340799	0.0353565226	0.999228393			COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	APExBIO	A4070	-1.91901333	-3.91066307	-6.2307895	-62.35340799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091208-11	HEXYLRESORCINOL		Tyrosinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	136-77-6		12.5892541179	-4.9	-35.0869858471	4	4		-18.731138308	-18.61828763	0.3384188591	0.922597748			CCCCCCC1=C(O)C=C(O)C=C1	Microsource	01500330	-3.84233904	-8.27322499	-7.97839642	-18.61828763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	908112-43-6		0.5011872336	-6.3	-67.6467696165	-1.4	4		-36.5151999159	-34.8602416	0.2581877298	0.956561633		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189	-2.76424167	-22.29946989	-27.10547115	-34.8602416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346637-05	Odanacatib	384568871	Cathepsin K Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	603139-19-1				-22.0722445868	4	4		0	-4.44395892				CTSK	CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C2=CC=C(C=C2)[S+](C)([O-])=O)C(F)(F)F)C(=O)NC3(CC3)C#N	MedChem Express	HY-10042	-4.33742022	-5.55178268	-5.4281744	-4.44395892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	657-27-2				-8.8883539252	4	4		0	-1.26532052					NCCCC[C@H](N)C(O)=O	Bosche	L1919	-2.73836733	-3.9975667	-1.57635901	-1.26532052												1.6E-9	8E-9	4E-8	2E-7											
NCGC00378984-02	Pritelivir (BAY 57-1293)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	348086-71-5				-26.7776671484	4	4		0	-7.68450754					CN(C(=O)CC1=CC=C(C=C1)C2=NC=CC=C2)C3=NC(=C(S3)[S+](N)([O-])=O)C	Selleck	S7546	-4.53232136	-5.25766924	-8.27698252	-7.68450754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016280-11	Zoxazolamine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	61-80-3				-21.6785634555	4	4		0	-4.14866414					NC1=NC2=C(O1)C=CC(=C2)Cl	APExBIO	B1871	-4.46332313	-5.64004519	-4.63247563	-4.14866414												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162241-09	N6-Methyladenosine		DNA oxidative demethylase ALKBH1 Substrate	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1867-73-8				-40.0044070514	4	4		0	-8.63680451			8846	ALKBH1	CNC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1	MedChem Express	HY-N0086	-9.41394627	-6.07456331	-7.53051726	-8.63680451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139527-01	NCGC00139527-01	24414910		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-31.1378335033	4	4		0	-2.71588367					CC1=CC=C(C)C(=C1)N2CCN(CC2)[S+]([O-])(=O)C3=C(F)C=CC(=C3)C(=O)NC4=CC=C(OC5=CC=CC=C5)C=C4	Sytravon	K781-7785	-7.94734276	-7.85035528	-4.75896984	-2.71588367												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137848-01	NCGC00137848-01	24413231		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-51.9041065749	4	4	methylethyl 2-{[5-phenyl-7-(trifluoromethyl)-8-hydropyrazolo[1,5-a]pyrimidin-2 -yl]carbonylamino}-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate;	0	-8.18344519					CC(C)OC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=CC=C4)SC5=C1CCCC5	Sytravon	K061-0473	-11.94539249	-11.76269155	-10.10345587	-8.18344519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016403-11	Mafenide (Acetate)		Carbonic anhydrase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	13009-99-9				-32.9427564352	4	4		0	-8.2664668					NCC1=CC=C(C=C1)[S+](N)([O-])=O	MedChem Express	HY-B0614A	-6.46427185	-7.93430086	-6.74014227	-8.2664668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00124402-01	NCGC00124402-01	24399785		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-100.815622652	-2.1	4		-90.7507619695	-88.77404922	0.0031906901	0.9999937214			CC1=CC(=NC2=CC=C(NC(=O)CC3=CC=CC(=C3)C(F)(F)F)C=C12)NC4=CC(=CC=C4)Cl	Sytravon	E683-0301	-8.36990086	-8.1842308	-10.54369359	-88.77404922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017251-06	alpha-MANGOSTIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	6147-11-1		3.5481338923	-5.45	-129.4759268207	-2.1	4		-97.1957257844	-99.69127517	0.0479453478	0.9985795433			COC1=C(CC=C(C)C)C2=C(OC3=C(C(=C(CC=C(C)C)C(=C3)O)O)C2=O)C=C1O	Microsource	MS-01504015	-4.90004876	-2.66244328	-58.07175875	-99.69127517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378657-01	Simeprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	923604-59-5		12.5892541179	-4.9	-88.0422664901	-3	4		-110.1271971084	-99.47535491	0.0478470515	0.998585365			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-2.05700979	-6.39610672	-5.677527	-99.47535491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346719-03	LY-2811376	384568932	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1194044-20-6				-9.8170992024	4	4		0	-1.11409396				BACE1	C[C@]\1(CCS\C(=N1)N)C2=CC(=C(F)C=C2F)C3=CN=CN=C3	Axon Medchem	2225	-2.61660978	-1.03587022	-2.25841955	-1.11409396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162068-04	Opipramol dihydrochloride	144206704	Serotonin 2 (5-HT2) receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	909-39-7	Opipramol dihydrochloride; Insidon; Hydrochloride, Opipramo; 			-31.0503525841	4	4	NCGC00093619-01;opipramol hydrochloride;Opipramol;1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-;NCGC00093619-02;CIPLUS_152628;Opipramolum;opipramolum;Opipramol Hydrochloride;OPIPRANMOL DIHYDROCHLORIDE;LS-112246;4-(3-(5H-Dibenz(b,f)azepin-5-yl)propyl)-1-piperazineethanol;LS-112248;OPIPRAMOL;OPIPRAMOL HYDROCHLORIDE;opipramol;Opipramol hydrochloride;Insidon;Hydrochloride, Opipramo;CIPLUS_213844;NCGC00162068-02;Opipramol dihydrochloride;4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol dihydrochloride;NCGC00162068-01;	0	-7.90494665					Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Kemprotec	909-39-7	-7.39574798	-5.24897888	-3.70158953	-7.90494665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163470-28	FK-506	384568242	mTOR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	104987-11-3				-23.0609670692	4	4		0	-2.16471211				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Bio Vision	1563	-4.56682048	-7.53454419	-6.45912005	-2.16471211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133280-01	NCGC00133280-01	24408663		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-46.7185947483	4	4		0	-15.33333333					FC(F)(F)C1=CC(=CC=C1)NC(=O)NCC2=CC=C3N(CCC3=C2)C(=O)C4=CC=CC=C4	Sytravon	G714-0224	-8.63806273	-8.86054276	-10.02421308	-15.33333333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116188-01	NCGC00116188-01	24390767		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-12.0051047271	4	4		0	-5.10514541					CC1=CC=C(CC2=CN=C(NC(=O)C3=CC4=C(C=C3)C(=O)OC(C4)C5=CC=CC=C5)S2)C=C1	Sytravon	D136-0114	-2.19405168	-2.53402962	-1.16662998	-5.10514541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686699-01	S(-)-Verapamil hydrochloride hydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	36622-28-3 (anhydrous)				-12.1381760189	4	4		0	-3.48545861					COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1	SIGMA	V105	-2.07215992	-1.63513398	-4.43319392	-3.48545861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346504-07	Avagacestat	384568808	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1146699-66-2				-12.8392047555	4	4		0	-5.42729306				NOTCH1	NC(=O)[C@@H](CCC(F)(F)F)N(CC1=C(F)C=C(C=C1)C2=NOC=N2)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-50845	-1.13765643	-4.46879548	-3.94012767	-5.42729306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344564-03	NCGC00344564-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-19.3218616466	4	4		0	-0.12975391				AHR	COC1=CC=C(C=C1O)C/2=C/C(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Analyticon	NP-010617	-4.49374289	-3.79248352	-7.29473916	-0.12975391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00138593-02	NCGC00138593-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-49.3696439455	4	4		-13.54615642	-19.950783	0.0723600511	0.9967892367			ClC1=CC(=CC=C1)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CC(=O)NCC5=CC=C6OCOC6=C5)C(=O)N24	Chemdiv	K279-1495	-8.88184625	-8.60371544	-8.24565265	-19.950783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017338-03	Antimycin A	124883057	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1397-94-0	Antimycin A;ANTIMYCIN A1	3.5481338923	-5.45	-152.4917778662	4	4	Antimycin- A from Streptomyces sp.;Antimycin A1;NCGC00016578-01;9   Antimycin A (A3+A4 >90%);ANTIMYCIN A;ANTIMYCIN A (A1 shown);NCGC00142516-03;NCGC_Prestw-222;NCGC00095884-01;ANTIMYCIN A1;Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester;LS-86460;CIPLUS_155874;Antimycin A;NCGC00142516-02;CIPLUS_158270;	20.2725767561	-34.90432942	1	0.998605003			CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)C2=C(O)C(=CC=C2)NC=O)[C@@H](C)OC1=O	BIOMOL	NP-009	-36.09038768	-36.42130877	-24.11082814	-34.90432942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510794-01	KIN1408			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1903800-11-2		1.1220184543	-5.95	-175.6417052502	-1.3	4		-85.8851456814	-97.85292302	0.0756253802	0.9964560086			COC1=CC=C2SC(=NC2=C1)NC(C3=CC=C(OC(F)F)C=C3)C4=CC=C5C=CC=NC5=C4O	SIGMA	SML1866	-8.03398163	-26.40132094	-90.89751471	-97.85292302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163163-01	NCGC00163163-01	144205574		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	17479-19-5	Dihydroergocristine methanesulfonate; Brinerdine; Iskedyl; Chrystepin CH; Kristepin; Ersilan; Crystepin CH; Briserin; 	11.220184543	-4.95	-41.0433061254	-3	4	Dihydroergocristine methanesulfonate salt;Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19alpha)-, mixt. with (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)ergotaman-3',6',18-trione;Dihydroergocristine methanesulfonate;CIPLUS_751524;Iskedyl;CIPLUS_773547;Kristepin;NCGC00016137-01;CIPLUS_3884556;Dihydroergocristine;P 3007;Ersilan;CIPLUS_774402;NCGC00025380-01;NCGC00025380-02;dihydroergotoxine ethansulfonate;NCGC00023148-05;NCGC00023148-02;CIPLUS_740293;CIPLUS_684973;Dihydroergocristine mesylate;CIPLUS_3885160;Brinerdine;PF 50;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(phenylmethyl)-;DIHYDROERGOTOXINE-MESYLATE;LS-175603;Dihydroergotoxine mesylate;Crystepin CH;Chrystepin CH;Briserin;P-3007;CIPLUS_3884046;defluina;	-46.909467308	-44.74720358	0.0651035078	0.9973783211			CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]8(O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O)C(C)C	BIOMOL	BIOMOL_NS-108	-1.07264749	-3.6983135	-3.25335681	-44.74720358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111245-01	NCGC00111245-01	24385824		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-24.8267417677	4	4		0	-3.91498881					COC1=CC=CC(=C1)N2CCN(CC2)C(=O)C3CCCN(C3)[S+]([O-])(=O)C4=CC5=C(C=C4)N(C)C(=O)O5	Sytravon	C648-0080	-6.93970421	-1.05299204	-4.92626018	-3.91498881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484798-01	Anagliptin	363681178	Dipeptidyl peptidase IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	739366-20-2				-30.5184877075	4	4		0	-6.38409438					CC1=N[N]2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N	MedChem Express	HY-14877	-6.1849177	-7.6910017	-6.54854959	-6.38409438												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262306-24	ML323		USP1/UAF1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1572414-83-5				-9.546201696	4	4		0	6.07821717				USP1	CC(C)C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NCC3=CC=C(C=C3)[N]4C=CN=N4	MedChem Express	HY-17543	-3.66560296	-3.77758913	-2.98766719	6.07821717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402349-02	GN6958	363681035	Sentrin-specific protease 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1392278-32-8		10	-5	-38.2897930181	-3	4		-46.4432377729	-37.26621924	0.0254014877	0.999602236	29843	SENP1	CCOC(=O)C1=CC=CC(=C1)CNC2=CC=C(C=C2)N(C)C(=O)NC3=CC=CC=C3	Glixx	GLXC-02687	-1.04014302	-2.26864138	-8.86198547	-37.26621924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347890-01	NCGC00347890-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			7.9432823472	-5.1	-103.160297706	-2.4	4		-66.2442243435	-70.04474273	0.0561765088	0.9980490743			CC1=C(N=C(NC(=O)CC2=CC=C(C=C2)C(F)(F)F)S1)C3=CC=C4N(CCC4=C3)[S+]([O-])(=O)C5=CC=CC=C5C	NCGCChem	LLI015-018	-11.75849179	-8.92903005	-20.80123267	-70.04474273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421826-01	NCGC00421826-01	363681094		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-20.3087202989	4	4		0	-5.25727069					CN1CCCC1CCOC(C2=CC3=C([NH]2)C(=CC=N3)C(O)=O)C4=C(Cl)C=CC=C4	NCGCChem	GRB052-095	-3.46172599	-4.76842736	-6.01804975	-5.25727069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00396146-01	NCGC00396146-01	375804793		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-38.6759915249	4	4		0	-6					OC(=O)C1=CC=CC=C1C(=O)N[C@H]2CO[C@@H]3[C@H](CO[C@H]23)[N]4N=NN=C4OC5=CC=CC(=C5)N6CCOCC6	Analyticon	NAT6-299670	-9.96261986	-5.7443712	-6.77525864	-6												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	259793-96-9				-17.5768200111	4	4		0	-4.7114094					NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1	-3.03104177	-5.97551579	-3.05965221	-4.7114094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167465-07	Calcipotriol		Vitamin D receptor Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	112965-21-6		14.1253754462	-4.85	-18.8786303488	4	4		-36.392617448	-29.91051454	0.1472984797	0.9863914321			C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(CCC[C@]23C)=C\C=C/4C[C@@H](O)C[C@H](O)C4=C	MedChem Express	HY-10001	0.65008939	-0.85609109	3.45586617	-29.91051454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346531-06	Oligomycin A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	579-13-5		12.5892541179	-4.9	-121.5264545201	-3	4		-97.8810029832	-99.75529823	0.0392527652	0.9990485247			[H][C@@]1(C)[C@@H]2CC[C@@H](CC)\C=C/C=C\C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@]([H])(O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)\C=C\C(=O)O[C@H]1[C@H](C)[C@@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)O2	APExBIO	A5588	-12.8191132	-9.62648557	-10.73475769	-99.75529823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346836-01	NCGC00346836-01	174006487		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1227911-45-6	GSK-2334470	11.220184543	-4.95	-107.1848577832	-3	4		-84.2793643329	-79.72706935	0.0249981337	0.9996144437	5170	PDPK1	CNC1=NC(=CC(=N1)C2=CC3=C(C=C2)C(=N[NH]3)N)N4C[C@H](CC[C@H]4C)C(=O)NC5CCCCC5	SIGMA	SML0217	-10.56395254	-12.1136889	-17.38498789	-79.72706935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016872-19	Ticlopidine hydrochloride	384567964	P2Y12 (P2T) Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	53885-35-1				-19.8641232587	4	4		0	-10.14317673				P2RY12	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1	MedChem Express	HY-B0153A	-2.87664554	-5.0338156	-2.02949593	-10.14317673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016012-08	Triflupromazine hydrochloride	124881619	Muscarinic acetylcholine receptor M2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			12.5892541179	-4.9	-71.6739293902	-3	4	Triflupromazinum;NCGC00094410-03;triflupromazinum;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-;Triflupromazine Hcl;NCGC00094410-02;NCGC00094410-01;CIPLUS_208142;Triflupromazine Hydrochloride;NCGC_Prestw-53;Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-, monohydrochloride;Trifluopromazine;NCGC00016012-02;NCGC00016012-01;NCGC00024300-04;Triflupromazina;TRIFLUPROMAZINE HYDROCHLORIDE;TRIFLUPROMAZINE;TRIFLUPROMAZINE MALEATE;trifluopromazine;Triflupromazine;LS-105501;Vesprin;Triflupromazine hydrochloride;LS-105500;10-3-(DIMETHYLAMINO)PROPYL-2-(TRIFLUOROMETHYL)PHENOTHIAZINE;triflupromazine;Vesprin hydrochloride;10-(3-(DIMETHYLAMINO)PROPYL)-2-(TRIFLUOROMETHYL)PHENOTHIAZINE MONOHYDROCHLORIDE;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-, MONOHYDROCHLORIDE;CIPLUS_170810;10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-;CIPLUS_152129;	-54.1480778121	-53.54162115	0.0849927245	0.9955201492	1129	CHRM2	CN(C)CCCN1C2=C(SC3=C1C=C(C=C3)C(F)(F)F)C=CC=C2	SIGMA	T-2896	-8.87218677	-5.08488964	-7.79051589	-53.54162115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163460-03	Leupeptin, Microbial			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	103476-89-7				-35.7281642132	4	4		0	-6.20930741					[H]C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O	APExBIO	A2570	-7.73849513	-7.99660441	-8.20739969	-6.20930741												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00538156-01	NCGC00538156-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-10.1876027681	4	4		0	-3.28162552					CN(C)C1=C2C=CC=C(C2=CC=C1)[S+]([O-])(=O)NC3=CC=C(NC(=O)C(C)(C)CO)C=C3	Pharmaron	PH-NIH-2017-009-L2-56-0	-2.01965065	-0.53480475	-3.15268369	-3.28162552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346399-01	NCGC00346399-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.8334345027	4	4		0	-5.44519016					CC1=CC=CC=C1C(=O)N2CCC3=CC(=CC=C23)N4CCCC(C4)NC(=O)CC5=CC=CC=C5	NCGCChem	LLI13-090	-7.35413619	-9.50261108	-9.07329958	-5.44519016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106733-02	NCGC00106733-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-46.5996870204	4	4		0	-6.52796421					CC1=CC=C(CNC(=O)C2=CC=C(CN3C(=O)N(CC(=O)NC4=C(C)C=C(C)C=C4C)C5=CC=CC=C5C3=O)C=C2)C=C1	Chemdiv	C260-2768	-9.45067447	-12.60166082	-12.55998239	-6.52796421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386343-01	PI-1840	363680225	26S proteosome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1401223-22-0				-21.6331202892	4	4		0	-8.83079094					CCCC1=CC=C(OCC(=O)N(CC2=NC(=NO2)C3=CC=CN=C3)C(C)C)C=C1	Selleck	S7462	-3.56634611	-5.94420787	-2.53359094	-8.83079094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092314-15	Triciribine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	35943-35-2				-33.1597678281	4	4		0	-3.08935984					CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)C3O)C4=C2C1=NC=N4	MedChem Express	HY-15457	-8.6790393	-5.21222411	-7.21730068	-3.08935984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163432-05	Calpeptin		Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	117591-20-5				-17.7944441873	4	4		0	-0.38890103					CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Cayman	14593	-3.74958011	-4.47368421	-6.86989752	-0.38890103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016441-03	(Z)-Capsaicin	124882263		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	25775-90-0				-23.8993906973	4	4	TRPV Cation Channels;CAPSAICIN (E);Zucapsaicin;LS-96940;Cation Channels, TRP;Zostrix;6-nonenamide, 8-methyl-n-vanillyl-, (z)- (8ci);CAPSAICIN (Z)-;TRANS-8-METHYL-N-VANILLYL-6-NONENAMIDE;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-;Z-Capsaicin;Receptors, Vanilloi;zucapsaicin;CIS-CAPSAICIN;LS-2138;CIPLUS_213626;Capsaicin;CIPLUS_153053;8-Methyl-N-vanillyl-trans-6-nonenamide;Vanilloid Receptors;NCGC_Prestw-879;TRPV1 protein, mouse;capsaicin;AB07930300-01;civamide;Channels, TRPV Catio;NCGC00016441-01;transient receptor potential cation channel V1, mouse;capsaicin receptor, mouse;NCGC00090853-02;CAPSAICIN;Receptors, Capsaici;CAPSAICIN OLEORESIN;CIS-8-METHYL-N-VANILLYL-6-NONENAMIDE;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (Z)-;N-1107;transient receptor potential cation channel, subfamily V, member 1 protein, mouse;zucapsaicinum;ZUCAPSAICIN;NCGC00024601-01;NCGC00024601-02;vanilloid receptor 1 receptor, mouse;Capsaicin Receptors;NCGC00090853-03;CIVAMIDE;E-CAPSAICIN;NCGC00090853-07;NCGC00090853-08;trans-n-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide;	0	-6.44526983					COC1=C(O)C=CC(CNC(=O)CCCC\C=C/C(C)C)=C1	Tocris	Tocris-0463	-4.54736312	-5.07640068	-5.61056106	-6.44526983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015989-22	Thalidomide	384567913	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	50-35-1				-25.1190587483	4	4		0	-6.59994709				TNF	O=C1CCC(N2C(=O)C3=C(C=CC=C3)C2=O)C(=O)N1	Microsource	01503607	-4.71344172	-8.16894064	-3.49082287	-6.59994709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168771-04	Fosamprenavir Calcium Salt			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	226700-81-8				-24.400402132	4	4		0	-5.02160303					CC(C)CN(C[C@@H](OP([O-])([O-])=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	APExBIO	A3421	-4.27357799	-6.4221778	-7.50417142	-5.02160303												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096023-03	3,4 -DIHYDROXYFLAVONE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	14919-49-4		11.220184543	-4.95	-48.2177301471	-3	4		-34.425972972	-32.06904086	0.184269629	0.9784908125			OC1=CC=C(C=C1)C/2=C(O)/C(=O)C3=C(O2)C=CC=C3	Microsource	01505138	-6.93231441	-2.13073005	-7.23467084	-32.06904086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378617-04	XL 413 hydrochloride	384569057	Serine/threonine-protein kinase PIM1  Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[1169562-71-3]				-31.972216905	4	4		0	-11.17325759					ClC1=CC=C2OC3=C(\N=C(NC3=O)\[C@@H]4CCCN4)C2=C1	Tocris	5493	-5.29475983	-4.58404075	-9.86624978	-11.17325759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165733-10	Apicidin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	183506-66-3		1	-6	-202.9585738706	-1.1	4		-86.2130524438	-99.47535491	0.008843823	0.9999517592			CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=C[N](OC)C3=CC=CC=C23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O	Enzo	GR-340	-13.71771098	-34.5876423	-99.29305348	-99.47535491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164524-02	D-Glucuronolactone	50111689		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox		Glucuronolactone; D-Glucurone; D-Glucurono-6,3-lactone; 			-33.7176014324	4	4	NCGC00164524-01;mannurono-gamma-lactone;D-(+)-Glucurono-6,3-lactone;GLUCUROLACTONE;GLUCURONOLACTONE, D-;CIPLUS_672794;D-Glucurone;D-Glucurono-6,3-lactone;Glucurolactone;CIPLUS_149024;mannuronolactone;D-(+)-Glucuronic acid gamma-lactone;Glucuronolactone;D(+)-Glucuronic acid gamma-lactone;	0	-7.48170355					[H][C@]1(O)C(O)O[C@]2([H])[C@]([H])(O)C(=O)O[C@]12[H]	Labotest	LT03210628	-5.80016387	-10.82819154	-8.94441029	-7.48170355												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00386235-06	Cobicistat		Cytochrome P450 3A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1004316-88-4				-37.1611975452	4	4		0	-11.59950622					CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	Cayman	13433	-6.58501876	-8.63822021	-8.06621586	-11.59950622												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346435-07	Niraparib	384568775	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1038915-60-4		10	-5	-44.5212894182	4	4		-23.514111996	-23.2827793	0.2739215002	0.9509240609		PARP1	NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	MedChem Express	HY-10619	-4.93768597	-9.6810637	-11.07842276	-23.2827793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263598-10	Chidamide		Histone deacetylase 8 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	743420-02-2		8.9125093813	-5.05	-39.6649884886	4	4		-18.819119772	-21.38081713	0.106015195	0.9930407579			NC1=C(NC(=O)C2=CC=C(CNC(=O)/C=C/C3=CN=CC=C3)C=C2)C=C(F)C=C1	MedChem Express	HY-13592	-5.83221364	-4.44821732	-8.12923398	-21.38081713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166236-04	Oxonic acid potassium salt			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2207-75-2				-40.8898320819	4	4		0	-8.59514966					OC1=NC(=NC(O)=N1)C([O-])=O	SIGMA	156124	-8.17517635	-8.37011885	-10.89108911	-8.59514966												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00169713-02	Oxyresveratrol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-44.6748761756	4	4		0	-10.02840288					OC1=CC(=C(C=C1)\C=C\C2=CC(=CC(=C2)O)O)O	Analyticon	NP-003143	-10.58532079	-6.4770798	-8.04238319	-10.02840288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379057-02	TMC353121		Respiratory syncytial virus Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	857066-90-1		10	-5	-71.5684084882	-3	4		-60.0939153167	-63.69674459	0.0240140158	0.9996442519			CC1=CC=C(CCCO)C(=C1)NCC2=CC=C3N=C(NCCCN4CCOCC4)[N](CC5=NC(=CC=C5O)C)C3=C2	MedChem Express	HY-11097	-6.31928116	-5.01697793	-6.17509119	-63.69674459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165783-04	Vadimezan		Interferon Inducer	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	117570-53-3				1.0640715341	4	4		0	-2.82602945					CC1=C(C)C2=C(C=C1)C(=O)C3=C(O2)C(=CC=C3)CC(O)=O	APExBIO	A8233	1.78964164	0.46058921	-2.45455344	-2.82602945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263617-13	M-344	384568694	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	251456-60-7		2.8183829313	-5.55	-177.2145458831	-1.3	4		-82.4928169988	-99.6067293	0.0984053953	0.993979821		HDAC1	CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-13506	-13.09623782	-22.74193548	-76.43738058	-99.6067293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168108-06	AG-14361		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	328543-09-5		8.9125093813	-5.05	-23.3912056982	4	4		-15.058078872	-13.80389736	0.0334727918	0.9993167995		PARP1	CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3[N]2CCNC4=O	APExBIO	A4158	-2.5054983	-3.28495698	-6.26591727	-13.80389736												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346519-03	Teicoplanin		glycopeptide antibiotic	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-14.2449439867	4	4		0	-1.24768539					CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	MedChem Express	HY-A0097	-4.06658329	-3.75423655	-0.43470624	-1.24768539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168703-01	NCGC00168703-01	85736125		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-26.3742080821	4	4		10.280594828	2.4295302	0.4628835977	0.8414140954			FC(F)(F)C1=CC=C(C=C1)C(=O)NCC(=O)OC(C(=O)NC2=CC(=CC=C2Cl)C(F)(F)F)C3=CC=CC=C3	NCGCChem	DJM02-036-B5	-8.15049569	-3.65550895	-6.8985252	2.4295302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-13.54653429	4	4		0	-4.17511683					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019	-1.36702747	-5.57921265	-4.34267147	-4.17511683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167356-14	Raltegravir Potassium		Human immunodeficiency virus type 1 integrase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	871038-72-1				-34.2215124867	4	4		0	-7.06727802					CN1C(=O)\C(=C(/N=C1/C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-]	Glixx	GLXC-90403	-6.98175859	-8.71643348	-7.17923948	-7.06727802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390668-02	(±)-BI-D			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1416258-16-6				-24.9838726772	4	4		0	-5.89454193					CC1=NC2=C(C=CC=C2)C(=C1C(OC(C)(C)C)C(O)=O)C3=CC4=C(OCCC4)C=C3	MedChem Express	HY-18601	-4.41157445	-6.96098027	-6.36251866	-5.89454193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137632-01	NCGC00137632-01	24413015		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-46.4962687868	4	4		0	-12.74720358					FC1=C(CNC(=O)C2CCN(CC2)CC3=CC4=CC=CC=C4[N]3CC5=CC(=CC=C5)Cl)C=CC=C1	Sytravon	G907-0444	-7.92296441	-9.57965928	-14.36495708	-12.74720358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398321-01	NCGC00398321-01	375805750		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-31.2105061395	4	4		0	-3.11856823					[O-][S+](=O)(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)[N]3N=NN=C3OC4=CC=C(C=C4)[N]5C=CN=C5)C6=CC7=CC=CC=C7C=C6	Analyticon	NAT6-298644	-7.38664066	-7.98732985	-6.34382567	-3.11856823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356145-10	CB-839	384569029	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1439399-58-2		0.3548133892	-6.45	-102.037211374	-1.2	4		-40.8952798008	-37.85821356	0.0171954712	0.999818035		GLS	FC(F)(F)OC1=CC=CC(=C1)CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=CC=CC=N4)S3)C=C2	MedChem Express	HY-12248	-12.49299237	-25.40192926	-34.45595855	-37.85821356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483210-07	NCGC00483210-07			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			0.3981071706	-6.4	-232.5124956472	-1.3	4		-93.8921707405	-97.4541387	0.0842657015	0.9955953347			CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049	-18.19437673	-72.28833148	-89.68082765	-97.4541387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168776-10	Delavirdine (mesylate)		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	147221-93-0				-13.5954152407	4	4		0	-8.2664668					CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C([NH]3)C=CC(=C4)N[S+](C)([O-])=O	MedChem Express	HY-10571A	0.04743628	-7.06526462	-3.71915342	-8.2664668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013216-05	2,3-Dimercapto-1-propanol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	59-52-9				-6.4203838062	4	4		0	0.32184111					OC[C@H](S)CS	SIGMA	D1129	-1.84139031	-1.16450856	-1.63783262	0.32184111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378687-03	Verbascoside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	61276-17-3				-13.6186282004	4	4		0	-5.55947447					C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(=C(O)C=C3)O)O[C@H](CO)[C@H]2OC(=O)\C=C\C4=CC(=C(O)C=C4)O)[C@H](O)[C@H](O)[C@H]1O	MedChem Express	HY-N0021	-2.67799388	-4.07577996	0.32054097	-5.55947447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00393868-01	NCGC00393868-01	375809842		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-42.6765476134	4	4		0	-6.15212528					CN(C)C1=CC=CC(=C1)OC2=NN=N[N]2[C@H]3CO[C@@H]4[C@H](CO[C@H]34)NC(=O)NC5=CC=CC6=CC=CC=C56	Analyticon	NAT6-298297	-11.04339347	-6.94289872	-7.1890821	-6.15212528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126637-01	NCGC00126637-01	24402020		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-47.944154739	4	4		0	-15.34228188					CC1=CC=C(CNC(=O)C2=CC3=C(NC(C[S+]([O-])(=O)CC4=CC=CC(=C4)F)C(=O)N3)C=C2)C=C1	Sytravon	K977-0077	-9.00373801	-10.61552949	-8.67708563	-15.34228188												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017115-04	Thiethylperazine Malate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	52239-63-1		12.5892541179	-4.9	-100.6564163229	-3	4		-100.9360558453	-98.96644295	0.0293742401	0.9994674593			CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN4CCN(C)CC4)C=C1	USP	1657005	-6.36274988	-8.45817995	-6.47589698	-98.96644295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346662-06	Geniposide		P2Y purinoceptor 14 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	24512-63-8				-32.6601191217	4	4		0	-9.77427035			171108	P2ry14	COC(=O)C/1=C/O[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]\3[C@@H]1C\C=C3CO	Glixx	GLXC-06546	-5.3775497	-8.39489007	-8.2330728	-9.77427035												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356069-06	GSK1324726A		Bromodomain-containing protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1300031-52-0		0.0794328235	-7.1	-353.0461243308	-1.3	4		-87.6107043175	-94.47579579	0.0567143882	0.9980139372	23476	BRD4	C[C@H]1C[C@@H](NC2=CC=C(Cl)C=C2)C3=C(C=CC(=C3)C4=CC=C(C=C4)C(O)=O)N1C(C)=O	MedChem Express	HY-13960	-62.83582733	-83.72295125	-90.78334943	-94.47579579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115604-01	NCGC00115604-01	24390183		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-41.9882314286	4	4		0	-11.68232662					CC1=CC2=C(OC(=C2C)C(=O)N(CC3=CC(=CC=C3)F)C4CC[S+]([O-])(=O)C4)C=C1	Sytravon	D076-0310	-10.17389891	-9.63102474	-0.77922078	-11.68232662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347888-01	NCGC00347888-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-38.471478499	4	4		-13.9667600401	-18.26845638	0.3148095602	0.9340595963			CC1=C(N=C(NC(=O)CC2=CC(=CC=C2)C(F)(F)F)S1)C3=CC=C4N(CCC4=C3)[S+]([O-])(=O)C5=CC=CC=C5C	NCGCChem	LLI015-016	-5.37948968	-8.99751734	-6.85450143	-18.26845638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095169-07	Miltefosine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	58066-85-6		1.1220184543	-5.95	-34.1416022269	4	4		-22.681341496	-21.81778458	0.0630945692	0.9975436071			CCCCCCCCCCCCCCCCO[P]([O-])(=O)OCC[N+](C)(C)C	Selleck	S3056	-0.10497145	1.00169779	-4.42070523	-21.81778458												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00345492-06	PCI-34051	384568736	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	950762-95-5		8.9125093813	-5.05	-71.1050910846	-2.2	4		-60.1661331684	-56.63535067	0.0410920866	0.9989575401		HDAC8	COC1=CC=C(C[N]2C=CC3=C2C=C(C=C3)C(=O)NO)C=C1	Selleck	S2012	-6.22690628	-4.66044143	-13.75716519	-56.63535067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016055-11	Trimethoprim	124881736	Bacterial dihydrofolate reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-30.6014381834	4	4	trimet;tridoxine;LS-31253;sulfaton;CIPLUS_751110;CN-3123;2,4-PYRIMIDINEDIAMINE, 5-((3,4,5-TRIMETHOXYPHENYL)METHYL)-, MONOHYDROCHLORIDE;kelfiprim;Proloprim;trimethoprim sulfamethizole;2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine;TRIMETHOPRIM LACTATE;syraprim;WHO NO. 1047;co-trimazine;berlocombin;NCGC_Prestw-208;cotrifamol;2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE SULFATE;Quam;Borgal;potrox;HS_1413;SULFAMETHOXAZOLE;LS-175750;CIPLUS_3886364;Trimethoprim-Sulfamethoxazole Combination;co-trifamole;Trimethoprim Sulfate;Benzenesulfonamide, 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;trimithoprime;Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;BACTRIM;sulfamoxole and trimethoprim;Trimethoprimum;TRIMETHOPRIM HYDROCHLORIDE;Co-soltrim;Tribrissen;CIPLUS_167341;Potesept;CIPLUS_732710;lidaprim;Trimethoprim sulfate;Trimethoprim lactate;CIPLUS_3883816;Supristol;trimerazine;CIPLUS_206865;CIPLUS_206866;CIPLUS_206868;CIPLUS_206867;CIPLUS_206869;benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;trimethoprim-sulfadiazine mixture;TRIMETHOPRIM SULFATE;NCGC00024707-08;sulfatroxazole-trimethoprim combination;LS-178642;BW-72U;NCGC00024707-06;NCGC00024707-04;Trimpex;NCGC00024707-05;NCGC00024707-01;cotrifamole;CIPLUS_206870;CIPLUS_156267;CIPLUS_206871;CIPLUS_206872;Trimetoprima;Trimethoprime;Trimethoprim;Co-trimadine;4-amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, mixt. with 5-((3,4,5-trimethoxyphenyl)meth yl)-2,4-pyrimidinediamine;LS-178650;2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-;Ditrim;Diaziprim Forte;PHENAZOPYRIDINE HYDROCHLORIDE;LS-1627;trimethoprimum;trimethoprim-sulfadoxine;SEPTRA;CIPLUS_740266;NCGC00016055-02;CN 3123;NCGC00016055-01;sulfadiazine-trimethoprim mixture;TRIMETHOPRIM;Linaris;BISPORIN;LS-2191;CIPLUS_748857;Poteseptyl;Bactrim;Triglobe;AB07944729-01;Ro 6-2153;	0	-5.95586629					COC1=CC(=CC(=C1OC)OC)CC2=C(N)N=C(N)N=C2	SIGMA	T7883	-6.3444743	-7.58913413	-6.64408546	-5.95586629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134078-01	NCGC00134078-01	24409461		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-49.0160583865	4	4		-15.5948783201	-19.31543624	0.5355056216	0.7687700515			COC1=C(C=CC=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0766	-10.28766455	-8.48386268	-3.40303764	-19.31543624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00121463-01	NCGC00121463-01	24396042		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-100.6700051492	-3	4		-89.1960713087	-88.63982103	0.0417737553	0.9989222406			CCC1CN(C(=O)N2CCC(CC2)C(=O)N3CCN(CC3)C4=CC=CC(=C4C)C)C5=CC=CC=C5O1	Sytravon	E216-5396	-9.58069235	-7.49079702	-6.74884438	-88.63982103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482516-02	Ginsenoside Rb2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	11021-13-9				-36.8055467777	4	4		0	-9.16585839					CC(C)=CCC[C@](C)(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0040	-5.90366122	-11.25401929	-8.6282603	-9.16585839												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00387769-02	Gardiquimod	363680656	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1020412-43-4				-26.5679842804	4	4		0	-5.82997763			51284	TLR7	CCNCC1=NC2=C([N]1CC(C)(C)O)C3=C(C=CC=C3)N=C2N	Bio Vision	2002	-5.25759792	-5.59027481	-6.97776799	-5.82997763												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263625-09	AnacardicAcid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	16611-84-0		14.1253754462	-4.85	-11.8391555532	4	4		-35.669543372	-26.80795281	0.2503417028	0.9592886101			CCCCCCCCCCCCCCCC1=C(C(O)=O)C(=CC=C1)O	Bio Vision	1849	0.54165267	2.04584041	7.7036651	-26.80795281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346692-04	CUDC-907		PI3K Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1339928-25-4		0.1	-7	-458.5288835543	5	4		-33.985013032	-99.52807516	0.0350994178	0.9993071826		PIK3CA	COC1=CC=C(C=N1)C2=NC3=C(SC(=C3)CN(C)C4=NC=C(C=N4)C(=O)NO)C(=N2)N5CCOCC5	Selleck	S2759	-95.89771582	-99.59252971	-99.63522668	-99.52807516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00138198-01	NCGC00138198-01	24413581		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-36.8530149809	4	4		0	-3.29753915					CCOC(=O)C1=C(NC(=O)C2=N[N]3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C(OC)C=C4)SC(=C1C)C	Sytravon	K061-0044	-9.15000813	-6.61758411	-9.15254237	-3.29753915												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346743-03	Givinostat hydrochloride	384568939	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			1.77827941	-5.75	-195.9538808015	-1.1	4		-81.9204867817	-99.54809843	0.02664233	0.9995619652		HDAC1	CCN(CC)CC1=CC2=C(C=C1)C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=C2	Bio Vision	9431-5	-15.94344222	-20.57186885	-95.0781422	-99.54809843												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111269-02	NCGC00111269-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-36.1757824311	4	4		-12.0366945519	-16.72035794	0.465457465	0.8386403019			CN1C(=O)OC2=C1C=CC(=C2)[S+]([O-])(=O)N3CCCC(C3)C(=O)N4CCN(CC4)C5=CC=CC(=C5C)C	Chemdiv	C648-0100	-5.21696733	-9.79368205	-5.02311248	-16.72035794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390429-01	Isoxanthohumol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	70872-29-6				-29.3484861336	4	4		0	-13.5503605					COC1=CC(=C(CC=C(C)C)C2=C1C(=O)CC(O2)C3=CC=C(O)C=C3)O	Bio Vision	2529	-4.36261337	-4.87266553	-6.68751086	-13.5503605												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188640-01	NCGC00188640-01	124899261		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-38.1143006467	4	4		0	-10.01092419					C[C@@H](NC(=O)C1=CC(N)=CC=C1C)C2=CC=CC3=CC=CC=C23	Acesys	A9608	-7.38579106	-7.79286927	-10.17891263	-10.01092419												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00163450-06	Ilomastat (GM6001, Galardin)	384568240	MMP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	142880-36-2				-39.5320697057	4	4		0	-12.01223509				MMP1	CNC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC(C)C)CC(=O)NO	Selleck	S7157	-6.43684918	-9.24448217	-10.95188466	-12.01223509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094047-16	Ivermectin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	70288-86-7		10	-5	-92.1164987748	-2.1	4		-118.6106333914	-99.7360179	0.012992293	0.999895877			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1	-2.29156509	-2.22583683	-14.54105217	-99.7360179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133197-01	NCGC00133197-01	24408580		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-76.9988264274	-3	4		-66.2764716535	-66.31319911	0.0219997846	0.9997014457			O=C(NCCCN1CCN(CC1)C2=CC=CC=C2)C3=CC=C4N=C(CC5=CC=CC=C5)OC4=C3	Sytravon	G706-0942	-6.51714611	-7.67913706	-7.76139115	-66.31319911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00125765-01	NCGC00125765-01	24401148		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-43.8175745721	4	4		-9.5238084481	-15.5212528	0.4642759655	0.8406682376			ClC1=CC(=CC=C1)NC(=O)CN2C(=O)N(CC3=NC(=NO3)C4=CC=CC=C4)C(=O)C5=CC=CC=C25	Sytravon	E842-0147	-8.84121567	-8.70644637	-5.08474576	-15.5212528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106729-01	NCGC00106729-01	24270074		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-44.5863385012	4	4		0	-10.96644295					CC1=CC=C(CNC(=O)C2=CC=C(CN3C(=O)N(CC(=O)NC4=CC=C(C)C=C4)C5=CC=CC=C5C3=O)C=C2)C=C1	Sytravon	C260-2754	-9.45880059	-8.75781183	-8.74752366	-10.96644295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485876-01	Nucleoside-Analog-1			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	876707-99-2				-20.5581734965	4	4		0	-1.76097881					OC[C@]1(O[C@@H]2[C@@H](OC\3=N\C(=O)\C=C/N23)[C@@H]1O)N=[N+]=[N-]	MedChem Express	HY-77651	-4.37101108	-4.12563667	-7.43442765	-1.76097881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178332-02	Genkwanin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	437-64-9				-14.9236201644	4	4		0	-0.75615213					COC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC=C(O)C=C3	DC Chemicals	DCY-091	-4.5912563	-2.92783152	-0.84085406	-0.75615213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015520-13	Hydroxyurea	384567861	Ribonucleoside-Diphosphate Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	127-07-1				-9.9269317169	4	4		0	-1.92841163				RRM1	NC(=O)NO	Selleck	S1896	-2.53534861	-3.92089718	1.04336342	-1.92841163												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399716-01	NCGC00399716-01	375799743		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-27.6368834084	4	4		0	-5.80313199					C[N]1N=C(C=C1[C@H]2CN3CC[C@H]2C[C@@H]3COC(=O)NC4=CC(=CC=C4)C(F)(F)F)C5=CC=CS5	Analyticon	NAT13-331659	-7.25662279	-3.89521445	-2.92758089	-5.80313199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262641-04	S31-201	384568576	STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	501919-59-1				-44.789306379	4	4		0	-8.36792659				STAT3	CC1=CC=C(C=C1)[S+]([O-])(=O)OCC(=O)NC2=CC=C(C(O)=O)C(=C2)O	Selleck	S1155	-9.72035606	-10.56027165	-9.05853743	-8.36792659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408803-01	Bicyclol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	118159-48-1				-27.5500339017	4	4		0	-1.16670308					COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3CO)OC	Glixx	GLXC-06162	-7.52015452	-5.91680815	-4.77679347	-1.16670308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482457-02	KDM5A-IN-1	363681129	Lysine-specific demethylase 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1905481-36-8				-32.1583122393	4	4		0	-4.1574817					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@H](C2)NC(=O)C3CC3	MedChem Express	HY-100014	-7.71486481	-7.70835144	-5.66874506	-4.1574817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015099-12	Alprenolol hydrochloride		Beta-adrenergic receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[13707-88-5]				-25.3714260508	4	4		0	-5.07319205					CC(C)NCC(O)COC1=C(CC=C)C=CC=C1	Tocris	2806	-5.84061135	-5.29711375	-4.23831857	-5.07319205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161602-07	Doxycycline		Matrix Metalloproteinase (MMP) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[1293992-19-4]				-23.3823482397	4	4		0	-9.43412716				MMP1	C[C@@H]1[C@H]\2[C@H](O)[C@H]3[C@H](N(C)C)\C(=C(C(N)=O)/C(=O)[C@@]3(O)\C(=C2C(=O)C4=C(O)C=CC=C14)O)O	Tocris	4090	-2.97699026	-5.29711375	-7.19124544	-9.43412716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00411883-01	NCGC00411883-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-11.8684345504	4	4		0	-7.476513					COCCNC(=O)NC1=CC2=C(C=C1)N=C(C3=CC=CS3)C(=N2)C4=CC=CS4	NCGCChem	MLS000534714-02pur	-2.93500168	-0.02546689	1.76307104	-7.476513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346498-06	Danoprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	850876-88-9				-16.7704155953	4	4		0	-5.09214355					CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(F)=CC=C5)C(=O)N[S+]([O-])(=O)C6CC6	MedChem Express	HY-10238	-2.56587175	-4.90136439	-4.27241591	-5.09214355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091023-07	CETYLPYRIDINIUM CHLORIDE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	6004-24-6, 123-03-5 [anhydrous]		11.220184543	-4.95	-106.6384504912	-2.1	4		-123.0239589246	-99.73988184	0.0360252846	0.9991987162			CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1	Microsource	MS-01500169	-4.78243995	-8.47310333	-19.96575042	-99.73988184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095133-09	Famciclovir	384568149	antiviral	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	104227-87-4				-28.4391848206	4	4		0	-5.78873115					CC(=O)OCC(CC[N]1C=NC2=CN=C(N)N=C12)COC(C)=O	APExBIO	B1942	-5.01530898	-8.93369253	-7.24071309	-5.78873115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186460-07	Bardoxolone methyl		NF-kappaB signaling Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	218600-53-4		0.316227766	-6.5	-212.288701579	-1.1	4		-104.0949180656	-99.89512781	0.0052140061	0.9999832322		NFKB1	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)\C=C\4[C@@](C)(CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)[C@]3(C)CC2	Adooq	A11323	0.58364125	-99.19354839	-99.8349835	-99.89512781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510317-02	Elbasvir		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1370468-36-2				-10.222444621	4	4		0	-2.70482849					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C4C(=C3)O[C@H]([N]5C6=C(C=C(C=C6)C7=CN=C([NH]7)[C@@H]8CCCN8C(=O)[C@@H](NC(=O)OC)C(C)C)C=C45)C9=CC=CC=C9	MedChem Express	HY-15789	0.70960699	-5.86587436	-8.45926698	-2.70482849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167959-12	(+)-Chelidonine		microtubule polymerization Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	476-32-4		1	-6	-61.000009828	-1.4	4		-37.7422329063	-39.57614158	0.1139037603	0.9919178318			CN1CC2=C(C=CC3=C2OCO3)[C@H]4[C@@H](O)CC5=CC6=C(OCO6)C=C5[C@@H]14	Enzo	NP050	0.16375546	-10.29711375	-35.2527358	-39.57614158												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00537955-01	GSK2838232			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1443460-91-0		2.8183829313	-5.55	-46.4322941661	-1.2	4		-46.9170417279	-44.2254752	0.032243788	0.9993584827			CC(C)\C1=C2/[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)CC6=CC=C(Cl)C=C6	DC Chemicals	LL-510	3.75797783	2.02037351	-34.88796248	-44.2254752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386258-01	Deoxyarbutin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	53936-56-4				-33.1898851277	4	4		0	-2.04937732					OC1=CC=C(OC2CCCCO2)C=C1	Selleck	S4132	-8.43550554	-6.17147708	-8.30293556	-2.04937732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095095-04	SENNOSIDE A		Helv Chim Acta 33: 313 (1950)	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	81-27-6				-31.2947573223	4	4		0	-13.77744467					[H][C@@]1(C2=CC(=CC(O)=C2C(=O)C3=C1C=CC=C3O[C@@H]4OC(CO)C(O)C(O)C4O)C(O)=O)[C@@]5([H])C6=CC(=CC(O)=C6C(=O)C7=C5C=CC=C7O[C@@H]8OC(CO)C(O)C(O)C8O)C(O)=O	Microsource	MS-01504078	-4.7220665	-7.7170418	-5.07157285	-13.77744467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345799-06	Oprozomib	384568748	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	935888-69-0		0.316227766	-6.5	-256.7715341343	-1.1	4		-91.8837152129	-98.72586192	0.029274072	0.9994711306		PSMD1	COC[C@H](NC(=O)[C@H](COC)NC(=O)C1=CN=C(C)S1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@@]3(C)CO3	MedChem Express	HY-12113	-20.71240674	-89.48466151	-96.63212435	-98.72586192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018100-16	Fasudil hydrochloride	384567990	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	105628-07-7				-22.8152422882	4	4		0	-5.70937307				ROCK1	[O-][S+](=O)(N1CCCNCC1)C2=C3C=CN=CC3=CC=C2	MedChem Express	HY-10341	-4.1442063	-5.72694881	-5.66874506	-5.70937307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386330-03	Z-FA-FMK			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	197855-65-5				-18.3825475459	4	4		0	-3.08173882					C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)CF	DC Chemicals	DC7567	-4.31670188	-3.18067263	-4.0528673	-3.08173882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263531-05	Linezolid		50S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	165800-03-3				-11.9032238799	4	4		0	-1.96198383				MAOA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Selleck	S1408	-3.59002351	-1.0950764	-0.72086156	-1.96198383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183867-02	Aloin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1415-73-2				-35.2537506641	4	4		0	-6.14813196					[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@]2([H])C3=C(C(O)=CC=C3)C(=O)C4=C2C=C(CO)C=C4O	APExBIO	N2491	-8.69583473	-5.11035654	-6.98280354	-6.14813196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379085-03	Kaempferide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	491-54-3				-34.5111216764	4	4		0	-6.85601923					COC1=CC=C(C=C1)/C2=C(O)/C(=O)C3=C(O)C=C(O)C=C3O2	MedChem Express	HY-15449	-7.10866644	-6.17996604	-9.89230502	-6.85601923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379064-01	R-7128	377020456		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	940908-79-2				-3.3806978025	4	4		0	1.50339476					CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240	-2.24675493	2.19866168	-0.43470624	1.50339476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247029-06	2-Deoxyglucose		sugar	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	154-17-6				-20.2426543386	4	4		0	-6.0268054					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	MedChem Express	HY-13966	-3.99758506	-4.69279569	-3.21858259	-6.0268054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371133-07	Atglistatin	363678049	Patatin-like phospholipase domain-containing protein 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1469924-27-3				-23.8809730264	4	4		0	-6.37069042			57104	PNPLA2	CN(C)C(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)N(C)C	Glixx	GLXC-04086	-3.16960628	-7.77787434	-7.99596031	-6.37069042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164557-06	Eprosartan (mesylate)	363676634	urate transport Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	144143-96-4				-22.5281137676	4	4		0	-6.15906887					CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O	MedChem Express	HY-15834A	-4.16145586	-6.31789346	-4.12312286	-6.15906887												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091011-20	CHLORAMPHENICOL			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	56-75-7				2.5831626165	4	4		0	-0.25130059					OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Microsource	MS-01500174	0.49592479	-0.51273138	2.6653201	-0.25130059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168902-03	Hyperoside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-17.6560547639	4	4		0	-4.333833					OC[C@H]1O[C@@H](O\C2=C(\OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC(=C(O)C=C4)O)[C@H](O)[C@@H](O)[C@H]1O	Analyticon	NP-001009	-4.10108241	-2.44199183	-3.20101871	-4.333833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016508-03	Methazolamide		Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	554-57-4				-34.3901430815	4	4		0	-5.71819064					CN/1\N=C(/SC1=N\C(C)=O)[S+](N)([O-])=O	MedChem Express	HY-B0553	-7.33537453	-9.85487095	-6.43277422	-5.71819064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386028-03	BAICALIN		prolyl endopeptidase inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	21967-41-9				-38.3493916415	4	4		0	-11.45842518					O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H]1O)C(O)=O)OC2=C(O)C(=C3C(=O)\C=C(/OC3=C2)C4=CC=CC=C4)O	Microsource	01505040	-7.05075682	-11.14104458	-5.71265478	-11.45842518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090782-17	Nelfinavir Mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	159989-65-8		11.220184543	-4.95	-96.5580354027	-3	4		-93.7053160547	-94.51106604	0.0342536178	0.9992756711			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	-5.61041873	-8.4557226	-8.12768947	-94.51106604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00382803-03	Desaminotyrosine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	501-97-3				-30.1523502343	4	4		0	-5.53302178					OC(=O)CCC1=CC=C(O)C=C1	MedChem Express	HY-W015346	-8.63771616	-2.04223516	-3.62255203	-5.53302178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	915087-33-1				-2.7962873247	4	4		0	-3.1610969				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	0.79779206	-1.64247849	-1.892509	-3.1610969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183912-01	FR-180204	174006438	ERK1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	865362-74-9		14.1253754462	-4.85	-33.3586881241	4	4		-25.6670217879	-24.17335332	0.3264254567	0.9281585187	5598	MAPK7	NC1=N[NH]C2=NN=C(C=C12)C3=C4C=CC=C[N]4N=C3C5=CC=CC=C5	NCGCChem	SP01-087	-2.36750183	-8.62083949	-4.6061298	-24.17335332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133175-01	NCGC00133175-01	24408558		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-51.3208935105	-3	4		-38.2526664174	-39.60178971	0.0458535612	0.998702251			FC1=C(C=CC=C1)N2CCN(CCCNC(=O)C3=CC=C4N=C(CC5=CC=CC=C5)OC4=C3)CC2	Sytravon	G706-0928	-5.89143507	-4.49447821	-5.0583315	-39.60178971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00125763-01	NCGC00125763-01	24401146		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-42.8177028494	4	4		0	-13.67785235					CC1=CC(=CC=C1)NC(=O)CN2C(=O)N(CC3=NC(=NO3)C4=CC=CC=C4)C(=O)C5=CC=CC=C25	Sytravon	E842-0144	-7.50853242	-11.06069686	-8.1399956	-13.67785235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160539-02	Adefovir	225144241	DNA polymerase/reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	106941-25-7				-6.9512547233	4	4		0	-2.78194163					NC1=NC=NC2=C1N=C[N]2CCOC[P](O)(O)=O	Bosche	A2312	1.03928587	-0.40844703	0.57521735	-2.78194163												1.6E-9	8E-9	4E-8	2E-7											
NCGC00018113-18	Sodium Phenylbutyrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1716-12-7				-19.1743826887	4	4		0	-5.97390001					OC(=O)CCCC1=CC=CC=C1	APExBIO	A4107	-5.2136789	-4.27565829	2.27891455	-5.97390001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165009-01	NCGC00165009-01	29216763		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-25.5154025887	4	4		0	-7.36017897					CC1CCC2=C(C1)SC(NC(=O)C3=NN4C(=C3)N=C(C=C4C(F)(F)F)C5=CC=C(Cl)C=C5)=C2C#N	Sytravon	A0005724	-3.39671705	-7.36238336	-8.86198547	-7.36017897												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116616-01	NCGC00116616-01	24391195		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.7575070222	4	4		0	-1.48098434					FC1=CC=C(C=C1)C/2=N/C(=N\C3=C(N2)C=CC=C3)C4=CC=CC(=C4)C(F)(F)F	Sytravon	D165-0058	-5.11945392	-10.13611848	-7.85824345	-1.48098434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126519-01	NCGC00126519-01	24401902		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			10	-5	-61.9179656599	-2.2	4		-43.617403515	-41.99105145	0.0261135894	0.9995796188			FC1=CC=C(C=C1)C2=NOC\3=C2C(=O)N(CCC(=O)NC4=CC=CC(=C4)C(F)(F)F)\C=N3	Sytravon	E910-0008	-6.49276776	-7.51647975	-12.44552058	-41.99105145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511370-02	ACY-738		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1375465-91-0		8.9125093813	-5.05	-109.530631459	-2.3	4		-124.2211411147	-98.99038885	0.1173576631	0.9914083192		HDAC1	ONC(=O)C1=CN=C(NC2(CC2)C3=CC=CC=C3)N=C1	MedChem Express	HY-19327	-0.97028764	-14.03493526	-33.27039607	-98.99038885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015619-13	Loratadine	170464867	Histamine H1 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	79794-75-5	 Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;	10	-5	-39.1008697912	-3	4		-51.383843912	-45.6176704	0.016039226	0.9998413865	9704	HRH1	Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3	Vitas	STK574925	-0.80641684	-0.49535066	-3.71915342	-45.6176704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00112475-01	NCGC00112475-01	24387054		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			15.8489319246	-4.8	-17.6491982353	4	4		8.539291216	1.80313199	0.7206931742	0.429534124			CC1=C(C)C=C(C=C1)[S+]([O-])(=O)\C2=C\N=C(/NC2=O)SCC(=O)NC3=CC=C4OCCOC4=C3	Sytravon	C716-0323	-5.10320169	0.24826642	-8.78274268	1.80313199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095707-04	SOLANESOL		tobacco isoprenoid alcohol	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	13190-97-1				-37.9129569462	4	4		0	-8.7262399					CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO	Microsource	01505325	-7.57054081	-7.11375212	-9.64043773	-8.7262399												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00109199-01	NCGC00109199-01	24383778		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-15.9218845955	4	4		0	-1.33780761					COC1=CC=C(C=C1)\C=C/C2=C(C(=NO2)C)[S+]([O-])(=O)N3CCC(CC3)C(=O)NC4=CC(=C(C)C=C4)F	Sytravon	C514-0081	-4.93255323	-3.56133893	0.233326	-1.33780761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00103892-01	NCGC00103892-01	24267237		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-60.720908159	-2.4	4		-48.0037616624	-46.12527964	0.0955393608	0.9943320548			CC1=CC=CC(=C1)CC(=O)N2CC(=O)NC3=C(C=C(Br)C=C3)C2C4=CC=C(F)C=C4	Sytravon	C076-0593	-5.09507557	-8.64651999	-10.28835571	-46.12527964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161626-04	Euphobiasteroid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	28649-59-4		11.220184543	-4.95	-54.0177691981	4	4		-22.657040408	-24.06379725	0.0563778787	0.9980464812			[H][C@]12CC[C@@]3(CO3)[C@@H](OC(C)=O)[C@@]4([H])[C@@H](OC(=O)CC5=CC=CC=C5)[C@@H](C)C[C@]4(OC(C)=O)C(=O)\C(C)=C\[C@@]1([H])C2(C)C	DC Chemicals	DCQ-059	-8.09959691	-9.2614601	-12.69758555	-24.06379725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00102146-01	NCGC00102146-01	24275844		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-39.9815621495	4	4		0	-8.77404922					CC1=C(C=CC=C1NC(=O)C2=CC=C(O2)C3=CC(=CC=C3)[N+]([O-])=O)C4=NC5=C(O4)C=CC(=C5)Cl	Sytravon	7645-1552	-10.31204291	-2.88502697	-7.25952014	-8.77404922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508898-01	UCPH 101			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[1118460-77-7]				-26.0232843627	4	4		0	-10.52654577					COC1=CC=C(C=C1)C\2C(=C(/N)O\C3=C2C(=O)CC(C3)C4=C5C=CC=CC5=CC=C4)/C#N	Tocris	3490	-4.42139738	-3.43803056	-6.38353309	-10.52654577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164563-06	Entecavir (monohydrate)		DNA Polymerase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	209216-23-9				-38.8237119068	4	4		0	-8.17566091					NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	MedChem Express	HY-13623A	-7.95683574	-8.00509338	-9.72728852	-8.17566091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00136000-01	NCGC00136000-01	24411383		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.6961358898	4	4		0	-7.01118568					COC1=CC=C(C=C1)N2CCN(CC2)C(CNC(=O)C3=C(F)C=CC=C3F)C4=CC5=C(OCO5)C=C4	Sytravon	G856-4236	-8.02047782	-8.261279	-6.00924499	-7.01118568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00400099-01	NCGC00400099-01	375800320		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-31.5974854541	4	4		0	-6.3310962					C[N]1C=CC=C1C(=O)N[C@H]2C[C@H](N(C2)C(=O)CSCC(=O)N3C[C@H](C[C@H]3C(O)=O)NC(=O)C4=CC=CS4)C(O)=O	Analyticon	NAT3-206772	-6.50901999	-6.78880233	-7.86704821	-6.3310962												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247606-02	Methyl gallate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	99-24-1				-34.886372192	4	4		0	-10.77998689					COC(=O)C1=CC(=C(O)C(=C1)O)O	DC Chemicals	DCM-014	-6.80634867	-5.8573854	-7.66023971	-10.77998689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164624-11	Adefovir dipivoxil	377020406	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	142340-99-6				-16.654234405	4	4		0	-9.39043041					CC(C)(C)C(=O)OCO[P](=O)(COCC[N]1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	MedChem Express	HY-B0255	-1.0875042	-6.46859083	-3.34375543	-9.39043041												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00109737-01	NCGC00109737-01	24384316		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-39.0113613455	4	4		0	-4.63087248					CC1=CC(=C(C)C=C1)CN2C(=O)C3=C(C=CC=C3)[S+]([O-])(=O)C4=C2C=C(C=C4)C(=O)N5CCN(CC5)C6=CC=CC=C6	Sytravon	C530-1332	-10.6858443	-7.38806609	-4.43319392	-4.63087248												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184994-11	Cidofovir	384568422	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	113852-37-2				-24.0579142308	4	4		0	-5.03823465					NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	MedChem Express	HY-17438	-4.56415855	-4.81324278	-7.06965433	-5.03823465												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00163523-01	CATALPOL	26756908		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-18.0183385776	4	4	NCGC00163523-01;CIPLUS_668279;CATALPOL;catalpol;	0	-1.42888355					[H][C@@]12C=CO[C@@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@]1([H])[C@@]4(CO)O[C@H]4[C@H]2O	BIOMOL	BIOMOL_NP-046	-4.9084649	0.16977929	-6.48775404	-1.42888355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378691-05	Asunaprevir (Prop INN; USAN) BMS-650032   Sunvepra  			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-10.2503047449	4	4		0	-6.09569587					COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)N[S+]([O-])(=O)C4CC4)C5=CC(Cl)=CC=C15	AK Scientific	Y1367	-2.02804837	1.84210526	-2.57946847	-6.09569587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167328-03	Aloxistatin	363676654	Calpain Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	88321-09-9				-24.7790694578	4	4		0	-2.9142051				CAPN1	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	Selleck	S7393	-5.23955324	-6.05718258	-7.13532976	-2.9142051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095122-14	Irbesartan			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	138402-11-6				-33.0786960618	4	4		0	-3.30217794					CCCCC/1=N/C2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5	MedChem Express	HY-B0202	-8.00810729	-7.63013818	-6.90699921	-3.30217794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186037-10	Ibandronate sodium hydrate	384568439	Treatment of Osteoporosis	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	138926-19-9				-27.7437870838	4	4		0	-5.07319205					CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	APExBIO	B1772	-5.28636211	-7.15619694	-8.10317874	-5.07319205												1.6E-8	8E-8	4E-7	0.000002											
NCGC00538163-01	NCGC00538163-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-26.7690576765	4	4		0	-8.55744643					CC1=C(N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CC[S+]([O-])(=O)CC4)C(=CC=C1)C	Pharmaron	PH-NIH-2017-009-L2-30-0	-4.73069128	-5.44016685	-6.42399227	-8.55744643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488726-01	NCGC00488726-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-32.4696887923	4	4		0	-8.31055462					NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ005-090	-7.15425417	-5.83123316	-5.59848951	-8.31055462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356073-10	RVX-208		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			10	-5	-59.9455328639	-2.4	4		-57.7053004972	-47.38911951	0.062533006	0.997582107		BRD4	COC1=CC(=C2C(=O)N\C(=N/C2=C1)C3=CC(=C(OCCO)C(=C3)C)C)OC	Bio Vision	9408-5	-3.62361438	-6.84210526	-15.00781657	-47.38911951												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-02	Glycyrrhizic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1405-86-3				-32.1424971263	4	4		0	-6.20056806					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	Prestwick	Prestw-NAT-0335	-6.29408801	-8.37011885	-7.99027271	-6.20056806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371158-09	XEN 445		Endothelial lipase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[1515856-92-4]				-22.3836419595	4	4		0	-8.75143285			9388	LIPG	OC(=O)C1=C(C=CC(=C1)C(F)(F)F)N2CC[C@@H](C2)OCC3=CC=CC=N3	Tocris	5839	-3.22997973	-6.89145737	-3.97382981	-8.75143285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386282-01	NSC 405020			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	7497-07-6				-31.1781414798	4	4		0	-6.92619698					CCCC(C)NC(=O)C1=CC=C(Cl)C(=C1)Cl	Selleck	S8072	-6.35214973	-7.63013818	-6.36251866	-6.92619698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094960-07	ANTHRAQUINONE		Beta amyloid A4 protein Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	84-65-1				-27.1127753224	4	4		0	-9.47447315					O=C1C2=C(C=CC=C2)C(=O)C3=CC=CC=C13	Microsource	MS-01502103	-5.13605589	-4.85791257	-5.03644507	-9.47447315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015067-24	Aspirin		HMG-CoA Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	50-78-2				-25.5960705366	4	4		0	-3.54906975				HMGCR	CC(=O)OC1=C(C=CC=C1)C(O)=O	Enzo	DL313	-5.61041873	-5.63135483	-6.69623255	-3.54906975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016535-12	Alprostadil			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	745-65-3				-12.5561860116	4	4		0	1.35349616					CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	Selleck	S1508	-3.06610893	-5.57052229	-2.63897427	1.35349616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017222-10	OLEANOIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	508-02-1				-29.0722475188	4	4		0	-6.43241337					[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]3(C)C2=CC[C@]4([H])[C@@]5(C)CC[C@H](O)C(C)(C)[C@]5([H])CC[C@@]34C)C(O)=O	Microsource	00100550	-5.67941696	-8.53393587	-5.43163256	-6.43241337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017254-11	Cyanein	404904668	Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	20350-15-6		0.1	-7	-436.8911529075	5	4		-81.6063318001	-98.57596332	0.1378168033	0.9882518972		GBF1	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	APExBIO	B1400	-88.39104748	-98.89632398	-97.81768684	-98.57596332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378589-01	Merimepodib	363678106	Inosine-5'-monophosphate dehydrogenase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	198821-22-6		7.9432823472	-5.1	-36.1282279393	4	4		-13.437078728	-17.40441337	0.021037405	0.9997296634			COC1=CC(=CC=C1C2=CN=CO2)NC(=O)NC3=CC(=CC=C3)CNC(=O)O[C@H]4CCOC4	MedChem Express	HY-13986	-5.42912328	-5.37351443	-7.8686816	-17.40441337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178090-03	Pristimerin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1258-84-0		1.1220184543	-5.95	-156.4488713858	-1.1	4		-99.3156688118	-99.61643594	0.0111199001	0.9999237265			COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)\C4=C\C=C\5\C(=C(\O)C(=O)\C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C	SIGMA	P0020	0.09056018	-18.53654297	-99.09985071	-99.61643594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263219-03	Elacridar	384568673	P-Glycoprotein (MDR-1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	143664-11-3				-16.69471194	4	4		0	-3.32863063				ABCBA	COC1=C2NC3=C(C=CC=C3C(=O)NC4=CC=C(CCN5CCC6=C(C5)C=C(OC)C(=C6)OC)C=C4)C(=O)C2=CC=C1	Selleck	S7772	-2.72974255	-6.37872599	-3.97382981	-3.32863063												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159564-05	Scriptaid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[287383-59-9]		1.1220184543	-5.95	-200.6742845033	-1.1	4		-84.1195209457	-99.54589542	0.0279526235	0.9995177958			ONC(=O)CCCCCN1C(=O)C2=CC=CC3=C2C(=CC=C3)C1=O	Tocris	2421	-14.9424296	-28.93890675	-97.12391323	-99.54589542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015950-14	SB-415286		GSK-3 beta Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	264218-23-7				-29.7460128131	4	4		0	-0.06613173				GSK3B	OC1=C(Cl)C=C(N\C2=C(\C(=O)NC2=O)C3=C(C=CC=C3)[N+]([O-])=O)C=C1	MedChem Express	HY-15438	-7.04213205	-7.66489963	-9.09370335	-0.06613173												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263639-15	Tacedinaline		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-62.9509003508	-2.4	4		-96.8652348935	-75.65548098	0.1669097838	0.9824161943		HDAC1	CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(N)C=CC=C2	SIGMA	C0621	3.41296928	-8.5780327	-13.05304865	-75.65548098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015810-24	Papaverine hydrochloride		Phosphodiesterase X (PDE10) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			6.3095734448	-5.2	-29.4640875454	4	4		-11.56237572	-14.4295302	0.115808322	0.9917475101		PDE10A	COC1=C(OC)C=C(CC2=C3C=C(OC)C(=CC3=CC=N2)OC)C=C1	Analyticon	NP-014100	-4.46123842	-3.5442171	-6.88091569	-14.4295302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00116379-01	NCGC00116379-01	24390958		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-10.9454616985	4	4		0	-0.00447427					CC1=C2C(=O)/C=C(\C=C(OC(=O)C3=C(Cl)C=CC=C3)/C2=C(C)O1)C4=CC5=C(OCO5)C=C4	Sytravon	D132-0061	-3.2341947	-2.93639243	-0.90248734	-0.00447427												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162178-02	NCGC00162178-02	144207066		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	208993-54-8		14.1253754462	-4.85	-70.9873259004	-3	4		-32.621362735	-37.67785235	0.1359948849	0.9884351147			Cl.COc1cccc2OC[C@H]3CN(C[C@H]3c12)CCCCN5C(=O)Nc4c6nc(cnc6sc4C5=O)c7ccccc7	SigmaAldrich	Lopac-F-4303	-11.75849179	-10.11899666	-8.19282412	-37.67785235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137713-01	NCGC00137713-01	24413096		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			11.220184543	-4.95	-52.7422831081	-3	4		-30.347842428	-32.93512304	0.0808538753	0.9959540856			FC1=CC=C(C=C1)C(=O)N2CCC3=CC(=CC=C23)CNC(=O)COC4=CC=CC=C4	Sytravon	G883-0846	-6.39525435	-8.3383272	-8.53620955	-32.93512304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165833-11	Entinostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	209783-80-2		8.9125093813	-5.05	-108.5658545185	-2.1	4		-115.2545696605	-93.99105145	0.0083192766	0.9999573133		HDAC1	NC1=C(NC(=O)C2=CC=C(CNC(=O)OCC3=CC=CN=C3)C=C2)C=CC=C1	Selleck	S1053	-4.83503982	-7.11411694	-30.03742021	-93.99105145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00135329-01	NCGC00135329-01	24410712		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-38.2882862077	4	4		0	-9.12304251					COC1=CC=C(CNC(=O)C2CCCN(C2)[S+]([O-])(=O)C3=CC4=C(C=C3)N(CCC4)C(C)=O)C=C1	Sytravon	G855-0851	-8.60555826	-5.49610479	-8.08716707	-9.12304251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510316-01	ombitasvir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1258226-87-7				9.1285814637	4	4		0	7.01118568					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)C=C5	MedChem Express	HY-13997	0.78823338	1.16428388	1.51882016	7.01118568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133169-02	NCGC00133169-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.4982542955	4	4		0	-10.30425056					ClC1=CC(=CC=C1)N2CCN(CCCNC(=O)C3=CC=C4N=C(CC5=CC=CC=C5)OC4=C3)CC2	Chemdiv	G706-0916	-5.11945392	-8.20135262	-5.70988334	-10.30425056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021394-04	Anisotropine methylbromide	144207024	Muscarinic acetylcholine receptor M3 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	80-50-2	Anisotropine methylbromide; Valpin; Lytispasm; Valpin 50; 			-18.599428507	4	4	LS-157873;Octatropini methylbromidum;ANISOTROPINE;(3-ENDO)-8,8-DIMETHYL-3-((2-PROPYLPENTANOYL)OXY)-8-AZONIABICYCLO(3.2.1)OCTANE BROMIDE;METHYLOCTATROPINE BROMIDE;OCTATROPINE METHYLBROMIDE;8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide;ANISOTROPINE METHYLBROMIDE;methylbromure d'octatropine;8-AZONIABICYCLO(3.2.1)OCTANE, 8,8-DIMETHYL-3-((1-OXO-2-PROPYLPENTYL)OXY)-, BROMIDE, (3-ENDO);3.ALPHA.-HYDROXY-8-METHYL-1.ALPHA.H,5.ALPHA.H-TROPANIUM BROMIDE 2-PROPYLVALERATE;Octatropine methylbromide;Valpin;CIPLUS_750008;Lytispasm;octatropine;Anisotropine methyl bromide;Metilbromuro de octatropina;CIPLUS_149624;anisotropine methylbromide;anisotropine methylbromide, (endo)-isomer;Methyloctatropine bromide;8-Azoniabicyclo(3.2.1)octane, 8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-, bromide, endo-, mixt. with 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;octotropine methylbromide;Valpin 50;valpinax;Methylbromure d'octatropine;CIPLUS_709435;octatropini methylbromidum;Methyloctatropine Bromide;Anisotropine methylbromide;	0	2.41163311					[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC	SigmaAldrich	A5181	-5.34698521	-3.72399623	-5.9300022	2.41163311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090726-30	Ribavirin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	36791-04-5				-24.1130768037	4	4		0	-4.05167093					NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Bio Vision	2199	-5.14468067	-6.50039107	-4.86958813	-4.05167093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00385072-01	Schisandrin C	363679517	<MOA Unknown> | Class: Shikimate | Genus: N/A | Family: N/A | Species: N/A	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-27.2612978817	4	4		0	-9.81835817					COC1=C2OCOC2=CC3=C1C4=C(CC(C)C(C)C3)C=C5OCOC5=C4OC	Analyticon	NP-015228	-4.60131959	-4.91005475	-5.48432423	-9.81835817												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00091502-16	COUMARIN		Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	91-64-5				-17.9006615441	4	4		0	-3.78714399					O=C\1OC2=C(C=CC=C2)\C=C1	Microsource	01400208	-3.48009832	-4.26696793	-4.71151313	-3.78714399												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00165045-01	NCGC00165045-01	29216799		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-38.3221700468	4	4		0	-9.48098434					FC(F)(F)C1=CC(=NC2=CC(=NN12)C(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C4=CC=C5OCOC5=C4	Sytravon	A0012923	-7.32163172	-8.34688811	-9.5927801	-9.48098434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389319-01	NCGC00389319-01	363680766		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	957116-20-0				-34.1876973861	4	4		0	-6.74272931					FC1=CC(=CC(=C1)F)C2CNC3(CCCC3)C(=O)N2CC(=O)NC4=CC5=C(CC6(C5)C(=O)NC7=C6C=CC=N7)C=C4	APExBIO	B1436	-7.43539737	-7.25109152	-7.2859344	-6.74272931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346555-08	Apixaban	363677453	Coagulation Factor Xa Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	503612-47-3				-23.38421984	4	4		0	-4.22818792				F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	Glixx	GLXC-90058	-4.55062571	-5.41905659	-6.88972045	-4.22818792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163469-10	Sodium Monensin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	22373-78-0		0.3548133892	-6.45	-198.41545851	-2.1	4		-77.0205608778	-82.86213677	0.0478585057	0.9985848402			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	Selleck	S2324	-8.54467585	-8.2852292	-49.43546986	-82.86213677												1.6E-8	8E-8	4E-7	0.000002											
NCGC00165841-02	NH125			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	278603-08-0		5.6234132519	-5.25	-145.0696096296	-2.3	4		-97.6510453158	-99.76403758	0.059061069	0.9978425166			CCCCCCCCCCCCCCCC[N+]1=C(C)[N](CC2=CC=CC=C2)C=C1	Selleck	S7436	-12.08851192	-10.57724958	-46.12645475	-99.76403758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178638-13	Valaciclovir	384568359	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	124832-27-5				-34.3388853148	4	4		0	-4.86344767					CC(C)[C@H](N)C(=O)OCCOC[N]1C=NC2=C1\N=C(N)/NC2=O	MedChem Express	HY-17425A	-7.95683574	-5.7385399	-9.11933299	-4.86344767												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481318-01	NCGC00481318-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			2.8183829313	-5.55	-17.9013396105	4	4		14.610433932	4.74720358	0.0288212698	0.9994932076			CN1C(=O)N(C)C2=C([N](CC(=O)NC3=CC=C(N=N3)C4=CC=CC=C4)C=N2)C1=O	MedChem Express	HY-18988	-7.17536161	-4.78554918	0.31256879	4.74720358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346655-06	Linagliptin	384568886	DPP-IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	668270-12-0				-5.5782791505	4	4		0	-0.79194631				DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	MedChem Express	HY-10284	-1.75524135	-0.48797192	-0.233326	-0.79194631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399585-01	NCGC00399585-01	375805247		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.7570429241	4	4		0	-4.09395973					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC=CC(=C4)C#N)N5CCOCC5	Analyticon	NAT6-322275	-6.38712823	-4.39174728	-6.17653533	-4.09395973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371093-04	Marimastat	384569041	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	154039-60-8				-30.7236148765	4	4		0	-8.44658073				MMP1	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	MedChem Express	HY-12169	-3.6907961	-10.69609508	-10.74344277	-8.44658073												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263103-09	Pelitinib		EGFR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	257933-82-7		0.3981071706	-6.4	-242.6842347112	-1.1	4		-99.5748245376	-99.68538344	0.0489726736	0.9985180527		EGFR	CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC(=C(F)C=C3)Cl)C#N	MedChem Express	HY-32718	-20.51142089	-72.43633277	-93.23432343	-99.68538344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179244-11	Dorzolamide hydrochloride	384568369	Carbonic Anhydrase Type II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	130693-82-2				-51.3215912713	4	4		0	-8.04457068				CA2	CCN[C@H]1C[C@H](C)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0109A	-11.76939872	-10.58573854	-11.23849227	-8.04457068												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00119654-01	NCGC00119654-01	24394233		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.6659302438	4	4		0	-6.18791946					COC1=CC=C(C=C1)C2\C=C(/NC3=NC(=N[N]23)NC(=O)/C=C/C4=CC=CC=C4)C5=CC=CC=C5	Sytravon	D413-0071	-8.22363075	-8.63795908	-5.72749285	-6.18791946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00104967-01	NCGC00104967-01	24268312		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-12.8817306472	4	4		0	1.04250559					ClC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC=C4C(=O)N(CCC5=CC=CC=C5)C(=O)NC4=C3	Sytravon	C190-0340	-3.21794247	-2.15734954	-5.63064055	1.04250559												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107780-01	NCGC00107780-01	24271125		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-27.5718949067	4	4		0	-4.30872483					FC1=C(NC(=O)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CCC(=O)NCC5=CC=CC=C5)C(=O)N24)C=CC=C1	Sytravon	C336-0111	-5.90768731	-8.0215735	-5.23442659	-4.30872483												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106236-02	NCGC00106236-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.5945709044	4	4		0	-8.7114094					CC1=CC(=CC=C1)CN2C(=O)N(CC3=CC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=CC=C5)C(=O)C6=CC=CC=C26	Chemdiv	C260-1272	-5.85080449	-8.00445167	-5.07594101	-8.7114094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346532-04	VX-222			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1026785-59-0				-36.306102341	4	4		0	-5.41402665					C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]2CC[C@H](O)CC2)C3=C(SC(=C3)C#CC(C)(C)C)C(O)=O	MedChem Express	HY-75800	-8.39351696	-8.9049236	-6.58328991	-5.41402665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507869-01	LY-3314814	384569343	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1383982-64-6				-36.5576876354	4	4		0	-5.70242517				BACE1	CO[C@H]1CC[C@]2(CC1)CC3=C(C=C(C=C3)C4=CN=CC(=C4)C#CC)[C@@]2/5\N=C(C)/C(=N5)N	Selleck	S8193	-8.37672153	-6.27334465	-9.32777488	-5.70242517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347894-01	NCGC00347894-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-42.2865191376	4	4		0	-5.96420582					CC(C)C1=CC=CC=C1C(=O)N2CCC3=CC(=CC=C23)C4=C(C)SC(=N4)NC(=O)CC5=CC6=C(OCO6)C=C5	NCGCChem	LLI015-025	-9.80009751	-9.62246383	-8.69469514	-5.96420582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017401-02	NCGC00017401-02	144206666		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	17479-19-5				-25.8294620064	4	4	Dihydroergocristine methanesulfonate salt;Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19alpha)-, mixt. with (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)ergotaman-3',6',18-trione;Dihydroergocristine methanesulfonate;CIPLUS_751524;Iskedyl;CIPLUS_773547;Kristepin;NCGC00016137-01;CIPLUS_3884556;Dihydroergocristine;P 3007;Ersilan;CIPLUS_774402;NCGC00025380-01;NCGC00025380-02;dihydroergotoxine ethansulfonate;NCGC00023148-05;NCGC00023148-02;CIPLUS_740293;CIPLUS_684973;Dihydroergocristine mesylate;CIPLUS_3885160;Brinerdine;PF 50;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(phenylmethyl)-;DIHYDROERGOTOXINE-MESYLATE;LS-175603;Dihydroergotoxine mesylate;Crystepin CH;Chrystepin CH;Briserin;P-3007;CIPLUS_3884046;defluina;	0	-4.61297539					CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]8(O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O)C(C)C	InterBioScreen	STOCK1N-23631	-4.98943605	-7.11411694	-6.67840634	-4.61297539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162409-10	Bafilomycin A1 from Streptomyces griseus			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	88899-55-2		0.0398107171	-7.3999999999	-251.4755665059	-1.2	4		-73.0927811577	-77.21252796	0.0132850426	0.9998911486			CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(C)/C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C	SantaCruz Bio	sc-201550B	-9.41004388	-68.16197243	-77.67114242	-77.21252796												1.6E-8	8E-8	4E-7	0.000002											
NCGC00510187-01	BMS-663068			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	864953-29-7				-32.4689249799	4	4		0	-4.67992135					COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[N]3CO[P](O)(O)=O)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5	Glixx	GLXC-90326	-7.06667786	-6.11205433	-9.51884662	-4.67992135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347398-04	Ginsenoside Rb1			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	41753-43-9				-31.3446444137	4	4		0	-10.01092419					CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0039	-5.3367484	-10.49235993	-2.13652944	-10.01092419												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00140594-02	NCGC00140594-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-36.3533235782	4	4		0	-2.07158837					[O-][S+]1(=O)C2=C(C=C(C=C2)C(=O)N3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F)N(CC5=CC=CC(=C5)Cl)C(=O)C6=C1C=CC=C6	Chemdiv	K788-8584	-8.11799122	-9.11737009	-11.01915034	-2.07158837												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111425-01	NCGC00111425-01	24386004		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-18.3805282327	4	4		0	-5.11409396					CC1CN(CCN1C2=CC=C(C)C=C2)C(=O)C3CCN(CC3)[S+]([O-])(=O)C4=CC5=C(C=C4)N(C)C(=O)O5	Sytravon	C648-0840	-3.09605071	-5.13654653	-4.3803654	-5.11409396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137821-01	NCGC00137821-01	24413204		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.1040673648	4	4		0	-13.67785235					COC1=CC=C2C=C([NH]C2=C1)C(=O)NCC3=CC=C4N(CCC4=C3)C(=O)C5=CC=C(C)C=C5	Sytravon	G883-0400	-4.2174549	-6.51485318	-12.24301123	-13.67785235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-12	NCGC00159456-12			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	152459-95-5	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	28.1838293126	-4.55	-105.4300633652	-1.1	4		-97.5070130912	-99.70022371	0.0222427793	0.9996947315	25	ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	AK Scientific	69412	-3.02291565	-1.07867477	-84.53885098	-99.70022371												0.0000016	0.000008	0.000039999999999	0.00019999999999											
NCGC00178734-13	Sitagliptin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	486460-32-6				-28.5891550824	4	4		0	-5.94712694					N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F	DC Chemicals	DC5112	-5.89099765	-5.57724958	-7.44311273	-5.94712694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482596-01	Germacrone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6902-91-6				-39.4148560398	4	4		0	-6.43653048					CC(C)=C1C\C=C(/C)CC\C=C(/C)CC1=O	DC Chemicals	DCJ-025	-9.05693651	-7.72495756	-8.69376411	-6.43653048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510887-02	Celgosivir (hydrochloride)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	141117-12-6				-23.1205741904	4	4		0	-5.26849484					CCCC(=O)O[C@H]1C[N@]2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O	MedChem Express	HY-16134A	-4.17870542	-5.66611628	-6.51181172	-5.26849484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090548-05	Deferiprone		Iron Chelating Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	30652-11-0				-14.3838962003	4	4		0	-4.77605418					CN/1\C=C/C(=O)/C(=C1C)O	APExBIO	B1723	-2.97699026	-1.8336163	-2.76185513	-4.77605418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387092-01	PF 429242		cholesterol biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[947303-87-9]		5.6234132519	-5.25	-109.1016260196	-2.1	4		-82.2651844476	-81.15796373	0.0479822204	0.9985775273			CCN(CC)CC1=CC=C(C=C1)C(=O)N(CCC2=CC=CC=C2OC)[C@@H]3CCNC3	Tocris	3354	-7.89805173	-6.96943973	-33.48097968	-81.15796373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159322-05	Cyclocytidine		antiviral	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	10212-25-6		1.1220184543	-5.95	-70.6154122059	4	4		-24.6353253839	-33.27507101	0.1681051035	0.9821889779			OC[C@H]1O[C@@H]2[C@@H](OC/3=N/C(=N)/C=C\N23)[C@@H]1O	Enzo	DL369	-6.49563319	-12.75891341	-28.9560535	-33.27507101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188641-04	PLpro inhibitor			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1093070-14-4				-30.4497699603	4	4		0	-8.1430209					C[C@@H](NC(=O)C1=C(C)C=CC(=C1)NC(C)=O)C2=C3C=CC=CC3=CC=C2	MedChem Express	HY-17542	-5.96403467	-7.93430086	-5.13304646	-8.1430209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482702-01	Dehydroandrographolide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	134418-28-3				-24.2903475717	4	4		0	-3.77832643					CC1(CO)C(O)CCC2(C)C(C\C=C3/C=C\OC3=O)C(=C)CCC12	DC Chemicals	DCT-012	-5.36892492	-6.60467541	-4.49196452	-3.77832643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016509-08	TRIMETHOBENZAMIDE HYDROCHLORIDE		Dopamine D2 receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	554-92-7, 138-56-7 [trimethobenzamide]		12.5892541179	-4.9	-20.6412292579	4	4		-10.646637984	-12.54533537	0.1423888128	0.9874605445			COC1=CC(=CC(=C1OC)OC)C(=O)NCC2=CC=C(OCCN(C)C)C=C2	Microsource	01500594	-2.74185422	-3.67572156	-2.42313705	-12.54533537												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379154-03	U-104	363678388	Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	178606-66-1				-21.0454335298	4	4		0	-5.75346089					N[S+]([O-])(=O)C1=CC=C(NC(=O)NC2=CC=C(F)C=C2)C=C1	APExBIO	A4358	-2.97123636	-7.9951334	-5.10670062	-5.75346089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229511-27	Tofacitinib			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	477600-75-2				-3.093938085	4	4		0	1.82082709					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1	-0.52179913	-2.35508821	-2.11205761	1.82082709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161634-09	Artemisinin	384568213	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	63968-64-9				-43.4448458633	4	4		0	-6.48896657				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S1282	-10.4845482	-8.14940577	-8.76324475	-6.48896657												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017236-16	Baicalein	384567977	Cyp2C9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	491-67-8		7.0794578438	-5.15	-33.3901127769	-2.4	4		-30.6692896881	-28.06641905	0.0169187359	0.9998237712		CYP2C9	OC1=CC2=C(C(=O)\C=C(/O2)C3=CC=CC=C3)C(=C1O)O	APExBIO	N1858	-1.67534431	-1.89303905	-9.74465868	-28.06641905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384199-05	4SC-202	384569106	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	910462-43-0		1.995262315	-5.7	-136.3497144895	-2.3	4		-102.2041967112	-91.59274634	0.0915938722	0.9947900997		HDAC1	C[N]1C=C(C=N1)C2=CC=C(C=C2)[S+]([O-])(=O)[N]3C=CC(=C3)/C=C/C(=O)NC4=C(N)C=CC=C4	MedChem Express	HY-16012A	-1.09590191	-28.73514431	-64.39117596	-91.59274634												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017331-07	CIANIDANOL		superoxide anion generation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	154-23-4				-29.4454192655	4	4		0	-8.566264					O[C@H]1CC2=C(O[C@@H]1C3=CC(=C(O)C=C3)O)C=C(O)C=C2O	Microsource	MS-00210205	-4.46332313	-7.80394542	-8.85659085	-8.566264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249611-05	Ixazomib	384568528	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1072833-77-2		0.2818382931	-6.55	-283.9813265721	-1.1	4		-88.0735869421	-98.60241601	0.0099520615	0.9999389188		PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Adooq	A10600	-30.60502825	-90.84035804	-98.19531044	-98.60241601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163544-09	E-64			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	66701-25-5				-2.0308456318	4	4		0	-2.3146107					CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(O)=O)C(=O)NCCCCNC(N)=N	Selleck	S7379	0.16818319	-1.26879291	0.22393958	-2.3146107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180911-03	Pyrvinium pamoate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	3546-41-6		1.4125375446	-5.85	-165.9038014092	-1.1	4		-95.1732848761	-99.63407107	0.0131426539	0.9998934495			CN(C)c1ccc2[n+](C)c(\C=C/c3cc(C)n(c3C)-c4ccccc4)ccc2c1.Oc5c(cc6ccccc6c5Cc7c(O)c(cc8ccccc78)C([O-])=O)C([O-])=O	Prestwick	Prestw-1040	-5.55004528	-11.35830364	-99.17888821	-99.63407107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013414-04	Procodazole	170466381		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	23249-97-0				-32.7628000662	4	4		0	-7.96666961					O=C(O)CCc1nc2ccccc2n1	Vitas	STK387005	-6.55914442	-7.33466586	-7.05629226	-7.96666961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023595-03	Loxistatin Acid (E-64C)	363676526		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	76684-89-4				-35.1643227584	4	4		0	-6.5734944					CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O	Selleck	S7392	-7.48199577	-8.20370209	-7.74128392	-6.5734944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023654-26	Captopril			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	62571-86-2 				-29.9915792851	4	4		0	-4.21038709					C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O	APExBIO	A4078	-6.54189486	-8.09072738	-6.41521033	-4.21038709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126027-01	NCGC00126027-01	24401410		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-43.5753850057	4	4		-28.65436242	-27.62863535	0.3541672392	0.9138266786			COC1=CC=C(C=C1)[N]2N=C3C(=NN=C(C)C3=C2C)N4CCCC(C4)C(=O)NCCC5=C(C)C=CC=C5	Sytravon	E859-1228	-8.18300016	-3.65550895	0.75280652	-27.62863535												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390740-02	Avibactam (sodium)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1192491-61-4				-10.6848035505	4	4		0	-2					NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S]([O-])(=O)=O	MedChem Express	HY-14879A 	-0.7476028	-3.53565619	-6.88091569	-2												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106464-01	NCGC00106464-01	24269809		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-6.8389322482	4	4		0	-1.31991051					COC1=C(OC)C=C(CCNC(=O)CCCCN2C(=O)N(CC(=O)NC3=C(C)C=CC=C3C)C4=CC=CC=C4C2=O)C=C1	Sytravon	C260-1456	-1.56834065	-2.87646606	0.233326	-1.31991051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1502654-87-6		3.5481338923	-5.45	-21.3843081409	4	4		-18.3298420479	-15.00223714	0.0956744435	0.9943584666			COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B	-0.5607021	-3.84384899	-8.65947612	-15.00223714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346443-01	Rupintrivir	174007383	HRV 3C Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	223537-30-2	AG-7088 (Rupintrivir)			-15.3041007114	4	4		0	-2.63204303					CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)C2=NOC(=C2)C)C(C)C)CC3=CC=C(F)C=C3	Axon Medchem	1571	-4.45469835	-1.65116885	-1.15482568	-2.63204303												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	53-86-1				-13.9726450563	4	4		0	0.28657085				PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	-4.00620984	-4.11054141	-1.55001317	0.28657085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274056-12	Risedronate sodium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-29.4461242466	4	4		0	-7.58751433					OC(CC1=CC=CN=C1)(P(O)(O)=O)P(O)([O-])=O	Selleck	S1428	-5.80878865	-7.33466586	-5.4579784	-7.58751433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133282-01	NCGC00133282-01	24408665		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-19.243711679	4	4		0	-6.59955257					CC1=CC(=CC=C1Br)NC(=O)NCC2=CC=C3N(CCC3=C2)C(=O)C4=CC=CC=C4	Sytravon	G714-0225	-2.22655615	-7.41374882	-4.92626018	-6.59955257												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139554-01	NCGC00139554-01	24414937		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-44.8235997501	4	4		0	-10.2147651					[O-][S+](=O)(N1CCC2(CC1)OCCO2)C3=CC(=CC=C3F)C(=O)NC4=CC(=C(F)C=C4)F	Sytravon	K784-0137	-10.67771819	-10.58984676	-3.605547	-10.2147651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165041-01	NCGC00165041-01	29216795		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.8505448938	4	4		0	-5.31991051					COC1=C(OC)C=C(C=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)F)C(=O)NC4=C(C=C(Cl)C=C4)C(F)(F)F	Sytravon	A0012890	-6.94783033	-4.97388922	-6.66079683	-5.31991051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015817-17	Promethazine HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	58-33-3				-7.1226092873	4	4		0	-8.1165682					CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C	Selleck	S4293	0.06468584	-0.45189884	-1.29533679	-8.1165682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510509-02	Vesnarinone		p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	81840-15-5				-10.6051479541	4	4		0	-2.60559034				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	-2.59174609	-2.72008343	-0.19759375	-2.60559034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381565-04	RG2833		Histone deacetylase 3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1215493-56-3		11.220184543	-4.95	-93.8989935655	-2.3	4		-93.9655404872	-81.55806366	0.0707806757	0.9968976624	8841	HDAC3	CC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NC2=CC=CC=C2N	MedChem Express	HY-16425	-5.57591962	-10.64569393	-16.11047686	-81.55806366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389337-01	Epoxomicin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	134381-21-8		0.1	-7	-405.9527554746	5	4		-81.1365591636	-98.87576051	0.0655285517	0.9973487385			CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	APExBIO	A2606	-76.04036397	-98.64430347	-98.60806182	-98.87576051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023212-30	Stavudine (d4T)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	3056-17-5				-36.4889066582	4	4		0	-7.7197778					CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O	Selleck	S1398	-7.81836215	-7.96906231	-7.41635198	-7.7197778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00098652-01	NCGC00098652-01	24272350		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.2067445896	4	4		0	-4.97986577					COC1=CC(=CC=C1)C(=O)NC2=CC=C3OC(=NC3=C2)C4=CC=C5C=CC=CC5=C4	Sytravon	3205-0102	-9.14188201	-1.96044859	-8.25445741	-4.97986577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168285-02	NCGC00168285-02	85736016		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-9.338622552	4	4		0	1.23042506					FC(F)(F)C1=CC(=C(Cl)C=C1)NC(=O)[C@@H](NC(=O)CNC(=O)C2=CC=CC=C2)C3=CC=CC=C3	NCGCChem	BTM01-55	-2.30781732	-4.70850098	-1.53642967	1.23042506												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263153-10	AR-42(HDAC-42)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	935881-37-1		0.8912509381	-6.05	-221.1069313855	-1.1	4		-86.2871091035	-99.76633454	0.0455154564	0.9987201747			CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Bio Vision	2716	-15.3132951	-54.28869384	-99.4160007	-99.76633454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016612-14	Sulfadoxine		Dihydropteroate Synthase (DHPS) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	2447-57-6				-6.3440985766	4	4		0	0.6216383					COC1=NC=NC(=C1OC)N[S+]([O-])(=O)C2=CC=C(N)C=C2	SIGMA	S7821	-1.20315667	-4.84053185	-0.5049618	0.6216383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090753-20	Azithromycin	384568081	50S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	83905-01-5				-20.6127420624	4	4		0	-3.89295477					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	MedChem Express	HY-17506	-5.4206736	-2.11175806	-3.41178537	-3.89295477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123513-01	NCGC00123513-01	24398896		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			15.8489319246	-4.8	-7.6321610222	4	4		-9.048322144	-6.70693512	0.723142671	0.420905135			CC1=CC=CC(=C1)[S+]([O-])(=O)/C2=C/N(CC3=CC=C(F)C=C3)C4=CC(=C(F)C=C4C2=O)N5CCCCC5	Sytravon	E599-0593	-1.67398017	-3.55277802	5.92119745	-6.70693512												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015992-01	Tyrphostin A9	11111849		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			0.2818382931	-6.55	-184.4488721099	-1.4	4	NCGC00015992-01;[[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile;SF6847;Malonoben;CIPLUS_168096;[[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]-propanedinitrile;NCGC00094494-01;TYRPHOSTIN 9;NCGC00094494-02;NCGC00094494-03;NCGC00094494-04;SF 6847;3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile;SF-6847;tyrphostin A9;Tyrphostin A9;	-76.5900134405	-75.24384787	0.088258543	0.9951652407			CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C(C#N)C#N	SigmaAldrich	Lopac-T-182	-6.40338046	-78.7603801	-81.27228703	-75.24384787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181129-22	Dasatinib			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	302962-49-8		14.1253754462	-4.85	-222.1230622696	-2.4	4		-38.2140605216	-72.1849925	0.4421987019	0.8561321442			CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Selleck	S1021_CM1	-38.81581784	-52.08134179	-46.70677088	-72.1849925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164319-07	EPIGALLOCATECHIN-3-MONOGALLATE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	989-51-5		14.1253754462	-4.85	-29.7093586516	4	4		-28.686220976	-23.88027092	0.2399911219	0.9628218644			OC1=CC(=C2C[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC2=C1)C4=CC(=C(O)C(=C4)O)O)O	Microsource	MS-00210239	-1.64175344	-6.32427844	-4.64651728	-23.88027092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159554-09	Salubrinal			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	405060-95-9		11.220184543	-4.95	-65.8874242022	-2.4	4		-42.921899476	-43.58750273	0.0713161878	0.9968530693			ClC(Cl)(Cl)C(NC(=O)\C=C\C1=CC=CC=C1)NC(=S)NC2=C3N=CC=CC3=CC=C2	SIGMA	SML0951	-7.4025865	-9.762309	-10.84766371	-43.58750273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484060-01	NM107	363681153	Picornaviridae Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	20724-73-6		11.220184543	-4.95	-22.6997271647	4	4		9.635299856	3.7360179	0.1526642425	0.9855764154			C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N2/C=C\C(=N/C2=O)N	MedChem Express	HY-10468	-6.36274988	-5.06805924	-3.80805635	3.7360179												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00263117-14	Panobinostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	404950-80-7		0.2238721139	-6.65	-381.5567155889	-1.2	4		-43.9828741105	-99.47651007	0.0126179263	0.9999018939		HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	Aobious	AOB87727	-65.91906387	-99.2123962	-99.47171473	-99.47651007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378907-02	Edoxaban 		Coagulation factor X Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	480449-70-5				-44.8364199975	4	4		0	-8.64758575					CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C	Glixx	GLXC-90139	-9.0485388	-11.7147708	-10.12680215	-8.64758575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025291-03	Arctigenin		tumor necrosis factor biosynthetic process Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1777				-12.5846894593	4	4		0	-0.48503386					COC1=C(O)C=CC(=C1)C[C@@H]2[C@H](COC2=O)CC3=CC(=C(OC)C=C3)OC	Tocris	1777	-4.52216997	1.91001698	-2.87476116	-0.48503386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263116-12	NCGC00263116-12			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	780757-88-2		14.1253754462	-4.85	-37.9607193514	4	4		-13.27540274	-17.72259508	0.2345243035	0.9648269699		CREBBP	OC1=CC=C(C[C@@H]2N3[C@H](CN(CC4=CC=CC5=C4C=CC=C5)C2=O)N(CCC3=O)C(=O)NCC6=CC=CC=C6)C=C1	Selleck	S2662	-5.82642613	-8.11574352	-5.95641646	-17.72259508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00105393-01	NCGC00105393-01	24268738		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-20.4276802872	4	4		-10.8427853481	-12.51454139	0.3556486516	0.913985819			COC1=CC=C(NC(=O)CSC2=NC3=C(C=N2)[S+]([O-])(=O)N(CC4=CC=C(C)C=C4)C5=CC=CC=C35)C=C1Cl	Sytravon	C200-5334	-2.61660978	-4.88828011	-1.3955536	-12.51454139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378626-06	TMP269	363678130	Histone deacetylase 9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1314890-29-3				-36.7678790259	4	4		0	-12.09088923			9734	HDAC9	FC(F)(F)C1=NC(=NO1)C2=CC(=CC=C2)C(=O)NCC3(CCOCC3)C4=NC(=CS4)C5=CC=CC=C5	Glixx	GLXC-05455	-6.72237151	-7.03735144	-8.0771235	-12.09088923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015529-22	Ibuprofen lysine	384567862	Cyclooxygenase-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	15687-27-1				-42.2208429388	4	4		0	-6.01704173				PTGS1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O	APExBIO	A8446	-9.72875378	-8.39558574	-8.43321174	-6.01704173												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00390724-02	E-7449	384569209	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1140964-99-3		11.220184543	-4.95	-40.8856353181	4	4		-16.5586628241	-18.08053691	0.1385459475	0.988107083		PARP1	O=C1NNC2=C3C(=NC(=N2)CN4CC5=C(C4)C=CC=C5)C=CC=C13	MedChem Express	HY-12418	-5.94831789	-7.73906344	-9.6896324	-18.08053691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390564-04	GS7340			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	379270-37-8				-36.0484839926	4	4		0	-8.97968101					CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3	Glixx	GLXC-07981	-6.89032583	-6.69779287	-10.10074692	-8.97968101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160217-03	Sophocarpine	363676600	HERG Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6483-15-4				-28.0403958788	4	4		0	-4.07690627				KCNH2	O=C1\C=C/C[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34	Selleck	S2405	-6.37806517	-5.95925297	-6.49643912	-4.07690627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091110-02	Glutaraldehyde	124890454		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	111-30-8				-20.7756700549	4	4	Glutaraldehyde	0	-2.12527964					O=CCCCC=O	SIGMA	NTP-SID_831	-5.33885909	-2.85934423	-3.7023993	-2.12527964												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00165722-19	Plerixafor hydrochloride	384568275	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-13.3553602453	4	4		0	-2.35794183			7852	CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	NCGCChem	AED021-093	-2.98228506	-3.46716891	-2.22320053	-2.35794183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095694-06	Ostol		GABAA Receptor Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-1.4283359279	4	4		0	-5.64124973					COC1=C(CC=C(C)C)C2=C(\C=C/C(=O)O2)C=C1	Analyticon	NP-000408	1.05391334	0.77249576	-0.63401077	-5.64124973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00076924-03	Salicylanilide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	87-17-2				-16.7417787053	4	4		0	-3.06487696					OC1=CC=CC=C1C(=O)NC2=CC=CC=C2	Selleck	S4187	-4.55062571	-1.1043575	-2.9451904	-3.06487696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185937-01	NCGC00185937-01	87225716		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-42.3284850538	4	4		-19.54194934	-24.01342282	0.147470881	0.9863961527			CC(=O)NC1=CC(=CC=C1)[S+]([O-])(=O)N2CCCN(CC2)[S+]([O-])(=O)C3=CC4=C(OCCO4)C=C3	NCGCChem	MBB09-018	-6.24085812	-7.26821334	-4.81179837	-24.01342282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165007-01	NCGC00165007-01	29216761		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			8.9125093813	-5.05	-40.7371471693	4	4		-12.30458986	-18.56375839	0.0526738655	0.9983008253			CC1CCC2=C(C1)SC(NC(=O)C3=NN4C(=C3)N=C(C=C4C(F)(F)F)C5=CC=C(C)C=C5)=C2C#N	Sytravon	A0005592	-6.85844304	-6.64326684	-6.73123487	-18.56375839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163572-01	ISORHAMNETINE	26756952		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-33.2506964513	4	4	ISOHAMNETIN:3'-METHOXY-3,4',5,7-TETRAHYDRO-XY-FLAVONE;3'-Methoxy-3,4',5,7-tetrahydroxyflavone;3-methyl-quercetin;3-methylquercetin;isorhamnetin;CIPLUS_153428;isorhamnetine;NCGC00163572-01;iso-rhamnetin;3'-methoxyquercetin;TAMARIXETINE;NCGC00163572-02;Isorhamnetin;3,4',5,7-tetrahydroxy-3'-methoxyflavone;ISORHAMNETIN;LS-69043;ISORHAMNETINE;CIPLUS_155089;3,4',5,7-tetrahydroxy-3'-methoxy-flavone;	0	-5.22176098					COC1=CC(=CC=C1O)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	BIOMOL_NP-148	-8.04921061	-4.32088285	-8.25951016	-5.22176098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346629-09	GSK1349572		HIV Integrase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1051375-16-6		14.1253754462	-4.85	-35.4954381647	4	4		-14.208836168	-17.88507756	0.2077609279	0.9726392072			C[C@@H]1CCO[C@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	DC Chemicals	DC7273	-5.23597581	-7.31748727	-5.21104742	-17.88507756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160580-02	2-Hydroxy-N-(4-hydroxyphenyl)-benzamide		Ribonucleoside-diphosphate reductase M2 chain Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	526-18-1				-9.860469324	4	4		0	-0.12975391					OC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1	DC Chemicals	DC8981	-3.35608646	0.74479925	-2.45212415	-0.12975391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386712-02	TMP195			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1314891-22-9		12.5892541179	-4.9	-37.7752714369	4	4		-22.5531282641	-22.64791465	0.3887196578	0.8939228221			CC(C)(CNC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C(F)(F)F)C3=COC(=N3)C4=CC=CC=C4	Selleck	S8502	-3.43697443	-10.00260711	-7.26705893	-22.64791465												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160391-12	Auranofin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	34031-32-8		1.995262315	-5.7	-165.7514662063	-1.3	4		-97.2686475058	-99.65916539	0.0725574784	0.9967387738			CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	Cayman	15316	-7.94004031	-1.98641766	-99.57443113	-99.65916539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246968-07	Olmesartan	384568514	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	144689-24-7				-15.3296432107	4	4		0	-3.72542104				AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	MedChem Express	HY-17004	-5.12743111	3.48483532	-2.70044788	-3.72542104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163409-07	Betulinic acid	384568234	Caspase 3/8 Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	472-15-1				-28.977822438	4	4		0	-3.99876554				CASP3	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	Prestwick	Prestw-NAT-0019	-6.35214973	-8.46441297	-5.51067006	-3.99876554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386289-08	Dynasore	387065823	Dynamin-2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[304448-55-3]				-17.902460788	4	4		0	-8.79552068			10059		OC1=C(O)C=C(C=C1)\C=N\NC(=O)C2=C(O)C=C3C=CC=CC3=C2	Tocris	2897	-2.21225581	-5.24028852	-2.88486871	-8.79552068												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162225-04	L-tetramisol		Nicotinic Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	16595-80-5	; Vetavia; Hydrochloride, Levamisol; Tetramisol hydrochloride; Levamisol;LEVAMISOLE HYDROCHLORIDE;Tetramisole hydrochloride; ; dexamisole, (R)-isomer; Levomysol; Tetramisol; Decaris; (-)-Tetramisole hydrochloride; Levamisol hydrochloride; Helmoral B; Solaskil; Levamisole Base; Dekaris; Nilverm; Dexamisol; Ergamisol;(-)-Tetramisole hydrochloride			-27.462203941	4	4		0	-7.74623049			1136	CHRNA3	C1CN\2C[C@@H](\N=C2S1)C3=CC=CC=C3	Enzo	AC-1102	-4.6789426	-7.75180325	-6.16053394	-7.74623049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386432-07	BLZ945			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	953769-46-5				-43.4325776305	4	4		0	-11.50251301					CNC(=O)C1=NC=CC(OC2=CC3=C(C=C2)N=C(N[C@@H]4CCCC[C@H]4O)S3)=C1	MedChem Express	HY-12768_cm2	-8.58596748	-9.41166247	-9.05857557	-11.50251301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018158-11	Doxazosin Mesylate		alpha1-Adrenoceptor Antagonists	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	77883-43-3		15.8489319246	-4.8	-33.7755477282	4	4		-11.288036224	-12.87805308	0.5885781412	0.7027740424			COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCN(CC3)C(=O)C4COC5=C(O4)C=CC=C5)N	Selleck	S1324	-7.32674975	-5.97896932	-1.80468956	-12.87805308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346533-07	Daclatasvir dihydrochloride		HCV NS5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1009119-64-5				-11.9738918881	4	4		0	-4.82849028					COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	MedChem Express	HY-10466	-3.97631844	0.86587436	1.69359041	-4.82849028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165962-02	L-685458			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	292632-98-5				-48.6410091664	4	4		0	-10.76250819					CC(C)C[C@H](NC(=O)[C@@H](C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(N)=O	Glixx	GLXC-06622	-11.3831038	-8.97283531	-7.52127844	-10.76250819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247490-02	3-Hydroxy-4-methoxycinnamic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-34.2835655024	4	4		0	-2.98448766					COC1=C(O)C=C(\C=C\C(O)=O)C=C1	Analyticon	NP-013745	-8.87218677	-5.21222411	-6.74830641	-2.98448766												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00247668-03	LDN-57444	384568515	Reversible, competitive Inhibitor of UCH-L1 deubiquitinase	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	668467-91-2		14.1253754462	-4.85	-44.6202885536	4	4		-18.8316974561	-23.18578609	0.2843508969	0.9468375344			CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13	XcessBio	M60204-2s	-5.82603821	-10.20248544	-7.55686309	-23.18578609												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092388-15	Conessine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	546-06-5				-48.8291864222	4	4		0	-12.62234371					[H][C@]12CC[C@@]3([H])[C@]4([H])CC=C5C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]13CN(C)[C@H]2C)N(C)C	Enzo	NP495	-10.09530381	-7.61275745	-9.33959779	-12.62234371												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00386265-04	TCID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	30675-13-9				-26.7874744949	4	4		0	-6.6375355					ClC1=C(Cl)C(=C2C(=O)CC(=O)C2=C1Cl)Cl	APExBIO	B1467	-5.94978166	-3.14091681	-6.34879277	-6.6375355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378968-01	Lersivirine	363678296	Reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	473921-12-9				-33.5841706809	4	4		0	-7.92258178					CCC1=N[N](CCO)C(=C1OC2=CC(=CC(=C2)C#N)C#N)CC	MedChem Express	HY-14267	-6.60226832	-7.96906231	-7.48660753	-7.92258178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345452-02	Ac-DEVD-CHO			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	184179-08-6		11.220184543	-4.95	-28.8744701136	4	4		15.878401076	6.73366834	0.1789624522	0.9798272822			CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(=O)N[C@@H](CC(O)=O)C=O	Cayman	10017	-9.06533423	-6.70628183	-8.68507903	6.73366834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522503-02	VELPATASVIR		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-29.5315398088	4	4		0	-3.0456631					COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=CC7=C(C=CC8=C7[NH]C(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56	Astatech	40127	-6.5544172	-6.55348048	-8.4940073	-3.0456631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480888-01	STING agonist G10			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	702662-50-8				-25.982842298	4	4		0	-5.99153514					FC1=C(CN2C(=O)CSC3=CC=C(C=C23)C(=O)NCC4=CC=CO4)C(=CC=C1)Cl	Glixx	GLXC-07341	-6.22277804	-3.25019553	-4.78176868	-5.99153514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159491-11	Rimantadine		M2 Channel Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1501-84-4				-35.629573806	4	4		0	-7.79031831					CC(N)C12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0338A	-6.22277804	-9.472495	-10.43734083	-7.79031831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371131-03	NMS-873		p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1418013-75-8		3.1622776602	-5.5	-152.7581073952	-1.1	4		-91.3374253477	-99.5717719	0.0188974791	0.9997796824		VCP	CC1=C(C=CC(=C1)OCC2=NN=C(SC3CCCC3)[N]2C4=CN=CC=C4)C5=CC=C(C=C5)[S+](C)([O-])=O	Selleck	S7285	-7.44457508	-9.20203735	-75.67309363	-99.5717719												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094932-06	LANATOSIDE C			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	17575-22-3		35.4813389234	-4.45	-457.6340745207	5	4		-4.90574284	-97.71184199	0.7104652404	0.8766313892			CC1O[C@@H](CC(O)[C@H]1O[C@H]2CC(O)[C@@H](O[C@H]3CC(OC(C)=O)[C@H](O[C@H]4OC(CO)C(O)C(O)C4O)[C@@H](C)O3)C(C)O2)OC5CC[C@]6(C)C(CCC7C6CC(O)[C@@]8(C)C(CC[C@@]78O)\C9=C\C(=O)OC9)C5	Microsource	MS-01501205	-97.42119108	-97.3668202	-96.95705629	-97.71184199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167803-13	GSI-IX	384568339	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	208255-80-5				-12.5219450684	4	4		0	-3.77832643				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@H](C(=O)OC(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-13027	-3.93721161	-0.43451812	0.94405901	-3.77832643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510505-01	WT-161	384569466	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1206731-57-8		11.220184543	-4.95	-93.57742612	-2.1	4		-114.6588624384	-99.68697646	0.0112932686	0.9999213318		HDAC1	ONC(=O)CCCCCCC(=O)N\N=C\C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-100871	-3.55772133	-4.18006431	-10.10362694	-99.68697646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160628-18	RUTOSIDE  (rutin)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	153-18-4				-10.9628700845	4	4		0	-5.33903536					[H][C@@]1(C)O[C@@]([H])(OC[C@@]2([H])O[C@@]([H])(OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC=C(O)C(O)=C5)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Microsource	MS-00300607	-0.81504161	-4.74493786	-2.25256872	-5.33903536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263136-04	Pracinostat	363677222	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	929016-96-6 		1	-6	-208.6218420741	-1.1	4		-83.1589214004	-99.62863535	0.0331415879	0.9993219834		HDAC1	CCCCC1=NC2=CC(=CC=C2[N]1CCN(CC)CC)/C=C/C(=O)NO	Arking Pharma	SB-939	-16.22785633	-34.91139457	-97.73717808	-99.62863535												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379032-06	Tasquinimod	384569088	S100A9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	254964-60-8				-35.4813472198	4	4		0	-7.74496644			6280	S100A9	COC1=CC=CC2=C1C(=C(/C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)C(=O)N2C)/O	MedChem Express	HY-10528	-8.10986511	-5.8214194	-7.03059652	-7.74496644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346712-02	Verteporfin		photosensitizer	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	129497-78-5		12.5892541179	-4.9	-36.9916700144	-3	4		-48.2602945068	-44.96517062	0.1028845787	0.9934175837			COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786	-0.91853896	-2.83305814	1.34802845	-44.96517062												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345539-05	Dacinostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	404951-53-7		0.2818382931	-6.55	-296.1192844237	-1.1	4		-82.4398975868	-99.59880081	0.0070081259	0.9999697127		HDAC1	OCCN(CCC1=C[NH]C2=C1C=CC=C2)CC3=CC=C(\C=C\C(=O)NO)C=C3	Selleck	S1095	-33.83069559	-94.02972104	-99.52138403	-99.59880081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178124-03	LOGANIN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	18524-94-2				-32.1943293403	4	4		0	-9.96825677					COC(=O)\C1=C\O[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]3[C@@H](C)[C@@H](O)C[C@H]13	Microsource	MS-01504066	-4.75656561	-8.53393587	-9.48889084	-9.96825677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168696-01	NCGC00168696-01	85736118		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			4.4668359215	-5.35	-23.4928128345	4	4		11.568746956	2.49217002	0.0476318867	0.9986204121			FC(F)(F)C1=CC=C(Cl)C(=C1)NC(=O)C(OC(=O)CNC(=O)C2=CC=C3C=CC=CC3=C2)C4=CC=CC=C4	NCGCChem	DJM02-036-A4	-7.55728913	-6.26658676	-2.39929562	2.49217002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166215-04	PHENYLETHYL ALCOHOL			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	60-12-8				-22.0866144901	4	4		0	-8.15183846					OCCC1=CC=CC=C1	Microsource	MS-01505398	-2.54862219	-7.66489963	-5.90585756	-8.15183846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247542-02	Amentoflavone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1617-53-4				0.1253388488	4	4		0	2.60850112					OC1=CC=C(C=C1)\C2=C\C(=O)C3=C(O2)C(=C(O)C=C3O)C4=C(O)C=CC(=C4)\C5=C\C(=O)C6=C(O5)C=C(O)C=C6O	DC Chemicals	DCS-044	0.00812612	-2.68812602	0.04842615	2.60850112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134146-01	NCGC00134146-01	24409529		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-39.5192878376	4	4		0	-6.56375839					CC1=C(Cl)C=CC=C1NC(=O)N2CCN(CC2)CC\3=C\C(=O)N\4\N=C(/SC4=N3)C5=C(F)C=CC=C5	Sytravon	G768-1351	-7.67918089	-9.13449191	-12.33105877	-6.56375839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00128693-01	NCGC00128693-01	24404076		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.9676090722	4	4		0	-8.78299776					[O-][S+]1(=O)N(CC2=CC=CC=C2)C3=CC(=CC=C3C4=C1C=NC(=N4)SCC(=O)NC5=CC=CC=C5C(F)(F)F)Cl	Sytravon	G071-0990	-6.77718186	-8.93759096	-8.36891922	-8.78299776												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164861-02	NCGC00164861-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-42.7570075099	4	4		0	-3.6196868					CCOC(=O)C1=C(NC(=O)CSC2=C[N](CCNC(=O)C3=CC=C(OC)C=C3)C4=C2C=CC=C4)SC5=C1CCC5	Chemdiv	C064-0046	-11.8560052	-8.03869532	-5.94761171	-3.6196868												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379171-01	NCGC00379171-01	363678396		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	[479232-57-0]				-42.5335490649	4	4		0	-10.12527964					CN1CCCN(CC1)C(=S)[C@@H]2CCCN2C(=O)NCC3=CC=C(C=C3C)C(=O)N4CC5=C(NC6=C4C=CC=C6)[N](C)N=C5	Tocris	4625	-8.15862181	-9.34851468	-10.86946951	-10.12527964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018257-16	Methocarbamol		Muscle relaxant	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	532-03-6				-40.927183013	4	4		0	-4.52261307					COC1=C(OCC(O)COC(N)=O)C=CC=C1	MedChem Express	HY-B0262	-10.0562647	-7.19864177	-9.77939899	-4.52261307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015442-24	Fluorouracil		Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	51-21-8		3.5481338923	-5.45	-70.669866097	4	4		-23.9963082241	-32.85558226	0.0486792994	0.998539145		TYMS	F\C1=C\NC(=O)NC1=O	MedChem Express	HY-90006	-9.44323144	-9.10865874	-22.36407851	-32.85558226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379210-02	LMK235		Histone deacetylase 6 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1418033-25-6		1	-6	-211.0344468067	-1.1	4		-83.0798832439	-99.53681451	0.0214973189	0.9997148761	10013	HDAC6	CC1=CC(=CC(=C1)C)C(=O)NOCCCCCC(=O)NO	XcessBio	M60145-2s	-16.71565334	-36.20543294	-98.21087372	-99.53681451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246187-06	Pyronaridine Tetraphosphate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	76748-86-2		8.9125093813	-5.05	-117.8872853986	-2.1	4		-104.5180392864	-99.48437841	0.0383800476	0.9990904166			COC1=CC=C2NC3=C(C=CC(Cl)=C3)C(N=C4C=C(CN5CCCC5)C(=O)C(CN6CCCC6)=C4)=C2N1	AvaChem	1554_cm1	-9.57759489	-6.8336163	-20.45336113	-99.48437841												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167491-06	Lenalidomide		TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	191732-72-6				-13.0285193477	4	4		0	0.72973563				TNF	NC1=CC=CC2=C1CN([C@H]3CCC(=O)NC3=O)C2=O	Selleck	S1029	-1.49059456	-6.01867572	-7.9555324	0.72973563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402247-01	BG45			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	926259-99-6		2.8183829313	-5.55	-42.3322852934	4	4		-21.2808826601	-17.43063142	0.1444342721	0.9870776422			NC1=C(NC(=O)C2=NC=CN=C2)C=CC=C1	SynKinase	SYN-5062	-5.52989587	-9.37181664	-12.35018239	-17.43063142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482045-01	NCGC00482045-01	375815951		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-39.9271082299	4	4		0	-2.63534676					FC(F)(F)C1=CC=CC(=C1)C2=CC(=N[N]3C=NN=C23)C(=O)NCC4=CC=C5OCOC5=C4	ChemRoutes	CA-37-245	-9.67007964	-11.83117884	-7.14505833	-2.63534676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179135-02	EPICATECHIN MONOGALLATE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1257-08-5				-25.1901037974	4	4		0	-11.49440716					OC1=CC2=C(C[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](O2)C4=CC(=C(O)C=C4)O)C(=C1)O	Microsource	MS-00210238	-3.48610434	-5.82998031	-5.18159806	-11.49440716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00124418-01	NCGC00124418-01	24399801		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-30.4817192466	4	4		0	-7.14541387					[O-][S+](=O)(CC1=CC=C(F)C=C1)C2=C[N](CC(=O)NCCC3=CC=CC=C3)C4=C2C=CC=C4	Sytravon	E690-0710	-4.75377864	-9.53685472	-9.06449483	-7.14541387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346546-02	NCGC00346546-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	957116-20-0				-26.4240388489	4	4		0	-4.43400447					FC1=CC(=CC(=C1)F)[C@@H]2CNC3(CCCC3)C(=O)N2CC(=O)NC4=CC=C5C[C@]6(CC5=C4)C(=O)NC7=C6C=CC=N7	Selleck	S1542	-4.10368926	-8.38969266	-9.68082765	-4.43400447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370733-05	Retro-2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1429192-00-6				-45.2961470679	4	4		0	-6.46274853					CC1=CC=C(S1)C2NC3=C(C=CC=C3)C(=O)N2C4=CC=CC=C4	Glixx	GLXC-02449	-10.45095734	-9.53310696	-10.17891263	-6.46274853												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378845-08	Trelagliptin (succinate)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1029877-94-8				-9.764238613	4	4		0	-1.46384094					CN1C(=O)\C=C(\N2CCC[C@@H](N)C2)N(CC3=C(C=CC(=C3)F)C#N)C1=O	MedChem Express	HY-15408A	-1.62495801	-0.87436333	-5.5931909	-1.46384094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00138211-01	NCGC00138211-01	24413594		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-40.658520748	4	4		0	-8.15659955					CC(=O)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC=C(CN4C(=O)NC5=CC=CC=C5C4=O)C=C3	Sytravon	K221-2840	-7.61417195	-12.02807979	-9.60158486	-8.15659955												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00129227-01	NCGC00129227-01	24404610		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-43.5858432074	4	4		0	-7.39597315					CCOC1=CC=CC=C1CNC(=O)CC2=CC=C(NC(=O)N3CCCCC4=CC=CC=C34)C=C2	Sytravon	G217-1159	-9.6050707	-9.26290557	-10.09465111	-7.39597315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00106735-02	NCGC00106735-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-24.2855893819	4	4		0	-2.61744966					CC1=CC=C(CNC(=O)C2=CC=C(CN3C(=O)N(CC(=O)NC4=C(C)C=C(C)C=C4)C5=CC=CC=C5C3=O)C=C2)C=C1	Chemdiv	C260-2769	-5.30635462	-6.18953857	-6.37023993	-2.61744966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013226-25	Trifluoperazine hydrochloride	384567788	CaMK-II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	440-17-5		10	-5	-67.1103459974	-3	4		-49.561237024	-52.99104217	0.0146036991	0.9998685054		DRD2	CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	MedChem Express	HY-B0532A	-6.85673497	-6.27334465	-8.02501303	-52.99104217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510789-01	RSV604			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	676128-63-5				-8.1649783374	4	4		0	-0.9919161					FC1=CC=CC=C1NC(=O)N[C@H]2\N=C(\C3=CC=CC=C3)C4=CC=CC=C4NC2=O	SIGMA	SML1695	-3.38847833	-0.56027165	2.3189161	-0.9919161												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00490649-01	NCGC00490649-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-23.7399600351	4	4		0	-3.86650207					CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024	-4.59269481	-7.83870687	-5.21208396	-3.86650207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262945-10	Rivaroxaban			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	366789-02-8				-17.5960313547	4	4		0	-7.08491315					ClC1=CC=C(S1)C(=O)NC[C@H]2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O	Glixx	GLXC-90151	-1.54814783	-5.53576084	-6.40642838	-7.08491315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370899-04	Golgicide A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1139889-93-2		2.5118864315	-5.6	-147.6042539454	-1.1	4		-93.2282884288	-98.5054228	0.0361885547	0.9991914021			[H][C@@]12CC=C[C@]1([H])C3=C(NC2C4=CN=CC=C4)C(F)=CC(F)=C3	APExBIO	B1385	-3.6525939	-7.53454419	-84.96092035	-98.5054228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161679-13	MG-132			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	133407-82-6		1.2589254118	-5.9	-169.2340327005	-1.1	4		-92.1506262412	-98.61918287	0.0217515328	0.9997080762			CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	APExBIO	A2585	-6.235304	-17.84380306	-96.03960396	-98.61918287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00599698-01	4-Butylresorcinol Rucinol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-21.271644855	4	4		0	-7.45525086					CCCCC1=C(O)C=C(O)C=C1	BLD Pharma	BD66959	-1.78101686	-9.0119058	-6.94212699	-7.45525086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166076-09	Arbutin		Free Radical Scavenger	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	497-76-7				-34.2887215722	4	4		0	-8.28410193					OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O	Prestwick	Prestw-1026	-6.6108931	-9.44642392	-7.31975059	-8.28410193												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00165993-02	Picolinic acid	170466822		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	98-98-6				-24.3935093355	4	4		0	-4.50136672					O=C(O)c1ccccn1	Bosche	P0843	-4.98080987	-8.91631181	-2.97268815	-4.50136672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166414-05	Pemetrexed	384568308	Thymidylate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	150399-23-8		6.3095734448	-5.2	-61.4354231827	-2.2	4		-33.3852085336	-36.34258248	0.0218739345	0.999705253			NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Selleck	S1135	-6.73916695	-7.24108659	-17.17040125	-36.34258248												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390769-01	HIV-1 integrase inhibitor			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	544467-07-4				-18.1186675734	4	4		0	-5.02075595					OC(=O)\C(O)=C\C(=O)C1=CC=CC(=C1)CN=[N+]=[N-]	MedChem Express	HY-13025	-1.98605979	-5.6196944	-7.67760987	-5.02075595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522539-01	Trovirdine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	149488-17-5				-43.883928499	4	4		0	-4.08564562					BrC1=CN=C(NC(=S)NCCC2=NC=CC=C2)C=C1	MedChem Express	HY-15349	-11.42509237	-6.79966044	-9.87493486	-4.08564562												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250401-11	Flavopiridol	384568550	CDK1/2/4/6/7/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	146426-40-6		0.3981071706	-6.4	-208.9266771578	-1.1	4		-89.828064627	-92.23613438	0.0114277828	0.9999194488		CDK1	CN1CC[C@H]([C@@H](O)C1)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	MedChem Express	HY-10005	-5.33442581	-87.6857565	-93.10178273	-92.23613438												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00169121-02	Neochlorogenic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-33.1606816153	4	4		0	-8.70734503					O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\C2=CC(=C(O)C=C2)O)[C@H]1O)C(O)=O	Analyticon	NP-000060	-5.59316917	-8.5947684	-9.10248529	-8.70734503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate			-24.3307240609	4	4		0	-6.2736972			7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	-3.12648238	-8.5947684	-8.08377975	-6.2736972												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016480-10	Kaempferol		flavanoid	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[520-18-3]		10	-5	-27.9201155087	4	4		-15.6096092801	-16.94122788	0.1474066822	0.9864516764			OC1=CC=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O	Tocris	3603	-4.17786362	-2.26655348	-4.29911412	-16.94122788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164566-08	Pitavastatin calcium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[147526-32-7]		2.8183829313	-5.55	-149.2714149348	-1.3	4		-84.0711806156	-94.79134804	0.0738515291	0.9966211106			O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	Tocris	4942	-7.31021162	-13.81154499	-71.67795727	-94.79134804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480786-05	Brequinar sodium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[96201-88-6]		0.4466835922	-6.35	-110.0341968795	4	4		-28.5933765548	-36.62224164	0.1244396954	0.9903477227			CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C3=CC=C(C=C3)C4=CC=CC=C4F	Tocris	6196	-13.0290561	-31.56196944	-39.10022581	-36.62224164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390686-01	NBD-557	363680970	Envelope glycoprotein gp160 Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	333352-59-3		11.220184543	-4.95	-53.8800867936	-2.4	4		-41.6219024312	-36.73838286	0.2392250989	0.9630084241			CC1(C)CC(CC(C)(C)N1)NC(=O)C(=O)NC2=CC=C(Br)C=C2	MedChem Express	HY-76649	-3.64396912	-10.9759277	-13.51102134	-36.73838286												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016925-21	Omeprazole	384567968	ABCC3 Expression Enhancer	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	73590-58-6				-4.0806451081	4	4		0	0.63927343				ABCC3	COC1=CC2=C([NH]C(=N2)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC)C=C1	MedChem Express	HY-B0113	-0.7374186	-3.87590163	0.04830069	0.63927343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263533-12	Penciclovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	39809-25-1				-16.1922786243	4	4		0	-3.48734679					N\C1=N\C2=C(N=CN2CCC(CO)CO)C(=O)N1	APExBIO	B1809	-3.03160981	-4.51029808	-3.85088259	-3.48734679												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381566-06	Nexturastat A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1403783-31-2		10	-5	-91.7643539697	-2.4	4		-52.0002651952	-49.58557446	0.1210571157	0.9908600236			CCCCN(CC1=CC=C(C=C1)C(=O)NO)C(=O)NC2=CC=CC=C2	MedChem Express	HY-16699	-10.79391091	-15.98157643	-22.84622815	-49.58557446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346526-03	PHA-680632	384568820	Aurora-A/B/c Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	398493-79-3				-43.3865949157	4	4		0	-15.13218265				AURKA	CCC1=CC=CC(=C1NC(=O)N2CC3=C(C2)C(=N[NH]3)NC(=O)C4=CC=C(C=C4)N5CCN(C)CC5)CC	Selleck	S1454	-7.60413168	-6.6893039	-11.42087893	-15.13218265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479258-01	NCGC00479258-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-41.0445652896	4	4		0	-6.80358313					OC(=O)C1=CC=NC2=C1[NH]C(=C2)C(OCCN3CCCCC3)C4=C(Cl)C=CC=C4	NCGCChem	GRB054-050_2nd_pos	-9.24168626	-6.76570458	-10.91714435	-6.80358313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164574-25	Erlotinib		EGFR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	183321-74-6		10	-5	-124.7320491956	-2.2	4		-87.288451838	-80.17915665	0.0079314955	0.9999612059		EGFR	COCCOC1=CC2=NC=NC(=C2C=C1OCCOC)NC3=CC=CC(=C3)C#C	DC Chemicals	DC2101	-13.37336245	-14.83022071	-29.02553413	-80.17915665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095191-16	Oseltamivir phosphate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	204255-11-8				-25.3949256005	4	4		0	-4.06816692					CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	APExBIO	B1803	-5.90779308	-5.91680815	-4.48150078	-4.06816692												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179342-03	Oxprenolol hydrochloride	170464995	Adrenergic receptor beta Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	6452-73-9				-8.6895930696	4	4		0	-4.79234635					Cl.CC(C)NCC(O)COc1ccccc1OCC=C	Tocris	3288	-0.95303808	-1.56426523	-2.26135066	-4.79234635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164564-09	Emtricitabine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	143491-57-0				-36.1394182308	4	4		0	-1.03561285					NC\1=N\C(=O)N(\C=C1F)[C@@H]2CS[C@H](CO)O2	MedChem Express	HY-17427	-9.88831038	-5.95925297	-8.51137745	-1.03561285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381559-05	Resminostat		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1187075-34-8		5.6234132519	-5.25	-138.9378144195	-2.3	4		-107.5407154083	-99.54555386	0.0725727887	0.9967376613		HDAC1	CN(C)CC1=CC=C(C=C1)[S+]([O-])(=O)[N]2C=CC(=C2)\C=C\C(=O)NO	MedChem Express	HY-14718A	-8.28434666	-15.82342954	-46.23936078	-99.54555386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183808-18	ML324		JMJ Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			12.5892541179	-4.9	-48.0953746622	-3	4		-66.398686184	-57.41557182	0.0767054552	0.9963544573		JARID2	CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O	NCGCChem	GRB059-084	-2.31575316	1.87711828	-0.82989374	-57.41557182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346581-06	AZ-960		Jak2/3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	(905586-69-8)		3.5481338923	-5.45	-142.6925003948	-2.3	4		-123.6827573442	-96.83890309	0.16417095	0.9830006101		JAK2	C[C@H](NC1=NC(=C(F)C=C1C#N)NC2=N[NH]C(=C2)C)C3=CC=C(F)C=C3	SynKinase	SYN-1015	-2.64349476	-32.91909273	-58.01791517	-96.83890309												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	51773-92-3		10	-5	-87.9590678753	-3	4		-101.9043232925	-99.70461159	0.0505224753	0.9984223977		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-1.65164518	-6.25706092	-6.93334504	-99.70461159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163413-03	Lycorine HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	2188-68-3		4.4668359215	-5.35	-125.133872285	-2.1	4		-90.9413798223	-90.85177674	0.021721867	0.9997088948			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046	-6.74026478	-9.4029721	-47.84842364	-90.85177674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379006-04	PSI-6206			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	863329-66-2				-25.8193361995	4	4		0	-6.17670399					C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2\C=C/C(=O)NC2=O	MedChem Express	HY-15236	-5.25680279	-6.85669592	-4.27241591	-6.17670399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183095-07	Tigecycline	384568415	glycylcycline antibiotics	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	220620-09-7				-35.0847348011	4	4		0	-8.62798695					CN(C)[C@H]\1[C@@H]2C[C@@H]\3CC4=C(C(=C(NC(=O)CNC(C)(C)C)C=C4N(C)C)O)C(=O)C3=C(O)/[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Enzo	AC3268	-7.18875329	-9.15095159	-5.55457978	-8.62798695												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263207-01	NCGC00263207-01	137276051		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1217444-15-9	QS11			-52.6435946207	4	4		0	-15.70917226			442334	ARF1	OC[C@H](CC1=CC=CC=C1)NC2=NC(=NC3=C2N=C[N]3CC4=CC=C(C=C4)C5=CC=CC=C5)OC6=CC7=C(CCC7)C=C6	Tocris	3324	-10.2632862	-11.10350141	-9.91855602	-15.70917226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00441105-01	NCGC00441105-01	375840228		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-8.9780930978	4	4		0	1.44519016					COC1=CC=C(NC(=O)N2CC(C2)OC3=CC=C(C=C3)C4=NC(=NO4)C5=CC=CC=C5)C=C1	Chemdiv	S050-0185	-1.50333171	-2.14022772	-6.75764913	1.44519016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370745-06	NCGC00370745-06			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-32.010528632	4	4		0	-1.30201342					CC1=NOC(N[S+]([O-])(=O)C2=CC=C(NC(=O)C3=C4C=C(C)C=C(C)C4=NC(=C3)C5=NC=CC=C5)C=C2)=C1C	NCGCChem	KKW009-092	-9.15000813	-3.98938447	-6.98657275	-1.30201342												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00651741-01	2,2 -Cyclouridine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	3736-77-4				-20.3278822925	4	4		0	-5.03923816					OC[C@H]1O[C@@H]2[C@@H](OC3=NC(=O)C=C[N@@]23)[C@@H]1O	Selleck	S4984	-5.0498081	-2.69401234	-2.55115483	-5.03923816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016435-06	HARMINE	124882259		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			8.9125093813	-5.05	-31.8865243193	4	4	LS-133548;HARMINE;HARMINE HYDROCHLORIDE;NCGC00094869-01;NCGC00094869-02;7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole;CIPLUS_711790;9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-;Harmine hydrochloride;Harmine;CIPLUS_153150;harmine;CIPLUS_165046;7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole hydrochloride;CIPLUS_758970;NCGC00016435-01;NCGC00094869-04;CIPLUS_152786;NCGC00094869-05;NCGC_Prestw-613;Harmine Hydrochloride;	-18.8336813561	-17.031126	0.1519582361	0.9856178332			COC1=CC2=C(C=C1)C3=CC=NC(=C3[NH]2)C	BIOMOL	AC-1053	-3.41972487	-6.03980186	-8.87415474	-17.031126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167474-06	Candesartan	363676659	Type-1 angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	139481-59-7				-34.5456307702	4	4		0	-7.66687241					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5)C(O)=O	Selleck	S1578	-7.15425417	-7.02181281	-8.06621586	-7.66687241												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386434-02	GSK744 (S/GSK1265744)	363680286	Solute carrier family 22 member 8 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1051375-10-0		14.1253754462	-4.85	-27.8471292848	4	4		-13.1179482321	-13.0720395	0.5599088142	0.7402587356			C[C@H]1CO[C@@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	APExBIO	A8566	-5.93816033	-4.11054141	-0.05708264	-13.0720395												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015798-15	Propranolol HCl			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	318-98-9				-30.4216380756	4	4		0	-9.87126356					CC(C)NCC(O)COC1=C2C=CC=CC2=CC=C1	APExBIO	B1346	-4.82556384	-6.60467541	-8.73364363	-9.87126356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387263-05	Oltipraz		Nuclear Factor Erythroid 2-Related Factor 2 (NFE2-Related Factor 2; NFE2L2; NRF2) Activator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	64224-21-1				-32.4863207767	4	4		0	-7.4464333				NRF2	C\C1=C(\SSC1=S)C2=CN=CC=N2	SIGMA	O9389	-7.13700461	-5.74432954	-6.69623255	-7.4464333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508866-01	MK-1439			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1338225-97-0 				-25.1378799223	4	4		0	-6.80275108					CN\1C(=O)N\N=C1CN2\C=C/C(=C(OC3=CC(=CC(=C3)C#N)Cl)\C2=O)C(F)(F)F	Bio Vision	B1250	-5.31717625	-5.49230903	-3.77184509	-6.80275108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00104961-01	NCGC00104961-01	24268306		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-17.2482857711	4	4		0	-5.38255034					FC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC=C4C(=O)N(CCC5=CC=CC=C5)C(=O)NC4=C3	Sytravon	C190-0322	-3.63237445	-1.46391576	-4.1866608	-5.38255034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095055-08	Salinomycin		Anticoccidial/Antibacterial	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	53003-10-4				-28.280902385	4	4		0	-5.90335949				WNT1	CCC(C1CCC(C)C(O1)C(C)C(O)C(C)C(=O)C(CC)C2OC\3(O[C@]4(CC[C@@](C)(O4)C5CC[C@@](O)(CC)C(C)O5)C(O)\C=C3)C(C)CC2C)C([O-])=O	Enzo	NP267	-5.170555	-7.34335622	-5.81803811	-5.90335949												1.6E-9	8E-9	4E-8	2E-7											
NCGC00250412-15	JQ1		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1268524-70-4		0.3981071706	-6.4	-347.4173199679	5	4		-27.7051091214	-87.58046028	0.104260409	0.9932465705		BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030	-61.69735651	-87.70313722	-90.28277861	-87.58046028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263555-02	Spautin-1	174006174	Ubiquitin Specific Peptidase (USP10/13) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1262888-28-7	Spautin-1	11.220184543	-4.95	-28.3124149676	4	4		-23.582280708	-20.72568557	0.4007900634	0.8861908671	84669	USP10	FC1=CC=C(CNC2=C3C=C(F)C=CC3=NC=N2)C=C1	SIGMA	SML0440	-1.07378498	-7.86477796	-6.55572144	-20.72568557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137717-01	NCGC00137717-01	24413100		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-45.7488163552	4	4		0	-17.06040268					FC1=CC=C(C=C1)C(=O)N2CCC3=CC(=CC=C23)CNC(=O)C4=CC5=C([NH]4)C=CC=C5	Sytravon	G883-0849	-7.84982935	-7.396627	-11.13361215	-17.06040268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163662-01	NCGC00163662-01	26757041		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			12.5892541179	-4.9	-22.6148680893	4	4	schisandrin A;deoxyschisandrin;Schizandrin A;CIPLUS_183967;SCHISANDRIN A, R(+)-;Deoxyschizandrin;schizandrin A;Dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer;CIPLUS_732662;NCGC00163662-01;	-14.983404064	-14.23595803	0.0942467982	0.9945419495			COC1=C(OC)C(OC)=C2C(C[C@H](C)[C@H](C)CC3=CC(OC)=C(OC)C(OC)=C23)=C1	BIOMOL	NP-455	-2.58312131	-3.59781003	-4.09677703	-14.23595803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132816-01	NCGC00132816-01	24408199		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.7684548569	4	4		0	-7.26174497					CC1=CC=C(CNC(=O)C2=CC=C(C=C2)C3=NC(=C(C)O3)CN4CCC5=C4C=CC=C5)C=C1	Sytravon	G659-0754	-7.0778482	-8.74069001	-8.80915694	-7.26174497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253439-03	NCGC00253439-03	384568562		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1089283-49-7		14.1253754462	-4.85	-45.3507526903	4	4		-30.221828556	-29.74049217	0.3401172758	0.9212414371		IGFR1	CCC1=CC(=C(OC)C=C1N2CCC(CC2)N3CCN(CC3)[S+](C)([O-])=O)NC4=NC(=CC=N4)C5=C(N=C6C=CC=C[N]56)C7=CC(=C(OC)C=C7)C(=O)NC8=C(F)C=CC=C8F	Selleck	S1093	-6.32211929	-9.17729646	-0.80563504	-29.74049217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346433-06	Peramivir		Influenza Infection Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	330600-85-6				-25.1297576676	4	4		0	-4.38278348					CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	APExBIO	A3709	-5.58028216	-7.84380306	-6.4616988	-4.38278348												1.6E-9	8E-9	4E-8	2E-7											
NCGC00163651-06	DIHYDROTANSHINONE I			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-50.4027116134	4	4		0	-13.17456849					C[C@H]1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CC=C4C	Microsource	01505825	-9.56919718	-10.00848896	-13.05367379	-13.17456849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182552-14	Atazanavir		Human immunodeficiency virus type 1 protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	198904-31-3				-44.1528658424	4	4		0	-8.2980118					COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	SIGMA	SML1796	-9.96388982	-7.05432937	-10.83897863	-8.2980118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485882-01	BCX 4430	363681391		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	222631-44-9				-30.5759611076	4	4		0	-8.29082774					NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649	-6.54965058	-4.88828011	-6.06207352	-8.29082774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111301-01	NCGC00111301-01	24385880		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-67.583354034	-3	4		-39.4249684479	-42.098434	0.0536650632	0.9982214212			COC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3CCCN(C3)[S+]([O-])(=O)C4=CC5=C(C=C4)N(C)C(=O)O5	Sytravon	C648-0204	-9.56444011	-8.75781183	-7.97270526	-42.098434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168284-02	NCGC00168284-02	85736014		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-23.32869024	4	4		0	0.3803132					FC(F)(F)C1=CC(=C(Cl)C=C1)NC(=O)[C@H](NC(=O)CNC(=O)C2=CC=CC=C2)C3=CC=CC=C3	NCGCChem	BTM01-69	-6.1839753	-5.12798562	-6.06207352	0.3803132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164100-01	Trisiloxane, octamethyl-	26757517		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	107-51-7	Octamethyltrisiloxane; Poly(dimethylsiloxane); Trisiloxane, octamethyl-; 			-17.7995299967	4	4	Trisiloxane, octamethyl-;Octamethyltrisiloxane;NCGC00164100-01;Poly(dimethylsiloxane);CIPLUS_208116;	0	-0.01342282					C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	SigmaAldrich	MFCD00008264	-4.95693158	-2.62819964	-2.58419547	-0.01342282												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00481317-01	CB-5083	363681118	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1542705-92-9		0.316227766	-6.5	-245.6922576578	-1.1	4		-95.247143941	-99.49311776	0.0109930178	0.9999254628		VCP	CC1=CC2=C(C=CC=C2C(N)=O)[N]1C3=NC(=C4COCCC4=N3)NCC5=CC=CC=C5	ActiveBioChem	A-1513	-14.45666779	-93.44651952	-98.85356957	-99.49311776												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137860-02	NCGC00137860-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-27.7633977699	4	4		0	-2.51901566					FC(F)(F)C1=CC(=NC2=CC(=N[N]12)C(=O)NC3=C(C#N)C4=C(CCCC4)S3)C5=CC=C(Br)C=C5	Chemdiv	K061-0771	-5.9970746	-7.59352795	-7.52366278	-2.51901566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485610-01	NCGC00485610-01	363681369		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	222036-17-1 (principal component)		1.2589254118	-5.9	-30.0624055181	4	4		15.19795222	4.03131991	0.0984764379	0.9940066264			[O-][S+](=O)(NC1=NC=CC=C1)C2=CC=C(N/C=C/3C(=O)NC4=C3C5=C(C=C4)N=CS5)C=C2	SIGMA	G7791	-11.83162685	-10.44431127	-9.51353731	4.03131991												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00507862-01	LDC4297 (LDC044297)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1453834-21-3		8.9125093813	-5.05	-152.6547501893	-2.3	4		-104.1562294485	-95.04478916	0.0523663409	0.998305054			CC(C)C1=C2N=C(OC3CCCNC3)N=C(NCC4=CC=CC=C4[N]5C=CC=N5)[N]2N=C1	Selleck	S7992	-14.72539469	-21.3582343	-41.61021365	-95.04478916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093704-43	Cyclosporin A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	59865-13-3		3.9810717055	-5.4	-56.2061668426	-3	4		-36.0477907374	-38.49246231	0.1001362325	0.9937701047			CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	Selleck	S2286	-4.86647632	-1.52801358	-5.46291471	-38.49246231												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00238451-08	Olaparib		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	763113-22-0				-42.7134876739	4	4		0	-11.34804457				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	Axon Medchem	1464	-8.09959691	-7.96264856	-11.42087893	-11.34804457												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166291-04	Lycopene		response to oxidative stress Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	502-65-8				-5.4248219872	4	4		0	-2.03579418					CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(C)\CCC=C(C)C	Glixx	GLXC-06674	-1.38143995	-2.61963873	2.08232446	-2.03579418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00140029-01	NCGC00140029-01	24415412		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.219379356	4	4		0	-8.28187919					CC1=C(OC2=CC=C(C=C12)[S+]([O-])(=O)N3CCC4(CC3)OCCO4)C(=O)NC5=CC=C(F)C(=C5)F	Sytravon	K786-1599	-7.95546888	-2.48266416	-8.55381906	-8.28187919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164361-03	Decanedioic acid			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			17.7827941004	-4.75	-53.6661782498	-3	4		-60.9792038077	-59.85143107	0.0465072234	0.998664024			OC(=O)CCCCCCCCC(O)=O	Analyticon	NP-002989	-3.95952301	-6.39219015	-6.00138961	-59.85143107												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00371134-02	PR-619		Ubiquitin carboxyl-terminal hydrolase isozyme L3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2645-32-1		8.9125093813	-5.05	-99.0177047962	-3	4		-97.5174133071	-98.85514529	0.0275898972	0.999530231	7347	UCHL3	NC1=NC(=C(SC#N)C=C1SC#N)N	Selleck	S7130	-6.25209943	-3.82852292	-9.28434949	-98.85514529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00128419-02	NCGC00128419-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-16.5459116091	4	4		0	-5.5704698					CC(=O)C1=CC(=CC=C1)NC(=O)CSC2=NC3=C(C=N2)[S+]([O-])(=O)N(CC4=CC=CC=C4)C5=CC=C(Cl)C=C35	Chemdiv	G071-1348	-2.25906062	-3.66406986	-5.79793088	-5.5704698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371045-07	AMD-3465	384569040	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	185991-07-5				-22.5188387322	4	4		0	-2.993227				CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CNCC3=NC=CC=C3)C=C2	MedChem Express	HY-15971	-4.76570373	-7.04584041	-4.55966649	-2.993227												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263606-06	Tubastatin A	384568693	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1310693-92-5		5.6234132519	-5.25	-31.376818008	4	4		-19.9197186521	-19.94183445	0.0468176433	0.9986524806		HDAC6	CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=C(C=C4)C(=O)NO	Selleck	S2627	-2.92540224	-3.04768427	-9.83050847	-19.94183445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00111803-01	NCGC00111803-01	24386382		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-20.6942057294	4	4		0	-4.35346756					COC1=CC(=CC=C1)NC(=O)C2=C(NC(=O)C3=CC=C(C=C3)C(F)(F)F)C4=C(O2)C=CC=C4	Sytravon	C686-0308	-3.6079961	-6.40356134	-5.36649791	-4.35346756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346469-08	Delanzomib		Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	847499-27-8		0.1122018454	-6.95	-386.1460320433	5	4		-89.7849137577	-98.19680804	0.0356311791	0.9992172681		PSMD1	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)[C@@H](C)O)B(O)O	Bio Vision	2433	-68.87317262	-97.34074911	-98.4851146	-98.19680804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481588-01	ACY-241	384569257		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			10	-5	-65.3207642932	-2.2	4		-39.7860656479	-36.5796667	0.049460368	0.9984908307		HDAC1	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=C(Cl)C=CC=C3	APExBIO	B5936	-7.49924533	-9.8896324	-17.0501449	-36.5796667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091149-26	Valproic acid sodium salt (Sodium valproate)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1069-66-5				-20.8008970923	4	4		0	-6.12379861					CCCC(CCC)C(O)=O	Selleck	S1168	-4.31670188	-2.71139307	-4.72907702	-6.12379861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092327-05	4-HQN			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[491-36-1]				-27.086402965	4	4		0	-9.4127502					OC1=NC=NC2=C1C=CC=C2	Tocris	2192	-3.56634611	-7.9951334	-7.66224642	-9.4127502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346512-02	BMS-707035	363677435	HIV Integrase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	729607-74-3				-5.4480114972	4	4		0	-7.65805485					CN\1C(=O)/C(=C(\N=C1N2CCCC[S+]2([O-])=O)C(=O)NCC3=CC=C(F)C=C3)O	Selleck	S1366	0.14230885	-1.02546276	0.90014929	-7.65805485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509914-02	NMS-P118		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1262417-51-5		11.220184543	-4.95	-33.599001339	4	4		-15.73256382	-16.23754519	0.187288959	0.9779927384		PARP1	NC(=O)C1=CC(=CC2=C1C(=O)N(C2)C3CCN(CC3)C4CCC(F)(F)CC4)F	MedChem Express	HY-18954	-4.37707534	-6.58729469	-8.12768947	-16.23754519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165875-04	PB-28	384568294	sigma1/2 Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	172907-03-8		14.1253754462	-4.85	-44.646644227	4	4		-14.9490425921	-20.26717221	0.1885079115	0.9775948592		SIGMAR1	COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1	Axon Medchem	1272	-7.55099401	-8.47310333	-6.14297005	-20.26717221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091162-09	Aminothiazole			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	96-50-4				-17.4288787441	4	4		0	-6.8732916					NC1=NC=CS1	APExBIO	B1659	-2.52274785	-5.16207526	-5.08035479	-6.8732916												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00421347-01	NCGC00421347-01	375798736		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			2.8183829313	-5.55	5.8198512543	4	4		12.075036388	-3.69127517	1	0.985692612			O[C@@H]1CCCN(C[C@H]1NC(=O)C2=CC=C(OCC3=CC=CC=C3)C=C2)C(=O)NC4=CC(=CC=C4)C(F)(F)F	Analyticon	NAT10-367732	-1.60084512	-2.97919699	8.28967643	-3.69127517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126065-01	NCGC00126065-01	24401448		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.8110612612	4	4		0	-7.08277405					CC1=C(NC(=O)C2=CC=CC(=C2)NC(=O)N3CCSC4=NC=CC=C34)C=CC=C1Cl	Sytravon	E867-0334	-8.2480091	-6.8487287	-6.67840634	-7.08277405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	52-86-8				-23.5011374598	4	4		0	-8.30173706					OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920	-3.87683816	-6.30051273	-4.28119786	-8.30173706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133970-01	NCGC00133970-01	24409353		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					1.5365203091	4	4		0	-0.40715884					CC1=C(C=CC=C1)C(=O)NC2=CC=CC(=C2)OCC\3=C\C(=O)N4/C=C\C=C(C)/C4=N3	Sytravon	G756-0565	0.2356574	-2.73093057	4.50363196	-0.40715884												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094614-07	CHLOROXYLENOL			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	88-04-0				-4.5328511009	4	4		0	-1.15069218					CC1=CC(=CC(=C1Cl)C)O	Microsource	01500182	-1.32390357	-1.59902668	1.18117151	-1.15069218												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510496-01	VLX-1570	384569458	Ubiquitin C-terminal Hydrolase L5 (UCH-L5) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1431280-51-1		1.1220184543	-5.95	-177.540881056	-1.1	4		-93.591037981	-99.68697646	0.0112281032	0.999922236		UCHL5	[O-][N+](=O)C1=CC(=CC=C1F)/C=C/2CCN(CC(=C/C3=CC=C(F)C(=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	MedChem Express	HY-12471	-6.91276036	-22.63839402	-99.51260209	-99.68697646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015036-23	Amantadine hydrochloride	384567799	Dopamine Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	665-66-7				-8.3713289408	4	4		0	-0.70246085				DRD1	NC12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0402A	-3.25044694	-2.55971235	3.20933304	-0.70246085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123501-02	NCGC00123501-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-33.5487612406	4	4		0	-5.91051454					CC1CCN(CC1)C2=C(F)C=C3C(=O)C(=C/N(CC4=CC=CC=C4)C3=C2)\[S+]([O-])(=O)C5=CC(=CC=C5)C	Chemdiv	E599-0577	-7.11035267	-8.44961904	-7.25071539	-5.91051454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00128071-01	NCGC00128071-01	24403454		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.8957030272	4	4		0	-4.99776286					CC(=O)C1=CC=C(NC(=O)C2CCC(CC2)CN[S+]([O-])(=O)C3=CC4=C(NC(=O)CCC4)C=C3)C=C1	Sytravon	G017-0209	-8.68681944	-8.88622549	-3.95773718	-4.99776286												1.6E-7	8E-7	0.000004	0.000019999999999											
MLS000543798-03	MLS000543798-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			3.9810717055	-5.4	-115.6849415725	-2.4	4		-80.7010976255	-64.22984488	0.1348430728	0.9886203108			C1CN(CCO1)C2=NC(NC3=CC=CC=C3)=NC(N\N=C\C4=CNC5=C4C=CC=C5)=N2	Specs	AG-205/33155024	-8.40191468	-25.49235993	-40.6374848	-64.22984488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164126-01	Octyl gallate	26757543		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1034-01-1		8.9125093813	-5.05	-79.2901597768	-2.2	4	OCTYL-GALLATE;CIPLUS_197519;NCGC00164126-01;3,4,5-trihydroxybenzoic acid octyl ester;octyl gallate dihydrate;Octyl gallate;octyl gallate;	-72.2265078623	-71.83307844	0.0213518692	0.9997187674			CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1	SigmaAldrich	MFCD00002197	-5.23597581	-7.89473684	-38.28382838	-71.83307844												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00379028-01	PSI-6130		Hepatitis C virus NS5B RNA-dependent RNA polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	817204-33-4				-3.6920098941	4	4		0	2.47760542					C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2/C=C\C(=N/C2=O)N	MedChem Express	HY-10165	-1.58296943	0.88285229	-3.03109258	2.47760542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398316-01	NCGC00398316-01	375800526		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-14.7038517378	4	4		0	0.76510067					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)[N]3N=NN=C3OC4=CC=C(C=C4)[N]5C=CN=C5)NC6=CC=C(OC7=CC=CC=C7)C=C6	Analyticon	NAT6-298623	-5.26572404	-1.94332677	-0.67356372	0.76510067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00065890-14	Nevirapine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	129618-40-2				-1.1081046417	4	4		0	1.97315436				TERT	CC1=CC=NC2=C1NC(=O)C3=CC=CN=C3N2C4CC4	MedChem Express	HY-10570	-0.32504469	-1.44679394	-1.06097293	1.97315436												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00105405-01	NCGC00105405-01	24268750		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.2977511792	4	4		0	-2.75167785					CC1=CC=C(C=C1)C2=NC(=NO2)/C3=C/C4=CC=CC(=C4OC3=O)OCC5=CC=CC(=C5)C	Sytravon	C200-5366	-7.99609946	-6.34363496	-10.57010786	-2.75167785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482751-01	Casticin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	479-91-4		5.0118723363	-5.3	-95.1806955855	-2.4	4		-70.6990357323	-67.27964206	0.0765725698	0.996367205			COC1=C(O)C=C(C=C1)\C2=C(/OC)C(=O)C3=C(O)C(=C(OC)C=C3O2)OC	DC Chemicals	DCM-037	-4.58313018	-13.09819365	-34.38696896	-67.27964206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381558-03	AZD-2461		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1174043-16-3				-50.8440377888	4	4		0	-15.5516714			142	PARP1	COC1CCN(CC1)C(=O)C2=CC(=CC=C2F)CC/3=N/NC(=O)C4=CC=CC=C34	Axon Medchem	2241	-9.33406114	-8.9049236	-13.10578426	-15.5516714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017159-23	Curcumin	384567975	NF-kappaB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	458-37-7		11.220184543	-4.95	-41.4717591269	-3	4		-67.2287743014	-60.28839851	0.0063088001	0.9999754567		NFKB1	COC1=CC(=CC=C1O)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(O)C=C2)OC	MedChem Express	HY-N0005	1.05391334	1.15449915	0.13027619	-60.28839851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399579-01	NCGC00399579-01	375800879		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			5.0118723363	-5.3	-35.8135500655	4	4		12.127986352	2.47427293	0.1620650647	0.9836039075			COC1=CC=C(C=C1)C(=O)N[C@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC=CC(=C5)F	Analyticon	NAT6-324238	-10.52332196	-8.70644637	-6.73123487	2.47427293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00102563-01	NCGC00102563-01	24276261		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-46.3543099568	4	4		0	-16.91722595					[O-][N+](=O)C1=CC=C(N2CCOCC2)C(=C1)C(=O)NC3=CC=CC(=C3)C4=NC5=C(O4)C=CC=C5	Sytravon	7793-3989	-10.28766455	-8.86910367	-1.77415805	-16.91722595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253627-01	Pleconaril	170466405	Human rhinovirus A protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	153168-05-9				-18.6116336686	4	4		0	-8.2639821			1461213		Cc1cc(on1)CCCOc2c(C)cc(cc2C)c3nc(on3)C(F)(F)F	GVK	FFS-12-73-NCI-1186	-3.63237445	-4.37462546	-0.14527845	-8.2639821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00141981-01	NCGC00141981-01	24417364		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.2301861538	4	4		0	-4.88143177					CC1=CC=C(CCNC(=O)C2=CNC3=CC=C(C=C3C2=O)S(=O)(=O)NC4=CC(=CC=C4)C(F)(F)F)C=C1	Sytravon	K788-0970	-6.1839753	-9.04032189	-12.11974466	-4.88143177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183682-13	VX-765		Caspase-1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	273404-37-8				-12.7584955117	4	4		0	-4.50513437				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C3=CC(=C(N)C=C3)Cl)C(C)(C)C	ChemieTek	CT-VX765	-2.11202553	-0.53480475	-5.18499218	-4.50513437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025208-05	Splitomicin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	5690-03-9				-29.9550225372	4	4		0	-3.36027966					O=C1CCC2=C3C=CC=CC3=CC=C2O1	Enzo	GR-331	-8.01561975	-4.15959253	-5.81900295	-3.36027966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1446502-11-9				-28.9324753184	4	4		0	-6.75114704				IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	-6.68878065	-6.7147708	-3.0224075	-6.75114704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181337-01	2,4-Dichlorobenzyl alcohol	144206349		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1777-82-8	DICHLOROBENZYL ALCOHOL; 			-5.3648019201	4	4	2,4-Dichlorobenzyl alcohol;DICHLOROBENZYL ALCOHOL;2,4-DICHLOROBENZYL ALCOHOL;CIPLUS_158985;	0	3.75355036					OCc1ccc(Cl)cc1Cl	SigmaAldrich	146668	-2.27997985	-3.08149406	-0.27792253	3.75355036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482790-01	tetrahydroxyl diphenylethylene-2-o-glucoside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	82373-94-2				-13.045407255	4	4		0	-1.20357942					OC[C@H]1O[C@@H](OC2=C(O)C=C(O)C=C2\C=C\C3=CC=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCS-029	-2.52722249	-4.81123191	-3.3325996	-1.20357942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00395224-01	NCGC00395224-01	375804301		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-41.58482262	4	4		0	-7.69127517					COC1=CC=C(C=C1)C(=O)N2C[C@@H]3C[C@H](C2)\C4=C\C=C(\N[S+]([O-])(=O)C5=CC(=CC=C5)C(F)(F)F)C(=O)N4C3	Analyticon	NAT11-274707	-10.36892573	-8.01301258	-5.37530266	-7.69127517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00169833-02	Aucubin	363676896	TNF-alpha Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-15.4346611173	4	4		0	-4.91588377					OC[C@H]1O[C@@H](O[C@@H]2O\C=C/[C@H]3[C@H](O)\C=C(\CO)[C@@H]23)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-009911	-3.20372859	-2.78438031	-1.91071739	-4.91588377												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00522278-01	Oglufanide		VEGF Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-18.1337865521	4	4		0	-2.84465807				FLT1	N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=CC=CC=C12)C(O)=O	Combi-Blocks	QM-5596	-4.29543164	-2.99660441	-4.21226333	-2.84465807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164975-01	NCGC00164975-01	29216729		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-28.5554610148	4	4		0	-7.79865772					COC1=CC=C(Cl)C=C1NC(=O)C2=NN3C(=C2)N=C(C=C3C(F)(F)F)C4=CC=C5OCOC5=C4	Sytravon	A0001410	-4.20120267	-10.17036213	-6.9953775	-7.79865772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479257-01	NCGC00479257-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-41.3584115724	4	4		0	-10.64889666					OC(=O)C1=CC=NC2=C1[NH]C(=C2)C(OCCN3CCCCC3)C4=C(Cl)C=CC=C4	NCGCChem	GRB054-049_1st_neg	-8.76301646	-6.53650255	-9.23223901	-10.64889666												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00685392-02	Cenicriviroc Mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	497223-28-6				-10.0963500853	4	4		0	-3.0107057					CCCCOCCOC1=CC=C(C=C1)C2=CC=C3N(CC(C)C)CCCC(=CC3=C2)C(=O)NC4=CC=C(C=C4)[S@@+]([O-])CC5=CN=CN5CCC	MedChem Express	HY-14882A	-1.41501512	-2.16468591	-3.89091541	-3.0107057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263237-09	JZL-184	384568681	Monoacylglycerol lipase (MAGL) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-14.7211849987	4	4		0	-3.77102906				MGLL	OC(C1CCN(CC1)C(=O)OC2=CC=C(C=C2)[N+]([O-])=O)(C3=CC4=C(OCO4)C=C3)C5=CC=C6OCOC6=C5	SIGMA	J3455	-2.80903594	-0.34804754	-6.41827341	-3.77102906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164140-08	DOCUSATE SODIUM			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	577-11-7				-21.8199140014	4	4		0	-2.7378538					CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	Microsource	01503881	-4.79106473	-5.24897888	-5.5370159	-2.7378538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166142-07	Diperodon HCl		sodium ion transmembrane transport Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	537-12-2				-19.4243111181	4	4		0	-9.38169106					O=C(NC1=CC=CC=C1)OCC(CN2CCCCC2)OC(=O)NC3=CC=CC=C3	APExBIO	A8413	-1.47379913	-5.3820034	-6.99148862	-9.38169106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016672-07	Chloropyramine hydrochloride		Histamine H1 Receptor Antagonists	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6170-42-9				0.5177395771	4	4		0	2.32029714					CN(C)CCN(CC1=CC=C(Cl)C=C1)C2=CC=CC=N2	Prestwick	Prestw-807	-1.91887807	1.96095076	3.30901511	2.32029714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016623-07	Moroxydine HCl		antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	3160-91-6				-34.3856752187	4	4		0	-5.44898405					NC(=N)NC(=N)N1CCOCC1	Selleck	S2486	-7.59573396	-7.80135823	-7.81657113	-5.44898405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161621-13	Cepharanthine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	481-49-2		11.220184543	-4.95	-102.7962745938	-2.1	4		-109.3297629526	-99.38824558	0.0417003415	0.9989259851			[H][C@@]12CC3=CC(OC4=CC=C(C[C@]5([H])N(C)CCC6=C5C(OC7=CC1=C(CCN2C)C=C7OC)=C8OCOC8=C6)C=C4)=C(OC)C=C3	APExBIO	N2771	-5.37873698	-9.0237691	-12.11568525	-99.38824558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379018-02	BMS-626529	363678318	Human immunodeficiency virus 1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	701213-36-7				-38.2486232745	4	4		0	-6.9967375					COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[NH]3)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5	MedChem Express	HY-15440	-7.86148605	-10.65438429	-7.86423114	-6.9967375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095143-05	Rosuvastatin Calcium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	147098-20-2		14.1253754462	-4.85	-40.8872562816	4	4		-12.46320166	-17.12475421	0.2567353019	0.9574843159			CC(C)C1=C(\C=C\C(O)CC(O)CC(O)=O)C(=NC(=N1)N(C)[S+](C)([O-])=O)C2=CC=C(F)C=C2	Selleck	S2169	-7.76368828	-6.74872666	-5.07208616	-17.12475421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163363-01	N'-NITROSONORNICOTINE	26756720		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-29.9373925299	4	4	N'-nitrosonornicotine, (S)-isomer;nitrosonornicotine;Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, (S)-;N-nitrosonor-nicotine;N'-nitrosonornicotine;CIPLUS_675838;N'-NITROSONORNICOTINE;NCGC00163363-01;N'-nitrosonornicotine, (+-)-isomer;N-nitrosonornicotine;CIPLUS_170449;CIPLUS_199562;	0	-5.75486126					O=NN1CCCC1C2=CN=CC=C2	BIOMOL	BIOMOL_AC-1066	-6.78115553	-4.32937182	-7.57338892	-5.75486126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390587-03	G-007-LK		Tachykinin NK1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			0.2238721139	-6.65	-72.1460074205	4	4		-20.8915735361	-20.31126003	0.4168645437	0.8751566116	80351	TACR1	C[S+]([O-])(=O)C1=CC=C(N=C1)C2=NN=C(\C=C\C3=NN=C(O3)C4=CC=C(C=C4)C#N)[N]2C5=C(Cl)C=CC=C5	APExBIO	B5830	-7.36987365	-27.69618493	-26.8771406	-20.31126003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178483-14	Limonin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1180-71-8				-39.5638145566	4	4		0	-8.27179375					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	-8.69583473	-7.5466893	-8.44189682	-8.27179375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021305-27	Sirolimus		mTOR Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	53123-88-9				-137.0204128126	4	4		0	-28.32642624				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Enzo	A275	-29.15606538	-30.59876597	-28.62474752	-28.32642624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017376-12	Tetrandrine		Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	518-34-3		12.5892541179	-4.9	-92.652711257	-3	4		-103.8960333844	-99.66052376	0.0550550689	0.9981258982			COC1=CC=C2C[C@@H]3N(C)CCC4=C3C(=C(OC)C(=C4)OC)OC5=C(OC)C=C6CCN(C)[C@@H](CC7=CC=C(OC1=C2)C=C7)C6=C5	Prestwick	Prestw-NAT-0181	-3.35935142	-8.26453463	-5.44919645	-99.66052376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522434-01	DPC-681			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	284661-68-3				-49.5998653011	4	4		0	-9.75748307					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNCC2=CC=CC(=C2)F)C(C)(C)C)[S+]([O-])(=O)C3=CC(=CC=C3)N	MedChem Express	HY-19400	-10.41736648	-12.75891341	-9.70991836	-9.75748307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016777-10	Probucol	384567958	Serine Protease Hepsin Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	23288-49-5				-35.4066989093	4	4		0	-9.41664846					CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C	Selleck	S2119	-6.74756466	-4.6179966	-11.31665798	-9.41664846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-06	Imatinib	124892208	Bcr-Abl Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	152459-95-5	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	8.9125093813	-5.05	-38.8263395201	4	4	STI571;Imatinib mesilate;IMATINIB;CIPLUS_700313;Imatinib Mesilate;4-(4-(4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)-PHENYL)BENZAMIDE MESYLATE;CIPLUS_670910;Imatinib mesylate;HS_649;imatinib;CPG-57148B;Glivec;Imatinib base;Genpharm brand of imatinib mesylate;IMATINIB MESILATE;Gleevec;CGP-57148;CGP 57148;imatinib mesylate;Imatinib;IMATINIB MESYLATE;CGP57148B;STI 571;imatinibum;Imatinib base(IMA-3);Novartis brand of imatinib mesylate;STI-571;	-22.794673336	-25.70679484	0.060436951	0.9977470241	25	ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	Sequoia	IMATINIB	-4.92526033	-3.79456706	-6.27062706	-25.70679484												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159459-03	Mycophenolate mofetil	29215410	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	3.5481338923	-5.45	-72.7666848321	-2.4	4	Mycophenolate mofetil hydrochloride;mycophenolic acid morpholinoethyl ester;RS 61443;Mycophenolate Mofetil;Mycophenolate Mofetil Hydrochloride;mycophenolate mofetil hydrochloride;MYCOPHENOLATE MOFETIL HYDROCHLORIDE;RS-61443;Cellcept;CIPLUS_196921;mycophenolate mofetil;CIPLUS_739758;2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE;HS_286;LS-172327;Mycophenolate mofetil;LS-172272;MYCOPHENOLATE MOFETIL;CIPLUS_660816;	-33.7688742009	-40.00969932	0.071413214	0.9968450103	727833	IMPDH1	COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C3C(=O)OCC3=C1C	AKos	AKJ-92025	-7.82698693	-6.53515252	-26.19214894	-40.00969932												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242506-13	Bortezomib	384568504	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	179324-69-7		0.1	-7	-460.3601463938	5	4		-7.25102004	-98.39079446	0.7301227969	0.7535802309		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	ActiveBioChem	A-1014	-97.67130967	-98.71382637	-97.8703785	-98.39079446												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095522-06	DIMETHYLCAFFEIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	14737-89-4				1.7846935573	4	4		0	3.59624208					COC1=CC=C(/C=C/C(O)=O)C=C1OC	Microsource	00210567	-1.04551562	1.87606112	0.65138093	3.59624208												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094565-03	Hinokitiol	26753708		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			4.4668359215	-5.35	-53.0522866911	4	4	beta-Thujaplicin;hinokitiol;4-isopropyltropolone;alpha-thujaplicin;NCGC00094565-03;NCGC00094565-01;NCGC00094565-02;4-Isopropyltropolone;2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one;CIPLUS_153635;HINOKITIOL;Hinokitiol;beta-thujaplicin;beta-thujaplicin, sodium salt;LS-56183;LS-173664;2-hydroxy-4-isopropyl- 2,4,6-cycloheptatriene-1-one;	-26.947757208	-30.67189842	0.1613412366	0.9836270673			CC(C)C\1=C\C=C/C(=O)\C(=C1)O	BIOMOL	FR-110	-6.58501876	-3.21543408	-15.82945464	-30.67189842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015793-12	Palmitoylethanolamide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[544-31-0]				-19.8808557656	4	4		0	-4.14866414					CCCCCCCCCCCCCCCC(=O)NCCO	Tocris	0879	-2.44512484	-8.36881898	-6.70501449	-4.14866414												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095649-07	Trigonelline hydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	6138-41-6				-27.6082470573	4	4		0	-5.74464333					C[N+]1=CC(=CC=C1)C([O-])=O	Prestwick	Prestw-NAT-0039	-5.64491785	-7.20431042	-5.52823395	-5.74464333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263621-06	I-BET762		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1260907-17-2		4.4668359215	-5.35	-127.4637131462	-2.1	4		-95.1421881001	-82.81015783	0.0147031843	0.9998666619		BRD4	CCNC(=O)C[C@@H]1\N=C(C2=CC=C(Cl)C=C2)/C3=C(C=CC(=C3)OC)[N]4C(=NN=C14)C	Cayman	10676	-7.27500108	-18.33666464	-48.89347502	-82.81015783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601806-01	TH34			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	2196203-96-8		10	-5	-35.9196660409	4	4		-23.1729768641	-26.03385945	0.0204518813	0.9997426123			CC1=CC=C(C=C1NCC2=CC=CC=C2)C(=O)NO	Selleck	S8773	-4.17008064	-3.80637873	-4.50952841	-26.03385945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480778-01	Scutellarin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	27740-01-8				-22.5002820636	4	4		0	-7.18190636					O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H]1O)C(O)=O)OC2=C(O)C(=C3C(=O)/C=C(OC3=C2)/C4=CC=C(O)C=C4)O	Adooq	A12117	-3.15235672	-7.38680803	-5.60727145	-7.18190636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016360-07	Monobenzone	384567934	topical medical depigmentation treatment	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	103-16-2				-16.8712604394	4	4		0	-9.26621924					OC1=CC=C(OCC2=CC=CC=C2)C=C1	Selleck	S1652	-1.01576467	-5.54747025	-4.97028395	-9.26621924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			5011.8723362727	-2.3	-456.0486102696	5	4		-3.887355524	-97.29741645	0.6101856246	0.9793745899			CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209	-97.00720169	-97.03658643	-96.97462018	-97.29741645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386403-01	Z-DEVD-FMK	363680258	Caspase-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	210344-95-9				-27.325989798	4	4		0	-7.24362931			836	CASP3	COC(=O)CC[C@@H](CC(=O)[C@H](CC(=O)OC)NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)OC)C(=O)CF	Selleck	S7312	-4.63581871	-7.79525506	-6.61719505	-7.24362931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00137466-01	NCGC00137466-01	24412849		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-34.2841303615	4	4		0	-8.65771812					COC1=C(C=CC=C1)N2CCN(CC2)C(=O)CN3C(=O)[N]4N=C(N=C4C5=CC=CC=C35)C6=CC(=CC=C6)F	Sytravon	G860-0124	-7.47602795	-3.15897612	-9.31983271	-8.65771812												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025297-10	Gabexate mesilate		NF-kappaB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	56974-61-9				-5.0284913738	4	4		0	-3.27964206				NFKB1	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	MedChem Express	HY-B0385	0.44693645	-2.25151956	-3.06845697	-3.27964206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421080-01	NCGC00421080-01	375803636		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.0204016972	4	4		0	-6.57270694					CC(=O)C1=CC=C(NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)[N]4N=NN=C4C5=CC=C(CN6CCOCC6)C=C5)C=C1	Analyticon	NAT6-296454	-8.84121567	-6.74599777	-4.02817521	-6.57270694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00099110-01	NCGC00099110-01	24272808		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-23.1099075226	4	4		0	-0.60402685					OC1=CC=C(NC(=O)C2=CC=C(O2)C3=CC=CC(=C3)Cl)C=C1C4=NC5=C(O4)C=CC=C5	Sytravon	3777-1655	-8.35364863	-1.84059584	-0.0572309	-0.60402685												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483052-01	Saikosaponin B2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	58316-41-9		5.0118723363	-5.3	-7.2340758862	4	4		11.2466324839	6.73221056	0.2032658418	0.9739310591			C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)C(CC[C@]4(C)[C@@H]3\C=C/C5=C6\CC(C)(C)CC[C@]6(CO)[C@H](O)C[C@]45C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]7O)[C@H]1O	DC Chemicals	DCC-051	-3.30760274	-5.20552707	-0.25906736	6.73221056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242597-10	Saxagliptin		DPP-IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	709031-78-7				-26.6659064781	4	4		0	-6.78511595				DPP4	N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4	DC Chemicals	DCAPI1568	-5.17917978	-6.75241158	-5.2208659	-6.78511595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379165-02	IT1t dihydrochloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1092776-63-0		0.3981071706	-6.4	-31.5109083836	4	4		-15.410169444	-14.96781589	0.2912227316	0.9443725605			CC1(C)CN2C(CS\C(NC3CCCCC3)=N\C4CCCCC4)=CSC2=N1	Glixx	GLXC-01713	-2.12600802	-10.00260711	-11.30675332	-14.96781589												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090705-24	Zalcitabine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	7481-89-2				-22.5787015928	4	4		0	-6.00917027					NC/1=N/C(=O)N(/C=C1)[C@H]2CC[C@@H](CO)O2	MedChem Express	HY-17392	-3.24722929	-7.29990441	-6.71379643	-6.00917027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015608-22	Loperamide hydrochloride	384567873	mu-Opioid Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	34552-83-5				-12.5322274889	4	4		0	-8.52217617				OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-B0418A	-2.10013368	-1.85973755	0.71572846	-8.52217617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00493059-01	NCGC00493059-01	375825413		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-43.4982543112	4	4		0	-10.22371365					COC1=CC=CC(=C1)C2=CC=CC(=C2)C(=O)N3CCCC3C(=O)N4CCN(CC4)CC5=CC=CC=C5	ChemRoutes	CA-207-256	-7.67105477	-11.78837428	-11.48580233	-10.22371365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-21	INCB018424			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	941678-49-5		14.1253754462	-4.85	-1.5758974966	4	4		-11.3985980039	-8.24883167	0.2159927089	0.9704764788			N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB	0.83229117	0.88641696	2.63897427	-8.24883167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263192-04	Silmitasertib	384568656	Casein Kinase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1009820-21-6 (parent)		11.220184543	-4.95	-91.4648254372	-2.3	4		-125.1221083028	-97.96755136	0.0645293057	0.9974230026		CSNK2A1	OC(=O)C1=CC2=C(C=C1)C3=CN=CC=C3C(=N2)NC4=CC=CC(=C4)Cl	Axon Medchem	1965	-0.84954073	-6.82193447	-16.17195047	-97.96755136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167535-16	Tenofovir		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	147127-20-6				-11.2978080436	4	4		0	-1.41834452					C[C@H](C[N]1C=NC2=C1N=CN=C2N)OC[P](O)(O)=O	MedChem Express	HY-13910	-3.98992361	-2.02037497	1.95025314	-1.41834452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347284-01	NCGC00347284-01	174006574		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	651031-01-5	XL-647	3.5481338923	-5.45	-189.7219543025	-2.1	4		-84.6218036508	-99.46756152	0.0197947411	0.9997582797	1956	EGFR	COC1=CC2=C(C=C1OC[C@H]3C[C@H]4CN(C)C[C@H]4C3)N=CN=C2NC5=C(F)C(Cl)=C(Cl)C=C5	SantaCruz Bio	sc-364659	-20.18527548	-26.41897098	-64.90424829	-99.46756152												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387111-01	TMCB			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[905105-89-7]				-37.9326801612	4	4		0	-5.91216954					CN(C)C1=NC2=C(Br)C(=C(Br)C(=C2[N]1CC(O)=O)Br)Br	Tocris	3675	-8.09959691	-8.81154499	-9.54490186	-5.91216954												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522444-01	TAK-220			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	333994-00-6				-28.3745699838	4	4		0	-5.0819314					CC(=O)N1CCC(CC1)C(=O)N(CCCN2CCC(CC2)CC3=CC=C(C=C3)C(N)=O)C4=CC=C(C)C(=C4)Cl	MedChem Express	HY-19974	-6.1849177	-6.50254669	-6.06218517	-5.0819314												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132638-01	NCGC00132638-01	24408021		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			3.5481338923	-5.45	-17.7933551037	4	4		9.917044768	3.1901566	0.1829357487	0.9790578834			COC1=CC=CC(=C1)N2CCN(CC2)C(=O)C3CCN(CC3)[S+]([O-])(=O)C4=C(ON=C4C)/C=C/C5=C(F)C=CC=C5	Sytravon	G637-0917	-5.81830002	-7.43087064	-0.18049747	3.1901566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390932-01	NCGC00390932-01	375807998		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-19.8629417772	4	4		0	-6.3310962					FC1=CC(=CC=C1)C2=CC=NC(=N2)N[C@H]3CO[C@@H]4[C@H](CO[C@H]34)NC(=O)NC5=CC(=CC=C5)C#N	Analyticon	NAT6-324295	-5.31448074	-1.24989299	-0.98173013	-6.3310962												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378559-03	Maribavir		Serine/threonine protein kinase UL97 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	176161-24-3				-42.9312727734	4	4		0	-8.16692156				UL97	CC(C)NC1=NC2=CC(=C(Cl)C=C2[N]1[C@H]3O[C@@H](CO)[C@H](O)[C@@H]3O)Cl	MedChem Express	HY-16305	-9.40124286	-9.46519525	-8.87615077	-8.16692156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162368-03	NCGC00162368-03			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	153190-29-5				-22.6304914036	4	4		0	-5.06040268					C[C@]12C\C=C3/[C@@H](CC\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8	Cayman	75860	-4.54249959	-3.35587707	-6.27338763	-5.06040268												1.6E-8	8E-8	4E-7	0.000002											
NCGC00015897-20	Ranolazine	384567904	Sodium channel Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	95635-56-6				-44.0414093617	4	4		0	-7.73869347				SCN9A	COC1=C(OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C)C=CC=C1	MedChem Express	HY-17401	-9.66996977	-7.37691002	-12.02883446	-7.73869347												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370872-07	UPF1069	363677900	Poly [ADP-ribose] polymerase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1048371-03-4				-21.7935236375	4	4		0	-3.22918943			10038	PARP2	O=C(COC1=C2\C=C/NC(=O)C2=CC=C1)C3=CC=CC=C3	Glixx	GLXC-06427	-5.21918038	-4.89813243	-3.76063922	-3.22918943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522453-02	IXAZOMIB CITRATE		Proteasome subunit beta type-5 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			0.316227766	-6.5	-313.3789141811	-1.2	4		-63.9263358395	-98.41817785	0.0105559855	0.9999312881	5693	PSMB5	CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(=CC=C1Cl)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2	MedChem Express	HY-10452	-41.22018811	-94.51612903	-97.99374674	-98.41817785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022304-23	ACETYLCYSTEINE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	616-91-1				-25.0169223131	4	4		0	-4.95958051					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-4.32902251	-5.88285229	-8.78929998	-4.95958051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386206-04	Azilsartan	363680151	Type-1 angiotensin II receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	147403-03-0				-28.6870161011	4	4		0	-2.21542495					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)ON5)C(O)=O	Glixx	GLXC-05169	-6.57121263	-6.16298812	-8.50269237	-2.21542495												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00123753-01	NCGC00123753-01	24399136		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-37.5576073425	4	4		0	-14.50111857					CC1=CC(=C(C=C1)[S+]([O-])(=O)/C2=C/N(CC3=CC=CC=C3)C4=CC(=C(F)C=C4C2=O)N5CCCC5)C	Sytravon	E599-0377	-6.93970421	-8.17566989	-4.69733656	-14.50111857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399500-01	NCGC00399500-01	375799043		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.0927647427	4	4		0	-3.36912752					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(=CC=N3)C4=CC=C(C=C4)C5=CC=CC=C5)NC6=CC=C(OC7=CC=CC=C7)C=C6	Analyticon	NAT6-321094	-7.57354136	-1.97757041	-4.08100374	-3.36912752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346694-03	MK-2048		HIV Integrase Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	869901-69-9				-51.1774148997	4	4		0	-11.88114485					CCN1C[C@H](C)[N]2C(=C(O)C3=C2\C(=N/N(CC4=CC=C(F)C(=C4)Cl)C3=O)C(=O)NC)C1=O	APExBIO	A4072	-10.55172993	-10.92529711	-11.03873545	-11.88114485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371259-05	Clevudine		Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	163252-36-6				-50.704963632	4	4		0	-12.25693686					C\C1=C\N([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O	MedChem Express	HY-13859	-11.08078603	-9.28692699	-9.66649296	-12.25693686												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390251-01	Isochlorogenic acid A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2450-53-5				-29.1601766129	4	4		0	-2.53004151					OC1[C@@H](CC(O)(C[C@H]1OC(=O)\C=C\C2=CC(O)=C(O)C=C2)C(O)=O)OC(=O)\C=C\C3=CC(O)=C(O)C=C3	Adooq	A12072	-7.46137051	-8.13242784	-3.62167796	-2.53004151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346705-02	PMSF	384568924	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	329-98-6				-18.4887630292	4	4		0	-2.5458613					[O-][S+](F)(=O)CC1=CC=CC=C1	Selleck	S3025	-5.16008451	-2.64532146	-2.23200528	-2.5458613												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00453407-01	NCGC00453407-01	375863775		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-16.8073831798	4	4		0	-3.67337808					O=C(N1CCCC(C1)CC2=NOC(=N2)C3=CC=CN=C3)C4=CC(=N[NH]4)C5=CC=CC=C5	Chemdiv	S427-0496	-3.19356412	-5.47898296	-2.97160467	-3.67337808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165862-04	Pamidronate Disodium		Farnesyl diphosphate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	57248-88-1				-36.1733398456	4	4		0	-5.54511689					NCCC(O)([P](O)([O-])=O)[P](O)([O-])=O	APExBIO	A2456	-7.28501847	-8.0475382	-11.16032656	-5.54511689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510231-01	GDC-0077	384569416	PARP inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			7.0794578438	-5.15	-43.0598432059	4	4	Pamiparib	-22.312775392	-24.4308499	0.1902471438	0.9770720199		PARP1	C[C@]12CCCN1C/C3=N/NC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F	ChemGood	C-1286	-6.12613369	-2.92020374	-10.17891263	-24.4308499												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161670-08	Pepstatin	384568214	Aspartyl Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	26305-03-3				-39.7942665823	4	4		0	-5.67620712					CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	Prestwick	Prestw-405	-8.69583473	-9.60101868	-9.49279138	-5.67620712												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522593-01	RSV604 (R enantiomer)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	932108-20-8				-22.1748794153	4	4		0	-5.92090889					FC1=CC=CC=C1NC(=O)N[C@@H]2\N=C(C3=CC=CC=C3)/C4=CC=CC=C4NC2=O	MedChem Express	HY-12993B	-4.58095398	-4.56706282	-4.09067223	-5.92090889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480790-01	Coptisine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	3486-66-6				-9.5791829281	4	4		0	-1.45510159					C1OC2=C(O1)C=C3C(=C2)CC[N+]4=C3C=C5C=CC6=C(OCO6)C5=C4	Adooq	A14548	-0.69281156	-3.24278438	-6.37484801	-1.45510159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347066-11	KUC105555N	384568981	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	177355-84-9		12.5892541179	-4.9	-66.7916454228	-3	4		-112.6105527611	-99.73781953	0.0318772986	0.9993727356		VCP	C(NC1=NC2=CC=CC=C2C(=N1)NCC3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-15945	1.29744709	2.37691002	3.9777662	-99.73781953												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126982-01	NCGC00126982-01	24402365		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-27.2668337315	4	4		0	-1.24832215					CC1=CC=CC(=C1)C(=O)NC2=C(OC3=C2C=CC=C3)C(=O)N4CCN(CC4)C5=CC=C(F)C=C5	Sytravon	E957-2050	-7.35413619	-6.80592415	-4.00176095	-1.24832215												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274063-04	Pimobendan		Phosphodiesterase III (PDE3) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	74150-27-9		8.9125093813	-5.05	-57.7966716392	4	4		-28.468989772	-31.78938169	0.0248553591	0.9996196865		PDE3A	COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)/C4=N/NC(=O)CC4C	Adooq	A10733	-7.97363117	-7.64855688	-11.91592843	-31.78938169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263093-14	Apilimod mesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	870087-36-8		14.1253754462	-4.85	-149.3098654264	-2.4	4		-37.8620340076	-58.05986454	0.2104440615	0.9716812973			CC1=CC=CC(\C=N\NC2=NC(OCCC3=CC=CC=N3)=NC(=C2)N4CCOCC4)=C1	AChemBlock	O33823	-27.96859254	-27.41086587	-21.93850964	-58.05986454												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180839-02	Penta-O-galloyl-Î²-D-glucose hydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	14937-32-7 (anhydrous)		7.0794578438	-5.15	-103.1641167896	-2.2	4		-74.7085350896	-74.13367428	0.0097906437	0.999940887			OC1=C(O)C(=CC(=C1)C(=O)OC[C@H]2O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC(=O)C4=CC(=C(O)C(=C4)O)O)[C@@H](OC(=O)C5=CC(=C(O)C(=C5)O)O)[C@@H]2OC(=O)C6=CC(=C(O)C(=C6)O)O)O	SIGMA	G7548	-8.4565958	-9.79403841	-27.63238781	-74.13367428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00319175-08	Rilpivirine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	500287-72-9		12.5892541179	-4.9	-95.7196734574	-3	4		-103.1693360916	-92.64174235	0.0266924713	0.9995603226			CC1=C(NC2=CC=NC(=N2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C	MedChem Express	HY-10574	-6.99900815	-4.81446076	-7.49538948	-92.64174235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091367-08	DANTHRON		DNA topoisomerase II alpha Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	117-10-2				-30.3306624936	4	4		0	-9.18349352					OC1=CC=CC2=C1C(=O)C3=C(O)C=CC=C3C2=O	Microsource	MS-00211468	-6.14515503	-4.97088729	-6.151752	-9.18349352												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180669-03	Gentiopicroside			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	20831-76-9				-9.2156664236	4	4		0	-1.52102989					OC[C@H]1O[C@@H](O[C@@H]2O\C=C/3C(=O)OC/C=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCL-005	-1.49639915	-3.24150517	-2.84974093	-1.52102989												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00109194-01	NCGC00109194-01	24383773		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-36.4186545324	4	4		0	-6.7606264					CCN1\C=C(C(=O)NCCC2=CC=C(Cl)C=C2)/C(=O)C3=CC(=CC=C13)[S+]([O-])(=O)N4CCC(C)CC4	Sytravon	C519-1832	-7.76856818	-7.84179437	-8.65067136	-6.7606264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263096-16	Iniparib	384568587	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	[160003-66-7]				-21.5141601338	4	4		0	-1.55257271				PARP1	NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O	Tocris	5817	-4.50999512	-8.21847445	-4.42438917	-1.55257271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345014-01	NCGC00345014-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.3764824544	4	4		0	-15.11856823					CC1=C(C=CC=C1)C(=O)N2CCC3=C2C=CC(=C3)C4=CC=CC(=N4)NC(=O)CC5=CC6=C(OCO6)C=C5	NCGCChem	JMR03-081	-5.29822851	-6.41212225	-8.67708563	-15.11856823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	59721-29-8				-13.6047181178	4	4		0	-3.04697987					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-4.07118479	-5.00813287	3.67598503	-3.04697987												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00395168-01	NCGC00395168-01	375800199		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-42.202481468	4	4		0	-5.67785235					CN(C)C1=CC=C(C=C1)C2=NN=N[N]2[C@H]3CO[C@@H]4[C@@H](CO[C@H]34)OC(=O)NC5=CC=C(OC6=CC=CC=C6)C=C5	Analyticon	NAT6-296297	-9.08499919	-10.29021488	-10.82544574	-5.67785235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244248-01	NCGC00244248-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-6.4541812421	4	4		0	-5.19795433					CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009	0.59942214	-3.83244981	-2.03302011	-5.19795433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1190307-88-0				3.4457031051	4	4		0	-0.71863151					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-0.52179913	4.64934388	2.95512426	-0.71863151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163532-06	Daidzin	384568245	Alcohol Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	552-66-9				-5.2043199464	4	4		0	-4.61297539				ADH1	OC[C@H]1O[C@@H](OC2=CC3=C(C=C2)C(=O)\C(=C/O3)C4=CC=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O	Adooq	A10283	-0.16252235	0.14553548	-2.06471495	-4.61297539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246387-06	Arbidol		antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	131707-23-8				-31.3242390775	4	4		0	-8.45190157					CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	-6.25711035	-4.14348087	-8.77393793	-8.45190157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263107-01	NCGC00263107-01	137275951		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1252806-86-2	GB 83			-53.2553656081	4	4		0	-11.76286353			55065	PAR2	CC[C@@H](C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C2=CC=NO2)C(=O)N3CCC4(CC3)CCC5=C4C=CC=C5	ChemAxon	Axon 1622	-13.00991386	-9.55397654	-6.52872551	-11.76286353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249377-04	IU1	363677167	Ubiquitin carboxyl-terminal hydrolase 14 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	314245-33-5				-26.8090658689	4	4		0	-6.2736972					CC1=CC(=C(C)[N]1C2=CC=C(F)C=C2)C(=O)CN3CCCC3	Selleck	S7134	-6.46427185	-4.26696793	-3.76306314	-6.2736972												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134056-01	NCGC00134056-01	24409439		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-22.6314617374	4	4		0	-5.42729306					FC1=C(C=CC=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0553	-4.54249959	-6.52341409	-3.45586617	-5.42729306												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091823-01	Chrysophanol	17389107	VEGFR-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	481-74-3	CHRYSOPHANOL;Chrysophanic acid (1,8-Dihydroxy-3-methylanthraquinone)			-30.0111593692	4	4	chrysophanic acid, ion (1-);Chrysophanic acid;chrysophanic acid;1,8-Dihydroxy-3-methylanthraquinone;CHRYSOPHANOL;NCGC00160154-01;Chrysophanol:9,10-Anthracenedione,1,8-dihydroxy-3-methyl;CHRYSOPHANIC ACID;Chrysophanic acid (1,8-Dihydroxy-3-methylanthraquinone);AB08582917-01;2-methyl-4,5-dihydroxyanthraquinone;chrysophanol 8-O-(6'-galloyl)glucopyranoside;1,8-Dihydroxy-3-methyl-anthraquinone;chrysophanol;CIPLUS_153453;3-methyl-1,8-dihydroxyanthraquinone;Chrysophanic Acid;NCGC00091823-02;chrysophanol 8-O-GGlc;	0	-6.67930518			2321	FLT1	CC1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	NIEHS	AB08582917	-5.77428953	-7.34335622	-7.35487837	-6.67930518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090730-05	Camphor			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	76-22-2				-9.9654445214	4	4		0	-4.02521823					CC1(C)C2CCC1(C)C(=O)C2	MedChem Express	HY-N0808	-0.74604338	-4.58851134	-2.63897427	-4.02521823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510921-01	Lucanthone	384569494	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	548-57-2		11.220184543	-4.95	-105.2843365526	-2.1	4		-109.2605314562	-99.69412279	0.0321097352	0.9993635692		TOP2A	CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1	SantaCruz Bio	sc-396381	-6.15132684	-8.94736842	-12.60204968	-99.69412279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016759-38	Naproxen sodium			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	26159-34-2				-44.9379980499	4	4		0	-8.78741534					COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(O)=O	DC Chemicals	DC9000	-9.61958347	-9.71986418	-10.03126628	-8.78741534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-25	MELOXICAM SODIUM		Neuropharmacol 39: 1653 (2000)	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	71125-38-7				-38.1374449127	4	4		0	-6.86475858					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	MS-01504150	-8.01561975	-7.39388795	-10.54368595	-6.86475858												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166323-16	Trifluorothymidine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[70-00-8]		6.3095734448	-5.2	-68.3917832403	4	4		-27.070801156	-32.75071007	0.173164849	0.9810834484			[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N2C=C(C(=O)NC2=O)C(F)(F)F	Tocris	4460	-10.41736648	-7.27504244	-17.49174917	-32.75071007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	56776-01-3				-12.1358451891	4	4		0	-0.72930649					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-1.85275475	-4.60577005	-5.20801233	-0.72930649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00100034-02	NCGC00100034-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-32.1129372614	4	4		0	-2.65324385					CC1=C(C=C(C=C1)C2=C3C=CC=CC3=C(NC4=CC=C(O)C=C4)N=N2)[S+]([O-])(=O)NCC5=NC6=C([NH]5)C=CC=C6	Chemdiv	4903-2136	-7.53291078	-6.30083041	-9.28461369	-2.65324385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107289-02	NCGC00107289-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-18.5365176491	4	4		0	-4.04026846					FC(F)(F)C1=CC=CC(=C1)N2CCN(CC2)C(=O)C3=CC=C(NC4=NC5=C(C=CC=C5)[N]6N=NN=C46)C=C3	Chemdiv	C301-4561	-3.36421258	-7.14836059	-2.76029056	-4.04026846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686698-01	Migalastat			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	75172-81-5				-2.0150986031	4	4		0	-0.50559284					OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	SIGMA	D9641	-0.35754916	-0.25682733	-0.77922078	-0.50559284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522552-01	PI4KIIIbeta-IN-10			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1881233-39-1		8.9125093813	-5.05	-94.3043169173	-2.2	4		-74.90018502	-79.54118418	0.0472612761	0.9986200138			COC1=CC=C(C=C1[S+]([O-])(=O)NC2=CC=C(O)C=C2)C3=C(C)N=C(NC(=O)C(C)(C)C)S3	MedChem Express	HY-100198	-9.09052738	-5.87436333	-10.77818308	-79.54118418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107850-02	NCGC00107850-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-23.5559671136	4	4		-21.632405868	-18.91275168	0.3026681296	0.9391846343			ClC1=CC(=CC=C1)CSC/2=N/C3=C(C=CC=C3)C/4=N/C(CCC(=O)N5CCN(CC5)C6=CC=CC=C6)C(=O)N24	Chemdiv	C336-0175	-0.88574679	-5.67588391	-4.56526524	-18.91275168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345794-11	MLN-4924	384568745	NEDD8-Activating Enzyme (NAE) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	905579-51-3		8.9125093813	-5.05	-37.5801607055	-3	4		-64.0200797324	-54.76513	0.2242067636	0.9676623987		NAE1	N[S+]([O-])(=O)OC[C@@H]1C[C@H](C[C@@H]1O)[N]2C=CC3=C2N=CN=C3N[C@H]4CCC5=C4C=CC=C5	ChemieTek	CT-M4924	-1.67534431	11.27334465	-0.35608824	-54.76513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163567-08	Honokiol		NF-kappaB Activation Modulator	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	35354-74-6				-18.2657449131	4	4		0	-2.48634477					OC1=CC=C(C=C1CC=C)C2=CC(=CC=C2O)CC=C	Adooq	A10453	-4.69012429	-0.80645161	-5.53239534	-2.48634477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180407-02	NCGC00180407-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-30.3041582217	4	4		0	-8.00087393					CC(=O)C\C1=C\C(=O)C2=C(O1)C(=C(O)C=C2C)C3OC(CO)C(O)C(O)C3O	Analyticon	NP-000313	-5.65586161	-7.62308998	-6.51380928	-8.00087393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115742-01	NCGC00115742-01	24390321		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-11.8557812999	4	4		0	-4.82774049					CC1=CC2=C(C=C1C)C(=O)\C=C(/O2)C(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)NC4=C(C)C(=NO4)C	Sytravon	D103-1958	-2.69787096	-1.1814057	-0.76161127	-4.82774049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350780-13	NCGC00350780-13			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	942183-80-4		10	-5	-50.7732430604	4	4		-21.736266808	-24.84563758	0.0352632977	0.9992359638		MAPK7	O=C(CN1CC[C@H](C1)C(=O)NC2=CC3=C([NH]N=C3C4=CC=NC=C4)C=C2)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7	MedChem Express	HY-50846	-7.56541524	-8.03869532	-10.39401277	-24.84563758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	57-41-0				-9.3444117493	4	4		0	-4.28187919					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	-1.7796197	-2.65388237	0.36539731	-4.28187919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164462-05	NCGC00164462-05			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.092839243	4	4		0	-9.60626398					C[C@@H](COc1ccc(Oc2ccccc2)cc1)Oc3ccccn3	EPA	TV000265	-6.45213717	-4.27189453	-4.8646269	-9.60626398												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00386421-08	Verdinexor		Exportin-1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1392136-43-4		6.3095734448	-5.2	-146.8150896981	-2.4	4		-66.2382051801	-61.1798121	0.2678549404	0.9530074823		XPO1	FC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)C2=N[N](\C=C/C(=O)NNC3=CC=CC=N3)C=N2	MedChem Express	HY-15970	-20.01595566	-32.97962649	-38.51832552	-61.1798121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346587-16	Bergenin monohydrate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	477-90-7				-4.0760246349	4	4		0	0.52348993					[H][C@]12OC(=O)C3=C(C(O)=C(OC)C(O)=C3)[C@]1([H])O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-NAT-0201	-0.39005363	-4.16060269	-0.80563504	0.52348993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686671-01	Brincidofovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	444805-28-1				-25.1535939156	4	4		0	-5.3557047					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532	-5.2494718	-5.56459207	-5.41052168	-5.3557047												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00178913-14	Celastrol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[34157-83-0]		1	-6	-188.9505445382	-1.1	4		-93.9323712259	-99.71160149	0.0199052328	0.9997555512			CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O	Tocris	3203	-6.73076923	-39.66893039	-99.44415494	-99.71160149												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345802-01	ACY-1215	174006356	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1316214-52-4	ACY-1215	3.9810717055	-5.4	-67.8084225537	4	4		-25.9856603132	-33.80817129	0.106909909	0.9928976131	10013	HDAC6	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	ChemieTek	CT-ACY12	-8.90577763	-6.6893039	-21.63453187	-33.80817129												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017013-06	Thiamine chloride			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	59-43-8				-24.0506106785	4	4		0	-4.99453791					CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N	DC Chemicals	DCZ-120	-5.25277125	-2.52122241	-7.35626194	-4.99453791												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00104965-01	NCGC00104965-01	24268310		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-36.7265860052	4	4		0	-3.36912752					CC1=CC(=C(C)C=C1)N2CCN(CC2)C(=O)C3=CC=C4C(=O)N(CCC5=CC=CC=C5)C(=O)NC4=C3	Sytravon	C190-0338	-8.47554039	-7.66201524	-10.31476998	-3.36912752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00396904-01	NCGC00396904-01	375800439		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-46.1514202804	4	4		0	-8.68456376					COC1=CC=C(NC(=O)O[C@@H]2CO[C@@H]3[C@H](CO[C@H]23)N[S+]([O-])(=O)C4=CC5=CC=CC=C5C=C4)C=C1	Analyticon	NAT6-270303	-9.6050707	-11.30896327	-10.34118424	-8.68456376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM			-14.8753153102	4	4		0	-1.43624161			217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-4.77003088	-1.5752076	-0.74400176	-1.43624161												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388427-02	Tizoxanide		Trichomonas vaginalis Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	173903-47-4		11.220184543	-4.95	-85.1433614825	-3	4		-70.3986330081	-68.73060957	0.0363608966	0.9991838633			OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O	MedChem Express	HY-12687	-8.76301646	-6.73174873	-9.5709571	-68.73060957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163699-10	Fumagillin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	23110-15-8				-31.5186720435	4	4		0	-5.4541387					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332	-8.06923452	-4.83691465	-4.94386969	-5.4541387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486532-01	NCGC00486532-01	375823985		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-31.9777083892	4	4		0	-4.87248322					O=C(NC1CCCC1)N2CCC(CC2)C(=O)N3CCCC3C4=NC5=CN=CC=C5[NH]4	ChemRoutes	CA-177-224	-7.30537949	-6.01832035	-7.83182919	-4.87248322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017400-10	Dihydroergotamine	174006617	serontonin, dopamine, epinephrine receptor agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	511-12-6	 Dihydroergotamine; ;Dihydroergotamine;DIHYDROERGOTAMINE MESYLATE; Dihydergot plus; Migranal; Dihidroergotamina; Venelbin; Silentan			-42.3307735562	4	4		0	-6.16107383					CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O	Microsource	01500248	-9.33690882	-9.78512114	-10.0770416	-6.16107383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015243-17	Clemizole (hydrochloride)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1163-36-6				-12.1370545476	4	4		0	-2.99356318					ClC1=CC=C(C[N]2C(=NC3=C2C=CC=C3)CN4CCCC4)C=C1	MedChem Express	HY-30234A	-2.47962396	-3.5804293	-1.52366734	-2.99356318												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485878-01	Nucleoside-Analog-2	363681388	NS5B Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	876708-01-9				-29.0660237338	4	4		0	-6.39714311					OC[C@]1(O[C@H]([C@@H](O)[C@@H]1O)N2\C=C/C(=O)NC2=O)N=[N+]=[N-]	MedChem Express	HY-77652	-6.55914442	-6.61336578	-4.16703258	-6.39714311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386395-01	YYA-021	363680252	Envelope glycoprotein gp160 Binding Agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	144217-65-2				-34.6733886666	4	4		0	-10.01234459				env	CC1=CC=C(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)C=C1	Selleck	S7487	-6.86963647	-8.16894064	-5.63361728	-10.01234459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386215-05	Alogliptin (SYR-322)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	850649-61-5				-30.2313236785	4	4		0	-6.78511595					CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC3=CC=CC=C3C#N)C1=O	APExBIO	A4038	-5.61041873	-8.04727557	-7.45147976	-6.78511595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346560-12	telbivudine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	3424-98-4				-7.5290092267	4	4		0	-5.59474473					C\C1=C\N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	DC Chemicals	DC4211	-0.17680797	-2.27687495	-1.86616317	-5.59474473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00385384-01	NCGC00385384-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-28.1498835897	4	4		0	-9.4953026					CC(=O)OC(C)(C)CCC(=O)[C@](C)(O)C1[C@H](O)C[C@@]2(C)C3C/C=C/4C(C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C	Analyticon	NP-015959	-4.81609002	-7.47877759	-5.04603092	-9.4953026												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015061-29	Acyclovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[59277-89-3]				-8.9751107524	4	4		0	-3.05440245					NC1=NC2=C(N=CN2COCCO)C(=O)N1	Tocris	2513	-0.67601612	-5.25466893	-1.84992183	-3.05440245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00115775-02	NCGC00115775-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			12.5892541179	-4.9	-103.6366616762	-3	4		-101.3016002765	-99.51933581	0.009342131	0.9999461687			CC(C)C[S+]([O-])(=O)C1=C(N=C(O1)C2=CC=C(F)C=C2)[S+]([O-])(=O)C3=CC=CC=C3	Chemdiv	D093-0011	-7.53694995	-6.97792869	-7.33889178	-99.51933581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159352-06	Etidronate		ATP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2809-21-4				-25.0649462559	4	4		0	-4.28665064					CC(O)([P](O)(O)=O)[P](O)(O)=O	Selleck	S1857	-3.8503527	-8.18336163	-8.58954316	-4.28665064												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263184-03	MK-0752		g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	471905-41-6				-19.5122476952	4	4		0	-3.12582665				NOTCH1	OC(=O)CCC1CCC(CC1)(C2=CC(=CC=C2F)F)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	Adooq	A11194	-3.42834965	-5.48361867	-6.56450338	-3.12582665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179623-07	Lisinopril		Angiotensin-converting enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	83915-83-7				-24.4539616221	4	4		0	-4.3073803					NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O	Prestwick	Prestw-301	-5.40342404	-5.19683671	-6.53815755	-4.3073803												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00168784-12	Gemcitabine		Ribonucleotide reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	122111-03-9		5.6234132519	-5.25	-159.7951237379	5	4		4.1940538	-31.87990477	0.7001953826	0.5036873513		RRM2	NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	MedChem Express	HY-B0003	-33.45983009	-37.96819327	-34.31544744	-31.87990477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095150-16	Telmisartan	384568151	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	144701-48-4		3.5481338923	-5.45	-13.0638553353	4	4		9.863604768	3.69015078	0.2746276339	0.9510918444		AGT	CCCC1=NC2=C(C=C(C=C2C)C3=NC4=CC=CC=C4[N]3C)[N]1CC5=CC=C(C=C5)C6=CC=CC=C6C(O)=O	Enzo	DL511	-4.42882401	-6.96967064	0.51374374	3.69015078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378881-01	Tegobuvir	363678254		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1000787-75-6				-21.1901301969	4	4		0	-4.65126532					FC1=CC=CC=C1C2=NC3=C[N](CC4=NN=C(C=C4)C5=CC=C(C=C5C(F)(F)F)C(F)(F)F)C=CC3=N2	MedChem Express	HY-10544	-3.60084523	-6.44824889	-5.73900061	-4.65126532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164600-15	Artesunate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	88495-63-0		4.4668359215	-5.35	-14.3905848971	4	4		-21.64161074	-18.86800895	0.0793259414	0.9961114399			C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	MedChem Express	HY-N0193	1.4058183	2.3628114	-7.91107198	-18.86800895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	17321-77-6				1.2857143604	4	4		0	-1.60038797				SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	1.67751951	-1.63378813	-0.94405901	-1.60038797												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482644-02	Scutellarein			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	529-53-3		14.1253754462	-4.85	-22.935475262	4	4		-21.4461147399	-20.66396261	0.2644339773	0.9543995605			OC1=CC=C(C=C1)C2=CC(=O)C3=C(O)C(O)=C(O)C=C3O2	MedChem Express	HY-N0752	-1.12553366	-5.34457287	-1.26020901	-20.66396261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601698-01	Glecaprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1365970-03-1				-30.2798029934	4	4		0	-4.89932886					[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347	-5.9970746	-7.34526154	-8.82676645	-4.89932886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250408-10	NCGC00250408-10			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1086062-66-9		0.1412537545	-6.85	-242.7260094184	-2.1	4		-88.8533016002	-84.82774049	0.0188692566	0.9997803805		PIK3CA	COC1=C(N[S+]([O-])(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C3=CC=C4N=CC=C(C5=CN=NC=C5)C4=C3	Aobious	AOB87781	-14.39135381	-35.84453386	-67.36077482	-84.82774049												1.6E-8	8E-8	4E-7	0.000002											
NCGC00399644-01	NCGC00399644-01	375804384		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-112.9721252531	-3	4		-99.6124581428	-99.59284116	0.0154350009	0.9998530373			COC1=CC=C(C=C1OC)C2=N[N](C)C(=C2)[C@H]3CN4CC[C@H]3C[C@@H]4COC(=O)NC5=CC=C(C=C5)C(C)C	Analyticon	NAT13-339048	-10.04388103	-8.86910367	-9.56636584	-99.59284116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016853-13	Nabumetone		Cyclooxygenase-2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	42924-53-8				-20.2852218291	4	4		0	0.11185682					COC1=CC2=CC=C(CCC(C)=O)C=C2C=C1	Enzo	DL454	-5.58264261	-4.08355449	-4.66211754	0.11185682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378896-04	MP-513   Tenelia   Tenglyn   Teneligliptin hydrobromide hydrate (Prop INNM)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox					-27.6540362055	4	4		0	-6.91737942					CC1=NN(C(=C1)N2CCN(CC2)[C@@H]3CN[C@@H](C3)C(=O)N4CCSC4)C5=CC=CC=C5	BLD Pharma	BD627730	-6.18827893	-4.18875467	-5.37015895	-6.91737942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346888-03	UK-383367	363677552	Procollagen C-Endopeptidase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	348622-88-8		12.5892541179	-4.9	-88.9864103286	-2.4	4		-82.6638172138	-72.65232343	0.0709836146	0.9968800202			NC(=O)C1=NOC(=N1)[C@H](CCCC2CCCCC2)CC(=O)NO	Selleck	S2224	-6.98175859	-11.28009038	-12.83481163	-72.65232343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378806-01	Nucleozin	363678210		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	341001-38-5				-39.0948059785	4	4		0	-12.36663434					CC1=C(C(=O)N2CCN(CC2)C3=C(Cl)C=C(C=C3)[N+]([O-])=O)C(=NO1)C4=CC=CC=C4	MedChem Express	HY-50001	-7.28362586	-7.83001651	-8.26820058	-12.36663434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180681-03	Isochlorogenic acid C			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	32451-88-0				-12.0093437302	4	4		0	-2.92170022					O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H]1OC(=O)\C=C\c3ccc(O)c(O)c3)C(O)=O	DC Chemicals	DCY-070	-2.73037543	-1.81491311	-2.2672243	-2.92170022												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346623-04	BMS-378806	384568863	HIV Attachment Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	357263-13-9				-30.6044492462	4	4		0	-6.97028481					COC1=C2C(=NC=C2C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C4=CC=CC=C4)[NH]C=C1	MedChem Express	HY-14134	-6.12790547	-7.24776223	-6.69623255	-6.97028481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274060-07	Posaconazole			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	171228-49-2		3.9810717055	-5.4	-86.9633136013	-2.2	4		-71.6474425121	-70.08641213	0.0133854195	0.9998894986			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718	-1.87588943	-4.65803424	-37.95995433	-70.08641213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510442-01	Abametapir	384569434	MMP-9 (Gelatinase B) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox			12.5892541179	-4.9	-68.0286794795	-3	4		-61.5057378332	-61.40992858	0.0205611437	0.9997392401		MMP	CC1=CN=C(C=C1)C2=NC=C(C)C=C2	SIGMA	513040	-5.81741343	-5.40540541	-5.00131729	-61.40992858												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164555-10	Entacapone		NCI-H1299 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	130929-57-6				-28.9560255093	4	4		0	-10.91173618					CCN(CC)C(=O)/C(=C/C1=CC(=C(O)C(=C1)[N+]([O-])=O)O)C#N	MedChem Express	HY-14280	-3.75609125	-8.72512384	-7.31096865	-10.91173618												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346487-05	Quisinostat	385842041	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	807640-87-5		0.2818382931	-6.55	-335.3942768113	-1.2	4		-60.4255906195	-99.55704698	0.010900628	0.9999267344		HDAC1	C[N]1C=C(CNCC2CCN(CC2)C3=NC=C(C=N3)C(=O)NO)C4=CC=CC=C14	ActiveBioChem	A-1162	-48.26101089	-97.59438404	-99.47171473	-99.55704698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168085-15	Vorinostat (SAHA)		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	149647-78-9		3.9810717055	-5.4	-166.8451607018	-2.1	4		-97.9373886486	-99.49440716	0.0191061484	0.9997748019		HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	Microsource	01502267	-13.25369738	-21.89024912	-61.99867929	-99.49440716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178869-11	Vidarabine	384568366	Adenosine Receptor Agonist; Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	5536-17-4				-34.7566650911	4	4		0	-6.6550142					NC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)C2=NC=N1	MedChem Express	HY-B0277	-7.85606315	-6.62988115	-7.27809623	-6.6550142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166328-02	Ammonium diethyldithiocarbamate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	21124-33-4				-38.535628428	4	4		0	-5.39654796					CCN(CC)C(S)=S	SIGMA	359548	-8.44390326	-7.31748727	-11.19506688	-5.39654796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178697-04	Irinotecan	170464824	DNA Topoisomerase I Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	100286-90-6	;Irinotecan hydrochloride trihydrate;Irinotecan; Campto;Irinotecan hydrochloride			-42.9439024824	4	4		0	-10.84116331			7150	TOP1	Cl.CC[C@]3(O)C=4C=C5c6nc7ccc(OC(=O)N1CCC(CC1)N2CCCCC2)cc7c(CC)c6CN5C(=O)C=4COC3=O	Prestwick	Prestw-1494	-9.67820575	-8.04725623	-6.44067797	-10.84116331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164859-01	NCGC00164859-01	29216613		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.0195520987	4	4		0	-4.10290828					CCOC(=O)C1=C(NC(=O)CSC2=CN(CCNC(=O)C3=CC=C(OC)C=C3)C4=C2C=CC=C4)SC5=C1CCCC5	Sytravon	C064-0045	-7.52478466	-8.58659361	-9.63680387	-4.10290828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018268-05	Itraconazole		cytochrome inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	84625-61-6		2.5118864315	-5.6	-127.0152020475	-1.1	4		-79.240964588	-82.29530201	0.0209271038	0.9997298038			CCC(C)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Prestwick	Prestw-1139	-3.99804973	-2.92783152	-76.18313889	-82.29530201												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00132517-01	NCGC00132517-01	24407900		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-25.4942586727	4	4		0	-8.04026846					CC1CN(CCN1C2=CC=CC(=C2)C)C(=O)C3CCN(CC3)[S+]([O-])(=O)C4=C(ON=C4C)/C=C/C5=CC=C(C)C=C5	Sytravon	G637-0523	-4.97318381	-5.24783837	-4.45960819	-8.04026846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00134114-01	NCGC00134114-01	24409497		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-8.9846175684	4	4		0	-2.32214765					COC1=CC=C(C=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0979	-2.48659191	-0.11985275	-1.16662998	-2.32214765												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126025-02	NCGC00126025-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.8306695073	4	4		0	-1.52572707					CCC1=CC=C(CNC(=O)C2CCCN(C2)C3=NN=C(C)C4=C(C)[N](N=C34)C5=CC=C(OC)C=C5)C=C1	Chemdiv	E859-1203	-5.77766943	-10.19604486	-9.74246093	-1.52572707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139531-02	NCGC00139531-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-37.5957751015	4	4		0	-13.17673378					CC1CN(CCN1C2=CC=CC(=C2)C)[S+]([O-])(=O)C3=C(F)C=CC(=C3)C(=O)NC4=CC=C(OC5=CC=CC=C5)C=C4	Chemdiv	K781-7795	-5.71266049	-10.28165397	-8.54501431	-13.17673378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160670-08	Mecarbinate	384568202	antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	15574-49-9				-35.7424418621	4	4		0	-4.32160804					CCOC(=O)C1=C(C)[N](C)C2=CC=C(O)C=C12	MedChem Express	HY-B0376	-8.22556265	-6.53650255	-9.92704534	-4.32160804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390283-02	Vesatolimod		Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1228585-88-3				-43.2761308241	4	4		0	-7.70373607				TLR7	CCCCOC1=NC2=C(NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4)C(=N1)N	MedChem Express	HY-15601	-10.52653678	-7.02886248	-8.19002953	-7.70373607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420698-02	BPTES	384569223	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	[314045-39-1]				-31.9975112649	4	4		0	-8.54271357				GLS	O=C(CC1=CC=CC=C1)NC2=NN=C(CCSCCC3=NN=C(NC(=O)CC4=CC=CC=C4)S3)S2	Tocris	5301	-5.7062479	-8.36162988	-7.43442765	-8.54271357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482601-01	Patchouli alcohol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	5986-55-0				-34.6729700301	4	4		0	-5.98208433					C[C@H]1CC[C@@]2(O)C(C)(C)[C@@H]3CC[C@@]2(C)[C@H]1C3	DC Chemicals	DC6504	-7.22623446	-8.13242784	-8.67639396	-5.98208433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00100267-01	NCGC00100267-01	24273965		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-28.6252663043	4	4		0	-10.4295302					CC1=CC=C(C=C1)C/2=N/N(CC(=O)NC3=CC=CC(=C3)C(F)(F)F)C(=O)C4=CC=CC=C24	Sytravon	5498-2707	-4.42060783	-5.59883572	-8.05194805	-10.4295302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482878-01	VR23			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1624602-30-7		10	-5	-21.4545697113	4	4		-19.9815159721	-16.51454139	0.1471015086	0.9865064352			[O-][N+](=O)C1=CC=C(C(=C1)[N+]([O-])=O)[S+]([O-])(=O)N2CCN(CC2)C3=CC=NC4=CC(=CC=C34)Cl	DC Chemicals	DC8448	-1.11327808	-3.39012071	-5.57781202	-16.51454139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016961-11	ATOVAQUONE		Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	95233-18-4		0.4466835922	-6.35	-195.792203478	-1.1	4		-81.903129479	-85.17806423	0.029008561	0.9994806794			O\C1=C(/C2CCC(CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O	Microsource	01504210	-6.63839436	-77.53820034	-87.2416189	-85.17806423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182080-04	Valpromide			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	2430-27-5				-36.2177175866	4	4		0	-6.48022722					CCCC(CCC)C(N)=O	SIGMA	V3640	-8.56147128	-4.65195246	-8.05975334	-6.48022722												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00163589-02	LUTEOLIN-7-GLUCOSIDE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox					-34.7524847494	4	4		0	-6.70745029					OC[C@H]1O[C@@H](OC2=CC(=C3C(=O)\C=C(/OC3=C2)C4=CC=C(O)C(=C4)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-001730	-7.10026873	-7.08828523	-9.51884662	-6.70745029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345451-03	A-966492		PARP-1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	934162-61-5				-7.6595414678	4	4		0	-7.28424732					NC(=O)C1=C2N=C([NH]C2=CC=C1)C3=C(F)C=C(C=C3)[C@@H]4CCCN4	MedChem Express	HY-10614	-1.41501512	1.00169779	0.99878409	-7.28424732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378650-01	Narlaprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	865466-24-6				-36.0242686723	4	4		0	-4.62748525					CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC3(CCCCC3)C[S+]([O-])(=O)C(C)(C)C)C(C)(C)C)C2(C)C)C(=O)C(=O)NC4CC4	MedChem Express	HY-10300	-8.67064159	-6.3327674	-8.58085809	-4.62748525												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00102565-01	NCGC00102565-01	24276263		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-29.8286939802	4	4		0	-10.04474273					COC1=CC2=C(OC(=N2)C3=CC(=CC=C3)NC(=O)C4=CC(=CC=C4N5CCOCC5)[N+]([O-])=O)C=C1	Sytravon	7793-4006	-5.50138144	-7.81611163	-4.01937046	-10.04474273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-06	NCGC00183128-06			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	11052-19-0				-30.3275630628	4	4		0	-4.53243848					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	SigmaAldrich	S369039	-5.97269625	-6.28370859	-10.43803654	-4.53243848												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00121465-02	NCGC00121465-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-32.2734515288	4	4		0	-3.03803132					CCC1CN(C(=O)N2CCC(CC2)C(=O)N3CCN(CC3)C4=C(C)C=CC(=C4)C)C5=CC=CC=C5O1	Chemdiv	E216-5397	-9.69445799	-4.30613817	-3.20052829	-3.03803132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399536-01	NCGC00399536-01	375805932		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-26.8377394204	4	4		0	-11.0917226					COC1=CC=C(NC(=O)N[C@H]2CO[C@@H]3[C@@H](CO[C@H]23)OC(=O)NC4=CC=C(OC5=CC=CC=C5)C=C4)C=C1	Analyticon	NAT6-270098	-3.36421258	-9.78512114	-4.45960819	-11.0917226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-05	Maraviroc	384568416		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	376348-65-1				-42.7875838917	4	4		0	-7.36290146				CCR5	CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Enzo	AC3169	-11.39989923	-3.98132428	-7.71235018	-7.36290146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384206-05	b-AP15			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1009817-63-3		10	-5	-103.611505828	-2.3	4		-123.965372095	-99.66790474	0.1043230042	0.9932271			[O-][N+](=O)C1=CC=C(C=C1)/C=C/2CN(CC(=C/C3=CC=C(C=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	Cayman	11324	-1.00352704	-11.54499151	-26.44606566	-99.66790474												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390255-01	Maslinic acid	384569181	Glycogen Phosphorylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	4373-41-5		10	-5	-60.4240803057	-3	4		-88.8850120116	-78.87699366	0.0358642206	0.9992059122		PYGL	CC1(C)CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Adooq	A12089	-0.2897212	2.32597623	-3.36981067	-78.87699366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263155-04	Belinostat	384568629	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	414864-00-9		1	-6	-215.450249536	-1.1	4		-81.7112897221	-99.69412279	0.0264768092	0.9995674098		HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	Selleck	S1085	-17.4882432	-40.32258065	-97.42053153	-99.69412279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345017-01	NCGC00345017-01	170466916		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-24.9324089008	4	4		0	-0.02237136					CC1=C(C=CC=C1)C(=O)N2CCC3=C2C=CC(=C3)C4=CC=CC(=C4)NC(=O)CC5=CC6=C(OCO6)C=C5	NCGCChem	JMR03-077	-7.43539737	-3.14185429	-5.34008365	-0.02237136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015074-17	ACETAZOLAMIDE		Carbonic anhydrase XII Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	59-66-5				-9.5694445873	4	4		0	0.41610738					CC(=O)NC1=NN=C(S1)[S+](N)([O-])=O	Microsource	01500102	-2.56785308	-3.56133893	-1.19304424	0.41610738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378916-02	MK-5172			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1350514-68-9		14.1253754462	-4.85	6.7852728861	4	4		19.2983711239	15.18120805	0.1795500258	0.9796664195			COC1=CC2=C(C=C1)N=C3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)N[S+]([O-])(=O)C7CC7)OC3=N2)C(C)(C)C	MedChem Express	HY-15298	-0.73947668	-0.65919014	-3.16530927	15.18120805												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346932-04	SB-3CT	384568968	MMP2/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	292605-14-2				-40.6765308039	4	4		0	-4.47891632				MMP2	[O-][S+](=O)(CC1CS1)C2=CC=C(OC3=CC=CC=C3)C=C2	MedChem Express	HY-12354	-10.06466241	-9.24448217	-7.39100226	-4.47891632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347708-02	NCGC00347708-02	363677669		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			4.4668359215	-5.35	-155.504166232	-3	4		-90.5374432336	-90.89485459	0.0232530312	0.9996663904			CC1CCC2(OC1)OC3CC4C5CCC6C[C@H](CC[C@]6(C)C5CC[C@]4(C)C3C2C)O[C@@H]7O[C@H](CO[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@H](O)[C@H]7O	Analyticon	NP-007320	-13.15618398	-11.65996062	-12.00528285	-90.89485459												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00400318-01	NCGC00400318-01	375800847		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-35.6988120613	4	4		0	-6.78747204					CC1=NC(=CC(=N1)C2=C(Br)C=CC=C2)[C@H]3CN4CC[C@H]3C[C@@H]4CNC(=O)NC5=CC=C(Cl)C=C5	Analyticon	NAT13-368693	-8.88997237	-4.29757726	-7.03940128	-6.78747204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015436-09	Fluphenazine hydrochloride	124880096	Nicotinic alpha7 Receptor Ligands	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	146-56-5	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S	8.9125093813	-5.05	-95.3932163114	-3	4	FLUPHENAZINE 2HCl	-96.4873798969	-99.63294735	0.0134145258	0.9998889984	1813	DRD2	OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	BIOMOL	AC753	-4.698522	-5.82342954	-6.94806323	-99.63294735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015818-25	Praziquantel	384567893	antiparasitic agent	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	55268-74-1				-28.3337658537	4	4		0	-0.44133712					O=C1CN(CC2N1CCC3=C2C=CC=C3)C(=O)C4CCCCC4	MedChem Express	HY-B0244	-7.67971112	-5.80645161	-6.20114643	-0.44133712												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522475-03	Verubecestat (MK-8931)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1286770-55-5(free base)				-50.3744580314	4	4		0	-11.58400699					CN1C(N)=N[C@@](C)(C[S+]1([O-])=O)C2=CC(NC(=O)C3=NC=C(F)C=C3)=CC=C2F	Selleck	S8173	-10.61051394	-10.70458404	-10.21365294	-11.58400699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378981-01	RO-9187			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	876708-03-1				-42.7775437069	4	4		0	-10.77998689					NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O	MedChem Express	HY-10870	-8.49428955	-8.53989813	-10.10074692	-10.77998689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346536-05	PIK-93		PI3K Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	593960-11-3		11.220184543	-4.95	-32.8510515152	-2.4	4		-35.630079128	-28.65195543	0.0231470189	0.9996700444		PIK3CA	CC(=O)NC1=NC(=C(S1)C2=CC(=C(Cl)C=C2)[S+]([O-])(=O)NCCO)C	Adooq	A10731	-1.87688949	-2.52122241	-6.98280354	-28.65195543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356067-12	OTX-015			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	202590-98-5		0.6309573445	-6.2	-208.3520047031	-1.2	4		-77.4472199728	-89.13698929	0.0366712468	0.9991697984			CC1=NN=C2[C@H](CC(=O)NC3=CC=C(O)C=C3)N=C(C4=C(SC(C)=C4C)N12)C5=CC=C(Cl)C=C5	APExBIO	A3692	-16.1110178	-58.79456706	-85.11377454	-89.13698929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370995-10	SRPIN340	363677983	Serine/threonine-protein kinase SRPK1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	218156-96-8				-32.2074828379	4	4		0	-8.18710872					FC(F)(F)C1=CC(=C(C=C1)N2CCCCC2)NC(=O)C3=CC=NC=C3	Glixx	GLXC-02516	-7.40437276	-3.94542452	-6.32739088	-8.18710872												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015034-21	INO-1001		PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	3544-24-9				-22.8418924344	4	4		0	-6.5734944				PARP1	NC(=O)C1=CC(=CC=C1)N	MedChem Express	HY-12022	-3.83371426	-6.31789346	-5.32624923	-6.5734944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179542-09	Brinzolamide		Carbonic anhydrase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	138890-62-7				-35.6805611034	4	4		0	-8.37666594					CCN[C@H]1CN(CCCOC)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0588	-7.16745045	-7.80135823	-8.10317874	-8.37666594												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346529-03	Safinamide		Sodium channel inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	133865-89-1				-31.2842717041	4	4		0	-6.57636006					C[C@H](NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O	MedChem Express	HY-70057	-5.95817938	-6.99490662	-8.96300156	-6.57636006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018261-09	Perhexiline	384568001	mitochondrial carnitine palmitoyltransferase-1 inhbitior	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	6724-53-4, 6621-47-2 [perhexiline]		12.5892541179	-4.9	-97.9996592492	-3	4		-110.8094210538	-99.67664409	0.0289740176	0.9994818803			C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3	Microsource	01503227	-4.92526033	-7.47877759	-8.14660413	-99.67664409												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371119-04	S1RA	363678035	Sigma opioid receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	878141-96-9				-46.6315114316	4	4		0	-7.25802928					CC1=CC(=N[N]1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4	Glixx	GLXC-90073	-11.24874034	-8.98132428	-8.87615077	-7.25802928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370887-06	AC-55541			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	916170-19-9		10	-5	-36.2276774275	-3	4		-40.2606729268	-37.11164518	0.1108907564	0.9923452149			C\C(=N/NC(=O)C(NC(=O)C1=CC=CC=C1)C/2=N/NC(=O)C3=CC=CC=C23)C4=CC=CC(=C4)Br	MedChem Express	HY-14350	-2.66627477	1.08658744	-3.49140177	-37.11164518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250390-07	ISOX		HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1045792-66-2		1.1220184543	-5.95	-154.6085416264	-1.3	4		-89.055199729	-99.72224672	0.1732236003	0.9810240956		HDAC6	CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO	Axon Medchem	1645	-3.3248523	-18.98844182	-83.42408009	-99.72224672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189073-04	Selumetinib	384568456	Mek1/2 inibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	606143-52-6		0.2511886432	-6.6	-103.2398599998	4	4		-25.25993358	-32.31196544	0.2619817617	0.9554432991		MAP2K1	C[N]1C=NC2=C1C=C(C(=O)NOCCO)C(=C2F)NC3=CC=C(Br)C=C3Cl	Selleck	S1008	-16.26202079	-25.98418354	-27.75533503	-32.31196544												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378936-01	Letermovir	363678286	Tripartite terminase subunit UL28 homolog Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	917389-32-3				-29.4725181878	4	4		0	-8.21356141			3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-4.5150718	-7.94299122	-8.94441029	-8.21356141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162073-12	H-89	384568218	AKT Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	130964-39-5		11.220184543	-4.95	-34.1561264566	-3	4		-45.0883960879	-39.65699674	0.0335479593	0.9993057338		AKT1	[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23	MedChem Express	HY-15979A	-1.21178145	0.00869036	-2.04180205	-39.65699674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485478-02	Oritavancin (diphosphate)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	192564-14-0		14.1253754462	-4.85	-15.8615104412	4	4		-23.513931756	-18.34494313	0.4039138277	0.8839097894			[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1	-3.08335849	2.54627618	5.64239923	-18.34494313												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263546-03	Moexipril HCl		Angiotensin-converting enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	82586-52-5				-31.6343512993	4	4		0	-4.72361809					CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(OC)C=C3C[C@H]2C(O)=O)OC	Selleck	S2079	-7.62932482	-4.05772496	-8.27688032	-4.72361809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522116-02	Presatovir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1353625-73-6				-45.5001958347	4	4		0	-10.64889666					CC1=C[N]2N=C(C=C2N=C1N3CC[C@H](N)C3)[C@@H]4CCCCN4C(=O)C5=CC(=CC=C5N[S+](C)([O-])=O)Cl	MedChem Express	HY-16727	-8.85539133	-8.98981324	-11.59458051	-10.64889666												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00370683-05	GI254023X			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	260264-93-5				-50.7116424915	4	4		0	-10.97225257					CNC(=O)[C@@H](NC(=O)[C@H](CCCC1=CC=CC=C1)[C@H](C)N(O)C=O)C(C)(C)C	SIGMA	SML0789	-11.03879745	-10.81494058	-9.67517804	-10.97225257												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160338-03	Oxymatrine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	16837-52-8				-17.482859323	4	4		0	-2.41160391					[O-][N@+]12CCC[C@@H]3C[N@@]4[C@H](CCCC4=O)[C@H](CCC1)[C@H]23	Selleck	S2338	-2.54862219	-6.03980186	-7.0826381	-2.41160391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371122-02	Betrixaban	363678038	Coagulation factor X Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	330942-05-7				-26.3637152907	4	4		0	-5.21558945					COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=NC=C(Cl)C=C3	MedChem Express	HY-10268	-5.32580103	-6.84800556	-5.835602	-5.21558945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095709-02	Tanshinone IIA	50107688	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	568-72-9	TANSHINONE IIA			-34.5404081505	4	4	Tanshinone Iia;tanshinone;Tanshinone IIA;CIPLUS_762550;1,6-dimethylphenanthro(1,2-b)furan-10,11-dione;NCGC00095709-01;Tanshinon I;NCGC00095709-02;tanshinone IIB;tanshinone IIA;LS-175776;TANSHINONE IIA;tanshinone II A;CIPLUS_742126;tanshinone II B;	0	-5.55385624			7124	TNF	CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C	Prestwick Chemical, Inc.	GPN1A_01G09	-7.2430299	-7.0713073	-9.94441549	-5.55385624												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482709-01	Licochalcone A			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	58749-22-7		12.5892541179	-4.9	-66.9389566717	-3	4		-112.7422110555	-98.95127813	0.1198487748	0.9910348445			COC1=CC(=C(C=C1\C=C\C(=O)C2=CC=C(O)C=C2)C(C)(C)C=C)O	DC Chemicals	DCG-033	0.07138058	-0.1188455	9.9009901	-98.95127813												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167778-02	ZK 756326			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	[874911-96-3]				-34.2504352386	4	4		0	-6.41477824					OCCOCCN1CCN(CC1)CC2=CC=CC(=C2)OC3=CC=CC=C3	Tocris	2565	-7.37849843	-8.62083949	-6.56450338	-6.41477824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509859-02	Paritaprevir			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1216941-48-8				-18.5053576692	4	4		0	-4.76589366					CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC\C=C/[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S+]([O-])(=O)C8CC8	MedChem Express	HY-12594	-3.08335849	-2.32901712	-7.78519364	-4.76589366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024415-61	Doxorubicin		DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	23214-92-8		2.8183829313	-5.55	-46.2741633418	-2.4	4		-41.844043376	-30.36328366	0.1017662429	0.9935702029		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(=C3C2=O)O	Microsource	01505483	-0.90991418	-10.50664813	-19.90427681	-30.36328366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00139425-01	NCGC00139425-01	24414808		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-21.2466563728	4	4		0	-3.1901566					CC1=CC(=CC=C1)N2C(=N/C3=C(C=CC=C3)C2=O)\C=C\C4=C5C=CC=CC5=CC=C4	Sytravon	K505-0626	-3.89241021	-7.3195788	-5.4457407	-3.1901566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00126890-02	NCGC00126890-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-24.8149129559	4	4		0	-5.47203579					[O-][S+](=O)(CC1NC2=C(NC1=O)C=C(C=C2)C(=O)NCC3=CC=C(Cl)C=C3)CC4=C(Cl)C=C(F)C=C4	Chemdiv	K977-0487	-6.12709248	-2.85934423	-4.40677966	-5.47203579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094931-06	Lapachol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	84-79-7		22.3872113857	-4.65	-38.7560041991	-3	4		-53.1832212151	-53.32885906	0.0919096092	0.9947557113			CC(C)=CCC/1=C(O)/C(=O)C2=C(C=CC=C2)C1=O	Prestwick	Prestw-NAT-0052	-2.25906062	-6.52341409	-5.6394453	-53.32885906												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00015801-17	Pentoxifylline	363676463	"3',5'-cyclic phosphodiesterase Inhibitor"	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	6493-05-6				-23.3741529951	4	4		0	-6.59112953					C[N]1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C	MedChem Express	HY-B0715	-4.42882401	-4.65803424	-5.55457978	-6.59112953												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166276-06	N-ACETYLNEURAMIC ACID			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	131-48-6				-19.974478711	4	4		0	-8.05484525					CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO	Microsource	MS-02300147	-1.970762	-6.73503085	-6.02880478	-8.05484525												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371120-06	Dapivirine?TMC-120	363678036	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	244767-67-7		7.9432823472	-5.1	-96.9941358073	-2.1	4		-100.1429978033	-92.83572877	0.0324446034	0.9993502278			CC1=CC(=C(NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C(=C1)C)C	Glixx	GLXC-04864	-4.42019923	-2.46806292	-20.87907263	-92.83572877												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346475-02	Birinapant	384568790	IAP Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1260251-31-7				-21.0735463813	4	4		0	-5.91217706				XIAP	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC2=C([NH]C3=C2C=CC(=C3)F)C4=C(C[C@@H]5C[C@H](O)CN5C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C6=C([NH]4)C=C(F)C=C6	Selleck	S7015	-1.72926819	-8.16894064	-7.5392992	-5.91217706												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00386847-01	NCGC00386847-01			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			14.1253754462	-4.85	-24.9715515697	4	4		-10.656187036	-12.52348993	0.2887166121	0.9455834698			COC1=CC=C(C=C1)C2=CC=C(C=C2)C3=C[N](N=N3)C(=O)N4CCCCC4C5=CC=CC=C5	Evotec	MLS004256815	-4.67251747	-3.28738978	-1.9766674	-12.52348993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182490-01	NCGC00182490-01	104223876		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-42.3161633501	4	4		0	-6.76957494					CC1=CC=C(NC(=O)CN2C(=O)N\C(=C/C3=CC=CN3C4=CC=C(C=C4)C(=O)N[S+](C)([O-])=O)C2=O)C=C1	NCGCChem	BTM03-098	-10.14139444	-9.81080387	-6.44067797	-6.76957494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263172-02	NCGC00263172-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1020172-07-9		8.9125093813	-5.05	-86.9529592694	-2.4	4		-76.2667505573	-71.93288591	0.0948360345	0.9944125681		ABL1	CNC(=O)C1=CC(=CC=N1)OC2=CC(=C(NC(=O)NC3=CC(=N[N]3C4=CC5=C(C=C4)N=CC=C5)C(C)(C)C)C=C2)F	Selleck	S2634	-8.28051357	-2.65388237	-14.57627119	-71.93288591												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017388-08	(+)-Usniacin			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	7562-61-0		12.5892541179	-4.9	-63.2550676003	-3	4		-53.6224221514	-53.93263381	0.0352334434	0.9992338953			CC(=O)C1=C(O)C(C)=C(O)C2=C1OC3=CC(=O)C(C(C)=O)=C(O)[C@@]23C	DC Chemicals	DCS-001	-6.27452672	-4.88398366	-5.01888118	-53.93263381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381560-10	RGFP966			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1357389-11-7		11.220184543	-4.95	-74.6087063467	-2.4	4		-67.3615178728	-58.57949034	0.0816921182	0.9958629307			NC1=CC(=CC=C1NC(=O)\C=C\C2=C[N](C\C=C\C3=CC=CC=C3)N=C2)F	MedChem Express	HY-13909	-5.38617448	-9.56808899	-14.85465882	-58.57949034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346545-08	Telaprevir (VX-950)	384568831	HCV NS3 NS4A Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	402957-28-2				-25.4198108479	4	4		0	-5.20357942					CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	APExBIO	A4031	-3.66487892	-7.63633251	-9.77767995	-5.20357942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370866-10	PJ34 Hydrochloride	363677895	Poly [ADP-ribose] polymerase-1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	344458-15-7		11.220184543	-4.95	-51.1936572567	-3	4		-35.9358788539	-34.5458613	0.0485535627	0.9985455458			CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1	Glixx	GLXC-05505	-5.49325532	-6.78880233	-9.44309927	-34.5458613												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00434879-01	NCGC00434879-01	375875258		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-24.615391973	4	4		0	-3.14541387					OC1=CC=C(CCC(=O)N[C@H]2CC[C@@H](C2)NC3=NC(=CC=N3)C4=CN=CC=C4)C=C1	Chembridge	15174553	-5.37948968	-7.38806609	-4.81179837	-3.14541387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159521-16	Zoledronic acid monohydrate	384568184	Farnesyl Pyrophosphate Synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	165800-06-6				-42.3930260483	4	4		0	-7.82608696				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	MedChem Express	HY-13777A	-9.48522002	-8.60780985	-11.39482369	-7.82608696												1.6E-8	8E-8	4E-7	0.000002											
NCGC00346566-10	Roflumilast	384568843	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	162401-32-3				-29.819949467	4	4		0	-5.64124973				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	MedChem Express	HY-15455	-6.89032583	-5.18675722	-6.27062706	-5.64124973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165001-01	NCGC00165001-01	29216755		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			12.5892541179	-4.9	-37.3644710947	-3	4		-31.017441972	-31.58389262	0.0117622737	0.9999147916			COC1=C(OC)C=C(C=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)F)C(=O)NC4=C(C#N)C5=C(CC(C)CC5)S4	Sytravon	A0005388	-3.55111328	-3.23602431	-3.47347568	-31.58389262												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017063-13	Amodiaquine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	86-42-0		14.1253754462	-4.85	-50.598049007	4	4		-12.040126424	-19.1610225	0.1268552356	0.990067253			CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1	Cayman	15954_cm1	-9.38444743	-9.32088285	-8.29425048	-19.1610225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263182-04	Mocetinostat	384568650	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	726169-73-9		1.5848931925	-5.8	-149.2154847322	-1.1	4		-96.2221534313	-99.44068167	0.0306921177	0.9994185406		HDAC1	NC1=C(NC(=O)C2=CC=C(CNC3=NC(=CC=N3)C4=CC=CN=C4)C=C2)C=CC=C1	Selleck	S1122	-1.35623111	-7.83531409	-94.35469863	-99.44068167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095802-05	Flavanone			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	487-26-32				-11.1543229075	4	4		0	-3.23792877					O=C1CC(OC2=CC=CC=C12)C3=CC=CC=C3	Enzo	AC1548	-1.47379913	-3.82852292	-3.28295987	-3.23792877												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094857-06	AMINACRINE			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox			5.0118723363	-5.3	-117.6019663702	-2.1	4		-100.4422535183	-98.3570024	0.0144700119	0.9998708428			NC1=C2C=CC=CC2=NC3=C1C=CC=C3	Microsource	MS-01500810	-4.10228418	-5.33106961	-42.75664409	-98.3570024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00399510-01	NCGC00399510-01	375801344		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-25.7289942623	4	4		0	-6.52796421					COC1=CC(=CC(=C1)NC(=O)N[C@H]2CO[C@@H]3[C@H](CO[C@H]23)NC4=NC(=CC=N4)C5=CC=C(C=C5)C6=CC=CC=C6)OC	Analyticon	NAT6-321099	-4.92442711	-6.47204863	-5.36649791	-6.52796421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262963-03	Fiacitabine			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	69123-90-6				-31.2537028335	4	4		0	-7.57264584					NC\1=N\C(=O)N(\C=C1I)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F	MedChem Express	HY-50735	-6.3948606	-6.76570458	-6.48775404	-7.57264584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159460-01	INDINAVIR SULFATE	363676591	HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	0157810-81-6				-33.5749152953	4	4		0	-5.56259559					CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=CC=CC=C34)CC5=CC=CN=C5	Microsource	01506401	-7.11706416	-5.99320883	-10.09206184	-5.56259559												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093656-03	Brivudine	90341813	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	69304-47-8	(E)-5-(2-Bromovinyl)-2'-deoxyuridine;Brivudine			-31.0067288883	4	4		0	-4.43521958			7015	TERT	OC[C@H]1O[C@H](C[C@@H]1O)N2/C=C(/C=C/Br)C(=O)NC2=O	SigmaAldrich	Lopac-B-9647	-6.80634867	-7.32597623	-7.42574257	-4.43521958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00490219-01	NCGC00490219-01	375820855		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox			10	-5	-84.2601079729	-2.4	4		-77.2680820629	-72.29977629	0.1030002457	0.9934002026			COC1=CC=C(NC2=NC(=NC=C2)N3CCCC(C3)C(=O)NCCC4=CC=C(Cl)C=C4)C=C1	ChemRoutes	CA-182-221	-8.23988298	-1.8063522	-11.32731675	-72.29977629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015156-28	Baclofen			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1134-47-0				0.1590727895	4	4		0	1.16778523					NCC(CC(O)=O)C1=CC=C(Cl)C=C1	MedChem Express	HY-B0007_cm1	0.06500894	-0.49653283	-1.23706802	1.16778523												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00482578-01	D-Pinitol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	10284-63-6				-22.6421200538	4	4		0	-4.17449664					COC1[C@@H](O)[C@@H](O)C(O)[C@H](O)[C@H]1O	DC Chemicals	DCS-033	-4.2174549	-6.90865508	-5.61303104	-4.17449664												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00119660-01	NCGC00119660-01	24394239		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-41.1584320752	4	4		0	-2.31319911					COC1=CC=C(C=C1)C2\C=C(/NC3=NC(=N[N]23)NC(=O)/C=C/C4=C(Cl)C=CC=C4)C5=CC=CC=C5	Sytravon	D413-0074	-10.19827726	-9.65670747	-9.4959278	-2.31319911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164615-05	Prulifloxacin	384568265	Antibacterial	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	123447-62-1				-18.2574191173	4	4		0	-1.39392615					CC1SC/2=C(C(O)=O)/C(=O)C3=CC(=C(C=C3N12)N4CCN(CC4)C\C5=C(C)\OC(=O)O5)F	Glixx	GLXC-06577	-5.02603292	-0.1188455	-6.14903596	-1.39392615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686670-01	GS-441524			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1191237-69-0				-22.1490273765	4	4		0	-2.49217002					NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586	-4.56687795	-5.29920384	-7.03940128	-2.49217002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00398287-01	NCGC00398287-01	375804744		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-46.9944852784	4	4		0	-11.67337808					O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)[N]3N=NN=C3OC4=CC=C5OCOC5=C4)NC6=CC=CC7=CC=CC=C67	Analyticon	NAT6-298378	-9.52380952	-11.08637959	-8.87079023	-11.67337808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00140656-02	NCGC00140656-02			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-21.4203597203	4	4		0	-1.5704698					COC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CC4=C(C=C3)[S+]([O-])(=O)C5=C(C=CC=C5)C(=O)N4CC6=CC=CC(=C6)Cl	Chemdiv	K788-8633	-3.92491468	-7.49079702	-7.13625358	-1.5704698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181785-11	Aprepitant			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	170729-80-3				-21.436522827	4	4		0	-7.21433253					C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	MedChem Express	HY-10052	-2.9433994	-4.95755518	-7.24335591	-7.21433253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378631-01	Boceprevir		"Hepatitis C virus serine protease, NS3/NS4A Inhibitor"	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	394730-60-0				-19.1216834726	4	4		0	-3.63119948					CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C	MedChem Express	HY-10237	-2.54030904	-5.93378608	-8.25951016	-3.63119948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350413-05	ESI-09			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	263707-16-0		5.6234132519	-5.25	-103.392128339	-2.2	4		-73.2685642312	-72.03408346	0.0221507108	0.9996973294			CC(C)(C)C1=CC(=NO1)C(=O)\C(=N\NC2=CC=CC(=C2)Cl)C#N	MedChem Express	HY-16704	-7.76368828	-9.09168081	-33.43755428	-72.03408346												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00133986-01	NCGC00133986-01	24409369		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox					-28.4450587284	4	4		0	-10.56375839					CC1=C(C=CC=C1)C/2=N/N\3C(=O)/C=C(CN4CCN(CC4)C(=O)/C=C/C5=CC=CC=C5)\N=C3S2	Sytravon	G768-0127	-5.12758004	-7.12267785	-3.54391371	-10.56375839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386359-03	Santacruzamate A (CAY10683)			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-3_Tox	1477949-42-0				-14.8532817595	4	4		0	-6.88590604					CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1	APExBIO	B4794	-2.12904274	-2.68812602	-3.42064715	-6.88590604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160398-13	NafamostatMesylate			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	82956-11-4				-16.1807668272	4	4		0	-5.40957588					NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC=C3C=C(C=CC3=C2)C(N)=N	Bio Vision	1760	-2.88498857	-4.45815591	-2.36673399	-5.40957588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189220-03	UNC-0638	363677129	EHMT2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	1255580-76-7	UNC0638;UNC-0638	12.5892541179	-4.9	-92.5095625156	-3	4		-103.957423172	-99.14028745	0.0600272164	0.9977710503	10919	EHMT2	COC1=C(OCCCN2CCCC2)C=C3N=C(N=C(NC4CCN(CC4)C(C)C)C3=C1)C5CCCCC5	SGC	UNC0638 	-4.29082755	-7.83001651	-2.83217704	-99.14028745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378604-04	ABT-333	377020340		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1132935-63-7		14.1253754462	-4.85	-51.0162296365	4	4		-27.7804041081	-29.44723618	0.049820676	0.9984698756			COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C	MedChem Express	HY-13998	-7.57893853	-7.09677419	-6.71356609	-29.44723618												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015273-15	Chlorpromazine hydrochloride	124879758	Histamine H1 receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	69-09-0		12.5892541179	-4.9	-78.4927844052	-3	4	CHLORPROMAZINE HCl	-51.0111823843	-55.26408606	0.0460391728	0.9986910495			CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2	BIOMOL	AC749	-9.94005779	-7.90822977	-8.97953807	-55.26408606												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482994-01	20(S)-Ginsenoside Rh2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	67400-17-3		11.220184543	-4.95	-40.1270233158	4	4		-15.136157056	-18.84754431	0.177635408	0.9802069033			CC(C)=CCC[C@](C)(O)[C@H]1CC[C@@]2(C)[C@H]1[C@@H](O)CC3[C@@]4(C)CC[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)C4CC[C@@]23C	DC Chemicals	DCR-036	-5.81741343	-7.84739724	-8.1540353	-18.84754431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346486-03	Abexinostat	384568795	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	783355-60-2		2.5118864315	-5.6	-188.0353200417	-1.3	4		-80.0837076434	-99.61546865	0.1070444835	0.992865774		HDAC1	CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO	Selleck	S1090	-14.1963386	-23.62478778	-87.00712176	-99.61546865												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378751-01	Balapiravir	377020534		SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	690270-29-2				-43.1839007924	4	4		0	-9.69630762					CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)N2/C=C\C(=N/C2=O)N)N=[N+]=[N-]	MedChem Express	HY-10443	-8.33473295	-8.73514431	-12.22859128	-9.69630762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346841-07	LY-411575	384568950	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	209984-57-6				-0.4944551409	4	4		0	-0.40637972				NOTCH1	C[C@H](NC(=O)[C@@H](O)C1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-50752	-0.61723211	3.67572156	-1.69359041	-0.40637972												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379005-02	Silvestrol			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	697235-38-4		1.4125375446	-5.85	-147.5792772928	-1.2	4		-74.295097748	-78.5973345	0.0475432316	0.998603527			CO[C@@H]1OC[C@@H](O[C@H]1OC2=CC(=C3C(=C2)O[C@]4([C@@H]([C@H]([C@@H](O)[C@@]34O)C(=O)OC)C5=CC=CC=C5)C6=CC=C(OC)C=C6)OC)[C@H](O)CO	MedChem Express	HY-13251	-9.24168626	-25.98471986	-67.34410283	-78.5973345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346946-03	CDK9 Inhibitor		CDK 9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	1415559-43-1		8.9125093813	-5.05	-13.4214582564	4	4		10.2164931079	5.40528731	0.3849421159	0.8973328191		CDK9	CC1=CC=C(NC2=NC=NC(=C2)C3=CC=CC(=C3)N4C(=O)C5=C(C=CC=C5)C4=O)C=C1N[S+](C)([O-])=O	MedChem Express	HY-13231	-5.59707759	-1.88455008	-2.64894911	5.40528731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	14.1253754462	-4.85	-40.4369870404	4	4		-18.576666444	-20.67292987	0.3439738725	0.9194713901	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-8.05760833	-3.61629881	-2.6923745	-20.67292987												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024246-18	Daunorubicin		DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	23541-50-6		10	-5	-117.0330799191	-2.3	4		-118.1368505636	-95.68380213	0.1901651599	0.9770122896		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(=C3C2=O)O	APExBIO	B2285	-3.47147354	-20.42235161	-32.01457803	-95.68380213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166300-02	Pyridoxal phosphate hydrate	170466028	P2X purinoceptor 2 Antagonist	SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-1_Tox	41468-25-1				-19.5785922929	4	4		0	-7.04964289					O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O	SIGMA	P3657	-2.61762042	-6.06587295	-4.84324229	-7.04964289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180420-04	Picroside 2			SARS-CoV-2_CPE_SRI	2020_Anti-Infectives-2_Tox	39012-20-9				-18.4951494739	4	4		0	-6.10443522					COc1cc(ccc1O)C(=O)O[C@@H]2[C@@H]3O[C@]3(CO)[C@@H]4[C@H]2C=CO[C@H]4O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O	DC Chemicals	DCH-008	-3.60681895	-3.05602716	-3.69984367	-6.10443522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379071-02	NCGC00379071-02	384569093		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1093403-33-8				-6.9105415193	4	4		0	3.22072717				SIRT1	CC1=C(SC(=N1)C2=CC=CN=C2)C(=O)NC3=CC=CC=C3C4=C[N]5C(=CSC5=N4)CN6CCOCC6	MedChem Express	HY-15262	-4.26661946	-1.21446916	3.47131445	3.22072717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346953-01	NCGC00346953-01	174006712		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	345987-15-7	JNK Inhibitor V	12.5892541179	-4.9	-91.3556011462	-3	4		-91.3851094682	-85.74768585	0.0076521714	0.9999638859	5599	MAPK8	N#CC(C1=NC2=CC=CC=C2S1)C3=CC=NC(=N3)NCCC4=CC=CN=C4	EMD Chemicals	420129	-6.56811543	-7.12575632	-7.88671024	-85.74768585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015159-22	NCGC00015159-22	384567818		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	63659-18-7				-11.2161844693	4	4		0	-2.15192289				ADRB1	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1	MedChem Express	HY-B0381	-3.10701956	-1.52788056	-0.86661825	-2.15192289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378611-03	NCGC00378611-03	384569055		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			8.9125093813	-5.05	-153.6163712692	-2.3	4		-113.5895784549	-98.49699399	0.1598653869	0.9838999276			CC(C)(C)C[C@H]1N[C@H]([C@H](C2=CC=CC(=C2F)Cl)[C@@]13C(=O)NC4=C3C=CC(=C4)Cl)C(=O)N[C@H]5CC[C@H](O)CC5	APExBIO	B4984	-11.87040807	-27.51490881	-43.56814331	-98.49699399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386417-06	NCGC00386417-06	384569134		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1454846-35-5				-33.0128797967	4	4		0	-9.07687111				ALK	C[C@H]1OC2=C(N)N=CC(=C2)C3=C(C#N)[N](C)N=C3CN(C)C(=O)C4=C1C=C(F)C=C4	ChemieTek	CT-PF0646_cm2	-5.52197059	-11.61446431	-5.73630555	-9.07687111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346580-05	NCGC00346580-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1201898-17-0		5.6234132519	-5.25	-104.5303749915	-2.4	4		-81.1915955229	-75.59233702	0.0655578758	0.9973403636			[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)\C=C/C3)C(=O)OC)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=C8C=CC=C9)C(C)(F)F)C(=O)OC	MedChem Express	HY-B0628A	-5.8197239	-12.29555944	-35.15926052	-75.59233702												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378621-01	NCGC00378621-01	384569058		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	775351-61-6				-13.8346483249	4	4		0	-2.80364812				PRKAA1	C[C@@H]\1/N=C(/N)NC(=N1)\N(C)C	MedChem Express	HY-14771A	-4.75503023	-0.45705068	1.0340959	-2.80364812												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263117-22	NCGC00263117-22	384568601		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	404950-80-7		0.2238721139	-6.65	-369.2771235623	-1.2	4		-51.8434858567	-99.46918882	0.028511345	0.9994986847		HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	MedChem Express	HY-10224	-61.10258955	-99.35923287	-99.36100678	-99.46918882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167356-11	NCGC00167356-11	384568309		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	518048-05-0				-8.4779904306	4	4		0	-4.01879157					CN1C(=O)\C(=C(/N=C1/C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-]	Glixx	GLXC-90212	-0.11478015	-4.07826707	-3.33427124	-4.01879157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262376-01	NCGC00262376-01	174006421		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	n				-11.4894034614	4	4		0	-1.74747139			2322	FLT3	C1C[C@H](CN1)NC2=CC=CC(=N2)C3=CN=C4C=CC(=C[N]34)C5=C[NH]N=C5	NCGCChem	JKJ21-005	-3.45932657	0.77756941	-2.70833333	-1.74747139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408915-01	NCGC00408915-01	363681083		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	870281-34-8		8.9125093813	-5.05	-32.9018654981	4	4		-19.5256963201	-22.5069186	0.0366891443	0.9991720846		PIK3CD	C[C@H](NC1=NC=NC2=C1[NH]C=N2)\C3=N\C4=C(C=C(F)C=C4)C(=O)N3C5=CC=CC=C5	Glixx	GLXC-90107	-3.735505	-4.36599486	-4.99152748	-22.5069186												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485046-01	NCGC00485046-01	363681205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			8.9125093813	-5.05	-30.1315518319	4	4		-19.559108028	-21.79120145	0.0511625514	0.9983885325		ALK	C[C@@H](OC1=C(N)N=CC(=C1)C2=C(C)N=C(S2)[C@](C)(O)CO)C3=C(C=CC(=C3)F)[N]4N=CC=N4	SIGMA	PZ0221	-2.99194476	-3.73917207	-5.13677076	-21.79120145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345842-03	NCGC00345842-03	384568764		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	874119-56-9		8.9125093813	-5.05	-71.681601988	-2.2	4		-62.2950027556	-59.91506823	0.0202940974	0.9997459863		ROCK1	CC\1=C(C(\N=C(/N1)C2=CC(=NC=C2)Cl)C3=C(F)C=C(Cl)C=C3)/C(=O)NC4=C(F)C=C5[NH]N=CC5=C4	SynKinase	SYN-1124	-5.58555369	-4.82740609	-13.25102881	-59.91506823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386401-01	NCGC00386401-01	384569132		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1453848-26-4				-20.5344356493	4	4		0	-9.37589465				ERK	C[N]1N=CC=C1NC2=NC=CC(=N2)C\3=C\C(=O)N(\C=C3)[C@H](CO)C4=CC(=C(Cl)C=C4)F	Selleck	S7554	-2.42542268	-7.37822661	-3.11304769	-9.37589465												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016285-09	NCGC00016285-09	384567929		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	63-74-1				-17.2574319752	4	4		0	-4.07004485				CA1	NC1=CC=C(C=C1)[S+](N)([O-])=O	Selleck	S1685	-3.60272639	-7.76128499	0.58581457	-4.07004485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346951-01	NCGC00346951-01	174007091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	132911-47-8	Fascaplysin	1.2589254118	-5.9	-154.2517622306	-1.1	4		-99.2796253282	-99.83593109	0.0049049698	0.9999851607	1019	CDK4	O=C1C2=CC=CC=C2[N+]3=C1C4=C(C=C3)C5=CC=CC=C5[NH]4	SantaCruz Bio	 sc-221607A	-1.04664802	-10.33293005	-99.77074289	-99.83593109												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386234-03	NCGC00386234-03	363680161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1188910-76-0		1.5848931925	-5.8	-9.2164685012	4	4		-16.998790644	-11.66565887	0.0703763571	0.9969587485		EGFR	COC1=CC2=NC=NC(=C2C=C1OC)OC3=CC(=CC=C3)NC(=O)NC4=NOC(=C4)C(C)(C)C(F)(F)F	MedChem Express	HY-15200	2.50750486	-2.23301836	-7.63927968	-11.66565887												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346517-10	NCGC00346517-10	384568815		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	103060-53-3				-11.8638691412	4	4		0	-4.62347086					CCCCCCCCCC(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)C4=CC=CC=C4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@@H](C)CC(O)=O	MedChem Express	HY-B0108	-2.5781388	-0.64628276	-1.08328644	-4.62347086												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263193-02	NCGC00263193-02	384568657		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[623142-96-1]		14.1253754462	-4.85	-12.0549291666	4	4		10.258581884	4.58625983	0.2616531984	0.9559273313		CSF1R	COC1=CC(=CC=C1NC(=O)NC(C)C2=NC=CS2)OC3=CC=NC4=CC(=C(OC)C=C34)OC	Tocris	4481	-3.31979516	-4.39026564	-5.63215157	4.58625983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347903-02	NCGC00347903-02	384568987		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[1050670-85-3]		7.0794578438	-5.15	4.2399011391	4	4		20.7869495439	16.52169868	0.1096459918	0.9925380292		P2RX3	COC1=CC(=C(OC2=CN=C(NC(CO)CO)N=C2N)C=C1I)C(C)C	Tocris	4391	-2.09253046	-3.98912462	0.03282686	16.52169868												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164634-07	NCGC00164634-07	384568272		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	80573-04-2				-21.9111204406	4	4		0	-4.63277362				ADORA1	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C2=CC=C(O)C(=C2)C(O)=O	MedChem Express	HY-B0667	-3.6817941	-6.84168301	-6.10110673	-4.63277362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346670-03	NCGC00346670-03	384568896		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	(913376-83-7)		1.77827941	-5.75	-19.9956002588	4	4		-13.316666668	-10.59879386	0.3999971694	0.8867571925		MET	COC1=CC2=NC=CC(=C2C=C1)OC3=CN=C(NC(=O)C/4=C(C)/N(CC(C)(C)O)N(C4=O)C5=CC=CC=C5)C=C3	SynKinase	SYN-1144	-1.82624347	3.41215753	-14.01388889	-10.59879386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018117-32	NCGC00018117-32	384567991		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	317-34-0				4.8696290689	4	4		0	-1.81395128				ADORA1	CN1C(=O)N(C)C2=C([NH]C=N2)C1=O	MedChem Express	HY-B0140	0.75508143	4.95814847	1.18981481	-1.81395128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379012-01	NCGC00379012-01	363678315		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	199986-75-9		12.5892541179	-4.9	-72.1788376261	-3	4		-85.746472591	-80.03633235	0.0562410509	0.9980442066		CDK1	COC1=CC=C(CNC2=C3N=C[N](C(C)C)C3=NC(=N2)N(CCO)CCO)C=C1	MedChem Express	HY-15339	-4.28506787	-1.61239614	-0.41245524	-80.03633235												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346972-08	NCGC00346972-08	384568978		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1706522-79-3]		12.5892541179	-4.9	-64.7742445891	-3	4		-88.2346782713	-81.34620901	0.1019131935	0.9935393034		SPHK1	CC1=CC(=CC(=C1)OCC2=CC=C(CN3CCC[C@@H]3CO)C=C2)C[S+]([O-])(=O)C4=CC=CC=C4	Tocris	5754	-0.83710407	-5.11565237	2.48832888	-81.34620901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016706-10	NCGC00016706-10	384567956		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			1	-6	-202.3427405345	5	4		-16.1736580361	-51.41234851	0.2417520472	0.9623156		TUBB	CCCCC1=CC2=C([NH]C(=N2)NC(=O)OC)C=C1	SIGMA	MFCD18910864	-37.41701337	-42.750185	-55.0617284	-51.41234851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161419-06	NCGC00161419-06	384568209		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[82952-64-5]		14.1253754462	-4.85	-20.0560884255	4	4		-10.5964928399	-12.38190667	0.2387251725	0.9636549777		DHFR	COC1=C(OC)C(=CC(=C1)NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)OC	Tocris	2039	-2.30149597	-4.34858312	-2.69668361	-12.38190667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378903-01	NCGC00378903-01	363678268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	911417-87-3		2.2387211386	-5.65	-24.797635185	4	4		-29.7725475599	-24.8104563	0.01688119	0.9998245307	59067	ROCK2	CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC(=C3C=CC=CC3=N2)NC4=CC5=C([NH]N=C5)C=C4	MedChem Express	HY-15307	2.73706516	-2.14387591	-16.80266367	-24.8104563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481596-01	NCGC00481596-01	377020230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			8.9125093813	-5.05	-47.9654576586	-3	4		-30.340511488	-32.87594772	0.0468644668	0.9986452632	2322	KIT	FC(F)(F)C1=CC=C(C\N=C/2N\C=C(CC3=C[NH]C4=C3C=CC=N4)/C=C2)C=C1	APExBIO	B5816	-5.75666608	-4.67552148	-7.76120803	-32.87594772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017338-03	Antimycin A	124883057	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1397-94-0	Antimycin A;ANTIMYCIN A1	7.9432823472	-5.1	-115.4757662995	4	4	Antimycin- A from Streptomyces sp.;Antimycin A1;NCGC00016578-01;9   Antimycin A (A3+A4 >90%);ANTIMYCIN A;ANTIMYCIN A (A1 shown);NCGC00142516-03;NCGC_Prestw-222;NCGC00095884-01;ANTIMYCIN A1;Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester;LS-86460;CIPLUS_155874;Antimycin A;NCGC00142516-02;CIPLUS_158270;	-11.3939010879	-33.85273734	0.0172858905	0.9998176727			CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)C2=C(O)C(=CC=C2)NC=O)[C@@H](C)OC1=O	BIOMOL	NP-009	-22.6911531	-22.80709574	-23.30238229	-33.85273734												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509947-01	NCGC00509947-01	384569394		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1708971-55-4				-4.1031772182	4	4		0	-0.58607377				FGFR4	COCCNC1=CC(=NC=C1C#N)NC(=O)N2CCCC3=CC(=C(C=O)N=C23)CN4CCN(C)CC4=O	ChemGood	C-1366	-0.46794985	-1.58227848	-1.83361471	-0.58607377												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00347956-02	NCGC00347956-02	384569000		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1379686-29-9		8.9125093813	-5.05	-60.6096815836	-3	4		-56.7395614961	-58.69941363	0.0232794413	0.9996657133		NR1D1	CCCCCNC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC3=CC=C(Cl)C=C3)C1	XcessBio	M66049-2s	-3.49977905	-4.68649886	-6.4716602	-58.69941363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-18	NCGC00244253-18	384568508		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	941678-49-5		10	-5	1.1021874632	4	4		-10.8580179519	-8.21501496	0.0599456341	0.9978051022		JAK1	N#CC[C@H](C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	Selleck	S1378	1.71210325	2.28696885	1.81944444	-8.21501496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016410-25	NCGC00016410-25	384567938		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	148-79-8				-17.8952945622	4	4		0	-6.33903815				METAP1	[NH]1C2=C(C=CC=C2)N=C1C3=CSC=N3	MedChem Express	HY-B0263	-2.37556561	-4.80125758	-5.34378824	-6.33903815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167430-04	Tioconazole	170465343	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	65899-73-2	 ; Vagistat-1;Tioconazole; Tioconazol;TIOCONAZOLE; Tioconazole	12.5892541179	-4.9	-51.7699609788	-3	4		-75.7366861042	-68.19007553	0.0447784764	0.998761452			Clc3sccc3COC(Cn1ccnc1)c2ccc(Cl)cc2Cl	Microsource	01505581	-1.03619909	1.10936447	1.52744414	-68.19007553												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161670-08	Pepstatin	384568214	Aspartyl Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	26305-03-3				-23.7279689607	4	4		0	-2.35232369					CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	Prestwick	Prestw-405	-7.67460388	-3.84364254	0.45025418	-2.35232369												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244257-02	NCGC00244257-02	384568509		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1056634-68-4	CYT387	7.0794578438	-5.15	-63.4272040228	-2.2	4		-69.4573010361	-58.6932394	0.0151777318	0.9998579396	3716	JAK1	O=C(NCC#N)C1=CC=C(C=C1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4	NCGCChem	DYD03-070	-0.84814581	-3.3427432	-21.54041266	-58.6932394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187911-06	NCGC00187911-06	363677115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	918505-84-7		8.9125093813	-5.05	-44.7448351511	-3	4		-58.2622001577	-54.21993656	0.0115934862	0.9999171204		BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(Cl)C=C23	ChemieTek	CT-P4720	-0.38002651	-0.04576659	-4.60258866	-54.21993656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015418-11	NCGC00015418-11	384567840		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	77-67-8				0.2661619802	4	4		0	1.37708343					CCC1(C)CC(=O)NC1=O	Microsource	01502196	-0.86922165	0.73183003	2.31944444	1.37708343												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00016806-17	NCGC00016806-17	384567961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	31431-39-7		0.316227766	-6.5	-107.7380845535	-1.4	4		-43.6153954491	-48.20741726	0.3381113637	0.9221910806		TUBB	COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)C(=O)C3=CC=CC=C3	MedChem Express	HY-17595	-7.96347513	-37.25929653	-36.23611111	-48.20741726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480777-01	NCGC00480777-01	384569244		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	552292-08-7		10	-5	-89.5956939318	-3	4		-102.5687392614	-99.69404341	0.0114401576	0.9999192715		TACR1	C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C3=CC=CC=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	Adooq	A13680	-3.1719457	-4.02874467	-5.96020487	-99.69404341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378999-05	NCGC00378999-05	377020528		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	937270-47-8		14.1253754462	-4.85	-406.1197967089	5	4		-18.4349617159	-99.55062625	0.3685662467	0.9060261567		CDK1	CN1C/C=C/CCOC2=CC=CC(=C2)C3=CC=NC(=N3)NC4=CC=CC(=C4)C1	MedChem Express	HY-15166	-83.95927602	-86.98405569	-80.85482482	-99.55062625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510492-02	NCGC00510492-02	384569454		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1058156-90-3		8.9125093813	-5.05	-84.0439923979	-2.1	4		-100.0980571588	-90.08016032	0.0112524368	0.9999219023		FLT4	COC1=C(OCC2(N)CC2)C=C3N=CC=C(OC4=C(F)C5=C([NH]C(=C5)C)C=C4)C3=C1	Adooq	A16253	-2.23068071	-1.71070387	-14.0547083	-90.08016032												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346632-02	NCGC00346632-02	384568868		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	741713-40-6		1	-6	-167.1273762341	-1.3	4		-78.5662852729	-89.6347054	0.0697458799	0.9969878963		CDK1	COC1=CC=C(F)C(=C1C(=O)C2=C(N)N=C(NC3CCN(CC3)[S+](C)([O-])=O)N=C2)F	Selleck	S2688	-8.38220698	-28.47156876	-84.16174821	-89.6347054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346937-01	NCGC00346937-01	174007341		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	253426-24-3	Ombrabulin	0.0316227766	-7.4999999999	-294.1182655517	5	4		-57.2891707161	-73.04444337	0.1741648419	0.9809470974	203068	TUBB	COC1=CC=C(\C=C/C2=CC(=C(OC)C(=C2)OC)OC)C=C1NC(=O)[C@H](N)CO	SynKinase	SYN-3001	-56.97013444	-65.89595376	-68.65030974	-73.04444337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250399-02	NCGC00250399-02	384568548		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	918504-65-1				0.1090660003	4	4		0	-2.84225257				BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4	Selleck	S1267	0.55039249	5.35018148	-4.16565046	-2.84225257												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346652-08	NCGC00346652-08	384568883		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	942487-16-3		7.0794578438	-5.15	-119.7999980612	-2.2	4		-69.8541442528	-75.53443034	0.0162002247	0.9998381364		AURKA	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C3=C2C=CC(=C3)NC4=NC(=C(C=N4)C(F)(F)F)NC5CCC5	MedChem Express	HY-14574	-13.20941983	-13.25446969	-29.11077508	-75.53443034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	915087-33-1				-8.9576855838	4	4		0	-4.35931943				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-1.82942996	-0.9610984	-0.50932199	-4.35931943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161408-07	NCGC00161408-07	384568206		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	58579-51-4				-13.5678720218	4	4		0	-2.88858983				PDE3A	ClC1=CC=C2N/C3=N/C(=O)CN3CC2=C1Cl	MedChem Express	HY-B0523A	-2.68669907	-4.5583524	-1.94850708	-2.88858983												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510495-01	NCGC00510495-01	384569457		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	942398-84-7		12.5892541179	-4.9	-65.9248367917	-3	4		-118.9288570625	-99.68759012	0.0780360726	0.9962251985			CCCCCCCOC1=CC=C(CCC(N)(CO)CO)C=C1C(F)(F)F	MedChem Express	HY-16734A	4.52496686	-2.98398169	-1.26629597	-99.68759012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499248-01	NCGC00499248-01	384569304		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			12.5892541179	-4.9	-57.5873458475	-3	4		-99.2651090062	-88.10245381	0.006704555	0.9999722754		CDK8	COC1CC(C1)C(=O)C2=NC3=C(C=NC(=C3C=C2)N)C4=CC=C(C=C4)C5=C[N](C)N=C5	APExBIO	A8739	2.10573882	2.08191591	2.04616753	-88.10245381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244250-02	NCGC00244250-02	174006689		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1261496-45-0	NCGC00244250-01; NCGC00244250-01	4.4668359215	-5.35	-11.8720676472	4	4		-17.2774464799	-15.2312054	0.1047668202	0.9932034523	7297	TYK2	CN(C)C1=CC=C(NC2=N[N](C(=N2)N)C(=O)C3=C(F)C=CC=C3F)C=C1	NCGCChem	DYD03-067	0.84048803	2.15448814	-5.92311654	-15.2312054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370805-01	NCGC00370805-01	384569036		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	3397				-7.9382789425	4	4		0	-3.66924325				SLC6A9	CN(CCOC1=C(C=C(C=C1)C2=CC3=C(OCO3)C=C2)C(C)(C)C)CC(O)=O	Tocris	3397	-1.32778614	-3.21681974	0.634229	-3.66924325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250404-06	NCGC00250404-06	384568552		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	912445-05-7				-2.2448811741	4	4		0	1.07784431				PARP1	C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3[NH]2)C(N)=O	MedChem Express	HY-10130	-2.22232079	1.38102472	2.37370075	1.07784431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351599-03	NCGC00351599-03	384569017		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1231930-82-7		7.0794578438	-5.15	-120.3585533916	-2.1	4		-91.3369698699	-80.25382425	0.0082009773	0.9999585238		CDK4	CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2	APExBIO	A1794	-9.24839845	-13.91764126	-38.67128433	-80.25382425												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016564-17	NCGC00016564-17	384567949		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1115-70-4				-6.8592641503	4	4		0	-1.36563239				PRKAA1	CN(C)C(=N)NC(N)=N	MedChem Express	HY-17471A	-1.37146982	-1.36219026	-1.9803912	-1.36563239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346696-07	NCGC00346696-07	384568916		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1373615-35-0 (free base)				-14.6780382342	4	4		0	-4.61805723				SMO	CC1=CC(=C(N=C1)C2=CC(=NC=C2Cl)N3CCN(CC3)C(=O)CC[S+](C)([O-])=O)C	SIGMA	PZ0217	-2.40007218	-6.7661424	-0.52680357	-4.61805723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386432-02	NCGC00386432-02	363680284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	(953769-46-5)				-12.3512808501	4	4		0	-2.10996828				CSF1R	CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(N[C@@H]4CCCC[C@H]4O)S3	SynKinase	SYN-1197	-3.25231993	-1.11670481	-2.41577496	-2.10996828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351477-05	NCGC00351477-05	384569006		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1431612-23-5		11.220184543	-4.95	-76.8176541544	-3	4		-108.3686898217	-99.60718563	0.0308690981	0.999411823		EZH1	CCCC\1=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC=C(N=C4)N5CCN(CC5)C(C)C)C(=O)NC(=C1)\C	APExBIO	B1583	0.4746274	-2.43981034	-2.6831037	-99.60718563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247954-03	NCGC00247954-03	384568521		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	615571-23-8				-28.6053858896	4	4		0	-10.0742515				SLC6A9	FC(F)(F)C1=CC=CC(=C1Cl)C(=O)N[C@H]([C@@H]2CCCCN2)C3=CC=CC=C3	Axon Medchem	1549	-6.94198013	-1.16006077	-3.63065023	-10.0742515												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159339-04	NCGC00159339-04	384568169		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	3810-74-0				-22.2971350072	4	4		0	-3.98083832					CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)C=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	MedChem Express	HY-B0472	-5.9838538	-4.52976108	-1.25211506	-3.98083832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142624-06	NCGC00142624-06	384568168		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	4618-18-2				-14.4173403594	4	4		0	-4					OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O	Microsource	01500363	-1.91181689	-5.77268333	-3.59197486	-4												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420895-01	NCGC00420895-01	384569227		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-19.2105927102	4	4		0	-6.32630411				HSP90AB1	CC(C)NCCC[N]1C(=NC2=C1N=CN=C2N)SC3=CC(=CC(=C3)Cl)Cl	Bio Vision	9442-5	-2.99557881	-6.16570328	-3.60958002	-6.32630411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024999-04	NCGC00024999-04	384568040		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[62929-91-3]				-0.7532975273	4	4		0	-1.6389503				ADRB2	CC[C@H](NC(C)C)[C@H](O)C1=CC=C(O)C2=C1\C=C/C(=O)N2	Tocris	1102	0.61864781	-3.05720824	1.47189384	-1.6389503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510480-01	NCGC00510480-01	384569443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1936529-65-5		3.1622776602	-5.5	-152.3735536488	-2.1	4		-94.9326794928	-98.91858118	0.0066417419	0.999972793		SIK	COC1=CN=C(C=C1)N2C(=O)N(CC3=CN=C(NC4=CC=C(C=C4OC)C5CCN(C)CC5)N=C23)C6=C(C)C=CC=C6Cl	MedChem Express	HY-101147	-8.53733981	-16.37528604	-64.6558572	-98.91858118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161602-23	NCGC00161602-23			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	10592-13-9				-12.8306070804	4	4		0	-7.63722003					[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]4(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]4([H])[C@H]2O	APExBIO	A8420	-2.16526734	-2.49885584	0.21961591	-7.63722003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379255-03	NCGC00379255-03	384569097		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1232030-35-1		1.1220184543	-5.95	-142.332002316	-1.2	4		-69.2373115292	-76.26165529	0.0387027982	0.9990751467		PAK1	CCN1C(=O)\C(=C/C2=C1N=C(NC3=CC=C(N4CCNCC4)C(=C3)F)N=C2)C5=CC=C(Cl)C=C5Cl	ChemieTek	CT-F486	-6.35439682	-28.13729977	-70.7303397	-76.26165529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095118-08	NCGC00095118-08	363676573		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	162011-90-7				-0.8408106616	4	4		0	-1.02374315				PTGS2	C[S+]([O-])(=O)C1=CC=C(C=C1)C/2=C(/C(=O)OC2)C3=CC=CC=C3	ChemieTek	CT-RX001	0.67167477	0.29290618	-2.85500678	-1.02374315												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346627-08	NCGC00346627-08	363677484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1138549-36-6				-17.8895414835	4	4		0	-6.12963144				POLR2A	CN1CCCN(CC1)C2=CC=C3C(=O)\C(=C/4SC5=C(C=CC=C5)N4C3=N2)C(=O)NCC6=CN=C(C)C=N6	Glixx	GLXC-90042	-0.6416629	-3.25214315	-7.95523716	-6.12963144												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00346950-03	NCGC00346950-03	363677566		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	444722-95-6		12.5892541179	-4.9	-30.4090626863	4	4		-34.271234192	-28.67337961	0.0811364732	0.9959246612		CDK1	N[S+]([O-])(=O)C1=CC=C(NC2=NC3=C([NH]C=N3)C(=N2)OCC4CCCCC4)C=C1	Bio Vision	2313	-2.60280163	-0.53068445	-2.80470103	-28.67337961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	SARS-CoV-2_CPE_SRI		52-86-8		0.0351987024	-7.4534733462	-64.9303798794	4	10		-20.043388516	-17.51268038	0.0302475293	0.82725964			OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920	-2.63437267	-1.17170605	-6.53481697	-0.39318995	-1.11665946	-6.70782055	-8.38280974	-11.30814296	-10.29371289	-17.51268038						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00024379-25	Emetine		antiprotozoal agent	SARS-CoV-2_CPE_SRI		316-42-7		0.0004971949	-9.3034733462	-477.4994002592	-1.1	10		-86.486211322	-99.43307576	0.0016115956	0.9368820311			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	USP	1235004_cm1	-22.64978837	-41.48254572	-66.85434707	-76.35226964	-78.01421194	-78.3559197	-83.93973518	-94.68799751	-98.82732109	-99.43307576						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015735-22	Niclosamide		STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI		50-65-7		0.0008841514	-9.0534733462	-376.2990992272	-1.2	10		-83.5767250414	-84.53772376	0.0001523616	0.9695515572		STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	MedChem Express	HY-B0497	4.67906652	2.10849221	-19.35696812	-58.3194191	-60.87446123	-82.56513804	-78.58113618	-69.88312041	-71.49070011	-84.53772376						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00179435-05	NCGC00179435-05	384568373		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	3778-73-2	 Isofamide (Ifosfamide?);Ifosfamide; Asta Z 4942; Ifosfamida;; Holoxan; Iso Endoxa;IFOSFAMIDE; Iphosphamide; Iso-Endoxan; Ifosfamide Sterile			-28.7579153668	4	4		0	-2.64923032					ClCCN[P]1(=O)OCCCN1CCCl	Microsource	MS-01505480	-6.81223495	-8.27172111	-5.15096825	-2.64923032												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024563-11	NCGC00024563-11	384568029		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	123040-16-4				-13.571036195	4	4		0	-4.64769778				HTR3A	CN1C(=O)COC2=C(C=C(Cl)C=C12)C(=O)NC3CN4CCC3CC4	MedChem Express	HY-B0068	-1.36986301	-5.00686499	-4.43437223	-4.64769778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159574-16	NCGC00159574-16	384568190		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	331771-20-1		11.220184543	-4.95	-37.9219714529	4	4		-30.8754232801	-25.97808325	0.1991198112	0.9747974549		AURKA	COC1=C(OCCCN2CCOCC2)C=C3N=CN=C(NC4=CC=C(NC(=O)C5=CC=CC=C5)C=C4)C3=C1	MedChem Express	HY-10128	-2.74856385	-7.1395881	-9.29395823	-25.97808325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017344-11	NCGC00017344-11	384567986		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	528-48-3				-17.529218827	4	4		0	-8.14351354				SIRT1	OC1=CC2=C(C=C1)C(=O)\C(=C(O2)\C3=CC(=C(O)C=C3)O)O	Adooq	A10388	-3.02756439	-2.89835352	-2.41138737	-8.14351354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189144-02	NCGC00189144-02	384568459		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[1320288-17-2]				-21.9587625204	4	4		0	-4.7609737				EHMT2	COC1=C(OCCCN2CCCCC2)C=C3N=C(N=C(NC4CCN(CC4)C5CCCCC5)C3=C1)N6CCCN(CC6)C(C)C	Tocris	4342	-4.20244013	-4.45865651	-6.51308704	-4.7609737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387038-01	NCGC00387038-01	363680531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	(1258292-64-6)		8.9125093813	-5.05	-57.2912583603	-3	4		-83.806188286	-72.95923355	0.0913012444	0.9948237645	3717	TYK2	ClC1=C(C(=O)NC2=CC(=NC=C2)NC(=O)C3CC3)C(=CC=C1)Cl	SynKinase	SYN-1198	-0.9670131	5.32045176	-5.73582432	-72.95923355												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263176-03	NCGC00263176-03	363677245		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1174046-72-0		12.5892541179	-4.9	-78.7210966125	-3	4		-96.7329815545	-90.17964072	0.0460654991	0.9986889617		KDR	NC1=C(Cl)C(=CC=N1)OC2=C(F)C=C(NC(=O)\C3=C\N\C=C(C3=O)\C4=CC=C(F)C=C4)C=C2	APExBIO	B1438	-3.64176721	-2.65156746	-0.23688663	-90.17964072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386306-06	NCGC00386306-06	363680199		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1202757-89-8		2.8183829313	-5.55	-125.9535731549	-2.1	4		-99.8421300141	-96.97920185	0.021181106	0.999723199		BTK	COCCOC1=CC=C(NC2=NC=C(F)C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)C=C1	MedChem Express	HY-18012	-0.96544257	-9.4994847	-63.47007463	-96.97920185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378942-03	NCGC00378942-03	384569077		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	603288-22-8		14.1253754462	-4.85	-121.8980581932	-2.4	4		-65.1820337562	-67.86179607	0.2634846807	0.9545966633		GSK3B	FC1=CC2=C3[N](CCN(CC3=C1)C(=O)N4CCCCC4)C=C2C/5=C(C(=O)NC5=O)\C6=CN=C7C=CC=C[N]67	ActiveBioChem	A-1239	-14.43652441	-26.89429583	-22.19403932	-67.86179607												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476170-03	NCGC00476170-03	384569240		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1448347-49-6		4.4668359215	-5.35	-17.5773461366	4	4		-15.3375503239	-11.76798921	0.1038239524	0.9933875018		IDH1	FC1=CN=CC(=C1)N([C@H](C(=O)NC2CC(F)(F)C2)C3=C(Cl)C=CC=C3)C(=O)[C@@H]4CCC(=O)N4C5=NC=CC(=C5)C#N	NCGCChem	JMR014-047_1st_pos	-0.65336394	-3.4096987	-6.76702307	-11.76798921												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522278-02	NCGC00522278-02	384569514		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	38101-59-6				-5.9108417758	4	4		0	-2.42718447				FLT1	N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=CC=CC=C12)C(O)=O	MedChem Express	HY-13718	0.33583738	-4.47597254	-2.61202748	-2.42718447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387878-04	NCGC00387878-04	384569167		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1401966-69-5				-15.2987183152	4	4		0	-4.53234644				KDM1A	OC(=O)C1=CC=C(CN2CCC(CC2)CN[C@@H]3C[C@H]3C4=CC=CC=C4)C=C1	DC Chemicals	DC8491	-3.16394167	-0.85125858	-4.63062474	-4.53234644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511383-01	NCGC00511383-01	384569500		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1628838-42-5		7.0794578438	-5.15	-60.9590810158	-2.2	4		-41.8735897575	-41.77338938	0.0169698586	0.9998225242		BRAF	CC1=NC=C(NC(=O)C2=CC(=CC=C2)C(F)(F)F)C=C1C3=CC(=C(OC4CCOCC4)N=C3)N5CCOCC5	Glixx	GLXC-10326	-5.63940352	-5.81938586	-16.12117807	-41.77338938												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247735-03	NCGC00247735-03	363677162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	375815-87-5				-21.8313524399	4	4		0	-3.93000293				CHRNA3	C1NCC2CC1C3=CC4=NC=CN=C4C=C23	Selleck	S1440	-5.20560325	-4.73080238	-3.2822962	-3.93000293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263205-02	NCGC00263205-02	384568664		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	857876-30-3				-10.353645107	4	4		0	0.79041916				FLT1	CC1(C)CNC2=C1C=CC(=C2)NC(=O)C3=CC=CN=C3NCC4=CC=NC=C4	Selleck	S1032	-3.05624556	-1.51912719	-2.97316896	0.79041916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481546-01	NCGC00481546-01	384569255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-17.5407458273	4	4		0	-5.21484187				EZH2	CC[S+]([O-])(=O)N1CCC(CC1)[C@@H](C)[N]2C(=C(\C(O)=N\CC3=C(OC)C=C(C)N=C3O)C4=CC=CC=C24)C	APExBIO	B4678	-3.08440124	-2.97482838	-5.27545442	-5.21484187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253587-02	NCGC00253587-02	384568564		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	210421-74-2	Sitaxentan			-0.5628077121	4	4		0	-0.70388112				EDNRA	CC1=C(CC(=O)C2=C(C=CS2)[S+]([O-])(=O)NC3=C(Cl)C(=NO3)C)C=C4OCOC4=C1	Selleck	S3034	0.72300045	-0.38553998	-2.30837664	-0.70388112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510167-01	NCGC00510167-01	384569412		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1702809-17-3		10	-5	-78.0851889414	-3	4		-81.7935738881	-81.15162772	0.0057765766	0.9999794205		CDK12	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)N2CCC[C@H](C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=C4C=CC=C5	Glixx	GLXC-09270	-4.07591505	-3.82364948	-6.2227841	-81.15162772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167433-06	NCGC00167433-06	384568312		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	119302-91-9				-10.7204424142	4	4		0	-1.74992668					CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CCCC6)CC=C	Enzo	DL187	-3.34387709	1.00240396	-2.25218898	-1.74992668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346539-05	NCGC00346539-05	363677446		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	942947-93-5		1.5848931925	-5.8	-45.588935119	4	4		-10.871478272	-16.97135595	0.1189092536	0.991277652		AURKA	CN(C)C1=CC=C(C=C1)C2=NC3=C(N4CCN(CC4)CC(=O)NC5=NC=CS5)C(=CN=C3[NH]2)Cl	MedChem Express	HY-12049	-6.52507908	-5.82845739	-12.90911645	-16.97135595												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00095150-16	Telmisartan	384568151	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	144701-48-4				-6.0173491976	4	4		0	4.22994012				AGT	CCCC1=NC2=C(C=C(C=C2C)C3=NC4=CC=CC=C4[N]3C)[N]1CC5=CC=C(C=C5)C6=CC=CC=C6C(O)=O	Enzo	DL511	-3.73048261	-1.51912719	2.01595359	4.22994012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179511-08	NCGC00179511-08	384568376		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	81110-73-8				-19.0627755112	4	4		0	-2.99401198					CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2	Microsource	01502331	-5.26525905	-2.7804631	-2.05462896	-2.99401198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013226-25	Trifluoperazine hydrochloride	384567788	CaMK-II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	440-17-5		12.5892541179	-4.9	-61.0486169173	-3	4		-113.6175682616	-99.74417415	0.0031370535	0.9999939302		DRD2	CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	MedChem Express	HY-B0532A	3.40808759	3.57015511	3.29675483	-99.74417415												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094358-38	NCGC00094358-38	384568128		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	4759-48-2				-14.3777917668	4	4		0	1.94655388				RARB	CC/1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1	Selleck	S1379	-3.72956253	-4.31121281	-4.71473296	1.94655388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522572-01	NCGC00522572-01	384569526		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1428569-85-0		11.220184543	-4.95	-77.8402984466	-2.2	4		-76.1806430483	-70.34989907	0.0448733427	0.9987562589		PIM1	C[N]1N=CC(=C1N2CC[C@@H](N)[C@H](F)CC2)NC(=O)C3=C(N)SC(=N3)C4=C(F)C=CC=C4F	MedChem Express	HY-16976	-4.96685815	-7.70709382	-10.28456614	-70.34989907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346568-05	NCGC00346568-05	363677455		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1032823-75-8				2.9923300115	4	4		0	3.16735557				GPR119	CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)[S+](C)([O-])=O	MedChem Express	HY-12066	-0.62748564	0.67734554	2.50922854	3.16735557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263149-06	NCGC00263149-06	384568624		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	497839-62-0		4.4668359215	-5.35	-156.5705064071	-2.1	4		-99.437832803	-99.76449101	0.0237610348	0.9996516442		EGFR	CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N[C@H](C)C5=CC=CC=C5)N=CN=C4[NH]3	MedChem Express	HY-10045	-11.41847106	-19.76201373	-55.8431849	-99.76449101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168109-05	NCGC00168109-05	363676677		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	853625-60-2				-5.1672714066	4	4		0	2.56238646				ARHGEF1	COC1=N[N](C2=CC=C(NC(=O)CSC3=CC=CC=C3)C=C2)C(=N1)C4=CC=C5OCOC5=C4	Selleck	S7685	-2.6199095	-1.08241635	0.52123465	2.56238646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379063-03	NCGC00379063-03	384569091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	175519-16-1		1.1220184543	-5.95	-65.1363194104	4	4		-25.773809436	-25.99961828	0.0214356943	0.9997175964		TOP2A	CN[C@H]1CN(C[C@@H]1OC)C2=NC3=C(C=C2)C(=O)C(=C\N3C4=NC=CS4)/C(O)=O	MedChem Express	HY-16518	-5.77144375	-8.26622557	-15.80731058	-25.99961828												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00165761-07	NCGC00165761-07	384568279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	547757-23-3		8.9125093813	-5.05	-85.7053075244	-2.1	4		-89.4047894799	-81.9782422	0.0324474829	0.9993501462		IKBKB	CC1=CC=C2N=C(NCCN)C3=NC=C(C)[N]3C2=C1	MedChem Express	HY-10518	-4.45250952	-2.75540852	-15.93318809	-81.9782422												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480898-01	NCGC00480898-01	384569249		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	849550-05-6		3.5481338923	-5.45	-170.9005184757	-2.3	4		-117.4537745553	-90.40461876	0.1773785072	0.9800816809			CNCCCOC1=CC(=C(C(=C1)F)C2=C(N[C@@H](C)C(F)(F)F)[N]3N=CN=C3N=C2Cl)F	Glixx	GLXC-06026	-13.23360184	-40.79136377	-58.69281046	-90.40461876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378902-02	NCGC00378902-02	384569074		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	874819-74-6		6.3095734448	-5.2	-42.6105289911	4	4		-24.295950344	-26.25727646	0.1262696689	0.9900607494		FLT1	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NCCN4CCCC4	MedChem Express	HY-10330A	-4.23121183	-5.26269969	-2.67731784	-26.25727646												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346660-03	NCGC00346660-03	384568891		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	32981-86-5				-19.4938537093	4	4		0	-6.15039603					CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](O)/C(=C(/[C@@H](O)C3=O)C5(C)C)C	MedChem Express	HY-16565	-3.92139506	-4.27023027	-2.71604938	-6.15039603												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389459-01	NCGC00389459-01	377020277		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	175865-59-5				-11.3020175527	4	4		0	-3.58802395					CC(C)C(N)C(=O)OCC(CO)OC[N]1C=NC2=C1N\C(=N/C2=O)N	APExBIO	B1864	-1.30855216	-4.89803434	-2.65409717	-3.58802395												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161927-04	NCGC00161927-04	384568217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			0.4466835922	-6.35	-133.4826155066	-1.4	4		-47.6945202085	-49.96886228	0.1479439199	0.9862626608		TUBB	COC1=C(O)C(=CC(=C1)[C@H]2C3C(COC3=O)[C@H](O)C4=C2C=C5OCOC5=C4)OC	Microsource	01505328	-11.03176011	-42.20411545	-55.03021513	-49.96886228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511370-01	NCGC00511370-01	384569499		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1375465-91-0		8.9125093813	-5.05	-149.1075519586	-2.3	4		-116.5057261297	-99.52417572	0.126254993	0.9900386351		HDAC1	ONC(=O)C1=CN=C(NC2(CC2)C3=CC=CC=C3)N=C1	Glixx	GLXC-09665	-10.97657976	-24.32951945	-42.46997804	-99.52417572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390699-04	NCGC00390699-04	377020209		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	882531-87-5		11.220184543	-4.95	-111.7521072746	-2.3	4		-113.9582870184	-93.47930012	0.1209033338	0.9908752029		FLT4	COC1=C(F)C=C\2C(=C1)\N=C/3NNC(=C3\N=C2C4=CC=CC=C4Cl)/C	MedChem Express	HY-13737	-5.36199095	-15.60745565	-24.72465213	-93.47930012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015529-22	Ibuprofen lysine	384567862	Cyclooxygenase-1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	15687-27-1				-19.7918034401	4	4		0	-3.28903337				PTGS1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O	APExBIO	A8446	-4.81900452	-2.48371884	-4.70924172	-3.28903337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344507-02	NCGC00344507-02	174006263		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	652973-93-8	 Calhex 231;Calhex 231	12.5892541179	-4.9	-91.1596583059	-3	4		-105.936640328	-99.54671247	0.0553649085	0.9981046784	846	CASR	CC(N[C@H]1CCCC[C@@H]1NC(=O)C2=CC=C(Cl)C=C2)C3=CC=CC4=C3C=CC=C4	SantaCruz Bio	sc-207394	-5.20492166	-4.23540678	-0.72137497	-99.54671247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179302-06	NCGC00179302-06	384568370		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	479-41-4				-39.1659563667	4	4		0	-6.49394026				CDK1	O=C\1NC2=C(C=CC=C2)C1=C3\NC4=C(C=CC=C4)C3=O	MedChem Express	HY-N0117	-10.17969372	-7.16928568	-4.73008957	-6.49394026												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351595-02	NCGC00351595-02	363677763		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	4279				4.5442978481	4	4		0	3.16646707				MAPKAPK2	C[C@@H]1CNC2=C(SC3=CC=C4N=C(C=CC4=C23)C5=CC=C(C)N=C5)C(=O)N1	Tocris	4279	0.07540809	0.92068315	1.91926517	3.16646707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090504-14	NCGC00090504-14	384568078		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	961-29-5		7.0794578438	-5.15	-7.0993328693	4	4		11.859829672	7.42035928	0.1335843047	0.9889683038		SIRT1	OC1=CC=C(C=C1)/C=C/C(=O)C2=C(O)C=C(O)C=C2	Selleck	S2404	-4.04985806	-2.62394697	-0.67198453	7.42035928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346563-03	NCGC00346563-03	384568841		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	29767-20-2		5.0118723363	-5.3	-60.4293884074	-2.4	4		-46.564615195	-37.97385925	0.3771556928	0.9006656282		TOP2A	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=CC8=C(OCO8)C=C27	MedChem Express	HY-13761	-3.15203955	-16.44232484	-17.89063965	-37.97385925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025346-15	NCGC00025346-15	384568069		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	85650-52-8				-7.0557924556	4	4		0	2.4560223				HTR2A	CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3	MedChem Express	HY-B0352	-1.99734865	-3.17620137	-2.24755853	2.4560223												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347068-02	NCGC00347068-02	384568983		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	314042-01-8				-2.1713396813	4	4		0	-2.90781505					CC1(C)CC2=C(CO1)SC(=C2C(O)=O)NC(=S)NC(=O)C3=CC=CC=C3	Axon Medchem	2184	0.36235086	0.37528604	-1.69618242	-2.90781505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	59721-29-8				-18.4856510248	4	4		0	-4.32119284					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-4.46024847	-3.13772126	-2.39351852	-4.32119284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167739-08	NCGC00167739-08	384568331		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	278779-30-9		12.5892541179	-4.9	-66.2388592432	-3	4		-62.989941069	-61.96875445	0.0292508984	0.9994720562		NR14H	CC(C)C1=C(COC2=CC=C(\C=C\C3=CC=CC(=C3)C(O)=O)C(=C2)Cl)C(=NO1)C4=C(Cl)C=CC=C4Cl	MedChem Express	HY-50108	-5.46117038	-3.87869917	-4.6712963	-61.96875445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507884-01	NCGC00507884-01	384569349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	2012607-27-9				-6.269616143	4	4		0	-7.10385108				WNK1	CC(C)(C)NC(=O)C1=CN=C[N]1C2CCN(CC2)C3=NC=C(C=C3)C4=NN=C(O4)C(F)(F)F	Selleck	S8358	0.91312173	-0.6677949	-4.04166667	-7.10385108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165719-16	NCGC00165719-16	384568274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-11.8315062221	4	4		0	-2.36160245					NCCCC(O)([P](O)(O)=O)[P](O)([O-])=O	Selleck	S1624	-3.16289593	-1.97170447	-0.87476771	-2.36160245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094112-11	NCGC00094112-11	384568126		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	667463-62-9		2.8183829313	-5.55	-155.2832792129	-2.1	4		-98.1466074596	-99.67077011	0.0169713504	0.9998223201		GSK3B	O\N=C1\C(NC2=CC=CC=C12)=C3\C(=O)NC4=CC(=CC=C34)Br	MedChem Express	HY-10580	-7.50641763	-18.69586036	-69.46017913	-99.67077011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346510-06	NCGC00346510-06	384568812		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	875337-44-3		10	-5	-44.9250030376	-3	4		-81.2064128296	-68.41778796	0.0379212087	0.9991121496		MET	C[N]1C=NC(=C1)C2=CC3=NC=CC(=C3S2)OC4=CC=C(NC(=S)NC(=O)CC5=CC=CC=C5)C=C4F	MedChem Express	HY-10991	1.83234487	4.18317155	-1.98983297	-68.41778796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024928-14	NCGC00024928-14	124886964		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	10540-29-1	Soltamox; "Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife			-17.2105705417	4	4		0	-4.20364539			2099	ESR1	CCC(/C1=CC=CC=C1)=C(C2=CC=CC=C2)/C3=CC=C(OCCN(C)C)C=C3	SIGMA	T5648	-2.89457378	-3.55634876	-6.56015493	-4.20364539												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00345784-11	NCGC00345784-11	384568740		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	898044-15-0		1.5848931925	-5.8	-73.3996330908	4	4		-32.1978882481	-29.00598802	0.0922941413	0.9947316848		PAK4	CN(C)C[C@@H](NC(=O)N1CC2=C([NH]N=C2NC3=C4SC=CC4=NC(=N3)C)C1(C)C)C5=CC=CC=C5	MedChem Express	HY-13007	-9.67441448	-14.85982599	-23.79018613	-29.00598802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015462-22	NCGC00015462-22	384567852		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	29094-61-9				-0.7473417432	4	4		0	2.76291921					CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)[S+]([O-])(=O)NC(=O)NC3CCCCC3	MedChem Express	HY-B0254	-1.35970334	-0.8334819	1.77734009	2.76291921												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510750-02	NCGC00510750-02	384569490		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1037592-40-7				3.1434725097	4	4		0	2.95827713				SLC7A5	N[C@@H](CC1=CC(=C(OCC2=C3OC(=NC3=CC(=C2)N)C4=CC=CC=C4)C(=C1)Cl)Cl)C(O)=O	MedChem Express	HY-100868	0.08829242	-0.86913888	1.88051022	2.95827713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015772-20	NCGC00015772-20	384567889		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	82419-36-1				-16.5336600631	4	4		0	-1.13015813					CC1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0125	-3.67004697	-4.12569181	-4.91203704	-1.13015813												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263621-12	NCGC00263621-12	384568695		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1260907-17-2		1.995262315	-5.7	-140.5623025272	-1.1	4		-78.3273753563	-82.32109787	0.0299020566	0.9994481883		BRD4	CCNC(=O)C[C@@H]1\N=C(C2=CC=C(Cl)C=C2)/C3=C(C=CC(=C3)OC)[N]4C(=NN=C14)C	MedChem Express	HY-13032	-6.9976733	-20.40891003	-67.09722222	-82.32109787												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167740-02	NCGC00167740-02	384568332		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	553-21-9				-14.0458351231	4	4		0	-3.3177168				TERT	CC/1=C/CC\C(=C/C2OC(=O)C(=C)C2CC1)C	APExBIO	N2333	-1.67873303	-5.09768695	-5.31659339	-3.3177168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247878-08	NCGC00247878-08	384568519		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	747412-49-3		0.2238721139	-6.65	-126.862070494	4	4		-9.606529624	-33.83433534	0.6561780336	0.585567201		HSP90AB1	CCNC(=O)C1=NOC(=C1C2=CC=C(CN3CCOCC3)C=C2)C4=C(O)C=C(O)C(=C4)C(C)C	MedChem Express	HY-10215_CM1	-23.18314597	-34.10525399	-26.51658194	-33.83433534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181350-14	NCGC00181350-14	384568397		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	212141-51-0				-8.608805359	4	4		0	-3.87918695				FLT1	ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C4=C2C=CC=C4)C=C1	Aobious	AOB5504	-2.15101354	-1.46693945	1.15710482	-3.87918695												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345858-03	NCGC00345858-03	384568772		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1125632-93-0		1.1220184543	-5.95	-77.7146635796	-1.4	4		-46.5640069469	-48.95111401	0.0754743654	0.9964716162		FLT1	FC1=C(NC(=O)C2=C(Cl)C(=CC=C2)C3(CC3)C#N)C=C(OC4=NC5=C(C=C4)N=C(NC(=O)C6CC6)S5)C=C1	SynKinase	SYN-1168	-1.08599682	-9.62292744	-45.24948415	-48.95111401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015067-22	NCGC00015067-22	384567805		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	50-78-2				-19.3344284521	4	4		0	-3.85134192				HMGCR	CC(=O)OC1=C(C=CC=C1)C(O)=O	MedChem Express	HY-14654	-4.52940138	-3.44535568	-3.54999062	-3.85134192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346936-13	NCGC00346936-13	384568971		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1033769-28-6		12.5892541179	-4.9	-95.0021467226	-3	4		-104.4290387938	-99.5963721	0.0382229448	0.9990978363		NTRK1	CC1=CC=C(NC(=O)NC2=CC(=CC=C2F)C(F)(F)F)C=C1NC3=CC4=C(C=C3)C(=C/C5=CC=C[NH]5)/C(=O)N4	MedChem Express	HY-13491	-5.18898986	-6.7694278	-3.68981481	-99.5963721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160391-11	NCGC00160391-11	384568191		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			1.995262315	-5.7	-154.8840780609	-1.3	4		-101.2664690691	-99.67492112	0.0739696546	0.9966099876		TXNRD1	CC[P](CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	SIGMA	A6733_cm1	-4.63800905	1.4596901	-99.51955763	-99.67492112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167811-13	NCGC00167811-13	363676671		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	885101-89-3		14.1253754462	-4.85	-7.204573036	4	4		22.3634628279	13.81585238	0.1756635703	0.9805383771		FFAR1	OC(=O)CCC1=CC=C(NCC2=CC=CC(=C2)OC3=CC=CC=C3)C=C1	MedChem Express	HY-15589	-3.45248869	-6.55288569	-5.91488012	13.81585238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263181-10	NCGC00263181-10	384568649		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	937174-76-0		6.3095734448	-5.2	-11.2596387874	4	4		-11.0717148639	-9.64309572	0.4167797219	0.8763285588		AKT1	CC[N]1C(=NC2=C(N=CC(=C12)OC[C@H]3CCCNC3)C#CC(C)(C)O)C4=NON=C4N	MedChem Express	HY-10249	-1.66415863	2.65964393	-2.37714839	-9.64309572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274056-12	Risedronate sodium			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-9.8909486788	4	4		0	-4.1025164					OC(CC1=CC=CN=C1)(P(O)(O)=O)P(O)([O-])=O	Selleck	S1428	-0.38848667	-6.52968444	-1.8148565	-4.1025164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161410-03	NCGC00161410-03	384568207		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[171009-07-7]		8.9125093813	-5.05	-41.2395355987	-3	4		-45.553281628	-44.74626727	0.0152188833	0.9998572077		HSP90AB1	CCC1=C(O)C=C(O)C(=C1)C2=N[NH]C(=C2C3=CC4=C(OCCO4)C=C3)C	Tocris	2435	-1.36853258	-1.9834195	-4.16901144	-44.74626727												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346702-05	NCGC00346702-05	363677527		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1029712-80-8				-27.6532048797	4	4		0	-6.99938269				MET	CNC(=O)C1=CC=C(C=C1F)C2=N[N]3C(=CN=C3N=C2)CC4=CC=C5N=CC=CC5=C4	MedChem Express	HY-13404	-6.44453224	-5.20514111	-3.3287037	-6.99938269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181754-07	NCGC00181754-07	384568398		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	201530-41-8		10	-5	-82.0338443067	-2.4	4		-89.7135562711	-75.80606866	0.0697177976	0.9969906009			OC(=O)C1=CC=C(C=C1)[N]2N=C(N=C2C3=CC=CC=C3O)C4=CC=CC=C4O	MedChem Express	HY-17359	-2.7920453	-7.94950373	-18.15277778	-75.80606866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263950-13	NCGC00263950-13	384568701		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	21462-39-5				-16.3861435005	4	4		0	-4.9431112					CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	APExBIO	B1913	-2.49321267	-3.741298	-5.30752844	-4.9431112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263169-06	NCGC00263169-06	384568639		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	714272-27-2		0.1	-7	-295.2978217481	5	4		-66.966318748	-63.6772158	0.5986739059	0.6849269373		TUBB	CC(C)(C)C1=C(/C=C/2NC(=O)\C(NC2=O)=C\C3=CC=CC=C3)N=C[NH]1	APExBIO	B2298	-57.45248869	-72.06377723	-72.42442098	-63.6772158												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378623-01	NCGC00378623-01	384569059		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	110417-88-4		0.1	-7	-341.6976401497	5	4		-41.329031828	-75.95667526	0.413015639	0.884249918		TUBB	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	MedChem Express	HY-15580	-70.68248207	-75.41461716	-73.99176955	-75.95667526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387826-01	NCGC00387826-01	363680682		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1440898-61-2		12.5892541179	-4.9	-90.9926272157	-3	4		-105.9428605576	-99.80437065	0.015956095	0.9998429416			C1CC(CCN1)C(COC2=CC=C(C=C2)C3=NC4=CC=CC=C4[N]3CC5=CC=CC=C5)[N]6C7=CC=CC=C7N=C6C8=CC=CC=C8	ChemieTek	CT-DELT	-4.51447287	-3.5128194	-3.45194868	-99.80437065												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356071-12	NCGC00356071-12	404904718		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			0.316227766	-6.5	-248.1386727786	-1.1	4		-81.173112495	-90.22330375	0.0209260349	0.9997298779			CC1=C(C)C\2=C(S1)[N]3C(=NN=C3[C@H](CC(N)=O)\N=C2C4=CC=C(Cl)C=C4)C	Bio Vision	9404-5	-24.7410817	-79.49767118	-88.64197531	-90.22330375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262642-10	NCGC00262642-10	384568577		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	857064-38-1		10	-5	-82.3991094369	-3	4		-100.5794145808	-99.30814009	0.0049062954	0.9999851531		STAT3	C[C@H](NC(=O)/C(=C/C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-15312	-1.95627158	-1.58882166	-2.95812152	-99.30814009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510078-03	NCGC00510078-03	384569408		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			0.6309573445	-6.2	-197.3749120002	-1.3	4		-95.0385402961	-97.15449102	0.0859271844	0.9954185101		CDK6	FC1=CC=CC(=C1)[N]2C=NC3=C2N=C(N=C3NCC4=NC5=C([NH]4)C(=C(F)C=C5)F)N6CCOCC6	Axon Medchem	2547	-5.74432221	-63.71127377	-93.79260334	-97.15449102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346706-07	NCGC00346706-07	363677528		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	433967-28-3				-20.4188290877	4	4		0	-7.41077844				GRM5	CCCCOC1=CC=C(C=C1)C(=O)NC2=C(F)C=C(F)C=C2	MedChem Express	HY-15393	-4.84829666	-1.86898679	-1.70655064	-7.41077844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346676-04	NCGC00346676-04	384568902		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1095382-05-0		11.220184543	-4.95	-95.7134616641	-2.3	4		-116.0494374924	-99.40598802	0.1229753271	0.9905553318		AURKA	CN1CCN(CC1)C2=CC=C(C=C2)C3=NC4=C(N5CCN(CC5)CC6=NOC(=C6)C)C(=CN=C4[NH]3)Br	Selleck	S2744	-1.35290987	-12.13460388	-13.56055112	-99.40598802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179501-09	NCGC00179501-09	384568375		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	520-26-3				-16.3533710915	4	4		0	-3.33038746					COC1=C(O)C=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-400	-1.83648243	-8.0094491	-5.11630088	-3.33038746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163505-09	NCGC00163505-09	384568244		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	133053-19-7		12.5892541179	-4.9	-60.4327660651	-3	4		-56.7343619154	-51.18377599	0.1145738678	0.991819597		PRKCA	COC1=CC=C2[N](CCCN(C)C)C=C(C2=C1)C/3=C(/C(=O)NC3=O)C4=C[NH]C5=C4C=CC=C5	MedChem Express	HY-13689	-3.96432986	-8.88304511	-8.36147064	-51.18377599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022735-16	NCGC00022735-16	384568013		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	83-43-2				-1.0521069914	4	4		0	-1.11633099				NRC31	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]\4(C)/C=C\C(=O)\C=C14	MedChem Express	HY-B0260	0.63570546	-3.26707078	0.63308948	-1.11633099												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263094-05	NCGC00263094-05	384568586		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	945595-80-2		14.1253754462	-4.85	-78.5837313908	-3	4		-37.0970042438	-42.38336667	0.260166462	0.9558312445		AURKA	CC1=CSC(=C1)C2=NN=C(NC3=CC=C(OC4=C(C=CC=N4)C5=CC=NC(=N5)N)C=C3)C6=C2C=CC=C6	APExBIO	A4119	-13.11142504	-13.18862542	-6.0166948	-42.38336667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015335-11	NCGC00015335-11	124879863		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	147-24-0	 Difenhidramina; Neo-fluvaleas; Diphenhydramine; Resmin; Benadryl; ;Diphenhydramine; Restamin;Pellit; Advil PM;Diphenhydramine hydrochloride; 2   Diphenhydramine Hcl; Dolestan; Dramamine; Somnium; 9   Dimenhydrinate; Dimenhidrinato; Bietanautine; Mandrax; Visano Cor; Diphenhydramine Tannate; Propain			-11.7641868841	4	4	DIPHENHYDRAMINE HCl	0	-2.12735647			9704	HRH1	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2	BIOMOL	AC763	-3.54712674	-0.78671728	-0.81018519	-2.12735647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408796-01	NCGC00408796-01	384569220		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1113025-87-8				-11.5250571257	4	4		0	1.0995315				PPP2CA	CN1CCN(CC1)C(=O)[C@@H]2[C@@H]3CC[C@@H](O3)[C@@H]2C(O)=O	Glixx	GLXC-03710	-3.16289593	-6.79541882	-3.57612292	1.0995315												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00016480-20	NCGC00016480-20	384567944		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	520-18-3				-8.779683769	4	4		0	-0.24334383					OC1=CC=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O	Enzo	NP156	-3.37257679	-0.78788143	0.80852094	-0.24334383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165966-05	NCGC00165966-05	384568301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	125317-39-7		3.9810717055	-5.4	-56.0418360421	-2.4	4		-36.8128316894	-37.26777011	0.0858635659	0.9954305128		TUBB	[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@@]7([H])CN(CC(CC)=C7)CC8=C6NC9=C8C=CC=C9)C(=O)OC	MedChem Express	HY-12053A	-2.64368853	-5.38602859	-10.37022584	-37.26777011												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00384250-02	NCGC00384250-02	384569109		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1496581-76-0		2.5118864315	-5.6	-153.5682508001	-2.1	4		-99.248771822	-97.86710418	0.0172903146	0.9998155793		MAP3K12	FC1(F)CCN(C1)C2=CC(=CC(=N2)NC3=CC(=CC=N3)C#N)C4CCN(CC4)C5COC5	MedChem Express	HY-12947	-6.74907516	-22.44029215	-67.9576606	-97.86710418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346537-04	NCGC00346537-04	384568826		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	862507-23-1		11.220184543	-4.95	-97.7653602467	-2.4	4		-75.374860552	-74.49648821	0.0797059701	0.996061881		MAPK14	CC(C)(C)C[N]1C(=NC2=C1N=C(C=C2)C3=C(N=C([NH]3)C(C)(C)C)C4=CC=C(F)C=C4)N	APExBIO	A5566	-8.76743775	-13.58976645	-14.58919527	-74.49648821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386332-03	NCGC00386332-03	363680217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	585543-15-3				-31.2628860257	4	4		0	-6.90441142					CC1=C(F)C=C(C=C1C2=CC=C(C=N2)C(=O)NCC(C)(C)C)C(=O)NC3CC3	MedChem Express	HY-10402	-6.31283199	-5.45213374	-8.8287037	-6.90441142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242598-10	NCGC00242598-10	377020452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	700874-71-1				-7.3287142175	4	4		0	-4.28339229				TGBR1	C1C[N]2N=C(C3=CC=CC=N3)C(=C2C1)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6	MedChem Express	HY-12075	1.11764706	-4.14551987	-5.84236051	-4.28339229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347958-03	NCGC00347958-03	384569001		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1421227-52-2		3.5481338923	-5.45	-123.0952079339	-2.3	4		-101.1099053452	-99.61755426	0.0579648688	0.9979219793			CN1CCN(CC1)CC2=CC=C(NC(=O)NC3=CC=C(OC4=CC(=NC=N4)NC(=O)C5CC5)C=C3)C=C2C(F)(F)F	Selleck	S7441	-2.33031674	0.21109364	-61.28359697	-99.61755426												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163424-11	NCGC00163424-11	384568237		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	75747-14-7				9.4527857454	4	4		0	-3.9105077				HSP90AB1	CO[C@H]1C[C@H](C)C\C2=C(NCC=C)\C(=O)\C=C(NC(=O)\C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C/[C@H](C)[C@H]1O)/C)C)/C2=O	MedChem Express	HY-10211	4.07692308	-0.08533573	2.89625164	-3.9105077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378793-02	NCGC00378793-02	384569069		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	855527-92-3				-19.1760129597	4	4		0	1.10909265				CXCR3	CCOC1=CC=C(C=C1)N2C(=O)C3=CC=CN=C3/N=C2/[C@@H](C)N(CC4=CC=CN=C4)C(=O)CC5=CC=C(F)C(=C5)C(F)(F)F	MedChem Express	HY-15320	-4.239819	-5.40309903	-7.72787019	1.10909265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262542-10	NCGC00262542-10			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-14.9296762975	4	4		0	-1.31214811					[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C3=CC=NC4=C3C=CC=C4	SIGMA	27370	-4.35513853	-4.4182301	0.37279109	-1.31214811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164631-19	NCGC00164631-19	384568270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	557795-19-4		7.9432823472	-5.1	-92.7503391553	-2.1	4		-112.5363288179	-99.4894551	0.0043087789	0.9999885493		FLT1	CCN(CC)CCNC(=O)C1=C(C)[NH]C(=C1C)/C=C/2C(=O)NC3=CC=C(F)C=C23	MedChem Express	HY-10255A	-0.73470833	-1.56270404	-22.06245461	-99.4894551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346626-05	NCGC00346626-05	384568866		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	405168-58-3		3.1622776602	-5.5	-189.4033712552	-1.3	4		-79.9473638349	-99.54671247	0.0624380481	0.9975879453		CHEK1	ClC1=CC\2=C(NC(=O)\C(=C2N[C@@H]3CN4CCC3CC4)C5=NC6=C([NH]5)C=CC=C6)C=C1	MedChem Express	HY-13263	-17.33203505	-22.42197362	-78.78479787	-99.54671247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249611-05	Ixazomib	384568528	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1072833-77-2		0.316227766	-6.5	-253.5018176038	-1.1	4		-94.5969497777	-98.56272385	0.0082449819	0.9999580737		PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Adooq	A10600	-18.8857496	-90.08290248	-98.20390171	-98.56272385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160163-01	NCGC00160163-01	50109897		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	512-04-9				-9.7610232793	4	4	(25R)-5-Spirosten-3beta-ol;CIPLUS_153822;NCGC00160163-01;CIPLUS_3729552;Yamogenin;CIPLUS_737995;CIPLUS_679130;DIOSGENIN;sarsasapogenone;sarsasapogenone, (5alpha-25R)-isomer;NCGC00095204-01;CIPLUS_676820;Diosgenin;3beta-Hydroxy-5-spirostene;Spirost-5-en-3-ol, (3beta,25R)-;NCGC00095204-02;	0	-4.2792688			5743	PTGS2	C[C@H]1C2C(CC3C4CC=C5CC(O)CCC5(C)C4CCC23C)O[C@]16CC[C@@H](C)CO6	Prestwick Chemical, Inc.		-2.27794455	-3.28489927	2.21815794	-4.2792688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015955-22	NCGC00015955-22	384567909		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	18559-94-9				-10.1551402518	4	4		0	-1.30778443				ADRB2	CC(C)(C)NCC(O)C1=CC(=C(O)C=C1)CO	Microsource	01500677	-3.01188786	-1.26133591	-0.86536137	-1.30778443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344549-05	NCGC00344549-05	384568721		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	53-39-4				-21.772772369	4	4		0	-0.54131737					C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0707	-5.03459901	-4.24434931	-7.93328499	-0.54131737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164549-12	NCGC00164549-12	384568251		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	115256-11-6				-15.7081477065	4	4		0	-2.96526946					CN(CCOC1=CC=C(N[S+](C)([O-])=O)C=C1)CCC2=CC=C(N[S+](C)([O-])=O)C=C2	MedChem Express	HY-B0232	-3.97001419	-1.58357501	-3.21489002	-2.96526946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242493-09	NCGC00242493-09	384568499		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	950769-58-1		1.77827941	-5.75	-29.0352085317	4	4		-12.4031907159	-10.77365269	0.4773322232	0.8273577655		KIT	CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=C[N]4C(=N3)SC5=C4C=CC(=C5)OCCN6CCOCC6	APExBIO	A5793	-3.73935415	0.6444782	-17.00265893	-10.77365269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510463-03	NCGC00510463-03	384569437		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1223001-53-3				-14.1769451971	4	4		0	-4.81107948				STK16	CC1=C(F)C=CC(=C1)N2C(=O)\C=C/C3=C2C4=C([NH]C=C4)N=C3	SIGMA	SML1728	-1.95795362	-4.90209258	-3.08277645	-4.81107948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346501-04	NCGC00346501-04	384568806		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	9041-93-4				-19.7231409558	4	4		0	-8.27165241					C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(=NC(=N1)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)N)C(O[C@H]2O[C@H](CO)[C@H](O)[C@@H](O)[C@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)C4=C[NH]C=N4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C	Adooq	A10152	-1.68802475	-4.39359268	-5.97635624	-8.27165241												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00159429-14	NCGC00159429-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	303-98-0				-12.4483168215	4	4		0	-3.08084206					COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O	Microsource	01504013	-2.08572691	-4.7597254	-2.13541423	-3.08084206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344509-02	NCGC00344509-02	384568719		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					8.7763765539	4	4		0	0.408536				CASR	CC1=CC=C(C(=C1)C)C(C)(O)C2=NC3=CC=CC=C3S2	SIGMA	SML0129	1.776403	5.40045767	0.22896126	0.408536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162400-09	NCGC00162400-09	363676610		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	62996-74-1		0.0891250938	-7.05	-376.9173577678	-1.3	4		-80.8800744964	-98.98328282	0.1184510848	0.9912600165		CDK1	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)[N]3C4=CC=CC=C4C5=C3C6=C(C7=C(C=CC=C7)[N]26)C8=C5CNC8=O	Selleck	S1421	-68.35065522	-89.44981177	-94.24076415	-98.98328282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187482-21	NCGC00187482-21	384568445		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	957054-33-0		3.9810717055	-5.4	-132.9664683577	-2.1	4		-96.4314838728	-89.28536514	0.0090173162	0.9999498511		PIK3CA	C[S+]([O-])(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=CC=CC5=C4C=N[NH]5)N6CCOCC6	MedChem Express	HY-20180	-6.93176683	-16.41493174	-53.01774594	-89.28536514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165727-10	NCGC00165727-10	377020224		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			12.5892541179	-4.9	-27.2512260831	4	4		-30.643152836	-28.47785707	0.0854980301	0.9954722182		AKT1	O=C1NC2=CC=CC=C2N1C3CCN(CC3)CC4=CC=C(C=C4)C5=C(N=C6C=C7[NH]C=NC7=CC6=N5)C8=CC=CC=C8	SIGMA	A6730	-0.85856304	-3.03442645	-2.36456431	-28.47785707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00180796-04	NCGC00180796-04	384568384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	5119-48-2		7.0794578438	-5.15	-95.5668594959	-2.1	4		-111.1745038629	-99.61873106	0.02916603	0.9994749839		NFKB1	C[C@H]([C@H]1C\C(=C(CO)/C(=O)O1)C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)\C=C/C(=O)[C@]6(C)[C@H]4CC[C@]23C	SIGMA	W4394	-1.10257569	0.24039552	-26.4128857	-99.61873106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095157-04	NCGC00095157-04	144206994		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	53716-50-0	; OXFENDAZOLE;OXFENDAZOLE;Oxfendazole; ; Synanthic; Oxfendazol	7.9432823472	-5.1	-29.1853387323	4	4	OXFENDAZOLE;CLOSANTEL / OXFENDAZOLE;COBALT EDTA / IVERMECTIN / LEVAMISOLE HYDROCHLORIDE / OXFENDAZOLE / SODIUM SELENATE / ZINC EDTA;LS-50557;OXFENDAZOLE / PIPERAZINE AS PIPERAZINE DIHYDROCHLORIDE;LS-177151;oxfendazole monohydrochloride;Methyl 5-(phenylsulfinyl)-benzimidazol-2-carbamate;NCGC00095157-02;NCGC00095157-01;Methyl (5-phenylsulfinyl)-1H-benzimidazol-2-yl carbamate;ABAMECTIN / COBALT AS COBALT DISODIUM EDTA / LEVAMISOLE AS LEVAMISOLE HYDROCHLORIDE / OXFENDAZOLE / SELENIUM AS SODIUM SELENATE;OXFENDAZOLE / PRAZIQUANTEL;oxfendazole;Oxfendazol;RS 8858;oxfendazolum;Oxfendazolum;CIPLUS_181660;methyl 5(6)-phenylsulfinyl-2-benzimidazolecarbamate;OXFENDAZOLE / PYRANTEL EMBONATE;Synanthic;Oxfendazole;COBALT EDTA / LEVAMISOLE HYDROCHLORIDE / OXFENDAZOLE / SODIUM SELENATE / ZINC EDTA;	-20.801761576	-20.4321048	0.0264965225	0.9995687269			O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3	SigmaAldrich	34176	-2.78355174	-2.68063682	-7.05623449	-20.4321048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017159-23	Curcumin	384567975	NF-kappaB Activation Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	458-37-7		12.5892541179	-4.9	-79.5212261791	-3	4		-74.5338891262	-72.84192003	0.1000830756	0.9937716754		NFKB1	COC1=CC(=CC=C1O)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(O)C=C2)OC	MedChem Express	HY-N0005	-7.97107998	-5.08459201	-1.67158309	-72.84192003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263133-09	NCGC00263133-09	363677220		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	869288-64-2		8.9125093813	-5.05	-48.9151794722	4	4		-21.4147759201	-25.7405416	0.039533157	0.9990386198		PTK2	C[S+]([O-])(=O)C1=CC=CC(=C1)CNC2=C(C=NC(=N2)NC3=CC=C4NC(=O)CCC4=C3)C(F)(F)F	Glixx	GLXC-05135	-7.07636692	-6.644895	-9.95926394	-25.7405416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386380-02	NCGC00386380-02	384569130		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	865854-05-3 				-12.6518159847	4	4		0	-2.81552449				GSK3B	O=C1SN(C(=O)N1CC2=CC=CC=C2)C3=C4C=CC=CC4=CC=C3	APExBIO	B1539	-2.05151378	-3.17957092	-4.41541415	-2.81552449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016925-21	Omeprazole	384567968	ABCC3 Expression Enhancer	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	73590-58-6				-7.761073334	4	4		0	-2.48516141				ABCC3	COC1=CC2=C([NH]C(=N2)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC)C=C1	MedChem Express	HY-B0113	-1.18199044	-0.20612089	-3.92175991	-2.48516141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509909-01	NCGC00509909-01	384569376		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1015474-32-4				-10.722678493	4	4		0	-1.5297013				TNF	CC/1=N/C2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N	Selleck	S7892	-2.58955157	-2.19563561	-2.04868055	-1.5297013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168785-05	NCGC00168785-05	384568349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	101831-37-2		12.5892541179	-4.9	-38.1362494702	-3	4		-50.9823079915	-43.28078439	0.0703472161	0.9969373221			ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O	Selleck	S2028	-0.45956695	-3.21281465	-3.38769216	-43.28078439												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023722-16	NCGC00023722-16	384568020		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	50-91-9		2.5118864315	-5.6	-113.8882559047	4	4		-28.4151001015	-43.65040571	0.0135024742	0.9998877475		TYMS	OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(F)/C(=O)NC2=O	Enzo	DL403	-16.53863534	-20.07075793	-35.76813223	-43.65040571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379214-02	NCGC00379214-02	363678422		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	838818-26-1		1.1220184543	-5.95	-46.0106271242	4	4		-17.783492484	-20.05748503	0.1901547964	0.9770919201		TACR1	COC1=CC=C(C=C1)[N]2C(=NN=C2C3=CC=NC=C3)SCCCN4C(=O)C5=C6C(=CC=C5)C=CC=C6C4=O	Selleck	S7490	-3.74822569	-7.11688073	-23.56780276	-20.05748503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346730-07	NCGC00346730-07	384568935		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	177036-94-1				-19.1422802737	4	4		0	-5.55209581				EDNRA	COC([C@H](OC1=NC(=CC(=N1)C)C)C(O)=O)(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-13209	-5.06121363	-2.78966994	-0.16920474	-5.55209581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347908-01	NCGC00347908-01	174006396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	861393-28-4	A 740003			-4.2226598811	4	4		0	-1.47913856			5027	P2RX7	COC1=C(OC)C=C(CC(=O)NC(N\C(NC2=CC=CC3=C2C=CC=C3)=N\C#N)C(C)(C)C)C=C1	Tocris	3701	-1.88062864	-2.17061865	4.58169199	-1.47913856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507890-02	NCGC00507890-02	384569354		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1005264-47-0		0.2818382931	-6.55	35.8204879178	4	4		-16.5246755681	-0.43722964	0.1621155959	0.9835710472		MDM2	CC1=C(C)C=C(N[S+]([O-])(=O)C2=CC3=C(NC(C4C\C=C/C34)C5=CC=C(C=C5)C(O)=O)C=C2)C=C1	MedChem Express	HY-100892	13.24386368	1.78730612	1.5428625	-0.43722964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345826-04	NCGC00345826-04	363677373		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1438391-30-0				-22.7181660503	4	4		0	-0.79073445				MAPK8	C1CCN(CC1)CCOC2=CC(=CC=C2)C3=N[NH]C4=CC=C(C=C34)C5=N[NH]C=N5	MedChem Express	HY-13022	-6.35705456	-6.11071492	-2.32132808	-0.79073445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025325-03	Vapiprost hydrochloride	174006925	Prostanoid TP Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	87248-13-3	GR 32191 hydrochloride; Vapiprost hydrochloride;GR-32191B; 			0.5254878646	4	4		0	-1.9657791			6915	TBXA2R	O[C@H]1C[C@H](OCC2=CC=C(C=C2)C3=CC=CC=C3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4	SIGMA	G5044	1.61732214	-2.94736842	-0.10747161	-1.9657791												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00270540-05	NCGC00270540-05	384568703		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	72432-03-2				-18.5173899383	4	4		0	-0.35194056				GAA	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	Selleck	S2589	-5.88341618	-3.90529324	-0.71639275	-0.35194056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387089-01	NCGC00387089-01	384569152		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[148869-05-0]				-24.7579851751	4	4		0	-5.82657151				CYP19A1	BrC1=CC=C(CN([N]2C=NN=C2)C3=CC=C(C=C3)C#N)C=C1	Tocris	3278	-6.26299141	-3.85086406	-2.45821042	-5.82657151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160397-13	NCGC00160397-13	384568192		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	57381-26-7				1.9844099292	4	4		0	0.11017964				CHRM1	NC1=NC(=NC(=N1)C2=CC(=CC=C2Cl)Cl)N	MedChem Express	HY-B0327	-1.62792761	2.10836441	6.5603094	0.11017964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390475-03	NCGC00390475-03	384569185		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[83280-65-3]		1.4125375446	-5.85	-177.6931419523	-1.3	4		-94.2803650814	-99.72215569	0.0590070955	0.9978463348		STAT3	CC(=O)C1=CC2=C(O1)C(=O)C3=C(C=CC=C3)C2=O	Tocris	5522	-9.7010291	-12.89877089	-99.24583031	-99.72215569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250406-03	NCGC00250406-03	384568554		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	192185-72-1		12.5892541179	-4.9	-82.9437167437	-2.2	4		-57.9948899	-58.66826347	0.0182027375	0.9997956734		COX10	C[N]1C=NC=C1[C@@](N)(C2=CC=C(Cl)C=C2)C3=CC=C4N(C)C(=O)\C=C(\C5=CC=CC(=C5)Cl)C4=C3	MedChem Express	HY-10502	-9.50585522	-10.34847857	-10.85327532	-58.66826347												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159341-17	NCGC00159341-17	384568170		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	134678-17-4				-5.1923747347	4	4		0	-4.13042467					NC\1=N\C(=O)N(\C=C1)[C@@H]2CS[C@H](CO)O2	MedChem Express	HY-B0250	-0.20307258	-1.97450526	-0.29544176	-4.13042467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346575-02	NCGC00346575-02	384568848		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	211914-51-1				-26.7816116174	4	4		0	-7.19103214					C[N]1C(=NC2=CC(=CC=C12)C(=O)N(CCC(O)=O)C3=NC=CC=C3)CNC4=CC=C(C=C4)C(N)=N	Selleck	S2196	-1.92477485	-7.9113924	-0.61433127	-7.19103214												1.6E-9	8E-9	4E-8	2E-7											
NCGC00346546-04	NCGC00346546-04	384568832		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	957116-20-0				-12.6825196096	4	4		0	-3.53263482					FC1=CC(=CC(=C1)F)[C@@H]2CNC3(CCCC3)C(=O)N2CC(=O)NC4=CC=C5C[C@]6(CC5=C4)C(=O)NC7=C6C=CC=N7	MedChem Express	HY-10302	-2.19178082	-3.11212815	-3.2475118	-3.53263482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250385-11	NCGC00250385-11	377020424		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1234480-50-2		3.1622776602	-5.5	-105.5862575788	-1.2	4		-76.0420455767	-78.63597039	0.0379457302	0.9991109482		MAPK7	CCOC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C)C3=N2)C=CC(=C1)N5CCC(O)CC5	MedChem Express	HY-14443	-0.91913389	-3.75286041	-59.86168871	-78.63597039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475765-01	NCGC00475765-01	384569238		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-14.810735344	4	4		0	-5.70800268				XIAP	CN[C@@H](C)C(=O)N[C@H]1[C@H](C)N(C(C)=O)C2=C(C=CC(=C2)C#N)N(CC3=C4C=CC=CC4=CC=C3C)C1=O	NCGCChem	DYD027-014	-3.27149321	-1.29800135	-1.83565245	-5.70800268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263090-09	NCGC00263090-09	384568583		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1124329-14-1		11.220184543	-4.95	-104.9330404501	-2.1	4		-119.8854812997	-96.94043408	0.0116793126	0.9999158629		TTK	COC1=C(NC2=NC=C3N(C)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)OC5CCN(C)CC5	MedChem Express	HY-14710	-5.62443439	-5.97799236	-19.93835834	-96.94043408												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274062-01	Zosuquidar trihydrochloride	174006281	P-Glycoprotein (MDR-1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	167465-36-3	LY335979	12.5892541179	-4.9	-82.2577487654	-3	4		-99.4698681064	-93.19246582	0.0170840369	0.9998199496		ABCBA	Cl.Cl.Cl.FC3(F)[C@@H]2c7ccccc7[C@H](c1ccccc1[C@@H]23)N4CCN(CC4)C[C@@H](O)COc6cccc5ncccc56	Selleck	S1481	-3.5158371	-2.80709634	-2.37954947	-93.19246582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347955-03	NCGC00347955-03	384568999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1338259-05-4				-15.4443620034	4	4		0	-1.14991889				PPARG	C[C@H](NC(=O)C1=CC2=C(C=C1)[N](CC3=CC=C(C=C3)C4=CC=CC=C4C(O)=O)C(=C2C)C)C5=CC=C(C=C5)[N+]([O-])=O	XcessBio	M66048-2s	-4.42595379	-2.06764463	-2.62890341	-1.14991889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351478-06	NCGC00351478-06	384569007		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-10.2843924778	4	4		0	-2.81992557			10927	EHMT2	COC1=CC2=C(C=C1OCCCN3CCCC3)\N=C(N)/C24CCC4	APExBIO	B4947	-3.71780119	1.41470422	0.46961995	-2.81992557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507875-01	NCGC00507875-01	384569346		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1234480-46-6				-6.5899888333	4	4		0	-6.80885581				TNK2	COC1=CC(=CC=C1NC2=NC3=C(NC(=O)C4=C(C=CC=C4)N3C)C=N2)N5CCN(C)CC5	Selleck	S8272	-1.2835266	0.30035259	2.24158799	-6.80885581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507873-02	NCGC00507873-02	384569345		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1942114-09-1 				-18.4012087414	4	4		0	-1.48982036				EGFR	OC1=CC=C(F)C=C1C(N2CC3=C(C=CC=C3)C2=O)C(=O)NC4=NC=CS4	Bio Vision	B1274	-6.25887154	-1.23371542	-0.63330916	-1.48982036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346634-02	NCGC00346634-02	384568870		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1062159-35-6		7.0794578438	-5.15	-132.2198943818	-2.1	4		-115.6081705221	-97.08742515	0.0090963466	0.9999489663		MTOR	C1CN(CCO1)C2=NC(=NC3=C2C=N[N]3C4CCN(CC4)CC5=CC=CN=C5)C6=CC7=C([NH]C=C7)C=C6	Selleck	S2689	-7.61621718	-13.36831929	-44.15276771	-97.08742515												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090752-04	NCGC00090752-04	26752780		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	65646-68-6	ST-602;NSC-374551;SYT-101;McN-R-1967; Fenretinide;Fenretinide	12.5892541179	-4.9	-25.7361964696	-3	4	4-HPR;NCGC00090752-03;NCGC00090752-06;NCGC00090752-05;NCGC00090752-08;LS-177208;fenretinidum;NCGC00090752-07;MCN-R-1967;MCNR196;CIPLUS_186933;4-HYDROXYPHENYLRETINAMIDE;Retinamide;NCGC00015516-01;4 Hydroxyphenylretinamid;Fenretinide, 13-cis-Isomer;N-(4-Hydroxyphenyl)retinamide;4-Hydroxyphenylretinamide;Fenretinide;Retinoic acid p-hydroxyanilide;CIPLUS_728212;fenretinide;LS-282;N-(4-Hydroxyphenyl)-trans-Retinamide;Retinamide, N-(4-hydroxyphenyl)-;Fenretinimide;13-cis-Isomer Fenretinid;MCN R 196;4-Hydroxyphenyl retinamide;Fenretinide, 13 cis Isome;N-(4-HYDROXYPHENYL)RETINAMIDE;FENRETINIDE;AB02540517-01;	-40.6601437108	-36.10538922	0.0861192982	0.9954014442	5915	RARB	C\C1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)NC2=CC=C(O)C=C2)C(C)(C)CCC1	BIOMOL	GR103	-0.50124202	1.18768126	2.4317138	-36.10538922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387868-06	NCGC00387868-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	891494-64-7				-33.6677708309	4	4		0	-12.35449102					CN1C=C(C=N1)C2=C3N=C([C@H]4CCCNC4)C(Br)=C(N)N3N=C2	MedChem Express	HY-15532B	-6.95085167	-5.87395848	-3.68866328	-12.35449102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165875-04	PB-28	384568294	sigma1/2 Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	172907-03-8				-16.3738652513	4	4		0	-9.42369413				SIGMAR1	COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1	Axon Medchem	1272	-1.20960622	-5.02317704	-3.90639655	-9.42369413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387037-01	NCGC00387037-01	363680530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(1220699-06-8)		2.5118864315	-5.6	-212.9109863672	-2.3	4		-99.7634840055	-94.42299642	0.1049976782	0.9931397971		MTOR	C[C@H](O)C(=O)N1CCC(CC1)N2C(=O)N(C)C3=C2C4=NC(=CC=C4N=C3)C5=CN=C(C)C=C5	SynKinase	SYN-1194	-24.1479781	-47.00035657	-68.41586944	-94.42299642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159458-11	NCGC00159458-11	384568180		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(134523-03-8)		6.3095734448	-5.2	-25.9908360577	4	4		-29.210265588	-25.59188799	0.1297146099	0.9894948821			CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C([N]1CC[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4	SynKinase	SYN-3020	-0.69751015	0.90479586	2.54642656	-25.59188799												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00024379-18	NCGC00024379-18	384568026		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	316-42-7		0.1	-7	-347.9850886002	-1.3	4		-104.874416348	-99.29764175	0.1164556817	0.991548158			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	Prestwick	Prestw-NAT-0129	-57.75207487	-87.34622927	-93.33614706	-99.29764175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344081-06	NCGC00344081-06	384568717		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	315702-99-9		10	-5	-57.1944061427	-2.4	4		-78.576179952	-64.0728636	0.1262451986	0.9900417783			CC1=CC=CC(=C1)NC2=NC(=CS2)C3=CC=NC=C3	SIGMA	S7448	1.63499779	-6.1784897	-13.10686417	-64.0728636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521941-01	NCGC00521941-01	384569506		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1800340-40-2		0.0316227766	-7.4999999999	-433.8783883601	5	4		-38.990628696	-98.58495076	0.013604155	0.9998877216		BRD4	C[N]1N=NC(=C1C2=CC3=C(N=C2)C4=CC=C(C=C4[N]3[C@@H](C5CCOCC5)C6=CC=CC=C6)C(C)(C)O)C	ChemieTek	CT-BMS986	-88.59276018	-94.39479003	-97.26238499	-98.58495076												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013822-04	NCGC00013822-04	384567789		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[64048-12-0]				-5.4150044824	4	4		0	2.60063104				SHH	S1C(=C(C2=CC=NC=C2)C(=C1C3=CC=NC=C3)C4=CC=NC=C4)C5=CC=NC=C5	Tocris	3889	-2.52036199	-2.33999551	1.01980692	2.60063104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095192-05	NCGC00095192-05	170466887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	145158-71-0	; ; Tegaserod;TEGASEROD MALEATE;Tegaserod Maleate;Tegaserod maleate; TEGASEROD	12.5892541179	-4.9	-90.2968077346	-3	4		-104.6196308512	-99.82789942	0.050805818	0.9984046145	3360	HTR4	N=C(NCCCCC)N\N=C\c2cnc1ccc(cc12)OC	Bosche	T3499	-2.90950226	-7.36132944	-4.44635816	-99.82789942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250377-09	NCGC00250377-09	384568537		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	503468-95-9		3.1622776602	-5.5	-135.8756227223	-2.1	4		-94.3245135468	-96.55024334	0.008631335	0.9999540498		PRKDC	O=C1\C=C(OC2=C(C=CC=C12)C3=CC=CC4=C3SC5=C4C=CC=C5)\N6CCOCC6	MedChem Express	HY-11006	-4.7800301	-10.52104645	-63.16630356	-96.55024334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346954-01	NCGC00346954-01	174007019		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	838823-31-7	TCS 2312	12.5892541179	-4.9	-66.8746342438	-3	4		-77.0883425335	-73.01077844	0.0834469427	0.9956810526	1111	CHEK1	OC1=CC=C(C(=C1)O)C2=CC=C(C=C2)C3=N[NH]C(=C3)NC4=CC=CC(=C4)CNC5CC5	Tocris	3038	-3.05624556	-5.90157897	-0.53662074	-73.01077844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	17321-77-6				-15.9869485147	4	4		0	-3.70566183				SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	-4.28634556	-3.00228833	-0.24765198	-3.70566183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016777-10	Probucol	384567958	Serine Protease Hepsin Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	23288-49-5				-8.2636545353	4	4		0	-2.26599101					CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C	Selleck	S2119	-1.1719457	-1.39681114	-3.72116213	-2.26599101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095460-08	NCGC00095460-08	384568157		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	517-28-2				-20.400938974	4	4		0	-4.91442777					OC1=CC2=C(C=C1O)C3C4=C(OCC3(O)C2)C(=C(O)C=C4)O	Microsource	00200010	-4.73755656	-2.25915113	-4.3647736	-4.91442777												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247877-09	NCGC00247877-09	384568518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	848695-25-0		0.3981071706	-6.4	-55.7528444862	4	4		-20.2985054081	-20.18357396	0.2494386741	0.95969693		HSP90AB1	COC1=C(C)C=NC(=C1C)C[N]2C=NC3=C(Cl)N=C(N)N=C23	MedChem Express	HY-10212	-3.62443439	-20.23355042	-24.70652223	-20.18357396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263151-07	NCGC00263151-07	384568625		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	443797-96-4		12.5892541179	-4.9	-40.3056622506	-3	4		-48.7759248069	-45.67706842	0.038197765	0.9990994969		AURKA	NC1=NC(=N[N]1C(=O)C2=C(F)C=CC=C2F)NC3=CC=C(C=C3)[S+](N)([O-])=O	MedChem Express	HY-10329	-2.00053111	-0.84882253	-0.66327766	-45.67706842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160519-13	NCGC00160519-13	384568197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	51037-30-0				-10.309703771	4	4		0	-3.19209848					CC1=[N+]([O-])C=C(N=C1)C(O)=O	MedChem Express	HY-B0283	-1.6376029	-3.37352544	-1.98015008	-3.19209848												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166111-06	NCGC00166111-06	384568304		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	50-27-1				-18.7772740398	4	4		0	-4.56627541				ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)O)[C@@H]1C[C@@H](O)[C@@H]2O	Selleck	S2466	-4.2046561	-2.44199713	-4.17816509	-4.56627541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482810-01	NCGC00482810-01	384569261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1675203-84-5		12.5892541179	-4.9	-82.9883540062	-3	4		-108.4070712901	-99.64214143	0.0651493311	0.9973730054			COC1=NC(=CC=C1CNCCNC(C)=O)OCC2=C(C)C(=CC=C2)C3=CC=CC=C3	DC Chemicals	DC8381	-3.19553864	-2.57258521	2.06729605	-99.64214143												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346707-05	NCGC00346707-05	384568925		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	193275-84-2		8.9125093813	-5.05	-91.7836432246	-3	4		-99.2074055931	-99.25269461	0.0070560317	0.9999692918		COX10	NC(=O)N1CCC(CC1)CC(=O)N2CCC(CC2)[C@H]3C4=C(CCC5=C3C(=CC(=C5)Cl)Br)C=C(Br)C=N4	MedChem Express	HY-15136	-3.59740951	-4.16148782	-7.87527194	-99.25269461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160421-04	NCGC00160421-04	384568194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	58-46-8				-13.5185341681	4	4		0	-4.31647984				SLC18A2	COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1	Enzo	AC3264	-1.53628819	-5.65608843	-3.45619959	-4.31647984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167803-13	GSI-IX	384568339	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	208255-80-5				-10.8269795172	4	4		0	-0.4465324				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@H](C(=O)OC(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-13027	-2.34857849	-4.53289356	-1.89926843	-0.4465324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263105-06	NCGC00263105-06	363677205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	629664-81-9				-19.9708227328	4	4		0	-2.77316112				NR14H	CC(C)OC(=O)/C1=C/N(CC(C)(C)C2=C1[NH]C3=CC=CC=C23)C(=O)C4=CC=C(F)C(=C4)F	MedChem Express	HY-50911	-3.78418719	-6.1748159	-5.60648148	-2.77316112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263163-11	NCGC00263163-11	384568634		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1022150-57-7				-8.8269807115	4	4		0	-1.29075437				MET	C[N]1C=C(C=N1)C2=N[N]3C(=NN=C3C=C2)SC4=CC5=C(C=C4)N=CC=C5	MedChem Express	HY-12019	-2.78280543	-0.66921177	-0.41245524	-1.29075437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183873-05	NCGC00183873-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	107007-99-8				-3.0257015929	4	4		0	-2.46677503					CN1N=C(C(=O)NC2C[C@H]3CCC[C@H](C2)N3C)C4=C1C=CC=C4	SIGMA	G3796	-0.41176471	0.58836739	-0.77505326	-2.46677503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510162-01	NCGC00510162-01	384569411		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1883423-59-3				29.8255216639	4	4		0	5.89922555				CDK8	CC1=N[NH]C2=C1C=C(C=N2)C(=O)N3CCC[C@H]3C4=CC=C(Cl)C=C4	Glixx	GLXC-09132	6.20361991	6.80440153	6.89389476	5.89922555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167472-10	NCGC00167472-10	384568317		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	68302-57-8				-20.7109215294	4	4		0	-5.76536954					CC(C)C1=CC=C2OC3=NC(=C(C=C3C(=O)C2=C1)C(O)=O)N	MedChem Express	HY-B0713	-3.96832579	-5.66359757	-3.30417441	-5.76536954												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159491-08	NCGC00159491-08	384568182		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	13392-28-4				-9.5214613877	4	4		0	-0.23902859					CC(N)C12CC3CC(CC(C3)C1)C2	Selleck	S1964	-2.70135747	-3.14843925	-0.34900059	-0.23902859												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-05	Maraviroc	384568416		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	376348-65-1				-0.1902050945	4	4		0	-3.3846448				CCR5	CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Enzo	AC3169	0.64705882	1.52256905	-0.53936455	-3.3846448												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386449-03	NCGC00386449-03	384569142		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1450833-55-2		0.316227766	-6.5	-216.6331073763	-1.1	4		-101.906658342	-99.70299401	0.0136562878	0.9998849592		UBA1	CO[S+]([O-])(=O)N[C@H]1C[C@@H](NC2=CC=NC3=CC(=N[N]23)C4=CC=CC(=C4)SC(F)(F)F)[C@H](O)[C@@H]1O	Aobious	AOB87172	-1.24645138	-99.49822768	-99.265168	-99.70299401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016103-16	NCGC00016103-16	384567922		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	170632-47-0		6.3095734448	-5.2	-4.6038793914	4	4		18.95599716	13.12095808	0.0269973481	0.9995522906		HIF1A	OCC1=CC=C(O1)C2=N[N](CC3=CC=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-14927	-4.5466643	-4.45610643	0.44960116	13.12095808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093684-06	NCGC00093684-06	384568117		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	378-44-9				-19.010463784	4	4		0	-2.79281437					C[C@H]1CC2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	Microsource	01500144	-6.58711852	-0.26699811	0.12086053	-2.79281437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386720-01	NCGC00386720-01	363680415		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	186390-48-7				-0.9054776292	4	4		0	3.1096799					FC(F)(F)C1=CC=C(C=C1)C2=CC=CC=C2C(=O)NC3=CC4=C(CN(CC4)CC5=NC=N[NH]5)C=C3	Axon Medchem	2216	-0.72470172	-0.16475973	-1.80832671	3.1096799												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025091-11	NCGC00025091-11	384568047		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	112648-68-7				-8.5828492226	4	4		0	1.71082217				PLCG1	COC1=CC=C2[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CCC2=C1)NCCCCCCN5C(=O)\C=C/C5=O	MedChem Express	HY-13419	-4.35607772	0.92076019	0.88495575	1.71082217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167785-11	NCGC00167785-11	384568336		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	315183-21-2		7.0794578438	-5.15	-87.3090829497	-2.2	4		-83.8103920377	-76.74259458	0.0125305992	0.9999031596		CASP3	OC1=C(C=CC=C1CC=C)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3	SIGMA	P0115	-3.74152734	-4.66730167	-24.51186964	-76.74259458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263598-06	NCGC00263598-06	384568691		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	743420-02-2		7.0794578438	-5.15	-9.8314742053	4	4		-16.3889820359	-13.65748503	0.2476749781	0.9603867561			NC1=C(NC(=O)C2=CC=C(CNC(=O)/C=C/C3=CN=CC=C3)C=C2)C=C(F)C=C1	Glixx	GLXC-05969	-0.23509581	3.26842517	-1.87092096	-13.65748503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386207-07	NCGC00386207-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1433953-83-3				-17.2118523632	4	4		0	-3.16293781					CCN1C(N)=C(C(=O)NC)C(=O)C2=CC=C(N=C12)C#C[C@@](C)(O)COC	APExBIO	B2301	-5.0326682	-2.96398645	0.10785969	-3.16293781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522303-03	NCGC00522303-03	384569516		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	834153-87-6				-25.6097436529	4	4		0	-5.88772469				GNRHR	COC1=C(F)C(=CC=C1)C/2=C(C)/N(CC3=C(F)C=CC=C3C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C4=CC=CC=C4)C2=O	Glixx	GLXC-10786	-4.59566947	-8.54919908	-5.00443904	-5.88772469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263165-02	NCGC00263165-02	363677239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	586379-66-0				-29.8885132822	4	4		0	-6.56060752				MAPK14	CNC(=O)C1=CC=C(C)C(=C1)N2C(=C/C(=C(/Br)C2=O)OCC3=C(F)C=C(F)C=C3)\C	Selleck	S2726	-4.76358816	-9.26315789	-9.079015	-6.56060752												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159570-14	NCGC00159570-14	384568189		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	213261-59-7				-10.9641995747	4	4		0	-2.3071659				MDM2	OCC1=CC=C(S1)C2=CC=C(O2)C3=CC=C(CO)S3	MedChem Express	HY-13424	-2.19611387	-3.52428902	-1.67158309	-2.3071659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263147-03	NCGC00263147-03	384568622		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	(552325-73-2 (free base))		2.8183829313	-5.55	-134.8048810098	-1.1	4		-93.1924839274	-96.43592814	0.0282442832	0.9995076577		AKT1	CC1=N[NH]C2=CC=C(C=C12)C3=CC(=CN=C3)OC[C@@H](N)CC4=CC=CC=C4	SynKinase	SYN-1110	-1.54808375	-4.42848594	-79.6567561	-96.43592814												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161834-01	NCGC00161834-01	26755470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	51333-22-3	; Horacort; Budesonido; Pulmicort;Budesonide; Budesonide, (S)-Isomer; Rhinocort; 6   Budesonide; Budesonide, (R)-Isomer			-4.0678190474	4	4	budesonidum;budesonide;(11b,16a)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione;NCGC_Prestw-518;6   Budesonide;NCGC00015165-01;NCGC00015165-03;Pulmicort;Budesonidum;dexbudesonidum;budesonide sulphotransferase;NCGC00016862-01;CIPLUS_205192;CIPLUS_180950;CIPLUS_205193;Horacort;Budesonide;testosterone sulfotransferase;LS-175261;BUDESONIDE;LS-175262;NCGC00089747-02;NCGC00089747-03;Budesonido;NCGC00094860-01;NCGC00094860-02;Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-;Budesonide, (S)-Isomer;16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione;testosterone sulphotransferase;LS-7235;Budesonide, (R)-Isomer;Rhinocort;	0	0.63712575				NRC31	[H][C@@]12CC3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)CC(O)[C@@]4([H])[C@@]2([H])CCC5=CC(=O)C=C[C@]45C	SigmaAldrich	B7777	-0.86497516	-3.26842517	-0.07251632	0.63712575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346940-03	NCGC00346940-03	384568974		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[164658-13-3]		10	-5	-329.3061952922	5	4		34.6307608775	-45.22634731	0.1929707423	0.9763352021		CDK1	OCCCNC1=CC(=CC=N1)C2=NC(=NC=C2)NC3=CC=CC(=C3)Cl	Tocris	5471	-73.59386089	-79.40892142	-74.49359439	-45.22634731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183808-01	NCGC00183808-01	85736407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1222800-79-4	 NCGC00183808-01;NCGC00183808-01	11.220184543	-4.95	-36.2675465433	-3	4		-37.9339556161	-32.12934132	0.0446219713	0.9987717123	3720	JARID2	CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O	NCGCChem	GRB09-026-A4	-2.87881476	-1.76771164	-5.24534687	-32.12934132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522470-01	NCGC00522470-01	384569519		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1333146-24-9		8.9125093813	-5.05	-95.4019953608	-3	4		-98.9317945536	-99.69766036	0.006965566	0.9999700743			CNC(=O)CCC1=N[N](C2=CC=C(C=C2)N3CCNCC3)C(=C1)C4=CC=C(C=C4)C5=CC=C(C=C5)C(F)(F)F	MedChem Express	HY-18676	-4.60886456	-4.21198075	-8.83042581	-99.69766036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263124-09	NCGC00263124-09	384568607		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	675576-97-3				-19.4346730478	4	4		0	-6.86821109				MDM2	COC1=CC=C(C(=C1)OC(C)C)C/2=N/[C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(Cl)C=C4)C5=CC=C(Cl)C=C5	MedChem Express	HY-15335	-4.46310208	0.04576659	-4.20073828	-6.86821109												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386735-01	NCGC00386735-01	363680425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	911715-90-7				-9.4806481713	4	4		0	-4.47467077				CX3CR1	CC(C)C[C@H](CO)NC1=C2SC(=NC2=NC(=N1)S[C@@H](C)C3=CC=CC=C3)N	Axon Medchem	2255	-2.34202386	0.58581236	-0.80837344	-4.47467077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015870-26	NCGC00015870-26	384567899		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	117-39-5	 Quercetine; quercetin-ATS; quercetin 3-O-glucuronide; quercetin RGRGal; ;quercetin 3-3AcAra-Gal;Quercetin dihydrate;Quercetine; quercetin HMGGlc; QME-Ara-Glc; amurenoside B; amurenoside A; Q-RR cpd; quercetin 3-O-fGalp; Q3MG cpd; Q-3-AP cpd; Q-tC-L-A-D-G;Sophoretin; Quercetin hydrate; Q-M-beta-D-G; flavonol 3-OMT; quercetin digal-Gal; quercetin 3-XR; Quercetine dihydrate;Meletin;Quercetin (Sophoretin); quercetin 3-RhaGlcGal			-15.3133449732	4	4		0	-3.59031049				CYP75A12	OC1=CC2=C(C(=C1)O)C(=O)\C(=C(/O2)C3=CC(=C(O)C=C3)O)O	Specs	AE-562/J257905	-3.29650906	-3.43249428	-2.59333676	-3.59031049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499786-01	NCGC00499786-01	384569310		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1224964-36-6		10	-5	-79.9582567525	-3	4		-91.866333798	-88.04379705	0.0137055024	0.9998841344		ADAM10	COCCOC(=O)N1CCN(C(C1)C(=O)NO)[S+]([O-])(=O)C2=CC(=C(OC3=CC=C(Cl)C=C3)C(=C2)F)F	TruePharmaChem	T16012	-2.68413918	-3.78736336	-6.65355621	-88.04379705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091231-18	NCGC00091231-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-9.487186226	4	4		0	-4.79030208					[H][C@@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	BIOMOL	AC-129	-2.03343877	0.32203928	-1.3438217	-4.79030208												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387475-01	NCGC00387475-01	384569160		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[1332331-08-4]		5.0118723363	-5.3	-37.5501478794	-2.4	4		-31.109101576	-30.09091798	0.176633035	0.9802803554		FAS	O=C1N\N=C(\C[C@@H]2CCN(C2)C(=O)C3CC3)N1C4=CC=C(C=C4)C5=CC=C6OC=CC6=C5	Tocris	5303	-2.84681428	1.47412346	-12.6188135	-30.09091798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345840-03	NCGC00345840-03	384568763		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	12847-42-4		11.220184543	-4.95	-86.7370650259	-3	4		-107.9318083846	-99.66467066	0.0564980915	0.9980260849		AKT1	CCN(CC)CCNC(=O)C1=CC=C2N=C(C3=CC=CC=C3)C(=NC2=C1)C4=CC=C(CN5CCC(CC5)N6C(=O)NC7=CC=CC=C67)C=C4	SynKinase	SYN-1118	-4.15631654	1.1416471	-3.47594876	-99.66467066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241108-15	NCGC00241108-15	384568476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	319460-85-0		7.0794578438	-5.15	-26.0964440871	4	4		-15.8191774801	-14.38562874	0.2068815539	0.9729819368		FLT1	CNC(=O)C1=CC=CC=C1SC2=CC=C3C(=C2)[NH]N=C3\C=C\C4=CC=CC=N4	SIGMA	PZ0193	-2.45298084	-5.37678958	-7.6142132	-14.38562874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347904-03	NCGC00347904-03	384568988		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	227088-94-0		11.220184543	-4.95	-44.9880043848	-3	4		-56.4335057861	-46.27991925	0.0639570493	0.9974701168		P2RX7	[O-][N+](=O)C1=CC(=CC=C1)C2=CC=C(OCC(CCC3=CC=NC=C3)N4C(=O)CSC4=O)C=C2	SIGMA	A7231	-0.96332302	-3.73455378	-7.6211392	-46.27991925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167429-10	NCGC00167429-10	384568311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	85622-93-1				-9.5386135134	4	4		0	0.35376231				TOP2A	CN1\N=N/C2=C(N=C[N]2C1=O)C(N)=O	APExBIO	B1399	-1.77828054	-3.48978217	-4.03843539	0.35376231												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507938-02	NCGC00507938-02	384569357		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-12.0878059249	4	4		0	-3.44201166					C[S+]([O-])(=O)C1=CC=C(C=C1)C2=CN=C(NCC3=CC=CO3)[N]4C=NN=C24	NCGCChem	PJM011-078	-2.01357466	-4.73837862	-1.51837919	-3.44201166												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263173-05	Rucaparib	384568643	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	459868-92-9				-23.2003681931	4	4		0	-9.65263861				PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	Selleck	S1098	-4.03646986	-6.55987464	-1.56378601	-9.65263861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016268-21	NCGC00016268-21	384567927		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	59-67-6		17.7827941004	-4.75	-33.3725789178	4	4		-9.918153972	-14.51017964	0.4598621998	0.843595865			OC(=O)C1=CC=CN=C1	MedChem Express	HY-B0143	-7.47427253	-2.49505133	-5.4580614	-14.51017964												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346535-02	NCGC00346535-02	384568825		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	173529-46-9		1.1220184543	-5.95	-82.99268592	-1.4	4		-40.7695996049	-47.76526946	0.1464831299	0.9865356462		PLK1	COC1=CC=C(C=C1)[S+]([O-])(=O)N(C(C)=O)C2=C(C=CC=C2)\C=C\C\3=C\C=[N](=O)\C=C3	MedChem Express	HY-12045	-3.59740951	-12.93559821	-41.58085569	-47.76526946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370984-01	NCGC00370984-01	363677978		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	3963		5.0118723363	-5.3	-121.5952120703	-2.1	4		-93.4769944013	-87.16167665	0.0440913768	0.9987991806	6714	SRC	COC1=CC=C(Cl)C(=C1)NC2=NC=NC3=CC(=C(OC)C=C23)OCC4CCN(C)CC4	Tocris	3963	-7.36781405	-10.19196244	-43.64998791	-87.16167665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390618-03	NCGC00390618-03	384569201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			11.220184543	-4.95	-138.5129663891	-2.3	4		-115.7296562671	-99.67797751	0.0971795093	0.9941301275			CCCCNC1=NC=C2C(=N1)[N](C=C2C3=CC=C(CN4CCN(C)CC4)C=C3)[C@@H]5CC[C@@H](O)CC5	MedChem Express	HY-12344A	-11.37428193	-19.87185355	-30.1527966	-99.67797751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346690-04	NCGC00346690-04	384568912		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	501951-42-4				-25.0703302243	4	4		0	-9.31942709				TRPV1	FC(F)(F)C1=CN=C(C=C1)N2CC[C@H](C2)NC(=O)NC3=CC=CC=C3Br	MedChem Express	HY-10633	-3.83561644	-8.15560641	-3.7334704	-9.31942709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00388364-06	NCGC00388364-06	384569169		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1154028-82-6				-21.010795563	4	4		0	-5.43072952				HIF1A	O=C\1N(N\C=C1[N]2C=CN=N2)C3=NC=NC(=C3)N4CCOCC4	MedChem Express	HY-12654	-4.80995475	-0.11228385	-6.56755654	-5.43072952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483927-02	NCGC00483927-02	384569267		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1818885-28-7		1.2589254118	-5.9	-149.4308182442	-1.1	4		-83.3651122906	-86.70044937	0.0288831002	0.9994851335	23476	BRD4	CC1=C(C)C\2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)NC4=CC=C(OCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C7CCC(=O)NC7=O)C6=O)C=C4)\N=C2C8=CC=C(Cl)C=C8)C	MedChem Express	HY-16954	-5.36199095	-13.33483045	-88.15210987	-86.70044937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420882-01	NCGC00420882-01	384569225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-11.2857893314	4	4		0	0.85094177				GRM3	NC(CC1C2=CC=CC=C2OC3=CC=CC=C13)(C4CC4C(O)=O)C(O)=O	Bio Vision	2875-5	-2.85520362	-3.12149113	-3.50360332	0.85094177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092344-05	NCGC00092344-05	174007302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	317318-84-6	 GW-0742;GW-0742;GW-610742???	6.3095734448	-5.2	-13.6314232486	4	4		10.9339366479	5.81317526	0.3149962811	0.9342213408	5467	PPARG	CC1=CC(=CC=C1OCC(O)=O)SCC2=C(C)N=C(S2)C3=CC=C(C(=C3)F)C(F)(F)F	NCGCChem	GRB27-096	-5.77828054	-2.63642488	-1.97162671	5.81317526												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351603-15	NCGC00351603-15	363677773		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1032900-25-6		12.5892541179	-4.9	-100.8021919639	-3	4		-102.5128480629	-99.68031301	0.0202755077	0.9997463681		ALK	CC(C)OC1=CC(=C(C)C=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)C4CCNCC4	Selleck	S7083	-7.08152607	-6.05493405	-5.69837812	-99.68031301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483923-01	NCGC00483923-01	363681142		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1173699-31-4				-9.5879462629	4	4		0	2.19963737				MET	COCCOC1=CN=C2\C=C/N([C@H](C)C3=NN=C4[N]3C=C(C=C4F)C5=C[N](C)N=C5)C(=O)C2=C1	ChemieTek	CT-AMG337	-3.32831725	-2.6074087	-1.3023481	2.19963737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346680-05	NCGC00346680-05	363677514		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1030612-90-8		0.316227766	-6.5	-219.9991627974	-1.1	4		-87.6168873788	-86.03113772	0.0346291371	0.9992598192		SCD	OC(=O)C[N]1N=NC(=N1)C2=CC(=NO2)N3CCC(CC3)OC4=CC(=CC=C4Br)F	MedChem Express	HY-13070	-19.62828247	-68.37913732	-82.66376601	-86.03113772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017352-22	NCGC00017352-22	384567987		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	501-36-0	trans-Resveratrol;Resveratrol;RESVERATROL	12.5892541179	-4.9	-31.8712439139	-3	4		-37.371497008	-32.80958084	0.292364744	0.9433258585	5743	PTGS2	OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O	Enzo	FR-104	-4.8571682	4.73231138	2.4993957	-32.80958084												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093644-09	NCGC00093644-09	384568116		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	51264-14-3		11.220184543	-4.95	-132.1119651987	-2.3	4		-110.385700246	-97.86347305	0.1443531433	0.986924491		TOP2A	COC1=C(NC2=C3C=CC=CC3=NC4=C2C=CC=C4)C=CC(=C1)N[S+](C)([O-])=O	MedChem Express	HY-13551	-9.73651526	-21.45191732	-27.3386512	-97.86347305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263107-03	NCGC00263107-03	384568594		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					-4.0686744848	4	4		0	-2.1508982				PAR2	CC[C@@H](C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C2=CC=NO2)C(=O)N3CCC4(CC3)CCC5=C4C=CC=C5	Axon Medchem	1622	-0.09315117	-1.06799245	-2.11264201	-2.1508982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346584-02	NCGC00346584-02	363677465		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	464-92-6				-16.3176265605	4	4		0	1.08742515					C[C@@H]1CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	Selleck	S2266	-6.40968772	0.25779128	-1.34880348	1.08742515												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242056-04	NCGC00242056-04	384568484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	862812-98-4				-11.164698755	4	4		0	-2.53965301				IKBKE	COC1=CC2=C(C=C1OC)[N](C=N2)C3=CC(=C(S3)C#N)OCC4=C(C=CC=C4)[S+](C)([O-])=O	Bio Vision	1811	-1.91594561	-1.40399358	-4.85368599	-2.53965301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024728-02	NCGC00024728-02	384568033		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[142523-38-4]				-8.3165159849	4	4		0	-1.24656961				INPPL1	CC(OC1=CC=C(O)C=C1)([P](O)(O)=O)[P](O)(O)=O	Tocris	0681	-2.76355289	0.53931182	-1.00825361	-1.24656961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371137-09	NCGC00371137-09	384569042		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	91396-88-2		3.9810717055	-5.4	-111.0652749176	-2.1	4		-89.5391412996	-88.20051908	0.0068588831	0.9999709856	6319	SCD1	O=C(NNC1=CC=CC=C1)C2=CC=NC=C2	Glixx	GLXC-01592	-2.95183385	-6.54462243	-47.25480118	-88.20051908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015092-11	NCGC00015092-11	384567807		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	60-32-2				-16.3614221375	4	4		0	-1.02586125				SERPINE1	NCCCCCC(O)=O	Selleck	S1671	-5.16066212	-2.15470335	-1.3023481	-1.02586125												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164624-11	Adefovir dipivoxil	377020406	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	142340-99-6				-13.3344278388	4	4		0	-4.43113772					CC(C)(C)C(=O)OCO[P](=O)(COCC[N]1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	MedChem Express	HY-B0255	-2.73687012	-3.01063389	-1.3294658	-4.43113772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379217-03	NCGC00379217-03	363678425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1216665-49-4		11.220184543	-4.95	-69.7420898102	-3	4		-97.1399329369	-84.75688623	0.0230836127	0.9996712287		ERN1	C1CC1C2=N[NH]C(=C2)NC3=NC(=NC=C3)NC4=CC5=C(C=C4)N=C[NH]5	Bio Vision	2591	-1.49485451	0.30382544	-3.98839739	-84.75688623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263198-07	NCGC00263198-07	363677259		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	417716-92-8				-18.4448948512	4	4		0	-3.27457091				FLT1	COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O	Glixx	GLXC-90055	-1.46565425	-6.95756819	-10.57493904	-3.27457091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347941-04	NCGC00347941-04	363677723		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	425399-05-9		12.5892541179	-4.9	-94.4585881722	-3	4		-109.9819026592	-99.6883576	0.0057899038	0.9999793238		CDC42	OCCNC1CCCC2=C1[NH]C3=C2C=C(C=C3)C4=CC=CC=C4	Glixx	GLXC-04909	-4.88257108	-5.01426279	-5.68842619	-99.6883576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421916-03	NCGC00421916-03	384569230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[1301214-47-0]		14.1253754462	-4.85	-14.8871830173	4	4		-12.3594060921	-12.01916368	0.1488164889	0.9862504796		ACC	CC(C)[N]1N=CC2=C1C(=O)CC3(CCN(CC3)C(=O)C4=CC=C5[NH]C(=NC5=C4)C)C2	Tocris	5790	-1.42150803	-2.36673204	-0.88632527	-12.01916368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351483-01	NCGC00351483-01	384569010		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1251156-08-7		11.220184543	-4.95	-57.4669339493	-2.4	4		-44.9286523268	-39.08067809	0.1512265549	0.9856425343		MTOR	CC1=C(F)C(=CC=C1C(=O)N2CCOC3=CC=C(C=C3C2)C4=CC=C(N)N=C4)[S+](C)([O-])=O	Arking Pharma	ARKS-00101	-4.71486896	-9.68760005	-13.51388889	-39.08067809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241102-08	NCGC00241102-08	384568472		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	120685-11-2		2.5118864315	-5.6	-120.1340592232	-1.4	4		-54.6883490353	-65.50339421	0.0787505435	0.9961563468		PRKCA	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N3C4=CC=CC=C4C5=C6CNC(=O)C6=C7C8=CC=CC=C8N2C7=C35)N(C)C(=O)C9=CC=CC=C9	Bio Vision	2052	-8.32126697	-13.29889962	-58.12899424	-65.50339421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390260-01	NCGC00390260-01	363680869		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	131179-95-8				3.6224957221	4	4		0	3.59498996					CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(OC(C)(C)C(O)=O)C=C2)C	Adooq	A12323	-0.2760181	1.10038177	1.24643068	3.59498996												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016258-06	Menadione	170464997	CDC25 Phosphatase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	58-27-5	 ; Menadione (K3);Menadione / vitamin K3;MENADIONE; Kappaxin; Kipca, oil soluble;Menadione; Menadione; Vitamin- K3			-11.6362689106	4	4		0	-3.9774357			5923	CDC25	O=C2C=C(C)C(=O)c1ccccc12	Specs	AE-562/J257372	-2.59276018	1.3518976	-4.2741241	-3.9774357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015094-18	NCGC00015094-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	315-30-0				-14.7382895065	4	4		0	-3.68104025					OC1=C2C=NNC2=NC=N1	MedChem Express	HY-B0219	-2.26696833	-5.73545924	-3.13194035	-3.68104025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386131-05	NCGC00386131-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	649735-63-7		0.7079457844	-6.15	-22.8052947291	4	4		-13.6784969238	-11.97125749	0.0308662987	0.9994198587			C[C@H](COC1=CN2N=CN=C(OC3=C(F)C4=C(NC(C)=C4)C=C3)C2=C1C)OC(=O)[C@H](C)N	APExBIO	A2633	-0.98917672	-5.92919947	-10.28281363	-11.97125749												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016467-10	NCGC00016467-10	384567943		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[491-70-3]		10	-5	-6.9494522958	4	4		-14.3425043	-11.53542025	0.1011083801	0.9937031052		PDE4A	OC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC(=C(O)C=C3)O	Tocris	2874	0.98887515	-0.16491353	-1.05514913	-11.53542025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159509-02	NCGC00159509-02	29215484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	82834-16-0	 ; Aceon; Perindopril;Perindopril; Pirindopril; Erbumine, Perindopri; Perindopril and diuretics; cpd with unspecified MF; Perstarium			-7.376431409	4	4	cpd with unspecified MF;S 9490-3;CIPLUS_196546;LS-82690;1-(2-((1-(ETHOXYCARBONYL)BUTYL)AMINO)-1-OXOPROPYL)OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID(2S-(1(R*(R*)),2A,3AB,7AB))-2-METHYL-2-PROPANAMINE;S-9490;Perindopril and diuretics;LS-82762;PERINDOPRIL;S 9490;LS-178402;CIPLUS_668001;S949;perindopril;Perindopril;(2S,3(infinity)S,7(infinity)S)-1-[(S)-N-[(S)-1-Carboxybutyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1);PERINDOPRIL ERBUMINE;CIPLUS_685081;HS_6;S 949;PERINDOPRIL T-BUTYLAMINE;Pirindopril;MCN-A-2833-109;perindoprilum;Perindopril erbumine;Aceon;Perindopril Erbumine;1H-Indole-2-carboxylic acid,              1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-;NCGC00095142-01;Perstarium;Erbumine, Perindopri;NCGC00095142-02;1H-Indole-2-carboxylic acid,;	0	-2.93967161			1636	ACE	O=C(OCC)[C@H](CCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C(=O)O	Enamine	T5568746	-1.8717994	-0.01337137	-0.55805665	-2.93967161												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496921-02	NCGC00496921-02	384569298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	N/A				-18.21720696	4	4		0	-6.25298786				RIPK1	CC(C)(C)C(=O)N1\N=C/C[C@H]1C2=CC=CC=C2	Glixx	GLXC-08006	-4.11312217	-0.1661801	-4.1834746	-6.25298786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263175-02	NCGC00263175-02	384568645		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[238750-77-1]		0.7079457844	-6.15	-23.7838391095	4	4		-14.11372214	-13.4047232	0.3694331051	0.9062117457		ANPEP	CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C2=CC=CC=C2	Tocris	3595	-0.80995475	-7.91825735	-8.81566423	-13.4047232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164385-06	NCGC00164385-06	363676631		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	50-41-9		12.5892541179	-4.9	-76.4865657614	-3	4		-111.0086419139	-99.64550898	0.0776918015	0.9962585894		ESR1	CCN(CC)CCOC1=CC=C(C=C1)\C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3	Selleck	S2561	-2.20457771	0.34065276	4.8392555	-99.64550898												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016014-09	NCGC00016014-09	124881627		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	133550-30-8	 ;AG-490; Tyrphostin-AG-490; Tyrphostin B42; tyrphostin AG-490;Tyrphostin B42; tyrphostin B42; Tyrphostin AG 490;Tyrphostin AG 490	11.220184543	-4.95	-36.343451433	-3	4		-42.2467349998	-37.59590793	0.0363363878	0.9991855558	3717	JAK2	OC1=C(O)C=C(C=C1)\C=C(/C#N)C(=O)NCC2=CC=CC=C2	BIOMOL	EI-272	-1.35342416	-2.5272214	-4.3217404	-37.59590793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507851-01	NCGC00507851-01	384569331		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1338540-63-8(free base)		1	-6	-156.8354836956	-1.1	4		-100.6912461011	-97.99525559	0.0057707847	0.9999794598		PBK	C[C@@H](CN)C1=CC=C(C=C1)C2=C3C(=C(C)C=C2O)NC(=O)C4=C3C=CS4	Selleck	S7652	2.23379834	-30.9279729	-96.82517351	-97.99525559												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165855-05	NCGC00165855-05	384568290		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	151720-43-3		3.5481338923	-5.45	-158.1911249807	-2.1	4		-124.4041386798	-99.06507279	0.0181163191	0.9997975321			ONC(=O)\C=C\C#CC1=CC=CC(=C1)N[S+]([O-])(=O)C2=CC=CC=C2	Bio Vision	2250	-5.40349638	-14.36530576	-45.9435378	-99.06507279												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510486-01	NCGC00510486-01	384569448		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1236199-60-2		10	-5	-66.7798970971	-2.4	4		-39.91283536	-38.1413089	0.1690448755	0.9819800123			C[N]1C(=NC2=CC(=CC=C12)N(CCCl)CCCl)CCCCCCC(=O)NO	MedChem Express	HY-101780	-7.02807699	-12.34177215	-16.73700994	-38.1413089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014911-03	NCGC00014911-03	384567796		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	2222-07-3		31.6227766017	-4.5	-462.3620971472	5	4		8.375318056	-97.93943904	0.7175757668	0.7127799036		JAK2	CC(C)(O)\C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@]2(C)[C@@H]3C\C=C4/[C@@H](/C=C(/O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@@]12C	Cayman	14747	-98.17234681	-99.01497593	-99.08553742	-97.93943904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390645-03	NCGC00390645-03	384569205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1802175-06-9				3.5495155516	4	4		0	-0.99719835				EZH2	COC/1=C(\CNC(=O)C2=C(C)[N]([C@H](C)C3CCOCC3)C4=CC=CC=C24)C(=O)NC(=C1)/C	MedChem Express	HY-15955	1.7384433	-0.13721813	-0.06944444	-0.99719835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263017-01	NCGC00263017-01	137275921		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1093135-60-4	CPG-52364	8.9125093813	-5.05	-41.8667561202	4	4		-24.032757272	-25.96514554	0.0131262292	0.9998940552	51284	TLR7	COC1=C(OC)C=C2C(=NC(=NC2=C1)C3=CC=C(C=C3)N4CCN(C)CC4)NCCN5CCOCC5	NCGCChem	BTM10-096	-5.15386979	-5.10451448	-8.19907407	-25.96514554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347217-03	NCGC00347217-03	377020175		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			7.9432823472	-5.1	-96.1022033581	-2.1	4		-108.7112445853	-99.65579883	0.0252449152	0.9996067318		DDR1	CCC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)CN3CCN(C)CC3)C#CC4=C[N]5N=CC=C5N=C4	NCGCChem	PRP008-041	-2.6199095	-1.17224343	-20.183112	-99.65579883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095348-11	NCGC00095348-11	384568156		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1968-05-4		14.1253754462	-4.85	-37.5102800363	4	4		-15.9432297321	-17.71461661	0.3987758627	0.8881807386		AR	C(C1=C[NH]C2=C1C=CC=C2)C3=C[NH]C4=C3C=CC=C4	MedChem Express	HY-15758	-4.8452585	-9.39194336	-7.62889615	-17.71461661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024717-10	NCGC00024717-10	384568032		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	51298-62-5				5.6378989578	4	4		0	-1.30238616				NOS3	COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O	Selleck	S2877	1.20077697	0.58388305	4.48790096	-1.30238616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507838-01	NCGC00507838-01	384569321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1448232-80-1		3.5481338923	-5.45	-110.920275571	-3	4		-98.2825759358	-98.99065073	0.03465323	0.9992586333		EGFR	CCC1=NC(=C(NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(C)CC4)N=C1O[C@@H]5CCN(C5)C(=O)C=C)C(N)=O	Selleck	S8412	0.32668197	-2.82135853	-8.43650347	-98.99065073												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00475734-01	NCGC00475734-01	384569234		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1037210-93-7		12.5892541179	-4.9	-90.2416747779	-3	4		-105.5911165237	-99.72556863	0.0130160671	0.9998954951		SHH	C[C@@H]1CN[C@H]2[C@@H](C)[C@@]3(CC[C@H]4[C@@H]5CC[C@@H]6C[C@@H](CC[C@]6(C)[C@H]5C\C4=C(C)\C3)N[S+](C)([O-])=O)O[C@@H]2C1	ActiveBioChem	A-1062	-3.67296486	-4.71117846	-4.3378353	-99.72556863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346669-05	NCGC00346669-05	384568895		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1000413-72-8				8.8878357127	4	4		0	7.68317584					CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC=C4[C@@H](COC4=C3)CC(O)=O)C)OCCC[S+](C)([O-])=O	Glixx	GLXC-04884	0.58826112	-0.28358414	2.63425926	7.68317584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505019-01	NCGC00505019-01	384569313		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	308246-57-3		3.9810717055	-5.4	-164.7259622005	-2.1	4		-92.6384501653	-99.64385773	0.0099271662	0.9999392179		TOP1	COC1=C(OC)C=C\2C(=C1)C(=O)N(CCCNCCO)\C3=C2C(=O)C4=C3C=C5OCOC5=C4	NCI	NSC706744	-13.48610562	-19.69537575	-60.15277778	-99.64385773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386747-06	NCGC00386747-06	363680432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1616632-77-9		12.5892541179	-4.9	-66.1822285177	-3	4		-58.8003675789	-59.26207322	0.0209589312	0.9997290605		TNFSF10	CC1=CC=CC=C1CN2C(=O)C/3=C(/CCN(CC4=CC=CC=C4)C3)N\5CC\N=C25	Glixx	GLXC-04984	-5.21532991	-6.2845904	-5.97685185	-59.26207322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378978-02	NCGC00378978-02	384569082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	898280-07-4		3.9810717055	-5.4	-119.6079128253	-2.2	4		-75.2371753755	-79.09628781	0.0280167074	0.9995156423		IGFR1	CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)NC3=N[NH]C(=C3)C4CC4)N5CCN(C)CC5	ChemieTek	CT-XL228	-7.86049394	-11.06951639	-46.75381264	-79.09628781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508867-01	NCGC00508867-01	384569367		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1260612-13-2		8.9125093813	-5.05	-61.0754815199	-3	4		-49.1365875073	-50.07479612	0.0393041609	0.9990465248		PIK3CB	CC1CC2=CC=CC=C2N1C(=O)C\C3=N\C(=O)\C=C(/N3)N4CCOCC4	Bio Vision	B1263	-5.58513038	-4.13137967	-9.29710746	-50.07479612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263606-06	Tubastatin A	384568693	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1310693-92-5		3.9810717055	-5.4	-46.8144129778	4	4		-14.199263188	-20.18530136	0.0281900262	0.9995134692		HDAC6	CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=C(C=C4)C(=O)NO	Selleck	S2627	-6.68591537	-7.15149886	-13.81396029	-20.18530136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483922-01	NCGC00483922-01	363681141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1626387-80-1		11.220184543	-4.95	-86.2925171442	-2.4	4		-49.3675234356	-47.63012233	0.1743543743	0.9807893864	1956	EGFR	COC1=C(OC(=O)N2CCN(C)C[C@H]2C)C=C3C(=NC=NC3=C1)NC4=CC=CC(=C4F)Cl	MedChem Express	HY-18750	-10.0035317	-16.19272598	-19.78521853	-47.63012233												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016418-23	NCGC00016418-23	384567939		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	298-81-7				-12.204654534	4	4		0	0.59831901				CYP1A2	COC1=C2OC(=O)\C=C/C2=CC3=C1OC=C3	MedChem Express	HY-30151	-2.90618552	-4.79348671	-2.68981481	0.59831901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483926-01	NCGC00483926-01	363681145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1123837-84-2		8.9125093813	-5.05	-85.8749278067	-3	4		-103.3573428226	-99.75782326	0.0058465364	0.9999789172	3815	FLT1	COCCNCC1=CC=C(N=C1)C2=CC3=NC=CC(=C3S2)OC4=C(F)C=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4	ChemieTek	CT-MG516	-1.90526362	-1.65576545	-7.56944444	-99.75782326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345790-03	NCGC00345790-03	384568743		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	571170-77-9				-11.9073063853	4	4		0	2.41896931				PTGDR	C[S+]([O-])(=O)C1=C2[N](CC3=CC=C(Cl)C=C3)C4=C(CC[C@@H]4CC(O)=O)C2=CC(=C1)F	ChemieTek	CT-LR001_cm1	-3.14479638	-3.76824613	-4.3647736	2.41896931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387824-01	NCGC00387824-01	384569163		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1061318-81-7		0.3548133892	-6.45	-82.0323042548	-1.4	4		-38.3121638956	-37.24065398	0.1960397477	0.9755609866		HSP90AB1	CN(C)C1=CC2=C(OCO2)C=C1SC3=NC4=C(C=CN=C4N)[N]3CCNCC(C)(C)C	ChemieTek	CT-CU305	-5.56108597	-26.22501684	-30.99759779	-37.24065398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161703-03	NCGC00161703-03	363676607		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			5.6234132519	-5.25	-87.1599610917	-2.4	4		-42.1239153969	-47.62405584	0.0552835133	0.9981120365		IKBKB	COC1=CC=CC2=C1C(=NC(=N2)C3=CC=CS3)NN4C(=O)\C=C(C)/C4=O	NCGCChem	DYD029-046	-10.73755656	-10.19986526	-24.34392422	-47.62405584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390670-01	NCGC00390670-01	363680965		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1588521-78-1		12.5892541179	-4.9	11.6471077026	4	4		15	12.16177455	0.060060508	0.9977910923		BRD4	CC1=NN=C(C[C@@H]2\C=C(C3=CC=C(Cl)C=C3)/C4=CC=CC=C4[N]5C(=NN=C25)C)O1	MedChem Express	HY-12421 	0.4479638	0.95665843	1.06513167	12.16177455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015834-27	NCGC00015834-27	384567897		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	125-33-7				-25.9270630102	4	4		0	-2.76266819					CCC1(C(=O)NCNC1=O)C2=CC=CC=C2	MedChem Express	HY-B0339	-7.77197486	-2.21564445	-3.52941176	-2.76266819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509987-01	NCGC00509987-01	384569396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1346623-17-3				-19.9127178688	4	4		0	-2.11375131					CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C3=CC=C(NC4CCCC4)C=C3)C(=O)C5=C(C)C=CC=C5F)C=C1C(F)(F)F	MedChem Express	HY-17627	-6.87793219	-2.70317329	1.60251755	-2.11375131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345847-02	NCGC00345847-02	377020179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	(951151-97-6)				-16.692028683	4	4		0	-3.1028326				FLT1	CCNC(=O)NC1=C(Cl)C=C(OC2=C(\C=N\OC)C(=NC=N2)N)C=C1	SynKinase	SYN-1133	-4.80916719	-2.99323386	0	-3.1028326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509944-01	NCGC00509944-01	384569392		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1492952-76-7		8.9125093813	-5.05	-62.1593597089	-3	4		-56.6224510973	-60.19881291	0.0295911942	0.9994597077	25	ABL1	O[C@@H]1CCN(C1)C2=NC=C(C=C2C3=CC=N[NH]3)C(=O)NC4=CC=C(OC(F)(F)Cl)C=C4	ChemGood	C-1325	-3.75349635	-5.32329614	-5.52168187	-60.19881291												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164626-07	NCGC00164626-07	384568269		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	145821-59-6				-10.6949163771	4	4		0	-2.84664403				SLC6A1	CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3	MedChem Express	HY-B0696A	-3.0990641	-1.13656623	0.20165072	-2.84664403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238453-16	NCGC00238453-16	384568466		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	761439-42-3		8.9125093813	-5.05	-122.0895304519	-2.3	4		-125.2235961812	-99.64184381	0.1134105356	0.9919826834		ALK	COC1=CC(=CC=C1NC2=NC(=C(Cl)C=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-10192	-3.16969804	-17.19112141	-39.35002814	-99.64184381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093347-12	NCGC00093347-12	384568112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	72-33-3				-3.3583892108	4	4		0	2.93461228				ESR1	COC1=CC=C2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCC2=C1	MedChem Express	HY-B0390	-2.2125642	1.00626629	-0.86574074	2.93461228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378617-04	XL 413 hydrochloride	384569057	Serine/threonine-protein kinase PIM1  Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[1169562-71-3]		3.9810717055	-5.4	-8.7016336099	4	4		-14.17119954	-11.80933295	0.2503164892	0.9595330505			ClC1=CC=C2OC3=C(\N=C(NC3=O)\[C@@H]4CCCN4)C2=C1	Tocris	5493	0.44259538	3.66952509	-5.1077221	-11.80933295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387870-04	NCGC00387870-04	384569165		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1047634-65-0		8.9125093813	-5.05	-72.7798779471	-2.3	4		-132.2980246139	-97.95304895	0.2362096769	0.9639268372			C[N]1N=CC(=C1C2=C(Cl)OC(=C2)C(=O)NC(CN)CC3=CC(=C(F)C=C3)F)Cl	MedChem Express	HY-15965	10.6134372	-13.49845471	-24.65746793	-97.95304895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346642-04	NCGC00346642-04	384568875		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	477575-56-7		11.220184543	-4.95	-87.5617551052	-3	4		-107.4489836849	-99.68031301	0.05052206	0.9984224122		MET	CC1=C(C(=C([NH]1)/C=C/2C(=O)NC3=C2C=C(C=C3)[S+]([O-])(=O)CC4=C(Cl)C=CC=C4Cl)C)C(=O)N5CCC[C@@H]5CN6CCCC6	Selleck	S1070	-4.24006373	0.4831759	-3.67465505	-99.68031301												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263235-01	NCGC00263235-01	137276079		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	n	ACC1 BMS	1	-6	-51.5834040744	-1.2	4		-38.2792066812	-35.44370989	0.0475149613	0.9986062235	31	ACACA	CC(C)OC1=CC=C(OC2=CC=C(C=C2)C(C)NC(C)=O)C=C1	NCGCChem	ACC1 BMS	2.65271136	-28.19375364	-33.80322911	-35.44370989												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00379246-01	NCGC00379246-01	363678445		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[328087-38-3]		10	-5	-69.2091161284	-3	4		-82.0480985464	-72.76371102	0.0664202521	0.9972695162		AHR	CC1=CC(=CC=C1NC(=O)[C@@H](N)CCCCN)C2=NC3=CC(=CC=C3S2)F	Tocris	4995	-3.74152734	0.58511362	-8.12380016	-72.76371102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178638-13	Valaciclovir	384568359	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	124832-27-5				-9.9376576135	4	4		0	1.81792156					CC(C)[C@H](N)C(=O)OCCOC[N]1C=NC2=C1\N=C(N)/NC2=O	MedChem Express	HY-17425A	-4.49676905	-0.13494102	0.40183975	1.81792156												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274064-02	NCGC00274064-02	384568710		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	2152-44-5				-5.0249841631	4	4		0	-1.98015078				NRC31	CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO	Selleck	S1690	-0.76126405	-3.83493666	1.54442024	-1.98015078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345806-02	NCGC00345806-02	384568752		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	302566-08-1	Cathepsin S Inhibitor			-10.5438181644	4	4		0	-0.75459002				CTSS	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)C=O	EMD Chemicals	219393_cm1	-3.62350862	-1.88558352	0.84575487	-0.75459002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346736-01	NCGC00346736-01	174007287		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	58-20-8	Testosterone cypionate			-17.9880074069	4	4		0	-0.79186626			374	AR	C[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC5CCCC5	Selleck	S1700	-4.88929056	-2.82578129	-4.20002809	-0.79186626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025195-09	NCGC00025195-09	384568055		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	78712-43-3				-13.8332295202	4	4		0	-1.92589696				TBXA2R	OC(=O)/C=C/C1=CC=C(C[N]2C=CN=C2)C=C1	Selleck	S2067	-4.56394035	-2.33591872	1.27826942	-1.92589696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263122-02	NCGC00263122-02	363677213		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	851776-28-8				-11.0873909741	4	4		0	1.43709062				NIACR1	C1CC2=C(C1)C(=N[NH]2)C3=N[NH]N=N3	Axon Medchem	1576	-3.39810212	-2.81670976	-2.16790748	1.43709062												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475723-01	NCGC00475723-01	377020299		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1169694-98-7				-16.0285914788	4	4		0	-8.63291994				CDK4	CN(CCO)C1CCN(CC1)C2=CC=C(NC3=NC=C4C5=CC=NC(=C5[N](C6CCCC6)C4=N3)F)N=C2	ActiveBioChem	A-1611	-0.80303167	-4.40919478	-2.98522023	-8.63291994												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378734-08	NCGC00378734-08	384569066		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	722543-31-9		2.8183829313	-5.55	-35.0718835339	4	4		-11.457869356	-16.32702105	0.1245539467	0.9903962514		AURKB	CCN(CCCOC1=CC2=NC=NC(NC3=NNC(CC(=O)NC4=CC=CC(F)=C4)=C3)=C2C=C1)CCOP(O)(O)=O	MedChem Express	HY-10127_cm3	-3.86212992	-5.51029748	-13.09751881	-16.32702105												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510350-01	NCGC00510350-01	384569428		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			1	-6	-160.6662785173	-1.2	4		-54.7282794957	-68.45243914	0.0338362021	0.9992934665		TUBB	COC1=CC=C(C=C1)[S+]([O-])(=O)N2CCC3=C2C(=CC=C3)C4=CC=NC=C4	Axon Medchem	2658	-14.83958427	-36.22715109	-66.22184764	-68.45243914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094087-07	NCGC00094087-07	384568124		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	50924-49-7				-0.2073568843	4	4		0	0.76253788				IMPDH1	NC(=O)C1=C(O)[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Selleck	S1384	0.76818798	-2.19077426	-1.72777075	0.76253788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496795-01	NCGC00496795-01	384569291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			7.0794578438	-5.15	-70.7111082472	-2.2	4		-50.3718262053	-51.82754491	0.039387575	0.9990424823			CNC(=O)C[N]1C=C(C=N1)C2=CC3=C(C=C2)C4(CC3F)NC(=O)N(CC(=O)N(CC5=CC=C(F)C=C5)C(C)C(F)(F)F)C4=O	ChemoGenics	CG-JDN-274-2	-6.5605039	-5.45044423	-16.32583998	-51.82754491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242486-04	NCGC00242486-04	384568494		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	935666-88-9, 1260222-79-4 (TFA)		8.9125093813	-5.05	-99.9689276961	-2.4	4		-96.3472182244	-79.26706587	0.1074894873	0.9928066364		JAK1	C[C@H](NC1=NC(=C(Cl)C=N1)NC2=N[NH]C(=C2)C)C3=NC=C(F)C=N3	Selleck	S2162	-3.98775727	-13.80104037	-29.89122553	-79.26706587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168114-09	NCGC00168114-09	363676679		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	371242-69-2				-20.1250552268	4	4		0	-7.30077862				PIK3CA	CC1=CC=CC=C1N2\C(=N/C3=C(C(=CC=C3)C)C2=O)C[N]4C=NC5=C4N=CN=C5N	ChemieTek	CT-IC871	-2.00618648	-6.33409611	-7.32208775	-7.30077862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00686694-01	Remdesivir			SARS-CoV-2_CPE_SRI		1809249-37-3				-9.3812632669	4	10		0	-1.604215					CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077	0.27523296	-2.22545512	2.96465222	-1.39189242	-1.28179924	-5.4889317	-2.06817914	-6.20453741	-0.18873118	-1.604215						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	SARS-CoV-2_CPE_SRI		192725-17-0		0.0702306445	-7.1534733462	-230.6782682077	-2.2	10		-96.9665985167	-76.86863524	0.0000210314	0.9831107291			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204	-3.43648016	-0.60551252	-5.73270947	4.7575984	-4.66323281	-5.02496756	0.14941218	-2.95678842	-11.0014548	-76.86863524						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378936-01	Letermovir	363678286	Tripartite terminase subunit UL28 homolog Inhibitor	SARS-CoV-2_CPE_SRI		917389-32-3				-25.9486555813	4	10		0	-6.67636535			3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-6.11803562	-4.41159124	-4.16781347	-1.11665946	-1.93449455	-2.05245154	-1.5884874	-6.50336177	2.80737624	-6.67636535						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00095196-07	TILORONE			SARS-CoV-2_CPE_SRI		27591-69-1, 27591-97-5 [tilorone]				-40.8692836524	4	10		0	-10.77340463					CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009	-10.87563402	-2.20186372	1.66712539	-3.09833681	-3.20842999	-4.04985649	-2.54787088	-6.54268077	-6.77859474	-10.77340463						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00250412-15	JQ1		Brd4 Inhibitor	SARS-CoV-2_CPE_SRI		1268524-70-4		0.0001979368	-9.7034733462	-423.8326642621	-1.2	10		-77.3146463233	-83.52140919	0.0001456248	0.9699776045		BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030	-36.35434278	-56.85526678	-69.12279322	-72.37054221	-78.07179648	-78.81099359	-78.83458499	-78.57507962	-74.0062124	-83.52140919						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00070736-17	Imiquimod	384568073	TLR 7 Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	99011-02-6				-15.242945567	4	4		0	-1.23179196				TLR7	CC(C)C[N]1C=NC2=C(N)N=C3C=CC=CC3=C12	MedChem Express	HY-B0180	-3.80478988	-2.58992153	-5.10839537	-1.23179196												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016599-10	NCGC00016599-10	384567951		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	2022-85-7				-4.2056810834	4	4		0	-2.52224069				TYMS	NC/1=N/C(=O)N/C=C1F	MedChem Express	HY-B0139	-0.83145052	0.33111081	-0.61338203	-2.52224069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346976-02	NCGC00346976-02	384568979		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-16.0574082379	4	4		0	-0.36171669				USP1	C(C(C([2H])([2H])[2H])(C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NC(C3=CC=C(C=C3)[N]4C=CN=N4)([2H])[2H])[2H])([2H])([2H])[2H]	NCGCChem	DKL016-046	-3.47040217	-3.19771397	-6.70974388	-0.36171669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016107-09	NCGC00016107-09	363676477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1021868-92-7				-31.4540665304	4	4		0	-6.12963144				JAK1	CC(C)N(CCC(=O)C1=CC=C2C=CC=CC2=C1)CC3=CC=CC=C3	Selleck	S8004	-7.6728423	-5.48373928	-4.93046776	-6.12963144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379060-01	NCGC00379060-01	363678333		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	902156-99-4		11.220184543	-4.95	-84.5616824799	-2.2	4		-85.7784236535	-78.16013296	0.0351239841	0.999238427		CDK1	C[S+]([O-])(=O)N1CCC(CC1)NC(=O)C2=C(NC(=O)C3=C(Cl)C=CC=C3Cl)C=N[NH]2	MedChem Express	HY-15241	-5.16945323	-7.47040414	-11.04555883	-78.16013296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016488-15	NCGC00016488-15	384567945		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	525-79-1				-13.4206407232	4	4		0	-0.59634373					C(NC1=C2[NH]C=NC2=NC=N1)C3=CC=CO3	APExBIO	A3528	-2.95526435	-2.80763823	-4.9585616	-0.59634373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015680-33	NCGC00015680-33	384567881		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	73-31-4				-16.8896187796	4	4		0	-1.74015055				MTNR1B	COC1=CC2=C([NH]C=C2CCNC(C)=O)C=C1	MedChem Express	HY-B0075	-5.07907817	-3.73293419	-0.01404692	-1.74015055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00343773-03	NCGC00343773-03	384568715		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	n				4.1489412215	4	4		0	0.35194056			29943	PADI1	CN(C)C1=CC=C2C=C(C=CC2=C1)C(=O)N[C@@H](CCCNC(=N)CCl)C(=O)NCC3=CC=CC=C3	NCGCChem	JKJ27-003	0.62358789	0.46718374	2.81406565	0.35194056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183881-01	NCGC00183881-01	124894598		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	192927-63-2	Moxifloxacin hydrochloride monohydrate	12.5892541179	-4.9	-39.1093965976	-3	4	BAY-12-8039;MOXIFLOXACIN HCl;HS_149;Moxifloxacin Hydrochloride;MOXIFLOXACIN HYDROCHLORIDE;Moxifloxacin hydrochloride;LS-173737;CIPLUS_730447;AVELOX;CIPLUS_678948;1-CYCLOPROPYL-7-((S,S)-2,8-DIAZABICYCLO(4.3.0)NON-8-YL)-6-FLUORO-8-METHOXY-1,4-DIHYDRO-4-OXO-3-QUINOLINE CARBOXYLIC ACID HYDROCHLORIDE;moxifloxacinum;Avelox;moxifloxacine;Moxifloxacin;MOXIFLOXACIN;NCGC00095130-02;Moxifloxacin Hcl;NCGC00095130-01;	-44.068862272	-39.64071856	0.1024210959	0.9934787805	7155	TOP2B	Cl.O.O=C(O)C2=CN(c1c(OC)c(c(F)cc1C2=O)N3C[C@@H]4CCCN[C@@H]4C3)C5CC5	Toronto Research	M745000	-3.41110717	0.28541178	-1.38747885	-39.64071856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346531-02	NCGC00346531-02	363677443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	579-13-5		12.5892541179	-4.9	-99.937691724	-3	4		-105.3160910211	-99.55928144	0.1103163936	0.9924182609			CC[C@@H]\1CC[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)/C=C/[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@](C)(O)[C@@H](O)[C@H](C)C/C=C\C=C1)[C@@H]2C	Selleck	S1478	-9.04453513	-4.2719698	0.79767948	-99.55928144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247029-02	NCGC00247029-02	174006875		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	154-17-6	2-Deoxyglucose			-0.0269709816	4	4		0	-1.92567096					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	SIGMA	D3179	0.08829242	3.4096987	-1.71168636	-1.92567096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271534-03	NCGC00271534-03	174006849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	105816-04-4	Nateglinide (Starlix)			-9.001018978	4	4		0	-2.30708405					CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(O)=O	Selleck	S2489	-2.03072576	-1.62684971	-1.36465954	-2.30708405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090851-17	NCGC00090851-17	384568089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	320-67-2		7.0794578438	-5.15	-61.6752906559	-2.2	4		-72.413819954	-62.73802175	0.0191836667	0.9997730101		DNMT1	NC/1=N/C(=O)N(/C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Adooq	A10105	-0.33364063	-0.70438641	-19.22685185	-62.73802175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165863-16	NCGC00165863-16	384568291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	219580-11-7		11.220184543	-4.95	-54.8141476248	-3	4		-74.6180579772	-58.97715941	0.0836907631	0.9956563902		FGFR1	CCN(CC)CCCCNC1=NC=C2C=C(C(=NC2=N1)NC(=O)NC(C)(C)C)C3=CC(=CC(=C3)OC)OC	MedChem Express	HY-10321	-0.19316037	-4.79348671	-9.85648148	-58.97715941												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024246-16	NCGC00024246-16	384568022		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	23541-50-6		10	-5	-129.0608469424	-2.3	4		-109.3428984407	-95.43663042	0.1274899363	0.9898401623		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(=C3C2=O)O	Selleck	S3035	-8.43759603	-19.60389699	-32.16203704	-95.43663042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263237-09	JZL-184	384568681	Monoacylglycerol lipase (MAGL) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox					-11.119996652	4	4		0	-4.36867847				MGLL	OC(C1CCN(CC1)C(=O)OC2=CC=C(C=C2)[N+]([O-])=O)(C3=CC4=C(OCO4)C=C3)C5=CC=C6OCOC6=C5	SIGMA	J3455	-2.34426445	-0.61290765	-2.06018519	-4.36867847												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370832-01	NCGC00370832-01	377020311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	3352		11.220184543	-4.95	-83.0489446358	-3	4		-116.2739900132	-97.33244096	0.0445833254	0.998772085		EGFR	NC1=C(\C=N\OCCN2CCOCC2)C(=NC=N1)NC3=CC(=C(OCC4=CC=CC=C4)C=C3)Cl	Tocris	3352	-0.23076923	-4.32517404	-9.56805511	-97.33244096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476204-01	NCGC00476204-01	363681102		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[900305-37-5]		8.9125093813	-5.05	-25.9734956211	4	4		-26.000326188	-23.86461421	0.0452861877	0.9987363738		BRPF1	COC1=C(C=CC=C1)C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCC4	Tocris	5576	-1.74208145	-0.94767572	-4.3285138	-23.86461421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091861-13	NCGC00091861-13	384568100		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	891986				-10.1068865527	4	4		0	-5.89273786					CN(C)/N=N/C1=C([NH]C=N1)C(N)=O	Enzo	DL371	-0.79667168	-4.57493579	-0.67296054	-5.89273786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015482-15	NCGC00015482-15	384567857		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	65-29-2				-19.0914539893	4	4		0	-4.59490409				ACHE	CC[N+](CC)(CC)CCOC1=CC=CC(=C1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC	MedChem Express	HY-B0416	-4.80658582	-3.89587777	-0.94408134	-4.59490409												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096095-02	NCGC00096095-02	26753806		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	34408-14-5				-5.8708198706	4	4	LS-174469;8-chloroadenosine;NCGC00096095-01;Kolibri-C 006;8-Chloroadenosine (8-Cl-Ado);CIPLUS_725292;	0	-2.86764004			7015	TERT	NC1=NC=NC2=C1N=C(Cl)[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Timtec	ST5298846	-3.0362043	1.22317503	4.53643186	-2.86764004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510233-01	NCGC00510233-01	384569418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1923833-60-6		12.5892541179	-4.9	-53.136510646	-3	4		-66.2143233549	-59.83712575	0.2064785628	0.9727529582		IDO1	C[C@H]([C@H]1CC[C@H](CC1)C2=CC=NC3=CC=C(F)C=C23)C(=O)NC4=CC=C(Cl)C=C4	ChemGood	C-1360	-5.18541519	0	6.90838772	-59.83712575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015242-16	NCGC00015242-16	384567829		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	58-94-6				-21.4586627442	4	4		0	-2.30419162					N[S+]([O-])(=O)C1=C(Cl)C=C2\N=C/N[S+]([O-])(=O)C2=C1	Microsource	01500180	-6.90649397	-3.03825438	0.03384095	-2.30419162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015226-17	NCGC00015226-17	384567827		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	53-19-0		14.1253754462	-4.85	-22.8002528261	4	4		-13.37901994	-14.23233533	0.2001582741	0.9746845939			ClC(Cl)C(C1=CC=C(Cl)C=C1)C2=C(Cl)C=CC=C2	Microsource	00330082	-3.65951029	-2.61474014	-1.41648538	-14.23233533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345829-03	NCGC00345829-03	377020285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	260415-63-2		0.2511886432	-6.6	-194.2767020219	-1.4	4		-47.7762190319	-63.80761896	0.1041808101	0.9932494429		SRC	CSC1=CC(=CC=C1)NC2=NC3=C(C=N2)/C=C(C(=O)N3C)/C4=C(Cl)C=CC=C4Cl	MedChem Express	HY-10395	-21.76408264	-67.030665	-63.17295067	-63.80761896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165880-14	NCGC00165880-14	377020303		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	656820-32-5		4.4668359215	-5.35	-93.1079537082	-2.4	4		-77.3558133879	-57.8910647	0.0850373312	0.9955155175		ADORA3	C1CCC(CC1)NC2=C3N=C[NH]C3=NC(=N2)NC4=CC=C(C=C4)N5CCOCC5	MedChem Express	HY-14711	-5.05032668	-18.14494562	-34.70737198	-57.8910647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241342-03	NCGC00241342-03	377020353		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			11.220184543	-4.95	-48.4277190011	-2.4	4		-51.3259086231	-42.54151356	0.0698028435	0.9969852365		CLK1	ClC1=CC(=CC(=C1)CNC2=C(C=NC=N2)C3=CC4=C(OCO4)C=C3)Cl	Evotec	MLS004256649	-2.35740773	-5.10340524	-10.07784656	-42.54151356												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390582-04	NCGC00390582-04	384569197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	784210-88-4		0.2511886432	-6.6	-145.2384302828	-1.4	4		-54.4893380591	-40.64375087	0.5591312198	0.7384356114		CDK1	COCCN1CCN(CC1)CC2=CC=C(C=C2)C3=N[NH]C4=C3C(=O)C5=C4C=CC=C5NC(=O)NN6CCOCC6	MedChem Express	HY-15504A	-8.7144623	-76.05188091	-56.43875446	-40.64375087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345791-06	NCGC00345791-06	384568744		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1097917-15-1		11.220184543	-4.95	-81.4892808923	-2.1	4		-104.4573104717	-82.13115533	0.0053599125	0.9999822824		ALK	COC1=CC(=CC=C1NC2=NC=NC(=N2)NC3=CC=CC=C3[S+]([O-])(=O)C(C)C)N4CCC(CC4)N5CCN(C)CC5	APExBIO	A3193	-2.87984547	-3.57681928	-14.66203704	-82.13115533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344623-17	NCGC00344623-17	384568726		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1415800-43-9				-10.4546134273	4	4		0	-0.64580464				L3MBTL3	O=C(N1CCC(CC1)N2CCCC2)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6	Selleck	S7088	-2.94130559	-3.98847368	0.46759259	-0.64580464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378919-01	NCGC00378919-01	363678276		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	894787-30-5		11.220184543	-4.95	-33.3721266305	-2.4	4		-32.540582892	-25.86067715	0.0340491286	0.9992861755		MYD88	NC(=O)[C@H]1CCS[C@@H]2C[C@]3(CCCN3C(=O)CC4=CC=C(NC(=O)COC5=CC=C(Cl)C=C5Cl)C=C4)C(=O)N12	MedChem Express	HY-50937	-2.49352474	-3.4213054	-7.56018519	-25.86067715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387769-02	Gardiquimod	363680656	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1020412-43-4				-16.3640745887	4	4		0	-4.20364539			51284	TLR7	CCNCC1=NC2=C([N]1CC(C)(C)O)C3=C(C=CC=C3)N=C2N	Bio Vision	2002	-3.1512791	-5.03634702	-2.3674655	-4.20364539												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510231-01	GDC-0077	384569416	PARP inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			11.220184543	-4.95	-39.3196104796	4	4	Pamiparib	-13.534957176	-18.32713045	0.179512163	0.9797878745		PARP1	C[C@]12CCCN1C/C3=N/NC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F	ChemGood	C-1286	-5.79799947	-7.76128499	-7.7124183	-18.32713045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025228-15	NCGC00025228-15	384568060		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	82-08-6				3.3266761921	4	4		0	5.10179641					CC(=O)C1=C(O)C(=C(O)C(=C1O)C)CC2=C(O)C(=C3OC(C)(C)\C=C/C3=C2O)C(=O)/C=C/C4=CC=CC=C4	Cayman	12006	-2.71912704	6.37112738	2.8668117	5.10179641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508985-02	NCGC00508985-02	384569373		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1642300-52-4		11.220184543	-4.95	-150.4008678761	-2.3	4		-99.6039834545	-94.69188824	0.1103843505	0.9924096723		XPO1	NC(=O)C(=C/[N]1C=NC(=N1)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)/C3=CN=CN=C3	MedChem Express	HY-100423	-16.00649644	-24.23264776	-31.20823374	-94.69188824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346578-08	NCGC00346578-08	384568849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	183320-51-6		11.220184543	-4.95	-88.0775189692	-2.3	4		-88.1015754085	-81.49881774	0.0793717591	0.9960946508		EGFR	COCCOC1=CC2=C(C=C1OCCO)C(=NC=N2)NC3=CC=CC(=C3)C#C	MedChem Express	HY-13256	-4.65577912	-10.24331227	-11.6091898	-81.49881774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263174-02	NCGC00263174-02	384568644		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	336113-53-2		11.220184543	-4.95	-171.3258348137	-3	4		-96.6739987463	-99.45953771	0.0145784793	0.9998689087		KIF11	CC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C/2=N/C3=CC(=CC=C3C(=O)N2CC4=CC=CC=C4)Cl	Selleck	S1452	-22.72850311	-23.9279473	-31.79357105	-99.45953771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253438-12	NCGC00253438-12	384568561		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	755038-02-9		1.995262315	-5.7	-145.1370539807	-2.3	4		-107.3775613875	-96.8789246	0.0651874056	0.997369998		PLK1	CC[C@H]1N(C2CCCC2)C3=NC(=NC=C3N(C)C1=O)NC4=CC=C(C=C4OC)C(=O)NC5CCN(C)CC5	MedChem Express	HY-50698	-1.52745894	-21.9869852	-76.48189833	-96.8789246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486904-01	MRT-68601 hydrochloride	377020217	IKK-epsilon Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			8.9125093813	-5.05	-50.3489380245	-3	4		-63.3497604504	-55.94678822	0.0708304341	0.9968938875		IKBKE	O=C(NCCCNC1=C(C=NC(=N1)NC2=CC=C(C=C2)N3CCOCC3)C4CC4)C5CCC5	Tocris	5067	-1.79233622	1.69816367	-7.35790658	-55.94678822												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378635-03	NCGC00378635-03	384569060		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	38647-11-9		0.2511886432	-6.6	-290.4669953183	-1.3	4		-63.26327205	-91.14392896	0.0691150599	0.997042932			CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CC\C6=C(COC6=O)/[C@@H]5C[C@@H]7O[C@]47C2=O	MedChem Express	HY-32736	-35.53272751	-94.65306683	-93.63425926	-91.14392896												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390255-01	Maslinic acid	384569181	Glycogen Phosphorylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	4373-41-5		12.5892541179	-4.9	-44.0399047382	-3	4		-60.981029484	-54.8079206	0.1330715295	0.9889199311		PYGL	CC1(C)CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Adooq	A12089	-2.37938452	-0.13721813	4.43055556	-54.8079206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345781-01	NCGC00345781-01	174006953		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	69123-94-0	1-(2 -Deoxy-2 -fluoro-b-D-arabinofuranosyl)uracil			-6.3613010085	4	4		0	2.21283062					OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N2\C=C/C(=O)NC2=O	Carbosynth	ND06062	-2.72180517	-1.50025157	-0.02314815	2.21283062												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015038-11	NCGC00015038-11	384567800		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	54-62-6, 58602-66-7 [aminopterin sodium]				6.8172932591	4	4		0	1.74747139				DHFR	NC1=NC2=NC=C(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N=C2C(=N1)N	Microsource	01500679	2.59888494	-2.7535105	1.14351852	1.74747139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378974-02	NCGC00378974-02	377020266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1225278-16-9		11.220184543	-4.95	-40.9178499081	-3	4		-41.8102809125	-41.57185199	0.0227081978	0.999682054		PDGFRA	C[N]1C=C(C=N1)C2=CC(=CC=N2)OC3=C(F)C=C(NC(=O)C4(CC4)C(=O)NC5=CC=CC=C5)C(=C3)F	MedChem Express	HY-15240	-2.66515837	-2.15135863	-2.19825046	-41.57185199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389632-06	NCGC00389632-06	384569178		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	183204-72-0				-13.0595538168	4	4		0	-3.10621242					ClC\1=C(/CN2CCCC2=N)NC(=O)NC1=O	MedChem Express	HY-A0063	-1.82349296	-5.81987551	-2.88065844	-3.10621242												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356071-11	NCGC00356071-11	384569026		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1446144-04-2		0.2818382931	-6.55	-275.582757122	-1.2	4		-74.9639865093	-89.95610268	0.0217539754	0.9997081239			CC1=C(C)C\2=C(S1)[N]3C(=NN=C3[C@H](CC(N)=O)\N=C2C4=CC=C(Cl)C=C4)C	MedChem Express	HY-15846	-36.0538196	-78.27884908	-88.08036795	-89.95610268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370979-01	NCGC00370979-01	363677973		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	3920				-18.8098669748	4	4		0	-4.32852386				MAPK14	CN\1C(=O)/C(=C(\N=C1NC[C@@H](N)CC2=CC=CC=C2)C3=CC=NC=C3)C4=CC5=C(C=CC=C5)C=C4	Tocris	3920	-2.3730037	-5.90581171	-7.70694112	-4.32852386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095042-08	NCGC00095042-08	174006555		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	52-24-4	;Thiotepa; THIOTEPA;Tris(aziridinyl)phosphine sulfide;Thio-TEPA; Thiofozil; Thio-Tep; ; Tiotepa; Tiofosyl; Tris(aziridinyl)phosphine sulfide; Tiofosfamid; Thio Tep; Tespamin; Thiopeta; Tespa; Girostan; Tiofozil;THIOTEPA; Thiotef; Thio-TEPA; Tio-tef	3.1622776602	-5.5	-17.239691073	4	4		-18.8630633999	-13.2192195	0.3755628982	0.9024937466			S=[P](N1CC1)(N2CC2)N3CC3	Microsource	MS-01503324	0.46794985	-5.78088786	-6.45751266	-13.2192195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509904-02	NCGC00509904-02	384569375		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	946128-88-7				-75.0382749449	4	4		0	-19.36834271				BRAF	CN[S+]([O-])(=O)NC1=NC=CC(=C1F)CC/2=C(C)/C3=CC=C(OC4=NC=CC=N4)C=C3OC2=O	MedChem Express	HY-18652	-13.04962034	-20.88161883	-18.08760083	-19.36834271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016229-20	NCGC00016229-20	384567923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	51-52-5		2.8183829313	-5.55	21.6853978518	4	4		14	0.70278741	1	0.999373838		TPO	CCC\C1=C\C(=O)NC(=S)N1	MedChem Express	HY-B0346	1.22920234	1.0794493	12.30092593	0.70278741												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345447-10	NCGC00345447-10	384568734		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	5142-23-4				-1.6783430957	4	4		0	-0.48435348				PIK3CA	C[N]1C=NC(=C2N=CN=C12)N	Enzo	AP502	0.13170025	-1.13433655	-1.49537037	-0.48435348												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346554-01	NCGC00346554-01	174006708		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	948557-43-5	Tie2 kinase inhibitor	12.5892541179	-4.9	-87.2986169083	-3	4		-102.5467601166	-92.73944632	0.0068995092	0.9999706398	7010	TEK	COC1=CC2=C(C=C1)C=C(C=C2)C3=C(N=C([NH]3)C4=CC=C(C=C4)[S+](C)[O-])C5=CC=NC=C5	Selleck	S1577	-4.40756837	-4.55564195	-5.06944444	-92.73944632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346534-03	NCGC00346534-03	384568824		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[852475-26-4]		10	-5	-23.7438185425	4	4		-38.06719218	-29.22266015	0.0938103614	0.9945412931		HDAC2	C[N]1C=C(/C=C/C(=O)C2=CC=CC(=C2)F)C=C1\C=C\C(=O)NO	Tocris	4077	1.33456254	-1.54599094	-6.05092593	-29.22266015												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386141-07	NCGC00386141-07	384569112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	592542-60-4		1	-6	-222.6655373397	4	4		-29.1151182259	-61.12439048	0.3342873298	0.9241405926		TUBB	COC1=CC(=C(\C=C\[S+]([O-])(=O)CC2=CC=C(OC)C(=C2)NCC([O-])=O)C(=C1)OC)OC	MedChem Express	HY-12037	-37.59728507	-44.29822592	-71.54512079	-61.12439048												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346567-12	NCGC00346567-12	377020162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	869357-68-6				-128.3302504556	4	4		0	-29.03719285				MAP2K1	CN1C(=O)\C(=C/C(=C1/NC2=C(F)C=C(I)C=C2)C(=O)NOCCO)C	MedChem Express	HY-12058	-24.54751131	-32.45003369	-30.41744096	-29.03719285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179363-05	NCGC00179363-05	384568372		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	128-13-2				-8.028746094	4	4		0	-3.23981296					C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Selleck	S1643	-1.91201204	0.2655291	-1.3023481	-3.23981296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00489873-03	NCGC00489873-03	384569285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1607837-31-9		14.1253754462	-4.85	-3.9732619695	4	4		-19.067099356	-13.80591613	0.2764831553	0.949904424		CDK8	C[N]1N=CC2=C1C=CC(=C2)C3=CN=C(N)C(=C3N4CCC5(CCNC5=O)CC4)Cl	MedChem Express	HY-19984	0.57746098	1.94470583	5.02414516	-13.80591613												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496841-01	NCGC00496841-01	384569295		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	935273-79-3				-27.3661290078	4	4		0	-2.72643922				SMO	C[N]1C(=NN=C1C23CCC(CC2)(CC3)C4=NOC(=N4)C5CC(F)(F)C5)C6=CC=CC=C6C(F)(F)F	Selleck	S8200	-6.69493819	-6.47040373	-5.30705819	-2.72643922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015243-14	NCGC00015243-14	384567830		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1163-36-6				-36.6264408675	4	4		0	-10.0902379					ClC1=CC=C(C[N]2C(=NC3=C2C=CC=C3)CN4CCCC4)C=C1	Prestwick	Prestw-227	-6.37913922	-10.19850338	-8.10692161	-10.0902379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164619-06	NCGC00164619-06	384568267		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	120511-73-1				-0.0764474773	4	4		0	-0.4465324				CYP19A1	CC(C)(C#N)C1=CC(=CC(=C1)C[N]2C=NC=N2)C(C)(C)C#N	Selleck	S1188	1.07716758	-1.19896595	-2.3682236	-0.4465324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263195-04	NCGC00263195-04	377020296		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	451492-95-8		10	-5	-104.4732024683	-2.1	4		-114.3222623267	-99.60799312	0.0395924194	0.9990319612		EGFR	CN1CCN(CC1)C(C)(C)C#CC2=C(NC(=O)C=C)C=C3C(=NC=NC3=C2)NC4=CC(=C(F)C=C4)Cl	MedChem Express	HY-10346A	-4.42081448	-8.11587694	-18.68739519	-99.60799312												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167565-02	NCGC00167565-02	384568329		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	51460-26-5				2.8070697788	4	4		0	1.45329381					CN1C(CC\2=C\C(=N\NC(N)=O)C(=O)\C=C12)[S]([O-])(=O)=O	Selleck	S3000	1	0.42667864	-1.61809364	1.45329381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346671-06	NCGC00346671-06	384568897		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	875446-37-0		3.1622776602	-5.5	7.7756612856	4	4		12.3900666	-0.94951808	1	0.9504667026		CETP	COC1=CC(=C(C=C1C2=CC=C(C=C2CN3[C@@H](C)[C@H](OC3=O)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C)F	MedChem Express	HY-12090	-0.45144729	-2.8250555	7.53812636	-0.94951808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015819-17	NCGC00015819-17	384567894		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	34183-22-7				-14.7004042314	4	4		0	-5.78776601					CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2	Selleck	S2500	-2.55820129	-3.91328951	-1.58315178	-5.78776601												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263092-02	NCGC00263092-02	384568584		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	287405-51-0				-36.5357198588	4	4		0	-10.82641473				TNF	CC1(C)SCCN([C@H]1C(=O)NO)[S+]([O-])(=O)C2=CC=C(OCC#CCO)C=C2	Axon Medchem	1507	-6.70974595	-9.65916511	-6.52142338	-10.82641473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508855-01	NCGC00508855-01	384569363		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	954126-98-8				-13.1530927312	4	4		0	-1.51039907				CXCR2	CC1=C(NC(=O)NC2=CC=C(Cl)C(=C2O)[S+]([O-])(=O)[C@H]3CCCNC3)C=CC=C1F	Bio Vision	B1103	-2.83316791	-4.36438589	-2.48768353	-1.51039907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249613-10	NCGC00249613-10	384568530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	868540-17-4		0.1	-7	-399.5851155304	5	4		-80.1708903916	-98.8225643	0.0930292133	0.9946365776		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	ActiveBioChem	A-1098	-74.49246594	-96.91266747	-96.9416126	-98.8225643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499576-01	NCGC00499576-01	384569308		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1024007-21-3		1.1220184543	-5.95	-189.7027456312	-1.1	4		-87.2948078056	-99.50779327	0.0388574843	0.9990676063		HDAC1	ONC(=O)C1=CC=C(C=C1)C/2=N/C3=CC=CC=C3OC4=C2C=CC=C4	Organix	O-10099	-11.35071731	-27.71877941	-95.80996049	-99.50779327												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185916-05	NCGC00185916-05	384568429		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1203494-49-8	 NCGC00185916;NCGC00185916			-13.6084716335	4	4		0	-3.7676171			5315	PKM2	NC1=CC(=CC=C1)[S+]([O-])(=O)N2CCCN(CC2)[S+]([O-])(=O)C3=CC4=C(OCCO4)C=C3	NCGCChem	MBB17-039	-2.77238213	-4.79140667	-0.52054024	-3.7676171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182037-01	Alacepril	124893756	Angiotensin-I Converting Enzyme Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	74258-86-9	Alacepril; ; Alacepril			-21.4108009295	4	4	N-(1-(3-(acetylthio)-2-methyl-1-oxopropyl)-L-prolyl)-L-phenylalanine;CIPLUS_214255;aracepril;alacepril;ALACEPRIL;DU-1219;Alacepril;DU 1219;cetapril;alaceprilum;LS-105750;Cetapril;	0	-4.81882878			1636	ACE	O=C(N[C@@H](Cc1ccccc1)C(=O)O)[C@@H]2CCCN2C(=O)[C@H](C)CSC(C)=O	ACC	ALACEPRIL	-3.95550062	-4.88946336	-6.13862315	-4.81882878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507856-01	NCGC00507856-01	384569334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1675201-83-8				-3.9303025055	4	4		0	2.29830476					COC1=CC(=CC(=C1CN2CCCC[C@H]2C(O)=O)OC)OCC3=C(C)C(=CC=C3)C4=CC=CC=C4	Selleck	S7911	-1.60674305	-0.57631615	-1.63425926	2.29830476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025245-05	NCGC00025245-05	384568062		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[15291-77-7]				6.7459799999	4	4		0	3.08656631				GABRA1	C[C@@H]1C(=O)OC2[C@H](O)[C@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]36[C@@H](O)C(=O)O[C@H]6O[C@@]4(C(=O)O5)[C@@]12O	Tocris	1657	2.72180517	-1.86616658	-1.72685185	3.08656631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015610-29	NCGC00015610-29	384567875		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	75706-12-6				-29.1275001449	4	4		0	-11.71945486				DHODH	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	MedChem Express	HY-B0083	-4.32854822	-8.56241138	-4.76388889	-11.71945486												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346938-02	NCGC00346938-02	384568972		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	474550-69-1		12.5892541179	-4.9	-67.3787871333	-3	4		-112.4124554833	-99.55838359	0.0337644964	0.9992961957			CCOC1=CC2=C(C(=C1OCC)F)C(=N)N(CC(=O)C3=CC(=C(OC)C(=C3)C(C)(C)C)N4CCOCC4)C2	Axon Medchem	2030	1.27310242	1.54599094	3.86574074	-99.55838359												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-24	NCGC00018248-24			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox					-34.4240921205	4	4		0	-7.16083385					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Bionet	KS-1084	-8.59563633	-4.60138133	-5.58796296	-7.16083385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238454-10	NCGC00238454-10	377020194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	677338-12-4		0.177827941	-6.75	-67.9529102217	-2.4	4		-31.5905256839	-27.67951047	0.0124284273	0.9999049106		PIK3CA	COC1=CC=C2/C3=N/CCN3\C(=N/C2=C1OC)NC(=O)C4=CC=CN=C4	MedChem Express	HY-12030	-0.1040724	-7.43319111	-20.35534605	-27.67951047												1.6E-8	8E-8	4E-7	0.000002											
NCGC00510347-01	NCGC00510347-01	384569427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			0.3981071706	-6.4	-382.4698667646	5	4		-16.686758364	-88.89951238	0.0596787386	0.997817052			CC1=CC=C(NC(=O)NCC2=CC3=C(C=C2)C(=O)N(C3)C4CCC(=O)NC4=O)C=C1Cl	Axon Medchem	2645	-76.24886878	-84.65753425	-88.90450075	-88.89951238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182549-04	Vicriviroc (SCH-417690)	384568410	Chemokine CCR5 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	541503-81-5				-26.8879869364	4	4		0	-3.31615612				CCR5	COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F	Adooq	A10971	-6.59467115	-7.47399121	-3.35511983	-3.31615612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263191-02	NCGC00263191-02	363677255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	(492445-28-0)		2.8183829313	-5.55	-107.5862859903	-1.3	4		-83.3141998235	-82.29315774	0.0588375686	0.9978588132		CDK2	CC(C)C1=CN=C(NC(=O)[C@@H](C)C2=CC=C(NC(C)=O)C=C2)S1	SynKinase	SYN-1097	-0.77011596	3.85234841	-66.96199467	-82.29315774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165898-11	NCGC00165898-11	384568296		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	627536-09-8		12.5892541179	-4.9	-25.3116694068	4	4		-14.9168230721	-14.90123103	0.0238954955	0.9996512901		TGBR1	FC1=C(C=C(Cl)C=C1)C2=NC3=NC=CN=C3C(=N2)NC4=CC=NC=C4	MedChem Express	HY-13227	-3.47879968	-3.30387847	-4.26531106	-14.90123103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346717-02	NCGC00346717-02	384568930		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1217486-61-7		6.3095734448	-5.2	-32.8163300727	4	4		-21.756077172	-18.26473001	0.331417196	0.9260551948		PIK3CA	CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(N)=O)C3=CC(=NC=C3)C(C)(C)C(F)(F)F	Selleck	S2814	-2.6346657	-8.27172111	-9.52148676	-18.26473001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387775-03	NCGC00387775-03	363680662		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	849727-81-7		11.220184543	-4.95	-38.7447057638	-3	4		-54.3413932441	-45.9730734	0.0146726635	0.9998672663		PRKAA1	OC(=O)C1=CC=C(CCCC2=CC=C(OCCC3=CC=C(F)C=C3)C=C2)O1	Bio Vision	2341	-0.4872327	-0.84240713	-3.64860251	-45.9730734												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510489-01	NCGC00510489-01	384569451		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1257213-50-5		14.1253754462	-4.85	-38.8805163956	4	4		-17.7728847119	-19.87646576	0.3234605877	0.9297234155			C[C@@H](OC(=O)NC1=C(ON=C1C)C2=CC=C(C=C2)C3=CC=C(C=C3)C4(CC4)C(O)=O)C5=CC=CC=C5	MedChem Express	HY-100619	-7.51601552	-4.34646234	-2.5657285	-19.87646576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263015-01	NCGC00263015-01	137275919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	n	NCGC00263015-01	12.5892541179	-4.9	-57.2932432566	-3	4		-56.7220821098	-54.88320677	0.0747056399	0.9965432612	7099	TLR4	CN(CC(O)COC1=CC=C(Cl)C=C1)CC2=C(C)[N](CC3=C(Cl)C=CC=C3)N=C2C	NCGCChem	BTM10-092	-4.79893946	-4.21052632	-1.53731134	-54.88320677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016855-19	NCGC00016855-19	384567963		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	43210-67-9		0.2511886432	-6.6	-135.6592784074	4	4		-28.6722198808	-49.98077478	0.4697993114	0.8333650821			COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)SC3=CC=CC=C3	MedChem Express	HY-B0413	-16.92443659	-43.07551487	-35.73197514	-49.98077478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522639-01	NCGC00522639-01	384569535		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	376641-49-5				-10.459682785	4	4		0	-1.9657791					CC1=C(C=CC=C1Cl)[S+]([O-])(=O)NC2=NC(=CS2)CCN3CCOCC3=O	Glixx	GLXC-04401	-1.62615996	-3.95423341	-2.96715107	-1.9657791												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522584-01	NCGC00522584-01	384569530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1093119-54-0				-11.3500609298	4	4		0	-5.58973373				ERN1	CN1CCN(CC1)C(=O)C2=CC=C(S2)C3=CC4=C(C=C3)C(=C(O)C=C4)C=O	MedChem Express	HY-19710	-0.30048608	-7.12128146	-2.04196066	-5.58973373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479074-01	NCGC00479074-01	363681103		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1420477-60-6				-16.9605389008	4	4		0	-4.34968422				BTK	CC#CC(=O)N1CCC[C@H]1C2=NC(=C3[N]2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=NC=CC=C5	MedKoo	206112	-3.00276571	-3.53107991	-4.53240741	-4.34968422												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510699-01	NCGC00510699-01	384569485		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1923851-49-3				-7.3989698785	4	4		0	-0.51813471				BRPF1	CCN(C(=O)C1=CC=CC=C1OC)C2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCNC[C@H]4C	MedChem Express	HY-100729	-1.23813827	-4.29536898	-1.21271714	-0.51813471												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250403-11	NCGC00250403-11	377020321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	796967-16-3		12.5892541179	-4.9	-69.4517121658	-3	4		-83.5377801853	-78.24839851	0.0297401543	0.9994541389		KDR	CC1=CC=C(F)C(=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=N[NH]C4=CC=C3)N	MedChem Express	HY-50751	-3.3800905	-1.38782843	-1.9534968	-78.24839851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162440-05	NCGC00162440-05	384568227		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			15.8489319246	-4.8	-280.628214443	-2.3	4		-51.7335470903	-91.71048857	0.2327777074	0.9650397201			CCC(\C=C\[C@@H]1OC(=O)\C=C/[C@@H]1C)=C\[C@H](C)C/C=C/C(C)=C/[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(O)=O	BioAustralis	BIA-L1046	-55.43438914	-54.00853357	-46.88845579	-91.71048857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247785-11	NCGC00247785-11	384568516		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			10	-5	-113.2497484349	-2.3	4		-121.0348947412	-99.67077011	0.2077967762	0.9723861991			OC1CCC(CC1)N2\C=N/C3=C(C2=N)C(=C([N]3CC4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6	Evotec	MLS003678589	-2.4519784	-19.94950594	-26.53594771	-99.67077011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189074-12	NCGC00189074-12	384568457		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	212631-79-3		12.5892541179	-4.9	-123.4593820786	-2.3	4		-90.2561701288	-87.34134937	0.149894479	0.9858828914		MAP2K1	FC1=C(F)C(=C(C=C1)C(=O)NOCC2CC2)NC3=CC=C(I)C=C3Cl	SIGMA	PZ0181	-11.37470125	-21.62973926	-20.04841443	-87.34134937												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346639-03	NCGC00346639-03	384568873		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	624-49-7				-21.2540573129	4	4		0	-3.47922598				NFKB1	COC(=O)\C=C\C(=O)OC	Selleck	S2586	-5.54903907	-7.32177264	0.90727282	-3.47922598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346830-03	NCGC00346830-03	384568946		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	10356-76-0		0.3548133892	-6.45	-87.7550429401	4	4		-19.923200656	-27.25956667	0.048016532	0.9985851945		DNMT1	NC\1=N\C(=O)N(\C=C1F)[C@H]2C[C@H](O)[C@@H](CO)O2	SIGMA	F5307	-12.74023279	-22.64641305	-27.20842886	-27.25956667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351606-08	NCGC00351606-08	384569020		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1370261-97-4		12.5892541179	-4.9	-24.0068215219	4	4		-20.2082869199	-19.67220994	0.167972927	0.982265323		SYK	N[C@H]1CCCC[C@H]1NC2=NC=C(C(N)=O)C(=N2)NC3=CC=CC(=C3)[N]4N=CC=N4	MedChem Express	HY-15323	-1.58197084	-4.32036613	-3.21013037	-19.67220994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346841-07	LY-411575	384568950	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	209984-57-6				-13.0158340537	4	4		0	-5.66663462				NOTCH1	C[C@H](NC(=O)[C@@H](O)C1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-50752	-1.73221388	-1.99542334	-4.23811971	-5.66663462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346896-03	NCGC00346896-03	384568966		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1108147-88-1		14.1253754462	-4.85	-23.4137226205	4	4		-31.7575699359	-28.13130828	0.1522311136	0.9854528414		OPRL1	CC1(CCCCCCC1)N2CCC(CC2)[N]3C4=C(C=CC=C4)N=C3[C@@H]5CCCNC5	Cayman	12037	-0.08837826	-3.35011442	0.25699734	-28.13130828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381563-08	NCGC00381563-08			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	945755-56-6		7.9432823472	-5.1	-65.2282609272	-2.2	4		-46.4476935382	-49.80774777	0.0224411356	0.9996894531			O=C(NC1=CC=C(C=C1)C2=CC=NC(NC3=CC=C(C=C3)N4CCOCC4)=N2)[C@@H]5CCCN5	APExBIO	A3937	-6.40742377	-5.67505721	-10.97612261	-49.80774777												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016686-07	NCGC00016686-07	363676490		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	7681-93-8				-5.8953792888	4	4		0	0.07820901					C[C@H]1C\C=C/C=C\C=C/C=C\[C@H](C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3\C=C/C(=O)O1)C[C@@H](O)[C@H]2C(O)=O)O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](N)[C@H]4O	Selleck	S1517	-2.28648893	-0.41275457	0.2481622	0.07820901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093976-15	NCGC00093976-15	384568121		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	57852-57-0		2.8183829313	-5.55	-208.0529869711	-2.2	4		-74.858072864	-96.88622754	0.0247400314	0.9996223586		TOP2A	C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C(O)C4=C(C(=C23)O)C(=O)C5=C(C=CC=C5)C4=O)C(C)=O	MedChem Express	HY-17381	-24.20599716	-31.16512452	-74.45491902	-96.88622754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390611-02	NCGC00390611-02	384569200		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			11.220184543	-4.95	-117.503711726	-2.3	4		-119.0786851685	-99.71046663	0.1010197449	0.9936528814			C[N]1N=CC(=C1C2=C(Cl)SC(=C2)C(=O)N[C@H](CN)CC3=CC=C(F)C(=C3)F)Cl	MedChem Express	HY-15966A	-5.95506632	-15.01993996	-24.71098971	-99.71046663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161630-03	NCGC00161630-03	384568212		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1476-53-5				-13.2690314994	4	4		0	2.91946147				HSP90AB1	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3\C(=C(NC(=O)C4=CC=C([O-])C(=C4)CC=C(C)C)/C(=O)OC3=C2C)O)OC1(C)C	Selleck	S2492	-4.34900298	-5.80723215	-0.40973611	2.91946147												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018268-14	NCGC00018268-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	84625-61-6		3.1622776602	-5.5	-104.7039574466	-2.1	4		-90.285110068	-81.90425839	0.0064652896	0.9999742206			CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(CN6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	MedChem Express	HY-17514	0.16791869	-1.67505721	-25.80720527	-81.90425839												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378692-06	NCGC00378692-06	384569063		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	869886-67-9		11.220184543	-4.95	-108.057767114	-2.3	4		-118.7166658401	-97.7939056	0.0609931164	0.997698582		ERK	CC(C)NC1=NC=C(Cl)C(=C1)C2=C[NH]C(=C2)C(=O)N[C@H](CO)C3=CC=CC(=C3)Cl	MedChem Express	HY-15816	-5.36456032	-10.70022883	-19.72337741	-97.7939056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481317-01	CB-5083	363681118	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1542705-92-9		0.4466835922	-6.35	-220.2051366209	-1.1	4		-95.9785388072	-99.27656662	0.0085761901	0.9999546341		VCP	CC1=CC2=C(C=CC=C2C(N)=O)[N]1C3=NC(=C4COCCC4=N3)NCC5=CC=CC=C5	ActiveBioChem	A-1513	-4.003615	-94.57522565	-99.68160322	-99.27656662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246958-03	NCGC00246958-03	363677155		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	58131-57-0				3.3755760894	4	4		0	4.64366018				MDM4	CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+]([O-])=O	Selleck	S2678	-0.22593764	2.14541661	-1.45619703	4.64366018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482383-01	NCGC00482383-01	363681128		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1700663-41-7				-23.5659676248	4	4		0	-5.53328771				PRMT6	CNCCN(C)CC1=C[NH]N=C1C2=CC=C(O[C@@H]3C[C@H](C3)OCCC4CCOCC4)C=C2	ActiveBioChem	A-1962	-5.594216	-2.89835352	-4.46223721	-5.53328771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185778-06	NCGC00185778-06	384568427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	104206-65-7				-15.0780587226	4	4		0	-0.67455274				HPD	[O-][N+](=O)C1=CC(=CC=C1C(=O)C2C(=O)CCCC2=O)C(F)(F)F	MedChem Express	HY-B0607	-4.18436512	-3.74200571	-1.82141687	-0.67455274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386757-02	NCGC00386757-02	384569145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	286936-40-1		0.6309573445	-6.2	-37.1328265885	4	4		-15.9391806919	-16.14038518	0.039267092	0.9990549554			CN(C)CCNC(=O)COC1=C2CC3=CC=CC(=C3OCC(=O)NCCN(C)C)CC4=CC=CC(=C4OCC(=O)NCCN(C)C)CC5=CC=CC(=C5OCC(=O)NCCN(C)C)CC1=CC=C2	Axon Medchem	2332	-2.02440127	-3.54243208	-10.81144355	-16.14038518												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00386367-02	NCGC00386367-02	363680236		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1536200-31-3		14.1253754462	-4.85	-26.1255663452	4	4		9.4566652599	0.55723922	0.4362932859	0.8629809677		LRRK2	CNC1=NC(=NC=C1C(F)(F)F)NC2=C(Cl)[N](N=C2)[C@H]3CCN(C[C@@H]3F)C4COC4	MedChem Express	HY-12282	-6.01897876	-6.43624983	-9.54722105	0.55723922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521067-01	NCGC00521067-01	384569504		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	509080-74-4				-21.636293333	4	4		0	-1.50898204				ICAM1	CN1C(=O)N(C(=O)[C@]12CN(C[C@H]2C3=CC=C(C=C3)C#N)CC4=CC(=CS4)C(O)=O)C5=CC(=CC(=C5)Cl)Cl	Key Organics	HE-0001	-5.01685593	-6.07650877	-4.93594392	-1.50898204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344630-02	NCGC00344630-02	384568728		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	437742-34-2		0.3981071706	-6.4	-267.3463166634	-1.1	4		-92.1657762542	-94.77844311	0.0360101758	0.9991996126		PSMD1	C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]\3CCC\C=C3	SIGMA	SML1916	-34.5235983	-66.02218846	-88.98718878	-94.77844311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482953-01	NCGC00482953-01	384569262		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1040526-12-2				-17.4726139508	4	4		0	0.11017964				TPH2	N[C@H](CC1=CC=C(C=C1)C2=NC(=NC(=C2)OC(C3=CC=C(C=C3)C4=CC=CC(=C4)F)C(F)(F)F)N)C(O)=O	DC Chemicals	DC9243	-4.61763662	-5.14661879	-3.09886391	0.11017964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386394-01	NCGC00386394-01	384569131		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1493694-70-4				-34.5737722423	4	4		0	-10.36167665			10461	MERTK	CCCCNC1=NC(=C(C=N1)C2=CC=C(CN3CCOCC3)C=N2)N[C@@H]4CC[C@@H](O)CC4	Selleck	S7342	-5.13218595	-6.50922985	-10.872613	-10.36167665												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00095112-07	NCGC00095112-07	384568146		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	70356-09-1				-1.8283005678	4	4		0	-4.21271051					COC1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)C(C)(C)C	Selleck	S1904	0.17143373	2.37487117	-1.11214087	-4.21271051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015609-15	NCGC00015609-15	384567874		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	50264-69-2				-28.2944432311	4	4		0	-5.79549293				HK1	OC(=O)C1=N[N](CC2=C(Cl)C=C(Cl)C=C2)C3=C1C=CC=C3	MedChem Express	HY-B0486	-6.66786971	-7.03499574	-2.88766402	-5.79549293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346543-05	NCGC00346543-05	384568829		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	334951-92-7		10	-5	-15.0198044884	4	4		-15.793248344	-14.79861578	0.0288805881	0.9994887912		MAP2K1	CNC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC(=CC=C3)CN(C)C)C4=CC=CC=C4	MedChem Express	HY-12202	-0.80424216	-0.81464531	-1.91112565	-14.79861578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378801-04	NCGC00378801-04	384569070		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	334949-59-6				-15.0054180165	4	4		0	-5.41670672					CN(C)CC1=CC(=CC=C1)NC(\C2=CC=CC=C2)=C3/C(=O)NC4=C3C=CC(=C4)C(N)=O	MedChem Express	HY-12055	-2.61599646	-3.91762014	-2.20083174	-5.41670672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370768-04	NCGC00370768-04	363677843		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	41964-07-2				-14.3213976517	4	4		0	-3.1479128				LYN	CC1=CC(=CC=C1)OC/2=C/NC(=O)/N=C2	SynKinase	SYN-5050	-3.42521464	-1.09311925	-3.51641148	-3.1479128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015439-20	NCGC00015439-20	384567845		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	78755-81-4				-12.1598637767	4	4		0	-1.79880731				GABRA1	CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(=C3)F)[N]2C=N1	MedChem Express	HY-B0009	-3.75056484	-3.15235633	1.38128014	-1.79880731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015437-22	NCGC00015437-22	384567844		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	49562-28-9				-17.8610049931	4	4		0	-5.62127285				PPARA	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2	Selleck	S1794	-3.94035246	-2.72599447	-2.42075198	-5.62127285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163169-05	Pizotifen	170466311	Antimigraine drugs	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	15574-96-6	 Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran			-16.3411655487	4	4		0	-4.37970476				CHRM1	CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23	BIOMOL	NS740	-4.53682784	-2.18170273	0.06086997	-4.37970476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242498-14	NCGC00242498-14	384568501		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	301836-43-1				-9.1732934613	4	4		0	-0.37844311				CSNK1A1	NC(=O)C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=NC=CC=C3)C4=CC=C5OCCOC5=C4	MedChem Express	HY-10324	-3.78371185	1.79533214	-0.69132221	-0.37844311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346618-07	NCGC00346618-07	363677479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	873697-71-3				-15.2366257619	4	4		0	-5.21676647				MYH7	COC(=O)N1CCN(CC1)CC2=CC=CC(=C2F)NC(=O)NC3=CN=C(C)C=C3	Glixx	GLXC-90072	-3.82806955	-1.41785205	-0.81701716	-5.21676647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263187-07	NCGC00263187-07	384568654		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1035555-63-5		0.3981071706	-6.4	-117.1680301968	-2.4	4		-36.103986692	-35.77005988	0.1902075193	0.9771704714		MAP2K1	CN1C(=O)/C(=C(NC2=CC=C(I)C=C2F)\C3=C1\N=C/N(C[C@@H](O)CO)C3=O)F	MedChem Express	HY-13449	-19.85007097	-26.92998205	-29.92990089	-35.77005988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025379-01	NCGC00025379-01	11114298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox		SR 33805; SR 33805	12.5892541179	-4.9	-65.0572001173	-3	4	SR 33805 oxalate;NCGC00025379-01;	-114.6584760891	-99.87453554	0.0245591584	0.9996278087			COC1=CC=C(CCN(C)CCCOC2=CC=C(C=C2)[S+]([O-])(=O)C3=C(C(C)C)C4=CC=CC=C4[N]3C)C=C1OC	Tocris	Tocris-1806	3.1850582	0.78863647	1.29749768	-99.87453554												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188863-06	NCGC00188863-06	384568452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	141625-93-6		10	-5	-75.2133877382	-3	4		-111.1336292977	-99.75872219	0.0067092087	0.9999722361		ADRA1A	CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C2=C(CCCC)OC3=C2C=C(N[S+](C)([O-])=O)C=C3	MedChem Express	HY-75839	0.60452946	0.86929247	-4.00956051	-99.75872219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378596-08	NCGC00378596-08	384569053		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1229208-44-9				6.1888392204	4	4		0	0.60078823				SYK	C1CN(CCO1)C2=CC=C(NC3=NC(=C[N]4C=CN=C34)C5=CC6=C(C=C5)C=N[NH]6)C=C2	MedChem Express	HY-15968	1.71453822	4.03661327	-2.08868744	0.60078823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015603-14	NCGC00015603-14	384567871		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	98079-52-8				-5.4919605802	4	4		0	-2.68843484					CCN1\C=C(C(O)=O)/C(=O)C2=C1C(=C(N3CCNC(C)C3)C(=C2)F)F	MedChem Express	HY-B0455	0.84952553	-1.22919218	-5.33314604	-2.68843484												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346837-02	NCGC00346837-02	363677547		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[1210004-12-8]				0.6411543466	4	4		0	-4.13530159				MGLL	[O-][N+](=O)C1=CC=C(OC(=O)N2CCN(CC2)CC3=CC=CC(=C3)OC4=CC=CC=C4)C=C1	Tocris	4715	1.73520108	-0.34925387	-0.65084047	-4.13530159												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164617-14	NCGC00164617-14	384568266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	106685-40-9				-10.1685801698	4	4		0	2.93283801					COC1=CC=C(C=C1C23CC4CC(CC(C4)C2)C3)C5=CC=C6C=C(C=CC6=C5)C(O)=O	Enzo	GR111	-4.26570267	-0.22225246	-1.87760453	2.93283801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346459-07	NCGC00346459-07	384568783		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1254473-64-7		0.7943282347	-6.1	-185.3003493591	-1.4	4		-52.5210388305	-62.79206179	0.345716658	0.9182069115		FGFR1	C[C@@H](OC1=CC2=C([NH]N=C2\C=C\C3=C[N](CCO)N=C3)C=C1)C4=C(Cl)C=NC=C4Cl	MedChem Express	HY-13304	-19.39448712	-46.42354969	-80.68080723	-62.79206179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387463-02	NCGC00387463-02	384569159		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1125593-20-5		11.220184543	-4.95	-22.7905717076	4	4		-13.9968707201	-13.68657738	0.0389140016	0.9990763574		TTK	COC1=C(NC2=NC3=C(C=C[NH]3)C(=C2)NC4=C(C=CC=C4)[S+]([O-])(=O)C(C)C)C=CC(=C1)N5CCC(O)CC5	MedChem Express	HY-13298	-2.85585178	-3.23400009	-4.30303882	-13.68657738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159455-27	NCGC00159455-27	384568178		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	184475-55-6		6.3095734448	-5.2	-44.4582680925	4	4		-22.8386610041	-20.82314987	0.2862039723	0.9462223597		EGFR	COC1=CC2=NC=NC(=C2C=C1OCCCN3CCOCC3)NC4=CC=C(F)C(=C4)Cl	MedChem Express	HY-50895A	-5.1242657	-10.36422189	-12.25359367	-20.82314987												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346557-02	NCGC00346557-02	363677454		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	533884-09-2		7.0794578438	-5.15	-38.1877643215	-3	4		-35.5554491	-32.96287425	0.1303570844	0.989384671		ESR1	OC1=CC=C(C=C1)[C@@H]2OC3=C(C=C(O)C=C3)[C@@H]4CCC[C@H]24	Selleck	S1598	-2.87881476	0.53399623	-9.402949	-32.96287425												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263233-01	NCGC00263233-01	137276077		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1332307-32-0	IPFK2	11.220184543	-4.95	-54.3831283838	-2.4	4		-55.6535067971	-60.54610778	0.1339258767	0.9887757619	5208	PFKFB2	NC1=CC=C(C=C1)C(=O)C2=CC3=C([NH]2)C=CC4=CC=CC=C34	NCGCChem	IPFK2	-2.39088006	-9.17921097	-20.19337684	-60.54610778												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00189220-12	NCGC00189220-12	384568460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1255580-76-7				-1.579382948	4	4		0	-0.49341317				EHMT2	COC1=C(OCCCN2CCCC2)C=C3N=C(N=C(NC4CCN(CC4)C(C)C)C3=C1)C5CCCCC5	MedChem Express	HY-15273	0.13750887	-1.8137458	-0.42059463	-0.49341317												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347944-06	NCGC00347944-06	363677725		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1351758-81-0				-16.8388279458	4	4		0	-9.93053892				LRRK2	CNC1=NC(=NC=C1Cl)NC2=CC=C(C=C2OC)C(=O)N3CCOCC3	Glixx	GLXC-02896	-2.86994322	-2.8080836	-0.17887358	-9.93053892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346666-01	NCGC00346666-01	174006218		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	15291-75-5	Ginkgolide A			-10.0713431645	4	4		0	-1.13532934			2554	GABRA1	C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)C36[C@@H](O)C(=O)O[C@H]6O[C@@]4(C(=O)O5)[C@@]12O	Selleck	S2026	-3.38449255	0.25779128	-1.08774474	-1.13532934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390577-02	NCGC00390577-02	384569196		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1474034-05-3		0.4466835922	-6.35	-220.4454306172	-1.1	4		-97.2388837488	-99.74131737	0.0047794765	0.999985911		NRF2	CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)\C=C\4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)NC(=O)C(C)(F)F	MedChem Express	HY-12212	-6.00159688	-87.14265985	-99.66159052	-99.74131737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346886-09	NCGC00346886-09	363677551		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1037184-44-3 		3.5481338923	-5.45	-70.7733108096	-2.2	4		-37.6785387624	-41.73892216	0.0293303574	0.999469582		EWSR1	COC1=CC=C(C=C1)C(=O)CC2(O)C(=O)NC3=C(Cl)C=CC(=C23)Cl	Glixx	GLXC-90037	-5.75319375	-8.34138931	-27.26130046	-41.73892216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483168-02	NCGC00483168-02	384569264		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-31.5988438182	4	4		0	-8.30478213				PRMT5	O[C@@H](CNC(=O)C1=CC(=NC=C1)NC2CCC2)CN3CCC4=CC=CC=C4C3	SGC	GSK591	-5.03473789	-7.68024376	-10.25315838	-8.30478213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507844-01	NCGC00507844-01	384569325		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	136553-81-6				1.3987651857	4	4		0	-0.8987792				EDNRA	CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](CC3=C[NH]C4=C3C=CC=C4)NC1=O)C(C)C	Selleck	S7883	2.97834733	-4.52173913	-3.39703752	-0.8987792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481567-03	NCGC00481567-03	377020225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	946518-61-2				-6.5705941447	4	4		0	-0.83149092				IKBKB	CN1CCN(CCCNC2=NC=C(Cl)C(=N2)C3=CC4=C(S3)C=CC=C4C(=O)NC5CC5)CC1	MedChem Express	HY-B0788	-1.41405214	-1.13501144	-2.21017709	-0.83149092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161398-06	NCGC00161398-06	384568205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	504433-23-2		11.220184543	-4.95	-24.6015538795	4	4		-12.4260812841	-14.23404047	0.1633449199	0.9833781465		NTRK1	C[N]1C=C(/C=C/2C(=O)NC3=CC=CN=C23)C4=C1C=CC=C4	MedChem Express	HY-18314	-3.0456394	-4.64915862	-4.20002809	-14.23404047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345853-03	NCGC00345853-03	384568768		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	885692-52-4		14.1253754462	-4.85	-23.6048233357	4	4		-9.198203588	-9.74850299	0.6516731159	0.5953099566		CSF1R	CN(C)CC(=O)N1CCC(CC1)C2=CC=C(NC(=O)C3=NC(=C[NH]3)C#N)C(=C2)\C4=C\CCCC4	Activate Scientific	AS10255	-6.55163236	0.30382544	0.28523084	-9.74850299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241107-12	NCGC00241107-12	384568475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	380843-75-4		7.9432823472	-5.1	-117.5169596558	-2.3	4		-121.0577092568	-99.3005988	0.0598701577	0.9977827941		ABL1	COC1=C(Cl)C=C(Cl)C(=C1)NC2=C(C=NC3=C2C=C(OC)C(=C3)OCCCN4CCN(C)CC4)C#N	Enzo	AC1546	-3.04737402	-12.40160199	-38.40947547	-99.3005988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165856-14	NCGC00165856-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					-15.0240147666	4	4		0	-0.15808383					[H]C(=O)N[C@@H](CC(C)C)C(=O)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC	Microsource	1504300	-4.61763662	-1.48229987	-2.97316896	-0.15808383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263208-09	NCGC00263208-09	384568667		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	877877-35-5		0.4466835922	-6.35	-174.1935258702	-1.3	4		-82.0716742423	-84.11497006	0.0650238661	0.9973833807		BCL2L1	CC(C)C1=CC=CC=C1CC2=CC(=C(O)C(=C2O)O)C(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)C4=C(C=CC=C4)C(C)(C)C	MedChem Express	HY-12020	-2.24006388	-71.78566496	-79.29900894	-84.11497006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161599-13	NCGC00161599-13	384568210		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	97322-87-7		14.1253754462	-4.85	1.4131015668	4	4		-11.0881437119	-6.74011976	0.5423752778	0.7617856745		CCL2	CC1=C(O)C(=C2CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)OC2=C1C)C	Enzo	GR210	0.59882896	0.819408	6.22189993	-6.74011976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167793-02	NCGC00167793-02	377020440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[212631-61-3]		2.5118864315	-5.6	-149.9836218713	-2.1	4		-94.9052882458	-96.68356668	0.0150942743	0.9998594577		ERK	CC1=C(NC2=C(C=C(F)C(=C2F)F)C(=O)NOCC3CC3)C=CC(=C1)I	Tocris	2605	-6.56012714	-17.27134962	-69.95404239	-96.68356668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015389-07	NCGC00015389-07	124879993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	2078-54-8	 ; Dipravan; Propofol;Propofol; propofol HP-beta-CD; 2,6-Bis(Isopropyl)-phenol;2,6-Diisopropylphenol;PROPOFOL			-15.6682339448	4	4	HS_1197;AB08007493-01;Propofol (2,6-diisopropylphenol);LS-996;2,6-Diisopropylphenol;Propofol;propofol HP-beta-CD;Diprivan;NCGC00015389-01;2,6-DIISOPROPYLPHENOL;ici 35868;NCGC00015389-02;propofol;Propofol(2,6-Diisopropylphenol);propofolum;NCGC00091538-06;NCGC00091538-03;NCGC00091538-02;PROPOFOL;NCGC00091538-05;NCGC00091538-04;DIPRIVAN;propofol hydroxypropyl-beta-cyclodextrin;2,6-Bis(Isopropyl)-phenol;NCGC_Prestw-931;CIPLUS_159631;Phenol, 2,6-bis(1-methylethyl)-;Dipravan;	0	-6.77208498			7442	TRPV1	CC(C)C1=CC=CC(=C1O)C(C)C	Tocris	Tocris_0939	-2.13875387	-1.71167048	-5.64926873	-6.77208498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263166-10	NCGC00263166-10	384568636		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	803712-79-0		4.4668359215	-5.35	-85.010115905	-2.1	4		-88.0453612255	-84.35819728	0.0358169035	0.9992079993		BCL2L1	COC\1=C\C(=N/C1=C/C2=C(C)C=C(C)[NH]2)C3=CC4=CC=CC=C4[NH]3	Adooq	A10665	0.65973791	1.19290606	-35.01896334	-84.35819728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165768-05	NCGC00165768-05	363676640		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	516480-79-8				-31.2112081885	4	4		0	-8.19239417				CHEK2	NC(=O)C1=CC2=C([NH]C(=N2)C3=CC=C(OC4=CC=C(Cl)C=C4)C=C3)C=C1	MedChem Express	HY-13946	-7.31134207	-3.34285844	-5.83883504	-8.19239417												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182059-11	NCGC00182059-11	384568409		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	144060-53-7				-5.4228163171	4	4		0	1.4994012				XDH	CC(C)COC1=CC=C(C=C1C#N)C2=NC(=C(S2)C(O)=O)C	MedChem Express	HY-14268	-1.10450674	-2.23726005	-3.08919507	1.4994012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250400-05	NCGC00250400-05	384568549		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[877399-52-5]		8.9125093813	-5.05	-97.6507172585	-2.1	4		-103.3336811529	-99.76047904	0.038907793	0.9990651793		MET	C[C@@H](OC1=C(N)N=CC(=C1)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C(=CC=C4Cl)F	Tocris	4368	-5.34510291	-1.92422778	-11.57843848	-99.76047904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179642-05	NCGC00179642-05	363676952		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	24168-96-5		12.5892541179	-4.9	-66.8861510461	-3	4		-93.5469700594	-85.19760479	0.0289813986	0.9994816318			ClC1=CC(=C(C=C1)C(C[N]2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl)Cl	Selleck	S2534	-1.38839603	-0.10127515	0.58496495	-85.19760479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522513-01	NCGC00522513-01	384569522		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1233948-61-2		0.1258925412	-6.9	-255.7915277428	-2.4	4		-95.154976645	-76.21749849	0.3433288984	0.919572494		HIF1A	COC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=CC=C2C)C3=CSC(=C3)C#N	MedChem Express	HY-16187	-44.21684619	-60.79960777	-62.11311199	-76.21749849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093704-19	NCGC00093704-19	384568118		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	59865-13-3		11.220184543	-4.95	-89.3254272186	-2.1	4		-94.8411499052	-81.44285302	0.0189475627	0.9997785342			CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	DC Chemicals	DC4115	-5.64737075	-6.84668192	-13.22835382	-81.44285302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510506-01	NCGC00510506-01	384569467		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1434048-34-6				-2.7494323644	4	4		0	0.01441892				BTK	C[C@H]1CN(CCN1C2=CN=C(NC/3=C/C(=C\N(C)C3=O)C4=CC=NC(=C4CO)N5CC[N]6C7=C(CC(C)(C)C7)C=C6C5=O)C=C2)C8COC8	MedChem Express	HY-19834	-0.0353513	-3.01144165	-0.80837344	0.01441892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262603-12	NCGC00262603-12	384568574		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	870281-82-6		11.220184543	-4.95	-31.4468616415	4	4		-14.927372896	-14.61597616	0.1916850348	0.9770044088		PIK3CD	CC[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=N/C4=C(C(=CC=C4)F)C(=O)N3C5=CC=CC=C5	MedChem Express	HY-13026	-4.25983208	-6.24256293	-7.5557217	-14.61597616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017291-12	NCGC00017291-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	83-88-5				-19.464041259	4	4		0	-8.14668846					CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2	Microsource	01505347	-2.35969951	-5.08009153	-5.4343255	-8.14668846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346481-02	NCGC00346481-02	363677418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	572924-54-0				-132.5801405708	-3	4		0	-33.24521773				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O[P](C)(C)=O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Selleck	S1022	-26.64604507	-27.45080092	-29.33040512	-33.24521773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263085-12	NCGC00263085-12	384568580		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1243243-89-1				-5.0978223144	4	4		0	-0.60611986				PORCN	CC1=CC(=CC=N1)C2=CC=C(CC(=O)NC3=CC=C(C=C3)C4=CC=CN=C4)C=C2	DC Chemicals	DC7340	-2.43108902	0.63047127	1.60603081	-0.60611986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346699-02	NCGC00346699-02	384568919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	871026-44-7		8.9125093813	-5.05	-130.4771365816	-2.1	4		-118.2926978859	-99.69404341	0.0393027207	0.9990461178		EGFR	CC(C)(O)CC(=O)NCC[N]1C=CC2=C1C(=NC=N2)NC3=CC=C(OC4=CC=CC(=C4)C(F)(F)F)C(=C3)Cl	Selleck	S2784	-8.01357466	-14.09836066	-36.69038662	-99.69404341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390618-04	NCGC00390618-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1429881-91-3		10	-5	-103.6602605756	-2.3	4		-119.7838839319	-99.2418252	0.1578117734	0.984318553			CCCCNC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C4=CC=C(CN5CCN(C)CC5)C=C4	DC Chemicals	DC7931	-1.05067985	-14.88233197	-23.46182705	-99.2418252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386373-08	NCGC00386373-08			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	901119-35-5		5.6234132519	-5.25	-109.7041347333	-2.4	4		-88.0967495161	-77.44400654	0.1993102691	0.9746747009			COC1=CC(NC2=NC=C(F)C(NC3=CC=C4OC(C)(C)C(=O)N(COP([O-])([O-])=O)C4=N3)=N2)=CC(OC)=C1OC	Adooq	A11926	-4.03004861	-21.72997712	-37.6851549	-77.44400654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484062-02	NCGC00484062-02	384569268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1206163-45-2				-0.2014490527	4	4		0	-1.00451793				JAK1	CC1(C)CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=N[N]34)NC(=O)C5CC5	MedChem Express	HY-16755_cm2	0.40653999	-1.18993135	0.49063128	-1.00451793												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480913-01	NCGC00480913-01	384569250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1345847-93-9				4.7128104128	4	4		0	2.71556282				MET	FC1=CC=C(NC(=O)C2(CC2)C(=O)NC3=CC(=C(OC4=CC(=NC=C4)NC(=O)C5CC5)C=C3F)F)C=C1	Glixx	GLXC-90229	0.97216085	0.79633867	-0.50932199	2.71556282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386721-01	NCGC00386721-01	363680416		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1262832-74-5		1	-6	-49.7610286464	4	4		-26.8405258279	-9.07911179	1	0.9998276616		FGFR1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)N4CCCC4	Axon Medchem	2217	-1.1931065	-8.59496567	-28.14354469	-9.07911179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091585-03	NCGC00091585-03	29215118		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	6197-30-4	2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; ; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; "2-Ethylhexyl-2-cyano-3; Octocrileno;OCTOCRYLENE			-2.1505678917	4	4	octocrilenum;UVINUL N-539;CIPLUS_165218;Octocrylene;2-ethylhexyl 2-cyano-3,3-diphenylacrylate;2-ETHYLHEXYL ESTER OF DIPHENYL METHYLIDINE CYANO ACETIC ACID;octocrylene;Octocrileno;2-Ethylhexyl 2-cyano-3,3-diphenylacrylate;2-ETHYLHEXYL 2-CYANO-3,3-DIPHENYLACRYLATE;Octocrilenum;OCTOCRYLENE;AB08080858-01;2-Ethylhexyl-2-cyano-3,3-diphenylacrylate;OCTOCRILENE;	0	-6.81053542					CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2	Labotest	LT00159303	2.50110473	-1.24485126	-3.68674361	-6.81053542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346547-03	NCGC00346547-03	384568833		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1191951-57-1		14.1253754462	-4.85	8.67254204	4	4		24.014027144	19.51429391	0.1603347933	0.9838499098		PDPK1	CCCCCCCCCCCCC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NN=CS2	Selleck	S1556	-2.09502262	0.85784864	-1.66341839	19.51429391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510484-01	NCGC00510484-01	384569447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	848259-27-8				3.7873608149	4	4		0	2.16146579				PPARA	CC[C@@H](OC1=CC=CC(=C1)CN(CCCOC2=CC=C(OC)C=C2)C3=NC4=CC=CC=C4O3)C(O)=O	MedChem Express	HY-17618	-1.02682128	0.31776433	6.54078916	2.16146579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508901-01	NCGC00508901-01	384569372		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[1391076-61-1]				-0.7846740542	4	4		0	-1.77974998				FFAR2	C[C@@]1(CCN1C(=O)C2=CSC3=C2C=CC=C3)C(=O)N(CCCC(O)=O)CC4=CC(=CC=C4)Cl	Tocris	5621	1.06222891	-2.65964393	-0.44057129	-1.77974998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346496-05	NCGC00346496-05	384568802		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1214265-56-1		0.6309573445	-6.2	-202.1740909175	-1.3	4		-95.4269241062	-98.23933581	0.1093211241	0.9925563582		EGFR	CN1CCN(CC1)C2=CC=C(NC3=NC=C(Cl)C(=N3)OC4=CC(=CC=C4)NC(=O)C=C)C=C2	Adooq	A10990_CM1	-10.54262193	-59.52640056	-86.15347374	-98.23933581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025251-08	NCGC00025251-08	384568063		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1664		1	-6	-20.3596842836	4	4		-16.159520956	-15.13293413	0.0488776655	0.9985308234		PPARG	CN(CCOC1=CC=C(C[C@H](NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C(O)=O)C=C1)C4=CC=CC=N4	Tocris	1664	1.35290987	-3.53542328	-14.35339618	-15.13293413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346962-03	NCGC00346962-03	377020391		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1469988-75-7		1.995262315	-5.7	-92.5289899772	-2.4	4		-48.7794124068	-49.67185629	0.0683513772	0.9971092836		BTK	C[N]1C=C(C=N1)C2=CC=C3N=CC\4=C(N(C(=O)\C=C4)C5=CC6=C(CCN6C(=O)C=C)C=C5)C3=C2	MedChem Express	HY-80003	-6.48953158	-7.35625834	-29.60116026	-49.67185629												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00182055-09	NCGC00182055-09	384568408		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	198481-33-3		12.5892541179	-4.9	-55.1888928368	-3	4		-73.1608143688	-65.93053892	0.1382064239	0.9880328139		ESR1	CC1=C([N](CC2=CC=C(OCCN3CCCCCC3)C=C2)C4=CC=C(O)C=C14)C5=CC=C(O)C=C5	MedChem Express	HY-A0036	-3.86355571	0.819408	4.8392555	-65.93053892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510443-01	NCGC00510443-01	384569435		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			4.4668359215	-5.35	-90.6968258792	-2.2	4		-82.1354677884	-79.86417973	0.0411351826	0.9989550193		MMP	NC(=O)C/1=C(O)/[C@]2(O)[C@@H](C[C@@H]\3CC4=C(C(=CC=C4)O)\C(=C3C2=O)O)CC1=O	SIGMA	PH000869	-1.5186297	-0.9315386	-37.87750891	-79.86417973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475728-01	NCGC00475728-01	384569231		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1296270-45-5		10	-5	-49.1366776196	-2.4	4		-30.515733848	-26.93148519	0.0332477349	0.9993199457		PIK3CA	C[C@@H](NC1=CC(F)=CC(F)=C1)C2=CC(=CC3=C2OC(=CC3=O)N4CCOCC4)C(=O)N(C)C	ActiveBioChem	A-1610	-5.66837365	-7.41219469	-13.37929094	-26.93148519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346468-03	NCGC00346468-03	384568787		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	19608-29-8				-20.1300579314	4	4		0	-6.44681148				AR	CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO	MedChem Express	HY-13331	-2.06604273	-8.30361918	-6.05421122	-6.44681148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183109-08	NCGC00183109-08			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	376348-65-1				-1.2176433651	4	4		0	-0.24858973					CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	APExBIO	A8311	-0.93665158	0.35481698	1.59089879	-0.24858973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263228-01	NCGC00263228-01	137276072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1291779-76-4	FASN BI	3.1622776602	-5.5	-55.6191148978	-1.4	4		-32.2398174896	-35.60569844	0.0652715907	0.9973658496	2194	FAS	CCC(=O)N[C@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=C(O3)C=CC=C4	NCGCChem	FASN BI	-2.37556561	-4.40601841	-28.41408693	-35.60569844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165909-10	NCGC00165909-10	384568298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	289905-88-0		10	-5	-23.0541497698	4	4		-23.5023724281	-20.16890925	0.0865569171	0.9953698021			[Cl]C1=CC=CC=C1[C]([N]2C=CC=N2)(C3=CC=CC=C3)C4=CC=CC=C4	SIGMA	T6700	-1.00026556	-2.62482044	-5.13677076	-20.16890925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263186-04	NCGC00263186-04	384568653		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1025065-69-3		11.220184543	-4.95	-103.607258473	-2.1	4		-109.7216878127	-99.67077011	0.014737245	0.9998660259		PIM1	CN1CCC(CC1)CNC2=N[N]3C(=NC=C3C4=CC=CC(=C4)OC(F)(F)F)C=C2	Selleck	S2198	-6.16092768	-7.44787359	-11.69208424	-99.67077011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241114-02	NCGC00241114-02	384568479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					-8.5147584721	4	4		0	-1.32694611				MAPK14	CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C	Astatech	44169	-1.67228531	-1.58357501	-3.06985738	-1.32694611												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346709-02	NCGC00346709-02	384568926		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	5289-74-7				-12.5726435599	4	4		0	-1.60479042					CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C/3=C/C(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C	Selleck	S2417	-3.45546487	-2.75284261	-0.8943679	-1.60479042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015647-31	NCGC00015647-31	384567878		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	31430-18-9		3.1622776602	-5.5	-236.0935725002	5	4		-23.0469864864	-66.78323353	0.0405347583	0.9989876314		TUBB	COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)C(=O)C3=CC=CS3	MedChem Express	HY-13520	-44.32665011	-43.93499977	-60.48344211	-66.78323353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379064-01	R-7128	377020456		SARS-CoV-2_CPE_SRI		940908-79-2		0.0027959323	-8.5534733462	-22.4001723254	4	10		-9.743738592	-5.54110201	0.3799008247	0.3955722228			CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240	-4.28299616	11.51322176	-1.78231662	-3.38989632	-2.7064808	-1.50273755	-6.10802625	-5.56440026	-9.36978216	-5.54110201						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00163699-10	Fumagillin			SARS-CoV-2_CPE_SRI		23110-15-8				5.0524691531	4	10		0	-0.99083867					[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332	2.41418629	-2.73660205	5.05642276	4.85982778	4.98564857	-1.73003578	-2.3827311	-2.83883144	19.87968388	-0.99083867						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686670-01	GS-441524			SARS-CoV-2_CPE_SRI		1191237-69-0				-33.0841644937	4	10		0	-8.6423151					NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586	-0.29882436	-2.79164865	-4.23858766	-3.40502497	-1.00656627	-6.3067668	-3.08260921	-3.99480989	-1.79294617	-8.6423151						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00024379-17	Emetine dihydrochloride hydrate			SARS-CoV-2_CPE_SRI		7083-71-8		0.0004971949	-9.3034733462	-472.69991359	-1.1	10		-89.6090086503	-99.37094707	0.0047003517	0.9105300404			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	SIGMA	E2375	-18.82887431	-46.44507436	-63.60035724	-73.1060459	-77.58707723	-75.03980119	-78.26272667	-94.66469926	-96.38877024	-99.37094707						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00018268-05	Itraconazole		cytochrome inhibitor	SARS-CoV-2_CPE_SRI		84625-61-6		0.0049719489	-8.3034733462	-269.9207459875	-1.2	10		-68.070030676	-25.62419912	0.0000788534	0.983752861			CCC(C)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Prestwick	Prestw-1139	0.08930998	7.8476294	-3.95682056	-8.36795713	-9.5639343	-38.7100532	-63.78674329	-67.02520095	-67.14169223	-25.62419912						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI		1190307-88-0				-17.5018056645	4	10		0	-2.51232866					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-5.23822467	-3.25787287	0.36112298	-0.85038636	-3.59958063	-7.5835825	-7.26517299	-4.89651691	-4.3140605	-2.51232866						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	SARS-CoV-2_CPE_SRI		1502654-87-6		0.0009920342	-9.0034733462	-44.0449448631	4	10		-14.5030676	-9.22999262	0.0276307993	0.8330961229			COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B	2.40360346	-0.0271813	0.14367258	-7.92529026	-8.3291267	-5.75078632	-12.94218149	-9.69595775	-14.169223	-9.22999262						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00505118-01	NCGC00505118-01	384569317		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					-11.724913656	4	4		0	-3.74131737				EP300	CNC(=O)C[N]1C=C(C=N1)C2=CC3=C(C=C2)C4(CC3F)NC(=O)N(CC(=O)N(CC5=CC=C(F)C=C5)[C@@H](C)C(F)(F)F)C4=O	NCGCChem	CAL008-010_2nd_pos	-2.33765082	-1.47309303	-2.76045444	-3.74131737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522633-01	NCGC00522633-01	384569534		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	26791-73-1		11.220184543	-4.95	-43.0395947469	-3	4		-47.9637514515	-41.43516293	0.086733243	0.9953348633		NFKB1	C[C@H]1C[C@@H]2OC(=O)C(=C)[C@H]2C\C=C1\C=C\C(C)=O	Glixx	GLXC-13186	-3.39372514	-0.19221968	-4.67735153	-41.43516293												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346824-01	NCGC00346824-01	174007400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1113-59-3	3-Bromopyruvate			-0.0242249442	4	4		0	-0.99490532			29911	HK2	CCOC(=O)C(=O)CBr	SIGMA	E14578	0.93680954	-1.07093822	-1.32236811	-0.99490532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522580-01	NCGC00522580-01	384569529		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1300118-55-1		5.0118723363	-5.3	-70.6853179492	-2.2	4		-60.8817330279	-52.06671153	0.0414497092	0.9989394171			CCN1C(=O)C\N=C/2N\C=C(/N=C12)C3=C(C)N=C(C=C3)C4=NN=C[NH]4	MedChem Express	HY-16962A	-2.16526734	-9.53775744	-28.00336433	-52.06671153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241111-12	NCGC00241111-12	377020233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	209410-46-8				-34.4118980361	4	4		0	-12.64539075				MAPK14	FC1=CC=C(SC/2=N/N3\C=N/C(=O)/C(=C3/C=C2)C4=C(Cl)C=CC=C4Cl)C(=C1)F	MedChem Express	HY-10328	-4.50729121	-9.95881007	-9.28461287	-12.64539075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390270-02	NCGC00390270-02	384569184		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	110267-81-7		3.5481338923	-5.45	-49.8071638655	4	4		-21.5434586561	-26.16091505	0.0941610388	0.9945072162		TOP2A	CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C3=C(O)C4=C(C(=C3C1)O)C(=O)C5=CC=CC=C5C4=O	MedChem Express	HY-B0067	-5.77496611	-4.04136617	-18.14393407	-26.16091505												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250408-02	NCGC00250408-02	384568556		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1086062-66-9		0.0707945784	-7.15	-370.7698221318	5	4		-71.2735197036	-95.17059341	0.0963853231	0.99424171		PIK3CA	COC1=C(N[S+]([O-])(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C3=CC=C4N=CC=C(C5=CN=NC=C5)C4=C3	Selleck	S2658	-70.02259376	-83.39003039	-89.47417708	-95.17059341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346617-03	NCGC00346617-03	384568860		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	602306-29-6		8.9125093813	-5.05	-59.7850516658	-3	4		-88.4539880278	-78.93173653	0.1147214474	0.9917944088		CDK1	CC(C)[N]1C(=NC=C1C2=NC(=NC=C2)NC3=CC=C(C=C3)[S+](C)([O-])=O)C	Selleck	S2621	-1.41501065	7.44832666	-3.40826686	-78.93173653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346893-01	NCGC00346893-01	174007040		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	7307-50-7	SL 0101-1			-26.0192107487	4	4		0	-2.28502994			6195	RPS6KA1	CC1OC(OC/2=C(/OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC=C(O)C=C4)C(O)C(OC(C)=O)C1OC(C)=O	Tocris	2250	-7.81139106	-4.7691387	-1.47449843	-2.28502994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187906-15	NCGC00187906-15	377020302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	371935-74-9		0.2238721139	-6.65	-172.8592420396	-1.4	4		-41.6085803487	-42.44790419	0.5736899714	0.7192941597		PIK3CA	OC1=CC(=CC=C1)C2=NC3=C(OC4=C3C=CC=N4)C(=N2)N5CCOCC5	Enzo	270460	-20.62189496	-69.64047323	-56.93497704	-42.44790419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346723-07	NCGC00346723-07	384568934		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	942425-68-5		12.5892541179	-4.9	-80.30759998	-3	4		-84.5322217549	-80.25389222	0.0865520562	0.9953514042		CDC7	O=C1NCCC2=C1C=C([NH]2)C3=CC=NC=C3	MedChem Express	HY-13461A	-6.88875089	-3.11190904	-0.79767948	-80.25389222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025099-02	NCGC00025099-02	384568048		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[110283-66-4]				-22.2578756915	4	4		0	-0.8				SLC6A1	OC(=O)/C1=C/CCN(CCOC(C2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)C(F)(F)F)C1	Tocris	1296	-6.84439319	-3.98655803	-1.99661591	-0.8												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189075-02	NCGC00189075-02	363677126		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	391210-10-9		3.5481338923	-5.45	-133.8131935137	4	4		-11.427222264	-36.58443114	0.052756912	0.9982999299		MAP2K1	OCC(O)CONC(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(=C(F)C=C1)F	ChemieTek	CT-PD03	-25.81174592	-25.91723058	-32.10539038	-36.58443114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346808-03	NCGC00346808-03	384568942		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox		GNF 2	12.5892541179	-4.9	-40.7093908481	-3	4		-45.6670077665	-42.69035769	0.1118711189	0.9922056401	25	ABL1	NC(=O)C1=CC(=CC=C1)C2=NC=NC(=C2)NC3=CC=C(OC(F)(F)F)C=C3	NCGCChem	AED003-034	-3.49638001	-0.60171153	0.78315513	-42.69035769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263140-03	NCGC00263140-03	363677225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	309913-83-5				-40.6581487393	4	4		0	-13.6643276				MAPK14	C[C@H]1CN([C@H](C)CN1CC2=CC=C(F)C=C2)C(=O)C3=C(Cl)C=C4[N](C)C=C(C(=O)C(=O)N(C)C)C4=C3	Axon Medchem	1671	-5.9036677	-10.95652174	-11.03219476	-13.6643276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016270-13	NCGC00016270-13	384567928		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	59-92-7				-10.0595945343	4	4		0	-3.7633375					N[C@@H](CC1=CC(=C(O)C=C1)O)C(O)=O	Selleck	S1726	-1.0251878	-3.50572082	-3.11667679	-3.7633375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371263-02	NCGC00371263-02	363678072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			3.5481338923	-5.45	-10.3829127269	4	4		-10.196157984	-9.74679832	0.2289187879	0.9666621221			CN1CCN(CC1)C2=C(NC(=O)C/3=C/NC(=O)/C=C3C(F)(F)F)C=C(C=C2)C4=CC(=CC=C4)CN5CCOCC5	Tocris	5267	-0.52417533	1.70091169	-1.92442759	-9.74679832												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00263111-11	NCGC00263111-11	384568597		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	188591-46-0				-20.9372698851	4	4		0	-1.50898204				PPARD	[O-][S+](=O)(CCNC(=O)C1=CC=C(Cl)C=C1)C2=NC=C(C=C2)C(F)(F)F	MedChem Express	HY-15577	-6.56937544	-3.7748009	-0.56562727	-1.50898204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386317-04	NCGC00386317-04	384569125		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1211441-98-3				-1.767378928	4	4		0	-2.16754268				CDK4	CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5	ChemieTek	CT-LEE011	-0.21190182	1.96559101	-1.40217595	-2.16754268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263091-15	NCGC00263091-15	377020489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1431697-85-6				-20.7498142407	4	4		0	-5.60956324				CDK1	ClC1=C(C(=O)NC2=C[NH]N=C2C(=O)NC3CCNCC3)C(=CC=C1)Cl	MedChem Express	HY-50940A	-4.64418153	-6.19094313	-0.52991934	-5.60956324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346719-03	LY-2811376	384568932	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1194044-20-6				-2.0318678057	4	4		0	-1.693102				BACE1	C[C@]\1(CCS\C(=N1)N)C2=CC(=C(F)C=C2F)C3=CN=CN=C3	Axon Medchem	2225	0.2295603	-1.02068105	-0.91446258	-1.693102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387832-02	NCGC00387832-02	384569164		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	75747-14-7		8.9125093813	-5.05	-37.1159068312	-2.4	4		-38.246984088	-30.30838644	0.1474556898	0.9863706414			COC1CC(C)C/C2=C(NCC=C)/C(=O)/C=C(/NC(=O)/C(=C/C=C/C(OC)C(OC(N)=O)/C(=C/C(C)C1O)C)C)C2=O	APExBIO	A4054	-0.9358997	-5.83437333	-11.43781654	-30.30838644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163409-07	Betulinic acid	384568234	Caspase 3/8 Activator	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	472-15-1				-14.8059430714	4	4		0	0.8987792				CASP3	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	Prestwick	Prestw-NAT-0019	-4.4719399	-5.00686499	-0.79902808	0.8987792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522008-01	NCGC00522008-01	384569510		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1607803-67-7]		2.8183829313	-5.55	-16.3764159326	4	4		17.986425336	6.51113873	0.1637421108	0.9832456041		ERN1	OC1=CC=C2\C3=C(CNCC3)/C(=O)OC2=C1C4OCCCO4	Tocris	6009	-7.48868778	-3.39995509	0.36713049	6.51113873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015209-16	NCGC00015209-16	384567825		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	6055-19-2				-23.3047177143	4	4		0	-3.9105077				BCL2	ClCCN(CCCl)[P]1(=O)NCCCO1	Selleck	S2057	-4.86425339	-5.57377049	-5.81516566	-3.9105077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346693-02	NCGC00346693-02	384568915		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	582315-72-8		5.6234132519	-5.25	-54.3542683204	-2.4	4		-59.6322784223	-52.30901616	0.1632195106	0.9832080155		CDK1	CCCCOC1=C2C=N[NH]C2=NC=C1C(=O)C3=C(F)C=C(C)C=C3F	Selleck	S2014	1.86877828	-7.79249944	-20.86298328	-52.30901616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475729-01	NCGC00475729-01	384569232		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1401066-79-2		1.1220184543	-5.95	-40.8482356978	4	4		-13.042577264	-1.20470408	1	0.9998172245			CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)\N=C(C2=CC=CC=C2)/C3=CC=CC=C13	ActiveBioChem	A-1401	-4.41176471	-6.39119695	-17.36391243	-1.20470408												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346532-01	NCGC00346532-01	174007365		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox		VX-222			-10.1715306167	4	4		0	1.321691					C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]2CC[C@H](O)CC2)C3=C(SC(=C3)C#CC(C)(C)C)C(O)=O	Selleck	S1480	-3.5053554	-0.92717538	-2.23190511	1.321691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347066-11	KUC105555N	384568981	p97 ATPase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	177355-84-9		12.5892541179	-4.9	-75.4503197832	-3	4		-112.2577726846	-99.87117091	0.1068541467	0.9928910155		VCP	C(NC1=NC2=CC=CC=C2C(=N1)NCC3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-15945	-2.61131274	0.99682236	7.39288308	-99.87117091												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016457-02	NCGC00016457-02	124882284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	480-41-1	Naringenine;NARINGENIN			-13.5185302031	4	4	4',5,7-trihydroxyflavanone;CIPLUS_727689;naringenin;4',5,7-Trihydroxyflavanone;flavanone 3-dioxygenase;4',5,7-TRIHYDROXYFLAVANONE;BE 14348A;naringenin-7-sulfate;naringenin 7-O-methyltransferase;dimethylallyl diphosphate naringenin 8-dimethylallyltransferase;DMAPP naringenin DMAtransferase;(2S)-flavanone 3-hydroxylase;(+/-)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;Naringenin;flavanone 3-hydroxylase;naringenin monooxygenase;genistein synthase;alhagitin;NCGC00095963-01;CIPLUS_153433;Naringenine;NCGC_Prestw-466;NCGC00163598-01;flavanone 3beta-hydroxylase;NARINGENIN;LS-39547;NCGC00016457-01;(+/-)-Naringenin;naringenin 5-methyl ether 4'-glucoside;NADPH-2'-hydroxydaidzein oxidoreductase;isoflavone synthase;BE-14348A;naringenin 3-dioxygenase;	0	0.1005988			1576	ESR1	OC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	NP-200	-4.20067424	-3.33287299	-0.76867295	0.1005988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016991-07	NCGC00016991-07	384567972		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	5875-06-9				-7.1578383805	4	4		0	-0.08143713					CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC	Selleck	S1828	-2.50621008	-1.03116512	0.03384095	-0.08143713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018176-05	NCGC00018176-05	384567995		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	53-16-7				-24.0611464486	4	4		0	0.06227545					C[C@]12CCC3C(CCC4=C3C=CC(=C4)O)C1CCC2=O	Microsource	01500286	-6.66696238	-7.02481241	-3.10853275	0.06227545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346963-01	NCGC00346963-01	174006744		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	n	HMSL10083	8.9125093813	-5.05	-54.8083388138	-3	4		-34.7917663559	-38.68263473	0.0298151966	0.9994519809	1436	CSF1R	CCN(CC)CCCCNC1=NC=C2CN(C(=O)N(C)C2=N1)C3=C(Cl)C(=CC(=C3Cl)OC)OC	LINCS	HMSL10083	-5.9394961	-6.73940064	-8.61010394	-38.68263473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346605-03	NCGC00346605-03	384568855		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	67920-52-9				-24.2282450583	4	4		0	-6.07904192				NR1I2	OC(CC1=CC(=C(O)C=C1)O)C([O-])=O	APExBIO	N1804	-6.01046842	-3.24080468	-2.99250665	-6.07904192												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00345810-01	NCGC00345810-01	174007307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	18771-50-1	Tetrahydrouridine			1.7287257358	4	4		0	0.9581841			978	CDA	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2CCC(O)NC2=O	EMD Chemicals	584222	0.22073106	-2.06364771	2.70587132	0.9581841												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522579-01	NCGC00522579-01	384569528		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1234479-76-5		3.5481338923	-5.45	-120.2603346006	-2.1	4		-86.9486726835	-89.43093338	0.0144064398	0.999871979		ERK5	COC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C)C3=N2)C=CC(=C1)N5CCN(C)CC5	MedChem Express	HY-14403	-4.39239947	-6.22425629	-54.15167516	-89.43093338												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522578-01	NCGC00522578-01	384569527		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1206123-37-6				3.3656753108	4	4		0	2.89820244				S1PR1	OC(=O)C[C@H]1CCC2=C1[NH]C3=CC=C(OCC4=CC=C(C5CCCC5)C(=C4)C(F)(F)F)C=C23	MedChem Express	HY-12789	0.14140521	0.51258581	0.68688379	2.89820244												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346500-08	NCGC00346500-08	384568805		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	372196-77-5		0.1	-7	-419.7308580012	5	4		-50.9815718321	-89.77913758	1	0.384313361		PIK3CA	CN(/N=C/C1=CN=C2C=CC(=C[N]12)Br)[S+]([O-])(=O)C3=C(C)C=CC(=C3)[N+]([O-])=O	MedChem Express	HY-13281	-87.5520362	-96.70334606	-88.88637085	-89.77913758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162385-04	Olprinone	170465898	Phosphodiesterase III (PDE3) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	119615-63-3	;Olprinone; Olprinone;Loprinone; Coretec;Olprinone hydrochloride			6.1637142633	4	4		0	-1.49153839			5139	PDE3A	Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O	SIGMA	O7389	3.67873303	-1.10936447	-1.917237	-1.49153839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480922-01	NCGC00480922-01	377020364		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1370256-78-2		14.1253754462	-4.85	1.2030006251	4	4		-12.586888064	-8.82240672	0.482490207	0.8238248742		FLT3	CC1=CC=C(NC(=O)NC2=NN=C(S2)SC3=NC=NC4=CC(=CC=C34)OCCCN5CCOCC5)C=C1	Glixx	GLXC-06725	3.37257679	-2.03282114	0.86661825	-8.82240672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386665-06	NCGC00386665-06	384569144		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1037624-75-1		11.220184543	-4.95	-66.2843207392	-3	4		-117.1338391052	-99.50854089	0.014532497	0.9998697197		AXL	NC1=NC(=N[N]1C2=NN=C3C(=C2)CCCC4=CC=CC=C34)NC5=CC=C6CC[C@@H](CCC6=C5)N7CCCC7	MedChem Express	HY-15150	3.0362043	1.64976276	-1.1667877	-99.50854089												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389085-04	NCGC00389085-04	384569171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1613028-81-1		1.995262315	-5.7	-48.4436043057	-2.4	4		-30.2403792559	-29.40838323	0.043056987	0.9988570131			CC1=CC(=C(C(=C1)C)[S+]([O-])(=O)N(CCC2=CC=CC(=C2)Br)CC3=CC=C(C=C3)C4=CC=CC(=C4)[S+](C)([O-])=O)C	DC Chemicals	DC8279	-2.12473385	-7.44832666	-22.64926275	-29.40838323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092384-05	NCGC00092384-05	384568110		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[57653-26-6]				-18.2971044181	4	4		0	-2.50538922				GRM5	CN1CC(=O)\N=C1\NC(=O)NC2=CC(=CC=C2)Cl	Tocris	2386	-5.47817601	-2.33853519	-1.1457578	-2.50538922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167773-13	NCGC00167773-13	384568335		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	507475-17-4		3.5481338923	-5.45	-80.354024901	-2.4	4		-50.7300579916	-53.68622754	0.1357462971	0.9884644702		IKBKB	NC(=O)NC1=C(C=C(S1)C2=CC=C(F)C=C2)C(N)=O	MedChem Express	HY-10074	-6.3387154	-0.81020117	-33.58472323	-53.68622754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178852-04	NCGC00178852-04	384568365		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	32986-56-4	 Nebcin; Tobrex; Obracin;TOBRAMYCIN; Tobramycin Sulphate;; Sulfate, Tobramyci; Brulamycin;Tobramycin; Tobramycin Base; Tobramicina; Tobracin; Nebicin			9.3371659048	4	4		0	-1.33029443					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	Microsource	MS-01500579	4.41462123	-2.58067392	1.23335209	-1.33029443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346467-01	NCGC00346467-01	174007403		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1200133-34-1	VCH-916			-17.2807515298	4	4		0	-1.94427648					COC1CCC(CC1)N(C(=O)C2CCC(C)CC2)C3=C(SC(=C3)\C4=C\CCCC4)C(O)=O	Ontario Chemicals	V1152 	-3.92018365	-4.80032091	-3.52185331	-1.94427648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346821-04	NCGC00346821-04	384568943		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	179528-45-1				-25.0403292719	4	4		0	-5.67468254				CAPN1	OC(=O)/C(S)=C/C1=CC=C(I)C=C1	Cayman	13859	-6.07451881	-4.05152434	-3.51247421	-5.67468254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481604-01	NCGC00481604-01	377020508		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			0.316227766	-6.5	-266.6266795929	-1.2	4		-62.4429454654	-84.2881861	0.0451472038	0.9987413122		BRAF	C\N=C/1NC2=NC(=C(C=C2/C=N1)C3=CC(=C(F)C=C3C)N\C(O)=N\CCC(C)(C)C)C	APExBIO	B5887	-35.14803358	-76.91533181	-86.00065417	-84.2881861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025060-22	NCGC00025060-22	384568045		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	59-05-2				-15.3111735827	4	4		0	-4.47467077				DHFR	CN(CC1=NC2=C(N)N=C(N)N=C2N=C1)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O	MedChem Express	HY-14519	-3.28767123	-3.90846682	-1.20087846	-4.47467077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016978-13	NCGC00016978-13	384567971		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	135062-02-1				-18.1815647275	4	4		0	-5.16643715					CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)C(O)=O	MedChem Express	HY-15209	-3.95978752	-1.71980058	-4.30092593	-5.16643715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379068-03	NCGC00379068-03	384569092		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	147030-01-1		10	-5	-82.7452508052	-3	4		-92.4765505485	-88.90907353	0.012414428	0.999904938			CC(C)(C)SC1=C(CC(C)(C)C(O)=O)[N](CC2=CC=C(Cl)C=C2)C3=C1C=C(OCC4=NC5=CC=CC=C5C=C4)C=C3	MedChem Express	HY-50714	-3.37104072	-4.21738154	-6.7760504	-88.90907353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015089-14	NCGC00015089-14	124879266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	17440-83-4	 Amilorida; uranidil-A;Amiloride HCl;Amiloride hydrochloride; Amiloride hydrochloride; ;;AMILORIDE; Moduretic;AMILORIDE HYDROCHLORIDE; Esmaloride; Esmalorid;Amiloride; uranidil A;Amiloride..HCl; Midamor; Moducren			-21.8655589237	4	4		0	-3.00219906			6339	SCNN1D	NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N	Tocris	Tocris-0890	-4.88235294	-5.18751404	-4.2378643	-3.00219906												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00167805-03	NCGC00167805-03	384568340		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[745046-84-8]				-13.2636515229	4	4		0	-1.8453007				CASP3	CC(=O)OCCN1C(=O)C2=C(C)N=C3C=CC(=CC3=C2C1=O)[S+]([O-])(=O)N4CCOCC4	Tocris	2636	-1.95022624	-3.29216259	-6.58568644	-1.8453007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250392-01	NCGC00250392-01	137275894		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	496791-37-8	AR-C155858			4.1655496873	4	4		0	-0.24858973			6566	SLC16A1	CC(C)CN1C(=O)N(C)C(=O)C2=C1SC(=C2C(=O)N3C[C@H](O)CO3)CC4=C(C)[NH]N=C4C	NCGCChem	AR-C155858	0.61085973	1.42375926	2.56991343	-0.24858973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016083-23	NCGC00016083-23	384567918		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[152-11-4]				-18.6323607433	4	4		0	-5.56458552				DRD2	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1	Tocris	0654	-2.41176471	-6.68762632	-5.20781399	-5.56458552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249612-02	NCGC00249612-02	384568529		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1201902-80-8		0.1	-7	-395.6965242311	5	4		-78.8577773516	-98.18207844	0.1540699275	0.9851022065		PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B2OC(=O)CC(CC(O)=O)(O2)C(O)=O	Selleck	S2181	-73.6301673	-96.82235668	-95.30380053	-98.18207844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351607-02	NCGC00351607-02	384569021		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1421783-64-3		0.1	-7	-351.0545169434	-1.3	4		-93.4933481436	-99.29101796	0.3247532926	0.9288035154		ABL1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC4=CN=C5[NH]N=CC5=C4)C=C2C(F)(F)F	Selleck	S7194	-60.1446061	-88.7354417	-87.60454436	-99.29101796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015705-13	NCGC00015705-13	384567883		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	41100-52-1				-23.5966099234	4	4		0	-1.78682635				GRIN2A	CC12CC3CC(C)(C1)CC(N)(C3)C2	APExBIO	B3308	-5.29187367	-6.57367767	-5.9415035	-1.78682635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386423-05	NCGC00386423-05	384569136		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1056901-62-2		3.9810717055	-5.4	-110.1547716588	-2.3	4		-126.8946090529	-99.5767245	0.0634851069	0.9975059957		AKT1	NC[C@@](O)(C1=CC=C(Cl)C=C1)C2=CC=C(C=C2)C3=C[NH]N=C3	AdvChemBlocks	M15888	4.60886456	-15.06061687	-52.89345339	-99.5767245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345823-02	NCGC00345823-02	363677370		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(473382-50-2)		7.9432823472	-5.1	-22.2197366667	4	4		-13.7847339361	-13.31224708	0.2695697821	0.9528327779		AKT1	CC(C)(N)C1=CC=C(C=C1)C2=NC3=C(C=CC=C3)N=C2C4=CC=CC=C4	SynKinase	SYN-1006	-3.29330743	-0.5749688	-4.94747702	-13.31224708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387145-01	NCGC00387145-01	384569153		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[1229652-21-4]		5.6234132519	-5.25	-76.4977391281	-2.2	4		-50.9200626761	-51.4079491	0.0294429657	0.9994652762			OB(O)C1=CC=CC(=C1)COC2=CC=C(C=C2)/C=C/3SC(=O)N(CC4=CC=C(F)C=C4)C3=O	Tocris	4196	-6.19869178	-7.09875132	-24.72685185	-51.4079491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390261-01	NCGC00390261-01	384569182		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	165668-41-7		14.1253754462	-4.85	-9.9065260704	4	4		-16.51102204	-12.9258517	0.2528954373	0.9586271001		CA1	N[S+]([O-])(=O)C1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC3=C2[NH]C=C3Cl	Adooq	A12325	-1.10648845	2.22435032	1.46695715	-12.9258517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507892-01	NCGC00507892-01	384569355		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1383716-46-8		12.5892541179	-4.9	-45.8544555119	-3	4		-42.0985885734	-41.62133791	0.0231468522	0.9996696641		PIK3C3	CC(C)(O)CNC1=NC=C(C(=N1)CC2CC2)C3=CC=NC(=N3)NC4=CC=NC=C4	Selleck	S8456	-3.93024697	-3.20811387	-3.52941176	-41.62133791												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159459-08	NCGC00159459-08	384568181		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	115007-34-6		2.5118864315	-5.6	-53.5020336471	-2.2	4		-33.049177532	-33.45149701	0.0099203194	0.9999393879		IMPDH1	COC1=C(C/C=C(C)/CCC(=O)OCCN2CCOCC2)C(=C3C(=O)OCC3=C1C)O	Microsource	01504567	-2.5771824	-7.56801547	-23.79018613	-33.45149701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242051-10	NCGC00242051-10	384568482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	870483-87-7				4.8581148594	4	4		0	1.72934132			1436	CSF1R	COC1=CC=C(COC2=C(OC)C=C(CC3=C(N)N=C(N)N=C3)C=C2)C=C1	MedChem Express	HY-10917	1.03353442	2.97380656	-1.64853759	1.72934132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016526-16	NCGC00016526-16	384567947		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	633-65-8, 2086-83-1				-21.0419146247	4	4		0	-2.46706587				PTP4A1	COC1=C(OC)C2=C(C=C1)C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=C2	Microsource	01500811	-4.75070972	-4.02338535	-6.08653614	-2.46706587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345082-02	NCGC00345082-02	363677344		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			11.220184543	-4.95	-89.7067815505	-3	4		-114.9081371888	-99.6883576	0.0354894046	0.9992223889			CC(C)CNC1=CC=NC(=N1)NCC2=CSC(=N2)C3=CC=CC=C3	Tocris	4888	-2.1013597	-5.28169014	-8.78353029	-99.6883576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188380-05	NCGC00188380-05	384568448		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	923032-37-5		12.5892541179	-4.9	-124.7684269273	-2.4	4		-58.6333707747	-60.07721289	0.3200074218	0.9310439176		MAP2K1	COC1=CC(=C(F)C(=C1N[S+]([O-])(=O)C2(CC2)C[C@H](O)CO)NC3=C(F)C=C(I)C=C3)F	Aobious	AOB87134	-15.5571252	-28.47655554	-28.94860251	-60.07721289												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378640-02	NCGC00378640-02	363678135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1383577-62-5				-14.340818486	4	4		0	-0.90236755				OPRM1	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(O)=O	MedChem Express	HY-76657	-2.34857849	-5.06774826	-5.90414556	-0.90236755												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347067-04	NCGC00347067-04	384568982		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	19992-50-8				-20.5915655635	4	4		0	-1.67149437				MITF	N[S+]([O-])(=O)C1=CC=C(NC/2=C/C(=O)C3=CC=CC=C3C2=O)C=C1	Glixx	GLXC-03936	-4.39878836	-7.20852582	-4.39351852	-1.67149437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480876-01	NCGC00480876-01	363681112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	900874-91-1				-5.940117193	4	4		0	1.1855818				PI4KB	COC1=CC=C(C=C1OC)C2=C3N=C(C)C=C(NCCN4CCOCC4)[N]3N=C2C	Glixx	GLXC-03509	-2.80090498	3.48978217	-3.02316095	1.1855818												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390715-04	NCGC00390715-04	384569208		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	956590-23-1				-21.4356251146	4	4		0	-6.88402333					CN(C)CCN1C(=O)C2=C3C(=CC=C2)C=C(NC(N)=O)C=C3C1=O	MedChem Express	HY-16509	-4.0678733	-4.37907029	-4.06563024	-6.88402333												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262641-04	S31-201	384568576	STAT-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	501919-59-1				-25.7286297975	4	4		0	-1.6253944				STAT3	CC1=CC=C(C=C1)[S+]([O-])(=O)OCC(=O)NC2=CC=C(C(O)=O)C(=C2)O	Selleck	S1155	-6.37556561	-5.55580508	-6.22308843	-1.6253944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379065-03	NCGC00379065-03	363678334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	625115-55-1				0.7955409345	4	4		0	-2.60998187				GUCY1A2	COC(=O)N(C)C1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24	Bio Vision	2644	0.84978313	-0.96199887	1.78649237	-2.60998187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508900-01	NCGC00508900-01	384569371		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[1206711-14-9]		4.4668359215	-5.35	-44.8884079729	4	4		-23.283953924	-26.67084882	0.0393374389	0.9990468438		TGFBR1	C1CN(CCO1)CCOC2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC6=C5C=CC=C6	Tocris	5580	-4.73698457	-3.93422055	-5.01438954	-26.67084882												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015981-12	NCGC00015981-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	330161-87-0				-5.2590839241	4	4		0	-1.15330792					CN(C)[S+]([O-])(=O)C1=CC2=C(NC(=O)\C2=C/C3=CC4=C(CCCC4)N3)C=C1	SIGMA	S9692	-0.62257511	-1.24568714	-2.77059656	-1.15330792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346536-06	NCGC00346536-06	363677444		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	593960-11-3		11.220184543	-4.95	-43.6715886038	-2.4	4		-31.33709842	-29.99083144	0.031331192	0.999395365		PIK3CA	CC(=O)NC1=NC(=C(S1)C2=CC(=C(Cl)C=C2)[S+]([O-])(=O)NCCO)C	MedChem Express	HY-12046	-4.70991609	-5.46668459	-7.73620799	-29.99083144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015599-10	NCGC00015599-10	384567870		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	79558-09-1		3.9810717055	-5.4	-10.7776545346	4	4		11.52860674	6.1305177	0.0390400093	0.9990697244		PPARG	CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(=C1O)C(C)=O	SIGMA	L2167	-5.02383895	-4.66660724	1.04577002	6.1305177												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346614-07	NCGC00346614-07	363677477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	900185-02-6		10	-5	-25.2512452517	4	4		-30.699581232	-23.13595981	0.1365834097	0.9883505813		PIK3CA	CC1=C(C=CC=C1)N2C(=O)C3=C(C=CC=C3C)\N=C2\C[N]4N=C(C5=CC(=CC=C5)O)C6=C(N)N=CN=C46	MedChem Express	HY-10303	-0.05297545	-3.52558388	-7.66741699	-23.13595981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510267-01	NCGC00510267-01	384569424		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1844849-10-0				-30.8843954456	4	4		0	-7.28405972				EZH2	CO[C@H](C1COC1)C2=C(Cl)C3=C(CCN(C\C4=C(OC)\C=C(\C)NC4=O)C3=O)C(=C2)Cl	ChemieTek	CT-PF0682	-4.90022956	-10.63915136	-7.85499906	-7.28405972												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242504-01	NCGC00242504-01	137275858		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1110-40-3	Cortivazol	12.5892541179	-4.9	-60.5434994559	-3	4		-88.305712522	-79.2155373	0.1018327365	0.9935495857		NRC31	C[C@@H]1C[C@H]2[C@@H]3\C=C(C)/C4=C/C5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=N[N]5C6=CC=CC=C6	NCGCChem	Cortivazol	-1.91404364	-0.23784476	5.31944444	-79.2155373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384168-11	NCGC00384168-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	912545-86-9		12.5892541179	-4.9	-87.6669470749	-3	4		-112.14281246	-99.71983475	0.0241505499	0.9996401013			CN[C@H]1CC[C@@H](CC1)N(CC2=CC=CC(=C2)C3=CC=NC=C3)C(=O)C4=C(Cl)C5=CC=CC=C5S4	DC Chemicals	DC8225	-3.62614689	-1.44536431	-4.09722222	-99.71983475												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164590-08	NCGC00164590-08	384568260		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	67392-87-4				-16.6295435217	4	4		0	-5.97369296				PGR	C[C@]\12CCC(=O)\C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7	MedChem Express	HY-B0111	-3.89832741	-0.79586516	-2.36574074	-5.97369296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345843-02	NCGC00345843-02	363677386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	(1003311-62-3)		8.9125093813	-5.05	-75.2490104325	-2.2	4		-87.0392877824	-71.74682092	0.0317419552	0.9993781727		KIT	CC\1=C(C(=O)N(\C=C1)C2=CC=C(C=C2)C3=NC=CO3)/C4=CC5=CN=C(N)N=C5C=C4	SynKinase	SYN-1125	-1.80542986	-4.8282057	-19.51230567	-71.74682092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371153-09	NCGC00371153-09	363678067		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1342278-01-6		3.5481338923	-5.45	-8.8002411077	4	4		-10.737259772	-9.78104981	0.1782503765	0.9801050925		ROCK1	OC1=CC(=CC=C1)CNC(=O)NC2=NC(=CS2)C3=CC=NC=C3	Glixx	GLXC-05200	0.28506787	1.97170447	-5.14435933	-9.78104981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249393-08	NCGC00249393-08	377020310		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1218779-75-9				-14.4139204734	4	4		0	-2.67712018				FLT1	O=C(NC1=CC=C(C=C1)C2(CCCC2)C#N)C3=CC=CN=C3NCC4=CC=NC=C4	MedChem Express	HY-13342	-2.41176471	-6.84931507	-2.09853601	-2.67712018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510483-02	NCGC00510483-02	384569446		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1129403-56-0		12.5892541179	-4.9	-82.7042340457	-3	4		-107.8361869127	-99.62305564	0.017033688	0.9998210052		PDGFRA	CCN(CC)CCNC(=O)C1=C(C)[NH]C(=C1C)\C=C2\C(=O)NC3=C2C=C(C=C3)C4=CSC(=N4)C5=CC=CC=C5	Selleck	S8572	-2.4519784	-0.87494015	-1.96078431	-99.62305564												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263182-04	Mocetinostat	384568650	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	726169-73-9		2.2387211386	-5.65	-147.2774860198	-1.3	4		-92.6760605743	-99.4894551	0.1089935665	0.9926006664		HDAC1	NC1=C(NC(=O)C2=CC=C(CNC3=NC(=CC=N3)C4=CC=CN=C4)C=C2)C=CC=C1	Selleck	S1122	-1.01796937	-12.37539721	-88.22561123	-99.4894551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510505-01	WT-161	384569466	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1206731-57-8		11.220184543	-4.95	-98.5668890538	-2.1	4		-119.9628650928	-98.92642428	0.014236622	0.999874975		HDAC1	ONC(=O)CCCCCCC(=O)N\N=C\C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-100871	-3.90369125	-5.19305271	-15.77826192	-98.92642428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510487-01	NCGC00510487-01	384569449		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1402837-78-8				6.2194584771	4	4		0	-0.69970564				IDO1	O[C@@H]1CC[C@H](CC1)[C@H](O)C[C@@H]2[N]3C=NC=C3C4=C2C(=CC=C4)F	MedChem Express	HY-18770B	2.65271136	0.94994847	-0.99507341	-0.69970564												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015790-18	NCGC00015790-18	384567891		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	167869-21-8				-26.894961407	4	4		0	-10.32606168				MAP2K1	COC1=CC=CC(=C1N)\C2=C\C(=O)C3=C(O2)C=CC=C3	MedChem Express	HY-12028	-4.44110895	-4.97860581	-6.23241418	-10.32606168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263223-02	NCGC00263223-02	384568677		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			8.9125093813	-5.05	-56.6098362181	-2.4	4		-62.7884459105	-50.37443602	0.0517007694	0.9983486541		PIK3CA	CN(C)CCN(C)C(=O)C1=CC=C(NC(=O)NC2=CC=C(C=C2)C3=NC4=C(C=C[N]4CC(F)(F)F)C(=N3)N5CCOCC5)C=C1	Cayman	13838	-1.42150803	-5.1747192	-16.75576815	-50.37443602												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345850-02	NCGC00345850-02	384568765		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(848344-36-5)		8.9125093813	-5.05	-36.2640920929	-3	4		-55.3909716764	-48.40225127	0.062579165	0.9975778849		MAPK8	N#CC(=C/1NC2=CC=CC=C2S1)\C3=NC(=NC=C3)OCC4=CC=C(CN5CCOCC5)C=C4	SynKinase	SYN-1147	0.15892636	2.91050098	-3.61564434	-48.40225127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345845-02	NCGC00345845-02	363677388		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	(936091-56-4)		3.1622776602	-5.5	-149.0161124058	-1.1	4		-89.4611031235	-97.47851275	0.0458528532	0.9987010414		JAK2	CC1=C(NC2=CC=CC(=C2)[S+]([O-])(=O)NC(C)(C)C)N=C(NC3=CC(=CC=C3)CN4CCOCC4)N=C1	SynKinase	SYN-1107	-6.42697221	-10.58409184	-74.89351852	-97.47851275												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091641-16	6-Mercaptopurine			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	50-44-2				-22.8428695311	4	4		0	-12.44870694					S=C1NC=NC2=C1NC=N2	MedChem Express	HY-13677	-2.46083031	-6.65563923	-3.72306947	-12.44870694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091112-15	NCGC00091112-15	384568094		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	548-62-9		0.8912509381	-6.05	-189.2891389548	-1.1	4		-95.8527210552	-99.2795114	0.0468791747	0.9986421354		TNFR1	CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)=C/3\C=C/C(/C=C3)=[N+](C)C	MedChem Express	HY-B0324A	-6.14322386	-42.68053802	-99.52553861	-99.2795114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025177-18	NCGC00025177-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	129-46-4				-17.0343331276	4	4		0	-0.78728886					CC1=CC=C(C=C1NC(=O)C2=CC=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC4=C(C)C=CC(=C4)C(=O)NC5=CC=C(C6=C5C(=CC(=C6)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O)=C2)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O	BIOMOL	G430	-5.44392317	-4.91446481	-0.73105786	-0.78728886												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00348107-03	NCGC00348107-03	363677735		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	885704-21-2				-7.860597781	4	4		0	-1.12435458				CSF1R	CC1CCN(CC1)C2=CC(=CC=C2NC(=O)C3=CC(=C[NH]3)C#N)N4CCN(C)CC4	MedChem Express	HY-13075	-1.10078499	-5.91477349	-0.10731184	-1.12435458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378713-03	NCGC00378713-03	384569064		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			11.220184543	-4.95	-22.9426981031	4	4		-21.0962026	-17.95589442	0.1568833863	0.9845960416		NOTCH1	CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C	Tocris	5751	-1.20905892	-3.67432899	-5.53143749	-17.95589442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390587-01	NCGC00390587-01	363680917		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1380672-07-0		0.2238721139	-6.65	-58.4340280635	4	4		-16.9650549959	-16.32485644	0.5194569336	0.7860106509	80351	TACR1	C[S+]([O-])(=O)C1=CC=C(N=C1)C2=NN=C(\C=C\C3=NN=C(O3)C4=CC=C(C=C4)C#N)[N]2C5=C(Cl)C=CC=C5	MedChem Express	HY-12438	-6.00920328	-25.14674911	-19.04297351	-16.32485644												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263189-06	NCGC00263189-06	363677254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	943540-75-8				-12.2495466789	4	4		0	-5.20024187				MET	C[N]1C=C(C=N1)C2=N[N]3C(=NN=C3C(F)(F)C4=CC=C5N=CC=CC5=C4)C=C2	Glixx	GLXC-90142	-0.45912061	-4.71117846	-5.57587695	-5.20024187												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167767-12	NCGC00167767-12	377020288		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	873225-46-8		11.220184543	-4.95	-79.9664103376	-3	4		-113.8117447275	-99.06507279	0.0370758591	0.9991512281		IKBKB	O=C(N1CCC(CC1)N2CCCC2)C3=CC=C(NC4=NC=CC(=N4)C5=CC6=C(S5)C=CC=C6)C=C3	MedChem Express	HY-13687	0.16775561	-3.27598502	-5.81035453	-99.06507279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164622-16	NCGC00164622-16	384568268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	137234-62-9				-18.4028871005	4	4		0	0.67429603				CYP51A1	C[C@@H](C1=NC=NC=C1F)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-76200	-4.80266913	-6.16566802	-3.33796296	0.67429603												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00273985-04	NCGC00273985-04	363677309		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	915363-56-3		11.220184543	-4.95	-77.6403632756	-3	4		-106.3421896002	-99.67234911	0.0029476391	0.9999946411		MAP3K8	CCN1CCC(CC1)[N]2C=C(CNC3=CC(=C4N=CC(=C(NC5=CC=C(F)C(=C5)Cl)C4=C3)C#N)Cl)N=N2	MedChem Express	HY-32018	-0.58826112	-0.76842153	-1.5787037	-99.67234911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390733-04	NCGC00390733-04	384569210		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[1527473-33-1]		4.4668359215	-5.35	2.9429622827	4	4		11.317924404	9.24070469	0.0286145565	0.9995006543		LRRK2	N#CC1=CC=CC(=C1)C2=C[NH]C3=NC=NC(=C23)N4CCOCC4	Tocris	5716	-1.93160367	-1.66491332	3.05092593	9.24070469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481611-02	NCGC00481611-02	377020235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	939805-30-8		3.5481338923	-5.45	-116.0803738104	-2.3	4		-99.9047533153	-99.30196116	0.0597472696	0.9977918341		FGFR1	COCC1=C(CN2CCOCC2)[N]3N=CN=C(N)C3=C1C4=CC=C(NC(=O)NC5=CC(=CC=C5F)C(F)(F)F)C(=C4)F	MedChem Express	HY-16025	-1.57162299	2.46992636	-56.61574074	-99.30196116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386370-01	NCGC00386370-01	384569129		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1246560-33-7		0.8912509381	-6.05	-177.0969743021	-1.2	4		-61.6817799231	-74.21359595	0.0243438327	0.9996344357		PIK3CA	CC(C)[N]1C(=NC2=C1N=C(N=C2C3=CN=C(N)N=C3)N4CCOCC4)C	Selleck	S7016	-17.01809955	-42.3310128	-69.50550696	-74.21359595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346448-03	NCGC00346448-03	384568779		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	206873-63-4				9.5224349874	4	4		0	3.30815566				ABCBA	COC1=CC2=C(CN(CCC3=CC=C(NC(=O)C4=CC(=C(OC)C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)C=C3)CC2)C=C1OC	Axon Medchem	1960	1.99547511	2.55558051	0.24022118	3.30815566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479176-02	NCGC00479176-02	363681104		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1448428-04-3		14.1253754462	-4.85	-10.6665867519	4	4		-13.508987476	-11.67415623	0.323655299	0.9298959985		MAP3K5	CC(C)[N]1C=NN=C1C2=CC=CC(=N2)NC(=O)C3=CC(=C(C)C=C3F)[N]4C=NC(=C4)C5CC5	Sun-shine	100503	-0.92760181	-1.48663822	2.09853601	-11.67415623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242596-05	NCGC00242596-05			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	146464-95-1		199.5262314969	-3.7	-381.3975778659	5	4		2.721313844	-80.81078497	0.569034729	0.951073281			NC1=NC(N)=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1	Selleck	S1497	-81.2081448	-81.4596901	-81.09957848	-80.81078497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189130-07	NCGC00189130-07	384568458		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1320288-19-4				-18.8009129706	4	4		0	-4.51856093			10919	EHMT2	COC1=C(OCCCN2CCCCC2)C=C3N=C(N=C(NC4CCN(CC4)CC5CCCCC5)C3=C1)N6CCCN(CC6)C(C)C	MedChem Express	HY-13808	-4.0895813	-5.53258173	-1.59283466	-4.51856093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509938-02	NCGC00509938-02	384569387		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1365888-06-7		12.5892541179	-4.9	-82.009168137	-3	4		-80.8317087341	-77.48395503	0.1797373731	0.9795324734		ESR1	CC\C(C1=C(Cl)C=C(F)C=C1)=C(\C2=CC=C(\C=C\C(O)=O)C=C2)C3=CC4=C([NH]N=C4)C=C3	MedChem Express	HY-12864	-6.48741316	-11.2111843	0.43900298	-77.48395503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263232-01	NCGC00263232-01	137276076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	311795-38-7	GLS968	12.5892541179	-4.9	-30.4470139893	4	4		-24.45183204	-22.98412392	0.1328389081	0.9889947968	27165	GLS	CN(C)C1=C(Br)C=C(C=C1)C\2NC3=C(\C4=C2C(=O)CC(C)(C)C4)C5=CC=CC=C5C=C3	NCGCChem	GLS968	-2.60759722	-5.03651925	-4.41929662	-22.98412392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00081778-05	NCGC00081778-05	384568076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[868224-64-0]				-1.1952093366	4	4		0	3.66589107				NR5A1	CCOC(=O)C(C)OC1=CC=CC2=C1\C=C/N(CC(=O)NC3=CC=C4OCCOC4=C3)C2=O	Tocris	3440	-2.07208394	-0.78671728	2.72685185	3.66589107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095191-14	NCGC00095191-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	204255-11-8				-7.8176754034	4	4		0	-1.36758631					CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	MedChem Express	HY-17016	-1.74722332	-2.20463797	-1.13425926	-1.36758631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250411-03	NCGC00250411-03	384568559		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[128253-31-6]				4.9088011854	4	4		0	6.94239992				ALOX5AP	OC(=O)[C@H](C1CCCC1)C2=CC=C(OCC3=NC4=CC=CC=C4C=C3)C=C2	Tocris	3541	-0.69362132	2.36015185	-0.22685185	6.94239992												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346519-04	NCGC00346519-04	384568816		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	61036-62-2		15.8489319246	-4.8	-16.7478559881	4	4		7.8833333279	0.18994254	0.7383855512	0.3739125322			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	Selleck	S1399	-2.38816454	-3.8695513	-11.56944444	0.18994254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025357-13	NCGC00025357-13	384568070		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	65141-46-0				-6.2827168485	4	4		0	-0.95611435					[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1	MedChem Express	HY-B0341	-0.81900452	-1.28003593	-3.69396728	-0.95611435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168774-04	NCGC00168774-04	384568347		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	161735-79-1				-1.7165415847	4	4		0	-1.86749023				MAOB	C#CCN[C@@H]1CCC2=C1C=CC=C2	Selleck	S2102	-0.39700442	-0.51082135	1.50236574	-1.86749023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024976-06	NCGC00024976-06	363676534		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	124431-80-7				-7.1854314478	4	4		0	-1.35598128				ADORA2A	CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=C(NCCC4=CC=C(CCC(O)=O)C=C4)N=C3N	Selleck	S2153	-2.45420915	-0.21508267	0.35120238	-1.35598128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164600-03	NCGC00164600-03	174006961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox		Artesunate (AS);Artesunate;ARTEMISININUM; Artesunate (AS)	10	-5	-14.0274437426	4	4		-16.964435656	-15.80369638	0.1406932901	0.9876535057		PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S2265	-1.04664802	1.09333692	-0.43900298	-15.80369638												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186009-04	NCGC00186009-04	363677107		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	648449-76-7		10	-5	-30.4840704355	-3	4		-43.855234064	-36.2539652	0.0222533422	0.9996947358		PIK3CG	FC1(F)OC2=C(O1)C=C(C=C2)\C=C\3SC(=O)NC3=O	Selleck	S2681	-0.12372956	0.28375286	-4.67735153	-36.2539652												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522632-01	NCGC00522632-01	384569533		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	104012-37-5				-14.9229069963	4	4		0	-6.64712102					CC\C(C)=C\C(=O)O[C@@H]1C[C@@H](C(C)C)[C@H]2[C@@H](CC(=O)[C@H]2[C@@H](C)OC(C)=O)C1=C	Glixx	GLXC-06911	-2.46575342	-1.99542334	-3.23816644	-6.64712102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507883-01	NCGC00507883-01	384569348		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1621862-70-1				-3.2959107563	4	4		0	-5.78198597				EZH2	COC/1=C(\CNC(=O)C2=C(C)[N]([C@H](C)C3CCN(CC3)CC(F)(F)F)C4=C2C=CC=C4)C(=O)N/C(=C1)C	Selleck	S8353	1.82942996	-3.71624714	-1.49992991	-5.78198597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186006-10	NCGC00186006-10	384568434		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	77191-36-7				-22.8324216692	4	4		0	-2.18433924				GABRA1	CC1=C(NC(=O)CN2CCCC2=O)C(=CC=C1)C	MedChem Express	HY-B0340	-6.11089161	-5.32406349	-2.68055556	-2.18433924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162073-12	H-89	384568218	AKT Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	130964-39-5		7.0794578438	-5.15	-22.9738751778	4	4		-16.7628800479	-16.05240004	0.3079155494	0.9369304144		AKT1	[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23	MedChem Express	HY-15979A	-3.18120199	1.09311925	-5.17394765	-16.05240004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263145-02	NCGC00263145-02	384568620		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	883065-90-5		12.5892541179	-4.9	-72.6911812967	-3	4		-110.1188928195	-99.29247538	0.0316853998	0.9993802753		MAPK8	OC1=NN=C(SC2=NC=C(S2)[N+]([O-])=O)[N]1C3=CC4=C(OCCO4)C=C3	Chemdea	CD0179	0.26696833	-0.68717718	1.89004215	-99.29247538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015223-21	NCGC00015223-21			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	41575-94-4				-18.1390572048	4	4		0	-3.48792824					[NH3+][Pt-6]1([NH3+])OC(=O)[C]2(C[CH2]C2)C(=O)O1	Selleck	S1215	-3.33716916	-8.30104906	-1.72839506	-3.48792824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386271-02	NCGC00386271-02	384569119		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1375465-09-0		6.3095734448	-5.2	-112.5821924543	-2.1	4		-95.5628111678	-92.28456914	0.0086727034	0.9999536097		EGFR	COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)NC4CN(CCF)C4	APExBIO	B3227	-6.05470479	-7.02999173	-33.23650448	-92.28456914												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015623-11	NCGC00015623-11	384567877		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	6620-60-6				-28.2958852074	4	4		0	-4.36712831					CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1	Prestwick	Prestw-240	-6.09040873	-9.45467581	-4.10711673	-4.36712831												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015672-15	NCGC00015672-15	384567879		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	6202-27-3	Morin;MORIN			-10.2551234694	4	4		0	-2.99432856			1544	CYP1A2	OC1=CC(=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O)O	Microsource	MS-01502259	-2.02386213	-3.27688787	-0.79902808	-2.99432856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263130-02	NCGC00263130-02	363677217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	628279-07-2				-2.6635920092	4	4		0	-1.62933769				PCK1	CCCCN1C(=O)N(CC2=C(F)C=CC=C2)C(=O)C3=C1[NH]C(=N3)CC4=CC=C(NC(C)=O)C=C4	Axon Medchem	1165	-1.59080866	6.65446224	-2.91107892	-1.62933769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015554-13	NCGC00015554-13	384567863		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	110448-33-4				-15.8168578226	4	4		0	-2.12141949				MYLK	[O-][S+](=O)(N1CCCNCC1)C2=CC=CC3=C(I)C=CC=C23	MedChem Express	HY-15417	-3.93131496	-3.34285844	-2.65486726	-2.12141949												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016060-14	NCGC00016060-14	384567917		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	67526-95-8		0.2818382931	-6.55	-352.3673998191	-1.3	4		-49.4624777138	-99.64805944	0.1692001968	0.9819303013			CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)\C(C)=C/C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(C)=O)[C@@H]12)OC(=O)CCC)C	Cayman	10522	-57.74062359	-93.29614006	-93.32303226	-99.64805944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386398-03	NCGC00386398-03	363680254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1431697-89-0		0.1122018454	-6.95	-241.2920835283	-1.1	4		-88.8428355039	-88.26864796	0.0023260939	0.9999966631		MELK	CN(C)C[C@@H]1CC[C@H](CC1)NC2=C(C=NC3=CC=C(N=C23)C4=CC(=C(O)C(=C4)Cl)Cl)C(C)=O	Glixx	GLXC-05730	-6.33529146	-59.03297501	-86.7116168	-88.26864796												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00163125-13	NCGC00163125-13	384568230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	145-13-1				-10.5394432414	4	4		0	1.85746407					CC(=O)[C@H]1CC[C@H]2[C@@H]3C/C=C4/C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0151	-2.92815183	-2.05470132	-4.31240343	1.85746407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00348110-01	NCGC00348110-01	384569002		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	n		1.4125375446	-5.85	-191.5988593364	-2.3	4		-116.6485581503	-99.72626845	0.1610283811	0.9836599891		TNK2	COC(C)(C)CC[N]1N=C(NC2=C(C)C=CC=C2C)C3=CN=C(NC4=CC(=C(OCCN5CCCC5)C=C4)F)N=C13	NCGCChem	PRP003-032	-13.70085856	-47.56656234	-69.85531676	-99.72626845												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378933-01	NCGC00378933-01	363678285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	956136-95-1				-6.0912105437	4	4		0	2.66723924				DGAT1	OC(=O)C[C@H]1CC[C@@H](CC1)C2=CC=C(C=C2)C3=NC=C(NC4=CC=C(N=C4)C(F)(F)F)C=C3	MedChem Express	HY-16278	-3.25750199	-1.59752753	1.93173566	2.66723924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351593-05	NCGC00351593-05	377020510		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1168091-68-6		12.5892541179	-4.9	-37.5543347148	4	4		-26.061911	-23.39229069	0.2571724197	0.9570346581		MAP2K1	OCCONC(=O)C1=C(NC2=CC=C(I)C=C2F)[N]3C=NC=C3C=C1	MedChem Express	HY-15610	-3.34069819	-7.98169336	-8.5276389	-23.39229069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346807-05	NCGC00346807-05	384568941		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1234480-84-2		5.0118723363	-5.3	-99.4153223119	-2.1	4		-90.9300104366	-86.89320388	0.040560101	0.9989840425		LRRK2	COC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C)C3=N2)C=CC(=C1)C(=O)N5CCC(CC5)N6CCN(C)CC6	Glixx	GLXC-02871	-2.6955369	-1.95881007	-37.5075931	-86.89320388												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485875-01	NCGC00485875-01	363681386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	865838-26-2		3.1622776602	-5.5	-38.7304191122	4	4		-27.465202348	-28.30433529	0.0814906987	0.9958883044		CDK1	NC\1=N\C(=O)N(\C=C1)[C@H]\2[C@H](O)[C@H](O)C(=C2F)\CO	MedChem Express	HY-15228	-1.64383562	0.19221968	-19.33087239	-28.30433529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024309-20	NCGC00024309-20	384568024		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[33286-22-5]				-24.0501522523	4	4		0	-9.38671537					COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O	Tocris	0685	-4.41007512	-1.67505721	-6.5838045	-9.38671537												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387215-01	NCGC00387215-01	384569154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			10	-5	-105.2249711193	-2.4	4		-85.3376589084	-76.16552917	0.0531010049	0.998257212	1956	EGFR	C[C@@H](NC1=C2C=C([NH]C2=NC=N1)C3=CC=C(O)C=C3)C4=CC=CC=C4	Tocris	4941	-8.91736633	-12.83295194	-23.68580907	-76.16552917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025330-09	NCGC00025330-09	384568068		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1431697-90-3				-12.9541941872	4	4		0	-3.08925604				HCRTR1	CN(C)C1=CC=C(NC(=O)NC2=CC(=NC3=C2C=C(F)C=C3F)C)C=C1	MedChem Express	HY-76612	-3.69633981	-0.81190185	-1.1752587	-3.08925604												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00164547-18	NCGC00164547-18	384568250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	107753-78-6				1.5324633016	4	4		0	5.35731743				CYSLTR1	COC1=CC(=CC=C1CC2=C[N](C)C3=CC=C(NC(=O)OC4CCCC4)C=C23)C(=O)N[S+]([O-])(=O)C5=CC=CC=C5C	MedChem Express	HY-17492	-2.0786263	3.67850501	0.37926675	5.35731743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094374-12	NCGC00094374-12	384568129		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	186692-46-6		14.1253754462	-4.85	-28.6607710621	4	4		-23.0318701679	-21.69322514	0.2455197421	0.9609962488		CDK1	CC[C@H](CO)NC1=NC(=C2N=C[N](C(C)C)C2=N1)NCC3=CC=CC=C3	Glixx	GLXC-04786	-4.58201536	-1.16569148	0.09832842	-21.69322514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379339-01	NCGC00379339-01	377020268		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-26.8727701319	4	4		0	-3.42164434					CCCCCCCCCCCCCCCCOCCCO[P](O)(=O)COC(CO)CN1/C=C\C(=N/C1=O)N	NCGCChem	PJM002-071	-6.21780389	-6.94425545	-5.1271246	-3.42164434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015436-14	NCGC00015436-14	384567843		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	146-56-5		12.5892541179	-4.9	-83.9131715409	-3	4		-107.5648135732	-99.55928144	0.0262082296	0.9995761229		DRD2	OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	Microsource	01500994	-3.04737402	-0.62606454	-1.83224559	-99.55928144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168085-26	NCGC00168085-26	384568346		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	149647-78-9		2.2387211386	-5.65	-169.782129254	-1.1	4		-93.404708996	-99.62634731	0.0158450538	0.999845126		HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	MedChem Express	HY-10221	-10.25993612	-21.98591355	-76.90113609	-99.62634731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250375-10	NCGC00250375-10	384568536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	867160-71-2				-3.4656193151	4	4		0	3.8754491				IGFR1	C[C@]1(O)CC(C1)C2=NC(=C3[N]2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6	MedChem Express	HY-10191	-2.32877928	-1.54674769	0.95238095	3.8754491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161679-02	NCGC00161679-02	26755342		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	133407-82-6	MG-132	1	-6	-167.2708388419	-1.1	4	NCGC00161679-02;Z-Leu-Leu-Leu-al;MG132;CIPLUS_684965;MG-132;LS-172868;benzyloxycarbonylleucyl-leucyl-leucine aldehyde;benzyloxycarbonyl-leucyl-leucyl-leucinal;	-92.5093888297	-97.38443114	0.0351594426	0.999236796	5707	PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	BIOMOL	BIOMOL_PI-102	-3.59740951	-27.9979745	-94.03432439	-97.38443114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488701-03	NCGC00488701-03	384569283		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-91.1116161947	4	4		0	-21.99005935				SLC2A1	CC1=C(NC(=O)C2=CC(=NC3=CC(=CC=C23)F)C(N)=O)C(=N[N]1CC4=CC=C(C=C4)C#N)C(F)(F)F	Axon Medchem	2660	-17.44112605	-21.83089125	-21.2867665	-21.99005935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378976-03	NCGC00378976-03	384569081		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1229705-06-9		12.5892541179	-4.9	-224.9922189854	-2.3	4		-92.5208487118	-99.35337548	0.2059187666	0.972906823		MDM2	COC1=C(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]2C3=C(F)C(=CC=C3)Cl)C4=CC=C(Cl)C=C4F)C=CC(=C1)C(O)=O	Aobious	AOB87132	-32.86113868	-45.58856477	-50.00731672	-99.35337548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509913-01	NCGC00509913-01	384569379		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	664969-54-4				-16.0400734349	4	4		0	-1.51039907					N[S+]([O-])(=O)C1=CC=C(NC(=S)N2CCN(CC2)C\C=C\C3=CC=CC=C3)C=C1	Selleck	S8474	-2.89632771	-6.92745441	-3.8242037	-1.51039907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168110-05	NCGC00168110-05	363676678		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	639089-54-6				-37.1389424447	4	4		0	-10.57279351				AURKA	CN1CCN(CC1)C2=CC(=NC(=N2)SC3=CC=C(NC(=O)C4CC4)C=C3)NC5=CC(=N[NH]5)C	Selleck	S1048	-5.57610755	-12.07151499	-9.38490805	-10.57279351												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389231-01	NCGC00389231-01	377020350		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	920113-03-7		2.2387211386	-5.65	-143.2499041666	-1.3	4		-80.4269033407	-88.16773633	0.0551792631	0.9981174515		CDK4	CN1CCC(C1CO)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	APExBIO	B1430	-5.32346837	-11.0050634	-80.21072143	-88.16773633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475744-02	NCGC00475744-02	377020261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[1101810-02-9]		2.5118864315	-5.6	-112.1406395526	-2.2	4		-44.2548827368	-52.19167548	0.0121938672	0.9999083626		MTOR	C[C@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S+]([O-])(=O)C4CC4)C5=CC=C(NC(=S)NCCO)C=C5	Tocris	5615	-12.50552364	-19.89016018	-39.04957712	-52.19167548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484080-02	NCGC00484080-02	384569271		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1192189-69-7				-16.9144651031	4	4		0	-3.58069788				LIMK1	CN(C)C(=O)OC1=CC=CC(=C1)NC(=O)C2(CN)CCN(CC2)C3=C4C(=C[NH]C4=NC=N3)C	MedChem Express	HY-12659_cm2	-4.21564295	-2.14187643	-2.8269707	-3.58069788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187481-08	NCGC00187481-08	384568444		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	915019-65-7		0.0316227766	-7.4999999999	-188.143742723	5	4		-27.5593134199	-45.12640584	0.0537042649	0.9982296175		MTOR	CN1C(=O)N(C2=CC=C(C=C2)C(C)(C)C#N)C3=C4C=C(C=CC4=NC=C13)C5=CC6=C(C=CC=C6)N=C5	Selleck	S1009	-31.91338931	-45.40045767	-45.71281716	-45.12640584												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00481403-01	NCGC00481403-01	377020458		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1609281-86-8				-6.627314021	4	4		0	5.53328771				IKBKB	CC1=C(C(=NO1)C)C2=CC=C(C(=C2)O[C@H]3CCNC3)C4=CC(=C(NC(N)=O)S4)C(N)=O	MedChem Express	HY-19362	-3.28965206	-2.62620765	-0.7538512	5.53328771												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091019-19	NCGC00091019-19	384568091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	50-02-2				-2.1416473517	4	4		0	0.66477662				NR3C1	C[C@@H]1C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	MedChem Express	HY-14648	-0.4789878	-0.22225246	-1.80268764	0.66477662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483210-07	NCGC00483210-07			SARS-CoV-2_CPE_SRI				0.0019793685	-8.7034733462	-403.7373971351	-1.1	10		-104.1610191463	-56.48566823	0.0053046076	0.927427684			CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049	-7.66720403	-27.96366925	-34.97031416	-45.35052884	-66.79510872	-52.0033028	-72.75586836	-83.28549522	-89.85963119	-56.48566823						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	SARS-CoV-2_CPE_SRI				0.0001979368	-9.7034733462	-486.8624029138	5	10		-0.585341876	-89.16761688	0.6036961315	0.441193239			CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209	-89.09684268	-89.23052727	-89.38780325	-89.15975308	-89.63158102	-89.84390359	-89.21479967	-90.33145913	-89.0103409	-89.16761688						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00180626-04	Cephaeline			SARS-CoV-2_CPE_SRI		483-17-0		0.0002795932	-9.5534733462	-498.1595903795	-1.1	10		-93.3457849615	-99.38647925	0.0009720607	0.9462306793			CC[C@H]1CN2CCC3=C(C=C(OC)C(=C3)OC)[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(=C5)O	Carbosynth	FC19891	-55.93523085	-66.94754009	-73.13711024	-78.55007184	-79.30338213	-80.25861065	-96.1402555	-98.15167165	-98.81178892	-99.38647925						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485478-02	Oritavancin (diphosphate)			SARS-CoV-2_CPE_SRI		192564-14-0		0.0788000792	-7.1034733462	-24.4023060818	4	10		-11.153380192	-8.46115016	0.2283933823	0.5687223366			[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1	-4.53151089	1.81338097	-3.25787287	-0.06601173	0.26792995	0.92804722	1.76678445	-0.28346212	1.42507669	-8.46115016						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346651-08	NCGC00346651-08	384568882		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	170151-24-3				-23.3608080687	4	4		0	-6.01197605					NCC/1=C/NC(=S)N1[C@H]2CCC3=C(F)C=C(F)C=C3C2	MedChem Express	HY-13289A	-5.90400994	-3.38811398	-2.03529127	-6.01197605												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016456-20	NCGC00016456-20	384567941		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	480-40-0				-17.7380259024	4	4		0	-2.39041916					OC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC=CC=C3	Enzo	NP051	-4.34261888	-4.25355614	-2.70244138	-2.39041916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387801-02	NCGC00387801-02	384569162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1352066-68-2		0.3981071706	-6.4	-161.5550916066	-1.4	4		-36.1150445863	-49.26946108	0.1725610004	0.981207522		MDM2	CC(C)[C@@H](C[S+]([O-])(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)C2=CC=CC(=C2)Cl)C3=CC=C(Cl)C=C3	MedChem Express	HY-12296	-23.48740241	-40.51005846	-52.12956248	-49.26946108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507887-01	NCGC00507887-01	384569351		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			3.9810717055	-5.4	-25.6307361256	4	4		-13.113293408	-14.26107784	0.3490207035	0.917117605		DHODH	FC(F)(F)OC1=CC=C(C=C1)C(=O)NCCC(=O)N[C@@H]2CCCC3=C2C=CC=C3	Selleck	S8382	-3.80145493	0.4695484	-8.00096688	-14.26107784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486892-01	NCGC00486892-01	384569280		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			14.1253754462	-4.85	18.6758527179	4	4		24	20.928437	0.1054409496	0.9931016628		KDM4B	CC(C)C/1=C(NC2=C(C=N[N]2C1=O)C#N)\C3=CC=CC=C3	NCGCChem	BTM024-079	0.50527835	2.13290317	0.360958	20.928437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378600-02	NCGC00378600-02	363678116		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1095173-27-5				-15.5668296171	4	4		0	-2.2060944				SHH	CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3[NH]2)NC(=O)NC4=CC=C(C=C4)C#N	Selleck	S7160	-3.77375166	-2.70938215	-3.41572824	-2.2060944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482879-02	NCGC00482879-02	377020215		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	937263-43-9		11.220184543	-4.95	-53.6298592148	-3	4		-52.9999529915	-48.74074786	0.0639307091	0.9974721227		ERBB2	CC1=C(OC2=CC3=NC=N[N]3C=C2)C=CC(=C1)NC4=NC=NC5=C4C=C(N\C6=N\C(C)(C)CO6)C=C5	MedChem Express	HY-16069	-3.26115776	-5.91304348	-6.78005701	-48.74074786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263162-08	NCGC00263162-08	384568633		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	847925-91-1				-6.0607826208	4	4		0	-1.41786023				NOTCH1	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)NC2=CC=CC=C2C3=C1C=CC=C3	MedChem Express	HY-11102	-0.28281043	-2.87414188	-3.2475118	-1.41786023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016306-09	NCGC00016306-09	384567930		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	68-41-7				-0.7039317099	4	4		0	1.20246358				GRIN2A	N[C@@H]1CONC1=O	Selleck	S1998	-0.66877542	-2.04562979	2.19600131	1.20246358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378622-10	NCGC00378622-10	363678127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1421373-65-0		11.220184543	-4.95	-106.5567581153	-2.1	4		-122.8110962508	-99.65783557	0.0351394057	0.9992376792		EGFR	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C	Glixx	GLXC-05459	-4.87121554	-8.37755704	-19.70782413	-99.65783557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379062-01	NCGC00379062-01	384569090		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	697235-39-5				-13.238576715	4	4		0	-2.57112132					CO[C@@H]1OC[C@@H](O[C@H]1OC2=CC(=C3C(=C2)O[C@]4([C@@H]([C@H]([C@@H](O)[C@@]34O)C(=O)OC)C5=CC=CC=C5)C6=CC=C(OC)C=C6)OC)[C@@H](O)CO	MedChem Express	HY-15359	-4.22051514	0.9842609	-1.75586459	-2.57112132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346487-03	NCGC00346487-03	384568796		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	875320-29-9		0.316227766	-6.5	-302.6374762673	-1.2	4		-71.8208592764	-99.58602726	0.012993811	0.999895872		HDAC1	C[N]1C=C(CNCC2CCN(CC2)C3=NC=C(C=N3)C(=O)NO)C4=CC=CC=C14	Selleck	S1096	-35.67896874	-96.54573008	-99.592009	-99.58602726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480919-01	NCGC00480919-01	384569251		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1346572-63-1				-9.4589315305	4	4		0	-6.0188846					CC(C)[N]1C=C(C)C2=C1C=C(C=C2C(=O)NC\C3=C(C)\C=C(C)/NC3=O)C4=CC=C(N=C4)N5CCN(C)CC5	Glixx	GLXC-06400	-0.7063394	-3.50775539	-1.00825361	-6.0188846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390264-01	NCGC00390264-01	384569183		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	188968-51-6		0.177827941	-6.75	-85.40664444	4	4		-26.3258587329	-24.83985085	0.4333780397	0.8629110941			CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O	Adooq	A12372	-5.60633484	-29.82708287	-37.03485473	-24.83985085												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263019-01	NCGC00263019-01	137275923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	884491-41-2 (diastereomeric mixture)	WAY-204688;SIM-688			-29.4655600171	4	4		0	-7.24734678			4790	NFKB1	COC1=C(C=CC=C1)[C@H](C2=C3C=CC=CC3=CC=C2)[C@@](C)(C#N)C(=O)N4CCC(CC4)C5=CC=CC(=C5)C(F)(F)F	NCGCChem	JKJ22-068	-3.85067873	-9.32854256	-11.00938222	-7.24734678												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093354-13	NCGC00093354-13	384568113		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	98-92-0				-13.9548191899	4	4		0	1.24294866					NC(=O)C1=CC=CN=C1	Selleck	S1899	-4.91855204	-1.23512239	-2.08947106	1.24294866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507888-01	NCGC00507888-01	384569352		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1792999-26-8		1.1220184543	-5.95	-104.2826959722	-1.4	4		-50.4277610054	-51.07834717	0.1918599363	0.9765932943		TNIK	O[C@H]1CC[C@H](CC1)OC2=CC=CC3=C2N=C(NC4=CC=C5N=C[NH]C5=C4)N=C3	Selleck	S8392	-5.4881827	-13.23727854	-61.28782377	-51.07834717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090766-15	NCGC00090766-15	384568085		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	53-03-2				-18.2189938611	4	4		0	-3.71257485				NRC31	C[C@]12CC(=O)[C@H]3[C@@H](CC\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	MedChem Express	HY-B0214	-3.75709723	-4.60341573	-3.76601402	-3.71257485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344620-03	NCGC00344620-03	384568724		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	328968-36-1	C646	14.1253754462	-4.85	-16.1383651166	4	4		-12.400669804	-12.00055817	0.4999866325	0.8069131198		HAT1	CC1=C(C)C=C(C(=C1)C2=CC=C(O2)/C=C3\C(=N/N(C3=O)C4=CC=C(C=C4)C(O)=O)C)[N+]([O-])=O	Selleck	S7152	-2.05721349	-4.4615796	1.72106547	-12.00055817												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507850-01	NCGC00507850-01	384569330		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1446790-62-0		10	-5	-17.6136002974	4	4		-33.719079956	-25.18256663	0.0655246657	0.9973479382		SYK	CC1=CC=C(NC2=C(N=NC(=C2)N[C@@H]3CCCC[C@@H]3N)C(N)=O)N=C1C	Selleck	S7286	1.73936076	-0.14708504	-4.47852185	-25.18256663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167520-05	NCGC00167520-05	384568323		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	153259-65-5				11.0889089283	4	4		0	-0.10233034				PDE4A	COC1=CC=C(C=C1OC2CCCC2)C3(CCC(CC3)C(O)=O)C#N	Axon Medchem	1592	3.44340456	-0.15599929	3.54999062	-0.10233034												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263127-03	NCGC00263127-03	363677215		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	199850-67-4				-6.3166537176	4	4		0	0.45893489				MMP13	CC(C)[C@H](C[S+]([O-])(=O)C1=CC=C(C=C1)C2=CC=C(Br)C=C2)C(O)=O	Axon Medchem	1271	-1.58823529	-0.03143948	-3.69396728	0.45893489												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015110-20	NCGC00015110-20	384567810		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	125-84-8				-7.9217137457	4	4		0	-3.19342193				CYP19A1	CCC1(CCC(=O)NC1=O)C2=CC=C(N)C=C2	MedChem Express	HY-B0237	-1.90497738	1.77408489	-2.73308254	-3.19342193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016959-17	NCGC00016959-17	384567969		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	85721-33-1				-1.3868883451	4	4		0	0.40156803				TOP2B	OC(=O)\C1=C\N(C2CC2)C3=CC(=C(F)C=C3C1=O)N4CCNCC4	MedChem Express	HY-B0356	-2.9638009	6.95710757	-1.90817205	0.40156803												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263196-01	NCGC00263196-01	137276040		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1265789-88-5	S6K-18			-15.7304188158	4	4		0	3.4706951			6198	RPS6KB1	CC(C)(C)C1=CC(=C(NC(=O)NC2=CC3=C([NH]N=C3)C=C2)S1)C(O)=O	SynKinase	SYN-1132	-5.36199095	-0.92971031	-5.69732131	3.4706951												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379044-02	NCGC00379044-02	384569089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			12.5892541179	-4.9	20.4908162915	4	4		17.5	15.3783758	0.1631523655	0.9833522584		VDR	C[C@H](\C=C\[C@H](C)C(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/[CH]=[C]3C[C@@H](O)[CH2][C@H](O)C3	MedChem Express	HY-76585	1.48712047	3.52152527	3.91672718	15.3783758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092310-14	NCGC00092310-14	384568104		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	71675-85-9				-22.0402244001	4	4		0	-4.62353278				DRD2	CCN1CCCC1CNC(=O)C2=C(OC)C=C(N)C(=C2)[S+]([O-])(=O)CC	MedChem Express	HY-14545	-5.05443923	-5.70669917	-2.41587993	-4.62353278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346488-03	NCGC00346488-03	384568797		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	869363-13-3		12.5892541179	-4.9	-62.4093481941	4	4		-17.2094511279	-27.15430862	0.2429436812	0.9619227855		AURKA	OC(=O)C1=CC=C(NC2=NC3=C(C\N=C(/C4=CC(=CC=C34)Cl)C5=C(F)C=CC=C5F)C=N2)C=C1	Selleck	S1100	-9.89643268	-13.50716058	-10.58823529	-27.15430862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091544-23	NCGC00091544-23	384568097		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	50-28-2				-16.0014824938	4	4		0	1.1257485				ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O	MedChem Express	HY-B0141	-5.20315827	-1.60198868	-3.4856176	1.1257485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163107-07	NCGC00163107-07	384568229		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[338404-52-7]				-25.8637109574	4	4		0	-4.36407186				NR1I3	ClC1=CC=C(C=C1)C2=C(\C=N\OCC3=CC(=C(Cl)C=C3)Cl)[N]4C=CSC4=N2	Tocris	3683	-7.51863023	-1.36261106	-3.50495528	-4.36407186												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178127-11	NCGC00178127-11	384568353		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	87333-19-5				-11.6486494032	4	4		0	-4.24205777				ACE	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(O)=O	MedChem Express	HY-B0279	-0.77697334	-6.19094313	-3.09979366	-4.24205777												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181011-02	Gimeracil	170466048	Dihydropyrimidine Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	103766-25-2	Gimeracil			-3.0071738626	4	4		0	-2.68849714			1806	DPYD	ClC1=CNC(=O)C=C1O	Bosche	G3084	0.3531697	0.3164557	-3.03413994	-2.68849714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183682-14	NCGC00183682-14	384568419		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	273404-37-8				-5.2071966018	4	4		0	-2.89702648				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C3=CC(=C(N)C=C3)Cl)C(C)(C)C	MedChem Express	HY-13205	-1.62443439	1.38782843	0.19489643	-2.89702648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522007-01	NCGC00522007-01	384569509		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1293395-67-1]				-13.1649810176	4	4		0	-3.5376231				CSNK1A1	NC1=NC(=CC=N1)C2=C(N=C[N]2C3CCN(CC3)CC4=NOC=C4)C5=CC=C(F)C=C5	Tocris	6346	-3.54298643	-1.43274197	-0.6753388	-3.5376231												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262228-03	NCGC00262228-03	384568571		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			2.8183829313	-5.55	-3.3459361507	4	4		15.71855204	7.21866335	0.4080268848	0.8826696176		HPGD	COC1=CC=C(C=C1)[N]2C=NC3=CC(=CC=C23)C(=O)N4CCCCC4	NCGCChem	DYD028-075	-3.9321267	0.85784864	1.00167702	7.21866335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263125-03	NCGC00263125-03	384568608		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	914913-88-5				-19.1857423301	4	4		0	-4.75713331				MTOR	COC1=CC=C(COC2=C(OC)C=C3C(=C2)OC(=O)C4=C3C=CC(=C4)C(C)O)C=C1	Axon Medchem	1718	-5.16066212	-3.68693684	0.17913338	-4.75713331												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509943-03	NCGC00509943-03	384569391		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1268454-23-4		14.1253754462	-4.85	-34.3523483137	4	4		-26.405477412	-25.39841588	0.0450354841	0.9987503853		PIK3CA	NC1=NC2=C(O1)C=CC(=C2)C3=C[N]4C(=NC=C4C(=O)N5CCOCC5)C=C3	ChemieTek	CT-SERA	-3.99221032	-4.00905411	-3.39385137	-25.39841588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484799-01	NCGC00484799-01	363681179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1338545-07-5		0.2818382931	-6.55	-252.1881444509	-1.1	4		-94.1050637817	-98.57245509	0.0156432394	0.999849051			C[C@@H](CN(C)C)C1=CC=C(C=C1)C2=C(O)C=C(C)C3=C2C4=C(SC=C4)C(=O)N3	ChemieTek	CT-OTS964	-17.14425124	-95.25387838	-97.50543872	-98.57245509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016569-10	NCGC00016569-10	384567950		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1197-18-8				0.5840550615	4	4		0	1.49774408				SERPINE1	NC[C@H]1CC[C@@H](CC1)C(O)=O	APExBIO	B1858	-0.47677909	0.11142806	0.01406865	1.49774408												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346645-06	NCGC00346645-06	384568877		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	934541-31-8		3.5481338923	-5.45	-21.1720348266	4	4		-21.8401056999	-14.88441323	0.3116380348	0.9354334328		AURKA	CC[S+]([O-])(=O)C1=CC=CC(=C1)C2=CC(=C(C)C3=C2C4=C([NH]3)N=CC(=C4)C)C(=O)NC5CCN(C)CC5	MedChem Express	HY-12201	-0.01765848	-6.35139954	-7.9581692	-14.88441323												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522455-01	NCGC00522455-01	384569517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	232931-57-6				-13.8217634641	4	4		0	-2.31638681					COC1=C(OCCCOC2=C(OC)C=C3C(=O)N4CC(=C)C[C@H]4\C=N/C3=C2)C=C5\N=C/[C@@H]6CC(=C)CN6C(=O)C5=C1	MedChem Express	HY-14573	-2.26911531	-5.32626137	-3.68129807	-2.31638681												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015096-27	NCGC00015096-27	384567808		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	19774-82-4				7.463448753	4	4		0	0.40837647					CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3	MedChem Express	HY-14188	2.2125642	3.39386178	-1.23611111	0.40837647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167768-11	NCGC00167768-11	377020487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	228559-41-9				0.4653697019	4	4		0	-3.6045511				FLT1	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)NC4=CC=C(F)C=C4F)C(=C3)F	MedChem Express	HY-12038	2.86425339	-3.25623175	-2.68775778	-3.6045511												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387035-02	NCGC00387035-02	384569149		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1184843-57-9		5.0118723363	-5.3	-20.6525608907	4	4		-25.262549	-21.8854575	0.046324765	0.9986779083		CHEK1	C[C@H](CN(C)C)OC1=NC(=CN=C1C#N)NC2=NC=C3C(=CC=CC3=C2)Cl	SynKinase	SYN-1189	1.1719457	-0.83988322	-9.58618502	-21.8854575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510235-01	NCGC00510235-01	384569420		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1702259-66-2				-13.3065659587	4	4		0	-0.3101441					CCN1CCN(CC1)C2=CC=C(NC3=NC=NC(=C3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C(=C2)NC(=O)C=C	ChemGood	C-1373	-4.16924847	-4.67940626	1.20551924	-0.3101441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387488-03	NCGC00387488-03	363680640		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1137868-52-0		1.1220184543	-5.95	-215.0736644134	-2.3	4		-112.8030515651	-96.41664281	0.1883156018	0.9774737931		PLK1	COC1=CC(=C(F)C=C1NC2=NC3=C(C=N2)N(C)C(=O)C(F)(F)CN3C4CCCC4)C(=O)NC5CCN(C)CC5	Glixx	GLXC-05988	-21.89076746	-54.21581857	-70.40910191	-96.41664281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485941-02	NCGC00485941-02	384569278		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	404844-02-6				-3.0923597131	4	4		0	1.16900468				LRRK2	CC1=C(NC2=NC(=CC=N2)C3=CN=CC=C3)C=C(NC(=O)C4=CC=C(CN5CCNCC5)C=C4)C=C1	MedChem Express	HY-G0017	-0.73470833	-1.48435119	-1.5056887	1.16900468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159549-16	NCGC00159549-16	384568187		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	3690-10-6				-22.0782114955	4	4		0	-2.49580838				CDA	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2/C=C\C=N/C2=O	SIGMA	Z4775	-5.93062456	-4.34562445	-2.90548707	-2.49580838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262604-18	NCGC00262604-18	384568575		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	944396-07-0		1.1220184543	-5.95	-144.422697949	-1.4	4		-66.3250025171	-81.03556435	0.1786900544	0.979776997		PIK3CA	NC1=CC(=C(C=N1)C2=CC(=NC(=N2)N3CCOCC3)N4CCOCC4)C(F)(F)F	Selleck	S2247	-8.1927276	-21.66061747	-68.37715233	-81.03556435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345838-04	NCGC00345838-04	363677381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1033735-94-2		0.7943282347	-6.1	-172.6978885597	-1.1	4		-89.4139159479	-80.04149978	0.0447462709	0.9987633992		PIK3CA	CC(C)(O)C1=CC2=C(S1)C(=NC(=N2)C3=CN=C(N)N=C3)N4CCOCC4	Glixx	GLXC-90035	-15.11323649	-41.38549088	-64.88463977	-80.04149978												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142605-05	NCGC00142605-05	384568166		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	138-52-3				-4.6498781673	4	4		0	-0.20749891					OC[C@H]1O[C@@H](OC2=CC=CC=C2CO)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2351	-1.97599928	-0.42120357	1.20969709	-0.20749891												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249759-02	NCGC00249759-02	174006307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1252807-76-3	NCGC00249759-01; NCGC00249759-01	12.5892541179	-4.9	-54.8996663851	-3	4		-56.5165580412	-54.75558558	0.0999480234	0.9937899671	5141	PDE4A	CC(C)(O)CCC1=CC=C(OCC2=CC3=CC=CN=C3C(=C2)C4=CC=CC(=C4)OC(F)F)C=C1	NCGCChem	PRP01-058	-3.52792565	-5.93269705	-1.1706746	-54.75558558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021301-09	NCGC00021301-09	384568006		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	67-73-2				0.6056102291	4	4		0	3.45132332				NRC31	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C/5=C/C(=O)/C=C\[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	APExBIO	B2095	-1.456825	0.655197	1.84299381	3.45132332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092372-12	NCGC00092372-12	384568108		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	4311-88-0				-20.3991229486	4	4		0	-2.18614819				RIPK1	CN1C(=O)C(CC2=C[NH]C3=C2C=CC=C3)NC1=S	Glixx	GLXC-12010	-5.83612926	-3.57906935	-1.94616395	-2.18614819												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347938-05	NCGC00347938-05	384568990		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1230487-00-9		6.3095734448	-5.2	-0.4560359934	4	4		12.347070392	9.15523054	0.1667467325	0.9826255982		S1PR1	CCC1=CC(=CC=C1CN2CC(C2)C(O)=O)\C(C)=N\OCC3=CC=C(C4CCCCC4)C(=C3)C(F)(F)F	MedChem Express	HY-12355	-1.83502349	-3.62255866	-0.11574074	9.15523054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475742-01	NCGC00475742-01	363681099		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1260533-36-5		2.8183829313	-5.55	-40.1820246551	4	4		-21.7833834159	-23.49172961	0.0855189165	0.9954726935		HSP90AB1	CCC1=CC(=CC=C1[N]2N=C(C(C)C)C3=C(C=CN=C23)[N]4C=NC(=C4)C5=C[N](C)N=C5)C(N)=O	ActiveBioChem	A-1924	-2.98190045	-1.17224343	-20.30095635	-23.49172961												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387224-01	NCGC00387224-01	363680579		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[161832-65-1]				-23.7048477517	4	4		0	-4.9957057					C[C@@H]1CC2=C(C=C3OCOC3=C2)C(=N\N1C(C)=O)/C4=CC=C(N)C=C4	Tocris	5032	-6.71859786	-4.15705393	0.13071895	-4.9957057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485951-02	NCGC00485951-02	384569279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1310340-58-9				-0.0480219587	4	4		0	-0.48738117				CTSS	CC[C@H](NC(=O)[C@H](C[S+]([O-])(=O)CC1CC1)N[C@@H](C2=CC=C(F)C=C2)C(F)(F)F)C(=O)C(=O)NC3CC3	MedChem Express	HY-15958	0.92935126	-0.69901869	-2.24379299	-0.48738117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345815-02	NCGC00345815-02	384568758		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	133407-86-0		1	-6	-166.7571010815	-2.3	4		-92.3464085883	5.71828403	1	0.9999029956		PSMD1	CCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Cayman	15413	-3.27528647	-28.81211632	-95.58558119	5.71828403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263137-03	NCGC00263137-03	384568615		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-15.8100700079	4	4		0	-4.4346861				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(C=C4)C#N)C(F)(F)F	Axon Medchem	1532	-3.98808987	-1.43388448	-1.87307936	-4.4346861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242495-18	NCGC00242495-18	377020400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	717907-75-0		10	-5	-38.0341853849	-3	4		-44.2558054387	-37.45290479	0.0333515086	0.999313996		PTK2	CN(C1=NC=CC=C1CNC2=NC(NC3=CC=C4NC(=O)CC4=C3)=NC=C2C(F)(F)F)[S+](C)([O-])=O	MedChem Express	HY-10459	-1.8717994	-0.98502407	-6.54192459	-37.45290479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346507-07	NCGC00346507-07	363677433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1002304-34-8				-3.1046893398	4	4		0	1.48844132				MET	COC1=CC=C2C(=CC=NC2=C1)OCC3=NN=C4C=CC(=N[N]34)C5=CC=CC=C5	MedChem Express	HY-12035	-0.91824121	-1.68924942	-0.9894954	1.48844132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166125-02	Meglumine	170465359	amino sugar	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	6284-40-8	 hypaque(M)90; Isopaque coronar; N-Methyl-D-glucamine; Isteropac; Banamine; Urovist; Isopaque cerebral;Meglumine; Renovue-65; ; Uropolinum Polfa; Vascoray; Uropolin; Renovist II; Conraxin-H; Hypaque 76; Telebrix 350; Salicylate Meglumine; Uromiron; Meglumine iotalamate; Meglumine; Fortombrine; Sch 14714 meglumine; N-Methyl-D-Glucamine; Vasurix; Visotrast; Meglumina			-4.5756344252	4	4		0	-0.58607377				GLUT1	O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO	Prestwick	Prestw-884	0.03531697	-2.53610269	-3.51247421	-0.58607377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510688-01	NCGC00510688-01	384569478		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1210608-43-7(free base)		12.5892541179	-4.9	-56.5383073201	4	4		-16.323841816	-21.56379366	0.3921274882	0.8924889765		PIM1	C[C@@H]1C[C@H](N)C[C@@H](C1)C2=C(NC(=O)C3=CC=C(F)C(=N3)C4=C(F)C=CC=C4F)C=NC=C2	Selleck	S7985	-8.79392548	-13.25102514	-12.45075971	-21.56379366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015365-22	NCGC00015365-22	384567838		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	486-66-8				-15.9561322254	4	4		0	-8.49985658				ESR1	OC1=CC=C(C=C1)\C2=C\OC3=C(C=CC(=C3)O)C2=O	Selleck	S1849	-2.04072398	-2.81607905	-3.46734352	-8.49985658												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386704-01	NCGC00386704-01	363680407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1260075-17-9				-0.0452684289	4	4		0	-2.11375131				PKM2	[O-][S+](=O)(NC1=CC=C(C=C1)C(=O)N2CCN(CC2)CC3CC3)C4=CC=CC5=C4N=CC=C5	Axon Medchem	2149	0.18589006	2.36364428	-0.84725248	-2.11375131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167798-06	NCGC00167798-06	384568337		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	61825-94-3		1.1220184543	-5.95	-71.301919912	4	4		-22.3972533241	-29.66409008	0.0210077437	0.9997284132			O=C1O[Pt]2(NC3CCCCC3N2)OC1=O	Adooq	A10346	-7.24971231	-9.58951813	-24.56063907	-29.66409008												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00167487-12	NCGC00167487-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	90357-06-5				-6.6951040021	4	4		0	-3.81238668					C[C@](O)(C[S+]([O-])(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	ChemieTek	CT-BIC	-1.17730371	0.51799939	-1.71871218	-3.81238668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025202-12	NCGC00025202-12	384568056		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	73573-88-3		12.5892541179	-4.9	-47.0520012468	-3	4		-65.7056971104	-60.26815536	0.0488770957	0.9985240094	3156	HMGCR	CC[C@H](C)C(=O)O[C@H]1CC\C=C2\C=C/[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	MedChem Express	HY-17408	-0.64618925	-1.50176294	0.99249576	-60.26815536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241411-01	NCGC00241411-01	137275845		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	509093-60-1	NCGC00241411-01			0.4569813084	4	4		0	1.36940548			3654	IRAK1	CC(C)(C)C(=O)OC1=CC2=C(C=C1)[N](CCCO)C(=N2)NC(=O)C3=CC=CC(=C3)[N+]([O-])=O	NCGCChem	JKJ14-093	-1.42515712	1.37988073	3.01621883	1.36940548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015882-15	Riluzole	170464928	Glutamate Release Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1744-22-5	 ; Rilutek;PK-26124/RP-54274/Rilute;Riluzol; Prestwick-03A08;Riluzole; Riluzole; Riluzole hydrochloride			-13.7552538395	4	4		0	-10.18674902			2911	GRM1	FC(F)(F)Oc1ccc2nc(N)sc2c1	Vitas	STK503686	-1.29026437	-1.7116996	-2.36086045	-10.18674902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345852-03	NCGC00345852-03	384568767		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1092443-55-4		0.2818382931	-6.55	-209.803076487	-1.3	4		-85.5641576043	-87.80099406	0.0804047359	0.9959916047		CDK1	CC(C)C1=C2N=C(N[C@@H](CO)[C@H](O)CO)C=C(NCC3=CC=CC=C3)[N]2N=C1	SynKinase	SYN-1151	-7.84986015	-91.59833311	-85.99580508	-87.80099406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508861-01	NCGC00508861-01	384569365		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1474110-21-8		12.5892541179	-4.9	-33.9231405573	-3	4		-48.2138006455	-44.48579004	0.0824991274	0.9957809288		RORC	CCC1=CC=C(C=C1)N(CC(C)C)[S+]([O-])(=O)C2=CC=C(OCC3CCOCC3)C(=C2)CO	Bio Vision	B1195	0.4149744	-2.63415939	0.15475521	-44.48579004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246968-07	Olmesartan	384568514	Angiotensin AT1 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	144689-24-7				-9.4641876977	4	4		0	-0.94971271				AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	MedChem Express	HY-17004	-1.98428377	-1.34473768	-3.93055556	-0.94971271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346483-11	NCGC00346483-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	714971-09-2		12.5892541179	-4.9	-50.2550449809	-3	4		-61.2693327536	-50.42024788	0.128469481	0.9896855859			CC1=C2N(C=C1NC(=O)OC[C@@H]3COCCN3)N=CN=C2NC4=CC5=C(C=C4)N(CC6=CC(F)=CC=C6)N=C5	APExBIO	A2822	-1.07116204	-6.81516718	-7.25462963	-50.42024788												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185990-14	NCGC00185990-14	384568431		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	74103-07-4				-6.1581857169	4	4		0	-0.71228453					OC(=O)C1CC[N]2C1=CC=C2C(=O)C3=CC=CC=C3	MedChem Express	HY-B0138	-1.25554239	-2.76265837	-0.69907407	-0.71228453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016611-11	NCGC00016611-11	384567953		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	2438-72-4		11.220184543	-4.95	-34.8125524907	4	4		-19.928867608	-19.88717851	0.1500228884	0.9859466343			CCCCOC1=CC=C(CC(=O)NO)C=C1	Selleck	S3023	-4.11312217	-6.26543903	-7.24742782	-19.88717851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347286-15	NCGC00347286-15	384568986		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1346574-57-9				-17.0181589127	4	4		0	-5.2299455				EZH2	CC[C@H](C)[N]1C=C(C)C2=C1C=C(C=C2C(=O)NC\C3=C(C)\C=C(\C)NC3=O)C4=CC=C(N=C4)N5CCNCC5	MedChem Express	HY-13470	-3.92307692	-3.10352571	-1.31895028	-5.2299455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182084-01	NCGC00182084-01	124893809		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	60200-06-8	Clorsulon			-17.894429592	4	4		0	1.26443363					Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl	APAC	854922	-5.85996282	-1.3276455	-4.21689664	1.26443363												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509886-03	NCGC00509886-03	384569374		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	195987-41-8		3.1622776602	-5.5	-145.0098215825	-2.1	4		-85.3396902782	-93.59166144	0.0139995712	0.9998791066		COX10	[O-][S+](=O)(N1CC2=CC(=CC=C2N(C[C@H]1CC3=CC=CC=C3)CC4=CN=C[NH]4)C#N)C5=CC=CS5	MedChem Express	HY-16111	-8.40927547	-7.81467043	-68.84542217	-93.59166144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263104-06	NCGC00263104-06	384568593		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	849217-64-7		8.9125093813	-5.05	-101.4808248972	-2.3	4		-128.8436997004	-99.65114656	0.0823393145	0.9957951294		KDR	COC1=CC2=C(C=C1OCCCN3CCOCC3)N=CC=C2OC4=CC=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4F	ChemieTek	CT-XL880	0.69751015	-9.6942414	-31.48096042	-99.65114656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015443-22	NCGC00015443-22	384567847		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	54143-56-5				-1.563572997	4	4		0	-3.20053184				SCN5A	FC(F)(F)COC1=CC(=C(OCC(F)(F)F)C=C1)C(=O)NCC2CCCCN2	MedChem Express	HY-17429	1.11506212	-1.94849746	-0.93981481	-3.20053184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346884-02	NCGC00346884-02	384568961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[412960-54-4]		12.5892541179	-4.9	-75.1788839474	-3	4		-93.2700624859	-86.61439908	0.0305261069	0.9994248587			CC1(C)C(N(O)C(=O)NC2=CC=C(Cl)C=C2)N(C(=O)N1CC(=O)N\N=C\C=C\C3=CC=C(O3)[N+]([O-])=O)C4=CC=C(Cl)C=C4	Tocris	3922	-3.23529412	-2.0076353	-1.11045642	-86.61439908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262608-11	NCGC00262608-11	377020442		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	936091-14-4		2.2387211386	-5.65	-151.1558988487	-1.3	4		-92.5103001659	-99.32115881	0.0632389123	0.9975252898		JAK2	CN1CCN(CC1)C2=CC=C(NC3=NC=C(C)C(=N3)NC4=CC(=CC=C4)[S+]([O-])(=O)NC(C)(C)C)C=C2	MedChem Express	HY-10410	-2.76470588	-10.11003818	-89.83819064	-99.32115881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186628-01	NCGC00186628-01	124897815		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	149-64-4	Butylscopolammonium Br			-24.3427675936	4	4	BUTYLSCOPOLAMMONIUM Br	0	-2.73448704			1128	CHRM1	CCCC[N+]1(C)[C@H]2CC(C[C@@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4	BIOMOL	AC216	-7.23529412	-5.60071862	0.13144178	-2.73448704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241101-10	NCGC00241101-10	384568471		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	698387-09-6		1.1220184543	-5.95	-169.5826257738	-1.3	4		-85.3539111769	-97.40893011	0.1029678059	0.9934034392		EGFR	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(=C(C=N2)C#N)NC3=CC=C(OCC4=CC=CC=N4)C(=C3)Cl	Adooq	A10638_CM1	-6.72850679	-25.68605435	-88.18836967	-97.40893011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346553-10	NCGC00346553-10	384568838		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1092443-52-1		8.9125093813	-5.05	-35.8766994585	-3	4		-39.9839372848	-36.35146764	0.0918963159	0.9947601514		CDK7	CC(C)C1=C2N=C(NCCCCCCN)C=C(NCC3=CC=CC=C3)[N]2N=C1	MedChem Express	HY-13266	-2.32126697	0.60633281	-4.58233241	-36.35146764												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249684-04	NCGC00249684-04	384568532		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	745833-23-2				-25.5602469434	4	4		0	-6.23628209				MAPK14	NC(=O)N(C1=NC(=C(C=C1)C(N)=O)C2=C(F)C=C(F)C=C2)C3=C(F)C=CC=C3F	Selleck	S6005	-5.14295831	-3.84364254	-7.26700557	-6.23628209												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00087387-05	Droxinostat	384568077	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	99873-43-5		12.5892541179	-4.9	-23.1196733772	4	4		-27.128842344	-25.10736862	0.0809267764	0.9959472628		HDAC6	CC1=CC(=CC=C1OCCCC(=O)NO)Cl	Selleck	S1422	-1.624109	0.25092978	-0.54631481	-25.10736862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015185-06	NCGC00015185-06	384567819		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	28860-95-9				-22.8892060584	4	4		0	-4.25471295				DDC	CC(CC1=CC(=C(O)C=C1)O)(NN)C(O)=O	MedChem Express	HY-B0311	-5.24166996	-4.83922609	-4.20833333	-4.25471295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014925-06	Topotecan hydrochloride	170465137	DNA Topoisomerase I Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	119413-54-6	; Hycamtamine; Topotecane; Nogitecan hydrochloride;Nogitecan hydrochloride/NSC-609699;Topotecan hydrochloride; Topotecan hydrochloride;TOPOTECAN HYDROCHLORIDE; Nogitecan Hydrochloride; Hycamtin	4.4668359215	-5.35	-54.1134815514	4	4		-28.179572228	-32.19526093	0.0388423498	0.999070118	7150	TOP1	Cl.CN(C)Cc1c2cc3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccc1O	Prestwick	Prestw-1196	-5.61043066	-5.37895074	-17.11574074	-32.19526093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263216-02	NCGC00263216-02	174006464		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1223001-51-1	Torin-2;Torin 2; Torin-2	5.0118723363	-5.3	-288.229585505	-2.2	4		-61.4062042245	-96.90333047	0.0155926374	0.9998501031	2475	MTOR	NC1=NC=C(C=C1)C2=CC=C3N=CC\4=C(N(C(=O)\C=C4)C5=CC(=CC=C5)C(F)(F)F)C3=C2	Tocris	4248	-48.90678941	-55.76546381	-74.30162188	-96.90333047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162399-13	NCGC00162399-13	384568224		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	139298-40-1		8.9125093813	-5.05	-78.7862571298	-3	4		-99.4018036118	-95.69138277	0.0223795507	0.9996909736			COC1=CC=C(C=C1)[S+]([O-])(=O)N(CCO)C2=C(CN(C)C/C=C/C3=CC=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-15465	-1.60219527	0.3264702	-4.86564996	-95.69138277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345805-01	NCGC00345805-01	174006676		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	n	STX-0119	6.3095734448	-5.2	-80.0822801953	-2.2	4		-71.4352472432	-66.16566466	0.038420435	0.9990886939	6774	STAT3	O=C(NC1=NN=C(O1)C2=CC=CO2)C3=CC(=NC4=CC=CC=C34)C5=CC=CC=C5	EMD Chemicals	573126	-4.03646986	-3.66952509	-25.40305011	-66.16566466												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090726-15	NCGC00090726-15	384568079		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	36791-04-5				-22.6758799078	4	4		0	-2.37899918				IMPDH1	NC(=O)C1=N[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Selleck	S2504	-5.90995218	-6.33597706	-1.97063558	-2.37899918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378630-01	NCGC00378630-01	363678131		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	859853-30-8		3.9810717055	-5.4	-155.8305025159	-2.1	4		-116.963899488	-97.78024417	0.0097423573	0.9999414604		FLT4	COC1=CC(=CC=C1)NC2=NC=N[N]3C=CC(=C23)CN4CC[C@@H](N)[C@H](O)C4	MedChem Express	HY-10333	-8.93259948	-24.68969844	-61.06043608	-97.78024417												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346625-03	NCGC00346625-03	384568865		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1218777-13-9		11.220184543	-4.95	6.4348611373	4	4		-17.5364798559	-11.28039988	0.0793396403	0.9961208122		PIK3CG	FC1=CC=C(C=C1)C2=CC=C(O2)\C=C/3SC(=O)NC3=O	Adooq	A11196	4.22448078	3.17620137	2.65875426	-11.28039988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162409-08	NCGC00162409-08	384568225		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			0.1	-7	-243.9268818787	-1.3	4		-81.6630075719	-89.6039604	0.2937956354	0.9426821363			CO[C@H]1\C=C/C=C(/C)C[C@H](C)[C@H](O)[C@H](C)\C=C(C)/C=C(/OC)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C	Analyticon	NP-007111	-16.65046399	-71.35926773	-70.72099435	-89.6039604												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00346612-06	NCGC00346612-06	384568858		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	635318-11-5				-20.2934382029	4	4		0	-5.09949053				GRM2	N[C@]1(C[S+]([O-])(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	MedChem Express	HY-50906	-3.65885992	-4.74141876	-5.47170693	-5.09949053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263102-06	Degrasyn	384568591	Jak2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	856243-80-6		2.5118864315	-5.6	-147.9652769391	-1.1	4		-98.7452807649	-99.83380585	0.0309213388	0.9994098135		JAK2	CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-13264	-3.199277	-0.73932961	-92.50831109	-99.83380585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346945-06	NCGC00346945-06	363677563		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	648903-57-5		10	-5	-26.7251007368	-3	4		-35.8412539359	-30.28437828	0.0499345709	0.9984611472		SYK	COC1=CC=C(C=C1OC)C2=CC3=NC=C[N]3C(=N2)NC4=NC=CC=C4C(N)=O	MedChem Express	HY-14985	-0.84093122	0.43094067	-3.20987654	-30.28437828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386436-01	NCGC00386436-01	384569141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1616391-65-				-20.0242710286	4	4		0	-8.05385321				PRMT5	O[C@@H](CNC(=O)C1=CC(=NC=N1)NC2COC2)CN3CCC4=C(C3)C=CC=C4	Selleck	S7748	-2.54443743	-5.40395214	-5.33632506	-8.05385321												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510264-02	NCGC00510264-02	384569422		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1616392-22-3				-19.6083427365	4	4		0	-6.0078174				PRMT5	CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NC[C@H](O)CN3CCC4=C(C3)C=CC=C4	MedChem Express	HY-101563	-1.84065686	-7.29488731	-7.60938491	-6.0078174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091533-17	NCGC00091533-17	384568096		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	57-63-6		11.220184543	-4.95	-29.824768113	4	4		-36.651322112	-29.47707392	0.0806180146	0.9959769114		ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)O)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0216	-0.60097216	-2.86498856	-6.08850054	-29.47707392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378599-01	NCGC00378599-01	384569054		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1269440-17-6		8.9125093813	-5.05	-34.5672229475	-3	4		-38.0986253984	-35.79255984	0.1031288768	0.9933889799		BRAF	COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C2=C[N](N=C2C3=CC(=CC(=C3F)N[S+](C)([O-])=O)Cl)C(C)C	MedChem Express	HY-15605	-2.34202386	1.03432494	-3.65870754	-35.79255984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346649-04	NCGC00346649-04	384568880		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1173204-81-3 		5.0118723363	-5.3	-35.6576789338	-2.2	4		-38.4500144191	-35.13890224	0.0351128439	0.9992396334		PIK3CA	CC[N]1N=NC2=C1N=C(N=C2N3CCOCC3)C4=CC=C(NC(=O)NC5=CC=C(C=C5)C(=O)N6CCN(C)CC6)C=C4	Adooq	A11089	0.85726911	-1.44622426	-15.12546143	-35.13890224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025297-06	NCGC00025297-06	384568066		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	56974-61-9				-3.4443541812	4	4		0	1.21223971				NFKB1	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	Selleck	S2101	0.37053773	-2.55363542	-5.02411387	1.21223971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378943-01	NCGC00378943-01	363678291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	929007-72-7		2.8183829313	-5.55	-86.4822376208	-2.2	4		-45.3593944241	-47.75637892	0.0129180528	0.9998971467		MAPK8	NC(=O)C1=CC=CC=C1NC2=NC(=NC=C2)NC3=CC=CC(=C3)O	MedChem Express	HY-15737	-7.0402169	-13.46668481	-33.4738025	-47.75637892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241982-07	NCGC00241982-07	384568481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[850664-21-0]		8.9125093813	-5.05	-90.6312506157	-2.2	4		-63.3273788005	-56.23228077	0.0171634407	0.9998183711		ROCK1	CC[N]1C2=C(C=NC(=C2)OC3=CC(=CC=C3)NC(=O)C4=CC=C(OCCN5CCOCC5)C=C4)N=C1C6=NON=C6N	Tocris	4009_CM1	-9.08269318	-11.67052207	-24.68043264	-56.23228077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508871-01	NCGC00508871-01	384569368		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	849675-66-7				-2.6138064304	4	4		0	-0.62567211				ABCBA	COC1=C(OC)C=C2CN(CCC3=CC=C(C=C3)[N]4N=NC(=N4)C5=CC(=C(OC)C=C5NC(=O)\C6=C\C(=O)C7=CC=CC=C7O6)OC)CCC2=C1	Bio Vision	B1285	-0.23497515	0.82097338	-1.91506298	-0.62567211												1.6E-9	8E-9	4E-8	2E-7											
NCGC00346802-02	NCGC00346802-02	363677541		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[913844-45-8]				-1.7519365379	4	4		0	-1.73892216				ROCK2	C[C@H]1CN(CCCN1[S+]([O-])(=O)C2=CC=CC3=C2C(=CN=C3)C)C(=O)CN	Tocris	2485	-0.06653655	1.97946877	-2.38336959	-1.73892216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511386-01	NCGC00511386-01	384569501		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1309684-94-3		5.6234132519	-5.25	-217.4683021833	-2.3	4		-103.1843205413	-99.62360662	0.1325107189	0.9890135291		MDM2	COC1=CC(=CC=C1NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@]3([C@H]2C4=CC=CC(=C4F)Cl)C(=O)NC5=C3C=CC(=C5)Cl)C(N)=O	Glixx	GLXC-10659	-26.9511865	-43.47358516	-62.66035803	-99.62360662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346505-02	NCGC00346505-02	363677432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	152044-53-6		3.5481338923	-5.45	-233.8150224086	5	4		14.164162376	-39.42612708	0.1453041367	0.9868335656		TUBB	C[C@H]1CCC[C@H]2O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Selleck	S1297	-52.82368537	-54.56292906	-44.80631746	-39.42612708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094810-08	NCGC00094810-08	384568136		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	81-81-2				-25.7834573806	4	4		0	-1.67171767				VKORC1	CC(=O)CC(C1=CC=CC=C1)C/2=C(O)/C3=CC=CC=C3OC2=O	Cayman	13566	-6.70582919	-5.20252189	-5.39869832	-1.67171767												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350264-01	NCGC00350264-01	384569003		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	n				-4.1557764467	4	4		0	2.77641998				SUCNR1	FC1=CC=C(C=C1C(F)(F)F)C2=NOC(=C2)CNC(=O)CCCC3=NC4=NC=CC=C4C=C3	NCGCChem	PRP003-062	-1.55445097	-3.33378691	0.09832842	2.77641998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142615-10	NCGC00142615-10	384568167		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	51-42-3				-20.0214337384	4	4		0	-2.77641998				ADRA1A	CNC[C@H](O)C1=CC=C(O)C(=C1)O	Selleck	S2521	-4.23859015	-4.01415159	-6.17596104	-2.77641998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163413-03	Lycorine HCl			SARS-CoV-2_CPE_SRI		2188-68-3		0.0176411403	-7.7534733462	-315.083903139	-1.1	10		-95.9821570372	-88.32619038	9.679E-7	0.9931131385			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046	-6.74713954	0.28309676	3.75103212	-2.44564149	-8.27271655	-16.83639366	-33.11445759	-59.0649943	-77.90665671	-88.32619038						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090782-17	Nelfinavir Mesylate			SARS-CoV-2_CPE_SRI		159989-65-8		0.0497194887	-7.3034733462	-320.5795931311	-2.1	10		-123.5311799676	-99.39841938	0.0000060521	0.9882734724			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	-3.43648016	-1.98954115	-7.92670939	0.39318995	-4.07344788	-8.42999253	-4.82050879	-16.45106751	-63.67318051	-99.39841938						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015256-29	Chloroquine		antimalarial agents	SARS-CoV-2_CPE_SRI		50-63-5				-37.3016513159	4	10		0	-7.82448001					CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1	-0.0235914	-0.32241576	-6.18880981	-6.24385641	-3.60161994	-3.1376558	-5.22942634	1.5570322	0.51114693	-7.82448001						1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00263084-02	NCGC00263084-02	174006719		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	612542-14-0	 Hh-Ag1.5;Hh-Ag1.5	12.5892541179	-4.9	-90.5456872623	-3	4		-106.760510512	-99.61676647	0.0577715401	0.9979358551	54498	SMO	CNC1CCC(CC1)N(CC2=CC(=CC=C2)C3=CC=NC=C3)C(=O)C4=C(Cl)C5=C(F)C=CC(=C5S4)F	Cellagen	C4412-2s	-5.62899219	-0.51558256	-1.93860285	-99.61676647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345851-06	NCGC00345851-06	384568766		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1032754-81-6		5.6234132519	-5.25	-97.0112561007	-2.4	4		-66.8489968379	-57.75808383	0.1428333133	0.9872093827		PIK3CA	CC1=C(CN2CCN(CC2)[S+](C)([O-])=O)SC3=C1N=C(N=C3N4CCOCC4)C5=CN=C(N)N=C5	MedChem Express	HY-11042	-7.02182399	-19.05814114	-32.31810491	-57.75808383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346698-10	NCGC00346698-10	384568918		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1009298-59-2				-13.1470318702	4	4		0	-0.8				MTOR	CNC(=O)C1=CC=CC(=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOC[C@@H]4C)N5CCOC[C@@H]5C	MedChem Express	HY-15247	-4.74183818	-0.83782166	0.20788011	-0.8												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165902-08	NCGC00165902-08	384568297		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	658084-23-2		4.4668359215	-5.35	-41.3352993835	4	4		-25.3581161639	-26.65154659	0.2048641586	0.9732501628		MET	CN1CCN(CC1)C(=O)C2=C(C)[NH]C(=C2C)\C=C3/C(=O)NC4=CC=C(C=C34)[S+]([O-])(=O)N(C)C5=CC(=CC=C5)Cl	Bio Vision	1938	-4.67382478	-0.51978312	-13.04326618	-26.65154659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016797-15	NCGC00016797-15	384567960		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	34642-77-8				-11.8000588746	4	4		0	-3.03277901					CC1(C)S[C@H]2[C@H](NC(=O)[C@@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O	Selleck	S2565	-2.36853734	-3.11212815	-1.87374422	-3.03277901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386284-05	NCGC00386284-05	363680185		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1240299-33-5		8.9125093813	-5.05	-48.1165789663	-3	4		-64.8035182104	-55.91175622	0.0432942519	0.9988425237	367	AR	CC(=O)N1CCN(CCOC2=CC=C(C=C2)C3CCN(CC3)/C4=N/[N]5C(=NN=C5C(F)(F)F)CC4)CC1	Glixx	GLXC-90100	-0.56562086	1.30892449	-8.29400495	-55.91175622												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013841-13	NCGC00013841-13	384567790		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	6202-23-9, 303-53-7 [cyclobenzaprine]		14.1253754462	-4.85	-27.3230521663	4	4		-12.6258301961	-14.85629145	0.2843720406	0.9471261878		HTR2A	CN(C)CCC=C1C2=C(C=CC=C2)\C=C/C3=C1C=CC=C3	Microsource	01503207	-4.04772426	-5.74828375	-2.66809962	-14.85629145												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187912-13	NCGC00187912-13	384568446		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	936563-96-1		5.0118723363	-5.3	-138.2282070305	-2.1	4		-92.1346005409	-94.81865285	0.0158554435	0.9998449278		BTK	NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H]5CCCN(C5)C(=O)C=C	Selleck	S2680	-10.16719385	-12.41438744	-46.80900876	-94.81865285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015513-20	NCGC00015513-20	384567859		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	51-45-6 [histamine]				-4.2242367899	4	4		0	0.78209014				HRH1	NCCC1=C[NH]C=N1	Microsource	01500331	-1.66290104	-0.31296775	-0.49164208	0.78209014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390563-02	NCGC00390563-02	384569193		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1133432-46-8				-17.9348058426	4	4		0	-6.74324714				BTK	CN1CCN(C)C(=O)C1C2=CC=C(N/C3=N/C(=C\N(C)C3=O)C4=C(C)C(=CC=C4)NC(=O)C5=CC6=C(CCCC6)S5)C=C2	MedChem Express	HY-15427A	-2.59832081	-5.88558352	-3.06995	-6.74324714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485486-02	NCGC00485486-02	384569277		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	209219-38-5				-15.6150372089	4	4		0	-2.69633759				CCK2	CC(C)(C)C(=O)CN1C(=O)[C@@H](CN(C2CCCCC2)C3=CC=CC=C13)NC(=O)NC4=CC(=CC=C4)C(O)=O	MedChem Express	HY-17617_cm1	-3.57931949	-3.46910755	-2.91107892	-2.69633759												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484800-01	NCGC00484800-01	384569272		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			7.9432823472	-5.1	-68.6962255715	-2.2	4		-59.215248736	-51.6277251	0.0051264852	0.9999837996		DYRK1A	CCOC(=N)C1=NC2=CC=C3N=CN=C(NC4=CC(=C(F)C=C4Cl)F)C3=C2S1	Felicitex	FX-9847	-4.52779033	-6.26389078	-20.2697008	-51.6277251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159349-15	NCGC00159349-15	384568171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	797-63-7		1	-6	-12.301225768	4	4		11.095812632	-2.02634731	1	0.9996678192		PGR	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0257	-6.32984386	-2.12677807	3.69833212	-2.02634731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00421877-04	NCGC00421877-04	384569229		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1448346-63-1				-24.6212478166	4	4		0	-2.8745523					FC1=CN=CC(=C1)N(C(C(=O)NC2CC(F)(F)C2)C3=C(Cl)C=CC=C3)C(=O)[C@@H]4CCC(=O)N4C5=NC=CC(=C5)C#N	Astatech	41508	-6.5512979	-4.1228383	-4.09397862	-2.8745523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091104-10	NCGC00091104-10	384568093		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	22839-47-0				-9.4514259478	4	4		0	-2.30708405					COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O	MedChem Express	HY-B0361	-1.73936076	-4.64877875	-0.05158507	-2.30708405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090749-19	NCGC00090749-19	384568080		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	56-53-1		11.220184543	-4.95	-51.8969181999	-3	4		-61.7806263599	-55.89097167	0.0228483054	0.999677992		ESR1	CCC(/C1=CC=C(O)C=C1)=C(/CC)C2=CC=C(O)C=C2	MedChem Express	HY-14598	-1.90711637	-3.01747192	-4.49728006	-55.89097167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094994-10	NCGC00094994-10	384568139		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	53230-10-7		14.1253754462	-4.85	-38.5724470718	-3	4		-33.193256852	-30.73631332	0.0997528386	0.993822119			OC(C1CCCCN1)C2=C3C=CC=C(C3=NC(=C2)C(F)(F)F)C(F)(F)F	Microsource	01503070	-4.72364471	-2.24193261	-2.81842056	-30.73631332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386692-01	NCGC00386692-01	363680398		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1350547-65-7		3.1622776602	-5.5	-68.013750502	-2.2	4		-32.5093394284	-39.49555186	0.0499397404	0.9984604814	558	MERTK	CCCCNC1=NC=C2C(=N1)[N](C[C@H]3CC[C@H](N)CC3)N=C2C4=CC=C(F)C=C4	Axon Medchem	2086	-6.26299141	-7.77883612	-10.09973311	-39.49555186												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00023037-06	NCGC00023037-06	124886818		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	15500-66-0	; ;Pancuronium bromide; Pancuronium bromide; Bromide, Pancuroniu; Pancuronium Organon; Pancuronium dibromide; Pancuronium Curamed; Bromuro de pancuronio; Pavulon			-14.7227499806	4	4	PANCURONIUM Br	0	-0.46925408					CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6	BIOMOL	AC232	-3.98553999	-2.08191591	-3.91908976	-0.46925408												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480972-03	NCGC00480972-03	363681115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-8.299615557	4	4		0	-0.54886274				IDH1	COC1=C(C)C=C(NC(=O)C2=N[N](CC3=CC=C(F)C=C3)C4=C2CN(C[C@]4(C)C(N)=O)C(=O)C5=CC=C[NH]5)C=C1C	SGC	GSK864	-0.98004591	-4.26546622	-3.81260551	-0.54886274												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00242511-04	NCGC00242511-04	384568505		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	134404-52-7				-0.1952803299	4	4		0	3.82101317				VDR	CCC(O)(CC)/C=C/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCCC12C)=C\C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32341	-2.43923995	0.90617849	3.64001682	3.82101317												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346592-02	NCGC00346592-02	384568852		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	489-32-7				-6.7819384896	4	4		0	-3.13851774				PDE5A	COC1=CC=C(C=C1)C/2=C(OC3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)/C(=O)C4=C(O2)C(=C(OC5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C=C4O)CC=C(C)C	Selleck	S2312	-0.85726911	-1.11670481	-2.0980328	-3.13851774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346640-05	NCGC00346640-05	384568874		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	908115-27-5		1.2589254118	-5.9	-55.7147454267	-2.4	4		-40.478462122	-34.57175815	0.2602196913	0.9558293392		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC=C(C(N)=O)C(=C3)NC4CCC(CC4)OC(=O)CN	MedChem Express	HY-10213	-0.7158639	-16.84210526	-23.28395869	-34.57175815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229512-05	NCGC00229512-05	384568462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[439575-02-7]		12.5892541179	-4.9	-49.374322206	-3	4		-45.0999432818	-44.55492877	0.0555478073	0.9980933576		ITK	COC1=C(C=C(SC2=CN=C(NC(=O)C3=CC=C(CNC(C)C(C)(C)C)C=C3)S2)C(=C1)C)C(=O)N4CCN(CC4)C(C)=O	Tocris	5009	-4.35746606	-4.41500112	-2.66056293	-44.55492877												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378593-02	NCGC00378593-02	384569052		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	848141-11-7				-22.9839006361	4	4		0	-4.73772455					C[N]1N=CC=C1C/2=C(\C)N(C(=O)C(=C2)/C(=O)NCC3=NC=C(C=C3)[S+](C)([O-])=O)C4=CC=CC(=C4)C(F)(F)F	Glixx	GLXC-90263	-6.19677076	-5.40441007	0.22721779	-4.73772455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274038-02	NCGC00274038-02	384568708		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	494772-86-0		0.8912509381	-6.05	-56.2174853599	4	4		-30.349089196	-24.31741011	0.4015392486	0.8858334626		MAP3K7	NC(=O)NC1=C(SC(=C1)C2=CC=C(CN3CCOCC3)C=C2)C(N)=O	Cayman	11140	-6.10983578	-16.01444108	-16.08985181	-24.31741011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384179-01	NCGC00384179-01	363679177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	n/a				-12.0251827689	4	4		0	-1.30238616				VCP	[O-][S+]1(=O)/N=C(/NC2=CC(=CC=C2)NC(=O)CCl)C3=CC=CC=C13	XcessBio	M60148-2s	-4.56471835	-0.58388305	1.44907147	-1.30238616												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263197-03	NCGC00263197-03	363677258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(1338247-35-0)		11.220184543	-4.95	-64.8885086137	-3	4		-75.02538482	-67.14730918	0.0422068263	0.9988998961		LIMK1	CC(C)C(=O)NC1=NC=C(S1)C2=CC(=N[N]2C3=C(Cl)C=CC=C3Cl)C(F)F	SynKinase	SYN-1024	-2.54282183	-5.04100553	-6.70136935	-67.14730918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346636-03	NCGC00346636-03	363677489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1062161-90-3		2.8183829313	-5.55	-144.8214518702	-2.1	4		-96.9662097506	-89.85562673	0.0138330014	0.9998819739		MTOR	COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCN(CC4)CC5=CC=CN=C5)C(=N2)N6CCOCC6	Selleck	S2668	-7.3438914	-22.65888165	-61.61900014	-89.85562673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345830-02	NCGC00345830-02	363677374		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	(185039-99-0)		0.8912509381	-6.05	-53.6015706091	4	4		-10.0818766641	-14.79108901	0.5039722001	0.803220862		SRC	CN1C(=O)C(=C\C2=C1N=C(NC3=CC=CC(=C3)C(O)=O)N=C2)/C4=C(Cl)C=CC=C4Cl	SynKinase	SYN-1062	-7.7239819	-11.94251067	-20.70887912	-14.79108901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263123-02	NCGC00263123-02	384568606		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	213252-19-8		3.1622776602	-5.5	22.7890364727	4	4		16.5	11.98011282	0.4315699258	0.8666125447		PPARA	COC1=C(C=C(CC2SC(=O)NC2=O)C=C1)C(=O)NCC3=CC=C(C=C3)C(F)(F)F	Axon Medchem	1567	1.86877828	6.61576465	6.34999773	11.98011282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253867-11	NCGC00253867-11	384568568		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	179474-85-2				-15.1751630733	4	4		0	-1.85486184				HTR4	COCCCN1CCC(CC1)NC(=O)C2=CC(=C(N)C3=C2OCC3)Cl	MedChem Express	HY-12694	-2.37556561	-7.11879632	-3.92965599	-1.85486184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024257-10	NCGC00024257-10	384568023		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	61-76-7				-23.4685652855	4	4		0	-5.33924993				ADRA1A	CNC[C@H](O)C1=CC=CC(=C1)O	Selleck	S2569	-6.3025582	-5.87211074	1.03122731	-5.33924993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015478-17	NCGC00015478-17	384567854		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	220904-83-6		14.1253754462	-4.85	-25.2869035142	-3	4		-36.1123872079	-30.92698934	0.1389688345	0.9879123145		BRAF	OC1=C(Br)C=C(C=C1Br)\C=C2/C(=O)NC3=C2C=C(I)C=C3	MedChem Express	HY-10542	-0.18045655	-3.10077519	0.65362665	-30.92698934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346648-05	NCGC00346648-05	384568879		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	942918-07-2		11.220184543	-4.95	-71.4317296359	-2.4	4		-66.7218711448	-57.77012884	0.1534956069	0.9851871923		AURKB	CC[N]1C=C(C2=C3C=C([NH]C3=NC=C2)C4=CC=CC(=C4)CN(C)C)C(=N1)C5=CC=C(NC(=O)N(C)C)C=C5	MedChem Express	HY-70044	-3.77891577	-11.38794794	-15.2269743	-57.77012884												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242227-11	NCGC00242227-11	377020378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	312917-14-9		3.1622776602	-5.5	-204.5228984474	5	4		-12.4029169401	-39.85301642	1	0.9166918584		MAPK8	O=C(NC1=C(C#N)C2=C(CCCC2)S1)C3=C4C=CC=CC4=CC=C3	MedChem Express	HY-15881	-41.60339043	-38.282225	-49.45132245	-39.85301642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498437-01	NCGC00498437-01	384569300		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1821428-35-6		3.9810717055	-5.4	-64.1713749283	-2.4	4		-66.35001628	-54.4583469	0.0623128894	0.9975983599		ATM	CN(C)CCCOC1=NC=C(C=C1)C2=CC3=C(C=C2)N=CC4=C3N(C5CCOCC5)C(=O)N4C	ChemieTek	CT-A0156	2.13667667	-1.92993403	-15.07690865	-54.4583469												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00163469-09	NCGC00163469-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox			1.2589254118	-5.9	-137.3785380283	-1.4	4		-68.8908780071	-72.12118334	0.1159277672	0.9916192298			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	Selleck	S2324	-7.54203433	0.47568952	-64.53240741	-72.12118334												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00379254-06	NCGC00379254-06	384569096		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1472795-20-2		12.5892541179	-4.9	-49.9543983386	-3	4		-51.9097042159	-50.3252766	0.086845352	0.9953213779		ALK	COC1=CC(=CC=C1NC2=NC(=C(Cl)C=N2)NC3=C(OC)C=C(C=C3)N4CCN(CC4)C(C)=O)N5CCN(CC5)C(C)=O	MedChem Express	HY-12331	-3.13446596	-4.9855921	-1.21759259	-50.3252766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346594-02	NCGC00346594-02	363677469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	508-02-1		0.1995262315	-6.7	22.3178615489	4	4		-9.693577368	2.08432929	0.4816044832	0.8258589347		PLA2G5	CC1(C)C[C@H](C2CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Selleck	S2334	8.19457014	-1.82798114	1.59089879	2.08432929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510356-01	NCGC00510356-01	384569431		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-36.6111840927	4	4		0	-8.8605783					COC1=CC2=C(OC\C(=C2\C3=CC=C(F)C=C3)CN4CCCC4)C=C1	Axon Medchem	2692	-9.10861291	-4.38340661	-5.2432825	-8.8605783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345824-02	NCGC00345824-02	363677371		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	(888719-03-7)				-10.7063241869	4	4		0	4.63735946				MET	FC1=CC=C(C=C1)N2/C=C\C=C(C(=O)NC3=CC=C(OC4=C5C=C[NH]C5=NC=C4)C(=C3)F)/C2=O	SynKinase	SYN-1022	-4.46629974	-2.22252095	-1.73650066	4.63735946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164569-08	NCGC00164569-08	384568255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	154361-50-9				-9.1050498289	4	4		0	-4.37229639				TYMS	CCCCCOC(=O)NC\1=N\C(=O)N(\C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	MedChem Express	HY-B0016	-0.75931485	-2.76787306	-2.80904146	-4.37229639												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188429-03	NCGC00188429-03	384568449		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	114607-46-4				-10.5049323262	4	4		0	0.91800442					OC(=O)C(=O)NC1=CC(=CC=C1)C2=NN=N[NH]2	Adooq	A10034	-3.22580645	-2.81922197	-1.40647633	0.91800442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346460-05	NCGC00346460-05	363677414		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	468740-43-4		5.0118723363	-5.3	-86.3121879504	-2.3	4		-86.0818513906	-84.88416803	0.0562295583	0.9980449885		IGFR1	CC1=C2N=C([NH]C2=CC(=C1)N3CCOCC3)\C4=C(NC[C@@H](O)C5=CC=CC(=C5)Cl)\C=C/NC4=O	MedChem Express	HY-10262	1.05170128	-2.03203661	-34.526424	-84.88416803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263532-10	NCGC00263532-10	384568685		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	140462-76-6				-12.0853495459	4	4		0	-1.40824762					CN(C)CC\C=C/1C2=C(COC3=CC=C(CC(O)=O)C=C13)C=CC=C2	MedChem Express	HY-B0426A	-2.77507733	-4.61327231	-1.03266203	-1.40824762												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346514-04	NCGC00346514-04	384568814		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	887650-05-7		12.5892541179	-4.9	-33.06302917	-3	4		-45.4026069639	-40.75217247	0.0910934296	0.9948506193		ABL1	CN(C)[C@H]1CCN(C1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=C(C=N4)C5=CN=CN=C5	MedChem Express	HY-12039	0.34242065	-3.09198189	-1.88425926	-40.75217247												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346508-12	NCGC00346508-12	384568810		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	677297-51-7				-14.339241434	4	4		0	-3.02008642				PIK3CA	NC1=NC2=NC(=C(N=C2C(=N1)N)C3=CC(=CC=C3)O)C4=CC=CC(=C4)O	MedChem Express	HY-10111	-2.65156504	-3.72318529	-3.875	-3.02008642												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346477-02	Emricasan	384568791	Caspase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	254750-02-2				-13.3313012906	4	4		0	-1.38636581				CASP3	C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F	MedChem Express	HY-10396	-2.80995475	-5.94206153	-1.38240493	-1.38636581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015452-23	NCGC00015452-23	384567851		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	13311-84-7				-11.0008683193	4	4		0	-0.70752462				AR	CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F	Selleck	S1908	-4.12217195	0.41769594	-0.33993564	-0.70752462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346595-02	NCGC00346595-02	363677470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	28957-04-2				9.8567300223	4	4		0	8.55722344				NFE2L3	CC1(C)CC[C@H](O)[C@]23CO[C@](O)([C@@H](O)[C@H]12)[C@@]45[C@H](O)[C@@H](CCC34)C(=C)C5=O	Selleck	S2335	-0.89140271	2.51066697	5.69732131	8.55722344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346550-03	NCGC00346550-03	384568835		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	936727-05-8		10	-5	-1.05107321	4	4		14.023981896	8.5476623	0.2501312766	0.9598473465		CFTR	CC1=C(N=C(NC(=O)C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)C=C1)C5=CC=CC(=C5)C(O)=O	APExBIO	A8351	-2.93665158	-0.34583427	0.43058514	8.5476623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508824-01	NCGC00508824-01	384569361		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	227947-06-0				-12.7474774564	4	4		0	2.39049528				AR	CC(C)(C1=CC=C(OCC(O)CO)C=C1)C2=CC=C(OCC(O)CCl)C=C2	SIGMA	92427	-5.04558732	-4.76646498	2.40619705	2.39049528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263172-10	NCGC00263172-10	384568642		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1020172-07-9		3.9810717055	-5.4	-67.9568307239	-2.4	4		-69.8458345275	-65.13503197	0.167162358	0.9823624606		ABL1	CNC(=O)C1=CC(=CC=N1)OC2=CC(=C(NC(=O)NC3=CC(=N[N]3C4=CC5=C(C=C4)N=CC=C5)C(C)(C)C)C=C2)F	Adooq	A11200_CM1	-1.40745331	7.73516737	-30.16702977	-65.13503197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378665-03	NCGC00378665-03	384569061		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	219989-84-1		1	-6	-141.9649901628	-1.2	4		-44.0791390919	-51.50777746	0.0169580606	0.9998228642			C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	MedChem Express	HY-10222	-19.77516155	-31.2932573	-44.48801743	-51.50777746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507854-01	NCGC00507854-01	384569332		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1857417-13-0		12.5892541179	-4.9	-62.5897406684	-3	4		-114.5365302014	-99.67077011	0.0640745165	0.9974592233			CC1=C2C=C(C#N)[N](CC3=C[NH]N=C3)C2=CC=C1CN4CCC(CC4)NC5=C6C=C(CC(F)(F)F)SC6=NC=N5	Selleck	S7817	1.37204568	4.60975928	7.41224885	-99.67077011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093802-09	NCGC00093802-09	363676565		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	53-43-0				-20.180531769	4	4		0	-1.70342132					C[C@]12CC[C@H]3[C@@H](C\C=C/4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	Selleck	S2604	-5.37760534	-5.40395214	-1.99990244	-1.70342132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351479-01	NCGC00351479-01	363677753		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-2.3321431627	4	4		0	-4.01968827			80854	SETD7	[O-][S+](=O)(N[C@H](CC1=CC=CC(=C1)C(F)(F)F)C(=O)N2CCCC2)C3=CC4=C(CNCC4)C(=C3)F	SGC	(R)-PFI-2	0.14436524	1.2636107	-0.82922784	-4.01968827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092360-02	NCGC00092360-02	384568106		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[73-03-0]				-35.3045926993	4	4		0	-15.75544081				HPRT1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)C[C@H]3O	Tocris	2294	-5.75656411	-6.74821885	-5.88263987	-15.75544081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263087-10	NCGC00263087-10	384568581		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	755038-65-4		0.5011872336	-6.3	-207.5749445758	-1.3	4		-94.0945482965	-98.69709984	0.0625989722	0.9975754229		PLK1	CC[C@H]1N(C(C)C)C2=NC(=NC=C2N(C)C1=O)NC3=CC=C(C=C3OC)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6	Selleck	S2235	-6.53252729	-74.39171932	-93.17594264	-98.69709984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346440-02	NCGC00346440-02	384568778		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[179386-44-8]				-8.2705939268	4	4		0	-0.44877672				DRD2	CN[C@H]1CN2C(=O)NC3=C2C(=CC=C3)C1	Tocris	2773	-1.63313182	-3.1814312	-2.2047705	-0.44877672												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263271-04	NCGC00263271-04	384568683		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1028486-01-2		7.0794578438	-5.15	-63.2192716984	-2.4	4		-47.8892146496	-44.99182928	0.4295042768	0.8656421296		AURKA	COC1=CC=CC(=C1/C2=N/CC3=C(N=C(NC4=CC(=C(C=C4)C(O)=O)OC)N=C3)C5=CC=C(Cl)C=C25)F	Selleck	S1133	-10.87052585	8.90617849	-11.52749872	-44.99182928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091014-06	NCGC00091014-06	174007324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	52806-53-8	Hydroxyflutamide;hydroxyflutamide			-16.7722815919	4	4		0	-2.42718447			374	AR	CC(C)(O)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F	SIGMA	H4166	-4.162616	-6.61784897	0.42521378	-2.42718447												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165869-22	NCGC00165869-22	384568292		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1219168-18-9		8.9125093813	-5.05	-98.4129229488	-2.1	4		-102.3380204721	-98.5801795	0.03443086	0.9992681351		TGBR1	C1CCN(CC1)CCOC2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC=C5	MedChem Express	HY-13418	-5.58409061	-2.60714449	-12.375	-98.5801795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025035-05	NCGC00025035-05	124886984		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	152121-47-6	 SB-203580;SB-203580			-17.7941771332	4	4		0	0.93071846			1432	MAPK14	C[S+]([O-])C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=NC=C3)C4=CC=C(F)C=C4	BIOMOL	EI-286	-5.68067079	-5.30576774	-0.39351852	0.93071846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015471-09	Ganciclovir	384567853	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	82410-32-0				-11.7745262383	4	4		0	-1.96500147					N\C1=N\C2=C(N=C[N]2COC(CO)CO)C(=O)N1	Selleck	S1878	-2.25033891	-4.47679956	-2.04616753	-1.96500147												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188344-07	NCGC00188344-07	384568447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	923564-51-6		1.1220184543	-5.95	-157.3691112272	-1.3	4		-85.2596743802	-96.17554259	0.14138937	0.9874642044		BCL2L1	CC1(C)CCC(=C(CN2CCN(CC2)C3=CC=C(C=C3)C(=O)N[S+]([O-])(=O)C4=CC(=C(N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)C=C4)[S+]([O-])(=O)C(F)(F)F)\C1)/C7=CC=C(Cl)C=C7	Selleck	S1001	-5.21719457	-19.75746688	-83.48366043	-96.17554259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095135-12	NCGC00095135-12	384568150		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	181183-52-8				-7.4384303425	4	4		0	-1.52022182				HTR1B	CN(C)CCC1=C[NH]C2=CC=C(C[S+]([O-])(=O)N3CCCC3)C=C12	MedChem Express	HY-B0383	-2.38461538	-0.40871323	0.10424693	-1.52022182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250405-15	NCGC00250405-15	384568553		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1009298-09-2		2.8183829313	-5.55	-73.8218391545	-2.4	4		-54.3513651036	-42.60425613	0.1202851469	0.9909786793		MTOR	COC1=C(CO)C=C(C=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOC[C@@H]4C)N5CCOC[C@@H]5C	MedChem Express	HY-10422	-4.07187749	-16.9024507	-28.2788671	-42.60425613												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091281-10	NCGC00091281-10	384568095		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1596-84-5				-13.1480795564	4	4		0	-1.84655024				KDM2A	CN(C)NC(=O)CCC(O)=O	MedChem Express	HY-13643	-2.53164557	-6.76881557	-0.81820382	-1.84655024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507859-01	NCGC00507859-01	384569335		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1223405-08-0				-2.1692781744	4	4		0	-2.96771703				NTRK2	O[C@H]1CCN(C1)C(=O)NC2=C3N=C(C=C[N]3N=C2)N4CCC[C@@H]4C5=CC(=CC=C5F)F	Selleck	S7960	-1.0737165	2.72438052	1.26823082	-2.96771703												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00372509-03	NCGC00372509-03	363678075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	905298-84-2				-15.552978165	4	4		0	-6.06572407				LIMK1	CCNC(=O)NC1=NC=C(S1)C2=NC(=NC(=C2)C3=C(C)C=C(OC)C=C3C)C4=CN=CC=N4	Axon Medchem	1949	-2.64368853	-3.63848187	-2.46817228	-6.06572407												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481652-04	NCGC00481652-04	384569258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1254053-43-4		2.8183829313	-5.55	-132.5058546418	-2.1	4		-89.3599611161	-87.74308739	0.0077557348	0.9999629021		AXL	CCC1=NC(=C(NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(C)CC4)OC)N=C1NC5CCOCC5)C(N)=O	MedChem Express	HY-12432	-5.26933141	-16.82125734	-59.6751378	-87.74308739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346465-06	NCGC00346465-06	384568786		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1207360-89-1		7.0794578438	-5.15	-48.7644650433	4	4		-33.817867564	-29.93292477	0.1163451366	0.9915777506		PIM3	CCNC(=O)NC1=CC=C(C=C1)C2=NC(=C3CCN(CC3=N2)C4COC4)N5CCOC[C@@H]5C	MedChem Express	HY-15248	-3.8347018	-8.44199489	-15.30657041	-29.93292477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507848-01	NCGC00507848-01	384569329		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1346547-00-9		11.220184543	-4.95	-26.5254378851	-3	4		-58.4561664924	-45.20330674	0.0322257746	0.999359251		RIPK2	CC(C)(C)[S+]([O-])(=O)C1=CC=C2N=CC=C(NC3=N[NH]C4=C3C=C(F)C=C4)C2=C1	Selleck	S8261	2.78391516	1.46453089	-1.24760525	-45.20330674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263101-07	NCGC00263101-07	363677202		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	383432-38-0		12.5892541179	-4.9	-39.7000475196	-3	4		-36.6987019898	-37.08084857	0.0959502979	0.9942843355		ERBB2	COCC(=O)NC/C=C/C1=CC=C2N=CN=C(NC3=CC=C(OC4=CN=C(C)C=C4)C(=C3)C)C2=C1	MedChem Express	HY-14674	-2.57568911	-5.1753073	-2.56122115	-37.08084857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346941-01	NCGC00346941-01	174006381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	439574-61-5	ITK inhibitor	8.9125093813	-5.05	-30.3065085882	4	4		-20.1984317879	-19.45449213	0.2838537476	0.9470032243	3702	ITK	COC1=C(C=C(SC2=CN=C(NC(=O)C3=CC=C(CNC(C)C(C)C)C=C3)S2)C(=C1)C)C(=O)N4CCN(CC4)C(C)=O	Chemscene	CS-0048	-4.74469047	-0.12246564	-5.09903076	-19.45449213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095133-09	Famciclovir	384568149	antiviral	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	104227-87-4				-15.7124818796	4	4		0	-2.99149477					CC(=O)OCC(CC[N]1C=NC2=CN=C(N)N=C12)COC(C)=O	APExBIO	B1942	-4.27474017	-2.55363542	-1.10970642	-2.99149477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481319-01	NCGC00481319-01	384569254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-11.1651023102	4	4		0	1.81835957				ESR1	C[C@@H]1CC2=C([NH]C3=C2C=CC=C3)[C@H](N1CC(C)(C)F)C4=C(F)C=C(\C=C\C(O)=O)C=C4F	MedChem Express	HY-12870	-3.91323995	-2.39941942	-1.22208175	1.81835957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094818-13	NCGC00094818-13	384568137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	84-16-2		12.5892541179	-4.9	-31.8843687241	-3	4		-33.864356236	-31.13696353	0.2766497334	0.9496687225		AKR1C1	CCC(C(CC)C1=CC=C(O)C=C1)C2=CC=C(O)C=C2	Adooq	A10451	-4.22051514	-1.12033383	4.21875732	-31.13696353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023373-10	NCGC00023373-10	384568017		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	25122-46-7				-23.0693779067	4	4		0	-1.45149701					CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	MedChem Express	HY-13600	-6.48953158	-5.89237214	-1.85158327	-1.45149701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181304-01	NCGC00181304-01	50125901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	59643-91-3	Imexon			-18.4158004764	4	4	CIPLUS_210928;4-IMINO-1,3-DIAZABICYCLO(3.1.0)HEXAN-2-ONE;4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one;BM-06002;4-amino-1,3-diazabicyclo(3.1.0)hex-3-en-2-one;BM 06002;imexon;LS-176018;Imexon;4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one;IMEXON;imexonum;Imexonum;	0	-1.95928144			6240	RRM1	O=C1N=C(N)C2CN12	ACC	imexon	-5.13218595	-3.55383695	-1.94827169	-1.95928144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344515-02	NCGC00344515-02	174006179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	4085-31-8	Piperaquine; Piperaquine			-17.0437546552	4	4		0	-4.68023952					ClC1=CC2=C(C=C1)C(=CC=N2)N3CCN(CCCN4CCN(CC4)C5=C6C=CC(=CC6=NC=C5)Cl)CC3	SIGMA	C7874	-3.01188786	-4.86120702	-3.51462412	-4.68023952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092284-04	NCGC00092284-04	384568102		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[125316-60-1]		12.5892541179	-4.9	-151.6303866965	-2.3	4		-88.4110631019	-99.74907108	0.0898548398	0.9949873848		RARG	OC(=O)C1=CC2=CC=C(C=C2C=C1)C3=CC=C(O)C(=C3)C45CC6CC(CC(C6)C4)C5	Tocris	1549	-17.59451412	-24.4208451	-21.56967953	-99.74907108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371001-05	NCGC00371001-05	384569039		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-14.6526054933	4	4		0	-3.93636451				SMARCA2	OC1=C(C=CC=C1)C(=O)\C=C\N2C[C@H]3C[C@@H]2CN3C4=NC=CC=C4	MedChem Express	HY-12409	-2.50110473	-2.45308924	-5.16331013	-3.93636451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420704-02	NCGC00420704-02	384569224		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-18.9736179395	4	4		0	-4.97604849				XIAP	C[C@@H]1CN(CC(=O)N2CC(C)(C)C3=C2C=C(CC4=CC=C(F)C=C4)C=N3)[C@H](CN1)CN5CCOC[C@H]5C	WuXi	AT-IAP	-4.23859015	-4.08672382	-2.25218898	-4.97604849												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402372-02	NCGC00402372-02	384569218		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1449578-65-7		12.5892541179	-4.9	-88.304152237	-3	4		-112.5864295922	-99.75559683	0.0432282518	0.9988456919		KIF11	CCCC1=C(C)SC(=C1)C(=O)N[C@H](CC2=CC=C(N=C2)C3=CC=CC(=C3)OC(F)(F)F)C(=O)N[C@@H]4CCNC4	Glixx	GLXC-03904	-4.29281518	-0.27668163	-3.7037037	-99.75559683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509985-02	NCGC00509985-02	384569395		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	308831-61-0				-21.2197137501	4	4		0	-3.0403754				GNRHR	CONC(=O)NC1=CC=C(C=C1)C2=C(CN(C)CC3=CC=CC=C3)C4=C(S2)N(CC5=C(F)C=CC=C5F)C(=O)N(C4=O)C6=CC=CC=C6	Glixx	GLXC-04354	-4.55490285	-5.31138023	-5.15521843	-3.0403754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263021-04	NCGC00263021-04	363677194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	783348-36-7				-4.9431505109	4	4		0	-3.77358491				IKBKB	COC1=C(Cl)C=C2C(=C1NC(=O)C3=C(C)N=CC=C3)[NH]C4=C2C=CN=C4	MedChem Express	HY-15473	-0.98508812	-0.29482469	0.85686192	-3.77358491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241097-06	NCGC00241097-06	384568469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	(387867-13-2)				-0.3518782338	4	4		0	-0.97245509				KIT	COC1=CC2=C(N=CN=C2C=C1OCCCN3CCCCC3)N4CCN(CC4)C(=O)NC5=CC=C(OC(C)C)C=C5	SynKinase	SYN-1088	-1.86745919	3.54463012	3.81435823	-0.97245509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090905-16	NCGC00090905-16	384568090		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	55-98-1				5.3777556392	4	4		0	4.53652695					C[S+]([O-])(=O)OCCCCO[S+](C)([O-])=O	Microsource	01500152	-1.34403833	3.59066427	4.16243655	4.53652695												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023230-28	NCGC00023230-28			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	912-60-7, 128-62-1 [noscapine]		14.1253754462	-4.85	-27.1933786034	4	4		-12.530656516	-14.35688623	0.2423348954	0.9623542207			COC1=CC=C2[C@H](OC(=O)C2=C1OC)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34	Microsource	01500443	-4.69748048	-4.14307416	-2.2480058	-14.35688623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179673-09	NCGC00179673-09	384568382		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	54-42-2				-22.630310578	4	4		0	-6.30700188					OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(\I)C(=O)NC2=O	Enzo	DL422	-5.22421727	-4.73181879	-1.81454563	-6.30700188												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015202-21	NCGC00015202-21			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-3.2367033279	4	4		0	-0.05308112					CC(C)(OC1=CC=C(C=C1)C2CC2(Cl)Cl)C(O)=O	SigmaAldrich	C0330	-1.20905892	0.4480889	-0.60484854	-0.05308112												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351602-09	NCGC00351602-09	363677771		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1197958-12-5		11.220184543	-4.95	-60.8276895345	-2.4	4		-52.581676794	-47.35318245	0.0988620795	0.9939273539		ALK	COC1=CC(=CC=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[P](C)(C)=O)N4CCC(CC4)N(C)C	Selleck	S7000	-4.5204367	-8.45991845	-11.41407736	-47.35318245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263226-01	NCGC00263226-01	137276070		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	439083-90-6	BAY-60-7550	10	-5	-42.8660474389	4	4		-27.162447964	-28.93876766	0.1024759379	0.9934808588	5138	PDE2A	COC1=C(OC)C=C(CC/2=N/N\3C(C(C)\N=C3[C@@H](CCCC4=CC=CC=C4)[C@@H](C)O)C(=O)N2)C=C1	Cayman	10011135	-5.75342466	-3.38672769	-5.97635624	-28.93876766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242489-02	NCGC00242489-02	363677145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	153559-76-3				-11.4941430481	4	4		0	-2.00422955				RXRA	CC1=CC2=C(C=C1C3(CC3)C4=CC=C(C=N4)C(O)=O)C(C)(C)CCC2(C)C	SIGMA	SML0279	-2.41272647	-2.40732265	-3.07929536	-2.00422955												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015646-03	NCGC00015646-03	90341211		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	7554-65-6	FOMEPIZOLE HYDROCHLORIDE;4-Methylpyrazole hydrochloride; 4-Methylpyrazole hydrochloride			-10.3653878029	4	4		0	-0.84110353			124	ADH1	CC1=C[NH]N=C1	SigmaAldrich	Lopac-M-1387	-2.41272647	-2.2791762	-2.83631606	-0.84110353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346522-06	NCGC00346522-06	384568817		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	959122-11-3				-13.981955093	4	4		0	2.83507674				DGAT1	OC(=O)[C@@H]1CCC[C@H]1C(=O)C2=CC=C(C=C2)C3=CC=C(NC(=O)NC4=CC=CC=C4)C=C3	MedChem Express	HY-10038	-4.88025305	-3.21585703	-1.98997987	2.83507674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507861-01	NCGC00507861-01	384569337		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1432908-05-8				-22.4463816484	4	4		0	-9.17978297				PAK1	CCN1C(=O)\C(=C/C2=CN=C(NCCC3CCN(C)CC3)N=C12)C4=CC=C(C=C4Cl)C5=CN=CC(=N5)C	Selleck	S7989	-1.06642567	-3.63314737	-3.16055626	-9.17978297												1.6E-8	8E-8	4E-7	0.000002											
NCGC00510519-01	NCGC00510519-01	384569472		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1857417-10-7		12.5892541179	-4.9	-89.7149791749	-3	4		-106.1731913959	-99.61873106	0.035614462	0.9992168882			OC1=C(CN2CCC(CC2)NC3=NC=NC4=C3C=C(CC(F)(F)F)S4)C=C5C=C(C#N)[N](CC6=C[NH]N=C6)C5=C1	MedChem Express	HY-19810	-4.71757795	-2.75320905	-1.84014609	-99.61873106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021336-14	NCGC00021336-14	384568007		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	15307-79-6				-5.3036928189	4	4		0	2.68849714				PTGS1	[O-]C(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	Prestwick	Prestw-594	-1.96892107	-0.43234088	-2.83717877	2.68849714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510779-01	NCGC00510779-01	384569491		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1799759-24-2		1.1220184543	-5.95	-52.3228315349	4	4		-23.198119804	-20.65212335	0.4404633456	0.8575055752		GLUT1	CC1=C(NC(=O)C2=CC(=NC3=CC(=CC=C23)F)C(N)=O)C(=N[N]1CC4=CC=C(C=C4)C(C)(C)C)C(F)(F)F	SIGMA	SML1780	-3.35511213	-7.41219469	-33.1035453	-20.65212335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387879-02	NCGC00387879-02	384569168		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1047645-82-8		11.220184543	-4.95	-99.880010556	-2.1	4		-113.5186311564	-90.40180717	0.0278613484	0.9995209597		AKT1	C[N]1N=CC(=C1C2=C(Cl)SC(=C2)C(=O)N[C@H](CN)CC3=CC=CC(=C3)F)Cl	MedChem Express	HY-15727A	-4.84312859	-7.6979405	-20.83547498	-90.40180717												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016017-20	NCGC00016017-20	363676471		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	175178-82-2		10	-5	-124.8467450861	-3	4		-94.4116173519	-92.7852185	0.0131183091	0.9998938546		EGFR	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC=CC(=C3)Cl	Bio Vision	1800	-12.4807953	-13.212682	-20.58809758	-92.7852185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022678-08	NCGC00022678-08	384568012		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	13292-46-1				-22.4380020008	4	4		0	-5.7483625				PRKDC	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(C)CC5	Selleck	S1764	-6.19972887	-0.03175035	-3.27293159	-5.7483625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386324-08	NCGC00386324-08	363680210		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1432597-26-6		10	-5	-90.2655493857	-3	4		-102.8118851968	-99.65508982	0.0265586798	0.999564707	657	ACVR1	C1CN(CCN1)C2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=CC6=C5C=CC=N6	Glixx	GLXC-03718	-4.07647268	-1.68485016	-5.99951656	-99.65508982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015144-05	NCGC00015144-05	384567813		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	19916-73-5		11.220184543	-4.95	-28.1958854785	4	4		-28.8935764439	-26.57798037	0.172218342	0.9812845026		MGMT	NC1=NC(=C2N=C[NH]C2=N1)OCC3=CC=CC=C3	Adooq	A13706	-3.0990641	1.1900517	-1.78671919	-26.57798037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346633-02	NCGC00346633-02	384568869		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	908112-43-6		0.3981071706	-6.4	-67.5659832373	-1.4	4		-32.1093981832	-35.51793107	0.3640215743	0.9083219261		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	APExBIO	A4068	-2.48984637	-24.61668747	-24.97186269	-35.51793107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250389-02	NCGC00250389-02	384568542		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	479422-22-5		14.1253754462	-4.85	-13.3395220189	4	4		-13.720235024	-11.58193404	0.2342817023	0.9650004047		PLCG1	CC1=C(CCOC2=CC=C(C=C2)C(O)=O)C3=CC(=CC=C3[N]1C(C4=CC=CC=C4)C5=CC=CC=C5)Cl	Axon Medchem	1609	-0.56507152	-2.83918702	-1.79609829	-11.58193404												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263153-07	NCGC00263153-07	384568627		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	935881-37-1		0.5011872336	-6.3	-227.8076047252	-1.1	4		-99.9272132995	-99.61393553	0.034113569	0.9992816081		HDAC1	CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Selleck	S2244	-13.81776444	-69.41968265	-99.49821797	-99.61393553												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263206-04	NCGC00263206-04	384568665		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	882663-88-9		1.1220184543	-5.95	-127.1948671014	-1.3	4		-90.6551475502	-94.32375276	0.1558919392	0.9847051198		LCK	CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)C3=CC4=CN=C(NCCN5CCOCC5)N=C4C=C3	Adooq	A13167	3.40256297	-14.22425629	-79.31872342	-94.32375276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096060-07	NCGC00096060-07	384568159		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	3681-99-0				5.5873794425	4	4		0	2.90350963					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=C(O)C=CC3=C2O/C=C(C3=O)/C4=CC=C(O)C=C4	Selleck	S2346	-0.19882512	1.55576722	4.05955893	2.90350963												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509995-02	NCGC00509995-02	384569402		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1639417-53-0				-9.2711493818	4	4		0	-4.39925701				PIK3CD	CC[C@H](NC1=C2[NH]C=NC2=NC=N1)/C3=C(/C(=O)C4=CC=CC=C4O3)C5=CC=CC(=C5)F	MedChem Express	HY-17645_cm1	-2.35878897	0.53068445	-0.47291286	-4.39925701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379024-02	NCGC00379024-02	384569087		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	189453-10-9		14.1253754462	-4.85	-197.534908518	4	4		44.1022249654	-22.79792746	0.1938805862	0.9761369166		TUBB	C[C@H]1CCC\C(=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C2=CSC(=N2)C)C	MedChem Express	HY-15278	-48.64889291	-42.35043317	-38.14674346	-22.79792746												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356073-13	NCGC00356073-13	384569027		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1044870-39-4		7.0794578438	-5.15	-61.0370434267	-2.4	4		-41.4612139865	-42.93909552	0.0532966958	0.9982455598		BRD4	COC1=CC(=C2C(=O)N\C(=N/C2=C1)C3=CC(=C(OCCO)C(=C3)C)C)OC	Cayman	16424	-6.239819	-4.76532675	-13.84671169	-42.93909552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167467-03	Vecuronium bromide	170465295	Steroid non-depolarizing neuromuscular Blocker	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	50700-72-6	 ; Vecuronium bromide;Vecuronium bromide;Vecuronium Bromide; Bromuro de vecuronio; Norcuron			-9.9489627797	4	4		0	-1.46285496					[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(C)=O	Prestwick	Prestw-1359	-2.09502262	-2.68133842	-2.33422472	-1.46285496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246187-03	NCGC00246187-03	384568510		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	76748-86-2		12.5892541179	-4.9	-16.4119684157	4	4		-17.485023116	-17.06664117	0.0822885064	0.9958210668			COC1=CC=C2NC3=C(C=CC(Cl)=C3)C(N=C4C=C(CN5CCCC5)C(=O)C(CN6CCCC6)=C4)=C2N1	Microsource	01502329	-0.88235294	-1.59443072	-0.41245524	-17.06664117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015451-11	NCGC00015451-11	384567850		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-12.0630153368	4	4		0	-1.79883577				KCNQ1	CCOC(=O)NC1=CC=C(NCC2=CC=C(F)C=C2)N=C1N	NCGCChem	NCGC00015451-10pur	-2.78835089	-2.01540939	-3.13241346	-1.79883577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274061-07	NCGC00274061-07	384568709		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	13647-35-3				6.2374829856	4	4		0	0.90180361				ESR1	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4\C(=C(/C[C@]35C)C#N)O)[C@@H]1CC[C@@H]2O	MedChem Express	HY-14281	2.00053111	-2.52034998	3.171145	0.90180361												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263100-02	NCGC00263100-02	363677201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	252003-65-9		10	-5	-65.2220330646	-2.2	4		-81.0675917777	-66.74778128	0.0145385278	0.9998696399		KDR	NC(=O)C1=C(NC(=O)NCCCCN2CCCC2)SN=C1OCC3=C(F)C=C(Br)C=C3F	Axon Medchem	1662	-1.69956626	-2.8250555	-12.90244493	-66.74778128												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507881-01	NCGC00507881-01	384569347		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1313883-00-9		10	-5	-131.8656181862	-2.3	4		-114.7498263582	-99.73173653	0.0751045293	0.996504997		AKT1	NC1=NC=CC=C1C2=NC3=CC=C(N=C3[N]2C4=CC=C(C=C4)C5(N)CCC5)C6=CC=CC=C6	Selleck	S8339	-9.25745209	-16.6459513	-31.54459753	-99.73173653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510705-01	NCGC00510705-01	384569488		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1126084-37-4				-6.6471768138	4	4		0	-1.47913856				AKR1C3	COC1=CC2=C([NH]C(=C2)C(=O)N3CCC(CC3)CC(C)(C)O)C=C1	MedChem Express	HY-19903	-1.91594561	0.36102692	-1.28962671	-1.47913856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345808-01	NCGC00345808-01	174006728		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	n	BP-1-102			-8.1428150442	4	4		0	-7.33987627			6774	STAT3	CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC=C(C(O)=O)C(=C3)O)[S+]([O-])(=O)C4=C(F)C(=C(F)C(=C4F)F)F	EMD Chemicals	573132	-0.3531697	-1.49313603	-1.01763271	-7.33987627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480817-01	NCGC00480817-01	384569247		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	223387-75-5				-8.7628507138	4	4		0	-0.65119308				HIF2A	OC(=O)CNC(=O)C1=C(O)C2=C(C=CC=C2)C(=N1)Cl	Glixx	GLXC-90112	-1.08599682	-4.78249242	-3.09041456	-0.65119308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015122-14	NCGC00015122-14	363676440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	31677-93-7				-10.9439310265	4	4		0	-3.29231952				SLC6A3	CC(NC(C)(C)C)C(=O)C1=CC=CC(=C1)Cl	Selleck	S2452	-2.03269996	-3.32265446	-1.38778562	-3.29231952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345819-01	NCGC00345819-01	174007301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	15183-37-6	Estetrol			-20.2112808347	4	4		0	-7.37767952			2099	ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O	Toronto Research	E668450	-2.59832081	-6.37070938	-5.16331013	-7.37767952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346655-06	Linagliptin	384568886	DPP-IV Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	668270-12-0				-8.6867631263	4	4		0	-3.4365087				DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	MedChem Express	HY-10284	-0.76889085	-2.42562929	-3.51852717	-3.4365087												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346581-05	NCGC00346581-05	384568850		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	905586-69-8		1.4125375446	-5.85	-169.848278236	-2.3	4		-108.5897881323	-98.20116423	0.2594502704	0.9560423393		JAK2	C[C@H](NC1=NC(=C(F)C=C1C#N)NC2=N[NH]C(=C2)C)C3=CC=C(F)C=C3	Axon Medchem	1778	-6.22289103	-48.67017803	-66.58436214	-98.20116423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511348-01	NCGC00511348-01	384569496		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	2055172-43-3				-3.869920707	4	4		0	-3.58335719				ABHD11	CCC1CCCCN1C(=O)[N]2N=CC(=N2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4	Glixx	GLXC-02169	-0.87633885	2.62482044	-1.12805616	-3.58335719												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480830-01	NCGC00480830-01	384569248		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	288628-05-7				-19.1586350028	4	4		0	2.05649394				CA2	N[S+]([O-])(=O)OC1=CC=C2\C3=C(CCCCC3)/C(=O)OC2=C1	Glixx	GLXC-06889	-7.16119324	-1.30152788	-2.14475914	2.05649394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509996-01	NCGC00509996-01	384569403		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	476617-51-3		11.220184543	-4.95	-36.389178933	4	4		-17.9124460759	-18.17964072	0.1128525789	0.9921340251		HIF1A	COC(=O)\C1=C(C)\N=C(N[C@@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029B	-4.91926899	-6.4355752	-8.21368141	-18.17964072												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345173-01	NCGC00345173-01	174006338		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1260530-25-3		10	-5	-28.9982570687	4	4		-17.948281368	-19.71257485	0.1046072622	0.9932221583		BRD4	CCNC(=O)C[C@H]1/N=C(/C2=CC=C(Cl)C=C2)C3=CC(=CC=C3[N]4C(=NN=C14)C)OC	NCGCChem	PRP01-073_2ND_NEG	-3.89017033	-2.25567371	-3.94005318	-19.71257485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181098-02	NCGC00181098-02	384568389		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	121032-29-9				-8.8962694707	4	4		0	-3.59086469				HPRT1	[CH3][O]C1=NC(=NC2=C1N=C[N]2[CH]3[O][CH]([CH2][OH])[CH]([OH])[CH]3[OH])[NH2]	APExBIO	A1379	-2.55165107	-1.49313603	1.92740574	-3.59086469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346943-03	NCGC00346943-03	384568975		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1088965-37-0		8.9125093813	-5.05	-57.9534350721	-2.4	4		-76.196529844	-58.1034317	0.081111244	0.9959215699		CENPE	CC(C)OC1=CC=C(C=C1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)CC2=CC=C(C=C2)C3=C[N]4C=CC=C([C@H](C)O)C4=N3	Adooq	A11435	0.91029607	-5.3180778	-18.78884164	-58.1034317												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475739-01	NCGC00475739-01	384569235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1276553-09-3		3.9810717055	-5.4	-93.9039427659	-2.2	4		-78.7084647	-63.419206	0.0114115645	0.9999197002		PIK3CA	FC1=CC(=CC=C1C2=C(SC(=C2C#N)N3CCOCC3)C4=NN=C[NH]4)C#N	ActiveBioChem	A-1184	-3.49977905	-14.50800915	-39.23648428	-63.419206												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179244-11	Dorzolamide hydrochloride	384568369	Carbonic Anhydrase Type II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	130693-82-2				-4.82233428	4	4		0	-1.65250012				CA2	CCN[C@H]1C[C@H](C)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0109A	-1.77356337	1.50939944	-0.16203704	-1.65250012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159508-05	NCGC00159508-05	174006187		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	632-69-9	; Bengal Rose B sodium salt; Rose Bengal Sodium I 125; ; Rose Bengal sodium salt; Rose bengal sodium;Rose bengal; Rose bengal;Rose Bengal; Bengal, Ros;Rose Bengal disodium; Acid Red- 94	12.5892541179	-4.9	-36.653907056	4	4		-18.0751378399	-21.16909635	0.1114918927	0.9922918066			[O-]C(=O)C1=C(C(=C(Cl)C(=C1Cl)Cl)Cl)C/2=C/3\C=C(I)/C(=O)/C(=C3OC4=C2C=C(I)C(=C4I)[O-])I	SIGMA	330000	-5.63677071	-5.18684536	-4.02314815	-21.16909635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182058-03	NCGC00182058-03	124893779		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	54573-75-0	TSA-840; ; Doxercalciferol; 1alpha(OH)2D2; 1alpha-hydroxyvitamin D2; 1alpha-OHD2;Hectorol			-14.2325694162	4	4	1alpha-hydroxyvitamin D2;1A-HYDROXYVITAMIN D2;DOXERCALCIFEROL;doxercalciferolum;doxacalciferol;1 alpha-hydroxyergocalciferol;doxercalciferol;Hectorol;HECTOROL;Bone Care brand of 1 alpha-hydroxyergocalciferol;1alpha-OHD2;1A-HYDROXYERGOCALCIFEROL;CIPLUS_700330;Draxis brand of 1 alpha-hydroxyergocalciferol;1alpha(OH)2D2;	0	0.18994254			7421	VDR	C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@H](C)C(C)C	APAC	555784	-5.03972958	-1.48195582	-0.6712963	0.18994254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185850-16	NCGC00185850-16	384568428		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	935693-62-2		10	-5	-84.2460692992	-3	4		-103.0444109095	-99.41677025	0.0161304512	0.9998394895		EHMT2	COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCCN(C)CC3)NC4CCN(CC4)CC5=CC=CC=C5	MedChem Express	HY-10587	-1.69683258	-3.13047384	-4.89054072	-99.41677025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182047-04	NCGC00182047-04	384568405		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	75607-67-9				-20.3986131795	4	4		0	-4.56066546				HPRT1	NC1=C2N=C[N]([C@@H]3O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(=N1)F	Selleck	S1229	-4.90950226	-3.18437009	-3.18633005	-4.56066546												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387189-01	NCGC00387189-01	363680564		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[1057394-06-5]				-27.2060323774	4	4		0	-8.20598802				MAPK14	CC1=C(F)C=C(C=C1C2=C(F)C3=NN=C([N]3C=C2F)C(C)(C)C)C(=O)NC4CC4	Tocris	4753	-4.59989354	-6.64733232	-6.69567319	-8.20598802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488771-02	NCGC00488771-02	384569284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1803274-65-8		12.5892541179	-4.9	-41.2714274055	-3	4		-76.9581317368	-66.62994012	0.1230018239	0.9905522451		IDH1	C[C@H]1C[C@H](CC(C)(C)C1)[N]2C(=NC3=CC(=CC=C23)CCC(O)=O)NC4=CC=C(OC(F)(F)F)C=C4	ChemieTek	CT-BAY143_cm1	0.89158978	1.02195829	7.92361615	-66.62994012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164246-18	NCGC00164246-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	50-70-4				-20.4479362783	4	4		0	-2.01676647					[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO	MedChem Express	HY-B0400	-6.14354152	-3.51700962	-1.13608895	-2.01676647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022848-25	NCGC00022848-25	384568014		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	50-23-7				-13.8721005392	4	4		0	-2.49774443					C[C@]\12CCC(=O)\C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23	MedChem Express	HY-N0583	-3.60858686	-1.03370992	-2.95833333	-2.49774443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356837-03	NCGC00356837-03	384569033		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1109276-89-2				-16.3617871259	4	4		0	-3.11505769				DGAT1	NC1=NC=NC2=C1C(=O)N(CCO2)C3=CC=C(C=C3)[C@@H]4CC[C@H](CC4)CC(O)=O	MedChem Express	HY-13009	-2.39694455	-6.76027992	-4.56018519	-3.11505769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015163-09	Benserazide	170465804	DOPA decarboxylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	14919-77-8	; ; Benserazida; Benserazide Hcl; Ro 8-0576-12; Ro 8-0576-7;Benserazide hydrochloride; Benserazide hydrochloride; Ro 8-0576;BENSERAZIDE HYDROCHLORIDE; Benseraszide; Ro 4460; Ro 4 460	7.0794578438	-5.15	-33.3156029442	4	4		-20.073360168	-20.04971795	0.2611052073	0.9556503815	1644	DDC	Cl.Oc1ccc(CNNC(=O)C(N)CO)c(O)c1O	Microsource	01500137	-4.70135747	-0.82191781	-8.22644246	-20.04971795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510269-04	NCGC00510269-04	384569426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1869912-40-2		0.1122018454	-6.95	-354.8830904614	5	4		-72.603881696	-91.24199254	0.0385924824	0.9990819149		BRD4	COC1=NN=C2C=CC(=N[N]12)N3CCC(CC3)C4=CC=C(OCCN5CCN(C)C(=O)[C@H]5C)C=C4	Selleck	S8344	-63.69683258	-86.09476757	-91.35203735	-91.24199254												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263129-31	NCGC00263129-31	384568610		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	827022-33-3		14.1253754462	-4.85	-48.8642505183	4	4		-29.0367063	-31.0668957	0.0682662269	0.9971203745		CDK4	CC(=O)C\1=C(/C)C2=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N=C2N(C5CCCC5)C1=O	MedChem Express	HY-A0065	-6.95759936	-5.61964045	-5.64996369	-31.0668957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181016-19	NCGC00181016-19	384568387		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[153559-49-0]		12.5892541179	-4.9	-53.5963134933	-3	4		-63.0893618402	-59.72421033	0.017719805	0.9998063428		RXRA	CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C3=CC=C(C=C3)C(O)=O	Tocris	5819	-2.08019828	-2.8859966	-2.32873396	-59.72421033												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509999-02	NCGC00509999-02	384569405		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1362850-20-1		11.220184543	-4.95	-26.3268832421	4	4		-16.3033033441	-17.08655406	0.1110006642	0.9923743129		PIK3CG	[O-][N+]1=CC(=CC=C1)C2=NC3=C(Cl)C=CC=C3C=C2[C@@H](NC4=C5N=CC=CC5=NC=N4)C(F)(F)F	MedChem Express	HY-16754	-3.64698593	-2.25046794	-3.81989833	-17.08655406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507847-01	NCGC00507847-01	384569328		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1306760-87-1				-6.8331187831	4	4		0	5.28383234				S1PR1	CC(C)OC1=CC=C(C=C1C#N)C2=NC(=NO2)C3=CC=CC4=C3CC[C@@H]4NCCO	Selleck	S7952	-3.26916253	-4.10624684	0.62364032	5.28383234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021191-15	NCGC00021191-15	384568005		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	50-04-4				-27.914909682	4	4		0	-5.46586826				NRC31	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	MedChem Express	HY-17461A	-6.48953158	-5.1189983	-5.26468455	-5.46586826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390634-03	NCGC00390634-03	384569203		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1619903-54-6		0.3548133892	-6.45	-174.3890691932	-1.2	4		-79.430330869	-79.23159217	0.0123524803	0.9999058881	1025	CDK9	CC(C)C1=C2C=C(C=CC2=N[N]1C)C3=NC(=NC=C3)N[C@H]4CC[C@@H](CC4)NC5CCOCC5	MedChem Express	HY-12293_CM1	-2.05721349	-77.25530398	-79.99906209	-79.23159217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253646-08	NCGC00253646-08	384568565		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	138112-76-2				-17.4619634272	4	4		0	-3.46062608				HTR2C	COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1	MedChem Express	HY-17038	-4.22037789	-2.31324657	-3.54999062	-3.46062608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181773-01	NCGC00181773-01	144206591		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	198470-85-8	PARECOXIB; Dynastat; 			-1.4576531691	4	4	Parecoxib;N-[4-(5-Methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide, sodium salt;PROPANAMIDE, N-((4-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)PHENYL)SULFONYL)-;N-((P-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)PHENYL)SULFONYL]PROPIONAMIDE;PARECOXIB;CIPLUS_696533;CIPLUS_696534;parecoxib sodium;PARECOXIB Na;PARECOXIB NA;N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide;N-((4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYL)SULFONYL)PROPANAMIDE SODIUM;parecoxibum;Pharmacia brand of parecoxib sodium;SC-69124A;N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt;Dynastat;parecoxib;Parecoxib sodium;PARECOXIB SODIUM;	0	-2.95827713					[Na+].CCC(=O)[N-]S(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2	Apin	40118p	-1.09482606	3.34729898	1.73044457	-2.95827713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159330-04	NCGC00159330-04	363676585		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	69975-86-6				7.5937858181	4	4		0	1.8899283				ADORA2	CN1C(=O)N(C)C2=C([N](CC3OCCO3)C=N2)C1=O	Selleck	S4164	1.75600334	4.0159173	-1.58796296	1.8899283												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159356-02	NCGC00159356-02	29215274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	62-90-8	 ; Nerobolil; Durabolin-50; Fenobolin; Nerobolyl; Nandrolone decanoate;Durabolin; Nandrolone phenpropionate			-26.3449521422	4	4	Nandroloni phenylpropionas;ESTR-4-EN-3-ONE, 17-(1-OXO-3-PHENYLPROPOXY)-, (17.BETA.);nortestosterone phenylpropionate;CIPLUS_149019;LS-64857;Nandrolone Phenpropionate;Nandrolone decanoate;Durabolin;NANDROLONE PHENPROPIONATE;LS-171982;norandrolone phenylpropionate;Nandrolone phenpropionate;NANDROLONE PHENYLPROPIONATE;Durabolin-50;Nerobolyl;nandrolone phenpropionate;19-nortestosterone phenylpropionate;Nandrolone Phenylpropionate;nandrolone phenpropionate, (17alpha)-isomer;17 beta-hydroxyestr-4-en-3-one hydrocinnamate;Nerobolil;Fenobolin;NSC-23162E;17.BETA.-HYDROXYESTR-4-EN-3-ONE HYDROCINNAMATE;Nandrolone phenylpropionate;	0	-4.89102047					O=C5CC[C@H]4C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	Pharmeks	PHAR048161	-6.26015189	-5.1319581	-4.45833333	-4.89102047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346641-07	NCGC00346641-07	363677491		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	850173-95-4				-13.0059047032	4	4		0	-1.56702597				OPRD1	CCN(CC)C(=O)C1=CC=C(C=C1)C/2=C/C3(CCNCC3)OC4=CC=CC(=C24)O	Glixx	GLXC-90067	-2.35304447	-3.28408727	-5.05092593	-1.56702597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016610-12	NCGC00016610-12	384567952		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	2398-96-1		11.220184543	-4.95	-37.0376464461	4	4		-19.64468708	-19.84899568	0.0164557754	0.9998340554			CN(C(=S)OC1=CC=C2C=CC=CC2=C1)C3=CC(=CC=C3)C	Microsource	01500583	-5.14508978	-5.37895074	-7.58796296	-19.84899568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015252-17	NCGC00015252-17	384567832		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	969-33-5				-20.8486320419	4	4		0	-8.5094259				HRH1	CN1CCC(CC1)=C2C3=C(C=CC=C3)\C=C/C4=C2C=CC=C4	APExBIO	B3309	-4.67974889	-2.51566574	-1.11574074	-8.5094259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263207-02	NCGC00263207-02	384568666		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[944328-88-5]				4.0283720472	4	4		0	3.95080488				ARF1	OC[C@H](CC1=CC=CC=C1)NC2=NC(=NC3=C2N=C[N]3CC4=CC=C(C=C4)C5=CC=CC=C5)OC6=CC7=C(CCC7)C=C6	Tocris	3324	-0.18438035	5.00388785	-2.79166667	3.95080488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346493-03	NCGC00346493-03	384568800		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	896466-04-9		7.0794578438	-5.15	-76.8137504912	-2.4	4		-43.6505715816	-47.63361698	0.0671514737	0.9972107363		AURKA	O=C(NC1CC1)NC2=C[NH]N=C2C3=NC4=CC(=CC=C4[NH]3)CN5CCOCC5	Selleck	S1134_CM1	-9.1719457	-7.27150236	-18.17975797	-47.63361698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510682-01	NCGC00510682-01	384569476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1246030-96-5]		12.5892541179	-4.9	-91.4489158665	-3	4		-106.3803217723	-99.45501482	0.0583095643	0.9978971246		ITK	CCC1=CC=C2N=C(NC3=NC(=NC(=C3)CC4=CC=CC=C4)N[C@H]5CC[C@H](O)CC5)SC2=C1	Tocris	5401	-5.7239819	-2.88794071	-0.68440375	-99.45501482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017280-37	NCGC00017280-37	384567982		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	302-79-4				6.7675857021	4	4		0	7.26646907				RORB	C/C1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1	MedChem Express	HY-14649	-1.06334842	0.51650573	5.28033359	7.26646907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179504-05	Etoposide	225144306	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	33419-42-0	Etoposide, (5S)-Isomer; ;Etoposide (VP-16); EI24 protein, human;Etoposide; Etoposide; Etoposide Phosphate; Etoposido; Lastet	5.0118723363	-5.3	-24.4171461552	4	4		-18.108296996	-16.0627211	0.0905615915	0.99494716	7153	TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC	Prestwick	Prestw-396	-1.38914027	-3.97484842	-8.70688483	-16.0627211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346840-06	NCGC00346840-06	384568949		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	537049-40-4				-10.3084376877	4	4		0	-2.62906766				HDAC6	OCC1=CC=C(C=C1)[C@@H]2C[C@H](CSC3=NC(=C(O3)C4=CC=CC=C4)C5=CC=CC=C5)O[C@@H](O2)C6=CC=C(NC(=O)CCCCCCC(=O)NO)C=C6	SIGMA	SML0065	-1.40745331	-5.64575806	0.07262164	-2.62906766												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00015769-14	NCGC00015769-14	384567888		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	11018-89-6		5623.4132519035	-2.25	-451.5845994311	5	4		-1.1613398279	-96.35938544	0.8193162826	0.6497572086	478	ATP1A3	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C/6=C/C(=O)OC6)[C@H](O)[C@H](O)[C@H]1O	Prestwick	Prestw-NAT-0107	-95.99893777	-96.63953337	-95.67175018	-96.35938544												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346548-07	NCGC00346548-07	363677450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	286370-15-8				4.1652030533	4	4		0	3.70387958				FLT1	CCCNC(=O)NC1=CC=C(OC2=NC=NC3=CC(=C(OC)C=C23)OC)C=C1Cl	MedChem Express	HY-12060	-0.29852057	2.95476376	0.13425926	3.70387958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379161-04	NCGC00379161-04	363678392		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1357171-62-0		0.5011872336	-6.3	-200.1395614201	-1.3	4		-92.3077287661	-96.50980578	0.0665752767	0.9972564559		HIF1A	C(NC1=C(N=NC(=N1)C2=NC=CC=C2)C3=CC=CC=C3)C4=CC=C(C=C4)C5=CC=CC=C5	Cayman	14568	-4.58316871	-75.51571148	-90.875	-96.50980578												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167816-03	NCGC00167816-03	384568341		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[349087-34-9]				-3.869835544	4	4		0	-5.44029066				MAPK14	COC1=C(C=CC(=C1)SC)C(=O)N2CCC(CC2)CC3=CC=CC=C3	Tocris	2657	0.74660633	-1.08241635	-1.36427503	-5.44029066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485484-02	NCGC00485484-02	384569276		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1604810-84-5		1.2589254118	-5.9	-125.8452780125	-1.3	4		-83.2109413997	-80.27536093	0.0722625155	0.9967655065	1022	CDK7	CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=C4C=CC=C5	MedChem Express	HY-12280	0.40271493	-9.53514485	-86.13969089	-80.27536093												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188690-09	NCGC00188690-09	384568451		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	150322-43-3				1.7986007724	4	4		0	3.65235682				P2RY12	CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C3CC3)C4=CC=CC=C4F)S1	MedChem Express	HY-15284	-0.94570136	1.81899843	0.30367584	3.65235682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379089-04	NCGC00379089-04	384569094		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	529488-28-6		0.2818382931	-6.55	-243.8281849488	-1.1	4		-102.7889621015	-99.19362535	0.0123492403	0.9999059357		TOP1	CNCCN1C(=O)C2=CC(=C(OC)C=C2C3=C1C4=CC5=C(OCO5)C=C4N=C3)OC	MedChem Express	HY-16228	-10.30362043	-37.33513255	-78.9009925	-99.19362535												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263200-02	NCGC00263200-02	377020413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	(1258296-60-4)		12.5892541179	-4.9	-102.5774469412	-2.3	4		-99.747440614	-85.61984269	0.1749264072	0.9806414361		TYK2	CC1=NC(=NC(=C1)NC2=CC(=CC=N2)NC(=O)C3=C(Cl)C=CC=C3Cl)N	SynKinase	SYN-1128	-5.58513038	-17.98628848	-16.80893615	-85.61984269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346435-07	Niraparib	384568775	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1038915-60-4		14.1253754462	-4.85	-23.7821637231	4	4		-17.3729923641	-17.24171211	0.2689366777	0.9528662559		PARP1	NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	MedChem Express	HY-10619	-1.93088514	-5.53837881	-2.99497585	-17.24171211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522475-03	Verubecestat (MK-8931)			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1286770-55-5(free base)				-13.5573597461	4	4		0	-4.38643054					CN1C(N)=N[C@@](C)(C[S+]1([O-])=O)C2=CC(NC(=O)C3=NC=C(F)C=C3)=CC=C2F	Selleck	S8173	-2.35495804	-3.79979388	-2.30232672	-4.38643054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509935-01	NCGC00509935-01	384569384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1644545-52-7		7.0794578438	-5.15	-5.418007593	4	4		10.634897164	7.1852531	0.0399429634	0.9990279772		IDH1	C[C@@H](NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)N[C@@H](C)C(F)(F)F)C(F)(F)F	ChemGood	C-1090	-2.89632771	-3.02908097	-1.82430125	7.1852531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163450-06	Ilomastat (GM6001, Galardin)	384568240	MMP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	142880-36-2				-14.2777028469	4	4		0	-4.81107948				MMP1	CNC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC(C)C)CC(=O)NO	Selleck	S7157	-1.7865199	-4.79455124	-3.9607824	-4.81107948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263188-03	NCGC00263188-03	363677253		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	209984-56-5				5.8447836357	4	4		0	-2.51411475				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	Selleck	S2711	3.62717676	-1.69377605	-0.50729233	-2.51411475												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378921-05	NCGC00378921-05	384569075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1206799-15-6		5.0118723363	-5.3	-53.8980448906	-2.4	4		-37.9213866704	-39.30415368	0.1004361713	0.9937325244		MET	C[N]1N=CC2=C1C=C(C(=C2)OC3=CC=C(NC(=O)\C4=C\C=C(\C)N(C4=O)C5=CC=C(F)C=C5)C=C3F)C6=C[NH]N=C6	MedChem Express	HY-15514	-4.23803638	-1.68924942	-17.90939786	-39.30415368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164587-01	NCGC00164587-01	144205766		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	67814-76-0	Isepamicin; Isepacin; Is??palline; Sch 21420; 			-23.3192232021	4	4	N-(S-3-amino-2-hydroxypropionyl)gentamicin;Sch-21420;ISEPAMICIN SULFATE;NCGC00164587-01;Isepacin;SCH-21420;O-6-AMINO-6-DEOXY-A-D-GLUCOPYRANOSYL-(1-4)-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-B-L-ARABINOPYRANOSYL-(1-6))-2-DEOXY-N1-((S)-ISOSERYL)-D-STREPTAMINE SULFATE;isepamicinum;ISEPAMICIN;CIPLUS_207475;HAPA-B;Is??palline;CIPLUS_749397;Schering-Plough brand of isepamicin sulfate;Isepamicin;D-Streptamine, O-6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-N1-(3-amino-2-hydroxy-1-oxopropyl)-2-deoxy-, (S)-;Isepamicin sulfate;isepamicin sulfate;isepamicin;Sch 21420;isepamicine;LS-146923;CIPLUS_775638;Isepamicin Sulfate;	0	-6.06946108					O=S(=O)(O)O.NCC(O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2OC[C@](C)(O)[C@H](NC)[C@H]2O	Sequoia	SRP01515i	-6.22338538	-0.53399623	-3.6016437	-6.06946108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378564-01	NCGC00378564-01	384569049		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	300353-13-3				-12.1762980974	4	4		0	-10.24223782				GCK	C[S+]([O-])(=O)C1=CC=C(C=C1)[C@@H](CC2CCCC2)C(=O)NC3=NC=CS3	MedChem Express	HY-10595	-1.30799823	-0.32036613	-1.3690949	-10.24223782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509910-02	NCGC00509910-02	384569377		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1532533-67-7				-8.6645288743	4	4		0	-8.22358935				CSNK1E	CC(C)OC1=C(F)C=C(C=C1)C2=N[N]([C@@H](C)C/3=C(C4=CC(=CC=C4)F)/C(=O)C5=CC(=CC=C5O3)F)C6=C2C(=NC=N6)N	MedChem Express	HY-12279	-0.98099867	-0.67734554	0.65884772	-8.22358935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015225-08	NCGC00015225-08	384567826		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[3895-92-9]		12.5892541179	-4.9	-66.8724257909	-3	4		-97.3121407326	-87.23925791	0.0510790084	0.9983874136		PRKCA	COC1=C(OC)C2=C[N+](=C3C(=C2C=C1)C=CC4=CC5=C(OCO5)C=C34)C	Tocris	1330	-1.66151127	2.34324943	1.34105883	-87.23925791												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386668-01	NCGC00386668-01	363680384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	477775-14-7				-1.8412249784	4	4		0	1.3890224				AGT	CCCCOC(=O)N[S+]([O-])(=O)C1=C(C=C(CC(C)C)S1)C2=CC=C(C[N]3C=CN=C3)C=C2	Axon Medchem	1969	-1.07821476	1.69336384	-1.87374422	1.3890224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017244-10	NCGC00017244-10	384567978		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	471-53-4		8.9125093813	-5.05	-14.41542825	4	4		19.8843199319	11.25232183	0.0663953671	0.9972839898			CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)\C=C/4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O	Enzo	NP116	-6.57026661	-5.5200254	-3.13246242	11.25232183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024415-57	NCGC00024415-57	384568027		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	25316-40-9		1.4125375446	-5.85	-55.7860009641	4	4		-20.6518075801	-21.96695669	0.0893195121	0.9950827397		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(=C3C2=O)O	Selleck	S1208	-7.25711704	-11.26230326	-18.54661235	-21.96695669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346946-02	NCGC00346946-02	363677564		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1415559-43-1				-8.9086976695	4	4		0	0.20529866				CDK9	CC1=CC=C(NC2=NC=NC(=C2)C3=CC=CC(=C3)N4C(=O)C5=C(C=CC=C5)C4=O)C=C1N[S+](C)([O-])=O	MedChem Express	HY-13231	-2.73836421	-2.56270694	-0.39799597	0.20529866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263214-02	NCGC00263214-02	363677270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[883031-03-6]		12.5892541179	-4.9	-57.1414940831	-3	4		-45.602270281	-46.77876625	0.0398151907	0.9990216161		TRPV4	CC1=C(C=C([N]1CCCN2CCOCC2)C3=CC=CC=C3)C(=O)NC4=CC=CC(=C4)C(F)(F)F	Tocris	4100	-6.06416629	-4.80337461	-4.77126937	-46.77876625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189073-04	Selumetinib	384568456	Mek1/2 inibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	606143-52-6		0.4466835922	-6.35	-77.0791134079	4	4		-12.6213096919	-21.3119562	0.3222059133	0.930745744		MAP2K1	C[N]1C=NC2=C1C=C(C(=O)NOCCO)C(=C2F)NC3=CC=C(Br)C=C3Cl	Selleck	S1008	-11.92950746	-19.37225019	-24.53059887	-21.3119562												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274030-16	NCGC00274030-16	384568707		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1310746-10-1		11.220184543	-4.95	-40.7029671367	4	4		-16.3127005521	-18.90702904	0.1959145907	0.9757885543		FGFR3	CCN1CCN(CC1)C2=CC=C(NC3=CC(=NC=N3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C=C2	MedChem Express	HY-13311A	-5.72977858	-8.08726811	-8.99470899	-18.90702904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142598-07	NCGC00142598-07	384568165		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	83-46-5				-10.3042850692	4	4		0	0.52215569					CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C	Selleck	S2273	-3.26916253	-1.21530175	-2.14164854	0.52215569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371125-09	NCGC00371125-09	363678041		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	487021-52-3		12.5892541179	-4.9	-38.5791154976	-3	4		-36.9157190092	-36.09580838	0.0751402208	0.9965052064		GSK3A	COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1	Glixx	GLXC-11026	-2.91430092	-4.08783317	-1.86125212	-36.09580838												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016889-15	NCGC00016889-15	384567965		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	59804-37-4				-21.2602315561	4	4		0	-3.31515707					CN1\C(=C(\O)C2=C(C=CS2)[S+]1([O-])=O)C(=O)NC3=CC=CC=N3	MedChem Express	HY-B0440	-5.9821348	-3.28001075	-1.73650066	-3.31515707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167521-07	NCGC00167521-07	384568324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	113712-98-4				-9.4120287638	4	4		0	1.10505236					COC1=CC=C2[NH]C(=NC2=N1)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC	Enzo	DL169	-3.19408102	-2.72438052	-0.25364616	1.10505236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242490-05	NCGC00242490-05	384568496		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[212391-63-4]		14.1253754462	-4.85	-277.1115812752	-2.3	4		-64.6828121492	-99.88945496	0.3983994639	0.8872813805		SRC	CCN(CC)CCOC1=CC=C(NC2=NC=C3\C=C(/C(=O)N(C)C3=N2)C4=C(Cl)C=CC=C4Cl)C=C1	Tocris	3785	-45.59434379	-64.79633867	-58.2729779	-99.88945496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345795-04	NCGC00345795-04	363677359		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1143532-39-1				-34.4839012572	4	4		0	-13.44323753				AKT1	NC1(CCN(CC1)C2=C3C=C[NH]C3=NC=N2)C(=O)N[C@@H](CCO)C4=CC=C(Cl)C=C4	ChemieTek	CT-A5363	-5.32920901	-5.3180778	-10.17242185	-13.44323753												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346608-02	NCGC00346608-02	384568856		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	83207-58-3				-20.0707673991	4	4		0	1.10470232					CC(C)(O)[C@H]1CC[C@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O	Selleck	S2415	-6.16357885	-2.93463963	-4.44350798	1.10470232												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092381-04	NCGC00092381-04	384568109		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[1188890-28-9]		10	-5	-38.1403104744	4	4		-19.1503147001	-21.28262782	0.0974774302	0.9941265956		ADK	NC1=C2C(=NC=N1)N=C(C=C2C3=CC(=CC=C3)Br)C4=CN=C(C=C4)N5CCOCC5	Tocris	2372	-4.90736557	-6.32739148	-7.55255888	-21.28262782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016463-08	NCGC00016463-08	384567942		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	485-35-8				-14.0871092501	4	4		0	-2.94261414				CHRNA3	O=C1\C=C/C=C2/[C@H]3CNC[C@H](C3)CN12	Selleck	S2287	-4.04880253	-1.85512768	-0.36053753	-2.94261414												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263116-09	NCGC00263116-09	384568600		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	847591-62-2				-24.8813558199	4	4		0	-3.2945547				CREBBP	OC1=CC=C(C[C@@H]2N3[C@H](CN(CC4=CC=CC5=C4C=CC=C5)C2=O)N(CCC3=O)C(=O)NCC6=CC=CC=C6)C=C1	Glixx	GLXC-02853	-6.78716674	-1.97305756	-5.30505221	-3.2945547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163135-04	NCGC00163135-04	124892401		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	113165-32-5	 Niguldipine;Niguldipine	12.5892541179	-4.9	-90.0549586397	-3	4	NIGULDIPINE	-105.6339302678	-99.61873106	0.0535331092	0.9982283141			COC(=O)C/1=C(C)/N/C(=C(\C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5)C	BIOMOL	CA216	-4.06687754	-6.00081644	-1.45619703	-99.61873106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263146-04	NCGC00263146-04	384568621		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			1.2589254118	-5.9	-145.3018724701	-1.1	4		-85.8970548245	-87.78961775	0.0349242995	0.9992469799		MAPK8	CC1=NC=C(C=C1)C2=N[N](C=N2)C3=CC=C(NC4=NC=CC(=N4)C5=CC(=CC=C5)N6CCOCC6)C=C3	MedChem Express	HY-12829	-3.17216448	-11.76123736	-90.65411809	-87.78961775												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351482-12	NCGC00351482-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1201438-56-3		5.6234132519	-5.25	-43.9176442107	4	4		-15.8965287081	-16.87359468	0.1030525021	0.9935008765			C[C@H](NC1=C2N=CNC2=NC=N1)C3=CC4=C(C(Cl)=CC=C4)C(=O)N3C5=CC=CC=C5	Bio Vision	2445	-6.54315409	-8.95813489	-11.92583228	-16.87359468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344508-02	NCGC00344508-02	384568718		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[177172-49-5]				-24.7887644831	4	4		0	-8.3488122				CASR	COC1=CC(=CC=C1)[C@@H](C)NCCCC2=CC=CC=C2Cl	Tocris	3815	-4.60009037	-4.30444051	-5.42679215	-8.3488122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI		53-86-1		0.0443125409	-7.3534733462	17.5624828151	4	10		7.4733417239	6.18880981	0.3874567681	0.3890377433		PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	1.13238706	-2.42991389	5.79561986	-3.48366296	-0.83356269	0.0314552	-0.12582078	-4.97778477	4.24645146	6.18880981						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159462-20	Ritonavir			SARS-CoV-2_CPE_SRI		155213-67-5		0.0557861839	-7.2534733462	-88.4296156593	4	10		-24.5944550159	-25.82611735	0.0002592203	0.9643129303			[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1	-3.3510659	-2.90839902	-4.78779171	-4.30629441	-6.06142974	-4.94311342	-6.43420184	-2.83073817	-11.37343222	-25.82611735						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00168784-10	NCGC00168784-10	384568348		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	122111-03-9		0.0316227766	-7.5	-144.273102258	5	4		0.6961845241	-28.6048287	1	0.8155755777		RRM2	NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	APExBIO	A1402	-30.84004603	-30.1701998	-30.71895425	-28.6048287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389197-01	NCGC00389197-01	363680736		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	934343-74-5		6.3095734448	-5.2	-128.7689829349	-2.4	4		-45.3808732612	-45.09495181	0.626832049	0.6376699768		HSP90AB1	COC1=CC=CC(=N1)C2=C(C=CC(=C2)F)C3CC4=C(C(=NC(=N4)N)C)C(=O)N3	APExBIO	B4797	-20.12038594	-35.24572324	-27.25248124	-45.09495181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025100-17	NCGC00025100-17	384568049		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	244240-24-2				-10.7415369193	4	4		0	-0.83832335				BTK	CC(/O)=C(C#N)/C(=O)NC1=C(Br)C=CC(=C1)Br	SIGMA	L6920	-3.50869411	-3.00142706	1.34880348	-0.83832335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522520-01	NCGC00522520-01	384569524		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1449277-10-4				-11.3959310415	4	4		0	2.03730406				MAP4K4	NC1=C2N=C(C=CC2=C(C=N1)C(=O)NC3CN(C3)C(=O)C4CC4)C5=CC=CC(=C5)F	MedChem Express	HY-100343	-4.17623168	-4.70226422	1.47720878	2.03730406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480785-05	NCGC00480785-05	377020469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1538604-68-0		12.5892541179	-4.9	-35.8682793376	4	4		-18.551232852	-21.34052747	0.1431363774	0.9872056793		FGFR4	COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=CN=C(NC4=C(C)C=CC=C4NC(=O)C=C)N=C3C=C2)OC	MedChem Express	HY-12823	-5.46530108	-5.14797647	-3.38116676	-21.34052747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095709-08	NCGC00095709-08	363676577		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	568-72-9				-19.2354624823	4	4		0	-5.12844864				TNF	CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C	Selleck	S2365	-3.44176654	-5.04962722	-4.41203704	-5.12844864												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345786-03	NCGC00345786-03	384568741		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1252003-13-6		5.6234132519	-5.25	-31.7730896068	4	4		-12.72118572	-15.7937224	0.0851873704	0.9955460359		HDAC6	CN1CCC2=C(C1)[N](CC3=CC=C(C=C3)C(=O)NO)C4=CC=CC=C24	Aobious	AOB87388	-4.40756837	-3.9427343	-8.52314815	-15.7937224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188399-16	NCGC00188399-16	377020258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	162359-56-0		12.5892541179	-4.9	-92.7252797828	-3	4		-105.2081830963	-99.57737784	0.0403096903	0.9989965027		SPHK1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1	MedChem Express	HY-12005	-5.32947013	-4.51905045	-2.18981481	-99.57737784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185997-11	NCGC00185997-11	384568433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	900515-16-4		10	-5	-17.5335388755	4	4		-36.016732	-29.18061	0.1534998559	0.9852012808		PIK3CG	OC1=CC(=CC=C1C2=CC=C(O2)\C=C\3SC(=O)NC3=O)F	MedChem Express	HY-13532	2.83710407	-1.54951718	-2.69682273	-29.18061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508850-01	NCGC00508850-01	384569362		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	253863-00-2		3.9810717055	-5.4	-49.0647610017	4	4		-23.1076312201	-20.61382541	0.0599589094	0.9977951856		COX10	ClC1=CC=CC(=C1)N2CCN(CC2=O)CC3=CN=C[N]3CC4=CC=C(C=C4)C#N	Bio Vision	9638	-6.35746606	-10.11003818	-14.81666138	-20.61382541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024901-04	NCGC00024901-04	384568035		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[138356-21-5]				-16.9284155974	4	4		0	-4.26427001				SIGMAR1	CN(C)CCN(C)CCC1=CC=C(Cl)C(=C1)Cl	Tocris	0956	-4.40271493	-2.66337301	-0.91102751	-4.26427001												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015429-18	NCGC00015429-18	384567842		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	25451-15-4				-16.5620805655	4	4		0	-3.92690142				GABRA1	NC(=O)OCC(COC(N)=O)C1=CC=CC=C1	MedChem Express	HY-B0184	-2.96538904	-5.47164062	-3.19051077	-3.92690142												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384172-01	NCGC00384172-01	363679175		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1422389-91-0				1.0120425026	4	4		0	-3.12529822					CN1CCN(CC1)C2=CC=C(C=C2NC(=O)C3=CC=C(F)C(=C3Cl)C)[N+]([O-])=O	XcessBio	M60118-2s	1.38089758	-0.05658817	-0.19849915	-3.12529822												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274065-06	NCGC00274065-06	384568711		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	638-94-8				-9.4720736907	4	4		0	0.26242962					CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	MedChem Express	HY-B0248	-2.31919979	-2.72058503	-2.6385863	0.26242962												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263109-15	NCGC00263109-15	384568596		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1032754-93-0		3.1622776602	-5.5	-101.6954961507	-2.2	4		-69.3609001801	-67.63853934	0.01668908	0.9998282205		MTOR	C[C@H](O)C(=O)N1CCN(CC1)CC2=C(C)C3=C(S2)C(=NC(=N3)C4=CN=C(N)N=C4)N5CCOCC5	Bio Vision	2668	-4.83778919	-12.47770205	-43.01388889	-67.63853934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188866-01	NCGC00188866-01	137275837		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	n		5.0118723363	-5.3	-12.8800603307	4	4		-15.6603114999	-13.46692625	0.3247725385	0.9291563348	5879	RAC1	FC(F)(F)C1=CC=C2C(SCCCCCO\C3=C\O\C(CN4CCOCC4)=C/C3=O)=CC=NC2=C1	NCGCChem	EHT1864	-0.8428816	3.65915016	-4.60648148	-13.46692625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018294-13	NCGC00018294-13	384568002		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	22916-47-8		12.5892541179	-4.9	-75.5595488117	-3	4		-110.5105133201	-95.86400114	0.0180101042	0.9997998921		CYP19A1	ClC1=CC=C(COC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(=C1)Cl	APExBIO	B1977	-1.24676237	0.35676714	-1.39351852	-95.86400114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016973-08	NCGC00016973-08	384567970		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[112809-51-5]				-8.3182520641	4	4		0	1.60627211				CYP19A1	N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N	Tocris	4382	-2.93665158	-1.21715697	-1.67248334	1.60627211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015520-13	Hydroxyurea	384567861	Ribonucleoside-Diphosphate Reductase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	127-07-1				-13.0082347962	4	4		0	-0.5927909				RRM1	NC(=O)NO	Selleck	S1896	-3.84162896	-1.15427801	-2.78747224	-0.5927909												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263142-04	NCGC00263142-04	363677226		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	393105-53-8				-23.2928058016	4	4		0	-7.00925661				SERPINE1	OC(=O)C(=O)C1=C[N](CC2=CC=CC=C2)C3=CC=C(C=C13)C4=CC=C(OC(F)(F)F)C=C4	Glixx	GLXC-04469	-3.99221032	-7.74387324	-3.50036311	-7.00925661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164575-06	NCGC00164575-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	191114-48-4				-25.0936090776	4	4		0	-8.61246302					CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CN=CC=C5)C(=O)O[C@]13C)OC	Enzo	AC3258	-4.17810038	-6.89069778	-4.53643186	-8.61246302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484069-01	NCGC00484069-01	363681161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1193383-09-3				-7.1206893693	4	4		0	-0.53917359				HIF1A	OC(=O)C1=C[N](N=C1)C2=NC3=CC(=C(OC(F)(F)F)C=C3[NH]2)Cl	MedChem Express	HY-12832	-3.05390812	2.52905585	-0.98281288	-0.53917359												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183844-04	NCGC00183844-04	384568421		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	163253-35-8				-13.7591317866	4	4		0	-2.39041916				TOP2B	N[C@@H]1CN(CC12CC2)C3=C(F)C=C4C(=O)\C(=C/N([C@@H]5C[C@@H]5F)C4=C3Cl)C(O)=O	MedChem Express	HY-B0395C	-4.6353797	-0.85623533	0.66231569	-2.39041916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346631-02	NCGC00346631-02	363677486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	566939-85-3				-25.7658616082	4	4		0	-3.56608599					CNC(=O)C1=CC=C2C=C(C=CC2=C1)C3(O)CC[N]4C=NC=C34	Selleck	S1195	-5.76558693	-7.53685531	-4.44856348	-3.56608599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241410-02	NCGC00241410-02	363677139		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1044733-37-0				-19.2055023648	4	4		0	-2.82803851				IRAK1	ClC1=C[N]2C(=NC=C2C3=CC=CC(=N3)NC4CNC4)C=C1	Axon Medchem	1385	-3.69062334	-6.01265823	-4.95685612	-2.82803851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241036-03	NCGC00241036-03	384568468		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	n	 NCGC00241036-01;NCGC00241036-01			-31.6276552556	4	4		0	-7.23681086			3720	JARID2	OC(=O)C1=CC=C(O)C2=NC=C(C=C12)N3CCOCC3	NCGCChem	GRB26-028	-7.04157338	-7.4006312	-4.38425926	-7.23681086												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346930-01	NCGC00346930-01	174007462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	181630-15-9	Picoplatin			-17.803611344	4	4		0	-7.01837694					CC\1=C/C=C\C=[N]1[Pt](N)(Cl)Cl	Sequoia	SRP02323p	-2.15110409	-6.00100627	-4.10648148	-7.01837694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166414-05	Pemetrexed	384568308	Thymidylate synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	150399-23-8		7.0794578438	-5.15	-21.3122903176	4	4		-24.924277128	-22.02023094	0.1131211619	0.9920462637			NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Selleck	S1135	-0.79667168	1.25799852	-5.29169693	-22.02023094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510232-02	NCGC00510232-02	384569417		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1874276-76-2				-24.2694754634	4	4		0	-8.13531826				PRKCA	CC1(N)CCN(CC1)C2=CC=CN=C2NC(=O)C3=NC(=CN=C3N)C4=NC=CC=C4C(F)(F)F	ChemieTek	CT-LXS196	-5.88651854	-3.66952509	-0.84725248	-8.13531826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386237-01	NCGC00386237-01	384569118		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	960203-27-4		8.9125093813	-5.05	-95.0507008813	-3	4		-96.8777494929	-99.60396984	0.0090421403	0.9999495703		HTR1D	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C	Selleck	S8021	-5.07214305	-4.34858312	-6.59888647	-99.60396984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345811-02	NCGC00345811-02	384568755		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			1.77827941	-5.75	-149.9583211025	-1.1	4		-100.9928241704	-99.71046663	0.0349334146	0.9992465547		STAT3	N[S+]([O-])(=O)C1=C2C(=O)C3=C(C(=CC=C3)O)C(=O)C2=CC=C1	Bio Vision	1792	-1.09176216	-4.47192723	-99.458563	-99.71046663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345834-05	NCGC00345834-05	363677378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	303162-79-0		11.220184543	-4.95	-42.7027495938	-3	4		-58.1897387957	-48.90701153	0.0438373511	0.9988134468		MAPK14	CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C	MedChem Express	HY-10456	-0.36091311	-2.3659094	-5.11194576	-48.90701153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164296-05	NCGC00164296-05	363676628		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	133-32-4				-0.1578685351	4	4		0	-0.45842783					OC(=O)CCCC1=C[NH]C2=CC=CC=C12	Selleck	S2253	-0.46918704	0.24196801	1.73650066	-0.45842783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522465-01	NCGC00522465-01	384569518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1243245-18-2				-15.0200575153	4	4		0	-4.3909019				PORCN	CC(=O)N1CCN(CC1)C2=CN=C(NC(=O)CC3=CN=C(C(=C3)C)C4=CC(=NC=C4)F)C=C2	MedChem Express	HY-100408	-1.02419212	-7.26956677	-5.78221722	-4.3909019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016994-20	NCGC00016994-20	384567973		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	7689-03-4		1.5848931925	-5.8	-185.1345220679	-2.1	4		-100.5772894084	-96.85101633	0.0157268259	0.9998474369		TOP1	CC[C@@]1(O)C(=O)OC\C2=C1\C=C\3N(CC4=C3N=C5C=CC=CC5=C4)C2=O	Selleck	S1288	-12.93484019	-37.2927438	-76.75389233	-96.85101633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016643-13	NCGC00016643-13	384567955		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	3902-71-4				-0.2555346942	4	4		0	-1.05418111					CC1=CC2=C(O1)C(=C3OC(=O)\C=C(C)/C3=C2)C	Enzo	NP323	0.07902015	1.83872296	-1.36574074	-1.05418111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386210-03	NCGC00386210-03	384569115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	928037-13-2		12.5892541179	-4.9	-80.2454139046	-3	4		-114.9095826044	-99.66285199	0.0347679386	0.9992537053		KDR	CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4)F	APExBIO	B1439	-2.06330392	1.21666743	-1.91203704	-99.66285199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346436-04	NCGC00346436-04	384568776		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox			11.220184543	-4.95	-89.3007606032	-3	4		-106.5998748756	-99.60586922	0.0296264974	0.9994582591		CHEK2	COC1=CC2=NC(=NC(=C2C=C1OC)N[C@@H]3CNC[C@H]3C(C)(C)O)C4=CC(=CC=C4O)F	Tocris	4968	-4.20562799	-1.47280794	-4.41203704	-99.60586922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521070-01	NCGC00521070-01	384569505		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1435467-37-0				-6.07554309	4	4		0	-0.38244574					COC1=CC=C(Cl)C=C1\C2=C\C(=O)NC(=S)N2CC(N)=O	BOC Sciences	1435467-37-0	-2.39366516	1.04648552	-0.5846893	-0.38244574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488783-01	NCGC00488783-01	363681476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1369764-02-2				-9.1946962936	4	4		0	-0.64059662				HCRTR1	CC1=NC(=C(OC[C@]2(C[C@H]2C(=O)NC3=NC=C(F)C=C3)C4=CC=CC(=C4)F)C=N1)C	MedChem Express	HY-16725	-1.35294118	-3.64248821	-3.88433123	-0.64059662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509937-01	NCGC00509937-01	384569386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1197996-80-7		1	-6	-156.2025535332	-1.1	4		-94.0751653463	-96.94043408	0.0460798138	0.9986881049		NFKB1	CC(C)NCC[N]1C2=C(C=C(C=C2)C(C)=O)C3=C1C=CC(=C3)C(C)=O	ChemGood	C-1118	-1.02714932	-23.37749832	-92.68458505	-96.94043408												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181034-04	NCGC00181034-04	384568388		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[145858-50-0]				-8.498665903	4	4		0	1.19514294				CYP17A1	ClC1=CC=CC(=C1)C([N]2C=CN=C2)C3=CC=C4N=C[NH]C4=C3	Tocris	2705	-1.9321267	-3.37300696	-3.00503105	1.19514294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091268-11	NCGC00091268-11	174007181		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	79-57-2	; ; Oxytetracycline hydrochloride; Terramycin hydrochloride; Oxitetraciclina;Oxytetracycline hydrochloride;OXYTETRACYCLINE; Oxytetracycline Base;Oxytetracycline; Riomitsin;Oxytetracycline dihydrate; Oxytetracycline HCl; Oxytetracycline base; Oxytetracycline dihydrate; oxycort A; Terramycin			-0.0953543449	4	4		0	-3.05000478					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@H]3\C(=C(O)/[C@]2(O)C(=O)\C(=C1O)C(N)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Microsource	MS-01500457	0.02262443	2.35796093	0.68440375	-3.05000478												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506868-01	NCGC00506868-01	384569320		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[1402438-74-7]				5.7938919585	4	4		0	2.58135318				NTRK1	CC(C)(CO)[N]1C=C(C(=O)C2=CN=CC(=C2)NC(=O)CC3=CC=C(Cl)C=N3)C4=CN=C(N)N=C14	Tocris	6115	-0.22129769	5.39328777	0.94408134	2.58135318												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347939-08	NCGC00347939-08	384568991		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	331244-89-4				-6.3882646787	4	4		0	0.03377889				BCL2	CCOC1=CC=CC=C1N/N=C2\C(=N/N(C2=O)C3=NC(=CS3)C4=CC=CC=C4)C	MedChem Express	HY-15341	-0.07218262	-3.13662231	-5.77532803	0.03377889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510508-01	NCGC00510508-01	384569469		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	2018300-62-2		6.3095734448	-5.2	-58.5696195422	-2.4	4		-40.2080185199	-37.56695459	0.2054813399	0.9730586843		EP300	CCC(=O)N1CCOC2=C(C=C(C=C2C1)C3=CC(=CC(=C3)OC)OC)C(=O)N[C@H]4CCCN(C)C4	MedChem Express	HY-100697	-4.06027249	-11.22910785	-17.56011902	-37.56695459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351598-04	NCGC00351598-04	384569016		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	211555-04-3		7.9432823472	-5.1	-94.3291521332	-2.3	4		-91.0417410563	-84.72228924	0.1228228407	0.9905795718		EGFR	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC=C(O)C(=C3)Br	Selleck	S2867	-7.65135794	1.17399292	-17.57963026	-84.72228924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378970-01	NCGC00378970-01	384569079		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	852391-19-6				-9.307532212	4	4		0	-2.10876804					CN1C(=O)N[C@H](CC2=C[NH]C3=C(Cl)C=CC=C23)C1=O	MedChem Express	HY-14622	-3.16701254	-1.01268092	1.52187698	-2.10876804												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016543-13	NCGC00016543-13	384567948		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	834-28-6				-22.6288442673	4	4		0	-5.32117773					NC(=N)NC(=N)NCCC1=CC=CC=C1	MedChem Express	HY-16397A	-4.9708635	-5.24603316	-3.27799662	-5.32117773												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025323-13	NCGC00025323-13	384568067		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	58970-76-6				-11.3097968883	4	4		0	-4.91001472				LTA4H	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	MedChem Express	HY-B0134	-1.91404364	-3.22920002	-0.70833333	-4.91001472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229511-21	NCGC00229511-21	384568461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	540737-29-9				6.243940091	4	4		0	0.17094829				JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354A	1.91404364	-0.23784476	1.99537037	0.17094829												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253562-10	NCGC00253562-10	384568563		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	852808-04-9		8.9125093813	-5.05	-92.464713726	-2.3	4		-115.4544660181	-89.38696044	0.0705225807	0.9969201591		BCL2L1	CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)[S+]([O-])(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=C(C=CC=C5)C6=CC=C(Cl)C=C6)[N+]([O-])=O	MedChem Express	HY-50907	0.3687607	-8.37945387	-29.6712963	-89.38696044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384204-04	NCGC00384204-04	363679195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1687736-54-4				-17.7746561753	4	4		0	-1.79749498				PRMT3	O=C(NCC(=O)N1CCCC1)NC2=CC3=C(C=C2)C=NC=C3	Aobious	AOB5757	-5.26244344	-2.60947676	-1.67248334	-1.79749498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263219-03	Elacridar	384568673	P-Glycoprotein (MDR-1) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	143664-11-3		1.1220184543	-5.95	19.4416092533	4	4		9.5	9.92446697	0.1321138218	0.989209896		ABCBA	COC1=C2NC3=C(C=CC=C3C(=O)NC4=CC=C(CCN5CCC6=C(C5)C=C(OC)C(=C6)OC)C=C4)C(=O)C2=CC=C1	Selleck	S7772	1	2.33999551	11.20881113	9.92446697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181296-08	NCGC00181296-08	384568395		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	112665-43-7				-14.2939349633	4	4		0	-0.80313605				TBXA2R	C\C1=C(/C)C(=O)\C(=C(\C)C1=O)C(CCCCCC(O)=O)C2=CC=CC=C2	Enzo	RA119	-2.71945701	-5.74444195	-3.91152608	-0.80313605												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346638-03	NCGC00346638-03	384568872		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	601514-19-6		5.0118723363	-5.3	-109.3401443237	-2.2	4		-75.7640723708	-78.28514171	0.0288578867	0.9994861027		GSK3B	NC1=CC(=CC=C1)C2=CC3=C([NH]2)N=CN=C3OC4=CC=CC(=C4)O	Selleck	S1590	-7.73656723	-7.76999086	-36.68361172	-78.28514171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510266-01	NCGC00510266-01	384569423		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1379545-95-5		7.9432823472	-5.1	-137.9945435258	-2.1	4		-98.7668406844	-99.51808379	0.0117176241	0.9999153119		AKT1	NC(=O)C1=CC=CC2=C1N=CN=C2NC(CN3CCC3)C4=CC(=C(Cl)C=C4)C(F)(F)F	ChemieTek	CT-M2698	-12.41037444	-13.68127802	-31.98741225	-99.51808379												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186037-10	Ibandronate sodium hydrate	384568439	Treatment of Osteoporosis	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	138926-19-9		0.7943282347	-6.1	-17.8488743514	4	4		12.208019828	3.5547285	0.0393635437	0.9990523627			CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	APExBIO	B1772	-8.50668319	-8.17046098	-7.34446865	3.5547285												1.6E-8	8E-8	4E-7	0.000002											
NCGC00093828-12	NCGC00093828-12	384568119		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	152121-53-4				-3.2412546399	4	4		0	-0.88307677				MAPK14	[O-][N+](=[O])C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=NC=C3)C4=CC=C([F])C=C4	MedChem Express	HY-10578	-0.55039249	-1.93574405	0.25364616	-0.88307677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263152-15	NCGC00263152-15	384568626		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	943319-70-8		1.1220184543	-5.95	-164.9065988526	-1.1	4		-96.6853211493	-99.75872219	0.0098118976	0.9999406167		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Selleck	S1490	-2.22863846	-22.29690371	-98.81469197	-99.75872219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00264052-02	NCGC00264052-02	384568702		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	83-49-8				11.6766522273	4	4		0	2.60477231				NRC31	C[C@H](CCC(O)=O)[C@H]1CCC2C3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C	Microsource	00270049	4.29984107	-0.94936709	-0.83942975	2.60477231												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351601-07	NCGC00351601-07	363677769		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	686344-29-6				1.934131437	4	4		0	3.90715847				CNR1	CCNC1(CCN(CC1)C2=C3N=C([N](C4=CC=C(Cl)C=C4)C3=NC=N2)C5=CC=CC=C5Cl)C(N)=O	MedChem Express	HY-10871	-0.5209253	-1.88536281	2.3776027	3.90715847												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386293-01	NCGC00386293-01	384569121		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1374640-70-6		8.9125093813	-5.05	-97.1045183584	-2.1	4		-105.8391489446	-93.72714754	0.024588744	0.9996269301		EGFR	COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)N4CCN(CC4)C(C)=O	Selleck	S7284	-4.59194872	-3.54937566	-18.375	-93.72714754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346478-06	NCGC00346478-06	384568792		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1050500-29-2		8.9125093813	-5.05	-143.0434807985	-2.1	4		-118.0147924754	-99.69404341	0.0298408154	0.9994504198		ERBB2	FC1=CC(=CC=C1)COC2=CC=C(NC3=C4C=C(NC(=O)C=C)C=CC4=NC=N3)C=C2Cl	Selleck	S2185	-11.40723982	-16.51470918	-39.8540543	-99.69404341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370909-03	NCGC00370909-03	363677927		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	217645-70-0				-25.5546273691	4	4		0	-12.27693482				CCR1	C[C@@H]1CN(CCN1C(=O)COC2=CC=C(Cl)C=C2NC(N)=O)CC3=CC=C(F)C=C3	MedChem Express	HY-12080	-4.77117819	-3.38223131	-2.61922053	-12.27693482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379032-06	Tasquinimod	384569088	S100A9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	254964-60-8				-22.1880073351	4	4		0	-2.31415211			6280	S100A9	COC1=CC=CC2=C1C(=C(/C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)C(=O)N2C)/O	MedChem Express	HY-10528	-6.0724086	-4.86222957	-2.22222222	-2.31415211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021925-05	NCGC00021925-05	363676517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	52-21-1				-24.3405647022	4	4		0	-1.38849127				NRC31	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	Selleck	S2570	-7.30282376	-7.44787359	0.78915517	-1.38849127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161923-31	NCGC00161923-31	384568216		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	477-47-4		0.5623413252	-6.25	-137.4382066476	-1.4	4		-68.563195488	-67.21517155	0.1450127118	0.9868063718		IGFR1	COC1=C(OC)C(=CC(=C1)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](O)C4=C2C=C5OCOC5=C4)OC	Bio Vision	2765	-7.57917531	-40.78505175	-56.28018145	-67.21517155												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185773-02	NCGC00185773-02	124896661		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	25507-04-4	Clindamycin palmitate hydrochloride			-8.4025393963	4	4	CLINDAMYCIN PALMITATE HYDROCHLORIDE	0	-2.43679708					Cl.CS[C@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl	LKT Lab	C4534	-1.58197084	-1.08009153	-2.55595533	-2.43679708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510355-01	NCGC00510355-01	384569430		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-12.2366989697	4	4		0	-7.42574257					CC(C)N1C(=O)NC(=C/C1=O)\N[C@@H](C)C2=CC=CC=C2	Axon Medchem	2683	-2.00618648	1.27231121	-3.50918181	-7.42574257												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347909-06	NCGC00347909-06	363677719		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	870061-27-1				-5.4832590016	4	4		0	-1.42747284				P2RX7	ClC1=C(Cl)C(=CC=C1)[N]2N=NN=C2NCC3=C(OC4=NC=CC=C4)C=CC=C3	Aobious	AOB1733	-0.32699956	-2.33409611	-2.78958927	-1.42747284												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379003-05	NCGC00379003-05	384569085		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1431866-33-9				-26.1625774684	4	4		0	-4.78655207				BCL2L1	NCC1=CC=C(OCCCC2=C(N=C(S2)C3=CC\4=C(CCCC4=N\NC5=NC6=C(S5)C=CC=C6)C=C3)C(O)=O)C=C1	Glixx	GLXC-03738	-5.59287063	-6.52243516	-5.35648148	-4.78655207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263103-02	NCGC00263103-02	384568592		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	257933-82-7		0.7943282347	-6.1	-212.6966652051	-1.1	4		-87.2225306835	-97.10812479	0.0234688831	0.9996601707		EGFR	CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC(=C(F)C=C3)Cl)C#N	Selleck	S1392	-15.06650863	-54.39326716	-91.02314815	-97.10812479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016794-14	NCGC00016794-14	174007259		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	25812-30-0	 Gemfibrozilo; ;; Lopid;GEMFIBROZIL; Gemfibrozil;Gemfibrozil			-9.7928766752	4	4		0	-2.20862415			5465	PPARA	CC1=CC(=C(C)C=C1)OCCCC(C)(C)C(O)=O	Microsource	MS-01500313	-2.07692308	-1.01055468	-3.0503558	-2.20862415												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263553-13	NCGC00263553-13	363677284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1227633-49-9		12.5892541179	-4.9	-83.1785840032	-3	4		-108.3905727092	-99.6271154	0.0573935856	0.9979628386		AHR	CC(C)[N]1C=NC2=C(NCCC3=CC=C(O)C=C3)N=C(N=C12)C4=CSC5=C4C=CC=C5	Glixx	GLXC-04564	-3.49773756	-1.2441051	1.55463899	-99.6271154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480794-01	NCGC00480794-01	384569246		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	945976-43-2				-19.7565433017	4	4		0	0.1529783				TPH2	N[C@@H](CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=CC=C(C=C3)C4=CC=CC(=C4)F)C(F)(F)F)C(O)=O	Adooq	A14325	-5.37104072	-1.51358635	-7.29275257	0.1529783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164563-12	NCGC00164563-12	384568253		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	142217-69-4				-5.976451695	4	4		0	-0.60597385					NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	SIGMA	SML1103	-1.61989909	-2.16340922	0.17913338	-0.60597385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160527-12	NCGC00160527-12	384568198		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	112885-42-4		2.8183829313	-5.55	-3.6862441366	4	4		8.0171393959	3.74945712	0.4766278171	0.8297174238		HTR4	CCOC1=CC(=C(Cl)C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(F)C=C3)N	MedChem Express	HY-B0189A	-1.60606334	-6.26428283	2.84864153	3.74945712												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017324-15	NCGC00017324-15	384567984		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	79902-63-9				7.4393272052	4	4		0	5.08358588				HMGCR	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	Enzo	G244	0.52417533	2.735066	0.55719436	5.08358588												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346579-03	NCGC00346579-03	363677461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	900185-01-5 				-11.8131650108	4	4		0	0.18574641				PIK3CA	CC1=C(C=CC=C1)N2\C(=N/C3=C(C(=CC=C3)C)C2=O)C[N]4N=CC5=C4N=CN=C5N	APExBIO	B2187	-2.59376412	-2.00934367	-5.61408438	0.18574641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347935-08	NCGC00347935-08	363677721		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1432660-47-3		12.5892541179	-4.9	-67.4330801719	-3	4		-91.2785787409	-84.61612701	0.0693331454	0.997023553		IDH2	[O-][S+](=O)(NC1CC1)C2=CC=C(C(=C2)NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C4=CSC=C4	Glixx	GLXC-04459	-0.10827393	-4.98274858	-0.61460417	-84.61612701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263179-09	NCGC00263179-09	377020324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	905281-76-7				23.2587338686	4	4		0	7.54109392				BRAF	OCC[N]1C=C(C2=CC=C\3C(=C2)CCC3=N\O)C(=N1)C4=CC=NC=C4	MedChem Express	HY-50864	3.57048166	5.57437071	6.59314985	7.54109392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092290-11	NCGC00092290-11	384568103		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	305350-87-2		5.0118723363	-5.3	-38.7296822247	4	4		-18.4833658521	-20.63740346	0.0251646618	0.9996114869		MAP2K1	NC(\SC1=CC=C(N)C=C1)=C(C#N)/C2=CC=CC=C2C(F)(F)F	MedChem Express	HY-15437	-4.40126525	-5.41116705	-11.85091539	-20.63740346												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248064-08	NCGC00248064-08	384568522		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	256373-96-3				-17.8687619443	4	4		0	-2.47336005					CC(C)(O)C1=COC(=C1)[S+]([O-])(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4	Glixx	GLXC-05963	-4.28377768	-2.24520343	-5.02411387	-2.47336005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386882-01	NCGC00386882-01	384569147		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			3.5481338923	-5.45	-70.5206083707	-2.2	4		-48.1183068641	-45.7327207	0.0146690541	0.9998673627			CN(C1CC[S+]([O-])(=O)CC1)C(=O)CNC(=O)\C=C\C2=CC(=CC=C2)Cl	Evotec	MLS003874889	-3.96746498	-9.03070713	-28.46373554	-45.7327207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386314-03	NCGC00386314-03	363680205		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1337532-29-2		12.5892541179	-4.9	-98.8479011775	-3	4		-85.1955010963	-83.99648059	0.1238818365	0.9904143638		EIF2AK3	C[N]1C=C(C2=C(F)C3=C(C=C2)N(CC3)C(=O)CC4=CC=CC(=N4)C)C5=C(N)N=CN=C15	MedChem Express	HY-13820	-11.87528242	-4.85780378	-3.35721309	-83.99648059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023193-11	NCGC00023193-11	384568016		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	76-25-5				-7.9996480392	4	4		0	0.42037345				NRC31	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	MedChem Express	HY-B0636	-2.01536376	-4.37701275	-0.15451608	0.42037345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346527-03	NCGC00346527-03	384568821		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	808118-40-3				-15.3984186156	4	4		0	2.13119562				HIF2A	CC1=NC(=C(O)C2=C1C=C(OC3=CC=CC=C3)C=C2)C(=O)NCC(O)=O	Selleck	S1007	-5.48576593	-5.88288656	1.61539542	2.13119562												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165815-06	NCGC00165815-06	384568286		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	205432-12-8		10	-5	-31.4236755502	-3	4		-45.6020138847	-40.16032848	0.0196100037	0.9997629184			CCOC(=O)N1CCN(CC1)[N+](/[O-])=N/OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O	Enzo	AC1550	0.3253502	-0.33111081	-2.87025331	-40.16032848												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181000-08	NCGC00181000-08	384568385		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	94055-76-2				-12.2047675587	4	4		0	-1.7005988					CCOCC(O)COC1=CC=C(NC(=O)CC[S+](C)C)C=C1	Bio Vision	2624	-2.59492548	-3.69193942	-2.47038917	-1.7005988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347948-15	NCGC00347948-15	384568995		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	686770-61-6				-20.0619507281	4	4		0	-1.72272354				PORCN	CC1=CC=C2N=C(NC(=O)CS\C3=N\C4=C(\SCC4)C(=O)N3C5=CC=CC=C5)SC2=C1	MedChem Express	HY-13912	-4.79112154	-4.83936013	-4.51685284	-1.72272354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408801-01	NCGC00408801-01	363681051		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1149705-71-4		0.2818382931	-6.55	-97.7790115615	4	4		-14.3349589401	-19.65979079	1	0.9997864184		HSP90AB1	CC[C@@H](C)NC1=CC(=C(C)C=C1C(N)=O)C(=O)NC2C[C@@H]3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5	Glixx	GLXC-90165	-15.68910981	-26.24846918	-27.21824226	-19.65979079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390545-02	NCGC00390545-02	384569188		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	56124-62-0		11.220184543	-4.95	-89.8033345281	-2.2	4		-88.7947671333	-76.89901261	0.0387982412	0.9990705756		TOP2A	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(=C4C(=O)C5=C(C(=O)C4=C3O)C(=CC=C5)OC)O	MedChem Express	HY-13772	-6.00994126	-8.65877444	-15.63421829	-76.89901261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346716-20	NCGC00346716-20	384568929		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1195765-45-7		0.8912509381	-6.05	-46.5400144528	4	4		-32.0101137839	-12.31791964	1	0.9998845041		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	Selleck	S2807	0.26208766	-12.34181521	-26.67509482	-12.31791964												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094047-16	Ivermectin			SARS-CoV-2_CPE_SRI		70288-86-7		0.0176411403	-7.7534733462	-353.4497319045	-1.1	10		-100.0848910779	-99.91457306	1.67E-8	0.9978575784			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1	-3.14914767	-4.904283	-4.57034132	-3.3510659	-3.1879781	-1.6891236	-21.79551897	-71.94113307	-99.91457306	-99.91457306						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	SARS-CoV-2_CPE_SRI		126544-47-6		0.0279593232	-7.5534733462	-105.4583834799	-2.4	10		-40.6674562179	-33.67762979	0.1229662566	0.6855383845			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625	1.77455054	-2.2793461	-3.81703103	6.43420184	21.23636081	-6.03036539	-11.39673048	-16.04084961	-15.31860366	-33.67762979						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	SARS-CoV-2_CPE_SRI		915087-33-1				-10.2559427751	4	10		0	-3.76266843				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-1.69688968	2.69094863	5.12949948	1.28528715	1.26198889	-1.64252708	-1.30081932	0.15143867	-4.60140566	-3.76266843						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485933-01	NCGC00485933-01	363681426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1005780-62-0		10	-5	-45.1269015678	-2.4	4		-32.4884531	-28.82341632	0.021750782	0.9997088257		PDGFRB	C[N]1N=C(C)C=C1C(=O)NC2=CC(=CC=C2C)OC3=N[N]4C=C(NC(=O)C5CC5)N=C4C=C3	MedChem Express	HY-15506	-4.66637207	-5.49199085	-11.2004112	-28.82341632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095187-09	NCGC00095187-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	196597-26-9				-17.3944609186	4	4		0	-4.04210324					CCC(=O)NCC[C@@H]1CCC2=C1C3=C(OCC3)C=C2	MedChem Express	HY-A0014	-2.85461776	-6.26086957	-3.87365076	-4.04210324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390660-02	NCGC00390660-02	363680961		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1627503-67-6		10	-5	-54.1698152134	-3	4		-66.3304285316	-57.86489393	0.0147625175	0.9998656046		ACVR1	COC1=C(OC)C(=CC(=C1)C2=CC(=CN=C2C)C3=CC=C(C=C3)N4CCNCC4)OC	Glixx	GLXC-05339	-1.85268866	-1.29269288	-7.56192349	-57.86489393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351592-01	NCGC00351592-01	384569012		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	88497-87-4	Manassantin A	2.8183829313	-5.55	-54.9733691785	4	4		-37.363759324	-26.77681103	0.284129089	0.946866098		HIF1A	COC1=CC=C(C=C1OC)[C@@H](O)[C@@H](C)OC2=C(OC)C=C(C=C2)[C@H]3O[C@@H]([C@H](C)[C@H]3C)C4=CC=C(O[C@H](C)[C@H](O)C5=CC(=C(OC)C=C5)OC)C(=C4)OC	Duke University	Manassantin A	-5.22367826	-14.1833356	-16.74860701	-26.77681103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250410-11	GSK-650394	384568558	SGK1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	890842-28-1				0.2890170907	4	4		0	0.5988024				SGK1	OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5	MedChem Express	HY-15192	-0.88271824	-0.30382544	3.3019096	0.5988024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345461-06	NCGC00345461-06	384568735		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1229236-86-5		5.0118723363	-5.3	-113.1669354615	-2.1	4		-98.0039236118	-94.58682635	0.0356827196	0.9992139158		JAK2	CC1=N[NH]C(=C1)NC2=N[N]3C(=C(C)N=C3C(=C2)CN4CCOCC4)CC5=CC=C(Cl)C=C5F	APExBIO	A4147	-2.98527324	-8.33218248	-41.52284264	-94.58682635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018172-18	NCGC00018172-18	384567994		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	26807-65-8				-5.9344906017	4	4		0	-0.5581655				CA7	CC1CC2=C(C=CC=C2)N1NC(=O)C3=CC=C(Cl)C(=C3)[S+](N)([O-])=O	MedChem Express	HY-B0259	-2.11018895	-2.22410412	2.03995498	-0.5581655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183105-01	NCGC00183105-01	124894305		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	136790-76-6	 Amitiza;Lubiprostone; Lubiprostone; 			-33.4956555169	4	4	PROSTAN-1-OIC ACID, 16,16-DIFLUORO-11-HYDROXY-9,15-DIOXO-, (11.ALPHA.)-;CIPLUS_735350;LUBIPROSTONE;SPI-0211;Lubiprostone;RU-0211;Amitiza;7-((2R,4AR,5R,7AR)-2-(1,1-DIFLUOROPENTYL)-2-HYDROXY-6-OXOOCTAHYDROCYCLOPENTA(B)PYRAN-5-YL)HEPTANOIC ACID;lubiprostone;RU 0211;CYCLOPENTA(B)PYRAN-5-HEPTANOIC ACID, 2-(1,1-DIFLUOROPENTYL)OCTAHYDRO-2-HYDROXY-6-OXO-, (2R,4AR,5R,7AR)-;SPI 0211;(11.ALPHA.,15R)-16,16-DIFLUORO-15-HYDROXY-9-OXO-11,15-EPOXYPROSTAN-1-OIC ACID;RU0211;SPI0211;7-((1R,3R,6R,7R)-3-(1,1-DIFLUOROPENTYL)-3-HYDROXY-2-OXABICYCLO(4.3.0)NONANE-8-ONE-7-YL)HEPTANOIC ACID, L-;	0	-6.81892181			1181	CLCN2	O=C(O)CCCCCC[C@H]1C(=O)C[C@H]2O[C@](O)(CC[C@H]12)C(F)(F)CCCC	APAC	600114	-6.22461593	-10.01515422	-7.87375727	-6.81892181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379021-02	NCGC00379021-02	384569086		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	849643-15-8		11.220184543	-4.95	-51.7759883098	-2.4	4		-57.198474894	-47.20219545	0.1211128164	0.9908483409		KDR	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NC[C@H](O)CN4CCOCC4	MedChem Express	HY-10501A	-1.75701925	-6.8595115	-10.32170325	-47.20219545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509989-01	NCGC00509989-01	384569397		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	328232-95-7				-0.5907967065	4	4		0	2.71536476					FC1=CC=CC=C1[N]2C=CC(=N2)NC(=O)[C@H]3CC[C@]4(CC3)OC(=O)C5=C4C=NC=C5	MedChem Express	HY-15411	-1.70588235	3.01369863	-0.5302996	2.71536476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508876-01	NCGC00508876-01	384569369		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1404095-34-6		4.4668359215	-5.35	-32.3105157345	4	4		-24.06924302	-22.49737069	0.0210892516	0.9997265584		CHEK1	COC1=CC(=NC=C1C2=C[N](C)N=C2)NC3=CN=C(C#N)C(=N3)O[C@H](C)CN(C)C	SynKinase	SYN-1216	-1.60633484	-3.78621154	-12.51416398	-22.49737069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485024-02	NCGC00485024-02	384569274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-1.9963675076	4	4		0	5.45941295				LRRK2	C[N]1C=C(C=N1)C2=C[NH]C3=NC=NC(=C23)N4CCOCC4	SIGMA	PZ0249	-2.59276018	0.13923198	0.639079	5.45941295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345816-01	NCGC00345816-01	174007112		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	170905-75-6	GM-1489			-14.4174232008	4	4		0	-6.09044842			4312	MMP1	CC(C)C[C@H](CC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@@H](C)C3=CC=CC=C3	SantaCruz Bio	sc-203978	-2.83710407	-0.42667864	-3.32230431	-6.09044842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016899-11	NCGC00016899-11	384567966		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	85416-75-7				-7.3967049753	4	4		0	-1.83700735				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)[C@@H]3CNC(=O)C3	MedChem Express	HY-16900A	-2.11560591	0.41352893	-1.3023481	-1.83700735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095129-15	NCGC00095129-15	384568148		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	181695-72-7				-21.1814879498	4	4		0	-5.21676647				COX2	CC1=C(C2=CC=C(C=C2)[S+](N)([O-])=O)C(=NO1)C3=CC=CC=C3	MedChem Express	HY-15762	-5.47817601	-3.50780279	-1.20377085	-5.21676647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346096-02	NCGC00346096-02	174006479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	864082-47-3	GSK429286A	12.5892541179	-4.9	-16.2377301046	4	4		-13.5384899039	-11.93543886	0.4127544946	0.8792867715	6093	ROCK1	CC/1=C(/C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(F)C=C4[NH]N=CC4=C3	Selleck	S1474	-0.65336394	-4.74683544	-3.33427124	-11.93543886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344625-13	NCGC00344625-13	363677341		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	931398-72-0				-16.699632854	4	4		0	-6.19532827				HIF1A	OC(=O)CNC(=O)\C1=C(/O)C2=CC=CC=C2N(CC3=CC=CC=C3)C1=O	Glixx	GLXC-01838	-2.9695095	-2.99313501	-3.42507359	-6.19532827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347278-03	NCGC00347278-03	384568984		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	552325-16-3		2.5118864315	-5.6	-148.8629789176	-1.3	4		-94.0055163696	-99.74526579	0.0840591009	0.9956164563		AKT1	CC1=N[NH]C2=C1C=C(C=C2)C3=CN=CC(=C3)OC[C@@H](N)CC4=C[NH]C5=C4C=CC=C5	MedChem Express	HY-10425	-2.03269996	-11.10297483	-87.78561749	-99.74526579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344513-02	NCGC00344513-02	363677334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[217461-40-0]				1.9782328435	4	4		0	5.71756382				OPRL1	CCN1C(=O)N([C@@H]2CCN(CC3CCCCCCC3)C[C@H]2CO)C4=CC=CC=C14	Tocris	2598	-0.24886878	-1.04648552	-1.32801523	5.71756382												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015708-19	NCGC00015708-19	363676460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	10347-81-6				-16.4594245625	4	4		0	-8.57429144					CNCCCC12CCC(C3=CC=CC=C13)C4=C2C=CC=C4	Selleck	S2517	-2.05364256	-5.41940539	-1.45727427	-8.57429144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509990-02	NCGC00509990-02	384569398		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1323403-33-3				-11.7708639359	4	4		0	-3.34478481					O=C1CC[C@H](N2CC3=C(C=CC=C3OCC4=CC=C(CN5CCOCC5)C=C4)C2=O)C(=O)N1	MedChem Express	HY-101291	-2.02708684	-4.57493579	-1.28298233	-3.34478481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483925-02	NCGC00483925-02	384569266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	936694-12-1		12.5892541179	-4.9	-48.447043777	-3	4		-89.4931018017	-78.94131737	0.0322496754	0.9993580299	4233	FLT1	COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(F)C=C(NC(=S)NC(=O)CC5=CC=C(F)C=C5)C=C4	ChemieTek	CT-MG265_cm1	2.94091554	1.12323344	3.2342277	-78.94131737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522492-01	NCGC00522492-01	384569521		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1462249-75-7				-24.6462504018	4	4		0	-9.03297828				PFKFB3	FC(F)(F)C1=CC=C2C=CC(=NC2=C1)\C=C\C(=O)C3=CC=NC=C3	MedChem Express	HY-12203	-4.24686562	-4.42592262	-5.66028888	-9.03297828												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378567-02	NCGC00378567-02	363678092		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1001917-37-8				11.844316528	4	4		0	-3.89785571				MET	C[N]1C=C(C=N1)C2=CN=C3\C=C/C4=CC=C(C[S+]([O-])(=O)NCC5=NC=CC=C5)C=C4C(=O)C3=C2	MedChem Express	HY-13299	2.92247925	5.44214655	4.99437254	-3.89785571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018099-17	NCGC00018099-17	384567989		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	479-18-5				-9.1641777663	4	4		0	-1.69998575				XDH	CN1C(=O)N(C)C2=C([N](CC(O)CO)C=N2)C1=O	Enzo	AC3105	-2.2125642	-0.64035128	-2.56944444	-1.69998575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346673-02	NCGC00346673-02	384568899		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	802539-81-7		0.7943282347	-6.1	-266.1148811881	-1.3	4		-58.4083133524	-89.21175685	0.1135536468	0.9919643882		CDK1	CNC(=O)C1=N[N](C)C2=C1C(C)(C)CC3=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N=C23	Selleck	S2751	-35.04470213	-63.43533713	-93.86105059	-89.21175685												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015254-30	NCGC00015254-30	384567833		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	5786-21-0				-24.3214274894	4	4		0	-7.42035928				DRD4	CN1CCN(CC1)\C2=N\C3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl	MedChem Express	HY-14539	-6.03708304	-3.17635686	-1.6291999	-7.42035928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510002-01	GLPG0187	384569406	Integrin Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	298708-81-3				-3.9509145218	4	4		0	-7.98562874					COC(=O)\C1=C(C)\N=C(N[C@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029	1.49485451	0.53399623	-3.10853275	-7.98562874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484080-01	NCGC00484080-01	363681171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1192189-69-7				-13.0875593328	4	4		0	0.02790827				LIMK1	CN(C)C(=O)OC1=CC=CC(=C1)NC(=O)C2(CN)CCN(CC2)C3=C4C(=C[NH]C4=NC=N3)C	MedChem Express	HY-12659	-5.51827653	-0.35211268	1.75858188	0.02790827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346965-01	NCGC00346965-01	174006428		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1001343-54-9	HMSL10087	8.9125093813	-5.05	-72.8389845645	-3	4		-62.3582847919	-65.64026234	0.0149473665	0.9998622082	2324	FLT4	COC1=CC(=CC=C1NC2=NC=C3N(C(C)C)C(=O)CCN(C4CCCC4)C3=N2)C(=O)NC5CCN(C)CC5	LINCS	HMSL10087	-5.34169168	-6.05722945	-8.44588257	-65.64026234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347398-04	Ginsenoside Rb1			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	41753-43-9				-19.5593603385	4	4		0	-3.24122765					CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0039	-3.9321267	-3.26521446	-7.18397317	-3.24122765												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346838-01	NCGC00346838-01	174007232		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	29388-59-8	Secoisolariciresinol			-26.8859073431	4	4		0	-1.68432102					COC1=CC(=CC=C1O)C[C@@H](CO)[C@H](CO)CC2=CC(=C(O)C=C2)OC	SIGMA	60372	-7.37363902	-5.57611109	-4.14911644	-1.68432102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263118-02	NCGC00263118-02	384568602		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	329306-27-6		1	-6	-10.4604771867	4	4		20.745564228	8.50299401	0.4511458806	0.849980983		PDE4A	C[S+]([O-])(=O)OC1=CC=C2C(=C(OC2=C1)C(=O)C3=C(Cl)C=C(Cl)C=C3)NC(N)=O	Axon Medchem	1178	-7.28797019	1.52833402	1.03940053	8.50299401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378324-03	NCGC00378324-03	384569047		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	41451-75-6		0.7943282347	-6.1	-255.8972799366	-1.2	4		-80.0215534008	-99.53053892	0.0477335851	0.9985923338		MYC	COC(=O)[C@@]12OC[C@@]34[C@@H](C[C@H]5\C(=C(\O)C(=O)C[C@]5(C)[C@H]3[C@@H](O)[C@@H]1O)C)OC(=O)[C@H](OC(=O)\C=C(/C)C(C)C)[C@@H]24	MedChem Express	HY-N0840	-29.08534422	-62.51438567	-90.90161953	-99.53053892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167503-02	Aclarubicin	174007366	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	57576-44-0	; Aclacin;Aclarubicin; Aclaplastin; Aclacinon; Aclarubicino;Aclacinomycin A	14.1253754462	-4.85	-55.1100936865	-3	4		-38.0500298684	-38.61556886	0.1144231443	0.9918458097	7153	TOP2A	CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C5=C(O)C6=C(C=C5[C@H]1C(=O)OC)C(=O)C7=CC=CC(=C7C6=O)O	Carbosynth	OA08264	-7.62508872	-5.55171938	-4.14309886	-38.61556886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018199-09	NCGC00018199-09	384567996		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	478-43-3				-20.2810590201	4	4		0	-7.35848179					OC(=O)C1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	Selleck	S2400	-2.41921243	-6.77036905	-5.53836053	-7.35848179												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262829-02	NCGC00262829-02	174006692		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	n	C-188-9	11.220184543	-4.95	-100.0355924635	-2.1	4		-99.3588867067	-93.29027969	0.0082521633	0.9999579989	6774	STAT3	COC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=C(O)C3=C2C=CC=C3)C4=C(O)C=CC5=C4C=CC=C5	EMD Chemicals	573128	-7.07669345	-7.39148333	-10.11574074	-93.29027969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262929-03	NCGC00262929-03	384568578		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	211915-06-9				-16.0957151623	4	4		0	-3.43245052					CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=NC=CC=C4)[N]2C)C=C1	Selleck	S2154	-2.42986425	-5.82528632	-4.65485201	-3.43245052												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481575-01	NCGC00481575-01	363681124		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			2.8183829313	-5.55	-165.3892176173	-2.1	4		-101.7653660814	-99.58887083	0.0030505681	0.9999942606		AURKA	CCNC(=O)C#CC1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(CN(C)C)C=C3)C4=CC=CC=C4	APExBIO	B5956	-8.98190045	-12.70604087	-45.58310293	-99.58887083												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00161418-13	NCGC00161418-13	384568208		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	244218-51-7		10	-5	-92.4882553317	-3	4		-104.4310596584	-99.73228798	0.0303042144	0.9994331732		OPRL1	CCC1=CC=C(OCC2=C(C=CC=C2)C(=O)NC3=CC4=C(C=C3)N=C(C)C=C4N)C=C1	MedChem Express	HY-13274	-4.63800905	-1.8998428	-6.8304401	-99.73228798												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480774-04	NCGC00480774-04	384569242		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			11.220184543	-4.95	-29.9734971943	4	4		-22.6081209481	-20.50865283	0.059533857	0.9978181698		CSF1R	FC(F)(F)C1=NC=C(CNC2=NC=C(CC3=C[NH]C4=C3C=C(Cl)C=N4)C=C2)C=C1	MedChem Express	HY-16749	-2.91855204	-3.88502133	-6.40438744	-20.50865283												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250402-05	NCGC00250402-05	384568551		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	461432-26-8		0.5011872336	-6.3	21.0965723616	4	4		-15.0893488919	-3.82445741	0.239114992	0.963391625		SCL5A2	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C1	MedChem Express	HY-10450	9.07239819	1.65730968	-0.5302996	-3.82445741												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090757-12	NCGC00090757-12	384568082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	148-82-3		4.4668359215	-5.35	-14.0998178453	4	4		-13.1521614599	-12.21013455	0.310540039	0.9358930336			N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O	MedChem Express	HY-17575	-1.25697088	2.55517346	-5.07867344	-12.21013455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390770-02	NCGC00390770-02	384569212		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	84692-91-1				-20.1260608649	4	4		0	-7.08559977				COX10	CC/1=C/C[C@]23O[C@@]2(C)CC[C@@H]4[C@H](OC(=O)C4=C)[C@@H]13	MedChem Express	HY-16059	-3.1512791	-5.24528795	-4.45896877	-7.08559977												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165770-04	NCGC00165770-04	384568280		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[1049741-55-0]		0.7943282347	-6.1	-20.0527563534	4	4		10.182398864	0.48383234	0.3225420425	0.9306799889			COC1=CC=C(NC2=NC(=CC=N2)NCCO)C=C1	Tocris	3851	-8.06866572	-3.38811398	3.65965676	0.48383234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186047-02	NCGC00186047-02	174006753		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	42521-82-4	p21-Activated Kianse Inhibitor III, IPA-3;IPA-3			-17.5109699516	4	4		0	-9.12512667			5585	PAK1	OC1=CC=C2C=CC=CC2=C1SSC3=C4C=CC=CC4=CC=C3O	EMD Chemicals	506106	-2.34593522	-4.26580634	-2.45841666	-9.12512667												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345451-04	NCGC00345451-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-10.3814814634	4	4		0	-7.06079353					NC(=O)C1=C2N=C(NC2=CC=C1)C3=C(F)C=C(C=C3)[C@@H]4CCCN4	Selleck	S2197	-0.36199894	-5.83437333	-0.1453761	-7.06079353												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274063-05	NCGC00274063-05	363677311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	74150-27-9		10	-5	-35.985805479	-3	4		-37.89218318	-30.81073538	0.1707486677	0.9816082542		PDE3A	COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)/C4=N/NC(=O)CC4C	MedChem Express	HY-B0204	-0.90058273	-5.81654484	-9.43068843	-30.81073538												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167490-03	Lumefantrine	170465388	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	82186-77-4	;benflumetol, (+-)-isomer;Lumefantrine; Lumefantrine			-14.5551056612	4	4		0	-4.46532397					CCCCN(CCCC)CC(O)c4cc(Cl)cc3c4c1ccc(Cl)cc1\C3=C\c2ccc(Cl)cc2	SIGMA	L5420	-2.26911531	-5.531289	-2.22753705	-4.46532397												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510354-01	NCGC00510354-01	384569429		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-10.4590109452	4	4		0	-2.05590958				HHAT	CCC(C)CNCC(=O)N1CCC2=C(C=CS2)C1C3=NC(=CC=C3)C	Axon Medchem	2673	-2.73706516	1.41290783	-4.17839055	-2.05590958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096077-20	NCGC00096077-20			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	132539-06-1				-4.9585413494	4	4		0	-1.19514294					CN1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(C)S4	Adooq	A10667	-1.43438914	2.48371884	-3.05942075	-1.19514294												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263603-10	NCGC00263603-10	384568692		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	120964-45-6		0.316227766	-6.5	-216.8531416019	-1.1	4		-80.3969286243	-82.78038053	0.0352702659	0.9992321503		EZH2	NC1=NC=CC2=C1N=C[N]2[C@@H]3\C=C(CO)/[C@@H](O)[C@H]3O	MedChem Express	HY-12186	-19.58823529	-69.91690995	-80.24747315	-82.78038053												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346935-09	NCGC00346935-09	384568970		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1202916-90-2		8.9125093813	-5.05	-84.6520446039	-2.1	4		-114.134869734	-99.76619906	0.0396734856	0.9990279663		PIM1	CN1CCCN(CC1)C(=O)C2=CC(=CC=C2)C3=CC=C(O3)/C=C4/C(=O)NC5=CC=C(Cl)C=C45	MedChem Express	HY-18095	-1.08878463	2.25917381	-12.70878722	-99.76619906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183031-08	D-Pantothenic acid			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	79-83-4				-13.7419853222	4	4		0	-2.5527245					[H][C@](O)(C(=O)NCCC(O)=O)C(C)(C)CO	Selleck	S2498	-2.74409135	-3.78270143	-3.12273057	-2.5527245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263229-03	NCGC00263229-03	363677274		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	13616-29-0				-13.5595531439	4	4		0	0.77774597				FAS	CC1=NC(=NC=C1)N[S+]([O-])(=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)NC4=NC(=CC=N4)C)C=C2	SIGMA	G5547	-3.99221032	-2.58129108	-3.06463326	0.77774597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386295-01	NCGC00386295-01	363680194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1421919-75-6		4.4668359215	-5.35	-122.1607824187	-2.4	4		-60.5604777772	-52.42001641	0.0840611214	0.9956215047		XPO1	FC1(F)CN(C1)C(=O)\C=C/[N]2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F	Selleck	S7251	-15.52828657	-25.43352601	-36.55431442	-52.42001641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159370-10	NCGC00159370-10	384568173		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	661-19-8				-0.3777581764	4	4		0	-0.17854558					CCCCCCCCCCCCCCCCCCCCCCO	Adooq	A10327	-1.10078499	2.01640005	1.2584752	-0.17854558												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00165736-13	NCGC00165736-13	384568276		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	2627-69-2				1.9442216729	4	4		0	1.37680822				PRKAA1	NC(=O)C1=C(N)[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	MedChem Express	HY-13417	-0.58273	-0.82456766	4.26280248	1.37680822												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346881-02	NCGC00346881-02	384568958		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[5291-32-7]				-0.8991559666	4	4		0	0.96870697				TP53	COCC1(CO)N2CCC(CC2)C1=O	Tocris	3710	-0.79898152	3.08283401	-2.48611111	0.96870697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025212-26	NCGC00025212-26	384568057		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	?56-25-7				-23.202420871	4	4		0	-10.42164643					C[C@@]12[C@H]3CC[C@H](O3)[C@]1(C)C(=O)OC2=O	Bio Vision	2510	-4.04977376	-2.56456322	-4.69111182	-10.42164643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344505-01	NCGC00344505-01	174006301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	729610-18-8	Calindol; Calindol	10	-5	-95.2615284838	-3	4		-99.29855656	-99.76097141	0.0084734272	0.9999557147	846	CASR	C[C@@H](NCC1=CC2=C([NH]1)C=CC=C2)C3=C4C=CC=CC4=CC=C3	SantaCruz Bio	sc-211006	-5.15384615	-4.45991466	-6.32280288	-99.76097141												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015605-13	NCGC00015605-13	384567872		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	84057-84-1				-17.800970689	4	4		0	-3.3846448					NC1=NC(=C(N=N1)C2=CC=CC(=C2Cl)Cl)N	Selleck	S3024	-2.6561086	-5.24141029	-6.90295971	-3.3846448												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183848-01	Troxacitabine	124894563	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	145918-75-8	Troxacitabine			-28.8564158644	4	4	2R(-)-cis-HMD-cytosine;Troxacitabine;LS-173247;LS-173246;LS-173400;TROXACITABINE;BCH-4556;BCH 4556, trans-(+-)-isomer;LS-173262;2'-DEOXY-3'-OXACYTIDINE,1'S,4'S,L-;BCH 4556, cis-(+-)-isomer;BCH 4556, (2S-trans)-isomer;BCH 4556, 2R(-)-cis-isomer;LS-173106;troxacitabine;CIPLUS_728716;troxacitabinum;CIPLUS_703293;	0	-6.24582498				POLB	OC[C@H]1OCC(O1)[N@@]2C=CC(N)=NC2=O	Pharmaron	PH-NIH-148677	-7.48871382	-1.86740957	-5.3788429	-6.24582498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498432-01	NCGC00498432-01	384569299		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1353550-13-6		11.220184543	-4.95	-76.3459027505	-3	4		-117.4462067045	-99.78528486	0.0509267787	0.99839698		JAK3	CN1CCN(CC1)C2=CC=C(NC3=NC4=C(SC=C4)C(=N3)OC5=CC(=CC=C5)NC(=O)C=C)C=C2	ChemieTek	CT-HM712	1.73497389	-3.08623166	-5.7758412	-99.78528486												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507845-01	Netarsudil	384569326	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1253952-02-1		4.4668359215	-5.35	-121.4503600028	-3	4		-98.8448972269	-99.77802442	0.020044734	0.9997521093		ROCK1	CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C	Selleck	S8226	-4.6828476	-2.93946319	-6.05824106	-99.77802442												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016371-06	NCGC00016371-06	363676482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	120-97-8				-8.9073297675	4	4		0	1.99295469				CA1	N[S+]([O-])(=O)C1=CC(=C(Cl)C(=C1)[S+](N)([O-])=O)Cl	Selleck	S2177	-2.66173419	-4.63323923	-0.51704795	1.99295469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345800-03	NCGC00345800-03	384568749		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	752222-83-6				-3.1855654705	4	4		0	-0.68840411				ADORA2B	CCCN1C(=O)N(CC)C2=C([NH]C(=N2)C3=C[N](CC4=CC=CC(=C4)C(F)(F)F)N=C3)C1=O	ChemieTek	CT-CV001	-0.34434046	-0.66411125	-1.89926843	-0.68840411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346747-02	NCGC00346747-02	174007018		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	n		14.1253754462	-4.85	-9.575041927	4	4		-16.256128192	-13.96344016	0.2476595951	0.9604081951	4790	NFKB1	CC(O)(C#CC1=CC2=C(CCN2C3=NC(=NC=C3Cl)N)C=C1)C4=NC=CS4	NCGCChem	PRP02-095	0.49443758	-1.94776252	1.37403864	-13.96344016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016092-09	NCGC00016092-09	384567919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	634908-75-1				-14.874664376	4	4		0	-2.36478465				HTR1A	COC1=C(C=CC=C1)N2CCN(CC2)CCN(C(=O)C3CCCCC3)C4=CC=CC=N4	MedChem Express	HY-13105	-3.72272707	-0.85990029	-4.29166667	-2.36478465												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485261-01	NCGC00485261-01	363681270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1310877-95-2		12.5892541179	-4.9	-72.2433815159	-3	4		-88.964561424	-78.66470393	0.0554068165	0.9981019626	390245	KDM4E	COC(=O)/C=C/C(=O)N(O)CCCCNCC1=CC=C(COC(=O)NC2=C3C=CC=CC3=CC=C2)C=C1	SIGMA	SML0343	-4.46902849	-0.77756941	-2.13425926	-78.66470393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346826-01	NCGC00346826-01	174006691		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	599150-20-6	HPI-1	11.220184543	-4.95	-72.4489458442	-2.2	4		-79.812820378	-67.6955221	0.0158233989	0.9998455761	54498	SMO	COCCOC(=O)C/1=C(C)/NC/2=C(C1C3=CC=CC(=C3)O)/C(=O)CC(C2)C4=C(OC)C=CC=C4	SIGMA	H1542	-4.15294789	-5.1319581	-10.95833333	-67.6955221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163548-03	NCGC00163548-03	384568246		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	512-64-1		2.8183829313	-5.55	-455.2270862457	5	4		-3.4853721041	-99.09169137	0.4687809227	0.8464809415			CS[C@H]1SC[C@H]2N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C(=O)[C@@H]1N(C)C(=O)[C@@H](C)NC(=O)[C@H](COC(=O)[C@@H](C(C)C)N(C)C2=O)NC(=O)C3=NC4=CC=CC=C4N=C3)NC(=O)C5=NC6=CC=CC=C6N=C5	SIGMA	SML4077	-96.50226244	-94.52054795	-98.24139963	-99.09169137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092318-12	NCGC00092318-12	384568105		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1177865-17-6				-21.3283520953	4	4		0	-4.5758183				RAC1	CCN(CC)CCCC(C)NC1=NC(=CC(=N1)C)NC2=CC3=C(N)C=C(C)N=C3C=C2	MedChem Express	HY-15723A	-4.96592016	-5.83728725	-1.64124909	-4.5758183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182965-11	NCGC00182965-11	384568413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1235-82-1				-22.019227591	4	4		0	-3.54518561					OC(CCN1CCCCC1)(C2CC\3CC2\C=C3)C4=CC=CC=C4	MedChem Express	HY-13204	-5.3731079	-4.2615244	-3.81989833	-3.54518561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347284-02	NCGC00347284-02	384568985		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	781613-23-8		1.2589254118	-5.9	-192.904242659	-1.1	4		-97.7812283517	-99.61351274	0.0113576071	0.9999204374		EGFR	COC1=CC2=C(C=C1OC[C@H]3C[C@H]4CN(C)C[C@H]4C3)N=CN=C2NC5=C(F)C(Cl)=C(Cl)C=C5	DC Chemicals	DC3129	-12.51659733	-40.12971749	-83.60687485	-99.61351274												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509914-01	NCGC00509914-01	384569380		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1262417-51-5				-15.2219190426	4	4		0	-7.74501761				PARP1	NC(=O)C1=CC(=CC2=C1C(=O)N(C2)C3CCN(CC3)C4CCC(F)(F)CC4)F	Selleck	S8363	-1.74140576	-2.61683918	-4.51685284	-7.74501761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249661-03	NCGC00249661-03	384568531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					10.0959725156	4	4		0	5.00410172				HPGD	CC1=CC=C(C=C1)[N]2C(=CC(=C2C)C3=NN=C4CCCCC[N]34)C	NCGCChem	DYD019-035	2.07525038	2.32110051	-0.8097166	5.00410172												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164632-07	NCGC00164632-07	384568271		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	5630-53-5		6.3095734448	-5.2	-12.0038123102	4	4		8.29143702	3.36341263	0.4466876264	0.8550230334			C[C@@H]1C\C2=C(CCC(=O)C2)/[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13	Microsource	01502343	-2.92339619	-6.90953085	-3.18033267	3.36341263												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094381-09	NCGC00094381-09	384568130		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	194413-58-6		12.5892541179	-4.9	-18.261278098	4	4		-11.955811852	-13.17270571	0.185987329	0.9782757712		FLT3	CC1=CC(=C([NH]1)/C=C/2C(=O)NC3=CC=CC=C23)C	Selleck	S2845	-1.94243334	-3.40078445	-1.5428625	-13.17270571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386321-01	NCGC00386321-01	384569126		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	236392-56-6				-19.370572713	4	4		0	-4.98599174				RRM1	NC(=S)N/N=C/C1=NC=CC=C1N	Selleck	S7470	-4.24952807	-4.58308558	-2.27314815	-4.98599174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510921-01	Lucanthone	384569494	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	548-57-2		12.5892541179	-4.9	-32.9295039796	-3	4		-38.2885231	-31.77306995	0.18564788	0.9781547899		TOP2A	CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1	SantaCruz Bio	sc-396381	-0.6993007	-5.80246376	-4.77850399	-31.77306995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510160-03	NCGC00510160-03	384569410		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1821908-48-8				-20.6316056407	4	4		0	-4.73387058				PRMT4	C[C@H](N)C(=O)NCC1=CC=C(OC2=CC(=CC(=C2)C)C)C(=C1)C	Selleck	S8340	-3.66326807	-7.60854954	-3.4632457	-4.73387058												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229735-09	NCGC00229735-09	384568464		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	925701-49-1				-3.3860496081	4	4		0	2.99667037				ATM	C[C@H]1CN(C[C@@H](C)O1)CC(=O)NC2=CC=C3SC4=C(CC3=C2)C=CC=C4\C5=C\C(=O)\C=C(/O5)N6CCOCC6	MedChem Express	HY-12061	-1.4616981	-2.57203029	-0.1365787	2.99667037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390570-02	NCGC00390570-02	384569194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1315329-43-1		1.1220184543	-5.95	-149.6997334291	-1.1	4		-99.684698157	-99.68151329	0.0208941239	0.9997306398		BRAF	CCN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)\C=C\C4=CN=C5[NH]C=CC5=C4OC)C=C2C(F)(F)F	MedChem Express	HY-12291	1.20905892	-14.61665995	-97.38061558	-99.68151329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263154-08	NCGC00263154-08	384568628		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1173900-33-8				-58.0384022645	4	4		0	-18.69903006				PIK3CB	C[C@@H](NC1=CC=CC=C1C(O)=O)C/2=C/C(=C\N3C(=O)/C=C(\N=C23)N4CCOCC4)C	MedChem Express	HY-10344	-10.68302806	-12.32244477	-11.68723477	-18.69903006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263131-05	NCGC00263131-05	384568611		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1196109-52-0		11.220184543	-4.95	-66.4163948747	-2.4	4		-99.5079784692	-76.52119581	0.058936826	0.9978517476		FAAH	FC(F)(F)C1=CN=C(OC2=CC(=CC=C2)CC3CCN(CC3)C(=O)NC4=CC=CN=C4)C=C1	APExBIO	A4374	0.56562086	-3.78947368	-11.47142657	-76.52119581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013917-09	NCGC00013917-09	363676433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	56990-57-9				-19.7165211856	4	4		0	-3.51940561					OC1=C(C=C(C2=CC=CN=C12)[S+](O)([O-])=O)\N=N\C3=CC=C4C=C(C=CC4=C3)[S+](O)([O-])=O	Glixx	GLXC-02436	-4.78987799	-2.99814034	-3.94718359	-3.51940561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510695-01	NCGC00510695-01	384569484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1357920-84-3		6.3095734448	-5.2	-37.7045151713	4	4		-14.4730739919	-17.54814742	0.2920658424	0.9438184201		ALK	CC(C)NC(=O)[C@@H]1CC[C@@H](CC1)[N]2C(=NC3=CC=C(CN4CCC(CC4)C(C)(C)O)C=C23)NC(=O)C5=CC=C(F)C=C5	MedChem Express	HY-17603	-6.04609128	-5.56538305	-2.57058576	-17.54814742												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00319019-01	Nemorubicin	170465590	DNA Topoisomerase II Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	108852-90-0		0.1	-7	-454.9138280097	5	4		-20.086168916	-97.88698728	0.2381220457	0.9701538175		TOP2A	COC1CN(CCO1)C6CC(OC5C[C@@](O)(Cc4c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c4O)C(=O)CO)OC(C)C6O	GVK	FFS-11-286-NCI-135	-95.7239819	-98.14956209	-98.29578933	-97.88698728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510683-01	NCGC00510683-01	384569477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1245603-92-2]				-17.6961698939	4	4		0	0.74576919				GCK	CN(C)C(=O)C1=NC=C(OC2=C3C=C(C)OC3=CC(=C2)C(=O)NC4=CN=C(C)C=N4)C=N1	Tocris	6049	-5.10859729	-1.98966989	-5.4616326	0.74576919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498438-01	NCGC00498438-01	384569301		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	888478-45-3		1.4125375446	-5.85	-248.2468765465	-2.3	4		-93.4574316232	-84.12392028	0.1836408568	0.9786227535		DDX5	COC1=CC(=CC(=C1)N2CCN(CC2)C(=O)NC3=NC4=C(C=CC(=C4)F)N=C3OC)OC	ChemieTek	CT-RX5902	-38.96057024	-56.88040507	-65.98702502	-84.12392028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165721-16	NCGC00165721-16	377020368		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	909910-43-6				-41.5621408867	4	4		0	-12.17487815				TGBR1	CC1=CC=CC(=N1)C2=N[N](C=C2C3=CC=NC4=C3C=CC=C4)C(=S)NC5=CC=CC=C5	MedChem Express	HY-10432	-7.75060904	-7.80570865	-10.32144773	-12.17487815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345799-06	Oprozomib	384568748	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	935888-69-0		0.2818382931	-6.55	-265.4851245478	-1.1	4		-95.8114243692	-98.31298664	0.0141289056	0.9998768722		PSMD1	COC[C@H](NC(=O)[C@H](COC)NC(=O)C1=CN=C(C)S1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@@]3(C)CO3	MedChem Express	HY-12113	-23.91515687	-89.05263158	-98.27110883	-98.31298664												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522107-03	NCGC00522107-03	384569513		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	737789-87-6				-3.7688457168	4	4		0	0.41814861				GNRHR	CONC(=O)NC1=CC=C(C=C1)C2=C(CN(C)C)C3=C(S2)N(CC4=C(F)C=CC=C4F)C(=O)N(C3=O)C5=CC=C(OC)N=N5	MedChem Express	HY-16474_cm2	0.0353513	-3.05720824	-2.91107892	0.41814861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241455-04	NCGC00241455-04	384568480		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	317318-70-0	GW-501516;GSK-516;501516			-16.2422888488	4	4		0	-2.50408536			5467	PPARD	CC1=CC(=CC=C1OCC(O)=O)SCC2=C(C)N=C(S2)C3=CC=C(C=C3)C(F)(F)F	NCGCChem	GRB30-029-C4	-3.87980557	-4.5583524	-1.82701743	-2.50408536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164553-07	NCGC00164553-07	384568252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	123318-82-1		2.8183829313	-5.55	-56.9622645772	-1.4	4		-35.1818222965	-37.38825339	0.0597378892	0.9977943473			NC1=NC(=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)Cl	MedChem Express	HY-A0005	-1.61732214	-3.78947368	-31.81627027	-37.38825339												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345832-03	NCGC00345832-03	384568759		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	271576-80-8				-22.3087028313	4	4		0	-5.63507968				MAPK14	OCC(=O)N1CCC(CC1)C2=N[NH]C(=C2C3=NC=NC=C3)C4=CC=C(Cl)C=C4	SynKinase	SYN-1078	-3.98335841	-4.92317068	-6.41491164	-5.63507968												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093985-19	NCGC00093985-19	384568122		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	17560-51-9				-12.8629108473	4	4		0	-1.26946108				CA7	CC1NC2=CC(=C(C=C2C(=O)N1C3=C(C)C=CC=C3)[S+](N)([O-])=O)Cl	MedChem Express	HY-B0209	-4.20067424	-1.12323344	-0.57529611	-1.26946108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386198-07	NCGC00386198-07	384569114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	211513-37-0				-28.9218927496	4	4		0	-1.17365269					CCC(CC)CC1(CCCCC1)C(=O)NC2=C(SC(=O)C(C)C)C=CC=C2	MedChem Express	HY-14950	-9.14212207	-3.3052525	-3.4179357	-1.17365269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00096081-05	NCGC00096081-05	384568160		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	7235-40-7				-13.9388258927	4	4		0	-1.70342132					CC\1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)/CCCC2(C)C)C(C)(C)CCC1	Selleck	S1767	-3.41965172	-3.32481964	-2.30232672	-1.70342132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346657-02	NCGC00346657-02	384568888		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1010085-13-8		12.5892541179	-4.9	-89.1087057045	-3	4		-59.6987767041	-59.75486175	0.0187763872	0.9997825881		AURKA	OC(=O)C1(CCC(CC1)OC2=C(F)C(=CC=C2)Cl)CC3=CC=CC(=N3)NC4=NC=CS4	ChemieTek	CT-MK5108	-11.16123793	-10.42254783	-12.38963953	-59.75486175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094792-07	NCGC00094792-07	384568135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	154-42-7, 5580-03-0 [hemihydrate]		10	-5	-56.5760748324	-3	4		-78.2507449751	-67.23541286	0.0505633575	0.998420115		HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	Microsource	01500573	0.41537782	-2.75514874	-7.80804635	-67.23541286												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347936-06	NCGC00347936-06	363677722		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	420831-40-9				-18.304075913	4	4		0	-9.62703066				SIRT2	[O-][S+](=O)(N1CCCCCC1)C2=CC(=CC=C2)C(=O)NC3=CC=CC(=C3)Br	Bio Vision	1857	-1.78524083	-5.25400458	-4.11663006	-9.62703066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183362-01	NCGC00183362-01	124894389		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	5534-95-2	Pentagastrin			-22.9868243448	4	4	N-t-Boc-beta-Ala-Trp-Met-Asp-Phe amide;Pentagastrin;	0	-4.18629242				CCK2	NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CCNC(=O)OC(C)(C)C)Cc3cnc2ccccc23	SigmaAldrich	B1636	-5.24966858	-2.99313501	-6.23802626	-4.18629242												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015580-22	NCGC00015580-22	384567867		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	34580-14-8				-21.1612702107	4	4		0	-5.02492912				HRH1	CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3	MedChem Express	HY-B0157A	-5.49480343	0.4218261	-5.24886454	-5.02492912												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402358-02	NCGC00402358-02	384569216		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1204669-58-8				-19.017997884	4	4		0	-2.58089745				IDO1	N[S+]([O-])(=O)NCCNC1=NON=C1\C(NC2=CC(=C(F)C=C2)Br)=N\O	Glixx	GLXC-90193	-3.98553999	-4.37701275	-5.51107365	-2.58089745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386179-04	NCGC00386179-04	363680137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	936890-98-1		3.1622776602	-5.5	-31.1358041202	4	4		-18.970026736	-17.34284876	0.0232096493	0.9996700548			COC1=CC=CC2=C1[NH]C(=C2)C3=C4[N](N=CN=C4N)C(=N3)[C@@H]5CC[C@H](CC5)C(O)=O	Glixx	GLXC-90206	-2.36782648	-5.60166916	-11.74790467	-17.34284876												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00501213-01	NCGC00501213-01	384569312		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1792180-81-4				-8.9134185005	4	4		0	-0.99716492				JAK3	C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=C3C=C[NH]C3=NC=N2	Toronto Research	P293775	-1.5996385	-1.50133805	-4.34049726	-0.99716492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163540-01	NCGC00163540-01	26756923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	520-33-2	DIOSMETINE;DIOSMETIN			-17.2818530726	4	4	CIPLUS_210346;diosmetin;NCGC00163540-01;DIOSMETINE;	0	-6.21317365					COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	BIOMOL_NP-082	-4.04098652	-2.57791281	-0.73966642	-6.21317365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481564-01	NCGC00481564-01	377020339		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			14.1253754462	-4.85	-27.1100234671	4	4		-29.128842344	-25.10736862	0.3866629207	0.8949071223		MET	CN\1N(C(=O)\C(=C1C)C(=O)NC2=CC=C(OC3=CC=NC4=C3C(=C[NH]4)C5=CC=CC=C5)C(=C2)F)C6=CC=C(F)C=C6	APExBIO	B5947	-3.8347018	-3.23520186	5.30705819	-25.10736862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165783-03	NCGC00165783-03	384568283		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	117570-53-3				-11.2721206676	4	4		0	-2.46585919					CC1=C(C)C2=C(C=C1)C(=O)C3=C(O2)C(=CC=C3)CC(O)=O	Selleck	S1537	-2.96851033	-2.41071829	-0.23413492	-2.46585919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017358-15	Rotenone	170466816	NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	83-79-4	;ROTENONE;Rotenone	0.316227766	-6.5	-91.0412664918	-1.4	4		-41.655195779	-47.77783139	0.539200929	0.7629790105	51103	NDUFAF1	C=C(C)[C@@H]2Oc3ccc1C(=O)[C@H]4c5cc(OC)c(OC)cc5OC[C@H]4Oc1c3C2	Microsource	00200013	-5.28737706	-33.33781422	-26.5060241	-47.77783139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378878-02	NCGC00378878-02	363678252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	N.A.				-21.944889042	4	4		0	-9.70419341				CSF1R	CNC(=O)C1=CC=CC2=C1C=CC(=C2)OC3=CC=NC4=CC(=C(OC)C=C34)OCC5(N)CC5	Axon Medchem	1942	-2.28277542	-5.43083748	-7.24842691	-9.70419341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250388-04	NCGC00250388-04	384568541		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	509088-69-1		12.5892541179	-4.9	-99.5103487364	-3	4		-111.5995615866	-99.58185139	0.0280664134	0.9995138514		S1PR1	NC(CO)(CO)CCC1=C(Cl)C=C(SC2=CC(=CC=C2)OCC3=CC=CC=C3)C=C1	Axon Medchem	1615	-6.6902342	-4.17391304	-7.26601561	-99.58185139												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387039-04	NCGC00387039-04	384569150		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1282512-48-4		8.9125093813	-5.05	-99.0983742301	-2.4	4		-63.3932858208	-56.00788234	0.0762144372	0.9964026209		PIK3CA	CC(C)[N]1N=C(C)N=C1C2=C[N]3CCOC4=CC(=CC=C4C3=N2)C5=C[N](N=C5)C(C)(C)C(N)=O	ChemieTek	CT-G0032	-10.03093239	-16.28375286	-28.95659081	-56.00788234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263209-09	NCGC00263209-09	363677266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	71203-35-5		14.1253754462	-4.85	-47.8086740603	4	4		-27.5989552999	-28.68315573	0.2088612662	0.972153487		CDC42	COC1=CC=C(C=C1)C2CC(=N/N2C3=CC=C(C=C3)[S+](N)([O-])=O)\C4=CC=CC=C4	Aobious	AOB1515	-8.11568007	-4.47679956	-3.60069298	-28.68315573												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387042-02	NCGC00387042-02	384569151		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1204144-28-4				-43.8530029322	4	4		0	-9.25799198				PIM1	NC1CCCN(C1)C2=C(C=CC=C2\C=C\3SC(=O)NC3=O)C4=CC=CC=C4	APExBIO	A3962	-9.85991866	-10.18279131	-6.63482699	-9.25799198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00494684-01	NCGC00494684-01	384569290		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-19.808093081	4	4		0	-7.6156027				GABRA1	CC1=C(COC2=NC=C(C=C2)C(=O)N3CC[S+]([O-])(=O)CC3)C(=NO1)C4=CC=C(F)C=C4	NCGCChem	PJM010-042	-3.71441482	-1.31083594	-5.31441682	-7.6156027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346684-02	NCGC00346684-02	384568908		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	65678-07-1		3.1622776602	-5.5	-100.3692626222	-2.2	4		-62.1608049054	-67.41616971	0.0122177835	0.99990794		EGFR	CC(C)(C)C1=C(O)C(=CC(=C1)C=C(C#N)C#N)Br	Selleck	S1234	-4.74469047	-5.8647435	-48.30734654	-67.41616971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378780-02	NCGC00378780-02	363678194		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			8.9125093813	-5.05	-47.2183036722	-3	4		-31.3310023919	-31.28622754	0.2048223434	0.9732454431		ULK1	O=C(NCCCNC1=NC(=NC=C1C2CC2)NC3=CC=CC(=C3)CN4CCOCC4)C5CCC5	Tocris	5134	-6.57824698	-1.42705888	-8.63911047	-31.28622754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179817-06	NCGC00179817-06	384568383		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	5508-58-7				14.7031394427	4	4		0	1.42275449					C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CC[C@H]12	MedChem Express	HY-N0191	3.00301632	-0.00920683	8.55209089	1.42275449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159510-16	NCGC00159510-16	384568183		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	129722-12-9		12.5892541179	-4.9	-37.7956895913	4	4		-19.139825632	-21.20718563	0.1687067839	0.9821099626		HTR2A	ClC1=CC=CC(=C1Cl)N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2	MedChem Express	HY-14546	-6.26774308	-3.59066427	-4.90693739	-21.20718563												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511392-01	NCGC00511392-01	384569503		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1354825-58-3		10	-5	-63.9023782693	-2.4	4		-82.7717181805	-65.42971577	0.0539480786	0.9982010793		RIPK2	CC1=CC=C(C=C1)C2=N[N](C3=NC=NC(=C23)N)C(C)(C)CNC(=O)C4=CC=NC=C4	Glixx	GLXC-10673	-0.49625553	-4.43608012	-15.20901419	-65.42971577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510482-01	NCGC00510482-01	384569445		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	910634-41-2		0.2238721139	-6.65	-79.2641111224	4	4		-24.7727862721	-26.61251562	0.1393375817	0.9878664597		KIF11	CCNCC[S+]([O-])(=O)NC[C@]1(S\C(=N/N1C(=O)C(C)(C)C)NC(=O)C(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-14846	-7.41493593	-29.30892449	-28.54539507	-26.61251562												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181785-01	NCGC00181785-01	50126334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	170729-80-3	 ;Merck brand of aprepitant; Aprepitant; Emend;Aprepitant;L-754030 /MK-0869/ONO-7436			-11.8504829079	4	4	aprepitantum;MK-0869;5-((2-(1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-1,2-DIHYDRO-3-OXO-3H-1,2,4-TRIAZOL, 2R-(2AR*,3A);Merck brand of aprepitant;CIPLUS_728707;MK 0869;MK-869;MK 869;L-754030-000Z;HS_534;(2R)-(1R)-3,5-bis(trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine;aprepitant;APREPITANT;Emend;Aprepitant;	0	-1.70623858			6869	TACR1	C[C@@H](O[C@H]2OCCN(CC1=NC(=O)N=N1)[C@H]2C3CCC(F)CC3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F	Toronto Research	A729800	-1.59964649	-5.29977117	-3.98579506	-1.70623858												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485430-01	NCGC00485430-01	363681335		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-6.8810952279	4	4		0	-3.13851774				BTK	NC(=O)C1=C(N)[N](N=C1C2=CC=C(OC3=CC=C(F)C=C3F)C=C2)[C@@H]4CCCN(C4)C#N	SIGMA	PZ0220	-1.54661953	0.08237986	-0.92051773	-3.13851774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262306-10	NCGC00262306-10	384568572		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-17.5054070498	4	4		0	-1.39798612				USP1	CC(C)C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NCC3=CC=C(C=C3)[N]4C=CN=N4	NCGCChem	NCGC00262306-03_06_07mix	-4.37415273	-3.39728761	-4.17193426	-1.39798612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161634-09	Artemisinin	384568213	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	63968-64-9				-6.0320768503	4	4		0	-0.36171669				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S1282	-0.41572526	-3.46078832	-3.26356698	-0.36171669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371131-09	NCGC00371131-09	363678047		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1418013-75-8		3.1622776602	-5.5	-143.7707339179	-1.1	4		-94.5137378484	-99.61873106	0.0414275714	0.9989399894		VCP	CC1=C(C=CC(=C1)OCC2=NN=C(SC3CCCC3)[N]2C4=CN=CC=C4)C5=CC=C(C=C5)[S+](C)([O-])=O	Glixx	GLXC-03842	-4.08495255	-7.92398059	-76.31689844	-99.61873106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390546-03	NCGC00390546-03	384569189		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	904763-27-5				-0.6657766617	4	4		0	-0.48383234					CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=C[NH]C=N2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O	MedChem Express	HY-13535A	0.73190206	-2.30170787	-0.80734832	-0.48383234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345789-16	NCGC00345789-16	384568742		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1257044-40-8		2.2387211386	-5.65	-111.5573817992	-2.2	4		-72.8797582232	-73.71037012	0.0084383407	0.9999560872		BCL2	CC1(C)CCC(=C(\C1)C2=CC=C(Cl)C=C2)/CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S+]([O-])(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7	Bio Vision	2253	-3.32942344	-13.35304924	-55.2655968	-73.71037012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188346-18	NCGC00188346-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1092351-67-1		2.2387211386	-5.65	-177.7463954402	-2.1	4		-99.6142969484	-93.99700816	0.0255388689	0.9995975586			CC(C)N1N=C(C2=CC3=C(N2)C=CC(O)=C3)C4=C(N)N=CN=C14	Bio Vision	1658	-13.67860688	-34.67311915	-69.13809082	-93.99700816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017248-18	NCGC00017248-18	384567980		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	550-24-3		8.9125093813	-5.05	-50.5488188634	-2.4	4		-53.7308774787	-43.37692419	0.0996329248	0.9938320773		XIAP	CCCCCCCCCCCC/1=C(O)/C(=O)/C=C(O)\C1=O	MedChem Express	HY-17473	-1.27221871	-6.27324461	-15.01390176	-43.37692419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346704-07	NCGC00346704-07	384568923		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	183133-96-2				-149.0964351785	4	4		0	-29.04502244				TUBB	CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)/C(=C(/[C@@H](OC)C(=O)[C@]13C)C5(C)C)C	MedChem Express	HY-15459	-31.93178742	-35.85607384	-29.73513487	-29.04502244												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163553-03	NCGC00163553-03	363676623		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	518-17-2		1	-6	-90.912471642	-1.2	4		-41.471122826	-45.27059502	0.0357114427	0.9992131246			CN1C2N(CCC3=C2[NH]C4=C3C=CC=C4)C(=O)C5=C1C=CC=C5	Selleck	S2382	-4.6752099	-18.45308924	-46.1240129	-45.27059502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159406-15	NCGC00159406-15	384568174		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	69815-49-2, 51-41-2 [norepinephrine]				-13.7184049526	4	4		0	-3.0012709				ADRA1A	NC[C@H](O)C1=CC=C(O)C(=C1)O	Microsource	01500436	-4.56394035	-0.9842609	1.24081098	-3.0012709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182051-05	NCGC00182051-05	384568406		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	841290-80-0		1.1220184543	-5.95	-115.0062727846	-2.4	4		-50.2666858307	-18.59419298	1	0.999992502		SYK	COC1=CC(=CC(=C1OC)OC)NC2=NC=C(F)C(=N2)NC3=NC4=C(OC(C)(C)C(=O)N4)C=C3	Selleck	S1533	-7.8445549	-15.77992471	-58.03717751	-18.59419298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016361-21	NCGC00016361-21	384567935		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	103-90-2				-14.6350180041	4	4		0	-2.31377246				PTGS1	CC(=O)NC1=CC=C(O)C=C1	MedChem Express	HY-66005	-4.1918027	-2.458224	-0.69132221	-2.31377246												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095486-03	NCGC00095486-03	174007452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	57-87-4	ERGOSTEROL			-12.9606221383	4	4		0	-0.90236755					CC(C)C(C)/C=C/C(C)C1CCC2\C3=C\C=C/4CC(O)CCC4(C)C3CCC12C	Microsource	MS-00200743	-2.04838425	-6.07505794	-4.01894579	-0.90236755												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094419-03	NCGC00094419-03	26753659		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	402-71-1	Tosyl-Phe-CMK (TPCK);TPCK;N-p-Tosyl-L-phenylalanine chloromethyl ketone	15.8489319246	-4.8	-6.1092574349	4	4	(S)-1-Chloro-3-tosylamido-4-phenyl-2-butanone;Tosylphenylalanyl Chloromethyl Ketone;NCGC00016020-01;NCGC00094419-03;TPCK;NCGC00094419-02;Ketone, Tosylphenylalanyl Chloromethy;NCGC00094419-01;CIPLUS_153043;Chloromethyl Ketone, Tosylphenylalany;Tosyl-L-phenylalanyl-chloromethane;Chloromethane, Tosylphenylalany;(S)-1-Chloro-4-phenyl-3-tosylamido-2-butanone;Tosyl-Phe-CMK (TPCK);CIPLUS_675469;LS-154112;Benzenesulfonamide, N-(3-chloro-2-oxo-1-(phenylmethyl)propyl)-4-methyl-, (S)-;N-p-Tosyl-L-phenylalanine chloromethyl ketone;	-9.9083213199	-7.4236011	0.5703900303	0.728081994			CC1=CC=C(C=C1)[S+]([O-])(=O)N[C@@H](CC2=CC=CC=C2)C(=O)CCl	BIOMOL	PI-122	-0.53858379	-2.20627563	3.37178766	-7.4236011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522629-01	NCGC00522629-01	384569532		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	300842-64-2		12.5892541179	-4.9	-72.5836860038	-3	4		-95.8371172708	-85.67240219	0.0408975985	0.998967028		KDR	CC1=C(Br)C=C(NC2=NN=C(CC3=CC=NC=C3)C4=CC=CC=C24)C=C1	Glixx	GLXC-07620	-1.13124171	-4.37528604	-3.72412504	-85.67240219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345802-09	NCGC00345802-09	384568750		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1316214-52-4		7.9432823472	-5.1	-28.1736671643	-2.4	4		-35.4169960159	-26.67716385	0.0196210491	0.9997629718		HDAC6	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-16026	-0.07966717	-1.3276455	-10.16218833	-26.67716385												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345813-03	NCGC00345813-03	384568757		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	118525-40-9		12.5892541179	-4.9	-51.6362966047	-3	4		-67.3211050758	-62.56766467	0.0322710358	0.9993572794			COC1=CC=C(C=C1)/C2=C(O)/C(=O)C3=C(O)C=C(O)C(=C3O2)CC=C(C)C	SIGMA	SML0551	-0.83836054	-2.58711964	-1.31979695	-62.56766467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346598-02	NCGC00346598-02	384568853		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	138-59-0				-22.0086652987	4	4		0	-4.23952096					O[C@@H]1C\C(=C/C(O)C1O)C(O)=O	Selleck	S2356	-6.03708304	-3.25921834	-1.63886875	-4.23952096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178734-10	NCGC00178734-10	384568363		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	486460-32-6				-17.4590352157	4	4		0	-3.63592814				DPP4	N[C@@H](CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F	MedChem Express	HY-13749	-4.88378282	-0.69051236	-2.55740875	-3.63592814												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346574-04	NCGC00346574-04	384568847		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	917111-44-5		0.0251188643	-7.5999999999	-295.8917798731	5	4		-80.8756062392	-77.48502994	0.3340904301	0.9244320784		TUBB	CCC[C@H](NC1=C(C)C=NC(=N1)C2=CC(=C(NC(=O)NCC)C=C2)OC)C3=CC=CN=C3	MedChem Express	HY-10498	-55.31848829	-68.91313354	-69.45612763	-77.48502994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356803-11	NCGC00356803-11	384569032		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1338466-77-5				-19.3416692348	4	4		0	-5.17844311				DOT1L	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)[N]3C=CC4=C3N=CN=C4N	APExBIO	A4170	-5.84190916	1.61119551	-2.40270728	-5.17844311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507846-01	NCGC00507846-01	384569327		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	890128-81-1				-24.0149101052	4	4		0	-7.27475697				KDR	OCC1=CC(=NC=N1)OC2=CC=C3C(=C2)C=CC=C3C(=O)NC4=CC(=CC=C4)C(F)(F)F	Selleck	S8188	-4.85608335	-3.37404172	-5.46332771	-7.27475697												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178697-07	NCGC00178697-07	384568360		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	97682-44-5		3.5481338923	-5.45	-39.2837486512	4	4		-25.115573728	-19.97245833	0.1962230427	0.9756438871		TOP1	CCC1=C2C=C(OC(=O)N3CCC(CC3)N4CCCCC4)C=CC2=NC\5=C1CN6C(=O)\C7=C(/C=C56)[C@@](O)(CC)C(=O)OC7	Selleck	S1198	-3.62614689	-9.09298815	-12.50462963	-19.97245833												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186046-02	NCGC00186046-02	174006990		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	55750-05-5	Caroverine hydrochloride;Spasmium; Caroverine hydrochloride			-14.5324889075	4	4		0	-6.9329028				GR1A1	CCN(CC)CCN1C(=O)\C(=N/C2=CC=CC=C12)CC3=CC=C(OC)C=C3	SIGMA	C1119	-2.01940384	-3.41215753	-2.58796296	-6.9329028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263114-01	NCGC00263114-01	137275958		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	949588-40-3	Org-25935;SCH-900435			-4.7438030377	4	4		0	0.21843392			6536	SLC6A9	COC1=CC=C2[C@@H]([C@@H](CCC2=C1)CN(C)CC(O)=O)C3=CC=CC=C3	ChemAxon	Axon 1563	-1.57162299	0.25614051	-0.76388889	0.21843392												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00378894-01	NCGC00378894-01	363678261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	201410-53-9		12.5892541179	-4.9	-77.4710305602	-3	4		-94.9158601993	-87.81043734	0.1127829014	0.9920720599		CYP26A1	CCC(CC)C([N]1C=NC=N1)C2=CC=C(NC3=NC4=CC=CC=C4S3)C=C2	MedChem Express	HY-14531	-4.80266913	-3.14686914	3.75462963	-87.81043734												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025000-22	NCGC00025000-22	384568041		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	65277-42-1				-6.663342455	4	4		0	-2.22232775				CYP19A1	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@@](C[N]4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	MedChem Express	HY-B0105	-0.08780017	-4.72945158	-2.10648148	-2.22232775												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178241-13	NCGC00178241-13			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	15663-27-1				-16.2956539349	4	4		0	-3.73604352					[NH3+][Pt--]([NH3+])(Cl)Cl	Selleck	S1166	-3.31061344	-4.91446481	-2.30936819	-3.73604352												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510190-02	NCGC00510190-02	384569413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1000998-59-3		0.7943282347	-6.1	10.7111853078	4	4		15.2306807079	10.61647104	0.4742809925	0.8312726007		PPARA	COC(=O)N(CC(O)=O)CC1=CC(=CC=C1)OCC2=C(C)OC(=N2)C3=CC=C(Cl)C=C3	MedChem Express	HY-10678	-1.85890059	5.73281678	5.03025902	10.61647104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185071-01	NCGC00185071-01	124896608		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1492-18-8				-20.9281776261	4	4	N5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid;FOLINIC ACID CALCIUM SALT;CIPLUS_148853;Levoleucovorin Calcium;CALCIUM N-(P-((((6S)-AMINO-5-FORMYL-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-L-GLUTAMATE (1:1);5-Formyl-5,6,7,8-tetrahydrofolic acid calcium salt;L-Glutamic acid, N-(4-(((2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-;LS-71774;Calcium levofolinate;CALCIUM FOLINATE;L-GLUTAMIC ACID, N-(4-(((2-AMINO-5-FORMYL-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-, CALCIUM SALT (1:1), (S)-;Calcium Folinate;Wellcovorin;CIPLUS_682532;CIPLUS_3741774;Calcium folinate;CIPLUS_711792;Levoleucovorin calcium;Citrovorum factor calcium salt;folinate de calcium;5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid calcium salt;Calcium Levofolinate;NCGC00094708-01;NCGC00094708-02;CIPLUS_192127;calcii folinas;Folinic acid calcium salt hydrate;leucovorin;citrovorum;N-(4-(((2-AMINO-5-FORMYL-1,4,5,6,7,8-HEXAHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-GLUTAMIC ACID;NCGC00017055-01;Calcii folinas;Leucovorin Calcium;Leucovorin;LEUCOVORIN CALCIUM;5-HCO-H4PteGlu;CIPLUS_158472;calcii levofolinas;Uzel;CIPLUS_756906;Folinic acid;LS-177560;HS_806;HS_805;NCGC_Prestw-738;LS-175894;Leucovorin calcium;LEVOLEUCOVORIN CALCIUM;LS-176087;Leucovorin calcium salt;Citrovorum factor;LEUCOVORIN;calcium leucovorin;Leucovorin Calcium (pentahydrate);Folinate de calcium;CIPLUS_727061;CALCIUM LEVOFOLINATE;levofolinate de calcium;Folinato calcico;Folinic acid calcium salt;	0	-2.39041916					N/C1=N/C(=O)C/2=C(NC[C@@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)N2C=O)\N1	SigmaAldrich	F8259	-5.20315827	-5.43203057	-2.94416244	-2.39041916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161641-05	NCGC00161641-05	363676605		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	115-53-7				-0.6258627088	4	4		0	-4.5748503					COC/1=C/[C@@H]2[C@@H]3CC4=C(C(=C(OC)C=C4)O)[C@]2(CCN3C)CC1=O	Selleck	S2359	2.01827537	-2.74363578	-0.63330916	-4.5748503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346718-02	NCGC00346718-02	384568931		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	343787-29-1		11.220184543	-4.95	-72.5751249196	-3	4		-97.4842351069	-86.48143713	0.0060812151	0.9999771917		PDGFRB	COCCOC1=CC=C2[N](C=NC2=C1)C3=NC4=C(C=CC=C4C=C3)N5CCC(N)CC5	Selleck	S1536	-1.35290987	-1.79533214	-4.61687213	-86.48143713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160514-14	NCGC00160514-14	384568196		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	58186-27-9				-1.3201847198	4	4		0	1.4054881					COC\1=C(/OC)C(=O)\C(=C(C)/C1=O)CCCCCCCCCCO	Enzo	FR114	-0.03167421	-0.60633281	-2.66962788	1.4054881												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015480-17	NCGC00015480-17	384567856		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	265129-71-3		10	-5	-23.107584892	4	4		-32.5511521159	-29.20929343	0.1439415302	0.9870168428		PPARA	CC(C)(SC1=CC=C(CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3)C=C1)C(O)=O	Cayman	10008613	-1.27149321	2.88794071	-0.06798713	-29.20929343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092289-01	NCGC00092289-01	26753179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	383907-43-5	NSC-663284; DA-3003-1;DA-3003-1	1.5848931925	-5.8	-167.1015926311	-1.1	4	NCGC00092289-02;NSC-663284;NSC663284;NSC 663284;6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione;	-96.0210179587	-99.85523332	0.0374381075	0.9991345222	5923	CDC25	ClC/1=C(NCCN2CCOCC2)/C(=O)C3=C(C=CC=N3)C1=O	Tocris	Tocris-1867	-6.69493819	-9.6607967	-98.17082094	-99.85523332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346667-07	NCGC00346667-07	384568894		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	70374-39-9				-1.9594018943	4	4		0	-1.77097911					CN1\C(=C(O)/C2=C(C=C(Cl)S2)[S+]1([O-])=O)C(=O)NC3=NC=CC=C3	MedChem Express	HY-B0367	0.41505008	-4.55258323	2.12672553	-1.77097911												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505021-01	NCGC00505021-01	384569315		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	Indotecan hydrochloride		1	-6	-87.948646798	4	4		16.2014421239	-13.18201244	0.5037799311	0.8020059559		TOP1	COC1=C(OC)C=C2C(=C1)C(=O)N(CCCN3CCOCC3)\C4=C2\C(=O)C5=C4C=C6OCOC6=C5	NCI	NSC743400	-24.32064621	-19.55815762	-3.31944444	-13.18201244												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182045-03	NCGC00182045-03	384568404		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	2033				-9.1012467234	4	4		0	-2.3457904				ADA	OC[C@H]1O[C@H](C[C@@H]1O)[N]2C=NC3=C2\N=C/NC[C@H]3O	Tocris	2033	-1.01848194	-3.80551617	-2.98611111	-2.3457904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185774-06	NCGC00185774-06	384568426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	84611-23-4				-11.7079981913	4	4		0	-0.17094829					OC(=O)CSCC(=O)NC1CCSC1=O	MedChem Express	HY-B0289	-4.06514772	0.6312034	-2.34722222	-0.17094829												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509932-01	NCGC00509932-01	384569382		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1234356-69-4		10	-5	-97.8218463544	-2.1	4		-104.5610740316	-99.71316569	0.0051005455	0.9999839544		FGFR1	COCCNCCC1=CC(=CC=C1)NC2=NC=C3C[C@@H](C4=CC=CC=C4F)C5=CC=CC=C5C3=N2	ChemGood	C-1033	-4.93665158	-5.19649674	-10.09382224	-99.71316569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093560-13	NCGC00093560-13	384568115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	98319-26-7				-16.1303022889	4	4		0	-1.34812124				AR	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)\C=C/[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-13635	-3.7239819	-1.10038177	-6.93015456	-1.34812124												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167441-07	NCGC00167441-07	384568313		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	104632-25-9				-10.3959194913	4	4		0	-2.31379673				DRD3	CCCN[C@H]1CCC2=C(C1)SC(=N2)N	MedChem Express	HY-17355	-2.97285068	-0.32786885	-1.21017087	-2.31379673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253439-03	NCGC00253439-03	384568562		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1089283-49-7		1.5848931925	-5.8	-8.0013585085	4	4		8.443520656	0.69185991	0.5433626595	0.7604139468		IGFR1	CCC1=CC(=C(OC)C=C1N2CCC(CC2)N3CCN(CC3)[S+](C)([O-])=O)NC4=NC(=CC=N4)C5=C(N=C6C=CC=C[N]56)C7=CC(=C(OC)C=C7)C(=O)NC8=C(F)C=CC=C8F	Selleck	S1093	-3.42568824	-6.20293388	6.53110627	0.69185991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481108-02	NCGC00481108-02	384569253		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1883429-22-8		14.1253754462	-4.85	-16.8527981921	4	4		-18.17703572	-15.16349598	0.287859188	0.9455398438		BRD9	COC1=C(CN(C)C)C=C(OC)C(=C1)C/2=C/N(C)C(=O)C3=C2C=CN=C3	MedChem Express	HY-100352	-0.43263288	-4.06935283	-2.24629525	-15.16349598												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242057-03	NCGC00242057-03	384568485		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	501693-25-0		10	-5	-68.5024474689	-3	4		-71.5637631658	-67.91395603	0.0297455447	0.9994539968		TEK	COC1=CC=C(C=C1)C2=C(C3=CC=C(NC(=O)NC4=C(F)C=CC(=C4)C(F)(F)F)C=C3)C5=C(O2)N=CN=C5N	Aobious	AOB4188	-4.14416787	-2.50651786	-7.73611111	-67.91395603												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015466-09	NCGC00015466-09	90340599		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	60142-96-3	 Go 3450;; Gabapentin hydrochloride;Gabapentin hydrochloride; ; Neurontin;Gabapentin; Gabapentino; Gabapentin; gabapentin ISTD			7.9431845985	4	4		0	0.2089368					NCC1(CCCCC1)CC(O)=O	SigmaAldrich	Lopac-G-154	2.20378419	1.39962494	1.68981481	0.2089368												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015082-09	NCGC00015082-09	170466652		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	996-19-0				-18.3663432975	4	4		0	-3.33349162				NOS2	NNC(N)=N.NNC(N)=N.OS(O)(=O)=O	Microsource	01505162	-4.06514772	-6.54073092	-1.31944444	-3.33349162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016872-19	Ticlopidine hydrochloride	384567964	P2Y12 (P2T) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	53885-35-1				2.5695959813	4	4		0	-3.86533074				P2RY12	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1	MedChem Express	HY-B0153A	1.62430309	0.73183003	1.14351852	-3.86533074												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095186-11	NCGC00095186-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	148553-50-8				-1.773426618	4	4		0	-0.29441094					CC(C)C[C@H](CN)CC(O)=O	MedChem Express	HY-17414	-0.64972123	-1.39962494	1.55092593	-0.29441094												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370777-10	NCGC00370777-10			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1197160-78-3				-17.8990955029	4	4		0	-4.75806069				PIK3CA	CN(C)C1CCN(CC1)C(=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6)C=C2	Selleck	S2628_CM1	-2.80082532	-5.67168275	-4.61574074	-4.75806069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164336-05	NCGC00164336-05	174006930		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	51-48-9	; Thyroxine I 131; ; Levotiroxina sodica; L-Thyroxine Sodium; Synthroid; Thyroxine I 125; Thyradin; DL-Levothyroxine sodium; Sodium Dextrothyroxine; Euthroid;THYROXINE;Thyroxine (L); Thyrolar; Levoxyl; Thyroxine (L); Levothroid; Euthyral; Sodium levothyroxine; D-Thyroxine; Dextroid;LEVOTHYROXINE; L-Thyroxine Sodium Salt; L-Thyroxine sodium salt; Thyreotom; D Thyroxin; Levothyroxine; D-T4 Thyroid Hormone; Dextrotiroxina sodica; Choloxin			-31.6071099484	4	4		0	-8.97791376					N[C@@H](CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C(O)=O	Microsource	MS-01500774	-5.56108597	-7.82843027	-7.47405158	-8.97791376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521943-01	NCGC00521943-01	384569508		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1330782-76-7		12.5892541179	-4.9	-77.0862699943	-3	4		-89.876728574	-75.9824075	0.0889289771	0.9950910266		CDK7	CC1=N[NH]C=C1C2=CC\3=C(S2)C(=O)NC(=N3)\[C@@H]4CC5CCN4CC5	ChemieTek	CT-TAK931	-6.42986425	-0.30092073	-5.24407379	-75.9824075												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095161-10	NCGC00095161-10	384568152		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	90098-04-7				-6.7474180346	4	4		0	0.08605029					OC(=O)C(CC/1=C/C(=O)NC2=CC=CC=C12)NC(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-B0360	-0.87330317	-2.8699753	-3.68490233	0.08605029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163489-03	NCGC00163489-03	384568243		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	517-89-5	SHIKONIN;Shikonin	7.9432823472	-5.1	-71.0016112086	-2.2	4		-77.8336053052	-72.20575581	0.015750303	0.9998469907	1234	CCR5	CC(C)=CC[C@@H](O)C/1=C/C(=O)C2=C(O)C=CC(=C2C1=O)O	Enzo	CT-115	-2.28506787	-1.64832697	-14.37247881	-72.20575581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510263-01	NCGC00510263-01	384569421		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1640247-87-5		11.220184543	-4.95	-52.1799725122	-2.4	4		-54.8041659995	-45.65798263	0.1279490202	0.9897723191		PIK3CD	NC1=NC(=C(C#N)C(=N1)N)N[C@@H](C2CC2)\C3=N\C4=C(C(=CC=C4F)Cl)C(=O)N3C5=CC=CN=C5	ChemieTek	CT-GS9901	-2.05364256	-7.27375615	-11.0530138	-45.65798263												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022858-10	NCGC00022858-10	384568015		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	15826-37-6				-23.9177815102	4	4		0	-4.93976464					OC(COC1=C2C(=O)\C=C(/OC2=CC=C1)C([O-])=O)COC3=C4C(=O)\C=C(/OC4=CC=C3)C([O-])=O	Prestwick	Prestw-812	-4.95320501	-5.7898021	-5.05064716	-4.93976464												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159544-04	NCGC00159544-04	384568186		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[109826-27-9]				10.0229341956	4	4		0	8.94925345				CALM1	CC1(CN2CCC(CC2)N3C(=O)NC4=C3C=CC=C4)OCC5=CC=CC=C5[N]6C=CC=C16	Tocris	2255	-0.15009712	1.25245142	4.06584131	8.94925345												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017112-14	NCGC00017112-14	384567974		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	41621-49-2		2.8183829313	-5.55	-102.7336569839	-2.2	4		-60.3916590121	-62.80715174	0.0145309677	0.9998697914			CC/1=C/C(=O)N(O)/C(=C1)C2CCCCC2	Prestwick	Prestw-541	-6.23076923	-12.948574	-44.10551602	-62.80715174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510527-02	NCGC00510527-02	384569474		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1622848-92-3				8.7651060754	4	4		0	0.34420117				RIPK1	CN1C(=O)[C@H](COC2=CC=CC=C12)NC(=O)C3=NC(=N[NH]3)CC4=CC=CC=C4	Selleck	S8484	2.80090498	4.03772737	-2.09853601	0.34420117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024683-28	NCGC00024683-28			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	20554-84-1				-0.791500765	4	4		0	-0.1529783					C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	MedChem Express	HY-N0141	0.56561086	-2.15135863	-0.88383266	-0.1529783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163329-11	NCGC00163329-11	384568233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	120202-66-6				-33.0988232444	4	4		0	-8.03034641				P2RY12	COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3	MedChem Express	HY-17459	-8.11719926	-8.37069603	-0.74074074	-8.03034641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390588-01	NCGC00390588-01	384569199		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1450655-76-1				-31.9927145478	4	4		0	-7.72497376					CC[S+]([O-])(=O)N1CCC(CC1)C(C)[N]2C(=C(C(=O)NC\C3=C(OC)\C=C(\C)NC3=O)C4=C2C=CC=C4)C	MedChem Express	HY-15956	-8.29423741	-3.58246637	-3.62624062	-7.72497376												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250396-13	NCGC00250396-13	384568545		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	938440-64-3		2.8183829313	-5.55	-51.1940020244	-2.2	4		-37.7676364704	-33.66256322	0.0212155413	0.9997226966		MTOR	COC1=C(CO)C=C(C=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOCC4)N5C[C@@H](C)O[C@@H](C)C5	MedChem Express	HY-50710	-1.80578915	-7.83093196	-22.81771968	-33.66256322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346549-08	NCGC00346549-08	384568834		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	857531-00-1		10	-5	-84.8608071281	-2.3	4		-114.0881763558	-93.01937208	0.0570380723	0.9979881461		AKT1	ClC1=CC=C(C=C1)C2(CCNCC2)C3=CC=C(C=C3)C4=C[NH]N=C4	MedChem Express	HY-12059	0.22129769	-5.2278762	-17.52118131	-93.01937208												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094226-13	NCGC00094226-13	384568127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	10083-24-6				-23.3572023342	4	4		0	-7.30106645				SYK	OC1=CC(=CC(=C1)/C=C/C2=CC(=C(O)C=C2)O)O	Selleck	S3026	-5.72949562	-4.35542412	-0.32193552	-7.30106645												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345822-02	NCGC00345822-02	363677369		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	(473382-39-7)				-14.0279089895	4	4		0	-4.07759494				AKT1	CN(C)CC(C)(C)CNC1=N[N]2C(=NN=C2C3=CC=CC=C3)C=C1C4CCC4	SynKinase	SYN-1005	-1.49778941	-8.11040911	-2.12672553	-4.07759494												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263132-03	NCGC00263132-03	384568612		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[952021-60-2]		11.220184543	-4.95	-32.2348846126	4	4		-26.768834984	-26.62449416	0.1158763688	0.9916461274		CHEK1	C[N]1C=C(C=N1)C2=C3\C=N/NC(=O)C4=C3C(=CC(=C4)NC(=O)[C@H](N)C5CCCCC5)[NH]2	Tocris	4277	-2.23379834	-4.77357818	-4.71299944	-26.62449416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263918-05	NCGC00263918-05	384568700		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	56390-09-1		7.0794578438	-5.15	-64.8443888863	-2.4	4		-36.0809393439	-32.49453463	0.2265447386	0.9670368674		TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	Selleck	S1223	-7.01041851	-14.06222143	-18.35021572	-32.49453463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00601952-15	NCGC00601952-15			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	145224-90-4				-14.0362039364	4	4		0	-6.57022013					N[C@@H](CC1=CNC2=CC=C(O)C=C12)C(O)=O	Enzo	AC1292	-2.17410517	-2.85583524	-2.25690388	-6.57022013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174736-02	Uridine triacetate	174006168	Pyrimidine Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	4105-38-8	Uridine triacetate			-4.8207362122	4	4		0	-1.44191617				TYMS	CC(=O)OC[C@@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2\C=C/C(=O)NC2=O	SIGMA	T6001	-0.7851313	-1.79533214	-0.69132221	-1.44191617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345831-03	NCGC00345831-03	363677375		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	193746-75-7				-15.3299210873	4	4		0	-4.56526946				MAPK14	COC1=NC=CC(=N1)C2=C(N=C[N]2C3CCNCC3)C4=CC=C(F)C=C4	MedChem Express	HY-18306	-3.26029099	-0.76416701	-4.37515108	-4.56526946												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024956-17	NCGC00024956-17	384568037		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	183322-45-4		11.220184543	-4.95	-130.5505633566	-2.1	4		-109.3041492034	-98.05047532	0.0210911137	0.9997255572		EGFR	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC=CC(=C3)Br	MedChem Express	HY-12013	-12.13570333	-14.06102971	-23.53055948	-98.05047532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015997-12	NCGC00015997-12	384567914		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	107-35-7				-9.1875407187	4	4		0	0.31366115					NCC[S+](O)([O-])=O	Selleck	S2008	-3.21212668	-4.9737868	3.22911078	0.31366115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092276-11	NCGC00092276-11	384568101		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-9.8013830863	4	4		0	0.88307677				ROCK1	C[C@@H](N)C1CC[C@@H](CC1)C(=O)NC2=CC=NC=C2	Tocris	1254_CM	-2.10231887	-5.18886947	-2.09745866	0.88307677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095986-04	NCGC00095986-04	363676578		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	19685-09-7		5.6234132519	-5.25	-131.7386640293	-2.3	4		-104.5496653637	-96.26501954	0.0643716127	0.9974357325		TOP1	CC[C@@]1(O)C(=O)OCC/2=C1/C=C3\N(CC4=CC5=CC(=CC=C5N=C34)O)C2=O	Selleck	S2423	-7.66038076	-13.63086436	-43.91980879	-96.26501954												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347943-09	NCGC00347943-09	363677724		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1373422-53-7				8.868721877	4	4		0	0.61040085				KDM6B	OC(=O)CCNC1=NC(=NC(=C1)N2CCC3=CC=CC=C3CC2)C4=NC=CC=C4	Glixx	GLXC-01837	1.93548387	3.2402746	1.72421849	0.61040085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346955-02	NCGC00346955-02	384568976		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	869748-10-7 		0.4466835922	-6.35	-93.792255233	-1.4	4		-42.4524565199	-49.30789195	0.3418108395	0.9202721158		LCK	COC1=CC(=CC=C1NC(=O)C2=CC3=C(C=CC=C3)[N]2C)C4=N[N](C5CCC(CC5)N6CCN(CC6)C(C)=O)C7=NC=NC(=C47)N	Axon Medchem	1698	-2.81926646	-35.62471396	-35.53572263	-49.30789195												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346688-04	NCGC00346688-04	363677517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1256580-46-7				-17.2506605197	4	4		0	-9.38671537				ALK	CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C)(C)C5=C(C2=O)C6=CC=C(C=C6[NH]5)C#N	ChemieTek	CT-CH542	-0.07070261	-4.73226545	-5.63992337	-9.38671537												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00390417-03	NCGC00390417-03	363680893		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1346546-69-7		12.5892541179	-4.9	-52.9671588288	-3	4		-41.9335522227	-37.74562518	0.2377635438	0.9634640598		RIPK3	CC(C)[S+]([O-])(=O)C1=CC2=C(C=C1)N=CC=C2NC3=CC4=C(SC=N4)C=C3	Glixx	GLXC-03990	-8.33258021	-0.52161292	-4.45287259	-37.74562518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182868-16	NCGC00182868-16	384568412		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	658084-64-1		0.0316227766	-7.4999999999	-449.4232725004	5	4		-68.309211012	-96.02111643	0.5771663429	0.756306054		NAMPT	O=C(NCCCCC1CCN(CC1)C(=O)C2=CC=CC=C2)\C=C\C3=CN=CC=C3	MedChem Express	HY-50876	-94.5594216	-97.10618225	-97.73376411	-96.02111643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177986-12	NCGC00177986-12	384568351		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	70458-95-6				-21.2707009145	4	4		0	-0.15641803					CCN1\C=C(C(O)=O)/C(=O)C2=C1C=C(N3CCN(C)CC3)C(=C2)F	MedChem Express	HY-B0147A	-5.83822865	-4.31351204	-4.62143559	-0.15641803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017369-07	NCGC00017369-07	124883152		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	491-80-5	BIOCHANIN A;Biochanin A (4-Methylgenistein);Biochanin A			10.5123437325	4	4	CIPLUS_206980;NCGC00022428-03;NCGC00022428-05;genistein 4-methyl ether;BIOCHANIN A;LS-39601;1   Biochanin A;biochanin A;5,7-dihydroxy-4'-methoxyisoflavone;Genistein 4'-methyl ether;5,7-Dihydroxy-4'-methoxyisoflavone;LS-173688;Biochanin A;biochanin A, 14C-labeled;	0	1.41317365					COC1=CC=C(C=C1)C/2=C/OC3=C(C(=CC(=C3)O)O)C2=O	BIOMOL	NP-034	0.29719659	4.16148782	8.28136331	1.41317365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238451-09	NCGC00238451-09	363677132		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	763113-22-0				-18.7785479375	4	4		0	-8.42059547				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	ChemieTek	CT-A2281	-3.26626365	-3.33378142	-2.59499537	-8.42059547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508823-01	NCGC00508823-01	384569360		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			12.5892541179	-4.9	-62.6404000492	-3	4		-73.7089629521	-67.22580025	0.0938088719	0.9945338961			CC1(C)N(CC2=CC=C(C=C2)C3=C[NH]N=N3)C(=S)N(C1=O)C4=CC=C(C#N)C(=C4)C(F)(F)F	NCI	BG-15a	-1.63499779	-7.2402746	-4.51848044	-67.22580025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390672-01	NCGC00390672-01	363680966		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1610537-15-9		8.9125093813	-5.05	-25.603225785	4	4		-13.5043246041	-14.75055273	0.0953174911	0.9944133589		CYP17A1	CC(C)[C@](O)(C1=CC2=CC(=C(OC(F)F)C=C2C=C1)OC(F)F)C3=C[NH]N=N3	MedChem Express	HY-15996	-3.57931949	-2.66361556	-5.11658334	-14.75055273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162249-09	NCGC00162249-09	384568221		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	118427-55-7		12.5892541179	-4.9	-68.9287277214	-3	4		-87.7230125872	-80.02018648	0.0815365249	0.9958773661		ALOX5AP	CC(C)C1=CC=C2[N](CC3=CC=C(Cl)C=C3)C(=C(SC(C)(C)C)C2=C1)CC(C)(C)C([O-])=O	Cayman	10133	-4.162616	1.48283753	0.67753843	-80.02018648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271596-15	NCGC00271596-15	384568705		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	107868-30-4				-1.6340605562	4	4		0	2.57137364				CYP19A1	C[C@]12CC[C@H]3[C@@H](CC(=C)\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CCC2=O	MedChem Express	HY-13632	-1.40521432	-0.64988558	0.69622915	2.57137364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522052-01	NCGC00522052-01	384569512		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1202402-40-1				-19.6653245205	4	4		0	-1.47619513				ADORA2A	CC1=CC=C(O1)C2=NC(=NC3=C2N=N[N]3CC4=NC(=CC=C4)CO[C@H]5CCOC5)N	ChemGood	C-1392	-5.90149119	-1.8914138	-3.10436859	-1.47619513												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024994-12	NCGC00024994-12	384568038		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	14611-52-0		1.77827941	-5.75	8.4626226936	4	4		19.1788502439	-3.27185629	1	0.9996315103		MAOB	C[C@H](CC1=CC=CC=C1)N(C)CC#C	MedChem Express	HY-14199	-3.89904187	-3.83004189	14.58544839	-3.27185629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507885-01	NCGC00507885-01	384569350		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1872382-47-2				-13.6515140359	4	4		0	-1.61437126					CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)C(C)(C)C)C(=O)N[C@@H](CO)C(=O)OC	Selleck	S8359	-2.7102555	-4.64944989	-3.25356539	-1.61437126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015205-10	NCGC00015205-10	384567822		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[85532-75-8]				-13.1783811367	4	4		0	-1.34610778				NR1I3	CCC(C)N(C)C(=O)C1=NC(=C2C=CC=CC2=C1)C3=C(Cl)C=CC=C3	Tocris	0670_cm1	-3.81032647	-2.14519173	-1.34880348	-1.34610778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159519-01	NCGC00159519-01			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-20.1483449161	4	4		0	-5.33048049					[H][C@@](CCN(C(C)C)C(C)C)(C1=CC=CC=C1)C2=CC(C)=CC=C2O	Microsource	MS-1504402	-2.66643122	-8.2679622	-5.11630088	-5.33048049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159453-14	NCGC00159453-14	384568177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	111406-87-2				-16.3475110471	4	4		0	0.30699102				ALOX5	CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1	MedChem Express	HY-14164	-4.79427865	-4.47049385	-1.73044457	0.30699102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346695-02	NCGC00346695-02	363677522		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	917879-39-1		10	-5	-41.617437744	-2.2	4		-54.6731575157	-43.23922043	0.0287254897	0.9994910817			CN(C[C@@H]1COCCO1)[S+]([O-])(=O)NC2=CC3=C(C=C2)\C=C/C4=C(C=C(C=N4)C5=C[N](C)N=C5)C3=O	Selleck	S2774	-0.33551121	-2.01016224	-10.06846745	-43.23922043												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164594-08	NCGC00164594-08	384568262		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	82034-46-6				1.613635434	4	4		0	0.85071614					CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl	MedChem Express	HY-17358	0.28281043	0.16475973	0.20092519	0.85071614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263575-10	NCGC00263575-10	384568690		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	163222-33-1				-9.4067132014	4	4		0	-3.849851					O[C@@H](CC[C@@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4	DC Chemicals	DCAPI1084	-1.85594344	0.22883295	-2.78958927	-3.849851												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178802-11	NCGC00178802-11	384568364		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	138-14-7		8.9125093813	-5.05	-16.8294484973	4	4		-20.223300976	-16.01941748	0.0856388966	0.9954776048			CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN	MedChem Express	HY-B0988	0.04418913	-1.69336384	-5.41563478	-16.01941748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015887-06	NCGC00015887-06	384567901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	23239-51-2				-11.9157342432	4	4		0	-1.71082217				ADRB2	CC(NCCC1=CC=C(O)C=C1)C(O)C2=CC=C(O)C=C2	APExBIO	B1347	-3.30772707	-0.68490044	-2.44884581	-1.71082217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090774-12	NCGC00090774-12	384568086		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	55981-09-4		12.5892541179	-4.9	-44.7991374001	-3	4		-60.9148661925	-55.50884739	0.0216201746	0.999711681			CC(=O)OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O	Enzo	AC3203	-1.10257569	-0.40368304	-0.30434986	-55.50884739												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017323-11	NCGC00017323-11	384567983		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	64-75-5				-15.3691642902	4	4		0	-2.39515104					CN(C)[C@H]\1[C@@H]2C[C@H]3C(=C(O)\[C@]2(O)C(=O)\C(=C1O)C(N)=O)/C(=O)C4=C(O)C=CC=C4[C@@]3(C)O	Selleck	S2574	-3.72345233	-2.9255681	-2.89834715	-2.39515104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387273-01	NCGC00387273-01	363680607		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			0.5623413252	-6.25	-5.118769301	4	4		12.1586231399	-4.36407186	1	0.9998295045		MAPK14	[F]C1=CC=C(C=C1)C2=C([NH]C(=N2)C3=C([F])C=CC=C3)C4=CC=NC=C4	Tocris	5384	-5.13218595	1.13244027	4.97461929	-4.36407186												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181306-04	Docetaxel	170464919	Tubulin depolymerization Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	114977-28-5	 Docetaxolum; Docetaxel Hydrate; ; AE-docetaxel;DOCETAXEL; 5   Docetaxel; Docetaxel hydrate; Docetaxel Anhydrous; Docetaxel Trihydrate; Docetaxel;Docetaxel; Taxoltere metro	0.2511886432	-6.6	-125.342047484	4	4		-27.918862908	-37.62874251	0.2237716277	0.9679868048	203068	TUBB	CC(C)(C)OC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]5C[C@@]6(O)[C@@H](OC(=O)c2ccccc2)[C@H]4[C@@](C)([C@@H](O)C[C@H]3OC[C@]34OC(C)=O)C(=O)[C@H](O)C(=C5C)C6(C)C	Alfa Aesar	J60174	-20.61302342	-30.65874879	-33.12061881	-37.62874251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263135-02	NCGC00263135-02	384568613		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	206884-98-2				-15.8027128101	4	4		0	-2.35209581				XDH	CC(C)(C)COC1=C(C=C(C=C1)[N]2C=C(C=N2)C(O)=O)C#N	Axon Medchem	1174	-4.24503194	-2.37536252	-2.20933043	-2.35209581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346836-09	NCGC00346836-09	384568948		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1227911-45-6		11.220184543	-4.95	-80.7872382885	-2.3	4		-96.5322720501	-80.24127655	0.1007429842	0.9936883559		PDPK1	CNC1=NC(=CC(=N1)C2=CC3=C(C=C2)C(=N[NH]3)N)N4C[C@H](CC[C@H]4C)C(=O)NC5CCCCC5	MedChem Express	HY-14981	-1.98851083	-9.18993135	-13.32180739	-80.24127655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387875-03	NCGC00387875-03	363680715		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	934493-76-2		3.5481338923	-5.45	-101.155045475	-2.1	4		-86.6699540405	-80.59694319	0.0109368987	0.9999262257		MTOR	CCN1C(=O)\C(=C/C2=C(C)N=C(N)N=C12)C3=CC=N[NH]3	MedChem Express	HY-15900	-0.59213433	-9.0617849	-47.31087332	-80.59694319												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165952-05	NCGC00165952-05	384568300		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	725247-18-7		3.1622776602	-5.5	-36.0505233113	4	4		-23.069878652	-5.40204608	1	0.9905097228		ESR1	COC1=C(OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F)C=CC(=C1)\C=C(C#N)\C(=O)NC3=NN=C(S3)C(F)(F)F	MedChem Express	HY-10426	-2.77375566	-0.82191781	-19.63015002	-5.40204608												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511388-01	NCGC00511388-01	384569502		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1334298-90-6				-8.16917301	4	4		0	-2.36186659				JAK1	FC1=C(C=CN=C1C(F)(F)F)C(=O)N2CCC(CC2)N3CC(CC#N)(C3)[N]4C=C(C=N4)C5=C6C=C[NH]C6=NC=N5	Glixx	GLXC-10668	-2.5670532	-2.10246811	2.31905108	-2.36186659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390775-03	NCGC00390775-03	384569213		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	73069-13-3				-13.6585823346	4	4		0	-0.75866018				TNF	CC/1=C/2C[C@H]3C(=C)CCC[C@]3(C)/C=C2OC1=O	MedChem Express	HY-N0201	-4.9039568	1.81517434	-2.62890341	-0.75866018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016407-16	NCGC00016407-16	384567937		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	144-82-1				-19.8595858309	4	4		0	-4.93892216					CC1=NN=C(N[S+]([O-])(=O)C2=CC=C(N)C=C2)S1	Microsource	01500549	-4.49343506	-4.81517286	-1.89992748	-4.93892216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346544-09	NCGC00346544-09	384568830		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1265916-41-3		11.220184543	-4.95	-51.8911796394	-3	4		-55.3988282119	-51.19520958	0.0064600653	0.9999742716		MAP2K5	CN(C)CC1=CC=CC(=C1)N/C(C2=CC=CC=C2)=C/3C(=O)NC4=CC(=CC=C34)C(=O)N(C)C	MedChem Express	HY-12056	-3.18931867	-2.94618607	-4.89726855	-51.19520958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346555-08	Apixaban	363677453	Coagulation Factor Xa Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	503612-47-3		0.1995262315	-6.7	-22.8743166775	4	4		10.9488999319	-1.24071856	0.3532944657	0.9155706553		F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	Glixx	GLXC-90058	-8.70741661	1.50992036	-1.09741358	-1.24071856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017236-16	Baicalein	384567977	Cyp2C9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	491-67-8		12.5892541179	-4.9	-39.9809941314	4	4		-31.436076892	-27.56886228	0.1809642384	0.9792974692		CYP2C9	OC1=CC2=C(C(=O)\C=C(/O2)C3=CC=CC=C3)C(=C1O)O	APExBIO	N1858	-3.45546487	-7.36546518	-7.7302393	-27.56886228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025230-21	NCGC00025230-21	377020509		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	301836-41-9				-0.726850793	4	4		0	-0.6697986				TGBR1	NC(=O)C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=NC=CC=C3)C4=CC5=C(OCO5)C=C4	MedChem Express	HY-10431	2.03955501	-4.86272063	-2.91221159	-0.6697986												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263098-05	NCGC00263098-05	384568589		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	117048-59-6		0.8912509381	-6.05	-163.4671837626	-1.2	4		-55.8222171359	-64.49602307	0.0142466877	0.9998748794		TUBB	COC1=CC=C(\C=C/C2=CC(=C(OC)C(=C2)OC)OC)C=C1O	Axon Medchem	1233	-19.33604097	-37.41754323	-56.8420559	-64.49602307												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510526-01	NCGC00510526-01	384569473		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1895895-38-1		14.1253754462	-4.85	-21.7101894603	4	4		-24.8784379601	-21.85427281	0.8491615591	0.9983545782		JAK2	C[N]1C(=NC2=C(C)C(=CC=C12)OC3=CC=NC(=C3)NC(C)=O)NC4=CC=C(F)C=C4F	MedChem Express	HY-18960	-26.98188246	-1.50114416	-0.70557451	-21.85427281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378614-02	NCGC00378614-02	384569056		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	895519-91-2				-5.7954771714	4	4		0	-4.64769778				ABL1	CN1CCN(CC1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC(=C(C)N=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	MedChem Express	HY-13905	-0.68051259	2.1784897	-3.01387786	-4.64769778												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263099-07	NCGC00263099-07	384568590		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1080622-86-1		3.5481338923	-5.45	-51.3987049549	-2.4	4		-30.9819680416	-33.83158704	0.0612583032	0.997681675		ATM	COC1=C(OC)C=C2C(=C1)N=CN=C2[N]3N=C(N=C3N)C4=NC=CC=C4	SIGMA	SML1115	-3.80026513	-3.40503432	-20.06915565	-33.83158704												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346894-04	NCGC00346894-04	384568965		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	121584-18-7		6.3095734448	-5.2	-47.7463312906	4	4		-28.282721032	-30.08891863	0.0516677772	0.9983529422		ABCBA	C/C=C/C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C	MedChem Express	HY-17384	-4.69230769	-4.45093196	-3.60331777	-30.08891863												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510464-01	NCGC00510464-01	384569438		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			14.1253754462	-4.85	-14.8136094793	4	4		-15.7281766879	-13.94014724	0.270855481	0.9521753025		PTK6	FC1=C(NC2=NC(=C[N]3C(=CN=C23)C4=C[NH]N=C4)C5CC5)C=CC(=C1)C(=O)N6CCOCC6	Tocris	6073	-1.52488688	-1.99865259	1.28269048	-13.94014724												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242487-08	NCGC00242487-08	384568495		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	896720-20-0		11.220184543	-4.95	-113.7301501944	-2.1	4		-124.3298173557	-99.65579883	0.017120892	0.9998191732		MAPK7	CC1=CN=C(NC2=CC=C(F)C=C2Cl)N=C1C3=C[NH]C(=C3)C(=O)N[C@H](CO)C4=CC=CC(=C4)Cl	MedChem Express	HY-14178	-6.42986425	-8.46620256	-24.18982006	-99.65579883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263521-07	NCGC00263521-07	384568684		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	14484-47-0				-8.3322510949	4	4		0	0.40156803					CC(=O)OCC(=O)[C@@]12\N=C(C)/O[C@@H]1C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]23C	MedChem Express	HY-13609	-2.71040724	-0.93869302	-1.50931424	0.40156803												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486932-01	NCGC00486932-01	384569281		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1103926-82-4]				-24.4703531457	4	4		0	-0.41112917			5054	SERPINE1	OC(=O)C1=C(NC(=O)COCC(=O)N2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C=CC(=C1)Cl	Tocris	5769	-7.18099548	-4.52279362	-3.81181163	-0.41112917												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346469-03	NCGC00346469-03	384568788		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	847499-27-8		0.2818382931	-6.55	-241.6535590036	-1.1	4		-92.2205810785	-98.79282374	0.0190216578	0.9997767816		PSMD1	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)[C@@H](C)O)B(O)O	Glixx	GLXC-90266	-6.32026202	-79.87202368	-97.29847495	-98.79282374												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00025092-02	NCGC00025092-02	174007484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	158848-32-9	GR-159897; GR-159897			-7.0703926333	4	4		0	-6.18443114			6865	TACR2	COC1(CCN(CCC2=C[NH]C3=CC=C(F)C=C23)CC1)C[S+]([O-])C4=CC=CC=C4	Axon Medchem	1119	1.21983676	-4.11545367	-3.84336476	-6.18443114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347063-02	NCGC00347063-02	384568980		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			14.1253754462	-4.85	-33.5138418309	4	4		-16.574283284	-18.98443114	0.271160933	0.9520191297			OC1=C(O)C=C(C=C1)C2CCN(CC2)C3=CC=NC4=CC=CC=C34	Evotec	MLS004820019	-4.83942512	-6.87750311	-3.08919507	-18.98443114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095124-31	NCGC00095124-31	384568147		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	122320-73-4				9.1328134831	4	4		0	5.82035928				PPARG	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=CC=CC=N3	Selleck	S2556	-0.55447126	5.2663076	3.6016437	5.82035928												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262995-02	NCGC00262995-02	384568579		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			3.1622776602	-5.5	-140.4524366817	-1.3	4		-87.0611199861	-93.96716126	0.0667934306	0.9972383313		USP2	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=CC=C2C(=O)NC3=NC(=CS3)C4=CC=CC=C4)C(F)(F)F	NCGCChem	RAP14-094	-4.71481547	-10.50543769	-72.73025699	-93.96716126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386361-02	NCGC00386361-02	384569128		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1034616-18-6		0.7079457844	-6.15	-95.2658060273	-1.4	4		-44.8597250521	-45.70445137	0.0741645142	0.9965943448		PLK1	CN1CCN(CC1)C2=CC=C(OC(F)(F)F)C(=C2)NC3=NC4=C(CCC5=C4[N](CCO)N=C5C(N)=O)C=N3	ChemieTek	CT-NMS128	-3.36394137	-27.41576038	-47.71618833	-45.70445137												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164578-06	NCGC00164578-06	384568258		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	202409-33-4				-14.2193921199	4	4		0	-2.40011163			5743	PTGS2	CC1=CC=C(C=N1)C2=NC=C(Cl)C=C2C3=CC=C(C=C3)[S+](C)([O-])=O	MedChem Express	HY-15321	-3.76125728	-1.92993403	-2.1056087	-2.40011163												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510491-01	NCGC00510491-01	384569453		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	923978-27-2		31.6227766017	-4.5	-14.2449860094	4	4		-20.1362621479	-16.36355179	0.2766247994	0.9498881241		PPARA	CSC1=CC=C(C=C1)C(=O)/C=C/C2=CC(=C(OC(C)(C)C(O)=O)C(=C2)C)C	MedChem Express	HY-16737	-2.03072576	-2.80353004	1.16769837	-16.36355179												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00508859-01	NCGC00508859-01	384569364		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1698878-14-6		1.4125375446	-5.85	-132.0653748249	-1.1	4		-101.0820038147	-96.88822736	0.0043095012	0.999988545		NAMPT	CC(C)(O)C[S+]([O-])(=O)NC1=CC2=C(CN(CC2)C(=O)COC3=CN=CC=C3)C=C1	Bio Vision	B1171	4.10559774	-4.86272063	-95.47458263	-96.88822736												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499351-01	NCGC00499351-01	384569305		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	501010-06-6				-23.9576216222	4	4		0	-6.06176499				GGTI	CC(C)C[C@H](NC(=O)N1CCN(CC2=C(C)N=C[NH]2)C(=O)[C@@H]1CC3=CC=CC=C3)C(O)=O	WuXi	GGTI-2418	-4.64705882	-6.75050528	-4.06563024	-6.06176499												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168459-04	NCGC00168459-04	174006302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1172617-47-8	 NCGC00168459-01;NCGC00168459-01	3.9810717055	-5.4	-91.6334337394	-2.2	4		-73.389076424	-73.9172005	0.0381080634	0.9991033785	5141	PDE4A	COC1=CC(=C(OC)C=C1)C2=NN=C3C=CC(=N[N]23)C4=CC(=C(OC)C=C4)O[C@@H]5CCOC5	NCGCChem	DYD09-025	-3.0361991	-2.03458343	-38.92942936	-73.9172005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346717-12	NCGC00346717-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1217486-61-7		11.220184543	-4.95	-54.3584397193	4	4		-21.245111724	-23.61602448	0.0847244994	0.995576386			CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C3=CC(=NC=C3)C(C)(C)C(F)(F)F	APExBIO	A8346	-8.41176471	-9.71479901	-12.06998142	-23.61602448												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346471-03	NCGC00346471-03	384568789		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	93908-02-2		3.1622776602	-5.5	-147.5669081218	-2.1	4		-95.0042234269	-94.58839277	0.0140453296	0.9998783191		TOP1	CO[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1CO)[N]2C3=C(C=CC=C3Cl)C4=C2C5=C(C6=C([NH]5)C(=CC=C6)Cl)C7=C4C(=O)NC7=O	Cayman	17914	-7.98642534	-19.63170896	-61.16575262	-94.58839277												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249392-05	NCGC00249392-05	377020517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	332012-40-5				1.4948492981	4	4		0	-5.77822311				KDR	CNC(=O)C1=NC=CC(=C1)COC2=NN=C(NC3=CC=C(Cl)C=C3)C4=C2OC=C4	MedChem Express	HY-10527	0.42489156	2.70317329	4.06197047	-5.77822311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346483-02	NCGC00346483-02	384568793		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	5022		12.5892541179	-4.9	-68.965127142	-3	4		-54.107991844	-53.74081496	0.0214328797	0.9997167084		EGFR	CC1=C2[N](C=C1NC(=O)OC[C@@H]3COCCN3)N=CN=C2NC4=CC5=C(C=C4)[N](CC6=CC(=CC=C6)F)N=C5	Tocris	5022	-6.98415509	-7.86575545	-7.81893004	-53.74081496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346711-02	NCGC00346711-02	363677531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	851983-85-2		12.5892541179	-4.9	-74.6151106486	-3	4		-109.4820923597	-99.71046663	0.0846137464	0.9955580947		AR	C[C@]\12CC[C@H](O)CC1=C/CC3C2CC[C@@]\4(C)C3C\C=C4[N]5C=NC6=C5C=CC=C6	Selleck	S2803	0.27970766	-4.42711834	3.27788888	-99.71046663												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161327-11	NCGC00161327-11	384568204		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	32222-06-3				28.0593864542	4	4		0	13.86382281			7421	VDR	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	Glixx	GLXC-06432	3.87981593	4.36438589	6.78015707	13.86382281												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378991-02	NCGC00378991-02	384569084		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	223132-38-5				-6.5501311312	4	4		0	-2.2060944				PPARG	C[N]1C(=NC2=CC=C(OC3=CC(=C(N)C(=C3)C)C)C=C12)COC4=CC=C(CC5SC(=O)NC5=O)C=C4	MedChem Express	HY-14792B	-0.22978347	-4.00915332	-2.16345031	-2.2060944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263617-13	M-344	384568694	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	251456-60-7		2.8183829313	-5.55	-174.3109950879	-1.3	4		-82.1351836821	-99.24497839	0.1381264518	0.9880454548		HDAC1	CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-13506	-10.93112077	-22.59525225	-80.72685185	-99.24497839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346932-04	SB-3CT	384568968	MMP2/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	292605-14-2				-13.8034934239	4	4		0	2.12141949				MMP2	[O-][S+](=O)(CC1CS1)C2=CC=C(OC3=CC=CC=C3)C=C2	MedChem Express	HY-12354	-4.87121554	-5.31138023	1.0909772	2.12141949												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263150-04	NCGC00263150-04	363677230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	401900-40-1				-20.0054366478	4	4		0	-2.56134519				AR	CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C=C1	MedChem Express	HY-12023	-6.31721645	-3.95972241	1.15652948	-2.56134519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095158-04	NCGC00095158-04	170466630		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	3366-95-8	Secnidazole;SECNIDAZOLE			-11.3357225326	4	4		0	-0.63103547					Cc1ncc([N+]([O-])=O)n1CC(O)C	Vitas	STK590474	-2.71040724	-3.69638446	-1.94443185	-0.63103547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185756-04	NCGC00185756-04	384568425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	52205-73-9				-8.7215915598	4	4		0	-9.30299264					C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)N(CCCl)CCCl)[C@@H]1CC[C@@H]2O[P]([O-])([O-])=O	MedChem Express	HY-13627	-0.13122172	-0.79496968	-1.25549563	-9.30299264												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346582-03	NCGC00346582-03	384568851		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	366017-09-6		0.6309573445	-6.2	-42.643272012	4	4		-23.223587004	-20.81460943	0.1724357514	0.9812506081		ERBB2	FC(F)(F)C1=CC=C(\C=C\C2=NC(=CO2)COC3=CC=C(CCCC[N]4C=CN=N4)C=C3)C=C1	Selleck	S2216	0.29411765	-15.47271502	-24.35298917	-20.81460943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024667-19	NCGC00024667-19	384568031		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	555-30-6		15.8489319246	-4.8	-28.3890615471	4	4		-11.9369491121	-13.56522569	0.3821166977	0.8988756837		DDC	C[C@](N)(CC1=CC(=C(O)C=C1)O)C(O)=O	Enzo	DL443	-5.1341064	-5.40199364	-1.95110143	-13.56522569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263281-01	NCGC00263281-01	137276089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1309805-49-9	GSK-1995010	14.1253754462	-4.85	-28.9158580329	4	4		-17.9999878401	-18.95696154	0.3143087275	0.9340014118	2194	FAS	O=C(C1CC1)N2CC[C@H](C2)C[N]3C4=CC=NC=C4N=C3C5=CC=C(C=C5)C6=CC=C7OC=CC7=C6	NCGCChem	JKJ21-051	-3.45224396	-6.61210987	-1.87363834	-18.95696154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378765-02	NCGC00378765-02	363678186		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	624733-88-6				-16.5842179831	4	4		0	-2.5527192				CCR2	CO[C@@H]1COCC[C@@H]1N[C@@H]2CC[C@](C2)(C(C)C)C(=O)N3CCC4=C(C3)C=C(C=N4)C(F)(F)F	Adooq	A11127	-4.38509429	-6.88264552	0.64387103	-2.5527192												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00346580-02	NCGC00346580-02	363677462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1201898-17-0		1.4125375446	-5.85	-122.5705606133	-2.2	4		-72.8401999119	-64.08247621	0.025655099	0.9995939671		TUBB	CC[C@]12\C=C/CN3CC[C@]4([C@@H](N(C)C5=CC(=C(C=C45)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6[NH]C9=C8C=CC=C9)C(C)(F)F)C(=O)OC)OC)[C@](O)([C@@H]1OC(C)=O)C(=O)OC)[C@H]23	Selleck	S2209	-4.21564295	-13.17162471	-37.0216345	-64.08247621												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00386301-06	NCGC00386301-06	363680195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1059734-66-5		12.5892541179	-4.9	-73.0292866404	-3	4		-108.5453426894	-99.31269826	0.0371912744	0.9991459229		SMO	CNCC1=CC(=C(C)C=C1)NC(=O)C2=CC=C(NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5)C=C2	Glixx	GLXC-90164	1.16659302	-2.26086957	-0.28503341	-99.31269826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344626-12	NCGC00344626-12	384568727		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1373423-53-0		5.6234132519	-5.25	-32.0706561086	4	4		-25.349875236	-22.344516	0.2361206609	0.9640995912		KDM6A	CCOC(=O)CCNC1=NC(=NC(=C1)N2CCC3=C(CC2)C=CC=C3)C4=CC=CC=N4	Bio Vision	2762	-1.21961997	-6.82837529	-10.70510724	-22.344516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371151-06	NCGC00371151-06	363678065		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	354813-19-7				-40.3936458461	4	4		0	-8.29993157					CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N	Glixx	GLXC-06343	-7.98011749	-8.94906336	-10.81144355	-8.29993157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163650-04	NCGC00163650-04	384568247		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	35825-57-1				-6.9996589894	4	4		0	-5.92433278				STAT3	C[C@H]1COC/2=C1/C(=O)C(=O)C3=C4CCCC(C)(C)C4=CC=C23	Selleck	S2285	-0.57840036	0.3583254	-1.92442759	-5.92433278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015840-09	NCGC00015840-09	174006856		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	60-82-2	Phloretin;PHLORETIN	1.2589254118	-5.9	16.4912244055	4	4		11.9098651479	1.43233533	1	0.9998312758	3383	ICAM1	OC1=CC=C(CCC(=O)C2=C(O)C=C(O)C=C2O)C=C1	Microsource	MS-00300554	-0.34155429	1.02195829	11.51075659	1.43233533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167328-03	Aloxistatin	363676654	Calpain Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	88321-09-9				-4.4481473151	4	4		0	1.12435458				CAPN1	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	Selleck	S7393	-1.68726879	-2.45552718	1.05360714	1.12435458												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163451-04	NCGC00163451-04	363676620		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	136194-77-9		5.6234132519	-5.25	-85.6791923627	-2.2	4		-47.976687744	-52.1787386	0.041284905	0.9989479743		PRKCA	C[N]1C2=C(C=CC=C2)C3=C4C(=O)NCC4=C5C6=C(C=CC=C6)[N](CCC#N)C5=C13	Selleck	S7119	-8.95966796	-8.66603934	-25.3841276	-52.1787386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346659-04	NCGC00346659-04	384568890		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1013101-36-4 		0.4466835922	-6.35	-231.8430120135	-1.3	4		-97.267931473	-96.23606621	0.07175809	0.9968111638		PIK3CA	COC1=CC=C(C=N1)C2=CC3=C(C)N=C(N)N=C3N([C@H]4CC[C@@H](CC4)OCCO)C2=O	Adooq	A11024	-21.73599206	-63.69135637	-85.68362519	-96.23606621												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015989-22	Thalidomide	384567913	TNF-alpha Production Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	50-35-1				-23.839987428	4	4		0	-3.77841046				TNF	O=C1CCC(N2C(=O)C3=C(C=CC=C3)C2=O)C(=O)N1	Microsource	01503607	-5.26933141	-6.64067751	-4.17540608	-3.77841046												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387310-02	NCGC00387310-02	384569158		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[1982372-88-2]				-13.1556936803	4	4		0	0.87342566					ClC1=C(Cl)C=C2C(=C1)C(=NN=C2C3=CC=NC=C3)NC4CCCC4	Tocris	6167	-4.46629974	-5.12613703	1.68772255	0.87342566												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346806-06	NCGC00346806-06	384568940		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	112093-28-4		12.5892541179	-4.9	-63.9093863785	-3	4		-115.2237948128	-99.93244221	0.0153279618	0.9998550637		PRKCA	CC\C(C1=CC=CC=C1)=C(\C2=CC=C(O)C=C2)C3=CC=C(OCCNC)C=C3	Axon Medchem	2221	3.27528647	1.7923556	1.66821131	-99.93244221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346877-07	Batimastat	384568955	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	130370-60-4				-19.1389821368	4	4		0	-8.59848121				MMP1	CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)[C@H](CSC2=CC=CS2)C(=O)NO	MedChem Express	HY-13564	-1.57313301	-6.84668192	-5.59319658	-8.59848121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507869-01	LY-3314814	384569343	beta-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1383982-64-6				-12.70205375	4	4		0	-3.29231952				BACE1	CO[C@H]1CC[C@]2(CC1)CC3=C(C=C(C=C3)C4=CN=CC(=C4)C#CC)[C@@]2/5\N=C(C)/C(=N5)N	Selleck	S8193	-1.07821476	-5.86727689	-4.84556796	-3.29231952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346805-02	NCGC00346805-02	363677543		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[729605-21-4]		0.316227766	-6.5	-108.0898312575	-1.4	4		-45.5276483016	-51.43220256	0.4667682198	0.8358936666		TUBB	CC1=N[N](C2=CC=CC=C2)C(=C1)C(=O)N3CCN(CC3)C4=CC(=CC=C4)Cl	Tocris	3101	-8.20605513	-36.49929696	-33.16477033	-51.43220256												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015251-13	Clotrimazole	170464807	Lanosterol 14alpha-demethylase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	23593-75-1	 ; Bay b 5097; Clotrimazole;Clotrimazole; b 5097, F; Clotrimazol; Kanesten; Baycuten; Canesten; Canesten HC; FB b 5097; b 5097, Ba; Baycuten SD; Lotrimin; Mycelex; Klotrimazole;CLOTRIMAZOLE; 5097, Bay	10	-5	-82.5606218873	-2.4	4		-88.4649753076	-78.15035683	0.0560573185	0.9980570716	1595	CYP51A1	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4	Vitas	STK700023	-5.32309083	-1.82791309	-13.27433628	-78.15035683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507855-03	NCGC00507855-03	384569333		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1239875-86-5		1.1220184543	-5.95	-169.48127773	-1.1	4		-93.9006444788	-99.74582071	0.033198095	0.9993196378		AXL	CN1CCN(CC1)C2=CC=C(NC3=NC4=C(C(=C[NH]4)C)C(=N3)C5=CC(=CC=C5)CC#N)C=C2F	Glixx	GLXC-09295	-4.03976502	-24.43416338	-96.61937538	-99.74582071												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162142-06	NCGC00162142-06	384568219		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1670-87-7				-2.0969102405	4	4		0	-1.16335908				MAPK14	NC(=O)C1=CC=C2[NH]C=CC2=C1	Cayman	14156	0.27112517	-1.94584297	-0.80067425	-1.16335908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263544-04	NCGC00263544-04	384568686		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	149003-01-0				-17.408894222	4	4		0	-6.46201975				TOP2A	C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2	Selleck	S1222	-2.71125169	-4.0504377	-4.0408297	-6.46201975												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346876-03	NCGC00346876-03	384568954		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	141400-58-0		11.220184543	-4.95	-27.913731281	4	4		-19.7993380959	-19.64023854	0.145719859	0.9867308384		TXNRD1	CCC(C)SSC1=NC=C[NH]1	Cayman	14192	-3.83190239	-1.47412346	-3.46022381	-19.64023854												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390592-01	NCGC00390592-01	363680919		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1584713-87-0				-15.2070696649	4	4		0	-0.05865676					NC(=O)[C@@H](CC1CC1)[C@@H](CCC(F)(F)F)C(=O)N[C@H]2\N=C(C3=CC=CC=C3)/C4=CC=CC(=C4NC2=O)F	MedChem Express	HY-12419	-3.66018979	-3.58778972	-4.73381093	-0.05865676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384181-09	NCGC00384181-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			1.2589254118	-5.9	-131.7117649625	-1.2	4		-77.6415433679	-74.0095546	0.0118756617	0.9999130244			C\C(=N/NC(=O)C1=CC=CC(=C1)[S+]([O-])(=O)N2CCOCC2)C3=CC(Cl)=CC=C3O	Bio Vision	9446-5	-5.657313	-27.54850562	-61.07994732	-74.0095546												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018100-16	Fasudil hydrochloride	384567990	ROCK Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	105628-07-7				-9.2529147079	4	4		0	-0.70652696				ROCK1	[O-][S+](=O)(N1CCCNCC1)C2=C3C=CN=CC3=CC=C2	MedChem Express	HY-10341	-2.02386213	-3.12128146	-1.96719779	-0.70652696												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522303-02	NCGC00522303-02	384569515		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	834153-87-6				-7.8799857702	4	4		0	-3.19619341				GNRHR	COC1=C(F)C(=CC=C1)C/2=C(C)/N(CC3=C(F)C=CC=C3C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C4=CC=CC=C4)C2=O	MedChem Express	HY-14789	-0.48608042	-5.29977117	-0.78033737	-3.19619341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183039-03	NCGC00183039-03	384568414		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1400-61-9		14.1253754462	-4.85	1.1646563491	4	4		15.9162803759	11.06657542	0.1574721376	0.9844991865			C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H]1C)O2)C(O)=O	Prestwick	Prestw-517	-1.26525079	-2.28148954	-3.26356698	11.06657542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250391-05	NCGC00250391-05	384568544		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	252017-04-2				-21.8341913259	4	4		0	-9.58060416				PDK2	CN(C)C(=O)C1=CC=C(C=C1)[S+]([O-])(=O)C2=CC=C(NC(=O)[C@@](C)(O)C(F)(F)F)C(=C2)Cl	Glixx	GLXC-05955	-4.32896521	-1.48319499	-3.69433909	-9.58060416												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179578-11	NCGC00179578-11	384568377		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	83919-23-7				-17.5828156525	4	4		0	-7.49828918					C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)CCl	MedChem Express	HY-13693	-2.83777677	-2.9255681	-3.84417287	-7.49828918												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	15.8489319246	-4.8	-16.629425282	4	4		-23.452194736	-17.46016228	0.3327924892	0.9250618757	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-2.75643922	1.58298181	3.3665777	-17.46016228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347905-02	NCGC00347905-02	363677717		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[607378-18-7]				-1.7035702916	4	4		0	0.30305993				P2RX7	OCCNCCNC1=NC2=CC=CC(=C2C=C1)NC(=O)CC34CC5CC(CC(C5)C3)C4	Tocris	3323	0.18075011	-1.33805053	-2.08362598	0.30305993												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016622-11	Hycanthone			SARS-CoV-2_CPE_SRI		3105-97-3		0.0625931278	-7.2034733462	-322.2046361446	-2.1	10		-126.4594817768	-99.70510754	0.0001243201	0.9713606368			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355	-0.95938348	-6.03939763	-8.72095309	-3.83753391	-8.08398537	-4.22286006	-15.28722526	-24.03963355	-40.42779067	-99.70510754						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00244248-01	NCGC00244248-01			SARS-CoV-2_CPE_SRI				0.0788000792	-7.1034733462	-14.9354552348	4	10		-9.228404036	-6.02367003	0.3598971638	0.4227975837			CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009	0.60551252	0.61337632	0.18086738	-0.33814336	6.03153383	0.37746235	-3.69598553	2.43777769	2.43777769	-6.02367003						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00242482-11	NCGC00242482-11	377020426		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1146618-41-8		12.5892541179	-4.9	-96.0444737842	-3	4		-98.358281784	-92.76710545	0.1864516943	0.9779266822		AURKA	ClC1=CC=CC(=C1)NC(=O)NC2=NC=C(CCNC3=NC=NC4=C3SC=C4)S2	MedChem Express	HY-12003	-10.37435988	-5.58477447	5.27574564	-92.76710545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346724-02	NCGC00346724-02	363677537		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	845272-21-1		10	-5	-47.4529596142	-2.4	4		-35.901036444	-30.98766612	0.1885499458	0.9774612895		EGFR	C[C@@H]\1COC(=N1)\NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(OCC5=NC=CS5)C=C4)Cl	Selleck	S2755	-3.57013575	-8.87042443	-12.8405022	-30.98766612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182047-14	NCGC00182047-14			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	75607-67-9				-26.2133788888	4	4		0	-2.93527106					Nc1nc(F)nc2n(cnc12)[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O	Bio Vision	1763	-6.42081448	-4.81024029	-6.09617912	-2.93527106												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480775-01	NCGC00480775-01	384569243		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	857679-55-1 				-18.1763832074	4	4		0	-5.10565064				CCR2	OC1(CCC(CC1)N[C@H]2CCN(C2)C(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)C4=NC=C(C=C4)C5=NC=CC=N5	Adooq	A11136	-3.54298643	-2.46575342	-5.13529438	-5.10565064												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351549-05	NCGC00351549-05	384569011		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1394854-52-4				-17.7054128657	4	4		0	-1.87398413				KDM6B	OC(=O)CCNC1=CC(=NC(=N1)C2=CC=CN=C2)N3CCC4=C(CC3)C=CC=C4	MedChem Express	HY-15648A	-4.4841629	-4.87311925	-2.07134116	-1.87398413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163470-28	FK-506	384568242	mTOR Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	104987-11-3				-6.0236188367	4	4		0	3.83401855				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Bio Vision	1563	-2.0678733	-3.4179205	-1.74500295	3.83401855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262009-03	NCGC00262009-03	377020269		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	119139-23-0		11.220184543	-4.95	-52.6281866324	-2.4	4		-31.0451999561	-29.35871743	0.0295771049	0.999461561		CDK4	O=C\1NC(=O)\C(=C1C2=C[NH]C3=C2C=CC=C3)C4=C[NH]C5=C4C=CC=C5	Cayman	13299	-7.0018589	-6.8210508	-11.49842653	-29.35871743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346697-02	NCGC00346697-02	384568917		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	666260-75-9				-15.8663779166	4	4		0	-2.89626873				CNR2	FC(F)(F)C1=NC(=NC=C1C(=O)NCC2CCOCC2)NC3=CC=C(Cl)C=C3Cl	Selleck	S2778	-2.8060547	-3.12976102	-6.22125393	-2.89626873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016360-07	Monobenzone	384567934	topical medical depigmentation treatment	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	103-16-2				-11.5680207253	4	4		0	-5.04342017					OC1=CC=C(OCC2=CC=CC=C2)C=C1	Selleck	S1652	-2.14216164	-2.41587951	-0.91503268	-5.04342017												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015917-09	NCGC00015917-09	384567906		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[1197334-04-5]				-18.6373891507	4	4		0	-5.4988366				HTR1A	C[N]1C=CC2=CC3=C(CCN3C(=O)NC4=CC=CN=C4)C=C12	Tocris	1661	-3.09056587	-5.51616887	-3.97685185	-5.4988366												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015578-18	NCGC00015578-18	384567866		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	22071-15-4				-5.101384458	4	4		0	-1.84244266					CC(C(O)=O)C1=CC=CC(=C1)C(=O)C2=CC=CC=C2	MedChem Express	HY-B0227	-0.87800167	-2.64373599	0.52314815	-1.84244266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351480-16	NCGC00351480-16	384569008		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1346704-33-3		10	-5	-27.7632035632	-3	4		-38.9828136401	-33.01462855	0.0167900746	0.9998262932		EZH2	CCCC\1=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC(=NC=C4)N5CCN(C)CC5)C(=O)NC(=C1)\C	SIGMA	SML0766	-0.22171946	-0.11228385	-3.49453837	-33.01462855												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024196-12	Megestrol acetate	384568021	Progesterone Receptor Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	595-33-5				-20.4658202403	4	4		0	-3.53564271				PGR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	MedChem Express	HY-13676	-5.02788351	-8.24881382	1.11837328	-3.53564271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016101-17	NCGC00016101-17	384567921		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1218-35-5		12.5892541179	-4.9	-23.8722906798	4	4		-10.8725971641	-12.41053536	0.3934480521	0.8917382624		ADRA2A	CC1=CC(=CC(=C1C\C2=N\CCN2)C)C(C)(C)C	MedChem Express	HY-B0475	-4.98362397	-1.26670439	-1.40885984	-12.41053536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346619-03	NCGC00346619-03	384568861		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1092788-83-4		0.3981071706	-6.4	-238.9402864523	-1.1	4		-91.6628864099	-95.27095498	0.0125114699	0.9999034537		PDGFRA	NC1=NC=NC2=C1C(=N[N]2C3CCCC3)C4=CN=C5[NH]C=CC5=C4	Selleck	S2622	-19.8321754	-74.31106331	-93.2052095	-95.27095498												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346661-05	NCGC00346661-05	384568892		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	71610-00-9		1.77827941	-5.75	-76.5653150971	-2.4	4		-49.1616564901	-44.60261545	0.1133598171	0.9919966877		TUBB	C/C=C(C)/C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]\1C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@H]4[C@@](C)([C@@H](O)C[C@H]5OC[C@@]45OC(C)=O)C(=O)[C@H](OC(C)=O)C(=C1C)/C2(C)C)C6=CC=CC=C6	MedChem Express	HY-77554	-3.09482992	-17.8966707	-32.64231013	-44.60261545												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475735-01	NCGC00475735-01	377020396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1346242-81-6		10	-5	-111.2269081397	-2.1	4		-107.3146337534	-99.25686435	0.0117927769	0.9999142195		FGFR1	COC1=CC(=CC(=C1)N(CCNC(C)C)C2=CC=C3N=CC(=NC3=C2)C4=C[N](C)N=C4)OC	ActiveBioChem	A-1278	-7.88595146	-7.18734597	-16.99429296	-99.25686435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015121-25	NCGC00015121-25	384567812		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	63-92-3				-6.1410730851	4	4		0	-4.87863726				ADORA1	CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2	MedChem Express	HY-B0431A	-0.40602725	-0.57355379	-1.51212136	-4.87863726												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263126-04	NCGC00263126-04	363677214		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	165377-44-6				-6.8037110929	4	4		0	-1.73031304				SIGMAR1	COC1=C(OC)C=C(CCN2CCN(CCCC3=CC=CC=C3)CC2)C=C1	MedChem Express	HY-13510	0.01765848	-4.23872348	-3.70943538	-1.73031304												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179308-13	NCGC00179308-13	384568371		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	80474-14-2				-0.8746862526	4	4		0	-2.26987302					CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF	MedChem Express	HY-B0154	1.43033728	-2.19736138	-1.85237291	-2.26987302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166281-02	NCGC00166281-02	124893255		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox		 Kinidin-duretter; Kinilentin; Quinact; Quinine,; Quinidine gluconate salt; Amidochin;Quinidine sulfate; Quinine sulfate anhydrous; Kinidin Durules; Quinaglute; Coco-quinine; Quinidex; Kinidine Durettes; Chinidin-retard-Isis; Chinidin-Duriles; Chinidin duriles; ; Quinine hydrobromide; Quinine, dihydrochloride; Natisedine; Biquin Durules; Quinine; Quinine sulfate dihydrate; Quinine Sulphate; Quindine			-26.857197038	4	4		0	-7.46081213					COC1=CC=C2N=CC=C([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)C2=C1	SIGMA	145904	-5.0326682	-6.69014085	-5.36953667	-7.46081213												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505020-01	NCGC00505020-01	384569314		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	915303-04-7		14.1253754462	-4.85	-119.4985352755	4	4		-28.9753610246	-42.19573579	0.5466467396	0.7543641676		TOP1	COC1=C(OC)C=C2C(=C1)C(=O)N(CCC[N]3C=CN=C3)\C4=C2\C(=O)C5=CC6=C(OCO6)C=C45	NCI	NSC725776	-25.20742789	-22.39399899	-11.35648148	-42.19573579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263139-03	NCGC00263139-03	384568617		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	136199-02-5				-26.5526105865	4	4		0	-1.14915238				ADORA1	CCCN1C(=O)N(CCC)C2=C([NH]C(=N2)C34C[C@@H]5CC(CC3C5)C4)C1=O	Axon Medchem	1603	-8.03371526	-6.32118191	-1.08796296	-1.14915238												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00079434-04	NCGC00079434-04	384568075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[309928-48-1]		2.2387211386	-5.65	6.8468045506	4	4		10.7755656119	8.53810116	0.021739819	0.9997127056		CRY	C[S+]([O-])(=O)N(CC(O)C[N]1C2=CC=CC=C2C3=CC=CC=C13)CC4=CC=CO4	Tocris	4685	-1.47963801	0.24702448	5.82423061	8.53810116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510690-01	NCGC00510690-01	384569480		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1282514-88-8		4.4668359215	-5.35	-57.8819529441	-2.2	4		-36.41799385	-38.90429295	0.011390243	0.999920064		PIK3CA	CC(C)[N]1N=CN=C1C2=C[N]3CCOC4=CC(=CC=C4C3=N2)O[C@@H](C)C(N)=O	Selleck	S8157	-4.24886878	-5.35818549	-20.3281512	-38.90429295												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024427-09	NCGC00024427-09	384568028		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	16590-41-3				-15.8792233597	4	4		0	0.94655321				OPRM1	OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC6CC6	MedChem Express	HY-76711	-5.09049774	-2.7621828	-2.37048452	0.94655321												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093356-10	NCGC00093356-10	384568114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	147-94-4		2.5118864315	-5.6	-63.171039254	4	4		-26.0034533959	-31.71581258	0.0342712837	0.9992760061			NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	Selleck	S1648	-6.13437196	-5.46293475	-28.58871944	-31.71581258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263194-02	NCGC00263194-02	384568658		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	280744-09-4				-27.758670297	4	4		0	-8.64109171				GSK3B	C[N]1C=C(C2=C1C=CC=C2)C/3=C(C(=O)NC3=O)\C4=CC(=CC(=C4)Cl)Cl	SynKinase	SYN-1075	-5.95733381	-0.13494102	-8.57419511	-8.64109171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015904-05	NCGC00015904-05			SARS-CoV-2_CPE_SRI		36791-04-5				-17.2860533091	4	10		0	-2.98824362					NC(=O)C1=N[N](C=N1)C2OC(CO)C(O)C2O	Bio Vision	2199	-2.60291747	-0.99083867	-3.81394252	-2.11536193	-1.78508237	-8.6580427	-7.02237251	-4.46663783	1.46266661	-2.98824362						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	SARS-CoV-2_CPE_SRI		55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	0.0557861839	-7.2534733462	-161.2250183761	-2.2	10		-67.7965635136	-52.87618448	0.0000940871	0.9736629836			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	4.89128298	4.7418708	-1.24248024	1.12452326	-3.09047301	-0.22018637	-1.27393544	-8.27271655	-21.02779853	-52.87618448						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	SARS-CoV-2_CPE_SRI		97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	0.0702306445	-7.1534733462	-88.389457716	4	10		-27.659104312	-26.16285928	0.0018381982	0.9343097037	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-7.18751229	-4.63177761	-5.27660913	-6.11803562	-5.70911807	-1.44693902	-6.02367003	-2.28836551	-6.88868793	-26.16285928						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00485882-01	BCX 4430	363681391		SARS-CoV-2_CPE_SRI		222631-44-9		0.0702306445	-7.1534733462	-67.2453363344	4	10		-15.711457548	-16.75775567	0.0178875687	0.8588274776			NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649	-8.57940471	-6.77073094	-5.69339048	-4.91487438	-6.2910392	-5.82707506	-7.74584202	-10.61612865	-10.09711792	-16.75775567						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00686671-01	Brincidofovir			SARS-CoV-2_CPE_SRI		444805-28-1				-23.1119723602	4	10		0	-2.15508873					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532	-7.01665825	-3.98011882	-10.76767755	-3.3510659	-6.93123131	0.0271813	-8.82615618	-6.53516095	-7.28847125	-2.15508873						3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9	1.7964071856E-8					
NCGC00229511-27	Tofacitinib			SARS-CoV-2_CPE_SRI		477600-75-2				-14.1977206294	4	10		0	-1.79784879					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1	-4.84215431	-4.60140566	-3.75490234	-6.38760533	-5.05960471	-3.68500757	3.38213024	-7.3661321	-0.01941521	-1.79784879						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	SARS-CoV-2_CPE_SRI				0.0157226828	-7.8034733462	-8.0563272157	4	10		-5.1553993759	-2.63658603	0.3043014512	0.4848711957			CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019	-2.93169728	-1.00570807	6.22451753	2.86180251	-0.0271813	0.53197686	1.56486623	-5.12949948	-4.98970994	-2.63658603						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00022398-13	NCGC00022398-13	384568010		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	356-12-7				-25.0460626408	4	4		0	-5.00498599				NRC31	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]3[C@@H]4C[C@H](F)C/5=C/C(=O)/C=C\[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]23C	MedChem Express	HY-B0485	-5.82993108	-5.97356264	-3.20833333	-5.00498599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161290-05	NCGC00161290-05	174006821		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	39746-25-3	16,16-DIMETHYL-PROSTAGLANDIN E2;16,16-dimethyl Prostaglandin E2;16,16-Dimethyl Prostaglandin E2			-23.1968612748	4	4		0	0.34216443					CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	Tocris	4027	-6.37144148	-5.71052751	-4.56524793	0.34216443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509991-01	NCGC00509991-01	384569399		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	77472-98-1		12.5892541179	-4.9	-64.0342586445	-3	4		-51.4153212593	-52.22349461	0.1050202033	0.9931384728			C1CC(CCN1)CCC2=CC(=NC3=CC=CC=C23)C4=CC=CC=C4	MedChem Express	HY-100140	-7.1169337	-6.75140382	-3.01621883	-52.22349461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507841-02	NCGC00507841-02	384569323		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1421438-81-4				-21.6829636098	4	4		0	-4.07004485					C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)C2=C(C=CC=N2)C3=C1C=CC=C3	MedChem Express	HY-12449	-6.13437196	-3.0427023	-1.21520213	-4.07004485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015950-05	NCGC00015950-05	124881443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	264218-23-7	SB 415286;SB-415286			-18.8810979273	4	4	3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione;3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione;3-[(3-Chloro-4-hydroxyphenyl)- amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione;SB-415286;NCGC00025233-04;NCGC00025233-03;SB 415286;NCGC00015950-01;NCGC00025233-01;NCGC00025233-02;CIPLUS_753362;	0	1.37894837			2932	GSK3B	OC1=C(Cl)C=C(N\C2=C(\C(=O)NC2=O)C3=C(C=CC=C3)[N+]([O-])=O)C=C1	BIOMOL	EI311	-5.82455519	-6.26387498	-0.94408134	1.37894837												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016645-03	NCGC00016645-03	124882458		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	3963-95-9	 ; Methacycline Hcl; Methyleneoxytetracycline;Methacycline hydrochloride; Methacycline hydrochloride; Rondomycin; Globociclina; Physiomycine; Lysocline; Metaciclina			-15.4479970181	4	4		0	-7.82040271					CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@@H]\3C(=C)C4=C(C(=CC=C4)O)C(=O)C3=C(\O)[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Vitas	STK177310	-2.8060547	-0.33517608	-3.15177923	-7.82040271												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346494-06	NCGC00346494-06	363677427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	141430-65-1		1	-6	-144.6958070292	-2.4	4		-77.2241629839	-64.58233202	0.5038050223	0.8013380778		TUBB	COC1=CC=C(C=C1)[S+]([O-])(=O)NC2=C(NC3=CC=C(O)C=C3)N=CC=C2	MedChem Express	HY-13270	-14.8121962	-44.68649886	-39.15237606	-64.58233202												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181343-04	NCGC00181343-04	384568396		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	148849-67-6				-14.2823820181	4	4		0	-3.07122945				HCN	COC1=C(OC)C=C2CC(=O)N(CCCN(C)C[C@H]3CC4=CC(=C(OC)C=C34)OC)CCC2=C1	Glixx	GLXC-03048	-2.4569156	-3.97254005	-4.20073828	-3.07122945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492447-02	NCGC00492447-02	384569288		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1629268-00-3				-4.186167344	4	4		0	1.98455372				KRAS	CC1(CC1)C2=C(Cl)C=C(O)C(=C2)NCC(=O)N3CCN(CC3)C4CN(C4)C(=O)C=C	MedChem Express	HY-19706	-2.8739268	0.85725949	1.53111392	1.98455372												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263097-03	NCGC00263097-03	384568588		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	288383-20-0		8.9125093813	-5.05	-108.7735727082	-2.1	4		-106.4727768516	-99.57962655	0.0055480972	0.9999810151		FLT1	COC1=CC2=C(C=C1OCCCN3CCCC3)N=CN=C2OC4=C(F)C5=C([NH]C(=C5)C)C=C4	Selleck	S1017	-6.20876638	-6.69932417	-19.75464719	-99.57962655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263180-08	Trametinib	384568648	Mek 1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	871700-17-3				-123.984641498	4	4		0	-32.15808383				MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	APExBIO	A3018	-23.03495387	-28.1452838	-30.69373942	-32.15808383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344622-15	NCGC00344622-15	384568725		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1561178-17-3				-25.6483778405	4	4		0	-8.69461078				DOT1L	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)[N]3C=C(Br)C4=C3N=CN=C4N	Selleck	S7079	-5.11444287	-3.55383695	-5.15832729	-8.69461078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00357427-09	NCGC00357427-09	384569034		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-14.6421959162	4	4		0	1.88679245					NCCOC1=CC(=NC(=C1)C(=O)NC2=NC3=CC=CC=C3C(=C2)OCCN)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN	MedChem Express	HY-15176A	-6.27988812	1.03060447	-1.05360714	1.88679245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351596-02	NCGC00351596-02	384569014		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1356962-20-3		5.0118723363	-5.3	-121.4858292829	-2.1	4		-110.8635827262	-99.7683733	0.048705282	0.9985340946		ALK	COC1=C(NC2=NC(=C(Cl)C=N2)C3=C[NH]C4=C3C=CC=C4)C=CC(=C1)N5CCC(N)CC5	Selleck	S7106	-1.89479383	-12.35829189	-47.8415687	-99.7683733												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242480-02	NCGC00242480-02	384568492		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	873054-44-5		12.5892541179	-4.9	-93.3865434879	-3	4		-104.8757128565	-99.82402972	0.0118888502	0.9999128141		CFTR	CC(C)(C)C1=CC(=C(NC(=O)C/2=C/NC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C	Selleck	S1144	-4.88929056	-4.64008709	-4.35922648	-99.82402972												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263016-01	NCGC00263016-01	137275920		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	379262-36-9	DE-096			-26.4291743489	4	4		0	-10.74396324			59341	TRPV4	CCCCCN(CCC12CC3CC(CC(C3)C1)C2)C(=O)NCCCC4=CC=NC=C4	NCGCChem	BTM10-095	-4.20244013	-4.23186828	-6.73783771	-10.74396324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164615-05	Prulifloxacin	384568265	Antibacterial	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	123447-62-1				-29.630527791	4	4		0	-2.76664386					CC1SC/2=C(C(O)=O)/C(=O)C3=CC(=C(C=C3N12)N4CCN(CC4)C\C5=C(C)\OC(=O)O5)F	Glixx	GLXC-06577	-7.95300497	-6.02803102	-4.34986187	-2.76664386												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379163-01	NCGC00379163-01	363678393		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[130065-61-1]		12.5892541179	-4.9	-76.5228874614	-3	4		-109.54237951	-99.76537296	0.0150257763	0.9998607241			CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1	Tocris	4580	-0.67781292	-0.47625527	0.15451608	-99.76537296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167746-09	NCGC00167746-09	384568333		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	501925-31-1		0.7943282347	-6.1	-2.7938237248	4	4		13.793493	6.19806433	0.2691511157	0.9533342876		CHRNA7	COC1=C(Cl)C=C(NC(=O)NC2=NOC(=C2)C)C(=C1)OC	MedChem Express	HY-12152	-3.9945775	1.21104912	2.75787798	6.19806433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346449-02	NCGC00346449-02	363677409		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	139145-27-0		8.9125093813	-5.05	-56.2647417941	-3	4		-39.1278572079	-43.25269461	0.0227964852	0.9996796087		PDE5A	ClC1=CC=C(CCCOC/2=N/NC(=O)C(=C2NCC3=CN=CC=C3)/Br)C=C1	Axon Medchem	1482	-5.8951384	-5.22948027	-7.47884941	-43.25269461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242476-03	NCGC00242476-03	384568489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[1216744-19-2]				-1.801337279	4	4		0	-5.15928144				NR1D1	CC(C)(C)OC(=O)CN(CC1=CC=C(S1)[N+]([O-])=O)CC2=CC=C(Cl)C=C2	Tocris	3663	0.83836054	1.97026193	-2.09330433	-5.15928144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381562-02	NCGC00381562-02	384569100		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1403254-99-8				-7.7218521439	4	4		0	-4.33532934				EZH2	CCN(C1CCOCC1)C2=C(C)C(=CC(=C2)C3=CC=C(CN4CCOCC4)C=C3)C(=O)NC\C5=C(C)\C=C(C)/NC5=O	XcessBio	M60122-2s	0.11089425	-2.78966994	-4.02707276	-4.33532934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492296-02	NCGC00492296-02	384569287		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1849590-01-7				-16.4525016216	4	4		0	-6.7895575				MKNK1	CC/1=C2/N(C(=O)C(=C1)/NC3=CC(=NC=N3)N)C4(CCCCC4)NC2=O	Selleck	S8275	-2.59857439	-3.80875566	-1.1706746	-6.7895575												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00475727-01	NCGC00475727-01	363681098		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1313725-88-0		12.5892541179	-4.9	-62.6769603094	-3	4		-69.6080576976	-66.56253004	0.014648387	0.9998676596		MET	C[C@H]([N]1N=NC2=C1N=C(C=N2)C3=C[N](C)N=C3)C4=C[N]5C=CN=C5C=C4	ActiveBioChem	A-1316	-3.42907645	-2.72768879	-3.23816644	-66.56253004												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241099-04	Saracatinib	384568470	cSRC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	379231-04-6		2.2387211386	-5.65	-164.3483708377	-2.1	4		-97.8731023192	-99.14947698	0.021867932	0.9997049585		SRC	CN1CCN(CCOC2=CC3=NC=NC(=C3C(=C2)OC4CCOCC4)NC5=C6OCOC6=CC=C5Cl)CC1	Selleck	S1006	-8.86579304	-24.67909466	-72.03727115	-99.14947698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018157-21	NCGC00018157-21	384567993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	5104-49-4				-17.4000275325	4	4		0	0.4399257					CC(C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2	Enzo	DL400	-5.24175328	-0.99333243	-5.22077071	0.4399257												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183862-01	NCGC00183862-01	144206867		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	75820-08-5				-40.6875894989	4	4	N-5-trifluoromethyl-6-methoxy-1-thionaphthoyl-N-methylglycine;Alredase;tolrestatum;tolrestat;AY-27,773;TOLRESTAT;N-((5-(trifluoromethyl)-6-methoxy-1-naphthalenyl)thioxomethyl)-N-methylglycine;CIPLUS_682579;Tolrestat;LS-71766;AY 27773;	0	-14.46866751				AKR1B1	O=C(O)CN(C)C(=S)c2cccc1c2ccc(OC)c1C(F)(F)F	Pharmaron	PH-NIH-172180	-4.74469047	-11.05365809	-14.35126656	-14.46866751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390283-03	NCGC00390283-03	363680873		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1228585-88-3				-28.861777756	4	4		0	-3.76380878				TLR7	CCCCOC1=NC2=C(NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4)C(=N1)N	Glixx	GLXC-90047	-6.5521916	-6.55417971	-6.77529616	-3.76380878												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	SARS-CoV-2_CPE_SRI		51773-92-3		0.0279593232	-7.5534733462	-334.856260447	-1.1	10		-105.7154877484	-99.72083514	0.0003184653	0.9619172262		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-0.7549247	1.5491684	0.09436559	-3.51511815	-2.13108953	-11.66201392	-14.68957653	-22.51405654	-99.73656273	-99.72083514						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	SARS-CoV-2_CPE_SRI		908112-43-6		0.0124889709	-7.9034733462	2.0509290001	4	10		18.8438434359	-4.904283	0.3796874998	0.4302850341		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189	7.26517299	-4.38395527	-12.6703685	-21.11986953	-16.97277987	-6.43420184	-2.72201297	11.08608706	5.31588553	-4.904283						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00378657-01	Simeprevir			SARS-CoV-2_CPE_SRI		923604-59-5		0.0176411403	-7.7534733462	-353.2723867456	-1.1	10		-93.5569525842	-99.75148526	0.0000573168	0.9772766609			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-3.52968586	-16.94948161	-4.55480915	1.49497146	-8.0650798	-7.68454161	-17.04267464	-72.31390518	-87.11606415	-99.75148526						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00263564-04	NCGC00263564-04	384568688		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	141505-33-1		0.5623413252	-6.25	-3.4071576698	4	4		9.29630944	3.25269461	0.3131312725	0.9353007476			C[C@@H]\1CC(=O)N\N=C1C2=CC=C(NN=C(C#N)C#N)C=C2	Microsource	01502356	-4.4135912	1.86898679	5.90282814	3.25269461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015100-16	NCGC00015100-16	384567809		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	645-05-6				-9.5192332134	4	4		0	-0.58389229					CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C	Selleck	S1278	-2.5354146	-3.90733522	0.17560119	-0.58389229												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346888-03	UK-383367	363677552	Procollagen C-Endopeptidase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	348622-88-8		12.5892541179	-4.9	-69.0110971862	-3	4		-76.5437970103	-72.61979443	0.0256831722	0.9995930025			NC(=O)C1=NOC(=N1)[C@H](CCCC2CCCCC2)CC(=O)NO	Selleck	S2224	-4.02418118	-3.67432899	-2.7023072	-72.61979443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262945-03	NCGC00262945-03	363677193		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	366789-02-8				-7.6759104479	4	4		0	-1.75167688				F10	ClC1=CC=C(S1)C(=O)NC[C@H]2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O	Selleck	S3002	-1.65117748	-2.27629162	-0.79996098	-1.75167688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00487085-02	NCGC00487085-02	384569282		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1338806-73-7		14.1253754462	-4.85	-44.9250918719	4	4		-19.9095887599	-23.53423732	0.3122571711	0.9348576922		PLK4	COC1=CC=C2NC(=O)[C@@]3(C[C@H]3C4=CC5=C(C=C4)C(=N[NH]5)/C=C/C6=CC=C(CN7C[C@@H](C)O[C@@H](C)C7)C=C6)C2=C1	ChemieTek	CT-CFI400_cm1	-7.29044483	-8.86319846	-3.60958002	-23.53423732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263158-07	NCGC00263158-07	363677235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	850879-09-3		0.2511886432	-6.6	-62.9090598225	4	4		-20.9648754039	-23.8921465	0.0352956691	0.9992336069		PDGFRA	S=C(NCC1=CC2=C(OCO2)C=C1)N3CCN(CC3)C4=NC=NC5=C4OC6=C5C=CC=C6	MedChem Express	HY-10206	-4.75475033	-23.77116705	-23.31199477	-23.8921465												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481574-01	NCGC00481574-01	384569256		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-22.2222723717	4	4		0	-9.52129194				EZH2	CC(C)[N]1C=C(C)C2=C(C=C(C=C12)C3=CN=C(C=C3)N4CCN(C)CC4)\C(O)=N\CC5=C(O)N=C(C)C=C5C	APExBIO	B5833	-2.4569156	-7.32265446	-5.31283585	-9.52129194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387877-01	NCGC00387877-01	363680717		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1000023 -04 - 0		14.1253754462	-4.85	-10.0322785101	4	4		-12.621215032	-10.93434586	0.3319670831	0.9261429645		CDK1	CN1CC[C@H]([C@@H]1CO)C2=C3OC(=C/C(=O)C3=C(O)C=C2O)\C4=C(Cl)C=C(C=C4)C(F)(F)F	ChemieTek	CT -VORU	0.2739726	-2.98398169	-0.67753843	-10.93434586												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015970-10	NCGC00015970-10	174007228		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	38194-50-2	 ; Sulindac;Sulindac; Sulindaco; Clinoril; Sulindac sulfide; Sulindac sulfone;SULINDAC; Suldinac			-15.0673140486	4	4		0	-3.52302221				ABCC1	C[S+]([O-])C1=CC=C(C=C1)\C=C2\C(=C(\CC(O)=O)C3=C2C=CC(=C3)F)C	Microsource	MS-01500556	-2.50994255	-4.97940503	-3.64001682	-3.52302221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346678-15	NCGC00346678-15	384568904		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	888216-25-9		1.4125375446	-5.85	-78.2048977555	4	4		-26.0878751752	-33.37569655	0.078498484	0.9961856099		HSP90AB1	CC(C)C1=C(O)C=C(O)C(=C1)C/2=N/NC(=O)N2C3=CC4=C(C=C3)[N](C)C=C4	Selleck	S1159	-8.41391776	-10.10114755	-35.35608934	-33.37569655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346513-02	NCGC00346513-02	384568813		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	69408-81-7		14.1253754462	-4.85	-35.1143718338	-3	4		-33.8411489401	-30.68726171	0.0617004405	0.9976484333		TOP2A	CN(C)CCN1C(=O)C2=C3C(=CC=C2)C=C(N)C=C3C1=O	Selleck	S1367	-3.00948938	-3.94157935	-2.48630426	-30.68726171												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480912-02	NCGC00480912-02	363681114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1652591-81-5				-18.6112320088	4	4		0	-3.25545019				PADI4	COC1=C2[N](C)C(=NC2=CC(=C1)C(=O)N3CC[C@@H](O)[C@@H](N)C3)C4=CC5=C(C=CC=C5)[N]4CC6CC6	Cayman	17488	-5.05196566	-2.69877988	-1.98997987	-3.25545019												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386413-01	NCGC00386413-01	363680266		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1352608-82-2		12.5892541179	-4.9	-43.9245059841	4	4		-14.432433076	-17.77299834	0.3489177143	0.91768469		TGFBR1	CC1=NC(=CC=C1)C2=C(N=C(CNC3=CC=CC=C3F)[NH]2)C4=C[N]5N=CN=C5C=C4	Selleck	S7530	-6.57930411	-10.04671837	-9.7532425	-17.77299834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017312-04	NCGC00017312-04	363676497		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	58-96-8				-17.5093067434	4	4		0	-0.59634373					OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2\C=C/C(=O)NC2=O	Selleck	S2029	-5.56710348	-0.86633102	-3.20737931	-0.59634373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247879-05	NCGC00247879-05	384568520		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	847559-80-2		7.0794578438	-5.15	-30.1003497388	4	4		-14.804903124	-16.56075863	0.1476354791	0.9864202469		HSP90AB1	CCNC(=O)C1=CC2=C(N=C(N)N=C2S1)C3=CC(=C(Cl)C=C3Cl)OCCN4CCCC4	MedChem Express	HY-10942	-2.97333936	-4.73080238	-3.90972515	-16.56075863												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00274171-10	NCGC00274171-10	384568713		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-6.055622681	4	4		0	2.41470329					NCC(=O)NC1=CC(=CN=C1)\C2=N\N/3C(=O)\C=C(/N=C3S2)N4CCNCC4	NCGCChem	JKJ031-018	-1.63578852	-4.43144192	-0.8381327	2.41470329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263121-03	NCGC00263121-03	384568605		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1243583-85-8		12.5892541179	-4.9	-43.9035338167	-3	4		-34.5497485004	-33.81556886	0.2928104696	0.9431488741		HAT1	CCCCCCCC1=CC=C(CCC2=CC=CC(=C2C(O)=O)O)C=C1	Axon Medchem	1785	-7.31458481	-1.89660728	1.96760938	-33.81556886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159322-18	NCGC00159322-18			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			5.0118723363	-5.3	-42.917084588	-2.4	4		-33.27581128	-29.09221557	0.0476584201	0.9985995632			[H][C@]1(CO)O[C@@]2([H])N3C=CC(=N)N=C3O[C@@]2([H])[C@]1([H])O	Selleck	S1973	-2.19570617	-6.21461124	-16.0551124	-29.09221557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386261-01	NCGC00386261-01	363680173		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1149705-71-4		0.2238721139	-6.65	-62.6070887082	4	4		-13.78000798	-18.59286783	0.6379724303	0.6189725049		HSP90AB1	CC[C@@H](C)NC1=C(C=C(C)C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C(N)=O	Selleck	S7122	-8.22881891	-25.12882556	-14.49685381	-18.59286783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015766-16	NCGC00015766-16	363676461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	2315-02-8				-15.1232265645	4	4		0	-3.28620373				ADRA1A	CC1=CC(=C(O)C(=C1C\C2=N\CCN2)C)C(C)(C)C	Selleck	S2495	-3.2843093	-5.09925169	-1.02434028	-3.28620373												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165782-07	NCGC00165782-07	384568282		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	6823-69-4		0.7079457844	-6.15	9.1402139773	4	4		14.75877134	10.14814457	0.105994142	0.9930576909		NSMAF	O=C(NC1=CC=C(C=C1)/C2=N/CCN2)\C=C\C3=CC=C(\C=C\C(=O)NC4=CC=C(C=C4)C/5=N/CCN5)C=C3	SIGMA	D1692	-3.06776144	-4.38230945	-1.09262963	10.14814457												1.6E-8	8E-8	4E-7	0.000002											
NCGC00016535-19	NCGC00016535-19			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	745-65-3				-15.1378908217	4	4		0	-4.69526613					CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	MedChem Express	HY-B0131	-3.36551475	-5.28744903	0.9462953	-4.69526613												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016447-01	NCGC00016447-01	144203993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	466-06-8	 Scillase; Proscillaridin;Proscillaridin; ; Caradrin; Sandoscill; Digitalysat; A, Proscillaridi; Proscillaridin A; Proscilaridina; Talusin; Rhamnoside, Scillareni	6.3095734448	-5.2	-444.5774292887	5	4	CIPLUS_168268;Proscillaridin A;Proscillaridin;Caradrin;CIPLUS_153303;3-(6-Deoxy-alpha-L-mannopyranosyloxyl)-14-hydroxybufa-4,20,22-trienolide;Ysatfabrik Brand of Proscillaridin;proscillaridinum;PROSCILLARIDIN;NCGC_Prestw-986;Scillarenin 3beta-rhamnoside;A, Proscillaridi;proscillaridine;Digitalysat;Knoll Brand of Proscillaridin;Proscilaridina;Scillase;LS-125804;Abbott Brand of Proscillaridin;Ziethen Brand of Proscillaridin;NCGC00016447-01;Sandoscill;Talusin;Rhamnoside, Scillareni;Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3beta)-;Proscillaridinum;Proscillaridine;	6.961673276	-89.90493654	0.2957921895	0.9438357745			O=C1C=CC(=CO1)[C@H]6CC[C@@]5(O)[C@]6(C)CC[C@H]3[C@H]5CCC2=C[C@H](CC[C@@]23C)O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O	Prestwick Chemical, Inc.	CAS-466-06-8	-95.3171524	-97.02020881	-94.65879713	-89.90493654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505919-02	NCGC00505919-02	384569318		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1799633-27-4				-28.6423947395	4	4		0	-6.98356243				MCL1	CN1CCN(CCOC2=C(Cl)C(=C(C=C2)C3=C(SC4=C3C(=NC=N4)O[C@@H](CC5=CC=CC=C5OCC6=CC=N[N]6CC(F)(F)F)C(O)=O)C7=CC=C(F)O7)C)CC1	ChemieTek	CT-S63845	-4.93150685	-7.39588101	-8.09775244	-6.98356243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090753-20	Azithromycin	384568081	50S Ribosomal Protein Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	83905-01-5				-19.3380000633	4	4		0	-4.51312121					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	MedChem Express	HY-17506	-4.00353513	-2.03203661	-6.18195411	-4.51312121												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253713-01	NCGC00253713-01	170466486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	72479-26-6	Fenticonazole nitrate;Fenticonazole	10	-5	-80.882437867	-3	4		-80.22613392	-79.49946231	0.0467290227	0.998650944			Clc4ccc(C(OCc2ccc(Sc1ccccc1)cc2)Cn3ccnc3)c(Cl)c4	GVK	FFS-12-73-NCI-1907	-5.98282874	-2.64435071	-6.20405488	-79.49946231												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165722-19	Plerixafor hydrochloride	384568275	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-4.3792476011	4	4		0	-0.39104507			7852	CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	NCGCChem	AED021-093	-0.18978762	-2.7985667	-2.3551997	-0.39104507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346573-02	NCGC00346573-02	384568846		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	848942-61-0		8.9125093813	-5.05	-93.4414793313	-2.2	4		-66.6869802909	-60.77817969	0.0095596743	0.999943656		ERBB2	CNC(=O)CN1CCC(CC1)OC2=C(OC)C=C3N=CN=C(NC4=C(F)C(=CC=C4)Cl)C3=C2	Selleck	S2192	-9.20018075	-10.6817254	-24.39949431	-60.77817969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162225-11	NCGC00162225-11	384568220		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	16595-80-5				-9.6404762983	4	4		0	-5.40490255				CHRNA3	C1CN\2C[C@@H](\N=C2S1)C3=CC=CC=C3	MedChem Express	HY-13666	-0.90941197	-2.32216081	-2.3682236	-5.40490255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381564-09	NCGC00381564-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	937272-79-2		10	-5	-105.868375505	-2.1	4		-124.2773922195	-99.42788037	0.0340406714	0.9992846512			C(CN1CCCC1)OC2=CC=C3NC4=NC=CC(=N4)C5=CC(COC\C=C\COCC2=C3)=CC=C5	MedChem Express	HY-16379	-2.98428395	-7.25173828	-26.98836991	-99.42788037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092364-11	NCGC00092364-11	384568107		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	123464-89-1				-18.906141912	4	4		0	-5.37825627				CHRNA7	ClC1=CC=C(C=C1)C(=O)N[C@H]2CN3CCC2CC3	MedChem Express	HY-12560A	-3.60583296	-4.54004577	-3.58394468	-5.37825627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510693-01	NCGC00510693-01	384569483		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1952251-28-3				-15.516983987	4	4		0	-3.70566183				SYK	C[N]1C=C(C=N1)C2=C3C(=O)NCC3=C(F)C(=N2)N[C@@H]4CCCC[C@@H]4N	Selleck	S8442	-2.35969951	-4.25629291	-3.43441895	-3.70566183												1.6E-8	8E-8	4E-7	0.000002											
NCGC00371093-04	Marimastat	384569041	Matrix Metalloproteinase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	154039-60-8				-28.8028834128	4	4		0	-8.31010285				MMP1	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	MedChem Express	HY-12169	-4.60450729	-7.12128146	-8.37811317	-8.31010285												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344764-12	NCGC00344764-12	384568729		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	95809-78-2				11.2602606516	4	4		0	4.18418223					OC(=O)CCCCC(CCSCC1=CC=CC=C1)SCC2=CC=CC=C2	Selleck	S2776	2.59376412	0.69397197	1.46556164	4.18418223												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242481-05	NCGC00242481-05	384568493		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	860352-01-8		10	-5	-76.5699072402	-2.4	4		-80.5558201876	-66.65868263	0.0727810533	0.9967194855		CHEK1	NC(=O)NC1=C(SC(=C1)C2=CC(=CC=C2)F)C(=O)N[C@H]3CCCNC3	Selleck	S1532	-3.27803407	-8.15725268	-18.13391346	-66.65868263												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014891-14	NCGC00014891-14	384567795		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	48208-26-0				-27.6947041639	4	4		0	-1.11616766				DNMT1	OC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)N3C(=O)C4=C(C=CC=C4)C3=O	MedChem Express	HY-13642	-9.01792051	-3.94052387	-1.54218032	-1.11616766												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	53-86-1				3.3214656322	4	4		0	6.93173653				PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	-2.15134847	2.26488054	2.93449359	6.93173653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346739-06	NCGC00346739-06	363677539		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	150812-12-7				-9.9728014428	4	4		0	-3.86064468				KCNQ1	CCOC(=O)NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1N	MedChem Express	HY-15471	-0.45912061	-4.45266536	-4.00956669	-3.86064468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263531-10	NCGC00263531-10	363677279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	165800-03-3				0.800105129	4	4		0	1.65589097					CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Adooq	A10533	-0.23838955	-0.20057051	0.44550741	1.65589097												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181002-10	NCGC00181002-10	384568386		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	364782-34-3		12.5892541179	-4.9	-87.605975341	-3	4		-110.7818628812	-99.63952706	0.0476070113	0.9985995479		CASR	C[C@@H](NCCCC1=CC=CC(=C1)C(F)(F)F)C2=CC=CC3=CC=CC=C23	MedChem Express	HY-70037A	-2.08572691	-6.39816934	-4.7708051	-99.63952706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165833-10	NCGC00165833-10	384568288		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	209783-80-2		7.9432823472	-5.1	-99.8504940254	-2.1	4		-92.8953306688	-86.75862732	0.0090503901	0.999949482		HDAC1	NC1=C(NC(=O)C2=CC=C(CNC(=O)OCC3=CC=CN=C3)C=C2)C=CC=C1	XcessBio	M60174-5s	-5.82412726	-5.98627002	-22.81669081	-86.75862732												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507962-02	NCGC00507962-02	384569358		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1415925-18-6				-8.1324338487	4	4		0	-3.01355378					CC(C)[N]1C=C(C2=CC3=C(CCN3C)C=C2)C4=C(N[S+]([O-])(=O)C5=N[N](C)C=C5)C=CN=C14	MedChem Express	HY-18950	-2.15642952	-1.04347826	0.50932199	-3.01355378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346650-02	NCGC00346650-02	384568881		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1007207-67-1		10	-5	-28.9616111767	4	4		-19.8679870841	-18.26178411	0.1835675795	0.9787694803		PIK3CA	C[S+]([O-])(=O)N1CCC2=C(N=C(N=C12)N3CCOCC3)C4=CN=C(N)N=C4	Selleck	S2699	-2.53846154	-5.34022008	-7.29275257	-18.26178411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016094-10	NCGC00016094-10	384567920		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	58053-83-1	17_-hydroxy Wortmannin;Wortmannin			-18.6889713103	4	4		0	-8.66972039			5290	PIK3CA	COC[C@H]1OC(=O)C2=COC3=C2[C@@]1(C)\C4=C(C5CCC(=O)[C@@]5(C)C[C@H]4OC(C)=O)/C3=O	BIOMOL	ST-415	-2.31919979	-5.53258173	-3.46163157	-8.66972039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378744-02	NCGC00378744-02	384569067		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	81409-90-7				1.7613814848	4	4		0	0.01431434					CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1CC2[C@@H](CC3=C[NH]C4=CC=CC2=C34)N(CC=C)C1	MedChem Express	HY-15296	0.20359387	1.91093893	-0.15008473	0.01431434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510691-01	NCGC00510691-01	384569481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	890405-51-3				-14.7061659472	4	4		0	-1.45529154					[O-][N+](=O)C1=C(OCC2CC(CC3=CC=CC=C3)C(=O)O2)C=CC=C1	Selleck	S8317	-5.44392317	1.04905759	-0.64391189	-1.45529154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386327-03	NCGC00386327-03	363680213		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1246529-32-7				-37.082017875	4	4		0	-12.534593				TTK	CC1=CC(=CC=C1NC2=NC3=C(N=C[NH]3)C(=N2)NC4CCCCC4)N5CCOCC5	APExBIO	B3706	-4.16039657	-13.97727767	-10.47204067	-12.534593												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346504-07	Avagacestat	384568808	g-Secretase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1146699-66-2				-24.9859402165	4	4		0	-5.42754491				NOTCH1	NC(=O)[C@@H](CCC(F)(F)F)N(CC1=C(F)C=C(C=C1)C2=NOC=N2)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-50845	-4.87491128	-6.28826589	-5.84481508	-5.42754491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346722-06	NCGC00346722-06	384568933		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	851881-60-2				-7.7807433147	4	4		0	-4.9490674				GRM5	FC1=CC=C(C=C1)C(=O)N2CCC[C@@H](C2)C3=NC(=NO3)C4=CC=C(F)C=C4	MedChem Express	HY-13058	-1.00653364	-0.44125513	-1.72106547	-4.9490674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510444-01	NCGC00510444-01	384569436		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			3.1622776602	-5.5	-114.2303311789	-2.1	4		-81.6756258839	-82.730943	0.0279599923	0.9995175712		CSNK1A1	NC1=NC2=C(N=C(C(=N2)N)C3=CC(=CC=C3)Cl)C(=N1)N	SIGMA	SML1647	-3.03137428	-9.08924485	-54.79650484	-82.730943												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242478-04	NCGC00242478-04	384568491		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			3.1622776602	-5.5	-91.5531315261	-2.2	4		-61.221066844	-58.75322689	0.0110997585	0.9999240349		HSP90AB1	CO[C@H]1C[C@H](C)C\C2=C(/NCCN(C)C)C(=O)\C=C(\NC(=O)\C(=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(=C/[C@H](C)[C@H]1O)C)C)C2=O	Selleck	S1142	-4.81900452	-12.33774983	-38.21329828	-58.75322689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246971-04	Polydatin	363677157	V/ICAM1 Expression Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	65914-17-2				-0.8878171206	4	4		0	-1.15689836				ICAM1	OC[C@H]1O[C@@H](OC2=CC(=CC(=C2)/C=C/C3=CC=C(O)C=C3)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2390	-0.88235294	0.04042219	3.15007025	-1.15689836												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347950-07	NCGC00347950-07	363677730		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1243244-14-5				-25.5351155164	4	4		0	-4.94850299				PORCN	CC1=NC=CC(=C1)C2=NC=C(CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4)C=C2C	MedChem Express	HY-17545	-5.76206529	-4.74151821	-5.44839255	-4.94850299												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402337-02	BGP-15	384569215	Insulin Sensitizers	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	66611-37-8				-11.5278557133	4	4		0	-3.40598802				PARP1	N\C(=N/OCC(O)CN1CCCCC1)C2=CN=CC=C2	Glixx	GLXC-05825	-1.61018453	-4.5942089	-2.37370075	-3.40598802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242249-05	NCGC00242249-05	384568487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	405554-55-4				6.8686716798	4	4		0	6.52934132				BRAF	CN(C)CCOC1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC4=C(C=C3)\C(CC4)=N\O)C5=CC=NC=C5	MedChem Express	HY-10966	-2.15134847	5.27551443	5.42905487	6.52934132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378579-06	NCGC00378579-06	384569051		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1005342-46-0				-31.2988503541	4	4		0	-11.79589748				XIAP	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(F)C=C4	MedChem Express	HY-15518	-4.52057213	-8.71367445	-6.93584693	-11.79589748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522488-01	NCGC00522488-01	384569520		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1346528-50-4				-25.9700812465	4	4		0	-13.39597191				FAAH	FC1(F)OC2=CC=C(CN3CCN(CC3)C(=O)NC4=C(Cl)C=CN=C4)C=C2O1	MedChem Express	HY-19636	-4.01730532	-3.89998217	-4.25342337	-13.39597191												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024359-10	NCGC00024359-10	384568025		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	52-67-5				-7.0217550686	4	4		0	-0.6697986					CC(C)(S)[C@@H](N)C(O)=O	Enzo	AC3217	-1.43916652	-2.42913175	-2.74338773	-0.6697986												1.6E-8	8E-8	4E-7	0.000002											
NCGC00242458-15	NCGC00242458-15	384568488		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	49843-98-3				-11.2016239455	4	4		0	0.01899425				SIRT1	NC(=O)C1CCCC2=C1[NH]C3=C2C=C(Cl)C=C3	MedChem Express	HY-15452	-3.68760701	-3.43045328	0.85648148	0.01899425												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389251-02	NCGC00389251-02	384569172		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[1594092-37-1]		14.1253754462	-4.85	-37.2417775367	4	4		-14.813175944	-18.73783181	0.0935576399	0.9946053671	9149	DYRK1B	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CN=C4)C=CC(=C1)N5CCN(C)CC5	Tocris	5232	-5.79481101	-6.51328729	-5.56018519	-18.73783181												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346952-01	NCGC00346952-01	174006970		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	359886-84-3	Cdk4/6 Inhibitor IV			-15.7482011893	4	4		0	-6.09715561			1019	CDK4	CCNC1=NC(=NC(=C1)NC2CCC(O)CC2)NC3=CC=C4[N](CC5=CC=CC=C5)C=CC4=C3	EMD Chemicals	219492	-3.07300584	-1.39962494	-3.38425926	-6.09715561												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386776-01	NCGC00386776-01	384569146		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	220619-73-8		12.5892541179	-4.9	-46.6614760674	-3	4		-59.5193135126	-54.40290659	0.092828221	0.9946490201		RXRA	CC(/C=C/[C@@H]1C[C@]1(C)C2=CC3=C(C=C2)C(C)(C)CCC3(C)C)=C\C(O)=O	Axon Medchem	2408	-2.85520362	0.13923198	1.70874314	-54.40290659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00261977-03	NCGC00261977-03	384568569		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	6506-37-2				-16.6444069587	4	4		0	-5.51677981					[O-][N+](=O)C1=CN=C[N]1CCN2CCOCC2	MedChem Express	HY-16349	-2.94570136	-3.02268134	-4.12908489	-5.51677981												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00408930-02	NCGC00408930-02	384569221		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1030123-90-0		14.1253754462	-4.85	-25.8721586931	4	4		-28.642284572	-25.95190381	0.1995116502	0.9746672061			FC1=CC=C(C=C1)C2=CSC3=C2C(=NC=N3)NCC4=CC5=C(OCO5)C=C4	Glixx	GLXC-06715	-2.06249447	-3.14717277	1.41854273	-25.95190381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015962-25	NCGC00015962-25	384567911		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	152121-30-7		12.5892541179	-4.9	-47.2068089149	-3	4		-62.2742785722	-57.88243153	0.0444649467	0.9987789281		MAPK14	OC1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=C(F)C=C3)C4=CC=NC=C4	MedChem Express	HY-10295	-0.59307781	-2.67705567	-0.79883805	-57.88243153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163411-06	NCGC00163411-06	384568235		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[38748-32-2]		1	-6	-443.4709761031	5	4		3.620504456	-92.1605115	0.145789527	0.9877509355		POLR2A	CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CC\C6=C(COC6=O)/[C@@H]5C[C@@H]7O[C@]47[C@@H]2O	Tocris	3253	-95.60060193	-94.89835894	-91.75018155	-92.1605115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263694-01	NCGC00263694-01	174007246		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	4727-31-5				1.6355204185	4	4		0	-1.1212902					OC(=O)C1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C3=CC=CC=C3	NCGCChem	DYD08-093	0.61078162	0.16976451	1.13773905	-1.1212902												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183095-07	Tigecycline	384568415	glycylcycline antibiotics	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	220620-09-7				-13.4061058989	4	4		0	-7.04670659					CN(C)[C@H]\1[C@@H]2C[C@@H]\3CC4=C(C(=C(NC(=O)CNC(C)(C)C)C=C4N(C)C)O)C(=O)C3=C(O)/[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Enzo	AC3268	-2.98527324	-0.22096396	-0.51728306	-7.04670659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346070-02	NCGC00346070-02	384568773		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1337531-36-8	Perk Inhibitor I, GSK2606414	3.5481338923	-5.45	-19.3142666625	4	4		9.476246372	1.85389222	0.4673084416	0.8373679039		EIF2AK3	C[N]1C=C(C2=CC3=C(C=C2)N(CC3)C(=O)CC4=CC(=CC=C4)C(F)(F)F)C5=C1N=CN=C5N	EMD Chemicals	516535	-4.98136977	-9.98020531	-1.43582306	1.85389222												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346942-01	NCGC00346942-01	174006541		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	211555-05-4	WHI-P97	12.5892541179	-4.9	-44.6490458767	-3	4		-38.8268951968	-34.81092144	0.1748099232	0.9806937505	1956	EGFR	COC1=C(OC)C=C2C(=NC=NC2=C1)NC3=CC(=C(O)C(=C3)Br)Br	Chemscene	CS-0054	-3.01960092	-7.97379212	-7.64865879	-34.81092144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-18	NCGC00018248-18	384567999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	71125-38-7				-10.5683073557	4	4		0	-3.31178194				PTGS1	CN1\C(=C(\O)C2=CC=CC=C2[S+]1([O-])=O)C(=O)NC3=NC=C(C)S3	MedChem Express	HY-B0261	-1.37736182	-5.21929043	-1.32714313	-3.31178194												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510503-01	NCGC00510503-01	384569464		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1349723-93-8		11.220184543	-4.95	-83.9045310702	-3	4		-109.8459762894	-99.7999907	0.0069448902	0.9999702514		ESR1	CCNCCC1=CC=C(CN(CC)C2=CC(=CC=C2[C@@H]3CCC4=CC(=CC=C4C3)O)OC)C=C1	MedChem Express	HY-19822A	-1.77467773	-2.32216081	-4.51603827	-99.7999907												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346829-02	NCGC00346829-02	384568945		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	92118-27-9				-20.7655462023	4	4		0	-3.49494278					CCO[P](=O)(OCC)C(C)NC(=O)N(CCCl)N=O	MedChem Express	HY-B0733	-5.49629044	-5.48872524	-0.40277778	-3.49494278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015385-22	Dipyridamole	384567839	Phosphodiesterase PDE3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	58-32-2				-18.1767572333	4	4		0	1.4720547				PDE5A	OCCN(CCO)C1=NC(=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO)N4CCCCC4	Prestwick	Prestw-142	-4.84656921	-7.02556831	-2.84722222	1.4720547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263167-10	NCGC00263167-10	384568637		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox			12.5892541179	-4.9	-88.1152851021	-3	4		-87.3586431894	-85.51213258	0.015013361	0.9998609647		CDK2	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Bio Vision	9490-5	-6.37429211	-5.43383799	-5.90277778	-85.51213258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178913-11	NCGC00178913-11	384568367		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	34157-83-0		0.5011872336	-6.3	-211.8233270341	-1.1	4		-98.5173664619	-99.79921599	0.0065551954	0.9999734965		HSP90AB1	CC/1=C(\O)C(=O)\C=C2/C1=C\C=C3/[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O	SIGMA	C0869	-2.0678733	-89.03211318	-99.74618139	-99.79921599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166413-09	NCGC00166413-09	384568307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	141396-28-3				-19.4278919772	4	4		0	-2.47638133					C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)N[S+]([O-])(=O)C2=CC=CC3=C2NCC(C)C3	MedChem Express	HY-B0375A	-5.02788351	-2.24176207	-4.53643186	-2.47638133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346463-01	Nesbuvir	174007343	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	691852-58-1	Nesbuvir			-6.5064733278	4	4		0	-0.71377245					CNC(=O)C1=C(OC2=CC(=C(C=C12)C3CC3)N(CCO)[S+](C)([O-])=O)C4=CC=C(F)C=C4	Chemscene	CS-0689	-3.53530873	0.6720987	3.69833212	-0.71377245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015208-25	NCGC00015208-25	384567824		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	58-08-2				-18.8159782432	4	4		0	-5.68622754					C[N]1C=NC2=C1C(=O)N(C)C(=O)N2C	Microsource	01500155	-4.02324344	-3.54463012	-2.59608412	-5.68622754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250382-06	NCGC00250382-06	384568538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1218778-77-8				-9.7563813886	4	4		0	-1.86347305				SMO	C[C@H]1CN(C[C@@H](C)O1)C2=NC=C(NC(=O)C3=C(C)C(=CC=C3)C4=CC=C(OC(F)(F)F)C=C4)C=C2	MedChem Express	HY-16582	-3.34013485	-1.93343461	2.17065506	-1.86347305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346691-07	NCGC00346691-07	384568913		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	842133-18-0				-22.7809063943	4	4		0	-4.75688623				SCL5A2	CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O	MedChem Express	HY-10451	-5.79755145	-4.11545367	-2.20933043	-4.75688623												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015060-28	NCGC00015060-28	384567803		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	446-86-6		10	-5	-31.3114872885	4	4		-15.2139524199	-14.56811945	0.216043692	0.9705376354		HPRT1	C[N]1C=NC(=C1SC2=C3[NH]C=NC3=NC=N2)[N+]([O-])=O	MedChem Express	HY-B0256	-3.9731591	-6.53859868	-8.16450947	-14.56811945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345812-03	NCGC00345812-03	384568756		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	75567-37-2		2.5118864315	-5.6	-32.3081304635	4	4		14.882599392	2.99548816	0.2079519298	0.9724677537		PRKCA	C\C=C(C)/C(=O)O[C@H]1C(=C/C23[C@H](C)C[C@@H]4[C@H](C(\C=C(CO)/[C@@H](O)[C@]12O)C3=O)C4(C)C)\C	MedChem Express	HY-B0719	-10.28606746	-13.65216616	1.8054774	2.99548816												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024762-06	NCGC00024762-06	384568034		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[1185241-83-1]				-2.9251646276	4	4		0	0.36089083				ESR1	CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1	Tocris	0743	-1.93160367	0.76842153	1.71759259	0.36089083												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346461-02	NCGC00346461-02	384568784		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	475489-16-8		12.5892541179	-4.9	-83.5876219914	-3	4		-106.8288599179	-99.44441806	0.0278926616	0.9995198506		IGFR1	NC1=NC=NC2=C1C(=CN2[C@@H]3C[C@H](CN4CCC4)C3)C5=CC(OCC6=CC=CC=C6)=CC=C5	APExBIO	A2278	-2.41450459	-3.29323515	-1.13425926	-99.44441806												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094571-10	NCGC00094571-10	384568131		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	483-63-6				-5.2246387069	4	4		0	-0.98770122					CCN(C(=O)\C=C\C)C1=CC=CC=C1C	Microsource	01505271	-0.74630142	-1.33558981	-2.35648148	-0.98770122												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024929-02	NCGC00024929-02	384568036		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[133059-99-1]				-8.9180751446	4	4		0	-1.24294866				HCN	CCN(C1=CC=CC=C1)C2=CC(=[N+](C)C(=N2)C)NC	Tocris	1000	-0.63800905	-5.20547945	-3.89339618	-1.24294866												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378588-02	NCGC00378588-02	363678105		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	939981-37-0		3.1622776602	-5.5	-129.5299482051	-2.3	4		-93.9539565911	-99.53716958	0.0717150812	0.9968145675		TP53	CCOC1=CC(=CC=C1C/2=N/[C@@](C)(C3=CC=C(Cl)C=C3)[C@](C)(N2C(=O)N4CCN(CC4)CC(=O)N5CCOCC5)C6=CC=C(Cl)C=C6)C(C)(C)C	MedChem Express	HY-70027	-2.73523944	-8.87563662	-35.91866376	-99.53716958												1.0699999999E-7	5.36E-7	0.00000268	0.0000134											
NCGC00346960-01	NCGC00346960-01	174006727		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	899804-90-1	HMSL10058	14.1253754462	-4.85	-26.9717340974	4	4		-28.1799069199	-23.75703789	0.3497998096	0.9162589378	5599	MAPK8	OC1CCC(CC1)NC2=NC=C3N=C(NC4=C(F)C=C(F)C=C4F)[N]([C@@H]5CCOC5)C3=N2	LINCS	HMSL10058	-0.69044879	-7.67422627	-2.98717018	-23.75703789												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025155-01	NCGC00025155-01	11114076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	26833-87-4	 Ceflatonin; ; Omacetaxine mepesuccinate;Homoharringtonine	1.1220184543	-5.95	-212.1109762623	-1.3	4	HOMOHARRINGTONINE HYDROCHLORIDE;HOMOHARRINGTONINE;Homoharringtonine;LS-52751;Ceflatonin;CIPLUS_214595;homoharringtonine;4'-METHYL-2'R-HYDROXY-2'-(4-HYDROXY-4-METHYLPENTYL)-BUTANEDIOATE CHLORIDE, 3R;homoharringtonine, 3H-labeled, (3(R))-isomer;NCGC00025155-01;	-91.1819236903	-99.05149701	0.0549393856	0.9981339396		RPL3	O=C(OC)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]2C(OC)=CC53CCCN5CCc1cc4OCOc4cc1[C@H]23	Tocris	Tocris-1416	-18.20883605	-43.49307186	-87.52719362	-99.05149701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162453-19	NCGC00162453-19	384568228		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	58880-19-6		0.1122018454	-6.95	-403.813088986	5	4		-82.0714253091	-99.70081552	0.0453378682	0.9987325635		HDAC1	C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C	Bio Vision	1606	-74.42930614	-99.61912443	-99.57563046	-99.70081552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017337-22	NCGC00017337-22	384567985		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	404-86-4				-12.0859189913	4	4		0	-3.0256237				NFKB1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1	MedChem Express	HY-10448	-2.77000812	-2.37487117	-1.56089947	-3.0256237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386427-01	NCGC00386427-01	363680279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1092364-38-9		1.77827941	-5.75	-174.4583955473	-2.1	4		-97.6130672112	-94.00665927	0.0390448241	0.9990586532		EGFR	COC1=CC2=C(C=C1OC3CCN(CC3)C(=O)C=C)C(=NC=N2)NC4=CC=C(Cl)C(=C4F)Cl	Selleck	S7358	-11.64847063	-32.46852175	-74.04516853	-94.00665927												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00032387-14	NCGC00032387-14	384568071		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	719277-26-6				-9.0837413567	4	4		0	-8.52132657				CLK1	CCN1\C(SC2=CC=C(OC)C=C12)=C\C(C)=O	MedChem Express	HY-15338	0.77697334	-3.46318417	-3.25923842	-8.52132657												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00492474-01	NCGC00492474-01	384569289		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox			2.2387211386	-5.65	-134.2820018954	-2.1	4		-103.3931212775	-94.89743709	0.0240281737	0.999643756			[O-][S+](=O)(NC1=C2N=CC=CC2=C(C=C1)C3=CN=CC=C3)C4=CC=CC(=C4)C(F)(F)F	NCGCChem	PJM010-024	-1.15663076	-20.81030487	-65.60213844	-94.89743709												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159418-07	NCGC00159418-07	384568175		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	17902-23-7				-17.9928684399	4	4		0	-2.66755904				TYMS	F\C1=C\N(C2CCCO2)C(=O)NC1=O	APExBIO	B1474	-3.83257919	-2.53761509	-6.34999773	-2.66755904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024631-03	NCGC00024631-03	384568030		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[4450-98-0]		3.1622776602	-5.5	-16.765205266	4	4		-17.299437976	-3.01176021	1	0.9847879533		AKR1B1	CCOC(=O)C/1=C(O)/C(=O)N(CC2=CC=CC=C2)C1	Tocris	0518	-0.0678733	1.78306759	-12.33286498	-3.01176021												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164789-05	NCGC00164789-05	174007328		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	129453-61-8	; Faslodex;Fulvestrant;Fulvestrant (Faslodex)			-25.1814965938	4	4		0	-3.7742151			2099	ESR1	C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)CC4=CC(=CC=C34)O)[C@@H]1CC[C@@H]2O	Selleck	S1191	-6.27600248	-5.44552301	-3.61655773	-3.7742151												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00506803-01	NCGC00506803-01	384569319		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-40.5272018586	4	4		0	-13.45847609				TOP1	CC[C@@]1(O)C(=O)OCC/2=C1/C=C/3N(CC4=C(CCNC(C)C)C5=CC=CC=C5N=C34)C2=O	Tocris	5125	-3.80763331	-6.61379218	-9.25808497	-13.45847609												1.6E-8	8E-8	4E-7	0.000002											
NCGC00510507-01	NCGC00510507-01	384569468		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1415823-73-2				-30.7712145553	4	4		0	-9.70419341				BTK	NC1=C(C(=NC=N1)NCC2CCN(CC2)C(=O)C=C)C3=CC=C(OC4=CC=CC=C4)C=C3	MedChem Express	HY-101215	-5.68438149	-6.69444818	-6.18506414	-9.70419341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160398-09	NCGC00160398-09	384568193		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	82956-11-4				-12.3922298341	4	4		0	-1.90609468				TPSAB1	NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC=C3C=C(C=CC3=C2)C(N)=N	MedChem Express	HY-B0190A	-3.89786159	-0.91410136	-0.53655919	-1.90609468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179532-03	NCGC00179532-03	170466730		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	96-82-2				-14.8078924072	4	4		0	-3.06060747				MMP1	O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	SIGMA	153516	-3.79657425	-4.14066679	0.09848059	-3.06060747												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522516-01	NCGC00522516-01	384569523		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1311982-88-3		10	-5	-78.3030100813	-3	4		-105.408553885	-99.72556863	0.0089859937	0.999950194			CN1CCN(CC1)C2=CC=C3N=C([NH]C3=C2)C4=CC(=C(OCCCC(=O)NCCCN=[N+]=[N-])C(=C4)C(C)(C)C)C(C)(C)C	MedChem Express	HY-15843	-0.54741303	0.03119986	-3.41868317	-99.72556863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178500-19	NCGC00178500-19	384568356		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[18883-66-4]				6.7791850173	4	4		0	-0.94021558					CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	Tocris	1621	3.11690592	-1.31729406	0.63425926	-0.94021558												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022001-19	NCGC00022001-19	384568009		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	518-28-5		0.1	-7	-318.6809154016	5	4		-55.83546264	-68.17037846	1	0.5926363899		TUBB	COC1=C(OC)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)C4=CC5=C(OCO5)C=C24)OC	MedChem Express	HY-15552	-65.51648448	-74.54603668	-68.63425926	-68.17037846												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356069-03	NCGC00356069-03	384569025		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1300031-52-0		0.0891250938	-7.05	-350.470567894	-1.3	4		-89.03981637	-93.91911273	0.0634397547	0.9975130835	23476	BRD4	C[C@H]1C[C@@H](NC2=CC=C(Cl)C=C2)C3=C(C=CC(=C3)C4=CC=C(C=C4)C(O)=O)N1C(C)=O	Selleck	S7620	-61.67873303	-84.97192904	-90.67216607	-93.91911273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166088-10	NCGC00166088-10	384568303		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	2353-33-5		1.2589254118	-5.9	12.0739595954	4	4		12.25403772	11.47999807	0.1072650742	0.9928886071		DNMT1	NC\1=N\C(=O)N(\C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	Adooq	A10292	-1.4616981	0.25092978	10.08731281	11.47999807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346438-02	NCGC00346438-02	384568777		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	857402-63-2		8.9125093813	-5.05	-44.6143226145	-2.4	4		-41.0891577864	-34.50393042	0.0725289774	0.9967461526			CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=CC(=C2O)NC(=O)C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C\[C@H](C)[C@H]1O)/C)/C)O	MedChem Express	HY-10210	-2.46335864	-5.38866108	-12.54455074	-34.50393042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510878-01	NCGC00510878-01	384569492		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	114560-48-4				-6.630351881	4	4		0	0.47485636					C[N]1C(=C(CO)C2=C1C(=O)\C=C(N3CC3)/C2=O)\C=C\CO	SantaCruz Bio	sc-480043	-1.62430309	-3.10112976	-0.95833333	0.47485636												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1446502-11-9		14.1253754462	-4.85	9.5177290357	4	4		-17.8538629599	-10.2948858	0.1987044005	0.9749613796		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	3.44176654	6.05589352	5.99537037	-10.2948858												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015155-14	NCGC00015155-14	384567817		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[68099-86-5]		10	-5	-17.9788316302	4	4		-22.7403409761	-19.89673965	0.0555237586	0.9981007598		KCNT1	CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3	Tocris	4117	-0.11312217	-1.1363126	-2.89625164	-19.89673965												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015818-25	Praziquantel	384567893	antiparasitic agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	55268-74-1				-12.9766921728	4	4		0	-0.50674061					O=C1CN(CC2N1CCC3=C2C=CC=C3)C(=O)C4CCCCC4	MedChem Express	HY-B0244	-3.23529412	-2.60049405	-3.60331777	-0.50674061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00489906-01	NCGC00489906-01	384569286		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			11.220184543	-4.95	-76.5947447664	-3	4		-111.5176307483	-99.83746056	0.0194079894	0.9997676108		MCL1	C[C@@H]1CN(C(=O)C2=C(CCCOC3=CC(=C(Cl)C(=C3)C)C)C4=CC=C(Cl)C(=C4[N]12)C5=C(C)[N](C)N=C5C)C6=C[N](C)C7=C6C=C(C=C7)C(O)=O	Vanderbilt	VU0661013	0.35746606	-1.41477656	-2.71495264	-99.83746056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160428-03	NCGC00160428-03	384568195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[204205-90-3]		31.6227766017	-4.5	-213.4225968474	5	4		44.7323740961	-41.44670173	0.4339944845	0.8681924472		TUBB	ClC1=CC=C(C[N]2C=C(C(=O)C(=O)NC3=CC=NC=C3)C4=CC=CC=C24)C=C1	Tocris	3728	-45.82694216	-45.70506789	-47.89034681	-41.44670173												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015519-15	NCGC00015519-15	384567860		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	62-31-7				-18.894537986	4	4		0	-0.57424118					NCCC1=CC(=C(O)C=C1)O	Selleck	S2529	-4.70991609	-5.26952547	-3.94127116	-0.57424118												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018218-13	NCGC00018218-13	384567997		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	89-25-8				-9.2904930611	4	4		0	-2.93876369					C\C1=N\N(C(=O)C1)C2=CC=CC=C2	Selleck	S1326	-1.30831002	-4.47192723	-0.89751719	-2.93876369												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263555-05	NCGC00263555-05	363677285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1262888-28-7		12.5892541179	-4.9	-18.8640303354	4	4		-19.03402484	-17.9450207	0.2123464675	0.9712334695		USP10	FC1=CC=C(CNC2=C3C=C(F)C=CC3=NC=N2)C=C1	Bio Vision	2037	-2.3927247	-0.26297023	1.20521478	-17.9450207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164380-01	NCGC00164380-01	26757799		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	566-48-3	4-OH Androstenedione;4-Hydroxyandrostenedione			-6.5019406305	4	4	NCGC00095102-02;4-Hydroxy-4-androstene-3,17-dione;NCGC00095102-01;NCGC00015070-01;4-OH Androstenedione;4-hydroxyandrost-4-ene-3,17-dione;formestane;NCGC00095102-03;NCGC00164380-01;Fromestane;CIPLUS_154577;CGP 32349;4-OHA;formestanum;CGP-32349;Formestane (4-Androsten-4-ol-3,17-dione);4-Hydroxyandrost-4-ene-3,17-dione;4-hydroxyandrostene-3,17-dione;4-Androsten-4-ol-3,17-dione;4-HYDROXYANDROSTENEDIONE;Lentaron;4-OH-A;LS-19455;4-hydroxy-4-androstene-3,17-dione;NCGC00093579-01;NCGC00093579-02;4-hydroxyandrostenedione;FORMESTANE;CGP 32 349;Novartis brand of formestane;Formestane;	0	0.98770122			1588	CYP19A1	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CCC4=C(O)C(=O)CC[C@]34C	SigmaAldrich	MFCD00057814	-0.77264147	-3.44874903	-3.3287037	0.98770122												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00346458-02	NCGC00346458-02	363677413		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1096708-71-2		7.0794578438	-5.15	-29.1456497024	-3	4		-33.446175036	-30.37181253	0.0409308959	0.9989668224		BRAF	C[C@@H](NC(=O)C1=C(Cl)C(N)=NC=N1)C2=NC=C(S2)C(=O)NC3=NC=C(Cl)C(=C3)C(F)(F)F	MedChem Express	HY-15246	-0.4741209	0.20125326	-7.68981481	-30.37181253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522011-01	NCGC00522011-01	384569511		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1155773-15-1		12.5892541179	-4.9	-85.4194979478	-3	4		-115.5449970492	-99.52194282	0.016862354	0.9998245893			CCN1C(=O)N\2CC3=CC(=CC(=C3[C@@H](C)\C=C2C14CCN(CC4)CC5=CC(=CC(=C5)C)C)OC)OC	Tocris	5924	-2.80090498	-1.32494947	-4.22879935	-99.52194282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346891-02	NCGC00346891-02	384568964		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[382180-17-8]		4.4668359215	-5.35	-48.3454779472	-2.4	4		-30.642865368	-28.10020078	0.0303959898	0.9994312708		HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CN=C1	Tocris	4403	-3.81447964	-7.88232652	-17.30045778	-28.10020078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370919-02	NCGC00370919-02	363677934		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	524684-52-4		2.8183829313	-5.55	-2.1252673593	4	4		14.092418336	-4.9075906	1	0.9521161166		ESR2	OC1=CC(=C2OC(=NC2=C1)C3=CC=C(O)C(=C3)F)C=C	Axon Medchem	1898	-3.23919516	-6.32701528	7.30696064	-4.9075906												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390575-03	NCGC00390575-03	384569195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1446182-94-0				3.8071346045	4	4		0	1.58760797				XIAP	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)NC3=C(N=C(S3)C4=NC=CO4)C5=CC=CC=C5	MedChem Express	HY-15835	3.21212668	-5.43979926	-2.54621726	1.58760797												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346444-07	NCGC00346444-07	363677406		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1232410-49-9				-29.2740328574	4	4		0	-12.54162042				ATR	C[S+]([O-])(=O)C1=CC=C(C=C1)C2=CN=C(N)C(=N2)C(=O)NC3=CC=CC=C3	MedChem Express	HY-14731	-3.49183434	-5.97750594	-9.73611043	-12.54162042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347303-01	NCGC00347303-01	174006484		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	n		11.220184543	-4.95	-70.2232586177	-3	4		-107.3519850044	-95.67913102	0.0424260861	0.9988882047	5578	PRKCA	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]3CC[C@@H](C)[C@H]3[C@@H]2OC(=O)\C=C\C4=CC=CC=C4	NCI	Englerin A	1.73221388	-2.12356979	-2.35970282	-95.67913102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346565-07	NCGC00346565-07	384568842		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	697761-98-1		12.5892541179	-4.9	-58.0887011888	-3	4		-79.0843402484	-64.67845814	0.0482084233	0.9985641733			COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	MedChem Express	HY-14740	-1.17543084	-3.98169336	-5.66795944	-64.67845814												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346710-03	NCGC00346710-03	363677530		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	130641-38-2				-14.6655071645	4	4		0	-5.09046014					CC(C)(OCC1=N[N](CC2=CC=CC=C2)C3=C1C=CC=C3)C(O)=O	APExBIO	B2156	-2.65156504	-2.72606687	-3.125	-5.09046014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345881-05	NCGC00345881-05	363677399		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	168626-94-6				-25.7554028913	4	4		0	-6.97089131				AVPR1A	CC1=NC2=C([NH]1)C3=CC=CC=C3N(CC2)C(=O)C4=CC=C(NC(=O)C5=CC=CC=C5C6=CC=CC=C6)C=C4	MedChem Express	HY-18347A	-5.28557004	-7.22682157	-2.85648148	-6.97089131												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015448-06	NCGC00015448-06	384567849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	162520-00-5				-25.8793560302	4	4		0	-1.15689836				MTOR	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1=C(C=CC=C1)C(O)=O	Selleck	S7684	-6.46606335	-4.98091174	-7.18397317	-1.15689836												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510234-01	NCGC00510234-01	384569419		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1557268-88-8		7.0794578438	-5.15	-97.9028496804	-2.1	4		-105.9667074084	-99.5601874	0.0060860776	0.9999771545		EGFR	CN1CCN(CC1)C2=CC=C(NC3=NC(=C4C=C[NH]C4=N3)OC5=CC(=CC=C5)NC(=O)C=C)C=C2F	ChemGood	C-1377	-1.79638009	-2.78913092	-24.25327471	-99.5601874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346827-02	NCGC00346827-02	377020326		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	112953-11-4		1.1220184543	-5.95	-102.69270203	-2.4	4		-50.8052745992	-56.17171814	0.0665468979	0.9972598316		CDK1	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)[N]3C4=C(C=CC=C4)C5=C6[C@H](O)NC(=O)C6=C7C8=C(C=CC=C8)[N]2C7=C35	SIGMA	U6508	-3.63348416	-6.73253986	-14.30902416	-56.17171814												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263093-04	NCGC00263093-04	384568585		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	541550-19-0		14.1253754462	-4.85	-133.4524480906	-2.4	4		-68.2386300024	-78.61172196	0.1711584672	0.9814895349		PIKFYVE	CC1=CC=CC(=C1)\C=N\NC2=NC(=NC(=C2)N3CCOCC3)OCCC4=CC=CC=N4	MedChem Express	HY-14644	-16.56561086	-26.14417247	-20.2012419	-78.61172196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168108-05	NCGC00168108-05	363676676		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	328543-09-5				2.8604026093	4	4		0	2.77273162				PARP1	CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3[N]2CCNC4=O	Selleck	S2178	1	0.65124635	-3.1772651	2.77273162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346832-02	NCGC00346832-02	384568947		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	24150-24-1		6.3095734448	-5.2	-13.78029779	4	4		14.798265032	7.45777269	0.0277164786	0.9995299501			COC1=C(OC)C=C(C[C@H](C)[C@H](C)CC2=CC(=C(OC)C=C2)OC)C=C1	SIGMA	T3455	-5.66522086	-5.59352283	-1.39917695	7.45777269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016246-10	NCGC00016246-10	384567925		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	55-56-1	 Corsodyl ICI; Chlorhexidine base; Anticataracticum; Arlacide H; Lisium; 8   Chlorhexidine Base; Hibiclens; Tubilicid blue label; Hexidine; Curasept ADS 220; Clorhexidina;Chlorhexidine; Eludril; Instillagel; Hibisol; Trisdine; A, Sebidi; Sebidin A; Chlorhexidine; Gibitan; Hibident; Progaron; ; Anticataracticum tablet; Perio Chip; Chlorhexamed; Tubilicid red label;CHLORHEXIDINE; Tubilicid; Acetate, Chlorhexidin;Chlorhexidine diacetate; Novalsan; Hibiscrub; Dyna-Hex; Peridex; Dantroche hibitane	12.5892541179	-4.9	-87.7069431365	-3	4		-102.3084519689	-92.80027023	0.0078235041	0.9999622488	4312	MMP1	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	Microsource	MS-01500177	-4.54750519	-4.24788278	-5.38510317	-92.80027023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509941-01	NCGC00509941-01	384569389		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1776112-90-3		2.8183829313	-5.55	-16.6079054642	4	4		-15.769112808	-11.06500024	0.2276953834	0.9671476913	1956	EGFR	COC1=N[N](C)C=C1NC2=C3N=C[N](C)C3=NC(=N2)N4C[C@H](F)[C@H](C4)NC(=O)C=C	ChemGood	C-1263	-0.4240729	-4.19411211	-6.18506414	-11.06500024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164588-06	NCGC00164588-06	384568259		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	59937-28-9				-12.1341032842	4	4		0	-3.07122945					CC(C)OC(=O)C(C(=O)OC(C)C)=C1S\C=C/S1	Adooq	A10552	-1.47591692	-5.9221968	-2.7615532	-3.07122945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271415-05	NCGC00271415-05	384568704		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	80621-81-4				-19.9639106598	4	4		0	-3.34999519				NR1I2	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(=C4C(=C(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C5=C(N=C6C=C(C)C=C[N]56)C4=C3C2=O)O)O	Adooq	A10793	-5.05523641	-3.91762014	-2.59333676	-3.34999519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507842-01	NCGC00507842-01	384569324		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	623152-17-0				-6.548924071	4	4		0	-2.3695088				MAPK14	CCCNC(=O)C1=C[N]2N=CN=C(NC3=CC(=CC=C3C)C(=O)NC4CC4)C2=C1C	Selleck	S8124	-1.30799823	-0.17391304	-1.88308958	-2.3695088												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390744-01	NCGC00390744-01	363680980		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	852391-20-9				-11.6054222394	4	4		0	-1.64238929				RIPK1	CN1C(=O)N[C@@H](CC2=C[NH]C3=C2C=CC=C3Cl)C1=O	MedChem Express	HY-14622B	-2.10573882	-2.61713612	-4.53715409	-1.64238929												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167525-11	NCGC00167525-11	384568325		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	118292-40-3		2.8183829313	-5.55	0.7401059828	4	4		14.9247627599	10.38224655	0.0257247882	0.9995945833		RARB	CCOC(=O)C1=CC=C(N=C1)C#CC2=CC=C3SCCC(C)(C)C3=C2	MedChem Express	HY-15388	-3.6873023	-2.33591872	5.76391815	10.38224655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485487-01	NCGC00485487-01	363681356		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1386874-06-1		1	-6	-165.2557867736	-2.4	4		-89.21309414	-79.92961189	0.058056757	0.9979159043		PIK3CA	CO[C@@H](C)CN1C(=O)N(C)C2=C1C3=CC(=CC=C3N=C2)C4=CC(=CN=C4)C(C)(C)O	MedChem Express	HY-12513	-13.50203344	-39.00303896	-62.62583696	-79.92961189												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263222-02	NCGC00263222-02	384568676		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1018340-07-2				-28.1956652704	4	4		0	-2.20940463				IDO1	CC1(C)OC/2=C(\[C@H](NCC3=CC=CC=C3)[C@@H]1O)C(=O)C4=CC=CC=C4C2=O	Cayman	16838	-7.12155445	-4.34979816	-7.60874655	-2.20940463												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167488-03	NCGC00167488-03	124893321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	475207-59-1	;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar	7.0794578438	-5.15	-76.0879996057	-2.1	4	4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate;4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE;BAY-439006;sorafenibum;2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-, MONO(4-METHYLBENZENESULFONATE);Sorafenib base;BAY 43-9006;4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID-4-METHYLBENZENESULFONATE;Nexavar;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N2-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE;SORAFENIB;BAY-43-9006 TOSYLATE;Sorafenib Tosilate;BAY-439006 TOSYLATE;4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID;2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N(SUP 2)-METHYLPYRIDINE-2-CARBOXAMIDE;sorafenib;CIPLUS_789424;sorafenib tosylate;SORAFENIB TOSYLATE;Sorafenib tosylate;Sorafenib;4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE;	-117.590311855	-99.90223873	0.0422073665	0.9988996408	2321	FLT1	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2	Pharmeks	PHAR202191	3.8409399	6.4271783	-22.48911364	-99.90223873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370980-01	NCGC00370980-01	384569038		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	3914		0.3981071706	-6.4	-302.5204369358	-1.1	4		-87.9812907006	-99.77514909	0.033223644	0.9993188672		HCK	CN1CCN(CC1)[C@H]2CC[C@@H](CC2)[N]3C=C(C4=CC=C(OC5=CC=CC=C5)C=C4)C6=C(N)N=CN=C36	Tocris	3914	-44.68142793	-70.7261759	-92.15245587	-99.77514909												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091823-09	NCGC00091823-09	384568098		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	481-74-3				2.1027836214	4	4		0	-1.43620574				FLT1	CC1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	Microsource	00300545	0.76126405	1.71940974	0.04357298	-1.43620574												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346878-04	NCGC00346878-04	384568956		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	(215543-92-3)				-10.0245294118	4	4		0	3.18255559				FGFR1	CC1=C[NH]C(=C1CCC(O)=O)\C=C\2C(=O)NC3=CC=CC=C23	SynKinase	SYN-1084	-4.13384084	-2.33752666	-0.30501089	3.18255559												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167578-04	NCGC00167578-04	384568330		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	145525-41-3				-25.9955334673	4	4		0	-5.22634731					O=C(C[C@H](CC1=CC=CC=C1)C(=O)O[Ca]OC(=O)[C@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)CC4=CC=CC=C4)N5C[C@H]6CCCC[C@H]6C5	MedChem Express	HY-17398	-6.73793471	-4.80596603	-2.18032391	-5.22634731												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160530-12	NCGC00160530-12	384568200		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	89778-26-7		12.5892541179	-4.9	-96.7846646676	-3	4		-105.2276911042	-99.41556886	0.0615819118	0.9976537226		ESR1	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)C2=CC=CC=C2)C3=CC=CC=C3	Enzo	DL519	-7.32345635	-2.02550292	-3.37926033	-99.41556886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347951-03	NCGC00347951-03	384568996		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1235864-15-9				-5.4998965671	4	4		0	-3.95209581				KDM1A	CC(N[C@H]1C[C@@H]1C2=CC=CC=C2)C3=CC=C4OCCOC4=C3	XcessBio	M66045-2s	-0.11976579	-1.54674769	-1.65820643	-3.95209581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381558-06	NCGC00381558-06	363679154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1174043-16-3		11.220184543	-4.95	-30.7266495281	4	4		-15.473996788	-14.93509627	0.1157961208	0.991754922	142	PARP1	COC1CCN(CC1)C(=O)C2=CC(=CC=C2F)CC/3=N/NC(=O)C4=CC=CC=C34	MedChem Express	HY-13536	-4.12343228	-5.52045526	-7.40451685	-14.93509627												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263138-10	NCGC00263138-10	384568616		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1019206-88-2		11.220184543	-4.95	-85.8771712343	-2.1	4		-106.0811729813	-90.87004777	0.0353410444	0.999228911		KDR	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C(=C2)F	MedChem Express	HY-10331A	-2.54443743	-5.52941704	-10.86776255	-90.87004777												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246966-11	NCGC00246966-11	384568513		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	31430-15-6		0.2238721139	-6.65	-123.5812254494	4	4		-28.093487905	-35.17347874	0.3944127937	0.890029213			COC(=O)NC1=NC2=CC(=CC=C2[NH]1)C(=O)C3=CC=C(F)C=C3	MedChem Express	HY-B0294	-15.55535505	-44.86266075	-37.50060973	-35.17347874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390558-02	NCGC00390558-02	384569192		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1186206-79-0		0.7943282347	-6.1	-185.0203430866	-1.1	4		-100.7426738734	-99.67186218	0.0278363051	0.9995217965		RET	CCN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)NC(=O)C4=CC(=CN=C4)C5=CC=CS5)C=C2C(F)(F)F	MedChem Express	HY-18007	-2.68880267	-49.28977909	-99.0098044	-99.67186218												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370777-04	NCGC00370777-04	363677849		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1197160-78-3		8.9125093813	-5.05	-34.5123814011	4	4		-29.974856332	-26.69015104	0.026649892	0.9995627915		PIK3CA	CN(C)C1CCN(CC1)C(=O)C2=CC=C(NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6)C=C2	APExBIO	B2179	-2.54443743	-3.31585787	-8.22398907	-26.69015104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378873-04	NCGC00378873-04	384569073		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	266359-93-7				-21.0840529417	4	4		0	-2.85975199				CXCR2	CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)N[S+](C)([O-])=O	MedChem Express	HY-15252	-4.29518338	-8.50343249	-2.91107892	-2.85975199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378895-01	NCGC00378895-01	363678262		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	863513-91-1				-21.907547132	4	4		0	-5.01297703			4987	OPRL1	CN(C)[C@@]1(CC[C@]2(CC1)OCCC3=C2[NH]C4=C3C=C(F)C=C4)C5=CC=CC=C5	MedChem Express	HY-15536	-4.45426425	-5.1624714	-4.54651652	-5.01297703												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480730-01	NCGC00480730-01	377020519		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			14.1253754462	-4.85	-37.6781196842	4	4		-21.7620490759	-21.46837423	0.4528757019	0.8478969008		EIF2AK3	CN1N(C2=CC=CC=C2)C(=O)C(=C1/C3=CC=CC=C3)/C(=O)C4=CC=C(C)C(=C4N)C5=CC=C6N=C(C)C=CC6=C5	Tocris	5517	-7.98915499	-3.17049939	1.40937398	-21.46837423												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095023-08	NCGC00095023-08	384568141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	434-03-7 				8.5260579504	4	4		0	1.8672402				PGR	CC\12CCC(=O)\C=C1CCC3C2CCC4(C)C3CCC4(O)C#C	Adooq	A11667	1.12968821	2.13634508	3.93781898	1.8672402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183044-01	NCGC00183044-01	124894250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	10118-90-8	Minocycline			-2.7466547045	4	4		0	1.20239521					CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O	Vitas	STK177317	-2.38200852	2.2832942	1.20377085	1.20239521												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384198-02	NCGC00384198-02	384569105		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	685898-44-6				-19.7278302501	4	4		0	-8.25652656				HIF1A	N[C@@H](CC1=CC=C(C=C1)[N+]([O-])(CCCl)CCCl)C(O)=O	Selleck	S7612	-4.64675629	-1.65792893	-0.76093849	-8.25652656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094594-17	NCGC00094594-17	384568133		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1405-89-6				1.184774064	4	4		0	3.99073493					CCC(C)C(N)\C1=N\C(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC3=CN=C[NH]3)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC	MedChem Express	HY-B0278	-1.64215465	0.92306314	0.07804497	3.99073493												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00507966-01	NCGC00507966-01	384569359		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1253573-53-3		1	-6	-82.0742213839	4	4		-25.9772747754	-29.21106658	0.3542532941	0.913748617		PIK3CA	COC1=C(F)C=C(NC2=NC=C(C=C2C3=NC(=NC(=N3)N)C)C(C)N4CCN(CC4)[S+](C)([O-])=O)C=N1	ChemieTek	CT-AMG511	-9.00135563	-14.30126548	-38.99892307	-29.21106658												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015598-16	NCGC00015598-16	384567869		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	4707-32-8		12.5892541179	-4.9	-21.7989160577	4	4		-15.05458068	-15.49516082	0.1113594888	0.9923296855		TDO2	CC1(C)CC\C2=C(/O1)C3=C(C=CC=C3)C(=O)C2=O	MedChem Express	HY-13555	-2.94622684	-2.15448814	-1.69967692	-15.49516082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379236-08	NCGC00379236-08	363678438		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1062368-49-3				-3.7152502032	4	4		0	-0.44970183				ACVR1	COC1=CC=C(C=C1)C2=C[N]3N=CC(=C3N=C2)C4=CC=CC5=C4C=CC=N5	Aobious	AOB4273	-2.83777677	2.65342223	2.87961792	-0.44970183												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023509-18	NCGC00023509-18	384568018		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	75330-75-5				-18.4925010537	4	4		0	-0.09776127				HMGCR	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	Selleck	S2061	-5.19656575	-5.3023087	-2.06489676	-0.09776127												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378675-01	NCGC00378675-01	384569062		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[223472-31-9]		10	-5	-29.6507968388	4	4		-10.946746792	-12.34491018	0.4779889623	0.8287012524		MMP1	CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)C1=CC=C(OC2=CC=CC=C2)C=C1	Tocris	2628	-5.97498226	-1.55595452	-5.83514624	-12.34491018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015508-23	Hydrochlorothiazide	384567858	Hypertension treatment	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	58-93-5				-17.0966396425	4	4		0	1.24071856					N[S+]([O-])(=O)C1=C(Cl)C=C2NCN[S+]([O-])(=O)C2=C1	Enzo	AC3145	-5.8507807	-1.01275146	-3.39859802	1.24071856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346552-08	NCGC00346552-08	384568837		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	391210-00-7				-111.5106554263	4	4		0	-29.68199585				MAP2K1	OCC(O)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(=C(F)C(=C1)Br)F	MedChem Express	HY-12062	-20.47279617	-28.75834566	-24.24271987	-29.68199585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095188-04	NCGC00095188-04	174007264		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	102625-70-7	; ; Protonix; PANTOPRAZOLE;Pantoprazole; Pantoprazol; Pantoprazole;PANTOPRAZOLE			-10.1013426713	4	4		0	3.43097042					COC1=C(OC)C(=NC=C1)C[S+]([O-])C2=NC3=CC(=CC=C3[NH]2)OC(F)F	Microsource	MS-01505818	-2.94144185	-5.29641081	-2.07794742	3.43097042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475726-01	NCGC00475726-01	377020349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1414943-88-6		1.2589254118	-5.9	-123.8001305585	-1.3	4		-79.5712148589	-76.59605269	0.0809069143	0.9959409852		CDK9	COC1=CC(=CC=C1C2=NC(=NC=N2)NC3=CC(=CC=C3)C[S+](C)([O-])=N)F	ActiveBioChem	A-1514	-1.2992872	-7.47412287	-82.99107361	-76.59605269												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188865-05	NCGC00188865-05	384568453		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	635702-64-6		10	-5	-59.7483649111	-3	4		-52.5166704435	-50.83723399	0.0372517367	0.9991435803		FLT1	C[N]1N=C2C=C(C=CC2=C1C)N(C)C3=NC(=NC=C3)NC4=CC=C(C)C(=C4)[S+](N)([O-])=O	Selleck	S1035	-5.31444555	-3.78187032	-7.9215648	-50.83723399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00350511-01	NCGC00350511-01	384569004		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-10.7353205101	4	4		0	1.31000098				SUCNR1	ClC1=CC=CC(=C1)C2=CC=C(C=C2)C3=NN=C(CCCC4=NC5=NC=CC=C5C=C4)O3	NCGCChem	PRP003-073	-2.96430185	-2.83485281	-3.09500398	1.31000098												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263221-03	NCGC00263221-03	384568675		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	168682-53-9				-8.9181671503	4	4		0	-0.91895591				GSTP1	CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)N[C@@H](C(=O)OCC)C2=CC=CC=C2	MedChem Express	HY-13634A	-1.85268866	-2.10005896	-2.90771176	-0.91895591												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018258-12	NCGC00018258-12	384568000		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	24169-02-6		14.1253754462	-4.85	-22.5450122014	4	4		-22.9306583681	-21.36083684	0.1119238422	0.9922187341			ClC1=CC=C(COC(C[N]2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C=C1	Selleck	S2535	-1.69001356	-2.65342223	-0.5852882	-21.36083684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249888-03	NCGC00249888-03	384568534		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	68-19-9				-10.5701668084	4	4		0	-5.96407186					CC(CNC(=O)CCC1(C)C(CC(N)=O)\C2=N\C1=C(C)/C3=N\C(=C/C4=N/C(=C(\C)C5=NC2(C)C(C)(CC(N)=O)C5CCC(N)=O)C(C)(CC(N)=O)C4CCC(N)=O)C(C)(C)C3CCC(N)=O)O[P]([O-])(=O)OC6C(O)C(OC6CO)[N]7C=[N+]([Co]C#N)C8=C7C=C(C)C(=C8)C	Prestwick	Prestw-433	-1.70777147	-2.76204944	0.25622432	-5.96407186												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347947-04	NCGC00347947-04	384568994		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[1099644-42-4]		7.9432823472	-5.1	-55.7336602164	-3	4		-54.369192784	-56.00479042	0.0070399712	0.9999694419		TGBR1	CCOC(=O)\C1=C(/C)N\C2=C(C1C3=CC=C(C=C3)C4=CC=CC=C4)\C(=O)CC(C)(C)C2	Tocris	5068	-2.932044	-2.7804631	-6.35726372	-56.00479042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167513-13	NCGC00167513-13	384568321		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	443913-73-3		10	-5	-100.646794904	-2.3	4		-126.9341987997	-99.64550898	0.1015955009	0.9935795995		EGFR	COC1=CC2=C(NC3=CC=C(Br)C=C3F)N=CN=C2C=C1OCC4CCN(C)CC4	Aobious	AOB87780	0.20848119	-10.50499471	-27.69639836	-99.64550898												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253740-06	NCGC00253740-06	384568567		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	175481-36-4				-9.3875546754	4	4		0	-3.95558973				GRIN2A	COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1	MedChem Express	HY-13015	-0.24745913	-5.2173913	-3.07929536	-3.95558973												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346874-02	NCGC00346874-02	384568952		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[130332-27-3]				5.5839534968	4	4		0	1.89849082				CCKB	C[C@](CC1=C[NH]C2=CC=CC=C12)(NC(=O)OC3C4CC5CC(C4)CC3C5)C(=O)NC[C@H](NC(=O)CCC(O)=O)C6=CC=CC=C6	Tocris	2607	1.23729563	0.70480549	0.73361058	1.89849082												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091835-15	NCGC00091835-15	384568099		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	55-86-7		12.5892541179	-4.9	-19.2308006348	4	4		-24.4804966279	-21.23374719	0.1459573631	0.986663745			CN(CCCl)CCCl	Enzo	AC3170	-1.62675102	1.36526512	-0.22943297	-21.23374719												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017363-15	NCGC00017363-15	384567988		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	66-81-9		1.4125375446	-5.85	-161.6418530703	-1.2	4		-54.0256613811	-66.63407958	0.0356794848	0.9992144514		GSK3B	C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2	Adooq	A10036	-19.11432445	-32.46246655	-57.70941612	-66.63407958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263148-07	NCGC00263148-07	384568623		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	154229-19-3				1.8073591777	4	4		0	-0.65500049				AR	C[C@]\12CC[C@H](O)CC1=C/C[C@@H]3[C@@H]2CC[C@@]\4(C)[C@H]3C\C=C4C5=CN=CC=C5	MedChem Express	HY-70013	-0.01807501	1.9549145	1.67158309	-0.65500049												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00481107-02	NCGC00481107-02	384569252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			4.4668359215	-5.35	-143.2213973476	-3	4		-108.4990155457	-99.49221557	0.057550343	0.9979516888		CECR2	CCC[S+]([O-])(=O)C1=NC(=CC(=N1)C2=CC3=C(C=C2)[N](C=C3)C4CC(C)(C)NC(C)(C)C4)NC5CC5	SGC	NVS-CECR2-1	-7.81139106	-3.26842517	-3.55329949	-99.49221557												5.2799999999E-8	2.64E-7	0.00000132	0.0000065999999999											
NCGC00244252-03	NCGC00244252-03	384568507		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	936091-26-8		2.8183829313	-5.55	-131.1818344746	-1.3	4		-98.3224847665	-99.62323829	0.0604670537	0.9977381036		JAK2	CC1=C(NC2=CC(=CC=C2)[S+]([O-])(=O)NC(C)(C)C)N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=C1	XcessBio	M60172-5s	1.70404379	-4.69334997	-82.68148565	-99.62323829												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346687-10	NCGC00346687-10	384568911		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	702674-56-4		11.220184543	-4.95	-13.8129071251	4	4		-26.7948741839	-24.82906182	0.1112861158	0.9922977268		PDPK1	BrC1=CN=C(NC2=CC(=CC=C2)NC(=O)N3CCCC3)N=C1NCCC4=CN=C[NH]4	MedChem Express	HY-11005	1.96009182	-0.77108219	0.39861189	-24.82906182												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142599-02	NCGC00142599-02	174007475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	83-48-7	Stigmasterol (Stigmasterin)			-9.4296206632	4	4		0	-0.05581655					CC[C@H](\C=C\[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C	Selleck	S2361	-2.20731061	-4.85380638	-1.43969237	-0.05581655												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00355875-04	NCGC00355875-04	384569024		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-12.8236521596	4	4		0	2.47336005				LDHA	COC1=NC(=C(C=N1)C2=CC=C3C(=C(C=NC3=C2)[S+]([O-])(=O)NC4CC4)NC5=CC(=CC(=C5)C(O)=O)OC6=CC(=CC(=C6)F)F)OC	APExBIO	B4929	-5.94667872	-1.56483875	2.29901203	2.47336005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263115-03	NCGC00263115-03	384568599		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	159752-10-0				-18.6885393541	4	4		0	-3.23589794				GH1	CC(C)(N)C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=C3C=CC=C4)[S+](C)([O-])=O	Axon Medchem	1376	-4.35607772	-3.41543067	-3.94718359	-3.23589794												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159422-10	NCGC00159422-10	384568176		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1953-02-2				5.2334934826	4	4		0	-0.85052302					CC(S)C(=O)NCC(O)=O	MedChem Express	HY-B0373	4.4826028	-4.60380097	-3.37594231	-0.85052302												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242506-13	Bortezomib	384568504	Proteasome Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	179324-69-7		0.1	-7	-457.8297311317	5	4		-13.640778856	-97.86880438	0.4206538178	0.9168209444		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	ActiveBioChem	A-1014	-96.76457298	-98.54855536	-98.28627616	-97.86880438												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025225-03	NCGC00025225-03	384568059		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[1216720-69-2]		10	-5	-120.7381876759	-2.3	4		-122.2496038526	-99.72215569	0.2064889039	0.9727455806		PAR1	CC(C)C1=CC=C(C[N]2C=CC3=C4C(=NC(=NC4=CC=C23)NC5CC5)N)C=C1	Tocris	1592	-3.98775727	-21.7097086	-29.82354363	-99.72215569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018296-15	NCGC00018296-15	384568003		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1104-22-9				-27.7025470099	4	4		0	-5.56167665				NR1I3	CC1=CC=CC(=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4	MedChem Express	HY-B0349	-7.6428318	-1.61119551	-4.15276771	-5.56167665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186528-19	NCGC00186528-19	384568443		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					4.2733363907	4	4		0	4.06706587				PKM2	C[N]1C2=C(SC(=C2)[S+](C)[O-])C\3=C1C(=O)N(CC4=CC(=CC=C4)N)\N=C3	Axon Medchem	2240	0.81174592	-0.82861483	-0.37225042	4.06706587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344510-06	NCGC00344510-06	384568720		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	284035-33-2		12.5892541179	-4.9	-96.7406287532	-3	4		-105.6897415869	-99.70299401	0.0663286899	0.9972767077		CASR	CC(C)(CC1=CC=C2C=CC=CC2=C1)NC[C@@H](O)COC3=C(C#N)C(=CC=C3)Cl	MedChem Express	HY-10007	-7.42991483	-2.32012153	-2.32535654	-99.70299401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386347-02	NCGC00386347-02	384569127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	128607-22-7		12.5892541179	-4.9	-39.6885206345	4	4		-28.867217872	-30.65942517	0.0654704465	0.9973516748	2100	ESR2	OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3	APExBIO	B4871	-4.13610252	-5.19908467	-3.68674361	-30.65942517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095164-06	NCGC00095164-06	384568153		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	14222-60-7				-8.094424117	4	4		0	-0.43025146					CCCC1=CC(=CC=N1)C(N)=S	Selleck	S1881	-1.35294118	1.4686728	-7.64628564	-0.43025146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095055-12	NCGC00095055-12	384568142		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	53003-10-4		0.1	-7	-257.1350217942	5	4		-64.176252123	-57.06174253	0.7532727494	0.3152328592		WNT1	CCC(C1CCC(C)C(O1)C(C)C(O)C(C)C(=O)C(CC)C2OC\3(O[C@]4(CC[C@@](C)(O4)C5CC[C@@](O)(CC)C(C)O5)C(O)\C=C3)C(C)CC2C)C([O-])=O	MedChem Express	HY-15597	-48.99530849	-74.47438297	-53.3865892	-57.06174253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346713-05	NCGC00346713-05	363677532		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1035270-39-3		12.5892541179	-4.9	-32.160987084	4	4		-16.5430521079	-19.71257485	0.1729988687	0.9811808825		FGFR3	COC1=CC(=CC(=C1)OC)CCC2=CC(=N[NH]2)NC(=O)C3=CC=C(C=C3)N4C[C@@H](C)N[C@@H](C)C4	ChemieTek	CT-A4547	-4.09421576	-6.13174976	-3.84336476	-19.71257485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347945-09	NCGC00347945-09	384568993		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	147591-46-6				-2.2360359276	4	4		0	2.04660682				DYRK1A	COC1=CC=C(C=C1)[N]2C(=C(C3=C2C=C(O)C=C3)[N+]([O-])=O)C	MedChem Express	HY-15838	-1.76584849	-3.1333571	4.19714875	2.04660682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390788-02	NCGC00390788-02	384569214		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	27314-97-2				-19.0575130269	4	4		0	-10.94934648					NC1=[N+]([O-])C2=CC=CC=C2[N+](=N1)[O-]	MedChem Express	HY-13767	-0.97121667	-3.53449813	-8.47401988	-10.94934648												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015785-10	NCGC00015785-10	384567890		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	57-83-0				-11.0912352848	4	4		0	-3.67458952				PGR	CC(=O)C1CCC2C3CC\C4=C\C(=O)CCC4(C)C3CCC12C	APExBIO	A8509	-0.77697334	-6.60991264	-2.49015194	-3.67458952												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263909-08	NCGC00263909-08	384568699		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	171596-29-5				9.4920885535	4	4		0	-4.2792688					CN1CC(=O)N2[C@H](CC3=C([NH]C4=C3C=CC=C4)[C@H]2C5=CC6=C(OCO6)C=C5)C1=O	DC Chemicals	DC5901	4.29101183	2.45587449	0.02344776	-4.2792688												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181033-02	NCGC00181033-02	174006814		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	103300-74-9	 ;Taltirelin; Taltirelin; Taltirelin Anhydride; Ceredist;TA-0910			-7.9806390314	4	4		0	-0.4465324			7201	TRHR	CN1C(=O)C[C@@H](NC1=O)C(=O)N[C@@H](CC2=CN=C[NH]2)C(=O)N3CCC[C@H]3C(N)=O	SantaCruz Bio	sc-204319 	-2.69291895	-1.35050811	0.24854624	-0.4465324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387023-02	NCGC00387023-02	384569148		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	319460-94-1		12.5892541179	-4.9	-70.5591250956	-3	4		-92.899025165	-85.96078054	0.0112060133	0.9999225456		FLT1	C[N]1N=C(C)C=C1C(=O)NC2=C(F)C=CC(=C2)NC3=CC4=N[NH]C(=C4C=C3)\C=C\C5=NC=CC=C5	SynKinase	SYN-1004	-1.75872735	-1.36384439	-1.23825989	-85.96078054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346714-02	NCGC00346714-02	384568928		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1001264-89-6		6.3095734448	-5.2	-16.8235693931	4	4		-17.51137776	-15.8428148	0.2423524377	0.9621295934		AKT1	CC(C)NC[C@@H](C(=O)N1CCN(CC1)C2=C3[C@H](C)C[C@@H](O)C3=NC=N2)C4=CC=C(Cl)C=C4	XcessBio	M60066-5s	-1.28054299	2.21423759	-4.66391697	-15.8428148												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167518-12	NCGC00167518-12	384568322		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	162635-04-3		0.2818382931	-6.55	-107.3992649696	4	4		-11.3095096919	-25.71947605	0.4904279495	0.8160086292		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(C)(CO)CO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	SIGMA	PZ0020	-17.56108597	-26.49449809	-31.98567738	-25.71947605												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00016244-21	NCGC00016244-21	384567924		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	54-85-3				-11.2576048986	4	4		0	-1.33856009				CYP1A2	NNC(=O)C1=CC=NC=C1	MedChem Express	HY-B0329	-2.41176471	-2.14237593	-3.72116213	-1.33856009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346895-01	NCGC00346895-01	174007115		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	100938-10-1	Amastatin			-21.2978256857	4	4		0	-5.2299455			51056	LAP3	CC(C)C[C@@H](N)[C@H](O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O	SIGMA	A1276	-4.25791855	-2.61845947	-6.7035308	-5.2299455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346623-04	BMS-378806	384568863	HIV Attachment Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	357263-13-9				-0.5651517787	4	4		0	2.26599101					COC1=C2C(=NC=C2C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C4=CC=CC=C4)[NH]C=C1	MedChem Express	HY-14134	0.05882353	0.20211094	-3.64864252	2.26599101												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345836-13	NCGC00345836-13	384568760		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	327033-36-3		12.5892541179	-4.9	-39.0849130539	-3	4		-50.5949040978	-47.01307377	0.0765803887	0.9963671803		PIM1	FC(F)(F)C1=CC=CC(=C1)/C=C/2SC(=O)NC2=O	Bio Vision	2211	-1.07993273	-2.450703	0.75042363	-47.01307377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263128-02	NCGC00263128-02	384568609		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	640736-79-4				-17.4495408865	4	4		0	-5.36787861				CXCR1	CCN(CC)CCCCNC1=NC2=CC(=C(Cl)C=C2N=C1C3=CC=C(S3)C4=CC=CS4)Cl	Axon Medchem	1501	-4.30202709	-2.8250555	-0.68264343	-5.36787861												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016438-06	NCGC00016438-06	384567940		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	366-70-1				-16.0797152645	4	4		0	-2.63861055					CNNCC1=CC=C(C=C1)C(=O)NC(C)C	Selleck	S1995	-4.30202709	-2.73799678	-1.72839506	-2.63861055												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386277-03	NCGC00386277-03	384569120		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	873652-48-3				-28.248337505	4	4		0	-12.42155689				XIAP	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)NC3=C(N=NS3)C4=CC=CC=C4	MedChem Express	HY-13638	-3.89017033	-7.38387884	-5.53541213	-12.42155689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015479-22	NCGC00015479-22	384567855		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	446-72-0	; ; Genistein;GENISTEIN;Genistein (4',5,7-Trihydroxyisoflavone); Genestein;Genistein			-16.1927479478	4	4		0	-2.37125749			7153	TOP2A	OC1=CC=C(C=C1)\C2=C\OC3=C(C(=CC(=C3)O)O)C2=O	SIGMA	G6649	-4.38697658	-3.3052525	-0.43026348	-2.37125749												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00390606-01	TNKS-656	363680925	Tachykinin NK2 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1419949-20-4		0.316227766	-6.5	-71.6274771143	4	4		-20.448888964	-24.20598802	0.0353395869	0.9992342859		TACR2	COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)C\C4=N\C5=C(\COCC5)C(=O)N4	MedChem Express	HY-13990	-9.24858055	-19.5737237	-23.22939328	-24.20598802												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345856-01	NCGC00345856-01	174006466		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1357158-81-6	AZD-26			-24.9366902918	4	4		0	-11.20982371			207	AKT1	NC(=O)C1=CN=C(C2=CC=C(C=C2)C3(N)CCC3)C(=C1)C4=CC=CC=C4	SynKinase	SYN-1160	-2.03955501	-7.85790694	-8.38022885	-11.20982371												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242497-14	NCGC00242497-14	384568500		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	879085-55-9				-6.2444196422	4	4		0	-2.14893716				SHH	C[S+]([O-])(=O)C1=CC=C(C(=C1)Cl)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC=CC=C3	Selleck	S1082	-1.48331273	-0.04902835	-1.16769837	-2.14893716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015830-08	Phenelzine	170465229	MAO Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	156-51-4	 ;PHENELZINE SULFATE;Phenelzine sulfate; Phenelzine sulfate; 2-Phenelzine; Nardil;Phenylethylhydrazine sulfate; Phenylethylhydrazine sulfate; Fenelzina; Felazine			-8.7852095233	4	4		0	-2.70668123			4128	MAOA	O=S(=O)(O)O.NNCCc1ccccc1	Microsource	01500476	-1.34334255	-2.80839775	-1.95833333	-2.70668123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167512-03	NCGC00167512-03	384568320		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	159351-69-6				-133.6038062262	4	4		0	-24.82072856				MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C\C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	MedChem Express	HY-10218	-27.65158371	-31.78531327	-31.79531342	-24.82072856												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387244-01	NCGC00387244-01	384569155		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1599432-08-2]				-14.7291344223	4	4		0	-6.24342671					COC1=CC=C(C=C1)C(=O)N2CCN(CC2)C(=O)/C=C/C3=CC=C(Br)C=C3	Tocris	5203	-2.11312217	-2.47473613	-4.2016045	-6.24342671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378973-06	NCGC00378973-06	384569080		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	934526-89-3		7.9432823472	-5.1	-77.6387906821	-2.4	4		-62.0228436121	-60.9934154	0.06155839	0.9976562932		PIK3CA	COC1=CC=C(Cl)C(=C1)NC2=NC3=CC=CC=C3N=C2N[S+]([O-])(=O)C4=CC(=CC=C4)NC(=O)C(C)(C)N	MedChem Express	HY-16526	-6.94874746	-4.15705393	-16.31082062	-60.9934154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387841-01	NCGC00387841-01	363680692		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1404456-53-6				-10.4765316863	4	4		0	-3.63107167			8493	PPM1D	CC1=NC=C(Cl)C=C1NCC2=CC=C(S2)C(=O)NC(CC3CCCC3)C(=O)NC4CC4	ChemieTek	CT-GSK283	-1.1684518	-3.53023114	-3.3067054	-3.63107167												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346542-12	NCGC00346542-12	384568828		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	422513-13-1		4.4668359215	-5.35	-130.3309844927	-2.2	4		-50.3378199483	-65.62171963	0.0255033834	0.9995988239		AURKA	CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1	MedChem Express	HY-12054	-16.69469771	-17.34645018	-37.95206972	-65.62171963												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186035-08	NCGC00186035-08	384568438		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[509093-47-4]				-17.7593736294	4	4		0	0.2232662				IRAK1	[O-][N+](=O)C1=CC=CC(=C1)C(=O)NC2=NC3=CC=CC=C3[N]2CCN4CCOCC4	Tocris	5665	-3.98198835	-4.96969157	-6.12924404	0.2232662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015615-15	NCGC00015615-15	170464649		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	103577-45-3	; ; Prevacid;Lansoprazole; Lansoprazole; Lansoprazol;LANSOPRAZOLE			-4.498072301	4	4		0	-1.82334062					FC(F)(F)COc3ccnc(CS(=O)c1nc2ccccc2n1)c3C	Microsource	01503926	0	-6.60991264	2.12436691	-1.82334062												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498399-01	NCGC00498399-01	363681480		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox					-0.7439369668	4	4		0	-1.62400874				ADAM10	COC(=O)N1CC2(CC2)C[C@@H]([C@H]1C(=O)N3CCN(CC3)C4=CC=CC=C4)C(=O)NO	NCGCChem	PJM010-074	-0.17560033	1.98508896	-0.6712963	-1.62400874												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346882-02	NCGC00346882-02	384568959		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[1203680-76-5]		14.1253754462	-4.85	-30.3182691768	4	4		-20.122373388	-20.15290375	0.2693568265	0.9526071061		INPPL1	C[C@H](NC(=O)C1=C(OCC2=CC=C(Cl)C=C2)C=CS1)C3=CC=CC=C3	Tocris	3718	-4.35488827	-5.03133147	-0.88425926	-20.15290375												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345056-07	NCGC00345056-07	384568731		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	717824-30-1		14.1253754462	-4.85	-32.3578811837	4	4		-28.760743628	-26.05061969	0.3768015578	0.9009139556		DHODH	COC1=CC(=CC=C1)C2=CC=C(NC(=O)/C3=C(/CCC3)C(O)=O)C(=C2)F	Selleck	S7262	-5.31191009	-3.18346064	4.15277778	-26.05061969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346498-01	NCGC00346498-01	174007476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	916881-67-9	Danoprevir			-21.0056662581	4	4		0	-1.66199725					CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)N[S+]([O-])(=O)C6CC6	Selleck	S1183	-5.08362966	-6.54987879	-3.15277778	-1.66199725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00415059-02	NCGC00415059-02	384569222		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1448671-31-5				-8.8897171362	4	4		0	0.19943967				SLC16A7	CC(C)N1C(=O)N(C)C(=O)C2=C1SC(=C2C(=O)N3C[C@](C)(O)CO3)CC4=C(C)[NH]N=C4C(F)(F)F	MedChem Express	HY-12750	-2.44962465	-3.36641815	-0.61574074	0.19943967												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532294-01	NCGC00532294-01	384569537		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox			0.3548133892	-6.45	-235.9038083491	-1.1	4		-95.1968339442	-99.26397265	0.0109372382	0.9999262164		HDAC1	CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC23CC4CC(CC(C4)C2)C3	NCGCChem	DYD034-032	-11.03648097	-91.69830307	-99.33796296	-99.26397265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017254-05	NCGC00017254-05	384567981		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[20350-15-6]		0.1	-7	-407.2986253466	5	4		-74.9249928197	-97.47585811	0.1017546218	0.9935779797		GBF1	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	Tocris	1231	-77.18099548	-98.27532001	-98.23233468	-97.47585811												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509997-02	NCGC00509997-02	384569404		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1320346-97-1		0.1	-7	-159.6101942427	5	4		-38.37634386	-31.03547184	0.7460187233	0.3458135505			COC1=CC=C(C=C1)[S+]([O-])(=O)N[C@@H](CNC2=NC(=NC(=C2C)N3CCC(CC3)C4=NC5=C(CCCN5)C=C4)C)C(O)=O	MedChem Express	HY-100506	-30.87330317	-40.76802156	-41.60358972	-31.03547184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250387-06	NCGC00250387-06	384568540		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[881375-00-4]		1.77827941	-5.75	-149.7050722745	-2.1	4		-88.084916971	-88.5075055	0.0300443832	0.9994428965		PRKDC	CCN1CCN(CC1)CC(=O)NC2=CC=C(C3=C2C4=C(S3)C=CC=C4)C5=C6O\C(=C/C(=O)C6=CC=C5)N7CCOCC7	Tocris	4840	-4.87330317	-10.75679317	-54.95626161	-88.5075055												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00351609-09	NCGC00351609-09	363677780		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	894187-61-2		0.0446683592	-7.3499999999	-445.4174094434	5	4		-37.049412224	-94.24419161	1	0.9974755549		SLC2A1	CC1=CC=C(C=C1)[S+]([O-])(=O)CC2=C(C)OC(=N2)C3=CC=C(C=C3)C(=O)NCC4=CC=CN=C4	MedChem Express	HY-12808	-92.90950226	-96.84706939	-97.11734578	-94.24419161												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253737-09	NCGC00253737-09	384568566		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	155270-99-8				-0.3846379664	4	4		0	3.25889875				ADORA2A	CCN1C(=O)N(CC)C2=C([N](C)C(=N2)\C=C\C3=CC=C(OC)C(=C3)OC)C1=O	MedChem Express	HY-10888	-1.71727007	-0.53541113	2.7741467	3.25889875												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346646-02	NCGC00346646-02	363677494		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	186392-40-5				-17.8783533727	4	4		0	-2.05649394				PYGL	CN(C)C(=O)[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC3=CC(=CC=C3[NH]2)Cl	Selleck	S2717	-4.92166062	-4.18317155	-1.21520213	-2.05649394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386260-02	NCGC00386260-02	363680172		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	194423-15-9		8.9125093813	-5.05	-150.8550439744	-2.1	4		-114.0108032635	-95.96812673	0.0355931478	0.9992179005		EGFR	BrC1=CC(=CC=C1)NC2=NC=NC3=CC=C(NC(=O)C=C)C=C23	APExBIO	A2024	-13.47260335	-20.11491751	-43.86831276	-95.96812673												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015558-16	NCGC00015558-16	384567864		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	51-30-9				-22.8924928696	4	4		0	-4.5853612				ADRB1	CC(C)NCC(O)C1=CC(=C(O)C=C1)O	Selleck	S2566	-5.51473843	-6.01140469	-1.68966352	-4.5853612												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386518-01	Cannabidiol	377020361	Cannabinoid Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	13956-29-1				-4.0799613964	4	4		0	-8.78083832				CNR1	CCCCCC1=CC(=C([C@@H]2\C=C(C)/CC[C@H]2C(C)=C)C(=C1)O)O	Axon Medchem	1234	0.94481902	-0.36827326	0.46893884	-8.78083832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510909-01	NCGC00510909-01	384569493		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	182167-02-8				-15.3118257617	4	4		0	-6.9508982				ESR1	C\C1=C(\[C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5	SantaCruz Bio	sc-480110	-3.97888573	-0.19334346	0.25622432	-6.9508982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387306-01	NCGC00387306-01	384569157		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-20.9673354921	4	4		0	-5.31187497				HIF2A	C[S+]([O-])(=O)C1=CC=C(OC2=CC(=CC(=C2)C#N)F)C3=C1[C@H](O)C(F)(F)C3	NCGCChem	PJM004-004	-4.14091471	-5.26386165	-3.92515476	-5.31187497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507893-01	NCGC00507893-01	384569356		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	256476-36-5				-21.5337857651	4	4		0	-2.21405647				PLAU	CC(C)(N[S+]([O-])(=O)C1=CC2=C(C=C1)C(=CN=C2NC(N)=N)Cl)C(O)=O	Selleck	S8457	-4.81193714	-7.56373685	-3.29675483	-2.21405647												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263144-09	NCGC00263144-09	384568619		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1213269-23-8		11.220184543	-4.95	-105.687960184	-2.1	4		-124.1520984366	-99.64184381	0.0135238724	0.9998871825		EGFR	COC1=CC(=CC=C1NC2=NC=C(Cl)C(=N2)OC3=CC(=CC=C3)NC(=O)C=C)N4CCN(C)CC4	MedChem Express	HY-12026	-5.06798517	-5.91460153	-20.22603639	-99.64184381												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018302-12	NCGC00018302-12	384568004		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	133-67-5				-5.4847136924	4	4		0	-0.71228453					N[S+]([O-])(=O)C1=C(Cl)C=C2NC(N[S+]([O-])(=O)C2=C1)C(Cl)Cl	MedChem Express	HY-B0235	-1.32578252	-1.07030142	-1.1712963	-0.71228453												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241104-09	NCGC00241104-09	384568474		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	285983-48-4		6.3095734448	-5.2	-11.9728026519	4	4		14.085418292	7.97758678	0.1392454383	0.9879431934		MAPK14	CC1=CC=C(C=C1)[N]2N=C(C=C2NC(=O)NC3=CC=C(OCCN4CCOCC4)C5=C3C=CC=C5)C(C)(C)C	MedChem Express	HY-10320	-4.65340884	-6.32118191	-2.33796296	7.97758678												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250380-10	NCGC00250380-10	377020384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	878739-06-1		10	-5	-77.9652623326	-2.4	4		-99.020168664	-77.9904079	0.0546229416	0.9981554831		BRAF	CN1\C=N/C2=CC=C(NC3=CC(=CC=C3C)NC(=O)C4=CC(=CC=C4)C(C)(C)C#N)C=C2C1=O	MedChem Express	HY-11004	-0.77264147	-5.76316151	-19.56018519	-77.9904079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014873-05	NCGC00014873-05	384567794		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[502137-98-6]				-14.1284469243	4	4		0	-3.39420595				MDM2	CN(C)CCCN\C1=C\2C(=O)N(C)C(=O)\N=C2N(C)C3=C1C=CC=C3	Tocris	3503	-4.0678733	-1.00157197	-0.72066355	-3.39420595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483135-03	CPI-0610	384569263	Bromodomain-containing protein 4 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1380087-89-7		0.2818382931	-6.55	-253.8644277431	-1.2	4		-71.6718410222	-83.32536571	0.0396163702	0.9990311485			CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(N)=O)C4=CC=C(Cl)C=C4	ChemieTek	CT-C0610_cm2	-31.64253394	-74.01302493	-84.48080497	-83.32536571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016497-13	NCGC00016497-13	384567946		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	536-33-4				-5.8695409448	4	4		0	-0.31968699					CCC1=NC=CC(=C1)C(N)=S	Microsource	01500292	-1.53138001	-1.02293997	-1.4379085	-0.31968699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095003-07	Tioxolone	384568140	Carbonic Anhydrase Type I Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	4991-65-5				-22.3334906544	4	4		0	-1.77974998				CA1	OC1=CC2=C(SC(=O)O2)C=C1	Selleck	S2603	-6.04585288	-4.55752405	-3.40353425	-1.77974998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094872-13	NCGC00094872-13	384568138		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	94-62-2				-26.1888817153	4	4		0	-7.9760479				MAOA	O=C(\C=C\C=C\C1=CC=C2OCOC2=C1)N3CCCCC3	Microsource	01500873	-5.37171753	-6.39874787	-2.91515591	-7.9760479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370925-02	NCGC00370925-02	363677938		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1188296-52-7		14.1253754462	-4.85	-24.0543367843	4	4		-10.628035676	-12.13413174	0.3737891106	0.9038548863		CSNK1E	NC1=C2C(=N[N](C3CCOCC3)C2=NC=N1)COC4=CC(=CC=C4)Cl	Axon Medchem	1792	-4.84829666	-2.53187865	-1.19410201	-12.13413174												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015257-18	NCGC00015257-18	384567834		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	637-07-0				-9.58464435	4	4		0	-0.62249674				PPARA	CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1	Microsource	01503429	-0.76694036	-7.5816642	-2.66328472	-0.62249674												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167982-11	NCGC00167982-11	384568345		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	72496-41-4		6.3095734448	-5.2	-50.3928047813	-2.4	4		-37.3226112816	-36.50533224	0.2084546996	0.9722419842		TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@H]6CCCCO6)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	Adooq	A10735	-2.32788956	-9.24855491	-15.30657041	-36.50533224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160664-04	NCGC00160664-04	384568201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	4008-48-4		11.220184543	-4.95	-54.1089877015	-3	4		-76.5982138708	-61.81682869	0.0961216408	0.9942593048		METAP2	OC1=CC=C(C2=C1N=CC=C2)[N+]([O-])=O	Microsource	01506173	0.76814409	-4.83597789	-9.28062277	-61.81682869												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346431-02	NCGC00346431-02	384568774		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[200189-97-5]				-16.4546614604	4	4		0	-4.85603982				GAPDH	CN(CC#C)C/C1=C/C2=CC=CC=C2OC3=CC=CC=C13	Tocris	2966	-2.41921243	-5.39757533	-4.11273682	-4.85603982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263164-07	NCGC00263164-07	384568635		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1140909-48-3		5.6234132519	-5.25	-38.8567155817	-2.4	4		-35.3171775439	-32.76431462	0.1053105888	0.9931061357		KDR	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3	ChemieTek	CT-XL184	-2.1013597	0.02228561	-12.90095667	-32.76431462												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484061-01	NCGC00484061-01	363681154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	916151-99-0		0.5011872336	-6.3	-95.9854628238	-1.4	4		-48.1141255755	-41.92981623	0.6638076784	0.5651123772	9314		CC1=C(C2=NC3=C([NH]2)C4=CC=CN=C4C5=NC=CC=C35)C6=C([NH]1)C=CC(=C6)F	MedChem Express	HY-16291	-2.44962465	-73.78676302	-26.75462963	-41.92981623												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00510073-01	NCGC00510073-01	384569407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1000009-73-3				-11.5193577984	4	4		0	-2.47875018				INPP5D	CC1=CC(=CC2=C1[C@]3(C)CC[C@H]4C(C)(C)CCC[C@]4(C)[C@H]3C2)O	Glixx	GLXC-01973	-2.70424514	-2.3052646	-1.96759259	-2.47875018												1.6E-8	8E-8	4E-7	0.000002											
NCGC00346450-01	NCGC00346450-01	174006450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	61966-08-3	Tricyclic Nucleoside Monophosphate (TCN-P)			-17.3269503364	4	4		0	-5.27090555			207	AKT1	CN1\N=C(N)/C2=C[N]([C@@H]3O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]3O)C4=C2C1=NC=N4	Berry & Associates	PRA 10162	-2.99398569	-4.79348671	-3.4212963	-5.27090555												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509936-02	NCGC00509936-02	384569385		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1661839-45-7				32.7594212348	4	4		0	4.88574434				CDK8	C[N]1C=C(C=N1)C2=CC=C(C=C2)C3=CN=CC(=C3N4CCC5(CCNC5=O)CC4)Cl	Glixx	GLXC-07110	5.77828054	10.74781046	9.78561392	4.88574434												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162398-11	NCGC00162398-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-8.9206951437	4	4		0	-3.51850081					CN([C@@H](CC1=CC=C(O[S+]([O-])(=O)C2=CC=CC3=C2C=CN=C3)C=C1)C(=O)N4CCN(CC4)C5=CC=CC=C5)[S+]([O-])(=O)C6=CC=CC7=C6C=CN=C7	BIOMOL	EI-230	-1.76923077	-2.16034134	-0.37619544	-3.51850081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345083-01	NCGC00345083-01	174007178		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	154589-96-5	Stauprimide	1.1220184543	-5.95	-128.2495220948	-1.4	4		-52.9771292675	-67.13903998	0.1692565499	0.9819090479			CO[C@@H]1C(C[C@H]2O[C@]1(C)[N]3C4=C(C=CC=C4)C5=C6C(=O)NC(=O)C6=C7C8=C(C=CC=C8)[N]2C7=C35)N(C)C(=O)C9=CC=CC=C9	LC Labs	S-9344	-9.17057626	-20.55891699	-57.62769305	-67.13903998												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092357-04	NCGC00092357-04	174007250		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	84485-00-7	;Sibutramine hydrochloride;SIBUTRAMINE HYDROCHLORIDE; Meridia			-15.9304165073	4	4		0	-1.35031969			3350	HTR1A	CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2	Microsource	MS-01505210	-5.85996282	0.14364689	-0.08230453	-1.35031969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347934-09	NCGC00347934-09	363677720		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1355326-35-0				-16.7671473148	4	4		0	-3.03527482				IDH1	CC1=CC=CC=C1C(N(C(=O)C[N]2C=CN=C2C)C3=CC=CC(=C3)F)C(=O)NC4CCCCC4	MedChem Express	HY-18082	-3.71740503	-6.1567415	-1.00482903	-3.03527482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496910-01	NCGC00496910-01	384569297		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-9.750556933	4	4		0	2.4755103				HIF2A	OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C3CCCCC3)C1=O	MedChem Express	HY-17608	-3.23017234	-2.02536183	-2.77059656	2.4755103												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496839-01	NCGC00496839-01	384569293		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1357470-29-1		0.7943282347	-6.1	-72.5079484129	4	4		-20.3356850559	-25.31004198	0.2695370632	0.9524891101		RET	CN1CCN(CC1)C2=CC=C(NC3=NC=C4\C=C(\C#N)C(=O)N(C5CCCC5)C4=N3)C=C2	Selleck	S8161	-7.96715691	-17.23349913	-30.33022779	-25.31004198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346686-10	NCGC00346686-10	384568910		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	905854-02-6		2.8183829313	-5.55	-77.9892440979	-1.4	4		-33.5010778459	-41.60193497	0.0946810476	0.9944354878		MET	O=C1NC(=O)[C@H]([C@@H]1C2=C[NH]C3=C2C=CC=C3)C4=C[N]5CCCC6=CC=CC4=C56	MedChem Express	HY-50686	-6.60427335	-10.11321091	-32.85030951	-41.60193497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499577-01	NCGC00499577-01	384569309		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1918238-72-8				-26.8873746368	4	4		0	-3.0105893				JAK3	CCOC(=O)C1=C[NH]C2=NC=NC(=C12)C3=CC(=CC=C3F)NC(=O)C=C	Organix	O-10105	-7.8405549	-2.54310936	-4.06018519	-3.0105893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016345-14	NCGC00016345-14	384567933		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	90-33-5				-19.4400006153	4	4		0	-2.55472719				MAOA	C\C1=C\C(=O)OC2=C1C=CC(=C2)O	Microsource	01506174	-5.70701084	-5.01303572	0.78240741	-2.55472719												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263224-03	NCGC00263224-03	384568678		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	35922-06-6		10	-5	-90.9018052402	-3	4		-102.7593324788	-98.66143991	0.0079850253	0.9999606731		CERS1	CCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Cayman	10006305	-3.57918552	-4.20839883	-7.26555772	-98.66143991												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025018-11	NCGC00025018-11	363676536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	65-19-0				-12.5567685425	4	4		0	-4.68561502				ADRA2A	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C([NH]C5=C4C=CC=C5)[C@@H]3C[C@H]12	Selleck	S2373	-1.82261121	-4.14930322	-2.14623677	-4.68561502												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346495-14	NCGC00346495-14	384568801		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[663619-89-4]		6.3095734448	-5.2	-68.2284402095	-2.4	4		-38.2730781479	-41.8906529	0.0588146565	0.9978627931		PIK3CB	CC(NC1=CC=CC=C1)C\2=C\C(=C/N3C(=O)\C=C(/N=C23)N4CCOCC4)C	Tocris	5832	-7.87692863	-6.6854864	-17.35525096	-41.8906529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509934-01	NCGC00509934-01	384569383		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1402608-02-9		6.3095734448	-5.2	-60.8377512684	-2.4	4		-40.178439704	-37.85648796	0.078049013	0.9962292872		AKT1	NC(=O)C1=N[N]2C(=NC(=C2C3=CC=CC=C3)C4=CC=C(C=C4)C5(N)CCC5)C=C1	ChemGood	C-1071	-4.79112154	-9.44571403	-19.60879957	-37.85648796												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242501-03	NCGC00242501-03	377020171		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	347323-96-0				-17.5594060279	4	4		0	-7.6581576				TRIO	CC1=CC(=C(C)[N]1C2=CC=CC=C2)\C=C3\SC4=NC5=C(C=CC=C5)[N]4C3=O	SIGMA	I1411	-3.1850582	-1.5503876	-3.74615872	-7.6581576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386224-06	NCGC00386224-06	377020161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1204313-51-8		11.220184543	-4.95	-49.1327025365	4	4		-22.9215362401	-25.39653007	0.2011409656	0.9743013337		EGFR	C#CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C4OCCOCCOCCOC4=C3	MedChem Express	HY-15164	-6.29524987	-9.71206989	-10.42487338	-25.39653007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166323-05	NCGC00166323-05	384568306		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	70-00-8		5.0118723363	-5.3	-42.9227984093	4	4		-30.1469546439	-24.94999767	0.0858950021	0.995438205		TYMS	OC[C@H]1O[C@H](C[C@@H]1O)N2/C=C(C(=O)NC2=O)/C(F)(F)F	Selleck	S1778	-3.1608688	-8.16990551	-15.01125492	-24.94999767												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250390-10	NCGC00250390-10	384568543		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1045792-66-2		2.5118864315	-5.6	-147.9594815641	-2.1	4		-97.7049551767	-99.52090795	0.0166839833	0.9998282843		HDAC6	CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-18613	-4.50291365	-14.91798895	-73.8932658	-99.52090795												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025288-07	NCGC00025288-07	384568065		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	522-17-8		0.7079457844	-6.15	-35.7014506033	4	4		-19.01692372	-17.10777245	0.2132501651	0.9709800507		PIK3CA	COC1=CC2=C(C=C1OC)[C@H]3[C@@H](CO2)OC4=C(C=CC5=C4\C=C/C(C)(C)O5)C3=O	MedChem Express	HY-13425	-0.36199894	-11.08486361	-20.37610204	-17.10777245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346825-02	NCGC00346825-02	384568944		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	413611-93-5		11.220184543	-4.95	-87.4411942695	-2.1	4		-97.980522284	-82.4730519	0.0243082151	0.9996354198		MYC	[O-][N+](=O)C1=CC=C(NC2=CC=CC=C2C3=CC=CC=C3)C4=NON=C14	SIGMA	G3798	-4.48658852	-6.46754791	-14.05092593	-82.4730519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345848-02	NCGC00345848-02	363677390		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	(913376-84-8)		12.5892541179	-4.9	-46.082399332	-3	4		-57.1680516693	-51.90179971	0.1981400684	0.9749846961		MET	COC1=CC=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)\C4=C(C)\N(CC(C)(C)O)N(C4=O)C5=CC=CC=C5)C=C3F	SynKinase	SYN-1143	-4.03880767	-1.30814618	5.63425926	-51.90179971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018185-20	NCGC00018185-20	363676503		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	53902-12-8				-22.2220988229	4	4		0	-2.8016525				TNF	COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC	MedChem Express	HY-B0195	-5.90895123	-5.26002836	-1.94907407	-2.8016525												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345492-06	PCI-34051	384568736	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	950762-95-5		5.6234132519	-5.25	-35.1894931053	-2.4	4		-32.6794625559	-30.71995411	0.059092333	0.997843461		HDAC8	COC1=CC=C(C[N]2C=CC3=C2C=C(C=C3)C(=O)NO)C=C1	Selleck	S2012	-1.37104072	-0.57040198	-11.91587726	-30.71995411												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159521-16	Zoledronic acid monohydrate	384568184	Farnesyl Pyrophosphate Synthase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	165800-06-6				-15.5836514185	4	4		0	-3.71695772				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	MedChem Express	HY-13777A	-4.21350801	-1.92835067	-1.70902929	-3.71695772												1.6E-8	8E-8	4E-7	0.000002											
NCGC00241113-04	NCGC00241113-04	384568478		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	252916-29-3		15.8489319246	-4.8	-36.4669363144	4	4		-9.50204246	-13.25031014	0.5102583335	0.7983730419		FLT1	CC1=C(CCC(O)=O)C(=C([NH]1)\C=C\2C(=O)NC3=CC=CC=C23)C	Axon Medchem	1891	-7.86049394	-6.03752231	-3.24860809	-13.25031014												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386429-04	NCGC00386429-04	384569139		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	955977-50-1		10	-5	-67.9548263738	-2.4	4		-66.6769972275	-55.73999903	0.1404919918	0.987630854	5293	PIK3CD	FC1=C(C2=NC3=C(SC(=C3)CN4CCN(CC4)CC5CC5)C(=N2)N6CCOCC6)C7=C([NH]C=C7)C=C1	Selleck	S7623	-2.83316791	-10.13577094	-17.13087166	-55.73999903												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242505-01	NCGC00242505-01	137275859		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	4906-84-7	deacetyl cortivazol	3.1622776602	-5.5	-116.4906689127	-2.1	4		-100.0294455404	-98.24349756	0.0144775271	0.9998707051		NRC31	C[C@@H]1C[C@H]2[C@@H]3\C=C(C)/C4=C/C5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)C=N[N]5C6=CC=CC=C6	NCGCChem	deacetyl cortivazol	0.75791753	-2.11497961	-62.26037754	-98.24349756												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346842-04	NCGC00346842-04	384568951		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-16.0560277768	4	4		0	-3.91352603				IDO1	C[N]1C=C(C[C@@H](N)C(O)=O)C2=C1C=CC=C2	APExBIO	B4900	-4.16854642	-6.41663306	2.60475099	-3.91352603												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00263239-03	NCGC00263239-03	384568682		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	821794-92-7				-19.2931113391	4	4		0	-10.37257547				RPS6KA1	COCCNCCC[N]1C2=NC=NC(=C2C(=C1C(=O)CF)C3=CC=C(C)C=C3)N	Chemscene	CS-0648	-0.75048561	-6.11071492	-7.65803789	-10.37257547												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185736-03	NCGC00185736-03	384568424		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	171228-49-2		7.9432823472	-5.1	-62.9856990773	-2.1	4		-102.4147361284	-88.66192444	0.01472987	0.9998661614		CYP51A1	CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5CO[C@@](C5)(C[N]6C=NC=N6)C7=C(F)C=C(F)C=C7)C=C4	Enzo	AC3226	3.50861688	4.28375286	-12.40596234	-88.66192444												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346621-05	NCGC00346621-05	363677482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	885499-61-6		11.220184543	-4.95	-60.9126626974	-2.4	4		-52.8965259844	-46.81133957	0.1084431302	0.9926814425		AKT1	NC1(CCN(CC1)C2=C3C=C[NH]C3=NC=N2)CC4=CC=C(Cl)C=C4	MedChem Express	HY-13260	-4.49536854	-8.75451676	-11.91203704	-46.81133957												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263183-02	NCGC00263183-02	384568651		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	955365-80-7		0.7943282347	-6.1	-141.0147114059	-1.4	4		-66.0745812554	-66.75590401	0.0592693377	0.9978279476		WEE1	CN1CCN(CC1)C2=CC=C(NC3=NC=C4C(=O)N(CC=C)N(C5=CC=CC(=N5)C(C)(C)O)C4=N3)C=C2	Selleck	S1525	-10.02262443	-36.01616887	-57.73013643	-66.75590401												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016759-08	NCGC00016759-08	384567957		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	22204-53-1				-21.2307430567	4	4		0	-3.04044364				PTGS2	COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(O)=O	MedChem Express	HY-15030	-4.36651584	-5.66359757	-5.50695735	-3.04044364												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00248196-04	NCGC00248196-04	384568523		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	2226-96-2				-4.9101537099	4	4		0	-0.92743092					CC1(C)CC(O)CC(C)(C)N1[O]	Selleck	S2910	-0.67420814	-4.13653717	0.5665594	-0.92743092												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00107508-04	NCGC00107508-04	384568161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[901245-65-6]				-23.9066631369	4	4		0	-8.84149251				BRPF1	COC1=CC=CC=C1C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCCC4	Tocris	5385	-5.07214305	-5.85469899	-0.36310821	-8.84149251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091149-26	Valproic acid sodium salt (Sodium valproate)			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1069-66-5				-14.0710523396	4	4		0	-5.99770971					CCCC(CCC)C(O)=O	Selleck	S1168	-2.75294326	-4.40081835	0.74074074	-5.99770971												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346560-03	NCGC00346560-03	384568840		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	3424-98-4				-22.7780403944	4	4		0	-3.88872984					CC/1=C/N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	Selleck	S1651	-5.54129415	-6.96034475	-1.22488502	-3.88872984												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094087-08	NCGC00094087-08	384568125		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	50924-49-7				-7.5672624945	4	4		0	-0.48738117				IMPDH1	NC(=O)C1=C(O)[N](C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	MedChem Express	HY-17470	-0.78498601	-3.92525877	-3.5120238	-0.48738117												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250386-10	NCGC00250386-10	384568539		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	702675-74-9		10	-5	-71.7624840147	-3	4		-90.1359980023	-78.67104184	0.0120985158	0.9999097198		IKBKE	IC1=C(NCCCNC(=O)C2=CC=CS2)N=C(NC3=CC(=CC=C3)NC(=O)N4CCCC4)N=C1	Glixx	GLXC-04290	-2.09329604	-1.65792893	-9.23857373	-78.67104184												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167751-05	NCGC00167751-05	384568334		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	344930-95-6		8.9125093813	-5.05	-12.6713653102	4	4		-11.884234904	-10.73686242	0.3830758312	0.8980344636		ELA2	COC1=CC(=C2C(=O)N(COC/3=C/C(=O)N4\C=C/C=C(OCCN5CCCCC5)\C4=N3)[S+]([O-])(=O)C2=C1)C(C)C	Axon Medchem	1269	-2.10231887	2.21355917	-1.18043022	-10.73686242												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250384-02	NCGC00250384-02	377020291		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	503555-55-3		10	-5	-30.9448133002	4	4		-18.085554884	-16.6923003	0.2332968825	0.9651994837		IKBKB	CN1CCN(CC1)C2=CC(=C(Cl)C=N2)C(=O)NC3=CC=C4CCC5=C([N](N=C5C(N)=O)C6=CC=C(F)C=C6)C4=C3	Axon Medchem	1651	-3.28767123	-6.41647597	-7.99495351	-16.6923003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022304-23	ACETYLCYSTEINE			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	616-91-1				-2.7095530481	4	4		0	0.15860809					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	0.61864781	-4.32036613	-1.98588851	0.15860809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483117-01	NCGC00483117-01	363681136		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox			7.0794578438	-5.15	-96.8239701358	-2.1	4		-92.8077414554	-88.80611362	0.0330138637	0.9993272203		EP300	CCCOC1=CC=C(CCC2=NC3=C(C=CC(=C3)C4=C(C)ON=C4C)[N]2CCN5CCOCC5)C=C1	Tocris	5801	-4.49845338	-3.02974828	-24.09700481	-88.80611362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509994-02	NCGC00509994-02	384569401		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1000025-07-9				2.8856822172	4	4		0	-6.19532827					OC(=O)CNC(=O)C1=NC=C(C=C1O)C2=CC=CC(=C2)Cl	MedChem Express	HY-101277	2.48342908	1.19908467	0.48128592	-6.19532827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483924-02	Brigatinib	384569265	IGF-1R Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1197953-54-0		1	-6	-99.1718536976	-1.4	4		-41.4375161367	-39.19464362	0.4013919314	0.8853192555		IGFR1	COC1=C(NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[P](C)(C)=O)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-12857	-6.37429211	-18.78058821	-57.90277778	-39.19464362												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249391-11	NCGC00249391-11	384568526		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	940310-85-0		11.220184543	-4.95	-73.6786030234	-3	4		-109.5154470745	-92.5590009	0.0399495965	0.9990143938		BRAF	C[N]1N=CC2=C1N=C(N=C2NC3=CC(=CC=C3C)C(=O)NC4=CC=CC(=C4)C(F)(F)F)C5=CC=CN=C5	MedChem Express	HY-13258	0.83410158	-2.61629237	-6.86574074	-92.5590009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00372530-03	NCGC00372530-03	384569044		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-20.4233950043	4	4		0	-7.65470721				LDHA	N[S+]([O-])(=O)C1=CC=C(CC2=C(CC3CC3)[N](N=C2C4=CC(=CC=C4)C5=CC=CC=C5)C6=NC(=CS6)C(O)=O)C=C1	NCGCChem	GRB048-023	-2.99141437	-6.35460607	-3.75052676	-7.65470721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484075-02	NCGC00484075-02	384569269		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1620576-64-8		10	-5	-60.3844784014	-2.4	4		-62.4167256277	-50.35308713	0.1431552002	0.9871509529		PIK3CA	CC[N]1N=C(N=C1C2=NC(=C(N)N=C2)C3=NN=C(O3)C(C)(C)C)C4CCN(CC4)C(=O)CCO	MedChem Express	HY-12869_cm2	-2.12445782	-8.99751883	-15.78794481	-50.35308713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499427-02	NCGC00499427-02	384569306		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1622849-58-4				-11.1825772979	4	4		0	-0.35785857				RIPK1	CN1C(=O)[C@H](COC2=C1C=CC=C2)NC(=O)C3=NOC(=C3)CC4=CC=CC=C4	Glixx	GLXC-08004	-3.42568824	-1.27541026	-1.82522392	-0.35785857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347949-11	NCGC00347949-11	363677729		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1118807-13-8				-12.5040250272	4	4		0	0.48880633				WNT5A	COC1=CC=C(CCC(=O)NC2=NC3=CC=C(Cl)C=C3S2)C=C1OC	Aobious	AOB3874	-4.33800271	-3.84179253	1.27826942	0.48880633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390584-01	Exatecan	384569198	DNA Topoisomerase I Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	169869-90-3		0.7943282347	-6.1	-241.4929820529	-1.2	4		-75.9768857989	-96.44148988	0.0386800572	0.9990762107		TOP1	CC[C@@]1(O)C(=O)OC/C2=C1/C=C3\N(CC4=C5[C@@H](N)CCC6=C5C(=CC(=C6C)F)N=C34)C2=O	MedChem Express	HY-13631A	-23.14505197	-60.25763142	-97.55583649	-96.44148988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015501-05	NCGC00015501-05	90341825		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	304-20-1	 Hydrochloride, Hydralazin; ; Apressoline; Rolazine;Hydralazine?HCl; Apressin; Hydrazinophthalazine; Hipoftalin;HYDRALAZINE HYDROCHLORIDE; Hidralazina; Hydralazine hydrochloride;Hydralazine hydrochloride; Nepresol; Apresoline			-4.1312249127	4	4		0	-3.45097272				SMO	NNC1=C2C=CC=CC2=CN=N1	SigmaAldrich	Lopac-H-1753	-1.13872571	2.56270694	-0.62274664	-3.45097272												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386948-01	NCGC00386948-01	363680520		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1291087-14-3		15.8489319246	-4.8	-14.3501140759	4	4		-22.824363008	-16.10363584	0.5092534851	0.7963195467		FFAR1	CC#C[C@@H](CC(O)=O)C1=CC=C(OCC2=CC(=CC=C2)C3=CC=C(C=C3)C(F)(F)F)C=C1	Axon Medchem	2405	-3.10701956	0.39611718	7.6446381	-16.10363584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387872-01	NCGC00387872-01	363680714		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1061353-68-1		11.220184543	-4.95	-56.4468005162	4	4		-14.7424141881	-20.94188377	0.3411993752	0.9215495201		ERK2	CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=C[NH]C(=C3)C(=O)NC(CO)C4=CC(=CC=C4)Cl	ChemieTek	CT-VS4718	-9.07320528	-12.67139686	-12.54417816	-20.94188377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370784-05	Resiquimod	363677855	Toll-Like Receptor 7 (TLR7) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	144875-48-9		8.9125093813	-5.05	-109.8171099642	-2.1	4		-117.848480757	-99.58500217	0.0120221719	0.9999108493		TLR7	CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2[N]1CC(C)(C)O	MedChem Express	HY-13740	-4.70089326	-6.30012995	-27.14989513	-99.58500217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488967-01	NCGC00488967-01	363681477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1449228-40-3				-3.9305360019	4	4		0	-0.38121894				CDK8	CN1CCN(CC1)C(=O)C2=CC3=CC=C(CCNC4=C5C=C(C=CC5=NC=N4)C#N)C=C3C=C2	APExBIO	A8732	-1.95795362	3.12766053	-1.19018584	-0.38121894												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509912-01	NCGC00509912-01	384569378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1707289-21-1				-9.222459026	4	4		0	-0.85412344				FGFR4	COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=C(C=C2)N=C(N[C@@H]4COCC[C@@H]4NC(=O)C=C)N=C3)OC	Selleck	S8503	-1.95795362	-6.3180535	1.19018584	-0.85412344												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167510-09	NCGC00167510-09			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-4.6172902099	4	4		0	-2.30222051					[H][C@](C)(O)[C@@]1([H])C(=O)N2C(C(O)=O)=C(S[C@]3([H])CN[C@]([H])(CN[S+](N)([O-])=O)C3)[C@]([H])(C)[C@]12[H]	Selleck	S1374	0.43305347	-2.57208238	-3.15405822	-2.30222051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370842-02	NCGC00370842-02	384569037		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	950912-80-8		6.3095734448	-5.2	-19.9943925236	4	4		-18.042295492	-16.70191291	0.3099024405	0.9359599544		CSNK1E	NC1=NC=CC(=N1)C2=C(N=C[N]2C3CCCCC3)C4=CC=C(F)C=C4	Adooq	A11781	-2.26248343	2.61784897	-5.09789262	-16.70191291												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164613-04	NCGC00164613-04	384568264		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	82159-09-9				3.236904532	4	4		0	7.01925897				AKR1B1	CC(=C/C1=CC=CC=C1)\C=C2/SC(=S)N(CC(O)=O)C2=O	Selleck	S2035	-2.53953909	3.84179253	2.56122115	7.01925897												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015924-24	NCGC00015924-24	384567908		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	5985-28-4				-26.174842907	4	4		0	-5.12269039				ADRA1A	CNCC(O)C1=CC=C(O)C=C1	MedChem Express	HY-N0132A	-6.86850429	-1.06590466	-5.81074121	-5.12269039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015034-15	NCGC00015034-15	384567798		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	3544-24-9				-11.942134186	4	4		0	0.72343338				PARP1	NC(=O)C1=CC(=CC=C1)N	Selleck	S1132	-3.27157704	0.21318093	-6.11977338	0.72343338												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381605-01	NCGC00381605-01	384569101		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			1.5848931925	-5.8	-183.8384847008	-2.3	4		-96.4006517313	-91.9444716	0.0762246145	0.9963997188		PRKCA	C[N]1C=C(C2=CC=CC=C12)/C3=C(/C(=O)NC3=O)C4=C[N](C)C5=CC(=CC=C45)[N+]([O-])=O	Angene	AGN-PC-0LQ2UY	-15.00225938	-34.7303488	-75.15568666	-91.9444716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345839-10	NCGC00345839-10	384568762		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1187595-84-1				-1.0023240308	4	4		0	0.08143713				JAK2	CC[S+]([O-])(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	Bio Vision	2841	-0.35042583	-1.07719928	0.83635485	0.08143713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181345-01	NCGC00181345-01	50125938		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	110221-44-8	 ;Temocapril hydrochloride; Temocapril hydrochloride; Acecol			-27.0254822338	4	4	LS-150463;CIPLUS_213546;LS-150462;CIPLUS_213547;Temocaprilum;1,4-Thiazepine-4(5H)-acetic acid, 6-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, (2S-(2alpha,6beta(R*)))-;TEMOCAPRIL HYDROCHLORIDE;Acecol;TEMOCAPRIL;CS 622;temocaprilum;Temocapril Hydrochloride;TEMOCAPRIL HYCROCHLORIDE;alpha-((2S,6R)-6-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl)acetic acid.HCl;CS622;Temocapril;Temocapril hydrochloride;temocapril;A-(6((S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL)AMINO-5-OXO-2-(2-THIENYL)PERHYDRO-1,4-THIAZEPIN-4-YL)ACETIC ACID(2S,6R)HYDROCHLORIDE;temocapril hydrochloride;CS-622;	0	-1.23113772			1636	ACE	Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3	APAC	872509	-8.68967353	-3.69193942	-1.90959633	-1.23113772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246387-06	Arbidol		antiinfluenza drug	SARS-CoV-2_CPE_SRI		131707-23-8		0.0625931278	-7.2034733462	-99.0665229266	-2.2	10		-38.208213744	-30.59017812	0.0140188043	0.8697255599			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	-8.11544057	2.46923289	-3.57016475	-3.38143357	-4.46663783	-3.54657335	2.31982071	-8.25698895	-12.33043683	-30.59017812						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00238624-07	NCGC00238624-07	163827054		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	n	NCGC00238624; NCGC00238624	11.220184543	-4.95	-49.9507283892	-3	4		-47.6982951778	-43.85628743	0.1097736696	0.9924984559	2584	GALK1	ClC1=C[NH]N=C1C\2NC(=N\C3=C2C(=O)CCC3)/NC4=NC5=CC=CC=C5O4	NCGCChem	LLI10-095	-5.14992903	-0.88385582	-4.86826203	-43.85628743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346304-02	NCGC00346304-02	174006393		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	303727-31-3	L-779,450	14.1253754462	-4.85	-42.2717046931	4	4		-23.56658552	-24.32095808	0.3534248701	0.9143019008	673	BRAF	OC1=CC(=CC=C1Cl)C2=C([NH]C(=N2)C3=CC=CC=C3)C4=CC=NC=C4	Tocris	3185	-8.38804116	-2.47663767	-1.34880348	-24.32095808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389582-02	NCGC00389582-02	363680807		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1286739-19-2		1.1220184543	-5.95	-105.5512466237	-2.4	4		-45.6617888588	-24.6923708	1	0.9998861944		PAK1	CCN1C(=O)\C(=C/C2=CN=C(NC3=CC=C(C=C3)N4CCN(C)CC4)N=C12)C5=C(Cl)C=C(C=C5)C6=CN=CS6	MedChem Express	HY-15542A	-7.46187855	-14.31195949	-52.88522511	-24.6923708												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346441-01	NCGC00346441-01	174006706		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	915385-81-8	ABC-294640			-5.3696784786	4	4		0	-3.66259711			56848	SPHK2	ClC1=CC=C(C=C1)C23C[C@@H]4C[C@@H](CC(C4)(C2)C(=O)NCC5=CC=NC=C5)C3	ActiveBioChem	A-1269	-0.39700442	0.3674329	-2.68279596	-3.66259711												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159360-03	NCGC00159360-03	384568172		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	5593-20-4				3.1304613567	4	4		0	-2.65788715				NRC31	CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CC\C4=C\C(=O)\C=C/C4(C)C3(F)C(O)CC12C	APExBIO	A8378	1.53778171	-1.64759725	3.35031073	-2.65788715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250393-01	NCGC00250393-01	137275895		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	147159-51-1	CAP-232	12.5892541179	-4.9	-76.7592037769	-3	4		-99.2849850999	-91.33423051	0.0441275436	0.9987971146	6754	SSTR4	CC(O)[C@H](NC(=O)[C@@H]1CSSC[C@H](CC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC4=C[NH]C5=CC=CC=C45)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O	NCGCChem	CAP-232	-3.2081308	-0.60411899	0.17288912	-91.33423051												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346475-02	Birinapant	384568790	IAP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1260251-31-7				-14.5590719176	4	4		0	-4.75119758				XIAP	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC2=C([NH]C3=C2C=CC(=C3)F)C4=C(C[C@@H]5C[C@H](O)CN5C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C6=C([NH]4)C=C(F)C=C6	Selleck	S7015	-3.60596475	-0.88447408	-1.69031231	-4.75119758												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381559-06	NCGC00381559-06	384569099		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1187075-34-8		8.9125093813	-5.05	-133.1496474117	-2.1	4		-122.9257123437	-99.16902923	0.0183697109	0.9997918286		HDAC1	CN(C)CC1=CC=C(C=C1)[S+]([O-])(=O)[N]2C=CC(=C2)\C=C\C(=O)NO	MedChem Express	HY-14718A	-8.3145052	-14.11076337	-39.96347802	-99.16902923												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142483-07	NCGC00142483-07	384568164		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	65-46-3				-22.3370526563	4	4		0	-2.88395738				CDA	NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	MedChem Express	HY-B0158	-5.19656575	-2.63527918	-7.25289132	-2.88395738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186464-04	NCGC00186464-04	384568441		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	173334-58-2				-14.1140691107	4	4		0	-0.92873204				REN	COCCCOC1=CC(=CC=C1OC)C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C	Selleck	S2199	-4.42837777	-2.43570554	-0.5852882	-0.92873204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015054-20	NCGC00015054-20	384567802		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	GRT00036				-21.6992246214	4	4		0	-2.86440512				ACHE	NC1=C2CCCCC2=NC3=CC=CC=C13	SIGMA	A3773	-5.01581563	-4.28629746	-5.37060449	-2.86440512												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00354729-02	NCGC00354729-02	384569023		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	630124-46-8		12.5892541179	-4.9	-84.3298334854	-3	4		-97.1366068961	-92.48774392	0.0587195643	0.9978674266		FLT3	CCN1CCN(CC1)CC2=CC=C(NC(=O)NC3=CC=C(OC4=NC=NC(=C4)NC)C=C3)C=C2C(F)(F)F	MedChem Express	HY-15002	-2.84577994	-7.4416476	-3.91103219	-92.48774392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018248-25	MELOXICAM SODIUM		Neuropharmacol 39: 1653 (2000)	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	71125-38-7				-2.1108310866	4	4		0	-2.38873402					CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	MS-01504150	1.35218736	-3.14874142	-2.25690388	-2.38873402												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510477-01	NCGC00510477-01	384569440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	497871-47-3		0.0794328235	-7.1	-296.6919792824	-1.1	4		-84.837874271	-96.4623769	0.0072683415	0.9999674175		POLR2A	COC1=CC=C2[NH]C3=C(CCN[C@]34CS[C@H]5[C@H]6[C@@H]7N(C)[C@@H](CC8=CC(=C(OC)C(=C78)O)C)[C@H](O)N6[C@@H](COC4=O)C9=C%10OCOC%10=C(C)C(=C59)OC(C)=O)C2=C1	MedChem Express	HY-16293	-13.09954751	-93.15517629	-96.94511173	-96.4623769												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00246835-02	NCGC00246835-02	384568512		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-15.0844133298	4	4		0	-0.97814677					COC12C(COC(N)=O)\C3=C(/N1CC4C2N4C)C(=O)C(=C(N)/C3=O)\C	NCI	NSC56410	-4.25776755	-4.54881818	-0.4308884	-0.97814677												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510490-01	NCGC00510490-01	384569452		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1207253-08-4				2.6184952826	4	4		0	-0.35785857				HCRTR1	COC1=C(OC)N=C(CNC(=O)C2=CC(=CN=C2C3=NC=CC=C3)C4=CC(=CN=C4)Cl)C=C1	MedChem Express	HY-19914	0.18589006	1.701998	1.74776083	-0.35785857												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00531749-01	NCGC00531749-01	384569536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1375466-18-4		8.9125093813	-5.05	-31.2996692294	4	4		-17.025143828	-16.45508982	0.4282653039	0.8674153221		HDAC1	ONC(=O)C1=CN=C(NC2(CCCCC2)C3=CC(=CC=C3)F)N=C1	MedChem Express	HY-19328	-5.95723918	-0.18413663	-5.23567803	-16.45508982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00184994-11	Cidofovir	384568422	DNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	113852-37-2		0.1	-7	3.5869328487	4	4		10.0092263999	3.77005988	0.2907787899	0.9447402974			NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	MedChem Express	HY-17438	-4.591022	3.02904755	6.48295867	3.77005988												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00345793-01	NCGC00345793-01	174006592		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1100598-32-0	EMD-1214063			-15.0903428519	4	4		0	-2.09312061			8731	MET	CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4/N=C(\C=C/C4=O)C5=CC(=CC=C5)C#N	ChemieTek	CT-EMD063	-4.30867032	-3.43644143	-0.17351341	-2.09312061												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345844-02	NCGC00345844-02	363677387		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(1251752-12-1)				-20.6669905723	4	4		0	-6.07470115				TYK2	CC(C)(C)NC(=O)NC1=CC=CC(=C1)NC2=NC(=C(F)C=N2)NC(C)(C)CO	SynKinase	SYN-1130	-1.90711637	-5.92351578	-10.18101669	-6.07470115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242217-09	NCGC00242217-09	384568486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	660868-91-7		0.8912509381	-6.05	-72.4903397316	4	4		-26.5911943441	-30.75491883	0.1095400308	0.9925401003		PLK1	COC1=CC2=C(C=C1OC)[N](C=N2)C3=CC(=C(S3)C(N)=O)OCC4=C(C=CC=C4)C(F)(F)F	MedChem Express	HY-11003	-5.60656896	-17.57443395	-32.76589758	-30.75491883												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015150-07	NCGC00015150-07	384567816		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	590-46-5				-17.9327541972	4	4		0	-3.22503124					C[N+](C)(C)CC(O)=O	MedChem Express	HY-N0739	-3.12859037	-5.01601831	-5.76141302	-3.22503124												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185000-18	NCGC00185000-18	384568423		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	850140-73-7		4.4668359215	-5.35	-160.1738128207	-2.1	4		-94.1655210396	-99.69720273	0.0216760248	0.9997101206		EGFR	CN(C)C\C=C\C(=O)NC1=CC2=C(NC3=CC(=C(F)C=C3)Cl)N=CN=C2C=C1O[C@H]4CCOC4	MedChem Express	HY-10261A	-13.59257623	-17.35469108	-55.53478809	-99.69720273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092375-02	NCGC00092375-02	174006314		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	409345-29-5	 JNJ-16259685;JNJ 16259685;JNJ-16259685			-10.0852784178	4	4		0	0.00480631			2911	GRM1	COC1CCC(CC1)C(=O)C2=CC3=C(C=C2)N=C4OCCCC4=C3	Tocris	2333	-2.55413168	-2.44393593	-2.65875426	0.00480631												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379220-07	NCGC00379220-07	384569095		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1359164-11-6		12.5892541179	-4.9	-40.4405707455	-3	4		-30.667441408	-31.35098958	0.0940935395	0.9945080692		RORC	OC(C1=CC(=C(C=C1)C2=CC=C(CN3CCN(CC3)CC4=CC=NC=C4)C=C2)F)(C(F)(F)F)C(F)(F)F	SIGMA	SML1170	-5.04524887	-3.02268134	-2.87812174	-31.35098958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247668-03	LDN-57444	384568515	Reversible, competitive Inhibitor of UCH-L1 deubiquitinase	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	668467-91-2		12.5892541179	-4.9	-44.0248634114	-3	4		-31.9742798961	-32.76603882	0.1295897345	0.9895124044			CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13	XcessBio	M60204-2s	-6.02262443	-3.15742196	-2.78747224	-32.76603882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016960-07	Glimepiride	170464966	K(ATP) Channel Blocker	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	93479-97-1	 Glimepride; Glimepiride; Amaryl;Glimepiride; 			-3.0080787056	4	4		0	4.7901329				KCNJ8	CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC	Sequoia	SRP01525g	-2.04977376	-2.27711655	0.33993564	4.7901329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496843-02	NCGC00496843-02	384569296		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	887375-67-9				-25.0819642628	4	4		0	-5.70187995				ROCK1	C[C@H]1CNCCCN1[S+]([O-])(=O)C2=CC=CC3=CN=CC(=C23)F	Glixx	GLXC-07646	-5.33770027	-6.02881644	-4.10070201	-5.70187995												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510442-01	Abametapir	384569434	MMP-9 (Gelatinase B) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			14.1253754462	-4.85	-5.8159567662	4	4		-24.198683084	-18.49890257	0.3295879318	0.9265828079		MMP	CC1=CN=C(C=C1)C2=NC=C(C)C=C2	SIGMA	513040	2.01823493	-1.47564532	5.56281772	-18.49890257												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386712-01	NCGC00386712-01	363680410		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1314891-22-9				-1.2607092932	4	4		0	-5.88319496			9734	HDAC9	CC(C)(CNC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C(F)(F)F)C3=COC(=N3)C4=CC=CC=C4	Axon Medchem	2180	1.31008232	1.10999869	-1.40885984	-5.88319496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025179-20	NCGC00025179-20	384568054		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	84371-65-3		12.5892541179	-4.9	-42.3713747667	-3	4		-49.865588324	-45.9347266	0.1242958067	0.9903534254		PGR	CC#C[C@]1(O)CC[C@H]2[C@@H]/3CCC/4=C/C(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C	MedChem Express	HY-13683	-3.68239356	0.97941061	0.97312999	-45.9347266												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346572-02	NCGC00346572-02	363677457		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	166518-60-1		7.9432823472	-5.1	-89.5704220054	-2.3	4		-89.7642084875	-83.47647676	0.0668089849	0.9972372046		CYP2C9	CC(C)C1=CC(=C(CC(=O)N[S+]([O-])(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C)C(C)C	Selleck	S2187	-5.57670178	-1.16223393	-17.34688937	-83.47647676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181111-05	NCGC00181111-05	384568390		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	94497-51-5				11.3548025766	4	4		0	7.21916168				RARB	[CH3][C]1([CH3])[CH2][CH2][C]([CH3])([CH3])C2=C1C=CC(=C2)[NH][C](=[O])C3=CC=C(C=C3)[C]([OH])=[O]	APExBIO	A3856	1.50372605	-0.58923721	3.62098139	7.21916168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510509-01	NCGC00510509-01	384569470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	81840-15-5				-23.050290614	4	4		0	-3.11929251				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	-6.25718073	-3.02059497	-3.76150647	-3.11929251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250379-21	NCGC00250379-21	377020168		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	252917-06-9		10	-5	-27.9870682881	4	4		-22.735163524	-21.64279535	0.0674853498	0.9971914672		GSK3B	CC1=C[NH]C(=N1)C2=C(N=C(NCCNC3=CC=C(C=N3)C#N)N=C2)C4=CC=C(Cl)C=C4Cl	MedChem Express	HY-10182	-2.28015908	-3.46910755	-5.09789262	-21.64279535												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164566-07	NCGC00164566-07	384568254		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	147526-32-7		0.6309573445	-6.2	-185.4899310022	-1.3	4		-97.2415083339	-96.28187473	0.1325234867	0.9890099162		HMGCR	O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	Enzo	AC3223	-5.76847096	-57.96093857	-83.38425926	-96.28187473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263096-16	Iniparib	384568587	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[160003-66-7]				-4.8355465679	4	4		0	3.18386079				PARP1	NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O	Tocris	5817	-1.74208145	-3.31911071	-0.639079	3.18386079												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508865-03	NCGC00508865-03	384569366		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					14.4418527214	4	4		0	3.79577397					CC[S+]([O-])(=O)C1=CC2=C(OC(=N2)C3=CC4=CC=CC=C4C=C3)C=C1	Axon Medchem	2481	2.07692308	1.50460364	7.51031138	3.79577397												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356119-03	NCGC00356119-03	384569028		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1619994-68-1]				-17.9828513112	4	4		0	-3.79577397				BAZ2B	CCCOC1=CC2=C(C=C([N]2C=C1)C(C)=O)C3=CC=CC=C3[S+](C)([O-])=O	Tocris	5635	-4.18552036	-1.4596901	-4.91773558	-3.79577397												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165759-02	NCGC00165759-02	384568278		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	4430		1	-6	-35.2642866324	4	4		-13.682034848	-15.10660675	0.1802450632	0.9795526424		GUCY1A2	NC1=C(C=NC(=N1)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24)C5CC5	Tocris	4430	-2.67420814	-7.11879632	-17.40923718	-15.10660675												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250401-11	Flavopiridol	384568550	CDK1/2/4/6/7/9 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	146426-40-6		0.3981071706	-6.4	-192.6913071262	-1.1	4		-91.1736408845	-90.25237659	0.0069362479	0.9999703262		CDK1	CN1CC[C@H]([C@@H](O)C1)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	MedChem Express	HY-10005	-0.55941532	-86.41842542	-90.70777035	-90.25237659												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016786-18	NCGC00016786-18	384567959		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	24280-93-1		3.5481338923	-5.45	-55.0172370212	4	4		-29.9584617935	-33.75476524	0.0345673458	0.9992634304		IMPDH1	COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2	Selleck	S2487	-4.60164215	-4.71389524	-21.09165407	-33.75476524												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483921-01	NCGC00483921-01	363681140		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1393466-87-9		14.1253754462	-4.85	-21.0799152565	4	4		-17.221906124	-16.97148096	0.2322219552	0.9653893545	673	BRAF	[O-][S+](=O)(NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=C2C=C(C=N3)C4=CN=C(N=C4)C5CC5)N6CC[C@@H](F)C6	MedChem Express	HY-18972	-2.06622756	-3.92525877	-0.53655919	-16.97148096												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090797-28	NCGC00090797-28	384568087		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[20830-75-5]		31.6227766017	-4.5	-451.6685636051	5	4		9.1148798841	-95.16081728	0.7343428836	0.5895023064	24377		C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C/8=C/C(=O)OC8)C4	Tocris	4583	-96.46633529	-95.27373339	-96.73175071	-95.16081728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179250-03	Halofantrine	170465140	antimalarial agents	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	36167-63-2	; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine	10	-5	-44.2367913285	-3	4		-36.6673784584	-34.93987682	0.1334462714	0.9888670337			Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F	Prestwick Chemical, Inc.	Prestw-1031	-5.16945323	-1.21104912	-5.82947043	-34.93987682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242479-03	NCGC00242479-03	363677141		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	186497-07-4				-13.140157074	4	4		0	0.71365725				EDNRA	COC1=C(N[S+]([O-])(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4)N=CC(=N1)C	Selleck	S1456	-3.28965206	-2.72599447	-4.81809243	0.71365725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181796-03	NCGC00181796-03	384568403		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	79517-01-4				8.2933553845	4	4		0	3.39231596				SSTR1	C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@H](CC4=C[NH]C5=CC=CC=C45)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1	Enzo	DL309	-0.74107546	5.60166916	3.56323454	3.39231596												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263086-08	NCGC00263086-08	363677195		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	501437-28-1		4.4668359215	-5.35	-96.5247435862	-2.2	4		-73.6931386247	-69.75266399	0.0088803485	0.9999513695		RPS6KA1	CC(C)CCN1C(C)C(=N)N(C)C2=C1N=C(NC3=CC(=C(O)C(=C3)F)F)N=C2	MedChem Express	HY-10510	-4.43741527	-9.42078287	-37.87516973	-69.75266399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091032-09	NCGC00091032-09	363676548		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	427-51-0				-11.561445985	4	4		0	-1.20239521				AR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(Cl)/C4=C/C(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	Selleck	S2042	-3.88129879	-1.40864521	0.33357505	-1.20239521												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095165-08	NCGC00095165-08	384568154		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	61422-45-5		5.0118723363	-5.3	-44.8589240705	4	4		-23.560368656	-26.42874251	0.1116904605	0.9922485714		TYMS	CCCCCCNC(=O)N1\C=C(F)/C(=O)NC1=O	Selleck	S1289	-5.15880057	-3.46176863	-13.60889533	-26.42874251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344053-04	NCGC00344053-04	384568716		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	483367-10-8		14.1253754462	-4.85	-14.1198658785	4	4		-17.223230228	-15.18602519	0.5586918747	0.740119872			C1CCC(CC1)[N]2C=NC3=C2N=C(OC4=CC=CC5=C4C=CC=C5)N=C3NC6=CC=C(C=C6)N7CCOCC7	Selleck	S3042	-0.65866643	-6.00439127	4.44856348	-15.18602519												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378854-02	NCGC00378854-02	384569072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	249921-19-5				-22.8583935062	4	4		0	-5.99816629					CN(C)N(C)C(=O)[C@]1(CCCN(C1)C(=O)[C@@H](CC2=C[NH]C3=CC=CC=C23)NC(=O)C(C)(C)N)CC4=CC=CC=C4	MedChem Express	HY-14734	-3.23919516	-8.18210333	-6.27286474	-5.99816629												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016423-15	NCGC00016423-15	170466800		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	303-45-7	 (-)-Gossypol;(-)-Gossypol	2.8183829313	-5.55	-147.9310555474	-1.1	4		-95.0564868236	-99.64290885	0.0225678784	0.9996857418	598	BCL2L1	CC(C)c4c3cc(C)c(c1c(C)cc2c(c1O)c(C=O)c(O)c(O)c2C(C)C)c(O)c3c(C=O)c(O)c4O	Microsource	01504019	-3.98808987	-6.18362683	-84.3373494	-99.64290885												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249685-09	NCGC00249685-09	384568533		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	405169-16-6		8.9125093813	-5.05	-134.6534003275	-2.3	4		-122.3915541704	-99.77802442	0.085263633	0.9954894626		FGFR1	CN1CCN(CC1)C2=CC3=C([NH]C(=N3)C/4=C(\N)C5=C(F)C=CC=C5NC4=O)C=C2	MedChem Express	HY-50905	-6.92953172	-18.57776583	-42.05648505	-99.77802442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179596-11	NCGC00179596-11	384568378		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	64872-77-1				-11.0456972666	4	4		0	-2.62977808					ClC1=CC=C(CCC(C[N]2C=CN=C2)SC3=C(Cl)C=CC=C3Cl)C=C1	MedChem Express	HY-B0293	-3.15408947	-2.39941942	0.93177881	-2.62977808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386231-04	NCGC00386231-04	384569117		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1186486-62-3				-26.5750469268	4	4		0	-6.85306482				CETP	C[N]1N=NC(=N1)N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)[C@H]3CCCN(C[C@H]4CC[C@@H](CC4)C(O)=O)C5=C3C=C(C)C=C5C	MedChem Express	HY-13327	-4.93447808	-5.97360185	-6.69101466	-6.85306482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351604-03	NCGC00351604-03	384569019		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1396772-26-1		11.220184543	-4.95	-79.0240118826	-3	4		-107.4243810881	-98.90778443	0.0052654183	0.9999829		EZH2	C/C1=C/C(=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C4CCCC4)C5=CC=C(CN6CCOCC6)C=C5)C(=O)N1)C	Selleck	S7004	-0.98030518	-1.07719928	-2.63475949	-98.90778443												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498442-01	NCGC00498442-01	384569303		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1801747-11-4				-0.8056619958	4	4		0	-2.60477231				PTP2C	CC1(N)CCN(CC1)C2=NC(=C(N=C2)C3=CC=CC(=C3Cl)Cl)N	ChemieTek	CT-SHP099	1.20960622	-2.34890355	1.20521478	-2.60477231												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015897-20	Ranolazine	384567904	Sodium channel Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	95635-56-6				-2.5973840558	4	4		0	-2.71556282				SCN9A	COC1=C(OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C)C=CC=C1	MedChem Express	HY-17401	0.99867433	-2.30663616	-2.15410495	-2.71556282												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345794-11	MLN-4924	384568745	NEDD8-Activating Enzyme (NAE) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	905579-51-3		11.220184543	-4.95	-14.7559230415	-3	4		-67.85230222	-54.46025185	0.1160466706	0.9916026976		NAE1	N[S+]([O-])(=O)OC[C@@H]1C[C@H](C[C@@H]1O)[N]2C=CC3=C2N=CN=C3N[C@H]4CCC5=C4C=CC=C5	ChemieTek	CT-M4924	4.79010163	11.83524027	7.78935564	-54.46025185												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165816-04	NCGC00165816-04	384568287		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[355025-24-0]				-24.272643482	4	4		0	-2.9462655				LPAR1	CC(OC(=O)NC1=C(ON=C1C)C2=CC=C(CSCCC(O)=O)C=C2)C3=C(Cl)C=CC=C3	Tocris	5056	-3.61467079	-10.60869565	-7.76131956	-2.9462655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346654-11	INK-128	384568885	mTORC1/2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	?1224844-38-5		11.220184543	-4.95	-258.3241848962	-2.3	4		-70.9331920337	-85.49937518	0.107782133	0.9927724839		MTOR	CC(C)[N]1N=C(C2=CC3=C(OC(=N3)N)C=C2)C4=C(N)N=CN=C14	ActiveBioChem	A-1023	-44.2333186	-53.00686499	-63.54375964	-85.49937518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483929-01	NCGC00483929-01	363681148		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					42.2511290192	4	4		0	14.36646707				KEAP1	COC1=CC(=CC2=C1[N](C)N=N2)[C@@H](CC(O)=O)C3=CC(=C(C)C=C3)CN4C[C@@H](C)OC5=C(C=CC=C5)[S+]4([O-])=O	NCGCChem	PJM008-063	5.87739532	10.66151084	12.95141407	14.36646707												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263159-10	NCGC00263159-10	363677236		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	728033-96-3				-8.7751608894	4	4		0	-6.45611424				PDGFRB	FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=C3C=CC=C4)C=CS2)C=C1	MedChem Express	HY-10204	0.82111955	-5.15689071	-3.493716	-6.45611424												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346700-13	NCGC00346700-13	384568920		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	944261-79-4		14.1253754462	-4.85	-10.7735228195	4	4		-12.532280568	-11.69356714	0.4128175258	0.8787502293		SCN10A	COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(Cl)C=C3)OC	MedChem Express	HY-11079	0.01765848	-3.7662685	0.79253423	-11.69356714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346499-02	NCGC00346499-02	384568804		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	841205-47-8		10	-5	-15.9376540628	4	4		-16.303130384	-14.41927532	0.2993249369	0.9406888		AR	C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	Selleck	S1174	-2.26911531	2.02799073	-1.12080285	-14.41927532												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250409-02	NCGC00250409-02	384568557		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	942206-85-1		12.5892541179	-4.9	-83.5486559126	-3	4		-90.4754505704	-86.11458233	0.0430630206	0.9988545781		TRPV4	CC(C)C[C@H](NC(=O)C1=CC2=CC=CC=C2S1)C(=O)N3CCN(CC3)C(=O)[C@H](CO)N[S+]([O-])(=O)C4=CC=C(Cl)C=C4Cl	SIGMA	G0798	-5.56783031	-4.54004577	-2.56530069	-86.11458233												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244253-21	INCB018424			SARS-CoV-2_CPE_SRI		941678-49-5		0.0222088798	-7.6534733462	-56.4957628537	4	10		-16.109306804	-16.75775567	0.0199590062	0.8520494149			N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB	-1.25034404	1.62780639	-3.68812173	-1.61994259	-2.15468093	6.08658043	-2.93319703	-8.50863052	-14.62666614	-16.75775567						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	SARS-CoV-2_CPE_SRI		747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine	0.0000716615	-10.1447142596	-19.7136458425	4	10		-6.568283308	-3.95682056	0.3858732406	0.3912580855	84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	-1.21539238	7.93305634	-3.48308935	-2.66765037	-0.55527511	-4.54704306	-3.16467984	-4.64023609	-2.32594261	-3.95682056						1.796407186E-11	3.592814371E-11	6.886227545E-11	1.4071856287E-10	2.8143712574E-10	5.6287425149E-10	1.122754491E-9	2.245508982E-9	4.491017964E-9	8.9820359281E-9					
NCGC00182390-05	NCGC00182390-05			SARS-CoV-2_CPE_SRI				0.0497194887	-7.3034733462	-130.6860489486	-2.2	10		-49.5803789856	-40.96998408	0.0009162871	0.9472234721			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029	2.56669126	-6.79920786	-5.34694987	-1.34741584	0.1359065	2.4890304	0.40771949	-8.52327884	-22.28478236	-40.96998408						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00181783-05	NCGC00181783-05	384568402		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	123663-49-0				-13.2418005953	4	4		0	-4.03832335			24835	NFKB1	C[S+]([O-])(=O)NC1=CC2=C(C=C1OC3=CC=CC=C3)C(=O)\C(=C/O2)NC=O	MedChem Express	HY-17009	-2.32877928	-3.98655803	-2.1319797	-4.03832335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510502-02	NCGC00510502-02	384569463		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1174428-47-7		1.2589254118	-5.9	-169.1707709132	-1.1	4		-91.2732251113	-91.32365005	0.024543496	0.9996283213		PIK3CB	O=C1\C=C(OC2=C1SC=C2C3=CC=C4OCCOC4=C3)\N5CCOCC5	Selleck	S8589	-9.1040332	-34.06371824	-77.0499	-91.32365005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163468-12	NCGC00163468-12	384568241		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	50-07-7				-20.5197261203	4	4		0	-1.33667905					CO[C@@]12[C@H](COC(N)=O)C/3=C(N1C[C@@H]4N[C@H]24)/C(=O)/C(=C(N)\C3=O)C	MedChem Express	HY-13316	-6.11747722	-3.65640543	-1.92185747	-1.33667905												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378853-02	NCGC00378853-02	384569071		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	195733-43-8				-3.1367561425	4	4		0	1.91771604				EDNRA	CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(OC)C=C2)C(O)=O)C3=CC=C4OCOC4=C3	MedChem Express	HY-15403A	-0.07954043	-3.99084668	-2.25690388	1.91771604												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095089-21	NCGC00095089-21	384568143		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	86386-73-4				-0.447973503	4	4		0	-3.87868884					OC(C[N]1C=NC=N1)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-B0101	1.59080866	-1.26315789	-1.04200738	-3.87868884												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092309-06	NCGC00092309-06	363676558		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	312636-16-1		12.5892541179	-4.9	-87.323512968	-3	4		-99.2793574671	-93.13178891	0.0546344168	0.9981545237		SPHK1	OC1=CC=C(NC2=NC(=CS2)C3=CC=C(Cl)C=C3)C=C1	Selleck	S7176	-5.82412726	-2.41647597	-1.64945563	-93.13178891												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186028-04	NCGC00186028-04	384568436		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	102767-28-2				-15.8366576234	4	4		0	0.5865676					CC[C@H](N1CCCC1=O)C(N)=O	Selleck	S1356	-4.86217804	-4.18651064	-1.33445709	0.5865676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00093926-10	NCGC00093926-10	384568120		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	3094-09-5				-23.7975325079	4	4		0	-3.05015153				TYMS	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2\C=C(F)/C(=O)NC2=O	MedChem Express	HY-B0021	-5.85630366	-5.60166916	-3.7879852	-3.05015153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263565-06	NCGC00263565-06	384568689		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	60282-87-3				-16.6286442692	4	4		0	-4.34060025				PGR	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1\C=C/[C@@]2(O)C#C	MedChem Express	HY-B0110	-4.09399006	-3.87807865	-0.31371447	-4.34060025												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510692-02	NCGC00510692-02	384569482		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1802220-02-5		2.5118864315	-5.6	-125.5619717301	-1.4	4		-67.2033716839	-75.99960895	0.0858613344	0.9954258702		ALK	C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=C(O1)C=CC(=C4)F)C=C[N]3N=C2	ChemGood	C-1409	-5.41346588	-12.01524017	-66.57770286	-75.99960895												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242492-04	NCGC00242492-04	384568498		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	321674-73-1		14.1253754462	-4.85	-22.3162716605	4	4		-31.582155692	-25.90179641	0.1938977393	0.9761201804		TERT	C\C(=C/C(=O)NC1=C(C=CC=C1)C(O)=O)C2=CC3=CC=CC=C3C=C2	Selleck	S1186	0.37704045	-4.15228099	-1.45516074	-25.90179641												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402345-02	NCGC00402345-02	363681031		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	944842-54-0		11.220184543	-4.95	-10.8664469125	4	4		-15.532355348	-13.77696279	0.1817364668	0.9792165729		JAK2	CC[C@@](C)(NC1=CC=NC(=N1)C2=C[NH]C3=C2C=CC=N3)C(=O)NCC(F)(F)F	Glixx	GLXC-90220	0.55941532	-1.76547027	-1.09262963	-13.77696279												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507871-01	NCGC00507871-01	384569344		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1554458-53-5		0.3981071706	-6.4	-118.2197985369	4	4		-24.4277213041	-34.99010761	0.0229743858	0.999676566		TTK	COC1=CC=C(OC2=N[N]3C(=CN=C3C(=C2)NCCC(F)(F)F)C4=CC(=C(C=C4)C(=O)NC5CC5)C)C(=C1F)F	Selleck	S8215	-19.63367319	-27.18107272	-32.8081557	-34.99010761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378563-01	NCGC00378563-01	363678091		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	892128-60-8		12.5892541179	-4.9	-34.8348255172	4	4		-31.5076344401	-27.87723785	0.1287778237	0.9896535867	6240	RRM2	CCCC(CCC)C(=O)NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	MedChem Express	HY-13672	-2.45420915	-5.41291392	-5.64850495	-27.87723785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263280-01	NCGC00263280-01	137276088		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	932726-23-3	Ac-SAH-p53-8			-12.8577347743	4	4		0	1.31737683			3306	MDM2	CC(C)C[C@@H]1NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@](C)(CCCCCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(N)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CCNC(C)=O)[C@H](C)O	NCGCChem	Ac-SAH-p53-8	-3.78056483	-4.82143657	-1.1706746	1.31737683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346682-08	NCGC00346682-08	384568906		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	187235-37-6				-20.2268431164	4	4		0	-5.08131062					[O-][N+](=O)C1=C[N]2C[C@@H](COC2=N1)OCC3=CC=C(OC(F)(F)F)C=C3	MedChem Express	HY-10844	-3.6091311	-5.31433436	-5.00463392	-5.08131062												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496836-02	NCGC00496836-02	384569292		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1228013-30-6		4.4668359215	-5.35	-98.1473603417	-2.2	4		-67.154572088	-59.8240892	0.018305754	0.9997933587		MTOR	CO[C@H]1CC[C@@H](CC1)N2C(=O)CNC3=NC=C(N=C23)C4=CN=C(C=C4)C(C)(C)O	Glixx	GLXC-90511	-6.77861246	-15.31350114	-36.36745946	-59.8240892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384474-01	NCGC00384474-01	384569111		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	192755-21-8				-14.7638931324	4	4		0	-1.14380682				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=C4C=CC=C5	DiverChem	DIV02676	-3.92227745	-1.51948111	-4.05019432	-1.14380682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386129-03	NCGC00386129-03	363680114		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	475488-23-4				-17.7900383477	4	4		0	-9.0011976				IGFR1	NC1=NC=NC2=C1C(=C[N]2[C@@H]3C[C@H](C3)CN4CCCC4)C5=CC(=CC=C5)OCC6=CC=CC=C6	MedChem Express	HY-10252	-3.58853797	-2.42139668	-0.29489969	-9.0011976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00498439-01	NCGC00498439-01	384569302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1627696-51-8				0.8881942145	4	4		0	0.51257485				CDK7	C[C@]1(NC(=O)C2=C1C=CC(=C2)C3=C[NH]N=C3)C4=NC=NC=C4F	ChemieTek	CT-LY3177	-1.07789212	0.28541178	4.37515108	0.51257485												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015199-24	NCGC00015199-24	384567821		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	305-03-3				2.359758023	4	4		0	-3.49221557					OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl	MedChem Express	HY-13593	1.88520227	0.4695484	-0.24655547	-3.49221557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165915-05	NCGC00165915-05	384568299		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	546141-08-6				-11.2928533518	4	4		0	-2.36167665				FAAH	NC(=O)C1=CC(=CC=C1)C2=CC=CC(=C2)OC(=O)NC3CCCCC3	Selleck	S2631	-2.11586231	-5.43203057	-0.46893884	-2.36167665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167403-06	NCGC00167403-06	384568310		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	839707-37-8		0.5011872336	-6.3	-185.5468048453	-1.3	4		-78.1922279081	-73.68714824	0.2531749269	0.9582617716		RASAL1	C[N]1N=C(C)C=C1NC2=NC=C3CN(C(=O)N(C)C3=N2)C4=C(C)C=CC(=C4)NC(=O)C5=CC=CC(=C5)C(F)(F)F	Cayman	10009557	-7.16934487	-68.47477269	-91.99493528	-73.68714824												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346721-04	NCGC00346721-04	363677536		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1019779-04-4				-15.0504716075	4	4		0	-3.91646123				P2RX7	CC1=C(NC(=O)CNC2=CC(=C(F)C=C2)F)C=C(CN3CCNCC3)C=C1	MedChem Express	HY-15469	-3.24916122	-2.22410412	-3.24985931	-3.91646123												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381477-05	NCGC00381477-05	384569098		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1523406-39-4				-10.1796483667	4	4		0	-2.44662542				PIK3C3	C[C@@H]1COCCN1C\2=C\C(=O)N\3CC[C@H](N(CC4=CN=CC(=C4)Cl)C3=N2)C(F)(F)F	Glixx	GLXC-05770	-1.08599682	-3.08878588	-4.8912024	-2.44662542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345841-02	NCGC00345841-02	363677384		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(1124381-69-6)				-23.2174709312	4	4		0	-5.51653565				MAP3K5	CC(C)NC1=CC(=CC2=NC(=N[N]12)NC(=O)C3=CN=CC=C3)C(F)(F)F	SynKinase	SYN-1119	-4.92671729	-5.47780353	-3.84074282	-5.51653565												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386713-03	NCGC00386713-03	363680411		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1123231-07-1		10	-5	-93.734236296	-2.1	4		-112.6339798795	-99.74526579	0.034413546	0.9992688689		DKK1	NCC1CCN(CC1)C2=NC=CC(=N2)C3=CC=C4C=CC=CC4=C3	Glixx	GLXC-04604	-2.47459125	-5.48283753	-12.91995701	-99.74526579												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167496-01	NCGC00167496-01	144206050		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	61-73-4	; Ehrlich's reagent III; Urolene Blue; Yamamoto Methylene Blue B; Methylene Blue Hydrate; Azure II eosinate; Blue, Swis; Taylor's Blue; Cloruro de metiltioninio; Blue, Methylen; ; Methylene blue trihydrate; N, Methylene Blu; Methylene blue; Methylene blue hydrate; Methylene Blue hydrate; Basic Blue 9; Chromosmon;Methylene blue; Methylene Blue solution; Blue N, Methylen; Azure II; Methylene Blue N;Methylene Blue	5.0118723363	-5.3	-49.6439222963	-2.4	4	Methylene Blue Hydrate;Chromosmon;3,7-bis(Dimethylamino)phenazathionium chloride;Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride;Urolene Blue;CIPLUS_682274;L+ ffler's alkaline methylene blue stain solution;chlorure de methylthioninium;Methylthioninium Chloride;Methylene Blue - potassium hydroxide solution;Methylene Blue N;Blue N, Methylen;Methylene Blue zinc chloride double salt monohydrate;Blue, Swis;Methylene blue hydrate;CIPLUS_148989;AB02540576-01;Ehrlich's reagent III;Cloruro de metiltioninio;Methylene blue;METHYLTHIONINIUM CHLORIDE;Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride, trihydrate;Methylene Blue solution alkaline according to L+ ffler;Yamamoto Methylene Blue B;Azure II;Methylene Blue zinc chloride double salt;Blue, Methylen;methylthioninii chloridum;Chlorure de methylthioninium;LS-268;Methylene Blue solution;Basic Blue 9;Methylene Blue;Taylor's Blue;1,9-Dimethyl-Methylene Blue;Tetramethylthionine chloride;Methylene blue trihydrate;Methylthioninii chloridum;LS-1619;METHYLENE BLUE;Methylene Blue hydrate;3,7-bis(dimethylamino)phenothiazin-5-ium chloride trihydrate;N, Methylene Blu;CIPLUS_657740;	-33.9995296924	-34.96587523	0.1747687589	0.9806994966			[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	Labotest	LT00032971	-4.99337163	-0.21967963	-15.17218822	-34.96587523												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167982-03	NCGC00167982-03	384568344		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	72496-41-4		14.1253754462	-4.85	-21.9125494459	4	4		-19.084712388	-18.78971551	0.132180202	0.9891181848		TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@H]6CCCCO6)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	Glixx	GLXC-06538	-1.63578852	-3.4880029	-1.79332303	-18.78971551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346672-02	NCGC00346672-02	384568898		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	937265-83-3				-12.2458650164	4	4		0	-1.10658683				ERBB2	CC1=CC(=CC=C1OC2=CC3=NC=N[N]3C=C2)NC4=C5C=C(C=CC5=NC=N4)C6=CC=C(CNCC[S+](C)([O-])=O)O6	Selleck	S2752	-3.94339957	-0.1749298	-1.75489485	-1.10658683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263184-06	NCGC00263184-06	384568652		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	471905-41-6				-18.209170229	4	4		0	-2.73532934				NOTCH1	OC(=O)CCC1CCC(CC1)(C2=CC(=CC=C2F)F)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	Chemscene	HY-10974	-4.94588361	-3.94052387	-1.11675127	-2.73532934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163510-01	Aloe-emodin	26756894	Caspase 3 Activator	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	481-72-1	ALOE-EMODINE;Aloe-emodin			-0.8319354642	4	4	ALOE-EMODINE;Aloe Emodin;aloe-emodin;ALOE-EMODIN;LS-2202;aloe-emodin 1-O-glucopyranoside;Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,;Aloe-emodin;ALOE EMODIN;Anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-;NCGC00163510-02;NCGC00163510-01;aloe-emodin 1-O-Glc;1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone;CIPLUS_153452;	0	-3.34899298			836	CASP3	OCC1=CC(O)=C2C(=O)C3=C(C=CC=C3O)C(=O)C2=C1	BIOMOL	BIOMOL_NP-005	0.04414621	-1.02959529	3.25923842	-3.34899298												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510946-01	NCGC00510946-01	384569495		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	3432-99-3		10	-5	-22.0849481593	4	4		-17.49941434	-17.36824969	0.0941010065	0.9945288608			NC/1=N/C(=O)C/2=C(/NCC3CN(CN23)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	SantaCruz Bio	sc-470660	-2.48984637	-1.11873774	-2.80904146	-17.36824969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242491-03	NCGC00242491-03	384568497		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[211096-49-0]		6.3095734448	-5.2	-16.3962198975	4	4		9.331125084	3.81489626	0.2226274592	0.9686221531		CXCR2	BrC1=CC=CC=C1NC(=O)NC2=C3N=N[NH]C3=C(C=C2)C#N	Tocris	2724	-4.58371041	-6.52593757	-4.26505915	3.81489626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095597-05	NCGC00095597-05	384568158		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[5508-58-7]		15.8489319246	-4.8	-3.6286038581	4	4		-8.750644148	-5.62553679	0.6773537387	0.5421653449		TNF	C[C@@]1(CO)C(O)CC[C@]2(C)C(C/C=C/3C(O)COC3=O)C(=C)CCC12	Tocris	4626	-0.94715411	-1.24929265	5.53376906	-5.62553679												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370783-06	NCGC00370783-06	363677854		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1285515-21-0				-14.1440431556	4	4		0	-2.39080887				LRRK2	FC1=NC=CC(=C1)C2=CC=C(OCC3=CC=CC=C3)C(=C2)C(=O)NC4=CC=CN=C4	Glixx	GLXC-05797	-3.9731591	-2.46478873	-0.6987432	-2.39080887												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510518-01	NCGC00510518-01	384569471		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1610759-22-2		1.2589254118	-5.9	-42.5582851638	4	4		-21.554091288	-18.84552533	0.3997647405	0.8869464856		TTK	CC1=CC(=CC=C1C(=O)NC2CC2)C3=C4N=C(OC5=CN=CC=C5)C=C(NC[C@@H]6C[C@](C)(O)C6)[N]4N=C3	MedChem Express	HY-101340	-0.88378259	-7.07551487	-4.73342367	-18.84552533												1.6E-8	8E-8	4E-7	0.000002											
NCGC00167493-04	Manidipine	174006297	Calcium Channel Blocker	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	89226-75-5	; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride	12.5892541179	-4.9	-62.0152762096	-3	4		-73.0083197076	-69.26367394	0.074148848	0.9965941443			Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5	Selleck	S2481	-2.16526734	-5.53775744	-1.21022382	-69.26367394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015937-04	NCGC00015937-04	124881420		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	124-20-9	SPERMIDINE;Spermidine trihydrochloride			-10.1331260431	4	4	SPERMIDINE;NCGC00015937-01;Spermidine 0.1 M solution;NCGC00024903-03;NCGC00024903-02;NCGC00094332-02;NCGC00024903-01;NCGC00094332-01;N-(3-Aminopropyl)-1,4-diaminobutane;1,4-Butanediamine, N-(3-aminopropyl)-;N-(3-Aminopropyl)-1,4-butanediamine trihydrochloride;Spermidine;Spermidine Trihydrochloride;1,8-Diamino-4-azaoctane;Spermidine trihydrochloride;CIPLUS_152753;CIPLUS_173341;CIPLUS_180523;Spermidine phosphate salt hexahydrate;Spermidine Phosphate;Additive Screening Solution 30/Fluka kit no 78374;Spermidine-8-14C trihydrochloride;Spermidine solution;SPERMIDINE TRIHYDROCHLORIDE;Dispermidine triphosphate;	0	2.36167665			2903	GRIN2A	NCCCCNCCCN	BIOMOL	AC-411	-4.8128105	-1.82295263	2.38336959	2.36167665												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346490-06	NCGC00346490-06	384568798		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[742112-33-0]		12.5892541179	-4.9	-103.567960008	-3	4		-110.9326735916	-99.88371552	0.0238260189	0.9996497175		PDPK1	NCC(=O)NC1=CC=C(C=C1)[N]2N=C(C=C2C3=CC4=C(C=C3)C5=C(C=CC=C5)C=C4)C(F)(F)F	Tocris	5682	-7.5490023	-5.44214655	-8.34271244	-99.88371552												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159559-10	NCGC00159559-10	384568188		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	107724-20-9				-4.0432914447	4	4		0	-0.94888134				NR3C2	COC(=O)[C@@H]1CC/2=C/C(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14	MedChem Express	HY-B0251	-0.02648773	-3.73061152	-0.94259989	-0.94888134												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390241-09	NCGC00390241-09	384569180		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	11137608-69-5				-20.0358492324	4	4		0	-3.92576399					CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(Cl)C=C3)[N]4C=CC(=N4)C)C(F)(F)F	Selleck	S2173	-4.83842486	-5.21929043	-1.57099981	-3.92576399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346503-01	NCGC00346503-01	174006514		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	157716-52-4	Perifosine	5.6234132519	-5.25	-67.549563577	-3	4		-38.8719797782	-42.94600883	0.0284609728	0.9995004891	5290	PIK3CA	CCCCCCCCCCCCCCCCCCO[P]([O--])(=O)OC1CC[N+](C)(C)CC1	Selleck	S1037 	-6.40063216	-5.48872524	-6.10648148	-42.94600883												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00378965-05	NCGC00378965-05	384569078		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1435488-37-1		3.1622776602	-5.5	-141.7638164818	-2.1	4		-97.4835001056	-99.66285199	0.0239714343	0.9996454302		ERK5	CCOC1=C(NC2=NC=C3N(C)C(=O)C4=C(C=CC=C4)N(C5CCCC5)C3=N2)C=CC(=C1)C(=O)N6CCC(CC6)N7CCN(C)CC7	MedChem Express	HY-15665	-4.89046929	-12.55088506	-65.8287037	-99.66285199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263199-04	NCGC00263199-04	384568659		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	870223-96-4		2.2387211386	-5.65	-112.8536714576	-2.1	4		-84.0543384097	-80.80122383	0.0248353633	0.9996194224		TEK	CNC1=NC(=CC=N1)C2=CC=CN=C2OC3=CC(=CC=C3C)C(=O)NC4=CC=CC(=C4)C(F)(F)F	SynKinase	SYN-1008	-0.21266968	-12.948574	-61.32892172	-80.80122383												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021569-20	NCGC00021569-20	384568008		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	76095-16-4		12.5892541179	-4.9	3.7566990526	4	4		19.3051809839	14.4239521	0.1125999107	0.9921387422		ACE	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O	MedChem Express	HY-B0331A	-2.33765082	-0.66289187	-0.84602369	14.4239521												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263170-02	NCGC00263170-02	384568640		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1258861-20-9				-13.5205239331	4	4		0	1.10702823				SMO	C[N]1N=CC=C1C2=C3C=CC=CC3=C(N=N2)N4CCC(CC4)N(C)C(=O)C5=C(C=C(F)C=C5)C(F)(F)F	Selleck	S2157	-4.14974395	-1.40399358	-3.96267117	1.10702823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164572-14	NCGC00164572-14	384568257		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	158681-13-1		11.220184543	-4.95	-90.2236751969	-2.1	4		-116.3178471197	-98.07683176	0.020041984	0.9997521795		CNR1	CC1=C([N](N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4	MedChem Express	HY-14137	-2.61644497	-4.34524082	-10.30092593	-98.07683176												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346520-02	NCGC00346520-02	363677439		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	155206-00-1				-23.2814063337	4	4		0	-3.4706951					CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@H](O)[C@@H]1/C=C/C(O)CCC2=CC=CC=C2	Selleck	S1407	-5.23529412	-5.9061307	-4.56420251	-3.4706951												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00177995-10	NCGC00177995-10	384568352		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	91296-87-6				-12.9833845156	4	4		0	-1.64311377					OC(=O)\C1=C\N(C2=CC=C(F)C=C2)C3=C(C=C(F)C(=C3)N4CCNCC4)C1=O	MedChem Express	HY-B0343A	-3.85468417	-3.96814436	1.23277737	-1.64311377												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00185956-04	NCGC00185956-04	384568430		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	3861				-18.1808849238	4	4		0	-5.13053892				EHMT2	COC1=CC2=C(NC3CCN(C)CC3)N=C(N=C2C=C1OCCCN(C)C)N4CCCN(C)CC4	Tocris	3861	-4.97249823	-1.07719928	-1.28112159	-5.13053892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095107-18	NCGC00095107-18	384568145		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	21187-98-4				-9.2598906861	4	4		0	-1.41401926					CC1=CC=C(C=C1)[S+]([O-])(=O)NC(=O)NN2CC3CCCC3C2	MedChem Express	HY-B0753	-1.69521455	-3.60581209	-1.93678484	-1.41401926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159337-12	NCGC00159337-12			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	154598-52-4		1.77827941	-5.75	-10.4752267643	4	4		12.685565656	-7.0753597	1	0.9995844087			FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#CC3CC3	Glixx	GLXC-04867	-5.98797138	-5.70827425	6.08796296	-7.0753597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402250-03	NCGC00402250-03	363680999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1404189-10-1				-39.440555946	4	4		0	-5.2519113				MAPK14	CC1=C(C=CC=C1)N2/N=C(\C=C/C2=O)C3=C4NC[C@@H](CO)C[N]4N=C3C5=CC=C(F)C=C5	Glixx	GLXC-01771	-8.0512753	-11.17870375	-10.21759259	-5.2519113												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346489-03	NCGC00346489-03	363677423		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	957217-65-1				-20.7149537198	4	4		0	-2.18433924					CC1COC2(CCN(CC2)C/3=N/C(=O)C4=CC(=CC(=C4S3)[N+]([O-])=O)C(F)(F)F)O1	APExBIO	A5118	-5.83871109	-5.15940173	-0.81018519	-2.18433924												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163128-17	NCGC00163128-17	384568232		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	112529-15-4				-4.7501731216	4	4		0	2.74466974				PPARG	CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1	Microsource	01504401	-3.13446596	0.5214289	1.19907407	2.74466974												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510494-01	NCGC00510494-01	384569456		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	925206-65-1				-27.0383105444	4	4		0	-3.95080488					[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O	MedChem Express	HY-16438	-5.80359103	-7.65677171	-4.80092593	-3.95080488												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00347285-06	NCGC00347285-06	363677575		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1047953-91-2		3.5481338923	-5.45	4.6865532377	4	4		10.83326748	8.70886557	0.0447468857	0.9987798151			COCCOC1=N[N](C2=CC=C(NC(=O)CCl)C=C2)C(=N1)C3=CC=C(Cl)C(=C3)Cl	MedChem Express	HY-12276	-1.5277229	-1.26240681	4.23611111	8.70886557												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346602-01	NCGC00346602-01	174006325		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	32854-75-4	Lappaconite Hydrobromide			-19.5674477532	4	4		0	-5.45376467					CCN1C[C@@]2(CC[C@H](OC)[C@@]34[C@@H]2C[C@@H]([C@@H]13)[C@@]5(O)C[C@H](OC)[C@H]6C[C@@H]4[C@]5(O)[C@H]6OC)OC(=O)C7=C(NC(C)=O)C=CC=C7	Selleck	S2387	-4.91280871	-3.86105428	-0.35342532	-5.45376467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378857-02	NCGC00378857-02	363678239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	377727-87-2				-8.1256523719	4	4		0	-1.63660655				ADORA2A	COCCOC1=CC=C(C=C1)N2CCN(CC2)CC[N]3N=CC4=C3N=C(N)[N]5N=C(N=C45)C6=CC=CO6	APExBIO	A3735	-2.72638754	0.27423497	-0.18881627	-1.63660655												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167972-02	NCGC00167972-02	384568343		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	126544-47-6		12.5892541179	-4.9	-26.9324152338	-2.4	4		-31.9963902999	-24.83713748	0.0233852062	0.9996634096			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	Prestwick	Prestw-1801	-1.50681223	-1.76547027	-4.70220965	-24.83713748												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509939-01	NCGC00509939-01	384569388		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1693758-51-8		3.1622776602	-5.5	-58.0935601594	-3	4		-38.5590686607	-41.17647059	0.0287634516	0.9994898108		PIK3CG	C[C@H](NC(=O)C1=C2N=CC=C[N]2N=C1N)\C3=C\C4=CC=CC(=C4C(=O)N3C5=CC=CC=C5)C#CC6=C[N](C)N=C6	ChemGood	C-1186	-3.20310385	-2.40175651	-8.62396956	-41.17647059												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00481603-01	NCGC00481603-01	377020212		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-30.0812348141	4	4		0	-9.80510721				FLT1	CNC(=O)C1=C(C)OC2=CC(=CC=C12)OC3=C4C=C(OC)C(=CC4=NC=N3)OC	APExBIO	B5864	-3.99964683	-6.70796933	-11.23147627	-9.80510721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263944-01	NCGC00263944-01	174006252		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	25389-94-0	KANAMYCIN A SULFATE			-1.8457303353	4	4		0	-4.67928741					NC[C@H]1O[C@H](O[C@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	Microsource	MS-01500360	1.94243334	-3.11552861	-1.61789533	-4.67928741												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167507-13	NCGC00167507-13	384568319		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	231277-92-2		11.220184543	-4.95	-93.8481839437	-2.1	4		-111.9168618593	-98.63716226	0.0280783349	0.9995134402		EGFR	C[S+]([O-])(=O)CCNCC1=CC=C(O1)C2=CC3=C(NC4=CC=C(OCC5=CC(=CC=C5)F)C(=C4)Cl)N=CN=C3C=C2	Aobious	AOB5254	-3.47688661	-6.00100627	-10.08796296	-98.63716226												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263204-09	NCGC00263204-09	384568663		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1059105-22-4; 693228-63-6		4.4668359215	-5.35	-99.5324043089	-2.2	4		-79.4487561361	-69.3385251	0.0113700567	0.9999202771		AURKA	CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4	Aobious	AOB87301	-4.38122832	-12.78872982	-39.45833333	-69.3385251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025207-15	NCGC00025207-15	363676538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	65673-63-4				-15.8690605687	4	4		0	-3.86270198				BCL2	CCOC(=O)C(C#N)C\1C2=CC(=CC=C2O\C(=C1C(=O)OCC)N)Br	Selleck	S1071	-4.99095023	-0.57938468	0.24022118	-3.86270198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238452-05	NCGC00238452-05	384568465		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	170364-57-5		14.1253754462	-4.85	-25.0623245771	4	4		-24.0370432799	-23.18446417	0.2898220737	0.9444850101		PRKCA	C[N]1C=C(C2=CC=CC=C12)\C3=C(\C(=O)NC3=O)C4=C[N](C5CCN(CC5)CC6=NC=CC=C6)C7=C4C=CC=C7	Axon Medchem	1682	-1.1684518	-6.14199277	-0.65359477	-23.18446417												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263155-04	Belinostat	384568629	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	414864-00-9		1	-6	-222.3093502226	-1.2	4		-78.9597033645	-99.55625537	0.0221194304	0.9996981344		HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	Selleck	S1085	-19.74860582	-41.47912767	-97.96659404	-99.55625537												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371443-05	NCGC00371443-05	384569043		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					4.3498069027	4	4		0	4.18375718				KDM5A	CCOC(=O)C1=CC=NC(=C1)CNCC(=O)N(CC)CCN(C)C	XcessBio	M60192-b_cm2	-0.51430118	0.77967469	2.84864153	4.18375718												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00521942-01	NCGC00521942-01	384569507		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1398568-47-2		7.9432823472	-5.1	-172.6600165347	-2.3	4		-105.0282567737	-95.10209777	0.1318678672	0.9891207718		MDM2	CC1(C)CCC2(CC1)N[C@H]([C@H](C3=C(F)C(=NC=C3)Cl)[C@]24C(=O)NC5=C4C=CC(=C5)Cl)C(=O)N[C@@H]6CC[C@H](OC6)C(N)=O	ChemieTek	CT-DS3032	-17.44658308	-28.6280977	-42.19189645	-95.10209777												1.28E-7	6.4E-7	0.0000032	0.000016											
NCGC00347065-03	NCGC00347065-03	363677570		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1346528-06-0				-19.4918675637	4	4		0	-7.61669595				VCP	C1CCC2=C(C1)N=C(N=C2NCC3=CC=CC=C3)N4CCOC5=C4C=CC=C5	Bio Vision	2697	-5.05728961	-3.65915016	2.39351852	-7.61669595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015191-21	NCGC00015191-21	384567820		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	80-77-3				-6.9484735563	4	4		0	-3.02132135				GABRA1	CN1C(C2=CC=C(Cl)C=C2)[S+]([O-])(=O)CCC1=O	MedChem Express	HY-B0353	-1.09049774	-2.23220301	-0.4940398	-3.02132135												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262061-03	NCGC00262061-03	384568570		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-22.8364728429	4	4		0	-6.29353946				PRKCA	C[N]1C=C(C2=C1C=CC=C2)\C3=C(\C(=O)NC3=O)C4=C5CC(CN)CC[N]5C6=C4C=CC=C6	SIGMA	B3931	-4.26661946	-6.29869847	-2.02856451	-6.29353946												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00389590-05	NCGC00389590-05	363680811		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1604810-83-4		0.4466835922	-6.35	-201.7840213558	-1.1	4		-87.009870983	-91.97992569	0.0354248531	0.9992252509		CDK7	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC(=CC=C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=CC=CC=C45	MedChem Express	HY-80013	-4.99864658	-82.93229377	-89.13711526	-91.97992569												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384249-01	NCGC00384249-01	384569108		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-4.6563087757	4	4		0	3.44062153				NOX1	CC1=C(C)N=C(CN2CCN(CC2)C(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)C(=N1)C	ChemoGenics	CXC195	-2.10231887	-0.47497423	-2.18525926	3.44062153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499575-01	NCGC00499575-01	384569307		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1024008-14-7		2.2387211386	-5.65	-190.2609589637	-1.3	4		-81.8303506934	-99.58500217	0.0706120168	0.9969121909		HDAC1	ONC(=O)C1=CN=C(N=C1)N2C[C@H]3C[C@@H]2CN3C4=CC(=CC=N4)C(F)(F)F	Organix	O-10104	-14.46359289	-21.58892324	-91.28335203	-99.58500217												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346889-03	NCGC00346889-03	363677553		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	928774-43-0				-22.9285017256	4	4		0	-4.93654394					CN(CCO)C(=O)C1=C[N]2C=C(C)N=C2C(=C1)N[C@@H]3CCOC4=CC=CC(=C34)C	Selleck	S2222	-4.17756925	-9.25751669	-3.00473148	-4.93654394												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509915-01	NCGC00509915-01	384569381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1910124-24-1		8.9125093813	-5.05	-7.7264011885	4	4		-19.622168472	-13.85180706	0.4167894789	0.8755980416		BRPF1	COC1=CC=CC=C1C(=O)NC2=CC3=C(C=C2N4CCNC[C@H]4C)N(C)C(=O)N3C	Selleck	S8265	2.91365001	-3.55232662	-3.33427124	-13.85180706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00381751-04	NCGC00381751-04	363679167		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	885060-09-3		14.1253754462	-4.85	-128.2994899603	4	4		-13.2404490241	-37.61105168	0.4271559289	0.8685134866		KIF11	CON(C)C(=O)N1/N=C(S[C@@]1(CCCN)C2=CC=CC=C2)/C3=CC(=CC=C3F)F	MedChem Express	HY-15187	-24.07734416	-29.3412373	-26.03170137	-37.61105168												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379091-01	NCGC00379091-01	363678347		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1311367-27-7				-4.5378288886	4	4		0	-8.18642728				RPS6KB2	C[C@@H]1CCNC(=O)C2=CC3=C(C=C(C=C3)C(=O)NC4=NC5=CC=CC=C5[N]4CCCN(C)C)[N]12	MedChem Express	HY-16104	1.79233622	-2.6965591	-1.58975802	-8.18642728												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386195-06	NCGC00386195-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox					-12.8765704528	4	4		0	-4.53962676					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@H](O)C[C@@]2([H])N3C	Selleck	S2545	-2.54620484	-2.8998765	-1.36574074	-4.53962676												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390643-01	NCGC00390643-01	384569204		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1234015-54-3		0.2818382931	-6.55	-109.7240941051	4	4		-22.1098953801	-33.0594995	0.2295867455	0.9662600311		CHEK1	COC1=CC=CC(=C1C2=CC(=N[NH]2)NC3=NC=C(N=C3)C#N)OCCCN	MedChem Express	HY-18174A	-17.55125335	-27.94675937	-29.56018519	-33.0594995												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390724-02	E-7449	384569209	PARP Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1140964-99-3				-29.8825582655	4	4		0	-10.24954585				PARP1	O=C1NNC2=C3C(=NC(=N2)CN4CC5=C(C4)C=CC=C5)C=CC=C13	MedChem Express	HY-12418	-4.75565611	-6.41814507	-7.9998187	-10.24954585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481588-01	ACY-241	384569257		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			12.5892541179	-4.9	-62.6670039045	-2.2	4		-33.626104888	-32.19295734	0.0457914239	0.9987079215		HDAC1	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=C(Cl)C=CC=C3	APExBIO	B5936	-8.7545366	-9.92904714	-13.31880901	-32.19295734												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025251-09	NCGC00025251-09	384568064		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	196808-24-9				32.2833347181	4	4		0	10.03435442				PPARG	CN(CCOC1=CC=C(C[C@H](NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C(O)=O)C=C1)C4=CC=CC=N4	Bio Vision	2057	5.31999646	10.39045836	5.63059792	10.03435442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160670-08	Mecarbinate	384568202	antiinfluenza drug	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	15574-49-9				-12.2145046143	4	4		0	-0.86377455					CCOC(=O)C1=C(C)[N](C)C2=CC=C(O)C=C12	MedChem Express	HY-B0376	-2.35495804	-5.43083748	-2.51695039	-0.86377455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346630-05	NCGC00346630-05	363677485		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	898562-94-2 (free base)		12.5892541179	-4.9	-42.4564271147	-3	4		-38.6401008347	-38.17845102	0.0815414628	0.9958804002		PDE10A	C[N]1C=C(C2=CC=NC=C2)C(=N1)C3=CC=C(OCC4=NC5=CC=CC=C5C=C4)C=C3	Glixx	GLXC-90150	-4.18806796	-3.04624251	-1.56944444	-38.17845102												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00174007-13	NCGC00174007-13	384568350		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox					-24.2489585737	4	4		0	-6.50553208					CN1CCC\N=C1\C=C\C2=CC=CS2	Microsource	MS-01500517	-4.10904781	-7.08045556	-5.64351852	-6.50553208												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090762-05	NCGC00090762-05	384568084		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	72559-06-9				-1.284751094	4	4		0	-1.92791681				PRKDC	[H][C@]1(C)\C=C\C=C(C)\C(=O)NC2=C3NC4(CCN(CC(C)C)CC4)N=C3C5=C(C2=O)C(O)=C(C)C6=C5C(=O)[C@](C)(O6)O\C=C\[C@]([H])(OC)[C@@]([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@]([H])(C)[C@@]1([H])O	APExBIO	B2126	0.33364063	-2.27782098	1.28240741	-1.92791681												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402368-01	NCGC00402368-01	384569217		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1253573-53-3		2.2387211386	-5.65	-142.1977649059	-2.2	4		-54.8046837621	-65.05532077	0.0183080923	0.9997933203		PIK3CA	COC1=C(F)C=C(NC2=NC=C(C=C2C3=NC(=NC(=N3)N)C)[C@H](C)N4CCN(CC4)[S+](C)([O-])=O)C=N1	Aobious	AOB33711	-15.97085034	-25.60490326	-49.9212963	-65.05532077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015823-23	NCGC00015823-23	384567895		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	36322-90-4				-4.7414980126	4	4		0	-0.18044542				PTGS1	CN1\C(=C(\O)C2=C(C=CC=C2)[S+]1([O-])=O)C(=O)NC3=CC=CC=N3	Microsource	01500491	-1.02726195	0.73183003	-3.56944444	-0.18044542												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166236-04	Oxonic acid potassium salt			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	2207-75-2				-18.9925930445	4	4		0	-1.97060788					OC1=NC(=NC(O)=N1)C([O-])=O	SIGMA	156124	-5.74488802	-3.37352544	-2.32873396	-1.97060788												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346701-09	NCGC00346701-09	384568921		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	248281-84-7		14.1253754462	-4.85	-36.3598317816	4	4		-13.10824444	-16.2885706	0.1767686622	0.9804430386			CCN(C(=O)C/1=C(O)/C2=C(C=CC=C2Cl)N(C)C1=O)C3=CC=CC=C3	MedChem Express	HY-13010	-6.62836942	-5.43707094	-4.9483669	-16.2885706												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346620-06	NCGC00346620-06	363677481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	801312-28-7				-10.2237268378	4	4		0	-4.27280592				PDE4A	COC1=CC=CC(=C1)NC2=C(C=NC3=C(C)C=C(C=C23)[S+]([O-])(=O)C4=CC=CC(=C4)C(=O)N(C)C)C(N)=O	MedChem Express	HY-10469	-2.11224039	0	-2.3410121	-4.27280592												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167801-02	NCGC00167801-02	384568338		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[1188890-36-9]				-16.0883841992	4	4		0	-5.49360761				MMP13	O=C(NCCCCN1CCOCC1)C2=CC3=CC=CC=C3O2	Tocris	2632	-1.86478126	-4.51258581	-5.81748516	-5.49360761												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015149-25	NCGC00015149-25	384567815		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	28395-03-1				-1.729948862	4	4		0	0.19705854				SLC12A2	CCCCNC1=CC(=CC(=C1OC2=CC=CC=C2)[S+](N)([O-])=O)C(O)=O	MedChem Express	HY-17468	0.45072912	-2.18764302	-2.14475959	0.19705854												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507863-01	NCGC00507863-01	384569338		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1219810-16-8		12.5892541179	-4.9	-74.2847833557	-3	4		-100.3411798396	-91.38540969	0.0782073119	0.996208626		GPX4	COC(=O)[C@H]1CC2=C([NH]C3=C2C=CC=C3)[C@@H](N1C(=O)CCl)C4=CC=C(C=C4)C(=O)OC	Selleck	S8155	-3.32579186	3.55266113	0.04079228	-91.38540969												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387711-02	NCGC00387711-02	363680649		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1352226-88-0		7.0794578438	-5.15	-41.9491631366	-2.4	4		-30.6046812441	-30.08891863	0.0802681334	0.996012711		ATR	C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@@+](C)([O-])=N)C4=CC=NC5=C4C=C[NH]5	MedChem Express	HY-19323	-3.90497738	-2.50168426	-11.07283688	-30.08891863												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00496840-01	NCGC00496840-01	384569294		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1883429-21-7				-3.3955997661	4	4		0	-1.23051682				BRD7	COC1=CC(=CC(=C1CN(C)C)OC)\C2=C\N(C)C(=O)C3=C2C=CN=C3	Selleck	S8179	0.09022828	-3.64744365	-0.2243793	-1.23051682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022037-07	NCGC00022037-07	363676518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	71-58-9				-15.2248929688	4	4		0	-3.77841046				PGR	C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(C)=O)C(C)=O)[C@@]\4(C)CCC(=O)\C=C14	Selleck	S2567	-3.13994406	-4.43608012	-1.83405688	-3.77841046												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092288-05	NCGC00092288-05	363676556		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	856925-71-8				-32.0754463818	4	4		0	-13.81556724				MYH2	CC1=CC=C2\N=C/3N(CC[C@@]3(O)C(=O)C2=C1)C4=CC=CC=C4	Selleck	S7099	-5.11594334	-7.41139042	-5.01438954	-13.81556724												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00373041-02	NCGC00373041-02	384569046		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	259793-96-9				-3.3000637344	4	4		0	-4.04210324					NC(=O)C1=NC(=CN=C1O)F	Adooq	A11590	1.99734865	-5.33638444	-2.35970282	-4.04210324												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014670-26	NCGC00014670-26	384567793		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	57808-66-9				-22.0419421296	4	4		0	-6.90666154				DRD1	ClC1=CC2=C(C=C1)N(C3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2	MedChem Express	HY-B0411	-4.33937251	-5.69336384	-2.60268212	-6.90666154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346883-02	6-Bromoindirubin-3'-acetoxime	384568960	GSK-3 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[667463-85-6]		5.0118723363	-5.3	-142.4376845759	-2.1	4		-100.8336374144	-95.79448236	0.0408277037	0.9989705807		GSK3B	CC(=O)O\N=C1\C(NC2=CC=CC=C12)=C3/C(=O)NC4=C3C=CC(=C4)Br	Tocris	3874	-8.64339373	-18.18764302	-51.58170179	-95.79448236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346644-04	NCGC00346644-04	384568876		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1038395-65-1		0.3981071706	-6.4	-219.5250271943	5	4		-22.700442296	-53.63183107	0.4310429733	0.8650660848		SRC	O=C(CC1=CC=C(C=N1)C2=CC=C(OCCN3CCOCC3)C=C2)NCC4=CC=CC=C4	APExBIO	A3535	-40.24401265	-49.69837166	-59.99438123	-53.63183107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389510-02	NCGC00389510-02	363680793		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	192185-72-1		8.9125093813	-5.05	-126.8209374388	-3	4		-89.7669614346	-98.32828233	0.0227595239	0.9996803972			C[N]1C=NC=C1C(N)(C2=CC=C(Cl)C=C2)C3=CC\4=C(C=C3)N(C)C(=O)\C=C4C5=CC(=CC=C5)Cl	Bio Vision	2296	-13.26705829	-11.49816302	-16.32719951	-98.32828233												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378595-03	NCGC00378595-03	377020160		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	874101-00-5		0.6309573445	-6.2	-117.2525893178	-2.4	4		-33.53534302	-33.35568862	0.264314993	0.954871839		MAP2K1	OCCONC(=O)C1=CC(=C(F)C(=C1NC2=CC=C(I)C=C2F)F)CN3OCCCC3=O	MedChem Express	HY-14719	-21.24290277	-26.49726097	-27.97679478	-33.35568862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346939-07	NCGC00346939-07	384568973		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1144035-53-9				-26.2269976694	4	4		0	-7.77397095				PDE2A	ClC1=CC(=CC(=C1)COC(=O)N2CCN(CC2)CCC(=O)C3=CC=C4NC(=O)OC4=C3)Cl	MedChem Express	HY-13344	-4.85428133	-6.03127661	-5.4436369	-7.77397095												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092361-06	Prostaglandin E2	174006772	prostaglandin	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	363-24-6	; alpha, Prostaglandin E; 15-ketoprostaglandin E; E2alpha, Prostaglandi; Prostenon; E2, Prostaglandi; ; PROSTAGLANDIN E2; Prostaglandin,PGE2; 8-iso-PGE2; Dinoprostone Betadex; Prepidil; alpha, PGE; 15-ketoprostaglandin E1; Dinoprostone; Dinoprostona;Prostaglandin E2; Gel, Prepidi; 8-isoprostaglandin E2; 8,12-epi-PGE2; 8,12-epi-prostaglandin E2; 15-keto-PGE;Dinoprostone; E2 alpha, Prostaglandi; 15-keto PGE1; Prepidil Gel; PGE2 alpha; Prostaglandin E2 alpha			-36.935517701	4	4		0	-5.11871576				PTGER2	O[C@@H]1CC(=O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC	Tocris	2296	-7.93636765	-7.71624714	-10.65838045	-5.11871576												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165772-06	NCGC00165772-06	384568281		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	218137-86-1				-1.8320889125	4	4		0	4.36893204				FAS	CCCCCCCCC1OC(=O)C(=C)C1C(O)=O	SIGMA	C5490	-1.91780822	-0.82379863	0.53735807	4.36893204												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345782-02	NCGC00345782-02	384568738		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	200484-11-3		0.316227766	-6.5	-217.8186080486	-1.1	4		-95.4892478227	-96.21663897	0.0168212841	0.9998254455		IKBKB	ClC1=CC=C(OCCCCCCN\C(NC2=CC=NC=C2)=N/C#N)C=C1	Cayman	11021	-4.26570267	-95.57309384	-97.58393033	-96.21663897												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00482799-01	NCGC00482799-01	384569260		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	N/A		2.8183829313	-5.55	-40.0564565115	4	4		-27.931834224	-21.21797037	0.4002562482	0.8866725579		PTK2	CONC(=O)C1=CC=CC=C1NC2=CC(=NC=C2Cl)NC3=CC(=N[N]3C(C)C)C	DC Chemicals	DC8331	-2.94144185	-11.77577631	-12.09697088	-21.21797037												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378557-07	NCGC00378557-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1391712-60-9		11.220184543	-4.95	-88.1097586423	-2.1	4		-129.8153892339	-99.66221107	0.0311509336	0.9994010322			CNC(=O)C1=CC=CC=C1NC2=NC(NC3=CC=C4C[C@H](CCCC4=C3OC)N5CCN(CCO)CC5)=NC=C2Cl	Glixx	GLXC-90189	-0.11729676	-3.47716987	-15.57972782	-99.66221107												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346506-05	LY-2886721	384568809	beta-Secretase 1/2 (BACE1/2) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1262036-50-9				-8.405206229	4	4		0	-7.12734643				BACE1	NC/1=N/[C@]2(COC[C@H]2CS1)C3=CC(=CC=C3F)NC(=O)C4=NC=C(F)C=C4	MedChem Express	HY-13240	0.89325995	-4.19411211	-3.47300132	-7.12734643												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163431-06	CA-074 Me	384568238	Cathepsin B Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	147859-80-1				7.3678505	4	4		0	5.88772469				CTSB	CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N2CCC[C@H]2C(=O)OC	APExBIO	A8239	0.05302696	2.66361556	1.38778562	5.88772469												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347952-11	NCGC00347952-11	384568997		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	71555-25-4		0.7079457844	-6.15	-153.839655272	-1.4	4		-75.097884984	-68.81415583	0.2631327689	0.9547108862			CC(=N/NC(=S)N1CCC1)\C2=NC=CC=C2	MedChem Express	HY-18634	-4.44645278	-44.22823967	-86.0373648	-68.81415583												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025172-03	NCGC00025172-03	384568053		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[84088-42-6]				-26.6789231972	4	4		0	-2.0138821					CN(C1=CC=CC=C1)C(=O)C/2=C(O)/C3=C(C=CC=C3)N(C)C2=O	Tocris	1461	-6.82331676	-6.68118111	-4.40604954	-2.0138821												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346890-02	NCGC00346890-02	384568963		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	[252979-56-9]		5.6234132519	-5.25	-20.0687595711	4	4		-14.5654155199	-14.14605533	0.1031541239	0.9934437826		TOP2A	C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	Tocris	4219	-1.17487573	-2.7985667	-6.49435782	-14.14605533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242503-02	NCGC00242503-02	384568503		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[146362-70-1]				-6.0913253956	4	4		0	-2.1988024				CPA1	COC1=C(C(=CC=C1)OC)C2=CC(=N[N]2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(O)=O	Tocris	3721	-1.37952449	-2.23726005	0.91370558	-2.1988024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015608-22	Loperamide hydrochloride	384567873	mu-Opioid Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	34552-83-5				-16.676421407	4	4		0	-5.45628743				OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-B0418A	-2.14247693	-5.18344612	-5.01329466	-5.45628743												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262398-01	NCGC00262398-01	161003999		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	n	 NCGC00262398;NCGC00262398	3.1622776602	-5.5	-108.50934156	-1.2	4		-71.9389892429	-74.95568862	0.0187313873	0.9997835597	9099	USP2	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=C(C=CC(=C2)Cl)C(=O)NC3=NC(=CS3)C4=CC=CC=C4	NCGCChem	RAP04-025	-3.94339957	-3.34207982	-57.34106841	-74.95568862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181170-09	NCGC00181170-09	384568394		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	3543-75-7				-17.881509333	4	4		0	-1.83853689				XRCC1	C[N]1C(=NC2=C1C=CC(=C2)N(CCCl)CCCl)CCCC(O)=O	MedChem Express	HY-B0077	-4.99864658	-4.41815656	-0.93653968	-1.83853689												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161602-13	NCGC00161602-13	384568211		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	24390-14-5				-4.8007560825	4	4		0	-4.84968393				MMP1	C[C@@H]1[C@H]\2[C@H](O)[C@H]3[C@H](N(C)C)\C(=C(C(N)=O)/C(=O)[C@@]3(O)\C(=C2C(=O)C4=C(O)C=CC=C14)O)O	MedChem Express	HY-N0565B	-0.84814581	-0.01792356	1.43407639	-4.84968393												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346658-03	NCGC00346658-03	384568889		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	670220-88-9		12.5892541179	-4.9	-89.2519057475	-3	4		-103.2161764923	-98.13733533	0.0301115581	0.999440366		PDGFRB	CC1(COC1)COC2=CC3=C(C=C2)[N](C=N3)C4=NC5=C(C=CC=C5C=C4)N6CCC(N)CC6	ChemieTek	CT-CREN	-3.36551475	-5.98646772	-4.46807473	-98.13733533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475743-01	NCGC00475743-01	384569237		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	926927-61-9				-3.352079448	4	4		0	-5.20522926				TLR8	CCCN(CCC)C(=O)C\1=C\C2=CC=C(C=C2\N=C(N)/C1)C3=CC=C(C=C3)C(=O)N4CCCC4	ActiveBioChem	A-1284	1.23729563	-1.88558352	-1.86439886	-5.20522926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386428-07	NCGC00386428-07	384569138		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1082949-68-5		10	-5	-34.1180302562	4	4		-20.8150472159	-22.54638085	0.0460609195	0.9986944579		RPS6KB1	C[N]1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=N[NH]4)C5=CC=C(F)C(=C5)C(F)(F)F	MedChem Express	HY-12493A	-3.95050817	-4.71395881	-5.55581515	-22.54638085												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091057-08	NCGC00091057-08	384568092		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	22888-70-6		6.3095734448	-5.2	-29.1737343899	4	4		13.8004970679	2.72753935	0.2918927952	0.944174029		ABCBA	COC1=C(O)C=CC(=C1)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=C(C(=CC(=C5)O)O)C(=O)[C@@H]4O	Selleck	S2357	-9.41708089	-5.91010115	-4.34049726	2.72753935												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345739-02	NCGC00345739-02	174007137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1354037-26-5	KH-CB19			-6.0810618603	4	4		0	3.49007723			78989	CLK1	CCOC(=O)C1=C(\C(=C/N)C#N)C2=CC=C(Cl)C(=C2[N]1C)Cl	Tocris	4262	-3.11793945	-1.1112623	0.07023458	3.49007723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510440-02	NCGC00510440-02	384569433		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1628214-07-2				-20.9290970279	4	4		0	1.48597126				KDM5A	CCC/1=C(/NC2=C(C=N[N]2C1=O)C#N)C3=CC=CC=C3C	Axon Medchem	2622	-6.60641663	-3.25214315	-4.14384043	1.48597126												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025329-02	NCGC00025329-02	174007082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	193551-21-2	SB 239063			-35.8376520614	4	4		0	-8.05269461			1432	MAPK14	COC1=NC(=CC=N1)C2=C(N=C[N]2C3CCC(O)CC3)C4=CC=C(F)C=C4	Tocris	1962	-8.54772889	-7.52198131	-3.91104665	-8.05269461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481082-01	NCGC00481082-01	363681116		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			5.6234132519	-5.25	-103.8722762202	-2.1	4		-108.6048340077	-99.69116441	0.0120250737	0.9999108052		CSNK2A1	COC(=O)NC1=CC(=C(Cl)C(=C1)NC2=N[N]3C(=CN=C3C(=C2)NC4CC4)C#N)N5CCN(C)CC5	Piramal	BMS-595 lot1	-0.63159794	-2.28525339	-37.41280913	-99.69116441												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263168-03	NCGC00263168-03	384568638		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	718630-59-2				-16.3129341468	4	4		0	-10.1674468				CDK1	CC(C)CC(=O)NC1=N[NH]C2=C1CN(C(=O)C3CCN(C)CC3)C2(C)C	Selleck	S1487	-0.92935126	-2.22252095	-6.84844642	-10.1674468												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507868-01	NCGC00507868-01	384569342		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1884712-47-3		10	-5	-53.6110812671	-2.4	4		-56.6318793124	-45.55897337	0.1584572119	0.9841984352		EP300	C[C@@H]1CC(=O)NC2=C(N1)C(=CC=C2)C3=CC4=C(C=C3)[N](C)N=C4C5=C[N](C)N=C5	Selleck	S8190	-1.25497128	-8.37528604	-15.02266249	-45.55897337												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346526-03	PHA-680632	384568820	Aurora-A/B/c Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	398493-79-3		11.220184543	-4.95	-10.0352902949	4	4		-17.9663701279	-13.30530844	0.0339048859	0.9992956525		AURKA	CCC1=CC=CC(=C1NC(=O)N2CC3=C(C2)C(=N[NH]3)NC(=O)C4=CC=C(C=C4)N5CCN(C)CC5)CC	Selleck	S1454	0.21690014	0.4218261	-1.3438217	-13.30530844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163700-14	NCGC00163700-14	384568248		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	2068-78-2		0.2511886432	-6.6	-165.2719638291	-2.4	4		-63.661815708	-56.32026591	0.288191221	0.9450960501	203068	TUBB	CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]67[C@H]89)C(=O)OC)C1	Selleck	S1241	-24.51875282	-41.76985531	-44.87989886	-56.32026591												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263217-05	NCGC00263217-05	384568671		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	362003-83-6		8.9125093813	-5.05	-95.1664740003	-2.2	4		-95.3884912637	-75.69654903	0.0244026577	0.999632608		CERK	O=C(NC1=CC2=C(C=C1)N=C(NC(=O)C3=CC=CC=C3)S2)C4C5CC6CC(C5)CC4C6	MedChem Express	HY-13945	-4.60912788	-9.19399465	-29.17544599	-75.69654903												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167431-03	NCGC00167431-03	124893311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	61379-65-5	Rifapentine; ; Rifapentine; Priftin; Rifapentine Hydrochloride			-15.5641695053	4	4		0	-2.47336005			5591	PRKDC	CO[C@H]1/C=C/O[C@@]2(C)OC3=C(C2=O)C4=C(C(=C3C)O)C(=C(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4O)\C=N/N5CCN(CC5)C6CCCC6)O	Toronto Research	R508500	-3.94035246	-4.30444051	-0.9224142	-2.47336005												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390649-02	NCGC00390649-02	384569206		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	600734-06-3		14.1253754462	-4.85	-50.1024648117	-3	4		-31.77911206	-30.64431138	0.2792485429	0.9486824679		NFKB	OC1=C(C(=CC=C1)OCC2CC2)C3=CC(=C4COC(=O)NC4=N3)[C@@H]5CCCNC5	MedChem Express	HY-50948	-9.08002129	-2.49505133	-3.24389654	-30.64431138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345539-10	NCGC00345539-10	384568737		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	404951-53-7		0.3548133892	-6.45	-258.1277688255	-1.1	4		-100.0239509273	-99.74131737	0.0278682955	0.9995207419		HDAC1	OCCN(CCC1=C[NH]C2=C1C=CC=C2)CC3=CC=C(\C=C\C(=O)NO)C=C3	Glixx	GLXC-90143	-22.60911994	-80.28357041	-99.75827895	-99.74131737												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00420698-02	BPTES	384569223	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[314045-39-1]		2.8183829313	-5.55	10.7725364245	4	4		16.9418791239	-1.67449649	1	0.989098048		GLS	O=C(CC1=CC=CC=C1)NC2=NN=C(CCSCCC3=NN=C(NC(=O)CC4=CC=CC=C4)S3)S2	Tocris	5301	-1.58926364	-3.28489927	11.84111799	-1.67449649												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015958-18	NCGC00015958-18	384567910		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	129-56-6		11.220184543	-4.95	-41.1070353419	-3	4		-47.0156243524	-38.28085027	0.1012958496	0.9936240645		MAPK8	[O]=[C]1C2=C(C=CC=C2)C3=N[NH]C4=CC=CC1=C34	MedChem Express	HY-12041	-1.26258167	-4.82706365	-8.43650347	-38.28085027												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345803-02	NCGC00345803-02	384568751		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	297730-17-7		3.5481338923	-5.45	-82.1180429929	-2.2	4		-47.7417970331	-50.78375738	0.0102413277	0.9999353458		IMPDH1	CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC=CC(NC(=O)NC2=CC=C(C3=CN=CO3)C(OC)=C2)=C1	ChemieTek	CT-AVN944_cm1	-5.95973865	-9.74772687	-31.65916338	-50.78375738												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346533-13	NCGC00346533-13	384568823		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1009119-64-5		12.5892541179	-4.9	-76.9240499941	-3	4		-101.3087050508	-90.71902336	0.0883407868	0.9951557864			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	MedChem Express	HY-10466	-0.20327	-7.58810069	-4.71473296	-90.71902336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344481-01	NCGC00344481-01	377020180		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	n		12.5892541179	-4.9	-87.076397626	-3	4		-115.241199658	-98.6878785	0.0561933852	0.9980473819		YES1	CN[S+]([O-])(=O)C1=CC=C2NC(=O)C(=C\C3=C(CCCN4CCN(C)CC4)C5=C(CCCC5)[NH]3)/C2=C1	NCGCChem	PRP01-012	-4.33053469	0.84210526	-4.06990328	-98.6878785												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387821-04	NCGC00387821-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1022958-60-6		10	-5	-94.6339100648	-2.3	4		-127.2675862668	-99.28386042	0.0577458446	0.9979377313			COC1=C(NC2=NC(N[C@@H]3[C@@H]4C[C@@H](C=C4)[C@@H]3C(N)=O)=C(Cl)C=N2)C=CC5=C1CC[C@H](CC5)N6CCOCC6	DC Chemicals	DC8138	0.43305347	-6.2791762	-24.52689127	-99.28386042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351594-01	NCGC00351594-01	384569013		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	301356-95-6	BCL6 Inhibitor			-9.0074666885	4	4		0	-2.06276273				BCL6	OC(=O)CC(N1C(=S)SC(/C1=O)=C2\C(=O)NC3=C2C=C(Br)C=C3)C(O)=O	EMD Chemicals	197345	-1.5996385	-1.01147548	-3.82544365	-2.06276273												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00068236-11	NCGC00068236-11	384568072		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	112811-59-3		8.9125093813	-5.05	-4.6347021818	4	4		17.357433348	10.04008212	0.2074941178	0.9726957247		TOP2B	COC1=C(N2CCNC(C)C2)C(=CC3=C1N(\C=C(C(O)=O)/C3=O)C4CC4)F	Prestwick	Prestw-1265	-4.46452779	-1.51040958	0.45418364	10.04008212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00077915-02	NCGC00077915-02	384568074		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-13.9556851388	4	4		0	-0.5474631				PTP2C	OC(=O)C1=CC=CC=C1C2=CC=C(O2)\C=C3/SC4=NC5=CC(=CN=C5[N]4C3=O)Br	Evotec	MLS002554729	-2.54857659	-6.28203384	-4.64952943	-0.5474631												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346725-06	NCGC00346725-06	363677538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	956104-40-8				-15.7789959352	4	4		0	3.51137725				AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C#N)C(=C4)C(F)(F)F	MedChem Express	HY-16060	-5.97498226	-4.43769277	-0.06284747	3.51137725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182052-15	NCGC00182052-15	384568407		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1001645-58-4		12.5892541179	-4.9	-93.163557857	-3	4		-104.6228399314	-99.56886228	0.0238190143	0.9996499215		SIRT1	O=C(NC1=CC=CC=C1C2=C[N]3C(=CSC3=N2)CN4CCNCC4)C5=NC6=C(C=CC=C6)N=C5	MedChem Express	HY-15145	-4.5023066	-6.03047461	-4.33647571	-99.56886228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165889-13	NCGC00165889-13	384568295		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	694433-59-5				-39.7083137759	4	4		0	-14.75417461				TGBR1	CC1=NC(=CC=C1)C2=C(N=C([NH]2)C(C)(C)C)C3=CC4=C(OCO4)C=C3	MedChem Express	HY-13521	-5.17393608	-8.53538955	-13.59501032	-14.75417461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015725-27	NCGC00015725-27	384567885		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	51803-78-2				-1.5918836088	4	4		0	-2.34429508				PTGS2	C[S+]([O-])(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O	MedChem Express	HY-B0363	1.85414091	-4.17632377	-2.3682236	-2.34429508												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015116-20	NCGC00015116-20	384567811		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	72432-10-1				-10.2520839446	4	4		0	-0.12977026					COC1=CC=C(C=C1)C(=O)N2CCCC2=O	MedChem Express	HY-10932	-3.57048166	1.48283753	-2.96715107	-0.12977026												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016256-20	NCGC00016256-20	384567926		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	58-14-0		7.9432823472	-5.1	-99.3828877982	-2.1	4		-98.9207370504	-82.17341152	0.0236174068	0.9996558637		DHFR	CCC1=C(C(=NC(=N1)N)N)C2=CC=C(Cl)C=C2	Selleck	S2006	-4.20680513	-8.51258581	-30.43315733	-82.17341152												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00273984-04	NCGC00273984-04	384568706		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-12.3550747668	4	4		0	-9.68470633				MAPK11	CC[N]1C(=NC2=CN=CC(=C12)CNC3CCNCC3)C4=NON=C4N	Tocris	4630	-0.12372956	-3.82608696	-3.04191393	-9.68470633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386362-01	NCGC00386362-01	363680233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1095253-39-6		10	-5	-67.8049565885	-3	4		-56.4125764998	-59.21843687	0.0188423242	0.9997810381		KIF11	NCCCN([C@H](CC#C)C/1=N/C2=C(C=CC(=C2)Cl)C(=O)N1NC3=CC=CC=C3)C(=O)C4=CC=CC(=C4F)Cl	Selleck	S7355	-5.49703461	-6.33352196	-7.26700557	-59.21843687												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263201-04	NCGC00263201-04	384568660		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	890019-63-3		10	-5	-77.0726441497	-3	4		-108.9898368143	-99.52762668	0.0574695668	0.9979574204		MET	COC1=C(OCCCN2CCOCC2)C=C3N=CC=C(OC4=CC=C(C=C4F)\C5=C\N=C(\NC6=CC=C(F)C=C6)N(C)C5=O)C3=C1	SynKinase	SYN-1111	-1.53138001	3.93940713	-2.18349068	-99.52762668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178377-07	NCGC00178377-07	384568355		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	29883-15-6				-19.2627145844	4	4		0	-1.65269461					OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC(C#N)C3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCK-001	-6.48953158	-2.71601528	0.63330916	-1.65269461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345846-01	NCGC00345846-01	174006734		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	936091-15-5	TG-46	1.2589254118	-5.9	-163.9087064999	-1.3	4		-89.9852749801	-97.78682635	0.0550882082	0.9981236166	3717	JAK2	CC1=C(NC2=CC=CC(=C2)[S+]([O-])(=O)NC(C)(C)C)N=C(NC3=CC=C(CN4CCOCC4)C=C3)N=C1	SynKinase	SYN-1106	-5.88626686	-16.21323022	-92.21658206	-97.78682635												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345496-08	NCGC00345496-08	363677349		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	192441-08-0		12.5892541179	-4.9	-31.5763713103	4	4		-20.01347388	-22.39173915	0.128903868	0.9896495668	4255	MGMT	NC1=NC2=C([NH]C=N2)C(=N1)OCC3=CC(=CS3)Br	MedChem Express	HY-13668	-3.21384425	-5.42431806	-4.06584131	-22.39173915												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263211-04	NCGC00263211-04	384568668		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	315703-52-7		1	-6	-228.6827331622	5	4		-27.5118558092	-65.88964722	0.0230699864	0.9996722008		ADH7	CCOC1=CC=C(NC2=NC(=CS2)C3=C(C)N=C4C=CC=C[N]34)C=C1	Chemdea	CD0243	-38.98365002	-49.32723112	-64.96425401	-65.88964722												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015026-16	NCGC00015026-16	384567797		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	5908-99-6				0.6034699058	4	4		0	0.98768966				CHRM1	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	MedChem Express	HY-B0394	0.95600602	-2.27658556	-1.40885984	0.98768966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346455-02	NCGC00346455-02	384568780		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	934660-93-2		11.220184543	-4.95	-141.9425983847	-2.3	4		-109.8225775719	-99.70696311	0.138348406	0.9880067768		MAP2K1	OC1(CN(C1)C(=O)C2=C(NC3=C(F)C=C(I)C=C3)C(=C(F)C=C2)F)[C@@H]4CCCCN4	MedChem Express	HY-13064	-12.08723292	-23.24389374	-29.05177265	-99.70696311												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263161-11	NCGC00263161-11	363677237		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	956905-27-4				-3.2257593046	4	4		0	-2.62337783				MET	OCC[N]1C=C(C=N1)C2=CN=C3N=N[N](CC4=CC=C5N=CC=CC5=C4)C3=N2	Glixx	GLXC-90210	-0.16775561	2.26867534	-3.46557869	-2.62337783												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164591-10	NCGC00164591-10	384568261		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	71963-77-4				-12.5420538964	4	4		0	0.75459002				PfATP6	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	Selleck	S2264	-3.05788776	-3.35011442	-4.22877436	0.75459002												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345855-06	NCGC00345855-06	384568770		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1206161-97-8				-13.0041158052	4	4		0	-3.49418437				JAK1	[O-][S+]1(=O)CCN(CC1)CC2=CC=C(C=C2)C3=CC=CC4=NC(=N[N]34)NC(=O)C5CC5	ChemieTek	CT-GLPG	-0.64516129	-6.56292906	-5.94832017	-3.49418437												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178318-05	NCGC00178318-05	384568354		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	19767-45-4				-19.8822780118	4	4		0	-5.79405297					[O-][S](=O)(=O)CCS	Selleck	S1735	-4.17647059	-2.74421738	-4.24692925	-5.79405297												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00246387-08	NCGC00246387-08	384568511		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	131707-23-8				-14.334031839	4	4		0	-8.14486115					CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	-2.17756927	-0.27423497	-3.56814331	-8.14486115												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347284-03	NCGC00347284-03			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	781613-23-8		3.1622776602	-5.5	-146.3723635467	-2.1	4		-97.5055034651	-99.65508982	0.007865509	0.9999618425			COC1=CC2=C(C=C1OC[C@H]3C[C@H]4CN(C)C[C@H]4C3)N=CN=C2NC5=C(F)C(Cl)=C(Cl)C=C5	MedChem Express	HY-13314	-6.61373314	-14.73093035	-63.95455644	-99.65508982												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249390-02	NCGC00249390-02	384568525		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	475108-18-0		8.9125093813	-5.05	-18.5626980332	-3	4		-51.265508988	-43.97125749	0.0268480348	0.9995553625		FLT1	COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1	Selleck	S1207_cm2	3.77484031	4.916448	1.75489485	-43.97125749												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00505117-01	NCGC00505117-01	384569316		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox			7.0794578438	-5.15	-69.5551734328	-2.2	4		-47.5547429577	-49.39401198	0.0243425583	0.9996345948		EP300	CNC(=O)C[N]1C=C(C=N1)C2=CC3=C(C=C2)C4(CC3F)NC(=O)N(CC(=O)N(CC5=CC=C(F)C=C5)[C@@H](C)C(F)(F)F)C4=O	NCGCChem	CAL008-010_1st_neg	-6.65809084	-6.37112738	-15.99709935	-49.39401198												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00021305-08	NCGC00021305-08	124886756		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox		; ;Rapamycin;Sirolimus; Sirolimus; Wyeth Brand of Sirolimus; Rapamune; Rapamycin (Sirolimus)			-141.0879190225	4	4		0	-32.87594772			2475	MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Selleck	S1039	-30.27547236	-27.67427349	-28.41399362	-32.87594772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00091455-13	NCGC00091455-13	363676552		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	169590-42-5				-3.970054543	4	4		0	-1.34859205				PTGS2	CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S+](N)([O-])=O)C(F)(F)F	Selleck	S1261	-0.81654155	-0.75927366	-0.49537037	-1.34859205												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025219-10	NCGC00025219-10	377020478		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	212844-53-6		7.9432823472	-5.1	-100.4065113921	-2.1	4		-94.3121674835	-87.82866431	0.0104457995	0.9999327012		CDK1	CC(C)[C@H](CO)NC1=NC(=C2N=C[N](C(C)C)C2=N1)NC3=CC(=CC=C3)Cl	MedChem Express	HY-18299A	-5.7239819	-5.65461487	-23.16548067	-87.82866431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511352-01	NCGC00511352-01	384569497		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	376638-65-2				-9.6274820859	4	4		0	0.68840233					CCN(CC)C(=O)CC1=CSC(=N1)N[S+]([O-])(=O)C2=C(C)C(=CC=C2)Cl	Glixx	GLXC-04311	-2.97285068	-2.4388053	-1.21017087	0.68840233												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015256-17	NCGC00015256-17	363676447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	50-63-5				-22.6850758825	4	4		0	-5.45376467					CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	Selleck	S4157	-5.89537045	-3.64340748	-1.88332123	-5.45376467												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00185994-09	NCGC00185994-09	384568432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	403811-55-2		11.220184543	-4.95	-29.3553246887	4	4		-21.9613308641	-20.17245509	0.1541931744	0.9851092077		MYC	CCC1=CC=C(C=C1)\C=C/2SC(=S)NC2=O	SIGMA	F3680	-3.96114265	-1.45467937	-4.50084602	-20.17245509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346491-08	NCGC00346491-08	363677425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	172732-68-2				-24.2336607319	4	4		0	-4.6994012				PLA2G5	CCC1=C(C(=O)C(N)=O)C2=C(C=CC=C2OCC(O)=O)[N]1CC3=CC=CC=C3	Glixx	GLXC-05612	-6.01933996	-4.5942089	-3.06018854	-4.6994012												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183912-09	NCGC00183912-09	363677100		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	865362-74-9		12.5892541179	-4.9	-16.7852494704	4	4		-14.081459536	-13.57272431	0.1030151209	0.9934599906		MAPK7	NC1=N[NH]C2=NN=C(C=C12)C3=C4C=CC=C[N]4N=C3C5=CC=CC=C5	MedChem Express	HY-12275	-1.42150803	-2.47370298	-1.83361471	-13.57272431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015693-19	NCGC00015693-19	384567882		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	70476-82-3		11.220184543	-4.95	-166.5140036965	-2.3	4		-87.7527358754	-84.74812782	0.1128942087	0.9920581403		TOP2A	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	MedChem Express	HY-13502A	-21.7552534	-29.2431806	-38.88107297	-84.74812782												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015147-04	NCGC00015147-04	124879400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	2898-76-2	Benzamil; Benzamil			-17.1058908356	4	4	NCGC00015147-02;NCGC00015147-01;BENZAMIL HYDROCHLORIDE;NCGC_Prestw-657;benzamil amiloride;NCGC00162093-01;NCGC00162093-02;NCGC00162093-03;N-(Benzylamidino)-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride;Benzamil hydrochloride;NCGC00093683-02;NCGC00093683-01;CIPLUS_685443;benzamil;BENZAMIL;N-(N-benzylamidino)-3,5-diamino-6-chloropyrazine carboxamide;	0	-9.63958403			6339	SCNN1D	N\C(NCC1=CC=CC=C1)=N/C(=O)C2=NC(=C(N)N=C2N)Cl	BIOMOL	NA-103	-1.94038369	-3.24749577	-3.8287037	-9.63958403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015204-09	Carmustine	170464880	DNA Alkylating Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	154-93-8	 Bicnu; Gliadel; ; Carmustina; Carmustine;Carmustine; 6   Carmustine; Nitrumon;CARMUSTINE; BiCNU			-19.0081688503	4	4		0	-1.76646564				H2AFX	O=C(NCCCl)N(CCCl)N=O	Microsource	01503110	-4.59194872	-4.04336093	-4.48611111	-1.76646564												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345857-05	NCGC00345857-05	384568771		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	910232-84-7				-18.7090985162	4	4		0	-0.62681039				BTK	CN1\C=C(/N=C(NC2=CC=C(C=C2)C(=O)N3CCOCC3)\C1=O)C4=C(C)C(=CC=C4)NC(=O)C5=CC=C(C=C5)C(C)(C)C	APExBIO	A3302	-5.43483033	-4.93070484	-1.31018519	-0.62681039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510689-01	NCGC00510689-01	384569479		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1943733-16-1				-6.1219516666	4	4		0	-1.6253944					COC1=CC=C(C=C1)[S+]([O-])(=O)NCC2=CC=C(C=C2)C(=O)NCCC3=CC=C(Cl)C=N3	Selleck	S8379	-1.42533937	-1.96272176	0.14957168	-1.6253944												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345837-03	NCGC00345837-03	384568761		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1033739-92-2		6.3095734448	-5.2	-135.8492736957	-2.4	4		-85.5346419234	-75.32268859	0.2433405138	0.9616141661		PIK3CA	CC1=C(C=NC(=N1)N)C2=NC3=C(SC(=C3)C(C)(C)O)C(=N2)N4CCOCC4	SynKinase	SYN-1114	-12.80995475	-28.24612621	-38.76626025	-75.32268859												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160529-08	NCGC00160529-08	384568199		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[64461-82-1]				-4.7969256171	4	4		0	-1.45529154				ADRA2A	ClC1=C(N\C2=N\CCN2)C3=NSN=C3C=C1	Tocris	3609	-0.6993007	-0.50058765	-2.25127088	-1.45529154												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094201-03	NCGC00094201-03	124891671		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	27686-84-6	 ; Dihydronorguaiaretic Acid; Nordihydroguaiaretic acid from Larrea divaricata (creosote bush);Nordihydroguaiaretic acid from Larrea divaricata (creosote bush)			-17.9014956698	4	4	NCGC00089785-03;1,2-BENZENEDIOL, 4,4'-(2,3-DIMETHYL-1,4-BUTANEDIYL)BIS-, (R*,S*)-;SP-134101;CIPLUS_153652;NORDIHYDROGUAIARETIC ACID;LS-136429;butane, 1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethyl-;4,4'-(2,3 Dimethyl-1,4-butanediyl)bis(1,2-benzenediol);ACTINEX;CIPLUS_213635;4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol;Nordihydroguaiaretic Acid;1,4-Bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane;MASOPROCOL;Masoprocolum;NDGA;masoprocol;LS-174190;MESO-4,4'-(2,3-DIMETHYLTETRAMETHYLENE)DIPYROCATECHOL;Masoprocol;NCGC00094201-02;NCGC00094201-01;masoprocolum;Dihydronorguaiaretic Acid;meso-Nordihydroguaiaretic Acid;NORDIHYDROGUARETIC ACID;Nordihydroguaiaretic acid;NCGC00015741-01;1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-;Nordihydroguaiaretic acid from Larrea divaricata (creosote bush);Actinex;MESO-NORDIHYDROGUAIARETIC ACID;Nordihydroguaiaretic Acid, (R*,S*)-Isomer;	0	-5.5969081			240	ALOX5	C[C@H](CC1=CC=C(O)C(=C1)O)[C@@H](C)CC2=CC(=C(O)C=C2)O	SIGMA	N5023	-3.71780119	-6.54246289	0.4986686	-5.5969081												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346635-10	NCGC00346635-10	377020163		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1144068-46-1		0.7943282347	-6.1	-171.3409243667	-2.4	4		-82.522153342	-68.69156705	0.2672106621	0.9532356819		MTOR	CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7	MedChem Express	HY-10044	-21.37559597	-43.66642895	-49.92027762	-68.69156705												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159456-30	NCGC00159456-30	384568179		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[220127-57-1]		14.1253754462	-4.85	-15.0924573105	4	4		-18.830154896	-15.27512908	0.3416076838	0.9206961733		ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	Tocris	5906	-2.64877274	1.77839187	2.6402176	-15.27512908												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378983-02	NCGC00378983-02	384569083		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1020315-31-4		12.5892541179	-4.9	-71.9894198198	-3	4		-81.5696006716	-71.53236146	0.0757779544	0.9964421535		FAAH	FC(F)(F)C1=CN=C(OC2=CC(=CC=C2)C=C3CCN(CC3)C(=O)NC4=NN=CC=C4)C=C1	MedChem Express	HY-14376	-2.96764564	-7.73910259	-7.9212963	-71.53236146												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346685-03	NCGC00346685-03	384568909		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	819812-04-9				-13.4730359487	4	4		0	0.24692531				HSP90AB1	CCC1=C(CC(=O)N(CCOC)CCOC)C(=C(O)C=C1O)C(=O)C2=CC=C(OCCN3CCOCC3)C(=C2)OC	APExBIO	A4062	-4.49536854	0.04573938	-3.16203704	0.24692531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345796-09	NCGC00345796-09	384568746		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1372540-25-4				-27.5222489283	4	4		0	-9.66807541				PIK3CB	CC1=NC2=C(C=C(C=C2[N]1CC3=CC=CC(=C3C)C(F)(F)F)N4CCOCC4)C(O)=O	Aobious	AOB87319	-3.96856754	-6.34862553	-8.18981481	-9.66807541												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181765-03	Pranlukast hydrate	384568399	Leukotriene CysLT1/2 (LTD4) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	103177-37-3				5.7705840777	4	4		0	5.21082321				CYSLTR1	O=C(NC1=CC=C2C(=O)\C=C(/OC2=C1)C3=NN=N[NH]3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4	Selleck	S1829	0.47511312	1.40579385	-0.45777999	5.21082321												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263548-23	NCGC00263548-23	384568687		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	143-67-9		4.4668359215	-5.35	-227.5198238541	-2.3	4		-43.7691310356	-80.29448322	0.0547547307	0.9981476339		TUBB	CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]7([C@H]89)C6=C5)C(=O)OC)C1	MedChem Express	HY-13780	-39.09049774	-38.37862115	-58.45533246	-80.29448322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015300-11	NCGC00015300-11	384567836		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[67469-78-7]		12.5892541179	-4.9	-77.6675675218	-3	4		-95.2468574108	-88.88039009	0.0264844704	0.9995671521			FC1=CC=C(C=C1)C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C4=CC=C(F)C=C4	Tocris	0421	-3.14479638	-3.04962946	-1.53650909	-88.88039009												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387725-02	NCGC00387725-02	363680650		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1668553-26-1				-4.3015355772	4	4		0	0.83500334				MCL1	CN(C)[S+]([O-])(=O)N1CCN(CC1)C2=CC=C(OCC3=C(C(=N[N]3C)C)C4=C5[N](CCN6CCOCC6)C(=C(CCCOC7=C8C=CC=CC8=CC=C7)C5=CC=C4)C(O)=O)C=C2	ChemieTek	CT-A121	-1.38974949	-2.20693858	0.23723069	0.83500334												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186465-06	NCGC00186465-06	384568442		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1032350-13-2		10	-5	-126.8578493748	-2.3	4		-121.6724213368	-99.72011774	0.0970519109	0.9941455679		AKT1	NC1(CCC1)C2=CC=C(C=C2)C3=C(C=C/4C(=N3)\C=C/N5C(=O)N\N=C45)C6=CC=CC=C6	Axon Medchem	1684	-6.6317784	-16.85710445	-33.77396225	-99.72011774												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263020-01	NCGC00263020-01	137275924		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1221153-14-5	NCGC00263020-01	12.5892541179	-4.9	-54.5003795164	-3	4		-84.7512560384	-73.91304348	0.2696107429	0.9523061778	4790	NFKB1	CC(C)[N]1C=C(C2=CC=NC(=N2)NC3=C(C)C=CC(=C3)C(N)=O)C4=C1C=NC=C4	NCGCChem	JKJ22-049	-2.99557881	-2.96634852	14.97487927	-73.91304348												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015148-12	NCGC00015148-12	384567814		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	5072-26-4				-16.6607098469	4	4		0	-6.4189032				GSS	CCCC[S+]([O-])(=N)CCC(N)C(O)=O	SIGMA	B2640	-1.81882394	-6.89516848	-4.59107109	-6.4189032												2.4E-7	0.0000012	0.000006	0.000029999999999											
NCGC00166207-01	NCGC00166207-01	144205901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	38609-97-1				-15.4422995833	4	4	9-oxo-10-acridineacetic acid;Kamedon;9-Oxo-10(9H)-acridineacetic acid;LS-14178;cridanimodum;NCGC_FLUKA_17927;acridone N-methyl-N-(alpha,D-glucopyranosyl)ammonium 10-methylenecarboxylate;(9,10-Dihydro-9-oxo-10-acridinyl)acetic acid;CIPLUS_179328;CIPLUS_737508;10-(Carboxymethyl)-9(10H)acridone;CIPLUS_729115;10(9H)-acridineacetic acid, 9-oxo-;10-carboxymethyl-9-acridanone, sodium salt;Neovir;Cridanimod;10-carboxymethyl-9-acridanone;10(9H)-Acridineacetic acid, 9-oxo-;9-oxo-10(9h)-acridineacetic acid;cycloferon;LS-175964;Camedon;NCGC00166207-01;	0	-0.74422066					O=C(O)CN3c1ccccc1C(=O)c2ccccc23	FLUKA	FLUKA-17927	-3.37277062	-6.12854341	-2.84655787	-0.74422066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168853-03	NCGC00168853-03	174006790		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	545-47-1	Lupeol			-12.9537657664	4	4		0	0.85474144					CC(=C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12	SIGMA	L5632	-3.79296721	-3.67744591	-1.91203704	0.85474144												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510478-01	NCGC00510478-01	384569441		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1949837-12-0		4.4668359215	-5.35	-81.8827546667	-2.2	4		-59.8526755759	-61.0861459	0.0160722568	0.9998406969		BRD4	C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]2\N=C(C3=CC=C(Cl)C=C3)/C4=C(SC(=C4C)C)[N]5C(=NN=C25)C)C(C)(C)C)C6=CC=C(C=C6)C7=C(C)N=CS7	MedChem Express	HY-100972	-4.26696833	-5.34920278	-30.88881838	-61.0861459												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390223-01	NCGC00390223-01	363680864		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	102676-47-1				-11.8464652091	4	4		0	0.44937374				CYP19A1	N#CC1=CC=C(C=C1)C2CCCC3=CN=C[N]23	Adooq	A11088	-2.86425339	-4.20839883	-4.1834746	0.44937374												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179599-13	NCGC00179599-13	384568379		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	62893-20-3				-18.0526730039	4	4		0	-2.9439832					CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4C)C5=CC=C(O)C=C5)C(=O)C1=O	Cayman	16113	-6.16092768	-0.63117573	0.45993706	-2.9439832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00189393-09	NCGC00189393-09	363677130		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1430213-30-1				-4.781091135	4	4		0	2.84664403				BLM	FC1=C(C=C(NC(=O)NC2=NN=C(S2)C3=CC=NC=C3)C=C1)C(F)(F)F	MedChem Express	HY-12342	-3.54935547	1.67142093	1.41155506	2.84664403												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263185-09	NCGC00263185-09	363677251		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1110813-31-4		3.1622776602	-5.5	-184.3709674698	-2.1	4		-88.3757315649	-99.77208242	0.025216154	0.9996076539		EGFR	COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C3C(=NC=NC3=C1)NC4=CC(=C(F)C=C4)Cl	Glixx	GLXC-90191	-16.98746248	-25.0802282	-69.94466329	-99.77208242												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164604-06	NCGC00164604-06	384568263		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	93957-55-2		3.5481338923	-5.45	-96.4039099135	-2.1	4		-91.1466207745	-85.88306433	0.0167582192	0.9998267591		HMGCR	CC(C)[N]1C2=C(C=CC=C2)C(=C1\C=C\[C@H](O)C[C@H](O)CC(O)=O)C3=CC=C(F)C=C3	DC Chemicals	DCAPI1585	1.43033728	-3.44535568	-47.86625399	-85.88306433												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164571-04	Dutasteride	384568256	Steroid 5alpha-Reductase Inhibitors	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox					-11.7893514797	4	4		0	-2.41871715					C[C@]12CCC3[C@@H](CC[C@H]4NC(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	Selleck	S1202	-1.07716758	-5.39757533	-4.94747702	-2.41871715												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344564-05	NCGC00344564-05	384568723		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	520-27-4				-21.8641249188	4	4		0	-5.9072515				AHR	COC1=CC=C(C=C1O)C/2=C/C(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-1503	-4.14091471	-4.5596363	-5.27574564	-5.9072515												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167524-02	Amorolfine hydrochloride	170466078	Antifungal Agent	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	78613-35-1	 ;Amorolfine Hydrochloride;Amorolfine; Amorolfine; Amorolfine [USAN:BAN:INN];Amorolfine hcL; Loceryl; Pekiron			-7.7774248904	4	4		0	-2.15125729					C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H](C)O2	Sequoia	SRP0563571a	-1.95927602	-1.90882551	0.24022118	-2.15125729												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510701-01	NCGC00510701-01	384569486		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1693731-40-6		0.1258925412	-6.9	-251.8722939097	-1.3	4		-82.527937372	-85.77631453	0.0894179074	0.9950365646		HSF1	CC1=CC=C(NC(=O)C2=CC3=C(OCCO3)C=C2)C=C1NC(=O)C4=CC5=C(C=C4)N=C(OCCN6CCCC6)C=C5	MedChem Express	HY-101026	-16.63273435	-86.42754538	-91.6533527	-85.77631453												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00347280-04	NCGC00347280-04	363677574		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	406209-26-5		12.5892541179	-4.9	-9.8824732059	4	4		-17.664042372	-15.97003531	0.297665477	0.941319643		IKBKB	NC1=C(C#N)C(=CC(=N1)C2=C(OCC3CC3)C=CC=C2O)C4CCNCC4	MedChem Express	HY-13060	1.38089758	-2.97305533	0.86661825	-15.97003531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182713-18	NCGC00182713-18	377020273		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[289499-45-2]		5.0118723363	-5.3	-146.9419264244	-2.1	4		-93.0957467539	-96.50629735	0.0328860147	0.999332433		EGFR	FC1=C(Cl)C=C(NC2=NC=NC3=C2C=C(NC(=O)C=C)C(=C3)OCCCN4CCOCC4)C=C1	Tocris	5916	-12.1266805	-15.0020164	-47.72450124	-96.50629735												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507865-01	NCGC00507865-01	384569340		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1439901-97-9				-4.597607941	4	4		0	0.51633451				BTK	CC#CC(=O)N1CC[C@H](C1)N2C(=O)N(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C25	Selleck	S8166	-1.89479383	-1.95366761	1.74625628	0.51633451												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507840-01	NCGC00507840-01	384569322		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1345407-05-7				-7.5076919488	4	4		0	2.03730406					NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@@H](CC3=C[NH]C4=C3C=CC=C4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=C[NH]C6=C5C=CC=C6)C(=O)N[C@@H](C(C7=CC=CC=C7)C8=CC=CC=C8)C(=O)N[C@@H](CCCCN)C(N)=O	Selleck	S8199	-3.12555183	-1.79622036	0.29544176	2.03730406												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510708-01	NCGC00510708-01	384569489		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1218816-71-7				-17.5341315025	4	4		0	-6.49332527				SPHK1	C[C@H](NC(=O)[C@H]1NCC[C@@H]1O)C2=CC=C(C=C2)C3=NOC(=N3)CCC4CCCC4	MedChem Express	HY-101805	-3.70828183	-2.72330184	-1.87113112	-6.49332527												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015316-08	NCGC00015316-08	384567837		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	68278-23-9				-36.5167930501	4	4		0	-14.94847809				ODC1	NCCCC(N)(C(F)F)C(O)=O	Glixx	GLXC-06672	-5.26801001	-6.92494168	-10.08796296	-14.94847809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242597-02	NCGC00242597-02	363677150		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	361442-04-8				-17.4709718902	4	4		0	-1.04468398				DPP4	N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4	Selleck	S1540	-4.97826946	-4.49160682	-1.19907407	-1.04468398												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346679-10	NCGC00346679-10	363677513		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	452342-67-5				-36.1319942294	4	4		0	-6.84742865				TGBR1	O=C(NC1CCOCC1)C2=CC=C(C=C2)C3=NC=CC(=C3)C4=C[NH]N=C4C5=NC=CC=C5	Glixx	GLXC-04575	-8.5253962	-7.79398985	-5.43055556	-6.84742865												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160396-04	NCGC00160396-04	170466117		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	92623-83-1	Pravadoline;Win-48098; Pravadoline			-24.230146521	4	4		0	-4.26421008				MT-CO1	COc1ccc(cc1)C(=O)c3c4ccccc4n(CCN2CCOCC2)c3C	Enzo	CR110	-6.17235173	-5.6899785	-1.86574074	-4.26421008												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389621-01	NCGC00389621-01	384569177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	905854-02-6		0.2818382931	-6.55	-143.0200695708	-1.4	4		-57.7399444202	-60.34037671	0.2957848586	0.9418682604			O=C1NC(=O)[C@@H]([C@@H]1C2=C[NH]C3=CC=CC=C23)C4=C[N]5CCCC6=C5C4=CC=C6	APExBIO	A8325	-12.33936652	-47.3164159	-47.69523637	-60.34037671												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386433-04	NCGC00386433-04	384569140		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox			5.0118723363	-5.3	-17.2384117602	4	4		-19.93407592	-17.0283966	0.2174310606	0.9698217779		FGFR1	CC1=NC2=C([NH]1)C=C(C=C2)[N]3N=CC(=C3N)C(=O)C4=CC5=C([NH]4)C=CC=C5	Selleck	S7665	1.13574661	-3.29216259	-7.31088247	-17.0283966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386818-01	NCGC00386818-01	363680447		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-15.8680143842	4	4		0	-3.20298308					OC1=C(C=CC=N1)C(=O)NCCCNC(=O)C2=NOC(=C2)C3=CC=CC=C3	Evotec	MLS004580709	-2.59276018	-5.34920278	-4.45542311	-3.20298308												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018139-05	NCGC00018139-05	170465997		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	35212-22-7	; (Ipriflavone); Osten; Osteoquine; Quinogin;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;IPRIFLAVONE; Ipriflavona;Ipriflavone			1.7934610135	4	4		0	4.83793862					CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3	Sequoia	35212-22-7	-2.2760181	2.3310128	3.37669401	4.83793862												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390633-02	NCGC00390633-02	384569202		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	918633-87-1				-13.9138712605	4	4		0	-4.45176066					C[N]1C(=CN=C1[N+]([O-])=O)CO[P](=O)(NCCBr)NCCBr	MedChem Express	HY-10535	-3.01850049	-1.44082183	-2.67731784	-4.45176066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510493-01	NCGC00510493-01	384569455		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	865783-99-9		0.1	-7	-310.3834838874	5	4		-62.632170896	-67.9311003	0.4337717008	0.8659170321		PLK1	COC1=CC(=C(/C=C/[S+]([O-])(=O)CC2=CC(=C(OC)C=C2)O[P](O)(O)=O)C(=C1)OC)OC	MedChem Express	HY-16366	-63.06098964	-71.08779872	-69.94432341	-67.9311003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346966-01	NCGC00346966-01	174006754		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	n	HMSL10088			-31.6769283292	4	4		0	-11.12224449			8737	RIPK1	O=C(NC1=N[NH]C2=CC(=CC=C12)C3=CC(=CC=C3)C(=O)NC4CC4)C5CC5	LINCS	HMSL10088	-5.9484819	-7.18669743	-4.5073832	-11.12224449												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351608-02	NCGC00351608-02	384569022		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	571203-78-6		0.8912509381	-6.05	-41.1641341785	4	4		-23.239278676	-22.53052164	0.0661471208	0.9973014773		VDAC2	CCOC1=CC=CC=C1N\2C(=O)C3=C(C=CC=C3)\N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(Cl)C=C5	Selleck	S7242	-1.49778941	-10.43150961	-18.89663919	-22.53052164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346947-02	NCGC00346947-02	363677565		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1001409-50-2				-29.5805044577	4	4		0	-12.82150268				PDPK1	FC1=CC=C(CN2\C=C/C=C(/C(=O)N[C@@H](COC3=CC4=C(NC(=O)N4)C=C3)C5=CC=CC=C5)C2=O)C=C1F	MedChem Express	HY-14440	-5.43174231	-5.78034682	-2.98522023	-12.82150268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00483118-01	NCGC00483118-01	363681137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-18.2507525173	4	4		0	-3.05457704				SIRT1	COCCCC1=C(N=C(S1)C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C4=NC5=C(S4)N=CC(=C5)CN6CCCC6	MedChem Express	HY-19758A	-5.41369665	-5.89684993	1.81454563	-3.05457704												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00242477-02	NCGC00242477-02	384568490		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[870773-76-5]				-2.044935519	4	4		0	3.69604922				RARB	CCCCOCCOC1=C(C)SC(=N1)C2=CC=C(C(O)=O)C(=C2)F	Tocris	4046	-1.75872735	-0.47597254	0.02336339	3.69604922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356145-10	CB-839	384569029	Glutaminase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1439399-58-2		1.5848931925	-5.8	-92.7594813049	-1.2	4		-33.953035725	-40.46725865	0.0178500278	0.9998037418		GLS	FC(F)(F)OC1=CC=CC(=C1)CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=CC=CC=N4)S3)C=C2	MedChem Express	HY-12248	-10.14969928	-18.33234231	-34.02314815	-40.46725865												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167831-05	NCGC00167831-05	363676672		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	86639-52-3		3.5481338923	-5.45	-136.9349797928	-2.2	4		-53.5515003329	-68.58930492	0.0304866612	0.9994265435		TOP1	CCC1=C2CN3C(=O)\C4=C(/C=C3/C2=NC5=CC=C(O)C=C15)[C@@](O)(CC)C(=O)OC4	ChemieTek	CT-SN38	-16.36692273	-17.39465687	-45.37622325	-68.58930492												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181771-06	NCGC00181771-06	384568401		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	122647-32-9				-10.0474131715	4	4		0	-2.10345157					CCCCCCCN(CC)CCCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0387	-2.28506787	-1.31596676	-2.46113403	-2.10345157												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183677-03	NCGC00183677-03	174006434		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	76958-67-3	Hypothemycin	10	-5	-41.4681711877	4	4		-25.546235708	-28.97700162	0.0918042722	0.9947775265	5604	MAP2K1	COC1=CC(=C2C(=O)O[C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)CC3OC3C2=C1)O	ChemieTek	CT-HPTM	-4.35513853	-6.40316894	-6.02759622	-28.97700162												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507860-01	NCGC00507860-01	384569336		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1393465-84-3		12.5892541179	-4.9	-71.5367649073	-3	4		-77.8387886121	-71.44235873	0.014256926	0.9998746355		BRAF	CCN(C)[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CN=C(N=C4)C5CC5	Selleck	S7964	-4.49336822	-4.80351302	-4.73147651	-71.44235873												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346959-11	NCGC00346959-11	384568977		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	837422-57-8		1.1220184543	-5.95	-103.2347140725	-1.4	4		-49.5024148856	-51.2329296	0.1515776515	0.9855607685		LCK	COC1=CC=C(N(C(=O)OC2=C(C)C=CC=C2C)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(C)CC5)C(=C1)OC	MedChem Express	HY-12299	-5.5580619	-13.61294081	-58.99224428	-51.2329296												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509942-01	NCGC00509942-01	384569390		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	198474-05-4				-19.3188963512	4	4		0	-5.11991507				IDO1	FC1=CC2=C([NH]C=C2C3CC(=O)NC3=O)C=C1	ChemGood	C-1264	-3.62717676	-4.66908635	-4.24369543	-5.11991507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346944-02	NCGC00346944-02	363677562		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	173897-44-4				-3.2238576688	4	4		0	1.74202577				ROCK1	C[C@@H](N)C1=CC=C(C=C1)C(=O)NC2=C3C=C[NH]C3=NC=C2	MedChem Express	HY-10069	-0.9113056	-0.17027378	-2.97546461	1.74202577												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095264-04	Chloroxine	170465084	Antibacterial	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	773-76-2	; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine	3.9810717055	-5.4	-59.3362940467	-2.2	4		-47.8025780199	-46.368769	0.0172499797	0.9998165429			Oc1c(Cl)cc(Cl)c2cccnc12	Vitas	STK075368	-1.47974375	-4.17618856	-25.72557436	-46.368769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015675-22	NCGC00015675-22	384567880		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	78415-72-2				-21.8854876669	4	4		0	-2.07253886				PDE3A	C\C1=C(\C=C(\C#N)C(=O)N1)C2=CC=NC=C2	MedChem Express	HY-14252	-5.32309083	-3.99600853	-5.65154282	-2.07253886												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014352-10	NCGC00014352-10	384567791		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	500579-04-4				-12.7646583928	4	4		0	-4.89783948				SHH	CN(C)C1=C(CN2CCCN(CC3=C(C=CC=C3)N(C)C)C2C4=CC=NC=C4)C=CC=C1	MedChem Express	HY-13901	-2.27745142	-1.63741099	-3.06691015	-4.89783948												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242514-13	NCGC00242514-13	384568506		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	781661?94?7		7.9432823472	-5.1	-32.5813129976	4	4		-20.117680112	-20.92091114	0.1437438897	0.9870931433		BIRC5	COCC[N]1C(=[N+](CC2=NC=CN=C2)C3=C1C(=O)C4=CC=CC=C4C3=O)C	ActiveBioChem	A-1061	-4.32896521	-2.07284438	-6.35388865	-20.92091114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386417-15	NCGC00386417-15			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1454846-35-5				-19.404327924	4	4		0	-4.09867354					C[C@H]1OC2=C(N)N=CC(=C2)C3=C(C#N)N(C)N=C3CN(C)C(=O)C4=C1C=C(F)C=C4	DC Chemicals	DC7924	-2.90342569	-6.8210508	-5.95013314	-4.09867354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263108-02	NCGC00263108-02	384568595		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	618385-01-6		14.1253754462	-4.85	-24.9259898838	4	4		-24.140768116	-23.00342614	0.2105150247	0.9717134846		PAR1	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\C4=CC=C(C=N4)C5=CC=CC(=C5)F	Axon Medchem	1755	-1.33537851	-4.96482502	-1.21945271	-23.00342614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386312-01	NCGC00386312-01	384569123		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1202759-32-7		10	-5	-90.497212069	-2.1	4		-100.3051907503	-86.79727839	0.0192137574	0.9997722579		BTK	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC3=NC(=C(F)C=N3)NC4=CC=CC(=C4)NC(=O)C=C)C=C2	Selleck	S7257	-4.06027249	-5.71761437	-16.10653139	-86.79727839												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015233-07	NCGC00015233-07	384567828		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	57265-65-3		12.5892541179	-4.9	-82.9431981611	-3	4		-111.7025169424	-99.62991445	0.0419281541	0.9989141809		CAMKK2	ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)[N+]3=C[N](CC(OCC4=C(Cl)C=C(Cl)C=C4)C5=C(Cl)C=C(Cl)C=C5)C=C3	Glixx	GLXC-04254	-0.89262042	-4.75057208	-4.11663006	-99.62991445												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387472-01	NCGC00387472-01	363680628		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[879487-87-3]				-32.8877861715	4	4		0	-4.47467077				TGBR1	CC1=NC(=CC=C1)C2=N[NH]C=C2C3=CC(=C(F)C=C3)C4=C[N](CCO)N=C4	Tocris	5288	-7.08793637	-6.95652174	-9.41544788	-4.47467077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263570-06	NCGC00263570-06			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	127373-66-4 (free acid)				-2.6050833538	4	4		0	-0.55723922					CC(C)(C)C(=O)OC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC=C2C(=O)NCC(O)=O	SIGMA	S7198	-0.35246272	-0.62139974	-1.22208175	-0.55723922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344588-08	NCGC00344588-08	363677337		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1300031-49-5		0.6309573445	-6.2	-198.4386105364	-1.1	4		-85.1535727509	-91.76850132	0.0314993784	0.9993876032		BRD4	COC1=CC2=C(C=C1C3=C(C)ON=C3C)N=CC4=C2N([C@H](C)C5=CC=CC=N5)C(=O)N4	Selleck	S2780_cm1	-11.41436963	-56.65623441	-87.41396264	-91.76850132												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160217-03	Sophocarpine	363676600	HERG Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	6483-15-4				-30.3147726101	4	4		0	-4.39925701				KCNH2	O=C1\C=C/C[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34	Selleck	S2405	-7.41075463	-5.83752892	-5.75455354	-4.39925701												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167462-06	NCGC00167462-06	384568315		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	77337-73-6				-15.2405501931	4	4		0	-1.27089647					CC(=O)NCCC[S]([O-])(=O)=O	Microsource	01505711	-4.12110258	-5.62888375	-0.98796647	-1.27089647												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00179492-08	NCGC00179492-08	384568374		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	3385-03-3				-5.4235833297	4	4		0	0.69461078					CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	Carbosynth	FF23333	-2.47959546	-1.94264144	2.4993957	0.69461078												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384199-05	4SC-202	384569106	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	910462-43-0		7.0794578438	-5.15	-25.9908121709	4	4		-26.323113768	-24.43592814	0.1523321261	0.9854434134		HDAC1	C[N]1C=C(C=N1)C2=CC=C(C=C2)[S+]([O-])(=O)[N]3C=CC(=C3)/C=C/C(=O)NC4=C(N)C=CC=C4	MedChem Express	HY-16012A	-1.90294535	1.30737007	-5.40971719	-24.43592814												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347957-09	NCGC00347957-09	363677733		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1314241-44-5				-18.9776275138	4	4		0	-3.67224823				L3MBTL3	BrC1=CN=CC(=C1)C(=O)N2CCC(CC2)N3CCCC3	MedChem Express	HY-15839	-4.97157809	-2.00743828	-3.05350958	-3.67224823												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250397-04	NCGC00250397-04	384568546		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	284028-89-3				-22.6701367396	4	4		0	-3.01597259				TNKS	OC1=NC(=NC2=C1CSCC2)C3=CC=C(C=C3)C(F)(F)F	XcessBio	M60010-2s	-5.24226293	-5.41291392	-4.64367592	-3.01597259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015735-18	NCGC00015735-18	384567886		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	50-65-7		0.2511886432	-6.6	-229.6706529626	-1.3	4		-87.3711334001	-95.55083723	0.1342706387	0.988713819		STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	Microsource	01503265	-12.44247947	-94.65429941	-86.29822935	-95.55083723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00159518-02	NCGC00159518-02	144205289		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	117976-90-6	; ; Pariet;RABEPRAZOLE SODIUM;Rabeprazole sodium; Rabeprazole sodium; Sodium rabeprazole; Aciphex; Sodium Rabeprazole			-11.4923260029	4	4	LS-172365;CIPLUS_660920;LS-172366;E3810;Sodium Rabeprazole;E-3810;rabeprazolum;Sodium rabeprazole;HS_13;E 3810;CIPLUS_196951;rabeprazole sodium;RABEPRAZOLE SODIUM;2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole;Aciphex;1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt;2-[[[4-??3-Methoxypropoxy??-3-methylpyridin-2-yl]methyl]sulfiny]-1H-benzimidazole sodium salt;LY-307640;LY307640;2-[[[4-??3-Methoxypropoxy??-3-methylpyridin-2-yl]methyl]sulfiny]-1H-benzimidazole sodium sal;Pariet;RABEPRAZOLE;Rabeprazole sodium;SODIUM 2-((4-(3-METHOXYPROPOXY)-3-METHYLPYRIDIN-2-YL)-METHYLSULFINYL)-1H-BENZIMIDAZOLE;Rabeprazole Sodium;rabeprazole;2-(cholromethyl)-4-(3-methoxypropoxy)-3-methylpyridine;Rabeprazole;	0	-0.79304047					[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1	Bionet	KS-1101	-2.68669907	-2.31578947	-3.46245503	-0.79304047												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345809-03	NCGC00345809-03	384568754		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	784211-09-2		31.6227766017	-4.5	-392.2488192583	5	4		83.927478716	-69.57669371	0.2896303843	0.9446160854		CDK1	CC(C)C1=N[N](C\2=C1C(=O)N\C(=N2)CC3=CC=C(OCCO)C=C3)C4=C(Cl)C=CC=C4Cl	Cayman	21195	-84.52779033	-88.86923391	-89.09959264	-69.57669371												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346663-04	NCGC00346663-04	384568893		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	27741-01-1				-18.4034189654	4	4		0	-2.18007625					OC[C@H]1O[C@@H](O[C@@H]2O\C=C(/[C@H]3C\C=C(CO)/[C@@H]23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2413	-3.45232716	-6.1459609	-5.23949993	-2.18007625												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00490649-01	NCGC00490649-01			SARS-CoV-2_CPE_SRI				0.0003949359	-9.4034733462	-7.6477852254	4	10		-10.2761373039	-1.25820784	0.4266664423	0.3403260734			CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024	6.18880981	-3.1769748	4.54527582	-3.31065938	2.82310384	-7.73011442	-3.81394252	-2.91746943	-2.79951244	-1.25820784						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	SARS-CoV-2_CPE_SRI		259793-96-9		0.0443125409	-7.3534733462	23.8974339758	4	10		13.67371132	8.88609287	0.2995016337	0.48755167			NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1	1.38402862	-11.8114261	2.16254473	0.10222939	-1.68285299	-0.84142649	0.35387095	-2.23331892	7.0852829	8.88609287						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00274060-07	Posaconazole			SARS-CoV-2_CPE_SRI		171228-49-2		0.0099203422	-8.0034733462	-198.8182487937	-1.2	10		-52.2164117491	-30.40931074	0.0121187568	0.9001904742			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718	-6.49549798	-4.23072386	-7.15605709	-12.09452286	-13.08536154	-12.19675225	-40.84457201	-72.96819093	-46.57728148	-30.40931074						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00346519-03	Teicoplanin		glycopeptide antibiotic	SARS-CoV-2_CPE_SRI				0.0557861839	-7.2534733462	14.5007859223	4	10		10.672610384	7.1167381	0.3659412117	0.4126511091			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	MedChem Express	HY-A0097	-1.30539063	-8.47717532	4.7261432	0.18873118	-2.13108953	-4.09703928	-7.58070224	-2.3905949	0.04718279	7.1167381						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	SARS-CoV-2_CPE_SRI		17321-77-6				-57.9907628428	4	10		0	-13.58864467				SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	-9.11414304	-5.76416467	-6.86509653	-10.36448708	-6.39326859	-5.15078835	-9.54665199	-6.07871663	-7.25828648	-13.58864467						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00159438-03	NCGC00159438-03	26754506		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	3211-76-5	Selenomethionine			-1.5709583418	4	4	BUTANOIC ACID, 2-AMINO-4-(METHYLSELENO-(SUP 75)SE)-, (S)-;(S)-2-AMINO-4-(METHYLSELENYL-(SUP 75)SE)BUTYRIC ACID;Sethotope;Selenomethioninum (75 Se);Selenomethionine Hydrochloride, (S)-Isomer;Selenometionina (75 Se);Selenomethionine, (S)-Isomer;NCGC00159438-03;SELENOMETHIONINE, DL-;selenomethionine (75 Se);Butanoic acid, 2-amino-4-(methylseleno)-;SELENOMETHIONINE, SE-75;selenomethioninum (75Se);Selenomethionine, (R)-Isomer;SELENOMETHIONINE, L-;CIPLUS_208331;Seleno-DL-methionine;SELENOMETHIONINE SE 75;CIPLUS_710865;(S)-2-Amino-4-(methylseleno)butyric acid;CIPLUS_682499;CIPLUS_160576;Se 75, Selenomethionin;SELENOMETHIONINE (75 SE);Selenomethionine, (+,-)-Isomer;Selenomethionine se 75;Seleno-D, L-methionine;Selenomethionine;DL-Selenomethionine-13C1 (methyl-13C1);Seleno-L-methionine;CIPLUS_158422;SELENOMETHIONINE, L-, SE-75;	0	-4.21077844					C[Se]CCC(N)C(O)=O	Labotest	LT00441028	0.89158978	-3.00142706	-0.19821126	-4.21077844												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00015884-15	NCGC00015884-15	384567900		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	85409-38-7				-19.8975476272	4	4		0	-6.22354528				NISCH	C1C\N=C(\NC(C2CC2)C3CC3)O1	Selleck	S7548	-4.63535229	-1.79622036	-3.08103545	-6.22354528												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00476210-01	NCGC00476210-01	377020190		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[839706-07-9]		0.2511886432	-6.6	-270.4918521638	-1.3	4		-68.3660931294	-87.35290013	0.1177551764	0.9913507845		ABL1	CN1C(=O)N(CC2=CN=C(NC3=CN=C(C)C=C3)N=C12)C4=C(C)C=CC(=C4)NC(=O)C5=CC(=CC=C5)C(F)(F)F	Tocris	5607	-29.242451	-93.22963095	-93.51435003	-87.35290013												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167532-05	NCGC00167532-05	384568327		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	127294-70-6				-21.878801846	4	4		0	-4.70719568					CNC1CCCN(C1)C2=C(F)C=C3C(=O)\C(=C/N(C4CC4)C3=C2OC)C(O)=O	MedChem Express	HY-B0159	-4.63535229	-4.83597789	-4.49728006	-4.70719568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356067-11	NCGC00356067-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	202590 -98 - 5		0.5011872336	-6.3	-215.5754267706	-1.1	4		-84.9513544241	-87.80873529	0.039408506	0.9990411013			CC1=NN=C2[C@H](CC(=O)NC3=CC=C(O)C=C3)N=C(C4=C(SC(C)=C4C)N12)C5=CC=C(Cl)C=C5	ChemieTek	CT -OTX015	-19.2389193	-58.74041719	-85.49521666	-87.80873529												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510498-01	NCGC00510498-01	384569460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1488363-78-5		12.5892541179	-4.9	-53.5379107917	-3	4		-93.5421032342	-81.61588003	0.1086394027	0.9926495353			CC1=C(C(=CC(=C1)O[C@@H](CCC(F)(F)F)C2=CC=C(C=C2)C(=O)NCCC(O)=O)C)C3=CC=C(C=C3)C(C)(C)C	MedChem Express	HY-19904	-0.04418913	2.48970252	8.3500771	-81.61588003												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384193-03	NCGC00384193-03	384569104		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	171927-40-5				-3.1858740274	4	4		0	-1.37940979			4521	MTH1	COC1=CC=C2N=C3[NH]N=C(C)C3=C(NCCOCCO)C2=C1	Chemdea	CD0168	-0.09721608	-2.94736842	0.21961591	-1.37940979												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347064-04	NCGC00347064-04	363677569		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1346527-98-7		1.995262315	-5.7	-172.5059827843	-1.3	4		-95.1963495037	-99.27424781	0.0665248658	0.9972604424		VCP	COC1=C2N=C(N=C(NCC3=CC=CC=C3)C2=CC=C1)[N]4C(=NC5=C4C=CC=C5)N	Glixx	GLXC-02188	-9.79231109	-5.34553776	-99.52338676	-99.27424781												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188689-09	NCGC00188689-09	384568450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	85650-56-2				-24.0179460895	4	4		0	-3.26034994				DRD1	CN1C[C@H]2[C@H](C1)C3=CC(=CC=C3OC4=C2C=CC=C4)Cl	MedChem Express	HY-11100	-6.9638009	-2.51066697	-2.92344649	-3.26034994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186030-12	NCGC00186030-12	384568437		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	648450-29-7		1.4125375446	-5.85	-47.8319805026	4	4		-8.829718512	-13.80379807	0.4350226598	0.86301187		PIK3CG	O=C1NC(=O)C(/S1)=C/C2=CC=C3N=CC=NC3=C2	SIGMA	A0233	-7.49756573	-7.67422627	-18.60566449	-13.80379807												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378723-01	NCGC00378723-01	384569065		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	193022-04-7		14.1253754462	-4.85	-33.4023263099	-3	4		-35.5964774161	-31.27683939	0.1084605317	0.9926838129		MMP12	ONC(=O)C1(CCOCC1)C[S+]([O-])(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2	MedChem Express	HY-10398	-3.31061344	-1.88482131	-0.36310821	-31.27683939												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510111-01	NCGC00510111-01	384569409		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	327031-55-0		2.8183829313	-5.55	-127.6583643583	-2.1	4		-82.7189522022	-88.54375418	0.0373284137	0.9991396512			CC1=CC=CC2=C1[NH]C3=C2N=NC(=N3)N\N=C(/C)C4=NC=CC=C4	Glixx	GLXC-06213	-4.11613703	-8.05728464	-64.86080852	-88.54375418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016916-15	NCGC00016916-15	384567967		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	70458-96-7				-18.0559100633	4	4		0	-5.74005153				TOP2B	CCN1\C=C(\C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(=C2)F	Prestwick	Prestw-221	-3.04505621	-7.16057981	-1.40885984	-5.74005153												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484078-02	NCGC00484078-02	384569270		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1297538-32-9				-32.8265448888	4	4		0	-12.22243584				AR	CC(O)C1=CC(=N[NH]1)C(=O)N[C@@H](C)C[N]2C=CC(=N2)C3=CC(=C(C=C3)C#N)Cl	MedChem Express	HY-16985_cm2	-6.98188246	-3.58810069	-4.79884118	-12.22243584												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163432-03	NCGC00163432-03	384568239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[117591-20-5]				-13.2090460387	4	4		0	1.0621936					CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Tocris	0448	-2.182943	-7.20366133	-4.85491332	1.0621936												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346514-07	NCGC00346514-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	859212-16-1				-24.7629264877	4	4		0	-9.67587723				ABL1	CN(C)[C@H]1CCN(C1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=C(C=N4)C5=CN=CN=C5	Adooq	A10119	-4.2760181	-4.01976196	-3.11381045	-9.67587723												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263639-13	NCGC00263639-13	384568696		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	112522-64-2		7.9432823472	-5.1	-61.4096397175	-2.2	4		-48.4312710483	-50.72186634	0.0038807095	0.9999907165		HDAC1	CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(N)C=CC=C2	MedChem Express	HY-50934	-4.98190045	-5.06175612	-10.3567058	-50.72186634												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346569-03	NCGC00346569-03	384568844		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1000669-72-6				-21.5426175476	4	4		0	-8.05897509				ABL1	O=C(N1CCNCC1)C2=CC=C(C=C2)/C=C/C3=N[NH]C4=C3C=CC=C4	Selleck	S2158	-3.34602107	-0.12623515	-9.852336	-8.05897509												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346879-04	NCGC00346879-04	384568957		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	113906-27-7		1	-6	10.1899630032	4	4		11.996096524	9.41317365	0.0315736414	0.9993925139		TCF4	CC1=CC=C(O1)/C=N/NC(=O)C2=C(OC3=CC=CC=C3)C=CC=C2	Enzo	WN101	-1.66341377	2.74363578	7.84626541	9.41317365												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346457-03	NCGC00346457-03	384568782		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1032568-63-0		0.1584893192	-6.8	-139.36850991	-1.4	4		-47.3455402786	-46.8579934	0.2674101057	0.9531539933		PIK3CA	COC1=C(OCCCN2CCOCC2)C=CC\3=C1/N=C(/NC(=O)C4=CN=C(N)N=C4)N5CC/N=C35	APExBIO	B2178	-7.57549002	-26.5065074	-55.81973363	-46.8579934												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00507864-01	NCGC00507864-01	384569339		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1382979-44-3		1.77827941	-5.75	-137.2651768523	-2.2	4		-75.1670282988	-72.78478069	0.0252238727	0.9996074936		PIK3CA	CC1(C)OCC[N]2C3=C(N=C12)C(=NC(=N3)C4=CN=C(N)N=C4)N5CCOCC5	Selleck	S8163	-9.92406851	-27.28204671	-55.01313074	-72.78478069												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346949-01	NCGC00346949-01	174007427		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	n	ICRF-193			-0.3332184642	4	4		0	-1.32010067			7153	TOP2A	CC(C(C)N1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2	SantaCruz Bio	sc-200889A	0.56192107	-2.85413713	1.73611111	-1.32010067												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092386-26	NCGC00092386-26	384568111		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	79559-97-0		11.220184543	-4.95	-81.478010355	-3	4		-108.4577501842	-99.76732039	0.0091155619	0.9999487473			CN[C@H]1CC[C@@H](C2=CC=C(Cl)C(=C2)Cl)C3=CC=CC=C13	MedChem Express	HY-B0176A	-1.65064314	-0.90563967	-2.94907407	-99.76732039												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00271789-11	NCGC00271789-11			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	50-76-0		3.1622776602	-5.5	-77.2341271015	-2.4	4		-49.0684825121	-48.94349364	0.0806234496	0.9959718058			CC(C)C1NC(=O)C(NC(=O)C2=CC=C(C)C3=C2\N=C4/C(O3)=C(C)\C(=O)\C(N)=C\4C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C7CCCN7C1=O	Bio Vision	1036	-5.40723982	-2.63642488	-17.01944432	-48.94349364												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510497-01	NCGC00510497-01	384569459		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	441045-17-6		0.2818382931	-6.55	-93.9117640653	-1.2	4		-31.0372624627	-35.64394302	0.0153569155	0.9998547444		TUBB	CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C	MedChem Express	HY-13442A	-5.91402715	-14.01751628	-30.88881838	-35.64394302												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00350780-09	NCGC00350780-09	384569005		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	942183-80-4				-33.7202698406	4	4		0	-10.71189999				MAPK7	O=C(CN1CC[C@H](C1)C(=O)NC2=CC3=C([NH]N=C3C4=CC=NC=C4)C=C2)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7	MedChem Express	HY-50846	-7.30282376	-6.90810952	-3.20019366	-10.71189999												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346551-05	NCGC00346551-05	384568836		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	19171-19-8				-15.9378299951	4	4		0	-1.41401926				TNF	NC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1	MedChem Express	HY-10984	-2.76355289	-5.67391692	-5.51960233	-1.41401926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510268-01	NCGC00510268-01	384569425		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1876467-74-1		5.0118723363	-5.3	-84.8662906593	-2.2	4		-62.772266196	-55.84025193	0.0400857174	0.9990081308		ATR	C[C@@H]1COCCN1C2=NC3=C(N=CC=C3C(=C2)C4=CC=N[N]4C)C5=CC=N[NH]5	ChemieTek	CT-BAY189	-4.7800301	-12.50598529	-31.73565723	-55.84025193												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263177-04	NCGC00263177-04	384568646		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1012054-59-9		1	-6	-216.6285111397	-1.3	4		-76.5176994427	-93.21977288	0.0760950707	0.9964118587		EGFR	COC1=C(OCCCCCCC(=O)NO)C=C2C(=NC=NC2=C1)NC3=CC(=CC=C3)C#C	Selleck	S1194	-18.63326547	-44.13441867	-98.03437424	-93.21977288												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167519-07	NCGC00167519-07	363676664		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	116649-85-5				-14.5108998899	4	4		0	0.26047723				PTGDR2	OC(=O)CC[N]1C2=C(C[C@@H](CC2)N[S+]([O-])(=O)C3=CC=C(F)C=C3)C4=CC=CC=C14	ChemieTek	CT-RAM	-3.79657425	-3.89998217	-3.26861752	0.26047723												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00343768-05	NCGC00343768-05	384568714		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	911222-45-2		5.6234132519	-5.25	-20.2532251204	4	4		-30.4558584159	-25.79654868	0.1654162859	0.9827690245		CHEK1	CC1=NC=C(NC(=O)NC2=C(OC[C@@H]3CNCCO3)C=C(C)C(=C2)Br)N=C1	MedChem Express	HY-14720	2.83418683	-2.28650383	-9.45882574	-25.79654868												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346474-01	NCGC00346474-01	174006243		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	40675-81-8	1-(1-Naphthylmethyl)piperazine	1.1220184543	-5.95	-26.7315419183	4	4		-12.23007862	-4.99558119	1	0.999188532			C1CN(CCN1)CC2=C3C=CC=CC3=CC=C2	SIGMA	651699	-1.78350698	-3.49884115	-13.64190583	-4.99558119												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015061-27	NCGC00015061-27	384567804		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	59277-89-3				-8.4887918529	4	4		0	0.28683431					N\C1=N\C2=C(N=C[N]2COCCO)C(=O)N1	MedChem Express	HY-17422	-3.37104072	1.95373905	-2.08947106	0.28683431												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351597-13	NCGC00351597-13	384569015		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1380288-87-8				9.0258553293	4	4		0	-0.79357491				DOT1L	CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=CN=C3N)[C@@H]4C[C@H](CCC5=NC6=CC(=CC=C6[NH]5)C(C)(C)C)C4	Selleck	S7062	5.33484163	-2.03458343	-3.69396728	-0.79357491												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163492-01	NCGC00163492-01	26756878		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	17397-89-6	CERULENIN;Cerulenin			-1.2184994216	4	4	CERULENIN;Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-;(2R,3S,E,E)-2,3-Epoxy-4-oxo-7,10-dodecadienamide;NCGC00163492-01;0   Cerulenin;helicocerin;2,3-Epoxy-4-oxo-7,10-dodecadienoylamide;Cerulenin;LS-63388;CIPLUS_170974;	0	3.65235682			2194	FAS	[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O	BIOMOL	BIOMOL_G-237	-0.50226244	-2.25016843	-1.56370394	3.65235682												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016311-32	NCGC00016311-32	384567931		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	65-28-1				-9.0699826045	4	4		0	-2.03740815				ADRA1A	CC1=CC=C(C=C1)N(C\C2=N\CCN2)C3=CC=CC(=C3)O	MedChem Express	HY-B0362A	-2.30149597	0.06529404	-2.45461147	-2.03740815												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163474-07	NCGC00163474-07	363676621		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	4449-51-8				-9.953607143	4	4		0	-0.40557305				SMO	C[C@@H]1CN[C@H]2[C@@H](C)[C@@]\3(CC[C@H]\4[C@@H]5C/C=C6/C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C)O[C@@H]2C1	Selleck	S1146	-2.39886696	-1.57140992	-3.47131445	-0.40557305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00238621-08	NCGC00238621-08	384568467		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	425637-18-9		14.1253754462	-4.85	-26.1402946365	4	4		-13.7629423281	-15.42609028	0.3992254276	0.8876884474			CN1CCN(CC1)C2=NC3=C(C=CC=C3)C(=N2)C/4=C(/C(=O)NC4=O)C5=C[NH]C6=C5C=CC=C6	MedChem Express	HY-10343	-3.37257679	-6.70787446	-1.87363834	-15.42609028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00187983-01	NCGC00187983-01	174006432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1226056-71-8				-21.0598431316	4	4		0	-3.03941216			6093	ROCK1	O=C(NCC1=CC=CC=C1)C2=CSC(=N2)NC3=CC=NC=N3	NCGCChem	XJB04-071	-5.97503762	-5.29752318	0.24691358	-3.03941216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510476-01	NCGC00510476-01	384569439		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1308672-74-3		12.5892541179	-4.9	-92.8337831344	-3	4		-101.5040194254	-96.92241626	0.0094072353	0.9999454158		KDR	CN(C)CCN[S+]([O-])(=O)CC1=CC=CC(=C1)NC2=NC=CC(=N2)OC3=CC4=C([NH]C(=C4)C)C=C3	MedChem Express	HY-12297	-5.29344074	-4.51399469	-5.32074558	-96.92241626												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346525-03	NCGC00346525-03	384568819		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1158838-45-9		10	-5	-92.8407243611	-2.3	4		-113.5056165714	-91.27302223	0.0734106315	0.9966615678		AURKA	CCN1CCN(CC1)C(=O)CC2=CC=C(NC3=NC(=C(F)C=N3)NC4=CC=C(C=C4)C(=O)NC5=CC=CC=C5Cl)C=C2	Selleck	S1451	-1.40745331	-8.30104906	-21.78165093	-91.27302223												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262195-03	NCGC00262195-03	377020177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	(449808-64-4)		3.1622776602	-5.5	-21.5520359728	4	4		-17.0587432799	-11.83708922	0.3018426582	0.9402945755		MAPK14	CN1C(=O)\C(=C/C2=C1N=C(NC3CCOCC3)N=C2)OC4=C(F)C=C(F)C=C4	SynKinase	SYN-1101	-1.37146982	-5.99542949	-7.17038193	-11.83708922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167533-04	NCGC00167533-04	384568328		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	224785-90-4				-7.4536876435	4	4		0	-8.07479418				PDE5A	CCCC1=NC(=C2[N]1NC(=N\C2=O)/C3=CC(=CC=C3OCC)[S+]([O-])(=O)N4CCN(CC)CC4)C	Prestwick	Prestw-1356	-0.0618047	-1.20788019	-0.59557306	-8.07479418												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347279-01	NCGC00347279-01	174006684		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	873305-35-2	AIM-100	11.220184543	-4.95	-62.2548762516	-3	4		-86.3069677692	-74.44997442	0.0638886747	0.9974743435	10188	TNK2	C1CO[C@@H](C1)CNC2=NC=NC3=C2C(=C(O3)C4=CC=CC=C4)C5=CC=CC=C5	Axon Medchem	2031	0.30019424	-4.1228383	-6.42937535	-74.44997442												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242054-15	NCGC00242054-15	384568483		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	446859-33-2		2.8183829313	-5.55	-1.60622055	4	4		22.089819568	11.32057553	0.0445989219	0.9987789532		TGBR1	CC1=NC(=CC=C1)C2=N[NH]C=C2C3=NC4=C(C=C3)N=CC=C4	MedChem Express	HY-13012	-5.07484964	-0.98797054	5.125	11.32057553												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346804-01	NCGC00346804-01	174007089		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	321351-00-2	EO 1428	10	-5	-106.7791158114	-2.1	4		-97.3976196	-98.14331165	0.0198229609	0.9997575713	1432	MAPK14	CC1=CC=CC=C1C(=O)C2=CC=C(NC3=C(N)C=C(Br)C=C3)C=C2Cl	Tocris	2908	-7.50691426	-9.10213603	-11.29166667	-98.14331165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484085-01	NCGC00484085-01	363681176		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1643913-93-2		3.1622776602	-5.5	-142.9811342571	-1.1	4		-90.2649256774	-94.93328268	0.0246699008	0.9996244521		PAK4	NC1=NC=C(C=C1)/C=C/C(=O)NCC2=CC3=CC(=CC(=C3O2)C4=CC=C(F)C=C4)C5=CC=C(C=C5)C(=O)N6CCC(F)(F)CC6	MedChem Express	HY-12793	-6.29527196	-4.93985272	-75.10648148	-94.93328268												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510528-01	NCGC00510528-01	384569475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	653592-04-2				-2.1735047579	4	4		0	-2.14169615					CSC[C@H]1CN(C[C@@H]1O)CC2=C[NH]C3=C(N)N=CN=C23	MedChem Express	HY-101496	-1.05429864	-0.50752302	3.53986312	-2.14169615												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00013724-04	NCGC00013724-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	155-41-9				-8.5590641684	4	4		0	-0.03824457					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@@H](C[C@@]2([H])[N+]3(C)C)OC(=O)[C@H](CO)C4=CC=CC=C4	MedChem Express	HY-B0344	-2.92760181	-0.56141927	-0.94728731	-0.03824457												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016023-19	NCGC00016023-19	384567916		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	83-67-0				-21.1139716198	4	4		0	-5.99483698				PDE4A	C[N]1C=NC2=C1C(=O)NC(=O)N2C	Selleck	S2368	-3.40723982	-5.98697507	-5.36191814	-5.99483698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016612-13	NCGC00016612-13	384567954		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	2447-57-6				-3.7800254842	4	4		0	-2.17037958					COC1=NC=NC(=C1OC)N[S+]([O-])(=O)C2=CC=C(N)C=C2	MedChem Express	HY-B0439	-0.99095023	1.17224343	-0.639079	-2.17037958												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015833-18	NCGC00015833-18	384567896		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	98-96-4				-12.4824278805	4	4		0	-3.13605507				FAS	NC(=O)C1=CN=CC=N1	Selleck	S1762	-3.41628959	-0.73209073	-1.29175543	-3.13605507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390536-02	NCGC00390536-02	384569187		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1361644-26-9		4.4668359215	-5.35	-36.309753535	4	4		-21.675028044	-20.02576582	0.0669190018	0.9972443032			COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O)\C(CO)=N\NC(=O)CCCCCN6C(=O)\C=C/C6=O)O)C(=O)C2=CC=C1	MedChem Express	HY-16261	-3.21324245	-6.47281591	-12.3214718	-20.02576582												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371045-07	AMD-3465	384569040	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	185991-07-5				-20.8792787008	4	4		0	-0.60319452				CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CNCC3=NC=CC=C3)C=C2	MedChem Express	HY-15971	-5.18812596	-7.0529193	-3.21935515	-0.60319452												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386177-01	NCGC00386177-01	363680135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	161796-78-7				11.5735984113	4	4		0	4.01968827					COC1=CC2=C([N-]C(=N2)[S+]([O-])CC3=NC=C(C)C(=C3C)OC)C=C1.COC4=CC5=C([N-]C(=N5)[S+]([O-])CC6=NC=C(C)C(=C6C)OC)C=C4	Selleck	S2233	3.72642786	-0.34950934	-1.00482903	4.01968827												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015889-21	NCGC00015889-21	384567903		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	82640-04-8		11.220184543	-4.95	-88.5381290824	-2.1	4		-103.8210578693	-92.11591237	0.0492070658	0.9985036903		ESR1	OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=C(S2)C=C(O)C=C5	MedChem Express	HY-13738A	-2.96662546	-7.07345338	-10.25604952	-92.11591237												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017245-15	NCGC00017245-15	384567979		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	476-66-4		1.4125375446	-5.85	-18.8438907518	4	4		-11.742235576	-11.62844783	0.0339706367	0.9992948341		AKR1B1	OC1=CC2=C3C(=C1O)OC(=O)C4=CC(=C(O)C(=C34)OC2=O)O	Selleck	S1327	-0.17658485	-0.71759672	-8.2301632	-11.62844783												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00015420-15	NCGC00015420-15	384567841		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	518-82-1		14.1253754462	-4.85	-22.2240216073	4	4		-13.743665944	-13.83731421	0.2663893263	0.9539425308		CSNK2A1	CC1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(O)C=C3O)C2=O	Microsource	01500898	-3.77540717	-2.48822211	-0.71759259	-13.83731421												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016831-09	NCGC00016831-09	384567962		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	35543-24-9				-20.6258412503	4	4		0	-5.87872169					COC1=CC(=C(C(=O)CCCN2CCCC2)C(=C1)OC)OC	APExBIO	B1889	-5.03972958	-3.76892467	-1.04166667	-5.87872169												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386310-03	NCGC00386310-03	363680201		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1393477-72-9		11.220184543	-4.95	-172.3281649464	-2.4	4		-68.033238562	-78.5543551	0.1431323093	0.9871532966		XPO1	FC(F)(F)C1=CC(=CC(=C1)C2=N[N](\C=C/C(=O)NNC3=CN=CC=N3)C=N2)C(F)(F)F	Selleck	S7252_CM1	-25.37104072	-32.53986077	-37.3158682	-78.5543551												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179034-15	NCGC00179034-15	384568368		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	140-64-7				-9.4922701328	4	4		0	-6.17902472					NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1	MedChem Express	HY-B0537B	-0.77896787	-2.1372916	-1.98983297	-6.17902472												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263171-03	NCGC00263171-03	384568641		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	881202-45-5		12.5892541179	-4.9	-70.9614093844	-3	4		-68.3446983202	-66.03206413	0.0780608186	0.9962236028		MDM2	C(CC1=C[NH]C2=CC=CC=C12)NC3=CC=C(NC4=CC=NC=C4)C=C3	Selleck	S1172	-6.84252456	-2.85987899	-3.05495038	-66.03206413												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263225-01	NCGC00263225-01	137276069		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	199800-49-2	AG-041R	12.5892541179	-4.9	-58.4914090413	-3	4		-61.1434209894	-58.94169291	0.0343008851	0.999273855	887	CCKB	CCOC(CN1C(=O)[C@](CC(=O)NC2=CC=C(C)C=C2)(NC(=O)NC3=CC=C(C)C=C3)C4=CC=CC=C14)OCC	Cayman	10010129	-3.93909888	-3.72176033	-2.54175744	-58.94169291												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242499-02	NCGC00242499-02	384568502		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[477845-12-8]				-20.3056378896	4	4		0	-1.17854757				PIM1	NC1=NC=CC(=N1)C2=CC3=C(ON=C3C=C2)C4=CC=C(Cl)C=C4	Tocris	3589	-6.40878109	-1.29282201	-3.08399903	-1.17854757												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346486-03	Abexinostat	384568795	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	783355-60-2		1.995262315	-5.7	-193.4934881126	-2.1	4		-87.698737239	-99.40356904	0.0134557997	0.999888322		HDAC1	CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO	Selleck	S1090	-16.49110383	-31.87655073	-78.40716534	-99.40356904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015977-06	NCGC00015977-06	384567912		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[85375-15-1]				-9.3172232203	4	4		0	-2.40795252				SLC6A1	OC(=O)C1CCCN(CCC=C(C2=CC=CC=C2)C3=CC=CC=C3)C1	Tocris	1081	-1.7233601	-2.96634852	-1.49261012	-2.40795252												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181129-08	NCGC00181129-08	384568391		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	302962-49-8		15.8489319246	-4.8	-228.4250516526	-2.4	4		-41.936870364	-74.8685036	0.5879196779	0.6992934041		ABL1	CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Selleck	S1021	-43.12009384	-56.78182551	-32.42768645	-74.8685036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484067-03	NCGC00484067-03	363681159		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1108743-60-7		5.0118723363	-5.3	-128.1509780801	-2.3	4		-103.4266454719	-99.7683733	0.0915286411	0.9947974152		NTRK1	CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=N[NH]C4=C3C=C(CC5=CC(=CC(=C5)F)F)C=C4)NC6CCOCC6	Selleck	S7998	-5.26933141	-13.37993458	-44.02712063	-99.7683733												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346443-01	Rupintrivir	174007383	HRV 3C Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	223537-30-2	AG-7088 (Rupintrivir)			-16.6124942945	4	4		0	-0.29435892					CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)C2=NOC(=C2)C)C(C)C)CC3=CC=C(F)C=C3	Axon Medchem	1571	-5.11594334	-3.1814312	-1.58041071	-0.29435892												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345085-02	NCGC00345085-02	384568733		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	90365-57-4		2.2387211386	-5.65	-21.4257473181	4	4		-23.85976934	-18.21647445	0.546105299	0.7550391459			CC(C)[C@@H]1N(C)C2=C3C(=C[NH]C3=CC=C2)C[C@@H](CO)NC1=O	SIGMA	I0661	-2.60759722	11.98189721	-6.90698015	-18.21647445												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346692-03	NCGC00346692-03	384568914		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1339928-25-4		0.1	-7	-464.3113505546	5	4		-9.345824936	-99.50230243	0.7390455334	0.6870633168		PIK3CA	COC1=CC=C(C=N1)C2=NC3=C(SC(=C3)CN(C)C4=NC=C(C=N4)C(=O)NO)C(=N2)N5CCOCC5	XcessBio	M60077-5s	-98.43722409	-99.55874487	-98.69161508	-99.50230243												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346835-01	NCGC00346835-01	174007481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	13395-35-2	2-Iminobiotin			-28.8196571474	4	4		0	-4.62510091			339345	NOS2	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12	SIGMA	I4632	-7.81421485	-4.94900059	-4.16203704	-4.62510091												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00387792-03	NCGC00387792-03	384569161		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	502632-66-8				-6.5633190195	4	4		0	-0.21843392					COC[C@@H]1OC(=O)C(=C\N(CC=C)CC=C)/C2=C(\O)C(=O)\C3=C([C@H](C[C@@]4(C)[C@@H]3CCC4=O)OC(C)=O)/[C@]12C	Bio Vision	1965	-2.02818385	1.62832182	-3.375	-0.21843392												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345024-01	NCGC00345024-01	174007010		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	603281-31-8		1.1220184543	-5.95	-72.412309964	4	4		-29.6175027273	-35.60569844	0.0398044939	0.999022733	2932	GSK3B	O=C/1NC(=O)C(=C1C2=CN=C3C=CC=C[N]23)/C4=C[N]5CCN(CC6=C5C4=CC=C6)C(=O)N7CCOCC7	NCGCChem	DYD11-007	-5.28054299	-11.71794296	-34.51479853	-35.60569844												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165799-03	NCGC00165799-03	384568284		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[880635-03-0]		12.5892541179	-4.9	-68.3617881635	-3	4		-78.2986180835	-74.77770341	0.0139346782	0.9998802351		PPARA	CCC(=O)NC[C@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C3=CC=CC=C3)C=C1)N\C(C)=C/C(=O)C4=CC=C(C=C4)C(F)(F)F	Tocris	4618	-2.87330317	-3.72333258	-3.62144767	-74.77770341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00402377-02	NCGC00402377-02	384569219		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	871266-63-6				-9.604165012	4	4		0	-0.55454632				F7	NC(=N)C1=CC2=C([NH]C(=N2)C3=C(O)C(=CC(=C3)CC(=O)N[C@@H](CC(O)=O)C(O)=O)C4=C(O)C=CC(=C4)[S+](N)([O-])=O)C=C1	Glixx	GLXC-90209	-1.5520362	-3.11250842	-4.3647736	-0.55454632												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025109-13	NCGC00025109-13	384568051		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	208260-29-1		3.5481338923	-5.45	-14.1802598335	4	4		8.8060114079	2.28552343	0.4814645062	0.8252856309		BRAF	CN(C)C1=CC=CC(=C1)C(=O)NC2=CC(=C(C)C=C2)NC(=O)C3=CC=C(O)C=C3	MedChem Express	HY-13343	-3.77976454	-8.58834284	-0.33405955	2.28552343												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015810-26	NCGC00015810-26	384567892		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	61-25-6, 58-74-2 [papaverine]		11.220184543	-4.95	-30.769051282	4	4		-24.9847048319	-22.2969749	0.0937228004	0.9945641335		PDE10A	COC1=C(OC)C=C(CC2=C3C=C(OC)C(=CC3=CC=N2)OC)C=C1	Microsource	01500459	-2.72638754	-4.38340661	-5.83393851	-22.2969749												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386723-01	NCGC00386723-01	363680418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1142090-23-0				-6.7095747818	4	4		0	-2.92911258					CNC1=NC(=NC(=N1)C)N[C@H]2CCC[C@H](C2)C(=O)NCC3=CC=C(C=C3C(F)(F)F)C#N	Axon Medchem	2220	-0.47820987	-2.99323386	-1.72674504	-2.92911258												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263210-04	NCGC00263210-04	363677267		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	329196-48-7		14.1253754462	-4.85	-29.7997756174	4	4		-22.867738036	-21.97311503	0.3264854824	0.9281159927		SMO	CCOC1=C(OCC)C(=CC(=C1)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC4=C([NH]3)C=CC=C4)OCC	Bio Vision	1976	-4.41462123	-4.34569442	1.33652223	-21.97311503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346509-08	NCGC00346509-08	384568811		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	958852-01-2		0.7943282347	-6.1	-168.4149328476	-1.2	4		-72.1096043349	-78.95250942	0.0147677038	0.9998654938		PIK3CA	O=C1NC(=O)/C(S1)=C/C2=CC=C3N=CC=C(C4=CC=NC=C4)C3=C2	MedChem Express	HY-12036	-10.33021367	-43.62185773	-75.15944476	-78.95250942												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346674-02	NCGC00346674-02	384568900		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	912999-49-6		0.4466835922	-6.35	-76.2509324423	-1.4	4		-37.908150376	-36.61565654	0.2496138588	0.9595536601		HSP90AB1	CC(C)C1=C(O)C=C(O)C(=C1)C(=O)N2CC3=C(C2)C=C(CN4CCN(C)CC4)C=C3	Selleck	S1163	-4.60886456	-24.21554644	-28.88294879	-36.61565654												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025103-05	NCGC00025103-05	384568050		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	[254753-54-3]				-3.257663888	4	4		0	-2.23182487				KIF11	CCOC(=O)C/1=C(C)/NC(=S)NC1C2=CC=CC(=C2)O	Tocris	1305	-1.2116423	1.54599094	0.60648148	-2.23182487												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346689-06	NCGC00346689-06	363677518		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1185763-69-2				-19.9449442235	4	4		0	-3.74186808				MET	C[N]1C=C(C=N1)C2=N[N]3C(=CN=C3C=C2)CC4=CC=C5N=CC=CC5=C4	Glixx	GLXC-04408	-4.33732824	-5.50702099	-3.18055556	-3.74186808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386415-05	NCGC00386415-05	384569133		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1198300-79-6		0.1995262315	-6.7	-39.7759627396	4	4		-8.279482424	-10.12393751	0.7094767385	0.4615286799		TYK2	CC[S+]([O-])(=O)N1CCN(CC1)C2=CC=C(NC3=NC(=C(C=N3)C(N)=O)NC4CC4)C=C2	MedChem Express	HY-15999	-5.51385048	-16.9967525	-8.93981481	-10.12393751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00182851-05	NCGC00182851-05	384568411		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1247-42-3				5.8458910548	4	4		0	1.56802754				NRC31	C[C@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO	MedChem Express	HY-B0243	2.2760181	-2.34897822	0.72066355	1.56802754												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00488781-01	NCGC00488781-01	363681475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1443763-60-7				-50.6554552917	4	4		0	-7.96443255				TTK	COC1=CC(=CC=C1NC2=N[N]3C=C(C=CC3=N2)C4=CC=C(NC(=O)[C@H](C)C5=CC=C(F)C=C5)C=C4)[S+](C)([O-])=O	MedChem Express	HY-12858	-10.13122172	-11.79878733	-15.14299959	-7.96443255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015697-01	NCGC00015697-01	11111487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	529-44-2	Myricetin;MYRICETIN			-20.1467634457	4	4	myricetin 3-O-(2''-O-galloyl)-beta-D-glucopyranoside;myricetin 3-O-neohesperidoside;NCGC00094083-01;myricetin 7-O-glucopyranosyl-(1-6)-glucopyranoside;NCGC00094083-03;Cannabiscetin;myricetin 7-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside;3,3',4',5,5',7-Hexahydroxyflavone;myricetin 3-O-(2'',3''-di-O-galloyl)rhamnopyranoside;myricetin 3-O-(4''-acetyl)rhamnopyranoside;myricetin 3-O-(2'',3'' -di-O-galloyl)-alpha-rhamnopyranoside;myricetin 3-O-(2''-O-galloyl)-alpha-rhamnopyranoside 7-methyl ether;myricetin 7-O-rhamnopyranosyl-(1-6)-glucopyranoside;myricetin;CIPLUS_154027;m(G)-Glu;MYRICETIN;NCGC00094083-04;NCGC_Prestw-465;myricetin 7-O-alpha-L-rhamnopyranosyl-(1-6)-beta-D-glucopyranoside;myricetin 3-O-(3''-galloyl)rhamnopyranoside 7-methyl ether;3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one;myricetin-DGR;myricetin-2 cpd;NCGC00015697-02;myricetin 3-O-(2''-O-galloyl)rhamnopyranoside 7-methyl ether;Myricetin;NCGC00015697-01;myricetin-3 cpd;myricetin 3-O-(4''-acetyl)-alpha-L-rhamnopyranoside;myricetin 3-O-(3''-galloyl)-alpha-rhamnopyranoside 7-methyl ether;	0	-11.57854479			1544	CYP1A2	OC1=CC2=C(C(=C1)O)C(=O)\C(=C(/O2)C3=CC(=C(O)C(=C3)O)O)O	SigmaAldrich	Lopac-M-6760	-2.80995475	-2.61845947	-3.55799302	-11.57854479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345018-01	NCGC00345018-01	174006279		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	n				-23.4962078743	4	4		0	-7.86882111			5141	PDE4A	COC1=CC=C(CC2=CC=C(NC(N)=O)C=C2)C=C1C3=CC=CC(=C3)Cl	NCGCChem	PRP01-072	-5.52488688	-2.56456322	-2.45206907	-7.86882111												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00188943-09	NCGC00188943-09	384568454		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	65-86-1				-9.13537288	4	4		0	-3.21118427					OC(=O)C/1=C/C(=O)NC(=O)N1	MedChem Express	HY-N0157	-2.69097991	-0.10011753	0.29532801	-3.21118427												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167491-14	NCGC00167491-14	384568318		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	191732-72-6				-23.3915325103	4	4		0	-3.73604352				TNF	NC1=CC=CC2=C1CN([C@H]3CCC(=O)NC3=O)C2=O	Glixx	GLXC-04181	-5.39081172	-7.10834458	-2.66763496	-3.73604352												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387248-01	NCGC00387248-01	363680593		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[917369-31-4]		7.0794578438	-5.15	-333.8829163466	5	4		14.751107084	-62.53936444	0.1936306126	0.9764105538		TUBB	COC1=CC=C(C=C1)N(C)C2=NC(=NC3=CC=CC=C23)C	Tocris	5231	-73.14331238	-74.41344187	-69.16969257	-62.53936444												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090808-05	NCGC00090808-05	384568088		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1397-89-3				-11.9907188859	4	4		0	-0.56459007					C[C@H]1O[C@@H](O[C@@H]\2C[C@@H]3O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C[C@H](O)[C@H]3C(O)=O)[C@@H](O)[C@@H](N)[C@@H]1O	Selleck	S1636	-1.94893079	-2.8946543	-6.53626652	-0.56459007												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346556-03	NCGC00346556-03	384568839		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	425386-60-3				-8.77539356	4	4		0	-1.75430164				NOTCH1	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCC2=C1C=CC=C2	MedChem Express	HY-10009	-1.36102519	-3.95423341	-1.75225457	-1.75430164												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00370731-05	NCGC00370731-05	384569035		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	936889-68-8		8.9125093813	-5.05	-51.4330476582	-2.4	4		-49.3537445148	-40.74305489	0.0616880781	0.9976478694			NC1=NC=C[N]2C(=NC(=C12)C3=CC4=C([NH]3)C(=CC=C4)Cl)[C@@H]5CC[C@H](CC5)C(O)=O	SynKinase	SYN-5214	-2.43923995	-5.85812357	-15.24695108	-40.74305489												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161825-08	NCGC00161825-08	384568215		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	405911-17-3		12.5892541179	-4.9	-67.270399658	-3	4		-96.9919350237	-88.33509565	0.0792852514	0.9961028915		ABCA1	OC(=O)CC1=CC=CC(=C1)OCCCN(CC(C2=CC=CC=C2)C3=CC=CC=C3)CC4=CC=CC(=C4Cl)C(F)(F)F	MedChem Express	HY-10627A	-0.53026955	-3.10297483	3.25685716	-88.33509565												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346492-03	NCGC00346492-03	384568799		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	(956958-53-5)				-34.814408053	4	4		0	-10.97859028				PIK3CA	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4	SynKinase	SYN-1127	-5.14234071	-7.08032839	-9.68769022	-10.97859028												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263212-05	NCGC00263212-05	384568669		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	431979-47-4				-22.5763244831	4	4		0	-1.40776224				MDM4	CCOC1=CC(=CC(=C1OCC(=O)OC)Cl)/C=C2\C(=N/N(C2=O)C3=CC=CC=C3)C	MedChem Express	HY-16664	-5.79304112	-6.57232277	-3.05754554	-1.40776224												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345828-07	NCGC00345828-07	377020265		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	457081-03-7		0.4466835922	-6.35	-74.3876188933	-1.4	4		-30.5285555193	-25.87245435	0.4127193804	0.877747461		JAK1	CC(C)(C)C1=NC2=C([NH]1)C3=CC=C(F)C=C3C4=C2\C=C/NC4=O	MedChem Express	HY-14435	-2.60180995	-30.03368516	-39.21950777	-25.87245435												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356746-04	NCGC00356746-04	384569031		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			12.5892541179	-4.9	-89.7423902039	-3	4		-103.193609066	-97.036931	0.0402583965	0.9989990651		NAMPT	[O-][S+](=O)(C1=CC=C(CNC(=O)C2=CC3=C([NH]N=C3)N=C2)C=C1)C4=CC(=CC=C4)C(F)(F)F	NCGCChem	DYD027-070	-5.20492166	-3.65211335	-1.96078431	-97.036931												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510199-01	NCGC00510199-01	384569414		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1225037-39-7		3.1622776602	-5.5	-121.4461820588	-2.4	4		-94.0699139203	-72.26357477	0.0675567947	0.9971753025		PIK3CA	NC1=NC=C(C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)C(=C1)C(F)(F)F	Glixx	GLXC-90536	-6.51500398	-25.23397031	-47.44129751	-72.26357477												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390552-02	NCGC00390552-02	384569191		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1313363-54-0		3.5481338923	-5.45	-60.3567084685	-2.2	4		-39.1985681422	-40.77202023	0.0280018094	0.999516524		MDM2	COC1=C(OC(C)C)C=C2[C@@H](N(C(=O)CC2=C1)C3=CC=C(C=C3)N(C)C[C@@H]4CC[C@H](CC4)N5CCN(C)C(=O)C5)C6=CC=C(Cl)C=C6	ChemieTek	CT-CGM097	-3.1512791	-5.58481696	-25.65480513	-40.77202023												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00499183-01	NCGC00499183-01	363681481		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox			8.9125093813	-5.05	-86.2624294123	-2.1	4		-90.1576099833	-87.72306518	0.0125194069	0.9999033245		MST	CN1C(=O)C2=C(C=CS2)N(C)C3=NC(=NC=C13)NC4=CC=C(C=C4)[S+](N)([O-])=O	TruePharmaChem	XMU-MP-1	-3.79746835	-4.30505376	-11.43064633	-87.72306518												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015399-27	NCGC00015399-27			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	41340-25-4				-1.5998726888	4	4		0	-1.55072049					CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(O)=O	Selleck	S1328	0	-0.16105863	-0.46961995	-1.55072049												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345807-02	NCGC00345807-02	384568753		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1173928-09-0				2.5105600821	4	4		0	0.77774597				CTSL1	OC1=CC=C(CCNC(=O)[C@H]2O[C@@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NCC4=CC=CC=C4)C=C1	EMD Chemicals	219502	0.9383022	-1.72811561	1.06027596	0.77774597												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510481-01	NCGC00510481-01	384569444		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1334294-76-6		12.5892541179	-4.9	-50.0461028595	-3	4		-62.1618358959	-57.8342904	0.0442146293	0.9987926624		GPR183	ClC1=CC=C(C=C1)/C=C/C(=O)N2CCC3(CC2)CN(CC4=CC=C(Cl)C(=C4)Cl)C(=O)O3	MedChem Express	HY-101192	-2.03013624	-2.11497961	-0.2243793	-57.8342904												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346606-02	NCGC00346606-02	363677475		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	860-79-7				-17.1547919412	4	4		0	-5.94540037					CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@H](CC[C@@]45C[C@@]35CC[C@]12C)NC	Selleck	S2402	-0.83075563	-6.51716247	-3.51852717	-5.94540037												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00346607-02	NCGC00346607-02	363677476		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	4871-97-0				-23.5701768593	4	4		0	-3.77295011					CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C	Selleck	S2407	-6.11577552	-3.43249428	-3.91103219	-3.77295011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263230-01	NCGC00263230-01	137276074		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	910249-49-9	FASN MRK	3.1622776602	-5.5	-39.7875231286	4	4		-24.791199192	-26.54218399	0.0118636377	0.9999133717	2194	FAS	COC1=CC=CC=C1C2=CC=CC(=C2)C/3=C(O)/C4=CC(=C(Cl)C=C4NC3=O)C#N	NCGCChem	FASN MRK	-2.13285133	-2.70785141	-18.04092335	-26.54218399												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346712-05	NCGC00346712-05	384568927		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	129497-78-5		3.1622776602	-5.5	-75.6404438478	-3	4		-58.6277737532	-5.64790419	1	0.9919386527			COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Aobious	AOB5623	-3.65063875	0.94830364	-46.30891951	-5.64790419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346885-02	NCGC00346885-02	384568962		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[130800-90-7]				-11.0847888491	4	4		0	-3.52095808				SCN2A	CN1CCN(CC1)C2=NC(=C(C=N2)C3=CC(=CC(=C3Cl)Cl)Cl)N	Tocris	4044	-2.55943932	-1.88740045	-0.85569253	-3.52095808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015649-08	Moxonidine hydrochloride hydrate	170466534	Imidazoline I1 Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	75438-57-2	 Zint; ; Moxon; MOXONIDINE HCl; Cynt;Moxonidine; Moxonidine; Lilly brand of moxonidine; Physiotens; Normatens;Moxonidine hydrochloride; Moxonidine hydrochloride			-18.9888555226	4	4		0	-4.01003716			11188	NISCH	COc2nc(C)nc(Cl)c2NC1=NCCN1	Prestwick	Prestw-1016	-4.80014437	-5.00067213	-0.34144676	-4.01003716												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346530-09	NCGC00346530-09	384568822		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1236699-92-5		0.1	-7	-111.0862013501	-1.4	4		-31.122508184	-31.86100163	0.2614287646	0.9557986121		MAP2K1	OC[C@@H](O)CNC(=O)C1=CC=NC=C1NC2=C(F)C=C(I)C=C2	MedChem Express	HY-12042	-18.84224481	-27.61556064	-28.40521471	-31.86100163												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00356417-05	NCGC00356417-05	384569030		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					0.0848579351	4	4		0	-0.86994136				SMYD2	CC1=C[N](CCN2CCN(CC2)C3=C(C=CC=C3)C4=CC(=CC(=C4)C#N)C(=O)NCCCN5CCCC5)C6=C1C=CC=C6	Tocris	5365	0.63632346	-0.56750572	-0.70557451	-0.86994136												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346675-02	NCGC00346675-02	384568901		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1071992-99-8				-6.780836969	4	4		0	0.2451216				XIAP	CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)CC(C)C	Axon Medchem	1985	-1.32567388	0.61327231	-5.73337694	0.2451216												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1190307-88-0				-13.6504942009	4	4		0	0.62567211					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	-4.41030276	-1.64648251	-2.4394812	0.62567211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263227-02	NCGC00263227-02	384568679		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	256498-66-5		5.6234132519	-5.25	-120.8011578598	-3	4		-96.6548417536	-95.55186235	0.0589837553	0.9978481129		GUCY1A2	NC1=C(N2CCOCC2)C(=NC(=N1)C3=N[N](CC4=C(F)C=CC=C4)C5=NC=CC=C35)N	Cayman	10011131	-7.02214189	-1.87327074	-4.99602004	-95.55186235												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00159483-06	NCGC00159483-06	363676594		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	747-36-4				9.8070057272	4	4		0	-0.72343338				MAP1LC3A	CCN(CCO)CCCC(C)NC1=CC=NC2=CC(=CC=C12)Cl	Selleck	S4430	2.95526435	5.5200254	3.75052676	-0.72343338												1.6E-8	8E-8	4E-7	0.000002											
NCGC00384220-02	NCGC00384220-02	384569107		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1401033-86-0				-8.6788784896	4	4		0	-1.91612083				CDK4	C[C@H]1CC[C@@H](CC1)[N]2C3=CN=CC=C3C4=CN=C(NC5=NC6=C(CN(CC6)C(=O)CO)C=C5)N=C24	ChemieTek	CT-AMG925_CM1	-3.90420244	2.97999728	-1.07224797	-1.91612083												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00384304-02	NCGC00384304-02	384569110		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1598383-40-4				-12.8026969683	4	4		0	-5.50395933					CCN([C@H]1CC[C@@H](CC1)N(C)CCOC)C2=C(C)C(=CC(=C2)C#CCN3CCOCC3)C(=O)NC\C4=C(C)\C=C(\C)NC4=O	Aobious	AOB87382	-1.90691369	-1.59205334	-3.8722667	-5.50395933												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509945-01	NCGC00509945-01	384569393		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1437321-24-8				-12.9469743667	4	4		0	-3.48263473				TYRO3	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)\C4=C\N(C(C)C)C(=O)N(C4=O)C5=CC=C(F)C=C5)C=C3F	ChemGood	C-1344	-2.9764017	-2.22805322	-1.6968818	-3.48263473												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00090903-01	NCGC00090903-01	144204588		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	599-79-1	; Sulfasalazine; Azulfidine;Sulfasalazine; Sulfasalazina;Azulfidine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulphasalazine, N-; Sulfasalazine DR; Salazosulfapiridina; Salazopyrine			-6.3999469015	4	4	Salazosulfapyridine;LS-46;SULFASALAZINE;Sulfasalazina;HS_159;SALAZOSULFAPYRIDINE;HS_1313;Sulfasalazine;Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-;HS_1312;sulfasalazine;Salazopyrine;Azulfidine;Salazosulfapiridina;AB07936213-01;Salazosulfapyridinum;Sulfasalazinum;4-(pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene;Salicylazosulfapyridine;sulfasalazinum;NCGC00090903-02;CIPLUS_684989;NCGC00016518-01;CIPLUS_155048;NCGC_Prestw-520;NCGC00090903-03;Sulfasalazine DR;Sulphasalazine, N-;	0	0.4294745			4790	NFKB1	O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3	NIEHS	AB07936213	-2.29179825	0.92306314	-2.16574801	0.4294745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386509-01	Fluticasone furoate	384569143	Glucocorticoid Receptor (GR) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	397864-44-7				-0.1677336865	4	4		0	-4.15480384				NRC31	C[C@@H]1CC2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)SCF	Axon Medchem	1172	0.27068483	1.27257248	1.94136871	-4.15480384												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378840-01	NCGC00378840-01	363678229		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	867331-82-6		2.5118864315	-5.6	1.4305627314	4	4		-16.5222532	-7.935211	0.3455371018	0.919259009		SRC	CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C5=CC(=CC=C5Cl)OC(=O)C6=CC=CC=C6	MedChem Express	HY-10186	4.64869642	-0.03661327	-0.99528059	-7.935211												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00163683-02	NCGC00163683-02	174006806		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	58569-55-4	Metenkephalin			-15.3359075817	4	4		0	-2.85975199					CSCC[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(O)=O	Alfa Aesar	J61154	-3.97702165	-2.53546911	-1.81767207	-2.85975199												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345849-02	NCGC00345849-02	377020186		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	(944396-88-7)		3.9810717055	-5.4	-116.1807453248	-2.1	4		-90.2102728201	-82.14879265	0.0083759305	0.9999567331		PIK3CA	COC1=CC=C(NC2=CC(=NC(=N2)N3CCOCC3)C4=CN=C(N)N=C4)C=N1	SynKinase	SYN-1145	-4.4735653	-13.66625845	-48.3635342	-82.14879265												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387868-07	NCGC00387868-07			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	891494-64-7		11.220184543	-4.95	-34.1046389239	4	4		-18.056456096	-17.52859517	0.1766407661	0.9804356492			CN1C=C(C=N1)C2=C3N=C([C@H]4CCCNC4)C(Br)=C(N)N3N=C2	Aobious	AOB5556	-4.14821509	-6.53603665	-8.35791544	-17.52859517												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00095099-11	NCGC00095099-11	384568144		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	171599-83-0				-23.6906923888	4	4		0	-2.14097175				PDE5A	CCCC1=N[N](C)C2=C1\N=C(/NC2=O)C3=CC(=CC=C3OCC)[S+]([O-])(=O)N4CCN(C)CC4	Enzo	DL261	-5.51287845	-4.59472944	-6.86894227	-2.14097175												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00022567-15	NCGC00022567-15	384568011		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	4291-63-8		5.0118723363	-5.3	-49.674459798	-2.2	4		-38.5808227255	-37.94114772	0.0302717638	0.999435007		ADA	NC1=NC(=NC2=C1N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)O3)Cl	MedChem Express	HY-13599	-2.41301401	-4.28629746	-17.39476518	-37.94114772												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015442-19	NCGC00015442-19	384567846		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	51-21-8		11.220184543	-4.95	-20.3471154155	4	4		-30.7538922159	-23.54491018	0.2403714446	0.9626795652		TYMS	F\C1=C\NC(=O)NC1=O	Selleck	S1209	1.34403833	-4.02338535	-4.81991781	-23.54491018												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015874-05	NCGC00015874-05	170466085		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	6151-30-0		8.9125093813	-5.05	-85.4710873487	-2.1	4		-124.4568257516	-99.40163104	0.0353108328	0.9992302026		PLA2G5	Cl.Cl.O.O.CCN(CC)CCCC(C)Nc1c3cc(OC)ccc3nc2cc(Cl)ccc12	Specs	AT-084/J177276	2.56248308	-2.24940628	-23.10131213	-99.40163104												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481573-01	NCGC00481573-01	377020380		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			14.1253754462	-4.85	-58.4499438558	-3	4		-31.1271166636	-34.62336534	0.1533060707	0.9852442213		MAPK14	CC1=CC=C(C=C1)[N]2N=C(C=C2N\C(O)=N\CC3=CC(=CC=C3OC4=CC=C5[N](CCO)N=CC5=C4)F)C(C)(C)C	APExBIO	B5955	-8.12054498	-10.3956625	-6.53626652	-34.62336534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250374-02	NCGC00250374-02	363677173		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	156897-06-2				-20.6786598673	4	4		0	-10.37012016				ALOX5	CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O	Selleck	S2121	-3.59108545	-6.71237173	1.33652017	-10.37012016												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263156-12	NCGC00263156-12	384568630		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	656247-18-6		11.220184543	-4.95	-93.0468420173	-2.1	4		-123.0260352336	-99.72604057	0.0386597411	0.9990770778	2324	FLT1	COC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)C5=CC=CC=C5	MedChem Express	HY-11106	-1.85594344	-5.56521739	-14.13485351	-99.72604057												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163127-08	NCGC00163127-08	384568231		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	55079-83-9		12.5892541179	-4.9	18.380908901	4	4		26	23.01300225	0.0303107492	0.9994343313			COC1=C(C)C(=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(=C1)C)C	APExBIO	A2415	0.08133755	0.69397197	0.69766353	23.01300225												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390693-06	NCGC00390693-06	384569207		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1233948-35-0		3.9810717055	-5.4	-297.5096051373	5	4		-18.360799988	-75.26639945	0.0230890158	0.9996730334		TUBB	CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC(=CC=C2C)C3=CC=C(S3)C#N	MedChem Express	HY-16191	-59.13239946	-61.05592598	-68.06667603	-75.26639945												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00484808-01	NCGC00484808-01	384569273		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-15.1131005044	4	4		0	-4.03754033				EP300	C[C@@H]1CC(=O)NC2=CC=CC(=C2N1)C3=C[N](N=C3)C(C)(C)C	NCGCChem	GRB056-041	-4.34704022	-3.19771397	1.77459381	-4.03754033												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094082-08	NCGC00094082-08	384568123		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	362-07-2		7.9432823472	-5.1	-39.0103318651	-3	4		-55.1484016071	-50.11242546	0.0064418082	0.9999744159			COC1=C(O)C=C2CC[C@@H]3[C@H](CC[C@]4(C)[C@@H](O)CC[C@@H]34)C2=C1	Selleck	S1233	0.85856304	1.02054701	-6.38198249	-50.11242546												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390695-02	NCGC00390695-02	377020505		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1184940-46-2				-18.4034374153	4	4		0	-4.05748503				SGK1	CCC1=C(C)C(=CC=C1C(=O)NNC(=O)[C@@H](O)C2=CC(=CC(=C2)F)F)O	MedChem Express	HY-15193B	-3.74822569	-3.35128665	-4.94561276	-4.05748503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347940-04	NCGC00347940-04	384568992		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1420071-30-2				-11.2053365105	4	4		0	-6.10778443				TNFRSF10B	BrC1=CC=C(C=C1)N2C(=N)S\C(=C/C3=CC=C(O3)C4=CC5=C(C=C4)C(=O)NC5=O)C2=O	Glixx	GLXC-01623	-2.8876863	0.86544216	1.57118685	-6.10778443												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00346683-02	YM-201636	384568907	PIKfyve Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	371942-69-7		5.6234132519	-5.25	-97.9481354669	-2.1	4		-100.9580353202	-91.59760479	0.0250726699	0.9996120949		PIKFYVE	NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6	Selleck	S1219	-0.97143364	-2.23726005	-36.3983563	-91.59760479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241103-11	NCGC00241103-11	384568473		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	790299-79-5		12.5892541179	-4.9	-73.6747756662	-3	4		-102.3774968735	-94.15072575	0.0545105294	0.9981628822		FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	MedChem Express	HY-10209	-0.80424216	-3.14874142	1.35974954	-94.15072575												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346732-02	NCGC00346732-02	384568936		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox					-9.0201365149	4	4		0	-3.61914832					C[C@@H]1CNC(=O)CC[C@]/2(C)[C@@H](CC(N)=O)[C@H]3N4C2=C(C)/C5=[N]6/C(=C\C7=[N]8\C(=C(C)/C9=[N](/[C@]3(C)[C@@](C)(CC(N)=O)[C@@H]9CCC(N)=O)[Co+]468(O)\[N]%10=C\N([C@H]%11O[C@H](CO)[C@@H](O[P]([O-])(=O)O1)[C@H]%11O)C%12=C%10C=C(C)C(=C%12)C)[C@@](C)(CC(N)=O)[C@@H]7CCC(N)=O)C(C)(C)[C@@H]5CCC(N)=O	Selleck	S1668	-0.08837826	-5.91304348	-2.79893463	-3.61914832												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386681-01	NCGC00386681-01	363680394		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1312815-93-2		12.5892541179	-4.9	-51.426824309	-3	4		-62.87647768	-55.68105354	0.0480092696	0.9985762164		PTGES	OC[C@H]1CCC[C@@H](C1)NC(=O)C2CCN(CC2)C3=NC4=CC(=C(C=C4O3)C5=CC=C(Cl)C=C5)Cl	Axon Medchem	2020	-1.61732214	-4.02745995	-4.09793935	-55.68105354												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00511354-01	NCGC00511354-01	384569498		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1361951-15-6		1.77827941	-5.75	-60.65616811	4	4		-22.0895167519	-22.07449409	0.4193072589	0.8731950885		PIM1	CC(C)(O)[C@@H]1CC[C@H](CC1)NC2=N[N]3C(=NC=C3C4=CC(=CC=C4)C(F)(F)F)C=C2	Glixx	GLXC-05022	-7.93492996	-2.47199165	-31.71325561	-22.07449409												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263231-01	NCGC00263231-01	137276075		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	394237-61-7	PDHK RIKEN			-5.5827641819	4	4		0	-3.53895786			5164	PDK2	COC1=CC=C(C=C1)C2=C(C)[NH]N=C2C3=CC=C(O)C=C3O	NCGCChem	PDHK RIKEN	-0.58743787	-3.00721187	0.95050803	-3.53895786												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166035-05	NCGC00166035-05	384568302		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	477-30-5		1.1220184543	-5.95	-210.093037395	5	4		-27.2616141632	-62.18443114	0.027280527	0.9995415336		TUBB	CN[C@H]1CCC2=CC(=C(OC)C(=C2C/3=C/C=C(OC)\C(=O)/C=C13)OC)OC	Cayman	15364	-35.30429383	-44.22961838	-60.87019579	-62.18443114												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186024-12	NCGC00186024-12	384568435		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	356559-20-1		3.9810717055	-5.4	-27.7481822362	4	4		-16.793453124	-13.06107261	0.4267369864	0.8700650391		TGBR1	CC1=NC(=CC=C1)C2=C(N=C([NH]2)C(C)(C)C)C3=CC=C4N=CC=NC4=C3	MedChem Express	HY-12043	-2.81652834	-7.8311642	-7.61114237	-13.06107261												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522550-01	NCGC00522550-01	384569525		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	858668-07-2		1.2589254118	-5.9	-46.3769762853	-2.4	4		-38.2176775959	-32.26473133	0.1137855728	0.9919403154		KIF11	CN(C)CCNC(=O)NC[C@H]1CC[C@H]2[C@@H](NC3=C(C=C(C=C3)C(F)(F)F)[C@H]2O1)C4=CC=CC=C4	MedChem Express	HY-15000	1.06053911	-11.98169336	-23.74188122	-32.26473133												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384167-11	NCGC00384167-11	384569102		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	700874-72-2				-14.0296169234	4	4		0	-8.71383255				TGBR1	CC1=CC=CC(=N1)C2=N[N]3CCCC3=C2C4=CC=NC5=CC=C(C=C45)C(N)=O	MedChem Express	HY-13226	-1.2638091	-2.59954233	-3.53721789	-8.71383255												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346577-02	NCGC00346577-02	363677460		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	N/A		10	-5	-73.4081420936	-3	4		-115.8855215561	-99.02238733	0.068820961	0.9970673595		BRAF	FC(F)(F)C1=CN=C([NH]1)C2=CC(=CC=N2)OC3=CC4=C([NH]C(=N4)NC5=CC=C(C=C5)C(F)(F)F)C=C3	Selleck	S2200	-0.24401265	6.25481925	-4.49969565	-99.02238733												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378460-08	NCGC00378460-08	363678082		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1218942-37-0				-28.2631071449	4	4		0	-6.481572				NOX1	CN(C)C1=CC(=CC=C1)C\2=C\3C(=O)N(NC3=C/C(=O)N2C)C4=CC=CC=C4Cl	MedChem Express	HY-12298	-6.28106643	-5.1118066	-5.44552137	-6.481572												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00389778-03	NCGC00389778-03			SARS-CoV-2_CPE_SRI		82956-11-4				-46.8558086963	4	10		0	-9.88479534					NC(N)=NC1=CC=C(C=C1)C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(N)=N	Bio Vision	1760	-15.05131129	-5.03283136	-12.46412142	-4.89914678	-9.39723981	-0.07077419	-10.02634373	-2.3670035	-8.87036527	-9.88479534						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00601698-01	Glecaprevir			SARS-CoV-2_CPE_SRI		1365970-03-1				-27.2311370037	4	10		0	-6.41866967					[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347	-3.00935813	-4.32182658	-2.50456258	-2.09296004	-5.13726556	-0.58633946	-3.21127636	-4.95864559	-4.43055178	-6.41866967						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00481577-01	NCGC00481577-01	377020308		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox			0.2238721139	-6.65	-183.2385009031	-1.4	4		-68.8086874422	-64.78639163	0.305636168	0.9375657268		AXL	CN(C)[S+]([O-])(=O)C1=CC=CC=C1\N=C/2N\C(=N/C=C2Cl)NC3=CC=C(CN4CCN(C)CC4)C=C3	APExBIO	B5940	-8.15183009	-19.0003175	-87.46078569	-64.78639163												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00183784-18	NCGC00183784-18	384568420		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	5852-78-8				-14.6515379986	4	4		0	-4.33532934				KDM4A	OC(=O)C1=C2C=CC=NC2=C(O)C=C1	SIGMA	SML0067	-2.18683463	-3.91290337	-4.42349529	-4.33532934												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347946-02	NCGC00347946-02	363677726		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	?1355324-14-9				-1.3136360048	4	4		0	-3.44431138				IDH1	CC1=CC=CC=C1C(N(C(=O)CNC2=CC=C(C=C2)C#N)C3=CC=CC(=C3)F)C(=O)NC4CCCCC4	XcessBio	M60043-2s	0.03992193	-0.57082355	2.22866812	-3.44431138												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015919-17	NCGC00015919-17	384567907		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	959-24-0				-12.2932412229	4	4		0	-5.15372808				ADRB1	CC(C)NCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0437	-0.67985167	-6.51185595	-3.08103545	-5.15372808												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263157-02	NCGC00263157-02	384568631		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1025720-94-8		11.220184543	-4.95	-32.9952608552	-3	4		-35.793994116	-30.31768919	0.051850477	0.9983409529		MET	CCOC\1=C(/C(=O)NC2=CC=C(OC3=C(Cl)C(=NC=C3)N)C(=C2)F)C(=O)N(\C=C1)C4=CC=C(F)C=C4	Selleck	S1561	-1.73936076	-3.06204314	-5.36953667	-30.31768919												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346931-02	NCGC00346931-02	384568967		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	761437-28-9		4.4668359215	-5.35	-137.0073701347	-2.1	4		-99.4801607827	-93.81831713	0.0239182997	0.9996470196		PTK2	CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=CC=C(C=C3OC)N4CCOCC4	Selleck	S2820	-7.37241745	-16.93260831	-51.8242356	-93.81831713												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00501212-01	NCGC00501212-01	384569311		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	944118-01-8				-16.4876416665	4	4		0	-7.73989488				JAK3	NC(=O)C1=CN=C2[NH]C=CC2=C1NC3C4CC5C[C@H]3CC(O)(C5)C4	MedChem Express	HY-19568	-2.04838425	-5.094491	-2.73400863	-7.73989488												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351482-09	NCGC00351482-09	384569009		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1201438-56-3		10	-5	-37.7679837891	4	4		-23.2670045959	-22.01768721	0.0466491021	0.998661985		PIK3CD	C[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=C/C4=C(C(=CC=C4)Cl)C(=O)N3C5=CC=CC=C5	MedChem Express	HY-17044	-4.29518338	-5.37299771	-9.42479323	-22.01768721												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018261-09	Perhexiline	384568001	mitochondrial carnitine palmitoyltransferase-1 inhbitior	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	6724-53-4, 6621-47-2 [perhexiline]		10	-5	-71.1212756396	-3	4		-107.6540613315	-99.95674325	0.0148033081	0.9998648181			C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3	Microsource	01503227	1.11356606	2.40732265	-1.34105883	-99.95674325												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00508883-01	NCGC00508883-01	384569370		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1825345-33-2		2.2387211386	-5.65	-103.5261385873	4	4		-22.517839316	-36.3227842	0.0106877555	0.9999298043		PARP1	O=C1N\N=C(\CC2=CC=CC(=C2)C(=O)N3CCN(CC3)C4=NC=CC=C4C#N)C5=CC=CC=C15	SynKinase	SYN-3046	-16.04072398	-20.27846396	-30.39024611	-36.3227842												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263190-11	NCGC00263190-11	384568655		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	587871-26-9		10	-5	-36.4675064351	-3	4		-35.2160474959	-32.70867196	0.0143759249	0.9998726924		ATM	O=C/1\C=C(/OC(=C1)/C2=C3SC4=C(SC3=CC=C2)C=CC=C4)N5CCOCC5	MedChem Express	HY-12016	-2.57466063	-2.52863238	-5.26220369	-32.70867196												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016000-21	NCGC00016000-21	384567915		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	97-77-8				-20.8683038884	4	4		0	-4.61398988				ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Selleck	S1680	-4.33743472	-8.34457842	-0.73105786	-4.61398988												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263220-07	NCGC00263220-07	384568674		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	128517-07-7		0.4466835922	-6.35	-228.7384233009	-1.1	4		-99.2993089599	-99.64550898	0.0177619448	0.9998053796		HDAC1	C\C=C1/NC(=O)[C@H]2CSSCC\C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C	DC Chemicals	DCAPI1434	-12.20280341	-77.2084887	-98.90742084	-99.64550898												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00244256-04	NCGC00244256-04	377020319		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	111358-88-4		2.2387211386	-5.65	-255.3240665696	-1.3	4		-67.1086160566	-97.94011976	0.1468278644	0.9864644485		JAK1	C[C@@]12O[C@@H](C[C@]1(O)CO)[N]3C4=C(C=CC=C4)C5=C6C(=O)NCC6=C7C8=C(C=CC=C8)[N]2C7=C35	Cayman	12094_CM1	-37.30039035	-27.25222115	-97.03166546	-97.94011976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI		59721-29-8		0.0702306445	-7.1534733462	12.7005756789	4	10		17.172610384	8.6659065	0.0197555943	0.853046767			CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-4.66323281	-8.47717532	-6.81791373	-3.20842999	-2.98824362	-4.54527582	-3.1769748	-5.26088153	-4.44304644	8.6659065						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00651732-01	ROC-325			SARS-CoV-2_CPE_SRI		1859141-26-6		0.0106262942	-7.9736181626	-64.3703180582	4	10		-18.119431452	-16.23088114	0.0113770771	0.8791562002			CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527	-1.73003578	3.35784217	-1.38402862	-1.92663076	-5.4732041	-2.02099634	-5.22156254	-9.06696025	-18.84952621	-16.23088114						8.682634731E-11	1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8					
NCGC00346712-02	Verteporfin		photosensitizer	SARS-CoV-2_CPE_SRI		129497-78-5		0.0702306445	-7.1534733462	-78.121735261	4	10		-27.078651032	-22.88277094	0.0014109128	0.9396689285			COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786	-3.49085543	-0.73389508	-4.53927698	-6.07696191	-4.46161612	-3.5607502	-4.64800217	-5.78961674	-7.82433115	-22.88277094						1.7664670658E-10	3.5029940119E-10	7.0059880239E-10	1.4041916167E-9	2.8083832335E-9	5.613772455E-9	1.122754491E-8	2.245508982E-8	4.491017964E-8	8.9820359281E-8					
NCGC00250373-04	NCGC00250373-04	384568535		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	844499-71-4		1	-6	-3.5989114766	4	4		12.913413768	6.40479042	0.0259125401	0.9995911454		PRKAA1	OC1=C(C=CC=C1)C2=CC=C(C=C2)C3=CSC4=C3C(=C(/C#N)C(=O)N4)/O	XcessBio	M60020-5s	-4.51117814	-0.23017079	4.71356055	6.40479042												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263136-07	NCGC00263136-07	384568614		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	929016-96-6		1.1220184543	-5.95	-206.4979092022	-1.1	4		-81.295170734	-99.62360662	0.0429915054	0.9988583622		HDAC1	CCCCC1=NC2=CC(=CC=C2[N]1CCN(CC)CC)/C=C/C(=O)NO	Axon Medchem	1777	-17.27871515	-29.77102657	-96.00507292	-99.62360662												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390402-02	NCGC00390402-02	363680887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	858474-14-3		10	-5	-78.601918916	-3	4		-95.4151556406	-87.95541186	0.0089157103	0.9999509726		ABCBA	COC1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(O)C4CCCCN4	SynKinase	SYN-5211	-2.49932329	-1.84612627	-7.4240281	-87.95541186												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346482-01	NCGC00346482-01	174006230		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	16208-51-8	Dimesna			-16.089852334	4	4		0	-1.68701336					[O-][S+](=O)(CCSSCC[S+]([O-])(=O)O[Na])O[Na]	Selleck	S1201 	-2.89880689	-5.60183066	-5.02312976	-1.68701336												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025012-06	NCGC00025012-06	384568043		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	164178-33-0		10	-5	-31.4541266599	4	4		-17.2163446319	-18.07651639	0.1046636762	0.9932340038		CNR2	COC1=CC=C(C=C1)C(=O)C2=C(C)[N](CCN3CCOCC3)C4=C2C=CC(=C4)I	MedChem Express	HY-15421	-3.72956253	-5.15331808	-6.8922013	-18.07651639												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015898-28	Rolipram	384567905	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	61413-54-5				-12.031120505	4	4		0	-5.70508507				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3	MedChem Express	HY-16900	-2.00618648	0.11899313	-3.90168684	-5.70508507												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163532-06	Daidzin	384568245	Alcohol Dehydrogenase Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	552-66-9				-5.2209625774	4	4		0	-2.93283801				ADH1	OC[C@H]1O[C@@H](OC2=CC3=C(C=C2)C(=O)\C(=C/O3)C4=CC=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O	Adooq	A10283	-0.98508812	1.28362135	-2.0180737	-2.93283801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346656-03	NCGC00346656-03	384568887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	779353-01-4		0.316227766	-6.5	-281.2667642295	-1.2	4		-68.8403154487	-92.05200899	0.0049798559	0.999984709		CDK1	CCC1=C2N=C(C=C(NCC3=CC=C[N+](=C3)[O-])[N]2N=C1)N4CCCC[C@H]4CCO	Axon Medchem	1776	-34.57749661	-85.60348347	-92.04008054	-92.05200899												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00166294-08	NCGC00166294-08	384568305		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	110871-86-8				-8.8992028427	4	4		0	-0.55723922				TOP2B	C[C@H]1CN(C[C@@H](C)N1)C2=C(F)C3=C(C(=C2F)N)C(=O)\C(=C/N3C4CC4)C(O)=O	MedChem Express	HY-B0308	-2.47627655	-1.48319499	-1.60603081	-0.55723922												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00014650-04	NCGC00014650-04	384567792		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	66547-09-9		0.0125892541	-7.8999999999	-305.9006068096	5	4		-72.772151868	-64.57131684	1	0.9995184618		TUBB	CO[C@@H]1/C=C/C=C(C)/CC2=CC(=C(Cl)C(=C2)OC)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]3(C)O[C@@H]3[C@H](C)[C@@H]4C[C@@]1(O)NC(=O)O4	DC Chemicals	DC8241	-61.21102576	-67.91400191	-70.60448565	-64.57131684												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378431-08	NCGC00378431-08	363678080		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1637739-82-2				-12.3824955555	4	4		0	-5.64082511				RALA	C[N]1N=C(C)C2=C1OC(=C(/C#N)C2C3=CC=C(C=C3)C(F)(F)F)/N	Glixx	GLXC-05808	-2.91911432	-0.05896494	-0.95987264	-5.64082511												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346590-02	NCGC00346590-02	363677468		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	71939-50-9				-21.6596888634	4	4		0	-5.83634764				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S2290	-5.40442838	-5.7377421	0.73512197	-5.83634764												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510440-01	NCGC00510440-01	384569432		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					-18.235778169	4	4		0	1.76766467				KDM5A	CCC/1=C(/NC2=C(C=N[N]2C1=O)C#N)C3=CC=CC=C3C	Axon Medchem	2622	-6.32984386	-3.16715003	-1.68721296	1.76766467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00344550-03	NCGC00344550-03	384568722		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	10418-03-8				16.491072142	4	4		0	6.6251497					C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC5=C(C[C@]4(C)[C@H]3CC[C@]12C)C=N[NH]5	Prestwick	Prestw-1161	1.37952449	6.99719192	4.4718395	6.6251497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162413-14	NCGC00162413-14	384568226		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	30562-34-6				-18.2881140375	4	4		0	-2.43832335				HSP90AB1	CO[C@H]1C[C@@H](C)C\C2=C(/OC)C(=O)\C=C(\NC(=O)\C(=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(=C/[C@H](C)[C@H]1O)C)C)C2=O	MedChem Express	HY-15230	-4.77732434	-2.35694886	-3.74667634	-2.43832335												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142423-05	NCGC00142423-05	384568163		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	60-81-1				-13.357775678	4	4		0	-0.91497006				SCL5A2	OC[C@H]1O[C@@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(=CC(=C2)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2343	-4.03211498	-2.44901717	-0.95238095	-0.91497006												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00186460-03	NCGC00186460-03	384568440		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	218600-53-4		0.2818382931	-6.55	-231.6073260422	-1.1	4		-101.7775812725	-99.56886228	0.0084574671	0.9999558818		NFKB1	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)\C=C\4[C@@](C)(CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)[C@]3(C)CC2	APExBIO	A3221	-7.49201561	-98.21847811	-99.29417452	-99.56886228												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346705-02	PMSF	384568924	Serine Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	329-98-6				-9.6747691958	4	4		0	-2.08946581					[O-][S+](F)(=O)CC1=CC=CC=C1	Selleck	S3025	-2.48127763	-3.02011919	0.47802546	-2.08946581												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345825-02	NCGC00345825-02	363677372		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	(1338247-30-5)		1.1220184543	-5.95	-169.201502518	-2.3	4		-96.5623289607	-86.5753028	0.1319447672	0.9891083117		LIMK1	FC(F)C1=N[N](C(=C1)C2=CN=C(NC(=O)C3CC3)S2)C4=C(Cl)C=CC=C4Cl	SynKinase	SYN-1023	-11.2153749	-43.06134337	-65.46022145	-86.5753028												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00522603-01	NCGC00522603-01	384569531		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	243984-11-4				-4.034122689	4	4		0	-3.11929251				TLR4	CCOC(=O)C1=CCCCC1[S+]([O-])(=O)NC2=CC=C(F)C=C2Cl	MedChem Express	HY-11109	0.10605391	-1.94965675	-0.87379094	-3.11929251												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253760-02	NCGC00253760-02	174006227		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	54029-12-8	Albendazole oxide;Albendazole Oxide (Ricobendazole)	11.220184543	-4.95	-26.9958041948	4	4		-18.3114238	-18.23031818	0.1749817442	0.9807497887			CCC[S+]([O-])C1=CC=C2[NH]C(=NC2=C1)NC(=O)OC	Selleck	S1836	-2.55413168	-4.97940503	-4.81753189	-18.23031818												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510488-01	NCGC00510488-01	384569450		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1808011-22-4				-24.8666264982	4	4		0	-1.05258099				SMYD3	[O-][S+](=O)(CC1CCN(CCCC(F)(F)F)CC1)N2[C@@H]3CC[C@H]2CC(C3)NC(=O)C4=CC5=C(NC(=O)C5)C=C4Cl	MedChem Express	HY-19324	-6.30136986	-8.24713959	-3.18209429	-1.05258099												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378789-02	NCGC00378789-02	384569068		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	124083-20-13				-0.6334348056	4	4		0	-1.94544921				CPT1	CCOC(=O)[C@@]1(CCCCCCOC2=CC=C(Cl)C=C2)CO1	MedChem Express	HY-50202	1.90691369	-2.735066	-3.05754554	-1.94544921												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263234-01	NCGC00263234-01	137276078		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	730970-25-9	IDH-001			-19.2396122626	4	4		0	3.24567406			3417	IDH1	CCCCC1=CC=C(N[S+]([O-])(=O)C2=CC=C(C)C(=C2)C(=O)N3CCN(CC3)C4=CC=CC(=C4C)C)C=C1	NCGCChem	IDH-001	-6.32625395	-1.82791309	-1.9337922	3.24567406												3.2E-7	0.0000016	0.000008	0.000039999999999											
NCGC00386425-01	NCGC00386425-01	384569137		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1073154-85-4		6.3095734448	-5.2	-112.8028189737	-2.1	4		-96.1592955763	-92.54081533	0.0154333091	0.9998530751		PTK2	CNC(=O)C1=CC=C(NC2=NC(=C(C=N2)C(F)(F)F)NCC3=C(N=CC=N3)N(C)[S+](C)([O-])=O)C=C1	Selleck	S7654	-6.20876638	-6.60860888	-33.1366765	-92.54081533												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00486944-01	NCGC00486944-01	363681470		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox					-30.8530842777	4	4		0	-11.17411282				PAK1	CC(C)NC(=O)N1CC[C@@H](C1)NC/2=N/C3=C(C=CC(=C3)F)N(CC(F)F)C4=C2C=C(Cl)C=C4	SGC	NVS-PAK1-1	-3.83190239	-4.53122874	-7.33717282	-11.17411282												4E-8	2E-7	0.000001	0.0000049999999999											
NCGC00476094-01	NCGC00476094-01	384569239		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	112924-45-5		12.5892541179	-4.9	-80.1125624972	-3	4		-111.9557556881	-99.59760479	0.1229572443	0.9905578415			CCCCCCC(C)(C)C1=CC2=C([C@H]3CC(=C/CC3C(C)(C)O2)\CO)C(=C1)O	Cayman	10006350	-4.97249823	3.8024214	6.25090645	-99.59760479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015848-05	NCGC00015848-05	384567898		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1986-47-6				-12.2368544262	4	4		0	-3.60016745				MAOA	N[C@@H]1C[C@H]1C2=CC=CC=C2	Adooq	A13358	-3.14321031	-1.11873774	-1.05514913	-3.60016745												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015590-08	NCGC00015590-08	384567868		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[113168-57-3]				-5.9446691006	4	4		0	-4.60486534					O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5	Tocris	1999	-0.82111955	0.70868247	-1.28962671	-4.60486534												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510496-01	VLX-1570	384569458	Ubiquitin C-terminal Hydrolase L5 (UCH-L5) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1431280-51-1		1	-6	-166.9258033259	-1.1	4		-101.6885705996	-99.88945496	0.0221884029	0.9996962265		UCHL5	[O-][N+](=O)C1=CC(=CC=C1F)/C=C/2CCN(CC(=C/C3=CC=C(F)C(=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	MedChem Express	HY-12471	0.74237738	-34.89244851	-99.8224382	-99.88945496												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179649-13	NCGC00179649-13	384568381		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	50-24-8				4.942737936	4	4		0	1.99461694				NRC31	C[C@]12C[C@H](O)[C@H]3[C@@H](CC\C4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	MedChem Express	HY-17463	0.91029607	-1.8215103	3.43441895	1.99461694												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346571-07	NCGC00346571-07	384568845		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	940929-33-9		10	-5	-195.5044533446	-3	4		-76.0774629116	-99.67797751	0.0152389491	0.9998567644		KIF11	CC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C/2=C(\CC3=CC=CC=C3)C(=O)C4=C(O2)C=C(Cl)C=C4	MedChem Express	HY-12069	-30.3756076	-29.40045767	-32.74146068	-99.67797751												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480771-01	NCGC00480771-01	384569241		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1351635-67-0		11.220184543	-4.95	-42.3385708344	-3	4		-37.400450636	-31.58223589	0.0716537621	0.9968257295		BTK	NC1=C2N(C(=O)N([C@H]3CCCN(C3)C(=O)C=C)C2=NC=N1)C4=CC=C(OC5=CC=CC=C5)C=C4	Adooq	A15558	-3.33186036	-5.4187643	-9.20985001	-31.58223589												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00384181-05	NCGC00384181-05	384569103		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1423715-09-6 		1.1220184543	-5.95	-151.7477432691	-1.4	4		-58.956090978	-76.41197605	0.1674093939	0.9823096739			CC(=N/NC(=O)C1=CC=CC(=C1)[S+]([O-])(=O)N2CCOCC2)\C3=CC(=CC=C3O)Cl	Glixx	GLXC-90051	-12.14070263	-25.02416793	-66.01401982	-76.41197605												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263236-02	NCGC00263236-02	384568680		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	957135-43-2				-16.0948348342	4	4		0	-4.41197605				XIAP	CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](C3=CC=CC=C3)C4=C[N](CCCCC5=CC=C(CCCC[N]6C=C(N=N6)[C@@H](NC(=O)[C@@H]7CC[C@@H]8CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N78)C9=CC=CC=C9)C=C5)N=N4	APExBIO	A8815	-4.49343506	-0.72733969	-1.16509548	-4.41197605												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00253909-02	NCGC00253909-02	137275916		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1194961-19-7	PRT-318?; PRT-060318;PRT-060318	11.220184543	-4.95	-41.9176929127	-3	4		-30.020317444	-33.01548909	0.0859743945	0.9954202458	6850	SYK	CC1=CC(=CC=C1)NC2=C(C=NC(=N2)N[C@@H]3CCCC[C@@H]3N)C(N)=O	NCGCChem	DYD07-064	-3.83189122	-6.05722945	-4.6098293	-33.01548909												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263215-04	NCGC00263215-04	384568670		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[1222998-36-8]		0.0891250938	-7.05	-180.0233150389	-1.4	4		-36.8235010858	-48.69063677	0.0635937645	0.9975050216		MTOR	CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)\C=C/C4=C3C5=CC(=CC=C5N=C4)C6=CN=C7C=CC=CC7=C6)C(F)(F)F	Tocris	4247_cm1	-27.65318736	-47.72241041	-47.67867192	-48.69063677												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00181767-12	NCGC00181767-12	384568400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[134308-13-7]		11.220184543	-4.95	-53.5587926899	-3	4		-63.8376947708	-51.40704219	0.017865489	0.9998031845		COMT	CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(=C2)[N+]([O-])=O)O	Tocris	5864	-2.5163341	-3.30272776	-9.15869443	-51.40704219												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025220-11	NCGC00025220-11	384568058		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	212844-54-7				-24.6320346503	4	4		0	-4.1676357				CDK1	CC(C)[C@H](CO)NC1=NC(=C2N=C[N](C(C)C)C2=N1)NC3=CC(=C(C=C3)C(O)=O)Cl	MedChem Express	HY-18299	-4.07911001	-9.12372972	-6.75764397	-4.1676357												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378575-03	NCGC00378575-03	384569050		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	153653-30-6				-5.3354693001	4	4		0	-3.01355378					OC(COC1=C2C=CC=NC2=CC=C1)CN3CCN(CC3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5	MedChem Express	HY-17013A	0.70702607	-6.28832952	-0.70557451	-3.01355378												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345854-05	NCGC00345854-05	384568769		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1257704-57-6		5.0118723363	-5.3	-76.2718510333	-2.2	4		-60.9922155969	-59.94905316	0.0207118044	0.9997354166		JAK2	CN1CCN(CC1)C2=CC=CC(=C2)NC3=N[N]4C=CC=C(C5=CC=C(C=C5)[S+](C)([O-])=O)C4=N3	APExBIO	A4146	-3.54396818	-4.48512586	-27.58282323	-59.94905316												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183001-01	Tolvaptan	124894207	Vasopressin (AVP) V2 Antagonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	150683-30-0	 ; Tolvaptan;Tolvaptan			-15.3580287215	4	4	OPC 41061;OPC-41061;7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine;tolvaptan;TOLVAPTAN;Tolvaptan;7-CHLORO-5-HYDROXY-1-(2-METHYL-4-(2-METHYLBENZOYLAMINO)BENZOYL)-2,3,4,5-TETRAHYDRO-1H-BENZAPINE, DL-;CIPLUS_789421;tolvaptanum;	0	-1.74992668			554	AVPR2	Cc1ccccc1C(=O)Nc2ccc(c(C)c2)C(=O)N4CCCC(O)c3cc(Cl)ccc34	Pharmaron	PH-NIH-116369	-5.17849074	-0.22225246	-0.95987264	-1.74992668												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346600-02	NCGC00346600-02	384568854		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	19057-60-4		2.8183829313	-5.55	-142.3631563627	-1.1	4		-96.4306660429	-99.95219428	0.0121180045	0.9999094185		PRDX1	C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5C/C=C6/C[C@H](CC[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O	Selleck	S2379	-3.01809955	-3.45385134	-82.31428183	-99.95219428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00242484-09	NCGC00242484-09	377020241		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1062169-56-5		0.7943282347	-6.1	-138.2504551871	-1.4	4		-39.6425410063	-49.01042165	0.2449323045	0.9611017958		MTOR	COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCN(CC4)C(=O)OC)C(=N2)N5CCOCC5	MedChem Express	HY-12034	-14.41176471	-34.92027846	-57.81172098	-49.01042165												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00161327-10	NCGC00161327-10	384568203		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	32222-06-3				10.5515455393	4	4		0	6.70388396				VDR	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-10002	-1.87660441	6.92552126	7.85766158	6.70388396												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347937-02	NCGC00347937-02	384568989		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	80306-38-3				-6.371261235	4	4		0	0.40557305				RARA	CC1=CC=C(C=C1)\C2=N\C3=CC=C(Cl)C=C3OC2	XcessBio	M60116-2s	-2.58475702	-2.16340922	2.05761317	0.40557305												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178869-11	Vidarabine	384568366	Adenosine Receptor Agonist; Anti-Herpes Simplex Virus Drug	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	5536-17-4				-1.9928710826	4	4		0	-3.46884245					NC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)C2=NC=N1	MedChem Express	HY-B0277	0.84093122	-1.84129195	-0.37279109	-3.46884245												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025125-23	NCGC00025125-23	384568052		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	64-86-8		0.5623413252	-6.25	-151.9771513748	-1.2	4		-59.554262592	-64.8	0.0101526089	0.9999364467		TUBB	COC/1=C/C=C2\C(=C/C1=O)[C@H](CCC3=CC(=C(OC)C(=C23)OC)OC)NC(C)=O	Microsource	01500205	-11.19144784	-44.32168669	-62.92965917	-64.8												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015207-24	NCGC00015207-24	384567823		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	73963-72-1				-20.3790715787	4	4		0	-4.68982036				PDE3A	O=C1CCC2=C(N1)C=CC(=C2)OCCCCC3=NN=N[N]3C4CCCCC4	MedChem Express	HY-17464	-5.11444287	-4.47452009	-0.98138748	-4.68982036												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015049-24	NCGC00015049-24	384567801		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	520-36-5		12.5892541179	-4.9	-22.0345006404	4	4		-18.7487236639	-18.55329341	0.1109049007	0.992371101		CYP2C9	OC1=CC=C(C=C1)\C2=C\C(=O)C3=C(O2)C=C(O)C=C3O	APExBIO	N1828	-2.3997516	-2.07153708	-0.84602369	-18.55329341												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00532324-01	NCGC00532324-01	384569538		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1476074-39-1				-15.5282188053	4	4		0	1.13493651				PRKDC	CNC(=O)C1=CC=NC2=C(C=CC=C12)[C@H](C)CNC3=NC=NC(=C3)C4=C(N=C(C)N=C4[2H])[2H]	Astatech	41568	-2.48984637	-8.59778927	-5.7353217	1.13493651												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481653-02	NCGC00481653-02	363681127		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1608125-21-8		3.9810717055	-5.4	-27.2828768161	4	4		-11.931798516	-13.69316543	0.4632102415	0.8401336374		PIK3CD	C[C@H](NC1=C2N=C[NH]C2=NC=N1)C3=CC4=CC=C(F)C=C4N=C3C5=NC=CC=C5	MedChem Express	HY-12948	-4.79010163	1.25400458	-8.14447923	-13.69316543												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00164574-14	NCGC00164574-14	363676637		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	183319-69-9		8.9125093813	-5.05	-99.7611630981	-2.2	4		-89.7900582272	-72.78898556	0.0101425871	0.9999365609		EGFR	COCCOC1=CC2=NC=NC(=C2C=C1OCCOC)NC3=CC=CC(=C3)C#C	ChemieTek	CT-EL002	-6.90950226	-10.1369863	-29.51094593	-72.78898556												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00168759-10	NCGC00168759-10	363676681		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	775304-57-9		10	-5	-26.0720808817	4	4		-12.02770674	-11.3035595	0.576043798	0.720095215		CFTR	OC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C3=CC=CC=C3F	MedChem Express	HY-14832	-5.81570328	-0.03047055	-3.93609296	-11.3035595												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183285-06	NCGC00183285-06	384568418		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	641571-10-0				9.0064260725	4	4		0	1.3748503				ABL1	CC1=C[N](C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC(=C(C)C=C3)NC4=NC(=CC=N4)C5=CC=CN=C5)C(F)(F)F	Selleck	S1033	3.57079489	1.37181789	-3.00217549	1.3748503												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250381-02	NCGC00250381-02	174006473		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	915720-21-7	 AZ-23;AZ-23	2.8183829313	-5.55	-119.6245080311	-2.2	4		-62.832403701	-70.71137725	0.0128821621	0.9998976577	4914	NTRK1	CC(C)OC1=CC(=N[NH]1)NC2=C(Cl)C=NC(=N2)N[C@@H](C)C3=CC=C(F)C=N3	Axon Medchem	1610	-8.56547197	-13.43276711	-50.80493111	-70.71137725												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510504-01	NCGC00510504-01	384569465		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1450824-22-2				-19.094143591	4	4		0	-4.47467077					OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)[N]3C=C(N=N3)C4=CC=CC(=C4)F)[C@H](O)[C@H]([C@H]1O)[N]5C=C(N=N5)C6=CC=CC(=C6)F	MedChem Express	HY-19940	-3.52629253	-7.09382151	-2.55595533	-4.47467077												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386309-03	NCGC00386309-03	384569122		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	[1214265-58-3]		11.220184543	-4.95	-99.5345769018	-2.1	4		-112.0439383888	-99.7548784	0.0360363161	0.999198218		NUAK	CCC(=O)NC1=CC=CC(=C1)OC2=NC(=NC=C2Cl)NC3=C(OC)C=C(C=C3)N4CCN(C)CC4	Tocris	5177	-4.4719399	-7.68878719	-11.70506051	-99.7548784												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00274067-09	NCGC00274067-09	384568712		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox			5.6234132519	-5.25	-86.8211322943	-2.1	4		-93.7993589451	-85.91101192	0.0142333516	0.9998750384		MPL	CC1=CC=C(C=C1C)N2/N=C(C)\C(=N/NC3=CC=CC(=C3O)C4=CC=CC(=C4)C(O)=O)C2=O	Bio Vision	9489-5	0.27218052	-2.05827197	-31.28240741	-85.91101192												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345833-01	NCGC00345833-01	174006422		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1072959-67-1	SR3677	7.0794578438	-5.15	-66.5272538299	4	4		-22.25902158	-28.6813239	0.0188856885	0.9997809163	9475	ROCK2	CN(C)CCOC1=CC(=CC=C1NC(=O)C2COC3=CC=CC=C3O2)C4=C[NH]N=C4	SynKinase	SYN-1083	-10.13213925	-10.85852811	-16.63425926	-28.6813239												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378390-01	NCGC00378390-01	384569048		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox					-29.4136953149	4	4		0	-4.36587461				LIMK1	CN(CC1=CC=CC=C1)C(=O)C2=CC=C(C=C2)[S+]([O-])(=O)NC3=CC=CC=C3	NCGCChem	DYD022-031	-7.40019474	-7.18669743	-3.19051077	-4.36587461												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263089-07	NCGC00263089-07	363677197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	722544-51-6				-31.9202404816	4	4		0	-11.89521901				AURKB	CCN(CCO)CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=N[NH]C(=C3)CC(=O)NC4=CC(=CC=C4)F	ChemieTek	CT-A1152H	-4.51447287	-7.73516737	-8.71943839	-11.89521901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178520-13	NCGC00178520-13	384568357		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	611-75-6				-15.8302350389	4	4		0	2.98215479					CN(CC1=C(N)C(=CC(=C1)Br)Br)C2CCCCC2	MedChem Express	HY-B0372A	-5.51473843	-3.66081922	-2.02856451	2.98215479												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263218-08	NCGC00263218-08	384568672		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	163451-81-8				-23.6984283783	4	4		0	-7.8236197				DHODH	C\C(O)=C(C#N)\C(=O)NC1=CC=C(C=C1)C(F)(F)F	MedChem Express	HY-15405	-3.86720819	-6.19094313	-5.21947102	-7.8236197												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00379063-04	NCGC00379063-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	175414-77-4 		1.995262315	-5.7	-58.9305293023	-2.4	4		-30.912442252	-28.21526583	0.0172370078	0.9998172293			CN[C@H]1CN(C[C@@H]1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(O)=O	Chemscene	CS-0790	-4.53823062	-8.92761633	-18.43462765	-28.21526583												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00159541-03	NCGC00159541-03	384568185		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[2799-07-7]				-13.7776507131	4	4		0	-7.84222522				KIF11	N[C@H](CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C(O)=O	Tocris	2191	-0.22073106	-5.47780353	-5.04126805	-7.84222522												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00094763-03	NCGC00094763-03	174006989		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1405-20-5	; ; polymyxin B(1);POLYMYXIN B SULFATE;Polymyxin B sulphate; Polymycin B sulfate			-10.5234070982	4	4		0	0.07442207					CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)NC([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)C(NC(=O)[C@@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O	TCI	P1923	-2.94013774	-4.77357818	0.37985369	0.07442207												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015754-17	NCGC00015754-17	384567887		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	[63612-50-0]				-5.9756127682	4	4		0	1.04190893				AR	CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O	Tocris	1759	-0.37082818	-4.70226422	-3.60626524	1.04190893												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181349-02	Ranelic acid distrontium salt	225144325	Calcium-Sensing Receptor (CaSR) Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	135459-87-9	Strontium Ranelate;3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; Strontium ranelate heptahydrate; 			-16.091160161	4	4		0	-3.73970882			846	CASR	O.O.O.O.O.O.O.[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(=C(S1)C([O-])=O)CC([O-])=O	APAC	825889	-2.65760198	-5.76305937	-3.54999062	-3.73970882												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263202-06	NCGC00263202-06	384568661		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1092499-93-8		10	-5	-80.8600773476	-3	4		-108.9173137278	-99.54888646	0.017444057	0.9998122751		JAK2	FC1=CC(=CC(=C1CN2CCOCC2)F)C3=C4N=C(C=NC4=CC=C3)C5=C[N](N=C5)C6CCNCC6	APExBIO	A3675	-0.40388077	-1.91190596	-5.84722222	-99.54888646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346624-10	NCGC00346624-10	384568864		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1166227-08-2				-23.1144659104	4	4		0	-11.07180419				PIK3CA	CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(N)=O)C3=CSC(=N3)C(C)(C)C	MedChem Express	HY-13261	-3.42533937	-4.45991466	-4.2559942	-11.07180419												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346456-07	NCGC00346456-07	384568781		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	441798-33-0		0.4466835922	-6.35	-3.880915756	4	4		12.9173674439	5.95953812	0.3000093427	0.9410325728		EDNRA	CCCN[S+]([O-])(=O)NC1=NC=NC(=C1C2=CC=C(Br)C=C2)OCCOC3=NC=C(Br)C=N3	MedChem Express	HY-14184	-4.51447287	1.74552736	2.82256112	5.95953812												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345804-10	NCGC00345804-10	363677367		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	606143-89-9		5.6234132519	-5.25	-67.3305884488	4	4		-18.4905747119	-23.73652695	0.053920119	0.9982209443		MAP2K1	C[N]1C=NC2=C(F)C(=C(C=C12)C(=O)NOCCO)NC3=CC=C(Br)C=C3F	Glixx	GLXC-04704	-10.82771469	-13.5156286	-17.87285473	-23.73652695												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263112-02	NCGC00263112-02	384568598		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	929095-18-1		10	-5	-209.2395484309	-2.3	4		-101.2047992517	-99.73173653	0.3590299528	0.9109974166		PLK1	C[C@@H](OC1=C(SC(=C1)[N]2C=NC3=C2C=C(CN4CCN(C)CC4)C=C3)C(N)=O)C5=CC=CC=C5C(F)(F)F	Selleck	S2193	-24.53424414	-50.46264328	-52.61300459	-99.73173653												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346453-03	NCGC00346453-03	363677410		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1001350-96-4				-24.7217724259	4	4		0	-3.68383234				IGFR1	C[C@]1(CCCN1C2=N[N]3C=CC=C3C(=N2)NC4=N[NH]C(=C4)C5CC5)C(=O)NC6=CN=C(F)C=C6	ChemieTek	CT-BMS75	-6.93310859	-5.31234176	-0.78801064	-3.68383234												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510200-01	NCGC00510200-01	384569415		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1263131-92-5		15.8489319246	-4.8	-27.1419723072	4	4		-20.430299404	-17.44191617	0.5069643544	0.7988589817		SHH	COC1=C(OC)C(=CC(=C1)C(=O)NC(=N)NC2=CC=C(C)C(=C2)NC(=O)C3=CC=C(C=C3)C4=CC=CC=C4)OC	Glixx	GLXC-90537	-5.53140525	-3.54463012	3.57263718	-17.44191617												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165740-14	NCGC00165740-14	384568277		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	86541-74-4				-13.8166221047	4	4		0	-3.11505769				ACE	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=C(C=CC=C3)N(CC(O)=O)C2=O	MedChem Express	HY-B0093A	-2.66912507	-4.97644422	-1.70833333	-3.11505769												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263088-02	NCGC00263088-02	384568582		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[853910-02-8]		0.2511886432	-6.6	-150.8497836402	-1.4	4		-43.5863279616	-48.61841476	0.183773925	0.9785924364		PIK3CA	CC1=NC2=CN=C3C=CC(=CC3=C2[N]1C4=CC=C(C=C4)C(C)(C)C#N)C#CC5=CN=CC=C5	Tocris	3606	-15.76923077	-51.1161015	-55.10130082	-48.61841476												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015622-10	NCGC00015622-10	384567876		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[934389-88-5]		8.9125093813	-5.05	-45.4034193286	4	4		-22.1551707479	-25.63698826	0.0243024251	0.9996368711		PIK3CA	O=C1\C=C(/OC2=C1C=CC=C2C3=CC=CC=C3)N4CCOCC4	Tocris	1130	-6.27600248	-5.92434597	-8.69038974	-25.63698826												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263178-03	NCGC00263178-03	384568647		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	1291074-87-7		5.6234132519	-5.25	-120.128566063	-2.3	4		-94.8454543614	-87.85666571	0.2376038614	0.9634827646		AURKA	CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)\C=C\C4=CC=CC=C4	Selleck	S1181	-4.42595379	-23.20550211	-38.54272573	-87.85666571												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250383-02	NCGC00250383-02	363677177		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	626221-47-4		15.8489319246	-4.8	-5.4460881786	4	4		-11.153914136	-7.62826178	0.5169690828	0.7903799024		ERN1	CC1=CSC(=N1)NC(=O)C2=C(N)C3=C(S2)N=C4CCCC4=C3C(F)(F)F	Axon Medchem	1656	-1.23609394	0.63736851	4.24404427	-7.62826178												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346541-04	NCGC00346541-04	384568827		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	1349796-36-6		12.5892541179	-4.9	-35.4155942931	-3	4		-36.49060222	-32.66198428	0.1070752352	0.9928715567		MTOR	COC1=CC(=CC(=C1)NC2=NC3=CC=CC=C3N=C2N[S+]([O-])(=O)C4=CC=C(NC(=O)C5=CC=C(C)C(=C5)OC)C=C4)OC	APExBIO	A5634	-1.83648243	-4.84489214	-4.18776965	-32.66198428												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346484-04	NCGC00346484-04	384568794		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	(475110-96-4)		0.316227766	-6.5	-192.5862593718	-1.2	4		-68.8115510133	-69.65905391	0.0350795178	0.9992406337		PIK3CA	FC(F)C1=NC2=C(C=CC=C2)[N]1C3=NC(=NC(=N3)N4CCOCC4)N5CCOCC5	SynKinase	SYN-1099	-20.91647537	-55.30843288	-69.31626337	-69.65905391												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015718-24	NCGC00015718-24	384567884		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	57149-07-2		15.8489319246	-4.8	-26.8819547059	4	4		-13.347488924	-13.53340614	0.5983773604	0.6881240575		ADRA1A	COC1=C(C=CC=C1)N2CCN(CC2)CC(O)COC3=C4C=CC=CC4=CC=C3	MedChem Express	HY-B0391	-2.82716537	-8.60815076	-5.05092593	-13.53340614												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160515-01	NCGC00160515-01	29216197		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	56180-94-0	; Lasa Brand of Acarbose; Glucobay; Glumida; Bayer Brand of Acarbose; Precose;ACARBOSE; Prandase;Acarbose; Glucor; Acarbosa			5.7879860082	4	4	Bayer Brand of Acarbose;Precose;acarbose;acarbose 7-phosphotransferase;CIPLUS_182443;D-glucose, O-4,6-dideoxy-4-(((1S-(1 alpha,4 alpha,5 beta,6 alpha))-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyr anosyl-(1-4)-;Bay g 5421;HS_1150;NCGC00096061-02;LS-71702;component C, acarbose byproduct;ACARBOSE;acarbose kinase;BAY G 5421;Glucobay;O-4,6-Dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-a-D-glucopyranosyl-(1-4)-O-a-D-glucopyranosyl-(1-4)-D-Glucose;acarbose byproduct, component C;Lasa Brand of Acarbose;O-4,6-DIDEOXY-4-(((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-D-GLUCOPYRANOSYL-(1,4)-O-D-GLUCOPYRANOSYL-(1,4)-D-GLUCOPYRANOSE;NCGC00096061-01;Glucor;acarbose 7-phosphate;Acarbosa;Prandase;WHO NO. 4527;Acarbose;acarbosum;Acarbosum;acarbose-7-phosphate;Glumida;	0	-0.11396553			2548	GAA	[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O[C@]3([H])[C@@]([H])(CO)OC(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]4([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]4([H])O	InterBioScreen	BB_NC-1311	2.54620484	-0.25614051	-0.64351852	-0.11396553												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510704-01	NCGC00510704-01	384569487		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1951483-29-6		4.4668359215	-5.35	-40.5265825883	4	4		-17.71636456	-21.15881059	0.0122224972	0.9999083595		ERK	C[N]1N=CC=C1NC2=NC=CC(=N2)C3=CC4=C(S3)C(C)(C)N(CCN5CCOCC5)C4=O	MedChem Express	HY-101494	-4.72850679	-5.4749607	-12.60481349	-21.15881059												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00347910-01	NCGC00347910-01	174006383		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	926319-75-7	CK59			-10.5637492882	4	4		0	3.5642714			10645	CAMKK2	CC(C)[N]1C=NC2=C(NCCCCCCNC(=O)OC(C)(C)C)N=C(NCCO)N=C12	EMD Chemicals	208922	-5.21377357	-0.75305794	0.87630114	3.5642714												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345818-01	NCGC00345818-01	174006826		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	192939-46-1	Ximelagatran			-14.5401388314	4	4		0	-0.04294303					CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)N(C)C3=CC=C(C=C3)\C(N)=N\O	SantaCruz Bio	sc-208491 	-4.8951049	-2.70317329	-0.1694505	-0.04294303												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167453-04	NCGC00167453-04	384568314		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	30299-08-2				-9.9737372004	4	4		0	0.98923901					CCC(C)(OC1=CC=C(C=C1)C2(CCCCC2)C3=CC=C(OC(C)(CC)C(O)=O)C=C3)C(O)=O	APExBIO	B2217	-2.14743301	-2.98427208	-4.49734159	0.98923901												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00178529-07	NCGC00178529-07	384568358		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	100986-85-4				-20.972269065	4	4		0	-3.98158054				TOP2B	C[C@H]1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0330	-5.2004238	-4.59529328	-2.15250422	-3.98158054												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346524-02	NCGC00346524-02	384568818		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	65101-87-3		1.2589254118	-5.9	-260.5162326741	-1.2	4		-74.3759910226	-99.71626587	0.0353101704	0.9992303849			CO[C@H]1CCC(O[C@@H]1C)O[C@H]2C[C@@H](O[C@]3(O[C@H](C[C@@H]3C)[C@H]4O[C@@](O)(CO)[C@H](C)C[C@@H]4C)[C@@H]2C)[C@]5(C)CC[C@]6(C[C@H](O)[C@@H](C)[C@H](O6)[C@@H](C)\C=C(/C)C(=O)[C@H](C)C[C@H](C)C([O-])=O)O5	Selleck	S1450	-33.2774148	-54.55072205	-89.95966986	-99.71626587												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346628-05	NCGC00346628-05	384568867		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1234703-40-2		12.5892541179	-4.9	-66.8645601559	-3	4		-81.9130063193	-77.11667221	0.0777418039	0.9962541467		GCK	[O-][S+](=O)(C1CC1)C2=CC=C(C=C2)[C@]3(C[C@H]3C4CCCCC4)C(=O)NC5=NC=C(SCCN6CCCC6)S5	MedChem Express	HY-13529	-2.3179244	-5.01303572	0.28240741	-77.11667221												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346566-10	Roflumilast	384568843	Phosphodiesterase IIII (PDE4) Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	162401-32-3				-13.7547866286	4	4		0	-6.58150909				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	MedChem Express	HY-15455	-2.34426445	-1.7106527	-2.36574074	-6.58150909												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015444-10	NCGC00015444-10	384567848		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	67227-56-9				-11.6213856559	4	4		0	1.0161926				DRD1	OC1=CC=C(C=C1)C2CNCCC3=C2C=C(O)C(=C3Cl)O	Prestwick	Prestw-1713	-4.47780851	-0.96967479	-0.38425926	1.0161926												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00092314-06	NCGC00092314-06	363676559		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	35943-35-2				-4.6425912886	4	4		0	3.89382212				AKT1	CN1\N=C(N)/C2=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C4=C2C1=NC=N4	Selleck	S1117	-2.37938452	-2.50651786	0.39351852	3.89382212												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480828-04	NCGC00480828-04	363681111		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1431326-61-2				2.3520143938	4	4		0	1.44356332				KDM1A	NC1CCC(CC1)N[C@@H]2C[C@H]2C3=CC=CC=C3	Selleck	S7795	-0.30730058	4.21717056	-1.27314815	1.44356332												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386313-08	NCGC00386313-08	384569124		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1232416-25-9		12.5892541179	-4.9	-18.153284608	4	4		-16.045597076	-13.05854979	0.0738674253	0.9966560464		ATR	CNCC1=CC=C(C=C1)C2=NOC(=C2)C3=C(N)N=CC(=N3)C4=CC=C(C=C4)[S+]([O-])(=O)C(C)C	ActiveBioChem	A-1613	-2.06330392	-1.35388556	-3.11574074	-13.05854979												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345783-02	NCGC00345783-02	384568739		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	58053-83-1				-31.7802609805	4	4		0	-12.21330548				PIK3CA	COC[C@H]1OC(=O)C2=COC3=C2[C@@]1(C)\C4=C(\[C@@H]5CC[C@H](O)[C@@]5(C)C[C@H]4OC(C)=O)C3=O	Chemdea	CD0278	-5.06606963	-7.15363857	-6.74537037	-12.21330548												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025072-08	NCGC00025072-08	384568046		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[300576-59-4]				-10.1370717475	4	4		0	2.9448322				DRD2	CCCN1CCO[C@H]2[C@H]1COC3=CC=C(O)C=C23	Tocris	1243	-3.91402715	0.8129351	-4.16534469	2.9448322												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015245-12	NCGC00015245-12	384567831		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	590-63-6				-10.6602197745	4	4		0	-0.42069031					CC(C[N+](C)(C)C)OC(N)=O	Selleck	S2455	-2.60180995	-1.74713676	-3.54892807	-0.42069031												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249389-22	NCGC00249389-22	384568524		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1062368-62-0		1.5848931925	-5.8	-158.8992667005	-1.1	4		-95.901654295	-99.70360455	0.0101908951	0.9999359392		ACVR1	C1CN(CCN1)C2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC6=C5C=CC=C6	MedChem Express	HY-12071A	-3.75113122	-7.70267236	-99.31106377	-99.70360455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00018238-11	NCGC00018238-11	384567998		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	20559-55-1		0.2238721139	-6.65	-118.2377698894	4	4		-20.3379788544	-37.33657792	0.4071314099	0.8818757639			CCCOC1=CC=C2[NH]C(=NC2=C1)NC(=O)OC	Prestwick	Prestw-1460	-17.28777552	-35.9770165	-30.09924958	-37.33657792												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00160338-03	Oxymatrine			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	16837-52-8				-17.7841108966	4	4		0	-3.03527482					[O-][N@+]12CCC[C@@H]3C[N@@]4[C@H](CCCC4=O)[C@H](CCC1)[C@H]23	Selleck	S2338	-3.36551475	-6.16570328	-3.7364031	-3.03527482												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165811-08	NCGC00165811-08	384568285		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-6_Tox	978-62-1		0.4466835922	-6.35	-203.308301205	-1.3	4		-91.9749265697	-96.27424531	0.0947313218	0.9944242779		IKBKB	OC1=C(C=C(Cl)C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F	Adooq	A12837	-6.20695744	-76.74719201	-88.49652973	-96.27424531												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181159-03	Trabectedin	384568393	DNA-Damaging Drug	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	114899-77-3		0.0354813389	-7.4499999999	-401.5854276427	5	4		-52.1087914134	-97.48800988	0.0238532982	0.9996494949		H2AFX	COC1=CC2=C(CCN[C@]23CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=C6C(=C(OC)C(=C7)C)O)[C@H](O)N5[C@@H](COC3=O)C8=C4C(=C(C)C9=C8OCO9)OC(C)=O)C=C1O	MedChem Express	HY-50936	-68.92313095	-93.21685039	-96.70833333	-97.48800988												3.2E-8	1.6E-7	8E-7	0.000004											
NCGC00346497-03	NCGC00346497-03	384568803		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1214265-57-2		11.220184543	-4.95	-121.9923661804	-2.1	4		-117.8374975899	-99.75782326	0.0424853005	0.9988851315		EGFR	CN1CCN(CC1)C2=CC=C(NC3=NC=C(Cl)C(=N3)SC4=CC(=CC=C4)NC(=O)C=C)C=C2	APExBIO	A1393	-8.54295623	-12.59662443	-24.05092593	-99.75782326												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00378941-04	NCGC00378941-04	384569076		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	329773-35-5				0.2592802706	4	4		0	2.67818985				GUCY1A2	OC(=O)CCCCN(CCC1=C(OCC2=CC=C(CCC3=CC=CC=C3)C=C2)C=CC=C1)CC4=CC=C(C=C4)C(O)=O	MedChem Express	HY-14181	-0.60582115	0.53057677	-0.81018519	2.67818985												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00163547-01	NCGC00163547-01	26756928		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	3604-87-3	ECDYSONE;Ecdysone			-15.8289434847	4	4	Ecdysone;NCGC00163547-01;alpha-Ecdysone;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2beta,3beta,5beta,22R)-;CIPLUS_774291;ECDYSONE;2 beta, 3 beta, 14, 22 S, 25-pentahydroxy-5 beta- cholest-7-en-6-one;CIPLUS_162150;2beta,3beta,14alpha,22(R),25-Pentahydroxy-7-cholesten-6-one;22-iso-ecdysone;	0	-1.21563227					[H][C@]12CC[C@]3(C)C(CC[C@@]3(O)C1=CC(=O)[C@]4([H])C[C@@H](O)[C@@H](O)C[C@]24C)[C@H](C)[C@H](O)CCC(C)(C)O	BIOMOL	BIOMOL_NP-089	-4.44268844	-3.07368614	-2.04166667	-1.21563227												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346615-02	NCGC00346615-02	384568859		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	[1784-03-8]				2.5629796098	4	4		0	1.60627211				ANAPC1	COC(=O)[C@H](CCCNC(N)=N)N[S+]([O-])(=O)C1=CC=C(C)C=C1	Tocris	4506	0.00452489	1.78306759	0.14957168	1.60627211												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00387263-04	NCGC00387263-04	384569156		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox					-21.8494731923	4	4		0	-5.64107467				NRF2	C\C1=C(\SSC1=S)C2=CN=CC=N2	APExBIO	B5958	-4.71945701	-3.05861217	-4.92680053	-5.64107467												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183878-01	NCGC00183878-01	124894594		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	74711-43-6	Zaltoprofen			-14.7470826795	4	4	CN 100;Zaltoprofenum;Zaltoprofen;CIPLUS_691922;CIPLUS_3889078;CN-100;Peon;10,11-dihydro-alpha-methyl-10-oxodibenzo(b,f)thiepin-2-acetic acid;zaltoprofenum;Zaltoprofeno;LS-61331;zaltoprofene;ZALTOPROFEN;Zaltoprofene;	0	0.21471514			5742	PTGS1	O=C(O)C(C)c1cc2CC(=O)c3ccccc3Sc2cc1	Toronto Research	Z146000	-4.38169426	-2.2939973	-3.02590172	0.21471514												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346875-02	NCGC00346875-02	384568953		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	2870		14.1253754462	-4.85	-20.338423575	4	4		-11.312744296	-11.09395358	0.5248296188	0.7816064844		NOTCH1	C[C@@H](N(C1=CC(=CC=C1F)F)[S+]([O-])(=O)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3CCCC(O)=O	Tocris	2870	-4.61066498	-1.87301161	1.48285449	-11.09395358												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00167466-04	NCGC00167466-04	384568316		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	13010-47-4				-15.8578543232	4	4		0	-3.69155045					ClCCN(N=O)C(=O)NC1CCCCC1	Selleck	S1840	-3.36551475	-4.22995922	-2.21452612	-3.69155045												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263192-04	Silmitasertib	384568656	Casein Kinase 2 Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1009820-21-6 (parent)		8.9125093813	-5.05	-80.1312714637	-2.1	4		-100.9354099264	-88.97842976	0.0446646787	0.9987676285		CSNK2A1	OC(=O)C1=CC2=C(C=C1)C3=CN=CC=C3C(=N2)NC4=CC=CC(=C4)Cl	Axon Medchem	1965	-1.93990797	1.30841959	-13.71640408	-88.97842976												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346839-01	NCGC00346839-01	174006584		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	15018-66-3	4-Quinazolinamine			-25.0494292806	4	4		0	-7.08930116			1956	EGFR	NC1=C2C=CC=CC2=NC=N1	SIGMA	CBR00181	-4.41007512	-4.41189931	-7.73328349	-7.08930116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510501-01	NCGC00510501-01	384569462		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1633350-06-7		11.220184543	-4.95	-61.1275969413	-3	4		-57.7966815883	-52.18206287	0.0654575328	0.9973493466		BTK	NC(=O)C1=C2NCCC(C3CCN(CC3)C(=O)C=C)[N]2N=C1C4=CC=C(OC5=CC=CC=C5)C=C4	MedChem Express	HY-101474	-4.12726469	-7.0389016	-9.53693753	-52.18206287												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181336-01	NCGC00181336-01	144206348		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	21679-14-1	 ; Fludarabine des-phosphate; Fludarabine;fludarabine; F-ara-A;2-Fluoroadenosine; Fludara; Fludarabine Base			-11.3376838152	4	4	2-fluoroadenosine;2-fluoroadenine arabinoside;FLUDARABINE;9-beta-D-Arabinofuranosyl-2-fluoroadenine;9-.BETA.-D-ARABINOFURANOSYL-2-FLUOROADENINE;2-FLUOROADENOSINE;Fludara;fludarabine;2-Fluoroadenosine;CIPLUS_152133;CIPLUS_172834;9h-purin-6-amine, 9-beta-d-arabinofuranosyl-2-fluoro- (9ci);Fludarabine Base;Fludarabine des-phosphate;F-ara-A;NSC-312887;2-FLUORO-ARA AMP;2-Fluoroadenine-9-beta-D-arabinofuranoside;FLUDARABINE PHOSPHATE SODIUM;LS-15061;2-FLUORO-9-(5-O-PHOSPHONO-BETA-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE;9-beta-D-arabinofuranosyl-2-fluoroadenine;2-Fluoroadenosine(Fludarabine Intermediate);FLUDARABINE PHOSPHATE;Fludarabine;9-D-arubinofuranosyl-2-fluoro-9H-purin-6-amine;9H-purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-;fludarabinum;2-FLUORO-ADENINE ARABINOSIDE-5-PHOSPHATE;	0	-5.17257864			5539	PNP	Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	SIGMA	F2773	-2.45701357	-0.03143948	-1.68154829	-5.17257864												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346647-03	NCGC00346647-03	384568878		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	1116235-97-2		12.5892541179	-4.9	-96.4103727673	-3	4		-110.1286375898	-99.74184913	0.0262825376	0.9995737185		IGFR1	CNC(=O)C1=C(F)C=CC=C1NC2=C3C=C[NH]C3=NC(=N2)NC4=C(OC)C=C5CCN(C(=O)CN(C)C)C5=C4	Selleck	S2703	-5.9321267	-3.56164384	-6.04178942	-99.74184913												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00241112-04	NCGC00241112-04	384568477		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	[215303-72-3]				-35.9507599485	4	4		0	-3.84101536				MAPK14	OCCC#CC1=NC(=C([N]1CCCC2=CC=CC=C2)C3=CC=NC=C3)C4=CC=C(F)C=C4	Tocris	2999	-8.48897937	-9.77234144	-6.54078916	-3.84101536												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00142400-07	NCGC00142400-07	384568162		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	474-25-9				-23.9998949852	4	4		0	-4.45176066				NR14H	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Selleck	S1843	-5.42621935	-8.18787272	-1.56378601	-4.45176066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346743-03	Givinostat hydrochloride	384568939	HDAC Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox			1.1220184543	-5.95	-194.8031467988	-1.1	4		-87.4600857968	-99.68151329	0.0180671356	0.999798625		HDAC1	CCN(CC)CC1=CC2=C(C=C1)C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=C2	Bio Vision	9431-5	-12.3522512	-29.05408433	-97.92693039	-99.68151329												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345792-02	NCGC00345792-02	363677355		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	906673-24-3		14.1253754462	-4.85	-22.1452534846	4	4		-21.355764132	-19.04647011	0.2546405109	0.9579081136		PDE4A	OB1OCC2=CC(=CC=C12)OC3=CC=C(C=C3)C#N	ChemieTek	CT-AN2728	-2.91437336	-2.03432361	1.36578703	-19.04647011												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00485481-02	NCGC00485481-02	384569275		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	913064-47-8		12.5892541179	-4.9	-84.1926401573	-3	4		-97.6271421733	-92.56464481	0.0346907414	0.9992570442		BDKRB1	ClC1=C2C(=CC=C1)CN(C3=CC=CC(=C3)C(=O)N4CCC5(CCN(CC5)C6=CC=NC=C6)CC4)C2=O	MedChem Express	HY-15043	-3.34069819	-5.78489703	-3.48114574	-92.56464481												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00510479-01	NCGC00510479-01	384569442		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1365267-27-1		10	-5	-75.6170001359	-2.1	4		-97.3989577979	-82.11573585	0.0096054294	0.9999430951		ALK	C[C@@H](OC1=CC(=NN=C1N)C(=O)NC2=CC=C(C=C2)C(=O)N3CCN(C)CC3)C4=C(Cl)C=CC(=C4Cl)F	MedChem Express	HY-16590	-1.66151127	-2.13272311	-12.1723284	-82.11573585												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00179619-17	NCGC00179619-17	384568380		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	114-07-8				-18.9916411801	4	4		0	-4.47467077					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	Selleck	S1635	-3.54396818	-5.9771167	-3.06060464	-4.47467077												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00510500-01	NCGC00510500-01	384569461		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1817626-54-2		7.0794578438	-5.15	-3.4482676593	4	4		-14.517398832	-10.84783236	0.3836496331	0.897278835			CC[C@H]1[C@@H](COC2=NC=CC3=CC(=C(OC)C=C23)C(N)=O)NC(=O)[C@H]1F	MedChem Express	HY-19836	0.14140521	5.53775744	0.61212093	-10.84783236												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00247866-05	NCGC00247866-05	384568517		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox		NCGC00247866-02; NCGC00247866-02			-16.5193493745	4	4		0	-1.120661			641	BLM	O=C(NC1=NN=C(S1)C2=CC=NC=C2)NC3=CC(=C(C=C3)C4=C[NH]N=C4)C#N	NCGCChem	DJM11-083	-5.05728961	-2.96391163	-0.99537037	-1.120661												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00017223-05	NCGC00017223-05	384567976		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	77-52-1				-5.6309264883	4	4		0	-1.11116387				STAT3	C[C@@H]1CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	Cayman	10072	-1.46626279	-1.75639208	0.24537037	-1.11116387												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00481572-02	NCGC00481572-02	377020298		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-8_Tox	1394076-92-6		1.4125375446	-5.85	-252.7372871168	-2.1	4		-106.1299713207	-92.95788024	0.0394641502	0.9990386064		MTOR	COC1(COC1)C2=C(C)C3=C(S2)C(=NC(=N3)C4=CN=C(N)N=C4)N5CCOCC5	MedChem Express	HY-12763	-36.5248694	-54.10968303	-74.63425926	-92.95788024												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346822-02	NCGC00346822-02	377020351		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	81267-65-4		8.9125093813	-5.05	-43.5991504452	-3	4		-69.8486471	-64.04053925	0.0961957195	0.9942498446		SPHK1	OC1=CC=C(C=C1)C/2=C/C3=C(OC2)C=C(O)C=C3	SIGMA	D7446	-0.01357466	6.13069841	0.02266238	-64.04053925												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015036-23	Amantadine hydrochloride	384567799	Dopamine Receptor Agonist	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-2_Tox	665-66-7				-10.9063981498	4	4		0	0.08605029				DRD1	NC12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0402A	-3.57013575	-1.37884572	-1.27362553	0.08605029												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00016024-05	NCGC00016024-05	90341784		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox		(?)-Taxifolin;Taxifolin (Dihydroquercetin)			-12.6438163656	4	4		0	-4.60444699				NFKB1	O[C@@H]1[C@H](OC2=C(C1=O)C(O)=CC(O)=C2)C3=CC(O)=C(O)C=C3	SigmaAldrich	Lopac-T-4512	-1.85004869	-3.91328951	-2.49334302	-4.60444699												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346545-08	Telaprevir (VX-950)	384568831	HCV NS3 NS4A Protease Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	402957-28-2				-12.5644585615	4	4		0	-0.18608646					CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	APExBIO	A4031	-3.08931575	-4.54881818	-1.94141854	-0.18608646												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250412-08	NCGC00250412-08	384568560		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	[1268524-70-4]		0.1	-7	-343.9531924611	5	4		-90.1979864144	-86.40158278	0.074529442	0.9965650889		BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	Tocris	4499	-61.69809618	-86.63350809	-87.65426077	-86.40158278												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390548-02	NCGC00390548-02	384569190		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1135237-88-5				-16.1389188463	4	4		0	-2.01225691					CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2=CN=C[NH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O	MedChem Express	HY-13541A	-3.92493007	-4.80351302	-1.79503439	-2.01225691												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475741-01	NCGC00475741-01	384569236		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1186231-83-3				-4.8724601613	4	4		0	3.01597259				SHH	CCC/1=C/C2=C(C(=O)N1CC(=O)C3=CC=CC=C3)C(=C([N]2C)C(=O)NC4CCN(CC4)C(=O)CO)OCC(F)(F)F	ActiveBioChem	A-1172	-3.45574303	1.54142582	0.88776157	3.01597259												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183656-11	NCGC00183656-11	363677096		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	488832-69-5				-28.7467926	4	4		0	-6.41316412				HSPA2	CN(NC(=O)CC(=O)NN(C)C(=S)C1=CC=CC=C1)C(=S)C2=CC=CC=C2	Selleck	S1052	-7.33555896	-6.30909172	-1.16091898	-6.41316412												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00351600-04	NCGC00351600-04	384569018		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1207456-01-6				-59.3976572313	4	4		0	-18.16821889				PARP1	C[N]1N=CN=C1[C@@H]2[C@H](NC3=CC(=CC4=C3\C2=N/NC4=O)F)C5=CC=C(F)C=C5	MedChem Express	HY-16106	-10.52963999	-11.0050634	-16.07726452	-18.16821889												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00262598-03	NCGC00262598-03	384568573		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	64228-81-5	Atracurium besylate			-8.478056216	4	4		0	-3.50379698					COC1=CC2=C(C=C1OC)C(CC3=CC(OC)=C(OC)C=C3)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=C(C=C(OC)C(OC)=C5)C4CC6=CC(OC)=C(OC)C=C6)CC2	Selleck	S2113	-1.66151127	-0.46681922	-1.84570814	-3.50379698												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00249417-03	NCGC00249417-03	384568527		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	254877-67-3		15.8489319246	-4.8	-16.665619818	4	4		-9.968134192	-8.72344516	0.6525860116	0.5937979361		GUCY1A2	[O-][S+](=O)(NC1=CC=C(Cl)C=C1C(=O)NC2=CC=C(C=C2)[S+]([O-])(=O)N3CCOCC3)C4=CC=C(Cl)S4	Cayman	16371	-4.14494034	-2.54462243	3.17274894	-8.72344516												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00229704-02	NCGC00229704-02	384568463		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	112887-68-0		0.1122018454	-6.95	-102.2332385495	4	4		-26.309133336	-28.10247044	0.0930782727	0.9946931048		TYMS	CN(CC1=CC2=C(N\C(=N/C2=O)C)C=C1)C3=CC=C(S3)C(=O)N[C@@H](CCC(O)=O)C(O)=O	DC Chemicals	DC8940	-17.42819266	-25.58352403	-26.95668427	-28.10247044												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346677-02	NCGC00346677-02	384568903		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-4_Tox	252935-94-7		3.1622776602	-5.5	-51.6878255379	4	4		-21.085062608	-25.40795877	0.0227831154	0.9996809612		GSK3B	NC1=NC(=CC=C1[N+]([O-])=O)NCCNC2=NC=C([N]3C=CN=C3)C(=N2)C4=CC=C(Cl)C=C4Cl	Selleck	S2745	-5.75373993	-8.00504941	-17.75357056	-25.40795877												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00386421-05	NCGC00386421-05	384569135		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1392136-43-4		11.220184543	-4.95	-155.0767820113	-2.3	4		-105.4526307872	-95.19041916	0.1781585083	0.9799003521		XPO1	FC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)C2=N[N](\C=C/C(=O)NNC3=CC=CC=N3)C=N2	Selleck	S7707_CM2	-14.74893542	-28.63324587	-37.55861736	-95.19041916												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165844-06	NCGC00165844-06	384568289		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox					-19.3331499151	4	4		0	-4.4502994					NC1=NC(=C(N=O)C(=N1)OCC2CCCCC2)N	SIGMA	N4411	-5.9394961	-2.93697924	1.73555717	-4.4502994												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00165873-03	NCGC00165873-03	384568293		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	[1049743-58-9]				-11.6169127783	4	4		0	-0.52215569				IKBKB	ClC1=CC2=C([NH]C3=C2C=CN=C3)C(=C1)NC(=O)C4=CC=CN=C4	Tocris	4569	-4.94588361	-1.94264144	2.04496012	-0.52215569												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263203-06	NCGC00263203-06	384568662		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	827318-97-8				-27.6434659766	4	4		0	-9.8251497				AURKA	CO[C@@H](C(=O)N1CC2=C(C1)C(=N[NH]2)NC(=O)C3=CC=C(C=C3)N4CCN(C)CC4)C5=CC=CC=C5	MedChem Express	HY-10179	-5.10557133	-3.25921834	-7.13077109	-9.8251497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181152-04	NCGC00181152-04			SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	95734-82-0				-24.3898108815	4	4		0	-3.66467066					O=C1C[O-][Pt++][O-]1	Selleck	S1826	-6.19677076	-3.34207982	-4.99395697	-3.66467066												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00509993-01	NCGC00509993-01	384569400		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	1401090-53-6		12.5892541179	-4.9	-31.4265719412	4	4		-15.393189976	-15.93772455	0.2844227819	0.9471656864		UGCG	CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)C3=CSC(=N3)C4=CC=C(F)C=C4	MedChem Express	HY-16743	-3.94339957	-6.94195093	-6.56997825	-15.93772455												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00162383-05	NCGC00162383-05	384568223		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1404-93-9				-5.3239742069	4	4		0	-2.11841915					CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=CC4=CC(=C3O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@H]6C[C@](C)(N)[C@H](O)[C@H](C)O6)OC7=C(Cl)C=C(C=C7)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C9=CC=C(O)C(=C9)C%10=C(C=C(O)C=C%10O)[C@H](NC8=O)C(O)=O)C(=C2)Cl	MedChem Express	HY-17362	-0.44211856	-2.64372451	-0.37071362	-2.11841915												8E-8	4E-7	0.000002	0.0000099999999999											
NCGC00263134-08	NCGC00263134-08	363677221		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1255517-76-0		8.9125093813	-5.05	-13.9083683352	4	4		-9.5795492959	-8.81629108	0.5309621747	0.7757449936		RPS6KB1	CCC1=C(N=CN=C1)N2CCN(CC2)CC3=NC4=C([NH]3)C=CC(=C4)C(F)(F)F	MedChem Express	HY-15773	-2.95046468	2.35694762	-2.04868055	-8.81629108												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346502-06	NCGC00346502-06	384568807		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	65928-58-7				-19.1872080526	4	4		0	-3.69537589				PGR	C[C@]12CCC\3=C\4CCC(=O)\C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	MedChem Express	HY-B0084	-4.25666516	-3.27028621	-4.67762326	-3.69537589												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00372956-01	NCGC00372956-01	384569045		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1223498-69-8		14.1253754462	-4.85	-16.0319373568	4	4		13.72580418	5.95366116	0.1587332457	0.9842823681		JAK2	C[C@@H](O)[C@@H](C)OC1=C(C=NC(=N1)NC2=CC=C(C=C2)[S+]([O-])(=N)C3CC3)C(F)(F)F	Adooq	A12742	-4.69046543	-5.72867057	-6.43817015	5.95366116												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346681-07	NCGC00346681-07	384568905		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1245537-68-1		1.2589254118	-5.9	-312.7052792249	-1.2	4		-49.9803182659	-99.98044775	0.0110673895	0.9999244711		PIK3CA	COC1=CC=C(C=N1)C2=CC=C3N=CC4=C(N(C(=O)N4C)C5=CC=C(N6CCNCC6)C(=C5)C(F)(F)F)C3=C2	APExBIO	A8488	-50.18526887	-57.29124144	-99.831437	-99.98044775												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00181131-08	NCGC00181131-08	384568392		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	152044-54-7		2.8183829313	-5.55	-204.0417849865	5	4		46.7990647016	-27.9010656	0.2301340203	0.9659708872		TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	MedChem Express	HY-17029	-50.21238138	-41.07134758	-37.56613757	-27.9010656												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00025001-03	NCGC00025001-03	384568042		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1104		12.5892541179	-4.9	-17.0771803874	4	4		-17.33326816	-16.1110568	0.2105681684	0.9717636507		ADORA3	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=C(Cl)N=C3NCC4=CC=CC(=C4)I	Tocris	1104	-2.03343877	-0.87540255	1.10034181	-16.1110568												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00250407-05	NCGC00250407-05	384568555		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	927880-90-8		14.1253754462	-4.85	-221.9121058469	-2.3	4		-76.1476855516	-99.2239521	0.1709239307	0.9815400173		BRAF	C[N]1C(=NC2=CC(=CC=C12)OC3=CC(=NC=C3)C4=NC(=C[NH]4)C(F)(F)F)NC5=CC=C(C=C5)C(F)(F)F	MedChem Express	HY-10248	-40.41430092	-29.65520416	-34.07783418	-99.2239521												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00024995-15	NCGC00024995-15	384568039		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-5_Tox	33069-62-4		1.4125375446	-5.85	-73.8431982893	-2.4	4		-58.3699161676	-50.34251497	0.3323899162	0.9250370699		TUBB	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)C2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)\C(=C1/C5(C)C)C	Selleck	S1150	1.36178141	-24.88606546	-31.90234469	-50.34251497												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345022-04	NCGC00345022-04	384568730		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox					-15.5724429332	4	4		0	-2.89050813					OC(=O)CCCCCC(=O)NN=C1CCCC1	Stemgent	04-0027	-3.24821799	-4.79455124	-2.52670601	-2.89050813												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00023673-18	NCGC00023673-18	384568019		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	58-61-7				-8.00071135	4	4		0	-3.56608599				ADORA1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-B0228	-0.93837409	-4.29269167	0.08780059	-3.56608599												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345798-03	NCGC00345798-03	384568747		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-3_Tox	1271022-90-2				-15.9988311511	4	4		0	-4.40573276				JAK2	CC[N]1C(=CC2=C3[N](C)C=NC3=C(NC4=N[N](C)C(=C4)C)N=C12)C(=O)N(C5CC5)C6CC6	ChemieTek	CT-BMS911_cm1	-3.01362447	-3.10973697	-4.05833862	-4.40573276												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346637-05	Odanacatib	384568871	Cathepsin K Inhibitor	SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	603139-19-1				-22.125675956	4	4		0	-7.3680669				CTSK	CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C2=CC=C(C=C2)[S+](C)([O-])=O)C(F)(F)F)C(=O)NC3(CC3)C#N	MedChem Express	HY-10042	-5.32037119	0.32951945	-4.66800617	-7.3680669												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263160-06	NCGC00263160-06	384568632		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	649735-46-6		5.6234132519	-5.25	-19.5446383766	4	4		-23.391473612	-19.07622801	0.1253668299	0.9902206433		KDR	C[C@@H](O)COC1=C[N]2N=CN=C(OC3=C(F)C4=C([NH]C(=C4)C)C=C3)C2=C1C	MedChem Express	HY-10337	0.9544852	-2.69107551	-8.35942246	-19.07622801												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00346703-08	NCGC00346703-08	384568922		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	262352-17-0				-32.5695483328	4	4		0	-13.29904835				CETP	CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C3=C1C=CC(=C3)C(F)(F)F	MedChem Express	HY-12089	-4.9138312	-6.73684211	-7.6865567	-13.29904835												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00390655-01	NCGC00390655-01	363680957		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	420126-30-3		10	-5	-221.8423478694	-2.3	4		-67.3141261612	-94.94857253	0.2263013192	0.9670279295			FC(F)(F)C1=CC=C(NC2=NC(=CS2)C3=C(N=C4C=CC=C[N]34)C(F)(F)F)C=C1	MedChem Express	HY-15961	-41.0251878	-27.63386728	-38.33932994	-94.94857253												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00507889-01	NCGC00507889-01	384569353		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1445993-26-9		1	-6	-431.0116883024	5	4		-13.107651284	-98.71671633	0.0304694816	0.9994352965		BRD4	CC[S+]([O-])(=O)NC1=CC(=C(OC2=C(F)C=C(F)C=C2)C=C1)\C3=C\N(C)C(=O)C4=C3C=C[NH]4	Selleck	S8400	-88.21034026	-92.05491991	-96.75716088	-98.71671633												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00015888-06	NCGC00015888-06	384567902		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	50-55-5		12.5892541179	-4.9	-20.6317400526	4	4		-20.215907768	-17.38440834	0.2238629219	0.9679476765			COC1C(CC2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)C3CC2C1C(=O)OC)OC(=O)C6=CC(=C(OC)C(=C6)OC)OC	APExBIO	N1867	-0.9544852	-4.14645309	-3.29423859	-17.38440834												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263143-07	NCGC00263143-07	384568618		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1134156-31-2		3.5481338923	-5.45	-19.1427631978	4	4		-9.5675286	-10.4729405	0.3349466931	0.9248151379		HSPA2	NC1=NC=NC2=C1N=C(NCC3=CC(=C(Cl)C=C3)Cl)[N]2[C@@H]4O[C@H](COCC5=CC=C(C=C5)C#N)[C@@H](O)[C@H]4O	DC Chemicals	DC8299	-2.6955369	0.42105263	-6.76136629	-10.4729405												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00345084-02	NCGC00345084-02	384568732		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-7_Tox	1132653-79-2				-8.9786353554	4	4		0	-3.73449966				SHH	ClC1=CC=C(CNC(=O)C[C@@H]2C\C=C/CCC(=O)O[C@@H](CNC2=O)C3=CC=CC=C3)C=C1	Cayman	13204	0.19443217	-5.46453089	-4.09793935	-3.73449966												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00183128-03	NCGC00183128-03	384568417		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1407-03-0				-17.8968836239	4	4		0	-0.35194056					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	APExBIO	B2155	-5.2869408	-4.51308568	-1.40000936	-0.35194056												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00371019-02	NCGC00371019-02	363677996		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	1078166-57-0				-24.2062303216	4	4		0	-1.24156809				PTGER2	COC1=CC=C2C=C(OCC3(CN(C3)C(=O)C4=CC=C(F)C=C4)C(O)=O)C=CC2=C1	Axon Medchem	2024	-6.81427926	-4.37701275	-4.03146509	-1.24156809												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00263119-07	NCGC00263119-07	384568603		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	169939-93-9		11.220184543	-4.95	-108.2804062355	-2.1	4		-99.4970273253	-99.75559683	0.0209092354	0.9997302622		PRKCB	CN(C)C[C@@H]1CC[N]2C=C(C3=C2C=CC=C3)C/4=C(/C(=O)NC4=O)C5=C[N](CCO1)C6=C5C=CC=C6	Bio Vision	2156	-7.78129236	-9.57499887	-10.24020228	-99.75559683												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00475733-01	NCGC00475733-01	384569233		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	289483-69-8				35.1227672578	4	4		0	6.50112425					CC1=CC=C(N[S+]([O-])(=O)C2=CC=CC(=C2)C#N)C3=C1C(=C[NH]3)C#N	ActiveBioChem	A-1283	5.90149119	13.2761827	8.46092616	6.50112425												1.6E-7	8E-7	0.000004	0.000019999999999											
NCGC00480786-02	NCGC00480786-02	384569245		SARS-CoV-2_CPE_SRI	2020_MIPE5.0-1_Tox	96187-53-0		0.3981071706	-6.4	-56.9673920657	4	4		-31.640118	-26.71815427	0.15830413	0.9842386287		DHODH	CC1=C(N=C2C=CC(=CC2=C1C(O)=O)F)C3=CC=C(C=C3)C4=CC=CC=C4F	DC Chemicals	DC9236	1.57252598	-27.30983807	-31.366765	-26.71815427												1.6E-7	8E-7	0.000004	0.000019999999999											